-- phpMyAdmin SQL Dump
-- version 5.1.0
-- https://www.phpmyadmin.net/
--
-- Host: localhost:8889
-- Generation Time: Apr 05, 2022 at 10:05 PM
-- Server version: 5.7.34
-- PHP Version: 7.4.21

SET SQL_MODE = "NO_AUTO_VALUE_ON_ZERO";
START TRANSACTION;
SET time_zone = "+00:00";


/*!40101 SET @OLD_CHARACTER_SET_CLIENT=@@CHARACTER_SET_CLIENT */;
/*!40101 SET @OLD_CHARACTER_SET_RESULTS=@@CHARACTER_SET_RESULTS */;
/*!40101 SET @OLD_COLLATION_CONNECTION=@@COLLATION_CONNECTION */;
/*!40101 SET NAMES utf8mb4 */;

--
-- Database: `urotec`
--

-- --------------------------------------------------------

--
-- Table structure for table `urotec_commentmeta`
--

CREATE TABLE `urotec_commentmeta` (
  `meta_id` bigint(20) UNSIGNED NOT NULL,
  `comment_id` bigint(20) UNSIGNED NOT NULL DEFAULT '0',
  `meta_key` varchar(255) COLLATE utf8mb4_unicode_520_ci DEFAULT NULL,
  `meta_value` longtext COLLATE utf8mb4_unicode_520_ci
) ENGINE=InnoDB DEFAULT CHARSET=utf8mb4 COLLATE=utf8mb4_unicode_520_ci;

-- --------------------------------------------------------

--
-- Table structure for table `urotec_comments`
--

CREATE TABLE `urotec_comments` (
  `comment_ID` bigint(20) UNSIGNED NOT NULL,
  `comment_post_ID` bigint(20) UNSIGNED NOT NULL DEFAULT '0',
  `comment_author` tinytext COLLATE utf8mb4_unicode_520_ci NOT NULL,
  `comment_author_email` varchar(100) COLLATE utf8mb4_unicode_520_ci NOT NULL DEFAULT '',
  `comment_author_url` varchar(200) COLLATE utf8mb4_unicode_520_ci NOT NULL DEFAULT '',
  `comment_author_IP` varchar(100) COLLATE utf8mb4_unicode_520_ci NOT NULL DEFAULT '',
  `comment_date` datetime NOT NULL DEFAULT '0000-00-00 00:00:00',
  `comment_date_gmt` datetime NOT NULL DEFAULT '0000-00-00 00:00:00',
  `comment_content` text COLLATE utf8mb4_unicode_520_ci NOT NULL,
  `comment_karma` int(11) NOT NULL DEFAULT '0',
  `comment_approved` varchar(20) COLLATE utf8mb4_unicode_520_ci NOT NULL DEFAULT '1',
  `comment_agent` varchar(255) COLLATE utf8mb4_unicode_520_ci NOT NULL DEFAULT '',
  `comment_type` varchar(20) COLLATE utf8mb4_unicode_520_ci NOT NULL DEFAULT 'comment',
  `comment_parent` bigint(20) UNSIGNED NOT NULL DEFAULT '0',
  `user_id` bigint(20) UNSIGNED NOT NULL DEFAULT '0'
) ENGINE=InnoDB DEFAULT CHARSET=utf8mb4 COLLATE=utf8mb4_unicode_520_ci;

--
-- Dumping data for table `urotec_comments`
--

INSERT INTO `urotec_comments` (`comment_ID`, `comment_post_ID`, `comment_author`, `comment_author_email`, `comment_author_url`, `comment_author_IP`, `comment_date`, `comment_date_gmt`, `comment_content`, `comment_karma`, `comment_approved`, `comment_agent`, `comment_type`, `comment_parent`, `user_id`) VALUES
(1, 1, 'Автор комментария', 'wapuu@wordpress.example', 'https://wordpress.org/', '', '2022-03-29 22:05:03', '2022-03-29 19:05:03', 'Привет! Это комментарий.\nЧтобы начать модерировать, редактировать и удалять комментарии, перейдите на экран «Комментарии» в консоли.\nАватары авторов комментариев загружаются с сервиса <a href=\"https://ru.gravatar.com\">Gravatar</a>.', 0, '1', '', 'comment', 0, 0);

-- --------------------------------------------------------

--
-- Table structure for table `urotec_links`
--

CREATE TABLE `urotec_links` (
  `link_id` bigint(20) UNSIGNED NOT NULL,
  `link_url` varchar(255) COLLATE utf8mb4_unicode_520_ci NOT NULL DEFAULT '',
  `link_name` varchar(255) COLLATE utf8mb4_unicode_520_ci NOT NULL DEFAULT '',
  `link_image` varchar(255) COLLATE utf8mb4_unicode_520_ci NOT NULL DEFAULT '',
  `link_target` varchar(25) COLLATE utf8mb4_unicode_520_ci NOT NULL DEFAULT '',
  `link_description` varchar(255) COLLATE utf8mb4_unicode_520_ci NOT NULL DEFAULT '',
  `link_visible` varchar(20) COLLATE utf8mb4_unicode_520_ci NOT NULL DEFAULT 'Y',
  `link_owner` bigint(20) UNSIGNED NOT NULL DEFAULT '1',
  `link_rating` int(11) NOT NULL DEFAULT '0',
  `link_updated` datetime NOT NULL DEFAULT '0000-00-00 00:00:00',
  `link_rel` varchar(255) COLLATE utf8mb4_unicode_520_ci NOT NULL DEFAULT '',
  `link_notes` mediumtext COLLATE utf8mb4_unicode_520_ci NOT NULL,
  `link_rss` varchar(255) COLLATE utf8mb4_unicode_520_ci NOT NULL DEFAULT ''
) ENGINE=InnoDB DEFAULT CHARSET=utf8mb4 COLLATE=utf8mb4_unicode_520_ci;

-- --------------------------------------------------------

--
-- Table structure for table `urotec_options`
--

CREATE TABLE `urotec_options` (
  `option_id` bigint(20) UNSIGNED NOT NULL,
  `option_name` varchar(191) COLLATE utf8mb4_unicode_520_ci NOT NULL DEFAULT '',
  `option_value` longtext COLLATE utf8mb4_unicode_520_ci NOT NULL,
  `autoload` varchar(20) COLLATE utf8mb4_unicode_520_ci NOT NULL DEFAULT 'yes'
) ENGINE=InnoDB DEFAULT CHARSET=utf8mb4 COLLATE=utf8mb4_unicode_520_ci;

--
-- Dumping data for table `urotec_options`
--

INSERT INTO `urotec_options` (`option_id`, `option_name`, `option_value`, `autoload`) VALUES
(1, 'siteurl', 'http://0026urotec.loc:8888', 'yes'),
(2, 'home', 'http://0026urotec.loc:8888', 'yes'),
(3, 'blogname', 'urotec', 'yes'),
(4, 'blogdescription', 'Ещё один сайт на WordPress', 'yes'),
(5, 'users_can_register', '0', 'yes'),
(6, 'admin_email', 'wol1414@gmail.com', 'yes'),
(7, 'start_of_week', '1', 'yes'),
(8, 'use_balanceTags', '0', 'yes'),
(9, 'use_smilies', '1', 'yes'),
(10, 'require_name_email', '1', 'yes'),
(11, 'comments_notify', '1', 'yes'),
(12, 'posts_per_rss', '10', 'yes'),
(13, 'rss_use_excerpt', '0', 'yes'),
(14, 'mailserver_url', 'mail.example.com', 'yes'),
(15, 'mailserver_login', 'login@example.com', 'yes'),
(16, 'mailserver_pass', 'password', 'yes'),
(17, 'mailserver_port', '110', 'yes'),
(18, 'default_category', '1', 'yes'),
(19, 'default_comment_status', 'open', 'yes'),
(20, 'default_ping_status', 'open', 'yes'),
(21, 'default_pingback_flag', '1', 'yes'),
(22, 'posts_per_page', '9', 'yes'),
(23, 'date_format', 'd.m.Y', 'yes'),
(24, 'time_format', 'H:i', 'yes'),
(25, 'links_updated_date_format', 'd.m.Y H:i', 'yes'),
(26, 'comment_moderation', '0', 'yes'),
(27, 'moderation_notify', '1', 'yes'),
(28, 'permalink_structure', '/%postname%/', 'yes'),
(29, 'rewrite_rules', 'a:94:{s:11:\"^wp-json/?$\";s:22:\"index.php?rest_route=/\";s:14:\"^wp-json/(.*)?\";s:33:\"index.php?rest_route=/$matches[1]\";s:21:\"^index.php/wp-json/?$\";s:22:\"index.php?rest_route=/\";s:24:\"^index.php/wp-json/(.*)?\";s:33:\"index.php?rest_route=/$matches[1]\";s:17:\"^wp-sitemap\\.xml$\";s:23:\"index.php?sitemap=index\";s:17:\"^wp-sitemap\\.xsl$\";s:36:\"index.php?sitemap-stylesheet=sitemap\";s:23:\"^wp-sitemap-index\\.xsl$\";s:34:\"index.php?sitemap-stylesheet=index\";s:48:\"^wp-sitemap-([a-z]+?)-([a-z\\d_-]+?)-(\\d+?)\\.xml$\";s:75:\"index.php?sitemap=$matches[1]&sitemap-subtype=$matches[2]&paged=$matches[3]\";s:34:\"^wp-sitemap-([a-z]+?)-(\\d+?)\\.xml$\";s:47:\"index.php?sitemap=$matches[1]&paged=$matches[2]\";s:47:\"category/(.+?)/feed/(feed|rdf|rss|rss2|atom)/?$\";s:52:\"index.php?category_name=$matches[1]&feed=$matches[2]\";s:42:\"category/(.+?)/(feed|rdf|rss|rss2|atom)/?$\";s:52:\"index.php?category_name=$matches[1]&feed=$matches[2]\";s:23:\"category/(.+?)/embed/?$\";s:46:\"index.php?category_name=$matches[1]&embed=true\";s:35:\"category/(.+?)/page/?([0-9]{1,})/?$\";s:53:\"index.php?category_name=$matches[1]&paged=$matches[2]\";s:17:\"category/(.+?)/?$\";s:35:\"index.php?category_name=$matches[1]\";s:44:\"tag/([^/]+)/feed/(feed|rdf|rss|rss2|atom)/?$\";s:42:\"index.php?tag=$matches[1]&feed=$matches[2]\";s:39:\"tag/([^/]+)/(feed|rdf|rss|rss2|atom)/?$\";s:42:\"index.php?tag=$matches[1]&feed=$matches[2]\";s:20:\"tag/([^/]+)/embed/?$\";s:36:\"index.php?tag=$matches[1]&embed=true\";s:32:\"tag/([^/]+)/page/?([0-9]{1,})/?$\";s:43:\"index.php?tag=$matches[1]&paged=$matches[2]\";s:14:\"tag/([^/]+)/?$\";s:25:\"index.php?tag=$matches[1]\";s:45:\"type/([^/]+)/feed/(feed|rdf|rss|rss2|atom)/?$\";s:50:\"index.php?post_format=$matches[1]&feed=$matches[2]\";s:40:\"type/([^/]+)/(feed|rdf|rss|rss2|atom)/?$\";s:50:\"index.php?post_format=$matches[1]&feed=$matches[2]\";s:21:\"type/([^/]+)/embed/?$\";s:44:\"index.php?post_format=$matches[1]&embed=true\";s:33:\"type/([^/]+)/page/?([0-9]{1,})/?$\";s:51:\"index.php?post_format=$matches[1]&paged=$matches[2]\";s:15:\"type/([^/]+)/?$\";s:33:\"index.php?post_format=$matches[1]\";s:12:\"robots\\.txt$\";s:18:\"index.php?robots=1\";s:13:\"favicon\\.ico$\";s:19:\"index.php?favicon=1\";s:48:\".*wp-(atom|rdf|rss|rss2|feed|commentsrss2)\\.php$\";s:18:\"index.php?feed=old\";s:20:\".*wp-app\\.php(/.*)?$\";s:19:\"index.php?error=403\";s:18:\".*wp-register.php$\";s:23:\"index.php?register=true\";s:32:\"feed/(feed|rdf|rss|rss2|atom)/?$\";s:27:\"index.php?&feed=$matches[1]\";s:27:\"(feed|rdf|rss|rss2|atom)/?$\";s:27:\"index.php?&feed=$matches[1]\";s:8:\"embed/?$\";s:21:\"index.php?&embed=true\";s:20:\"page/?([0-9]{1,})/?$\";s:28:\"index.php?&paged=$matches[1]\";s:27:\"comment-page-([0-9]{1,})/?$\";s:38:\"index.php?&page_id=2&cpage=$matches[1]\";s:41:\"comments/feed/(feed|rdf|rss|rss2|atom)/?$\";s:42:\"index.php?&feed=$matches[1]&withcomments=1\";s:36:\"comments/(feed|rdf|rss|rss2|atom)/?$\";s:42:\"index.php?&feed=$matches[1]&withcomments=1\";s:17:\"comments/embed/?$\";s:21:\"index.php?&embed=true\";s:44:\"search/(.+)/feed/(feed|rdf|rss|rss2|atom)/?$\";s:40:\"index.php?s=$matches[1]&feed=$matches[2]\";s:39:\"search/(.+)/(feed|rdf|rss|rss2|atom)/?$\";s:40:\"index.php?s=$matches[1]&feed=$matches[2]\";s:20:\"search/(.+)/embed/?$\";s:34:\"index.php?s=$matches[1]&embed=true\";s:32:\"search/(.+)/page/?([0-9]{1,})/?$\";s:41:\"index.php?s=$matches[1]&paged=$matches[2]\";s:14:\"search/(.+)/?$\";s:23:\"index.php?s=$matches[1]\";s:47:\"author/([^/]+)/feed/(feed|rdf|rss|rss2|atom)/?$\";s:50:\"index.php?author_name=$matches[1]&feed=$matches[2]\";s:42:\"author/([^/]+)/(feed|rdf|rss|rss2|atom)/?$\";s:50:\"index.php?author_name=$matches[1]&feed=$matches[2]\";s:23:\"author/([^/]+)/embed/?$\";s:44:\"index.php?author_name=$matches[1]&embed=true\";s:35:\"author/([^/]+)/page/?([0-9]{1,})/?$\";s:51:\"index.php?author_name=$matches[1]&paged=$matches[2]\";s:17:\"author/([^/]+)/?$\";s:33:\"index.php?author_name=$matches[1]\";s:69:\"([0-9]{4})/([0-9]{1,2})/([0-9]{1,2})/feed/(feed|rdf|rss|rss2|atom)/?$\";s:80:\"index.php?year=$matches[1]&monthnum=$matches[2]&day=$matches[3]&feed=$matches[4]\";s:64:\"([0-9]{4})/([0-9]{1,2})/([0-9]{1,2})/(feed|rdf|rss|rss2|atom)/?$\";s:80:\"index.php?year=$matches[1]&monthnum=$matches[2]&day=$matches[3]&feed=$matches[4]\";s:45:\"([0-9]{4})/([0-9]{1,2})/([0-9]{1,2})/embed/?$\";s:74:\"index.php?year=$matches[1]&monthnum=$matches[2]&day=$matches[3]&embed=true\";s:57:\"([0-9]{4})/([0-9]{1,2})/([0-9]{1,2})/page/?([0-9]{1,})/?$\";s:81:\"index.php?year=$matches[1]&monthnum=$matches[2]&day=$matches[3]&paged=$matches[4]\";s:39:\"([0-9]{4})/([0-9]{1,2})/([0-9]{1,2})/?$\";s:63:\"index.php?year=$matches[1]&monthnum=$matches[2]&day=$matches[3]\";s:56:\"([0-9]{4})/([0-9]{1,2})/feed/(feed|rdf|rss|rss2|atom)/?$\";s:64:\"index.php?year=$matches[1]&monthnum=$matches[2]&feed=$matches[3]\";s:51:\"([0-9]{4})/([0-9]{1,2})/(feed|rdf|rss|rss2|atom)/?$\";s:64:\"index.php?year=$matches[1]&monthnum=$matches[2]&feed=$matches[3]\";s:32:\"([0-9]{4})/([0-9]{1,2})/embed/?$\";s:58:\"index.php?year=$matches[1]&monthnum=$matches[2]&embed=true\";s:44:\"([0-9]{4})/([0-9]{1,2})/page/?([0-9]{1,})/?$\";s:65:\"index.php?year=$matches[1]&monthnum=$matches[2]&paged=$matches[3]\";s:26:\"([0-9]{4})/([0-9]{1,2})/?$\";s:47:\"index.php?year=$matches[1]&monthnum=$matches[2]\";s:43:\"([0-9]{4})/feed/(feed|rdf|rss|rss2|atom)/?$\";s:43:\"index.php?year=$matches[1]&feed=$matches[2]\";s:38:\"([0-9]{4})/(feed|rdf|rss|rss2|atom)/?$\";s:43:\"index.php?year=$matches[1]&feed=$matches[2]\";s:19:\"([0-9]{4})/embed/?$\";s:37:\"index.php?year=$matches[1]&embed=true\";s:31:\"([0-9]{4})/page/?([0-9]{1,})/?$\";s:44:\"index.php?year=$matches[1]&paged=$matches[2]\";s:13:\"([0-9]{4})/?$\";s:26:\"index.php?year=$matches[1]\";s:27:\".?.+?/attachment/([^/]+)/?$\";s:32:\"index.php?attachment=$matches[1]\";s:37:\".?.+?/attachment/([^/]+)/trackback/?$\";s:37:\"index.php?attachment=$matches[1]&tb=1\";s:57:\".?.+?/attachment/([^/]+)/feed/(feed|rdf|rss|rss2|atom)/?$\";s:49:\"index.php?attachment=$matches[1]&feed=$matches[2]\";s:52:\".?.+?/attachment/([^/]+)/(feed|rdf|rss|rss2|atom)/?$\";s:49:\"index.php?attachment=$matches[1]&feed=$matches[2]\";s:52:\".?.+?/attachment/([^/]+)/comment-page-([0-9]{1,})/?$\";s:50:\"index.php?attachment=$matches[1]&cpage=$matches[2]\";s:33:\".?.+?/attachment/([^/]+)/embed/?$\";s:43:\"index.php?attachment=$matches[1]&embed=true\";s:16:\"(.?.+?)/embed/?$\";s:41:\"index.php?pagename=$matches[1]&embed=true\";s:20:\"(.?.+?)/trackback/?$\";s:35:\"index.php?pagename=$matches[1]&tb=1\";s:40:\"(.?.+?)/feed/(feed|rdf|rss|rss2|atom)/?$\";s:47:\"index.php?pagename=$matches[1]&feed=$matches[2]\";s:35:\"(.?.+?)/(feed|rdf|rss|rss2|atom)/?$\";s:47:\"index.php?pagename=$matches[1]&feed=$matches[2]\";s:28:\"(.?.+?)/page/?([0-9]{1,})/?$\";s:48:\"index.php?pagename=$matches[1]&paged=$matches[2]\";s:35:\"(.?.+?)/comment-page-([0-9]{1,})/?$\";s:48:\"index.php?pagename=$matches[1]&cpage=$matches[2]\";s:24:\"(.?.+?)(?:/([0-9]+))?/?$\";s:47:\"index.php?pagename=$matches[1]&page=$matches[2]\";s:27:\"[^/]+/attachment/([^/]+)/?$\";s:32:\"index.php?attachment=$matches[1]\";s:37:\"[^/]+/attachment/([^/]+)/trackback/?$\";s:37:\"index.php?attachment=$matches[1]&tb=1\";s:57:\"[^/]+/attachment/([^/]+)/feed/(feed|rdf|rss|rss2|atom)/?$\";s:49:\"index.php?attachment=$matches[1]&feed=$matches[2]\";s:52:\"[^/]+/attachment/([^/]+)/(feed|rdf|rss|rss2|atom)/?$\";s:49:\"index.php?attachment=$matches[1]&feed=$matches[2]\";s:52:\"[^/]+/attachment/([^/]+)/comment-page-([0-9]{1,})/?$\";s:50:\"index.php?attachment=$matches[1]&cpage=$matches[2]\";s:33:\"[^/]+/attachment/([^/]+)/embed/?$\";s:43:\"index.php?attachment=$matches[1]&embed=true\";s:16:\"([^/]+)/embed/?$\";s:37:\"index.php?name=$matches[1]&embed=true\";s:20:\"([^/]+)/trackback/?$\";s:31:\"index.php?name=$matches[1]&tb=1\";s:40:\"([^/]+)/feed/(feed|rdf|rss|rss2|atom)/?$\";s:43:\"index.php?name=$matches[1]&feed=$matches[2]\";s:35:\"([^/]+)/(feed|rdf|rss|rss2|atom)/?$\";s:43:\"index.php?name=$matches[1]&feed=$matches[2]\";s:28:\"([^/]+)/page/?([0-9]{1,})/?$\";s:44:\"index.php?name=$matches[1]&paged=$matches[2]\";s:35:\"([^/]+)/comment-page-([0-9]{1,})/?$\";s:44:\"index.php?name=$matches[1]&cpage=$matches[2]\";s:24:\"([^/]+)(?:/([0-9]+))?/?$\";s:43:\"index.php?name=$matches[1]&page=$matches[2]\";s:16:\"[^/]+/([^/]+)/?$\";s:32:\"index.php?attachment=$matches[1]\";s:26:\"[^/]+/([^/]+)/trackback/?$\";s:37:\"index.php?attachment=$matches[1]&tb=1\";s:46:\"[^/]+/([^/]+)/feed/(feed|rdf|rss|rss2|atom)/?$\";s:49:\"index.php?attachment=$matches[1]&feed=$matches[2]\";s:41:\"[^/]+/([^/]+)/(feed|rdf|rss|rss2|atom)/?$\";s:49:\"index.php?attachment=$matches[1]&feed=$matches[2]\";s:41:\"[^/]+/([^/]+)/comment-page-([0-9]{1,})/?$\";s:50:\"index.php?attachment=$matches[1]&cpage=$matches[2]\";s:22:\"[^/]+/([^/]+)/embed/?$\";s:43:\"index.php?attachment=$matches[1]&embed=true\";}', 'yes'),
(30, 'hack_file', '0', 'yes'),
(31, 'blog_charset', 'UTF-8', 'yes'),
(32, 'moderation_keys', '', 'no'),
(33, 'active_plugins', 'a:4:{i:0;s:41:\"advanced-custom-fields-pro-master/acf.php\";i:1;s:27:\"cyr-and-lat/cyr-and-lat.php\";i:2;s:33:\"duplicate-post/duplicate-post.php\";i:3;s:45:\"enable-svg-webp-ico-upload/itc-svg-upload.php\";}', 'yes'),
(34, 'category_base', '', 'yes'),
(35, 'ping_sites', 'http://rpc.pingomatic.com/', 'yes'),
(36, 'comment_max_links', '2', 'yes'),
(37, 'gmt_offset', '3', 'yes'),
(38, 'default_email_category', '1', 'yes'),
(39, 'recently_edited', '', 'no'),
(40, 'template', 'mega', 'yes'),
(41, 'stylesheet', 'mega', 'yes'),
(42, 'comment_registration', '0', 'yes'),
(43, 'html_type', 'text/html', 'yes'),
(44, 'use_trackback', '0', 'yes'),
(45, 'default_role', 'subscriber', 'yes'),
(46, 'db_version', '51917', 'yes'),
(47, 'uploads_use_yearmonth_folders', '1', 'yes'),
(48, 'upload_path', '', 'yes'),
(49, 'blog_public', '0', 'yes'),
(50, 'default_link_category', '2', 'yes'),
(51, 'show_on_front', 'page', 'yes'),
(52, 'tag_base', '', 'yes'),
(53, 'show_avatars', '1', 'yes'),
(54, 'avatar_rating', 'G', 'yes'),
(55, 'upload_url_path', '', 'yes'),
(56, 'thumbnail_size_w', '150', 'yes'),
(57, 'thumbnail_size_h', '150', 'yes'),
(58, 'thumbnail_crop', '1', 'yes'),
(59, 'medium_size_w', '300', 'yes'),
(60, 'medium_size_h', '300', 'yes'),
(61, 'avatar_default', 'mystery', 'yes'),
(62, 'large_size_w', '1024', 'yes'),
(63, 'large_size_h', '1024', 'yes'),
(64, 'image_default_link_type', 'none', 'yes'),
(65, 'image_default_size', '', 'yes'),
(66, 'image_default_align', '', 'yes'),
(67, 'close_comments_for_old_posts', '0', 'yes'),
(68, 'close_comments_days_old', '14', 'yes'),
(69, 'thread_comments', '1', 'yes'),
(70, 'thread_comments_depth', '5', 'yes'),
(71, 'page_comments', '0', 'yes'),
(72, 'comments_per_page', '50', 'yes'),
(73, 'default_comments_page', 'newest', 'yes'),
(74, 'comment_order', 'asc', 'yes'),
(75, 'sticky_posts', 'a:0:{}', 'yes'),
(76, 'widget_categories', 'a:2:{i:1;a:0:{}s:12:\"_multiwidget\";i:1;}', 'yes'),
(77, 'widget_text', 'a:2:{i:1;a:0:{}s:12:\"_multiwidget\";i:1;}', 'yes'),
(78, 'widget_rss', 'a:2:{i:1;a:0:{}s:12:\"_multiwidget\";i:1;}', 'yes'),
(79, 'uninstall_plugins', 'a:1:{s:27:\"cyr-and-lat/cyr-and-lat.php\";a:2:{i:0;s:19:\"WCTLR_Admin_Notices\";i:1;s:9:\"uninstall\";}}', 'no'),
(80, 'timezone_string', '', 'yes'),
(81, 'page_for_posts', '0', 'yes'),
(82, 'page_on_front', '2', 'yes'),
(83, 'default_post_format', '0', 'yes'),
(84, 'link_manager_enabled', '0', 'yes'),
(85, 'finished_splitting_shared_terms', '1', 'yes'),
(86, 'site_icon', '0', 'yes'),
(87, 'medium_large_size_w', '768', 'yes'),
(88, 'medium_large_size_h', '0', 'yes'),
(89, 'wp_page_for_privacy_policy', '3', 'yes'),
(90, 'show_comments_cookies_opt_in', '1', 'yes'),
(91, 'admin_email_lifespan', '1664132703', 'yes'),
(92, 'disallowed_keys', '', 'no'),
(93, 'comment_previously_approved', '1', 'yes'),
(94, 'auto_plugin_theme_update_emails', 'a:0:{}', 'no'),
(95, 'auto_update_core_dev', 'enabled', 'yes'),
(96, 'auto_update_core_minor', 'enabled', 'yes'),
(97, 'auto_update_core_major', 'enabled', 'yes'),
(98, 'wp_force_deactivated_plugins', 'a:0:{}', 'yes'),
(99, 'initial_db_version', '51917', 'yes'),
(100, 'urotec_user_roles', 'a:5:{s:13:\"administrator\";a:2:{s:4:\"name\";s:13:\"Administrator\";s:12:\"capabilities\";a:62:{s:13:\"switch_themes\";b:1;s:11:\"edit_themes\";b:1;s:16:\"activate_plugins\";b:1;s:12:\"edit_plugins\";b:1;s:10:\"edit_users\";b:1;s:10:\"edit_files\";b:1;s:14:\"manage_options\";b:1;s:17:\"moderate_comments\";b:1;s:17:\"manage_categories\";b:1;s:12:\"manage_links\";b:1;s:12:\"upload_files\";b:1;s:6:\"import\";b:1;s:15:\"unfiltered_html\";b:1;s:10:\"edit_posts\";b:1;s:17:\"edit_others_posts\";b:1;s:20:\"edit_published_posts\";b:1;s:13:\"publish_posts\";b:1;s:10:\"edit_pages\";b:1;s:4:\"read\";b:1;s:8:\"level_10\";b:1;s:7:\"level_9\";b:1;s:7:\"level_8\";b:1;s:7:\"level_7\";b:1;s:7:\"level_6\";b:1;s:7:\"level_5\";b:1;s:7:\"level_4\";b:1;s:7:\"level_3\";b:1;s:7:\"level_2\";b:1;s:7:\"level_1\";b:1;s:7:\"level_0\";b:1;s:17:\"edit_others_pages\";b:1;s:20:\"edit_published_pages\";b:1;s:13:\"publish_pages\";b:1;s:12:\"delete_pages\";b:1;s:19:\"delete_others_pages\";b:1;s:22:\"delete_published_pages\";b:1;s:12:\"delete_posts\";b:1;s:19:\"delete_others_posts\";b:1;s:22:\"delete_published_posts\";b:1;s:20:\"delete_private_posts\";b:1;s:18:\"edit_private_posts\";b:1;s:18:\"read_private_posts\";b:1;s:20:\"delete_private_pages\";b:1;s:18:\"edit_private_pages\";b:1;s:18:\"read_private_pages\";b:1;s:12:\"delete_users\";b:1;s:12:\"create_users\";b:1;s:17:\"unfiltered_upload\";b:1;s:14:\"edit_dashboard\";b:1;s:14:\"update_plugins\";b:1;s:14:\"delete_plugins\";b:1;s:15:\"install_plugins\";b:1;s:13:\"update_themes\";b:1;s:14:\"install_themes\";b:1;s:11:\"update_core\";b:1;s:10:\"list_users\";b:1;s:12:\"remove_users\";b:1;s:13:\"promote_users\";b:1;s:18:\"edit_theme_options\";b:1;s:13:\"delete_themes\";b:1;s:6:\"export\";b:1;s:10:\"copy_posts\";b:1;}}s:6:\"editor\";a:2:{s:4:\"name\";s:6:\"Editor\";s:12:\"capabilities\";a:35:{s:17:\"moderate_comments\";b:1;s:17:\"manage_categories\";b:1;s:12:\"manage_links\";b:1;s:12:\"upload_files\";b:1;s:15:\"unfiltered_html\";b:1;s:10:\"edit_posts\";b:1;s:17:\"edit_others_posts\";b:1;s:20:\"edit_published_posts\";b:1;s:13:\"publish_posts\";b:1;s:10:\"edit_pages\";b:1;s:4:\"read\";b:1;s:7:\"level_7\";b:1;s:7:\"level_6\";b:1;s:7:\"level_5\";b:1;s:7:\"level_4\";b:1;s:7:\"level_3\";b:1;s:7:\"level_2\";b:1;s:7:\"level_1\";b:1;s:7:\"level_0\";b:1;s:17:\"edit_others_pages\";b:1;s:20:\"edit_published_pages\";b:1;s:13:\"publish_pages\";b:1;s:12:\"delete_pages\";b:1;s:19:\"delete_others_pages\";b:1;s:22:\"delete_published_pages\";b:1;s:12:\"delete_posts\";b:1;s:19:\"delete_others_posts\";b:1;s:22:\"delete_published_posts\";b:1;s:20:\"delete_private_posts\";b:1;s:18:\"edit_private_posts\";b:1;s:18:\"read_private_posts\";b:1;s:20:\"delete_private_pages\";b:1;s:18:\"edit_private_pages\";b:1;s:18:\"read_private_pages\";b:1;s:10:\"copy_posts\";b:1;}}s:6:\"author\";a:2:{s:4:\"name\";s:6:\"Author\";s:12:\"capabilities\";a:10:{s:12:\"upload_files\";b:1;s:10:\"edit_posts\";b:1;s:20:\"edit_published_posts\";b:1;s:13:\"publish_posts\";b:1;s:4:\"read\";b:1;s:7:\"level_2\";b:1;s:7:\"level_1\";b:1;s:7:\"level_0\";b:1;s:12:\"delete_posts\";b:1;s:22:\"delete_published_posts\";b:1;}}s:11:\"contributor\";a:2:{s:4:\"name\";s:11:\"Contributor\";s:12:\"capabilities\";a:5:{s:10:\"edit_posts\";b:1;s:4:\"read\";b:1;s:7:\"level_1\";b:1;s:7:\"level_0\";b:1;s:12:\"delete_posts\";b:1;}}s:10:\"subscriber\";a:2:{s:4:\"name\";s:10:\"Subscriber\";s:12:\"capabilities\";a:2:{s:4:\"read\";b:1;s:7:\"level_0\";b:1;}}}', 'yes'),
(101, 'fresh_site', '0', 'yes'),
(102, 'WPLANG', 'ru_RU', 'yes'),
(103, 'widget_block', 'a:6:{i:2;a:1:{s:7:\"content\";s:19:\"<!-- wp:search /-->\";}i:3;a:1:{s:7:\"content\";s:167:\"<!-- wp:group --><div class=\"wp-block-group\"><!-- wp:heading --><h2>Свежие записи</h2><!-- /wp:heading --><!-- wp:latest-posts /--></div><!-- /wp:group -->\";}i:4;a:1:{s:7:\"content\";s:247:\"<!-- wp:group --><div class=\"wp-block-group\"><!-- wp:heading --><h2>Свежие комментарии</h2><!-- /wp:heading --><!-- wp:latest-comments {\"displayAvatar\":false,\"displayDate\":false,\"displayExcerpt\":false} /--></div><!-- /wp:group -->\";}i:5;a:1:{s:7:\"content\";s:150:\"<!-- wp:group --><div class=\"wp-block-group\"><!-- wp:heading --><h2>Архивы</h2><!-- /wp:heading --><!-- wp:archives /--></div><!-- /wp:group -->\";}i:6;a:1:{s:7:\"content\";s:154:\"<!-- wp:group --><div class=\"wp-block-group\"><!-- wp:heading --><h2>Рубрики</h2><!-- /wp:heading --><!-- wp:categories /--></div><!-- /wp:group -->\";}s:12:\"_multiwidget\";i:1;}', 'yes'),
(104, 'sidebars_widgets', 'a:4:{s:19:\"wp_inactive_widgets\";a:0:{}s:9:\"sidebar-1\";a:5:{i:0;s:7:\"block-2\";i:1;s:7:\"block-3\";i:2;s:7:\"block-4\";i:3;s:7:\"block-5\";i:4;s:7:\"block-6\";}s:6:\"lang-1\";a:0:{}s:13:\"array_version\";i:3;}', 'yes'),
(105, 'cron', 'a:5:{i:1649185504;a:6:{s:32:\"recovery_mode_clean_expired_keys\";a:1:{s:32:\"40cd750bba9870f18aada2478b24840a\";a:3:{s:8:\"schedule\";s:5:\"daily\";s:4:\"args\";a:0:{}s:8:\"interval\";i:86400;}}s:18:\"wp_https_detection\";a:1:{s:32:\"40cd750bba9870f18aada2478b24840a\";a:3:{s:8:\"schedule\";s:10:\"twicedaily\";s:4:\"args\";a:0:{}s:8:\"interval\";i:43200;}}s:16:\"wp_version_check\";a:1:{s:32:\"40cd750bba9870f18aada2478b24840a\";a:3:{s:8:\"schedule\";s:10:\"twicedaily\";s:4:\"args\";a:0:{}s:8:\"interval\";i:43200;}}s:17:\"wp_update_plugins\";a:1:{s:32:\"40cd750bba9870f18aada2478b24840a\";a:3:{s:8:\"schedule\";s:10:\"twicedaily\";s:4:\"args\";a:0:{}s:8:\"interval\";i:43200;}}s:16:\"wp_update_themes\";a:1:{s:32:\"40cd750bba9870f18aada2478b24840a\";a:3:{s:8:\"schedule\";s:10:\"twicedaily\";s:4:\"args\";a:0:{}s:8:\"interval\";i:43200;}}s:34:\"wp_privacy_delete_old_export_files\";a:1:{s:32:\"40cd750bba9870f18aada2478b24840a\";a:3:{s:8:\"schedule\";s:6:\"hourly\";s:4:\"args\";a:0:{}s:8:\"interval\";i:3600;}}}i:1649185513;a:2:{s:19:\"wp_scheduled_delete\";a:1:{s:32:\"40cd750bba9870f18aada2478b24840a\";a:3:{s:8:\"schedule\";s:5:\"daily\";s:4:\"args\";a:0:{}s:8:\"interval\";i:86400;}}s:25:\"delete_expired_transients\";a:1:{s:32:\"40cd750bba9870f18aada2478b24840a\";a:3:{s:8:\"schedule\";s:5:\"daily\";s:4:\"args\";a:0:{}s:8:\"interval\";i:86400;}}}i:1649185515;a:1:{s:30:\"wp_scheduled_auto_draft_delete\";a:1:{s:32:\"40cd750bba9870f18aada2478b24840a\";a:3:{s:8:\"schedule\";s:5:\"daily\";s:4:\"args\";a:0:{}s:8:\"interval\";i:86400;}}}i:1649271904;a:1:{s:30:\"wp_site_health_scheduled_check\";a:1:{s:32:\"40cd750bba9870f18aada2478b24840a\";a:3:{s:8:\"schedule\";s:6:\"weekly\";s:4:\"args\";a:0:{}s:8:\"interval\";i:604800;}}}s:7:\"version\";i:2;}', 'yes'),
(106, 'widget_pages', 'a:1:{s:12:\"_multiwidget\";i:1;}', 'yes'),
(107, 'widget_calendar', 'a:1:{s:12:\"_multiwidget\";i:1;}', 'yes'),
(108, 'widget_archives', 'a:1:{s:12:\"_multiwidget\";i:1;}', 'yes'),
(109, 'widget_media_audio', 'a:1:{s:12:\"_multiwidget\";i:1;}', 'yes'),
(110, 'widget_media_image', 'a:1:{s:12:\"_multiwidget\";i:1;}', 'yes'),
(111, 'widget_media_gallery', 'a:1:{s:12:\"_multiwidget\";i:1;}', 'yes'),
(112, 'widget_media_video', 'a:1:{s:12:\"_multiwidget\";i:1;}', 'yes'),
(113, 'widget_meta', 'a:1:{s:12:\"_multiwidget\";i:1;}', 'yes'),
(114, 'widget_search', 'a:1:{s:12:\"_multiwidget\";i:1;}', 'yes'),
(115, 'widget_tag_cloud', 'a:1:{s:12:\"_multiwidget\";i:1;}', 'yes'),
(116, 'widget_nav_menu', 'a:1:{s:12:\"_multiwidget\";i:1;}', 'yes'),
(117, 'widget_custom_html', 'a:1:{s:12:\"_multiwidget\";i:1;}', 'yes'),
(119, 'recovery_keys', 'a:0:{}', 'yes'),
(120, 'https_detection_errors', 'a:1:{s:20:\"https_request_failed\";a:1:{i:0;s:36:\"HTTPS запрос неудачен.\";}}', 'yes'),
(132, '_site_transient_timeout_browser_988d7a8c53614fb951ba87aef4ed3ae4', '1649185514', 'no'),
(133, '_site_transient_browser_988d7a8c53614fb951ba87aef4ed3ae4', 'a:10:{s:4:\"name\";s:6:\"Chrome\";s:7:\"version\";s:12:\"99.0.4844.83\";s:8:\"platform\";s:9:\"Macintosh\";s:10:\"update_url\";s:29:\"https://www.google.com/chrome\";s:7:\"img_src\";s:43:\"http://s.w.org/images/browsers/chrome.png?1\";s:11:\"img_src_ssl\";s:44:\"https://s.w.org/images/browsers/chrome.png?1\";s:15:\"current_version\";s:2:\"18\";s:7:\"upgrade\";b:0;s:8:\"insecure\";b:0;s:6:\"mobile\";b:0;}', 'no'),
(134, '_site_transient_timeout_php_check_20f4df878f211a5689e76acb3f9067a8', '1649185515', 'no'),
(135, '_site_transient_php_check_20f4df878f211a5689e76acb3f9067a8', 'a:5:{s:19:\"recommended_version\";s:3:\"7.4\";s:15:\"minimum_version\";s:6:\"5.6.20\";s:12:\"is_supported\";b:1;s:9:\"is_secure\";b:1;s:13:\"is_acceptable\";b:1;}', 'no'),
(143, 'can_compress_scripts', '1', 'no'),
(152, 'finished_updating_comment_type', '1', 'yes'),
(153, 'theme_mods_twentytwentytwo', 'a:1:{s:16:\"sidebars_widgets\";a:2:{s:4:\"time\";i:1648580805;s:4:\"data\";a:3:{s:19:\"wp_inactive_widgets\";a:0:{}s:9:\"sidebar-1\";a:3:{i:0;s:7:\"block-2\";i:1;s:7:\"block-3\";i:2;s:7:\"block-4\";}s:9:\"sidebar-2\";a:2:{i:0;s:7:\"block-5\";i:1;s:7:\"block-6\";}}}}', 'yes'),
(154, 'current_theme', 'mega', 'yes'),
(155, 'theme_mods_mega', 'a:3:{i:0;b:0;s:18:\"nav_menu_locations\";a:2:{s:9:\"menu-main\";i:3;s:11:\"menu-footer\";i:4;}s:18:\"custom_css_post_id\";i:-1;}', 'yes'),
(156, 'theme_switched', '', 'yes'),
(157, 'recovery_mode_email_last_sent', '1648580805', 'yes'),
(158, 'recently_activated', 'a:1:{s:27:\"svg-support/svg-support.php\";i:1648584062;}', 'yes'),
(159, 'acf_version', '5.9.1', 'yes'),
(160, 'duplicate_post_copytitle', '1', 'yes'),
(161, 'duplicate_post_copydate', '0', 'yes'),
(162, 'duplicate_post_copystatus', '0', 'yes'),
(163, 'duplicate_post_copyslug', '0', 'yes'),
(164, 'duplicate_post_copyexcerpt', '1', 'yes'),
(165, 'duplicate_post_copycontent', '1', 'yes'),
(166, 'duplicate_post_copythumbnail', '1', 'yes'),
(167, 'duplicate_post_copytemplate', '1', 'yes'),
(168, 'duplicate_post_copyformat', '1', 'yes'),
(169, 'duplicate_post_copyauthor', '0', 'yes'),
(170, 'duplicate_post_copypassword', '0', 'yes'),
(171, 'duplicate_post_copyattachments', '0', 'yes'),
(172, 'duplicate_post_copychildren', '0', 'yes'),
(173, 'duplicate_post_copycomments', '0', 'yes'),
(174, 'duplicate_post_copymenuorder', '1', 'yes'),
(175, 'duplicate_post_taxonomies_blacklist', 'a:0:{}', 'yes'),
(176, 'duplicate_post_blacklist', '', 'yes'),
(177, 'duplicate_post_types_enabled', 'a:2:{i:0;s:4:\"post\";i:1;s:4:\"page\";}', 'yes'),
(178, 'duplicate_post_show_original_column', '0', 'yes'),
(179, 'duplicate_post_show_original_in_post_states', '0', 'yes'),
(180, 'duplicate_post_show_original_meta_box', '0', 'yes'),
(181, 'duplicate_post_show_link', 'a:3:{s:9:\"new_draft\";s:1:\"1\";s:5:\"clone\";s:1:\"1\";s:17:\"rewrite_republish\";s:1:\"1\";}', 'yes'),
(182, 'duplicate_post_show_link_in', 'a:4:{s:3:\"row\";s:1:\"1\";s:8:\"adminbar\";s:1:\"1\";s:9:\"submitbox\";s:1:\"1\";s:11:\"bulkactions\";s:1:\"1\";}', 'yes'),
(183, 'duplicate_post_show_notice', '0', 'no'),
(188, 'duplicate_post_version', '4.4', 'yes'),
(205, 'ideastocode_module_settings', 'a:1:{s:14:\"itc_svg_upload\";a:5:{s:4:\"name\";s:14:\"itc_svg_upload\";s:5:\"title\";s:33:\"Enable SVG, WebP &amp; ICO Upload\";s:4:\"slug\";s:14:\"itc-svg-upload\";s:7:\"version\";s:5:\"1.0.1\";s:8:\"settings\";s:23:\"itc_svg_upload_settings\";}}', 'yes'),
(206, 'itc_svg_upload_settings', 'a:3:{s:3:\"svg\";i:1;s:4:\"webp\";i:1;s:3:\"ico\";i:1;}', 'yes'),
(209, '_transient_itc_svg_upload_settings_notice_dismiss_alert', '9', 'yes'),
(210, 'bodhi_svgs_plugin_version', '2.4.2', 'yes'),
(259, 'wp_calendar_block_has_published_posts', '1', 'yes'),
(273, 'options_лого_в_шапке', '176', 'no'),
(274, '_options_лого_в_шапке', 'field_62445c114bad0', 'no'),
(275, 'options_лого_в_подвале', '177', 'no'),
(276, '_options_лого_в_подвале', 'field_62445c8d4bad1', 'no'),
(277, 'options_адрес', '123610 г. Москва,  Краснопресненская наб., д. 12,  под. 7, эт. 6, пом. IАЖ', 'no'),
(278, '_options_адрес', 'field_62445cd94bad2', 'no'),
(279, 'options_телефон', '+7 (495) 225-80-01', 'no'),
(280, '_options_телефон', 'field_62445d0a4bad3', 'no'),
(281, 'options_факс', '+7 (495) 258-20-07', 'no'),
(282, '_options_факс', 'field_62445d0f4bad4', 'no'),
(283, 'options_email', 'info@rusfic.com', 'no'),
(284, '_options_email', 'field_62445d164bad5', 'no'),
(285, 'options_источники', '<ol>\r\n 	<li>https://grls.rosminzdrav.ru/Grls_View_v2.aspx?routingGuid=89a66596-ce1d-454a-a356-5d4a4a0b191e&amp;t= 07.12.2021</li>\r\n 	<li>Котов С.В., Богданов Д.А. Силодозин — место в лечении СНМП/ДГПЖ с позиции доказательной медицины и реальной практики. Урология. 2021;5:94—98</li>\r\n 	<li>Материалы ХVIII конгресса российского общества урологов и российско-китайского форума по урологии, 8-10 ноября 2018г, Екатеринбург «СНМП/ДГПЖ — кто лечит? Предварительные результаты российского эпидемиологического исследования» Пушкарь Д.Ю., Раснер П.И., Неймарк А.И., Капсаргин Ф.П., Коган М.И., Медведев В.Л., Абоян И.А., Аль-Шукри С.Х., Корнеев И.А., Асфандияров Ф.Р., Братчиков О.И,, Котов С.В., Крупин В.Н., Новиков А.И., Павлов В.П., Цуканов А.Ю., Шарманов И.С., стр. 288</li>\r\n 	<li>Fusco F et al., Adv Ther 2017;34(4):773-783</li>\r\n 	<li>Curran M.P., Drugs 2011; 71(7): 897-907</li>\r\n 	<li>Инструкция по медицинскому применению лекарственного препарата Урорек, РУ ЛСР-005971/10 от 25.06.2010</li>\r\n 	<li>Kim T.N. et al., Urology 2014; dx.doi.org/10.1016/J.Urology.2014.02.068</li>\r\n 	<li>Choi et al.Prostate Int 5 (2017) 113-8</li>\r\n 	<li>Chapple C.R. et al. Silodosin therapy for lower urinary tract symptoms in men with suspected benign prostatic hyperplasia: results of an international, randomized, double-blind, placebo- and active-controlled clinical trial performed in Europe. Eur Urol. 2011;59:342</li>\r\n 	<li>Силодозин — новый α-адреноблокатор для выигрыша в матче против ДГПЖ. Эффективная фармакотерапия. Урология и нефрология. 5/2012</li>\r\n 	<li>Creta M et al. Eur Urol Focus 2020; 1-6.</li>\r\n 	<li>Takao T et al. Early efficacy of silodosin in patients with lower urinary tract symptoms suggestive of benign prostatic hyperplasia. Int J Urol 2008; 15: 992-996</li>\r\n 	<li>Montorsi F et al., Int J Urol 2016;23(7):572-9</li>\r\n 	<li>Marks LS, Gittelman MC, HiII LA, Volinn W, Hoel G. J Urol. 2009;181:2634-2640</li>\r\n 	<li>Yamanishi T. Et al., Int J. Urol. 2015 Dol: 10.1111/Iju.12915</li>\r\n 	<li>Fusco F et al., Adv Ther 2017;34(4):773-783</li>\r\n 	<li>Capitanio U. et al., Int. J. Clin. Pract. 2013; doi: 10.1111/ijcp.12135</li>\r\n 	<li>Nasu K, et al. Br J Pharmacol. 1996;119:797-803</li>\r\n 	<li>Smith D.J. et all,1994</li>\r\n 	<li>Ford APWD et all, 1996</li>\r\n 	<li>Rudner XL, Berkowitz DE, Circulation. 1999;100:2336-2343</li>\r\n 	<li>Townsend SA, Jung AS, Hoe YSG, et al. Hypertension. 2004;44:776-782</li>\r\n 	<li>Masaki KH, Schatz I, Burchfiel CM, et al. Circulation. 1998;98:2290-2295</li>\r\n 	<li>Schwinn DA, Roehrborn CG, Int J Urol. 2008 March;15(3):193—199</li>\r\n 	<li>Tatemichi S et.al. Comparison of the effects of four α1-adrenoreceptor antagonists on ejaculatory function In rats. Urol 2012,80(2):486,e9-16</li>\r\n 	<li>Katzung BG. Basic and clinical pharmacology. 6th ed. Norwalk4 CT: Appleton &amp; Lange; 1995</li>\r\n 	<li>Данные IQVIA 3 квартал 2021</li>\r\n 	<li>https://legalacts.ru/doc/klinicheskie-rekomendatsii-dobrokachestvennaja-giperplazija-predstatelnoi-zhelezy-utv-minzdravom-rossii/</li>\r\n 	<li>https://uroweb.org/guideline/treatment-of-non-neurogenic-male-luts/#5</li>\r\n 	<li>http://www.rosminzdrav.ru/documents/8422-prikaz-ministerstva-zdravoohraneniya-rossiyskoy-federatsii-ot-9-noyabrya-2012-g-697n-ob-utverzhdenii-standarta-pervichnoy-mediko-sanitarnoy-pomoschi-pri-giperplazii-predstatelnoy-zhelezy</li>\r\n 	<li>https://minzdrav.gov.ru/documents/8863-prikaz-ministerstva-zdravoohraneniya-rossiyskoy-federatsii-ot-9-noyabrya-2012-g-745n-ob-utverzhdenii-standarta-spetsializirovannoy-meditsinskoy-pomoschi-pri-zaderzhke-mochi</li>\r\n 	<li>http://www.rosminzdrav.ru/documents/8425-prikaz-ministerstva-zdravoohraneniya-rossiyskoy-federatsii-ot-9-noyabrya-2012-g-775n-ob-utverzhdenii-standarta-pervichnoy-mediko-sanitarnoy-pomoschi-pri-hronicheskom-prostatite</li>\r\n 	<li>http://www.rosminzdrav.ru/documents/9044-prikaz-ministerstva-zdravoohraneniya-rossiyskoy-federatsii-ot-9-noyabrya-2012-g-696n-ob-utverzhdenii-standarta-spetsializirovannoy-meditsinskoy-pomoschi-pri-ostryh-prostatite-orhite-i-epididimite</li>\r\n 	<li>https://www.ema.europa.eu/en/medicines/human/EPAR/urorec</li>\r\n 	<li>https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&amp;ApplNo=022206</li>\r\n 	<li>https://www.ema.europa.eu/en/medicines/human/EPAR/urorec</li>\r\n 	<li>https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&amp;ApplNo=022206</li>\r\n 	<li>П.В. Глыбочко, Ю.Г. Аляев, Междисциплинарные проблемы в урологии, руководство для врачей, Медфорум, 2015, стр.132</li>\r\n 	<li>Roehrborn CG, McConnell JD. Benign prostatic hyperplasia: etiology, pathophysiology, epidemiology, and natural history. In: Wein AJ et al. (eds) Campbell-Walsh Urology, Elsevier Saunders, Philadelphia, 9th ed 2007</li>\r\n 	<li>Kupelian V et al. Association of urological symptoms and chronic illness in men and women: contributions of symptom severity and duration-results from the BACH Survey. J Urol 2009; 181: 694-700</li>\r\n 	<li>Адаптировано из материалов XIX конгресса Российского общества урологов, 19-21 сентября 2019, г.Ростов-на-Дону, «СНМП/ДГПЖ — кто лечит?» результаты российского эпидемиологического исследования, Пушкарь Д.Ю., Раснер П.И., Абоян И.А., Асфандияров Ф.Р., Котов С.В., Коган М.И., Корнеев И.А., Медведев В.Л., Неймарк А.И., Новиков А.И., Павлов В.Н., Цуканов А.Ю., Шабалкин С.А., Шорманов И.С.</li>\r\n 	<li>Tanguay S et al. Diagnosis and management of benign prostatic hyperplasia in primary care. Can Urol Assoc J 2009; 3(2): S92-100</li>\r\n 	<li>Kirby R et al. Shared care for prostatic diseases. Isis Medical Media Ltd, Oxford, 2nd ed 2000</li>\r\n 	<li>Hernández Fernández C et al. The importance of nocturia and the repercussion in the quality of sleep and quality of life in patients with benign prostatic hyperplasia. Actas Urol Esp 2007; 31: 262-269</li>\r\n 	<li>Roehrborn CG. Current medical therapies for men with lower urinary tract symptoms and benign prostatic hyperplasia: achievements and limitations. Rev Urol 2008; 10: 14-25</li>\r\n 	<li>Montorsi F. Eur Urol Suppl 2010; 9: 491-495</li>\r\n 	<li>https://grls.rosminzdrav.ru/Grls_View_v2.aspx?routingGuid=a486a508-348f-4db7-98a1-c7c4e639de42&amp;t= 07.12.2021</li>\r\n 	<li>https://grls.rosminzdrav.ru/Grls_View_v2.aspx?routingGuid=17f19e8b-59e8-4fa1-a951-045e0819ea9a&amp;t= 07.12.2021</li>\r\n 	<li>Пушкарь Д.Ю. и соавт., Учебное издание Урология, 2-е издание, переработанное и дополненное, 2016, стр.212</li>\r\n 	<li>Fusco F et al., Eur Urol 2016;69(6):1091—1101</li>\r\n 	<li>Roehrborn CG et al., Adv Ther. 2017;33(12):2110—2121</li>\r\n 	<li>Kobayashi K et al. Orgasm is preserved regardless of ejaculatory dysfunction with selective alpha1A-blocker administration. Int J Impot Res 2009; 21(5): 306-310</li>\r\n 	<li>Gacci M. et al. Impact of medical treatments for male lower urinary tract symptoms due to benign prostatic hyperplasia on ejaculatory function: a systematic review and metaanalysis. J Sex Med. 2014;11:1554.</li>\r\n</ol>', 'no'),
(286, '_options_источники', 'field_62445d424bad6', 'no'),
(288, 'nav_menu_options', 'a:2:{i:0;b:0;s:8:\"auto_add\";a:0:{}}', 'yes'),
(297, 'widget_recent-posts', 'a:2:{i:1;a:0:{}s:12:\"_multiwidget\";i:1;}', 'yes'),
(298, 'widget_recent-comments', 'a:2:{i:1;a:0:{}s:12:\"_multiwidget\";i:1;}', 'yes'),
(309, 'category_children', 'a:0:{}', 'yes'),
(317, 'wbcr_cyrandlat_an__activated_on', '1648661076', 'yes'),
(318, 'wbcr_wp_term_1_old_slug', '%d0%b1%d0%b5%d0%b7-%d1%80%d1%83%d0%b1%d1%80%d0%b8%d0%ba%d0%b8', 'no'),
(319, 'wbcr_wp_term_3_old_slug', '%d0%bc%d0%b5%d0%bd%d1%8e-%d0%b2-%d1%88%d0%b0%d0%bf%d0%ba%d0%b5', 'no'),
(320, 'wbcr_wp_term_4_old_slug', '%d0%bc%d0%b5%d0%bd%d1%8e-%d0%b2-%d0%bf%d0%be%d0%b4%d0%b2%d0%b0%d0%bb%d0%b5', 'no'),
(323, 'wbcr_cyrandlat_an__dismissed_suggestions_on', '1648661150', 'yes'),
(345, '_transient_health-check-site-status-result', '{\"good\":11,\"recommended\":7,\"critical\":1}', 'yes'),
(382, 'options_текст', '<h3>Урорек значительно улучшает клинические проявления и качество жизни у всех пациентов с СНМП/ДГПЖ, в том числе с тяжелым течением<sup>11</sup></h3>\r\n<ul>\r\n 	<li>Эффективен в отношении всех СНМП (накопления, опорожнения, постмиктурических)<sup>12,13</sup></li>\r\n 	<li>Значимо улучшает состояние пациентов с СНМП уже на старте терапии<sup>14</sup></li>\r\n 	<li>Одновременно влияет на несколько симптомов, причиняющих наиболее сильное беспокойство: учащенное мочеиспускание, ощущение неполного опорожнения мочевого пузыря и ноктурии<sup>46</sup></li>\r\n 	<li>Превосходит другие альфа-адреноблокаторы по влиянию на основные уродинамические показатели<sup>4</sup></li>\r\n 	<li>Эффект сохраняется в течение длительного времени<sup>15</sup></li>\r\n 	<li>При смене тамсулозина на силодозин усиливается эффективность терапии<sup>17</sup></li>\r\n</ul>', 'no'),
(383, '_options_текст', 'field_624588d7e7ec9', 'no'),
(384, 'options_текст-мод', '<h3>Урорек значительно улучшает клинические проявления и качество жизни у всех пациентов с СНМП/ДГПЖ, в том числе с тяжелым течением<sup>11</sup></h3>\r\n<ul>\r\n 	<li>Эффективен в отношении всех СНМП (накопления, опорожнения, постмиктурических)<sup>12,13</sup></li>\r\n 	<li>Значимо улучшает состояние пациентов с СНМП уже на старте терапии<sup>14</sup></li>\r\n 	<li>Одновременно влияет на несколько симптомов, причиняющих наиболее сильное беспокойство: учащенное мочеиспускание, ощущение неполного опорожнения мочевого пузыря и ноктурии<sup>46</sup></li>\r\n 	<li>Превосходит другие альфа-адреноблокаторы по влиянию на основные уродинамические показатели<sup>4</sup></li>\r\n 	<li>Эффект сохраняется в течение длительного времени<sup>15</sup></li>\r\n 	<li>При смене тамсулозина на силодозин усиливается эффективность терапии<sup>17</sup></li>\r\n</ul>', 'no'),
(385, '_options_текст-мод', 'field_624588d7e7ec9', 'no'),
(387, 'options_текст-мод2', '&nbsp;\r\n<h3>При ДГПЖ количество альфа1А-адренорецепторов в простате увеличивается<sup>18,19,20</sup></h3>\r\n<div class=\"table-wrap\">\r\n<table class=\"table table-bordered\">\r\n<thead>\r\n<tr>\r\n<th scope=\"col\">альфа1-адренорепторы</th>\r\n<th scope=\"col\">Нормальная ткань простаты</th>\r\n<th scope=\"col\">ДГПЖ</th>\r\n</tr>\r\n</thead>\r\n<tbody>\r\n<tr>\r\n<td>α<sub>1A</sub></td>\r\n<td class=\"text-center\">63%</td>\r\n<td class=\"text-center\">85%</td>\r\n</tr>\r\n</tbody>\r\n</table>\r\n</div>\r\n<h3>Количество альфа1B-адренорецепторов в сосудистом русле тоже увеличивается с возрастом*<sup>21,22,23</sup></h3>\r\n<div class=\"table-wrap\">\r\n<table class=\"table table-bordered\">\r\n<thead>\r\n<tr>\r\n<th scope=\"col\">Возраст</th>\r\n<th scope=\"col\">&lt;55 лет</th>\r\n<th scope=\"col\">≥65 лет</th>\r\n</tr>\r\n</thead>\r\n<tbody>\r\n<tr>\r\n<td>Экспрессия α<sub>1B</sub> адренорецепторов в сосудистом русле</td>\r\n<td>α<sub>1A</sub> &gt; α<sub>1B</sub></td>\r\n<td>α<sub>1B</sub> &gt; α<sub>1A</sub></td>\r\n</tr>\r\n</tbody>\r\n</table>\r\n</div>\r\n*Изменения соотношения подтипов адренорецепторов являются причиной склонности пожилых пациентов к нестабильности АД во время лечения альфа-адреноблокаторами<sup>24</sup>\r\n<h3>Максимальная уроселективность силодозина в классе альфа-адреноблокаторов обуславливает его уродинамическую эффективность и высокий профиль безопасности<sup>4</sup></h3>\r\nПрофиль связывания антагонистов α1-адренорецепторов с подтипами рекомбинантных альфа1-адренорецепторов человека<sup>25</sup>\r\n<div class=\"table-wrap\">\r\n<table class=\"table table-bordered\">\r\n<thead>\r\n<tr>\r\n<th class=\"align-top\" rowspan=\"2\">Альфа-адреноблокатор</th>\r\n<th class=\"text-center\" colspan=\"2\">Селективность к альфа1-адренорепторам</th>\r\n</tr>\r\n<tr>\r\n<th class=\"text-center\" scope=\"col\">α1A:α1B</th>\r\n<th class=\"text-center\" scope=\"col\">α1A:α1D</th>\r\n</tr>\r\n</thead>\r\n<tbody>\r\n<tr>\r\n<td>Алфузозин</td>\r\n<td>0.309:1</td>\r\n<td>0.617:1</td>\r\n</tr>\r\n<tr>\r\n<td>Нафтопидил</td>\r\n<td>0.372:1</td>\r\n<td>0.209:1</td>\r\n</tr>\r\n<tr>\r\n<td>Тамсулозин</td>\r\n<td>9.55:1</td>\r\n<td>2.51:1</td>\r\n</tr>\r\n<tr>\r\n<td>Силодозин</td>\r\n<td>162:1</td>\r\n<td>55:1</td>\r\n</tr>\r\n</tbody>\r\n</table>\r\n</div>\r\nВ исследованиях in vitro было показано, что сродство силодозина к альфа1A-адренорецепторам в 162 раза превосходит его способность взаимодействовать с альфа1B-адренорецепторами, которые расположены в гладких мышцах сосудов. Благодаря высокой селективности силодозин не вызывает клинически значимого снижения артериального давления (АД)<sup>6</sup>\r\n<h3 class=\"h3\">Максимальная уроселективность обеспечивает:<sup>25,26</sup></h3>\r\n<ul>\r\n 	<li>Быстрое начало действия</li>\r\n 	<li>Эффективное снятие СНМП</li>\r\n 	<li>Минимум побочных эффектов со стороны сердечно-сосудистой системы</li>\r\n</ul>', 'no'),
(388, '_options_текст-мод2', 'field_62458b094139d', 'no'),
(389, 'options_текст_вверху', 'Силодозин (действующее вещество препарата Урорек), высокоселективный конкурентный антагонист альфа1А-адренорецепторов, которые в основном расположены в предстательной железе, в тканях дна и шейки мочевого пузыря, капсуле предстательной железы и простатической части мочеиспускательного канала.\r\n\r\nБлокада альфа1А-адренорецепторов снижает тонус гладкой мускулатуры в этих тканях, что ведет к улучшению оттока мочи из мочевого пузыря. Одновременно уменьшаются симптомы обструкции и раздражения, связанные с доброкачественной гиперплазией предстательной железы.<sup>6</sup>', 'no'),
(390, '_options_текст_вверху', 'field_62458fbbf228d', 'no'),
(391, 'options_столбик_0_изображение', '', 'no'),
(392, '_options_столбик_0_изображение', 'field_624591bf67a0c', 'no'),
(393, 'options_столбик_0_заголовок', 'альфа <span>1A</span> адренорепторы', 'no'),
(394, '_options_столбик_0_заголовок', 'field_624591cd67a0d', 'no'),
(395, 'options_столбик_0_текст', '<img class=\"alignnone size-full wp-image-237\" src=\"http://0026urotec.loc:8888/wp-content/uploads/2022/03/modal-row-img-1.png\" alt=\"\" width=\"256\" height=\"153\" />\r\n<ul class=\"list\">\r\n 	<li class=\"item\">Простата</li>\r\n 	<li class=\"item\">Уретра</li>\r\n 	<li class=\"item\">Мочевой пузырь</li>\r\n 	<li class=\"item\">Семенные пузырьки</li>\r\n</ul>', 'no'),
(396, '_options_столбик_0_текст', 'field_624591eb67a0e', 'no'),
(397, 'options_столбик_1_изображение', '', 'no'),
(398, '_options_столбик_1_изображение', 'field_624591bf67a0c', 'no'),
(399, 'options_столбик_1_заголовок', 'альфа <span>1B</span> адренорепторы', 'no'),
(400, '_options_столбик_1_заголовок', 'field_624591cd67a0d', 'no'),
(401, 'options_столбик_1_текст', '<img class=\"alignnone size-full wp-image-238\" src=\"http://0026urotec.loc:8888/wp-content/uploads/2022/03/modal-row-img-2.png\" alt=\"\" width=\"256\" height=\"153\" />\r\n<ul class=\"list\">\r\n 	<li class=\"item\">Кровеносные сосуды</li>\r\n</ul>', 'no'),
(402, '_options_столбик_1_текст', 'field_624591eb67a0e', 'no'),
(403, 'options_столбик_2_изображение', '', 'no'),
(404, '_options_столбик_2_изображение', 'field_624591bf67a0c', 'no'),
(405, 'options_столбик_2_заголовок', 'альфа <span>1D</span> адренорепторы', 'no'),
(406, '_options_столбик_2_заголовок', 'field_624591cd67a0d', 'no'),
(407, 'options_столбик_2_текст', '<img class=\"alignnone size-full wp-image-239\" src=\"http://0026urotec.loc:8888/wp-content/uploads/2022/03/modal-row-img-3.png\" alt=\"\" width=\"256\" height=\"153\" />\r\n<ul class=\"list\">\r\n 	<li class=\"item\">Мочевой пузырь</li>\r\n 	<li class=\"item\">Спинной мозг</li>\r\n 	<li class=\"item\">Носовые пазухи</li>\r\n</ul>', 'no'),
(408, '_options_столбик_2_текст', 'field_624591eb67a0e', 'no'),
(409, 'options_столбик', '3', 'no'),
(410, '_options_столбик', 'field_624591aa67a0b', 'no'),
(445, '_transient_timeout_acf_plugin_updates', '1649336172', 'no'),
(446, '_transient_acf_plugin_updates', 'a:4:{s:7:\"plugins\";a:1:{s:41:\"advanced-custom-fields-pro-master/acf.php\";a:8:{s:4:\"slug\";s:26:\"advanced-custom-fields-pro\";s:6:\"plugin\";s:41:\"advanced-custom-fields-pro-master/acf.php\";s:11:\"new_version\";s:6:\"5.12.1\";s:3:\"url\";s:36:\"https://www.advancedcustomfields.com\";s:6:\"tested\";s:5:\"5.9.2\";s:7:\"package\";s:0:\"\";s:5:\"icons\";a:1:{s:7:\"default\";s:63:\"https://ps.w.org/advanced-custom-fields/assets/icon-256x256.png\";}s:7:\"banners\";a:2:{s:3:\"low\";s:77:\"https://ps.w.org/advanced-custom-fields/assets/banner-772x250.jpg?rev=1729102\";s:4:\"high\";s:78:\"https://ps.w.org/advanced-custom-fields/assets/banner-1544x500.jpg?rev=1729099\";}}}s:10:\"expiration\";i:172800;s:6:\"status\";i:1;s:7:\"checked\";a:1:{s:41:\"advanced-custom-fields-pro-master/acf.php\";s:5:\"5.9.1\";}}', 'no'),
(450, '_site_transient_update_core', 'O:8:\"stdClass\":4:{s:7:\"updates\";a:1:{i:0;O:8:\"stdClass\":10:{s:8:\"response\";s:6:\"latest\";s:8:\"download\";s:65:\"https://downloads.wordpress.org/release/ru_RU/wordpress-5.9.2.zip\";s:6:\"locale\";s:5:\"ru_RU\";s:8:\"packages\";O:8:\"stdClass\":5:{s:4:\"full\";s:65:\"https://downloads.wordpress.org/release/ru_RU/wordpress-5.9.2.zip\";s:10:\"no_content\";s:0:\"\";s:11:\"new_bundled\";s:0:\"\";s:7:\"partial\";s:0:\"\";s:8:\"rollback\";s:0:\"\";}s:7:\"current\";s:5:\"5.9.2\";s:7:\"version\";s:5:\"5.9.2\";s:11:\"php_version\";s:6:\"5.6.20\";s:13:\"mysql_version\";s:3:\"5.0\";s:11:\"new_bundled\";s:3:\"5.9\";s:15:\"partial_version\";s:0:\"\";}}s:12:\"last_checked\";i:1649163375;s:15:\"version_checked\";s:5:\"5.9.2\";s:12:\"translations\";a:1:{i:0;a:7:{s:4:\"type\";s:4:\"core\";s:4:\"slug\";s:7:\"default\";s:8:\"language\";s:5:\"ru_RU\";s:7:\"version\";s:5:\"5.9.2\";s:7:\"updated\";s:19:\"2022-03-30 14:45:05\";s:7:\"package\";s:64:\"https://downloads.wordpress.org/translation/core/5.9.2/ru_RU.zip\";s:10:\"autoupdate\";b:1;}}}', 'no'),
(451, '_site_transient_update_themes', 'O:8:\"stdClass\":5:{s:12:\"last_checked\";i:1649163375;s:7:\"checked\";a:1:{s:4:\"mega\";s:5:\"1.0.0\";}s:8:\"response\";a:0:{}s:9:\"no_update\";a:0:{}s:12:\"translations\";a:0:{}}', 'no');
INSERT INTO `urotec_options` (`option_id`, `option_name`, `option_value`, `autoload`) VALUES
(452, '_site_transient_update_plugins', 'O:8:\"stdClass\":5:{s:12:\"last_checked\";i:1649163376;s:8:\"response\";a:1:{s:41:\"advanced-custom-fields-pro-master/acf.php\";O:8:\"stdClass\":8:{s:4:\"slug\";s:26:\"advanced-custom-fields-pro\";s:6:\"plugin\";s:41:\"advanced-custom-fields-pro-master/acf.php\";s:11:\"new_version\";s:6:\"5.12.1\";s:3:\"url\";s:36:\"https://www.advancedcustomfields.com\";s:6:\"tested\";s:5:\"5.9.2\";s:7:\"package\";s:0:\"\";s:5:\"icons\";a:1:{s:7:\"default\";s:63:\"https://ps.w.org/advanced-custom-fields/assets/icon-256x256.png\";}s:7:\"banners\";a:2:{s:3:\"low\";s:77:\"https://ps.w.org/advanced-custom-fields/assets/banner-772x250.jpg?rev=1729102\";s:4:\"high\";s:78:\"https://ps.w.org/advanced-custom-fields/assets/banner-1544x500.jpg?rev=1729099\";}}}s:12:\"translations\";a:3:{i:0;a:7:{s:4:\"type\";s:6:\"plugin\";s:4:\"slug\";s:11:\"hello-dolly\";s:8:\"language\";s:5:\"ru_RU\";s:7:\"version\";s:5:\"1.7.2\";s:7:\"updated\";s:19:\"2018-06-04 21:57:16\";s:7:\"package\";s:78:\"https://downloads.wordpress.org/translation/plugin/hello-dolly/1.7.2/ru_RU.zip\";s:10:\"autoupdate\";b:1;}i:1;a:7:{s:4:\"type\";s:6:\"plugin\";s:4:\"slug\";s:11:\"svg-support\";s:8:\"language\";s:5:\"ru_RU\";s:7:\"version\";s:5:\"2.4.2\";s:7:\"updated\";s:19:\"2022-02-16 08:40:11\";s:7:\"package\";s:78:\"https://downloads.wordpress.org/translation/plugin/svg-support/2.4.2/ru_RU.zip\";s:10:\"autoupdate\";b:1;}i:2;a:7:{s:4:\"type\";s:6:\"plugin\";s:4:\"slug\";s:14:\"duplicate-post\";s:8:\"language\";s:5:\"ru_RU\";s:7:\"version\";s:3:\"4.4\";s:7:\"updated\";s:19:\"2022-02-23 17:50:59\";s:7:\"package\";s:79:\"https://downloads.wordpress.org/translation/plugin/duplicate-post/4.4/ru_RU.zip\";s:10:\"autoupdate\";b:1;}}s:9:\"no_update\";a:7:{s:19:\"akismet/akismet.php\";O:8:\"stdClass\":10:{s:2:\"id\";s:21:\"w.org/plugins/akismet\";s:4:\"slug\";s:7:\"akismet\";s:6:\"plugin\";s:19:\"akismet/akismet.php\";s:11:\"new_version\";s:5:\"4.2.2\";s:3:\"url\";s:38:\"https://wordpress.org/plugins/akismet/\";s:7:\"package\";s:56:\"https://downloads.wordpress.org/plugin/akismet.4.2.2.zip\";s:5:\"icons\";a:2:{s:2:\"2x\";s:59:\"https://ps.w.org/akismet/assets/icon-256x256.png?rev=969272\";s:2:\"1x\";s:59:\"https://ps.w.org/akismet/assets/icon-128x128.png?rev=969272\";}s:7:\"banners\";a:1:{s:2:\"1x\";s:61:\"https://ps.w.org/akismet/assets/banner-772x250.jpg?rev=479904\";}s:11:\"banners_rtl\";a:0:{}s:8:\"requires\";s:3:\"5.0\";}s:45:\"enable-svg-webp-ico-upload/itc-svg-upload.php\";O:8:\"stdClass\":10:{s:2:\"id\";s:40:\"w.org/plugins/enable-svg-webp-ico-upload\";s:4:\"slug\";s:26:\"enable-svg-webp-ico-upload\";s:6:\"plugin\";s:45:\"enable-svg-webp-ico-upload/itc-svg-upload.php\";s:11:\"new_version\";s:5:\"1.0.1\";s:3:\"url\";s:57:\"https://wordpress.org/plugins/enable-svg-webp-ico-upload/\";s:7:\"package\";s:75:\"https://downloads.wordpress.org/plugin/enable-svg-webp-ico-upload.1.0.1.zip\";s:5:\"icons\";a:2:{s:2:\"2x\";s:79:\"https://ps.w.org/enable-svg-webp-ico-upload/assets/icon-256x256.png?rev=2510822\";s:2:\"1x\";s:79:\"https://ps.w.org/enable-svg-webp-ico-upload/assets/icon-256x256.png?rev=2510822\";}s:7:\"banners\";a:1:{s:2:\"1x\";s:81:\"https://ps.w.org/enable-svg-webp-ico-upload/assets/banner-772x250.png?rev=2510822\";}s:11:\"banners_rtl\";a:0:{}s:8:\"requires\";s:3:\"4.7\";}s:9:\"hello.php\";O:8:\"stdClass\":10:{s:2:\"id\";s:25:\"w.org/plugins/hello-dolly\";s:4:\"slug\";s:11:\"hello-dolly\";s:6:\"plugin\";s:9:\"hello.php\";s:11:\"new_version\";s:5:\"1.7.2\";s:3:\"url\";s:42:\"https://wordpress.org/plugins/hello-dolly/\";s:7:\"package\";s:60:\"https://downloads.wordpress.org/plugin/hello-dolly.1.7.2.zip\";s:5:\"icons\";a:2:{s:2:\"2x\";s:64:\"https://ps.w.org/hello-dolly/assets/icon-256x256.jpg?rev=2052855\";s:2:\"1x\";s:64:\"https://ps.w.org/hello-dolly/assets/icon-128x128.jpg?rev=2052855\";}s:7:\"banners\";a:2:{s:2:\"2x\";s:67:\"https://ps.w.org/hello-dolly/assets/banner-1544x500.jpg?rev=2645582\";s:2:\"1x\";s:66:\"https://ps.w.org/hello-dolly/assets/banner-772x250.jpg?rev=2052855\";}s:11:\"banners_rtl\";a:0:{}s:8:\"requires\";s:3:\"4.6\";}s:27:\"svg-favicon/svg-favicon.php\";O:8:\"stdClass\":10:{s:2:\"id\";s:25:\"w.org/plugins/svg-favicon\";s:4:\"slug\";s:11:\"svg-favicon\";s:6:\"plugin\";s:27:\"svg-favicon/svg-favicon.php\";s:11:\"new_version\";s:5:\"1.2.2\";s:3:\"url\";s:42:\"https://wordpress.org/plugins/svg-favicon/\";s:7:\"package\";s:54:\"https://downloads.wordpress.org/plugin/svg-favicon.zip\";s:5:\"icons\";a:3:{s:2:\"2x\";s:64:\"https://ps.w.org/svg-favicon/assets/icon-256x256.png?rev=2350150\";s:2:\"1x\";s:56:\"https://ps.w.org/svg-favicon/assets/icon.svg?rev=2350150\";s:3:\"svg\";s:56:\"https://ps.w.org/svg-favicon/assets/icon.svg?rev=2350150\";}s:7:\"banners\";a:2:{s:2:\"2x\";s:67:\"https://ps.w.org/svg-favicon/assets/banner-1544x500.png?rev=2687234\";s:2:\"1x\";s:66:\"https://ps.w.org/svg-favicon/assets/banner-772x250.png?rev=2687234\";}s:11:\"banners_rtl\";a:0:{}s:8:\"requires\";s:3:\"5.1\";}s:27:\"svg-support/svg-support.php\";O:8:\"stdClass\":10:{s:2:\"id\";s:25:\"w.org/plugins/svg-support\";s:4:\"slug\";s:11:\"svg-support\";s:6:\"plugin\";s:27:\"svg-support/svg-support.php\";s:11:\"new_version\";s:5:\"2.4.2\";s:3:\"url\";s:42:\"https://wordpress.org/plugins/svg-support/\";s:7:\"package\";s:60:\"https://downloads.wordpress.org/plugin/svg-support.2.4.2.zip\";s:5:\"icons\";a:3:{s:2:\"2x\";s:64:\"https://ps.w.org/svg-support/assets/icon-256x256.png?rev=1417738\";s:2:\"1x\";s:56:\"https://ps.w.org/svg-support/assets/icon.svg?rev=1417738\";s:3:\"svg\";s:56:\"https://ps.w.org/svg-support/assets/icon.svg?rev=1417738\";}s:7:\"banners\";a:2:{s:2:\"2x\";s:67:\"https://ps.w.org/svg-support/assets/banner-1544x500.jpg?rev=1215377\";s:2:\"1x\";s:66:\"https://ps.w.org/svg-support/assets/banner-772x250.jpg?rev=1215377\";}s:11:\"banners_rtl\";a:0:{}s:8:\"requires\";s:3:\"4.8\";}s:27:\"cyr-and-lat/cyr-and-lat.php\";O:8:\"stdClass\":10:{s:2:\"id\";s:25:\"w.org/plugins/cyr-and-lat\";s:4:\"slug\";s:11:\"cyr-and-lat\";s:6:\"plugin\";s:27:\"cyr-and-lat/cyr-and-lat.php\";s:11:\"new_version\";s:5:\"1.2.0\";s:3:\"url\";s:42:\"https://wordpress.org/plugins/cyr-and-lat/\";s:7:\"package\";s:54:\"https://downloads.wordpress.org/plugin/cyr-and-lat.zip\";s:5:\"icons\";a:2:{s:2:\"2x\";s:64:\"https://ps.w.org/cyr-and-lat/assets/icon-256x256.jpg?rev=1877806\";s:2:\"1x\";s:64:\"https://ps.w.org/cyr-and-lat/assets/icon-128x128.jpg?rev=1877806\";}s:7:\"banners\";a:2:{s:2:\"2x\";s:67:\"https://ps.w.org/cyr-and-lat/assets/banner-1544x500.jpg?rev=1877806\";s:2:\"1x\";s:66:\"https://ps.w.org/cyr-and-lat/assets/banner-772x250.jpg?rev=1877806\";}s:11:\"banners_rtl\";a:0:{}s:8:\"requires\";s:3:\"4.2\";}s:33:\"duplicate-post/duplicate-post.php\";O:8:\"stdClass\":10:{s:2:\"id\";s:28:\"w.org/plugins/duplicate-post\";s:4:\"slug\";s:14:\"duplicate-post\";s:6:\"plugin\";s:33:\"duplicate-post/duplicate-post.php\";s:11:\"new_version\";s:3:\"4.4\";s:3:\"url\";s:45:\"https://wordpress.org/plugins/duplicate-post/\";s:7:\"package\";s:61:\"https://downloads.wordpress.org/plugin/duplicate-post.4.4.zip\";s:5:\"icons\";a:2:{s:2:\"2x\";s:67:\"https://ps.w.org/duplicate-post/assets/icon-256x256.png?rev=2336666\";s:2:\"1x\";s:67:\"https://ps.w.org/duplicate-post/assets/icon-128x128.png?rev=2336666\";}s:7:\"banners\";a:2:{s:2:\"2x\";s:70:\"https://ps.w.org/duplicate-post/assets/banner-1544x500.png?rev=2336666\";s:2:\"1x\";s:69:\"https://ps.w.org/duplicate-post/assets/banner-772x250.png?rev=2336666\";}s:11:\"banners_rtl\";a:0:{}s:8:\"requires\";s:3:\"5.6\";}}s:7:\"checked\";a:8:{s:41:\"advanced-custom-fields-pro-master/acf.php\";s:5:\"5.9.1\";s:19:\"akismet/akismet.php\";s:5:\"4.2.2\";s:45:\"enable-svg-webp-ico-upload/itc-svg-upload.php\";s:5:\"1.0.1\";s:9:\"hello.php\";s:5:\"1.7.2\";s:27:\"svg-favicon/svg-favicon.php\";s:5:\"1.2.2\";s:27:\"svg-support/svg-support.php\";s:5:\"2.4.2\";s:27:\"cyr-and-lat/cyr-and-lat.php\";s:5:\"1.2.0\";s:33:\"duplicate-post/duplicate-post.php\";s:3:\"4.4\";}}', 'no'),
(454, '_site_transient_timeout_browser_886aa8f0a3040198bf97c9bdf4169483', '1649788627', 'no'),
(455, '_site_transient_browser_886aa8f0a3040198bf97c9bdf4169483', 'a:10:{s:4:\"name\";s:6:\"Chrome\";s:7:\"version\";s:13:\"100.0.4896.75\";s:8:\"platform\";s:9:\"Macintosh\";s:10:\"update_url\";s:29:\"https://www.google.com/chrome\";s:7:\"img_src\";s:43:\"http://s.w.org/images/browsers/chrome.png?1\";s:11:\"img_src_ssl\";s:44:\"https://s.w.org/images/browsers/chrome.png?1\";s:15:\"current_version\";s:2:\"18\";s:7:\"upgrade\";b:0;s:8:\"insecure\";b:0;s:6:\"mobile\";b:0;}', 'no'),
(456, '_site_transient_timeout_community-events-d41d8cd98f00b204e9800998ecf8427e', '1649227034', 'no'),
(457, '_site_transient_community-events-d41d8cd98f00b204e9800998ecf8427e', 'a:4:{s:9:\"sandboxed\";b:0;s:5:\"error\";N;s:8:\"location\";a:1:{s:2:\"ip\";b:0;}s:6:\"events\";a:1:{i:0;a:10:{s:4:\"type\";s:8:\"wordcamp\";s:5:\"title\";s:15:\"WordCamp Europe\";s:3:\"url\";s:33:\"https://europe.wordcamp.org/2022/\";s:6:\"meetup\";s:0:\"\";s:10:\"meetup_url\";s:0:\"\";s:4:\"date\";s:19:\"2022-06-02 00:00:00\";s:8:\"end_date\";s:19:\"2022-06-04 00:00:00\";s:20:\"start_unix_timestamp\";i:1654124400;s:18:\"end_unix_timestamp\";i:1654297200;s:8:\"location\";a:4:{s:8:\"location\";s:5:\"Porto\";s:7:\"country\";s:2:\"PT\";s:8:\"latitude\";d:41.147;s:9:\"longitude\";d:-8.625;}}}}', 'no'),
(458, '_transient_timeout_feed_92227bfe1354c9fe21266d111aae5ed4', '1649227035', 'no');
INSERT INTO `urotec_options` (`option_id`, `option_name`, `option_value`, `autoload`) VALUES
(459, '_transient_feed_92227bfe1354c9fe21266d111aae5ed4', 'a:4:{s:5:\"child\";a:1:{s:0:\"\";a:1:{s:3:\"rss\";a:1:{i:0;a:6:{s:4:\"data\";s:3:\"\n\n\n\";s:7:\"attribs\";a:1:{s:0:\"\";a:1:{s:7:\"version\";s:3:\"2.0\";}}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";s:5:\"child\";a:1:{s:0:\"\";a:1:{s:7:\"channel\";a:1:{i:0;a:6:{s:4:\"data\";s:49:\"\n	\n	\n	\n	\n	\n	\n	\n	\n	\n	\n		\n		\n		\n		\n		\n		\n		\n		\n		\n	\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";s:5:\"child\";a:3:{s:0:\"\";a:7:{s:5:\"title\";a:1:{i:0;a:5:{s:4:\"data\";s:39:\"Блог | WordPress.org Русский\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}s:4:\"link\";a:1:{i:0;a:5:{s:4:\"data\";s:24:\"https://ru.wordpress.org\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}s:11:\"description\";a:1:{i:0;a:5:{s:4:\"data\";s:14:\"Русский\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}s:13:\"lastBuildDate\";a:1:{i:0;a:5:{s:4:\"data\";s:31:\"Thu, 23 Dec 2021 05:43:51 +0000\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}s:8:\"language\";a:1:{i:0;a:5:{s:4:\"data\";s:5:\"ru-RU\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}s:9:\"generator\";a:1:{i:0;a:5:{s:4:\"data\";s:40:\"https://wordpress.org/?v=6.0-alpha-53068\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}s:4:\"item\";a:10:{i:0;a:6:{s:4:\"data\";s:57:\"\n		\n		\n		\n		\n		\n				\n		\n\n					\n										\n					\n		\n		\n			\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";s:5:\"child\";a:3:{s:0:\"\";a:6:{s:5:\"title\";a:1:{i:0;a:5:{s:4:\"data\";s:77:\"Основные моменты выступления State of the Word 2021\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}s:4:\"link\";a:1:{i:0;a:5:{s:4:\"data\";s:77:\"https://ru.wordpress.org/news/2021/12/highlights-from-state-of-the-word-2021/\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}s:7:\"pubDate\";a:1:{i:0;a:5:{s:4:\"data\";s:31:\"Mon, 20 Dec 2021 13:25:37 +0000\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}s:8:\"category\";a:1:{i:0;a:5:{s:4:\"data\";s:14:\"Новости\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}s:4:\"guid\";a:1:{i:0;a:5:{s:4:\"data\";s:32:\"https://ru.wordpress.org/?p=2400\";s:7:\"attribs\";a:1:{s:0:\"\";a:1:{s:11:\"isPermaLink\";s:5:\"false\";}}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}s:11:\"description\";a:1:{i:0;a:5:{s:4:\"data\";s:733:\"Посмотреть на WordPress.TV с субтитрами на русском языке. 14 декабря 2021 состоялось ежегодное выступление со-основателя WordPress Мэтта Мулленвега. Мероприятие прошло в Нью Йорке с небольшой аудиторией (требовалось подтверждение вакцинации). По словам Мэтта присутствовали как те, &#171;кто добирался самолетом, поездом и на автомобиле&#187;, так и те (виртуально), кто наблюдал за живым стримом онлайн, из дома, с [&#8230;]\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}}s:32:\"http://purl.org/dc/elements/1.1/\";a:1:{s:7:\"creator\";a:1:{i:0;a:5:{s:4:\"data\";s:3:\"Yui\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}}s:40:\"http://purl.org/rss/1.0/modules/content/\";a:1:{s:7:\"encoded\";a:1:{i:0;a:5:{s:4:\"data\";s:5932:\"\n<figure class=\"wp-block-embed is-type-video is-provider-youtube wp-block-embed-youtube wp-embed-aspect-16-9 wp-has-aspect-ratio\"><div class=\"wp-block-embed__wrapper\">\n<iframe class=\"youtube-player\" width=\"612\" height=\"345\" src=\"https://www.youtube.com/embed/OpiH_P9aGhQ?version=3&#038;rel=1&#038;showsearch=0&#038;showinfo=1&#038;iv_load_policy=1&#038;fs=1&#038;hl=ru-RU&#038;autohide=2&#038;wmode=transparent\" allowfullscreen=\"true\" style=\"border:0;\" sandbox=\"allow-scripts allow-same-origin allow-popups allow-presentation\"></iframe>\n</div></figure>\n\n\n\n<div class=\"wp-container-1 wp-block-columns\">\n<div class=\"wp-block-column\" style=\"flex-basis:100%\">\n<p class=\"has-text-align-center\"><a rel=\"noreferrer noopener\" href=\"https://wordpress.tv/2021/12/15/matt-mullenweg-2021-state-of-the-word/\" target=\"_blank\">Посмотреть на WordPress.TV с субтитрами на русском языке</a>.</p>\n</div>\n</div>\n\n\n\n<p>14 декабря 2021 состоялось ежегодное выступление со-основателя WordPress Мэтта Мулленвега. Мероприятие прошло в Нью Йорке с небольшой аудиторией (требовалось подтверждение вакцинации). По словам Мэтта присутствовали как те, &#171;кто добирался самолетом, поездом и на автомобиле&#187;, так и те (виртуально), кто наблюдал за живым стримом онлайн, из дома, с работы или с иного места. В одиннадцати странах более 300 зрителей вместе могли наблюдать выступление онлайн в 26 местах подготовленных организаторами.</p>\n\n\n\n<p>Выступление Мэтта явилось значимым событием для сообщества WordPress, также как и первый, спустя длительное время очный <a rel=\"noreferrer noopener\" href=\"https://sevilla.wordcamp.org/2021/\" target=\"_blank\">WordCamp в Севилье</a> (Испания). </p>\n\n\n\n<p>Вы можете <a rel=\"noreferrer noopener\" href=\"https://wordpress.tv/2021/12/15/matt-mullenweg-2021-state-of-the-word/\" target=\"_blank\">посмотреть выступление (с субтитрами на русском языке) на WordPress.TV</a>. </p>\n\n\n\n<p>Как и на выступлениях в предыдущие годы Мэтт Мулленвег затронул широкий ряд тем касательно прошлого, настоящего и будущего WordPress, к примеру основные моменты касались роста числа <a href=\"https://make.wordpress.org/\" target=\"_blank\" rel=\"noreferrer noopener\">участников сообщества</a>, <a rel=\"noreferrer noopener\" href=\"https://ru.wordpress.org/team/handbook/translations/\" target=\"_blank\">переводчиков</a>, ключевых этапов разработки предстоящего выпуска WordPress 5.9, а также образовательной инициативы <a href=\"https://learn.wordpress.org/\" target=\"_blank\" rel=\"noreferrer noopener\">Learn WordPress</a>.</p>\n\n\n\n<p>Касательно предстоящего выпуска WordPress были продемонстрированы несколько видеороликов с примерами полного редактирования сайта, паттернами блоков, расширенного управления изображениями, а также глобальными возможностями стилизации. </p>\n\n\n\n<p>Мэтт также напомнил о будущих фазах развития редактора блоков в направлении совместной работы над публикациями и многоязычности, он также упомянул о том, что каждый может внести свой вклад в развитие WordPress различными способами, от создания новых возможностей, до тестирования, обучения других и популяризации WordPress в обществе.</p>\n\n\n\n<blockquote class=\"wp-block-quote\"><p>Чем больше людей станут использовать WordPress, тем лучше он от этого станет.</p></blockquote>\n\n\n\n<p>Он также затронул такие темы как развитие глобальной сети в целом (Web3) и приобретение активов (на ряде слайдов в презентации).</p>\n\n\n\n<p>После выступления состоялась одночасовая <a rel=\"noreferrer noopener\" href=\"https://wordpress.tv/2021/12/15/matt-mullenweg-state-of-the-word-2021-qa/\" target=\"_blank\">сессия вопросов и ответов</a>, на которой Мэтт ответил на ряд вопросов, часть из которых были подготовлены заранее, так и поступили из зала или от участников живого стрима.</p>\n\n\n\n<p class=\"has-text-align-center\"><a rel=\"noreferrer noopener\" href=\"https://wordpress.tv/2021/12/15/matt-mullenweg-2021-state-of-the-word/\" target=\"_blank\">Посмотреть на WordPress.TV с субтитрами на русском языке</a>.</p>\n\n\n\n<div class=\"wp-container-2 wp-block-buttons\"></div>\n\n\n\n<p>Вы можете принять участие в обсуждении выступления используя хэш-тег <a rel=\"noreferrer noopener\" href=\"https://twitter.com/hashtag/ILoveWP\" target=\"_blank\">#ILoveWP в Twitter</a>. </p>\n\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}}}}i:1;a:6:{s:4:\"data\";s:60:\"\n		\n		\n		\n		\n		\n				\n		\n		\n\n					\n										\n					\n		\n		\n			\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";s:5:\"child\";a:3:{s:0:\"\";a:6:{s:5:\"title\";a:1:{i:0;a:5:{s:4:\"data\";s:45:\"Люди WordPress: Девин Мейстри\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}s:4:\"link\";a:1:{i:0;a:5:{s:4:\"data\";s:72:\"https://ru.wordpress.org/news/2021/12/people-of-wordpress-devin-maeztri/\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}s:7:\"pubDate\";a:1:{i:0;a:5:{s:4:\"data\";s:31:\"Thu, 02 Dec 2021 10:15:02 +0000\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}s:8:\"category\";a:2:{i:0;a:5:{s:4:\"data\";s:18:\"Люди WordPress\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}i:1;a:5:{s:4:\"data\";s:19:\"people-of-wordpress\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}s:4:\"guid\";a:1:{i:0;a:5:{s:4:\"data\";s:32:\"https://ru.wordpress.org/?p=2382\";s:7:\"attribs\";a:1:{s:0:\"\";a:1:{s:11:\"isPermaLink\";s:5:\"false\";}}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}s:11:\"description\";a:1:{i:0;a:5:{s:4:\"data\";s:688:\"В серии статей «Люди WordPress» мы делимся вдохновляющими историями о том, как WordPress и его глобальное сообщество меняют жизни людей к лучшему. В этом месяце мы рассказываем о переводчице, которая использует WordPress для освещения добрых дел и помогает людям в своем регионе использовать преимущества платформы с открытым исходным кодом. Девин Мейстри обнаружила, что поездка на [&#8230;]\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}}s:32:\"http://purl.org/dc/elements/1.1/\";a:1:{s:7:\"creator\";a:1:{i:0;a:5:{s:4:\"data\";s:3:\"Yui\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}}s:40:\"http://purl.org/rss/1.0/modules/content/\";a:1:{s:7:\"encoded\";a:1:{i:0;a:5:{s:4:\"data\";s:24211:\"\n<p>В серии статей «Люди WordPress» мы делимся вдохновляющими историями о том, как WordPress и его глобальное сообщество меняют жизни людей к лучшему. В этом месяце мы рассказываем о переводчице, которая использует WordPress для освещения добрых дел и помогает людям в своем регионе использовать преимущества платформы с открытым исходным кодом.</p>\n\n\n\n<div class=\"wp-block-image\"><figure class=\"aligncenter size-large\"><a href=\"https://ru.wordpress.org/files/2021/12/devin-with-her-cat-scaled-1.jpg\"><img loading=\"lazy\" width=\"768\" height=\"1024\" src=\"https://ru.wordpress.org/files/2021/12/devin-with-her-cat-scaled-1-768x1024.jpg\" alt=\"Девин изображена с одной из своих кошек\" class=\"wp-image-2384\" srcset=\"https://ru.wordpress.org/files/2021/12/devin-with-her-cat-scaled-1-768x1024.jpg 768w, https://ru.wordpress.org/files/2021/12/devin-with-her-cat-scaled-1-225x300.jpg 225w, https://ru.wordpress.org/files/2021/12/devin-with-her-cat-scaled-1.jpg 1152w\" sizes=\"(max-width: 768px) 100vw, 768px\" /></a><figcaption>Девин изображена с одной из своих кошек</figcaption></figure></div>\n\n\n\n<p>Девин Мейстри обнаружила, что поездка на WordCamp может изменить жизнь. Каждое следующее мероприятие для нее — очередной шаг на пути к открытию для себя сообщества WordPress и его многочисленных возможностей.</p>\n\n\n\n<blockquote class=\"wp-block-quote\"><p>Влюбиться в WordPress не так уж сложно, если вы можете испытать его на себе. Для меня это был WordCamp</p></blockquote>\n\n\n\n<p>В 2016 году, не особо размышляя, Девин стала волонтером на WordCamp Denpasar, Бали. Это был ее первый опыт участия в мероприятиях WordPress.&nbsp;</p>\n\n\n\n<p>Здесь она сделала удивительное открытие: «WordCamp объединяет людей, которые вносят вклад в сообщество, не получая прямой выгоды от WordPress».</p>\n\n\n\n<p>С каждым следующим WordCamp все становилось только интересней и Девин поняла, что хочет посещать мероприятия WordPress чаще. Она стала постоянным участником митапов в Убуде и Джакарте, а позже — соорганизатором этих митапов и WordCamp Jakarta в 2017 и 2019 годах.&nbsp;</p>\n\n\n\n<p>Вдохновленная тем, что могут предложить мероприятия WordCamp и как они объединяют людей несмотря на национальные границы, она присоединилась к команде организаторов WordCamp Asia 2020. К сожалению, это оказалось первым крупным мероприятием WordPress, которое было отменено в связи с пандемией COVID-19.&nbsp;</p>\n\n\n\n<p>Девин надеется, что WordCamp Asia состоится в скором будущем. Помимо возможности получить новые знания о WordPress и обмена опытом, которые являются неотъемлемой частью любого WordCamp, она считает, что столько масштабное мероприятие может стать наглядным примером, как WordCamp способствует международному туризму и культурному обмену везде, где проводится.</p>\n\n\n\n<div class=\"wp-block-image\"><figure class=\"aligncenter size-full\"><a href=\"https://ru.wordpress.org/files/2021/12/wcasia_2020_organizers_in_wceu_2019.jpeg\"><img loading=\"lazy\" width=\"1024\" height=\"1024\" src=\"https://ru.wordpress.org/files/2021/12/wcasia_2020_organizers_in_wceu_2019.jpeg\" alt=\"Девин на фото с другими организаторами WordCamp Asia на WordCamp Europe в 2019 году\" class=\"wp-image-2386\" srcset=\"https://ru.wordpress.org/files/2021/12/wcasia_2020_organizers_in_wceu_2019.jpeg 1024w, https://ru.wordpress.org/files/2021/12/wcasia_2020_organizers_in_wceu_2019-300x300.jpeg 300w, https://ru.wordpress.org/files/2021/12/wcasia_2020_organizers_in_wceu_2019-150x150.jpeg 150w, https://ru.wordpress.org/files/2021/12/wcasia_2020_organizers_in_wceu_2019-768x768.jpeg 768w\" sizes=\"(max-width: 1024px) 100vw, 1024px\" /></a><figcaption>Организаторы WordCamp Asia 2020 на WordCamp Europe 2019. Девин — вторая слева в первом ряду. Фото: Аба Такор</figcaption></figure></div>\n\n\n\n<h2 id=\"wordpress-как-платформа-для-развития-местного-бизнеса\">WordPress как платформа для развития местного бизнеса</h2>\n\n\n\n<p>После посещения нескольких мероприятий у Девин возникли вопросы: «На WordCamps и Meetups вы слышите истории о том, как WordPress обогащает интернет. Как он меняет жизнь многих людей, как помогает мечтам сбываться. Это заставило меня задуматься: если WordPress настолько мощный инструмент, почему в Индонезии ни так много людей имеющих веб сайты и не так много использует WordPress? Почему ни так много талантливых индонезийских пользователей, разработчиков WordPress, дизайнеров и владельцев бизнеса принимают участие в проектах WordPress.org? Языковой барьер для меня стал главным ответом».</p>\n\n\n\n<p>Девин нашла решение — сделать WordPress доступным на основном местном языке. Она говорит: «Я считаю, что чем больше контента будет переведено на индонезийский язык, тем больше индонезийских пользователей WordPress увидят, что WordPress — это не просто платформа для ведения блогов или система управления контентом. Они поймут, что это огромное сообщество программного обеспечения открытым исходным кодом, которое работает сообща, чтобы сделать Интернет лучше. Чем больше плагинов и тем будет переведено, тем легче будет работа разработчиков и дизайнеров. Чем больше людей увидят, как WordPress может улучшить их жизнь, тем лучше станет экосистема для владельцев бизнеса».</p>\n\n\n\n<h2 id=\"вдохновление-собственным-примером\">Вдохновление собственным примером</h2>\n\n\n\n<p>Поговорив с другими людьми о том, как WordPress может быть более полезным в Индонезии, Девин почувствовала, что должна взять на себя личное обязательство возродить проект Polyglots в Индонезии. С помощью еще одного добровольного помощника и благодаря продвижению проекта местная команда «Полиглотов» стала больше, и интерес к переводу WordPress вырос. Она также взяла на себя обязанности главного редактора переводов (GTE) для индонезийского языка.</p>\n\n\n\n<figure class=\"wp-block-image size-large\"><a href=\"https://ru.wordpress.org/files/2021/12/featured-img-used-for-devin-pow2.jpg\"><img loading=\"lazy\" width=\"1024\" height=\"515\" src=\"https://ru.wordpress.org/files/2021/12/featured-img-used-for-devin-pow2-1024x515.jpg\" alt=\"Девин Мейстри — номинант WordPress Polyglosts Особая признательность\" class=\"wp-image-2388\" srcset=\"https://ru.wordpress.org/files/2021/12/featured-img-used-for-devin-pow2-1024x515.jpg 1024w, https://ru.wordpress.org/files/2021/12/featured-img-used-for-devin-pow2-300x151.jpg 300w, https://ru.wordpress.org/files/2021/12/featured-img-used-for-devin-pow2-768x386.jpg 768w, https://ru.wordpress.org/files/2021/12/featured-img-used-for-devin-pow2.jpg 1247w\" sizes=\"(max-width: 1024px) 100vw, 1024px\" /></a></figure>\n\n\n\n<p>Благодаря усилиям Девин и других редакторов переводов Индонезия приняла участие в WordPress Translation Day в 2020 году, а в 2021 году проводила спринты и обучающие сессии в течение всех 30 дней мероприятия.</p>\n\n\n\n<p>Ее энтузиазм и преданность делу помощи другим в переводе WordPress на местном уровне и по продвижению глобального сообщества были отмечены в номинации WordPress Polyglosts «Особая признательность» в 2021 году.</p>\n\n\n\n<h2 id=\"диверсификация-сообщества\">Диверсификация сообщества</h2>\n\n\n\n<p>Занимаясь переводами, Девин заметила, что в сообществе WordPress в Индонезии не так много женщин. Часто она оказывалась единственной женщиной на каком-либо мероприятии.</p>\n\n\n\n<p>Поэтому вместе с несколькими членами сообщества она основала местное сообщество Perempuan WordPress. Эта группа открыта для всех желающих, но приоритет отдается женщинам в качестве докладчиков на мероприятиях.</p>\n\n\n\n<p>Девин пошла дальше и поддержала работу группы по диверсификации спикеров (Diversity Speaker Training group) в Команде сообщества (Community Team), переводя материалы и продвигая инициативы группы в Индонезии. Она стремится поощрять других к участию в этой инициативе, которая помогает увеличить разнообразие докладчиков на митапах и WordCamp.</p>\n\n\n\n<div class=\"wp-block-image\"><figure class=\"aligncenter size-full\"><a href=\"https://ru.wordpress.org/files/2021/12/devin-at-wc-jakarta2019.png\"><img loading=\"lazy\" width=\"600\" height=\"534\" src=\"https://ru.wordpress.org/files/2021/12/devin-at-wc-jakarta2019.png\" alt=\"Девин — организатор WordCamp Jakarta 2019\" class=\"wp-image-2389\" srcset=\"https://ru.wordpress.org/files/2021/12/devin-at-wc-jakarta2019.png 600w, https://ru.wordpress.org/files/2021/12/devin-at-wc-jakarta2019-300x267.png 300w\" sizes=\"(max-width: 600px) 100vw, 600px\" /></a><figcaption>Девин — организатор WordCamp Jakarta 2019</figcaption></figure></div>\n\n\n\n<p>В своей профессиональной деятельности Девин выступает за WordPress как инструмент для людей с самыми разными навыками. Она не пишет код, но широко использует платформу для своих проектов. В 2014 году она зарегистрировала бесплатный аккаунт на WordPress.com, чтобы сохранять и делиться заметками о том, что она видела или о чем думала, когда ехала на работу в общественном транспорте. Этот сайт не превратился в блог, но познакомил ее с широкими возможностями платформы.</p>\n\n\n\n<h2 id=\"wordpress-для-поддержки-талантов-и-развития-инициатив\">WordPress для поддержки талантов и развития инициатив</h2>\n\n\n\n<p>Имея опыт работы в экологическом активизме, Девин принимала участие в международном развитии организаций, занимаясь всем от политики до конкретных кампаний.&nbsp;</p>\n\n\n\n<p>Она работала с политиками и организовывала конференции и встречи. Это означало — много писать, переводить и работать с людьми на местах, на которых влияла политика. «Моя работа на местах обычно включала в себя исследования, организацию общественных движений и расширение прав и возможностей сообщества», — отметила она.</p>\n\n\n\n<p>Опыт проведения мероприятий вдохновил Девин на участие в митапах и WordCamp, делиться с другими своей энергией, чтобы задумано реализовывалось. Как и в своей профессиональной деятельности, она почувствовала, что WordPress — это возможность работать и делиться с людьми тем, что может изменить чью-то жизнь к лучшему.</p>\n\n\n\n<p>«Для меня все идет от сердца. Я делаю то, к чему испытываю сильные чувства. То, что зовет меня, и то, что у меня хорошо получается, но при этом дает мне возможность учиться и становиться лучше. WordPress может быть идеальным местом для этого».</p>\n\n\n\n<p>Во время между сменой работы, Девин предложили стать волонтером на WordCamp Denpasar 2016. С некоторой помощью она создала себе онлайн-резюме (CV), научилась управлять сайтом на WordPress, ориентироваться в wp-admin и делать контент привлекательным для потенциальных работодателей.&nbsp;</p>\n\n\n\n<p>В результате она получила работу в качестве организатора кампании по продвижению онлайн и оффлайн. Эта кампания была детищем группы университетских друзей в Америке, которым собрались выйти на мировой уровень, и в ней использовался WordPress. </p>\n\n\n\n<p>Девин работала вместе со специалистом по продвижению и помогала формировать содержимое, призывы к действию (CTA) и пользовательский опыт (UX). Ей также пришлось работать с бэкендом для внесения корректировок. Поскольку компания была глобальной, все материалы разрабатывались на английском и Девин плотно работала с переводчиками и контролировала их работу.</p>\n\n\n\n<div class=\"wp-block-image\"><figure class=\"aligncenter size-full\"><a href=\"https://ru.wordpress.org/files/2021/12/cat-watching-translation-scaled-1.jpg\"><img loading=\"lazy\" width=\"1024\" height=\"768\" src=\"https://ru.wordpress.org/files/2021/12/cat-watching-translation-scaled-1.jpg\" alt=\"Одна из кошек Девин наблюдает за онлайн-трансляцией событий WPTranslationDay 2021.\" class=\"wp-image-2391\" srcset=\"https://ru.wordpress.org/files/2021/12/cat-watching-translation-scaled-1.jpg 1024w, https://ru.wordpress.org/files/2021/12/cat-watching-translation-scaled-1-300x225.jpg 300w, https://ru.wordpress.org/files/2021/12/cat-watching-translation-scaled-1-768x576.jpg 768w, https://ru.wordpress.org/files/2021/12/cat-watching-translation-scaled-1-440x330.jpg 440w\" sizes=\"(max-width: 1024px) 100vw, 1024px\" /></a><figcaption>Кошка Девин стала постоянной участницей публикаций в социальных сетях о #WPTranslationDay 2021</figcaption></figure></div>\n\n\n\n<p>В конце 2018 года она оставила свою работу в качестве организатора кампаний, чтобы сосредоточиться на фриланс проектах и проводить больше времени, внося свой вклад в сообщество WordPress. Она также выступила с инициативой помощи уличным кошкам в Джакарте.&nbsp;</p>\n\n\n\n<p>Девин сказала: </p>\n\n\n\n<blockquote class=\"wp-block-quote\"><p>Итак, я занята тем, что помогаю этим кошкам, а также учусь собирать средства с помощью веб-сайта. Я учусь использовать онлайн-формы, настраивать платежные системы, работать над SEO и делать другие новые вещи, которые мне необходимо изучить для развития моей инициативы. У меня есть привилегия учиться непосредственно у личного гуру. Того самого человека, который убедил меня стать волонтером на WordCamp Denpasar, и за которого я вышла замуж в 2018 году.</p></blockquote>\n\n\n\n<h2 id=\"wordpress-дает-возможность-учиться-всем\">WordPress дает возможность учиться всем</h2>\n\n\n\n<p>Девин нравится участие в жизни сообщества WordPress, поэтому она с удовольствием снялась для серии видеороликов, завершивших мероприятия в рамках Translation Day 2021.</p>\n\n\n\n<figure class=\"wp-block-embed is-type-rich is-provider-вставить-обработчик wp-block-embed-вставить-обработчик\"><div class=\"wp-block-embed__wrapper\">\n<iframe loading=\"lazy\" class=\"youtube-player\" width=\"612\" height=\"345\" src=\"https://www.youtube.com/embed/VsiQzdmAz8g?version=3&#038;rel=1&#038;showsearch=0&#038;showinfo=1&#038;iv_load_policy=1&#038;fs=1&#038;hl=ru-RU&#038;autohide=2&#038;wmode=transparent\" allowfullscreen=\"true\" style=\"border:0;\" sandbox=\"allow-scripts allow-same-origin allow-popups allow-presentation\"></iframe>\n</div></figure>\n\n\n\n<p>В этом коротком ролике Девин рассказывает о переводах (открывается в новой вкладке на YouTube).</p>\n\n\n\n<p>Она также активно участвует в работе других команд Сообщества WordPress и решила стать представителем команды Сообщества (Community Team Deputy), чтобы поддерживать встречи в новых городах Индонезии и, возможно, будущие мероприятия WordCamp.&nbsp;</p>\n\n\n\n<p>Она говорит: «Мне нравится в WordPress то, что он очень гостеприимен и открыт для таких людей, как я, которые совсем не пишут код. В то же время, он открывает мне новый взгляд на мир».</p>\n\n\n\n<p>Девин верит в силу WordPress, которая дает «каждому шанс научиться новому» и позволяет ей вносить свой вклад и делиться своими знаниями и опытом. «Внося свой вклад, я надеюсь изменить чью-то жизнь к лучшему. Я надеюсь, что они почувствуют пользу от использования WordPress и захотят внести свой вклад, чтобы создать более здоровое сообщество WordPress».</p>\n\n\n\n<h2 id=\"авторы-и-редакторы\">Авторы и редакторы</h2>\n\n\n\n<p>Спасибо Абе Такор (<a href=\"https://profiles.wordpress.org/webcommsat/\">@webcommsat</a>) и Мери Баум (<a href=\"https://profiles.wordpress.org/marybaum/\">@marybaum</a>) за проведение интервью и написание данной статьи, и Девин Мейстри (<a href=\"https://profiles.wordpress.org/devinmaeztri/\">@devinmaeztri</a>) за то, что поделилась своей историей. Спасибо Мехер Бала (<a href=\"https://profiles.wordpress.org/meher/\">@meher</a>) за работу над фотографиями и Хлое Брингманн (<a href=\"https://profiles.wordpress.org/cbringmann/\">@cbringmann</a>) и Коллис Кларк (<a href=\"https://profiles.wordpress.org/callye/\">@callye</a>) за редактуру.&nbsp;</p>\n\n\n\n<p>Спасибо Джозефе Хайден (<a href=\"https://profiles.wordpress.org/chanthaboune/\">@chanthaboune</a>) и Тоферу ДеРозиа (<a href=\"https://profiles.wordpress.org/topher1kenobe/\">@topher1kenobe</a>) за поддержку данной серии.<br>Перевод на русский: Ольга Глеклер (<a href=\"https://profiles.wordpress.org/oglekler/\">@oglekler</a>)</p>\n\n\n\n<div class=\"wp-block-media-text alignwide is-stacked-on-mobile\" style=\"grid-template-columns:25% auto\"><figure class=\"wp-block-media-text__media\"><img loading=\"lazy\" width=\"180\" height=\"135\" src=\"https://ru.wordpress.org/files/2021/03/heropress-logo.png\" alt=\"\" class=\"wp-image-2268 size-full\" /></figure><div class=\"wp-block-media-text__content\">\n<p>Эта статья основана на первоначальной публикации HeroPress.com, инициативе, ориентированной на людей в сообществе WordPress, созданной Тофером ДеРозиа <a href=\"https://profiles.wordpress.org/topher1kenobe/\">@topher1kenobe</a>.</p>\n\n\n\n<p>Читайте эту и другие истории серии «<a href=\"https://wordpress.org/news/category/interviews/\">People of WordPress</a>» (на английском) или «<a href=\"https://ru.wordpress.org/news/category/people-of-wordpress/\">Люди WordPress</a>» (на русском).</p>\n</div></div>\n\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}}}}i:2;a:6:{s:4:\"data\";s:60:\"\n		\n		\n		\n		\n		\n				\n		\n		\n\n					\n										\n					\n		\n		\n			\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";s:5:\"child\";a:3:{s:0:\"\";a:6:{s:5:\"title\";a:1:{i:0;a:5:{s:4:\"data\";s:116:\"Ежегодный опрос пользователей и участников разработки WordPress 2021\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}s:4:\"link\";a:1:{i:0;a:5:{s:4:\"data\";s:57:\"https://ru.wordpress.org/news/2021/11/2021-annual-survey/\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}s:7:\"pubDate\";a:1:{i:0;a:5:{s:4:\"data\";s:31:\"Fri, 12 Nov 2021 09:16:36 +0000\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}s:8:\"category\";a:2:{i:0;a:5:{s:4:\"data\";s:14:\"Новости\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}i:1;a:5:{s:4:\"data\";s:25:\"Общие вопросы\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}s:4:\"guid\";a:1:{i:0;a:5:{s:4:\"data\";s:32:\"https://ru.wordpress.org/?p=2373\";s:7:\"attribs\";a:1:{s:0:\"\";a:1:{s:11:\"isPermaLink\";s:5:\"false\";}}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}s:11:\"description\";a:1:{i:0;a:5:{s:4:\"data\";s:715:\"Каждый год сообщество WordPress проводит ежегодный опрос для пользователей и участников сообщества. Ключевые выводы и тенденции, выявляемые в результате этого опроса, часто отражаются в ежегодном обращении State of the Word, публикуются в общедоступных блогах проекта и могут влиять на направление и стратегию проекта WordPress. Проще говоря: этот опрос помогает тем, кто создает WordPress, больше узнать [&#8230;]\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}}s:32:\"http://purl.org/dc/elements/1.1/\";a:1:{s:7:\"creator\";a:1:{i:0;a:5:{s:4:\"data\";s:3:\"Yui\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}}s:40:\"http://purl.org/rss/1.0/modules/content/\";a:1:{s:7:\"encoded\";a:1:{i:0;a:5:{s:4:\"data\";s:5922:\"\n<div class=\"wp-block-media-text alignwide has-media-on-the-right is-stacked-on-mobile\"><figure class=\"wp-block-media-text__media\"><img loading=\"lazy\" width=\"768\" height=\"342\" src=\"https://ru.wordpress.org/files/2019/11/image-12-1.png\" alt=\"\" class=\"wp-image-2145 size-full\" srcset=\"https://ru.wordpress.org/files/2019/11/image-12-1.png 768w, https://ru.wordpress.org/files/2019/11/image-12-1-300x134.png 300w\" sizes=\"(max-width: 768px) 100vw, 768px\" /></figure><div class=\"wp-block-media-text__content\">\n<p style=\"font-size:18px\">Каждый год сообщество WordPress проводит ежегодный опрос для пользователей и участников сообщества. </p>\n</div></div>\n\n\n\n<p>Ключевые выводы и тенденции, выявляемые в результате этого опроса, часто отражаются в ежегодном обращении <a href=\"https://wordpress.tv/tag/state-of-the-word/\" target=\"_blank\" rel=\"noreferrer noopener\">State of the Word</a>, публикуются в общедоступных блогах проекта и могут влиять на направление и стратегию проекта WordPress.</p>\n\n\n\n<p>Проще говоря: этот опрос помогает тем, кто создает WordPress, больше узнать о том, как и кем используется программное обеспечение. Опрос также помогает руководителям проектов с открытым исходным кодом WordPress больше узнать об опыте наших участников.</p>\n\n\n\n<p>В этом году мы также предлагаем пройти вам этот опрос</p>\n\n\n\n<div class=\"wp-container-3 wp-block-buttons\">\n<div class=\"wp-block-button is-style-outline\"><a class=\"wp-block-button__link\" href=\"https://wordpressdotorg.survey.fm/wordpress-2021-survey-russian\" target=\"_blank\" rel=\"noreferrer noopener\">На русском</a></div>\n\n\n\n<div class=\"wp-block-button is-style-outline\"><a class=\"wp-block-button__link\" href=\"https://wordpressdotorg.survey.fm/wordpress-2021-survey-english\" target=\"_blank\" rel=\"noreferrer noopener\">On english</a></div>\n</div>\n\n\n\n<p>как и в прошлом году, предлагаются и другие языки &#8212; <a href=\"https://wordpressdotorg.survey.fm/wordpress-2021-survey-french\">французский</a>, <a href=\"https://wordpressdotorg.survey.fm/wordpress-2021-survey-german\">немецкий</a>, <a href=\"https://wordpressdotorg.survey.fm/wordpress-2021-survey-spanish\">испанский</a> и <a href=\"https://wordpressdotorg.survey.fm/wordpress-2021-survey-japanese\">японский</a>. Это пять наиболее используемых языков, помимо английского, основываясь на количестве загрузок программного обеспечения WordPress. Возможно в 2022 году будут добавлены и другие.</p>\n\n\n\n<p>Сбор данных осуществляется в полном соответствии с <a rel=\"noreferrer noopener\" href=\"https://ru.wordpress.org/about/privacy/\" target=\"_blank\">политикой конфиденциальности WordPress.org</a>: все данные будут анонимизированы и не будут ассоциироваться с IP-адресами и адресами e-mail.</p>\n\n\n\n<p>Опрос открыт до конца 2021 года, его результаты будут опубликованы позже в блоге WordPress.org. В следующем году у опроса будет новый формат, который позволит наиболее эффективно использовать потраченное на него ваше время.</p>\n\n\n\n<h2 id=\"результаты-опроса-2020-г\">Результаты опроса 2020 г.</h2>\n\n\n\n<p>В опросе 2020 года было собрано более 17000 ответов, что представляет собой самый высокий объем за четыре года и в три раза больше, чем в предыдущем году. В первый год опроса (2015) было собрано более 50 000 ответов. Учитывая охват и распространение WordPress, мы еще не достигли значительного числа участников. Принимая участие в опросе 2021 года, подумайте о том, чтобы поделиться ссылкой в ​​социальных сетях с коллегами и друзьями, которые используют WordPress. Получение отзывов от большего числа людей, пользующихся WordPress, укрепит наш проект.</p>\n\n\n\n<div class=\"wp-container-4 wp-block-buttons\">\n<div class=\"wp-block-button aligncenter is-style-outline\"><a class=\"wp-block-button__link\" href=\"https://wordpress.org/news/files/2021/11/WordPress.org-2020-Annual-Survey.pdf\" target=\"_blank\" rel=\"noreferrer noopener\">PDF-файл с результатами опроса 2020г.</a></div>\n</div>\n\n\n\n<p>Результаты опроса 2020 года показывают, что пандемия оказала серьезное влияние на то, как мы работаем как сообщество. Из-за небольшого количества очных мероприятий многим членам сообщества по-прежнему сложно сбалансировать вклад сообщества со своими личными и профессиональными обязательствами.</p>\n\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}}}}i:3;a:6:{s:4:\"data\";s:60:\"\n		\n		\n		\n		\n		\n				\n		\n		\n\n					\n										\n					\n		\n		\n			\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";s:5:\"child\";a:3:{s:0:\"\";a:6:{s:5:\"title\";a:1:{i:0;a:5:{s:4:\"data\";s:45:\"Люди WordPress: Йордан Суарес\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}s:4:\"link\";a:1:{i:0;a:5:{s:4:\"data\";s:72:\"https://ru.wordpress.org/news/2021/10/people-of-wordpress-yordan-soares/\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}s:7:\"pubDate\";a:1:{i:0;a:5:{s:4:\"data\";s:31:\"Thu, 07 Oct 2021 15:49:16 +0000\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}s:8:\"category\";a:2:{i:0;a:5:{s:4:\"data\";s:18:\"Люди WordPress\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}i:1;a:5:{s:4:\"data\";s:19:\"people-of-wordpress\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}s:4:\"guid\";a:1:{i:0;a:5:{s:4:\"data\";s:32:\"https://ru.wordpress.org/?p=2362\";s:7:\"attribs\";a:1:{s:0:\"\";a:1:{s:11:\"isPermaLink\";s:5:\"false\";}}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}s:11:\"description\";a:1:{i:0;a:5:{s:4:\"data\";s:804:\"WordPress — программное обеспечение с открытым исходным кодом, поддерживаемое волонтерами. В серии «Люди WordPress» мы рассказываем, как WordPress меняет жизни людей к лучшему.В Международный день переводчика и заключительный день празднования Переводов WordPress 2021, мы представляем историю человека, оказавшего большое влияние на команду переводчиков (Polyglots) WordPress. За пределами программного обеспечения, знакомство с сообществом WordPress Открыв для [&#8230;]\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}}s:32:\"http://purl.org/dc/elements/1.1/\";a:1:{s:7:\"creator\";a:1:{i:0;a:5:{s:4:\"data\";s:3:\"Yui\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}}s:40:\"http://purl.org/rss/1.0/modules/content/\";a:1:{s:7:\"encoded\";a:1:{i:0;a:5:{s:4:\"data\";s:19502:\"\n<p>WordPress — программное обеспечение с открытым исходным кодом, поддерживаемое волонтерами. В серии «Люди WordPress» мы рассказываем, как WordPress меняет жизни людей к лучшему.<br>В Международный день переводчика и заключительный день <a href=\"https://wptranslationday.org/\">празднования Переводов WordPress 2021</a>, мы представляем историю человека, оказавшего большое влияние на<a rel=\"noreferrer noopener\" href=\"https://make.wordpress.org/polyglots/\" target=\"_blank\"> команду переводчиков (Polyglots) WordPress</a>.</p>\n\n\n\n<h2>За пределами программного обеспечения, знакомство с сообществом WordPress</h2>\n\n\n\n<div class=\"wp-block-image\"><figure class=\"aligncenter size-full\"><a href=\"https://ru.wordpress.org/files/2021/10/yordan-min-300x300@2x.jpg\"><img loading=\"lazy\" width=\"600\" height=\"600\" src=\"https://ru.wordpress.org/files/2021/10/yordan-min-300x300@2x.jpg\" alt=\"\" class=\"wp-image-2364\" srcset=\"https://ru.wordpress.org/files/2021/10/yordan-min-300x300@2x.jpg 600w, https://ru.wordpress.org/files/2021/10/yordan-min-300x300@2x-300x300.jpg 300w, https://ru.wordpress.org/files/2021/10/yordan-min-300x300@2x-150x150.jpg 150w\" sizes=\"(max-width: 600px) 100vw, 600px\" /></a></figure></div>\n\n\n\n<p>Открыв для себя WordPress, Йордан Суарес из Венесуэлы (Южная Америка) нашел друзей, сообщество и новые возможности. Он и представить себе не мог, что за разработкой WordPress стоит огромное международное движение единомышленников.</p>\n\n\n\n<p>Йордан вспоминает: «Когда я начал пользоваться WordPress, я понятия не имел о том, что стоит за этим программным обеспечением или выходит за его пределы. Я знал, что есть кто-то, кто заставляет все это работать, но я даже отдаленно не мог представить, всех тех людей, которые делают WordPress не просто инструментом для разработки веб-сайтов, а целым движением, которые объединяются, чтобы делиться, создавать и изменять мир к лучшему»</p>\n\n\n\n<h2>Превратите хобби в работу</h2>\n\n\n\n<p>По началу Йордан работал в технической поддержке и прокладывал компьютерные сети для малого и среднего бизнеса. В 2005 году веб-разработка и программирование были для него просто хобби, но когда он познакомился с CSS и его динамическими возможностями, то открыл для себя совершенно новый карьерный путь.</p>\n\n\n\n<p>В 2010 году благодаря другу Йордан познакомился с WordPress и для него открылось будущее, которое он и представить себе не мог. Он перестал использовать какие-либо другие системы управления контентом (CMS) и сосредоточился на изучении возможностей WordPress.</p>\n\n\n\n<p>Три года спустя, в 2013 году, Йордан с несколькими друзьями основал рекламное агентство. Они ни только снимали рекламные ролики для местных радио- и телеканалов, но и с помощью WordPress создали более 15 веб-сайтов для компаний, которые ранее недооценивали важность присутствия в Интернете.</p>\n\n\n\n<p>Йордан комментирует: «Мы работали почти четыре года, пока в конце 2017 года экономический кризис в Венесуэле не стал настолько остро, что мы решили закрыть агентство, перестав получать прибыль. Подводя итоги того периода, я думаю, что мы изменили взгляд предпринимателей на интернет-бизнес в городе».</p>\n\n\n\n<h2>Работа фрилансером полный рабочий день</h2>\n\n\n\n<p>Год спустя, в 2018 году, Йордан целиком посвятил себя работе веб-разработчика на фрилансе. Его первыми клиентами стали агентства и друзья, эмигрировавшие в другие страны. Позже он начал работать на фриланс-биржах.</p>\n\n\n\n<p>В то время быть фрилансером в Венесуэле было довольно сложной задачей. Первостепенной трудностью было получение справедливого вознаграждения. Но помимо этого ухудшающиеся условия в стране с постоянными отключениями электричества и Интернета усложняли ситуацию.</p>\n\n\n\n<p>Тогда Йордан жил в Гуаренасе, где ситуация была относительно лучше чем в других городах, и ему удалось найти достаточно стабильное электроснабжение и адекватную скоростью Интернета, достаточные для работы над проектами.</p>\n\n\n\n<h2>Знакомство с сообществом WordPress</h2>\n\n\n\n<p>«Конечно, если бы я не познакомился с сообществом, я бы продолжал работать самостоятельно, как волк-одиночка, выполняя обычную работу по решению проблем для случайных клиентов, чтобы оплачивать собственные счета», — признается Йордан.</p>\n\n\n\n<p>Живя в Гуаренасе, Йордан почувствовал стабильность в работе, нашел новых друзей и знакомых. Он начал искать ко-воркинг или местные IT-группы, и именно тогда познакомился с сообществом WordPress в Каракасе.</p>\n\n\n\n<p>Не раздумывая он зарегистрировался на оффлайн встречу. Как только мероприятие завершилось, он подошел поговорить с одним из организаторов и предложил свою помощь. Йордан загорелся желанием помочь в разработке рекламных материалов, управлении социальными сетями и организации мероприятий.</p>\n\n\n\n<p>Благодаря последующим мероприятиям он познакомился с людьми, живущими в соседних городах.</p>\n\n\n\n<div class=\"wp-block-media-text alignwide is-stacked-on-mobile\" style=\"grid-template-columns:27% auto\"><figure class=\"wp-block-media-text__media\"><img loading=\"lazy\" width=\"240\" height=\"600\" src=\"https://ru.wordpress.org/files/2021/10/WP_Guarenas-Guatire-120x300-1.png\" alt=\"\" class=\"wp-image-2366 size-full\" srcset=\"https://ru.wordpress.org/files/2021/10/WP_Guarenas-Guatire-120x300-1.png 240w, https://ru.wordpress.org/files/2021/10/WP_Guarenas-Guatire-120x300-1-120x300.png 120w\" sizes=\"(max-width: 240px) 100vw, 240px\" /></figure><div class=\"wp-block-media-text__content\">\n<p>Несколькими месяцами позже, вместе с другими пользователями WordPress в своем регионе, возникла идея создать новый митап Гуаренас-Гуатире и в декабре 2019 года они подали заявку на рассмотрение команды сообщества WordPress.</p>\n\n\n\n<p>После получения необходимых разрешений команда Гуаренас-Гуатире приступила к планированию будущих встреч.</p>\n\n\n\n<p>В течение первого квартала 2020 года, Йордан и его коллеги организовали пять офлайн встреч, но из-за начавшейся пандемии и вынужденной изоляции личные встречи пришлось прекратить. Однако сообщество Гуаренас-Гуатире искало возможности продолжить общение и при поддержке спонсоров начало проводить онлайн-мероприятия под названием «WordPress a la medianoche» (WordPress в полночь).</p>\n\n\n\n<p>Формат этих мероприятий был вдохновлен Алексисом Арналом, который предложил встретиться в полночь, чтобы максимально использовать скорость интернета, которая обычно несколько улучшается в это время.</p>\n</div></div>\n\n\n\n<p>На момент написания статьи Йордан и его команда организовали уже 16 мероприятий «WordPress a la medianoche», каждое из которых посетили до 50 человек. Эти впечатляющие результаты для сравнительно молодого митапа позволили поддерживать обмен информацией в это трудное время.</p>\n\n\n\n<p>Один из плюсов онлайн-мероприятий — это возможность приглашать людей из других стран и проводить встречи в партнерстве с другими митапами. Примером может служить специальное мероприятие по переводу с Хавьером Эстебаном, членом группы переводчиков из Испании. Во встрече также с радостью приняли участие переводчики из Мексики, Коста-Рики, Перу и Колумбии.</p>\n\n\n\n<div class=\"wp-block-image\"><figure class=\"aligncenter size-full\"><a href=\"https://ru.wordpress.org/files/2021/10/wp-translation-2020.jpg\"><img loading=\"lazy\" width=\"1024\" height=\"390\" src=\"https://ru.wordpress.org/files/2021/10/wp-translation-2020.jpg\" alt=\"\" class=\"wp-image-2367\" srcset=\"https://ru.wordpress.org/files/2021/10/wp-translation-2020.jpg 1024w, https://ru.wordpress.org/files/2021/10/wp-translation-2020-300x114.jpg 300w, https://ru.wordpress.org/files/2021/10/wp-translation-2020-768x293.jpg 768w\" sizes=\"(max-width: 1024px) 100vw, 1024px\" /></a><figcaption>Йордан (на фото внизу слева) выступает на мероприятиях WordPress Translation Day 2020</figcaption></figure></div>\n\n\n\n<h2>Укрепленный сообществом</h2>\n\n\n\n<p>Йордан уверен, что продолжил бы работать самостоятельно, даже если бы не познакомился с сообществом WordPress.</p>\n\n\n\n<p>Он говорит: «К счастью, это было не так, и я смог получить много трансформирующего опыта, открывшего мне значение слов «сообщество» и «волонтерство»».</p>\n\n\n\n<p>Йордан почувствовал поддержку сообщества, и это побудило его участвовать во многих других мероприятиях в новых для себя качествах, включая роль управляющего локалью <a href=\"https://translate.wordpress.org/locale/es-ve/\">Венесуэло-испанской локали</a>, модератора <a href=\"https://make.wordpress.org/tv/\">WordPress.tv</a> и участника <a href=\"https://make.wordpress.org/support/\">Форума поддержки</a>, помогая людям с техническими проблемами. Он также разработал бесплатные плагины для официального каталога WordPress и <a href=\"https://wordpress.tv/speakers/yordan-soares/\">выступил на различных мероприятии</a>, включая <a href=\"https://spain.wordcamp.org/2020/session/actualizaciones-automaticas-para-tus-plugins-y-temas-personalizados/\">WordCamp Spain 2020</a>.</p>\n\n\n\n<p>«Все это имеет эффект бумеранга», &#8212; объясняет Йордан. Этот опыт помог ему вырасти в личном и профессиональном плане, получая удовольствие от своего вклада в экосистему WordPress. Йордану нравится помогать людям, когда они в этом нуждаются, и он считает это двусторонним процессом обучения.</p>\n\n\n\n<p>«Сначала, когда я рассказывал своей семье и друзьям о сообществе и о работе, которую я делал, они спрашивали меня:«Что ты получаешь взамен?» Возможно, они ожидали, что я скажу им определенную сумму, но ответ более сложный», —&nbsp; объясняет Йордан, — «Приятно знать, что вы помогли улучшить экосистему WordPress, средство, который вы используете, в работе и которое позволяет вам себя обеспечить».</p>\n\n\n\n<p>На своем пути Йордан встретил много замечательных людей с общими интересами и ценностями, и самое приятное то, что многие из этих людей теперь его друзья, деловые партнеры или клиенты.</p>\n\n\n\n<p>В то же время он приобрел новые навыки и опыт, которые придали ему уверенности в трудных жизненных ситуациях.</p>\n\n\n\n<div class=\"wp-block-image\"><figure class=\"aligncenter size-full\"><a href=\"https://ru.wordpress.org/files/2021/10/special-acknowledgement-yordansoares.png\"><img loading=\"lazy\" width=\"1024\" height=\"538\" src=\"https://ru.wordpress.org/files/2021/10/special-acknowledgement-yordansoares.png\" alt=\"\" class=\"wp-image-2368\" srcset=\"https://ru.wordpress.org/files/2021/10/special-acknowledgement-yordansoares.png 1024w, https://ru.wordpress.org/files/2021/10/special-acknowledgement-yordansoares-300x158.png 300w, https://ru.wordpress.org/files/2021/10/special-acknowledgement-yordansoares-768x404.png 768w\" sizes=\"(max-width: 1024px) 100vw, 1024px\" /></a></figure></div>\n\n\n\n<p>В рамках <a href=\"https://wordpress.org/news/2021/09/join-us-for-wordpress-translation-day-global-events-in-september-2021/\">празднования Дня переводов WordPress 2021</a> года Йордан был номинирован за его вклад в работу команды переводчиков (полиглотов) WordPress. Полный список номинаций и рассказы о номинантах будут опубликованы в октябре и ноябре 2021 на сайте <a href=\"https://wptranslationday.org/\">WordPress Translation Day</a>. Ознакомьтесь с заключительными мероприятиями <a href=\"https://make.wordpress.org/polyglots/2021/09/30/30-days-of-translation-celebration/\">Международного дня переводчиков</a>.</p>\n\n\n\n<h2>Авторы и редакторы</h2>\n\n\n\n<p>Спасибо Абе Такор (<a href=\"https://profiles.wordpress.org/webcommsat/\">@webcommsat</a>), Ларисе Мурильо (<a href=\"https://profiles.wordpress.org/lmurillom/\">@lmurillom</a>), Майде Батул (<a href=\"https://profiles.wordpress.org/maedahbatool/\">@maedahbatool</a>), Хлое Брингманн (<a href=\"https://profiles.wordpress.org/cbringmann/\">@cbringmann</a>) и Налини Такор (<a href=\"https://profiles.wordpress.org/nalininonstopnewsuk/\">@nalininonstopnewsuk</a>) за работу над этой публикацией. Спасибо Йордану Суаресу (<a href=\"https://profiles.wordpress.org/yordansoares/\">@yordansoares</a>) за то, что он поделился своей историей, а также Джозефе Хаден (<a href=\"https://profiles.wordpress.org/chanthaboune/\">@chanthaboune</a>) и Тоферу ДеРозиа (<a href=\"https://profiles.wordpress.org/topher1kenobe/\">@topher1kenobe</a>) за поддержку серии. Логотип WordPress Guarenas-Guatire на этой странице был разработан <a href=\"https://profiles.wordpress.org/bragnieljimenez/\">Брагьелем Хименесом</a>.<br>Перевод на русский: Ольга Глеклер (<a href=\"https://profiles.wordpress.org/oglekler/\">@oglekler</a>)</p>\n\n\n\n<div class=\"wp-block-media-text alignwide is-stacked-on-mobile\" style=\"grid-template-columns:25% auto\"><figure class=\"wp-block-media-text__media\"><img loading=\"lazy\" width=\"180\" height=\"135\" src=\"https://ru.wordpress.org/files/2021/03/heropress-logo.png\" alt=\"\" class=\"wp-image-2268 size-full\" /></figure><div class=\"wp-block-media-text__content\">\n<p>Эта статья основана на первоначальной публикации HeroPress.com, инициативе, ориентированной на людей в сообществе WordPress, созданной Тофером ДеРозиа <a href=\"https://profiles.wordpress.org/topher1kenobe/\">@topher1kenobe</a>.</p>\n\n\n\n<p>Читайте эту и другие истории серии «<a href=\"https://wordpress.org/news/category/interviews/\">People of WordPress</a>» (на английском) или «<a href=\"https://ru.wordpress.org/news/category/people-of-wordpress/\">Люди WordPress</a>» (на русском).</p>\n</div></div>\n\n\n\n<p></p>\n\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}}}}i:4;a:6:{s:4:\"data\";s:79:\"\n		\n		\n					\n		\n		\n		\n				\n		\n		\n		\n\n					\n										\n					\n					\n			\n		\n		\n			\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";s:5:\"child\";a:5:{s:0:\"\";a:7:{s:5:\"title\";a:1:{i:0;a:5:{s:4:\"data\";s:77:\"WordPress Translation Day 2021 — Переводим WordPress вместе!\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}s:4:\"link\";a:1:{i:0;a:5:{s:4:\"data\";s:171:\"https://ru.wordpress.org/news/2021/09/wordpress-translation-day-2021-%d0%bf%d0%b5%d1%80%d0%b5%d0%b2%d0%be%d0%b4%d0%b8%d0%bc-wordpress-%d0%b2%d0%bc%d0%b5%d1%81%d1%82%d0%b5/\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}s:8:\"comments\";a:1:{i:0;a:5:{s:4:\"data\";s:179:\"https://ru.wordpress.org/news/2021/09/wordpress-translation-day-2021-%d0%bf%d0%b5%d1%80%d0%b5%d0%b2%d0%be%d0%b4%d0%b8%d0%bc-wordpress-%d0%b2%d0%bc%d0%b5%d1%81%d1%82%d0%b5/#respond\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}s:7:\"pubDate\";a:1:{i:0;a:5:{s:4:\"data\";s:31:\"Thu, 09 Sep 2021 07:17:24 +0000\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}s:8:\"category\";a:3:{i:0;a:5:{s:4:\"data\";s:14:\"Новости\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}i:1;a:5:{s:4:\"data\";s:25:\"Общие вопросы\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}i:2;a:5:{s:4:\"data\";s:4:\"WPTD\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}s:4:\"guid\";a:1:{i:0;a:5:{s:4:\"data\";s:32:\"https://ru.wordpress.org/?p=2355\";s:7:\"attribs\";a:1:{s:0:\"\";a:1:{s:11:\"isPermaLink\";s:5:\"false\";}}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}s:11:\"description\";a:1:{i:0;a:5:{s:4:\"data\";s:653:\"11 сентября 2021 в 12:00 по Москве на YouTube пройдет, ставший уже традиционным, стрим c Денисом Янчевским по переводу плагинов и тем для WordPress на русский язык. Планируемая продолжительность мероприятия — 3 часа. Присоединиться к стриму Перевод — отличный шанс внести свой вклад в развитие WordPress. Для участия не обязательно быть разработчиком и безупречно знать [&#8230;]\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}}s:32:\"http://purl.org/dc/elements/1.1/\";a:1:{s:7:\"creator\";a:1:{i:0;a:5:{s:4:\"data\";s:17:\"Denis Yanchevskiy\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}}s:40:\"http://purl.org/rss/1.0/modules/content/\";a:1:{s:7:\"encoded\";a:1:{i:0;a:5:{s:4:\"data\";s:5902:\"\n<figure class=\"wp-block-image size-large\"><a href=\"https://ru.wordpress.org/files/2021/09/wptd2021-logo-hashtag-onwhite.jpg\"><img loading=\"lazy\" width=\"1024\" height=\"640\" src=\"https://ru.wordpress.org/files/2021/09/wptd2021-logo-hashtag-onwhite-1024x640.jpg\" alt=\"\" class=\"wp-image-2356\" srcset=\"https://ru.wordpress.org/files/2021/09/wptd2021-logo-hashtag-onwhite-1024x640.jpg 1024w, https://ru.wordpress.org/files/2021/09/wptd2021-logo-hashtag-onwhite-300x188.jpg 300w, https://ru.wordpress.org/files/2021/09/wptd2021-logo-hashtag-onwhite-768x480.jpg 768w, https://ru.wordpress.org/files/2021/09/wptd2021-logo-hashtag-onwhite.jpg 1440w\" sizes=\"(max-width: 1024px) 100vw, 1024px\" /></a></figure>\n\n\n\n<p>11 сентября 2021 в 12:00 по Москве на YouTube пройдет, ставший уже традиционным, стрим c <a rel=\"noreferrer noopener\" href=\"https://profiles.wordpress.org/denisco/\" data-type=\"URL\" data-id=\"https://profiles.wordpress.org/denisco/\" target=\"_blank\">Денисом Янчевским</a> по переводу плагинов и тем для WordPress на русский язык. Планируемая продолжительность мероприятия — 3 часа.</p>\n\n\n\n<p><a href=\"https://www.youtube.com/watch?v=tcg2bzFIX30\" data-type=\"URL\" data-id=\"https://www.youtube.com/watch?v=tcg2bzFIX30\" target=\"_blank\" rel=\"noreferrer noopener\">Присоединиться к стриму</a></p>\n\n\n\n<p>Перевод — отличный шанс внести свой вклад в развитие WordPress. Для участия не обязательно быть разработчиком и безупречно знать английский язык — достаточно базовых знаний и желания учиться. Это также позволит пообщаться с единомышленниками и узнать новые темы и плагины.</p>\n\n\n\n<p>Стримы проходят в дружеской атмосфере, с возможностью пообщаться в чате или голосом. Плагины и темы для перевода можно предложить в комментариях к стриму. На данный момент проведено <a href=\"https://ru.wordpress.org/team/category/%D1%81%D1%82%D1%80%D0%B8%D0%BC%D1%8B/\" data-type=\"URL\" data-id=\"https://ru.wordpress.org/team/category/%D1%81%D1%82%D1%80%D0%B8%D0%BC%D1%8B/\" target=\"_blank\" rel=\"noreferrer noopener\">более 20 стримов</a> и переведено несколько десятков плагинов (в том числе Gutenberg). Наиболее активные участники получили статус редакторов переводов с возможностью переводить плагины и темы без дополнительной проверки и проверять переводы других участников.</p>\n\n\n\n<p><a href=\"https://www.youtube.com/watch?v=tcg2bzFIX30\" target=\"_blank\" rel=\"noreferrer noopener\">Присоединиться к стриму</a></p>\n\n\n\n<p>Для координации и обсуждения вопросов можно воспользоваться:</p>\n\n\n\n<ul><li>каналом <code>translations</code> в <a rel=\"noreferrer noopener\" href=\"https://ruwp.slack.com/\" target=\"_blank\">Slack-группе русскоязычного сообщества WordPress</a> (при регистрации введите адрес вида <code>username@chat.wordpress.org</code>, где <code>username</code> — ваш логин на WordPress.org).</li><li>группой по <a rel=\"noreferrer noopener\" href=\"https://t.me/wp_translate\" data-type=\"URL\" data-id=\"https://t.me/wp_translate\" target=\"_blank\">переводам WordPress в Telegram</a>.</li></ul>\n\n\n\n<p>Чтобы составить представление о мероприятии, можно посмотреть как оно проходило в <a rel=\"noreferrer noopener\" href=\"https://www.youtube.com/watch?v=RMcDQvlBRSM\" data-type=\"URL\" data-id=\"https://www.youtube.com/watch?v=RMcDQvlBRSM\" target=\"_blank\">прошлом году</a>.</p>\n\n\n\n<p><strong>Полезные ресурсы</strong></p>\n\n\n\n<ul><li><a rel=\"noreferrer noopener\" href=\"https://ru.wordpress.org/team/handbook/translations/\" target=\"_blank\">Как перевести тему или плагин?</a></li><li><a rel=\"noreferrer noopener\" href=\"https://codex.wordpress.org/Вниманию_переводчиков#.D0.A1.D1.82.D0.B8.D0.BB.D1.8C_.D0.BF.D0.B5.D1.80.D0.B5.D0.B2.D0.BE.D0.B4.D0.B0\" target=\"_blank\">Рекомендации по стилю перевода</a></li><li><a rel=\"noreferrer noopener\" href=\"https://codex.wordpress.org/Вниманию_переводчиков#.D0.9A.D0.B0.D0.BA_.D1.81.D0.B4.D0.B5.D0.BB.D0.B0.D1.82.D1.8C_.D1.85.D0.BE.D1.80.D0.BE.D1.88.D0.B8.D0.B9_.D0.BF.D0.B5.D1.80.D0.B5.D0.B2.D0.BE.D0.B4.3F\" target=\"_blank\">Как сделать хороший перевод</a></li><li><a rel=\"noreferrer noopener\" href=\"https://translate.wordpress.org/locale/ru/default/glossary\" target=\"_blank\">Словарь терминов</a></li><li><a rel=\"noreferrer noopener\" href=\"https://make.wordpress.org/polyglots/handbook/about/get-involved/first-steps/\" target=\"_blank\">Первые шаги переводчика</a></li><li><a rel=\"noreferrer noopener\" href=\"https://make.wordpress.org/polyglots/handbook/tools/glotpress-translate-wordpress-org/\" target=\"_blank\">Как работать с сайтом translate.wordpress.org (GlotPress)</a></li><li><a href=\"https://wptranslationday.org/\" data-type=\"URL\" data-id=\"https://wptranslationday.org/\" target=\"_blank\" rel=\"noreferrer noopener\">Официальный сайт WordPress Translation Day</a></li></ul>\n\n\n\n<p></p>\n\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}}s:36:\"http://wellformedweb.org/CommentAPI/\";a:1:{s:10:\"commentRss\";a:1:{i:0;a:5:{s:4:\"data\";s:176:\"https://ru.wordpress.org/news/2021/09/wordpress-translation-day-2021-%d0%bf%d0%b5%d1%80%d0%b5%d0%b2%d0%be%d0%b4%d0%b8%d0%bc-wordpress-%d0%b2%d0%bc%d0%b5%d1%81%d1%82%d0%b5/feed/\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}}s:38:\"http://purl.org/rss/1.0/modules/slash/\";a:1:{s:8:\"comments\";a:1:{i:0;a:5:{s:4:\"data\";s:1:\"0\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}}}}i:5;a:6:{s:4:\"data\";s:60:\"\n		\n		\n		\n		\n		\n				\n		\n		\n\n					\n										\n					\n		\n		\n			\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";s:5:\"child\";a:3:{s:0:\"\";a:6:{s:5:\"title\";a:1:{i:0;a:5:{s:4:\"data\";s:71:\"Запуск каталога паттернов блоков WordPress\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}s:4:\"link\";a:1:{i:0;a:5:{s:4:\"data\";s:78:\"https://ru.wordpress.org/news/2021/07/the-wordpress-pattern-directory-is-live/\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}s:7:\"pubDate\";a:1:{i:0;a:5:{s:4:\"data\";s:31:\"Wed, 21 Jul 2021 18:46:42 +0000\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}s:8:\"category\";a:2:{i:0;a:5:{s:4:\"data\";s:14:\"Новости\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}i:1;a:5:{s:4:\"data\";s:25:\"Общие вопросы\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}s:4:\"guid\";a:1:{i:0;a:5:{s:4:\"data\";s:32:\"https://ru.wordpress.org/?p=2343\";s:7:\"attribs\";a:1:{s:0:\"\";a:1:{s:11:\"isPermaLink\";s:5:\"false\";}}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}s:11:\"description\";a:1:{i:0;a:5:{s:4:\"data\";s:557:\"В WordPress 5.8 появилась встроенная поддержка каталога паттернов, в который была добавлена коллекция красивых и полезных паттернов созданных дизайнерами сообщества. All patterns on the homepage  Patterns in the Images categoryCategory The &#8216;category&#8217; taxonomy lets you group posts / content together that share a common bond. Categories are pre-defined and broad ranging.  Single pattern page, default [&#8230;]\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}}s:32:\"http://purl.org/dc/elements/1.1/\";a:1:{s:7:\"creator\";a:1:{i:0;a:5:{s:4:\"data\";s:3:\"Yui\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}}s:40:\"http://purl.org/rss/1.0/modules/content/\";a:1:{s:7:\"encoded\";a:1:{i:0;a:5:{s:4:\"data\";s:5798:\"\n<p>В WordPress 5.8 появилась встроенная поддержка <a rel=\"noreferrer noopener\" href=\"https://ru.wordpress.org/patterns/\" data-type=\"URL\" data-id=\"https://ru.wordpress.org/patterns/\" target=\"_blank\">каталога паттернов</a>, в который была добавлена коллекция красивых и полезных паттернов созданных дизайнерами сообщества. </p>\n\n\n<figure class=\"wp-block-gallery columns-2 is-cropped\">\n<ul class=\"blocks-gallery-grid\">\n<li class=\"blocks-gallery-item\">\n<figure><a href=\"https://i1.wp.com/make.wordpress.org/meta/files/2021/07/grid-home.jpg?ssl=1\"><img loading=\"lazy\" class=\"wp-image-19596\" src=\"https://i1.wp.com/make.wordpress.org/meta/files/2021/07/grid-home.jpg?resize=776%2C776&amp;ssl=1\" alt=\"\" width=\"776\" height=\"776\" data-id=\"19596\" data-full-url=\"https://i1.wp.com/make.wordpress.org/meta/files/2021/07/grid-home.jpg?resize=776%2C776&amp;ssl=1\" data-link=\"https://make.wordpress.org/meta/?attachment_id=19596#main\" data-recalc-dims=\"1\" /></a>\n<figcaption class=\"blocks-gallery-item__caption\">All patterns on the homepage</figcaption>\n</figure>\n</li>\n<li class=\"blocks-gallery-item\">\n<figure><a href=\"https://i1.wp.com/make.wordpress.org/meta/files/2021/07/grid-category-images.jpg?ssl=1\"><img loading=\"lazy\" class=\"wp-image-19595\" src=\"https://i1.wp.com/make.wordpress.org/meta/files/2021/07/grid-category-images.jpg?resize=776%2C776&amp;ssl=1\" alt=\"\" width=\"776\" height=\"776\" data-id=\"19595\" data-full-url=\"https://i1.wp.com/make.wordpress.org/meta/files/2021/07/grid-category-images.jpg?resize=776%2C776&amp;ssl=1\" data-link=\"https://make.wordpress.org/meta/?attachment_id=19595#main\" data-recalc-dims=\"1\" /></a>\n<p> </p>\n<figcaption class=\"blocks-gallery-item__caption\">Patterns in the Images <span class=\"glossary-item-container\">category<span class=\"glossary-item-hidden-content\"><span class=\"glossary-item-header\">Category</span> <span class=\"glossary-item-description\">The &#8216;category&#8217; taxonomy lets you group posts / content together that share a common bond. Categories are pre-defined and broad ranging.</span></span></span></figcaption>\n</figure>\n</li>\n<li class=\"blocks-gallery-item\">\n<figure><a href=\"https://i0.wp.com/make.wordpress.org/meta/files/2021/07/single-960.jpg?ssl=1\"><img loading=\"lazy\" class=\"wp-image-19598\" src=\"https://i0.wp.com/make.wordpress.org/meta/files/2021/07/single-960.jpg?resize=617%2C1024&amp;ssl=1\" alt=\"\" width=\"617\" height=\"1024\" data-id=\"19598\" data-full-url=\"https://make.wordpress.org/meta/files/2021/07/single-960.jpg\" data-link=\"https://make.wordpress.org/meta/?attachment_id=19598#main\" data-recalc-dims=\"1\" /></a>\n<p> </p>\n<figcaption class=\"blocks-gallery-item__caption\">Single pattern page, default preview</figcaption>\n</figure>\n</li>\n<li class=\"blocks-gallery-item\">\n<figure><a href=\"https://i0.wp.com/make.wordpress.org/meta/files/2021/07/single-480.jpg?ssl=1\"><img loading=\"lazy\" class=\"wp-image-19597\" src=\"https://i0.wp.com/make.wordpress.org/meta/files/2021/07/single-480.jpg?resize=617%2C1024&amp;ssl=1\" alt=\"\" width=\"617\" height=\"1024\" data-id=\"19597\" data-full-url=\"https://make.wordpress.org/meta/files/2021/07/single-480.jpg\" data-link=\"https://make.wordpress.org/meta/?attachment_id=19597#main\" data-recalc-dims=\"1\" /></a>\n<p> </p>\n<figcaption class=\"blocks-gallery-item__caption\">Single pattern page, small screen preview</figcaption>\n</figure>\n</li>\n</ul>\n</figure>\n<p>Попробуйте найти и использовать понравившиеся вам паттерны на своем сайте, Вы можете просматривать паттерны по категориям, а также добавлять понравившееся в избранное. Нажмите кнопку скопировать и вставьте скопированный код паттерна в запись на вашем сайте, чтобы использовать паттерн.</p>\n<p>.</p>\n<div class=\"wp-block-image\">\n<figure class=\"aligncenter size-full is-resized\"><a href=\"https://i2.wp.com/make.wordpress.org/meta/files/2021/07/copy-paste-demo.gif?ssl=1\"><img loading=\"lazy\" class=\"wp-image-19606\" src=\"https://i2.wp.com/make.wordpress.org/meta/files/2021/07/copy-paste-demo.gif?resize=444%2C255&amp;ssl=1\" alt=\"\" width=\"444\" height=\"255\" data-recalc-dims=\"1\" /></a></figure>\n<p>В настоящее время мы реализовали  <a href=\"https://github.com/WordPress/pattern-directory/milestone/1\">первый этап</a> создания каталога паттернов, с ограниченным набором паттернов, следующим этапом станет открытие в каталоге возможности принимать паттерны от всех, также как в каталогах плагинов и тем. Вы можете помочь своим участием в реализации второго этапа на <a href=\"https://github.com/WordPress/pattern-directory/\">GitHub</a>.</p>\n<p>Вы также можете помочь  <a href=\"https://translate.wordpress.org/projects/patterns/core/\">переводом</a>, <a href=\"https://github.com/WordPress/pattern-directory/issues\">тестированием и сообщением о проблемах</a>, и обсуждением в <a href=\"https://make.wordpress.org/meetings/#meta\">Meta Team chat.</a></p>\n<p>Список благодарностей участникам можно посмотреть в <a href=\"https://make.wordpress.org/meta/2021/07/20/the-wordpress-pattern-directory-is-live/\">оригинальной публикации</a> на английском языке.</p>\n</div>\n\n\n<p></p>\n\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}}}}i:6;a:6:{s:4:\"data\";s:60:\"\n		\n		\n		\n		\n		\n				\n		\n		\n\n					\n										\n					\n		\n		\n			\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";s:5:\"child\";a:3:{s:0:\"\";a:6:{s:5:\"title\";a:1:{i:0;a:5:{s:4:\"data\";s:66:\"WP Moscow #17, в очном формате + трансляция\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}s:4:\"link\";a:1:{i:0;a:5:{s:4:\"data\";s:51:\"https://ru.wordpress.org/news/2021/07/wp-moscow-17/\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}s:7:\"pubDate\";a:1:{i:0;a:5:{s:4:\"data\";s:31:\"Wed, 07 Jul 2021 13:51:33 +0000\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}s:8:\"category\";a:2:{i:0;a:5:{s:4:\"data\";s:14:\"Новости\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}i:1;a:5:{s:4:\"data\";s:25:\"Общие вопросы\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}s:4:\"guid\";a:1:{i:0;a:5:{s:4:\"data\";s:32:\"https://ru.wordpress.org/?p=2332\";s:7:\"attribs\";a:1:{s:0:\"\";a:1:{s:11:\"isPermaLink\";s:5:\"false\";}}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}s:11:\"description\";a:1:{i:0;a:5:{s:4:\"data\";s:722:\"Друзья, пробуем новый формат, живая встреча (для тех у кого есть qr-код и прививка) + качественная (в плане картинки и звука) онлайн-трансляция. Первый доклад будет состоять из 2-х блоков «Обзор инструментов создания гутенберг-блоков», «Гутенберг как конструктор для создания лендингов». И пройдет в режиме мастер-класса / диалога / демонстрации процесса создания и работы с блоками. Докладчик: [&#8230;]\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}}s:32:\"http://purl.org/dc/elements/1.1/\";a:1:{s:7:\"creator\";a:1:{i:0;a:5:{s:4:\"data\";s:3:\"Yui\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}}s:40:\"http://purl.org/rss/1.0/modules/content/\";a:1:{s:7:\"encoded\";a:1:{i:0;a:5:{s:4:\"data\";s:2735:\"\n<p>Друзья, пробуем новый формат, живая встреча (для тех у кого есть qr-код и прививка) + качественная (в плане картинки и звука) онлайн-трансляция.</p>\n\n\n\n<h2>Первый доклад будет состоять из 2-х блоков</h2>\n\n\n\n<ul><li><strong>«Обзор инструментов создания гутенберг-блоков»,</strong></li><li><strong>«Гутенберг как конструктор для создания лендингов».</strong></li></ul>\n\n\n\n<p>И пройдет в режиме мастер-класса / диалога / демонстрации процесса создания и работы с блоками.</p>\n\n\n\n<p>Докладчик: Николай Миронов /&nbsp;<a href=\"http://www.wpfolio.ru/\" target=\"_blank\" rel=\"noreferrer noopener\">www.wpfolio.ru</a></p>\n\n\n\n<p>Тема 2-го и 3-го докладов уточняется, присылайте ваши заявки на nikolay@wpfolio.ru</p>\n\n\n\n<p>Митапы проходят благодаря вашей поддержке. Станьте спонсором и информация о вас / вашей компании появится <a href=\"https://www.meetup.com/ru-RU/wordpress-moscow/events/279121737\" data-type=\"URL\" data-id=\"https://www.meetup.com/ru-RU/wordpress-moscow/events/279121737\" target=\"_blank\" rel=\"noreferrer noopener\">на странице мероприятия на meetup.com</a>, на сайте <a href=\"https://wpmoscow.ru\" data-type=\"URL\" data-id=\"https://wpmoscow.ru\" target=\"_blank\" rel=\"noreferrer noopener\">wpmoscow.ru</a>, на слайдах во время трансляции / перерывах между докладами.<br><a rel=\"noreferrer noopener\" href=\"https://wpmoscow.ru/donate-next-meetup/\" target=\"_blank\">https://wpmoscow.ru/donate-next-meetup/</a></p>\n\n\n\n<p>Ссылка на онлайн-трансляцию появится в нашей группе VK (<a rel=\"noreferrer noopener\" href=\"https://vk.com/wpmeetup\" target=\"_blank\">https://vk.com/wpmeetup</a>) и Телеграм-канале (<a rel=\"noreferrer noopener\" href=\"https://t.me/wpmeetup\" target=\"_blank\">https://t.me/wpmeetup</a>)</p>\n\n\n\n<p><strong>Дата начала:</strong> 08.07.2021 19:00:00<br><strong>Дата завершения:</strong> 08.07.2021 21:00:00</p>\n\n\n\n<p></p>\n\n\n\n<div class=\"wp-container-5 wp-block-buttons\">\n<div class=\"wp-block-button is-style-outline\"><a class=\"wp-block-button__link\" href=\"https://www.meetup.com/wordpress-moscow/events/279121737/\">Записаться на конференцию</a></div>\n</div>\n\n\n\n<p></p>\n\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}}}}i:7;a:6:{s:4:\"data\";s:60:\"\n		\n		\n		\n		\n		\n				\n		\n		\n\n					\n										\n					\n		\n		\n			\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";s:5:\"child\";a:3:{s:0:\"\";a:6:{s:5:\"title\";a:1:{i:0;a:5:{s:4:\"data\";s:45:\"Люди WordPress: Тияна Андреич\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}s:4:\"link\";a:1:{i:0;a:5:{s:4:\"data\";s:74:\"https://ru.wordpress.org/news/2021/06/people-of-wordpress-tijana-andrejic/\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}s:7:\"pubDate\";a:1:{i:0;a:5:{s:4:\"data\";s:31:\"Tue, 08 Jun 2021 09:09:49 +0000\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}s:8:\"category\";a:2:{i:0;a:5:{s:4:\"data\";s:18:\"Люди WordPress\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}i:1;a:5:{s:4:\"data\";s:19:\"people-of-wordpress\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}s:4:\"guid\";a:1:{i:0;a:5:{s:4:\"data\";s:32:\"https://ru.wordpress.org/?p=2306\";s:7:\"attribs\";a:1:{s:0:\"\";a:1:{s:11:\"isPermaLink\";s:5:\"false\";}}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}s:11:\"description\";a:1:{i:0;a:5:{s:4:\"data\";s:658:\"WordPress — программное обеспечение с открытым исходным кодом, поддерживаемое волонтерами. В серии «Люди WordPress» мы рассказываем, как WordPress меняет жизни людей к лучшему. В этом месяце, пришедшемся на WordCamp Europe, мы беседуем с Тияной Андреич из Белграда, Сербия, о ее пути фитнес-тренера в мир WordPress и какие возможности она открыла как фрилансер и сотрудник крупной [&#8230;]\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}}s:32:\"http://purl.org/dc/elements/1.1/\";a:1:{s:7:\"creator\";a:1:{i:0;a:5:{s:4:\"data\";s:3:\"Yui\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}}s:40:\"http://purl.org/rss/1.0/modules/content/\";a:1:{s:7:\"encoded\";a:1:{i:0;a:5:{s:4:\"data\";s:25343:\"\n<p>WordPress — программное обеспечение с открытым исходным кодом, поддерживаемое волонтерами. В серии «Люди WordPress» мы рассказываем, как WordPress меняет жизни людей к лучшему.</p>\n\n\n\n<p>В этом месяце, пришедшемся на WordCamp Europe, мы беседуем с Тияной Андреич из Белграда, Сербия, о ее пути фитнес-тренера в мир WordPress и какие возможности она открыла как фрилансер и сотрудник крупной компании.</p>\n\n\n\n<div class=\"wp-block-image\"><figure class=\"aligncenter size-full\"><a href=\"https://ru.wordpress.org/files/2021/06/2021-07-Tijana-Andrejic_Featured-Img_1.jpg\"><img loading=\"lazy\" width=\"1024\" height=\"627\" src=\"https://ru.wordpress.org/files/2021/06/2021-07-Tijana-Andrejic_Featured-Img_1.jpg\" alt=\"Тияна Андреич, портретное изображение\" class=\"wp-image-2308\" srcset=\"https://ru.wordpress.org/files/2021/06/2021-07-Tijana-Andrejic_Featured-Img_1.jpg 1024w, https://ru.wordpress.org/files/2021/06/2021-07-Tijana-Andrejic_Featured-Img_1-300x184.jpg 300w, https://ru.wordpress.org/files/2021/06/2021-07-Tijana-Andrejic_Featured-Img_1-768x470.jpg 768w\" sizes=\"(max-width: 1024px) 100vw, 1024px\" /></a></figure></div>\n\n\n\n<p>Будучи профессиональным менеджером с высшим образованием в области организационных наук и сертифицированным инструктором по фитнесу, Тияна является упорным и целеустремленным человеком.</p>\n\n\n\n<p>В 2016 году, оставив работу фитнес-тренера, Тияна окунулась в мир IT. Начав с копирайта и дизайна, она сконцентрировала свои усилия в области SEO и стала независимым специалистом.</p>\n\n\n\n<p>Ни так давно Тияна оставила фриланс и устроилась специалистом службы технической поддержки в хостинговую компанию, где открыла для себя преимущества работы в команде. Она поняла, что тесные рабочие отношения с коллегами не только помогают добиться успеха в делах, но и ускоряют личностный рост.</p>\n\n\n\n<p>Тияна надеется, что, поделившись своей историей, она сможет помочь другим, кто-либо только начинает свою карьеру, либо хочет сменить сферу деятельности. Она описывает возможности, которые открыла для себя в сообществе WordPress как «огромное прозрение», особенно мир фриланса.<br>Она выделяет 5 вещей, которые помогли ей начать карьеру фрилансера. Давайте рассмотрим их.</p>\n\n\n\n<h2>5 шагов чтобы начать карьеру фрилансера</h2>\n\n\n\n<h3>Каковы ваши мотивы?</h3>\n\n\n\n<p>«Почему я это делаю?» — это первый вопрос, который задает себе Тияна, прежде чем начинать что-то новое. Она считает, что самоанализ и честность позволяют ей правильно определять свои приоритеты. Она также взвешивает причины таких стремлений, как желание иметь гибкий график и профессиональный рост.</p>\n\n\n\n<p>Тияна оценивает причины, чтобы сделать правильный выбор, например, стать ли фрилансером, что помогает ей найти подходящую работу и путь развития или альтернативные варианты.</p>\n\n\n\n<p>Она рекомендует другим использовать аналогичный подход. Если после изучения всех целей и мотивов фриланс по-прежнему остается лучшим решением, Тияна считает, что следующим шагом должно стать получение навыков, связанных с WordPress.</p>\n\n\n\n<div class=\"wp-block-image\"><figure class=\"aligncenter size-large\"><a href=\"https://ru.wordpress.org/files/2021/06/2021-07-Tijana-Andrejic-4.jpg\"><img loading=\"lazy\" width=\"1024\" height=\"683\" src=\"https://ru.wordpress.org/files/2021/06/2021-07-Tijana-Andrejic-4-1024x683.jpg\" alt=\"WordCamp Europe 2019, групповая фотография\" class=\"wp-image-2312\" srcset=\"https://ru.wordpress.org/files/2021/06/2021-07-Tijana-Andrejic-4-1024x683.jpg 1024w, https://ru.wordpress.org/files/2021/06/2021-07-Tijana-Andrejic-4-300x200.jpg 300w, https://ru.wordpress.org/files/2021/06/2021-07-Tijana-Andrejic-4-768x512.jpg 768w, https://ru.wordpress.org/files/2021/06/2021-07-Tijana-Andrejic-4-1536x1024.jpg 1536w, https://ru.wordpress.org/files/2021/06/2021-07-Tijana-Andrejic-4.jpg 1600w\" sizes=\"(max-width: 1024px) 100vw, 1024px\" /></a></figure></div>\n\n\n\n<h3>Развивайте навыки, связанные с WordPress</h3>\n\n\n\n<p>Вы можете спросить: «Почему именно WordPress?».</p>\n\n\n\n<p>WordPress используется более чем 40% сайтов по всеми миру, которым требуется различные специалисты, список которых далеко не ограничивается разработчиками. Тияна выделяет популярные направления:</p>\n\n\n\n<ul><li>Сборка сайтов (создание сайтов без программирования)</li><li>Разработка (разработка сайтов, тем и плагинов)</li><li>Веб-дизайн (разработка макетов сайтов, редактирование изображений или создание онлайн-инфографики)</li><li>Поддержка клиентов (помощь людям с их сайтами)</li><li>Обслуживание (WordPress, темы и плагины поддерживаются и регулярно обновляются)</li><li>Обучение WordPress (помощь клиентам в использовании платформы или обучение других веб-профессионалов)</li><li>Копирайт</li><li>Работа в области доступности (специалист по доступности следит за соблюдением стандартов и предлагает решения для обеспечения удобства сайтов для людей с ограниченными возможностями)</li><li>SEO (улучшение результатов поиска и восприятия контента)</li><li>Аналитика (анализ статистики, особенно важно для интернет-магазинов)</li><li>Управление контентом (добавление нового контента и редактирование существующих материалов)</li><li>Миграция сайтов (перенос сайтов с одного сервера на другой)</li><li>Веб-безопасность</li></ul>\n\n\n\n<div class=\"wp-block-image\"><figure class=\"aligncenter size-large\"><a href=\"https://ru.wordpress.org/files/2021/06/2021-07-Tijana-Andrejic-3.jpg\"><img loading=\"lazy\" width=\"1024\" height=\"682\" src=\"https://ru.wordpress.org/files/2021/06/2021-07-Tijana-Andrejic-3-1024x682.jpg\" alt=\"WordCamp Белград 2017, групповая фотография\" class=\"wp-image-2315\" srcset=\"https://ru.wordpress.org/files/2021/06/2021-07-Tijana-Andrejic-3-1024x682.jpg 1024w, https://ru.wordpress.org/files/2021/06/2021-07-Tijana-Andrejic-3-300x200.jpg 300w, https://ru.wordpress.org/files/2021/06/2021-07-Tijana-Andrejic-3-768x512.jpg 768w, https://ru.wordpress.org/files/2021/06/2021-07-Tijana-Andrejic-3-1536x1023.jpg 1536w, https://ru.wordpress.org/files/2021/06/2021-07-Tijana-Andrejic-3.jpg 1600w\" sizes=\"(max-width: 1024px) 100vw, 1024px\" /></a></figure></div>\n\n\n\n<p>Тияна добавляет: «Еще одна причина, по которой WordPress отлично подходит для фрилансеров, — это сильное сообщество, которое существует вокруг этой системы управления контентом (CMS)». Конференции WordCamp и митапы — это способ получать актуальную информацию и возможность лично задавать вопросы специалистам.</p>\n\n\n\n<p>В прошлом году эти мероприятия проводились в основном в Интернете. Организаторы прилагают значительные усилия, чтобы приблизить их по уровню ощущений к тому, что дают личные встречи. Самым большим преимуществом онлайн формата является то, что мы можем посещать мероприятия со всего мира, даже если часто в эти нелегкие времена нам трудно найти достаточно времени, чтобы глубоко погрузиться в этот новый опыт. Со времени первого митапа Тияны она не только посетила множество мероприятий сообщества WordPress, но и стала спикером.</p>\n\n\n\n<h3>Планируйте наперед</h3>\n\n\n\n<p>Чтобы стать фрилансером, нужно время. Для Тияны успех пришел с правильным планированием и следованием ее плану «приобрести или улучшить соответствующие навыки, которые позволят выделиться на рынке фриланса». Она твердо убеждена, что обучение и профессиональный рост открывает больше возможностей для бизнеса.</p>\n\n\n\n<p>Если вы подумываете о карьере фрилансера, она советует улучшить соответствующие навыки или развить новые навыки, связанные с вашими хобби, поскольку «нет ничего лучше, чем заниматься любимым делом». В тех случаях, когда нельзя использовать предыдущий опыт и знания, она предлагает выбрать «работу с более короткой кривой обучения и строить свои знания на ее основе».</p>\n\n\n\n<p>Тияна начинала как копирайтер, а затем стала экспертом по поисковой оптимизации. Она подчеркивает, что существует множество альтернативных путей, так, те, кто хотят стать разработчиком, могут начать со сборки сайтов.</p>\n\n\n\n<p>Она также напоминает: «Неплохо проанализировать рынок, прежде чем начинать процесс обучения». Тияна также рекомендует проверить последние тенденции и думать о будущем навыков, которые планируется развивать.</p>\n\n\n\n<p>Посетите новый сайт <a href=\"https://learn.wordpress.org/\">Learn WordPress.org</a>, чтобы найти интересующие вас темы. На этой недавно созданной платформе сообщество WordPress объединяет материалы для тех, кто хочет начать и совершенствовать свои навыки, предоставляет планы уроков для преподавателей WordPress и всех планирующих свое профессиональное развитие самостоятельно. Там также есть материалы для желающих принять участие в организации мероприятий или стать самостоятельным организатором.</p>\n\n\n\n<p>Тияна подчеркивает, что есть множество мест, где фрилансеры могут найти клиентов. В самом сообществе WordPress есть место, где компании и отдельные владельцы сайтов публикуют свои объявления о вакансиях — <a href=\"https://jobs.wordpress.net/\">Jobs.WordPress.net</a>.</p>\n\n\n\n<h3>Ура, пора получить первую фриланс-работу</h3>\n\n\n\n<p>Как прагматичный человек, Тияна рекомендует: «Отложите деньги, прежде чем полностью уйти во фриланс. Как альтернативный вариант, попробуйте фриланс несколько часов в неделю, чтобы узнать, нравится ли вам это. Хотя некоторые люди действительно любят рисковать, дважды подумайте, прежде чем принимать какие-либо необратимые решения».</p>\n\n\n\n<p>Она предлагает следующий чек-лист:</p>\n\n\n\n<ul><li>использовать фриланс-платформу</li><li>трижды проверить резюме</li><li>профессионально представить себя</li><li>пополнить портфолио презентабельными примерами</li><li>использовать видеоматериалы</li></ul>\n\n\n\n<p>«Имея видеоматериалы, ваши клиенты будут видеть вас не как список навыков и предыдущего опыта, а как реального человека, обладающего этими навыками и опытом и предоставляющего им определенные услуги».</p>\n\n\n\n<p>Она добавляет: «При выборе первого работодателя имейте детальную стратегию. Выбирайте первого работодателя с умом, очень мудро. Я не могу переоценить, насколько это важно».</p>\n\n\n\n<p>Когда Тияна выбирала свой первый фриланс-заказ, она рассматривала следующие аспекты:</p>\n\n\n\n<ul><li>Как оценили работодателя другие фрилансеры, работавшие на него ранее?</li><li>Как работодатель оценивает других фрилансеров?</li><li>Сколько денег он уже потратил на платформе?</li><li>Количество заявок на определенный вид работ и количество фрилансеров, которые уже высказали желание выполнить конкретную работу.</li></ul>\n\n\n\n<p>«Первая работа — это не только деньги. Не жадничайте на своем первом заказе. Если вы получите хорошие рекомендации, ваша вторая работа может принести в два-три раза больше. И ваша третья работа может дать и в пять раз. Это был мой опыт».</p>\n\n\n\n<h3>Фриланс — это ответственность</h3>\n\n\n\n<p>Тияна напоминает: «Свобода часто сопровождается ответственностью, когда дело доходит до фриланса, ключевую роль играет индивидуальная ответственность».</p>\n\n\n\n<p>Она советует не браться за работу, если вы не можете уложиться в срок и у вас нет надежного человека, который сможет вам помочь в случае необходимости.</p>\n\n\n\n<p>Несоблюдение сроков будет стоить вашему клиенту денег и повлияет на отзыв, который клиент захочет оставить о вашей работе, и это может оказать большое влияние на ваши будущие возможности и успехи во фрилансе в целом.</p>\n\n\n\n<p>Она добавляет: «Это может начать нисходящую спираль в вашей карьере. Однако все мы люди, и могут случаться непредсказуемые вещи. Если по какой-то причине вы не можете своевременно завершить работу, немедленно сообщите об этом клиенту, чтобы у него было достаточно времени, чтобы нанять кого-то другого».</p>\n\n\n\n<p>Тияна также подчеркнула важность четкого определения ожиданий перед тем как взяться работу, как того, что клиент хочет получить в результате, так и того, что вы ждете от него в процессе.</p>\n\n\n\n<p>Наконец, она также отмечает, что если вы работаете из дома, ваши друзья и семья должны относиться к вам так, как если бы вы находились в офисе. Она советует: «Сообщите им о своем рабочем графике».</p>\n\n\n\n<p>Она надеется, что эти основные рекомендации будут полезны при начале карьеры фрилансера, как помогли ей, несмотря на то, что универсального рецепта для всех не существует.</p>\n\n\n\n<p>Тияна подчеркивает: «Просто важно оставаться сосредоточенным на своих целях и быть открытым для новых возможностей». Фриланс был не единственным способом, которым она могла достичь своих целей, но это была важная часть ее пути и она помогала ей приобрести уверенность в своих способностях, чтобы сделать следующий большой шаг в своей жизни.</p>\n\n\n\n<p>Будучи фрилансером, ей не хватало тесных отношений с коллегами и командной работы, которые она нашла в организации, где теперь работает. Коллеги описывают ее как «Ходячая и говорящая совокупность суперсил: спортивный медик и фитнес-профессионал, SEO-эксперт, блоггер, дизайнер и приемная мать для котят».</p>\n\n\n\n<div class=\"wp-block-image\"><figure class=\"aligncenter size-large\"><a href=\"https://ru.wordpress.org/files/2021/06/2021-07-Tijana-Andrejic-1.jpg\"><img loading=\"lazy\" width=\"1024\" height=\"682\" src=\"https://ru.wordpress.org/files/2021/06/2021-07-Tijana-Andrejic-1-1024x682.jpg\" alt=\"WordCamp Белград 2017, ресепшн\" class=\"wp-image-2316\" srcset=\"https://ru.wordpress.org/files/2021/06/2021-07-Tijana-Andrejic-1-1024x682.jpg 1024w, https://ru.wordpress.org/files/2021/06/2021-07-Tijana-Andrejic-1-300x200.jpg 300w, https://ru.wordpress.org/files/2021/06/2021-07-Tijana-Andrejic-1-768x512.jpg 768w, https://ru.wordpress.org/files/2021/06/2021-07-Tijana-Andrejic-1-1536x1023.jpg 1536w, https://ru.wordpress.org/files/2021/06/2021-07-Tijana-Andrejic-1.jpg 1600w\" sizes=\"(max-width: 1024px) 100vw, 1024px\" /></a></figure></div>\n\n\n\n<p>Если вы планируете начать свою карьеру в качестве фрилансера, пройдите курсы, предлагаемые на <a href=\"https://learn.wordpress.org/\">learn.wordpress.org</a>, обратитесь в компании, с которыми вам будет интересно работать, и помните, что проект WordPress открывает множество возможностей.</p>\n\n\n\n<p><a href=\"https://make.wordpress.org/\">Команды WordPress.org</a> — чем они занимаются, когда и где встречаются.</p>\n\n\n\n<p><a href=\"https://learn.wordpress.org/\">Learn WordPress</a> — бесплатная платформа, чтобы расширить свои знания и навыки работы с WordPress и узнать о сообществе вокруг нее.</p>\n\n\n\n<p>Трехдневная онлайн-конференция <a href=\"https://europe.wordcamp.org/2021/\">WordCamp Europe 2021</a> проходит с 7 по 9 июня 2021 года. Вы можете узнать больше о том, как принять участие в развитии WordPress в сессиях, которые пройдут в прямом эфире, а также из опубликованных на сайте мероприятия материалов.</p>\n\n\n\n<h2>Авторы и редакторы</h2>\n\n\n\n<p>Спасибо Тияне Андреич (<a href=\"https://profiles.wordpress.org/andtijana/\">@andtijana</a>) за ее #ContributorStory.</p>\n\n\n\n<p>Спасибо Ольге Глеклер (<a href=\'https://profiles.wordpress.org/oglekler/\' class=\'mention\'><span class=\'mentions-prefix\'>@</span>oglekler</a>), Абе Такор (<a href=\'https://profiles.wordpress.org/webcommsat/\' class=\'mention\'><span class=\'mentions-prefix\'>@</span>webcommsat</a>), Хлое Брингманн (<a href=\'https://profiles.wordpress.org/cbringmann/\' class=\'mention\'><span class=\'mentions-prefix\'>@</span>cbringmann</a>), Сурендре Такор (<a href=\'https://profiles.wordpress.org/sthakor/\' class=\'mention\'><span class=\'mentions-prefix\'>@</span>sthakor</a>) и Мехер Бала (<a href=\'https://profiles.wordpress.org/meher/\' class=\'mention\'><span class=\'mentions-prefix\'>@</span>meher</a>) за работу над серией «Люди WordPress». Спасибо Джозефе Хаден (<a href=\"https://profiles.wordpress.org/chanthaboune/\">@chanthaboune</a>) и Тоферу ДеРозиа (<a href=\'https://profiles.wordpress.org/topher1kenobe/\' class=\'mention\'><span class=\'mentions-prefix\'>@</span>topher1kenobe</a>) создавшему HeroPress.</p>\n\n\n\n<p>Перевод на русский: Ольга Глеклер</p>\n\n\n\n<div class=\"wp-block-media-text alignwide is-stacked-on-mobile\" style=\"grid-template-columns:25% auto\"><figure class=\"wp-block-media-text__media\"><img loading=\"lazy\" width=\"180\" height=\"135\" src=\"https://ru.wordpress.org/files/2021/03/heropress-logo.png\" alt=\"\" class=\"wp-image-2268 size-full\" /></figure><div class=\"wp-block-media-text__content\">\n<p>Эта статья основана на первоначальной публикации HeroPress.com, инициативе, ориентированной на людей в сообществе WordPress, созданной Тофером ДеРозиа <a href=\"https://profiles.wordpress.org/topher1kenobe/\">@topher1kenobe</a>.</p>\n\n\n\n<p>Читайте эту и другие истории серии «<a href=\"https://wordpress.org/news/category/interviews/\">People of WordPress</a>» (на английском) или «<a href=\"https://ru.wordpress.org/news/category/people-of-wordpress/\">Люди WordPress</a>» (на русском).</p>\n</div></div>\n\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}}}}i:8;a:6:{s:4:\"data\";s:60:\"\n		\n		\n		\n		\n		\n				\n		\n		\n\n					\n										\n					\n		\n		\n			\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";s:5:\"child\";a:3:{s:0:\"\";a:6:{s:5:\"title\";a:1:{i:0;a:5:{s:4:\"data\";s:39:\"Люди WordPress: Тайлер Лау\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}s:4:\"link\";a:1:{i:0;a:5:{s:4:\"data\";s:68:\"https://ru.wordpress.org/news/2021/04/people-of-wordpress-tyler-lau/\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}s:7:\"pubDate\";a:1:{i:0;a:5:{s:4:\"data\";s:31:\"Tue, 13 Apr 2021 19:35:52 +0000\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}s:8:\"category\";a:2:{i:0;a:5:{s:4:\"data\";s:18:\"Люди WordPress\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}i:1;a:5:{s:4:\"data\";s:19:\"people-of-wordpress\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}s:4:\"guid\";a:1:{i:0;a:5:{s:4:\"data\";s:32:\"https://ru.wordpress.org/?p=2292\";s:7:\"attribs\";a:1:{s:0:\"\";a:1:{s:11:\"isPermaLink\";s:5:\"false\";}}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}s:11:\"description\";a:1:{i:0;a:5:{s:4:\"data\";s:643:\"WordPress — программное обеспечение с открытым исходным кодом, поддерживаемое волонтерами. В серии «Люди WordPress» мы рассказываем, как WordPress меняет жизни людей к лучшему. Принять себя и пройденный путь Сегодня мы беседуем с Тайлером Лау из США о его работе по развитию отношений в области маркетинга и роли WordPress в его жизни. Читайте дальше, чтобы узнать [&#8230;]\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}}s:32:\"http://purl.org/dc/elements/1.1/\";a:1:{s:7:\"creator\";a:1:{i:0;a:5:{s:4:\"data\";s:3:\"Yui\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}}s:40:\"http://purl.org/rss/1.0/modules/content/\";a:1:{s:7:\"encoded\";a:1:{i:0;a:5:{s:4:\"data\";s:15092:\"\n<p>WordPress — программное обеспечение с открытым исходным кодом, поддерживаемое волонтерами. В серии «Люди WordPress» мы рассказываем, как WordPress меняет жизни людей к лучшему.</p>\n\n\n\n<h2>Принять себя и пройденный путь</h2>\n\n\n\n<p>Сегодня мы беседуем с Тайлером Лау из США о его работе по развитию отношений в области маркетинга и роли WordPress в его жизни.</p>\n\n\n\n<figure class=\"wp-block-image size-large\"><img src=\"https://i1.wp.com/wordpress.org/news/files/2021/04/people-of-wp-tyler-thumb.jpg\" alt=\"\" /></figure>\n\n\n\n<p>Читайте дальше, чтобы узнать его историю, демонстрирующую, как уроки, полученные в результате негативного жизненного опыта, позволяют добиться профессионального успеха.</p>\n\n\n\n<h2>Предпринимательское мышление</h2>\n\n\n\n<p>Тайлер вспоминает, что он всегда умел замечать бизнес-возможности. Еще будучи старательным семилетним мальчиком, он уже находил способы продавать и зарабатывать во время школьных каникул.</p>\n\n\n\n<p>Хотя у многих предпринимателей есть похожие истории, на пути Тайлера было много поворотов, прежде чем он открыл для себя WordPress и добился с ним успеха.</p>\n\n\n\n<p>В поисках личной и профессиональной свободы его привлек WordPress и сообщество людей сформированное этой системой управления контентом, где он в конце концов смог объединить свои разносторонние деловые интересы и навыки работы с людьми в профессиональной маркетинговой работе.</p>\n\n\n\n<h2>Использовать навыки, чтобы найти свой путь</h2>\n\n\n\n<figure class=\"wp-block-image size-large\"><img src=\"https://i0.wp.com/wordpress.org/news/files/2021/04/people-of-wp-tyler-2.jpg\" alt=\"\" /></figure>\n\n\n\n<p>В настоящее время Тайлер — специалист по построению маркетинговых отношений в Канзасе, США. Его обязанности распространяются на широкий спектр электронных ресурсов и продуктов и находят применение его разнообразным деловым и человеческим качествам.</p>\n\n\n\n<p>Его навыки усиливаются креативностью и способностью к адаптации. Тайлер говорит, что одна из причин, по которой он всегда ищет новые проекты — синдром дефицита внимания и гиперактивности (СДВГ), диагностированный у него в 2005 году.</p>\n\n\n\n<p>В индустрии, созданной программистами и разработчиками, которые часто обладают выдающимися способностями к фокусировке внимания, Тайлер чувствовал, что человеку с СДВГ будет сложно стать своим. Однако, он обнаружил, что в сообществе WordPress каждый может найти свои место и применение своим способностям. Талант Тайлера в общении с людьми, и это привело к появлению множества возможностей и обязанностей в его профессиональной жизни. Его навыки также позволили ему принимать участие в жизни сообщества WordPress и вносить свой вклад в качестве спикера и волонтера, а также в течение многочисленных дней участников-волонтеров (Contributor days).</p>\n\n\n\n<h2>Построение отношений как карьера</h2>\n\n\n\n<p>Большая часть опыта Тайлера приходилась на ресторанную индустрию, и его резюме вовсе не указывало на карьеру в сфере технологий. Но сфера услуг на самом деле хорошо подготовила его ко всему, за что бы он ни брался.</p>\n\n\n\n<p>Когда он находится на различных мероприятиях по работе, то знакомится с людьми со всего мира и налаживает с ними отношения. Как экстраверту, ему это нравится, и он не может представить себе работу, где бы он был изолирован от новых знакомств и общения с другими людьми.</p>\n\n\n\n<p>Понимание людей и способность работать в любых условиях — его ключевые компетенции. Социальные навыки и такт полезны для построения сообщества и нашли применение в пространстве WordPress, а в жизни Тайлера в разное время они были непременными условиями выживания.</p>\n\n\n\n<h2>Истинный смысл свободы</h2>\n\n\n\n<p>В сообществе WordPress часто затрагивается понятие свободы. WordPress построен на GPL (General Public License или Открытое лицензионное соглашение), бесплатном программном обеспечении и ценностях открытого исходного кода. Фактически, каждый может работать удаленно или быть сам себе начальником, чтобы получить больше свободы в работе и жизни. Тайлер чувствует, что он никогда не вписывался в традиционные рабочие шаблоны. Он обнаружил, что его сильное стремление к свободе, перекликается со свободой и возможностями, которые, по его мнению, WordPress предоставляет ему и тысячам других.</p>\n\n\n\n<p>Тайлер описывает, как в 2013 году его «внутренний оппортунист» навлек на него проблемы. Оставив колледж из-за аневризмы мозга, он нуждался в капитале для финансирования своего первого стартапа. Он рассказывает, что нашел быстрый, но незаконный способ заработать деньги. Параллельно между сменами официантом он работал над прототипами своего первого продукта. Компания быстро росла, и чтобы защитить свои патенты и вывести исследования и разработки на новый уровень, ему пришлось много работать. Все пошло прахом, когда в результате своих незаконных действий, он попал в тюрьму.</p>\n\n\n\n<p>Он вспоминает, что встреча с другими заключенными показала ему, насколько хорошо его положение, относительно большинства. Он был образованным, обеспеченным, любимым и знал, что у него есть будущее после освобождения. Он узнал, что многие заключенные так и не закончили среднюю школу и не умеют пользоваться компьютером. Находясь внутри, Тайлер преподавал естественные науки, математику, письмо, чтение и общественные науки. Он понимал, что из-за отсутствия навыков и поддержки многие заключенные окажутся в плачевной ситуации после освобождения. Он говорит, что там нелегко получить психологическую поддержку и профессиональную подготовку, необходимые для благополучной жизни после тюрьмы.</p>\n\n\n\n<blockquote class=\"wp-block-quote\"><p>«Свобода — это нечто большее, чем просто быть по другую сторону. Вам также необходимо чувство собственного достоинства и наличие гражданских прав»</p></blockquote>\n\n\n\n<p> Он считал, что его целеустремленность и поддержка близких были достаточными, чтобы он смог приступить к следующей (законной) бизнес-задаче, как только сможет.</p>\n\n\n\n<h2>Позитивное движение вперед</h2>\n\n\n\n<figure class=\"wp-block-image size-large\"><img src=\"https://i0.wp.com/wordpress.org/news/files/2021/04/FF50DF21-38AA-4778-B465-C2DF0B441AD7.jpeg\" alt=\"\" /></figure>\n\n\n\n<p>Идея о том, что ваше прошлое не определяет вас, и вы можете принять его, является силой движущей Тайлера вперед.</p>\n\n\n\n<p>Он описывает себя как особенного человека во многих отношениях. Он вспоминает, как политика влияла на его жизнь начиная со дня его рождения. Отец Тайлера — китайский визуальный антрополог, полудиссидент, его мать — профессор искусства, покинувшая свою родную страну, Японию, чтобы освободиться от традиционных японских гендерных ролей. Тайлер чувствует, что унаследовал большую часть этого бесстрашия.</p>\n\n\n\n<blockquote class=\"wp-block-quote\"><p><em>«Я никогда не вписывался, но это то, что позволяет мне адаптироваться к большинству ситуаций и общаться практически с кем угодно. Я принимаю свое эклектичное, диссонирующее прошлое и вижу красоту в человеке, которым меня сделал полученный опыт»</em></p></blockquote>\n\n\n\n<p>Теперь он нашел применение полученным навыкам в сообществе WordPress и за его пределами.</p>\n\n\n\n<blockquote class=\"wp-block-quote\"><p>«Независимо от ваших физических способностей, проблем с психическим здоровьем, воспитания и даже ваших стычек с законом, никому не запрещается занять свое место в индустрии WordPress».</p></blockquote>\n\n\n\n<h2>Авторы и редакторы</h2>\n\n\n\n<p>Спасибо Тайлеру Лау (<a href=\'https://profiles.wordpress.org/tylermaximus/\' class=\'mention\'><span class=\'mentions-prefix\'>@</span>tylermaximus</a>) за его #ContributorStory.</p>\n\n\n\n<p>Спасибо Ларисе Мурильо (<a href=\'https://profiles.wordpress.org/lmurillom/\' class=\'mention\'><span class=\'mentions-prefix\'>@</span>lmurillom</a>), Сурендре Такор (<a href=\'https://profiles.wordpress.org/sthakor/\' class=\'mention\'><span class=\'mentions-prefix\'>@</span>sthakor</a>), Ольге Глеклер (<a href=\'https://profiles.wordpress.org/oglekler/\' class=\'mention\'><span class=\'mentions-prefix\'>@</span>oglekler</a>), Мехер Бала (<a href=\'https://profiles.wordpress.org/meher/\' class=\'mention\'><span class=\'mentions-prefix\'>@</span>meher</a>), Иветт Сонневельд (<a href=\'https://profiles.wordpress.org/yvettesonneveld/\' class=\'mention\'><span class=\'mentions-prefix\'>@</span>yvettesonneveld</a>), Абе Такор (<a href=\'https://profiles.wordpress.org/webcommsat/\' class=\'mention\'><span class=\'mentions-prefix\'>@</span>webcommsat</a>), Джозефе Хаден, Хлое Брингманн (<a href=\'https://profiles.wordpress.org/cbringmann/\' class=\'mention\'><span class=\'mentions-prefix\'>@</span>cbringmann</a>) и Тоферу ДеРозиа (<a href=\'https://profiles.wordpress.org/topher1kenobe/\' class=\'mention\'><span class=\'mentions-prefix\'>@</span>topher1kenobe</a>) за работу над серией «Люди WordPress».</p>\n\n\n\n<p>Перевод на русский: Ольга Глеклер</p>\n\n\n\n<div class=\"wp-block-media-text alignwide is-stacked-on-mobile\" style=\"grid-template-columns:25% auto\"><figure class=\"wp-block-media-text__media\"><img loading=\"lazy\" width=\"180\" height=\"135\" src=\"https://ru.wordpress.org/files/2021/03/heropress-logo.png\" alt=\"\" class=\"wp-image-2268 size-full\" /></figure><div class=\"wp-block-media-text__content\">\n<p>Эта статья основана на первоначальной публикации HeroPress.com, инициативе, ориентированной на людей в сообществе WordPress, созданной Тофером ДеРозиа <a href=\"https://profiles.wordpress.org/topher1kenobe/\">@topher1kenobe</a>.</p>\n\n\n\n<p>Читайте эту и другие истории серии «<a href=\"https://wordpress.org/news/category/interviews/\">People of WordPress</a>» (на английском) или «<a href=\"https://ru.wordpress.org/news/category/people-of-wordpress/\">Люди WordPress</a>» (на русском).</p>\n</div></div>\n\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}}}}i:9;a:6:{s:4:\"data\";s:60:\"\n		\n		\n		\n		\n		\n				\n		\n		\n\n					\n										\n					\n		\n		\n			\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";s:5:\"child\";a:3:{s:0:\"\";a:6:{s:5:\"title\";a:1:{i:0;a:5:{s:4:\"data\";s:45:\"Люди WordPress: Ольга Глеклер\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}s:4:\"link\";a:1:{i:0;a:5:{s:4:\"data\";s:72:\"https://ru.wordpress.org/news/2021/03/people-of-wordpress-olga-gleckler/\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}s:7:\"pubDate\";a:1:{i:0;a:5:{s:4:\"data\";s:31:\"Sun, 14 Mar 2021 17:24:53 +0000\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}s:8:\"category\";a:2:{i:0;a:5:{s:4:\"data\";s:18:\"Люди WordPress\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}i:1;a:5:{s:4:\"data\";s:19:\"people-of-wordpress\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}s:4:\"guid\";a:1:{i:0;a:5:{s:4:\"data\";s:32:\"https://ru.wordpress.org/?p=2278\";s:7:\"attribs\";a:1:{s:0:\"\";a:1:{s:11:\"isPermaLink\";s:5:\"false\";}}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}s:11:\"description\";a:1:{i:0;a:5:{s:4:\"data\";s:723:\"WordPress — программное обеспечение с открытым исходным кодом, поддерживаемое волонтерами. В серии «Люди WordPress» мы рассказываем, как WordPress меняет жизнь людей к лучшему.&#160; Естественный интерес к компьютерам и стремление чинить все, что можно, для Ольги Глеклер из Санкт-Петербурга (Россия) стали отправной точкой на пути в сферу информационных технологий, где WordPress помог ей добиться успеха как [&#8230;]\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}}s:32:\"http://purl.org/dc/elements/1.1/\";a:1:{s:7:\"creator\";a:1:{i:0;a:5:{s:4:\"data\";s:3:\"Yui\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}}s:40:\"http://purl.org/rss/1.0/modules/content/\";a:1:{s:7:\"encoded\";a:1:{i:0;a:5:{s:4:\"data\";s:28503:\"\n<p>WordPress — программное обеспечение с открытым исходным кодом, поддерживаемое волонтерами. В серии «Люди WordPress» мы рассказываем, как WordPress меняет жизнь людей к лучшему.&nbsp;</p>\n\n\n\n<p>Естественный интерес к компьютерам и стремление чинить все, что можно, для Ольги Глеклер из Санкт-Петербурга (Россия) стали отправной точкой на пути в сферу информационных технологий, где WordPress помог ей добиться успеха как женщине-предпринимателю. В Международный женский день мы делимся ее историей.</p>\n\n\n\n<div class=\"wp-block-image\"><figure class=\"aligncenter size-large\"><a href=\"https://ru.wordpress.org/files/2021/03/olga1.jpg\"><img loading=\"lazy\" width=\"768\" height=\"1018\" src=\"https://ru.wordpress.org/files/2021/03/olga1.jpg\" alt=\"\" class=\"wp-image-2280\" srcset=\"https://ru.wordpress.org/files/2021/03/olga1.jpg 768w, https://ru.wordpress.org/files/2021/03/olga1-226x300.jpg 226w\" sizes=\"(max-width: 768px) 100vw, 768px\" /></a><figcaption>Фото с WCEU 2020</figcaption></figure></div>\n\n\n\n<p></p>\n\n\n\n<h2>Поиск пути требует времени</h2>\n\n\n\n<p>Когда Ольге исполнилось 15 лет, для нее остро встал вопрос получения профессионального образования: «Я не знала, насколько высоки или малы мои шансы, несмотря на хорошие оценки. Я вполне могла оказаться большой рыбой в маленьком пруду. Но как бы то ни было, я решила пойти в техникум».</p>\n\n\n\n<p>Окончив 9 классов в Санкт-Петербурге, Ольга получила аттестат, но имела слабое представление о доступных направлениях, и пыталась представить себя экологом или гидом-переводчиком немецкого языка, опираясь на знания, полученные в школе. В России в этот период происходил рекламный бум, и карьера в рекламной сфере также казалась заманчивой. В то же время у нее уже были навыки работы на компьютере, проверенные на практике помощью учителям в административной работе.</p>\n\n\n\n<p>Никто не спешил советовать, и оценив возможные варианты, она выбрала программирование: «Диапазон подходящих техникумов не был велик, и я провела четыре года изучая маркировку транзисторов, пайку и чертя разводку печатных плат. Курс программирования ограничился Паскалем, и мы даже не пытались написать что-то осмысленное».</p>\n\n\n\n<p>Курс английского языка стал еще одним слабым местом ее обучения, однако Ольга была полна решимости изучить его в будущем. Окончив техникум с отличием она опасалась, что только улучшенные навыки машинистки имеют практическое применение.</p>\n\n\n\n<p>«Я оказалась на диком и неизведанном рынке труда, где было сложно отличить нормальное предложение от сомнительного, и еще бы долго искала работу без посторонней помощи».</p>\n\n\n\n<h2>Смените точку зрения, чтобы найти свое место</h2>\n\n\n\n<p>Отец Ольги работал в ИТ-компании и не только помог советом, но и познакомил с людьми, которым требовались сотрудники. Когда она еще училась, он предположил ее в качестве машинистки на подмену, а когда окончила техникум, помог устроиться на работу по обновлению информационно-правовой системы на компьютерах клиентов.</p>\n\n\n\n<p>Через шесть месяцев Ольга получила работу на полную ставку в том же отделе. Ей нравились и обязанности, и клиенты, однако вскоре она получила дружеский совет, что без высшего образования на карьерный рост может не рассчитывать.</p>\n\n\n\n<p>В это время Ольга пробовала изучить PHP по книге. Это было захватывающее чтение, но описание функций не давало понимания как из них построить сайт, и когда она перешла от теории к практике, то уперлась в отсутствие целостного понимания и сдалась, так и не написав ничего работающего.</p>\n\n\n\n<p>«Было сложно признаться, даже самой себе, что я не смогла, и это неприятное чувство преследовало меня долгое время. Нужно было выбрать то, с чем точно справлюсь, интересное и обучение чему смогу оплачивать. Это оказалась реклама».</p>\n\n\n\n<p>Следующие шесть лет большая часть отпусков Ольги и ее мужа уходила на ее сессии: «Мужу было сложно добраться до компьютера, я к нему приклеилась, поэтому он купил мне ноутбук. Английский по-прежнему давался трудно, я получила итоговое «отлично» проштудировав учебник и запомнив перевод и звучание каждого слова».</p>\n\n\n\n<blockquote class=\"wp-block-quote\"><p><strong>Сомнения в собственных профессиональных навыках случаются, когда вы вырваны из привычной жизни в отпуске по уходу за ребенком. Поэтому так важно сохранить интересы.</strong></p></blockquote>\n\n\n\n<p>Жизнь Ольги изменилась после рождения ребенка, и три года прошли в сомнениях о профессиональных навыках и шансах на хорошую работу. Она старалась сохранять прежние интересы, занималась образованием, выпечкой и рисованием, но «оказалась не готова быть привязанной к коляске» и обнаружила, что сложно с уверенностью смотреть в будущее, сидя дома с ребенком и полагаясь на зарплату мужа.</p>\n\n\n\n<blockquote class=\"wp-block-quote\"><p>«Я была убеждена, и обоснованно, что ни так много компаний готовы взять на офисную позицию женщину с маленьким ребенком и кучей больничных».</p></blockquote>\n\n\n\n<p>Получив высшее образование, Ольга вернулась на работу после трех лет отпуска по уходу. Несмотря на повышение по службе, ситуация в отделе была далека от комфортной, и казалось непосредственный руководитель относится к молодым женщинам как к мебели. Мириться с таким отношением она оказалась не готова, и вскоре решилась уйти.</p>\n\n\n\n<h2>Открытия в неожиданных местах</h2>\n\n\n\n<p>Будучи преисполненной решимости не повторять подобный опыт, Ольга нашла положительные стороны в случившемся. Она говорит: «Я хотела быть маркетологом. Зная, как непросто продавать неосязаемое, решила работать с физическими товарами».</p>\n\n\n\n<p>Молодой маме оказалось сложнее найти работу вне привычной IT-сферы. Некоторые HR отвечали и советовали остаться в области информационных технологий.</p>\n\n\n\n<p>Ольга сохраняла надежду и продолжала учиться, получив в процессе опыт, который, как она надеется, будет полезен другим. Она пришла к выводу, что устанавливала низкую планку для работодателей: «Компании, в которых я работала, хотели публикаций и увеличения продаж без бюджета, исключительно за счет моей зарплаты». Обжегшись один раз, и не желая наступать на те же грабли, она решила прояснить финансовую сторону, прежде чем согласиться на новое место: «Я специально уточнила вопрос с бюджетом, и меня заверили, что он есть. Оказалось, что это по-прежнему только зарплата. Это был период разочарований. Поэтому, когда мне предложили административную работу на полставки с терпимым отношением к больничным, я с радостью ухватилась за возможность взять передышку».</p>\n\n\n\n<p>Дорога на работу занимала много времени, Ольга проводила два-три часа в день в автобусах в компании аудиокниг о Гарри Поттере. «В этих дорожных пробках я наконец почувствовала и полюбила английский язык. Он дал мне свободу, которую невозможно купить за деньги, и изменил жизнь к лучшему».</p>\n\n\n\n<p>Работа не оплачивалась высоко, но дала Ольге нечто другое — рабочий веб-сайт. После того, как начальник прекратил сотрудничество с разработчиком, она получила этот сайт на поддержку. Изучив и разобрав его по частям, она поняла как он устроен и этого оказалось достаточно, чтобы начать писать простые сайты с нуля.</p>\n\n\n\n<p>Знакомство Ольги с JavaScript не было простым: «Мой первый калькулятор на JavaScript чуть не свел меня с ума, но я справилась».</p>\n\n\n\n<p>Вскоре она начала получать небольшие задания от друзей и родственников, в основном решая неотложные проблемы, и начала знакомиться с популярными системами управления контентом. Одной из первых CMS, с которой она познакомилась, был WordPress. Проблема оказалась в модифицированной теме с отсутствием поддержки. На решение потребовались целые выходные, но она была намерена разобраться и справилась. Тогда WordPress для нее был «просто системой» и она еще не знала, что он займет видное место в ее жизни.</p>\n\n\n\n<p>На административной работе Ольга провела следующие два года, уже понимая, что засиделась и не получая удовлетворения. Последней каплей стало негативное заявление начальника, который не был программистом и полагал, что на сайте все случается самой собой. Она посчитала это несправедливым, поскольку проделала значительную работу: «Я разозлилась, и это было то, что нужно, чтобы начать шевелиться».</p>\n\n\n\n<p>Когда Ольга искала новую работу, у нее не хватило смелости претендовать на позицию разработчика, несмотря на знания и опыт. Поэтому она начала работать над проектами, которые в большинстве случаев были «сайтами из коробки». Это были еще одни сложные полгода: много работы, низкая зарплата и неоправдавшиеся ожидания. Эти напряженные дни закончились воспалением легких. Она замечает: «Сейчас, думаю, я оказывала клиентам медвежью услугу, сайт – не готовое блюдо для микроволновки, быстрое, дешевое и бездушное. В этих сайтах не было жизни без вложения труда, за который никто не хотел платить. Большая часть сайтов умерли через год, но они и живыми то не были».</p>\n\n\n\n<h2>Нужно быть храбрым и смелым</h2>\n\n\n\n<div class=\"wp-block-image\"><figure class=\"aligncenter size-large\"><a href=\"https://ru.wordpress.org/files/2021/03/olga2.jpg\"><img loading=\"lazy\" width=\"1024\" height=\"684\" src=\"https://ru.wordpress.org/files/2021/03/olga2.jpg\" alt=\"\" class=\"wp-image-2282\" srcset=\"https://ru.wordpress.org/files/2021/03/olga2.jpg 1024w, https://ru.wordpress.org/files/2021/03/olga2-300x200.jpg 300w, https://ru.wordpress.org/files/2021/03/olga2-768x513.jpg 768w\" sizes=\"(max-width: 1024px) 100vw, 1024px\" /></a><figcaption>Berlin 2019</figcaption></figure></div>\n\n\n\n<p>Ольге очень хотелось найти работу разработчика, но поиск оказался разочаровывающим. Из объявлений о вакансиях она сделала вывод, что большинство ИТ-компаний ищут гениев, знающих множество технологий и фреймворков. Изучая такие объявления, было сложно сохранять оптимизм.</p>\n\n\n\n<p>Неожиданно она нашла предложение на сайте вне популярных порталов вакансий, и оно показалось идеальным — автору нужен был разработчик с опытом написания с нуля, способный понимать и поддерживать чужой код, умеющий переводить техническую документацию и статьи, а также создавать несложные макеты полиграфической продукции. После выполнения пробного задания Ольга получила работу, более высокую зарплату, хорошие условия без переработок и замечательных коллег.</p>\n\n\n\n<p>Вакансия оказалась прямым объявлением одного из отделов продаж технологической компании. Успешно выполнив тестовое задание, Ольга прошла мимо отдела кадров, который, как она думала, даже не стал бы рассматривать ее резюме.</p>\n\n\n\n<p>Новый начальник согласился на ее удаленную работу большую часть времени, что решило потенциальные проблемы с больничными, которые могли стать препятствием.</p>\n\n\n\n<p>К этому моменту для Ольги прошло 14 лет после первоначального решения стать программистом, и это стало только началом.</p>\n\n\n\n<p>После нескольких лет в этой компании, которые она запомнила как «потрясающий опыт», Ольга решила идти дальше как разработчик, и принять следующий вызов.</p>\n\n\n\n<h2>Хорошие решения опираются на обширные знания</h2>\n\n\n\n<p>Приобретя опыт работы с разными системами управления контентом, Ольга убедилась, что WordPress — лучшая CMS как для разработчиков, так и для клиентов. Однако, изучая сайты, с которыми работала, она оказалась обескуражена тем, что простота решения задач на WordPress ведет в тому, что хороший код встречается довольно редко.</p>\n\n\n\n<p>«Самый большой недостаток WordPress — очень просто сделать, чтобы все работало, поэтому некоторые не беспокоятся о том, чтобы делать правильно, что позже выливается в проблемы».</p>\n\n\n\n<p>Так, в покупные темы вносятся изменения, остающиеся затем без какой-либо поддержки, а в шаблоны прописываются напрямую данные и элементы, которые должны быть доступны клиенту для редактирования и внесения изменений.</p>\n\n\n\n<p>Ольга привыкла полагаться на примеры под рукой, документацию и поисковые системы, в своей работе с WordPress, но уделяя внимание только конкретной задаче или поиску сиюминутного решения, поняла, что упускает всю картину.</p>\n\n\n\n<p>Она обратилась к онлайн-курсам, чтобы расширить знания, а затем начала посещать мероприятия WordPress, сначала онлайн, затем проводимые в родном Санкт-Петербурге, а после и за рубежом отправляясь на поездах и самолетах. Так она открыла для себя активное мировое сообщество. Когда Ольга начала изучать онлайн-материалы и курсы, она не имела представления, что спустя несколько лет сама будет участвовать в запуске образовательной платформы <a href=\"https://learn.wordpress.org/\">Learn WordPress</a>.</p>\n\n\n\n<p>Конференции WordCamp и дни участников-волонтеров (Contributor days) стали значительной частью ее жизни. С началом посещения международных мероприятий WordPress, она начала вносить вклад в его развитие как активный член глобальных команд маркетинга (<a href=\"https://make.wordpress.org/marketing/\">Marketing Team</a>) и переводчиков (<a href=\"https://make.wordpress.org/polyglots/\">Polyglots Team</a>) WordPress.org, а недавно участвовала в поддержке выпуска WordPress 5.6. <a href=\"https://europe.wordcamp.org/2021/\">WordCamp Europe 2021</a> — первая конференция, где Ольга выступает в качестве организатора в команде участников (Contribute Team).</p>\n\n\n\n<div class=\"wp-block-image\"><figure class=\"aligncenter size-large\"><a href=\"https://ru.wordpress.org/files/2021/03/olga3.jpg\"><img loading=\"lazy\" width=\"1024\" height=\"976\" src=\"https://ru.wordpress.org/files/2021/03/olga3.jpg\" alt=\"\" class=\"wp-image-2283\" srcset=\"https://ru.wordpress.org/files/2021/03/olga3.jpg 1024w, https://ru.wordpress.org/files/2021/03/olga3-300x286.jpg 300w, https://ru.wordpress.org/files/2021/03/olga3-768x732.jpg 768w\" sizes=\"(max-width: 1024px) 100vw, 1024px\" /></a><figcaption>Санкт-Петербург 2018</figcaption></figure></div>\n\n\n\n<blockquote class=\"wp-block-quote\"><p>«Благодаря обширному сообществу WordPress я теперь знаю не только, где искать, но и у кого спросить. Наиболее ценным оказалось найти союзников, не считающих человека ненормальным, если он с удовольствием говорит о работе, и с которыми я разделяю страсть и привязанность к WordPress. Это то, что имеет значение».</p></blockquote>\n\n\n\n<blockquote class=\"wp-block-quote\"><p>«Теперь, после семи лет работы разработчиком, я по-прежнему наслаждаюсь бесконечным обучением, частыми открытиями, ошибками и страстным стремлением сделать лучше».</p></blockquote>\n\n\n\n<p>Это, а также желание помочь другим в изучении WordPress, привело Ольгу к работе в командах поддержки (<a href=\"https://make.wordpress.org/support/\">Support Team</a>) и маркетинга (<a href=\"https://make.wordpress.org/marketing/\">Marketing Team</a>), и ее участию в написании Вопросов и ответов к релизам (<a href=\"https://github.com/wpmarketingteam/WP5.5\">5.5</a> и <a href=\"https://github.com/wpmarketingteam/WP5.6Marcomms\">5.6</a>) в 2020 году.</p>\n\n\n\n<h2>Никаких финишных ленточек</h2>\n\n\n\n<div class=\"wp-block-image\"><figure class=\"aligncenter size-large\"><a href=\"https://ru.wordpress.org/files/2021/03/olga4.jpg\"><img loading=\"lazy\" width=\"683\" height=\"1024\" src=\"https://ru.wordpress.org/files/2021/03/olga4-683x1024.jpg\" alt=\"\" class=\"wp-image-2284\" srcset=\"https://ru.wordpress.org/files/2021/03/olga4-683x1024.jpg 683w, https://ru.wordpress.org/files/2021/03/olga4-200x300.jpg 200w, https://ru.wordpress.org/files/2021/03/olga4-768x1151.jpg 768w, https://ru.wordpress.org/files/2021/03/olga4.jpg 1025w\" sizes=\"(max-width: 683px) 100vw, 683px\" /></a><figcaption>Berlin 2019</figcaption></figure></div>\n\n\n\n<p>Путь к свободе и возможности стать самой себе начальником не был прост для Ольги. Он привел ее к этому моменту и ведет дальше, радуя самим процессом. Она ценит полученный опыт и жаждет новых знаний.</p>\n\n\n\n<blockquote class=\"wp-block-quote\"><p>«Мой путь извилист, со множеством препятствий и шума, но это как калейдоскоп, где каждый поворот показывает новую картинку, новое озарение, дает энергию двигаться дальше после казавшихся напрасными усилий. В периоды сомнений я напоминаю себе о Дэвиде Огилви (он считается отцом-основателем современной рекламной индустрии), который сменил множество специальностей, пока не добился успеха в рекламе, и может быть как раз поэтому он смог это сделать».</p></blockquote>\n\n\n\n<p>Наконец, она научилась не только сохранять хорошее настроение и пробовать новое, но и смело двигаться вперед.</p>\n\n\n\n<h2>Авторы и редакторы</h2>\n\n\n\n<p>Спасибо Абе Такор (<a href=\"https://profiles.wordpress.org/webcommsat/\">@webcommsat</a>), Налини Такор (<a href=\"https://profiles.wordpress.org/nalininonstopnewsuk/\">@nalininonstopnewsuk</a>), Ларисе Мурильо (<a href=\"https://profiles.wordpress.org/lmurillom/\">@lmurillom</a>), Мехер Бала (<a href=\"https://profiles.wordpress.org/meher/\">@meher</a>), Джозефе Хаден (<a href=\"https://profiles.wordpress.org/chanthaboune/\">@chanthaboune</a>), Хлое Брингманн (<a href=\"https://profiles.wordpress.org/cbringmann/\">@cbringmann</a>) и Тоферу ДеРозиа (<a href=\"https://profiles.wordpress.org/topher1kenobe/\">@topher1kenobe</a>) за работу над серией в этом месяце.<br>Спасибо за фотографии с WCEU 2019 в Берлине (2 и 4) Пабло Гигена. </p>\n\n\n\n<p>Спасибо Ольге Глеклер (<a href=\"https://profiles.wordpress.org/oglekler/\">@oglekler</a>) за #ContributorStory.</p>\n\n\n\n<div class=\"wp-block-media-text alignwide is-stacked-on-mobile\" style=\"grid-template-columns:25% auto\"><figure class=\"wp-block-media-text__media\"><img loading=\"lazy\" width=\"180\" height=\"135\" src=\"https://ru.wordpress.org/files/2021/03/heropress-logo.png\" alt=\"\" class=\"wp-image-2268 size-full\" /></figure><div class=\"wp-block-media-text__content\">\n<p>Эта статья основана на первоначальной публикации HeroPress.com, инициативе, ориентированной на людей в сообществе WordPress, созданной Тофером ДеРозиа <a href=\"https://profiles.wordpress.org/topher1kenobe/\">@topher1kenobe</a>.</p>\n\n\n\n<p>Читайте эту и другие истории серии «<a href=\"https://wordpress.org/news/category/interviews/\">People of WordPress</a>» (на английском) или «<a href=\"https://ru.wordpress.org/news/category/people-of-wordpress/\">Люди WordPress</a>» (на русском).</p>\n</div></div>\n\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}}}}}}s:27:\"http://www.w3.org/2005/Atom\";a:1:{s:4:\"link\";a:1:{i:0;a:5:{s:4:\"data\";s:0:\"\";s:7:\"attribs\";a:1:{s:0:\"\";a:3:{s:4:\"href\";s:35:\"https://ru.wordpress.org/news/feed/\";s:3:\"rel\";s:4:\"self\";s:4:\"type\";s:19:\"application/rss+xml\";}}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}}s:44:\"http://purl.org/rss/1.0/modules/syndication/\";a:2:{s:12:\"updatePeriod\";a:1:{i:0;a:5:{s:4:\"data\";s:9:\"\n	hourly	\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}s:15:\"updateFrequency\";a:1:{i:0;a:5:{s:4:\"data\";s:4:\"\n	1	\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}}}}}}}}}}}s:4:\"type\";i:128;s:7:\"headers\";O:42:\"Requests_Utility_CaseInsensitiveDictionary\":1:{s:7:\"\0*\0data\";a:8:{s:6:\"server\";s:5:\"nginx\";s:4:\"date\";s:29:\"Tue, 05 Apr 2022 18:37:14 GMT\";s:12:\"content-type\";s:34:\"application/rss+xml; charset=UTF-8\";s:6:\"x-olaf\";s:3:\"⛄\";s:13:\"last-modified\";s:29:\"Tue, 05 Apr 2022 18:25:54 GMT\";s:4:\"link\";s:61:\"<https://ru.wordpress.org/wp-json/>; rel=\"https://api.w.org/\"\";s:15:\"x-frame-options\";s:10:\"SAMEORIGIN\";s:4:\"x-nc\";s:9:\"HIT ord 1\";}}s:5:\"build\";s:14:\"20211220193300\";}', 'no');
INSERT INTO `urotec_options` (`option_id`, `option_name`, `option_value`, `autoload`) VALUES
(460, '_transient_timeout_feed_mod_92227bfe1354c9fe21266d111aae5ed4', '1649227035', 'no'),
(461, '_transient_feed_mod_92227bfe1354c9fe21266d111aae5ed4', '1649183835', 'no'),
(462, '_transient_timeout_feed_d117b5738fbd35bd8c0391cda1f2b5d9', '1649227036', 'no');
INSERT INTO `urotec_options` (`option_id`, `option_name`, `option_value`, `autoload`) VALUES
(463, '_transient_feed_d117b5738fbd35bd8c0391cda1f2b5d9', 'a:4:{s:5:\"child\";a:1:{s:0:\"\";a:1:{s:3:\"rss\";a:1:{i:0;a:6:{s:4:\"data\";s:3:\"\n\n\n\";s:7:\"attribs\";a:1:{s:0:\"\";a:1:{s:7:\"version\";s:3:\"2.0\";}}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";s:5:\"child\";a:1:{s:0:\"\";a:1:{s:7:\"channel\";a:1:{i:0;a:6:{s:4:\"data\";s:61:\"\n	\n	\n	\n	\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";s:5:\"child\";a:1:{s:0:\"\";a:5:{s:5:\"title\";a:1:{i:0;a:5:{s:4:\"data\";s:16:\"WordPress Planet\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}s:4:\"link\";a:1:{i:0;a:5:{s:4:\"data\";s:28:\"http://planet.wordpress.org/\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}s:8:\"language\";a:1:{i:0;a:5:{s:4:\"data\";s:2:\"en\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}s:11:\"description\";a:1:{i:0;a:5:{s:4:\"data\";s:47:\"WordPress Planet - http://planet.wordpress.org/\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}s:4:\"item\";a:50:{i:0;a:6:{s:4:\"data\";s:13:\"\n	\n	\n	\n	\n	\n	\n\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";s:5:\"child\";a:2:{s:0:\"\";a:5:{s:5:\"title\";a:1:{i:0;a:5:{s:4:\"data\";s:57:\"WordPress.org blog: The Month in WordPress – March 2022\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}s:4:\"guid\";a:1:{i:0;a:5:{s:4:\"data\";s:35:\"https://wordpress.org/news/?p=12583\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}s:4:\"link\";a:1:{i:0;a:5:{s:4:\"data\";s:69:\"https://wordpress.org/news/2022/04/the-month-in-wordpress-march-2022/\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}s:11:\"description\";a:1:{i:0;a:5:{s:4:\"data\";s:12488:\"<p>We hope that you and your beloved ones are staying safe during these difficult times. If you’re looking for a way to help support the humanitarian crisis in Ukraine, a list of Non-Governmental Organizations (NGOs) was shared earlier last month in the 26th episode of WP Briefing, <a href=\"https://wordpress.org/news/2022/03/episode-26-matt-mullenweg-on-ukraine-community-and-wordpress/\">Matt Mullenweg on Ukraine, Community, and WordPress</a>.</p>\n\n\n\n<p>In parallel to the work the community is doing in preparation for the next major release, WordPress 6.0, March has seen the launch of some exciting new projects and proposals. Read on to find out more about the latest updates and how to get involved. </p>\n\n\n\n<hr class=\"wp-block-separator\" />\n\n\n\n<h2>The Pattern Directory is open for public submissions</h2>\n\n\n\n<a href=\"https://i2.wp.com/wordpress.org/news/files/2022/04/home-patterns.png?ssl=1\"><img width=\"1024\" height=\"659\" src=\"https://i2.wp.com/wordpress.org/news/files/2022/04/home-patterns.png?resize=1024%2C659&ssl=1\" alt=\"View of the Pattern Directory page at WordPress.org.\" class=\"wp-image-12584\" /></a>\n\n\n\n<p>The <a href=\"https://wordpress.org/patterns/new-pattern/\">WordPress Pattern Creator</a> is live! This new tool allows anyone with a WordPress.org user account to build, edit and submit their best block patterns to the <a href=\"https://wordpress.org/patterns/\">Pattern Directory</a>.<br /><br />If you&#8217;ve used patterns in WordPress, you&#8217;ll know that they make it easy to add unique layouts to your website, such as galleries, call-to-action sections, testimonials, pricing tables, and more. Opening the directory to public submissions enables any WordPress user to enjoy a wider variety of patterns to customize and use on their sites.</p>\n\n\n\n<div class=\"wp-container-1 wp-block-buttons\">\n<div class=\"wp-block-button aligncenter\"><a class=\"wp-block-button__link\" href=\"https://wordpress.org/news/2022/03/get-creative-with-the-all-new-pattern-creator/\" target=\"_blank\" rel=\"noreferrer noopener\"><strong>Check out the Pattern Creator announcement to learn more</strong></a></div>\n</div>\n\n\n\n<h2>WordPress 6.0 Walkthrough scheduled for today, April 5</h2>\n\n\n\n<p>A few updates to the <a href=\"https://make.wordpress.org/core/2022/03/11/wordpress-6-0-planning-update/\">WordPress 6.0 planning</a> were published last month. In case you missed them, <strong>today (April 5) at 15:00 UTC</strong> there is a live and interactive <a href=\"https://make.wordpress.org/core/2022/03/30/6-0-product-walk-through/\">WordPress 6.0 walkthrough</a> hosted by contributors of the release squad.</p>\n\n\n\n<p>The event will take place via Zoom and include a discussion on the new features, potential blockers, and a Q&amp;A session with the community. Attendance is open to anyone who wants to know more about what’s coming in WordPress 6.0.</p>\n\n\n\n<div class=\"wp-container-2 wp-block-buttons\">\n<div class=\"wp-block-button aligncenter\"><a class=\"wp-block-button__link\" href=\"https://make.wordpress.org/core/2022/03/30/6-0-product-walk-through/\" target=\"_blank\" rel=\"noreferrer noopener\"><strong>Join the WordPress 6.0 product walkthrough</strong></a></div>\n</div>\n\n\n\n<h2>Gutenberg releases: Versions 12.8 and 12.9 are here</h2>\n\n\n\n<p>Versions 12.8 and 12.9 of the Gutenberg plugin were released last month and with them, some new exciting features and updates.</p>\n\n\n\n<ul><li><a href=\"https://make.wordpress.org/core/2022/03/16/whats-new-in-gutenberg-12-8-16-march/\">Gutenberg 12.8</a> includes a new Webfonts API, iterative UX enhancements, and bug fixes to increase the editor’s stability.</li><li><a href=\"https://make.wordpress.org/core/2022/03/30/whats-new-in-gutenberg-12-9-30-march/\">Gutenberg 12.9</a> introduces the new block locking UI, support for spacing between Gallery images, and many other improvements that give you more control over what is editable and presented to users.</li></ul>\n\n\n\n<div class=\"wp-container-3 wp-block-buttons\">\n<div class=\"wp-block-button aligncenter\"><a class=\"wp-block-button__link\" href=\"https://make.wordpress.org/core/tag/gutenberg-new/\" target=\"_blank\" rel=\"noreferrer noopener\"><strong>Follow #gutenberg-new to stay updated on the latest Gutenberg releases</strong></a></div>\n</div>\n\n\n\n<div class=\"wp-container-4 wp-block-buttons\"></div>\n\n\n\n<h2>Team updates: Team Reps for the Photo Directory team, community proposals, and more</h2>\n\n\n\n<ul><li><a href=\"https://wordpress.org/news/2022/03/wordpress-5-9-2-security-maintenance-release/\">WordPress 5.9.2</a> is available for download. This security and maintenance release features one bug fix in addition to 3 security fixes.</li><li>The Team Representatives for the Make Photo Directory team for 2022 <a href=\"https://make.wordpress.org/photos/2022/03/23/announcement-photo-directory-team-reps-2022/\">have been announced</a>. Congrats to Marcus Burnette (<a href=\"https://profiles.wordpress.org/mdburnette/\" class=\"mention\"><span class=\"mentions-prefix\">@</span>mdburnette</a>), Katie Richards (<a href=\"https://profiles.wordpress.org/katiejrichards/\" class=\"mention\"><span class=\"mentions-prefix\">@</span>katiejrichards</a>), and Topher DeRosia (<a href=\"https://profiles.wordpress.org/topher1kenobe/\" class=\"mention\"><span class=\"mentions-prefix\">@</span>topher1kenobe</a>)!</li><li>The Community team considered <a href=\"https://make.wordpress.org/community/2022/03/17/discussion-revisiting-in-person-regional-wordcamps/\">revisiting the existing guidelines</a> for in-person regional WordCamps. Conclusions and next steps will be shared soon.</li><li>On a similar note, Cate DeRosia (<a href=\"https://profiles.wordpress.org/mysweetcate/\" class=\"mention\"><span class=\"mentions-prefix\">@</span>mysweetcate</a>) is <a href=\"https://make.wordpress.org/community/2022/03/23/return-to-events-blue-sky-thinking/\">looking for ideas</a> on how the Community team can support organizers who are trying to restart in-person events in their communities. Share yours by April 13, 2022.</li><li>The Training team published new lesson plans, workshops, and social learning spaces on Learn WordPress. <a href=\"https://make.wordpress.org/updates/2022/04/01/whats-new-on-learnwp-in-march-2022/\">Check out what’s new in March 2022.</a></li><li>How has WordPress helped grow your story? The Make Marketing team <a href=\"https://make.wordpress.org/marketing/2022/04/01/grow-your-story-on-wordpress/\">wants to hear about your experience</a>!</li><li>The <a href=\"https://make.wordpress.org/core/2022/03/07/the-performance-lab-plugin-has-been-released/\">Performance Lab plugin</a>, a set of modules that aim to improve performance in WordPress, was released last month.</li><li>Openverse released <a href=\"https://make.wordpress.org/openverse/2022/03/10/openverse-frontend-v3-1-1-release/\">new updates</a> in March, including a redesigned content reporting flow and new image detail pages.</li><li>WordPress Executive Director Josepha Haden Chomphosy posted a <a href=\"https://make.wordpress.org/project/2022/03/23/removal-of-the-zamir-plugin/\">public statement</a> on the removal of the Zamir plugin a few weeks ago.</li><li>The March 2022 editions of the <a href=\"https://make.wordpress.org/community/2022/03/14/meetup-organizer-newsletter-march-2022/\">Meetup Organizer Newsletter</a> and the <a href=\"https://make.wordpress.org/polyglots/2022/03/22/polyglots-monthly-newsletter-march-2022/\">Polyglots Monthly Newsletter</a> were published.</li><li>The latest edition of People of WordPress features the contributor story of the Argentinian web developer and product manager <a href=\"https://wordpress.org/news/2022/03/people-of-wordpress-juanfra-aldasoro/\">Juanfra Aldasoro</a>.</li><li>WordPress community members launched the <a href=\"https://block-museum.com/\">Museum of Block Art (MOBA)</a>, a new initiative that seeks to inspire creativity and push the limits around what can be done with WordPress. All of the art curated in this virtual museum is built using the block editor.</li></ul>\n\n\n\n<div class=\"wp-container-5 wp-block-buttons\">\n<div class=\"wp-block-button aligncenter\"><a class=\"wp-block-button__link\" href=\"https://make.wordpress.org/community/2022/03/30/proposal-steps-to-integrate-wpdiversity-into-wordpress-event-organizing/\" target=\"_blank\" rel=\"noreferrer noopener\"><strong>Help us build a thriving and inclusive community. Share your thoughts on this </strong><strong>proposal</strong><strong> to introduce WordCamp and Meetup organizers to #WPDiversity programs by April 8, 2022.</strong></a></div>\n</div>\n\n\n\n<h2>Testing requests: WebP feature, template for author pages</h2>\n\n\n\n<ul><li>The Performance Team has published a <a href=\"https://make.wordpress.org/core/2022/03/28/enabling-webp-by-default/\">proposal</a> to integrate the WebP image format by default into WordPress core. Your feedback on this feature is appreciated.</li><li><a href=\"https://make.wordpress.org/mobile/2022/04/04/call-for-testing-wordpress-for-ios-19-6/\">Version 19.6</a> of WordPress for iOS is available for testing.</li></ul>\n\n\n\n<div class=\"wp-container-6 wp-block-buttons\">\n<div class=\"wp-block-button aligncenter\"><a class=\"wp-block-button__link\" href=\"https://make.wordpress.org/test/2022/03/31/fse-program-testing-call-13-authoring-an-author-template/\" target=\"_blank\" rel=\"noreferrer noopener\"><strong> There&#8217;s a new call for testing as part of the Full Site Editing Outreach Program: Authoring an Author Template. The deadline to participate is April 21, 2022.</strong></a></div>\n</div>\n\n\n\n<h2>The first flagship in-person WordCamp Asia is looking for organizers</h2>\n\n\n\n<ul><li>After two years since the WordCamp Asia organizing team announced that the first flagship WordCamp Asia was canceled due to the pandemic, they are back together and <a href=\"https://asia.wordcamp.org/2023/call-for-organisers/\">looking for more members</a> to join them in planning the event tentatively scheduled for February 2023.</li><li>The <a href=\"https://us.wordcamp.org/2022/apply-to-speak-at-wcus/\">Call for Speakers</a> for WordCamp US 2022 is now open. You can submit your application by April 17, 2022.</li><li>Three in-person WordCamps are happening this month:<ul><li><img src=\"https://s.w.org/images/core/emoji/13.1.0/72x72/1f1e8-1f1ed.png\" alt=\"🇨🇭\" class=\"wp-smiley\" /> <a href=\"https://geneve.wordcamp.org/2022/\">WordCamp Genève</a>, Switzerland on April 9, 2022</li><li><img src=\"https://s.w.org/images/core/emoji/13.1.0/72x72/1f1ec-1f1f7.png\" alt=\"🇬🇷\" class=\"wp-smiley\" /> <a href=\"https://athens.wordcamp.org/2022/\">WordCamp Athens</a>, Greece on April 9-10, 2022</li><li><img src=\"https://s.w.org/images/core/emoji/13.1.0/72x72/1f1e6-1f1f9.png\" alt=\"🇦🇹\" class=\"wp-smiley\" /> <a href=\"https://vienna.wordcamp.org/2022/\">WordCamp Vienna</a>, Austria on April 23-24, 2022</li></ul></li><li>Check out the latest episodes of WordPress Briefing with Josepha Haden:<ul><li><a href=\"https://wordpress.org/news/2022/04/episode-28-coming-to-a-wordcamp-near-you-a-return-to-in-person-wp-events/\">Coming to a WordCamp Near You: A Return to In-Person WP Events</a></li><li><a href=\"https://wordpress.org/news/2022/03/episode-27-is-wordpress-made-for-me/\">Is WordPress Made for Me?</a></li></ul></li></ul>\n\n\n\n<div class=\"wp-container-7 wp-block-buttons\">\n<div class=\"wp-block-button aligncenter\"><a class=\"wp-block-button__link\" href=\"https://europe.wordcamp.org/2022/call-for-volunteers/\" target=\"_blank\" rel=\"noreferrer noopener\"><strong><strong>The </strong><strong>Call for Volunteers</strong><strong> for WordCamp Europe 2022 is still open. If you want to get involved with the WordPress community and have a lot of fun, this is your chance!</strong></strong></a></div>\n</div>\n\n\n\n<hr class=\"wp-block-separator\" />\n\n\n\n<p><strong><em>Have a story that we could include in the next ‘Month in WordPress’ post? Let us know by filling out </em></strong><a href=\"https://make.wordpress.org/community/month-in-wordpress-submissions/\"><strong><em>this form</em></strong></a><strong><em>.</em></strong></p>\n\n\n\n<p><em>The following folks contributed to this Month in WordPress: </em><a href=\"https://profiles.wordpress.org/rmartinezduque/\" class=\"mention\"><span class=\"mentions-prefix\">@</span>rmartinezduque</a>, <a href=\"https://profiles.wordpress.org/mysweetcate/\" class=\"mention\"><span class=\"mentions-prefix\">@</span>mysweetcate</a>, <a href=\"https://profiles.wordpress.org/anjanavasan/\" class=\"mention\"><span class=\"mentions-prefix\">@</span>anjanavasan</a>.</p>\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}s:7:\"pubDate\";a:1:{i:0;a:5:{s:4:\"data\";s:31:\"Tue, 05 Apr 2022 13:00:00 +0000\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}}s:32:\"http://purl.org/dc/elements/1.1/\";a:1:{s:7:\"creator\";a:1:{i:0;a:5:{s:4:\"data\";s:14:\"rmartinezduque\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}}}}i:1;a:6:{s:4:\"data\";s:13:\"\n	\n	\n	\n	\n	\n	\n\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";s:5:\"child\";a:2:{s:0:\"\";a:5:{s:5:\"title\";a:1:{i:0;a:5:{s:4:\"data\";s:86:\"WPTavern: FSE Outreach #13: Building an Author Template from the WordPress Site Editor\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}s:4:\"guid\";a:1:{i:0;a:5:{s:4:\"data\";s:30:\"https://wptavern.com/?p=132478\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}s:4:\"link\";a:1:{i:0;a:5:{s:4:\"data\";s:95:\"https://wptavern.com/fse-outreach-13-building-an-author-template-from-the-wordpress-site-editor\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}s:11:\"description\";a:1:{i:0;a:5:{s:4:\"data\";s:6707:\"<p class=\"has-drop-cap\">Anne McCarthy <a href=\"https://make.wordpress.org/test/2022/03/31/fse-program-testing-call-13-authoring-an-author-template/\">announced round #13 of the FSE Outreach Program</a> on March 31. This call for testing focuses on creating an author template via the site editor. Several of the new features used during this round were only added in <a href=\"https://wptavern.com/gutenberg-12-9-adds-block-locking-ui-automatic-pattern-registration-and-full-theme-exports\">Gutenberg 12.9</a> last week.</p>\n\n\n\n<p>The call asks volunteers to test and provide feedback on features related to Full Site Editing before they land in WordPress. Anyone can participate, and the deadline is April 21.</p>\n\n\n\n<p>For this round of testing, I used the <a href=\"https://wordpress.org/themes/archeo\">Archeo block theme</a>. It is a recent favorite, and I have been working with it <a href=\"https://wptavern.com/the-archeo-wordpress-theme-blends-mayan-history-with-magazine-style-block-patterns\">since I first reviewed it</a>.</p>\n\n\n\n<p>The following is a screenshot of my final author template design:</p>\n\n\n\n<img />\n\n\n\n<p>I read through the testing instructions and forged my own path. I still managed to cover everything except block locking. I had already extensively tested it with Gutenberg 12.9&#8217;s launch and wanted to focus on the other features.</p>\n\n\n\n<p>Outside of the user-experience issues noted below, everything went well. No editor crashes. No problems saving. And the front-end matched what I was seeing in the editor.</p>\n\n\n\n<h2>Building an Author Template</h2>\n\n\n\n<p>The most immediate issue when creating a new author template is that it was devoid of default blocks. Where was the&#8212;at minimum&#8212;header and footer?</p>\n\n\n\n<img />A blank canvas to start from.\n\n\n\n<p>The empty template would make sense if I was building something from scratch. However, this is not a from-scratch project. It was built from a theme with existing <code>archive.html</code> and <code>index.html</code> files, ancestors in the template hierarchy.</p>\n\n\n\n<p>Since the author template is merely a more specific version of the archive template, it should be a copy of its &#8220;parent&#8221; in the hierarchy.</p>\n\n\n\n<p>Users will most likely want to make modifications rather than start from scratch. Using an ancestor template as a base means that they are less likely to unnecessarily deviate from the existing layout, especially with more complex designs.</p>\n\n\n\n<p>The second set of actions I took was to go back to the Templates panel, open the archive template, copy all content, and paste it into the new author template.</p>\n\n\n\n<img />Copying the content of the author template.\n\n\n\n<p>This is &#8212; while a bit irritating &#8212; easy enough to do, at least from a developer perspective. However, it is a massive boulder sitting in the middle of a user&#8217;s path to success.</p>\n\n\n\n<p>For the design, I fell back on the ever-trustworthy Cover block. I snagged an image that worked with the theme&#8217;s style. Then, I placed the Avatar, Archives Title, and Post Author Biography blocks in two columns.</p>\n\n\n\n<img />Creating a custom author archive page header.\n\n\n\n<p>I spent some time pondering the idea of featured images for authors, categories, and tags. <em>How awesome would it be if the Cover block background was contextually displayed based on the current author?</em> Unfortunately, such a feature does not exist.</p>\n\n\n\n<p>I was surprised that the Avatar and Post Author Bio blocks worked. I tested these both inside of the Query Loop and outside of it. When an author has published posts, the two blocks appear as they should.</p>\n\n\n\n<p>However, if the author has not published any posts, the avatar reverts to the site default, and the bio disappears. I have not performed a deep dive into the code, but I am guessing they pick up on WordPress&#8217;s global <code>$post</code> variable, which is why it works in the first scenario.</p>\n\n\n\n<img />Missing avatar and author bio for unpublished author.\n\n\n\n<p>This limitation means that the block system is still not up to par with what is currently possible with classic, PHP-based themes. Avatar, Post Author Biography, and similar blocks should rely on the queried author variable as a fallback when viewing an author archive.</p>\n\n\n\n<p>One part of this FSE testing round was using the new No Results block from Gutenberg 12.9. It is a conditional block that appears when there are no posts to show. WordPress creates &#8220;author views&#8221; for every user on the site, regardless of whether they have written posts. The No Results block will likely be the most useful in this context.</p>\n\n\n\n<p>Working with the block felt odd at first. <em>Where does it go? After the Post Template? Before?</em></p>\n\n\n\n<p>It turns out that you can actually stick it in anywhere inside of the Query Loop parent block. I even tested before and after pagination. Basically, it just works.</p>\n\n\n\n<p>The UI left something to be desired. It simply reads:</p>\n\n\n\n<blockquote class=\"wp-block-quote\"><p>Add a text or blocks that will display when a query returns no results.</p></blockquote>\n\n\n\n<p><em>Aside from the glaring grammatical error</em>, displaying the message is necessary, but I expected it to look and feel more like the Group block. After all, it is essentially a container for other blocks, and WordPress already has an existing UI for that.</p>\n\n\n\n<p>It was also odd to visually edit a feature that is conditionally displayed. There should be an indicator that its contents may or may not be shown on the front end. I am not aware of any precedent for such a block in core WordPress, but we should look at other projects and how they handle this.</p>\n\n\n\n<p>The <a href=\"https://wordpress.org/plugins/block-visibility/\">Block Visibility</a> plugin by Nick Diego might be a plugin to borrow from. It adds an overlay, border, and icon for contextual blocks:</p>\n\n\n\n<img />Overlay design from Block Visibility plugin.\n\n\n\n<p>Ultimately, I decided to copy McCarthy&#8217;s original message from her test and paste it into the No Results block. Then, I took things one step more and put a Query Loop inside of it &#8212; <em>yes, a Query Loop inside of a Query Loop</em>.</p>\n\n\n\n<p>It worked without issue:</p>\n\n\n\n<img />Querying latest posts when no results are found.\n\n\n\n<p>Overall, the No Results block is a welcome addition to the theme-blocks toolset. I would like to see the UI fleshed out a bit. Theme authors will likely start using this more when 6.0 lands, and I could see users inadvertently trying to delete it, thinking it is part of the default output. This would make it a candidate for block-level locking.</p>\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}s:7:\"pubDate\";a:1:{i:0;a:5:{s:4:\"data\";s:31:\"Tue, 05 Apr 2022 00:46:31 +0000\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}}s:32:\"http://purl.org/dc/elements/1.1/\";a:1:{s:7:\"creator\";a:1:{i:0;a:5:{s:4:\"data\";s:14:\"Justin Tadlock\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}}}}i:2;a:6:{s:4:\"data\";s:13:\"\n	\n	\n	\n	\n	\n	\n\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";s:5:\"child\";a:2:{s:0:\"\";a:5:{s:5:\"title\";a:1:{i:0;a:5:{s:4:\"data\";s:92:\"WPTavern: WordPress.com Makes Major Unannounced Pricing Changes, Slashes Free Storage Limits\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}s:4:\"guid\";a:1:{i:0;a:5:{s:4:\"data\";s:30:\"https://wptavern.com/?p=132482\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}s:4:\"link\";a:1:{i:0;a:5:{s:4:\"data\";s:102:\"https://wptavern.com/wordpress-com-makes-major-unannounced-pricing-changes-slashes-free-storage-limits\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}s:11:\"description\";a:1:{i:0;a:5:{s:4:\"data\";s:8128:\"<p>Over the weekend, a post regarding WordPress.com&#8217;s as yet unannounced pricing changes went viral on Hacker News. In a post titled &#8220;<a href=\"https://rootprivileges.net/2022/04/03/what-are-you-doing-wordpress-com/\">What are you doing, WordPress.com?</a>&#8221; one user identified as &#8220;VM&#8221; expressed concerns about the <a href=\"https://wordpress.com/pricing/\">pricing</a>, which has changed from five plans to two plans, and slashed storage on the free tier from 3GB to 500MB.</p>\n\n\n\n<img />\n\n\n\n<p>&#8220;At some point late last week, WordPress replaced all of the paid plans with a single ‘Pro’ plan and reduced the storage on the free plan 6x, from 3 GB to 500 MB,&#8221; VM wrote. &#8220;It also imposed a traffic ceiling on both plans where none existed: 10,000 visits a month and 100,000 visits a month (and it hasn’t said anything about overages – so far).&#8221;</p>\n\n\n\n<p>Other WordPress.com users took to the forums to express <a href=\"https://wordpress.com/forums/topic/reason-behind-plan-upgrades/\">frustrations with the new pricing</a>. Although WordPress.com representatives have confirmed that the storage and traffic limits should only affect new sites, many long-time users have reported that their storage has been cut back to 500MB. This may be a bug in the rollout but at the time of publication, WordPress.com has not published a public notice the price changes beyond updating the pricing page.</p>\n\n\n\n<p>In the absence of communication about the change, VM speculated that it may be a cascading effect of the block editor changing how well commercial themes can be monetized:</p>\n\n\n\n<blockquote class=\"wp-block-quote\"><p>With the benefit of hindsight, perhaps we should have seen this coming: the new full-site editing option has rendered premium themes, and thus the premium and business plans redundant; the Gutenberg upgrade allowed users on free as well as personal plans to do some of the things that were previously only possible with premium or business plans. But to be honest, the hindsight doesn’t explain why WordPress.com – whose free plan, pro-open-source stance and focus on making publishing technology more democratic made it many a modern (non-technical) blogger’s host of choice – would pull the rug out like this.</p></blockquote>\n\n\n\n<p>WordPress.com CEO Dave Martin <a href=\"https://news.ycombinator.com/item?id=30896807\">responded</a> to these concerns on Hacker News, apologizing for the lack of communication in the rollout:</p>\n\n\n\n<blockquote class=\"wp-block-quote\"><p>You&#8217;re right to call us out. I did a poor job of sharing context around why we are making change, so I can see how they could come as a shock. I&#8217;m sorry! That&#8217;s on me.</p><p>Yes, as of this week we&#8217;ve gone from 5 plans down to just 2. That said, we&#8217;re not done making changes. This was the first of a couple of phases of changes.</p><p>Those 5 older plans that you mentioned were the culmination of like 10 years worth of plans and features sort of haphazardly being added to WordPress.com with no real strategy. With those older plans, it was really hard for customers to see at-a-glance why they should choose one plan over another.</p></blockquote>\n\n\n\n<p>Martin said WordPress.com generally adjusts its subscription plan pricing to make it affordable in different regions of the world but neglected to do so for the new Pro plan. The company is working on updating that.</p>\n\n\n\n<p>He also said the traffic limits will &#8220;only be enforced on the honor system.&#8221; Users who consistently go over the monthly cap will be prodded with notices to pay more, but their sites will not be shut off.</p>\n\n\n\n<p>&#8220;The Pro plan you see now (at $15/mo) is essentially the the exact same plan as the old Business plan (which used to cost $25/mo),&#8221; Martin said. &#8220;The only difference being the default storage that is available and a cost savings to customers of $10/mo.&#8221; This plan currently has no option for monthly billing.</p>\n\n\n\n<p>The cost savings only affects users who were already paying. New users on the free plan will need to work within the confines of the 500MB storage limit or pay $180/year for the upgrade. This is surprising, given how many people use WordPress.com simply to blog with no business interests.</p>\n\n\n\n<p>&#8220;Again, this may be great for businesses – but it’s a shit move for bloggers,&#8221; VM said in his post. &#8220;Matt Mullenweg, the CEO of Automattic, which runs WordPress.com, <a rel=\"noreferrer noopener\" href=\"https://www.theverge.com/2022/3/15/22977857/wordpress-tumblr-simplenote-internet-automattic-matt-mullenweg-interview\" target=\"_blank\">recently said in an interview</a>: &#8216;I’ll tell you a stat most people don’t realize. Half of all users who sign up for WordPress.com every day are there to blog.&#8217; I’ll tell you that for all of <em>these</em> people as well as the people who are using WordPress.com to blog (including me), the new plan is a betrayal of our interests.&#8221;</p>\n\n\n\n<p>One Hacker News commenter @username223 <a href=\"https://news.ycombinator.com/item?id=30896980\">noted</a> how easy it will be for users to max out the free tier in a short amount of time:</p>\n\n\n\n<blockquote class=\"wp-block-quote\"><p>Cutting the free tier from 3 GB to 500 MB makes it useless for many people: that&#8217;s 500 images at okay resolution, and lots of people like to put photos on their blogs. And 300 &#8220;visits&#8221; (page hits?) per day is almost as bad, as a runaway crawler or minor spike in interest can blow through that in no time.</p><p>I moved away from WP.com when they started putting ads on the free tier. I thought their business model was upselling some people, so monetizing the free version felt scummy. The fact that they&#8217;re crippling the free version now makes me even more glad I moved away.</p></blockquote>\n\n\n\n<p>Martin said WordPress.com has plans to offer some à la carte features that may help new free users avoid having to pay $180/year just to increase storage.</p>\n\n\n\n<p>&#8220;We will be announcing affordable add-ons for both the free plan and the Pro plan to extend both your traffic and your storage as needed,&#8221; Martin said. &#8220;In fact, we plan to also add a handful of affordable add-ons to the free plan to make it easy for customers to pick and choose which additional functionality they want, without needing to upgrade to the Pro plan.&#8221;</p>\n\n\n\n<p>Martin&#8217;s responses were reassuring to some users, including the author of the original post. Other found the changes to the free plan to be discouraging,  <a href=\"https://news.ycombinator.com/item?id=30895947\">saying</a> &#8220;the internet has become gentrified.&#8221; The comments on the <a href=\"https://news.ycombinator.com/item?id=30894980&p=1\">Hacker News</a> post are a gold mine of feedback from a demographic that has developed strong expectations about blogging for free.</p>\n\n\n\n<p>&#8220;The point is here that &#8216;just here to blog&#8217; bloggers like me have been able to pay WP to have a custom domain, some storage, some SEO and some SM tools managed by WP – and nothing else,&#8221; user <a href=\"https://news.ycombinator.com/user?id=panicpanicpanic\">panicpanicpanic</a> said. &#8220;But now, to point a custom domain at my WP site, I need to cough up $180/yr. It&#8217;s not just the free plan shrinking further, a fact you&#8217;re commenting on, but that the sole alternative plan lies at the other extreme.&#8221;</p>\n\n\n\n<p>It&#8217;s not yet clear whether WordPress.com will offer custom domains as an add-on to the free plan or force users to upgrade to the Pro plan. At the time of publishing, no public announcement has been made about the full range of add-ons that will be available. WordPress.com has published a page to its support forums with <a href=\"https://wordpress.com/forums/topic/pricing-feedback/\">FAQ&#8217;s regarding pricing feedback.</a> The post indicates an announcement may be coming in the next few days after the team has the chance to work out any remaining issues.</p>\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}s:7:\"pubDate\";a:1:{i:0;a:5:{s:4:\"data\";s:31:\"Mon, 04 Apr 2022 19:02:32 +0000\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}}s:32:\"http://purl.org/dc/elements/1.1/\";a:1:{s:7:\"creator\";a:1:{i:0;a:5:{s:4:\"data\";s:13:\"Sarah Gooding\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}}}}i:3;a:6:{s:4:\"data\";s:13:\"\n	\n	\n	\n	\n	\n	\n\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";s:5:\"child\";a:2:{s:0:\"\";a:5:{s:5:\"title\";a:1:{i:0;a:5:{s:4:\"data\";s:107:\"WordPress.org blog: WP Briefing: Episode 28: Coming to a WordCamp Near You: A Return to In-Person WP Events\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}s:4:\"guid\";a:1:{i:0;a:5:{s:4:\"data\";s:53:\"https://wordpress.org/news/?post_type=podcast&p=12506\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}s:4:\"link\";a:1:{i:0;a:5:{s:4:\"data\";s:108:\"https://wordpress.org/news/2022/04/episode-28-coming-to-a-wordcamp-near-you-a-return-to-in-person-wp-events/\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}s:11:\"description\";a:1:{i:0;a:5:{s:4:\"data\";s:11926:\"<p>In the twenty-eighth episode of the WordPress Briefing, Executive Director, Josepha Haden Chomphosy discusses returning to in-person WordPress events.</p>\n\n\n\n<p><em><strong>Have a question you&#8217;d like answered? You can submit them to <a href=\"mailto:wpbriefing@wordpress.org\">wpbriefing@wordpress.org</a>, either written or as a voice recording.</strong></em></p>\n\n\n\n<h2 id=\"credits\">Credits</h2>\n\n\n\n<ul><li>Editor:&nbsp;<a href=\"https://profiles.wordpress.org/dustinhartzler/\">Dustin Hartzler</a></li><li>Logo:&nbsp;<a href=\"https://profiles.wordpress.org/beafialho/\">Beatriz Fialho</a></li><li>Production:&nbsp;<a href=\"https://profiles.wordpress.org/cbringmann/\">Chloé Bringmann</a> &amp; <a href=\"https://profiles.wordpress.org/santanainniss/\">Santana Inniss</a> </li><li>Song: Fearless First by Kevin MacLeod</li><li>Special thanks to: <a href=\"https://profiles.wordpress.org/angelasjin/\">Angela Jin</a></li></ul>\n\n\n\n<h2>References</h2>\n\n\n\n<ul><li><a href=\"https://wordcampcentral.survey.fm/2022-host-in-person-wordpress-event-checklist\">Event Safety Checklist</a></li><li><a href=\"https://asia.wordcamp.org/2023/call-for-organisers/\">WordCamp Asia Call for Organizers</a></li><li><a href=\"https://make.wordpress.org/community/2022/03/23/return-to-events-blue-sky-thinking/\">Open Discussion: Returning to In-Person Events</a></li><li><a href=\"https://make.wordpress.org/community/2022/03/17/discussion-revisiting-in-person-regional-wordcamps/\">Open Discussion: Returning to Regional Events</a></li></ul>\n\n\n\n<h2>Transcript</h2>\n\n\n\n<span id=\"more-12506\"></span>\n\n\n\n<p><strong>Josepha Haden Chomphosy [00:00:00] </strong>&nbsp;</p>\n\n\n\n<p>Hello everyone! And welcome to the WordPress Briefing: the podcast where you can catch quick explanations of the ideas behind the WordPress open source project, some insight into the community that supports it and get a small list of big things coming up in the next two weeks. I&#8217;m your host, Josepha Haden Chomphosy. Here we go.</p>\n\n\n\n<p><strong>Josepha Haden Chomphosy [00:00:40]&nbsp;</strong></p>\n\n\n\n<p>I was checking the list of upcoming events recently as part of just my regular work and saw that the call for organizers for WordCamp Asia is open. On the one hand, it made my heart skip a beat with excitement. That event is six years or so in the making. And on the other hand, it reminded me of February 10th, 2020, the day that Matt told me that we had to proactively cancel WordCamp Asia. That week was truly heartbreaking for me as well as I think the entire organizing team.</p>\n\n\n\n<p>But it also, fortunately, was prescient. As I think back over the two years since then, I&#8217;m grateful for our community wranglers and deputies who have consistently hosted important discussions about how to return to in-person events safely. And with two of our major flagship events returning this year, I&#8217;m here to summarize, sort of, what the rules and guidelines are.</p>\n\n\n\n<p>But certainly I hope that you come away from this with an idea of what&#8217;s being done to keep everyone safe as we are best able.</p>\n\n\n\n<p><strong>Josepha Haden Chomphosy [00:01:44]&nbsp;</strong></p>\n\n\n\n<p>Firstly, before we dig into specifics, I want to be clear upfront that the guidelines for COVID-aware events are mandatory, unless otherwise stated. For folks who&#8217;ve been attending WordPress events, or participating in the community for a long time, this is a change. As a program, we have always done our best to be flexible with guidelines so that we can prioritize local knowledge. But our responsibility is to the long-term success of this community and this program. So moving forward with in-person events that risk the health of our community members poses risks to the program itself. So with that in mind, let&#8217;s learn what we&#8217;re going to see at events for the rest of the.&nbsp;</p>\n\n\n\n<p><strong>Josepha Haden Chomphosy [00:02:28]&nbsp;</strong></p>\n\n\n\n<p>For any WordPress event that is gathering more than 50 people, the new mandatory guidelines are:</p>\n\n\n\n<p>Number one, follow local laws and guidelines. If your area has suggested guidelines on top of the mandatory ones, follow those.</p>\n\n\n\n<p>Second, is if you are in a location where laws or guidelines require or permit venues to limit admission based on a person&#8217;s vaccination status and masking, then events can only happen in venues that are willing to provide staff to check for vaccination status at the door. And then also to remind participants to wear masks during the event.</p>\n\n\n\n<p>And the third thing is if your area or venue legally cannot check vaccination status, your area must pass the in-person checklist, which I will link in the show notes below. But that in-person checklist has to be passed at the time of the application and then again at the time of the event. And in addition to that, the venue must be willing to provide staff who will remind participants to wear masks and check for temperature during the event.</p>\n\n\n\n<p><strong>Josepha Haden Chomphosy [00:03:33]&nbsp;</strong></p>\n\n\n\n<p>Organizers in these areas must be prepared to move online or cancel if the region fails the safety checklist, which again, will be linked in the show notes below. So those are the three things and they are pretty dense, but also I think allow for a fair amount of flexibility. There is also a tidy flow chart linked in the sidebar of make.wordpress.org/community that will help you to decide what sort of event your own area can support right now.&nbsp;</p>\n\n\n\n<p>So those are the mandatory guidelines for WordPress events in general right now, but you probably also have a few specific questions. So I&#8217;ve got the three most common questions ready to go with answers from Angela Jin who helped me to kind of pull together the information for this particular podcast props to Angela. Thank you.&nbsp;</p>\n\n\n\n<p><strong>Josepha Haden Chomphosy [00:04:25]&nbsp;</strong></p>\n\n\n\n<p>So, first question, anything specific to know about WordCamp Europe? WordCamp Europe will be following these guidelines as well. All attendees and participants are expected to wear a mask while they are at the event and catering will be offered outside so people can remove their masks to eat.&nbsp;</p>\n\n\n\n<p>The second common question is how will these guidelines change as countries and local governments begin deescalating restrictions and safety measures? We should consider these guidelines to be subject to evolution based on what the team is hearing and seeing from the community. But right now we intend to keep these stricter guidelines in place until we see how the loosened rules play out elsewhere.&nbsp;</p>\n\n\n\n<p>And then a third frequent question is what&#8217;s going to happen to all these online events?</p>\n\n\n\n<p>The community team will continue to support online events right now. So if your community doesn&#8217;t feel ready to have an in-person event, but still wants to kind of get everyone together that is still allowed, and still&nbsp; encouraged. And finally the community team will continue to keep a close eye on situations around the world.</p>\n\n\n\n<p>If it becomes safe to do so, and your community is interested, they of course will be happy to chat with you about a WordCamp. There is an application that I will share the link to in the show notes below as well. In case that is something that your community is wanting to look into.&nbsp;</p>\n\n\n\n<p><strong>Josepha Haden Chomphosy [00:05:54]</strong></p>\n\n\n\n<p>Oh, and I have a little postscript also. I know I was like finally, and now I&#8217;m doing a finally, finally. That&#8217;s what postscripts are about. P.S. If you have not stopped by the community team’s site or any of their meetings, they&#8217;ve been doing a really great job of keeping things moving through two years of unpredictable changes. If you are a community team member, I want to offer you a huge thanks. Thank you so much for helping us to stay aware and able to move forward.&nbsp;</p>\n\n\n\n<p>If you are an organizer, pat yourself on the back. I want to thank you for pivoting with us, moving through online events, even though they are not at all the same as in-person events and certainly they don&#8217;t share the reasons that we get people together sometimes.</p>\n\n\n\n<p>And finally, if you are an end to end attendee, if you go to WordPress meetups or you go to any sort of WordPress online events or WordCamps, anything like that, thank your local organizer. They have been doing this probably for a while, and I&#8217;m sure that they are looking forward to getting back to in-person events themselves, but even, so they have been putting in a lot of volunteer hours to help make sure that we all know how to use WordPress.</p>\n\n\n\n<p>And so find them, thank them, and I&#8217;m sure that they&#8217;ll appreciate it.</p>\n\n\n\n<p><strong>Josepha Haden Chomphosy [00:07:20]</strong></p>\n\n\n\n<p>And with that, it is time for our small list of big things. Number one, WordCamp Asia has a call for organizers open! This event will be in 2023. And I think that we all simply cannot wait. So I&#8217;ll link the call for organizers in the show notes. And then of course you can follow that whole site to stay up to date on what&#8217;s happening there.</p>\n\n\n\n<p>The second thing is, while we&#8217;re on the topic of events, there&#8217;s also an open discussion about how we can best support organizers who are getting back to in-person events. We&#8217;d like thoughts from both organizers and attendees. So feel free to drop by and leave a note in the comments section. And while you&#8217;re over there, the third thing in my small list of big things, there&#8217;s also an open discussion about regional events. So go over there, get all your thoughts about WordPress events together. Get them all sorted out in one go. Just leave comments, boom, boom, boom, boom, boom. All over the place.&nbsp;</p>\n\n\n\n<p>And that my friends is your small list of big things. Thank you for tuning in today for the WordPress Briefing. I&#8217;m your host Josepha Haden Chomphosy.</p>\n\n\n\n<p>And I&#8217;ll see you again in a couple of weeks.</p>\n\n\n\n<p><strong>Josepha Haden Chomphosy [00:08:54]</strong></p>\n\n\n\n<p>So my most embarrassing WordCamp story actually has to do with where I was supposed to be versus where people thought I was supposed to be. This was early on in my time with WordPress, with Automattic. And I had convinced someone, I had convinced a colleague and friend of mine to go to my home WordCamp, WordCamp Fayetteville over there in Arkansas.</p>\n\n\n\n<p>And then I didn&#8217;t go. But I knew I wasn&#8217;t going, I knew I was going to WordCamp Boston, but he did not know that I was not going to go. And so he arrived at WordCamp Fayetteville, WordCamp Northwest Arkansas. I can&#8217;t remember what it was called at the time. And immediately was confused about where I was and why I wasn&#8217;t there.</p>\n\n\n\n<p>And so there was this excellent moment of mass confusion among states where the folks at WordCamp Fayetteville started tweeting about how I had convinced this contributor to go to that event and then didn&#8217;t show up. And then the folks at WordCamp Boston, we&#8217;re looking at all of those tweets, because if you are a WordCamp organizer, you are always looking at the tweets from all the other WordCamps happening in your weekend.</p>\n\n\n\n<p>And people got very confused about why I was in Boston while they were thinking that I was in Fayetteville, even though the tweets were talking about how, like, I wasn&#8217;t in Fayetteville. They probably didn&#8217;t say that it was probably more along the lines of like, “Hey, let&#8217;s share a photo with Josepha” to, like, make fun of the fact that I wasn&#8217;t there.</p>\n\n\n\n<p>And so I caused mass confusion in multiple states. That&#8217;s probably my most embarrassing WordCamp story. You&#8217;re welcome. Bye!</p>\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}s:7:\"pubDate\";a:1:{i:0;a:5:{s:4:\"data\";s:31:\"Mon, 04 Apr 2022 12:00:00 +0000\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}}s:32:\"http://purl.org/dc/elements/1.1/\";a:1:{s:7:\"creator\";a:1:{i:0;a:5:{s:4:\"data\";s:14:\"Santana Inniss\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}}}}i:4;a:6:{s:4:\"data\";s:13:\"\n	\n	\n	\n	\n	\n	\n\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";s:5:\"child\";a:2:{s:0:\"\";a:5:{s:5:\"title\";a:1:{i:0;a:5:{s:4:\"data\";s:92:\"Gutenberg Times: Gutenberg Changelog #64 – Gutenberg 12.9, Example Repo, and Inline Tokens\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}s:4:\"guid\";a:1:{i:0;a:5:{s:4:\"data\";s:53:\"https://gutenbergtimes.com/?post_type=podcast&p=20855\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}s:4:\"link\";a:1:{i:0;a:5:{s:4:\"data\";s:87:\"https://gutenbergtimes.com/podcast/gutenberg-changelog-64-gutenberg-12-9-inline-tokens/\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}s:11:\"description\";a:1:{i:0;a:5:{s:4:\"data\";s:31210:\"<p>Birgit Pauli-Haack and Mary Job talked about Gutenberg 12.9 new features and enhancements, updates to the Gutenberg Example Repo and share a post  on how to implement inline tokens for Rich Text. And so much more.</p>\n\n\n\n<ul><li>Music:&nbsp;<a href=\"https://soundcloud.com/xirclebox\">Homer Gaines</a></li><li>Editor:&nbsp;<a href=\"https://www.linkedin.com/in/sandy-reed/\">Sandy Reed</a></li><li>Logo:&nbsp;<a href=\"https://markuraine.com/\">Mark Uraine</a></li><li>Production:&nbsp;<a href=\"https://icodeforapurpose.com\">Birgit Pauli-Haack</a></li></ul>\n\n\n\n<span id=\"more-20855\"></span>\n\n\n\n<p><a href=\"https://gutenbergtimes.com/podcast/gutenberg-changelog-64-gutenberg-12-9-inline-tokens#shownotes\">Show Notes</a> / <a href=\"https://gutenbergtimes.com/podcast/gutenberg-changelog-64-gutenberg-12-9-inline-tokens/#transcript\">Transcript</a></p>\n\n\n\n<p class=\"has-large-font-size\" id=\"shownotes\"><strong>Show Notes</strong></p>\n\n\n\n<h2>Announcements</h2>\n\n\n\n<ul><li><a href=\"https://wpafrica.org\">WPAfrica Community</a></li><li>Call for testing through the FSE program. <a href=\"https://make.wordpress.org/test/2022/03/31/fse-program-testing-call-13-authoring-an-author-template/\">Authoring an Author Template</a></li></ul>\n\n\n\n<h3>WordPress Pattern Directory</h3>\n\n\n\n<ul id=\"block-674b70a5-45e2-4595-89ed-48e1ab5bed15\"><li>Browse the <a href=\"https://wordpress.org/patterns/\">Pattern Directory</a></li><li>Create a new patter via the <a href=\"https://wordpress.org/patterns/new-pattern/\">Pattern Creator Page</a> (needs login)</li><li>Study the <a href=\"https://github.com/WordPress/pattern-directory/\">Code Repo of the Pattern Directory</a></li></ul>\n\n\n\n<h2>What&#8217;s Released? </h2>\n\n\n\n<ul><li><a href=\"https://make.wordpress.org/core/2022/03/30/wordpress-5-9-3-rc-1/\">WordPress 5.9.3 RC1  </a>Security and Maintenance Update. Final release April 6, 2022</li><li><a href=\"https://github.com/WordPress/gutenberg-examples/releases/tag/v1.1.0\">Gutenberg Examples Repo 1.1</a></li></ul>\n\n\n\n<h3>Gutenberg 12.9 </h3>\n\n\n\n<ul><li><a href=\"https://make.wordpress.org/core/2022/03/30/whats-new-in-gutenberg-12-9-30-march/\">What’s new in Gutenberg 12.9? (30 March)</a></li><li><a href=\"https://wptavern.com/gutenberg-12-9-adds-block-locking-ui-automatic-pattern-registration-and-full-theme-exports\">Gutenberg 12.9 Adds Block Locking UI, Automatic Pattern Registration, and Full Theme Exports</a></li></ul>\n\n\n\n<h2>Work in Progress and Discussed</h2>\n\n\n\n<ul><li><a href=\"https://github.com/WordPress/gutenberg/discussions/39831\">Dynamic replacement of server-provided content in blocks and in HTML attributes</a></li><li><a href=\"https://make.wordpress.org/design/2022/03/28/design-share-mar-14-25/\">Design Share: Mar&nbsp;14–25</a> </li></ul>\n\n\n\n<p class=\"has-large-font-size\">Stay in Touch</p>\n\n\n\n<div class=\"wp-container-1 wp-block-group\"><div class=\"wp-block-group__inner-container\">\n<ul><li>Did you like this episode? <a href=\"https://lovethepodcast.com/gutenbergchangelog\"><strong>Please write us a review </strong></a></li><li>Ping us on Twitter or send DMs with questions. <a href=\"https://twitter.com/maryojob\">@maryojob </a>and <a href=\"https://twitter.com/bph\">@bph</a>.</li><li><em>If you have questions or suggestions, or news you want us to include, send them to <a href=\"mailto:changelog@gutenbergtimes.com\">changelog@gutenbergtimes.com</a>. </em></li><li><em>Please write us a review on iTunes! <a href=\"https://gutenbergtimes.com/itunes/\">(Click here to learn how)</a></em></li></ul>\n</div></div>\n\n\n\n<p class=\"has-large-font-size\" id=\"transcript\"><strong>Transcript</strong></p>\n\n\n\n<p><em>Birgit Pauli-Haack</em>: Hello, and welcome to our 64th episode of the Gutenberg Changelog podcast. In today&#8217;s episode, we will talk about Gutenberg 12.9, WordPress 5.9.3 and the Gutenberg Examples repository, the walkthrough WordPress 6.0 and so much more. I&#8217;m Birgit Pauli-Haack, curator at the Gutenberg Times and WordPress developer advocate. I&#8217;m here with co-host, Mary Job, also a WordPress advocate, support engineer at Paid Membership Pro and organizer of the WP Africa community. Good evening, Mary, how are you today?</p>\n\n\n\n<p><em>Mary Job</em>: I&#8217;m doing very good, Birgit. Hi everyone, hope everyone is doing awesome today in the world.</p>\n\n\n\n<p><em>Birgit Pauli-Haack</em>: So, the WP Africa community, tell me more about it.</p>\n\n\n\n<p><em>Mary Job</em>: Yeah, that was born out of the needs to be able to connect with more WordPressers on our continent, and to also be able to get more people to be interested in contributing to the WordPress open source project, because &#8230; So, there&#8217;s a colleague of mine named from Benin, but it&#8217;s pronounced Benin over here. It&#8217;s the country right next to ours and there was a survey they did one time to see where the contributors to the open source project were from. When it came to our continent, the percentage was quite very, very, very low. So, we thought to ourselves a good way to get started would be to get to know who and who are using WordPress, doing WordPress on our continent. If we&#8217;re able to connect with more people outside our respective countries, then we can get going from there. Maybe in 2024, 2025, we&#8217;ll get to have a WordCamp Africa, I don&#8217;t know, but we want to have one.</p>\n\n\n\n<p><em>Birgit Pauli-Haack</em>: That&#8217;s awesome. So, how can people connect with WP Africa community?</p>\n\n\n\n<p><em>Mary Job</em>: If you go to the website, wpafrica.org, you can see the directory there. You can join the directory. You can also join the Slack channel. There&#8217;s a Slack channel, Slack workspace for their community. You can also join that, the information is also on the website. Everything you need to know about the project is on wpafrica.org, yes.</p>\n\n\n\n<p><em>Birgit Pauli-Haack</em>: Wonderful, wonderful. You can use your WordPress login information to actually register with the Slack, I found. So, that&#8217;s very good, yeah. Thank you.&nbsp;</p>\n\n\n\n<h3><strong>Announcements</strong></h3>\n\n\n\n<p>Yeah, so we have some announcements and there&#8217;s the all-new Pattern Creator, is live now, so on wordpress.org and it was taken online or opened up for public submissions last week and within a few days, 90 patterns, by about 30 plus designers have been submitted since March 25th. So Mary, did you get a chance to browse the pattern directory? What did you see?</p>\n\n\n\n<p><em>Mary Job</em>: Oh, yes. I got a chance to look at it, it is amazing. I mean, literally, if you wanted to build your site as a newbie, or as a business owner, you can simply take the designs from there and then use them on your site and modify them to your own advantage. You don&#8217;t have to start thinking, &#8220;Oh, how do I get creative with building blocks?&#8221; You can simply take the patterns and use them.</p>\n\n\n\n<p>I particularly like that they have like buttons and the fact that you can submit your own pattern to the directory. I mean, that&#8217;s perfect. You could create a block pattern and then submit it right there on the page. I think it also opens up a chance to contribute. People would think that WordPress is maybe too technical for them, this is something good they could play with and they could see maybe it would bring out a creative spirit in them, you know?</p>\n\n\n\n<p><em>Birgit Pauli-Haack</em>: Yeah and I tested that block Pattern Creator and it&#8217;s actually a block editor, that is standalone. It&#8217;s quite an interesting experience and then you submit it and then there is no curation for that matter. There are certain things that you can see on the about page, like the dos and don&#8217;ts, and then it&#8217;s going to be online and people can &#8230; there&#8217;s a little hard, so what you say is a like button, they&#8217;re their favorites. So if you have 90 patterns, or now 160 patterns with the ones that were already in there, or 170 actually, I feel a little bit decision paralysis, where you say, &#8220;Oh, I like them all.&#8221; So yeah, when I look for a price list or column blocks or something like that, I don&#8217;t know. So, you can browse them at your leisure. Put some hearts or check the hearts on it and then you have a separate page that says, &#8220;My favorites,&#8221; and that&#8217;s a really good way to curate the whole directory.</p>\n\n\n\n<p><em>Mary Job</em>: Yes. I just actually thought of something, this is something that teenagers would also want to play with. I&#8217;m just thinking off the top of my head. I mean, a teen would want to play with something like this. There&#8217;s always been discussion in the community about how to get next generation into WordPress, get them using WordPress because they seem to like the newer social media channels. Because I know my daughter is always telling me, &#8220;Oh you&#8217;re not on TikTok, you don&#8217;t know what Snapchat is.&#8221; I&#8217;m like, &#8220;I don&#8217;t know what those are.&#8221; So, I think this would also be a very good way to get them interested in WordPress, and if they like what they see, which I&#8217;m sure a lot of them would, that could also spur them to become WordPressers. I mean, that&#8217;s good, to get a future generation interested.</p>\n\n\n\n<p><em>Birgit Pauli-Haack</em>: Yeah, and I like what you said as well, that it&#8217;s another way for people that don&#8217;t code to contribute. Yeah, it&#8217;s a second place. The first one was actually the WordPress Photos Directory where you can submit your photos that then could end up in one of the panels because the WordPress Photos Directory is also fed into the Openverse directory and Openverse is actually driving the media library in the patterns submission or pattern creator. So when you say, &#8220;Okay, I need an image.&#8221; You go to the Openverse and you can punch in a keyword like forest, or mountains, or blocks. Then you get a series of pictures that you can use on your block pattern. So, you don&#8217;t have to upload them, you don&#8217;t have to manage them. The people who use the pattern actually can also see the pictures without having to download them because they&#8217;re available on the internet.</p>\n\n\n\n<p>So, it&#8217;s really a great integration on multiple levels. The repositories code is actually available on GitHub and you can see how you can learn or experiment with it, how the Openverse directory is added to the media library, also how block custom post types are actually handled by the block pattern directory, because any block pattern is a custom post type. So, if you want to learn that, you can look at the code and figure out how they deal with the custom post types. It&#8217;s actually a great tool on so many levels.</p>\n\n\n\n<p><em>Mary Job</em>: Yes.</p>\n\n\n\n<p><em>Birgit Pauli-Haack</em>: &#8230; take a shout out on that. Or speaking of testing and new features, Anne McCarthy just posted a new call for testing through the FSE, the Full Site Editing program. It&#8217;s all about authoring an author template, but she also writes that you create a template for your author pages, you learn how the locking UI for blocks works and it allows a site builder to prevent an editor to remove or move locked blocks. You also get to test the new design options and the new, no result block. If you have half an hour or so, spin up a new test site with local WP and follow Anne&#8217;s meticulous instructions. You have until April 21st to leave your feedback on the experience. So, I think I&#8217;m going to carve out a few minutes, well the half an hour, and participate in that because it&#8217;s a great way to learn the new features and also contribute by thinking through, &#8220;Okay, what do I feel? What do I see? Is there something that crashes my computer?&#8221; Or these kind of questions.</p>\n\n\n\n<p>So it&#8217;s ahead of WordPress 6.0 release, that&#8217;s the best way to &#8230; or one of the few ways, to walk through some of the new features that will come to a WordPress instance near you soon. You have until April 21st to leave your feedback on the experience for the call for testing on FSE. If you&#8217;re more interested in watching other people walking through the current stage of WordPress 6.0, then join a panel on April 5th at 11:00 Eastern, 15:00 UTC, and you will hear from Channing Ritter, she&#8217;s a designer on the WordPress project, Hector Prieto and Matias Ventura, both developers on the Gutenberg plugin and the event will be moderated by Daisy Olsen and Dan Sulchin on April 5th, put it in your calendars. We have the link to the announcement post on May Core in the show notes. That&#8217;s also because the Zoom link where it&#8217;s going to happen will be shared on the Make blog, but it&#8217;s on Tuesday, April 5th.</p>\n\n\n\n<p>If you are listening to this episode after April 5th, I&#8217;m sure there will be a recording and it will be also shared on the post where that recording will live. So, going through the link will also benefit you who have not listened to this in time to get to the live show. So, that&#8217;s for you too.</p>\n\n\n\n<h3><strong>What’s Released &#8211; WordPress 5.9.3 and Gutenberg 12.9</strong></h3>\n\n\n\n<p>Now we come to the section of what&#8217;s released and a 5.9.3 security maintenance update is coming to you. The release candidate is out and the scheduled release is on Tuesday, also April 5th. There are nine bug fixes on Core and nine bug fixes from the block editor that come to your 5.9 instance, and of course, the security features that are coming as well. Now it&#8217;s your turn.</p>\n\n\n\n<h3><strong>Features</strong></h3>\n\n\n\n<p><em>Mary Job</em>: So, now we can talk about the features, the new features that are coming in this release, yes?</p>\n\n\n\n<p><em>Birgit Pauli-Haack</em>: This is Gutenberg 12.9 release. Yes, yes, we are. Gutenberg 12.9 is out.</p>\n\n\n\n<p><em>Mary Job</em>: Okay, awesome. So, the Block Editor has introduced what they call the block lock in UI, which allows the admin to have more control over the blocks, if you don&#8217;t want &#8230; maybe if you have built a site and you don&#8217;t want the editor, or the other to be to move around the blocks or rearrange your design, you can now lock those blocks. The post-date block now allows the user to pick a site default. So, the post-date block also now allows the users to pick their date format. This is great because you can now pick a date format for that post-block that is independent of the site&#8217;s defaults. You can select this and create your own individual format string. For instance, I&#8217;ve noticed most, I think the US date format is the day, the month and the year, I think. Whenever I look at these dates, I know that I get confused, because for us, it&#8217;s the other way round.</p>\n\n\n\n<p><em>Birgit Pauli-Haack</em>: Yeah, that&#8217;s certainly one thing. It&#8217;s actually quite nifty because the person who creates the post can actually select the date, so it could &#8230; even outside of the site default, or you have an individual format. So, that&#8217;s quite helpful. And yeah, I know what you&#8217;re saying. I confuse everybody with dates, especially when I&#8217;m talking to Europe. So, most of the time I start with the year, month, and day, just to be sure, or I use the month and then the day and the year, so put the month and like April 5th, or not 4/5 because it could also be 5/4, especially &#8230; So, only in October, November, December, it&#8217;s relatively clear that it&#8217;s &#8230; or what is it? No, after the 12th of the month, it&#8217;s relatively clear what format is here.</p>\n\n\n\n<p>All right and there is a no results block container now available for the query block. It&#8217;s the first iteration and it follows the idea that if there are no posts available for a certain criteria that the template has, that it should show some notification and that the site owner could modify that notification, or that saying, there are no blocks with that kind of criteria. It&#8217;s a first iteration but try it out. It might help with the theme development quite a bit.</p>\n\n\n\n<p>In with 12.9, there are some great enhancements on the list view. So now, you can actually &#8230; multiple select on the list view is now available and it supports the shift plus for Home and the End keys. So you can navigate through it by using the keyboard shortcuts that you know also from &#8230; Page Down, Page Up, from earlier days in the computer as well.</p>\n\n\n\n<h3><strong>Enhancements</strong></h3>\n\n\n\n<p>Some of us actually have muscle memory for those and now it&#8217;s great that we can use it in the list view. But even more helpful is the collapsed list view by default of the editor. So if you have, I don&#8217;t know, 30 blocks in your post or page and you open the list view, it also is now &#8230; everything is collapsed. So, if you have a group block, it only shows the group block, but when you click on it to extend, you&#8217;ll see what blocks are inside the group block or same with a cover block.</p>\n\n\n\n<p>So, you get a compressed version on the list view, and you can easily and better navigate that. So, all nodes are collapsed and the initial impact on heavy nested pages is reduced, reducing the cognitive load, so to speak.&nbsp;</p>\n\n\n\n<p>Also, there was a nice feature and I don&#8217;t know how critical that is, but when you have a color palette and as a user, you create a new color that you want to make available through all the color selectors throughout the site, so you can add a blue and you can change actually the label that is displayed in the list of which color is selected. So, that&#8217;s quite nifty to actually put in, because then as a theme developer or a site owner, you can make clear it&#8217;s not a blue, it&#8217;s the brand blue, or it&#8217;s the sale-able blue, or whatever your lingo is in your own company to identify the colors of your brand. So, I think that&#8217;s a nice quality of life kind of feature, and it helps reduce the worry of which color is it that we want to do.</p>\n\n\n\n<p>Speaking of controls, there&#8217;s also now to the number control in this release was added the minimal and maximum font size for the tag cloud block. So now you can say, so the smaller size is six and the largest size is 25, or something like that through all your tag cloud. That is now pretty precise. Yeah, that wasn&#8217;t available before, but people knew it from the classic editor or the classic widget section, when you selected a tag cloud, those choices were actually available. It&#8217;s glad that this is back and on feature parity with the previous versions.</p>\n\n\n\n<p>So then, the gallery block got a little easier now because you can control the gutter, or the space between the images. You can make them all together, or have a nice little space in between, and from zero white space to a large art gallery, kind of style gaps. With that, you also can have different layouts for your gallery images. I&#8217;m thinking that would be actually quite a nice experiment for block patterns to figure out additional ways to style the gallery block and have different ideas on how to make it work.</p>\n\n\n\n<p>The separator block received a refactor on the color support. So, now you can have different colors, but also with different views. For designers, that&#8217;s very important to make sure that the separator block is also within the design. Back to you, Mary.</p>\n\n\n\n<p><em>Mary Job</em>: Thank you for that, Birgit. So, the post editor also got some enhancement. First is the show view per view link for drafts saved on snackbar notice. This aims to make previewing a post, more visible and more consistent so that the auto always drafts and a post can easily preview their posts as the link to preview their posts in the snackbar notice.</p>\n\n\n\n<p><em>Birgit Pauli-Haack</em>: The snackbar notices are the black little notices that are on the bottom of the screen when you save things. So you would say, &#8220;Okay, post is saved,&#8221; and then you had to go up and preview. So now, you can do it from the bottom of the screen.</p>\n\n\n\n<p><em>Mary Job</em>: Yes. Do you know sometimes I have to click twice just because I want to quickly go down to click on the links?</p>\n\n\n\n<p><em>Birgit Pauli-Haack</em>: Yeah.</p>\n\n\n\n<p><em>Mary Job</em>: So, this is a good one. Thank you for your time for this. The site editor also now, you can add more template types as the site editor. Previously, when creating new templates in the site editor, we linked that to a more site of template types. Now you&#8217;re able to create a template for many different types of pages as you would need on your website. So, the theme exports, so now you can also export the whole theme.</p>\n\n\n\n<p><em>Birgit Pauli-Haack</em>: So, what kind of pages I can do category pages and I can do author pages, taxonomy, dates, tags.</p>\n\n\n\n<p><em>Mary Job</em>: Tags.</p>\n\n\n\n<p><em>Birgit Pauli-Haack</em>: &#8230; and attachment pages? Okay.</p>\n\n\n\n<p><em>Mary Job</em>: Yes, yes, great. Still on the site editor, you can also now export the old theme. I believe there is second feedback for this, to see if this is going to be a helpful tool or not. So, it&#8217;ll be good if more people can test this out and comment and let them know if this is a tool that would be helpful for site builders or not, okay?</p>\n\n\n\n<p><em>Birgit Pauli-Haack</em>: Yeah.</p>\n\n\n\n<p><em>Mary Job</em>: So, you can also export a theme using the name for this ZIP file. This is done so that it makes it easier to add a theme to your WordPress install. So, this is also a good one because I know that in the past when I export themes, it usually has these random numbers on it and then you have to the name, if you plan to import that or install that on the site. There&#8217;s a concern that supporting the old theme might mean that the size would be bigger, but like I said, it&#8217;ll be great to have people test out these features and comment to let the builders know if this is something that would be very useful for them to add or not.</p>\n\n\n\n<p><em>Birgit Pauli-Haack</em>: Yeah, yeah, definitely. Yeah, if you find something quirky, definitely file an issue on the GitHub repository, or just ping me and I&#8217;ll walk you through it, if there&#8217;s something happening. Even if it&#8217;s not part of the call for testing for FSE, there is a Slack channel in WordPress Slack, that is the FSE outreach dash experiment. Yeah, experiment. That&#8217;s where site builders actually come together to discuss certain things. Now there will be some more traffic and some more conversation happening, now that another call for testing is out. It will also be additional information coming out because the call for questions that Anne had put out four weeks ago, I think, just closed the week. So, she&#8217;s working on getting answers to your questions and she will post that also at the Full Site Editing program Slack channel probably, and of course also in the Make blog of the site.</p>\n\n\n\n<h3><strong>New APIs</strong></h3>\n\n\n\n<p>So, the block library, there are new APIs in this release for the block patterns, is one that it automatically loads the file with headers, from a theme pattern directory. So, as a theme developer, you can, now &#8230; You don&#8217;t have to create a PHP file with all the patterns in there. Now, you just copy and paste the pattern that you built and put it into an HTML file and just store it in the directory called patterns and the editor will pick it up. So, it will show up in the inserter. If you use it a block template, it will also show up there for that. So, that&#8217;s certainly another way to simplify the whole theme production workflow. It&#8217;s similar to templates and template parts, the directory structure, where you pick up the templates and whether the editor picks up the templates list and the list of template parts from the directory and now you can do it with patterns, so really easy to follow along.</p>\n\n\n\n<h3><strong>Experiments</strong></h3>\n\n\n\n<p>Then there were some, two &#8230; we didn&#8217;t have a whole lot of experiments lately in the Gutenberg plugin, but now there are a few, again &#8230; Well, two, actually. One is a generic avatar block for authors. So, if the author, like the comment or the editor that created a post, doesn&#8217;t have an avatar on site, or in Gravatar, you actually control what the generic avatar is going to be. Then there&#8217;s also a new version of the list block implemented as a nested block and transformed, and also has a few PRs in there that are all around the refactor of the list block, because it&#8217;s been said quite a bit, that there is no inner block, so you couldn&#8217;t have an image in a list block where you couldn&#8217;t have quote in a list block.</p>\n\n\n\n<p>So, this is going to change and you can enable those by going through the experiment section and click on the list block there. Yeah, so it&#8217;s implement the nested block behavior, transform the list for the list block. And then also change the start number, the order and the reverse list block attributes, also for a nested block list. Yeah, those are the things in the experiments.</p>\n\n\n\n<p>There were also some great changes in the documentation. You can read up about them in the release documentation. There was quite a few things for code quality and the tools, but I don&#8217;t see anything that I would want to point out, except that they&#8217;re adding now the infrastructure for writing end-to-end tests in a different library or different format. It&#8217;s called Playwright instead of &#8230; what&#8217;s the other one? Puppeteer, yeah. Justin Anyon had a Make blog about that, so I&#8217;ll share the note in the show notes.</p>\n\n\n\n<h3><strong>Gutenberg Block Examples Repo 1.1</strong></h3>\n\n\n\n<p>So, that concludes the Gutenberg plugin 12.9 change log for today. There was also another release. So 5.9.3 release candidate, and then Gutenberg 12.9. Ryan Welcher released a new version of the Gutenberg Examples repo and it&#8217;s now in version 1.1. That Examples repo has examples for a lot of different blocks, with a lot of different settings and controls. You can really learn from that how the various items work, so you can replicate it in your blocks.</p>\n\n\n\n<p>It was quite a bit behind because the blocks haven&#8217;t been migrated to the new API that uses the block JSON. So it was not really teaching the best practices or the newer way to do this, but now that has changed. This is definitely a major update, so this plugin includes completely updated block examples, as well as new non-block examples, comprises of 40 PRs by eight contributors, and it&#8217;s actually were the first release since the start of the repo in 2018. How to use it, you the instructions are in the README file. So yeah, go ahead and learn and check it out. Of course, if you have any questions, send them our way. We try to all answer that.</p>\n\n\n\n<h3><strong>What’s in Active Development and Discussed</strong></h3>\n\n\n\n<p>This brings us to the section of what&#8217;s an active development and discussed. Dennis Snell, and he&#8217;s one of the core contributors on Gutenberg development since the beginning. He had a proposal on a concept of dynamic token in Core, and the GitHub discussion link will be in the show notes. But this goes back to the preliminary roadmap of Gutenberg phase two for 6.0, that Matius Ventura published on the Make Core blog. He wrote, “As one of those things that are supposed to come, is explore the viability of inline tokens.</p>\n\n\n\n<p>“This has come up repeatedly in the content of rendering dynamic strings, such as the current date in rich text blocks.” Snell wrote then on that proposal, &#8220;One area the block model has been deficient however, is in establishing more granular semantic types of inline content that carry meaning, not associated with a block. These inline semantic parts represent content or metadata that comes from outside the document being edited and may be relatively static or highly dynamic.&#8221; He continues to outline the character of the token concept. He offers us code examples of possible how this going to work with in different context with the block JSON example, a save and edit example, and then the token execution, maybe in a PHP file. Dear listeners, if you feel that this all rings like Shortcodes, you are not wrong. It definitely would be the Shortcode 2.0, which are much better interface.</p>\n\n\n\n<p><em>Mary Job</em>: Okay. So, still on active development and what&#8217;s discussed in a newest design share Channing Ritter highlights a merit of design the team is working on. This could use your input and critique. Under the headline, &#8220;Status and visibility panel improvements,&#8221; she links to a prototype you can browse the aspirations to improve, the publish and posts matter in panel. Birgit, you noted here that you enjoy the various views of how the panels could look, as much cleaner and clearer too and so you can….</p>\n\n\n\n<p><em>Birgit Pauli-Haack</em>: Yeah, go ahead. Sorry.</p>\n\n\n\n<p><em>Mary Job</em>: So, you can browse the prototype. We&#8217;re going to put a link to that in the show notes. There are other highlights that are also interesting, such as adding the post-category templates, the page start options, star version, over animation, icons for groups through and stack, new blocks, comment query loops design, default design. All of this is work in progress and soon to come to a Gutenberg plug-in near you.</p>\n\n\n\n<p><em>Birgit Pauli-Haack</em>: Yeah, I&#8217;m really looking forward to the stack new block, because it should give control on how your group block behaves with different screen sizes.&nbsp;</p>\n\n\n\n<p>All right, so thank you everyone. I think that is the end of our show. No, I know so. Yeah, before we end the show, I want to remind everybody, April 5th is the walk-through on the features, where the three Channing Ritter, Hector Prieto, Matias Ventura walk through all the features and figure out, &#8220;Okay, is this good enough or is it &#8230; &#8221; Yeah, &#8220;What&#8217;s coming in and do we find still bugs?&#8221; So, there will also be a note taker, April 1st, 11:00 AM Eastern and 15:00 UTC.</p>\n\n\n\n<p>As always, the show notes will be published on the gutenbergtimes.com/podcast. This is episode 64. If you have questions, or suggestions or news you want us to include, send them to <a href=\"mailto:changelog@gutenbergtimes.com\">changelog@gutenbergtimes.com</a>. That&#8217;s <a href=\"mailto:changelog@gutenbergtimes.com\">changelog@gutenbergtimes.com</a>. Well, it&#8217;s so great to see you again, Mary, and thank you for having this conversation with me. Well, until the next time, dear listeners, thank you for staying with us through the show.</p>\n\n\n\n<p><em>Mary Job</em>: Yes, thank you everyone. And thank you for bearing with my audio.</p>\n\n\n\n<p><em>Birgit Pauli-Haack</em>: wpafrica.org, if you are on the continent and want to meet more WordPressers. Yeah, check out the site. That&#8217;s it, thank you for listening. Goodbye.</p>\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}s:7:\"pubDate\";a:1:{i:0;a:5:{s:4:\"data\";s:31:\"Sun, 03 Apr 2022 08:42:29 +0000\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}}s:32:\"http://purl.org/dc/elements/1.1/\";a:1:{s:7:\"creator\";a:1:{i:0;a:5:{s:4:\"data\";s:19:\"Gutenberg Changelog\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}}}}i:5;a:6:{s:4:\"data\";s:13:\"\n	\n	\n	\n	\n	\n	\n\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";s:5:\"child\";a:2:{s:0:\"\";a:5:{s:5:\"title\";a:1:{i:0;a:5:{s:4:\"data\";s:71:\"WPTavern: How To Build Book and Book Review Cards with WordPress Blocks\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}s:4:\"guid\";a:1:{i:0;a:5:{s:4:\"data\";s:30:\"https://wptavern.com/?p=132408\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}s:4:\"link\";a:1:{i:0;a:5:{s:4:\"data\";s:82:\"https://wptavern.com/how-to-build-book-and-book-review-cards-with-wordpress-blocks\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}s:11:\"description\";a:1:{i:0;a:5:{s:4:\"data\";s:9652:\"<p class=\"has-drop-cap\">I was neck-deep into the block system during the months leading up to its debut in 2018. This also just happened to coincide with the first November I had ever completed <a href=\"https://nanowrimo.org/\">National Novel Writing Month</a>, a 30-day challenge to write a 50,000-word first draft of a novel. I have since won a second time in 2021.</p>\n\n\n\n<p>As a starry-eyed, wanna-be novelist, one of the first things that excited me about the block system was how writers could show off their books with WordPress. Of course, I had no choice but to create a custom grouping of blocks to show off the manuscript I had somehow managed to hammer out in a month.</p>\n\n\n\n<img />Homepage design of theme for novelists.\n\n\n\n<p>This was the pre-pattern era of WordPress. The interface was clunky. Things seemed to break at random. Design tools were almost non-existent, but there was a bit of magic in the air. At no point in the platform&#8217;s history could users visually build such a simple layout with stock WordPress. For all its faults during the beta run, this was the moment that I became a block fanboy.</p>\n\n\n\n<p>It was not until months later that I released the theme for novelists &#8212; it was a child of another project that had yet to launch.</p>\n\n\n\n<p>For this entry in the <a href=\"https://wptavern.com/category/building-with-blocks\">Building with Blocks series</a>, I wanted to walk readers through creating one of the patterns that inspired me to continue designing and developing with the block system. As a bonus, I will also show how to create a book review pattern.</p>\n\n\n\n<p>I am using the <a href=\"https://wordpress.org/themes/archeo/\">Archeo theme</a> by Automattic throughout this tutorial. However, it should work with any theme that supports blocks. You will also get more mileage out of a block theme.</p>\n\n\n\n<h2>Book Card</h2>\n\n\n\n<p>This card is meant to be a starting point for authors who want to showcase one of their books, but it could be applied to any product. There are 1,000s of ways you could alter this, and I encourage everyone to customize it once they have walked through the steps. The end result should look similar to the following:</p>\n\n\n\n<img />Final book card design.\n\n\n\n<p>The final block HTML code is <a href=\"https://gist.github.com/justintadlock/fc776ca766fe789dcc317e83c6b5f15f\">available via Gist</a>. You can copy and paste it into the editor, but I encourage you to try building from scratch the first go-round. This series is all about learning to build with blocks. The copy-ready code is there just in case you get stuck.</p>\n\n\n\n<h3>Step 1: Container Group (optional)</h3>\n\n\n\n<img />Group block with padding and colors.\n\n\n\n<p>Almost as a rule, I start with a Group block when building patterns or sections of blocks. I chose to add it this time because I wanted a dark background with some padding around the card&#8217;s content. You may opt-out of this if you prefer.</p>\n\n\n\n<p>Once the block is in place, add text color, background color, and padding to the block. I chose <code>2rem</code> for the padding because my active theme&#8217;s default is not consistent on all sides.</p>\n\n\n\n<h3>Step 2: Adding Media</h3>\n\n\n\n<img />Media &amp; Text block inside of a Group.\n\n\n\n<p>One of my favorite blocks in WordPress is Media &amp; Text. It has so many use cases, and it is sort of like a mini pattern all on its own. On one side, you drop in your media. On the other, you add whatever content you want.</p>\n\n\n\n<p>Inside the Group block from Step 1, insert Media &amp; Text. Go ahead and grab an image of your choosing. The <a href=\"https://wordpress.org/photos/\">WordPress photo directory</a> has plenty if you do not have one on hand.</p>\n\n\n\n<p>The only alteration I made to this block is to set the &#8220;Media width&#8221; option to <code>35</code> in the block options sidebar. Depending on the dimensions of your image, you may choose another option. Just be sure to give room for your content.</p>\n\n\n\n<h3>Step 3: Group (optional)</h3>\n\n\n\n<img />Adding an inner Group block.\n\n\n\n<p>Inside of the Media &amp; Text block, I added another Group. It enables consistent spacing, which WordPress does not apply to the &#8220;content&#8221; area of the Media &amp; Text block for some reason. This is an optional step, but it provides more control over the design.</p>\n\n\n\n<p>If you do not feel good with the spacing of your theme, you can change the &#8220;Block spacing&#8221; option in the block options sidebar. I adjusted this to <code>2rem</code>, but it will depend on the active theme.</p>\n\n\n\n<p>As an aside, these are details I rarely see mentioned in other tutorials&#8212;the &#8220;gotchas&#8221; and other problems that you might encounter. I feel like they are helpful inclusions but can be a bit of a bore. Feel free to let me know in the comments if you want me to continue covering this level of detail.</p>\n\n\n\n<h3>Step 4: Card Content</h3>\n\n\n\n<img />Adding Heading, Paragraph, and Buttons blocks.\n\n\n\n<p>The final step in creating the book card should be relatively straightforward. I included a Heading, two Paragraphs, and a Buttons block. I encourage experimentation.</p>\n\n\n\n<p>I made no changes to the Heading and Paragraph blocks. However, I selected the &#8220;Outline&#8221; style for the lone Button.</p>\n\n\n\n<p>And, that is it! The inclusion of the built-in Media &amp; Text block made it easier than building with others. Continue reading if you prefer reviewing books to writing and selling them.</p>\n\n\n\n<h2>Book Review Intro Card</h2>\n\n\n\n<p>This walkthrough will take you through creating a book review (or review intro) card. Like before, you can snag the full <a href=\"https://gist.github.com/justintadlock/86f0a4d532dfd420d1c198d967c18408\">block HTML from Gist</a>. The result should look a little something like the following:</p>\n\n\n\n<img />Final book review card intro design.\n\n\n\n<p>With all the fuss over the previous <a href=\"https://wptavern.com/how-to-build-a-recipe-card-via-the-wordpress-block-editor\">recipe card tutorial</a>, let me preface this section with a quick note. This tutorial series is about learning to build with blocks, not creating fleshed-out solutions for every possible scenario.</p>\n\n\n\n<p>For those folks who want more, there are existing solutions. Donna Peplinskie&#8217;s <a href=\"https://wordpress.org/plugins/book-review-block/\">Book Review Block</a> is an excellent choice. It has ISBN integration, review Schema, and plenty of other bells and whistles. I even <a href=\"https://wptavern.com/diving-into-the-book-review-block-plugin\">wrote about it back in 2020</a>.</p>\n\n\n\n<p>This is for the <em>sometimes</em> book reviewers, people not starting a review site, or those who just want to pick up a tip.</p>\n\n\n\n<h3>Steps 1-3: Rinse and Repeat</h3>\n\n\n\n<img />Adding a Group, Media &amp; Text, and another Group block.\n\n\n\n<p>These steps are literally the same as the book card above: add a Group block, add Media &amp; Text, and nest another Group inside the content area. The only change I made was to widen the Media section to <code>40</code> (it was <code>35</code> before).</p>\n\n\n\n<p>Feel free to mix this up and try new things. Skip the initial Group block if you do not want the padded background.</p>\n\n\n\n<h3>Step 4: Card Content</h3>\n\n\n\n<img />Adding a Heading, List, and Quote block.\n\n\n\n<p>Like the earlier book card, add a Heading block for the book title. This goes within the Group nested inside of the Media &amp; Text block.</p>\n\n\n\n<p>The next part of the content is where things divert. For the book &#8220;info,&#8221; you must insert a List block. Then, fill in the details that you think are relevant, like so:</p>\n\n\n\n<ul><li><img src=\"https://s.w.org/images/core/emoji/13.1.0/72x72/270d.png\" alt=\"✍\" class=\"wp-smiley\" /> Written by Justin Tadlock</li><li><img src=\"https://s.w.org/images/core/emoji/13.1.0/72x72/1f516.png\" alt=\"🔖\" class=\"wp-smiley\" /> Tagged Adult Fiction</li><li><img src=\"https://s.w.org/images/core/emoji/13.1.0/72x72/1f4da.png\" alt=\"📚\" class=\"wp-smiley\" /> Published by Words &amp; Press</li><li><img src=\"https://s.w.org/images/core/emoji/13.1.0/72x72/1f4c5.png\" alt=\"📅\" class=\"wp-smiley\" /> Published on May 01, 2099</li><li><img src=\"https://s.w.org/images/core/emoji/13.1.0/72x72/1f4c3.png\" alt=\"📃\" class=\"wp-smiley\" /> 599 Pages</li><li><img src=\"https://s.w.org/images/core/emoji/13.1.0/72x72/2b50.png\" alt=\"⭐\" class=\"wp-smiley\" /><img src=\"https://s.w.org/images/core/emoji/13.1.0/72x72/2b50.png\" alt=\"⭐\" class=\"wp-smiley\" /><img src=\"https://s.w.org/images/core/emoji/13.1.0/72x72/2b50.png\" alt=\"⭐\" class=\"wp-smiley\" /><img src=\"https://s.w.org/images/core/emoji/13.1.0/72x72/2b50.png\" alt=\"⭐\" class=\"wp-smiley\" /><img src=\"https://s.w.org/images/core/emoji/13.1.0/72x72/2b50.png\" alt=\"⭐\" class=\"wp-smiley\" /> / 5 Stars</li></ul>\n\n\n\n<p>I wanted to spice things up with a few emoji. If that is not your thing, there is no need to include them.</p>\n\n\n\n<p>In a real-world project, I would also include a &#8220;no marker&#8221; style for the List block, allowing the emoji to act as <em>faux</em> bullet points. However, the theme I was testing with did not have a style for this.</p>\n\n\n\n<p>That brings us to the final section. I like to kick off book reviews by including a favorite quote. It gets me in the mood for writing about the book and lets me share something from the author. Therefore, I opted for placing a Quote block as the final piece.</p>\n\n\n\n<p>An alternative might be a quick summary. You might even simply dive right into the review from there or leave the space empty. It is your card, and you can do what you want with it.</p>\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}s:7:\"pubDate\";a:1:{i:0;a:5:{s:4:\"data\";s:31:\"Sat, 02 Apr 2022 03:41:23 +0000\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}}s:32:\"http://purl.org/dc/elements/1.1/\";a:1:{s:7:\"creator\";a:1:{i:0;a:5:{s:4:\"data\";s:14:\"Justin Tadlock\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}}}}i:6;a:6:{s:4:\"data\";s:13:\"\n	\n	\n	\n	\n	\n	\n\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";s:5:\"child\";a:2:{s:0:\"\";a:5:{s:5:\"title\";a:1:{i:0;a:5:{s:4:\"data\";s:109:\"Gutenberg Times: Future of Themes is here, Block Examples updated and a Walk-Through – Weekend Edition #209\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}s:4:\"guid\";a:1:{i:0;a:5:{s:4:\"data\";s:35:\"https://gutenbergtimes.com/?p=20826\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}s:4:\"link\";a:1:{i:0;a:5:{s:4:\"data\";s:114:\"https://gutenbergtimes.com/future-of-themes-is-here-block-examples-updated-and-a-walk-through-weekend-edition-209/\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}s:11:\"description\";a:1:{i:0;a:5:{s:4:\"data\";s:15355:\"<p>Howdy, </p>\n\n\n\n<p>This week went fast, didn&#8217;t it?  How has your week been? </p>\n\n\n\n<p>I am excited about next week&#8217;s <a href=\"https://make.wordpress.org/core/2022/03/30/6-0-product-walk-through/\">WordPress 6.0 Product Walk-through</a>, identifying the features, that might or might not be ready for the release.  </p>\n\n\n\n<p>There is a ton of updates, discussions, and tutorials below. Enjoy! </p>\n\n\n\n<p>Yours, 💕<br />Birgit </p>\n\n\n\n\n\n<p><strong>Anne McCarthy </strong>just posted a new call for testing through the FSE program. <a href=\"https://make.wordpress.org/test/2022/03/31/fse-program-testing-call-13-authoring-an-author-template/\">Authoring an Author Template</a></p>\n\n\n\n<p>The meticulous testinstructions walk you through creating a template for your author pages, learn how to the locking UI for blocks works. It allows a site builder to prevent and editor to remove or move locked blocks. You’ll also get to test new design options and the new No Results block. If you have a half an hour or so spin up a new test site with LocalWP and follow the instructions. You have until April 21st to leave your feedback on your experience.&nbsp;</p>\n\n\n\n<h2>Gutenberg Development &amp; Design</h2>\n\n\n\n<p><strong><a href=\"https://twitter.com/andraganescu\">Andrei Draganescu</a></strong>, was the release wrangler for <a href=\"https://make.wordpress.org/core/2022/03/30/whats-new-in-gutenberg-12-9-30-march/\"><strong>Gutenberg 12.9. </strong></a>It is a feature packed release. The highlights are:</p>\n\n\n\n<ul><li>Block locking UI. Prevent editors from moving or removing blocks.</li><li>Better galleries are possible the gutter controls </li><li>New Block themes features</li><li>Easier management of deeply nested block structures</li><li>Better defaults and more intuitive controls</li></ul>\n\n\n\n<p>56 people contributed to this feature set, 8 of which were first time contributors.&nbsp;</p>\n\n\n\n<p><strong>Justin Tadlock</strong>, WPTavern has a taken a closer look: <a href=\"https://wptavern.com/gutenberg-12-9-adds-block-locking-ui-automatic-pattern-registration-and-full-theme-exports\"><strong>Gutenberg 12.9 Adds Block Locking UI, Automatic Pattern Registration, and Full Theme Exports</strong></a></p>\n\n\n\n<p><strong>Mary Job </strong>and I also discussed all the new features on the <strong>64th Gutenberg Changelog</strong> podcast, but we also talk about so much more!  The episode will come out later this weekend and land in your favorite podcast app. </p>\n\n\n\n<hr class=\"wp-block-separator is-style-wide\" />\n\n\n\n<p>In her newest <a href=\"https://make.wordpress.org/design/2022/03/28/design-share-mar-14-25/\"><strong>Design Share</strong></a>, <strong>Channing Ritter</strong>, highlights a myriad of design updates the team is working on and that could use your input and critique. </p>\n\n\n\n<p>Under the headline <strong>Status &amp; visibility&nbsp;panel&nbsp;improvements</strong> ,she links to a prototype you can browse the explorations to improve the Publish and Post meta in panel in the post editor. I really enjoyed the various views of how the panel could look. A much cleaner look and so much clearer, too. <a href=\"https://www.figma.com/proto/8vEDwRwmzWhxvcvhc6yaQk/Status-%26-visibility?page-id=1%3A2&node-id=1%3A2&scaling=min-zoom&starting-point-node-id=343%3A2605&show-proto-sidebar=1\"><strong>Browse the prototype on Figma</strong></a>. Other highlight are not less interesting: </p>\n\n\n\n<ul><li>Adding post&nbsp;category&nbsp;templates</li><li>Page start options</li><li>Style variation hover animation</li><li>Icons for Group, Row and Stack (new) blocks</li><li>Comments&nbsp;query&nbsp;loop, default design mockups</li></ul>\n\n\n\n<p>All work in progress, and soon to come to a Gutenberg plugin near you! </p>\n\n\n\n<img />Screenshot from the Prototype: Exploring Status &amp; visibility&nbsp;panel&nbsp;improvements\n\n\n\n<hr class=\"wp-block-separator is-style-wide\" />\n\n\n\n<p><strong>Dave Smith</strong> and <strong>Ben Dwyer</strong> walkthrough covers a new variation of a popular block <a href=\"https://www.youtube.com/watch?v=2-1kwfDzZXg\">Using the Featured Image with the Cover Block</a>. It&#8217;s spectacular, and a long awaited enhancement for the post template. Now you can add a cover block to your post template, used the featured image as background, and display the post title on top of it. Smith and Dwyer demonstrate the usage with the new block theme by Automattcians called <a href=\"https://wordpress.org/themes/archeo/\">Archeo</a>  </p>\n\n\n\n<hr class=\"wp-block-separator is-style-wide\" />\n\n\n\n<p><strong>Block related News on the WPTavern</strong></p>\n\n\n\n<ul><li><a href=\"https://wptavern.com/webman-design-launches-abs-additional-styles-for-native-wordpress-blocks\">WebMan Design Launches Abs, Additional Styles for Native WordPress Blocks</a> by Justin Tadlock</li><li><a href=\"https://wptavern.com/snow-monkey-editor-plugin-adds-custom-styles-to-wordpress-core-blocks\">Snow Monkey Editor Plugin Adds Custom Styles to WordPress Core Blocks</a> by Sarah Gooding</li><li><a href=\"https://wptavern.com/text-selection-across-multiple-blocks-is-coming-to-wordpress\">Text Selection Across Multiple Blocks Is Coming to WordPress</a> by Justin Tadlock </li><li><a href=\"https://wptavern.com/how-to-build-book-and-book-review-cards-with-wordpress-blocks\">How To Build Book and Book Review Cards with WordPress Blocks</a> by Justin Tadlock</li></ul>\n\n\n\n<hr class=\"wp-block-separator is-style-wide\" />\n\n\n\n<p><strong>Ivan Messina</strong>, Support Host, published <a href=\"https://supporthost.com/gutenberg/\">Gutenberg: the complete guide at the WordPress editor</a>. It&#8217;s a walk-through the differences to classic editor, and the various interfaces that come with the block editor. It&#8217;s also a great link to point people, too, that just want to  learn more before they make the jump from Classic Editor to the Block Editor. </p>\n\n\n\n<h2>Building Themes for the block editor and Full-site editing</h2>\n\n\n\n<p><strong>Rich Tabor</strong>, product manager at Extendify, thinks &#8220;<a href=\"https://richtabor.com/a-new-era/\">A new era of WordPress themes is finally here</a>&#8220;. In his post he explains the four concepts, what makes a block theme different from classic themes. He continues to ouline the Future of Theme development: &#8220;It’s more apparent than ever to me that the barriers of theme development are slowly becoming smaller and smaller. There may always be some level of technical skillset required to produce phenomenal block themes, but generally speaking designing, assembling and launching a theme has never been easier.&#8221; </p>\n\n\n\n<h2>Developing for the Block Editor and Gutenberg</h2>\n\n\n\n<p>On GitHub Discussions, <strong>Dennis Snell</strong> posted a proposal on <a href=\"https://github.com/WordPress/gutenberg/discussions/39831\"><strong>concept of dynamic Token in Core</strong></a> in a the GitHub discussion post.&nbsp;</p>\n\n\n\n<p>This goes back to the preliminary roadmap for <a href=\"https://make.wordpress.org/core/2022/01/26/preliminary-roadmap-for-6-0/\">Gutenberg phase 2 post for 6.0</a> by <strong>Matias Ventura</strong> when he wrote: “Explore the viability of inline tokens. This has come up repeatedly in the context of rendering dynamic strings (such as current date) in rich text blocks.</p>\n\n\n\n<p>Snell wrote: “One area the block model has been deficient, however, is in establishing more granular semantic types of &#8220;inline&#8221; content that carry meaning not associated with a block. These inline semantic parts represent content or metadata that comes from outside the document being edited and may be relatively static or highly dynamic.”&nbsp;</p>\n\n\n\n<p>He then outlines the Token concept, followed by code examples.  He shows the usage in different context, for in block.json, save and edit space and the token execution in a PHP file. And if you feel this all rings like Shortcodes, you are not wrong. It definitely would be Shortcode 2.0 with a much better interface.  <a href=\"https://github.com/WordPress/gutenberg/discussions/39831\">Check it out and let your opinion known.</a></p>\n\n\n\n<hr class=\"wp-block-separator is-style-wide\" />\n\n\n\n<p><strong>Rich Tabor</strong> released <a href=\"https://richtabor.com/blocks-on-github/\">all his personal plugins on GitHub</a>. In the spirit of the second open-source principle: scratching a personal itch,  he wrote: &#8220;Every single block I’ve added, I built out of a need of my own.&#8221; You will find:</p>\n\n\n\n<ul><li><a href=\"https://richtabor.com/todo-list-block/\">Todo List block</a></li><li><a href=\"https://richtabor.com/markdown-comments/\">Markdown comment block</a>,</li><li><a href=\"https://github.com/richtabor/share-on-twitter-block\">Share on Twitter block</a></li><li>&nbsp;<a href=\"https://github.com/richtabor/post-reading-time-block\">Post Reading Time</a>&nbsp;&nbsp;</li><li><a href=\"https://github.com/richtabor/post-modified-time-block\">Post Modified Time</a>&nbsp;</li></ul>\n\n\n\n<p>Rich Tabor has been a very early adopter of the block editor, so his plugins are also great teaching tools, to solve common block builiding problems. </p>\n\n\n\n<hr class=\"wp-block-separator is-style-wide\" />\n\n\n\n<p><strong>Ryan Welcher</strong> released <a href=\"https://github.com/WordPress/gutenberg-examples/releases/tag/v1.1.0\"><strong>Gutenberg Examples Repo 1.1.</strong></a> &#8220;This release marks a major update to this plugin that includes completely updated block examples as well as new non-block examples.&#8221; he wrote.</p>\n\n\n\n<p>The release contains around 40 PRs by eight contributors.&nbsp;It’s the first new release in over two years.&nbsp;The instructions on how to use it have been updated, too.</p>\n\n\n\n<p>Yesterday, Ryan <strong>Welcher</strong> held his weekly live programming session on <a href=\"https://www.twitch.tv/videos/1442143491\"><strong>&#8220;Creating a custom admin screen using Gutenberg packages and components.&#8221;</strong></a></p>\n\n\n\n<h2 id=\"4-upcoming-word-press-events\">Upcoming WordPress Events</h2>\n\n\n\n<h3 id=\"5-social-learning-and-other-events\">8 Social Learning Meetups</h3>\n\n\n\n<p><strong>April 6, 2022, 12 pm EDT / 16:00 UTC</strong> <br /><a href=\"https://www.meetup.com/wordpress-social-learning/events/284752435/\"><strong>Creating A Sidebar For Your Posts Using The Full Site Editing Blank Template</strong></a> with Bud Kraus, JoyofWP</p>\n\n\n\n<p><strong>April 6, 2022, 2pm EDT / 18:00 UTC</strong> <br /><a href=\"https://www.meetup.com/wordpress-social-learning/events/284700789/\"><strong>Builder Basics: Designing with Columns, Group, and Row Blocks (Part 2)</strong></a> with Nick Diego</p>\n\n\n\n<p><strong>April 8, 2022, 11 am EDT / 15:00 UTC </strong><br /><a href=\"https://www.meetup.com/wordpress-social-learning/events/284701015/\"><strong>Block Theme Discussions: Supports in theme.json</strong></a> with Daisy Olsen </p>\n\n\n\n<p><strong>April 12, 2022 2pm EDT 18:00 UTC</strong> <br /><strong><a href=\"https://www.meetup.com/wordpress-social-learning/events/284700822/\">Builder Basics: Headers and Footers in Full Site Editing</a></strong> w/ Nick Diego</p>\n\n\n\n<p><strong>April 13, 2022, 10 am EDT / 14:00 UTC </strong><br /><a href=\"https://www.meetup.com/wordpress-social-learning/events/284753523/\"><strong>Create a Magazine Layout with the WordPress Gutenberg Block Editor</strong></a> with Wes Theron</p>\n\n\n\n<p><strong>April 15, 2022, 11 am EDT / 15:00 UTC</strong> <br /><strong><a href=\"https://www.meetup.com/wordpress-social-learning/events/284701295/\">Block Theme Discussions: Presets in theme.json</a></strong> with Daisy Olsen</p>\n\n\n\n<p><strong>April 19, 2022 2pm EDT / 18:00 UTC</strong> <br /><strong><a href=\"https://www.meetup.com/wordpress-social-learning/events/284700867/\">Builder Basics: Exploring Block Layout, Alignment, and Dimensions </a>(Part 2)</strong></p>\n\n\n\n<p><strong>April 21, 2022 3 am EDT / 7 am UTC</strong> <br /><a href=\"https://www.meetup.com/wordpress-social-learning/events/284753652/\"><strong>Using Block Patterns</strong></a> with Wes Theron</p>\n\n\n\n<h2 id=\"6-w\">WordCamps and other events</h2>\n\n\n\n<p><em>More and more WordCamps are being scheduled! <a href=\"https://central.wordcamp.org/schedule/\">On WordCamp Central you can view the whole calendar.</a></em></p>\n\n\n\n<p><strong>April 8, 2022 9 am &#8211; 5 pm CDT / 14:00 &#8211; 20:00 UTC</strong><br /><a href=\"http://wpcareersummit.com/\"><strong>WP Career Summit</strong></a>&nbsp;conference for Careers in WordPress, organized by team at Post Status </p>\n\n\n\n<p><strong>April 20th, 2022 &#8211; 10 am &#8211; 4 pm CST</strong><br /><a href=\"https://events.wpengine.com/event/61de3570-be6a-4182-a365-c12d5236cef3/websitePage:645d57e4-75eb-4769-b2c0-f201a0bfc6ce?rp=db966373-a266-42c7-a3f2-434f409cfd8c\"><strong>DE{CODE} 2022</strong></a><br />a virtual developer conference by WPEngine</p>\n\n\n\n<p><strong>May 16-20, 2022 </strong><br /><strong><a href=\"https://wordsesh.com/\">WordSesh</a></strong><br />A virtual conference. <a href=\"https://wordsesh.com/speak/\">Call for Speaker is open</a></p>\n\n\n\n<p><strong>June 2 &#8211; 4th, 2022</strong> <br /><strong><a href=\"https://europe.wordcamp.org/2022/\">WordCamp Europe</a></strong><br />Sign up for updates to get notifications about speakers, sessions, and schedule.</p>\n\n\n\n<p><strong>June 25, 2022 </strong><br /><strong><a href=\"https://montclair.wordcamp.org/2022/\">WordCamp Montclair, NJ</a></strong><br />The <a href=\"https://montclair.wordcamp.org/2022/call-for-speakers/\">call for speakers</a> is open only until April 15th, 2022</p>\n\n\n\n<p><strong>June 20 &#8211; 24, 2022</strong> <br /><strong><a href=\"https://pagebuildersummit.com/\">Page Builder Summit </a></strong>will take place June 20th to June 24, 2022. <a href=\"https://pagebuildersummit.com/sponsors/\"><em>The call for sponsors is still open</em></a>. Sign-up for the VIP list to learn first when tickets are available and the schedule is published. </p>\n\n\n\n<p><strong>September 9 &#8211; 11, 2022</strong><br /><strong><a href=\"https://us.wordcamp.org/2022/\">WordCamp US</a></strong> <br />in-person conference in San Diego. <a href=\"https://us.wordcamp.org/2022/apply-to-speak-at-wcus/\">Call for Speakers is open</a>, deadline April 17th, 2022</p>\n\n\n\n<p><br /></p>\n\n\n\n\n<hr class=\"wp-block-separator is-style-wide\" />\n\n\n\n<p class=\"has-text-align-left\"><strong>Don&#8217;t want to miss the next Weekend Edition? </strong></p>\n\n\n\n<form class=\"wp-block-newsletterglue-form ngl-form ngl-portrait\" action=\"https://gutenbergtimes.com/feed/\" method=\"post\"><div class=\"ngl-form-container\"><div class=\"ngl-form-field\"><label class=\"ngl-form-label\" for=\"ngl_email\"><br />Type in your Email address to subscribe.</label><div class=\"ngl-form-input\"><input type=\"email\" class=\"ngl-form-input-text\" name=\"ngl_email\" id=\"ngl_email\" /></div></div><button class=\"ngl-form-button\">Subscribe</button><p class=\"ngl-form-text\">We hate spam, too and won&#8217;t give your email address to anyone except Mailchimp to send out our Weekend Edition</p></div><div class=\"ngl-message-overlay\"><div class=\"ngl-message-svg-wrap\"></div><div class=\"ngl-message-overlay-text\">Thanks for subscribing.</div></div><input type=\"hidden\" name=\"ngl_list_id\" id=\"ngl_list_id\" value=\"26f81bd8ae\" /><input type=\"hidden\" name=\"ngl_double_optin\" id=\"ngl_double_optin\" value=\"yes\" /></form>\n\n\n\n<hr class=\"wp-block-separator is-style-wide\" />\n\n\n\n\n<p> </p>\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}s:7:\"pubDate\";a:1:{i:0;a:5:{s:4:\"data\";s:31:\"Fri, 01 Apr 2022 23:06:00 +0000\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}}s:32:\"http://purl.org/dc/elements/1.1/\";a:1:{s:7:\"creator\";a:1:{i:0;a:5:{s:4:\"data\";s:18:\"Birgit Pauli-Haack\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}}}}i:7;a:6:{s:4:\"data\";s:13:\"\n	\n	\n	\n	\n	\n	\n\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";s:5:\"child\";a:2:{s:0:\"\";a:5:{s:5:\"title\";a:1:{i:0;a:5:{s:4:\"data\";s:116:\"WPTavern: WordPress Product Launches Roundup: APPExperts, WP Wallet, Block Styles, and Stock Control for WooCommerce\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}s:4:\"guid\";a:1:{i:0;a:5:{s:4:\"data\";s:30:\"https://wptavern.com/?p=132359\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}s:4:\"link\";a:1:{i:0;a:5:{s:4:\"data\";s:123:\"https://wptavern.com/wordpress-product-launches-roundup-appexperts-wp-wallet-block-styles-and-stock-control-for-woocommerce\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}s:11:\"description\";a:1:{i:0;a:5:{s:4:\"data\";s:5162:\"<p>Despite the flurry of <a href=\"https://twitter.com/karks88/status/1509906509395865627\">April</a> <a href=\"https://twitter.com/gravityforms/status/1509923985152221185\">Fools</a> <a href=\"https://twitter.com/scottkclark/status/1509885233918849039\">day</a> <a href=\"https://twitter.com/GiveWP/status/1509877186014109701\">jokes</a> circulating today, the WordPress product market has been heating up in the past couple weeks with new entrants that we are highlighting in a roundup. These products range from newly in beta to fully launched. Some are banking on the freemium model and others are fully commercial products.</p>\n\n\n\n<h3>APPExperts Mobile Application Builder Plugin Now in Beta</h3>\n\n\n\n<p><a href=\"https://appexperts.io/\">APPExperts</a> is a new mobile application builder plugin that is now in beta, developed by the WPExperts team. It turns WordPress and WooCommerce websites into fully functional apps for  iOS and Android phones, tablets, and other mobile devices. The <a href=\"https://wordpress.org/plugins/appexperts/\">plugin on WordPress.org</a> functions as a connector to the APPExperts platform, which is powered by <a href=\"https://flutter.dev/\">Flutter</a>. </p>\n\n\n\n<img />\n\n\n\n<p>Users can create their first app for free and the commercial version includes additional features like push notifications, ads integration, and plugin integrations.  APPExperts is going up against more established competitors like <a href=\"https://apppresser.com/\">AppPresser</a>, which bills annually for the use of its platform. During its pre-beta period, APPExperts added 500 users on its connector plugin who generated more than 1,000 apps for iOS and Android.</p>\n\n\n\n<h3>WP Wallet Organizes Commercial Theme and Plugin Licenses Into a Single Dashboard</h3>\n\n\n\n<p><a href=\"https://wpwallet.com/\">WP Wallet</a> is a new product, created by the team behind MasterWP, that helps WordPress site owners keep track of their license keys for commercial themes and plugins. The idea is to prevent users from missing license renewals, losing license keys, and struggling with invoicing. The service scans each website added to the account and retrieves any commercial license subscription fees, capturing any administrative details. It can also send invoices for payment via PayPal or Stripe with no transaction fees. Everything related to commercial licenses is organized into a single dashboard.</p>\n\n\n\n<img />\n\n\n\n<p>WP Wallet is free forever for up to three websites and is supported by ads. Free users can share access with unlimited team members and connect to Stripe or PayPal. <a href=\"https://wpwallet.com/pricing/\">Upgrading to Pro</a> is less than $10 per month and allows users to add unlimited sites, connect multiple payment gateways, and will soon include a Chrome Extension and API.</p>\n\n\n\n<h3>Block Styles Plugin Now in Beta, Brings Advanced Styles to the Block Editor</h3>\n\n\n\n<p><a href=\"https://blockstyles.com/\">Block Styles</a> is a new plugin now in beta that lets users further customize core blocks with unique styles. It <a href=\"https://blockstyles.com/compatibility/\">works with many popular block collection plugins</a> and boasts &#8220;fully responsive block-level design control.&#8221; This allows users to change style attributes based on desktop, tablet, and mobile sizes, and eventually customer device sizes, hover/action states and pseudo elements. </p>\n\n\n\n<img />\n\n\n\n<p>The Block Styles plugin has advanced layout controls with visibility settings that can be set based on user role, device size, and login status. It also adds the ability to customize the background of every Gutenberg block with colors, gradient options, and linear and radial settings. The team is working on adding multiple backgrounds and video backgrounds. The plugin has support for advanced border styles, typography controls, special effects, animations, and custom CSS for every block.</p>\n\n\n\n<p>Pricing for the Block Styles plugin ranges from $69/year for one site to $499/year for unlimited sites.</p>\n\n\n\n<h3>Stock Control for WooCommerce Makes It Easier to Manage Inventory</h3>\n\n\n\n<p><a href=\"https://scwstockcontrol.com/\">Stock Control for WooCommerce</a> is a new plugin that launched this week, created by plugin developer Edith Allison. It makes it easier to manage WooCommerce inventory and make quick adjustments. Store owners can manipulate stock, and change descriptions, images, attributes, and categories all on one page. </p>\n\n\n\n<img />\n\n\n\n<p>Product changes can be published immediately or saved for review later. The plugin also logs who made the changes and when. It uses the Heartbeat API to monitor the shop and will notify if there is an editing conflict with another site manager. It will also notify if stock quantities change while the site owner is working on the products.</p>\n\n\n\n<p>Stock Control for WooCommerce starts at €29,90/year for single site licenses and goes up to €149,90/year for agencies. The roadmap for future updates includes more translations, an attribute manager, bulk actions, scheduled publication of changes, compatibility with Woo Product Bundles, and a way to show &#8220;held&#8221; stock.</p>\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}s:7:\"pubDate\";a:1:{i:0;a:5:{s:4:\"data\";s:31:\"Fri, 01 Apr 2022 21:22:00 +0000\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}}s:32:\"http://purl.org/dc/elements/1.1/\";a:1:{s:7:\"creator\";a:1:{i:0;a:5:{s:4:\"data\";s:13:\"Sarah Gooding\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}}}}i:8;a:6:{s:4:\"data\";s:13:\"\n	\n	\n	\n	\n	\n	\n\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";s:5:\"child\";a:2:{s:0:\"\";a:5:{s:5:\"title\";a:1:{i:0;a:5:{s:4:\"data\";s:59:\"Post Status: BobWP’s Woo Snippet for the Week of March 27\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}s:4:\"guid\";a:1:{i:0;a:5:{s:4:\"data\";s:31:\"https://poststatus.com/?p=95330\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}s:4:\"link\";a:1:{i:0;a:5:{s:4:\"data\";s:67:\"https://poststatus.com/bobwps-woo-snippet-for-the-week-of-march-27/\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}s:11:\"description\";a:1:{i:0;a:5:{s:4:\"data\";s:6168:\"<div class=\"has-background has-theme-palette-8-background-color wp-block-post-excerpt\"><p class=\"wp-block-post-excerpt__excerpt\">WooCommerce 6.4 RC 1 <img src=\"https://s.w.org/images/core/emoji/13.1.0/72x72/1f4e6.png\" alt=\"📦\" class=\"wp-smiley\" /> Blocks and Admin <img src=\"https://s.w.org/images/core/emoji/13.1.0/72x72/1f50c.png\" alt=\"🔌\" class=\"wp-smiley\" /> Time to Retire ZeroClipboard <img src=\"https://s.w.org/images/core/emoji/13.1.0/72x72/26a0.png\" alt=\"⚠\" class=\"wp-smiley\" /> Clients in a Candy Store <img src=\"https://s.w.org/images/core/emoji/13.1.0/72x72/1f36c.png\" alt=\"🍬\" class=\"wp-smiley\" /> Sustainable Woo? <img src=\"https://s.w.org/images/core/emoji/13.1.0/72x72/1fab4.png\" alt=\"🪴\" class=\"wp-smiley\" /> Zach Stepek, Carl Alexander, Till Krüss, and JJJ <img src=\"https://s.w.org/images/core/emoji/13.1.0/72x72/1f399.png\" alt=\"🎙\" class=\"wp-smiley\" /> </p></div>\n\n\n<h2 id=\"h-what-s-new-in-woocommerce-6-4-rc1-blocks-and-admin-feature-plugins\">What\'s New in WooCommerce 6.4 RC1 + Blocks and Admin Feature Plugins <img src=\"https://s.w.org/images/core/emoji/13.1.0/72x72/1f50c.png\" alt=\"🔌\" class=\"wp-smiley\" /></h2>\n\n\n\n<p>This week saw some updates from core and <a href=\"https://developer.woocommerce.com/2022/03/29/woocommerce-6-4-rc/\">the release</a> of <strong>WooCommerce 6.4 RC 1</strong>. We\'re still headed for an April 12th final release. <strong>WooCommerce Admin</strong> (3.3.0 RC 2) and <strong>WooCommerce Blocks</strong> (7.2.1) are both included in this release.</p>\n\n\n\n<p>If you want to install it separately as a feature plugin, <strong>WooCommerce Blocks 7.3</strong> <a href=\"https://developer.woocommerce.com/2022/03/28/woocommerce-blocks-7-3-0-release-notes/\">is available now</a>. The <strong>Mini Cart</strong> block has been added to it, and all instances of the “Legacy Block” have been renamed — it\'s now the “Classic Block.”</p>\n\n\n\n<h2>Time to Retire ZeroClipboard <img src=\"https://s.w.org/images/core/emoji/13.1.0/72x72/26a0.png\" alt=\"⚠\" class=\"wp-smiley\" /></h2>\n\n\n\n<p>If you have bundled the <strong>ZeroClipboard</strong> library with plugins, themes, or other projects that still rely on it as a dependency, <a href=\"https://developer.woocommerce.com/2022/03/30/removal-of-zeroclipboard/\">you will need to find another solution</a>. <img src=\"https://s.w.org/images/core/emoji/13.1.0/72x72/1f4cb.png\" alt=\"📋\" class=\"wp-smiley\" /></p>\n\n\n\n<p>ZeroClipboard is a <strong>JQuery</strong> plugin used to manage clipboard interactions, and it\'s being removed from WooCommerce because it uses obsolete, potentially insecure, Flash-based methods to do what all browsers can do natively now. </p>\n\n\n\n<p>For many years now, it\'s been possible to do what ZeroClipBoard does without JQuery. <strong>Marcus Burnette</strong> has <a href=\"https://twitter.com/marcusdburnette/status/1509214884327825415\">suggested</a> a fine <a href=\"https://css-tricks.com/native-browser-copy-clipboard/\">solution</a> from <strong>Chris Coyier</strong> back in 2016 at <strong>CSS Tricks</strong>. </p>\n\n\n\n<h2>Like Clients in a Candy Store <img src=\"https://s.w.org/images/core/emoji/13.1.0/72x72/1f36c.png\" alt=\"🍬\" class=\"wp-smiley\" /></h2>\n\n\n\n<p>For those who are starting to build sites in the Woo ecosystem, <strong>Eric Karkovack</strong> has  <a href=\"https://thewpminute.com/overcoming-the-challenge-of-selling-clients-on-woocommerce/\">some advice for selling clients on WooCommerce</a>. It can be difficult, due to the wide array of features and add-ons. Eric offers his own experience and insights. </p>\n\n\n\n<h2>Woo and Sustainability <img src=\"https://s.w.org/images/core/emoji/13.1.0/72x72/1fab4.png\" alt=\"🪴\" class=\"wp-smiley\" /></h2>\n\n\n\n<p>Have you given any thought to sustainable design for the web? Or how eCommerce sites using WooCommerce might have their own unique challenges? It’s probably not something most site builders are thinking about, or even most hosting companies. </p>\n\n\n\n<p>Listening to <strong>Tom Greenwood</strong> from <strong>Wholegrain Digital</strong> will certainly <a href=\"https://dothewoo.io/sustainable-web-design-now-and-in-the-future/\">open your eyes and make you more aware of the importance of sustainable websites</a>, both now and in the future. <strong>Kathy Zant</strong> and <strong>Ronal Gijsel</strong> sat down to talk with Tom in the latest <a href=\"https://dothewoo.io/series/woocommerce/\">Do the Woo</a> podcast episode.</p>\n\n\n\n<h2>Four Developers and a Microphone <img src=\"https://s.w.org/images/core/emoji/13.1.0/72x72/1f399.png\" alt=\"🎙\" class=\"wp-smiley\" /></h2>\n\n\n\n<p>And last but not least, there is that nagging question — <a href=\"https://dothewoo.io/woocommerce-dev-chat-with-jjj/\">What happens when you get four developers together on a podcast?</a> Well, it depends. If you want to truly dive into the depths of code and geek out, <strong>Zach Stepek</strong>, <strong>Carl Alexander</strong>, and <strong>Till Krüss</strong> had a lively conversation with <strong>John James Jacoby</strong> this week on Do the Woo too.</p>\n\n\n\n<div class=\"wp-container-624c8ab06e96a wp-block-group\"><div class=\"wp-block-group__inner-container\">\n<div class=\"wp-block-spacer\"></div>\n\n\n\n<div class=\"wp-block-media-text alignwide is-stacked-on-mobile has-background\"><a href=\"https://dothewoo.io/post-status-members/\"><img width=\"400\" height=\"400\" src=\"https://cdn.poststatus.com/wp-content/uploads/2022/02/hg1C04vb_400x400.jpg\" alt=\"Do the Woo\" class=\"wp-image-93517 size-full\" /></a><div class=\"wp-block-media-text__content\">\n<p class=\"has-text-align-left\" id=\"h-get-ready-for-remote-work\"><strong><strong>Do the Wo</strong>o!</strong> <a href=\"https://dothewoo.io/subscribe\" target=\"_blank\" rel=\"noreferrer noopener\">Get the Podcast</a>. <a href=\"https://dothewoo.io/subscribe\" target=\"_blank\" rel=\"noreferrer noopener\">Subscribe to the Newsletter</a>.</p>\n\n\n\n<p>Learn from others. Grow your business. Connect with a community of like-minded developers and builders who freelance, run agencies, and build really cool products and sites in the <strong>WooCommerce</strong> ecosystem.</p>\n</div></div>\n\n\n\n<div class=\"wp-block-spacer\"></div>\n</div></div>\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}s:7:\"pubDate\";a:1:{i:0;a:5:{s:4:\"data\";s:31:\"Fri, 01 Apr 2022 18:45:07 +0000\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}}s:32:\"http://purl.org/dc/elements/1.1/\";a:1:{s:7:\"creator\";a:1:{i:0;a:5:{s:4:\"data\";s:8:\"Bob Dunn\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}}}}i:9;a:6:{s:4:\"data\";s:13:\"\n	\n	\n	\n	\n	\n	\n\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";s:5:\"child\";a:2:{s:0:\"\";a:5:{s:5:\"title\";a:1:{i:0;a:5:{s:4:\"data\";s:35:\"Post Status: Post Status Notes #492\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}s:4:\"guid\";a:1:{i:0;a:5:{s:4:\"data\";s:31:\"https://poststatus.com/?p=95218\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}s:4:\"link\";a:1:{i:0;a:5:{s:4:\"data\";s:45:\"https://poststatus.com/post-status-notes-492/\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}s:11:\"description\";a:1:{i:0;a:5:{s:4:\"data\";s:14400:\"<p class=\"has-theme-palette-5-color has-text-color\">The first-ever core preview walkthru with contribs for WP 6.0. Lots of Gutenberg news, big WordCamp comebacks, and other cool things!</p>\n\n\n\n<div class=\"wp-container-624c8ab067afd wp-block-group has-theme-palette-8-background-color has-background\"><div class=\"wp-block-group__inner-container\">\n<p>Don\'t miss <strong>David</strong>&#8216;s fresh <a href=\"https://poststatus.com/wordpress-podcast-and-video-picks-for-the-week-of-march-27/\">podcast picks for the week</a>! <img src=\"https://s.w.org/images/core/emoji/13.1.0/72x72/1f399.png\" alt=\"🎙\" class=\"wp-smiley\" /> As usual, <strong>Courtney</strong> has <a href=\"https://poststatus.com/this-week-at-wordpress-org-march-28-2022/\">the week\'s news</a> from the people making WordPress at .org. <img src=\"https://s.w.org/images/core/emoji/13.1.0/72x72/1f3d7.png\" alt=\"🏗\" class=\"wp-smiley\" /> </p>\n</div></div>\n\n\n.kt-block-spacer-_0a42b9-10 .kt-block-spacer{height:30px;}.kt-block-spacer-_0a42b9-10 .kt-divider{width:80%;}\n<div class=\"wp-block-kadence-spacer aligncenter kt-block-spacer-_0a42b9-10\"><div class=\"kt-block-spacer kt-block-spacer-halign-center\"><hr class=\"kt-divider\" /></div></div>\n\n\n\n<h2 id=\"h-core-and-block-editor-updates\">Core and Block Editor Updates <img src=\"https://s.w.org/images/core/emoji/13.1.0/72x72/1f4e6.png\" alt=\"📦\" class=\"wp-smiley\" /></h2>\n\n\n\n<p>Join contributors to WordPress core and other teams on <strong>April 5th</strong> for a first-of-it\'s-kind <a href=\"https://make.wordpress.org/core/2022/03/30/6-0-product-walk-through/\">video product walk-through</a> of the major features coming in <strong>WordPress 6.0</strong>.</p>\n\n\n.kt-block-spacer-_e5c05c-a8 .kt-block-spacer{height:30px;}.kt-block-spacer-_e5c05c-a8 .kt-divider{width:80%;}\n<div class=\"wp-block-kadence-spacer aligncenter kt-block-spacer-_e5c05c-a8\"><div class=\"kt-block-spacer kt-block-spacer-halign-center\"><hr class=\"kt-divider\" /></div></div>\n\n\n\n<p>The newly released <strong>Gutenberg 12.9</strong> has a new block locking UI. It\'s also easier as of this release to build block themes, and manage deeply nested block structures. There are performance improvements <a href=\"https://make.wordpress.org/core/2022/03/30/whats-new-in-gutenberg-12-9-30-march/\">and several more goodies</a>.</p>\n\n\n.kt-block-spacer-_81118f-f7 .kt-block-spacer{height:30px;}.kt-block-spacer-_81118f-f7 .kt-divider{width:80%;}\n<div class=\"wp-block-kadence-spacer aligncenter kt-block-spacer-_81118f-f7\"><div class=\"kt-block-spacer kt-block-spacer-halign-center\"><hr class=\"kt-divider\" /></div></div>\n\n\n\n<p>It\'s time! The WordPress <a href=\"https://wordpress.org/patterns/\">pattern directory</a> is <em>live</em>. Now you can log into your WordPress.org user account to build, edit, and submit <a href=\"https://wordpress.org/news/2022/03/get-creative-with-the-all-new-pattern-creator/\">block patterns to the Pattern Directory</a>. J<strong>ustin Tadlock</strong> <a href=\"https://wptavern.com/the-wordpress-org-pattern-creator-now-open-to-the-public\">shares his day one experience</a>.</p>\n\n\n.kt-block-spacer-_ca97c0-67 .kt-block-spacer{height:30px;}.kt-block-spacer-_ca97c0-67 .kt-divider{width:80%;}\n<div class=\"wp-block-kadence-spacer aligncenter kt-block-spacer-_ca97c0-67\"><div class=\"kt-block-spacer kt-block-spacer-halign-center\"><hr class=\"kt-divider\" /></div></div>\n\n\n\n<p>According to <strong>Matías Ventura</strong>, soon <a href=\"https://twitter.com/matias_ventura/status/1508386768864911372\">you\'ll be able to select text across blocks</a> in the WordPress editor while retaining the fundamental mechanics of content blocks.</p>\n\n\n.kt-block-spacer-_8745d6-3a .kt-block-spacer{height:30px;}.kt-block-spacer-_8745d6-3a .kt-divider{width:80%;}\n<div class=\"wp-block-kadence-spacer aligncenter kt-block-spacer-_8745d6-3a\"><div class=\"kt-block-spacer kt-block-spacer-halign-center\"><hr class=\"kt-divider\" /></div></div>\n\n\n\n<h2 id=\"h-proposal-for-webp-by-default\">Proposal for WebP by Default <img src=\"https://s.w.org/images/core/emoji/13.1.0/72x72/26a1.png\" alt=\"⚡\" class=\"wp-smiley\" /></h2>\n\n\n\n<p><strong>Adam Silverstein</strong> has proposed adopting <strong>WebP</strong> as <a href=\"https://make.wordpress.org/core/2022/03/28/enabling-webp-by-default/\">the default image format in WordPress core</a> for uploads in the Media Library. If Adam\'s proposal is adopted as he describes, “WebP images [would be] generated by default for new JPEG uploads&#8221; and &#8220;used by default for the website content.”</p>\n\n\n\n<p>You can test this proposed feature with the <a href=\"https://wordpress.org/plugins/performance-lab/\">Performance Lab plugin</a>&#8216;s <strong>WebP Uploads</strong> module.&nbsp; Developers can review code and give technical feedback on the&nbsp;latest patch on the associated <a href=\"https://core.trac.wordpress.org/ticket/55443\">Trac ticket</a> or <a href=\"https://github.com/WordPress/wordpress-develop/pull/2393\">Pull Request</a>.&nbsp;</p>\n\n\n.kt-block-spacer-_6a50f5-e6 .kt-block-spacer{height:30px;}.kt-block-spacer-_6a50f5-e6 .kt-divider{width:80%;}\n<div class=\"wp-block-kadence-spacer aligncenter kt-block-spacer-_6a50f5-e6\"><div class=\"kt-block-spacer kt-block-spacer-halign-center\"><hr class=\"kt-divider\" /></div></div>\n\n\n\n<h2 id=\"h-big-wordcamp-comebacks\">Big WordCamp Comebacks! <img src=\"https://s.w.org/images/core/emoji/13.1.0/72x72/26fa.png\" alt=\"⛺\" class=\"wp-smiley\" /></h2>\n\n\n\n<p>Large <strong>WordCamps</strong> are making their return. In addition to <strong>WordCamp Europe</strong> on <a href=\"https://europe.wordcamp.org/2022/\">June 2-4</a>, <strong>WordCamp US</strong> is happening on <strong>September 9-1</strong>. The <a href=\"https://us.wordcamp.org/2022/\">call for speakers</a> closes on April 17th.) <strong>WordCamp Asia</strong> has <a href=\"https://asia.wordcamp.org/2023/\">recently announced</a> it\'s going to take place early next year on <strong>February 17-19, 2023</strong>, in <strong>Bangkok</strong>, <strong>Thailand</strong>.</p>\n\n\n.kt-block-spacer-_a00d15-71 .kt-divider{width:80%;}\n<div class=\"wp-block-kadence-spacer aligncenter kt-block-spacer-_a00d15-71\"><div class=\"kt-block-spacer kt-block-spacer-halign-center\"><hr class=\"kt-divider\" /></div></div>\n\n\n\n<h2 id=\"h-shiny-new-things-shared\">Shiny New Things Shared <img src=\"https://s.w.org/images/core/emoji/13.1.0/72x72/2728.png\" alt=\"✨\" class=\"wp-smiley\" /></h2>\n\n\n\n<p><strong>Rich Tabor</strong> has placed <a href=\"https://richtabor.com/blocks-on-github/\">all his blocks</a> on <strong>Github</strong>, including a new <strong>Share to Twitter</strong> block. He also explains in another post <a href=\"https://richtabor.com/a-new-era/\">why the &#8220;new era&#8221; of WordPress themes is finally here</a>. The future of publishing happens in a block editor, not a code editor. Rich also shares an important block development tip:</p>\n\n\n\n<blockquote class=\"wp-block-quote\"><p>An important concept to grasp is that <strong>when you do make changes to a template, or part, within the Template editor, those changes will immediately take precedence</strong> over the theme’s bundled template files.</p></blockquote>\n\n\n.kt-block-spacer-_e1e93f-9d .kt-block-spacer{height:30px;}.kt-block-spacer-_e1e93f-9d .kt-divider{width:80%;}\n<div class=\"wp-block-kadence-spacer aligncenter kt-block-spacer-_e1e93f-9d\"><div class=\"kt-block-spacer kt-block-spacer-halign-center\"><hr class=\"kt-divider\" /></div></div>\n\n\n\n<p><strong>Brian Gardner</strong> <a href=\"https://briangardner.com/border-block-style/\">shows a simple way</a> of adding &#8220;a bit of pizzazz&#8221; to images in the block editor.</p>\n\n\n.kt-block-spacer-_5e747d-01 .kt-block-spacer{height:30px;}.kt-block-spacer-_5e747d-01 .kt-divider{width:80%;}\n<div class=\"wp-block-kadence-spacer aligncenter kt-block-spacer-_5e747d-01\"><div class=\"kt-block-spacer kt-block-spacer-halign-center\"><hr class=\"kt-divider\" /></div></div>\n\n\n\n<p>Here\'s a brilliant WordPress plugin from <strong>Brian Henry</strong> that creates <a href=\"https://github.com/BrianHenryIE/bh-wp-autologin-urls\">single-use passwords in the URLs in WordPress login emails</a> for a &#8220;frictionless login&#8221; experience.</p>\n\n\n.kt-block-spacer-_72f35a-46 .kt-block-spacer{height:30px;}.kt-block-spacer-_72f35a-46 .kt-divider{width:80%;}\n<div class=\"wp-block-kadence-spacer aligncenter kt-block-spacer-_72f35a-46\"><div class=\"kt-block-spacer kt-block-spacer-halign-center\"><hr class=\"kt-divider\" /></div></div>\n\n\n\n<h2>Developer Happiness <img src=\"https://s.w.org/images/core/emoji/13.1.0/72x72/1f6aa.png\" alt=\"🚪\" class=\"wp-smiley\" /><img src=\"https://s.w.org/images/core/emoji/13.1.0/72x72/1f6b6-1f3ff-200d-2640-fe0f.png\" alt=\"🚶🏿‍♀️\" class=\"wp-smiley\" /></h2>\n\n\n\n<p>Tech has one of <a href=\"https://hbr.org/2021/09/who-is-driving-the-great-resignation\">the highest resignation rates in any industry</a>. Why? <strong>David Gibson</strong> at <strong>Stack Overflow</strong> <a href=\"https://stackoverflow.blog/2022/03/17/new-data-what-makes-developers-happy-at-work/\">examines survey results</a> to find out what makes developers happy at work. While about 70% say they are happy, 20% of developers are looking for new opportunities. On a global scale that adds up.</p>\n\n\n.kt-block-spacer-_3a39b2-3d .kt-block-spacer{height:30px;}.kt-block-spacer-_3a39b2-3d .kt-divider{width:80%;}\n<div class=\"wp-block-kadence-spacer aligncenter kt-block-spacer-_3a39b2-3d\"><div class=\"kt-block-spacer kt-block-spacer-halign-center\"><hr class=\"kt-divider\" /></div></div>\n\n\n\n<p><strong>John Hughes</strong> from <strong>CodeInWP</strong> looks <a href=\"https://www.codeinwp.com/blog/web-developer-salary/\">at the average wages for web developers</a> across different development fields. From the data, John concludes that backend developers should expect $67k-$116k with frontend developers making a bit less. Of course, location and experience are big factors, so the details in this post are worth digging into.</p>\n\n\n.kt-block-spacer-_fc6181-31 .kt-block-spacer{height:30px;}.kt-block-spacer-_fc6181-31 .kt-divider{width:80%;}\n<div class=\"wp-block-kadence-spacer aligncenter kt-block-spacer-_fc6181-31\"><div class=\"kt-block-spacer kt-block-spacer-halign-center\"><hr class=\"kt-divider\" /></div></div>\n\n\n\n<h2>Good to Know <img src=\"https://s.w.org/images/core/emoji/13.1.0/72x72/1f4a1.png\" alt=\"💡\" class=\"wp-smiley\" /></h2>\n\n\n\n<p><strong>Eric Karkovack</strong> examines <a href=\"https://thewpminute.com/overcoming-the-challenge-of-selling-clients-on-woocommerce/\">some pain points</a> when it comes to selling <strong>WooCommerce</strong>, like the dizzying array of features and extensions available. Eric has some good advice for getting past that potential barrier by accurately assessing project needs and communicating them to clients.</p>\n\n\n.kt-block-spacer-_aaf202-5a .kt-block-spacer{height:30px;}.kt-block-spacer-_aaf202-5a .kt-divider{width:80%;}\n<div class=\"wp-block-kadence-spacer aligncenter kt-block-spacer-_aaf202-5a\"><div class=\"kt-block-spacer kt-block-spacer-halign-center\"><hr class=\"kt-divider\" /></div></div>\n\n\n\n<p>I liked this <a href=\"https://bkardell.com/blog/UAGottaBeKidding.html\">review of the history of the UA string</a> from <strong>Brian Kardell. </strong>It\'s amazing how complex it is with the &#8220;lies&#8221; and workarounds — not to mention the money and time — that have gone into the evolution of a string.</p>\n\n\n.kt-block-spacer-_483925-62 .kt-block-spacer{height:30px;}.kt-block-spacer-_483925-62 .kt-divider{width:80%;}\n<div class=\"wp-block-kadence-spacer aligncenter kt-block-spacer-_483925-62\"><div class=\"kt-block-spacer kt-block-spacer-halign-center\"><hr class=\"kt-divider\" /></div></div>\n\n\n\n<p>If you\'re looking for an educational <strong>Twitter</strong> thread, <a href=\"https://twitter.com/JosephHHoward/status/1508838529924837382\">the responses</a> to <strong>Joe Howard\'s</strong> questions about a minimalist WordPress blog are worth a look.</p>\n\n\n.kt-block-spacer-_31a606-1e .kt-block-spacer{height:30px;}.kt-block-spacer-_31a606-1e .kt-divider{width:80%;}\n<div class=\"wp-block-kadence-spacer aligncenter kt-block-spacer-_31a606-1e\"><div class=\"kt-block-spacer kt-block-spacer-halign-center\"><hr class=\"kt-divider\" /></div></div>\n\n\n\n<h2>Upgrades <img src=\"https://s.w.org/images/core/emoji/13.1.0/72x72/1f199.png\" alt=\"🆙\" class=\"wp-smiley\" /></h2>\n\n\n\n<p>If you use <strong>PHPStorm</strong>, check out <a href=\"https://blog.jetbrains.com/phpstorm/2022/03/phpstorm-2022-1-eap-7/#improvements_for_wordpress\">its latest improvements for WordPress development</a>.</p>\n\n\n.kt-block-spacer-_18795b-b2 .kt-block-spacer{height:30px;}.kt-block-spacer-_18795b-b2 .kt-divider{width:80%;}\n<div class=\"wp-block-kadence-spacer aligncenter kt-block-spacer-_18795b-b2\"><div class=\"kt-block-spacer kt-block-spacer-halign-center\"><hr class=\"kt-divider\" /></div></div>\n\n\n\n<p><strong>WP Migrate DB Pro</strong> has been capable of migrating much more than databases for quite some time. Understandably, they\'ve shortened this indispensable plugin\'s name to <strong>WP Migrate</strong>. The simpler brand is official as of <a href=\"https://deliciousbrains.com/wp-migrate-db-pro-2-3-released/\">the latest 2.3 version</a>. This release also offers a UI for including or excluding the database in a migration, making version comparisons, and some other enhancements.</p>\n\n\n.kt-block-spacer-_0a153b-c7 .kt-block-spacer{height:30px;}.kt-block-spacer-_0a153b-c7 .kt-divider{width:80%;}\n<div class=\"wp-block-kadence-spacer aligncenter kt-block-spacer-_0a153b-c7\"><div class=\"kt-block-spacer kt-block-spacer-halign-center\"><hr class=\"kt-divider\" /></div></div>\n\n\n\n<h2>Support Ukraine! <img src=\"https://s.w.org/images/core/emoji/13.1.0/72x72/1f1fa-1f1e6.png\" alt=\"🇺🇦\" class=\"wp-smiley\" /></h2>\n\n\n\n<p><strong>Tetiana Pryhorovska</strong> from <strong>Crocoblock</strong> offers <a href=\"https://crocoblock.com/blog/wordpress-community-supports-ukraine/\">a perspective</a> as an employee of a WordPress company based in <strong>Ukraine</strong>. Learn how some members of the WordPress community are offering support.</p>\n\n\n.kt-block-spacer-_7146af-ef .kt-block-spacer{height:30px;}.kt-block-spacer-_7146af-ef .kt-divider{width:80%;}\n<div class=\"wp-block-kadence-spacer aligncenter kt-block-spacer-_7146af-ef\"><div class=\"kt-block-spacer kt-block-spacer-halign-center\"><hr class=\"kt-divider\" /></div></div>\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}s:7:\"pubDate\";a:1:{i:0;a:5:{s:4:\"data\";s:31:\"Fri, 01 Apr 2022 16:45:07 +0000\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}}s:32:\"http://purl.org/dc/elements/1.1/\";a:1:{s:7:\"creator\";a:1:{i:0;a:5:{s:4:\"data\";s:10:\"Dan Knauss\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}}}}i:10;a:6:{s:4:\"data\";s:13:\"\n	\n	\n	\n	\n	\n	\n\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";s:5:\"child\";a:2:{s:0:\"\";a:5:{s:5:\"title\";a:1:{i:0;a:5:{s:4:\"data\";s:61:\"Post Status: WordPress Podcast Picks for the Week of March 27\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}s:4:\"guid\";a:1:{i:0;a:5:{s:4:\"data\";s:31:\"https://poststatus.com/?p=95183\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}s:4:\"link\";a:1:{i:0;a:5:{s:4:\"data\";s:86:\"https://cdn.poststatus.com/wordpress-podcast-and-video-picks-for-the-week-of-march-27/\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}s:11:\"description\";a:1:{i:0;a:5:{s:4:\"data\";s:3660:\"<div class=\"wp-block-post-excerpt\"><p class=\"wp-block-post-excerpt__excerpt\">Here\'s David\'s weekly roundup of recent WP and web biz/tech podcasts worth listening to. Also: Ukrainian startup Lemon.io on work in wartime and Sherry Walling on grief. </p></div>\n\n\n<h2 id=\"h-my-podcast-picks\">My Podcast Picks</h2>\n\n\n\n<ul><li><strong>Matt Report:</strong> <strong>Rob Howard</strong> <a href=\"https://mattreport.com/buying-a-wordpress-media-property-plugin-business-ecosystem/\">talks about</a> building an agency, hiring, and purchasing <a href=\"https://masterwp.com/\">MasterWP</a>.</li><li><strong>Reverse Engineered:</strong> Jon <a href=\"https://kinsta.com/podcast/frontend-developer-seo-specialist/\">has a conversation</a> with <strong>Aleyda Solis</strong>, an international SEO consultant and founder of <strong>Orainti</strong>, a boutique SEO consultancy specialized in international, mobile, technical, and strategic SEO processes audits, advice and training. </li><li><strong>Syntax.fm</strong>: Developer-related discussions focused on <a href=\"https://syntax.fm/show/440/potluck-handling-auth-are-web-dev-real-developers-handling-git-conflicts-converting-png-to-box-shadow-bad-docs-vs-no-docs-making-shopify-headless\">&#8220;real&#8221; web developers</a>, handling Git conflicts, bad docs vs no docs, and more.</li><li><strong>Make Lemonade:</strong> <strong>Mark Zahar</strong> <a href=\"https://make-lemonade.simplecast.com/episodes/wp-mayor-8v6bLJE6\">talks about the WordPress ecosystem</a>, <strong>WP Mayor</strong>, <strong>SpotlightWP</strong>, and <strong>WP RSS Aggregator</strong>.</li><li><strong>That Talking Thing:</strong> <strong>Jason Coleman</strong> and <strong>Kim Coleman</strong> discuss whether <a href=\"https://www.strangerstudios.com/podcast/that-talking-thing-season-2-episode-13/\">the freemium model</a> is the best way to monetize membership sites.</li><li><strong>Leading To Fulfillment:</strong> <strong>Dr. Sherry Walling</strong> explains <a href=\"https://ciircles.com/podcast/leading-to-fulfillment/fulfillment-in-the-face-of-transition-loss-and-grief-with-dr-sherry-walling/\">how to find fulfillment</a> in the face of grief, loss, and transition — all things happening daily in the WordPress community.</li><li><strong>Techmeme Ride Home:</strong> Not WordPress-related, but an interesting story nonetheless — how a tech startup in <strong>Ukraine</strong> is <a href=\"https://www.ridehome.info/show/techmeme-ride-home/profile-of-ukrainian-startup-lemonio/\">managing it\'s employees in the middle of a war</a>.</li></ul>\n\n\n\n<div class=\"wp-container-624c8ab064d80 wp-block-group has-theme-palette-8-background-color has-background\"><div class=\"wp-block-group__inner-container\">\n<p><strong>Get our weekly WordPress community news digest</strong> — Post Status\' <a href=\"https://poststatus.com/news/week-in-review/\">Week in Review</a> — also available in <a href=\"https://poststatus.com/newsletter\">our newsletter</a>. <img src=\"https://s.w.org/images/core/emoji/13.1.0/72x72/1f48c.png\" alt=\"💌\" class=\"wp-smiley\" />  </p>\n\n\n\n<p>And don\'t miss the latest updates from the people making WordPress. We\'ve got you covered with <a href=\"https://poststatus.com/make-wordpress/\">This Week at WordPress.org</a>. <img src=\"https://s.w.org/images/core/emoji/13.1.0/72x72/2699.png\" alt=\"⚙\" class=\"wp-smiley\" /></p>\n\n\n\n<p>Are you interested in giving back and contributing your time and skills to WordPress.org? <img src=\"https://s.w.org/images/core/emoji/13.1.0/72x72/1f64f.png\" alt=\"🙏\" class=\"wp-smiley\" /> <a href=\"https://wordpress.org/support/article/contributing-to-wordpress/\">Start Here ›</a></p>\n</div></div>\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}s:7:\"pubDate\";a:1:{i:0;a:5:{s:4:\"data\";s:31:\"Fri, 01 Apr 2022 16:00:07 +0000\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}}s:32:\"http://purl.org/dc/elements/1.1/\";a:1:{s:7:\"creator\";a:1:{i:0;a:5:{s:4:\"data\";s:12:\"David Bisset\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}}}}i:11;a:6:{s:4:\"data\";s:13:\"\n	\n	\n	\n	\n	\n	\n\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";s:5:\"child\";a:2:{s:0:\"\";a:5:{s:5:\"title\";a:1:{i:0;a:5:{s:4:\"data\";s:76:\"WordCamp Central: Represent Your Community: Join the WordCamp Asia 2023 Team\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}s:4:\"guid\";a:1:{i:0;a:5:{s:4:\"data\";s:39:\"https://central.wordcamp.org/?p=3146748\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}s:4:\"link\";a:1:{i:0;a:5:{s:4:\"data\";s:100:\"https://central.wordcamp.org/news/2022/04/represent-your-community-join-the-wordcamp-asia-2023-team/\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}s:11:\"description\";a:1:{i:0;a:5:{s:4:\"data\";s:1449:\"<p>It&#8217;s hard to believe over 2 years have passed since we <a href=\"https://asia.wordcamp.org/2020/cancellation/\">announced the cancellation</a> of our first flagship WordCamp in the region, WordCamp Asia 2020.</p>\n<p>Now, I&#8217;m happy to announce the organising team is back together and ready to plan our event in February 2023! While the majority of the team is coming back, we are <a href=\"https://asia.wordcamp.org/2023/call-for-organisers/\">looking for some additional members to join us</a>.</p>\n<blockquote class=\"wp-embedded-content\"><p><a href=\"https://asia.wordcamp.org/2023/call-for-organisers/\">Call for Organisers</a></p></blockquote>\n<p></p>\n<p>To make WordCamp Asia a truly diverse and inclusive event, <strong>we need your help</strong>. If you are someone who is passionate about WordPress and want to help shape the future of it in Asia, please consider joining us on this new journey.</p>\n<p>And even if that&#8217;s not an option for you right at the moment, I hope you can take a few minutes to help spread the word. We&#8217;d love to reach as many active members of Asian WordPress communities as possible. Please share this news with your friends, colleagues, or anyone who may be interested.</p>\n<p>Over the years, the support from the WordPress community for our event has been overwhelmingly warm and kind. Thanks again for trusting us to stay strong. We can&#8217;t wait to meet you in Bangkok.</p>\n<p>&nbsp;</p>\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}s:7:\"pubDate\";a:1:{i:0;a:5:{s:4:\"data\";s:31:\"Fri, 01 Apr 2022 08:47:04 +0000\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}}s:32:\"http://purl.org/dc/elements/1.1/\";a:1:{s:7:\"creator\";a:1:{i:0;a:5:{s:4:\"data\";s:12:\"Naoko Takano\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}}}}i:12;a:6:{s:4:\"data\";s:13:\"\n	\n	\n	\n	\n	\n	\n\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";s:5:\"child\";a:2:{s:0:\"\";a:5:{s:5:\"title\";a:1:{i:0;a:5:{s:4:\"data\";s:73:\"Akismet: The Pros and Cons of Enabling Comments on Your WordPress Website\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}s:4:\"guid\";a:1:{i:0;a:5:{s:4:\"data\";s:31:\"http://blog.akismet.com/?p=2365\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}s:4:\"link\";a:1:{i:0;a:5:{s:4:\"data\";s:81:\"https://blog.akismet.com/2022/04/01/wordpress-pros-and-cons-of-enabling-comments/\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}s:11:\"description\";a:1:{i:0;a:5:{s:4:\"data\";s:14147:\"<p>For many bloggers, having comments is the best part of their blog ownership experience. They enjoy interacting with readers, getting real-time feedback, and seeing their community grow. However, while there are a lot of benefits to enabling comments on your WordPress website, you might run into a few problems along the way.&nbsp;</p>\n\n\n\n<p>If you’re on the fence about enabling comments, you’ve come to the right place. We’ll cover the pros and cons and discuss how you can protect your site from unwanted spam.&nbsp;</p>\n\n\n\n<span id=\"more-2365\"></span>\n\n\n\n<h2>The pros of enabling comments on WordPress</h2>\n\n\n\n<p>With the potential risks comments pose, why do so many bloggers keep them around? Here are a few benefits to enabling comments on your site:</p>\n\n\n\n<h3>1. They build a strong community&nbsp;</h3>\n\n\n\n<p>Behind every successful WordPress website is a group of loyal followers. Enabling comments on your website allows people to share stories, connect with like-minded readers, and gain a sense of ownership and pride.</p>\n\n\n\n<p>Even if you can’t respond to every comment, your audience members will feel acknowledged and appreciated when they see that you’re reading and engaging with fellow followers.&nbsp;</p>\n\n\n\n<h3>2. You can receive valuable feedback</h3>\n\n\n\n<p>The comments section of your website gives visitors an easy way to leave feedback on your site. Much of this will come naturally. If a post sees substantially more comments than normal and a plethora of positive responses, it’s a good indication that the subject matter really resonated with your audience.&nbsp;</p>\n\n\n\n<p>Asking the following questions could help solicit feedback from your readers:</p>\n\n\n\n<ul><li>Do you like this style of post? Do you want to see more or less?</li><li>What other topics would you like me to cover?&nbsp;</li><li>What are the most common problems you encounter with (the subject matter of your site)?&nbsp;</li><li>What’s the most helpful advice you’ve seen on this site?&nbsp;</li></ul>\n\n\n\n<p>By asking direct questions, you can better gauge if you’re serving your audience well. And when readers feel acknowledged and see that you take action based on their feedback, they’ll have a greater sense of loyalty and ownership. This is a key part of developing brand advocates that will proactively share your site with their friends and family.&nbsp;</p>\n\n\n\n<h3>3. You can increase views and conversions</h3>\n\n\n\n<p>When a person leaves a comment on your website and you or another reader replies, they’ll come back to view that response. Imagine if every commenter visited your website multiple times to reply to comments. Your page views would go through the roof!</p>\n\n\n\n<p>With commenters regularly returning to your site, the increase in page views could bump up ad revenue or improve the chances that they take a desired action —&nbsp;register for your email list, purchase a product, leave you a tip, follow you on social media, and more.&nbsp;</p>\n\n\n\n<h2>The cons of enabling comments on WordPress</h2>\n\n\n\n<p>While enabling comments on your website seems to be a great choice, remember that everything has two sides. Now that we’ve covered the benefits of comments, let’s examine the&nbsp;potential downsides.</p>\n\n\n\n<h3>1. Moderating comments is time-consuming&nbsp;</h3>\n\n\n\n<p>While getting feedback and connecting with your audience is great, moderating comments is a time-consuming process. You’ll need to read each comment, formulate a response, and do your best to keep spam comments at bay. You might be able to handle it when your blog has a few readers, but as your audience grows, comments can quickly get out of hand.&nbsp;</p>\n\n\n\n<h3>2. You may attract unwanted spam&nbsp;</h3>\n\n\n\n<p>Unfortunately, the moment you enable comments on your website, spambots will come running. You can get hit with a wave of bot-generated comments&nbsp;even if your audience is small. While there are ways to <a href=\"https://blog.akismet.com/2022/01/12/how-to-stop-comment-spam-in-wordpress/\">protect your WordPress site from comment spam</a>, dealing with spam is one of the many responsibilities that fall under site management.</p>\n\n\n\n<h3>3. They could negatively affect your brand&nbsp;</h3>\n\n\n\n<p>No matter how hard you try, you can’t make everyone happy. There will always be people who disagree with you or aren’t big fans of your content. This can be emotionally exhausting, but also make others wonder about the validity of your work.&nbsp;</p>\n\n\n\n<p>Malicious comments with links that lead to viruses or other nefarious traps could harm your visitors and cause distrust and frustration.&nbsp;</p>\n\n\n\n<p>But a comment section that’s filled with gibberish spam remarks, lewd or obscene comments, or even no comments at all can make readers associate your site with bad feelings. Allowing each and every comment with no moderation is an express lane to a tarnished reputation.&nbsp;</p>\n\n\n\n<h2>The SEO benefits of enabling comments on WordPress</h2>\n\n\n\n<p>Bloggers put a lot of work into search engine optimization (SEO). With all the hours that go into creating content, it’s natural that they want people to see and read the fruits of their labor.</p>\n\n\n\n<p>Google has made it clear that <a href=\"https://www.searchenginejournal.com/google-removing-blog-comments-may-impact-search-rankings/395400/#close\" target=\"_blank\" rel=\"noreferrer noopener\">comments can have a positive impact on search rankings</a>. Let’s look at three SEO benefits of enabling comments on your website:</p>\n\n\n\n<h3>1. Increased natural keyword density&nbsp;</h3>\n\n\n\n<p>When search engines crawl your site, they’re looking, in part, to understand what each page is about, based on the content it contains. When your readers comment and mention the keywords you’re trying to rank your blog post for, search engines will take notice and may give your rankings a boost.</p>\n\n\n\n<p>This is especially true when it comes to semantically similar keywords. These are search terms closely related to the keywords you’re targeting. Imagine you wrote a blog post on chocolate cake. While “chocolate cake” is your main keyword, words like “icing,” “gluten-free,” “recipe,” and “ingredients” are all semantically similar keywords that help improve your content’s relevance.&nbsp;</p>\n\n\n\n<p>While search engines don’t appreciate, and will even penalize, stuffing your page full of keywords, organic comments can do the work for you while staying on search engines’ ‘good side.’</p>\n\n\n\n<h3>2. More webpage content</h3>\n\n\n\n<p>To Google and other search engines, the comment section of your website is simply additional content. Your blog post could only be 600 words long, but if you have 800 words worth of comments, you now have 1,400 words of content on your page.&nbsp;</p>\n\n\n\n<p>Of course, these comments need to add to the value of your blog post. On the other hand, long comments unrelated to the post could have the opposite effect. This is why comment moderation, although time-consuming, is essential.&nbsp;</p>\n\n\n\n<h3>3. More linking opportunities</h3>\n\n\n\n<p>Comments on a WordPress website increase linking opportunities — both internal and external. Answering questions in your comment section gives you the chance to link to relevant articles on your website, giving visitors a reason to stay on your site longer.&nbsp;</p>\n\n\n\n<p>Even referring to third-party sites when a question goes beyond the scope of your expertise can help search engines better understand the full context of your site and where it fits in the online ecosystem. Plus, honest referrals to other experts is a great way to build a relationship with sites who may return the favor in the future.&nbsp;</p>\n\n\n\n<h2>How to disable WordPress comments&nbsp;</h2>\n\n\n\n<p>You can choose to either disable comments on individual pages of your WordPress site or disable them across the entire site.&nbsp;</p>\n\n\n\n<h3>How to disable comments on your entire WordPress website</h3>\n\n\n\n<p>To completely disable comments on your site, navigate to your dashboard and go to <strong>Settings</strong> → <strong>Discussion</strong>. Look for <strong>Default post settings</strong> at the top of your screen. Uncheck the box that says <strong>Allow people to comment on new posts</strong>.&nbsp;</p>\n\n\n\n<img />\n\n\n\n<h3>How to disable comments on individual pages&nbsp;</h3>\n\n\n\n<p>What if you want to disable comments only on specific pages? You might notice that some blog topics or articles are more prone to spam than others. To disable those comment sections, go to the <strong>Posts</strong> or <strong>Pages</strong> tab. Find the post or page you’re looking for and click on <strong>Quick edit</strong> below its name. Next, you’ll see a box that reads <strong>Allow Comments</strong>.&nbsp;</p>\n\n\n\n<img />\n\n\n\n<p>If the box is checked, disable it. You can repeat this process across your website for all the pages and posts where you want to turn off comments.&nbsp;</p>\n\n\n\n<p>Keep in mind that depending on the nature of your blog, disabling comments on your website could cost you valuable engagement. Thankfully, you can take steps to avoid spam comments on your website without sacrificing your comment section entirely.&nbsp;</p>\n\n\n\n<h2>An overview of comment spam</h2>\n\n\n\n<p>If you want the benefits of robust reader engagement without the annoyance of dangerous spam, there are some steps you can take to prevent comment spam.&nbsp;</p>\n\n\n\n<h3>What spam comments look like</h3>\n\n\n\n<p>Spam comments are often easy to spot. Since bots behave according to how they’re programmed, they tend to follow a few general guidelines. Here are warning signs a comment might be spam:</p>\n\n\n\n<ul><li>The message leads readers to a third-party website that’s unrelated to the subject matter of the post</li><li>The comment comes from a guest account or one with no name&nbsp;</li><li>There is no user avatar/profile picture&nbsp;</li><li>There are direct mentions of products and services</li><li>The comment is unrelated to the blog topic or comment discussion&nbsp;</li><li>The comment is rife with grammatical errors or gibberish that doesn’t contribute to meaningful discussion</li></ul>\n\n\n\n<p>Let’s say you run a blog that caters to dessert recipes. A spam comment posted by a bot might look something like this:</p>\n\n\n\n<p><strong>“Find out how to keep your Air conditioners clean all year round here!!! → (insert link)”</strong> &#8211; <strong>Guest 0123r67</strong></p>\n\n\n\n<p>The vague name and unrelated comment are clear signs of spam, so the comment should be removed as soon as possible.&nbsp;</p>\n\n\n\n<h3>Why spam comments are harmful</h3>\n\n\n\n<p>From the moment you allow comments on your site, you’re bound to attract some spam. As your content and audience grow, this spam can become overwhelming to manage while the number of people who could be impacted increases. Let’s review a few of the reasons why spam comments are harmful.&nbsp;</p>\n\n\n\n<h4>1. Spam comments foster distrust with your readers&nbsp;</h4>\n\n\n\n<p>Not only do spam comments make your site look unprofessional, they foster distrust with your readers. No matter how credible a website looks, a comment section riddled with spam will raise red flags among visitors.&nbsp;</p>\n\n\n\n<p>While some people may understand that spam comments are a natural occurrence, others may not be so understanding. This is especially true if they fall prey to following a link from one of these comments.&nbsp;</p>\n\n\n\n<p>Remember, if you choose to enable comments on your site, it’s your job to monitor them and keep your followers safe.&nbsp;</p>\n\n\n\n<h4>2. Spam comments ruin the user experience&nbsp;</h4>\n\n\n\n<p>Followers looking to have real, meaningful conversations with other readers will be put off by bots taking over the comment section.&nbsp;</p>\n\n\n\n<p>If you sit back and let spam comments wreak havoc across your website, you miss out on valuable feedback, suggestions, and potential connections with your audience.&nbsp;</p>\n\n\n\n<h4>3. Spam comments impact your SEO</h4>\n\n\n\n<p>Failing to delete low-quality comments could severely harm your site’s search engine rankings. You’ve put months, maybe even years of hard work into your website, but letting comments build up with links to malicious sites can undo much of your progress.&nbsp;</p>\n\n\n\n<h3>How to avoid spam comments</h3>\n\n\n\n<p>If you decide that it’s worth it to have comments on your WordPress website, remember that the best defense is a good offense. Don’t wait for your website to become overrun with spam comments before investing in a <a href=\"https://akismet.com/\">spam-fighting plugin like Akismet</a>.&nbsp;</p>\n\n\n\n<img />\n\n\n\n<p>Akismet can automatically detect spam on your website by sifting through comments and separating the good from the bad. Within seconds, Akismet analyzes the comments submitted to your site and runs them through their global database. If a comment is flagged, it won’t get posted — plain and simple.&nbsp;</p>\n\n\n\n<p>One major benefit of Akismet is the time it saves you when moderating comments. Instead of viewing every comment submission manually, you only need to check the ones that Akismet flags as potential spam. Or, you can just let it get rid of the worst spam without having to review it at all!&nbsp;</p>\n\n\n\n<h2>Should you allow comments on your website?</h2>\n\n\n\n<p>We can’t make the decision for you, so you’ll need to weigh the risks and benefits of comments on your website yourself. While building a rapport with your audience and using comments to improve SEO may be worth it for some, the need to constantly moderate comments for spam may put others off.&nbsp;</p>\n\n\n\n<p>If you’re really on the fence about enabling comments on your site, you can always try it out with a spam-fighting plugin like <a href=\"https://akismet.com/\">Akismet</a>. This way, you can prevent harmful comments from appearing on your site without missing out on real, meaningful comments and engagement. If you find that they do more harm than good, you can always disable them and try again in the future.&nbsp;</p>\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}s:7:\"pubDate\";a:1:{i:0;a:5:{s:4:\"data\";s:31:\"Fri, 01 Apr 2022 08:16:30 +0000\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}}s:32:\"http://purl.org/dc/elements/1.1/\";a:1:{s:7:\"creator\";a:1:{i:0;a:5:{s:4:\"data\";s:13:\"Simon Keating\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}}}}i:13;a:6:{s:4:\"data\";s:13:\"\n	\n	\n	\n	\n	\n	\n\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";s:5:\"child\";a:2:{s:0:\"\";a:5:{s:5:\"title\";a:1:{i:0;a:5:{s:4:\"data\";s:83:\"WPTavern: WebMan Design Launches Abs, Additional Styles for Native WordPress Blocks\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}s:4:\"guid\";a:1:{i:0;a:5:{s:4:\"data\";s:30:\"https://wptavern.com/?p=132209\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}s:4:\"link\";a:1:{i:0;a:5:{s:4:\"data\";s:93:\"https://wptavern.com/webman-design-launches-abs-additional-styles-for-native-wordpress-blocks\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}s:11:\"description\";a:1:{i:0;a:5:{s:4:\"data\";s:4505:\"<p class=\"has-drop-cap\">WebMan Design owner Oliver Juhas released the first version of the <a href=\"https://wordpress.org/plugins/additional-block-styles/\">Abs &#8211; Additional block styles plugin</a> on Monday. Unlike many block-related extensions, it does not offer any blocks of its own. Instead, it registers custom styles to enhance those packaged with core WordPress.</p>\n\n\n\n<p>In total, the plugin adds 18 styles. Some are specific to a single block, such as Accessibility Hidden, which creates invisible Headings, making them available to screen readers. Others, such as the Drop Shadow style, are registered for multiple blocks.</p>\n\n\n\n<p>On the whole, it is a well-rounded set that often leans into more practical use cases. The Overlap Above and Overlap Below styles fit into this scenario. The former allows users to bump Image, Cover, and other blocks up, overlapping the section above them. The latter goes in the opposite direction.</p>\n\n\n\n<img />Image overlapping section above it.\n\n\n\n<p>The downside to such overlaps is that the user cannot control how far up or down the block shifts. <a href=\"https://github.com/WordPress/gutenberg/issues/32644\">Negative vertical margin controls</a> are a sought-after feature in WordPress, often necessary to create specialized layouts.</p>\n\n\n\n<p>Juhas provided a <code>--abs_overlap_value</code> CSS custom property. DIY users could control this via CSS. At the very least, theme authors could integrate directly with the plugin. However, they may simply want to register the styles for their own themes if going through all the trouble.</p>\n\n\n\n<p>While the plugin styles may be practical in many ways, Juhas also threw a bit of whimsy in the mix. Almost as a signature, nearly every similar plugin offers at least one SVG mask for image-related blocks. Abs follows the same path with its Paint Brush style:</p>\n\n\n\n<img />Paint Brush style applied to an image.\n\n\n\n<p>That is the only such SVG mask in the plugin, a style that has almost been overdone. At least the Paint Brush option breaks from the mold of &#8220;blob shapes&#8221; that have become commonplace.</p>\n\n\n\n<p>Juhas has several example screenshots and GIFs on the plugin page that explore what the plugin is capable of, many of them mixing and matching different blocks and styles. It is unlikely that I will do it justice here. However, I did try my hand at several layouts.</p>\n\n\n\n<p>One of my favorite creations was mixing the Wavy style for the Media &amp; Text block with Zigzag for Separator:</p>\n\n\n\n<img />Wavy style for Media &amp; Text with mix of Zigzag Separator blocks.\n\n\n\n<p>Abs also includes a Double Line option for the Separator block. But, the plugin shines the most with Media &amp; Text. I can only assume that Juhas looked at it and realized that not enough designers were doing anything interesting with it, taking the responsibility upon himself. <em>That is merely a guess, anyway.</em></p>\n\n\n\n<p>The plugin adds a Paint Brush style for Media &amp; Text as it does for other image-type blocks. It also has a Media on Top option for stacking the block&#8217;s contents on both desktop and mobile displays and a similar stacking option for tablets. It supports both the previously-mentioned overlapping styles. Plus, users can get some mileage from its Gradient variation, as shown in the following screenshot:</p>\n\n\n\n<img />Gradient style used for the Media &amp; Text block.\n\n\n\n<p>I am merely scratching the surface of possibilities with the plugin&#8217;s out-of-the-box styles. With time and creativity, users can create some unique layouts with it.</p>\n\n\n\n<p>I tested Abs against several block-based themes, and it held up well. The only issues I ran into were likely related to running the latest Gutenberg plugin. After selecting a custom color when using the Zigzag style for the Separator block, the background color overtakes the shape. And, the alignment styles for the Column block do not align left or right in the editor. However, they do work on the front end.</p>\n\n\n\n<p>I am a fan of plugins that offer custom styles, and Abs is a welcome departure from the carousel of block libraries. It has just enough variety to please those looking for business-friendly design options while not neglecting users who just want to have a little fun.</p>\n\n\n\n<div class=\"wp-block-embed__wrapper\">\n<blockquote class=\"wp-embedded-content\"><a href=\"https://wordpress.org/plugins/additional-block-styles/\">Abs &#8211; Additional block styles</a></blockquote>\n</div>\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}s:7:\"pubDate\";a:1:{i:0;a:5:{s:4:\"data\";s:31:\"Fri, 01 Apr 2022 02:41:15 +0000\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}}s:32:\"http://purl.org/dc/elements/1.1/\";a:1:{s:7:\"creator\";a:1:{i:0;a:5:{s:4:\"data\";s:14:\"Justin Tadlock\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}}}}i:14;a:6:{s:4:\"data\";s:13:\"\n	\n	\n	\n	\n	\n	\n\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";s:5:\"child\";a:2:{s:0:\"\";a:5:{s:5:\"title\";a:1:{i:0;a:5:{s:4:\"data\";s:46:\"WPTavern: WP Migrate DB Rebrands to WP Migrate\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}s:4:\"guid\";a:1:{i:0;a:5:{s:4:\"data\";s:30:\"https://wptavern.com/?p=132290\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}s:4:\"link\";a:1:{i:0;a:5:{s:4:\"data\";s:57:\"https://wptavern.com/wp-migrate-db-rebrands-to-wp-migrate\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}s:11:\"description\";a:1:{i:0;a:5:{s:4:\"data\";s:2782:\"<p><a href=\"https://wordpress.org/plugins/wp-migrate-db/\">WP Migrate DB</a>, a popular WordPress site migration plugin by Delicious Brains, has rebranded to WP Migrate with its latest <a href=\"https://deliciousbrains.com/wp-migrate-db-pro-2-3-released/\">version 2.3 release</a>. The original name was always a bit of a mouthful but also became a less accurate representation of the plugin&#8217;s full capabilities as they grew over time. </p>\n\n\n\n<p>&#8220;This plugin has been capable of migrating more than just the database for a long time, so it&#8217;s nice to officially rebrand with an emphasis on full site WordPress migrations,&#8221; Delicious Brains Product Manager Kevin Hoffman said.</p>\n\n\n\n<p>Database-less migrations is one of the major features of the 2.3 release. No database tables are required anymore to migrate media, theme, and plugin files. The plugin added a new checkbox in the Database panel of users&#8217; migration profiles so they can choose if they want to include the database in the migration, just the files, or both.</p>\n\n\n\n<p>&#8220;With the introduction of database-less migrations in version 2.3, the time is right to officially &#8216;drop the DB&#8217; from our name and move forward as <em>WP Migrate</em>,&#8221; Hoffman said. &#8220;This new name better suits the plugin that is now capable of migrating any combination of WordPress database tables, media files, uploads, themes, and plugins.&#8221;</p>\n\n\n\n<p>WP Migrate Pro 2.3 also introduces the ability to migrate from one multisite to another, making it easy to migrate from subsite-to-subsite. The interface now has new indicators showing theme and plugin version differences. Users will find the plugin installation workflow much easier, as version 2.3 moves addon functionality into the core plugin. Separate plugins, such as the Media Files and Multisite Tools addons, will automatically deactivate because they are now included in the core plugin.</p>\n\n\n\n<p>The <a href=\"https://wordpress.org/plugins/wp-migrate-db/\">free version of WP Migrate</a>, which has 300,000 active installs on WordPress.org, has also been updated and includes the following changes for version 2.3: </p>\n\n\n\n<ul><li>New: “WP Migrate DB” is now “WP Migrate Lite”</li><li>New: CLI commands now support <code>migrate</code> base command as an alias of <code>migratedb</code></li><li>Improvement: CLI exports no longer require find/replace arguments</li><li>Improvement: Notices are now styled to reflect their state (success, error, warning, or information)</li></ul>\n\n\n\n<p>The WP Migrate team plans to release an expansion of these features in the next release, including the ability to migrate must-use plugins, languages, and third-party directories found within <code>wp-content</code>.</p>\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}s:7:\"pubDate\";a:1:{i:0;a:5:{s:4:\"data\";s:31:\"Fri, 01 Apr 2022 00:56:25 +0000\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}}s:32:\"http://purl.org/dc/elements/1.1/\";a:1:{s:7:\"creator\";a:1:{i:0;a:5:{s:4:\"data\";s:13:\"Sarah Gooding\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}}}}i:15;a:6:{s:4:\"data\";s:13:\"\n	\n	\n	\n	\n	\n	\n\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";s:5:\"child\";a:2:{s:0:\"\";a:5:{s:5:\"title\";a:1:{i:0;a:5:{s:4:\"data\";s:54:\"WordPress.org blog: People of WordPress: Juan Aldasoro\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}s:4:\"guid\";a:1:{i:0;a:5:{s:4:\"data\";s:35:\"https://wordpress.org/news/?p=12512\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}s:4:\"link\";a:1:{i:0;a:5:{s:4:\"data\";s:72:\"https://wordpress.org/news/2022/03/people-of-wordpress-juanfra-aldasoro/\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}s:11:\"description\";a:1:{i:0;a:5:{s:4:\"data\";s:16649:\"<p><strong>In this series, we share some of the inspiring stories of how WordPress and its global network of contributors can change people’s lives for the better. This month we feature a website developer and product manager from Argentina, who found in the software a way to live his life in the way he dreamed.</strong></p>\n\n\n\n<img width=\"1024\" height=\"768\" src=\"https://i2.wp.com/wordpress.org/news/files/2022/03/Juanfra_2333.jpg?resize=1024%2C768&ssl=1\" alt=\"Juan standing in front of a mural\" class=\"wp-image-12525\" />\n\n\n\n<p>WordPress offers something to everyone. For Juan Aldasoro, a developer and product manager for a large distributed company, it provides an opportunity to combine his different interests and skills to live the type of life he wanted.&nbsp;</p>\n\n\n\n<p>“I like visual, creative and technical things. The joy of WordPress is that you can do all of these things, you don’t have to limit yourself to any one aspect . You can also do this from almost anywhere in the world!”</p>\n\n\n\n<p>From working in products since 2012, Juan sees WordPress as a major part of his skillset and toolbox. He said: “It gives you an opportunity to be part of building a product which could potentially be used by thousands of people and more on your site. It encourages you to think about different languages and how you can make it accessible. It allows you to work on different platforms. Working in WordPress gives you this broad approach. Working this way on products ended up pushing me into learning about all these different things. Only in open source can you really do this and use your creative side to find solutions.”</p>\n\n\n\n<h2><strong>Learning about being part of a community</strong></h2>\n\n\n\n<img width=\"1024\" height=\"924\" src=\"https://i0.wp.com/wordpress.org/news/files/2022/03/Juanfra_2813.jpeg?resize=1024%2C924&ssl=1\" alt=\"Juan standing in a astreet with murals behind him\" class=\"wp-image-12529\" />\n\n\n\n<p>Born in a mid-sized city in Argentina, Juan was raised in a family in which music, arts and sports were always an essential part of everyday life.</p>\n\n\n\n<p>“These activities encourage human beings to be creative and participative, and at the same time they are highly formative when it comes to mould people in order to become part of a group, a team, a community.”</p>\n\n\n\n<p>The youngest of five siblings, Juan became highly motivated, trying to follow the steps of his siblings. Having a computer at home, he started to make connections that laid the foundation for his career as a developer. His interest in computers grew through that access to a machine running MS-DOS &#8211; the one with the black screen command line! Mastering this became a challenge to him and something to share with others. Through doing this, he found a way to more social interaction and new friendships.&nbsp;</p>\n\n\n\n<blockquote class=\"wp-block-quote\"><p>Without being conscious of it, my friends and I were sharing pieces of code.</p></blockquote>\n\n\n\n<p>He said: “I started learning some super easy stuff that made me feel like Houdini at that time. I could save a game play, something intangible, on a floppy disk and carry that piece of plastic and magnetic material back home. I was saving the play or game in a square object and then loading that back at home. I now realize, those were my first interactions with computer commands. Without being conscious of it, my friends and I were sharing pieces of code in a unique way.”</p>\n\n\n\n<p>This interest grew further through computer magazines and experimenting as &#8220;there was always something new to learn.” Although sport became a big part of Juan’s life in his teens, he kept up his computer learning. Taking a new direction, he found online tutorials enabling him to learn how to play the guitar. This led to setting up a punk rock band with his friends.&nbsp;</p>\n\n\n\n<p>“Education has always been important in my family, and thanks to my parent’s efforts, I attended a school where I learned to express myself in another language.” The school had hired a satellite internet connection in the mid-nineties and had HTML on the computer studies program. These facilities were not that common in Argentina or many other countries either at that time. Also, his parents had the foresight to secure a rare internet connection at the house in 1997. </p>\n\n\n\n<p>Juan recalled: “Browsing around the Internet opened a new universe in my mind. This new universe was extremely fantastic but also extremely expensive. I needed to make the most of every second online.”<br /><br />“It was a whole new world and one thing led to the other. I started learning a bit of everything, editing graphics, scripting and so on. I still remember my first website in the fantastic sunset strip, Geocities.”</p>\n\n\n\n<h3><strong>Trying to go pro</strong></h3>\n\n\n\n<p>After high school, Juan moved to the city along with his brother and began to study IT at University. When he was asked by a friend to work at a software company, he decided to try that whilst continuing his studies. Through his job he had the chance to explore web-related opportunities, and with a friend from university, they started managing teams and projects across Latin America and Spain.<br /><br />Juan describes this experience as one of the most fulfilling in his life. He was able to travel abroad for work, experience remote working, manage teams, present projects and speak formally in front of senior people. As the company grew at a fast pace, they learned how to set up and run a large organization. Eventually, he decided to drop out of his university program and focus on the opportunity of learning first hand.</p>\n\n\n\n<img width=\"600\" height=\"600\" src=\"https://i0.wp.com/wordpress.org/news/files/2022/03/juanfra.jpg?resize=600%2C600&ssl=1\" alt=\"Juan riding a bicycle in a historical city during his travels\" class=\"wp-image-12509\" />\n\n\n\n<p>One of the key early learning from working internationally was that business and web development could be just as fast-moving and successful in Argentina as in other places. “I realized there’s no such thing as a secret sauce for success. Projects are backed by people’s talent and time, and you can find that in any latitude.”<br /><br />By his mid-20s, Juan decided he wanted to try building something from scratch. He created a social network for photo sharing in Latin America, which was used by more than 30,000 people across Latin America and Spain in its time. Through this, he discovered that other people had a blog and he did not want to be left behind. The discovery of WordPress was to change the focus of his life.<br /></p>\n\n\n\n<h2>Hello to WordPress</h2>\n\n\n\n<p>Spending some time traveling around Europe, Juan found himself ‘surrounded by uncertainty’ and worried about what the future could bring. “I had some clues, but under uncertainty, the more you ask the less you answer. I started thinking about embracing the following philosophy: I didn’t want to be part of a large company, I didn’t want to continue studying and I wanted to travel as much as I could.” He did not realize at that time how this vision for his life was to mirror what he would find in WordPress.</p>\n\n\n\n<p>He started using WordPress for a few sites in 2005. By 2007 he was using it for almost everything. He was struck by the magnitude and range of what the software could do, from a simple tool used to create a blog in the blink of an eye through to complex projects.</p>\n\n\n\n<p>His first problem-solving project was simple and saved data received through a contact form plugin. “To complete this project I discovered the Codex and I learned how easy and intuitive it is to create a plugin. I had fallen in love with WordPress.”</p>\n\n\n\n<blockquote class=\"wp-block-quote\"><p>I was truly amazed by how I could learn from others.</p></blockquote>\n\n\n\n<p>As he explored the options with the software, Juan was unsure of how intellectual property worked and wanted to be respectful of other people’s work. “I didn’t understand open source yet, and I wasn’t sure if I was stealing from others. That was my first interaction with GPL and open source. I was truly amazed by how I could learn from others and improve things created by others or by myself.”</p>\n\n\n\n<p>He realized: “WordPress was the way to go if I wanted to pursue a dream of traveling, skipping winter, and working at the same time; what we now call a digital nomad. I already knew how to work remotely, I could work for companies located anywhere, as long as they could communicate in English or Spanish.”</p>\n\n\n\n<p>Juan started his own web agency, where he provided services to small and medium-sized companies abroad in the USA, UK, and Australia. He built his reputation and developed strong relationships in WordPress. “The experience couldn’t be better. I was learning, having fun, making a living out of it, and at the same time exploring the world.”</p>\n\n\n\n<p>In mid-2012, he discovered the full power of the WordPress community firsthand. In his spare time he started developing themes and from all he heard, wanted to attend a major event with lots of others in WordPress, a WordCamp. He took the plunge and booked for WordCamp in Edinburgh, in the UK. He said: “I got to meet many super talented people, and the atmosphere of the event was awesome. A place where competitors were also colleagues. Seeing the humility of somebody like Mike Little, the co-founder of WordPress, was amazing.”</p>\n\n\n\n<p>He added: “While there, unconsciously, I started dreaming of holding something like that in Argentina &#8211; the joy of hosting the WordPress community in my home country.”</p>\n\n\n\n<p>Back home, while browsing the Codex, he happened to see that WordPress was turning 10. A lot of meetups were going to be organized worldwide to celebrate the birthday. But there was nothing organized in Argentina. This was a catalyst for starting a local meetup. Together with a colleague, he&nbsp; organized an Argentinian 10th birthday meetup. </p>\n\n\n\n<p>More than 20 people showed up. “There was a common denominator. We all loved WordPress, it was part of our day-to-day life. We wanted to share experiences, make new friends and continue growing from what we could learn from others. That day we were a group of people with shared interests. That’s the simplest way to define a community, isn’t it?” This early meetup led to the formation of what is now called <a href=\"http://wpargentina.org/\">WordPress Argentina</a>.</p>\n\n\n\n<p>In his desire to skip winters and do more traveling, his next adventure was to take him to visit family working in the US and attend one of the biggest WordCamps in the world in San Francisco. His interest kept growing and he traveled across Europe to be part of the first edition of WordCamp Europe in the Netherlands in 2013.</p>\n\n\n\n<p>He said: “There’s almost nothing I could write to fully express what you experience in such events. They are the main WordPress events worldwide. The best part: I made a lot of good friends from many different places. I’m glad I have more excuses to continue traveling.”</p>\n\n\n\n<p>Once again in Argentina, our organization started growing thanks to the energy of the whole group, we started hosting formal meetups. In May 2015, we crowned all these efforts with a new <a href=\"https://buenosaires.wordcamp.org/2015/\">WordCamp in Buenos Aires</a>, Argentina.</p>\n\n\n\n<img width=\"1024\" height=\"683\" src=\"https://i0.wp.com/wordpress.org/news/files/2022/03/Juanfra-WCBA15-51.jpg?resize=1024%2C683&ssl=1\" alt=\"Juan speaking at WordCamp Buenos Aires\" class=\"wp-image-12528\" />\n\n\n\n<p>“Organizing such an event in my home country with many of the contributors I had met from the very first meetup was an experience I will always keep with me.”</p>\n\n\n\n<p>Juan believes one of his biggest contributions to open source was as part of being able to expand the community in Argentina and to share this with other Latin American and Spanish speaking countries. He also contributes as a volunteer translator in the Polyglots Team, to the Make WordPress Support team, and contributes to code blocks and Gutenberg. “I am really excited about seeing the future of Gutenberg as it is the future of WordPress.”</p>\n\n\n\n<p>Throughout his time contributing, Juan believes in helping to set the foundations and encouraging others to give their time and talents. He is keen to share that contributing does not have to be the same all the time and that you can have breaks and focus on one area in a particular period too. He gives the example of how in his spare time he watches Trac, where tickets about the software are logged, and looks where he might be able to help or think of solutions.</p>\n\n\n\n<p>He said: “Anytime I find I can contribute to or make improvements in code-related areas, I will do as it is important to keep giving to the community. I enjoy crawling over meta, trac, GitHub and the different places that are requesting help. There is always somewhere you can help. At the moment, my focus is code and translations. I always try to save time to help these two areas. It is like you give and you get, you learn things. You meet amazing people and opportunities arrive.”</p>\n\n\n\n<h2>Finding your path in WordPress</h2>\n\n\n\n<img width=\"768\" height=\"1024\" src=\"https://i1.wp.com/wordpress.org/news/files/2022/03/Juanfra_1505.jpeg?resize=768%2C1024&ssl=1\" alt=\"Juan sat in a street cafe surrounded by parked motorcycles\" class=\"wp-image-12527\" />\n\n\n\n<p>“Life is about experiences, it is about the people you surround yourself with and trying to do what you love. What you can find in an open source project like WordPress is an environment full of people who work with a tool they love. An environment that is ready to help and to give advice. Follow what makes you happy, try to be surrounded by people who make you better, try to empower others, try to give back. Try. Make your own path.”</p>\n\n\n\n<h2 id=\"share-the-stories\">Share the stories</h2>\n\n\n\n<p>Help share these stories of open source contributors and continue to grow the community. Meet more WordPressers in the <a href=\"https://wordpress.org/news/category/newsletter/interviews/\">People of WordPress series</a>.</p>\n\n\n\n<h2 id=\"contributors-to-this-feature\">Contributors to this feature</h2>\n\n\n\n<p>Thank you to Juan Aldasoro (<a href=\"https://profiles.wordpress.org/juanfra/\" class=\"mention\"><span class=\"mentions-prefix\">@</span>juanfra</a>) for sharing his story.&nbsp;</p>\n\n\n\n<p>Interviews and feature by Abha Thakor (<a href=\"https://profiles.wordpress.org/webcommsat/\" class=\"mention\"><span class=\"mentions-prefix\">@</span>webcommsat</a>) and Surendra Thakor (<a href=\"https://profiles.wordpress.org/sthakor/\" class=\"mention\"><span class=\"mentions-prefix\">@</span>sthakor</a>). Reviews by Mary Baum (<a href=\"https://profiles.wordpress.org/marybaum/\" class=\"mention\"><span class=\"mentions-prefix\">@</span>marybaum</a>), Chloe Bringmann (<a href=\"https://profiles.wordpress.org/cbringmann/\" class=\"mention\"><span class=\"mentions-prefix\">@</span>cbringmann</a>), Meher Bala (<a href=\"https://profiles.wordpress.org/meher/\" class=\"mention\"><span class=\"mentions-prefix\">@</span>meher</a>), Anjana Vasan (<a href=\"https://profiles.wordpress.org/anjanavasan/\" class=\"mention\"><span class=\"mentions-prefix\">@</span>anjanavasan</a>) and Yvette Sonneveld (<a href=\"https://profiles.wordpress.org/yvettesonneveld/\" class=\"mention\"><span class=\"mentions-prefix\">@</span>yvettesonneveld</a>).</p>\n\n\n\n<p><em>Thanks to Josepha Haden Chomphosy&nbsp;(<a href=\"https://profiles.wordpress.org/chanthaboune/\" class=\"mention\"><span class=\"mentions-prefix\">@</span>chanthaboune</a>) and Topher DeRosia (<a href=\"https://profiles.wordpress.org/topher1kenobe/\" class=\"mention\"><span class=\"mentions-prefix\">@</span>topher1kenobe</a>) and others for their support&nbsp;</em>of this initiative.</p>\n\n\n\n<div class=\"wp-block-media-text is-stacked-on-mobile is-vertically-aligned-center\"><img width=\"180\" height=\"135\" src=\"https://i1.wp.com/wordpress.org/news/files/2020/03/heropress_logo_180.png?resize=180%2C135&ssl=1\" alt=\"HeroPress logo\" class=\"wp-image-8409 size-full\" /><div class=\"wp-block-media-text__content\">\n<p class=\"has-small-font-size\"><em>This People of WordPress feature is inspired by an essay originally published on </em><a href=\"https://heropress.com/\"><em>HeroPress.com</em></a><em>, a community initiative created by Topher DeRosia. It highlights people in the WordPress community who have overcome barriers and whose stories might otherwise go unheard. </em>#HeroPress </p>\n</div></div>\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}s:7:\"pubDate\";a:1:{i:0;a:5:{s:4:\"data\";s:31:\"Thu, 31 Mar 2022 21:42:10 +0000\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}}s:32:\"http://purl.org/dc/elements/1.1/\";a:1:{s:7:\"creator\";a:1:{i:0;a:5:{s:4:\"data\";s:28:\"webcommsat AbhaNonStopNewsUK\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}}}}i:16;a:6:{s:4:\"data\";s:13:\"\n	\n	\n	\n	\n	\n	\n\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";s:5:\"child\";a:2:{s:0:\"\";a:5:{s:5:\"title\";a:1:{i:0;a:5:{s:4:\"data\";s:75:\"Post Status: WooCommerce Function of the Week: get_european_union_countries\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}s:4:\"guid\";a:1:{i:0;a:5:{s:4:\"data\";s:31:\"https://poststatus.com/?p=94980\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}s:4:\"link\";a:1:{i:0;a:5:{s:4:\"data\";s:85:\"https://poststatus.com/woocommerce-function-of-the-week-get_european_union_countries/\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}s:11:\"description\";a:1:{i:0;a:5:{s:4:\"data\";s:11493:\"<p class=\"has-theme-palette-8-background-color has-background\">You can use <code>get_european_union_countries()</code> for currency switching, to display conditional notices, content, or fields. Basically, whenever there is a country dropdown, <code>get_european_union_countries()</code> may be what you need.</p>\n\n\n\n<p class=\"has-drop-cap\">Before we dive into WooCommerce again, here\'s a little historical context for the function we\'re going to look at this week: <code>get_european_union_countries</code>.</p>\n\n\n\n<p>In 1957, Belgium, France, Italy, Luxembourg, the Netherlands, and West Germany signed the Treaty of Rome, which created the European Economic Community. The European Union was formally established with the Maastricht Treaty on 1 November 1993. There are now 27 EU members, yet <em>the list is always subject to change</em>. With Brexit, the United Kingdom left the EU. There is talk currently about Ukraine joining.</p>\n\n\n\n<p>Thankfully, WooCommerce developers coded a function called <code>get_european_union_countries()</code>, which returns an array of &#8230; countries in the EU! (Did you see that coming?) Once again, we can rely on a lazy WooCommerce function and stop worrying about who is and who is not in the EU.</p>\n\n\n\n<p>But why would you ever need to use <code>get_european_union_countries()</code>? Let\'s look at its syntax, its arguments, and some possible uses. </p>\n\n\n\n<span id=\"more-94980\"></span>\n\n\n\n<h2 id=\"h-function-syntax\">Function Syntax</h2>\n\n\n\n<p>You can find the <code>european_union_countries()</code> function under <code>\\woocommerce\\includes\\class-wc-countries.php</code>:</p>\n\n\n\n<pre class=\"wp-block-code\"><code>/**\n * Gets an array of countries in the EU.\n *\n * @param  string $type Type of countries to retrieve. Blank for EU member countries. eu_vat for EU VAT countries.\n * @return string&#91;]\n */\npublic function get_european_union_countries( $type = \'\' ) {\n	$countries = array( \'AT\', \'BE\', \'BG\', \'CY\', \'CZ\', \'DE\', \'DK\', \'EE\', \'ES\', \'FI\', \'FR\', \'GR\', \'HR\', \'HU\', \'IE\', \'IT\', \'LT\', \'LU\', \'LV\', \'MT\', \'NL\', \'PL\', \'PT\', \'RO\', \'SE\', \'SI\', \'SK\' );\n\n	if ( \'eu_vat\' === $type ) {\n		$countries&#91;] = \'MC\';\n	}\n\n	return apply_filters( \'woocommerce_european_union_countries\', $countries, $type );\n}</code></pre>\n\n\n\n<p>There\'s nothing very complex here — a hard-coded list of EU member country codes, and the function returns this array. Simple!</p>\n\n\n\n<p>A couple of important notes:</p>\n\n\n\n<ul><li>The function accepts a parameter, <code>$type</code>. This can either be left blank or set to <code>\"eu_vat\"</code>, in which case <code>MC</code> would also be included in the returned list of countries for Monaco, which is not a EU member, but it <em>is</em> subject to European VAT/tax.</li><li>The function provides a filter hook, <code>woocommerce_european_union_countries</code>, which you can use in your customization should you need to remove or add countries to the list.  </li></ul>\n\n\n\n<p>Let\'s imagine you need to get a list of European countries — you\'d notice many are not in the list as they don\'t belong to the EU. This includes Albania, Andorra, Armenia, Azerbaijan, Belarus, Bosnia and Herzegovina, Georgia, Iceland, Kosovo, Liechtenstein, Moldova, Montenegro, North Macedonia, Norway, Russia, San Marino, Serbia, Switzerland, Turkey, Ukraine, United Kingdom, and Vatican City. With the <code>woocommerce_european_union_countries</code> filter you can add them and return the full list of European countries.</p>\n\n\n\n<p>Are you wondering if this is a political history post or a WooCommerce development tutorial? I don\'t blame you. Let\'s look at the case studies I promised to show how <code>get_european_union_countries()</code> might be used in a real-world scenario.</p>\n\n\n\n<h2>Case Studies</h2>\n\n\n\n<p>Why is <code>get_european_union_countries()</code> useful to WooCommerce devleopers? </p>\n\n\n\n<p>Well, first of all it\'s important to understand why WooCommerce has this function and what it uses it for.</p>\n\n\n\n<p>By doing a quick file search through the WooCommerce plugin, we can see <code>get_european_union_countries()</code> is called at least 3 times:</p>\n\n\n\n<ol><li>The <code>get_vat_countries()</code> function merges the <code>get_european_union_countries()</code> array with another manual array of countries that use &#8220;VAT.&#8221; This is used in the WooCommerce back end and front end to call taxes either VAT or TAX, based on the country code.</li><li><code>get_automated_support_countries()</code> merges the list of EU countries with &#8216;US\', &#8216;CA\', and &#8216;AU\' in order to return the list of countries that support automated tax calculations within WooCommerce.</li><li><code>get_note()</code> uses <code>get_european_union_countries()</code> to check if your store\'s country belongs to the EU. If it is and the WooCommerce AvaTax plugin is active, a banner ad is displayed to ask the store manager to install the EU VAT Number extension.</li></ol>\n\n\n\n<p>When I first looked into <code>get_european_union_countries()</code>, I was expecting it to be used more extensively within WooCommerce itself, but that\'s it. It\'s still useful for developers of course because we can come up with additional ways to use the function and save on development time.</p>\n\n\n\n<p>You can use <code>get_european_union_countries()</code> for currency switching, to display conditional notices, content, or fields. Basically, whenever there is a country dropdown, <code>get_european_union_countries()</code> may be what you need.</p>\n\n\n\n<p>Let\'s analyze two more detailed scenarios for using this function.</p>\n\n\n\n<h3>Set Currency to EUR if the Order Billing Country is in the EU</h3>\n\n\n\n<p>I issue a lot of manual orders on Business Bloomer, where my main currency is USD, like most of the WordPress ecosystem.</p>\n\n\n\n<p>While that is a great currency to sell memberships, plugins, and online courses, EUR is the currency I actually use myself.  If I\'m on the receiving end of transactions form<strong> countries within the EU where EUR is the main currency</strong>, I pay lower fees, have greater trust, and my PayPal/Stripe accounts are filled with euros, so I pay no conversion fees. Naturally I want my customers to at least have the option to pay in EUR!</p>\n\n\n\n<p>The way I coded this is fairly simple — this is straight out of my own <code>functions.php</code>:</p>\n\n\n\n<pre class=\"wp-block-code\"><code>/**\n * @snippet       Set new manual order currency | WooCommerce Admin\n * @how-to        Get CustomizeWoo.com FREE\n * @author        Rodolfo Melogli\n * @compatible    WooCommerce 6\n * @donate $9     https://businessbloomer.com/bloomer-armada/\n */\n \nadd_action( \'woocommerce_new_order\', \'bbloomer_update_order_currency_on_creation\', 9999, 2 );\n\nfunction bbloomer_update_order_currency_on_creation( $order_id, $order ){\n    if ( $order && $order-&gt;is_created_via( \'admin\' ) ) { \n		if ( get_post_meta( $order_id, \'_billing_country\', true ) && in_array( get_post_meta( $order_id, \'_billing_country\', true ), WC()-&gt;countries-&gt;get_european_union_countries( \'eu_vat\' ) ) ) {	\n			$order-&gt;set_currency( \'EUR\' );\n			$order-&gt;save();\n		}\n	}\n}</code></pre>\n\n\n\n<p>W<strong>hat It Does:</strong> When I create and save a new order from the WooCommerce backend and the billing country belongs to the EU, the order currency is set to EUR by default.</p>\n\n\n\n<p>There is another piece to this. If the order is manually set to the status of <em>pending</em> and the customer still needs to pay online, I also need to make EUR the default currency on the payment screen. Here\'s how I do that:</p>\n\n\n\n<pre class=\"wp-block-code\"><code>/**\n * @snippet       Set currency | WooCommerce Order Pay page\n * @how-to        Get CustomizeWoo.com FREE\n * @author        Rodolfo Melogli\n * @compatible    WooCommerce 6\n * @donate $9     https://businessbloomer.com/bloomer-armada/\n */\n \nadd_filter( \'woocommerce_currency\', \'bbloomer_switch_currency\' );\n\nfunction bbloomer_switch_currency( $currency ) {\n	if ( is_wc_endpoint_url( \'order-pay\' ) && in_array( WC()-&gt;customer-&gt;get_billing_country(), WC()-&gt;countries-&gt;get_european_union_countries( \'eu_vat\' ) ) ) {\n		return \'EUR\';\n	}\n	return $currency;\n}</code></pre>\n\n\n\n<p>In this way I\'ve created a multi-currency setup <em>without any plugins!</em> Cool, ha?!</p>\n\n\n\n<h2>Show Conditional Content if the Order Billing Country is in the EU</h2>\n\n\n\n<p>I use <code>get_european_union_countries()</code> in my PDF invoices as well. </p>\n\n\n\n<ol><li>If the billing country is Italy, I need to show certain messages in Italian by law.</li><li>On the other hand, if the <strong>billing country belongs to the EU </strong>array, I need to display a notice called &#8220;Reverse Charge.&#8221; (This is for intra-EU transactions when the VAT is recorded by the buyer instead of the seller.)</li><li>Otherwise, the function will show a message for extra-EU transactions.</li></ol>\n\n\n\n<p>Here\'s my code:</p>\n\n\n\n<pre class=\"wp-block-code\"><code>/**\n * @snippet       Display VAT notices | WooCommerce PDF Invoices & Packing slips\n * @how-to        Get CustomizeWoo.com FREE\n * @author        Rodolfo Melogli\n * @compatible    WooCommerce 6\n * @donate $9     https://businessbloomer.com/bloomer-armada/\n */\n\nadd_action( \'wpo_wcpdf_after_order_details\', \'bbloomer_invoice_dpr_info\', 9999, 2 );\n\nfunction bbloomer_invoice_dpr_info( $template_type, $order ) {\n	if ( $order-&gt;get_billing_country() == \"IT\" ) {\n		?&gt;\n		&lt;?php if ( $order-&gt;get_total() &gt; 77.47 ) echo \'&lt;p&gt;(*) Imposta di bollo assolta ai sensi dell\\\'art. 13 della Tariffa allegata al DPR 26.10.72, n. 642&lt;/p&gt;\'; ?&gt;\n		&lt;p&gt;Operazione fuori campo IVA ai sensi dell\'art. 1, commi 54-89, L. 23/12/2014, n. 190&lt;/p&gt;\n		&lt;p&gt;Prestazione non soggetta a ritenuta d\'acconto ai sensi del comma 5.2 del Provvedimento Agenzia delle entrate del 22.12.2011 n. 185820&lt;/p&gt;		\n		&lt;?php\n	} elseif ( in_array( $order-&gt;get_billing_country(), WC()-&gt;countries-&gt;get_european_union_countries( \'eu_vat\' ) ) && ! empty( get_post_meta( $order-&gt;get_id(), \'_billing_vat_number_eu\', true ) ) ) {\n		// Intra EU Service\n		?&gt;\n		&lt;p&gt;Invoice subject to Reverse Charge rule in the country of receipt according to Italian law art. 7-TER, D.P.R. n. 633/1972&lt;/p&gt;	\n		&lt;?php\n	} else {\n		// Extra EU Service\n		// print_r($order);\n		?&gt;\n		&lt;?php /* if ( $order-&gt;get_total() &gt; 77.47 ) echo \'&lt;p&gt;(*) Cost of &euro;2 Italian stamp duty included in payment according to the Tariffa attachment, art. 13, DPR 26.10.72, n. 642&lt;/p&gt;\'; */ ?&gt;\n		&lt;p&gt;Invoice exempt from VAT/TAX according to Italian law art. 7, D.P.R. n. 633/1972&lt;/p&gt;		\n		&lt;?php\n	}\n}</code></pre>\n\n\n\n<p>Wherever you have access to <code>$order-&gt;get_billing_country()</code>, you may use <code>get_european_union_countries()</code> for conditional content. I\'ve seen an example for using it in PDF invoices. It could also apply to the &#8220;Thank You&#8221; screen, customer account pages, order admin pages, and more.</p>\n\n\n\n<p class=\"has-theme-palette-8-background-color has-background\"><strong>We hope this guide has been educational and useful for you!</strong> <a href=\"https://poststatus.com/planet/feed/#comment\">Tell us in the comments</a> how you\'re using <code>get_european_union_countries()</code> and dealing with multi-currency situations in WooCommerce in your own code. <img src=\"https://s.w.org/images/core/emoji/13.1.0/72x72/1f4b6.png\" alt=\"💶\" class=\"wp-smiley\" /></p>\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}s:7:\"pubDate\";a:1:{i:0;a:5:{s:4:\"data\";s:31:\"Thu, 31 Mar 2022 16:00:08 +0000\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}}s:32:\"http://purl.org/dc/elements/1.1/\";a:1:{s:7:\"creator\";a:1:{i:0;a:5:{s:4:\"data\";s:15:\"Rodolfo Melogli\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}}}}i:17;a:6:{s:4:\"data\";s:13:\"\n	\n	\n	\n	\n	\n	\n\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";s:5:\"child\";a:2:{s:0:\"\";a:5:{s:5:\"title\";a:1:{i:0;a:5:{s:4:\"data\";s:102:\"WPTavern: Gutenberg 12.9 Adds Block Locking UI, Automatic Pattern Registration, and Full Theme Exports\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}s:4:\"guid\";a:1:{i:0;a:5:{s:4:\"data\";s:30:\"https://wptavern.com/?p=132214\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}s:4:\"link\";a:1:{i:0;a:5:{s:4:\"data\";s:111:\"https://wptavern.com/gutenberg-12-9-adds-block-locking-ui-automatic-pattern-registration-and-full-theme-exports\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}s:11:\"description\";a:1:{i:0;a:5:{s:4:\"data\";s:10266:\"<p class=\"has-drop-cap\">Gutenberg 12.9 landed in the WordPress.org plugin directory today, and it is a beefy release, packed with a little something for everyone. Even after tinkering with new features over the last few days, I have yet to explore everything as much as I would like. Given the practical limitation of time, I will not be able to dive into everything in this post, but I will attempt to introduce you all to some of the highlights.</p>\n\n\n\n<p>The following are some selected items that I was unable to dive into, but I still encourage readers to check out:</p>\n\n\n\n<ul><li>The selected <a href=\"https://github.com/WordPress/gutenberg/pull/39386\">color&#8217;s name now appears</a> in the color picker.</li><li>Users can now <a href=\"https://github.com/WordPress/gutenberg/pull/39209\">choose from a suggested list</a> of date formats or add a custom one for the Post Date block. These are internationalized, so the suggestions will be locale-specific.</li><li>Themes can add blocks to a <a href=\"https://github.com/WordPress/gutenberg/pull/38806\">No Results container block</a> when a Query returns no posts.</li><li>The Tag Cloud block now has <a href=\"https://github.com/WordPress/gutenberg/pull/37311\">minimum and maximum size controls</a>.</li><li>The Separator block <a href=\"https://github.com/WordPress/gutenberg/pull/38428\">supports the newer color control</a>, allowing users to select transparent colors.</li></ul>\n\n\n\n<h2>Block Locking UI</h2>\n\n\n\n<img />Customizing a locked block.\n\n\n\n<p>Gutenberg 12.9 introduces a new <a href=\"https://github.com/WordPress/gutenberg/pull/39183\">UI for locking blocks</a>. Under the &#8220;more options&#8221; dropdown in the toolbar, users can select the lock option, which will bring up a screen with two options:</p>\n\n\n\n<ul><li><strong>Disable movement:</strong> Disallows moving the block itself. However, sibling blocks can be moved around it.</li><li><strong>Prevent removal:</strong> Prevents the block from being deleted.</li></ul>\n\n\n\n<p>Andrei Draganescu noted the following in the <a href=\"https://make.wordpress.org/core/2022/03/30/whats-new-in-gutenberg-12-9-30-march/\">12.9 announcement post</a>:</p>\n\n\n\n<blockquote class=\"wp-block-quote\"><p>When a block is locked, users are either unable to move it, remove it, or both. This is particularly useful with site level blocks like Post Content which many themes will want to lock down.</p></blockquote>\n\n\n\n<p>However, that definition does not entirely explain block-level locking. There is a caveat: this new UI hands end-users the key to the lock. Technically, they already had this capability via the code editor, but it is now available through the interface.</p>\n\n\n\n<p>From a theme dev perspective, block-level locking merely requires additional steps of the user to move and/or remove blocks. It is not a &#8220;forced&#8221; or &#8220;permanent&#8221; lock. It is a welcome feature, but themers should understand its limits and that this new UI offers more power to users, not less.</p>\n\n\n\n<p><strong>Update:</strong> there is a <a href=\"https://github.com/WordPress/gutenberg/pull/39566\">hook for site builders to overwrite this</a>.  See <a href=\"https://wptavern.com/gutenberg-12-9-adds-block-locking-ui-automatic-pattern-registration-and-full-theme-exports#comment-421351\">more in the comments</a>.</p>\n\n\n\n<h2>Block Gap Support for Galleries…<em>Sort Of</em></h2>\n\n\n\n<img />Block spacing for the Gallery block.\n\n\n\n<p>One of the features I was most excited about with this release was the addition of support for <a href=\"https://github.com/WordPress/gutenberg/pull/38164\">spacing between Gallery images</a>. Theme authors have relied on specialized block styles to give users choices, usually limited to default and a &#8220;no gap&#8221; options. The latter would remove any spacing between the images.</p>\n\n\n\n<p>Unfortunately, the feature is broken in 12.9 when users manually set a gap. Checking the source code, it is outputting an <code>Array</code> instead of valid CSS. On the front end, the following warning displays:</p>\n\n\n\n<pre class=\"wp-block-code\"><code>Warning: preg_match() expects parameter 2 to be string, array given in ...wp-content/plugins/gutenberg/build/block-library/blocks/gallery.php on line 51</code></pre>\n\n\n\n<p>I am sure this will be corrected in 12.9.1. Until then, I suggest not using the &#8220;Block Spacing&#8221; control.</p>\n\n\n\n<p><strong>Theme author warning:</strong> This is a breaking change for themes that target the <code>--gallery-block--gutter-size</code> to control the default gap for galleries. This previously-reliable CSS custom property no longer exists in the code. It is unclear why this variable was removed altogether, and there was no mention of it in the ticket.</p>\n\n\n\n<p>A new <code>--wp--style--unstable-gallery-gap</code> variable seems to do a similar job. However, as the <code>unstable</code> part of its name suggests, it may not always be around. It is also defined on the <code>.wp-container-*</code> class instead of the gallery itself. I have yet to do enough CSS testing to figure out how to overwrite it for the default gap. If anyone has a solution, please post it in the comments for others.</p>\n\n\n\n<h2>Children Collapsed by Default in List View</h2>\n\n\n\n<img />Opening a collapsed set of nested blocks in the list view.\n\n\n\n<p>I have often shied away from the list view in the editor for most real-world scenarios, at least for pages with many nested blocks. With every level open by default, it was a bit of a nightmare to browse through and locate a specific block. It was easier to take my chances clicking around in the content canvas.</p>\n\n\n\n<p>However, the latest Gutenberg release may just change my usage of it. Version 12.9 <a href=\"https://github.com/WordPress/gutenberg/pull/39611\">collapses all child blocks by default</a>.</p>\n\n\n\n<h2>Automatic Pattern Registration for Themes</h2>\n\n\n\n<p>Theme authors can now let Gutenberg <a href=\"https://github.com/WordPress/gutenberg/pull/36751\">handle pattern registration for them</a>. They only need to follow a few rules:</p>\n\n\n\n<ul><li>Add block patterns inside PHP files in a <code>/patterns</code> folder.</li><li>Add pattern data to the file header.</li><li>Add pattern content, of course.</li></ul>\n\n\n\n<p>Individual pattern files should look like the following:</p>\n\n\n\n<pre class=\"wp-block-code\"><code>&lt;?php\n/**\n * Title: A Pattern Title\n * Slug: namespace/slug\n * Description: A human-friendly description.\n * Viewport Width: 1024\n * Categories: comma, separated, values\n * Keywords: comma, separated, values\n * Block Types: comma, separated, values\n * Inserter: yes|no\n */\n ?&gt;\n &lt;!-- some-block-content /--&gt;</code></pre>\n\n\n\n<p>Only the <code>Title</code> and <code>Slug</code> header fields are required. Each option matches a <a href=\"https://developer.wordpress.org/reference/functions/register_block_pattern/\"><code>register_block_pattern()</code> function argument</a>.</p>\n\n\n\n<p>Theme authors who want to use this feature now but provide backward compatibility with WordPress 5.9 can check for the existence of the <code>gutenberg_register_theme_block_patterns()</code> function. That is the function name for the moment, at least.</p>\n\n\n\n<p>This change further builds on top of the existing standards for block themes. Authors now have clear-cut guidelines on registering most features via standard files and folders:</p>\n\n\n\n<ul><li><code>/parts</code> &#8211; Block template parts</li><li><code>/patterns</code> &#8211; Block patterns</li><li><code>/styles</code> &#8211; Global style variations</li><li><code>/templates</code> &#8211; Block templates</li><li><code>theme.json</code> &#8211; Global settings and styles</li></ul>\n\n\n\n<p>Aside from custom block styles and variations (not to be confused with global style variations), nearly everything is covered. This well-rounded set lowers the barrier to entry for future theme authors. Even seasoned developers should appreciate the simplicity of what to name things and where to put them. It is one less thing to worry about. It will also continue simplifying the WordPress.org theme review system.</p>\n\n\n\n<h2>Theme Exporting and Template Building</h2>\n\n\n\n<p>Speaking of lowering barriers, creators can now build an entire theme from the site editor. Well, assuming they start from an existing block theme.</p>\n\n\n\n<p>Gutenberg 12.9 introduces two vital features to the site-building process. The first allows users to <a href=\"https://github.com/WordPress/gutenberg/pull/39202\">export a copy of their active theme</a> directly from the editor:</p>\n\n\n\n<img />Exporting the active theme with customizations.\n\n\n\n<p>The downloaded ZIP file from this export is a fully-functioning theme. It includes all user customizations alongside every file that already exists in the original.</p>\n\n\n\n<p>There are still a few things that are not yet possible from the editor, and these will need to be manually adjusted before public release. The theme name and other data in <code>style.css</code> will remain the same as the original theme. There is also no method for snagging a screenshot of the customized version and bundling it in the ZIP.</p>\n\n\n\n<p>This is a leap forward for democratizing design, but other flows will need to be considered. Users should be able to export as a child theme with only their customizations or even as a <code>*.json</code> file (global style variation).</p>\n\n\n\n<p>But, there is a more immediate and practical use case. Users can download their customized themes and upload them to another site.</p>\n\n\n\n<p>The second crucial update for development within the site editor is <a href=\"https://github.com/WordPress/gutenberg/pull/39353\">support for more templates</a>. Users can now create the following from the templates management panel in addition to the existing ones;</p>\n\n\n\n<ul><li>Author</li><li>Category</li><li>Date</li><li>Tag</li><li>Taxonomy</li></ul>\n\n\n\n<img />Adding a new Author template.\n\n\n\n<p>The new templates are welcome additions, but the template-creation feature still has limits. There is no way to create variations on those templates via the UI, such as <code>category-wordpress</code>, <code>taxonomy-genre</code>, or the dozens of other possibilities. However, it will happen one day.</p>\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}s:7:\"pubDate\";a:1:{i:0;a:5:{s:4:\"data\";s:31:\"Thu, 31 Mar 2022 03:38:57 +0000\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}}s:32:\"http://purl.org/dc/elements/1.1/\";a:1:{s:7:\"creator\";a:1:{i:0;a:5:{s:4:\"data\";s:14:\"Justin Tadlock\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}}}}i:18;a:6:{s:4:\"data\";s:13:\"\n	\n	\n	\n	\n	\n	\n\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";s:5:\"child\";a:2:{s:0:\"\";a:5:{s:5:\"title\";a:1:{i:0;a:5:{s:4:\"data\";s:76:\"Post Status: Post Status Excerpt (No. 52) — Improving Your Live Video Self\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}s:4:\"guid\";a:1:{i:0;a:5:{s:4:\"data\";s:31:\"https://poststatus.com/?p=94877\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}s:4:\"link\";a:1:{i:0;a:5:{s:4:\"data\";s:80:\"https://poststatus.com/post-status-excerpt-no-52-improving-your-live-video-self/\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}s:11:\"description\";a:1:{i:0;a:5:{s:4:\"data\";s:4689:\"<h2 id=\"more-important-than-being-responsive-is-setting-expectations-dave-rodenbaugh\">“Embrace Progress Over Perfection” — Roshanda Pratt</h2>\n\n\n\n<p class=\"has-drop-cap\">In this episode of Post Status Excerpt, David meets <strong>Roshanda Pratt</strong> and welcomes her to the WordPress community. Soon, Roshanda will be speaking at the upcoming <a href=\"https://wpcareersummit.com/\">WP Career Summit</a> on “<a href=\"https://wpcareersummit.com/roshanda-pratt/\">Secrets to Being on Camera in Live Video</a>.” Roshanda has been a television producer for a number of years and shares some tips to improve your image and confidence in video calls or at conferences and job interviews. </p>\n\n\n\n<p>If you want to stand out <em>and</em> express yourself professionally, you\'ll want to hear Roshanda\'s advice and attend <a href=\"https://wpcareersummit.com/roshanda-pratt/\">her WP Career Summit talk</a>.</p>\n\n\n\n<p><strong>Why This Is Important: </strong>Many companies in the WordPress space are distributed or have a remote workforce. This means they\'re likely to interview job candidates remotely too, via live video. </p>\n\n\n\n\n\n\n\n<p class=\"has-background\">Every week <strong><a href=\"https://poststatus.com/podcast/the-excerpt/\">Post Status Excerpt</a></strong> brings you insightful guests and timely conversations about WordPress, the WordPress community, and the WordPress business ecosystem. <img src=\"https://s.w.org/images/core/emoji/13.1.0/72x72/1f310.png\" alt=\"🌐\" class=\"wp-smiley\" /><br /><br />You can listen to <a href=\"https://poststatus.com/podcast/the-excerpt/\">past episodes</a> of <strong>The Excerpt</strong>, <a href=\"https://poststatus.com/category/post-status-podcasts/\">browse all our podcasts</a>, and don’t forget to subscribe on <a href=\"https://open.spotify.com/show/1m3xwXbe0MG5BzFVPtB0A7\">Spotify</a>, Amazon Music, <a href=\"https://podcasts.google.com/feed/aHR0cHM6Ly9mZWVkcy5zaW1wbGVjYXN0LmNvbS8ySkU5c2M4UA\">Google Podcasts</a>, <a href=\"https://itunes.apple.com/us/podcast/post-status-draft-wordpress/id976403008\">iTunes</a>, <a href=\"https://castro.fm/podcast/c53552c6-1ee0-4fc4-9de4-08ed6bf1ee4d\">Castro</a>, <a href=\"https://www.youtube.com/c/PostStatus\">YouTube</a>, <a href=\"http://www.stitcher.com/podcast/krogsgard/post-status-draft-wordpress-podcast\">Stitcher</a>, <a href=\"https://player.fm/series/wordpress-post-status-podcasts\">Player.fm</a>, <a href=\"https://pca.st/05rR\">Pocket Casts</a>, <a href=\"https://wordpress-post-status-draft-podcast.simplecast.com/\">Simplecast</a>, or by <a href=\"https://feeds.simplecast.com/2JE9sc8P\">RSS</a>. <img src=\"https://s.w.org/images/core/emoji/13.1.0/72x72/1f3a7.png\" alt=\"🎧\" class=\"wp-smiley\" /></p>\n\n\n\n<h3 id=\"h-mentioned-in-the-show\"><img src=\"https://s.w.org/images/core/emoji/13.1.0/72x72/1f517.png\" alt=\"🔗\" class=\"wp-smiley\" /> Mentioned in the show:</h3>\n\n\n\n<ul><li><a href=\"https://wpcareersummit.com/\">WP Career Summit</a></li><li><a href=\"http://www.therepnetwork.com\">REP NETWORK</a></li><li>Follow Roshanda on <a href=\"http://wwww.linkedin.com/roshandaepratt\">Linkedin</a>, <a href=\"https://www.instagram.com/therosholive/\">Instagram</a>, and <a href=\"https://twitter.com/therosholive\">Twitter</a>.</li><li><a href=\"https://twitter.com/dimensionmedia\" target=\"_blank\" rel=\"noreferrer noopener\">David Bisset</a> (Twitter)</li><li><a href=\"https://twitter.com/post_status\" target=\"_blank\" rel=\"noreferrer noopener\">Post Status</a> (Twitter)</li></ul>\n\n\n.kt-block-spacer-_138506-a0 .kt-divider{width:80%;}\n<div class=\"wp-block-kadence-spacer aligncenter kt-block-spacer-_138506-a0\"><div class=\"kt-block-spacer kt-block-spacer-halign-center\"><hr class=\"kt-divider\" /></div></div>\n\n\n\n<h3 id=\"sponsor\"><img src=\"https://s.w.org/images/core/emoji/13.1.0/72x72/1f64f.png\" alt=\"🙏\" class=\"wp-smiley\" /> Sponsor: <a href=\"https://poststatus.com/stellarwp\">StellarWP</a></h3>\n\n\n\n<p>We are a collective of WordPress innovators, empowering business owners and creators with plugins and tools to help them thrive. We build great plugins, but we don’t stop there; we continually challenge ourselves to keep innovating and improving.</p>\n\n\n\n<p>Our solutions include the most trusted names in WordPress, with more than 2.5 Million installs. Since 2021, we’ve grown to encompass seven brands and dozens of plugins.</p>\n\n\n\n<p>StellarWP is part of the Liquid Web family of brands.</p>\n\n\n.kt-block-spacer-_ad0578-69 .kt-divider{width:80%;}\n<div class=\"wp-block-kadence-spacer aligncenter kt-block-spacer-_ad0578-69\"><div class=\"kt-block-spacer kt-block-spacer-halign-center\"><hr class=\"kt-divider\" /></div></div>\n\n\n\n<h2 id=\"h-transcript\"><strong>Transcript</strong></h2>\n\n\n\n<p>(coming soon)</p>\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}s:7:\"pubDate\";a:1:{i:0;a:5:{s:4:\"data\";s:31:\"Wed, 30 Mar 2022 23:30:07 +0000\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}}s:32:\"http://purl.org/dc/elements/1.1/\";a:1:{s:7:\"creator\";a:1:{i:0;a:5:{s:4:\"data\";s:12:\"David Bisset\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}}}}i:19;a:6:{s:4:\"data\";s:13:\"\n	\n	\n	\n	\n	\n	\n\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";s:5:\"child\";a:2:{s:0:\"\";a:5:{s:5:\"title\";a:1:{i:0;a:5:{s:4:\"data\";s:79:\"WPTavern: Snow Monkey Editor Plugin Adds Custom Styles to WordPress Core Blocks\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}s:4:\"guid\";a:1:{i:0;a:5:{s:4:\"data\";s:30:\"https://wptavern.com/?p=132205\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}s:4:\"link\";a:1:{i:0;a:5:{s:4:\"data\";s:90:\"https://wptavern.com/snow-monkey-editor-plugin-adds-custom-styles-to-wordpress-core-blocks\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}s:11:\"description\";a:1:{i:0;a:5:{s:4:\"data\";s:3709:\"<p>In the early days after the block editor landed in WordPress, block collection plugins exploded on the scene and were quick to rack up hundreds of thousands of users. Plugins like <a href=\"https://wordpress.org/plugins/coblocks/\">CoBlocks</a>, <a href=\"https://wordpress.org/plugins/kadence-blocks/\">Kadence Blocks</a>, and <a href=\"https://wordpress.org/plugins/ultimate-addons-for-gutenberg/\">Ultimate Addons for Gutenberg</a> offer dozens of blocks in one package, focusing mostly on blocks not offered in core. WordPress.org&#8217;s Block Directory gave some incentive for creating single-block plugins, allowing users to search for and install them inside the block editor. </p>\n\n\n\n<p>As <a href=\"https://richtabor.com/a-new-era/\">block themes generally include less custom CSS than traditional themes</a>, some plugin developers are experimenting with applying interesting styles to WordPress&#8217; core blocks. <a href=\"https://wordpress.org/plugins/snow-monkey-editor/\">Snow Monkey Editor</a>, created by developer Takashi Kitajima, is one such plugin that doesn&#8217;t include any custom blocks. Instead, it extends the block editor to give unique styles to core blocks, giving them the appearance of custom blocks. </p>\n\n\n\n<p>For example, Snow Monkey Editor will take a simple paragraph and transform it into various alert styles, post-it, speech, etc. </p>\n\n\n\n<img />\n\n\n\n<p>In addition to paragraphs, the plugin has extra styles for image blocks, including different fluid shapes and shadowed.</p>\n\n\n\n<img />\n\n\n\n<p>The List block also includes several different pre-set styles to make lists more interesting.</p>\n\n\n\n<img />\n\n\n\n<p>The plugin puts a monkey icon inside the block toolbar that offers more formatting options for text, including background color, badge, font size, highlighter, letter spacing, line height, and text color.</p>\n\n\n\n<img />\n\n\n\n<p>Snow Monkey Editor also includes some utility and display settings for all blocks, including the following:  </p>\n\n\n\n<ul><li>Hide on smartphone size or tablet size or PC size. (Using media query)</li><li>Hide by user roles. (Using <code>render_block</code> filter hook. If it does not pass this filter, it is ignored)</li><li>Scroll animation</li><li>Publish date time settings</li><li>Unpublish date time settings</li><li>Edit lock by user roles. (Only administrators can set it)</li></ul>\n\n\n\n<p>These settings essentially allow editors to do things like disappear selected blocks on a set date, hide content depending on device display size, and lock content from being edited by different user roles. Some of these could be helpful when building websites for clients.</p>\n\n\n\n<p>The collection of styles for different blocks reminds me of the old days before the block editor when users would create similar formatted text using shortcodes. This new block-based approach is far less clunky and allows users to quickly preview the styles as they are working in the editor.</p>\n\n\n\n<p>The <a href=\"https://wordpress.org/plugins/snow-monkey-editor/\">Snow Monkey Editor</a> plugin is available on WordPress.org, and has more than 10,000 active installs. It can be used with any theme, as the styles are mostly subtle and harmonious. If the plugin is deactivated, the block styles revert to the default core styles. Takashi Kitajima has also created a <a href=\"https://wordpress.org/plugins/snow-monkey-blocks/\">Snow Monkey Blocks</a> plugin with ~3 dozen custom blocks, a <a href=\"https://wordpress.org/plugins/snow-monkey-forms/\">Snow Monkey Forms</a> plugin with 13 blocks, and a <a href=\"https://snow-monkey.2inc.org/\">Snow Monkey theme</a> for those who want more complimentary extensions designed to work with Snow Monkey Editor.</p>\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}s:7:\"pubDate\";a:1:{i:0;a:5:{s:4:\"data\";s:31:\"Wed, 30 Mar 2022 22:32:34 +0000\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}}s:32:\"http://purl.org/dc/elements/1.1/\";a:1:{s:7:\"creator\";a:1:{i:0;a:5:{s:4:\"data\";s:13:\"Sarah Gooding\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}}}}i:20;a:6:{s:4:\"data\";s:13:\"\n	\n	\n	\n	\n	\n	\n\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";s:5:\"child\";a:2:{s:0:\"\";a:5:{s:5:\"title\";a:1:{i:0;a:5:{s:4:\"data\";s:56:\"Post Status: This Week at WordPress.org (March 28, 2022)\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}s:4:\"guid\";a:1:{i:0;a:5:{s:4:\"data\";s:31:\"https://poststatus.com/?p=95192\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}s:4:\"link\";a:1:{i:0;a:5:{s:4:\"data\";s:64:\"https://poststatus.com/this-week-at-wordpress-org-march-28-2022/\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}s:11:\"description\";a:1:{i:0;a:5:{s:4:\"data\";s:9619:\"<p>Each week we are highlighting the news from WordPress.org that you don\'t want to miss.  If you or your company create products or services that use WordPress, we\'ve got the news you need to know. Be sure to share this resource with your product and project managers.</p>\n\n\n\n<h2 id=\"h-news\">News</h2>\n\n\n\n<ul><li><a href=\"https://make.wordpress.org/core/2022/03/30/wordpress-5-9-3-rc-1/\">WordPress 5.9.3 RC 1</a></li><li><a href=\"https://make.wordpress.org/core/2022/03/30/6-0-product-walk-through/\">6.0 Product Walk-Through</a></li><li><a href=\"https://make.wordpress.org/test/2022/03/31/fse-program-testing-call-13-authoring-an-author-template/\">FSE Program Testing Call #13: Authoring an Author Template</a></li><li><a href=\"https://wordpress.org/news/2022/03/people-of-wordpress-juanfra-aldasoro/\">People of WordPress: Juan Aldasoro</a></li><li><a href=\"https://wordpress.org/news/2022/03/get-creative-with-the-all-new-pattern-creator/\">Get Creative with the All-New Pattern Creator</a></li></ul>\n\n\n.kt-block-spacer-_a98156-c2 .kt-divider{width:80%;}\n<div class=\"wp-block-kadence-spacer aligncenter kt-block-spacer-_a98156-c2\"><div class=\"kt-block-spacer kt-block-spacer-halign-center\"><hr class=\"kt-divider\" /></div></div>\n\n\n\n<div class=\"wp-block-columns\">\n<div class=\"wp-block-column\">\n<h2 id=\"h-central\">Central</h2>\n\n\n\n<ul><li><a href=\"https://central.wordcamp.org/represent-your-community-join-the-wordcamp-asia-2023-team/\">Represent Your Community: Join the WordCamp Asia 2023 Team</a></li></ul>\n\n\n\n<h2 id=\"h-core\"><a href=\"https://make.wordpress.org/core\">Core</a> </h2>\n\n\n\n<ul><li><a href=\"https://make.wordpress.org/core/2022/03/30/whats-new-in-gutenberg-12-9-30-march/\">What’s new in Gutenberg 12.9? (30 March)</a></li><li><a href=\"https://make.wordpress.org/core/2022/03/28/enabling-webp-by-default/\">Enabling WebP by default</a></li><li><a href=\"https://make.wordpress.org/core/2022/03/23/migrating-wordpress-e2e-tests-to-playwright/\">Migrating WordPress E2E tests to Playwright</a><a href=\"https://make.wordpress.org/core/2022/03/07/the-performance-lab-plugin-has-been-released/\"></a><a href=\"https://make.wordpress.org/core/2022/03/07/a-week-in-core-march-7-2022/\"></a><a href=\"https://make.wordpress.org/core/2022/03/14/a-week-in-core-march-14-2022/\"></a></li></ul>\n\n\n\n<h2 id=\"h-community\"><a href=\"https://make.wordpress.org/community\">Community</a></h2>\n\n\n\n<ul><li><a href=\"https://make.wordpress.org/community/2022/03/03/2022-community-team-goals-summary/\"></a><a href=\"https://make.wordpress.org/community/2022/03/14/meetup-organizer-newsletter-march-2022/\">Meetup Organizer Newsletter: March 2022</a></li><li><a href=\"https://make.wordpress.org/community/2022/03/23/return-to-events-blue-sky-thinking/\">Return to In-Person Events: Blue Sky Thinking</a></li><li><a href=\"https://make.wordpress.org/community/2022/03/17/discussion-revisiting-in-person-regional-wordcamps/\">Discussion: Revisiting In-person Regional WordCamps</a></li></ul>\n\n\n\n<h2 id=\"h-design\">Design</h2>\n\n\n\n<ul><li><a href=\"https://make.wordpress.org/design/2022/03/28/design-share-mar-14-25/\">Design Share: Mar&nbsp;14–25</a></li></ul>\n\n\n\n<h2 id=\"h-docs\"><a href=\"https://make.wordpress.org/docs\">Docs</a>:</h2>\n\n\n\n<ul><li><a href=\"https://make.wordpress.org/docs/2022/03/23/working-on-wordpress-release-6-0-selecting-trac-tickets-for-devnotes/\"></a><a href=\"https://make.wordpress.org/docs/2022/03/28/onboarding-sessions-live/\">Onboarding sessions – live!</a></li></ul>\n\n\n\n<h3 id=\"h-support-articles\">Support Articles:</h3>\n\n\n\n<ul><li><a href=\"https://wordpress.org/support/article/submit-your-block-pattern-to-the-directory/\"></a><a href=\"https://wordpress.org/support/article/post-content-block/\">Post Content Block</a></li><li><a href=\"https://wordpress.org/support/article/submit-your-block-pattern-to-the-directory/\"></a><a href=\"https://wordpress.org/support/article/pinterest-embed/\">Pinterest Embed</a></li></ul>\n\n\n\n<h3 id=\"h-developer-articles\">Developer Articles:</h3>\n\n\n\n<ul><li><a href=\"https://developer.wordpress.org/block-editor/reference-guides/components/toggle-group-control-option-base/\">ToggleGroupControlOptionBase</a></li><li><a href=\"https://developer.wordpress.org/block-editor/reference-guides/components/toggle-group-control-option-icon/\">ToggleGroupControlOptionIcon</a></li></ul>\n\n\n\n<h2 id=\"h-hosting\">Hosting</h2>\n\n\n\n<ul><li><a href=\"https://make.wordpress.org/hosting/2022/03/30/wordpress-hosting-and-webp-support/\">WordPress Hosting and WebP support</a></li></ul>\n\n\n\n<h2 id=\"h-photos\">Photos</h2>\n\n\n\n<ul><li><a href=\"https://make.wordpress.org/photos/2022/03/23/announcement-photo-directory-team-reps-2022/\">Announcement: Photo Directory Team Reps 2022</a></li></ul>\n\n\n\n<h2 id=\"h-polyglots\">Polyglots</h2>\n\n\n\n<ul><li><a href=\"https://make.wordpress.org/polyglots/2022/03/22/polyglots-monthly-newsletter-march-2022/\">Polyglots Monthly Newsletter: March 2022</a></li></ul>\n</div>\n\n\n\n<div class=\"wp-block-column\">\n<h2 id=\"h-plugins\"><a href=\"https://make.wordpress.org/plugins\">Plugins</a></h2>\n\n\n\n<ul><li><a href=\"https://make.wordpress.org/updates/2022/02/22/plugin-review-team-21-february-2022/\"></a><a href=\"https://make.wordpress.org/updates/2022/02/28/plugin-review-team-update-28-feb-2022/\"></a><a href=\"https://make.wordpress.org/updates/2022/03/15/plugin-review-team-14-march-2022/\"></a><a href=\"https://make.wordpress.org/updates/2022/03/22/plugin-review-team-21-march-2022/\"></a><a href=\"https://make.wordpress.org/updates/2022/03/28/plugin-review-team-28-march-2022/\">Plugin Review Team: 28 March 2022</a></li></ul>\n\n\n\n<h2 id=\"h-project\"><a href=\"https://make.wordpress.org/project\">Project</a></h2>\n\n\n\n<ul><li><a href=\"https://make.wordpress.org/project/2022/03/16/proposal-to-remove-spam-dormant-five-for-the-future-pledges/\">Proposal to remove spam/dormant Five for the Future pledges</a></li></ul>\n\n\n\n<h2 id=\"h-themes\"><a href=\"https://make.wordpress.org/themes\">Themes</a></h2>\n\n\n\n<ul><li><a href=\"https://make.wordpress.org/updates/2022/03/29/themes-team-update-march-29-2022/\">Themes team update March 29, 2022</a><a href=\"https://make.wordpress.org/updates/2022/03/02/themes-team-update-march-02-2022/\"></a><a href=\"https://make.wordpress.org/updates/2022/03/15/themes-team-update-march-15-2022/\"></a></li></ul>\n\n\n\n<h2 id=\"h-training\"><a href=\"https://make.wordpress.org/training\">Training</a></h2>\n\n\n\n<ul><li><a href=\"https://make.wordpress.org/updates/2022/02/28/whats-new-on-learnwp-in-february-2022/\"></a><a href=\"https://make.wordpress.org/training/2022/03/03/march-2022-team-sprint/\">March 2022 Team Sprint</a></li><li><a href=\"https://make.wordpress.org/training/2022/01/31/faculty-program-structure-proposal/\">Faculty Program: Structure Proposal</a></li></ul>\n\n\n\n<h4 id=\"h-lesson-plans\">Lesson Plans</h4>\n\n\n\n<ul><li><a href=\"https://learn.wordpress.org/lesson-plan/how-to-add-and-remove-logo-and-site-icon-in-site-editor/\">How To Add and Remove Logo And Site Icon in Site Editor</a></li><li><a href=\"https://learn.wordpress.org/lesson-plan/how-to-use-and-contribute-to-the-wordpress-photo-directory-and-openverse/\">How to Use and Contribute to the WordPress Photo Directory and Openverse</a></li></ul>\n\n\n\n<h4 id=\"h-workshops\">Workshops</h4>\n\n\n\n<ul><li><a href=\"https://learn.wordpress.org/workshop/adding-a-site-tagline-to-block-themes/\"></a><a href=\"https://learn.wordpress.org/workshop/taking-advantage-of-query-loops/\">Taking Advantage of Query Loops</a></li><li><a href=\"https://learn.wordpress.org/workshop/adding-a-site-tagline-to-block-themes/\"></a><a href=\"https://learn.wordpress.org/workshop/using-plugin-favorites-on-wordpress-org/\">Using Plugin Favorites on WordPress.org</a></li></ul>\n\n\n\n<h4 id=\"h-social-learning-spaces\">Social Learning Spaces:</h4>\n\n\n\n<ul><li><a href=\"https://learn.wordpress.org/social-learning/\">Calendar</a></li></ul>\n\n\n\n<h2 id=\"h-support\">Support</h2>\n\n\n\n<ul><li><a href=\"https://make.wordpress.org/support/2022/03/health-check-troubleshooting-upcoming-release-of-version-1-5-0/\">Health Check & Troubleshooting – Upcoming release of version 1.5.0</a></li></ul>\n\n\n\n<h2 id=\"h-openverse\">Openverse</h2>\n\n\n\n<ul><li><a href=\"https://make.wordpress.org/openverse/2022/03/10/openverse-frontend-v3-1-1-release/\">Openverse Frontend v3.1.1 Release</a></li></ul>\n</div>\n</div>\n\n\n\n<div class=\"wp-block-spacer\"></div>\n\n\n\n<div class=\"wp-block-media-text alignwide is-stacked-on-mobile has-background\"><a href=\"https://poststatus.com/\"><img src=\"https://cdn.poststatus.com/wp-content/uploads/2021/09/vertical-post-status-logo-250.png\" alt=\"Post Status\" class=\"wp-image-85823 size-full\" /></a><div class=\"wp-block-media-text__content\">\n<p class=\"has-text-align-left has-normal-font-size\" id=\"h-get-ready-for-remote-work\">You — and <a href=\"https://poststatus.com/business-membership/\">your whole team</a> can <a href=\"https://poststatus.com/post-status-membership-club/\">Join Post Status</a> too!</p>\n\n\n\n<p class=\"has-text-align-left has-small-font-size\"><strong>Build your network. Learn with others. Find your next job — or your next hire.</strong> Read the <strong>Post Status</strong> <a href=\"https://poststatus.com/newsletter/\">newsletter</a>. <img src=\"https://s.w.org/images/core/emoji/13.1.0/72x72/2709.png\" alt=\"✉\" class=\"wp-smiley\" /> Listen to <a href=\"https://poststatus.com/podcasts/\">podcasts</a>. <img src=\"https://s.w.org/images/core/emoji/13.1.0/72x72/1f399.png\" alt=\"🎙\" class=\"wp-smiley\" /> Follow <a href=\"https://twitter.com/post_status/\">@Post_Status</a>. <img src=\"https://s.w.org/images/core/emoji/13.1.0/72x72/1f426.png\" alt=\"🐦\" class=\"wp-smiley\" /></p>\n</div></div>\n\n\n\n<div class=\"wp-block-spacer\"></div>\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}s:7:\"pubDate\";a:1:{i:0;a:5:{s:4:\"data\";s:31:\"Wed, 30 Mar 2022 14:32:00 +0000\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}}s:32:\"http://purl.org/dc/elements/1.1/\";a:1:{s:7:\"creator\";a:1:{i:0;a:5:{s:4:\"data\";s:12:\"David Bisset\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}}}}i:21;a:6:{s:4:\"data\";s:13:\"\n	\n	\n	\n	\n	\n	\n\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";s:5:\"child\";a:2:{s:0:\"\";a:5:{s:5:\"title\";a:1:{i:0;a:5:{s:4:\"data\";s:64:\"WPTavern: #20 – Oliver Sild on the State of WordPress Security\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}s:4:\"guid\";a:1:{i:0;a:5:{s:4:\"data\";s:48:\"https://wptavern.com/?post_type=podcast&p=131983\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}s:4:\"link\";a:1:{i:0;a:5:{s:4:\"data\";s:78:\"https://wptavern.com/podcast/20-oliver-sild-on-the-state-of-wordpress-security\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}s:11:\"description\";a:1:{i:0;a:5:{s:4:\"data\";s:62232:\"<p>On the podcast today we have <a href=\"https://twitter.com/OliverSild\">Oliver Sild</a>.</p>\n\n\n\n<p>Oliver has been working in the WordPress space for many years, and specifically with WordPress security, as one of the founders of Patchstack, formerly called WebARX.</p>\n\n\n\n<p>Patchstack is a product which is designed to help you identify plugin vulnerabilities in your WordPress sites.</p>\n\n\n\n<p>Over the past couple of years Patchstack has released an annual report about the state of WordPress security. The report for 2021 has just been released, and the podcast today is concerned with what they found out.</p>\n\n\n\n<p>We talk about why they produce this report, and who the intended audience is. What are the main takeaways in terms of the overall security of WordPress Core, plugins and themes.</p>\n\n\n\n<p>We then get into more specific details of what types of vulnerabilities and attacks seem to be prevalent in the WordPress space. Are there any trends which are useful to think about, and how WordPress security is managed by the community as a whole; are budgets and time typically allocated for prevention and restoration of websites?</p>\n\n\n\n<p>Towards the end we talk about how some people have pushed back on the usefulness of the report. They’ve questioned the motivations of security companies to write such reports and the use of the language which they contain. Do they paint more of a negative picture in order to drive sales of their commercial solutions?</p>\n\n\n\n<h2>Useful links.</h2>\n\n\n\n<p><a href=\"https://patchstack.com/whitepaper/the-state-of-wordpress-security-in-2021\">State of WordPress Security in 2021 Report</a></p>\n\n\n\n<p><a href=\"https://patchstack.com/\">Patchstack website</a></p>\n\n\n\n<p><a href=\"https://masterwp.com/is-wordpress-security-getting-better-or-worse/\">Is WordPress security getting better or worse?</a></p>\n\n\n\n<p><a href=\"https://masterwp.com/rebuttal-how-patchstack-is-improving-wordpress-security/\">Rebuttal: How Patchstack is improving WordPress security</a></p>\n\n\n\n<p><a href=\"https://twitter.com/OliverSild\">Oliver&#8217;s Twitter</a></p>\n\n\n\nTranscript<div>\n<p>[00:00:00] <strong>Nathan Wrigley:</strong> Welcome to the Jukebox podcast from WP Tavern. My name is Nathan Wrigley. Jukebox is a podcast which is dedicated to all things WordPress. The people, the events, the plugins, the blocks, the themes, and in this case, the security of WordPress. If you&#8217;d like to subscribe to the podcast, you can do that by searching for WP Tavern in your podcast player of choice, or by going to WP Tavern dot com forward slash feed forward slash podcast. And you can copy that URL into most podcast players.</p>\n\n\n\n<p>If you have a topic that you&#8217;d like us to feature on the podcast, I&#8217;m very keen to hear from you and hopefully get you or your idea on the show. Head over to WP Tavern dot com forward slash contact forward slash jukebox, and use the contact form there.</p>\n\n\n\n<p>So on the podcast today, we have Oliver Sild. Oliver has been working in the WordPress space for many years, and specifically with WordPress security, as one of the founders of Patchstack, formerly called WebARX. Patchstack is a product which is designed to help you identify plugin vulnerabilities in your WordPress sites.</p>\n\n\n\n<p>Over the past couple of years, Patchstack has released an annual report about the state of WordPress security. The report for 2021 has just been released, and the podcast today is concerned with what they found out. We talk about why they produce this report. Who the intended audience is. What are the main takeaways in terms of the overall security of WordPress Core plugins and themes?</p>\n\n\n\n<p>We then get into more specific details about what types of vulnerabilities and attacks seem to be prevalent in the WordPress space. Are there any trends which are useful to think about, and how WordPress security is managed by the community as a whole. Are budgets and time typically allocated for prevention and restoration of websites.</p>\n\n\n\n<p>Towards the end we talk about how some people have pushed back on the usefulness of the report. They&#8217;ve questioned the motivations of security companies to write such reports and the use of language which they contain. Do they paint a more negative picture in order to drive sales of their commercial solutions?</p>\n\n\n\n<p>If you&#8217;re interested in finding out more, you can find all the links and the show notes by heading over to. WP Tavern dot com forward slash podcast, where you&#8217;ll find all of the other episodes. And so without further delay, I bring you all Oliver Sild.</p>\n\n\n\n<p>I am joined on the podcast today by Oliver Sild. Hello Oliver.</p>\n\n\n\n<p>[00:03:16] <strong>Oliver Sild:</strong> Hello Nathan, how are you?</p>\n\n\n\n<p>[00:03:17] <strong>Nathan Wrigley:</strong> I&#8217;m very well, thank you for joining us today. Oliver Sild will no doubt be able to introduce himself, but I&#8217;ll just do a very quick job. Oliver is, I believe, one of the founders, if not the founder of Patchstack, formerly WebARX, which is a security solution for WordPress websites amongst other things.</p>\n\n\n\n<p>So my first question to you all about, just give us a little bit of background, certainly more than I just provided. Tell us about your history with WordPress and how you came to be involved with WordPress.</p>\n\n\n\n<p>[00:03:47] <strong>Oliver Sild:</strong> Yeah. So in 20, 20 13, 20 14, around that time I was actually running a web development company we were mostly back then building websites in Joomla and then I remember just at one point, the demand on the market changed pretty much everyone wanted to WordPress site. So that kind of naturally moved us from Joomla to WordPress, and because our company was, we were calling our services like a secure web development. So what we wanted to do is that if we are building you something we&#8217;ll also make sure that the security side of that is covered as well. So we already had some level of internal tools built which were helping us to track what kind of software we were using on our different kind of customer&#8217;s websites. And that eventually, well, by now has turned into what Patchstack is.</p>\n\n\n\n<p>Okay.</p>\n\n\n\n<p>[00:04:40] <strong>Nathan Wrigley:</strong> Thank you very much, indeed. So security is your thing. And very recently there was a piece on the WP Tavern website, which I will link to a little bit later, which was highlighting the fact that you had released one of your annual reports.</p>\n\n\n\n<p>I believe we&#8217;re on possibly the second iteration now. It&#8217;s called the state of WordPress security. And in this case it was 2021. So it&#8217;s a look back over the last year in WordPress security. And we&#8217;ll go into that. And that really is the point of the podcast today. We&#8217;re just going to appraise all of the different bits and pieces that you highlighted there because I&#8217;m imagining that most people listening to this podcast are deeply into WordPress. And this is obviously a seriously important side of any WordPress website, keeping it updated and secure.</p>\n\n\n\n<p>And then towards the end of the podcast, we&#8217;ll go into a little bit of an exchange that happened over on a website where somebody called into question the language that you&#8217;re using over here, but, okay, so first thing I&#8217;m going to suggest then is that if you&#8217;re listening to this, you may like to go to Patchstack dot com forward slash white paper forward slash the state of WordPress security in 2021. All of those words are separated by hyphens. And you&#8217;re going to find the article that we&#8217;re talking about.</p>\n\n\n\n<p>It&#8217;s broken up into lots of different sections. But first question is why are you making the efforts to write this report? And we know that you have a WordPress security company. That is your job. That&#8217;s what you do, but why go to the lengths of illustrating what&#8217;s going on in the WordPress space so that people like me, the general public can consume it? It must require quite a lot of resources and effort.</p>\n\n\n\n<p>[00:06:14] <strong>Oliver Sild:</strong> Indeed yeah. I think we put that report together for three months. So it&#8217;s quite in depth by the way. If you want to quickly open up the white paper, you can just go to Patchstack dot com, we have with the banner on our front page that&#8217;s actually linking to that, but that&#8217;s a side note.</p>\n\n\n\n<p>We actually did that first, last year. So we last year released one about the previous year and we started doing that on the point where as a company, we decided to switch into a very specific focus on security vulnerabilities found in the software that is built for and around the WordPress ecosystem, which is the WordPress Core, the plugins and themes and the wordpress.org repository.</p>\n\n\n\n<p>But also the WordPress plugins and themes that are built as a premium ones that are not in the WordPress repository or the ones that are actually built or like being provided, some other marketplaces like Envato and so on. And by doing that, we switch the, like we have a SaaS product that is providing, we have a free version of a SaaS product where you can like, just connect like 99 websites, for example, and have a central overview if any of the plugins on any of your websites is becoming vulnerable. And at the same time, we started, looking into those different kinds of popular plugins and if they are vulnerable or not, then for years we&#8217;ve been providing code review and security auditing services for plugins.</p>\n\n\n\n<p>By doing that over the time, what we&#8217;ve collected together is like a quite big database, so security issues around the WordPress ecosystem. So if you go to Patchstack dot com slash database, you actually see a full-blown list of all of the security vulnerabilities that are in the plugins, themes, WordPress Core, and so on.</p>\n\n\n\n<p>And last year, what we did is that we figured, we understood already by doing surveys and so on that actually plugin vulnerabilities and theme vulnerabilities, and like anything that you are running on your website that becomes vulnerable, is pretty much the number one security threat to the website. And then we started a thing that we call it today Patchstack Alliance, where we just decided to start building a community of ethical hackers, who then submit vulnerabilities that they find in any WordPress plugins in the ecosystem to us. We make sure that we help the plugin developer to fix those issues. And then we actually pay to those ethical hackers for the contribution that they make to the WordPress security.</p>\n\n\n\n<p>And that&#8217;s on the other hand, generates a lot of data for us. So a lot of data about new vulnerabilities. A lot of data about, what is actually happening in that ecosystem. And we just decided to pull all that information and data that we have collected over this time and make it into a kind of annual report or a white paper.</p>\n\n\n\n<p>[00:09:09] <strong>Nathan Wrigley:</strong> Yeah. It&#8217;s really definitely worth having a look at, because it portrays, obviously now that you&#8217;re in the second iteration of this, you&#8217;re able to compare the way that things were last year. And in many ways, this is a comparison piece based upon last year. And so we often hear the phrases, such and such a thing is up such and such a thing as down, you&#8217;re looking for trends basically.</p>\n\n\n\n<p>The main gist is three sections. As you described, we&#8217;re talking about WordPress Core, WordPress themes and finally WordPress plugins. There&#8217;s obviously a little bit of nuance in there. Do you want to illustrate for us what you&#8217;ve found to be the big highlight bullet items, if you&#8217;d like for those three areas.</p>\n\n\n\n<p>So should we start with Core? Let&#8217;s discuss what it is that you found over the last year in terms of the security or otherwise of WordPress Core. To paraphrase, it seems pretty good.</p>\n\n\n\n<p>[00:10:02] <strong>Oliver Sild:</strong> Yeah. Like WordPress has quite mature software development cycle. WordPress the core, also has the bug bounty program.</p>\n\n\n\n<p>They have the bounty program on hacker one. And who doesn&#8217;t know what backcountry program is? It&#8217;s basically, like you say to hackers, come hack my software. If you find something report it directly to me so I can fix it, then they will pay to you. So this is the approach that is being, is becoming very popular.</p>\n\n\n\n<p>That&#8217;s the same thing, what we do to plugins, but WordPress has its for it&#8217;s own core. So they do that, which is nice because that is actually getting much more security attention on the WordPress Core. And at the same time we see less major security vulnerabilities being discovered in the Core itself. And something that we also saw this year, which was a little bit different was the dependency confusion attacks, where there was like a high risk of being maybe like a custom plugin being updated from the wrong source. I think the Core had an interesting year, but what we see is in general that the Core has a matured development kind of processes and cycle in place. So it&#8217;s getting better each year.</p>\n\n\n\n<p>[00:11:14] <strong>Nathan Wrigley:</strong> I think in the year 2017, I believe it was, the bug bounty program began with hacker one and it would appear, it seems to have worked because over the years after that, there&#8217;s been a fairly precipitous drop in the amount of concern with WordPress Core. In fact of the four security updates that were released in 2021. And again, we&#8217;re talking about Core it would appear that only one of them had a critical vulnerability, which wasn&#8217;t actually concerning something that was Core. It was an insecure component. It was PHP mailer library if I remember rightly.</p>\n\n\n\n<p>So that points to the idea that anybody these days is saying that WordPress itself is an insecure platform, which I&#8217;m sure we&#8217;ve all encountered when we&#8217;ve been building client websites and so on, people have this fear that WordPress itself is pretty insecure and your document seems to imply exactly the opposite. It&#8217;s very robust and very secure.</p>\n\n\n\n<p>[00:12:13] <strong>Oliver Sild:</strong> Yeah, and if you read our white paper, we actually say that, we are saying that WordPress has done a very good job at that. WordPress is getting more and more security attention, obviously, as it&#8217;s running, soon, almost like the half of web, basically.</p>\n\n\n\n<p>It makes sense that it gets more attention. More attention means more stuff is being found, more stuff being found means more stuff is fixed. And this is a good thing. And in terms of like the whole mature way of how there&#8217;s regular security updates and regular updates for the core itself. It shows that the core is doing really well.</p>\n\n\n\n<p>[00:12:51] <strong>Nathan Wrigley:</strong> Do you want to illustrate for those people who perhaps aren&#8217;t familiar, one of the headline paragraphs that you&#8217;ve got right near the top is, the dependency confusion attacks. Now this may be something that people are very familiar with. I suspect maybe not. Do you just want to outline what those are and why you&#8217;ve illustrated it in the report this year?</p>\n\n\n\n<p>[00:13:09] <strong>Oliver Sild:</strong> Yeah, we call it the fear of dependency confusion attacks, because we didn&#8217;t really see any dependency confusion attacks specifically. Like I was mentioning before, there was a risk where if you have a custom plugin that is not on the wordpress.org repo. And if you are adding a new plugin to the repo with the same slug that this custom plugin was using, then you could pretty much overwrite the custom plugin on the websites that it was running at.</p>\n\n\n\n<p>So this was like, a risk where if there is like a plugin made by someone, maybe installed on like very high profile websites. This plugin is not known to the WP dot org, or it is not on the WordPress dot org repo, but someone made a plugin for, with the same slug and it went past it. And then the auto-update mechanism in the WordPress Core would basically update this plugin, now, which was a core, which was a custom plugin into the plugin that is now in the WordPress repository.</p>\n\n\n\n<p>So basically replacing someone else&#8217;s plugin with a plugin made by another author. The content can be checked by the wordpress.org, like what actually this new plugin would do. But at the same time, of course a bit of a fear, I think a lot of people were afraid that this is going to affect everyone, but it was more of a theoretical thing that was a risk, but we didn&#8217;t really see any of such effects happening.</p>\n\n\n\n<p>[00:14:37] <strong>Nathan Wrigley:</strong> Yeah in software, in general, nothing to do with WordPress, this kind of supply chain attack is potentially a real problem, isn&#8217;t it? Because if you can somehow become the official canonical source of the software, even though you are not the official canonical source of the software, you could in theory, get to many, many places very, very quickly.</p>\n\n\n\n<p>And and it&#8217;s nice to see that you&#8217;ve not really found too much evidence of that over the last year. So WordPress core itself, I think it&#8217;s fair to say, you feel is in very good shape. The problem is really for WordPress and I&#8217;m sure this is something that many people can relate to if they&#8217;ve been using the software for any length of time, we&#8217;re going to get into themes and plugins. This is where I guess the problems begin to arise. Let&#8217;s tackle them in turn. Let&#8217;s go for themes first. What were the broad sweeping outlines that you that you discovered in your exploration of themes this year?</p>\n\n\n\n<p>[00:15:32] <strong>Oliver Sild:</strong> I think this has been happening over the time, but basically what we see is that the line between themes and plugins is getting blurrier and blurrier Themes now use a lot of PHP code for, site builders are also, people considered as themes in a way, but then at the same time they actually a plugin. Yeah, so the line is getting blurrier and more PHP code is being introduced into the functionality of the themes, which basically brings the same kind of threats to the themes that we have with plugins, where there can be a kind of vulnerable PHP code that can be a trick doing something that was not meant to.</p>\n\n\n\n<p>And what you saw is that there are vulnerabilities within themes that are as critical as you could expect from the plugins. It isn&#8217;t from this report, but I think a good example is. It was just recently with Freemius library, which was used by a lot of themes. And this is like exactly the supply chain issue where, there&#8217;s thousands of websites that are using one theme, and if this one theme becomes vulnerable, then all these thousands of websites are vulnerable. But now we&#8217;re also seeing where there&#8217;s thousands of themes on these themes use a library, and if this library gets vulnerable, then all these thousands of themes become vulnerable. And all those, I don&#8217;t know, hundreds of thousands of websites that use these thousands of themes become vulnerable as well. So this, you can see how this is coming, like from top to the bottom and eventually affecting a lot of websites. So as an example, I think two or three weeks ago when the Freemius thing happened, I think we, I believe we added 1,800 different vulnerabilities or vulnerable components to the Patchstack database in a single day.</p>\n\n\n\n<p>So next year is going to be definitely more, we have more data that&#8217;s definitely from this year about theme vulnerabilities than we have from the past year.</p>\n\n\n\n<p>[00:17:35] <strong>Nathan Wrigley:</strong> There were a fair number of what you might describe as critical vulnerabilities. There&#8217;s a list that you&#8217;ve described, depending on how interested you are in security.</p>\n\n\n\n<p>The names of these things may be of interest or otherwise, but things like unauthenticated, arbitrary file upload and option deletion, that would appear to have been found at least in your case, 10 times in 10 different themes. Unauthenticated upload vulnerability, leading to remote code execution, which you&#8217;ve found in one theme.</p>\n\n\n\n<p>Arbitrary file upload vulnerability, 42 themes were affected. So it&#8217;s fairly widespread. And I guess if any of those themes are incredibly popular, that can quickly get out of hand.</p>\n\n\n\n<p>[00:18:16] <strong>Oliver Sild:</strong> Absolutely. If a single plugin that has, especially those unauthenticated vulnerabilities are the scariest ones because they require no access to the website, like any permissions to your websites and someone could basically, the malicious hacker could potentially upload file to your site without gaining access to the website. So this kind of vulnerabilities are very scary as they can be abused automatically and on scale. So indeed, like if a single plugin would have a hundred thousand installations and it would have just one, this one vulnerability, especially for unauthenticated one, then what we are seeing is that hackers very quickly build custom tools to start finding all the websites on the internet that use that theme and then start exploiting them automatically to inject backdoors or redirect traffic from the website, change the search engine results for your website. So if you watch, if you look at the website everything seems to be okay. But if you Google your website, for example, then it would give completely different results and redirect your site to somewhere else.</p>\n\n\n\n<p>[00:19:24] <strong>Nathan Wrigley:</strong> So, is the trend in terms of themes, is your experience that there was more concern over the last year than there was in the previous 12 months? Or is it essentially the same quantity of vulnerabilities?</p>\n\n\n\n<p>[00:19:39] <strong>Oliver Sild:</strong> I guess the trend is the fact that the vulnerabilities are just becoming a little bit more critical. I wouldn&#8217;t say that there is a big trend in terms of that there is like a massive increase in the vulnerabilities in themes, but I think the fact that so much more functionality is being shipped with the themes in terms of the PHP code in general than they are just more and more prone to being introduced or introducing that kind of critical vulnerabilities into the code.</p>\n\n\n\n<p>[00:20:07] <strong>Nathan Wrigley:</strong> Yeah. Okay. Thank you. Let&#8217;s move on to WordPress plugins and this, as one might expect, has possibly greater numbers attached to it. There&#8217;s more plugins out there, and I would imagine that most websites have got one, possibly two themes, whereas they might have 15, 18 20, whatever the average number now is plugins. So there&#8217;s probably a bit of a larger target painted on plugins back than there is on themes back. Give us the overarching findings in terms of WordPress plugins for 2021.</p>\n\n\n\n<p>[00:20:40] <strong>Oliver Sild:</strong> Yeah. Plugins are the ones that we&#8217;ve been focusing the most on. And these are the ones that our Alliance members or like the community of the ethical hackers that are reporting new vulnerabilities to us. Majority of the vulnerabilities that are being reported to us are about the plugins. If we&#8217;re looking about the total number of new vulnerabilities that we&#8217;ve added to the database of vulnerabilities that effect the WordPress Core, plugins and themes, then there has been quite heavy increase in if we compare it to the last year.</p>\n\n\n\n<p>But that means that is actually very good news because that means that these are vulnerabilities that the developer has been able to get fixed because these vulnerabilities didn&#8217;t appear this year. These vulnerabilities probably in many cases at least they were sitting in those plugins for quite some time already. What just happened, why there is an increase in new identified vulnerabilities is just the fact that there&#8217;s more people looking at those, and reporting them to the developers.</p>\n\n\n\n<p>[00:21:49] <strong>Nathan Wrigley:</strong> There was a couple of plugins, and I guess this is the difference with plugins is that really the sky is the limit in terms of the numbers of installs. I don&#8217;t know what the largest install base of any particular theme is, but I&#8217;m guessing it is nowhere near the install base of the largest WordPress plugins. And so there was a couple that you mentioned in one case, one of the plugins that had a critical vulnerability this year was over 3 million website installs.</p>\n\n\n\n<p>And then there was another one with over a million. The seriousness of that is pretty obvious I&#8217;m sure. The quantity of people that are affected. You seem to be saying that in terms of the conscientiousness of the developers, you seem to be fairly happy with that, in that a lot of vulnerabilities got patched fairly quickly and disclosed in the appropriate way.</p>\n\n\n\n<p>However, we&#8217;ve still got this legacy of older plugins. In fact, you mentioned nine that have been removed from the repository, completely gone from the repository and yet have vulnerabilities, which essentially are going to stick around for ever.</p>\n\n\n\n<p>[00:22:56] <strong>Oliver Sild:</strong> Yeah, these are the most scariest ones. Like in, in most cases what we see is that developers, once a security report is being delivered to them, they look into it and they release a patch. So they fix it in most cases, the vulnerability doesn&#8217;t become publicly disclosed before that happens. Like, we also have our own disclosure policy where we just don&#8217;t like, we let the developer know about the vulnerability that was reported to us about, his, or her plugin, but at the same time, we keep it.</p>\n\n\n\n<p>We don&#8217;t publish that before we make sure that the developer had enough time to fix that. And also after that, that they have time to let their own users know that there is a security update and they should basically, update the sites as fast as possible. Just to make sure that we don&#8217;t cause any unwanted damage where this information might get in front of the wrong person.</p>\n\n\n\n<p>And we, what we wanted to do this year is we counted all the critical vulnerabilities and by critical, we mean the ones that are actually being, are actually the vulnerabilities that have the characteristics that hackers would want to automate exploitation attempts. So that means that it&#8217;s usually unauthenticated vulnerability, that basically you can either inject something to the website, add a back door or something, and you can fully automate that. And there was, yeah, like I think we counted, I think it was 35 different plugins that had that kind of vulnerabilities in last year. The scary part was that many of them didn&#8217;t really receive a fix at all.</p>\n\n\n\n<p>So these are plugins where the developer was either, had abandoned the plugin, was not active anymore. So in that sense, if you were running this plugin for example, if you were part of those plugins that didn&#8217;t ever receive a patch for this critical vulnerability. In your WordPress website, you would just see that everything is up to date.</p>\n\n\n\n<p>You would never see that there is an issue with this plugin unless you are being notified by like some security product or something that would say that, Hey, there is a vulnerability in this plugin. So this is a bit scary.</p>\n\n\n\n<p>[00:25:09] <strong>Nathan Wrigley:</strong> Yeah. This, I think we should dwell on this actually, because it seems like this is a real failing, or at least an area of possible improvement in the future. So let&#8217;s just reiterate what we&#8217;ve just said. So we&#8217;ve got a plugin, which has discontinued support. There are no ongoing updates for whatever reason, this plugin, which is in the repository is stalled. Nobody&#8217;s going to update it in the future.</p>\n\n\n\n<p>Now, at some point in the future, a vulnerability is discovered in it. It could be severe, it could be minor. It doesn&#8217;t really matter, but the point being that any WordPress user would never be alerted to the fact that something here is awry and something needs updating, because the only mechanism we&#8217;ve got in the WordPress admin area is to see when things need updating.</p>\n\n\n\n<p>And so we update them. And if there&#8217;s no update, the assumption would be everything must be fine. How on earth do we overcome this problem in the future? Do you have any thoughts on a process that we could adopt or some direction of travel that we might move in to make this go away?</p>\n\n\n\n<p>[00:26:15] <strong>Oliver Sild:</strong> Oh yeah, it requires a lot of awareness building around the ecosystem in general. We need to talk even more about the security in the WordPress ecosystem. We need to make sure that developers are also the ones that are not afraid to talk about security, because over the years, what we&#8217;ve seen is a lot of developers, like the plugin developers, specifically have been worried about like even dealing with security issues because they don&#8217;t want to be highlighted as, oh, this plugin had the vulnerability.</p>\n\n\n\n<p>So they see this as a negative kind of attention. In fact, for me, for example, completely from the opposite side see it as a very good sign that this developer actually takes attention on security. But that&#8217;s obviously because, from my end, I just see that there are so many vulnerabilities in different plugins.</p>\n\n\n\n<p>And the fact that there&#8217;s just increasing numbers of them now being reported from the last year, in our white paper, for example, that just the fact that more of them are being identified and being reacted on. It&#8217;s not the fact that there&#8217;s now, more of them, but they are at the same time what they see constantly is that the developers don&#8217;t need to be afraid of the security issues in a sense where they try to avoid those issues. And I think there should be even more and more open discussion about, hey, let&#8217;s together make the security in the plugins and in the software better.</p>\n\n\n\n<p>And I guess in terms of the core, I guess at one point core would need to have some level of security incorporated to basically give an insight on the plugins that are being used on the websites. For that specific reason, for example, because there&#8217;s been so much people saying, even from people that worked in the wordpress.org, we&#8217;ve seen people saying that, yeah, basically you just need to enable auto updates and you would be fine.</p>\n\n\n\n<p>But it&#8217;s not true. It&#8217;s just not true because in many cases like that, you can have auto updates enabled, but this there&#8217;s no update, if there is no update for the plugin, basically you don&#8217;t even know about issue. So I guess, yeah, this is definitely something that needs attention over the years. We are doing our best, like our product is actually literally covering that area of letting the users know if there&#8217;s a vulnerability, even if this plugin is being removed from the repo, or even if this plugin didn&#8217;t even receive a patch. So we are letting our customer know about that. Then we are also providing a patch to protect against the attacks against these plugins. But at the same time, yeah, I think this is clearly a issue that needs more and more attention.</p>\n\n\n\n<p>[00:28:58] <strong>Nathan Wrigley:</strong> Yeah, it would be nice to come up with some kind of system which didn&#8217;t break things, which enabled, I don&#8217;t know, perhaps these particular plugins to be disabled. In some way removed, but then that of course has all sorts of implications in terms of the ownership of the site and whether you actually want people to have the capacity to be able to remove things from your website. People flock to WordPress because you get to own everything. It&#8217;s yours, and you can modify it as you like. And the idea that some plugin could be removed, disabled without your say so, is one that I&#8217;m sure the community would definitely want to have a long and deep conversation about. But interesting. You found nine that had these problems this year and there seemingly is no way of automating that problem to go away, as yet.</p>\n\n\n\n<p>Okay, so we&#8217;ve dealt with core, we&#8217;ve dealt with themes and plugins and what I&#8217;ve just described as orphaned plugins. Let&#8217;s just talk about the broad bits and pieces that your report highlighted this year. Some of it is good. Some of it is less good, but the first sort of headline pieces that you&#8217;ve definitely found that there was a rise in vulnerabilities found compared to 2022. On the face of it that sounds like a bad thing, but you&#8217;re saying that there were many more in the previous year than in the year prior to that.</p>\n\n\n\n<p>[00:30:24] <strong>Oliver Sild:</strong> Yeah, it&#8217;s the best news of the white paper, to be honest, because that means that there was 150% more vulnerabilities being identified. Imagine if there was zero vulnerabilities being identified and only, and all those vulnerabilities would be sitting there, still doing that, and just nobody would know about those, until someone who with malicious intention could just take advantage of them.</p>\n\n\n\n<p>I wouldn&#8217;t be surprised if this year we are going to see even a bigger increase because there&#8217;s just so much more attention being put into identifying those vulnerabilities and helping the plugin developers to make their code even more secure.</p>\n\n\n\n<p>We are for sure investing a lot into it with Patchstack Alliance. Like last year we paid out like 13 K in the bounties for like individual ethical hackers who just let us know about vulnerabilities that they found in any plugins in the WordPress ecosystem, and we just paid them for that effort. So we&#8217;re definitely going to double down this year on that as well. So we&#8217;ll see how that will affect this year.</p>\n\n\n\n<p>[00:31:31] <strong>Nathan Wrigley:</strong> Yeah, it&#8217;s interesting because on the face of it, if the number of vulnerabilities is larger, the immediate instinct around that is to assume that things have got worse. And of course the statistics could be for all sorts of reasons. As you&#8217;ve just described, there&#8217;s perhaps more eyeballs looking to discover these things. There&#8217;s initiatives like your own and the bug bounty, which have enabled people to actually feel that they&#8217;re getting remunerated for that. And so they&#8217;re more serious in the endeavor to search for them. But also, maybe it&#8217;s a product of the fact that WordPress itself is just growing, and as it grows, there&#8217;s going to be more eyeballs looking for these things, but also possibly it becomes a bigger target. And so there are more of these things out there. There&#8217;s more plugins, there&#8217;s more themes, there&#8217;s more code and it&#8217;s just a sort of byproduct.</p>\n\n\n\n<p>But anyway, interesting take on it. Definitely worth looking at. That was the rise in vulnerabilities now onto more sort of specific details about what these types of vulnerabilities are. A significant proportion of the things that you concerned yourself this year with were XSS vulnerabilities, which is cross site scripting. For those people who are not really familiar with that, would you just paint a picture of what cross site scripting vulnerabilities are, and any thoughts on why it represents almost 50% of everything that you&#8217;re seeing?</p>\n\n\n\n<p>[00:32:54] <strong>Oliver Sild:</strong> I think cross site scripting is just one of the easiest things to find the web. See, cross-site scripting, for example, you take like a website search bar, if you go to a WordPress site and there&#8217;s like a search bar. And if you, for example, write inside of this search bar, like HTML code, for example, and then what happens is that this, the functionality that is searching this information from the site for example, is going to show you the results, and this HTML code that you put there would then basically be meshed together with the kind of code of the website and it would just basically load it.</p>\n\n\n\n<p>I think actually even a better example would be with comments. Wherever you have, like WordPress don&#8217;t have that issue, but for example, or earlier days, there was a lot of websites with commenting sections. And then if there was an issue where if you basically post any HTML code with some, maybe Java script, something that was maybe popping up like an alert for you and you post that comment there, then what would happen is that the site would then basically render that into as part of the code of the website.</p>\n\n\n\n<p>So when it was even saved in that case, then the siet would basically load the code that was posted there as actual comment. So this is like a sanitation thing as well. So you want to make sure that you make a difference between actual code and what the content is that is being submitted to the website or the input in that sense.</p>\n\n\n\n<p>[00:34:26] <strong>Nathan Wrigley:</strong> So it represents almost the majority, 49.8 something percent of everything that you find. But I guess that is as you describe, it&#8217;s because it&#8217;s relatively straightforward to pull off. Possibly at least from my perspective, the vulnerabilities then shrink in terms of percentage and towards the very bottom, I guess the worst really that you could have is remote code execution. And that number is not 0.94% of everything that you were looking at. So I guess there&#8217;s some positive message to come out with that. Less than 1% of all the things were truly very serious indeed.</p>\n\n\n\n<p>[00:35:02] <strong>Oliver Sild:</strong> Yeah, indeed. As always easiest stuff comes out the first. So these are the ones that are usually reported the most, that are mostly visible and accessible in terms of, for even a simple thing can just submit something into a comment form, and see if it&#8217;s going to load something in a weird way. So this kind of vulnerability is going to be found very easily.</p>\n\n\n\n<p>[00:35:27] <strong>Nathan Wrigley:</strong> Yeah. Now moving on to plugins. Curious thing that you&#8217;ve discovered again from the data that you&#8217;ve managed to gather is that there are actually fewer plugins in use, which, you would imagine, would reduce the attack surface. And so you would equally think that the number of things that you were having to clean up regularly or that you were discovering had been broken, would go down. But it seems that there&#8217;s a sting in the tail. So there&#8217;s fewer plugins, but more of them are being left without being updated.</p>\n\n\n\n<p>[00:35:56] <strong>Oliver Sild:</strong> Indeed. Yeah. This was an interesting find. I expect that, I do still expect that the number of plugins, we&#8217;re going to see this number dropping more and more, even in the upcoming years, as people are getting more and more aware around the security implications when you&#8217;re just, using a lot of plugins on the website.</p>\n\n\n\n<p>But I think it&#8217;s also about the kind of hygiene thing where users are also not so prone anymore to leave like deactivated plugins standing there on the website. So they&#8217;re starting to delete those things. And I think people are seeing more and more that plugins, like each of the plugin that you install to your website can be like a link, can be like an entry point for a hacker if there is a vulnerability found in that specific plugin.</p>\n\n\n\n<p>So basically the less buttons you have, you reduce the risk significantly. So it was interesting yes, to see that even though the number of plugins installed per website is actually dropping. But at the same time, the amount of plugins out of those that were outdated was actually higher. I&#8217;m not a hundred percent sure that what is like the actual cause of that, or if it&#8217;s just like something that we see this year, but I think next year we&#8217;re going to have more data to see more into why that could be.</p>\n\n\n\n<p>[00:37:21] <strong>Nathan Wrigley:</strong> Yeah, it&#8217;s curious on the 50,000 websites that you were analyzing in order to generate this report down from 23 plugins and themes, now residing at about 18. 18 different plugins and themes installed. Yeah, that&#8217;s interesting. We&#8217;ll revisit that next year and see where we&#8217;re at. I guess this is a fairly obvious thing to say, but it was worth pointing out, the seventh point on your list of things was that the easy to exploit vulnerabilities remain the main targets, like I said, that&#8217;s fairly straightforward.</p>\n\n\n\n<p>[00:37:52] <strong>Oliver Sild:</strong> Anything that is unauthenticated and basically that can be automated.</p>\n\n\n\n<p>[00:37:57] <strong>Nathan Wrigley:</strong> So it&#8217;s old tried and tested things that the hackers know can be achieved. They&#8217;re going to go after the low hanging fruit. And sadly, the eight point that you make is that old vulnerabilities remain as great big targets. So things which could have been fixed from last year, still are hanging out there and being exploited.</p>\n\n\n\n<p>[00:38:19] <strong>Oliver Sild:</strong> Yeah, indeed. I think a big reason for that, there are all these automated hacking tools. I mean that people don&#8217;t load from Github or from hacking forums and places like that, where guys who, you know, sometimes kids who get into, like looking into hacking, trying to maybe yeah getting into that field. They are basically downloading software that is prebuilt by someone and there&#8217;s someone made it at the point where there was specific vulnerabilities just introduced. So they have hard-coded the exploitations into those tools and these tools are still available, and people who are getting into the kind of dark side, I&#8217;d say, are then starting to play with those tools.</p>\n\n\n\n<p>So this is one of the reasons why we see that happening. We&#8217;ve seen a few of those tools as well. This kind of proves the point. But then in terms of that, like there isn&#8217;t a lot of hits that these tools are probably getting, because most of those websites that running those plugins have already been either patched or either hacked already and then patched.</p>\n\n\n\n<p>[00:39:29] <strong>Nathan Wrigley:</strong> Yeah. An interesting thing that comes up later is really around the personnel who are responsible for updating things. And you&#8217;ve got a couple of points on this, but we&#8217;ll try to tackle them in one go. Whilst there&#8217;s an increase in awareness of security on WordPress websites, no doubt because of publications such as your own, it would appear that there&#8217;s not a lot of time, space, money provided. So who is responsible for updating things could be really crucial. And it says on your report that 53% of respondents stated that they updated their components weekly. Some, perhaps as many as 20% did things daily. 18% possibly monthly updates happening. So that&#8217;s quite an important blend in the picture. That the frequency of updates, crucial I suppose. If you&#8217;re leaving things for an entire month and a not keeping yourself up to date with the news, I&#8217;m sure that there&#8217;s many websites where monthly is just off the charts. It would probably be more like every six months or possibly not at all.</p>\n\n\n\n<p>But then also, the difficulty in actually finding a budget to do these things. And you make the point that many, many websites be they run by an agency or an individual, or just a solopreneur. They have no budget for this kind of thing. They&#8217;re just crossing their fingers and hoping for the best. So do you want to talk around that? The people involved, the time that they&#8217;ve got, the frequency of updates and the budget that they&#8217;ve got?</p>\n\n\n\n<p>[00:40:59] <strong>Oliver Sild:</strong> Yeah. The frequency is an interesting take because in terms of how fast we are often seeing attacks happen against websites when a new vulnerability, or let&#8217;s say a critical vulnerability is being found in a plugin that the website is using. These like when we are not even talking about zero days in this case. Zero days are the ones that nobody knows the vulnerability before it&#8217;s already being attacked.</p>\n\n\n\n<p>But for example, sometimes the vulnerability is being discovered, disclosed. And after that, hackers learn about that and then they are going to basically exploit that. So there&#8217;s like a cat and mouse game. Who patches first? Is it the hacker or, sorry, who uses the vulnerability first? Is it like the website owner who was going to update this and patches it, or is it the hacker who manages to exploit this before to website owner managers to update it?</p>\n\n\n\n<p>And this time period is actually somewhere around one hour.</p>\n\n\n\n<p>[00:41:54] <strong>Nathan Wrigley:</strong> Wow.</p>\n\n\n\n<p>[00:41:54] <strong>Oliver Sild:</strong> Yeah. So this is something that has to be kept in mind that, daily updates sounds good as well. And from there on, the longer time to take for updating, the more risk there is for the website.</p>\n\n\n\n<p>But the interesting thing is like the auto updates. Have you put like WordPress autoupdate into Google search and look that into what kind of articles are popping up?</p>\n\n\n\n<p>[00:42:21] <strong>Nathan Wrigley:</strong> No, but I can imagine you&#8217;ve got some interesting insights there.</p>\n\n\n\n<p>[00:42:25] <strong>Oliver Sild:</strong> Basically the majority of the articles are about how to turn off WordPress auto updates.</p>\n\n\n\n<p>[00:42:32] <strong>Nathan Wrigley:</strong> Yeah.</p>\n\n\n\n<p>[00:42:33] <strong>Oliver Sild:</strong> I remember when WordPress auto updates came for the plugins, and basically like most of the kinds of articles or like how-to&#8217;s use we&#8217;re about to come to turn it off. Because people are still scared the websites are going to break down if there&#8217;s some feature breaking update coming for a plugin. So this is something interesting about the updating side of things that we&#8217;ve been seeing over the year.</p>\n\n\n\n<p>[00:43:00] <strong>Nathan Wrigley:</strong> Yeah. That&#8217;s a really interesting, difficult seesaw to think about. The idea of being, if you switch off auto updates, which of course is available for multitude of things in WordPress, including plugins, you can just have click a button next to the plugin and it will just automatically update it.</p>\n\n\n\n<p>A lot of people concerned that the update might break the site. So in terms of them having to do some additional work to un-break it, or re-install from a backup or whatever it is that they need to do. That concern in many cases overrides the possibility that there could be some vulnerable software there, a plugin, which is vulnerable.</p>\n\n\n\n<p>I guess it&#8217;s a difficult one to decide which way to go. But it&#8217;s curious that a lot of people have decided to not implement automatic updates because presumably of the fear of things going astray in the way it looks or a plugin breaking. And of course that is a legitimate concern.</p>\n\n\n\n<p>Just seen over the last week that a couple of major plugins had problems where they broke significant parts of the websites, and they had to roll back those updates and then ultimately figure out a patch and then release that as the new update, which then got automatically updated. So I can see where people&#8217;s concerns come from there. I guess your advice would be switch on automatic updates because having a hacked website is probably better than having a modestly broken website.</p>\n\n\n\n<p>[00:44:23] <strong>Oliver Sild:</strong> Yeah. And actually the other way around. I heard you were saying that the hacked website is better than broken website. So I was saying the other way around, so it&#8217;s better to have a broken website than a hacked website.</p>\n\n\n\n<p>[00:44:37] <strong>Nathan Wrigley:</strong> That&#8217;s what I intended to say if I got that wrong. I apologize. Yeah.</p>\n\n\n\n<p>[00:44:40] <strong>Oliver Sild:</strong> But yeah, basically, yeah, it&#8217;s better to have a broken website because you can at least put the maintenance mode on and do something about that and fix it. And usually like how WordPress is behaving right now is that it also lets you know if something was breaking down and it doesn&#8217;t like, the site doesn&#8217;t throw you a bunch of errors.</p>\n\n\n\n<p>It isn&#8217;t like that anymore. So it isn&#8217;t that much of a risk at that point anymore to be completely afraid of plugin auto updates.</p>\n\n\n\n<p>[00:45:09] <strong>Nathan Wrigley:</strong> Yes. Then that&#8217;s a good point. And you will also hopefully receive an email with some kind of information about the problem that may have brought your site down.</p>\n\n\n\n<p>Okay. Turning then to the budget. This is really interesting, the data that you&#8217;ve gathered, as much as 28% of people who responded said that they basically had zero budget to protect their websites. In other words, 28% of those people were just hoping for the best and crossing their fingers. And a further 27% said that they had a monthly budget of between $1 and $3.</p>\n\n\n\n<p>The numbers vary. There are people who had significantly more and people who were somewhere in between, but quite an interesting spread there from zero to quite a lot. And the majority of these numbers are tending towards a very small budget I guess that you would argue that, it ultimately, it would be better to have something than nothing.</p>\n\n\n\n<p>[00:46:01] <strong>Oliver Sild:</strong> For sure. Yeah. I guess the zero budget also means free plugins right? In a way of using like free security plugins and then it doesn&#8217;t mean a hundred percent that don&#8217;t use anything or they don&#8217;t have any measures in place. But at the same time, what we are also seeing is that security is still a hard sell.</p>\n\n\n\n<p>Especially when we talk to agencies where the customers are like, aren&#8217;t you supposed to take care of it? Not understanding that the security is a thing that needs to be taken care of separately. That is a part of ongoing process and that you should basically prevent them rather than just deal with the consequences later on.</p>\n\n\n\n<p>There was another good point where we also asked from the same people about how much they have paid for malware cleanups within the past year. And that was like, there was one, I think the highest responder was like, who said he spent 4.8 K dollars on cleanups last year. That&#8217;s a lot of websites that you can secure or protect.</p>\n\n\n\n<p>And basically we even get some sort of service on top of it, or like incident response assistance that like we offer where, specialists are jumping in and fixing everything if something should happen, even though we had security in place.</p>\n\n\n\n<p>[00:47:21] <strong>Nathan Wrigley:</strong> Now, obviously you&#8217;re here representing Patchstack, and Patchstack is a commercial company. You&#8217;re in the business of securing websites, but you&#8217;re also in the business of paying your employees. So you need to pay to use the service. There was an interesting piece which got written over on the Master WP website, and I will make sure to link to it in the show notes. And there&#8217;s a further piece which we&#8217;ll get to in a minute.</p>\n\n\n\n<p>It was written by Rob Howard on March the 14th and it was called, is WordPress security getting better or worse. In this piece, he takes your report to task and largely it&#8217;s around the kind of language that you use. There&#8217;s definitely merit in going and reading it, but you then, one of your team members issued a non rebuttal rebuttal of that piece.</p>\n\n\n\n<p>But just for a couple of minutes, let&#8217;s just delve into that. I think his concern is that the way that you portray the report is, let&#8217;s use the word sensational. His argument would be that it&#8217;s in your interest as a provider of security solutions to paint a picture, which is, let&#8217;s say somewhat alarming, there&#8217;s all of these problems, and look at the enormous array of different vulnerabilities that there are out there.</p>\n\n\n\n<p>And therefore you bring the statistics to bear that best represent the fact that there are problems. So just wanted to give you a chance to talk about that. And I will also mention. The rebuttal piece, again on the same website, interestingly, Master WP it&#8217;s by Robert Rowley, they&#8217;re both Robs, so you&#8217;ll probably have to read them one at a time.</p>\n\n\n\n<p>And this is called, rebuttal, how Patchstack is improving WordPress security. So I&#8217;m just giving you a platform here to reply to Rob Howard&#8217;s piece, where he takes you to task for using sensational language and massaging the figures so that they, he accuses you of using sloppy statistics.</p>\n\n\n\n<p>[00:49:08] <strong>Oliver Sild:</strong> Yeah, to be honest, I&#8217;m not a hundred percent sure like what is really sensational about that? But in a way, when we put together the whole white paper, we just basically looked at the numbers. We look at the numbers and we are presenting what it is. I understood that one of the things that may be what he thinks about is sensational is the, that there is 150% increase in vulnerabilities being discovered.</p>\n\n\n\n<p>It is something that we can just say, and it&#8217;s a fact. The question how do you interpret that, whether negative or positive? That needs more context. And the context we do give. The context is that just means that there is more vulnerabilities being identified, which is a good thing because to WordPress is getting more secure because of that.</p>\n\n\n\n<p>So when this post was published by Rob, we actually went over it, then we were like, oh, actually there&#8217;s like a lot of good points because obviously we are also a little bit tunnel visioned when we are dealing with that much of data and hooking into the problem that we are trying to solve. And then we&#8217;re obviously talking about that, how we&#8217;re talking in house, in a way.</p>\n\n\n\n<p>So we should, I get his in terms of like a criticism that we probably should also be more specific in terms of how we are, or like what our intentions behind that are, like whether we see in a negative way or in a positive way. But yeah, like I, we were really happy about the piece that he wrote. We even shared his piece, which wrote criticism about Patchstack on the Patchstack Facebook page, on the Patchstack Twitter. We were like, hey, see what he wrote. There were really good points. And then later on we obviously responded to that with our take on what we actually meant by that and where we thought he may be, in some cases, wrong and where he was right as well.</p>\n\n\n\n<p>[00:51:11] <strong>Nathan Wrigley:</strong> Yeah. It&#8217;s interesting. Obviously statistics can be in every walk of life, statistics can be looked at in a variety of different ways. And you only have to look at virtually any parliamentary system on earth to realize that the opposition can present the same statistics in an entirely different fashion and it&#8217;s completely plausible and the numbers are correct.</p>\n\n\n\n<p>Yeah, I think some of the things that he was saying was it would just be nice to have some sort of background, some insight into, so for example, does the increase, this 150% figure that was mentioned, is that because there are more plugins that are out there? How serious are these vulnerabilities that we&#8217;re talking about? If there&#8217;s an increase, but 99% of those were benign and did virtually nothing, could they be lumped in as 150% increase? Has the total number of plugins in the entire market changed? And what are your reporting methodologies in terms of what is it that you&#8217;re actually trying to do from the report? Are you just trying to be a purveyor of information? Or is there a hope from the Patchstack piece that some customers will come your way as well? So just those pieces really?</p>\n\n\n\n<p>[00:52:18] <strong>Oliver Sild:</strong> Yeah. I guess if the statistics didn&#8217;t come from like some internal data that we are not showing anyone, it&#8217;s the public CVE&#8217;s that we are one of the authorities to generate the publicly or like the internationally kind of standard vulnerability identification IDs. There&#8217;s three companies in the space which can do that in the WordPress ecosystem. And we&#8217;re one of them. So like this vulnerability information, it&#8217;s all public to the, to everyone, we are just showing that&#8217;s how much there was in 2020. That&#8217;s how much there is in 2021.</p>\n\n\n\n<p>There is no kind of translation whether if it was actually not that much of an increase or not. The question isn&#8217;t about about like increase, I guess in general, I think the question is about why it was increasing. And the increase isn&#8217;t because, at this point the increase isn&#8217;t because the WordPress is getting more plugins to the wordpress.org.</p>\n\n\n\n<p>We actually, even, I think in the rebuttal piece have shown how much percentage the wordpress.org repo has grown over the year compared to the same period. The thing literally is, there&#8217;s just more eyes. There&#8217;s more people looking for the vulnerabilities in the plugins and they&#8217;re identifying more vulnerabilities.</p>\n\n\n\n<p>These vulnerabilities may or may not be in there already for years. It&#8217;s the number of vulnerabilities that the 150% of increasing vulnerabilities found in WordPress ecosystem means that there was just 150% more vulnerabilities found in WordPress ecosystem. Basically, it means just that.</p>\n\n\n\n<p>Now, if you want to give that positive or negative meaning, it is definitely up to you. Of course we could have tried probably present that in a better way and maybe, I&#8217;m not sure if we actually wrote in our white paper that we find this a good thing. I need to double check it really quickly, but we usually like anywhere we talk, we always say that it&#8217;s a good thing. It is what it is.</p>\n\n\n\n<p>[00:54:31] <strong>Nathan Wrigley:</strong> Yeah. It&#8217;s interesting because the language that Rob would like is definitely more on the sort of optimistic side, isn&#8217;t it? So instead of bringing out the things that are going wrong, he would like to emphasize the things that are going right, so for example, he rewrites something where the illustration is that there&#8217;s problems, and he says that a possible alternative headline would be not 0.65% of WordPress sites get an important update. So I guess it&#8217;s stressing the negative.</p>\n\n\n\n<p>[00:54:59] <strong>Oliver Sild:</strong> Would you read that?</p>\n\n\n\n<p>[00:55:00] <strong>Nathan Wrigley:</strong> Yeah. And that&#8217;s an interesting thing about human nature, isn&#8217;t it? Because you only have to look at newspapers for example, or headlines in articles on the web to realize that well, people are, they&#8217;re drawn to controversy to some extent aren&#8217;t they? They like the sort of sensational aspect. And so yes, interesting point. Yeah, really interesting point.</p>\n\n\n\n<p>[00:55:19] <strong>Oliver Sild:</strong> And in our case, if, when we released the white paper as well, we even saw in some cases where journalists were, we didn&#8217;t tell them what, we didn&#8217;t actually even send it out in that way that all you need to use, like some sort of headlines, but we did see the journalists just take out some piece of data and they would just make their own kind of headline based on that.</p>\n\n\n\n<p>In a way, I think people need to also think. I understand that, okay, let&#8217;s then talk about this issue in a so positive way that like nobody would even understand that there is like a problem at all. But is that our goal? If we want to make WordPress ecosystem more secure, we need to talk about those issues.</p>\n\n\n\n<p>There are issues and these issues are being solved, and we are showing that there is like increased effort in solving those. Let&#8217;s talk about those things. We shouldn&#8217;t just let&#8217;s try to somehow sugar coat it in a way or</p>\n\n\n\n<p>[00:56:17] <strong>Nathan Wrigley:</strong> Thank you. I will definitely mention both of those articles in the show notes. We&#8217;re going to have to round it up because we&#8217;re approaching the amount of time that we&#8217;ve got. Before we go though, obviously we know that you&#8217;re at Patchstack, which is at patchstack.com. But should anybody wish to reach out to you personally, are there any good ways for people to do that?</p>\n\n\n\n<p>[00:56:38] <strong>Oliver Sild:</strong> Yeah, anyone can reach out to me on Twitter. I think that&#8217;s the easiest way to reach out either DM or just tag me. It&#8217;s @oliversild. And then yeah, if you want to look at what we are doing. If you&#8217;re a plugin developer, you can always get like security testing for you&#8217;re plugin through Patchstack. If you&#8217;re an agency and you want to have security overview and a vulnerability overview, every single website that you have across your portfolio, then you can use Patchstack for that.</p>\n\n\n\n<p>And for hosting companies, we also have so they would always know if new vulnerabilities are being reported to us by the ethical hackers community. Or if we are adding new items to the database from any other sources. So Patchstack database, Patchstack audits. We&#8217;re basically doing anything around WordPress plugins and trying to make the whole ecosystem more secure.</p>\n\n\n\n<p>[00:57:31] <strong>Nathan Wrigley:</strong> Oliver Sild, thank you very much for joining me on the podcast.</p>\n\n\n\n<p>[00:57:35] <strong>Oliver Sild:</strong> Thanks Nathan.</p>\n</div>\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}s:7:\"pubDate\";a:1:{i:0;a:5:{s:4:\"data\";s:31:\"Wed, 30 Mar 2022 14:00:00 +0000\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}}s:32:\"http://purl.org/dc/elements/1.1/\";a:1:{s:7:\"creator\";a:1:{i:0;a:5:{s:4:\"data\";s:14:\"Nathan Wrigley\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}}}}i:22;a:6:{s:4:\"data\";s:13:\"\n	\n	\n	\n	\n	\n	\n\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";s:5:\"child\";a:2:{s:0:\"\";a:5:{s:5:\"title\";a:1:{i:0;a:5:{s:4:\"data\";s:77:\"WPTavern: Performance Team Proposes Enabling WebP by Default in WordPress 6.0\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}s:4:\"guid\";a:1:{i:0;a:5:{s:4:\"data\";s:30:\"https://wptavern.com/?p=132138\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}s:4:\"link\";a:1:{i:0;a:5:{s:4:\"data\";s:88:\"https://wptavern.com/performance-team-proposes-enabling-webp-by-default-in-wordpress-6-0\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}s:11:\"description\";a:1:{i:0;a:5:{s:4:\"data\";s:3570:\"<p>WordPress&#8217; Performance Team has published a <a href=\"https://make.wordpress.org/core/2022/03/28/enabling-webp-by-default/\">feature proposal</a> that would enable WebP images by default, expanding core support for the modern image format. </p>\n\n\n\n<p>In July, 2021, WordPress 5.8 <a href=\"https://wptavern.com/wordpress-5-8-introduces-support-for-webp-images\">introduced WebP support</a>, allowing users to upload and use WebP images in their content. If the proposal is approved, version 6.0 will generate WebP images by default for new JPEG uploads and will use WebP images by default for website content.</p>\n\n\n\n<p>&#8220;WebP was developed as a modern image format that provides superior compression on the web,&#8221; WordPress core contributor Adam Silverstein said in the feature proposal. &#8220;Images are often some of the largest resources used by websites, and using WebP creates websites that are lighter and faster. Compared to JPEG images, WebP images generated by WordPress are almost always smaller, with a <a href=\"https://github.com/WordPress/performance/issues/7#issuecomment-1080901577\">~30% file size reduction</a> on average (with the same visual quality).&#8221;  </p>\n\n\n\n<p>With WebP enabled by default, WordPress users would not experience any changes to their usual image upload workflow. WordPress would automatically convert JPEG uploads to WebP in the background and use them on the website.</p>\n\n\n\n<p>According to <a href=\"https://caniuse.com/webp\">Can I Use</a>, the WebP image format is supported by 94.25% of web browsers. A very small number of browsers, such as Internet Explorer 11 or Safari on MacOS &lt; v11 Big Sur, do not support WebP. </p>\n\n\n\n<p>The proposed feature would ship with two filters to control or disable WebP uploads, and a user-friendly plugin would be created to do the same.  </p>\n\n\n\n<p>Despite the significant performance benefits, support for the feature proposal is not unopposed. Several contributors participating in the discussion expressed concerns about email clients and social media platforms not supporting WebP.</p>\n\n\n\n<p>&#8220;I feel like WebP is not yet ready to become a &#8216;hardcoded default&#8217; in the <code>post_content</code> due to all the reasons mentioned in the previous comments,&#8221; Kaspars Dambis said. &#8220;Many web clients (which are not just browsers) don’t support WebP formats — RSS clients, email clients, smart TVs, ebook readers, open graph parsers, desktop image viewers, etc. These are all important users of the web.&#8221;</p>\n\n\n\n<p>Silverstein answered these concerns, confirming that WordPress will continue generating the JPEG image sub sizes as it always has.</p>\n\n\n\n<p>&#8220;One important note about what this feature doesn’t change: JPEG sub sizes are still generated and stored in the same meta fields,&#8221; he said. &#8220;For that reason, consumers of RSS feeds or REST media endpoints or OG tags for example will continue to use the JPEG sub sized versions.&#8221;</p>\n\n\n\n<p>The Performance Team contributors are targeting WordPress 6.0 for enabling WebP by default and are seeking approval from maintainers of the image component. Anyone is welcome to test the feature by installing the <a href=\"https://wordpress.org/plugins/performance-lab/\">Performance Lab plugin</a> with the “WebP Uploads” module activated. Testers are encouraged to leave feedback on the <a href=\"https://core.trac.wordpress.org/ticket/55443\">Trac ticket</a> or <a href=\"https://github.com/WordPress/wordpress-develop/pull/2393\">Pull Request</a>.</p>\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}s:7:\"pubDate\";a:1:{i:0;a:5:{s:4:\"data\";s:31:\"Wed, 30 Mar 2022 02:41:46 +0000\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}}s:32:\"http://purl.org/dc/elements/1.1/\";a:1:{s:7:\"creator\";a:1:{i:0;a:5:{s:4:\"data\";s:13:\"Sarah Gooding\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}}}}i:23;a:6:{s:4:\"data\";s:13:\"\n	\n	\n	\n	\n	\n	\n\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";s:5:\"child\";a:2:{s:0:\"\";a:5:{s:5:\"title\";a:1:{i:0;a:5:{s:4:\"data\";s:70:\"WPTavern: Text Selection Across Multiple Blocks Is Coming to WordPress\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}s:4:\"guid\";a:1:{i:0;a:5:{s:4:\"data\";s:30:\"https://wptavern.com/?p=132141\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}s:4:\"link\";a:1:{i:0;a:5:{s:4:\"data\";s:81:\"https://wptavern.com/text-selection-across-multiple-blocks-is-coming-to-wordpress\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}s:11:\"description\";a:1:{i:0;a:5:{s:4:\"data\";s:5371:\"<p>Yesterday, Ella van Durpe merged a long-awaited feature into the Gutenberg plugin that allows users to <a href=\"https://github.com/WordPress/gutenberg/pull/38892\">select and modify text across multiple Rich Text blocks</a>. It should land in version 13.0 of the plugin and WordPress 6.0 in May.</p>\n\n\n\n<p>Users can currently select text across multiple blocks, but the editor automatically adjusts that selection to all of the blocks themselves, essentially creating a group. The change will allow users to highlight the specific text. This ability should work with any Rich Text block, such as Paragraph, Heading, List, and Quote.</p>\n\n\n\n<img />Selecting text across two blocks.\n\n\n\n<p>Anyone who wants to test this feature early can grab a development copy of <a href=\"https://github.com/WordPress/gutenberg/pull/38892/checks\">Gutenberg from the ticket.</a> Click on the &#8220;Build Gutenberg Plugin ZIP&#8221; tab.</p>\n\n\n\n<p>If there is one thing that any text-based editor should do well, it should be to allow users to manipulate text according to standard conventions. Users should be able to select, copy, cut, paste, and generally move characters and words around as they please.</p>\n\n\n\n<p>When WordPress 5.0 launched its new block-based editor in late 2018, some of the tools that writers had expected were non-existent. Every paragraph, list, heading, and blockquote was a separate entity and not simply a continuation of the text. Blocks were the sludge that plugged the editing flow.</p>\n\n\n\n<p>The block system solved a ton of problems that needed solutions. The new post editor even looked sleeker than its classic predecessor. But, those things did not matter much when stuff under the hood did not meet the demands users needed of an editor. Every missing feature that had become a standard to any particular user or another was a blight, another one-star review, on the revolution the block system was meant to bring about.</p>\n\n\n\n<p><em>If a user could not do something as simple as select and delete text across two paragraphs, what good were all the other bells and whistles?</em></p>\n\n\n\n<p>It is now over three years since the launch of the block editor. Perhaps it is too late to win back some who have chosen a different path for their websites. For others, maybe their writing flows have changed so drastically that the news is inconsequential. For those who have been patiently waiting, knowing that WordPress would one day make this right, it is a moment to rejoice.</p>\n\n\n\n<p>Judging by the response to Matías Ventura&#8217;s <a href=\"https://twitter.com/matias_ventura/status/1508386768864911372\">tweet yesterday</a>, it is a reminder of just how much people have wanted this feature:</p>\n\n\n\n<div class=\"wp-block-embed__wrapper\">\n<blockquote class=\"twitter-tweet\"><p lang=\"en\" dir=\"ltr\">Soon you\'d be able to select text across blocks in WordPress while retaining the fundamental mechanics of content blocks. <img src=\"https://s.w.org/images/core/emoji/13.1.0/72x72/2604.png\" alt=\"☄\" class=\"wp-smiley\" /><br /><br />Major kudos to <a href=\"https://twitter.com/ellatrx?ref_src=twsrc%5Etfw\">@ellatrx</a> for the steady work that lead us here! <a href=\"https://t.co/e6tL7r434j\">pic.twitter.com/e6tL7r434j</a></p>&mdash; Matías Ventura (@matias_ventura) <a href=\"https://twitter.com/matias_ventura/status/1508386768864911372?ref_src=twsrc%5Etfw\">March 28, 2022</a></blockquote>\n</div>\n\n\n\n<p>The implementation does not yet offer complete coverage of capabilities when selecting text across Rich Text blocks. It currently includes the following:</p>\n\n\n\n<ul><li><strong>Enter:</strong> Hitting the <code>Enter</code> key will delete the selected text and create a new paragraph.</li><li><strong>Backspace:</strong> Hitting the <code>Backspace</code> key removes the selected text and merges anything left of the latter block with the former.</li><li><strong>Delete:</strong> Hitting the <code>Del</code> key removes the selected text and forward merges the previous text.</li><li><strong>Input:</strong> Typing will replace the selected text with new input.</li></ul>\n\n\n\n<p>The difference between <code>Backspace</code> and <code>Del</code> is relevant when dealing with different block types. For example, when highlighting text from a list followed by a paragraph, backspacing will merge the remainder of the paragraph text as a list item. When deleting, the list items become paragraphs.</p>\n\n\n\n<img />Backspacing selected text across List and Paragraph blocks.\n\n\n\n<p>I did notice a bug when backspacing into a list.  It leaves an empty list item, as shown in the above screenshot.</p>\n\n\n\n<p>There is still no current method of selecting text from two or more blocks and copying or cutting it. Attempting this falls back to the previous behavior. The copy/cut action grabs the entire block code instead of the text itself.</p>\n\n\n\n<img />Copy action when selecting partial text.\n\n\n\n<p>The new feature does not do away with the ability to partially select text across multiple blocks and manipulate them as a group. Users can still shift their position, copy them, and modify them.</p>\n\n\n\n<p>Instead, the text-selection feature is an enhancement to the current tools, and it is one that many will be happy to see land in WordPress.  It is not a complete set of capabilities, but this is a win for the project and a necessary step forward.</p>\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}s:7:\"pubDate\";a:1:{i:0;a:5:{s:4:\"data\";s:31:\"Wed, 30 Mar 2022 01:38:43 +0000\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}}s:32:\"http://purl.org/dc/elements/1.1/\";a:1:{s:7:\"creator\";a:1:{i:0;a:5:{s:4:\"data\";s:14:\"Justin Tadlock\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}}}}i:24;a:6:{s:4:\"data\";s:13:\"\n	\n	\n	\n	\n	\n	\n\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";s:5:\"child\";a:2:{s:0:\"\";a:5:{s:5:\"title\";a:1:{i:0;a:5:{s:4:\"data\";s:84:\"WPTavern: WordCamp Asia 2023 Tentatively Set For February 17-19 in Bangkok, Thailand\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}s:4:\"guid\";a:1:{i:0;a:5:{s:4:\"data\";s:30:\"https://wptavern.com/?p=132098\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}s:4:\"link\";a:1:{i:0;a:5:{s:4:\"data\";s:94:\"https://wptavern.com/wordcamp-asia-2023-tentatively-set-for-february-17-19-in-bangkok-thailand\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}s:11:\"description\";a:1:{i:0;a:5:{s:4:\"data\";s:2996:\"<p><a href=\"https://asia.wordcamp.org/2023/\">WordCamp Asia</a> is tentatively back on the schedule of in-person WordPress events with new dates: February 17-19, 2023, in Bangkok, Thailand. It will begin with a Contributor day, followed by two conference days.</p>\n\n\n\n<p>Asia&#8217;s inaugural flagship WordCamp was originally scheduled for March 2020 but was the first international WordPress event to be <a href=\"https://wptavern.com/wordcamp-asia-2020-canceled-over-covid-19-concerns\">cancelled due to the pandemic</a>. It was cancelled just nine days before it was scheduled to happen, a difficult but necessary decision, despite all the hard work volunteers had invested. At that time, organizers hoped to push the event to the next year, but the pandemic forced it to be put on hold again.</p>\n\n\n\n<p>The WordPress community in Asia is quite large and spans across a wide land area with many diverse cultures. Prior to the pandemic, Asia was home to 127 WordPress meetup chapters with 73,000 members across 23 countries. The region had hosted 137 WordCamps in 18 Asian countries and 52 cities.</p>\n\n\n\n<p>WordCamp Asia organizers <a href=\"https://wptavern.com/wordsesh-asia-now-in-planning-for-2018-wordcamp-asia-targeted-for-2019\">began preliminary planning in 2017</a>, inspired by other successful regional camps. Five years later, they have once again <a href=\"https://asia.wordcamp.org/2023/call-for-organisers/\">opened the call for organizers</a>. They are aiming to build a team of 15 local (Thai) organizers and 30-35 organizers from other parts of Asia. This group will be broken up into teams that will lead audio/visual tech, design, speakers, volunteers, and other practical aspects of event planning.</p>\n\n\n\n<p>Prospective organizers must reside in Asia and have experience organizing meetups or WordCamps. They must also be willing to commit at least three hours per week for planning and meetings.</p>\n\n\n\n<p>&#8220;Because the main venue will be the same place as originally planned, we will be able to reuse some work from 2020,&#8221; organizer Naoko Takano said.</p>\n\n\n\n<p>&#8220;We will comply with any COVID-19 guidelines provided by the local government and WordPress Community Team (<a href=\"https://make.wordpress.org/community/2022/01/24/updated-guidelines-for-in-person-wordcamps-and-meetups-2022/\">such as this one</a>) to ensure the safety of the attendees.&#8221; If for some reason the event needs to be postponed again, organizers have a much more structured approach to managing this risk and making decisions.</p>\n\n\n\n<p>After five years of planning and so many unavoidable delays, the persistence and resilience of WordCamp Asia&#8217;s organizers is admirable. The call to join their team is open until April 30, and selected organizers will be notified by mid-May. Follow <a href=\"https://twitter.com/wordcampasia\">@wordcampasia</a> on Twitter for the latest updates or <a href=\"https://asia.wordcamp.org/2023/\">subscribe to the event&#8217;s website</a>.</p>\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}s:7:\"pubDate\";a:1:{i:0;a:5:{s:4:\"data\";s:31:\"Mon, 28 Mar 2022 21:52:20 +0000\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}}s:32:\"http://purl.org/dc/elements/1.1/\";a:1:{s:7:\"creator\";a:1:{i:0;a:5:{s:4:\"data\";s:13:\"Sarah Gooding\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}}}}i:25;a:6:{s:4:\"data\";s:13:\"\n	\n	\n	\n	\n	\n	\n\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";s:5:\"child\";a:2:{s:0:\"\";a:5:{s:5:\"title\";a:1:{i:0;a:5:{s:4:\"data\";s:101:\"Gutenberg Times: 59 FSE Themes, WordPress for Writers, Automating Development – Weekend Edition 208\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}s:4:\"guid\";a:1:{i:0;a:5:{s:4:\"data\";s:35:\"https://gutenbergtimes.com/?p=20789\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}s:4:\"link\";a:1:{i:0;a:5:{s:4:\"data\";s:106:\"https://gutenbergtimes.com/59-fse-themes-wordpress-for-writers-automating-development-weekend-edition-208/\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}s:11:\"description\";a:1:{i:0;a:5:{s:4:\"data\";s:17378:\"<p>Howdy, </p>\n\n\n\n<p><a href=\"https://make.wordpress.org/core/6-0/\"><em>WordPress 6.0</em></a> is coming to a WordPress instance near you on May 24th, 2022. The teams are all working hard to get things finished, patched and updated by April 12 before Beta 1 is release. <strong>Save the date <em>April 5th, 2022</em></strong> for a first walk-through with the release team. </p>\n\n\n\n<p>Working on the release has been a great opportunity to reconnect with the WordPress documentation team. It&#8217;s a lot of work, and if you can spare a few hours before the release, there are a few pages of the End user documentation that would need updating. Connect with the <a href=\"https://wordpress.slack.com/archives/C02RP4WU5\">#docs team via WPSlack</a> (account required) or <a href=\"https://github.com/WordPress/Documentation-Issue-Tracker/labels/good%20first%20issue\">grab one of the Good First issues on the GitHub repo</a>, if you want to help. </p>\n\n\n\n<p>Have a great weekend! </p>\n\n\n\n<p>Yours, 💕<br />Birgit </p>\n\n\n\n\n\n\n<div class=\"wp-container-2 wp-block-group has-light-background-background-color has-background\"><div class=\"wp-block-group__inner-container\">\n<p><strong>Table of Contents</strong></p>\n\n\n\n<div class=\"wp-block-sortabrilliant-guidepost\"><ul><li><a href=\"https://gutenbergtimes.com/feed/#0-g\">Themes with blocks and Full-site Editing</a><ul><li><a href=\"https://gutenbergtimes.com/feed/#1-5\">59 Themes </a></li></ul></li><li><a href=\"https://gutenbergtimes.com/feed/#2-block-building-and-developing-for-the-block-editor\">Block Building and Developing for the Block Editor</a></li><li><a href=\"https://gutenbergtimes.com/feed/#3-s\">Gutenberg tips for content creators and #nocde site builders</a></li><li><a href=\"https://gutenbergtimes.com/feed/#4-upcoming-word-press-events\">Upcoming WordPress Events</a><ul><li><a href=\"https://gutenbergtimes.com/feed/#5-social-learning-and-other-events\">11 Social Learning Meetups</a></li></ul></li><li><a href=\"https://gutenbergtimes.com/feed/#6-w\">WordCamps and other events</a></li></ul></div>\n</div></div>\n\n\n\n\n<hr class=\"wp-block-separator is-style-wide\" />\n\n\n\n<p>In his <a href=\"https://www.youtube.com/watch?v=8rFiFJ1nDp0\">3rd episode of the <strong>WordPress Gutenberg Block News</strong></a>, <strong>Jamie Marsland</strong> covers among other topics, the new pattern directory, Google&#8217;s <a href=\"https://wordpress.org/themes/material-design-google/\">Material Design </a>theme<a href=\"https://wordpress.org/themes/material-design-google/\"> </a>and Automattic&#8217;s newest Block theme, <a href=\"https://wordpress.org/themes/archeo/\">Archeo</a>.</p>\n\n\n\n<h2 id=\"0-g\">Themes with blocks and Full-site Editing</h2>\n\n\n\n<p><br />In  the <a href=\"https://make.wordpress.org/themes/2022/03/18/gutenberg-themes-week-of-march-14th-2022/\"><strong>77th round-up posts from the Themes Team</strong></a>, <strong><a href=\"https://twitter.com/jcristpbking\">Jason Crist </a></strong>posted about theme-related discussions, fixes, and developments in&nbsp;Gutenberg. He highlighted the new features, with links to PRs </p>\n\n\n\n<ul><li>Webfonts&nbsp;API: Font Configuration via theme.json</li><li>Included in the Zip: Global Styles and More</li><li>Pattern Registration with theme.json</li></ul>\n\n\n\n<p>As active discussion, Crist links to the issues: </p>\n\n\n\n<ul><li><a href=\"https://github.com/WordPress/gutenberg/issues/39189\">Visual Theme Building Tracking Issue</a></li><li><a href=\"https://github.com/WordPress/gutenberg/discussions/39586\">AppearanceTools in theme.json might not be the right idea.</a></li><li>Standardization of colors, themes and typography is discussed in multiple issues from different angles. </li></ul>\n\n\n\n<p>You&#8217;ll also find General Resource links to catch up on FSE and Themes. </p>\n\n\n\n<hr class=\"wp-block-separator is-style-wide\" />\n\n\n\n<p>In the new workshop, <a href=\"https://learn.wordpress.org/workshop/taking-advantage-of-query-loops/\"><strong>Taking Advantage of Query&nbsp;Loops</strong></a>, <strong>Wes Theron</strong> explores how to use the Query Loop block to showcase blog posts, pages, categories, tags and more!&nbsp;</p>\n\n\n\n<h3 id=\"1-5\">59 Themes </h3>\n\n\n\n<p>The WordPress repository now sports <strong><a href=\"https://wordpress.org/themes/tags/full-site-editing/\">59 themes made for full-site editing</a>.</strong> </p>\n\n\n\n<p>The newest Themes are</p>\n\n\n\n<ul><li><a href=\"https://wordpress.org/themes/archeo/\">Archeo</a> by Automattic</li><li><a href=\"https://wordpress.org/themes/grigora-blocks/\">Girgora Blocks</a> by Latracal Solutions</li><li><a href=\"https://wordpress.org/themes/hello-gutenify/\">Hello Gutenify</a> by Gutenify Dev</li><li><a href=\"https://wordpress.org/themes/ona-creative/\">Ona Creative</a> by Deo Themes</li><li><a href=\"https://wordpress.org/themes/oscura/\">Oscura </a>by <a href=\"https://twitter.com/alexandrebuffet\">Alexandre Buffet</a></li></ul>\n\n\n\n<p>Justin Tadlock gave Archeo Theme a whirl and posted his findings: <a href=\"https://wptavern.com/the-archeo-wordpress-theme-blends-mayan-history-with-magazine-style-block-patterns\"><strong>The Archeo WordPress Theme Blends Mayan History With Magazine-Style Block Patterns</strong></a></p>\n\n\n\n<p>The WPTavern Review of the Ona Theme is available here: <a href=\"https://wptavern.com/deothemes-launches-ona-creative-another-well-designed-wordpress-block-theme\"><strong>DeoThemes Launches Ona Creative, Another Well-Designed WordPress Block Theme</strong></a>, also by Justin Tadclosk</p>\n\n\n\n<p><strong><a href=\"https://twitter.com/alexandrebuffet\">Alexander Buffet</a></strong>, frontend developer from Nantes, France and translation contributor,  built his first theme as an FSE theme called &#8220;Oscura&#8221; (<a href=\"https://www.alexandrebuffet.com/themes/oscura/\">demo</a>) for photographers and creatives. It emphasizes white space and is visually subtle to not take attention away from the creations by its site owner. You can also look under the hood on <a href=\"https://github.com/alexandrebuffet/oscura\">its GitHub repository</a>. Buffet uses well-structured code with multiple template parts, and patterns in their respective directories. </p>\n\n\n\n<img />\n\n\n\n\n<p><strong>&nbsp;<a href=\"https://make.wordpress.org/core/handbook/references/keeping-up-with-gutenberg-index/\" target=\"_blank\" rel=\"noreferrer noopener\">&#8220;Keeping up with Gutenberg &#8211; Index 2022&#8221;</a>&nbsp;</strong><br />A chronological list of the WordPress Make Blog posts from various teams involved in Gutenberg development: Design, Theme Review Team, Core Editor, Core JS, Core CSS, Test and Meta team from Jan. 2021 on. Updated by yours truly.  <a href=\"https://make.wordpress.org/core/handbook/references/keeping-up-with-gutenberg-index/keeping-up-with-gutenberg-index-2020/\"><em>The index 2020 is here</em></a></p>\n\n\n\n\n<h2 id=\"2-block-building-and-developing-for-the-block-editor\">Block Building and Developing for the Block Editor</h2>\n\n\n\n<p>The recording of this week&#8217;s Webinar with <strong>Grzegorz Ziolkowski</strong> and <strong>Maciek Palmowski</strong> <a href=\"https://www.youtube.com/watch?v=RTficEgju7k\"><strong>How to automate Gutenberg block development in WP projects</strong></a> is now available on YouTube. On Twitter, <a href=\"https://twitter.com/gziolo/status/1506967009921323014\">Ziolkowski shared</a> additional resources:  </p>\n\n\n\n<ul><li>A very comprehensive tutorial in the WordPress Block Editor Handbook that explains <a href=\"https://developer.wordpress.org/block-editor/getting-started/create-block/\"><strong>how to create your first block.</strong></a></li><li><a href=\"https://www.npmjs.com/package/@wordpress/create-block\">The tool to scaffold blocks</a> you can run with a single `npx @wordpress/create-block` command from your terminal.</li><li>&#8220;All the commands tailored for block development can also run with continuous integration, and they get installed when scaffolding the project. You can also install [<a href=\"https://www.npmjs.com/package/@wordpress/scripts\">@wordpress/scripts</a>] without scaffolding by executing `npm install @wordpress/scripts`&#8221; Ziolkowski <a href=\"https://twitter.com/gziolo/status/1506970281767809027\"><em>continued</em></a>.</li></ul>\n\n\n\n<hr class=\"wp-block-separator is-style-wide\" />\n\n\n\n<p><strong><a href=\"https://twitter.com/leeshadle\">Lee Shadle</a> </strong>of creator of the <a href=\"https://blockhandbook.com/\">BlockHandbook </a>site, answered the question many developers have: &#8220;Is there a fun/easy/lightweight way to add frontend interactivity to custom Gutenberg blocks w/o using React or jQuery?&#8221; <a href=\"https://twitter.com/leeshadle/status/1506780446612332547\">with &#8220;Yes&#8221;</a>, and with yet another JavaScript tool:  <a href=\"https://alpinejs.dev/\">AlpineJS</a>. Shadle published his proof-of-concept code  on GitHub. <a href=\"https://github.com/blockhandbook/alpine\"><strong>Add Alpinejs to Custom Gutenberg Blocks</strong></a></p>\n\n\n\n<hr class=\"wp-block-separator is-style-wide\" />\n\n\n\n<p><strong><a href=\"https://twitter.com/m_munirkamal\">Munir Kamal</a></strong>, creator of Gutenberg Hub and Editor Plus, published a tutorial on <a href=\"https://gutenberghub.com/how-to-create-gutenberg-unsplash-block/\"><strong>How to Create a WordPress Gutenberg block that displays an Unsplash image</strong></a>. </p>\n\n\n\n<p>After you follow this tutorial, you built a block that generates a random image from Unsplash to be used in a post. It&#8217;s an easy to follow along article with code examples and explanations. Personally, I would have favored a custom block that displays media from Openverse. Maybe I find the time to rewrite it for Openverse. Wanna race me? Just kidding. </p>\n\n\n\n<hr class=\"wp-block-separator is-style-wide\" />\n\n\n\n<p><strong><a href=\"https://twitter.com/mikejolley\">Mike Jolley</a></strong>, WooCommerce, updated the developer this week that the <strong><a href=\"https://developer.woocommerce.com/2022/03/25/store-api-is-now-considered-stable/\">Store API is now considered&nbsp;stable</a>.</strong> &#8220;It not only powers the new Block-based Cart and Checkout experience, but also the various product Blocks as well.&#8221; he wrote. The API is now available for 3rd party tools and services, and the article provides use cases and code examples. </p>\n\n\n\n\n<p><strong><a href=\"https://gutenbergtimes.com/need-a-zip-from-master/\">Need a plugin .zip from Gutenberg&#8217;s master branch?</a></strong><br />Gutenberg Times provides daily build for testing and review. <br />Have you been using it? Hit reply and let me know.</p>\n\n\n\n<p><img alt=\"GitHub all releases\" src=\"https://img.shields.io/github/downloads/bph/gutenberg/total?style=for-the-badge\" /></p>\n\n\n\n\n<h2 id=\"3-s\">Gutenberg tips for content creators and #nocde site builders</h2>\n\n\n\n<p>In the recording of the recent WordPress Social Learning meetup, <strong><a href=\"https://wordpress.tv/2022/03/21/wordpress-for-writers-launching-your-writer-website/\" rel=\"nofollow\">WordPress for Writers: Launching your Writer&nbsp;Website</a></strong>,  <a href=\"https://twitter.com/TheeDestinyWP\"><strong>Destiny Kanno</strong></a>, fledgling writer and WordPress enthusiast, walked attendees  through setting up a writer’s website with a literature-focused theme.  By the end of this session, participants had the tools you need to </p>\n\n\n\n<ul><li>apply a theme, </li><li>create an engaging story publication, and </li><li>set up your about page and a contact form </li></ul>\n\n\n\n<p>using Full Site Editing, and the Block Editor.</p>\n\n\n\n<hr class=\"wp-block-separator is-style-wide\" />\n\n\n\n<p>The writers at WPTavern, Sarah Gooding and Justin Tadlock created new articles for their <strong>&#8220;Building with Block Series&#8221;</strong> </p>\n\n\n\n<ul><li><a href=\"https://wptavern.com/how-to-build-a-two-column-single-post-header-with-the-wordpress-site-editor\">How To Build a Two-Column Single Post Header with the WordPress Site Editor</a></li><li><a href=\"https://wptavern.com/how-to-build-a-single-product-sales-page-with-blocks\">How to Build a Single-Product Sales Page with Blocks</a></li></ul>\n\n\n\n<h2 id=\"4-upcoming-word-press-events\">Upcoming WordPress Events</h2>\n\n\n\n<h3 id=\"5-social-learning-and-other-events\">11 Social Learning Meetups</h3>\n\n\n\n<p><strong>March 28, 2022, at 11 am ET / 15:00 UTC</strong><br /><strong><a href=\"https://www.meetup.com/wordpress-social-learning/events/284387767/\">Hello Blocks! Coding a custom block</a></strong>&nbsp;with Wes Theron and Ryan Welcher</p>\n\n\n\n<p><strong>March 29, 2022, at 3 pm ET / 20:00 UTC</strong><br /><strong><a href=\"https://www.meetup.com/wordpress-social-learning/events/284252760/\">Beginner’s Guide to Full Site Editing&nbsp;</a></strong>with Sarah Snow</p>\n\n\n\n<p><strong>April 1, 2022, 11 am EDT / 15:00 UTC </strong><br /><strong><a href=\"https://www.meetup.com/wordpress-social-learning/events/284700941/\">Block Theme Discussions: JSON Schema</a></strong> with Daisy Olsen </p>\n\n\n\n<p><strong>April 6, 2022, 12 pm EDT / 16:00 UTC</strong> <br /><a href=\"https://www.meetup.com/wordpress-social-learning/events/284752435/\"><strong>Creating A Sidebar For Your Posts Using The Full Site Editing Blank Template</strong></a> with Bud Kraus, JoyofWP</p>\n\n\n\n<p><strong>April 6, 2022, 2pm EDT / 18:00 UTC</strong> <br /><a href=\"https://www.meetup.com/wordpress-social-learning/events/284700789/\"><strong>Builder Basics: Designing with Columns, Group, and Row Blocks (Part 2)</strong></a> with Nick Diego</p>\n\n\n\n<p><strong>April 8, 2022, 11 am EDT / 15:00 UTC </strong><br /><a href=\"https://www.meetup.com/wordpress-social-learning/events/284701015/\"><strong>Block Theme Discussions: Supports in theme.json</strong></a> with Daisy Olsen </p>\n\n\n\n<p><strong>April 12, 2022 2pm EDT 18:00 UTC</strong> <br /><strong><a href=\"https://www.meetup.com/wordpress-social-learning/events/284700822/\">Builder Basics: Headers and Footers in Full Site Editing</a></strong> w/ Nick Diego</p>\n\n\n\n<p><strong>April 13, 2022, 10 am EDT / 14:00 UTC </strong><br /><a href=\"https://www.meetup.com/wordpress-social-learning/events/284753523/\"><strong>Create a Magazine Layout with the WordPress Gutenberg Block Editor</strong></a> with Wes Theron</p>\n\n\n\n<p><strong>April 15, 2022, 11 am EDT / 15:00 UTC</strong> <br /><strong><a href=\"https://www.meetup.com/wordpress-social-learning/events/284701295/\">Block Theme Discussions: Presets in theme.json</a></strong> with Daisy Olsen</p>\n\n\n\n<p><strong>April 19, 2022 2pm EDT / 18:00 UTC</strong> <br /><strong><a href=\"https://www.meetup.com/wordpress-social-learning/events/284700867/\">Builder Basics: Exploring Block Layout, Alignment, and Dimensions </a>(Part 2)</strong></p>\n\n\n\n<p><strong>April 21, 2022 3 am EDT / 7 am UTC</strong> <br /><a href=\"https://www.meetup.com/wordpress-social-learning/events/284753652/\"><strong>Using Block Patterns</strong></a> with Wes Theron</p>\n\n\n\n<h2 id=\"6-w\">WordCamps and other events</h2>\n\n\n\n<p><strong>April 8, 2022 9 am &#8211; 5 pm CDT / 14:00 &#8211; 20:00 UTC</strong><br /><a href=\"http://wpcareersummit.com/\"><strong>WP Career Summit</strong></a>&nbsp;conference for Careers in WordPress, organized by team at Post Status </p>\n\n\n\n<p><strong>May 16-20, 2022 </strong><br /><strong><a href=\"https://wordsesh.com/\">WordSesh</a></strong><br />A virtual conference. <a href=\"https://wordsesh.com/speak/\">Call for Speaker is open</a></p>\n\n\n\n<p><strong>June 2 &#8211; 4th, 2022</strong> <br /><strong><a href=\"https://europe.wordcamp.org/2022/\">WordCamp Europe</a></strong><br />Sign up for updates to get notifications about speakers, sessions, and schedule.</p>\n\n\n\n<p><strong>June 20 &#8211; 24, 2022</strong> <br /><strong><a href=\"https://pagebuildersummit.com/\">Page Builder Summit </a></strong>will take place June 20th to June 24, 2022. <a href=\"https://pagebuildersummit.com/sponsors/\"><em>The call for sponsors is still open</em></a>. Sign-up for the VIP list to learn first when tickets are available and the schedule is published. </p>\n\n\n\n<p><strong>September 9 &#8211; 11, 2022</strong><br /><strong><a href=\"https://us.wordcamp.org/2022/\">WordCamp US</a></strong> <br />in-person conference in San Diego. <a href=\"https://us.wordcamp.org/2022/apply-to-speak-at-wcus/\">Call for Speakers is open</a>, deadline April 17th, 2022<br /></p>\n\n\n\n\n<hr class=\"wp-block-separator is-style-wide\" />\n\n\n\n<p class=\"has-text-align-left\"><strong>Don&#8217;t want to miss the next Weekend Edition? </strong></p>\n\n\n\n<form class=\"wp-block-newsletterglue-form ngl-form ngl-portrait\" action=\"https://gutenbergtimes.com/feed/\" method=\"post\"><div class=\"ngl-form-container\"><div class=\"ngl-form-field\"><label class=\"ngl-form-label\" for=\"ngl_email\"><br />Type in your Email address to subscribe.</label><div class=\"ngl-form-input\"><input type=\"email\" class=\"ngl-form-input-text\" name=\"ngl_email\" id=\"ngl_email\" /></div></div><button class=\"ngl-form-button\">Subscribe</button><p class=\"ngl-form-text\">We hate spam, too and won&#8217;t give your email address to anyone except Mailchimp to send out our Weekend Edition</p></div><div class=\"ngl-message-overlay\"><div class=\"ngl-message-svg-wrap\"></div><div class=\"ngl-message-overlay-text\">Thanks for subscribing.</div></div><input type=\"hidden\" name=\"ngl_list_id\" id=\"ngl_list_id\" value=\"26f81bd8ae\" /><input type=\"hidden\" name=\"ngl_double_optin\" id=\"ngl_double_optin\" value=\"yes\" /></form>\n\n\n\n<hr class=\"wp-block-separator is-style-wide\" />\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}s:7:\"pubDate\";a:1:{i:0;a:5:{s:4:\"data\";s:31:\"Sat, 26 Mar 2022 05:14:00 +0000\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}}s:32:\"http://purl.org/dc/elements/1.1/\";a:1:{s:7:\"creator\";a:1:{i:0;a:5:{s:4:\"data\";s:18:\"Birgit Pauli-Haack\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}}}}i:26;a:6:{s:4:\"data\";s:13:\"\n	\n	\n	\n	\n	\n	\n\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";s:5:\"child\";a:2:{s:0:\"\";a:5:{s:5:\"title\";a:1:{i:0;a:5:{s:4:\"data\";s:66:\"WPTavern: The WordPress.org Pattern Creator Now Open to the Public\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}s:4:\"guid\";a:1:{i:0;a:5:{s:4:\"data\";s:30:\"https://wptavern.com/?p=132032\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}s:4:\"link\";a:1:{i:0;a:5:{s:4:\"data\";s:77:\"https://wptavern.com/the-wordpress-org-pattern-creator-now-open-to-the-public\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}s:11:\"description\";a:1:{i:0;a:5:{s:4:\"data\";s:5240:\"<img />\n\n\n\n<p class=\"has-drop-cap\">The WordPress <a href=\"https://wordpress.org/patterns/\">pattern directory</a> finally <a href=\"https://wordpress.org/news/2022/03/get-creative-with-the-all-new-pattern-creator/\">opened its gates</a> to the entire community today. Anyone with a WordPress.org account can log in, go to the <a href=\"https://wordpress.org/patterns/new-pattern/\">pattern creator</a>, and start designing.</p>\n\n\n\n<p>For some of us, this has felt like an unbearably long wait. In reality, it took the development team less than a year since the <a href=\"https://wptavern.com/the-wordpress-org-block-pattern-directory-now-live\">directory launch</a> to put this together. It was no small feat to make it work and put in all the guardrails for such a system in that amount of time.</p>\n\n\n\n<p>Some community members have already got a head start. Ana Segota of Anariel Design announced <a href=\"https://twitter.com/Ana_Segota/status/1507407534650445831\">via Twitter</a> that three of her patterns had already landed. &#8220;More coming soon,&#8221; she said.</p>\n\n\n\n<img /><a href=\"https://wordpress.org/patterns/author/anariel-design/\">Patterns by Anariel Design.</a>\n\n\n\n<p>The pattern directory has the potential to be an onramp for creators who want to contribute to the WordPress project but do not know where to start. The barrier to entry is one of the lowest in the community. There is no requirement to write code or understand all the intricacies of theme design. It is nowhere near as complex as plugin development. It is simply a visual builder that allows sharing art with the world.</p>\n\n\n\n<p>I have no idea where this thing is going. I hope to see 1,000s of patterns in the directory a year from now.</p>\n\n\n\n<p>I played a small role in building two of the initial patterns from last year. I was excited about the potential for the directory and happy to contribute in any way. However, I was not entirely satisfied with the process because I did not have the creative freedom I wanted.</p>\n\n\n\n<p>For example, my vision for an &#8220;about me&#8221; columns pattern had <a href=\"https://wordpress.org/patterns/pattern/about-me-cards/\">morphed into something entirely different</a>:</p>\n\n\n\n<img />Final about me cards pattern.\n\n\n\n<p>By the time it was added to the directory, there was hardly any of myself in it. The first designs that launched were tightly curated, and that was OK. It was more about getting production-ready patterns out to users at the time, and I knew that WordPress.org would eventually open it up.</p>\n\n\n\n<p>Today, I started work anew, rebuilding my original &#8220;about me&#8221; pattern. I have made some alterations because we now have new spacing controls. And the built-in, <a href=\"https://wordpress.org/openverse/\">Openverse</a>-powered search did not seem to locate some of my early images, despite being available via the Openverse site. Nevertheless, it is a work in progress:</p>\n\n\n\n<img />Building with the new pattern creator.\n\n\n\n<p>Users can save draft patterns, too. So, if you want to try your hand at designing one but are unsure if you can finish it in one sitting or do not have a fully-fleshed-out idea, there is no need to worry about losing work. You can save it and pull it up later from <a href=\"https://wordpress.org/patterns/my-patterns/\">your patterns page</a>.</p>\n\n\n\n<p>The pattern creator runs Twenty Twenty-One under the hood. The classic theme has a few quirks, CSS that often overrules the core WordPress styles. I would rather have seen Twenty Twenty-Two because it sticks much more closely to the global styles standard. At least people who want to try designing off-site will be able to test with a similar setup.</p>\n\n\n\n<p>Patterns should, ideally, be theme-agnostic. However, in practice, the theme that showcases those patterns &#8212; Twenty Twenty-One in this case &#8212; can make or break a design. Creators should not design specifically for it, but they should at least check its output.</p>\n\n\n\n<p>Using the pattern creator is straightforward. It is merely an instance of the block editor with some modifications specific to the directory. It also provides a quick welcome screen:</p>\n\n\n\n<img />Welcome screen to the pattern creator.\n\n\n\n<p>Overall, my experience with it went reasonably well for a Day 1 launch. Most of the hiccups that I encountered were with the image search. It timed out on occasion, and filtering images was not a perfect experience. Despite being powered by Openverse, it does not offer the same filtering tools.</p>\n\n\n\n<p>I hope that the pattern creator will eventually tie into the <a href=\"https://wordpress.org/photos/\">WordPress photo directory</a>. The built-in search is a neat tool, but you sometimes have to wade through dozens or hundreds of outdated images to find something worth using. The photo directory feels fresh and modern. Plus, we should be prioritizing the work of those contributing to WordPress.</p>\n\n\n\n<p>There are still many <a href=\"https://github.com/WordPress/pattern-directory/issues\">open tickets</a> for the pattern directory, and it will undoubtedly evolve based on feedback and usage. However, this is a solid launch of the pattern creator. Well done to all the folks who made this happen.</p>\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}s:7:\"pubDate\";a:1:{i:0;a:5:{s:4:\"data\";s:31:\"Sat, 26 Mar 2022 03:16:34 +0000\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}}s:32:\"http://purl.org/dc/elements/1.1/\";a:1:{s:7:\"creator\";a:1:{i:0;a:5:{s:4:\"data\";s:14:\"Justin Tadlock\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}}}}i:27;a:6:{s:4:\"data\";s:13:\"\n	\n	\n	\n	\n	\n	\n\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";s:5:\"child\";a:2:{s:0:\"\";a:5:{s:5:\"title\";a:1:{i:0;a:5:{s:4:\"data\";s:88:\"WPTavern: WooCommerce Store API Now Stable, Provides Better Support for Custom Frontends\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}s:4:\"guid\";a:1:{i:0;a:5:{s:4:\"data\";s:30:\"https://wptavern.com/?p=132009\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}s:4:\"link\";a:1:{i:0;a:5:{s:4:\"data\";s:98:\"https://wptavern.com/woocommerce-store-api-now-stable-provides-better-support-for-custom-frontends\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}s:11:\"description\";a:1:{i:0;a:5:{s:4:\"data\";s:5730:\"<p>WooCommerce <a href=\"https://developer.woocommerce.com/2022/03/25/store-api-is-now-considered-stable/\">announced</a> today that its new Store API is now stable after two years in development. It powers the plugin&#8217;s new block-based cart and checkout experience as well as all products blocks.</p>\n\n\n\n<p>The Store API is a public, unauthenticated API, that provides REST API endpoints for cart, checkout, and product functionality. WooCommerce core developer Mike Jolley explained how the new API is different from the plugin&#8217;s REST API:</p>\n\n\n\n<blockquote class=\"wp-block-quote\"><p>The main difference between the Store API and WC REST API is that the Store API&nbsp;<strong>allows unauthenticated access</strong>&nbsp;to store data, for example, products. This makes it suitable for a variety of use-cases, including custom frontends.</p><p>This is an&nbsp;<strong>unauthenticated API</strong>. It does not require API keys or authentication tokens for access.</p><p>Another difference is that the Store API has support for&nbsp;<strong>Cart data.</strong>&nbsp;This allows for cart operations such as adding items to the cart, updating quantities, applying coupons, and submitting orders. Only the current customer’s cart can be accessed.</p><p>Data returned from the Store API is always reflective of the current user (cookie-based), whereas the WC REST API allows more extensive access to any data, should you have the correct access rights.</p></blockquote>\n\n\n\n<p>In an <a href=\"https://hollerwp.com/mike-jolley-interview/\">interview with HollerWP</a> last year, Jolley said it&#8217;s helpful to think of the Store API as for clients and the core REST API as the API for store management.</p>\n\n\n\n<p>&#8220;Keeping them separate like this makes it clear that one exposes data in a public context,&#8221; he said.</p>\n\n\n\n<p>Scott Bolinger, co-founder of <a href=\"https://apppresser.com/\">AppPresser</a>, explained how the Store API fixes a problem with the original WooCommerce REST API.</p>\n\n\n\n<p>&#8220;It [the WC REST API] was never meant for mobile, headless, or any other front end implementation,&#8221; Bolinger said. &#8220;It was only meant for back end admin stuff like inventory, adding/removing products, etc. </p>\n\n\n\n<p>&#8220;The problem is that there was no alternative, so headless/mobile apps used it for displaying products. With the WC REST API, everything requires authentication, which doesn’t make sense, because products are public on your website. You shouldn’t have to authenticate to see someone’s products.&#8221;</p>\n\n\n\n<p>The new Store API allows developers to get products, attributes, collections, and other data without authentication, and adds a cart API, making it possible to checkout. </p>\n\n\n\n<p>&#8220;I think most implementations of the WC Rest API that are for the front end should switch to the Store API,&#8221; Bolinger said.</p>\n\n\n\n<p>The WooCommerce team is still working on making this API suitable for headless and mobile apps. In an ideal world, the best cart API for headless WooCommerce apps would be made by WooCommerce. In the meantime, Bolinger recommended <a href=\"https://cocart.xyz/\">CoCart</a>. </p>\n\n\n\n<p>CoCart is a customizable, WordPress REST API for WooCommerce that allows developers to build headless (or decoupled) e-commerce stores using their choice of frameworks.</p>\n\n\n\n<p>&#8220;I&#8217;m not using the Store API and I don&#8217;t see that I will,&#8221; Co-Cart founder Sébastien Dumont said. &#8220;Both API&#8217;s are unique for their individual purposes. WooCommerce&#8217;s Store API is designed for the Gutenberg blocks, which only requires a fixed format and is still prone to be used on native storefronts. </p>\n\n\n\n<p>&#8220;I don&#8217;t see today&#8217;s news affecting CoCart. Most of my users have already known about the Store API while it was still experiential and failed after trying it for headless purposes. It also requires tweaking while CoCart does not&#8221;. </p>\n\n\n\n<p>Dumont said the Store API is still missing a lot of valuable information that developers require and that using CoCart saves them considerable development time. </p>\n\n\n\n<p>&#8220;With the WC Rest API, there is no cart or checkout, so it’s cool they added that,&#8221; Bolinger said. &#8220;Nonces only work when you are on the site though, so for mobile apps or headless WP, you will run into issues. Unfortunately it’s not where it needs to be for headless (yet).</p>\n\n\n\n<p>&#8220;There is a filter to disable nonce authentication: <code>add_filter( \'woocommerce_store_api_disable_nonce_check\', \'__return_true\' );</code> Even changing this to use something like JWT won’t fully work for headless, at least in my testing. I hope they will address this in the future.&#8221;</p>\n\n\n\n<p>This particular <a href=\"https://github.com/woocommerce/woocommerce-gutenberg-products-block/issues/5683\">issue</a> is still open on the WooCommerce GitHub repository. Maintainers seem open to exploring how core can accommodate this. In the meantime, third-party solutions are available to developers building mobile apps. </p>\n\n\n\n<p>For a technical breakdown of what&#8217;s currently possible with the new Store API, check out Mike Jolley&#8217;s <a href=\"https://developer.woocommerce.com/2022/03/25/store-api-is-now-considered-stable/\">announcement</a> post. He demonstrated how you can go through the entire purchase flow using the Insomnia API client- without even visiting the store. The API&#8217;s <a href=\"https://github.com/woocommerce/woocommerce-gutenberg-products-block/tree/trunk/src/StoreApi\">technical documentation and guide to extensibility</a> is available on GitHub.</p>\n\n\n\n<p><a href=\"https://twitter.com/scottbolinger\"></a></p>\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}s:7:\"pubDate\";a:1:{i:0;a:5:{s:4:\"data\";s:31:\"Fri, 25 Mar 2022 21:42:12 +0000\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}}s:32:\"http://purl.org/dc/elements/1.1/\";a:1:{s:7:\"creator\";a:1:{i:0;a:5:{s:4:\"data\";s:13:\"Sarah Gooding\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}}}}i:28;a:6:{s:4:\"data\";s:13:\"\n	\n	\n	\n	\n	\n	\n\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";s:5:\"child\";a:2:{s:0:\"\";a:5:{s:5:\"title\";a:1:{i:0;a:5:{s:4:\"data\";s:76:\"Post Status: Fall of the Zamir: A Hate Symbol Enters and Exits WordPress.org\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}s:4:\"guid\";a:1:{i:0;a:5:{s:4:\"data\";s:31:\"https://poststatus.com/?p=95034\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}s:4:\"link\";a:1:{i:0;a:5:{s:4:\"data\";s:41:\"https://poststatus.com/fall-of-the-zamir/\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}s:11:\"description\";a:1:{i:0;a:5:{s:4:\"data\";s:11491:\"<p>How did a hate symbol get into WordPress.org\'s plugin repository? What can we learn from the community response? Will more transparent governance help us navigate <a href=\"https://poststatus.com/an-inside-job/\">the age of weaponized open source</a>?</p>\n\n\n\n<p class=\"has-drop-cap\">Since the Russian invasion of Ukraine began, the letter `Z` has been used as a symbol by the Russian government <a href=\"https://twitter.com/Rarst/status/1506685664242417665\">as a pro-war propaganda tool</a>. It\'s also being used by Russian civilians <a href=\"https://en.wikipedia.org/wiki/Z_(military_symbol)\">as a sign of support for the ongoing invasion</a> of Ukraine. The colors and ribbon of St. George are often used with the &#8216;Z\', and the Lithuanian parliament has <a href=\"https://hromadske.radio/en/news/2022/03/24/in-lithuania-parliament-puts-up-proposal-to-equate-the-z-symbol-and-the-ribbon-of-st-george-with-the-nazi-symbols\">proposed banning and equating</a> them with Nazi and Communist images. </p>\n\n\n\n<p><a href=\"https://www.newyorker.com/news/our-columnists/z-is-the-symbol-of-the-new-russian-politics-of-aggression\">Earlier this month</a>, <strong>Masha Gessen</strong> described the &#8216;Z\' in <strong>The New Yorker</strong> as having come &#8220;to stand for devotion to the state, murderous rage, and unchecked power.&#8221; While Gessen\'s definition stopped short of calling &#8216;Z\' a hate symbol in early March, it has been affirmed as one since then — definitely in the view of many Ukrainians. </p>\n\n\n\n<div class=\"wp-block-embed__wrapper\">\n<blockquote class=\"twitter-tweet\"><p lang=\"en\" dir=\"ltr\">Russians have chosen the letter Z as the symbol for their invasion of Ukraine. It is marking the Russian military vehicles and is widely used by the supporters of the war in Russia.<br /><br />I don\'t understand why they didn\'t go for the full swastika.</p>&mdash; Olga Rudenko (@olya_rudenko) <a href=\"https://twitter.com/olya_rudenko/status/1500073792961400832?ref_src=twsrc%5Etfw\">March 5, 2022</a></blockquote>\n</div>\n\n\n\n<p>At some point in the past few days, a <a href=\"https://profiles.wordpress.org/vovasik/\">Russian developer</a> forked the <a href=\"https://wordpress.org/plugins/stand-ukraine/\">&#8220;Stand with Ukraine&#8221;</a> plugin, as <strong>Nate Conley</strong> <a href=\"https://twitter.com/NateConley123/status/1506713410599149568\">later pointed out</a>. (There are quite a few pro-Ukraine plugins in the .org repo.) The forked plugin\'s author called it <strong><a href=\"https://wordpress.org/plugins/zamir/\">Zamir</a></strong> and made it &#8220;display the `Z` symbol in support of Russia.&#8221; </p>\n\n\n\n<p>The plugin was submitted for review, and it was approved.</p>\n\n\n\n<p>Here is <a href=\"https://web.archive.org/web/20220323182342/https://wordpress.org/plugins/zamir/\">how the Zamir plugin page looked</a> before it was taken down.</p>\n\n\n\n<h3 id=\"h-first-reactions-on-twitter-and-post-status-slack\">First Reactions on Twitter and Post Status Slack</h3>\n\n\n\n<p>When Zamir appeared in the WordPress plugin repository, it was very quickly noticed <a href=\"https://twitter.com/Rarst/status/1506681883404472324\">with many</a> <a href=\"https://twitter.com/ciorici/status/1506663406060851200\">negative reactions</a> on <strong>Twitter</strong>. Apart from complaints about the plugin being morally offensive, many people felt it violated the guidelines plugins must follow to be accepted in the WordPress.org repo. </p>\n\n\n\n<p>While reactions on Twitter exploded, a heated conversation opened in the main <code>#club</code> channel in <strong>Post Status Slack</strong>. Initially, there was shock and dismay that the Zamir plugin was appearing prominently on the new plugin list for all WordPress.com customers. One of the first to notice the plugin and recognize its significance, <strong>Carl Hancock</strong> fired off a terse takedown request to the plugin review team, which he shared in Post Status Slack. The request was denied, and Carl shared <a href=\"https://poststatus.slack.com/archives/CHNM7Q7T8/p1648053721931799\">the response he received</a>.</p>\n\n\n\n<p>Among Post Status members, the discussion was focused on whether the plugin should (or could) be removed under current guidelines. There was no disagreement on it being offensive, although not everyone knew about the &#8216;Z\' symbol\'s emerging significance. The <a href=\"https://poststatus.com/wordpress-as-a-commons/\">lack of protocols and governance</a> in place to handle a situation like this was noted by several people, including <strong>Lesley Sim</strong>:</p>\n\n\n\n<blockquote class=\"wp-block-quote\"><p>You know what would be cool? If the guidelines had examples or precedents so that we would have something more tangible to go on. Not just subject to everyone\'s interpretations which, clearly, we all seem to disagree on. Kinda like case law in the legal system.</p></blockquote>\n\n\n\n<h3 id=\"h-the-openness-of-making-wordpress-despite-unclear-decision-procedures\">The Openness of Making WordPress Despite Unclear Decision Procedures</h3>\n\n\n\n<p>The Making WordPress <code>#pluginreview</code> Slack channel had a Zamir discussion underway at the same time, including <a href=\"https://wordpress.slack.com/archives/C1LBM36LC/p1648057102435389\">an initial response</a> from <strong>Mika Epstein</strong> to confirm that the plugin had been approved. (Anyone interested in how WordPress gets made should read the open and transparent discussion in the plugin review channel for context.)</p>\n\n\n\n<p>Very quickly a number of people in the <strong>WordPress Foundation</strong> examined the situation and took some time to make a decision. The plugin was taken down, and <strong>Josepha Haden Chomphosy</strong> posted an explanation of <a href=\"https://make.wordpress.org/project/2022/03/23/removal-of-the-zamir-plugin/\">why Zamir violated community guidelines</a>:</p>\n\n\n\n<blockquote class=\"wp-block-quote\"><p>While it is true that there is no current plugin guideline barring plugins that “support” political leanings, this icon symbolizes something more complicated than that. Contributors were right to report this and, with their help and the help of WordPress community members, the plugin has been removed from the directory.</p></blockquote>\n\n\n\n<p>According to Josepha, &#8220;The plugin’s description eluded initial plugin checks.&#8221; Even if it was an honest oversight, which appears to be the case, it still raises some important questions about review procedures and governance for WordPress.org. To Josepha\'s credit she does this address this:</p>\n\n\n\n<blockquote class=\"wp-block-quote\"><p>I am aware that this issue leads to natural questions about clarifying our plugin policies moving forward. I’ll work with the community to explore our guidelines and create a clearer framework for how plugins can be evaluated in the context of current events.</p></blockquote>\n\n\n\n<h3 id=\"h-don-t-assume-the-worst-of-others\">Don\'t Assume the Worst of Others</h3>\n\n\n\n<p><strong>Matt Mullenweg</strong> also <a href=\"https://poststatus.slack.com/archives/CHNM7Q7T8/p1648089238895559\">shared some thoughts</a> in Post Status Slack after the Zamir plugin\'s takedown:</p>\n\n\n\n<blockquote class=\"wp-block-quote\"><p>Thank you to everyone who raised this issue, regardless of how you did it&#8230; Extra thanks to people who did it in a way knowing there are humans on the other side of the screen, and sometimes it may take a few hours to respond to something. This moved pretty quickly, but if it had happened in the middle of the night on a holiday or something similar it could have taken longer.</p><p>100% promise there will be mistakes or things we reverse in the future. What\'s important isn\'t trying to avoid mistakes, as that\'s impossible, but responding to them in a thoughtful and hopefully fast way. Please don\'t bash people or teams for making a mistake, we\'re all human and fallible.</p><p>Thank you as well to those who didn\'t jump to conclusions based on this one plugin being up for a few hours.</p></blockquote>\n\n\n\n<p>It doesn\'t seem there was any ill-will from anyone involved in the plugin\'s entry into the repo or in the removal of some hostile &#8220;reviews&#8221; in the plugin support forum before its removal. I hope we can take a lesson from this and reexamine the plugin review policies, including how takedown requests work. The procedures and policies for removal need to be clear to everyone. </p>\n\n\n.kt-block-spacer-_bb762c-8f .kt-divider{width:80%;}\n<div class=\"wp-block-kadence-spacer aligncenter kt-block-spacer-_bb762c-8f\"><div class=\"kt-block-spacer kt-block-spacer-halign-center\"><hr class=\"kt-divider\" /></div></div>\n\n\n\n<div class=\"wp-container-624c8ab07e5cb wp-block-group has-theme-palette-8-background-color has-background\"><div class=\"wp-block-group__inner-container\">\n<h4 class=\"has-text-align-center\" id=\"h-post-status-postscript\"><strong>Post Status Postscript</strong></h4>\n\n\n\n<p>The saddest and most concerning part of this story — and the part of it that is not likely to go away soon — is how anger and suspicion quickly focused a very prejudicial eye on contributors who might be Russian and/or sympathetic to the Russian invasion of Ukraine. </p>\n\n\n\n<p>The WordPress Plugin Review team and a moderator in the Support Forum who is also on the Russian language Translation Team became the target of hasty scrutiny from the outside. Even within the Make WordPress Slack channels for those teams, there was some emotional and accusatory communication. <br /><br />That\'s understandable; I had similar suspicions myself. But the reality is the plugin review team is constantly making good-faith efforts as they carry out a very difficult and essential task. They will never please everyone all the time. They are targets of complaints, criticism, and even <a href=\"https://halfelf.org/2021/when-its-not-burnout/\">hateful, violent threats directed at individual members</a>.</p>\n\n\n\n<p>The suspicion and distrust that flared up in the Zamir controversy underscores the very serious risks facing all open source projects now. Loss of the trust and goodwill that makes open source possible could kill it. David and I emphasize this in <a href=\"https://poststatus.com/an-inside-job/\">our discussion</a> of &#8220;weaponized open-source code.&#8221; What a terrible phrase! Even using code as a form of political protest against a specific nation may harm open source by dividing us with deep distrust. </p>\n\n\n\n<p>It\'s probably good to have gotten through the Zamir plugin debacle as a relatively harmless learning experience. It could have been worse.</p>\n\n\n\n<p>And it may well get worse. It will definitely get more complicated. </p>\n\n\n\n<p>Other scenarios come to mind. What if instead of the &#8216;Z\' — a fairly explicit hate symbol — the flag of the Russian Federation had been used? <br /><br />So what\'s to be done, constructively? At a minimum, we need the greater transparency that\'s increasingly being called for in the WordPress community. Formal guidelines, processes, and roles will provide clarity about who decides, and how they decide to include or exclude plugins, themes, reviews, etc.</p>\n\n\n\n<p>Yes, it will always be messy, and there will always be mistakes. Project and community boundaries necessarily differ and disagree. That is exactly why everyone needs to know what the boundaries are and how they are negotiated. </p>\n\n\n\n<p class=\"has-text-align-right\"><strong>— Dan Knauss</strong></p>\n</div></div>\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}s:7:\"pubDate\";a:1:{i:0;a:5:{s:4:\"data\";s:31:\"Fri, 25 Mar 2022 17:47:17 +0000\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}}s:32:\"http://purl.org/dc/elements/1.1/\";a:1:{s:7:\"creator\";a:1:{i:0;a:5:{s:4:\"data\";s:12:\"David Bisset\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}}}}i:29;a:6:{s:4:\"data\";s:13:\"\n	\n	\n	\n	\n	\n	\n\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";s:5:\"child\";a:2:{s:0:\"\";a:5:{s:5:\"title\";a:1:{i:0;a:5:{s:4:\"data\";s:65:\"WordPress.org blog: Get Creative with the All-New Pattern Creator\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}s:4:\"guid\";a:1:{i:0;a:5:{s:4:\"data\";s:35:\"https://wordpress.org/news/?p=12460\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}s:4:\"link\";a:1:{i:0;a:5:{s:4:\"data\";s:81:\"https://wordpress.org/news/2022/03/get-creative-with-the-all-new-pattern-creator/\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}s:11:\"description\";a:1:{i:0;a:5:{s:4:\"data\";s:3130:\"<p>It’s been less than a year since the <a rel=\"noreferrer noopener\" href=\"https://wordpress.org/patterns/\" target=\"_blank\">WordPress Pattern Directory</a> was launched, and we already have more exciting news to share. <strong>The <a rel=\"noreferrer noopener\" href=\"https://wordpress.org/patterns/new-pattern/\" target=\"_blank\">Pattern Creator</a> is live! You can now build, edit, and submit your best block patterns to the Pattern Directory—submissions are open to all with a WordPress.org user account!</strong></p>\n\n\n\n\n<img width=\"2800\" height=\"3000\" src=\"https://i0.wp.com/wordpress.org/news/files/2022/03/patterns.png?resize=2800%2C3000&ssl=1\" alt=\"Pattern Directory, showing gallery patterns.\" class=\"wp-image-12485\" />\n\n\n\n<img width=\"2800\" height=\"2841\" src=\"https://i0.wp.com/wordpress.org/news/files/2022/03/community-pattern-3-1-1.png?resize=2800%2C2841&ssl=1\" alt=\"View of a user-submitted pattern.\" class=\"wp-image-12468\" />\nPattern Directory — List of patterns, and a single pattern detail.\n\n\n\n<p>The <a rel=\"noreferrer noopener\" href=\"https://wordpress.org/support/article/block-pattern-directory/\" target=\"_blank\">WordPress Pattern Directory</a> includes attractive, handy patterns created by designers that can make your experience building a stunning site <em>much</em> easier. <a href=\"https://wordpress.org/support/article/block-pattern/\" target=\"_blank\" rel=\"noreferrer noopener\">Patterns</a> can save you a significant amount of time and also give you greater freedom when you’re building your site. With patterns, you can make or replicate complex layouts with just a few clicks, and using them is as simple as copy and paste.</p>\n\n\n\n<h2>Create Your Own Bold, Beautiful Patterns Built Entirely with Blocks</h2>\n\n\n\n<a href=\"https://i1.wp.com/wordpress.org/news/files/2022/03/submission-2.png?ssl=1\"><img width=\"1024\" height=\"683\" src=\"https://i1.wp.com/wordpress.org/news/files/2022/03/submission-2.png?resize=1024%2C683&ssl=1\" alt=\"Pattern submission screen, successfully submitted pattern with a \" /></a>\n\n\n\n<p>As the name implies, the <a rel=\"noreferrer noopener\" href=\"https://wordpress.org/patterns/new-pattern/\" target=\"_blank\">Pattern Creator</a> allows anyone, from designers to content creators, to make custom patterns: a collection of blocks arranged in any way, for any purpose intended by the creator. Like most things in WordPress, these are available for public use once it’s submitted to the WordPress Pattern Directory. Have a look at <a rel=\"noreferrer noopener\" href=\"https://wordpress.org/patterns/about/\" target=\"_blank\">these guidelines</a> to learn more about what makes a pattern suitable for listing in the directory.</p>\n\n\n\n<p>So what are you waiting for? Check out <a href=\"https://wordpress.org/patterns/\" target=\"_blank\" rel=\"noreferrer noopener\">all the patterns</a> already available or better yet, make your own!</p>\n\n\n\n<div class=\"wp-container-8 wp-block-buttons\">\n<div class=\"wp-block-button aligncenter is-style-fill\"><a class=\"wp-block-button__link\" href=\"https://wordpress.org/patterns/about/\"><strong>Learn more about creating patterns</strong></a></div>\n</div>\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}s:7:\"pubDate\";a:1:{i:0;a:5:{s:4:\"data\";s:31:\"Fri, 25 Mar 2022 17:34:42 +0000\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}}s:32:\"http://purl.org/dc/elements/1.1/\";a:1:{s:7:\"creator\";a:1:{i:0;a:5:{s:4:\"data\";s:12:\"Anjana Vasan\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}}}}i:30;a:6:{s:4:\"data\";s:13:\"\n	\n	\n	\n	\n	\n	\n\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";s:5:\"child\";a:2:{s:0:\"\";a:5:{s:5:\"title\";a:1:{i:0;a:5:{s:4:\"data\";s:73:\"Post Status: An Inside Job: The Danger of Weaponized Open Source Projects\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}s:4:\"guid\";a:1:{i:0;a:5:{s:4:\"data\";s:31:\"https://poststatus.com/?p=95001\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}s:4:\"link\";a:1:{i:0;a:5:{s:4:\"data\";s:37:\"https://poststatus.com/an-inside-job/\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}s:11:\"description\";a:1:{i:0;a:5:{s:4:\"data\";s:10690:\"<p class=\"has-drop-cap\">In a widely circulated article this week, <strong>Gerald Benischke</strong> is making the open-source community take <a href=\"https://beny23.github.io/posts/on_weaponisation_of_open_source/\">a hard look at the possible consequences of weaponized code</a>. He\'s right to be concerned that everything &#8220;open source has achieved over the last 30 years &#8230; [is] now at risk of becom[ing] collateral damage.&#8221; Why?</p>\n\n\n\n<blockquote><p>It’s not about sitting on the fence or taking sides in a war. It’s about what open source has achieved over the last 30 years and I think that’s now at risk of become collateral damage.</p><cite>Gerald Benischke</cite></blockquote>\n\n\n\n<h3 id=\"h-open-source-softwar-e\">Open Source Softwar(e)</h3>\n\n\n\n<p>Following the Russian invasion of Ukraine, many western companies cut their services and sales to some or all Russian customers. Open-source <strong>NoSQL</strong> database <strong>MongoDB</strong> <a href=\"https://www.theregister.com/2022/03/15/mongodb_terminates_russian_saas/\">is among them</a>. </p>\n\n\n\n<div class=\"wp-block-embed__wrapper\">\n<blockquote class=\"twitter-tweet\"><p lang=\"en\" dir=\"ltr\">MongoDB is terminating Russian accounts. Makes you wonder how your IT may look like if other IaaS, PaaS and SaaS providers will decide to shut you down. What if AWS decided to shut down your account? How business critical is your reliance on the cloud? <a href=\"https://t.co/UerJ4TGPMn\">pic.twitter.com/UerJ4TGPMn</a></p>&mdash; Oleg Brodt (@BrodtOleg) <a href=\"https://twitter.com/BrodtOleg/status/1502587827783098371?ref_src=twsrc%5Etfw\">March 12, 2022</a></blockquote>\n</div>\n\n\n\n<p>Benischke also looked at how <a href=\"https://github.com/RIAEvangelist/node-ipc/issues/233#issuecomment-1068182278\">a modified <strong>node</strong> library</a> now <a href=\"https://www.theregister.com/2022/03/18/protestware_javascript_node_ipc/\">tries to delete files on Russian IPs</a>. </p>\n\n\n\n<p>Both of these actions are potentially destructive, albeit in different ways. Both turn open source into a weapon.</p>\n\n\n\n<h3 id=\"h-is-this-even-open-source\">Is this even Open Source?</h3>\n\n\n\n<p>Less damaging but more personally intrusive, a community <strong>Terraform AWS</strong> module changed its code and added requirements after its <strong>Apache</strong> license. These &#8220;<a href=\"https://github.com/terraform-aws-modules/terraform-aws-ec2-instance/commit/6867788411a202b61187f9935e9eaa72a18f0bbe\">Additional terms of use for users from Russia and Belarus</a>&#8221; require those users to agree with three statements. One of those statements is &#8220;Putin is a dickhead.&#8221; Benischke notes this violates part of the <strong>Open Source Initiative</strong>&#8216;s <a href=\"https://opensource.org/osd\">definition of open source</a>:</p>\n\n\n\n<blockquote class=\"wp-block-quote is-style-large\"><p><strong>5. No Discrimination Against Persons or Groups. </strong><br />The license must not discriminate against any person or group of persons.</p><cite>OSI, The Open Source Definition</cite></blockquote>\n\n\n\n<p>What does it even mean to target people who are &#8220;from&#8221; a certain country? You might be &#8220;from&#8221; a country you do not currently live in. And not everyone living or born in a country has citizenship there. How a person defines their origins is completely subjective. Nationality is a legal fiction. Ethnicity and race are socially constructed and imaginary. Currently, <a href=\"https://www.unhcr.org/ibelong/statelessness-around-the-world/\">10 Million people are stateless</a> — without citizenship in any nation. </p>\n\n\n\n<h3 id=\"h-protestware-or-malware\">Protestware or Malware?</h3>\n\n\n\n<blockquote><p>Once our software can\'t be trusted, what will happen? </p></blockquote>\n\n\n\n<p>Benischke warns about the possible &#8220;unintended consequences&#8221; of weaponized and discriminatory code. He\'s right it goes beyond protest, especially in the case of the destructive Node library:</p>\n\n\n\n<blockquote class=\"wp-block-quote\"><p>&#8220;In my mind, the term &#8216;protestware\' is attempting to legitimize the malicious actions and very much turns open source libraries into weapons to be aimed and fired at your opponent&#8230; I do think that these actions are to be condemned — especially as the “delete files based on geofencing IP addresses” has got the potential of causing collateral damage.&#8221;</p></blockquote>\n\n\n\n<h3 id=\"h-collateral-damage-to-trust-in-open-source-could-kill-it\">Collateral damage to trust in open source could kill it.</h3>\n\n\n\n<p>The deeper (and probably the worst) unintended consequence is the loss of trust in the open-source community. Benischke asks if it\'s even open-source code if you can\'t trust it. </p>\n\n\n\n<p><strong>The Open Source Initiative</strong> <strong>(OSI) </strong>has <a href=\"https://opensource.org/blog/open-source-protestware-harms-open-source\">a positive, agreeing response</a> to Benischke\'s post. OSI supports &#8220;creative&#8221; forms of &#8220;protestware&#8221; that are informational or symbolic, but they distinguish this from weaponized code, which they condemn. However, OSI does not mention trust at all or the consequences of losing it. </p>\n\n\n\n<p>Why does trust matter so much? </p>\n\n\n\n<p>If you can\'t trust your dependencies, who is in a position to take ownership of them all to ensure their secure functioning? Benischke points out that only a few large companies allied with the most powerful nations could afford to do this. Exclusive multinational blocs using trusted but closed source software might emerge if we go down this path. And it\'s not as if we didn\'t already have enormous challenges with security, maintenance, project sustainability, and the &#8220;<a href=\"https://poststatus.com/missing-the-bus/\">bus factor</a>.&#8221; </p>\n\n\n\n<p>This is why Benischke\'s concerns about the death of trust as a lethal poison are not far-fetched or of secondary importance to WordPress and open source.  If anything, he understates the precarity of the moment we are in. </p>\n\n\n\n<p><strong>What about you?</strong> Let us know <a href=\"https://poststatus.com/planet/feed/#comment\">in the comments</a>. </p>\n\n\n.kt-block-spacer-_31bf24-7a .kt-divider{width:80%;}\n<div class=\"wp-block-kadence-spacer aligncenter kt-block-spacer-_31bf24-7a\"><div class=\"kt-block-spacer kt-block-spacer-halign-center\"><hr class=\"kt-divider\" /></div></div>\n\n\n\n<div class=\"wp-container-624c8ab081862 wp-block-group has-theme-palette-8-background-color has-background\"><div class=\"wp-block-group__inner-container\">\n<h4 class=\"has-text-align-center\" id=\"h-post-status-postscript\"><strong>Post Status Postscript</strong></h4>\n\n\n\n<h5 id=\"h-wordpress-may-not-be-interested-in-the-us-department-of-defense-but-the-dod-is-interested-in-wordpress\">WordPress may not be interested in the US Department of Defense, but the DoD is interested in WordPress</h5>\n\n\n\n<p>It wasn\'t hard to see the weaponization of open source coming long ago. I just thought it would be done by malign individuals and organizations outside the open-source community. </p>\n\n\n\n<p>Government actors have been <a href=\"https://www.schneier.com/blog/archives/2013/09/the_nsa_is_brea.html\">exploiting open (and closed) source code to spy on and harm enemies</a> for a long time. I just didn\'t think it would be members of open source projects doing this themselves. </p>\n\n\n\n<p>And now we\'ve experienced this in the WordPress community, with the Zamir plugin. (See our related thoughts on that story <a href=\"https://poststatus.com/fall-of-the-zamir\">over here</a>.) </p>\n\n\n\n<p>These developments are all very concerning. I hope it\'s not as bad as <strong>Heather Burns</strong> says it is, but <a href=\"https://twitter.com/WebDevLaw/status/1506712423230849030\">she may be right</a>:</p>\n\n\n\n<blockquote class=\"wp-block-quote is-style-default has-small-font-size\"><p>&#8220;The .org OSS project is entirely legally controlled by a US company which could, at any time, fall under scrutiny for providing services to Russia, or be brought into the sanctions regime.&#8221;</p><cite><a href=\"https://twitter.com/WebDevLaw/status/1506712423230849030\">Heather Burns @WebDevLaw</a></cite></blockquote>\n\n\n\n<p>Is this how we need to think now, of globalized, international, open-source projects and communities? In a somewhat paranoid, suspicious way?</p>\n\n\n\n<p>Imagining the worst — the ways open source could be destroyed — reminds me of a conversation I had at the last <strong><a href=\"https://poststatus.com/partner-summit/\">Post Status Partners Retreat</a></strong>. I asked a WordPress OG why he thought there always seems to be a constant sense of anxiety in the WordPress community — as if a massive disaster is just around the corner. I haven\'t seen that in other projects that are healthy even if they have a much smaller market share — like <strong>Drupal</strong>, for instance. (Speaking of which, you should check out <strong>Amy June Hineline</strong>&#8216;s <a href=\"https://poststatus.com/post-status-excerpt-no-51-comparing-the-drupal-and-wordpress-communities-with-amy-june-hineline/\">comparison of the Drupal and WordPress communities</a> in her recent chat with David.)</p>\n\n\n\n<p>My question led to the response that only WordPress can destroy WordPress, it\'s so big. Then we had some fun imagining &#8220;evil&#8221; self-sabotage scenarios that might realistically play out if things went sideways. Later I posed this as a thought experiment with other people — imagine a <em><a href=\"https://en.wikipedia.org/wiki/The_Screwtape_Letters\">Screwtape Letters</a></em> take on WordPress. What would a clever demon do to ruin the project by manipulating its insiders?</p>\n\n\n\n<p>Even in the worst-case scenarios, most people agreed that some massive corporations are so dependent on WordPress, they would take it over in their own — in-house (and likely as good as proprietary) distribution. WordPress would not die. The project as we know it might die. The community would die. The software, at the end of the day, is the most durable thing — but it\'s not worth much to us if it\'s torn away from open source freedoms and an open, cooperative community of contributors. </p>\n\n\n\n<p>Can an open-source community like ours survive abandoning a fully globalized, international openness — at least as a possibility and ideal? Would survival in that context be worth anything, or be truly open? I don\'t think so. But we\'re now looking at a darkening world where every open-source project has reason to worry about that as a non-zero possibility.</p>\n\n\n\n<p></p>\n\n\n\n<p class=\"has-text-align-right\"><strong>— Dan Knauss</strong></p>\n</div></div>\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}s:7:\"pubDate\";a:1:{i:0;a:5:{s:4:\"data\";s:31:\"Fri, 25 Mar 2022 17:11:20 +0000\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}}s:32:\"http://purl.org/dc/elements/1.1/\";a:1:{s:7:\"creator\";a:1:{i:0;a:5:{s:4:\"data\";s:12:\"David Bisset\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}}}}i:31;a:6:{s:4:\"data\";s:13:\"\n	\n	\n	\n	\n	\n	\n\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";s:5:\"child\";a:2:{s:0:\"\";a:5:{s:5:\"title\";a:1:{i:0;a:5:{s:4:\"data\";s:85:\"WPTavern: How To Build a Two-Column Single Post Header with the WordPress Site Editor\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}s:4:\"guid\";a:1:{i:0;a:5:{s:4:\"data\";s:30:\"https://wptavern.com/?p=131951\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}s:4:\"link\";a:1:{i:0;a:5:{s:4:\"data\";s:96:\"https://wptavern.com/how-to-build-a-two-column-single-post-header-with-the-wordpress-site-editor\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}s:11:\"description\";a:1:{i:0;a:5:{s:4:\"data\";s:8719:\"<p class=\"has-drop-cap\">One of the features I liked about <a href=\"https://wptavern.com/the-archeo-wordpress-theme-blends-mayan-history-with-magazine-style-block-patterns\">Automattic&#8217;s Archeo theme</a> that I reviewed earlier this week was its split-screen single post header. I loved that an author was doing a little something different with the Featured Image block, giving users some variety.</p>\n\n\n\n<p>The design was simple. It is a two-column section with an image on the right and the post title and date on the left.</p>\n\n\n\n<img />Split-screen post title and image.\n\n\n\n<p>It reminded me to dust off one of the untold numbers of &#8220;ideas&#8221; folders on my computer. I knew I had built something similar last year. I merely needed to find it.</p>\n\n\n\n<p>I finally stumbled upon it after a bit of rummaging &#8212; <em>I really need to learn how to name things to make them easier to find</em>:</p>\n\n\n\n<img />Old split post header design idea.\n\n\n\n<p>My approach to the problem was different, and I remember why it went to the scrap-heap. It used the Media &amp; Text block instead of Columns. Then, and this is still the case, it is impossible to use the Featured Image inside of Media &amp; Text.</p>\n\n\n\n<p>The Columns block is a decent second choice, but it stacks differently on mobile views, with the first column always landing on top. The image takes precedence when using the Media &amp; Text block, regardless of its horizontal position on desktop views.</p>\n\n\n\n<p>There is an open ticket to use the post&#8217;s featured image <a href=\"https://github.com/WordPress/gutenberg/issues/35221\">within the Media &amp; Text block</a>. There is a similar ticket for using it <a href=\"https://github.com/WordPress/gutenberg/issues/13795\">within a Cover</a>. Both would be solved by addressing an issue that would have farther reach by allowing <a href=\"https://github.com/WordPress/gutenberg/issues/37753\">generic blocks to utilize site or post metadata</a>.</p>\n\n\n\n<p>At least for now, we must work with the tools we have.</p>\n\n\n\n<p>For this entry in the <a href=\"https://wptavern.com/category/building-with-blocks\">Building with Blocks</a> series, I will walk you through modifying Twenty Twenty-Two&#8217;s single post template to create a similar layout.</p>\n\n\n\n<p>It is hard for some people to visualize the result without the post data. As shown in the following screenshot, the editor has placeholders:</p>\n\n\n\n<img />Editor view of split-screen post header.\n\n\n\n<p>However, those placeholders will be transformed on the front end. <em>How do we know that what we see there will translate correctly and turn out like the following?</em></p>\n\n\n\n<img />Front-end view of single post with split-screen header.\n\n\n\n<p>Even I struggle with this visualization at times. The placeholders used for Post* blocks do not offer me enough direct feedback, so I often refresh an example post on the front end as I build layouts like this. I wanted to note this in case it disorients or even throws anyone else off. It is OK to save and check your work on the front end as you go through this.</p>\n\n\n\n<p><strong>Side note:</strong> <em>I would love to see a plugin that adds dummy post data instead of the default placeholders.</em></p>\n\n\n\n<h2>Step 1: Selecting the Single Post Template</h2>\n\n\n\n<img />Select the Single Post template.\n\n\n\n<p>To make this layout change for all single posts, you must go to the site editor via Appearance &gt; Editor in the admin. Select the WordPress logo/icon in the top left corner to open the slide-out panel. From there, click on the Templates link. The next screen should display a list of editable templates. Select &#8220;Single Post.&#8221;</p>\n\n\n\n<p>If you prefer to make this an optional template, you should build this from the <a href=\"https://make.wordpress.org/core/2021/06/16/introducing-the-template-editor-in-wordpress-5-8/\">template editor</a>. The process is similar, but the UI does have some differences.</p>\n\n\n\n<h2>Step 2: Adjusting Site Header (Optional)</h2>\n\n\n\n<img />Adjusting header Row blocks&#8217; alignment and padding.\n\n\n\n<p>Twenty Twenty-Two&#8217;s header does not work well for the type of layout that we are building. It has a ton of padding at the bottom, and its width is limited. You will want to make a few changes for a more ideal design. Note that this will change the header across the entire site unless you save it as a separate template part. This step is optional, but the final result will look better.</p>\n\n\n\n<p>In the Header area of the editor, select the Row block that holds the Site Title and Navigation blocks. From the toolbar, select the &#8220;Full width&#8221; alignment option. In the block sidebar panel on the right, set the &#8220;Padding&#8221; option to <code>2rem</code> or a value of your preference.</p>\n\n\n\n<h2>Step 3: Creating Columns</h2>\n\n\n\n<img />Wrapping the Post Title and Post Featured Image blocks in columns.\n\n\n\n<p>Because Twenty Twenty-Two already has the Post Title and Post Featured Image blocks grouped together, there is no need to start from scratch here. Select both with your mouse or keyboard, click the &#8220;Transform To&#8221; button in the toolbar, and choose the Columns option.</p>\n\n\n\n<p>If working from a theme with a different layout, you can manually add a Columns block with a 50/50 setting and insert the Post Title and Post Featured Image blocks in the two columns.</p>\n\n\n\n<h2>Step 4: Designing Columns</h2>\n\n\n\n<img />Adjusting alignment, colors, and padding of Columns block.\n\n\n\n<p>We have gotten some of the boring layout stuff out of the way. Now, you can start adding your own brand of artistry to this thing. I chose a black background and white text for the Columns block. However, feel free to add whatever colors you want. Maybe even try out the border options to mix it up.</p>\n\n\n\n<p><em>Now, back to boring layout adjustments.</em></p>\n\n\n\n<p>For this layout to work, there are two changes you should make to the Columns block. First, select the &#8220;Full width&#8221; alignment from the toolbar.</p>\n\n\n\n<p>Then, change the &#8220;Padding&#8221; option in the block sidebar to <code>0</code>. Zeroing this out allows the featured image to stretch to the edge. This is not a hard requirement if you want a little space around it.</p>\n\n\n\n<h2>Step 5: Title Group</h2>\n\n\n\n<img />Grouping the Post Title block and adding some padding.\n\n\n\n<p>Because we zeroed out the padding in the previous step, the Post Title block will now butt against the side of the layout. Text always needs room to breathe in design, so we need to fix this problem we have created for ourselves.</p>\n\n\n\n<p>There are two ways of going about this. The first is to simply add padding to the Column block that the Post Title is in. This should work fine, but WordPress does not handle this well (it does not use <code>box-sizing: border-box</code> for Column blocks). If you add padding here, it will make the left side wider than the right. Unfortunately, this is a little quirk that creates extra work.</p>\n\n\n\n<p>The best option is to select the Post Title and transform it into a Group. Then, find the &#8220;Padding&#8221; control in the sidebar and change it to <code>2rem</code> or your preferred value.</p>\n\n\n\n<p>Some themes may correct the column-padding issue, so give the first option a shot if using something other than Twenty Twenty-Two.</p>\n\n\n\n<h2>Step 6: Adjusting Featured Image</h2>\n\n\n\n<img />Removing margin from Post Featured Image block.\n\n\n\n<p>Neither WordPress nor Twenty Twenty-Two adds any default margin handling for the Post Featured Image block. The <code>&lt;figure&gt;</code> wrapping element will fall back to the browser&#8217;s default (browsers generally add some margin to the top and bottom).</p>\n\n\n\n<p>To ensure that the image does not have extra spacing, select it in the editor, find the &#8220;Margin&#8221; setting in the sidebar, and set it to <code>0</code>.</p>\n\n\n\n<h2>Step 7: Have Fun</h2>\n\n\n\n<img />Customized split-screen post header.\n\n\n\n<p>The foundation of the layout is in place now. Adjusting paddings, margins, and similar settings is the giant mountain you must conquer to do some of the <em>really</em> cool stuff that is possible. I do not want to limit folks with the rest of the design and would love for everyone to put their own spin on it.</p>\n\n\n\n<p>I changed the vertical alignment on the Columns block to the &#8220;Align bottom&#8221; setting for my layout. Above the Post Title, I added a Row with the Post Author Name, Post Date, and Post Categories blocks. I also removed the Separator that Twenty Twenty-Two adds before the content.</p>\n\n\n\n<p>Please share customizations you made in the comments if you followed along with this tutorial.</p>\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}s:7:\"pubDate\";a:1:{i:0;a:5:{s:4:\"data\";s:31:\"Fri, 25 Mar 2022 04:42:33 +0000\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}}s:32:\"http://purl.org/dc/elements/1.1/\";a:1:{s:7:\"creator\";a:1:{i:0;a:5:{s:4:\"data\";s:14:\"Justin Tadlock\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}}}}i:32;a:6:{s:4:\"data\";s:13:\"\n	\n	\n	\n	\n	\n	\n\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";s:5:\"child\";a:2:{s:0:\"\";a:5:{s:5:\"title\";a:1:{i:0;a:5:{s:4:\"data\";s:53:\"Post Status: Finding the Upside in WordPress Security\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}s:4:\"guid\";a:1:{i:0;a:5:{s:4:\"data\";s:31:\"https://poststatus.com/?p=95029\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}s:4:\"link\";a:1:{i:0;a:5:{s:4:\"data\";s:64:\"https://poststatus.com/finding-the-upside-in-wordpress-security/\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}s:11:\"description\";a:1:{i:0;a:5:{s:4:\"data\";s:6263:\"<h3>Can exposing security vulnerabilities in the open be done in a way that doesn\'t hurt WordPress?</h3>\n\n\n\n<p class=\"has-drop-cap\"><strong>Rob Howard</strong>, who recently acquired <strong>MasterWP</strong>, used it last week to <a href=\"https://masterwp.com/is-wordpress-security-getting-better-or-worse/\">criticize</a> <strong>Patchstack</strong>’s <a href=\"https://patchstack.com/whitepaper/the-state-of-wordpress-security-in-2021/\">Security WhitePaper for 2021</a>. He called the report &#8220;sensationalist&#8221; with &#8220;sloppy data reporting,&#8221; &#8220;too much information,&#8221; and some important good news left out. He also advocated &#8220;WordPress security messaging&#8221; that would clean up the &#8220;wasteland of poorly framed articles about security patches&#8221; in <strong>Google News</strong>. We thought that is <a href=\"https://poststatus.com/would-wordpress-benefit-from-public-relations-messaging-around-security-issues/\">a worthwhile and promising idea to develop</a>. However, Rob expressed skepticism that security companies have an interest in accentuating the positive. </p>\n\n\n\n<blockquote><p>What if the way we talk about WordPress security focused on public acknowledgement of the security team members\' work, goals, and successes?</p></blockquote>\n\n\n\n<p>This week, Patchstack Security Advocate <strong>Robert Rowley</strong> has written a response in MasterWP. Robert countered that Patchstack is helping &#8220;open source projects reach security maturity.&#8221;&nbsp;In <a href=\"https://masterwp.com/rebuttal-how-patchstack-is-improving-wordpress-security/\">a polite &#8220;rebutal-but-not-a-rebuttal response,&#8221;</a> he explains Patchstack\'s perspective and intentions. </p>\n\n\n\n<p>According to Robert, the large increase in vulnerabilities emphasized in Patchstack\'s report has to do with an increase in code review and bug reporting. WordPress core is secure, and increased attention to vulnerabilities in themes and plugins is a good thing. Patchstack is helping that happen, in their view. &#8220;Vulnerability disclosure for the commons&#8221; is how they understand what they\'re doing with projects like <a href=\"https://patchstack.com/alliance/\">The Patchstack Alliance</a>.</p>\n\n\n\n<div class=\"wp-container-624c8ab08416d wp-block-group has-theme-palette-7-background-color has-background\"><div class=\"wp-block-group__inner-container\">\n<h4>What we\'ve learned and agree on about WordPress security:</h4>\n\n\n\n<p><strong>There are two good, compatible takeaways from this discussion everyone seems to agree on</strong>.</p>\n\n\n\n<ol><li>WordPress is getting more secure, and open source ways of addressing vulnerabilities openly together is helping.</li><li>WordPress could benefit from (and deserves) better messaging about security that contextualizes it in open source values and practices where we give and grow together. </li></ol>\n</div></div>\n\n\n\n<p class=\"has-theme-palette-8-background-color has-background\"><strong>A noteworthy aside:</strong> Robert brought up <a href=\"https://poststatus.com/are-active-installs-of-wordpress-plugins-declining-in-2021/\">some numbers we rarely see that I follow closely</a>. The WordPress.org plugin repository grew by less than 3% in 2021, from 58,151 to 59,800 plugins. Themes grew by around 10%. That\'s decent growth in both cases.</p>\n\n\n\n<h3 id=\"h-how-can-we-do-security-related-messaging-better-for-wordpress\">How can we do security-related messaging better for WordPress?</h3>\n\n\n\n<p>When the discussion began between Robert and Rob, <a href=\"https://poststatus.com/would-wordpress-benefit-from-public-relations-messaging-around-security-issues/\">we posed this question</a> here at <strong>Post Status</strong>: <a href=\"https://poststatus.com/would-wordpress-benefit-from-public-relations-messaging-around-security-issues/\">Would WordPress benefit from public relations messaging around security issues?</a> </p>\n\n\n\n<p>Robert <a href=\"https://poststatus.slack.com/archives/C02S57UHCKD/p1647876595955309\">responded</a> in <strong>Post Status Slack</strong>: </p>\n\n\n\n<blockquote class=\"wp-block-quote\"><p>&#8220;There are many teams in the open source WordPress project who publicly share details on progress, metrics and planning&#8230; I would disagree with calling this PR, that has some other connotations. But I would love to see more regular updates on metrics.&#8221; </p></blockquote>\n\n\n\n<p>Robert\'s view of good PR is &#8220;public acknowledgement of the security team members and sharing some of the teams plans and goals.&#8221;</p>\n\n\n\n<p><strong>Kimberly Lipari</strong> joined the Slack convo and wants to flip the narrative: </p>\n\n\n\n<blockquote class=\"wp-block-quote\"><p>Why not flip the narrative? Instead of “core vulnerabilities reported” it could be “security code pushed” or “release improvements.” Why not educate on what open source is and updating is a good thing, not something to fear?</p></blockquote>\n\n\n\n<p>Robert agreed with Kim\'s approach and acknowledged it was a mistake to have used the term &#8220;vulnerabilities&#8221; rather than &#8220;security bugs patched.&#8221;</p>\n\n\n\n<h3>WordPress is different, and we should embrace that</h3>\n\n\n\n<p>This is a good approach moving forward. It doesn\'t matter what company or open source project you are working with. If you are releasing information about security and your product, you need to educate and reassure your audiences. WordPress is not selling the same experience as other (especially non-open-source) web publishing platforms. <strong>Wix</strong> and <strong>Shopify</strong> only make public the security information they\'re legally obligated to release. When they do they are often on the defensive. Openness and transparency are our strengths, but it is easy to make them liabilities. </p>\n\n\n\n<p class=\"has-theme-palette-8-background-color has-background\"><strong>Do you have ideas</strong> for specific strategies to make openness around security issues something that educates and reassure? Is it a way to attract contributors or draw WordPress users deeper into the community? Could it spread a better understanding and appreciation of open source? <strong>Tell us</strong> in <a href=\"https://poststatus.com/planet/feed/#comment\">the comments</a>!</p>\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}s:7:\"pubDate\";a:1:{i:0;a:5:{s:4:\"data\";s:31:\"Fri, 25 Mar 2022 03:31:08 +0000\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}}s:32:\"http://purl.org/dc/elements/1.1/\";a:1:{s:7:\"creator\";a:1:{i:0;a:5:{s:4:\"data\";s:12:\"David Bisset\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}}}}i:33;a:6:{s:4:\"data\";s:13:\"\n	\n	\n	\n	\n	\n	\n\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";s:5:\"child\";a:2:{s:0:\"\";a:5:{s:5:\"title\";a:1:{i:0;a:5:{s:4:\"data\";s:52:\"WPTavern: Weglot Raises €45M From Partech Partners\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}s:4:\"guid\";a:1:{i:0;a:5:{s:4:\"data\";s:30:\"https://wptavern.com/?p=131912\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}s:4:\"link\";a:1:{i:0;a:5:{s:4:\"data\";s:61:\"https://wptavern.com/weglot-raises-e45m-from-partech-partners\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}s:11:\"description\";a:1:{i:0;a:5:{s:4:\"data\";s:2679:\"<p>Weglot, a popular WordPress multilingual plugin, has <a href=\"https://weglot.com/blog/weglot-announces-45m-growth-investment/\">raised €45M</a> from&nbsp;<a rel=\"noreferrer noopener\" href=\"https://partechpartners.com/\" target=\"_blank\">Partech Partners</a>. This is the first time the Paris-based company has taken outside capital since it <a href=\"https://wptavern.com/weglot-multilingual-plugin-closes-450k-in-seed-funding\">closed €450K in seed funding</a> from SIDE Capital in 2017. Since that initial round Weglot has expanded its offerings to include more translations and integrations for other platforms. </p>\n\n\n\n<p>Weglot co-founder Augustin Prot confirmed that the company is profitable with 25k customers paying for its SaaS translation platform and 60k+ websites using the company&#8217;s products, including IBM, Microsoft, Spotify, Steve Madden, and Volcom.</p>\n\n\n\n<p>In 2021, Weglot <a href=\"https://weglot.com/blog/2021-year-in-review/\">passed €10M ARR</a>, primarily through the sale of its WordPress, Shopify, and Webflow products, but the company also has growing user bases on Squarespace, Wix, Magento, BigCommerce, Square Online, and Salesforce.</p>\n\n\n\n<p>Weglot has a free version of its <a href=\"https://wordpress.org/plugins/weglot/\">plugin on WordPress.org</a> for small websites (under 2,000 words) with one translation language. It includes a Gutenberg block that makes it easy for users to position and customize their language switcher. The plugin has 40,000 active installs. Commercial plans range from €99/year for 10,000 words and one translated language to €4,990/year for 5 million words and 20 translated languages. </p>\n\n\n\n<p>Weglot&#8217;s chief competitors are <a href=\"https://wpml.org/\">WPML</a> (a commercial product with no free version) and <a href=\"https://wordpress.org/plugins/polylang/\">Polylang</a> (700K installs), a free plugin with a pro version that provides additional features and support. Despite having a much smaller WordPress user base and going up against more established competitors, Prot said the company is aiming to &#8220;become the category leader for web translation.&#8221; Weglot employs a team of 30 people and plans to use the new funding to hire more over the coming year.</p>\n\n\n\n<p>&#8220;We found success by focusing on usability and simplicity,&#8221; Prot said. &#8220;The SaaS model allows us to develop very quickly on the product side and the plugin is based on users’ and customers’ feedback. If you don’t take that into account they would simply leave. That’s why the SaaS approach favors continuous and fast improvement to make sure we match users’ expectations.&#8221; </p>\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}s:7:\"pubDate\";a:1:{i:0;a:5:{s:4:\"data\";s:31:\"Fri, 25 Mar 2022 01:39:19 +0000\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}}s:32:\"http://purl.org/dc/elements/1.1/\";a:1:{s:7:\"creator\";a:1:{i:0;a:5:{s:4:\"data\";s:13:\"Sarah Gooding\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}}}}i:34;a:6:{s:4:\"data\";s:13:\"\n	\n	\n	\n	\n	\n	\n\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";s:5:\"child\";a:2:{s:0:\"\";a:5:{s:5:\"title\";a:1:{i:0;a:5:{s:4:\"data\";s:77:\"Post Status: Post Status Comments (No. 6) — Getting Up To Speed On PHP News\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}s:4:\"guid\";a:1:{i:0;a:5:{s:4:\"data\";s:31:\"https://poststatus.com/?p=94825\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}s:4:\"link\";a:1:{i:0;a:5:{s:4:\"data\";s:81:\"https://poststatus.com/post-status-comments-no-6-getting-up-to-speed-on-php-news/\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}s:11:\"description\";a:1:{i:0;a:5:{s:4:\"data\";s:4982:\"<h2 id=\"h-these-php-deprecation-notices-are-warnings-to-project-managers-and-developers-do-we-have-enough-time-for-wordpress-core-but-especially-the-community-to-fix-the-codebases-tonya-mork\">“These [PHP] deprecation notices are warnings to project managers and developers… do we have enough time for [WordPress] core but especially the community to fix the codebases?” — Tonya Mork</h2>\n\n\n\n<p class=\"has-drop-cap\">Anyone seriously invested in WordPress, from developers to agency owners, has a big stake in the primary language WordPress is built with: <strong>PHP</strong>. WordPress professionals have a lot to keep track of, so it\'s not surprising they often overlook important news from the PHP community and development team. To bring you up to speed, <strong>David Bisset</strong> speaks with <strong>Carl Alexander</strong> and <strong>Tonya Mork</strong> in this episode of The Excerpt. Tonya and Carl have been deep into WordPress and PHP for many years. Here they offer a &#8220;Cliffs Notes&#8221; take on the PHP news the WordPress community should be paying attention to now. This includes big changes to code for developers and the need for a <strong>PHP Foundation</strong>. </p>\n\n\n\n<p><strong>Why This Is Important:</strong> WordPress depends on PHP, so developers and professionals should be aware of what is coming down the road as features are added, modified, and deprecated. There are also challenges of governance and sustainability that PHP is facing now that impact WordPress and relate to similar issues in the WordPress project.</p>\n\n\n\n\n\n\n\n<p class=\"has-background\"><strong>Post Status Comments</strong> <img src=\"https://s.w.org/images/core/emoji/13.1.0/72x72/1f4ac.png\" alt=\"💬\" class=\"wp-smiley\" /> is a stage for WordPress professionals to exchange ideas and talk about recent topics and trends.<br /><br /><a href=\"https://poststatus.com/podcast/comments/\">Browse past episodes</a> and subscribe to <a href=\"https://poststatus.com/podcasts/\">our podcasts</a> on&nbsp; <a href=\"https://open.spotify.com/show/1m3xwXbe0MG5BzFVPtB0A7\">Spotify</a>, Amazon Music, <a href=\"https://podcasts.google.com/feed/aHR0cHM6Ly9mZWVkcy5zaW1wbGVjYXN0LmNvbS8ySkU5c2M4UA\">Google Podcasts</a>, <a href=\"https://itunes.apple.com/us/podcast/post-status-draft-wordpress/id976403008\">iTunes</a>, <a href=\"https://castro.fm/podcast/c53552c6-1ee0-4fc4-9de4-08ed6bf1ee4d\">Castro</a>, <a href=\"https://www.youtube.com/c/PostStatus\">YouTube</a>, <a href=\"http://www.stitcher.com/podcast/krogsgard/post-status-draft-wordpress-podcast\">Stitcher</a>, <a href=\"https://player.fm/series/wordpress-post-status-podcasts\">Player.fm</a>, <a href=\"https://pca.st/05rR\">Pocket Casts</a>, <a href=\"https://wordpress-post-status-draft-podcast.simplecast.com/\">Simplecast</a>, or get them by <a href=\"https://feeds.simplecast.com/2JE9sc8P\">RSS</a>. <img src=\"https://s.w.org/images/core/emoji/13.1.0/72x72/1f399.png\" alt=\"🎙\" class=\"wp-smiley\" /></p>\n\n\n\n<h3 id=\"%f0%9f%99%8f-sponsor-godaddy-pro\"><img src=\"https://s.w.org/images/core/emoji/13.1.0/72x72/1f64f.png\" alt=\"🙏\" class=\"wp-smiley\" /> Sponsor: <a href=\"https://poststatus.com/godaddy-pro\">GoDaddy Pro</a></h3>\n\n\n\n<p>Manage your clients, websites, and tasks from a single dashboard with <strong>GoDaddy Pro</strong>. Perform security scans, backups, and remote updates to many sites on any host. Check up on site performance, monitor uptime and analytics, and then send reports to your clients. GoDaddy Pro is free — and designed to make your life better.</p>\n\n\n.kt-block-spacer-_fa223a-7a .kt-divider{width:80%;}\n<div class=\"wp-block-kadence-spacer aligncenter kt-block-spacer-_fa223a-7a\"><div class=\"kt-block-spacer kt-block-spacer-halign-center\"><hr class=\"kt-divider\" /></div></div>\n\n\n\n<h3 id=\"h-mentioned-in-the-show\"><img src=\"https://s.w.org/images/core/emoji/13.1.0/72x72/1f517.png\" alt=\"🔗\" class=\"wp-smiley\" /> Mentioned in the show:</h3>\n\n\n\n<ul><li><a href=\"https://opencollective.com/phpfoundation\">PHP Foundation</a></li><li><a href=\"https://www.php.net/\">PHP Project</a></li><li><a href=\"https://blog.krakjoe.ninja/2021/05/avoiding-busses.html\">Avoiding Buses</a></li><li><a href=\"https://blog.krakjoe.ninja/2021/11/2-1.html\">2-1</a></li><li><a href=\"https://twitter.com/jrf_nl/status/1459221992876515328\">Juliette\'s Tweet</a></li><li><a href=\"https://wordpress.org/about/stats/\">Key WordPress Statistics</a></li><li><a href=\"https://carlalexander.ca/how-to-start-unit-testing-wordpress-code/\">How do you start unit testing existing WordPress code?</a></li><li><a href=\"https://getrector.org/\">Rector</a></li></ul>\n\n\n\n<h3 id=\"follow-our-panelists-and-post-status-on-twitter-a4ffc805-90f1-41dc-9135-61b3ff20cb40\">Follow Our Panelists (and Post Status) on Twitter:</h3>\n\n\n\n<ul><li><a href=\"http://twitter.com/dimensionmedia/\">David Bisset</a></li><li><a href=\"https://twitter.com/twigpress?lang=en\">Carl Alexander</a></li><li><a href=\"https://twitter.com/hellofromtonya\">Tonya Mork</a></li></ul>\n\n\n\n<p></p>\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}s:7:\"pubDate\";a:1:{i:0;a:5:{s:4:\"data\";s:31:\"Thu, 24 Mar 2022 15:03:19 +0000\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}}s:32:\"http://purl.org/dc/elements/1.1/\";a:1:{s:7:\"creator\";a:1:{i:0;a:5:{s:4:\"data\";s:12:\"David Bisset\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}}}}i:35;a:6:{s:4:\"data\";s:13:\"\n	\n	\n	\n	\n	\n	\n\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";s:5:\"child\";a:2:{s:0:\"\";a:5:{s:5:\"title\";a:1:{i:0;a:5:{s:4:\"data\";s:92:\"WPTavern: The Archeo WordPress Theme Blends Mayan History With Magazine-Style Block Patterns\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}s:4:\"guid\";a:1:{i:0;a:5:{s:4:\"data\";s:30:\"https://wptavern.com/?p=131868\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}s:4:\"link\";a:1:{i:0;a:5:{s:4:\"data\";s:103:\"https://wptavern.com/the-archeo-wordpress-theme-blends-mayan-history-with-magazine-style-block-patterns\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}s:11:\"description\";a:1:{i:0;a:5:{s:4:\"data\";s:4732:\"<p class=\"has-drop-cap\">The day has finally arrived when a block theme does something interesting with the featured image on single post views. One of my biggest pet peeves is when themers simply dump it at the top of the content and call it a day.</p>\n\n\n\n<p>I nearly always bolt straight for the site editor to remove the single-post featured image upon installing block themes from some authors. However, after installing <a href=\"https://wordpress.org/themes/archeo/\">Archeo</a>, Automattic&#8217;s latest, I simply let it be. At least in this instance, the implementation did not make me wonder if we were ever going to get this whole block-based theme venture <em>right</em>.</p>\n\n\n\n<img />Split-screen post title and featured image.\n\n\n\n<p>Perhaps the most impressive thing about the single-post header design is that it works with the limited toolset offered by the current Featured Image block.</p>\n\n\n\n<p>If there is one knit-pick I have it is that the post and site titles do not align on the left side of the page, at least on wide-desktop views.</p>\n\n\n\n<p><em>So, the single-post header is well-designed. How does the rest of the theme hold up?</em> I am getting to that, but every now and again, something special about a design catches my eye. And, I cannot wait to let others know about it.</p>\n\n\n\n<p>Automattic is the most prolific block theme creator to date. Its Theme Team has rolled out a dozen designs to the WordPress directory over the last year. Many of its initial outings had a familiar feel &#8212; tiny variations on a simple base. However, things have livened up recently. <a href=\"https://wptavern.com/automattics-livro-is-a-minimal-block-theme-for-writers\">Livro</a>, the dark theme that made me dislike dark themes a little less, and <a href=\"https://wptavern.com/skatepark-is-a-bold-and-vibrant-block-theme-for-events-and-organizations\">Skatepark</a>, a unique experiment in its own right, represented a fresh start after the previous months began to feel stale.</p>\n\n\n\n<p>Archeo continues that momentum. The theme is bold when it needs to be while making enough use of whitespace to not overwhelm readers.</p>\n\n\n\n<img />Intro section of Archeo&#8217;s homepage.\n\n\n\n<p>It is one of the few faithful representations of magazine designs that I have seen. No, I am not talking about the muddied term in some circles that confuses it with news design. It reminds me of those stunning feature layouts that would draw a reader into a story as they flipped through the latest gloss-covered print that arrived in the mail. I am a product of my generation and will always have a sense of nostalgia for the dying art form, and I love seeing web-based implementations of it when they work well.</p>\n\n\n\n<p>Nearly every one of Archeo&#8217;s image-categorized patterns captures that essence of a magazine featured article. The following is one of my favorites.</p>\n\n\n\n<img />Two-column image pattern with header on the left and additional text.\n\n\n\n<p>The theme is described as being inspired by Mayan history and culture. Archeo&#8217;s patterns are littered with tidbits of historical text and images that make me want to learn more about the subject. Great design can speak to us in ways that we were not expecting.</p>\n\n\n\n<p>As an aside, I would love to see creators who describe their designs as &#8220;inspired by&#8221; something to provide more insight into the subject via a blog post. For those unfamiliar with whatever that subject may be, it would pull back the curtain a bit, giving us a glimpse into why it was important to the designer.</p>\n\n\n\n<p>Archeo is the first theme that I have seen use the <a href=\"https://wptavern.com/the-wordpress-web-fonts-api-has-arrived\">upcoming web fonts API</a> expected to land in WordPress 6.0. Users with the Gutenberg plugin installed should see the theme&#8217;s only font, Chivo, gracing the front end and editor. Those without the plugin should see their system&#8217;s default sans-serif font.</p>\n\n\n\n<p>The following screenshot is of the theme&#8217;s 404 template and shows the Chivo font:</p>\n\n\n\n<img />404 page template in site editor.\n\n\n\n<p>It looks far better than the default, at least on Windows. I recommend running this theme alongside the Gutenberg plugin for the ideal result.</p>\n\n\n\n<p>I am surprised the Theme Team did not include a backward-compatible method of handling web fonts for WordPress 5.9 users. It would not have taken much code: a single hook and a check for whether the <code>wp_webfonts()</code> function exists.</p>\n\n\n\n<p>Archeo is now the 59th block theme to land in the WordPress.org directory. I am eager to see more from Automattic&#8217;s Theme Team, especially if this will be its minimum standard with future designs.</p>\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}s:7:\"pubDate\";a:1:{i:0;a:5:{s:4:\"data\";s:31:\"Thu, 24 Mar 2022 04:37:29 +0000\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}}s:32:\"http://purl.org/dc/elements/1.1/\";a:1:{s:7:\"creator\";a:1:{i:0;a:5:{s:4:\"data\";s:14:\"Justin Tadlock\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}}}}i:36;a:6:{s:4:\"data\";s:13:\"\n	\n	\n	\n	\n	\n	\n\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";s:5:\"child\";a:2:{s:0:\"\";a:5:{s:5:\"title\";a:1:{i:0;a:5:{s:4:\"data\";s:34:\"Matt: Guy Raz’s How I Built This\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}s:4:\"guid\";a:1:{i:0;a:5:{s:4:\"data\";s:22:\"https://ma.tt/?p=55744\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}s:4:\"link\";a:1:{i:0;a:5:{s:4:\"data\";s:48:\"https://ma.tt/2022/03/guy-razs-how-i-built-this/\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}s:11:\"description\";a:1:{i:0;a:5:{s:4:\"data\";s:1104:\"<p>I spoke with <a href=\"https://www.guyraz.com/\">Guy Raz</a> about the early days of <a href=\"https://wordpress.org/\">WordPress</a> and <a href=\"https://automattic.com/\">Automattic</a> on the latest episode of “<a href=\"https://pca.st/ofk85jgu\">How I Built This (listen on Pocket Casts)</a>.” We ended up talking for over four hours and the show has skillfully edited this down to just over an hour. We discussed my time at <a href=\"https://en.wikipedia.org/wiki/CNET\">CNET</a>, how I accidentally invented a new way to spam, why we didn’t sell Automattic, my feelings on Wix and competitors like Shopify (sponsor of this episode, hah, in which I speak about how their dashboard looks just like WordPress’s). Guy pivoted the conversation to grief that came with the loss of my father and challenges we faced during the pandemic. He kept the conversation going effortlessly and I had a great time taping the episode. Thanks to Guy and his team for a great experience. </p>\n\n\n\n<a href=\"https://wondery.com/shows/how-i-built-this/episode/10386-wordpress-amp-automattic-matt-mullenweg/\"><img /></a>\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}s:7:\"pubDate\";a:1:{i:0;a:5:{s:4:\"data\";s:31:\"Thu, 24 Mar 2022 02:40:29 +0000\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}}s:32:\"http://purl.org/dc/elements/1.1/\";a:1:{s:7:\"creator\";a:1:{i:0;a:5:{s:4:\"data\";s:4:\"Matt\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}}}}i:37;a:6:{s:4:\"data\";s:13:\"\n	\n	\n	\n	\n	\n	\n\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";s:5:\"child\";a:2:{s:0:\"\";a:5:{s:5:\"title\";a:1:{i:0;a:5:{s:4:\"data\";s:69:\"WPTavern: WordPress.org Removes Russian Pro-War Plugin From Directory\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}s:4:\"guid\";a:1:{i:0;a:5:{s:4:\"data\";s:30:\"https://wptavern.com/?p=131835\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}s:4:\"link\";a:1:{i:0;a:5:{s:4:\"data\";s:80:\"https://wptavern.com/wordpress-org-removes-russian-pro-war-plugin-from-directory\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}s:11:\"description\";a:1:{i:0;a:5:{s:4:\"data\";s:7710:\"<p>After considerable pushback from the Plugin Review team, WordPress.org has removed a plugin called <a href=\"https://web.archive.org/web/20220323182342/https://wordpress.org/plugins/zamir/\">Zamir</a>, which was created by a <a href=\"https://profiles.wordpress.org/vovasik/\">Russian developer</a> to display the Z symbol in support of Russia&#8217;s 2022 invasion of Ukraine.</p>\n\n\n\n<p>The plugin gained attention after Gravity Forms founder and CEO Carl Hancock noticed that it was listed under the &#8220;New&#8221; list of plugins for WordPress.com customers.</p>\n\n\n\n<img />\n\n\n\n<p>Hancock contacted WordPress&#8217; plugin team to request its removal but was met with a defense for its inclusion based on what the representative deemed to be a lack of violation of the guidelines. The representative told Hancock via email that &#8220;it is permitted as long as it does not devolve into hate speech or encouraging violence.&#8221;</p>\n\n\n\n<p>Outrage over the plugin being hosted on WordPress.org sparked heated conversations on Twitter, Post Status Slack, and in WordPress&#8217; #pluginreview Slack channel where project contributors work in the open.</p>\n\n\n\n<p>Mika Epstein responded to discussion in the #pluginreview channel to confirm that the plugin was allowed to be in the directory: </p>\n\n\n\n<blockquote class=\"wp-block-quote\"><p>This is an annoying, but allowable, thing at this time. We have no restrictions about plugins that are for &#8216;support&#8217;, as long as they avoid hate speech, encouraging violence, and raising money for military orgs (regardless of which side).We have a number of plugins that people find personally objectionable. Someone might hate a &#8216;show support for LGBTQ&#8217; plugin after all. In this case, the plugin is a &#8216;show support for Russia&#8217; and has no violation to the guidelines. Much like the porn-embed plugin that a number of people hate, you don&#8217;t have to use it. Hosting plugins here does not now, nor has it ever that I&#8217;m aware of, conferred any sort of approve besides it being secure and not violating guidelines at the time of submission.</p></blockquote>\n\n\n\n<p>Meanwhile, the plugin had begun racking up negative reviews and Hancock had managed to get WordPress&#8217; project leadership to take a second look. The plugin was temporarily suspended while leadership considered the matter.</p>\n\n\n\n<img />\n\n\n\n<p>The &#8220;Z&#8221; symbol has been used by the Russian government as a <a href=\"https://www.nytimes.com/2022/03/07/world/europe/russia-letter-z-ivan-kuliak.html\">pro-war symbol and a propaganda tool</a>, and is frequently seen painted on the Russian tanks and military trucks that have invaded Ukraine. It is widely regarded as a symbol of war and violence. The <a href=\"https://web.archive.org/web/20220323182342/https://wordpress.org/plugins/zamir/\">Zamir plugin&#8217;s header image</a> includes a black and orange ribbon, the <a href=\"https://en.wikipedia.org/wiki/Ribbon_of_Saint_George\">Ribbon of St. George</a>, which is also a symbol of the Russian military. The symbol was <a href=\"https://www.rferl.org/a/ukraine-bans-st-georges-ribbon-separatist-symbol/28491961.html\">banned by Ukrainian lawmakers in 2017</a> as a symbol of &#8220;Russia&#8217;s war and occupation of Ukraine.&#8221;</p>\n\n\n\n<p>A few participants in the discussion in the #pluginreview channel seemed blissfully unaware of the symbol and flippant in response to concerns, while others who have been more immediately impacted by Russia&#8217;s aggression tried to explain what it symbolizes.</p>\n\n\n\n<p>&#8220;Here is some context about what this plugin is actually in support of, from a person sitting in a city bombed by cruise missiles,&#8221; Ukrainian WordPress contributor Andrey Savchenko said. </p>\n\n\n\n<p>&#8220;To be crystal fucking clear, this is way &#8216;morally offensive&#8217; and &#8216;abuse directed at any other member of WordPress community&#8217; under item 9 of WordPress plugin guidelines.</p>\n\n\n\n<p>&#8220;For anyone not closely familiar with the context &#8211; Z and V, that started as markings on Russian military vehicles invading Ukraine, were adopted by Russian state as symbols of gleeful support for the war, denying it is a war, denying they are killing civilians, and so on.&#8221;</p>\n\n\n\n<p>Many are incredulous that the plugin was even approved in the first place.</p>\n\n\n\n<p>&#8220;I&#8217;m completely appalled by having such a thing even being considered for inclusion,&#8221; Bas Schuiling said in the #pluginreview channel discussion. &#8220;I&#8217;m a refugee and fled Ukraine, and this exact symbol is being used to applaud and cheer the murder on my country, friends, and family.&#8221;</p>\n\n\n\n<p>&#8220;We&#8217;re watching the birth of a hate symbol in real time,&#8221; Hancock contended.  &#8220;You&#8217;d have to be living under a rock to not see that.&#8221;</p>\n\n\n\n<p>After a lengthy discussion, WordPress Executive Director Josepha Haden Chomphosy decided made the call to have the plugin permanently removed from the directory, overruling the plugin team&#8217;s decision. She followed up later with a published <a href=\"https://make.wordpress.org/project/2022/03/23/removal-of-the-zamir-plugin/\">statement</a>, clarifying why it was removed:</p>\n\n\n\n<blockquote class=\"wp-block-quote\"><p>The plugin’s description, “Shows the Z symbol to support Russia,” eluded initial plugin checks. While it is true that there is no current plugin guideline barring plugins that “support” political leanings, this icon symbolizes something more complicated than that. Contributors were right to report this and, with their help and the help of WordPress community members, the plugin has been removed from the directory. </p></blockquote>\n\n\n\n<p>In a separate post on the <a href=\"https://make.wordpress.org/plugins/2022/03/23/journal-entry-removal-of-the-zamir-plugin/\">Make WordPress Plugins</a> blog, Haden Chomphosy said that since Z is an emerging symbol of hate, &#8220;it was considered a grey area in initial checks and on further review was removed.&#8221;</p>\n\n\n\n<p>&#8220;As a reminder, WordPress guidelines call upon all community members–including extenders like plugin authors– to &#8216;be kind, helpful, and respectful,&#8217; she said. &#8220;A symbol that is connected to an ongoing war and humanitarian crisis is none of those things.&#8221; </p>\n\n\n\n<p>Many of those initially outraged about WordPress.org hosting this plugin are satisfied with the outcome, but it highlighted a disconnect between WordPress&#8217; values and the current processes in place for addressing symbols of hate in extensions.</p>\n\n\n\n<p>&#8220;I’m glad that plugin was removed from the repository,&#8221; Hancock said. &#8220;It was absolutely the right call. But I wish that it didn’t take rattling cages for that to happen. I think comparisons that were made between this situation and others that may offend people (such as a porn embed plugin) were completely off base. </p>\n\n\n\n<p>&#8220;I would hope that the WordPress Plugin Repository is not a place for plugins used to facilitate the spreading of propaganda and hate symbols that support war crimes and genocide in Ukraine. And that is exactly what the Z symbol has become.”</p>\n\n\n\n<p>Haden Chomphosy&#8217;s statement indicated that the project may be reexamining its plugin review policies in the future.</p>\n\n\n\n<p>&#8220;I am aware that this issue leads to natural questions about clarifying our plugin policies moving forward,&#8221; she said. &#8220;I’ll work with the community to explore our guidelines and create a clearer framework for how plugins can be evaluated in the context of current events.&#8221;</p>\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}s:7:\"pubDate\";a:1:{i:0;a:5:{s:4:\"data\";s:31:\"Wed, 23 Mar 2022 23:01:03 +0000\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}}s:32:\"http://purl.org/dc/elements/1.1/\";a:1:{s:7:\"creator\";a:1:{i:0;a:5:{s:4:\"data\";s:13:\"Sarah Gooding\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}}}}i:38;a:6:{s:4:\"data\";s:13:\"\n	\n	\n	\n	\n	\n	\n\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";s:5:\"child\";a:2:{s:0:\"\";a:5:{s:5:\"title\";a:1:{i:0;a:5:{s:4:\"data\";s:95:\"WPTavern: #19 – Evangelia Pappa &amp; Bernhard Kau on Making WordCamp Europe Safe and Diverse\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}s:4:\"guid\";a:1:{i:0;a:5:{s:4:\"data\";s:48:\"https://wptavern.com/?post_type=podcast&p=131164\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}s:4:\"link\";a:1:{i:0;a:5:{s:4:\"data\";s:103:\"https://wptavern.com/podcast/19-evangelia-pappa-bernhard-kau-on-making-wordcamp-europe-safe-and-diverse\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}s:11:\"description\";a:1:{i:0;a:5:{s:4:\"data\";s:51217:\"<p>On the podcast today we have Evangelia Pappa &amp; Bernhard Kau.</p>\n\n\n\n<p>WordCamp Europe is the biggest in-person event in WordPress. Last time the event was held, in 2019, there were over 3,000 attendees and hundreds of volunteers who participated.</p>\n\n\n\n<p>The 2020 event, which was due to take place in Porto Portugal was cancelled due to the outbreak of Covid. Ever since then pretty much all WordPress events have been done online. The community has stayed together and kept things going, but it’s time to return to the in-person event.</p>\n\n\n\n<p>This is great news, but what can we expect from such an event. Whilst the pandemic is less of a concern than it was just a few months ago, it’s not gone away.</p>\n\n\n\n<p>On the podcast today we talk to two of the WordCamp Europe 2022 organisers and discuss what preparations they’ve been making to ensure that the event is as safe as possible. How will social distancing work? Will you need to wear a mask? Will there be social&nbsp; aspects to the event?</p>\n\n\n\n<p>Hopefully the podcast will put your mind at rest about the precautions that have been taken, and possibly help you make up your mind about whether you want to attend in-person, or participate via the live streaming.</p>\n\n\n\n<p>We also get into the subject of diversity. A few months ago, some members of the community questioned the makeup of the event in terms of the organising team.&nbsp;&nbsp;</p>\n\n\n\n<p>We discuss how the team reacted to this. Whether they thought that the concern was justified and what they’ve been doing since then to address those concerns.</p>\n\n\n\n<p>Hopefully the event will take place this year, and if you enjoy WordCamps, but have never been a part of the organising team,&nbsp; it’s really interesting to pull back the curtain and see some of what’s required to put an event of this scale on.</p>\n\n\n\n<h2 id=\"useful-links\">Useful links.</h2>\n\n\n\n<p><a href=\"https://twitter.com/EvangeliaPappas\">Evangelia&#8217;s Twitter</a></p>\n\n\n\n<p><a href=\"https://evangeliapappa.me/\">Evangelia&#8217;s website</a></p>\n\n\n\n<p><a href=\"https://twitter.com/2ndkauboy\">Bernhard&#8217;s Twitter</a></p>\n\n\n\n<p><a href=\"https://capital-p.de/\">Bernhard&#8217;s Capital P podcast</a></p>\n\n\n\n<p><a href=\"https://kau-boys.com/\">Bernhard&#8217;s website</a></p>\n\n\n\nTranscript<div>\n<p>[00:00:00] <strong>Nathan Wrigley:</strong> Welcome to the Jukebox podcast from WP Tavern. My name is Nathan Wrigley. Jukebox is a podcast which is dedicated to all things WordPress. The people, the events, the plugins, the blocks the themes, and in this case, diversity within the community. If you&#8217;d like to subscribe to the podcast, you can do that by searching for WP Tavern in your podcast player of choice, or by going to WP Tavern.com forward slash feed forward slash podcast. And you can copy that URL into most podcasts players.</p>\n\n\n\n<p>If you have a topic that you&#8217;d like us to feature on the podcast, well, then I&#8217;m very keen to hear from you and hopefully get you, or your idea, featured on the show. Head over to WP Tavern.com forward slash contact forward slash jukebox. And you can use the contact form there.</p>\n\n\n\n<p>So on the podcast today, we have Evangelia Pappa, and Bernhard Kau. WordCamp Europe is the biggest in-person event in WordPress. Last time the event was held in 2019, they were over 3000 attendees, and hundreds of volunteers who participated. The 2020 event, which was due to take place in Porto. Portugal, was canceled due to the outbreak of COVID. Ever since then, pretty much all WordPress events have been done online.</p>\n\n\n\n<p>The community has stayed together, but it&#8217;s time to return to in-person event. This is great news, but what can we expect from such an event. Whilst the pandemic is less of a concern than it was just a few months ago, it&#8217;s not gone away. On the podcast today, we talk to two of the WordCamp Europe 2020 organizers, and discuss what preparations they&#8217;ve been making to ensure that the event is as safe as possible.</p>\n\n\n\n<p>How will social distancing work? Will you need to wear a mask? Will there be a social aspect to the event? Hopefully, the podcast will put your mind at rest about the precautions that have been taken, and possibly help you make up your mind about whether you want to attend in-person, or participate via the live streaming.</p>\n\n\n\n<p>We also get into the subject of diversity. A few months ago, some members of the community questioned the makeup of the event, in terms of the organizing team. Some felt that not enough work had been done to ensure that everyone was represented in the decision making of the event. We discuss how the team reacted to this, whether they thought that the concern was justified, and what they&#8217;ve been doing since to address those concerns.</p>\n\n\n\n<p>Hopefully the events will take place this year, and if you enjoy WordCamps, but have never been part of the organizing team, it&#8217;s really interesting to pull back the curtain and see some of what&#8217;s required to put on an event of this scale.</p>\n\n\n\n<p>If you&#8217;re interested in finding out more, you can find all the links in the show notes by heading over to WP Tavern.com forward slash podcast, where you&#8217;ll find all the other podcast episodes.</p>\n\n\n\n<p>And so. without further delay. I bring you, Evangelia Pappa, and Bernhard Kau. I am joined on the podcast today by Evangelia and Bernhard. Hello both of you.</p>\n\n\n\n<p>[00:03:58] <strong>Evangelia Pappa:</strong> Hey there.</p>\n\n\n\n<p>[00:03:59] <strong>Nathan Wrigley:</strong> Very nice to have you on the podcast today. These two fine people are going to be talking to us today about WordCamp Europe, which is happening later in 2022. There&#8217;s a couple of things that we&#8217;re going to be talking about, particularly around the two topics of COVID and also about the diversity aspect of the organization of the event. We&#8217;ll come to those two things later, but I&#8217;m just going to ask you, one at a time to introduce yourself properly. We always do this at the beginning of the podcast. Just to let the listeners know who you are, what&#8217;s your relationship with WordPress and so on. So, let&#8217;s make a start. Let&#8217;s go for Evangelia, let&#8217;s begin there.</p>\n\n\n\n<p>[00:04:34] <strong>Evangelia Pappa:</strong> Hey there to everyone. My name is Evangelia. I come from Greece. I am a recruitment specialist for WPMU Dev. I like blogging. I love and breathe for the WordPress community, not only the global one. And I&#8217;m really happy and passionate about the people and culture.</p>\n\n\n\n<p>[00:04:54] <strong>Nathan Wrigley:</strong> Thank you so much and the same question, Bernhard.</p>\n\n\n\n<p>[00:04:57] <strong>Bernhard Kau:</strong> Yeah. Hello. I&#8217;m Bernhard Kau. I&#8217;m located in Berlin, Germany. I&#8217;m a WordPress developer for a small agency in Potsdam and, I&#8217;m also an active blogger on my blog posts, also a podcaster and longtime contributor to the community. I think it was in 2009. I started.</p>\n\n\n\n<p>[00:05:13] <strong>Nathan Wrigley:</strong> Thank you both very much indeed. Now we know that in the recent past, all events have been called off. WordCamp Europe last took place, I believe it was in 2019 in Berlin. Subsequent events have been online. There were possibly attempts made to put things back in the real world, but then they were kiboshed by the reality, the COVID strain, which was spreading throughout the world, but it has been decided that the time is now right to bring this event back. Just very briefly, is it going to be the same event that we would have been attending back in 2020 had COVID not have taken hold of the world.</p>\n\n\n\n<p>In other words, are you trying to put on the full scale event, or is it in some way pared back?</p>\n\n\n\n<p>[00:05:56] <strong>Evangelia Pappa:</strong> We&#8217;re going back to in-person events. In fact, we were going back to the events we didn&#8217;t have in 2020. It&#8217;s a live event, an in person event. We can host 4,500 people, which is an amazing number judging, from the pandemic that has kept us in lockdown. I&#8217;m not quite sure yet if we will be able to have everyone, but at least we will be able to see a smiley faces.</p>\n\n\n\n<p>[00:06:22] <strong>Nathan Wrigley:</strong> Okay, and Bernhard.</p>\n\n\n\n<p>[00:06:23] <strong>Bernhard Kau:</strong> Yeah, I think in general it&#8217;s going to be the exact same when we&#8217;ve initially planned in 2020. We&#8217;ve canceled in 2020, I think in March. Like around the time, we just decided just after WordCamp Asia postponed their events and for 2021, we, in the beginning said it&#8217;s going to be online as well.</p>\n\n\n\n<p>We think now is the time to have an in-person event again. And we hope that we get the same amount of attendees we were expecting in 2020. But we cannot tell if that&#8217;s going to happen. And also if all attendees will be able to join the event, but we probably come to that a bit later.</p>\n\n\n\n<p>[00:06:57] <strong>Nathan Wrigley:</strong> I guess only time will really tell whether that&#8217;s the case or not. In terms of the organization of the event, it strikes me that many people listening to this podcast, perhaps they&#8217;ve never attended a WordPress event and they may very well of course be new to the WordPress community. So maybe just if we spend a very brief amount of time discussing the structure of the organization team. In other words, explain how it is that you came to be involved, and perhaps emphasize the fact that everybody involved in the event is a volunteer. So let&#8217;s go for Evangelia.</p>\n\n\n\n<p>[00:07:26] <strong>Evangelia Pappa:</strong> This is a very important topic because we will need to share stories with Bernard. I was with the WordPress Greek community since 2015 and it was pure luck. I mean, I met the community in 2015 and I was just attending a meetup to see what exactly is. What is WordPress? What is a WordPress meetup? What is that community I&#8217;m reading about? My skillset at that point had to do with PR and media, as I was working as a radio producer and as a generalist at that point. And I started writing the press releases that had to do with events of the WordPress Greek community, and suddenly I became a member of the organizing team. After two local WordCamps in Athens, the team that has become a family decided that we should volunteer to a bigger event to see how exactly it is happening. And we had never been to a WordCamp Europe, so we decided to apply as volunteers altogether. Since we were selected, we traveled to Belgrade and this was our first experience with WordCamp Europe. When we finished, let&#8217;s say WordCamp Europe in 2018 in Belgrade, we decided we would like to apply as organizers and some of us are organizing WordCamp Europe for around two, three years now.</p>\n\n\n\n<p>[00:08:47] <strong>Nathan Wrigley:</strong> Thank you very much, and Bernhard.</p>\n\n\n\n<p>[00:08:49] <strong>Bernhard Kau:</strong> Yeah. Usually becoming an organizing team member for WordCamp Europe, you probably have been a volunteer before for WordCamp Europe, or you&#8217;ve been an organizer for a local WordCamp. We really want to see some experienced organizers in the team. It&#8217;s not a necessity. So we even have some people very new to the community.</p>\n\n\n\n<p>In fact, in Berlin, we even had one in the local team who never attended a WordCamp himself before joining the organizing team, but he was organizing a local meetup in a city in Germany. But because it&#8217;s a huge time investment, we really need people dedicated enough to spent nine months organizing an event that size. A usual WordCamp, a local one, is maybe four or five months of organizing and WordCamp European is a whole lot different, and this is also why we need people being willing to go all the way from the beginning to the end and organizing events. And quite naturally, there&#8217;s always things happening that become more important than organizing a WordCamp, and so those people drop off because they just volunteer their time, they&#8217;re not getting paid. Yeah that&#8217;s also natural. And from the 2020 organizers we initially had for Porto, many of them continued. Some take a break. I personally took a break in 2021 because it was an online event. And I could see myself in better health for the in-person events once it&#8217;s going to happen.</p>\n\n\n\n<p>And so many of the organizers that were initially on board for 2020 are back again, but some didn&#8217;t have the time again to join the organizing team for this year. So, we are a bit smaller in size, but still we have quite a good team to organize this year&#8217;s event.</p>\n\n\n\n<p>[00:10:35] <strong>Nathan Wrigley:</strong> How many people do you have currently, and how many people did you have previously? You mentioned that it was smaller this time. I&#8217;m just curious to know what kind of numbers we&#8217;re dealing with on the volunteer side, whether that&#8217;s organizers who are doing the event prior to the actual event, as well as those people who show up and volunteer their time during the event. How many people in total are you looking at there?</p>\n\n\n\n<p>[00:10:54] <strong>Bernhard Kau:</strong> So organizers plus volunteers, I would say it&#8217;s around 260 to 300 people.</p>\n\n\n\n<p>[00:11:01] <strong>Nathan Wrigley:</strong> Okay. That gives us a really good metric as to just how large it is. Needless to say it&#8217;s incredibly complicated to sort out and incredibly complicated to put on. It&#8217;s a marvelous event, but there&#8217;s so many moving parts. It must be really difficult to get right. And so rewind to whenever it was now, I can&#8217;t remember the exact month of the year, but WordCamp Asia was about to have its first meeting and we all know the story, COVID spread throughout the world, and WordCamp Asia was canceled. The events around the world, the whole thing just rippled and all of those events were canceled and it feels to me like WordCamp Europe is one of the first, if not the first, I think there&#8217;s been a, maybe a couple in the United States that have happened more recently. But you&#8217;ve taken the decision that you&#8217;re going to bring it back. And, as with all these things, safety and keeping everybody updated about the situation and how you are hoping to maintain safety is going to be important.</p>\n\n\n\n<p>And that&#8217;s a big component of this podcast episode, to reassure people as to what you&#8217;ve done. So, let&#8217;s get into that discussion.</p>\n\n\n\n<p>In terms of the organization team, what are some of the key things that you would like the audience to hear? If they were hovering over the hotel booking button or the airplane purchasing button, or maybe just getting the ticket itself, and something in the back of their mind is niggling them. They&#8217;re potentially a little bit worried thinking about all of the different things that could happen that have happened over the last few years. What are some of the main things that you could highlight, which would assuage their fears and let them know that you&#8217;re taking the safety in terms of COVID seriously.</p>\n\n\n\n<p>[00:12:40] <strong>Evangelia Pappa:</strong> To be honest because I am at this let&#8217;s say situation at the moment, trying to book my accommodation and flights for a Porto. I did make a list with the things that I would need to have ready or have with me do to arrange my travel. But first of all I felt safe to go there. Not everyone feels safe because we have been through two very difficult years, but this is the reason because we are also humans and we do care about safety and health, not only of the attendees, but also our families.</p>\n\n\n\n<p>We are going to come back home after the event and we don&#8217;t want to contaminate anyone or give COVID to our family and put anyone in danger. We are taking measures for the venue and for the event, measures that are regulations of the Portuguese government, and also some extra measures right now that are mandatory, like the facial masks, which is not a measure that is mandatory in other countries most probably. We do have hand sanitizers that will be available inside the venue. And we will keep also social distancing guidelines, at the moment is to respect the distance of two meters.</p>\n\n\n\n<p>We also know that the regulations are changing. So we are keeping an eye and monitoring the whole situation and the restrictions in Portugal. And at the same time, it&#8217;s not only you know, about the event and the venue, but we need to be careful a little bit outside, and before we get to the venue or while traveling. And also make sure we have whatever is needed to travel for the entry to Portugal.</p>\n\n\n\n<p>[00:14:25] <strong>Nathan Wrigley:</strong> Thank you very much Bernhard. Anything that you would like to add into that?</p>\n\n\n\n<p>[00:14:29] <strong>Bernhard Kau:</strong> Yeah. In the organizing team, we agreed that the bare minimum would be any regulation the Portugal government would put in place. But on top of that, we really want to make sure that everyone is safe. We have parents within the organizing team, just having a new child and, they want to come home to a family and not having bad feelings about infecting them.</p>\n\n\n\n<p>And so we also take additional measurements that might not be necessary by like government law, but we still think they are something we want to have. Serving food outside, not inside, because we really want to have a strict mask mandate and eating with a mask is not possible. So we&#8217;ve moved the catering to outside.</p>\n\n\n\n<p>You have fresh air and it&#8217;s safer to eat without a mask being outside and not inside. So things like these. We really try to make the best possible measures to keep everyone safe. And we probably also provide some testing stations where people can get themselves tested, if they feel that they want to know if they are infected or not. We really want to make everyone feeling safe, attending the event.</p>\n\n\n\n<p>[00:15:33] <strong>Nathan Wrigley:</strong> Let&#8217;s just drill down into a few of those. You mentioned that there was going to be social distancing. Maybe the word in forced is the wrong word, but the request to be socially distant. So in an ideal world, in all of the indoor components of WordCamp EU this year, you&#8217;re going to be asking people to stay whatever the minimum safe distance is, be that a couple of meters or six feet or whatever it works out to be. That&#8217;s going to be a request. And I think I heard the word mask being used as well. So if you&#8217;re in an indoor space, there&#8217;s going to be a supposition that you&#8217;re going to be wearing a mask as well. Is that right? Did I hear that correctly?</p>\n\n\n\n<p>[00:16:09] <strong>Evangelia Pappa:</strong> You will need to wear your mask, covering all over the nose and your mouth. Also went in closed spaces and outside the venue. At the moment though, the Portuguese government requires the face mask covering only in closed spaces, but we will also see how that goes in the future. At the moment the facial mask is mandatory in and outside of the venue. We&#8217;d like to see people wearing it, that if they don&#8217;t wear it correctly, we might popup, pinging on your shoulder and asking you to wear it properly.</p>\n\n\n\n<p>[00:16:42] <strong>Nathan Wrigley:</strong> Thank you. The event arena itself is a simply magnificent piece of architecture. I believe, forgive me if I&#8217;ve got this wrong, it&#8217;s called the Superblock Arena and it&#8217;s a giant dome, and so the central auditorium where I guess some of the larger events will take place are going to be in that gigantic auditorium, but there&#8217;ll be many smaller. spaces in use as well. And I would imagine a lot of people would want to know whether or not you&#8217;re kind of limiting the amount of people that can go into certain spaces at certain times. So for example, this room over here we&#8217;ve only got a capacity for 15 people and you may not sit in this chair, but you can sit in this one so that we maintain the social distancing. Is that all happening as well? You&#8217;re limiting the numbers that can go into different parts of the building. Is that happening?</p>\n\n\n\n<p>[00:17:31] <strong>Bernhard Kau:</strong> We are limiting the number of people who could go into the arena and that we would allow as attendees. I think the arena has a capacity of well over 7,000 people. And we are not going to have 7,000 attendees. And also we have different floors. So like the place we were talking about is the main floor.</p>\n\n\n\n<p>And this is going to be split between an exposition, area and track one. And then one level lower, we have the second track and we also have the workshop rooms and those rooms are quite large and we would not allow too many people into the workshops. So there&#8217;s enough space between attendees. So it&#8217;s not really a fully packed area. And also we have lots of area around. There&#8217;s a huge, a nice park around and we&#8217;d like to see attendees browsing through the park and enjoying everything around. So only when they go to visit the sponsors or some of the sessions or workshops, they go inside. And as we said earlier, we have the catering outside and also things like WP Cafe would be located outside. So it&#8217;s really attendees going in and out. And if they need to. distance themselves a bit, they can find places around.</p>\n\n\n\n<p>[00:18:43] <strong>Nathan Wrigley:</strong> It&#8217;s lucky that you&#8217;re doing it in Portugal and not Great Britain. You may have found it quite difficult to have the outdoor component quite so easily, but I presume the weather in Porto, Portugal is going to be fairly predictable.</p>\n\n\n\n<p>An important question I suppose to ask is, whether or not you guys have actually seen this space because it&#8217;s very easy on a piece of paper or on a computer screen to take a look at what the venue looks like, but actually being there in person and imagining it on a piece of paper are two very different things. So have people from the committee been, looked around, made judgments based upon being there in the real world?</p>\n\n\n\n<p>[00:19:19] <strong>Bernhard Kau:</strong> We just had a venue visit last month and a huge number of our organizing team was there, I think it was 15 people, something like that. I don&#8217;t know the exact number. And some organizers have been there multiple times. I was not there, unfortunately myself, because in 2020, when we decided to go online, I was not going to see the venue.</p>\n\n\n\n<p>And then this year, just two weeks before I was going to go to Portugal, I got to COVID myself, canceling my travel plans. But those organizers who went there, they took pictures. They even had a video walkthrough. So all the organizers who were not able to go to the place, they have a pretty good impression of what it looks inside.</p>\n\n\n\n<p>And those teams really need to know how it looks. Like the sponsor&#8217;s team, the content team. They really know how to arrange things And we also have a company helping us with many of the logistics and they have been to the arena multiple times. So they really have a good plan on how to make things in the best way possible in the arena and the park around.</p>\n\n\n\n<p>[00:20:20] <strong>Nathan Wrigley:</strong> Thank you. That&#8217;s great. Evangelia, it sounded like you needed to add something to that.</p>\n\n\n\n<p>[00:20:24] <strong>Evangelia Pappa:</strong> A team that is seeing the venues very often in every WordCamp Europe is always a local team. That is the one also that selects the venue after a very careful research, when they apply for the call for her city. Because you see, we are always in search of a venue that can provide us certain things.</p>\n\n\n\n<p>The ability of people that have certain issues to be able to enter and navigate a big space that can host a specific amount of people and stuff like that. So, they have already checked the venue before they apply for the called for host city, and also, they need to visit it often in order to check other things that are necessary.</p>\n\n\n\n<p>And usually we have two visits, two venue visits for the rest of the team, where the team leads are available to the visit, or they send a representative of the team. I wasn&#8217;t able this year to the venue, visit too. But I had a representative of the team to check for the spaces that my team would need so we can discuss further. It&#8217;s not only, the plans, for floor plans.</p>\n\n\n\n<p>[00:21:28] <strong>Nathan Wrigley:</strong> Thank you very much, indeed. Now the next question is, obviously the answer that you give here is subject to change, but assuming that WordCamp Europe were to happen over the next week or so, do you know what the restrictions are right now in Portugal, in terms of, let&#8217;s say, for example, as Bernhard, you just said you had COVID relatively recently. Do you know what the restrictions are in terms of accessibility, your ability to fly into Portugal? Should you have had COVID and I guess, it&#8217;s a question nobody wants to probably happen to them, but nevertheless, if you were to catch COVID in Portugal, do you know what your options are there in terms of repatriating yourself and getting yourself home? Do you have to isolate in a hotel or wherever you may be settled for a period of time before you can come out and resume normal life?</p>\n\n\n\n<p>[00:22:21] <strong>Bernhard Kau:</strong> I cannot tell you what would happen if you get COVID while being in Portugal. The local team could probably answer the question. For entering Portugal, as of today, you need to have proof of full vaccination. That&#8217;s between 14 and 270 days old. You can also have a proof of recovery from COVID 19. That&#8217;s quite usual in European countries. It&#8217;s not so normal in other countries that a proof of recovery is also treated the same as the vaccination. And you also need to present a negative pre-departure test. So it&#8217;s a PCR test or a rapid antigen test, that&#8217;s not older than 24 hours. And for me, when I was planning to travel to Portugal, I would just get a test at the airport, like an antigen test. And that would be enough to enter the country. But Portugal is lowering restrictions right now. And, our local team leads was telling us that they are at level one and level zero would be no restrictions. And they will soon be at level 0.5. So they are about to lift all restrictions.</p>\n\n\n\n<p>So I would assume that even having a negative tests for entering the country would not be in place anymore when we have the event, but you&#8217;d never know. It&#8217;s still a long time to go. I mean for your own safety, it&#8217;s probably good advice to have full vaccination, if it&#8217;s possible for yourself.</p>\n\n\n\n<p>If there&#8217;s no medical condition hindering you from being vaccinated. And then also when I see my family or people, I know that&#8217;s not as healthy. I just get myself tested. So I&#8217;m safe that I&#8217;m not infecting someone. So that would be my advice to get yourself tested before you travel to Portugal, because you don&#8217;t want to get stuck in another country, you being infected and then you might not know how to isolate in a hotel room or something. And then how many days you need to stay there before you can leave. But that&#8217;s something I don&#8217;t really know, like the restrictions in Portugal, if you are getting infected and then traveling back to your country.</p>\n\n\n\n<p>[00:24:21] <strong>Nathan Wrigley:</strong> Yes, but thank you. That was an excellent answer nevertheless, and like everything else, if you are planning to travel, just make sure you&#8217;ve got the necessary documents. And now along with the ride, is have your documents. Your travel insurance, your passport, and also some proof that you have been inoculated or that you have had COVID or that you are COVID free. So that&#8217;s just another thing to add into the itinerary of things, which you must bring along. But thank you. Yeah, that&#8217;s great.</p>\n\n\n\n<p>You mentioned that there was going to be testing stations in the venue. Is that, presumably they are what we call in the UK at least anyway, lateral flow tests. So you just had a different word for it, but they&#8217;re going to be freely available are they, or is it, do we need to pay for those? How does that work?</p>\n\n\n\n<p>[00:25:03] <strong>Bernhard Kau:</strong> Those will be freely available for attendees. If they choose to get a test and we would not have testing mandatory for everyone entering. And we would probably need to have some kind of proof that you are not positive. So either recovery, vaccination, something like this, which would be checked when you get your tickets. Your badge for the event. But we would not have a mandatory test for every single day for every attendee, that would just be too much. But if you feel you would want to get tested, we have some testing next to the venue. So you don&#8217;t have to go to a public testing place somewhere in Portugal.</p>\n\n\n\n<p>Because I also think that they are not free for people not located in Portugal. So that Like be a high cost. And then also let&#8217;s say we have 4,000 attendees and they all want to get tested in the testing centers around the venue. That would be quite a lot of work for them. And we probably would have attendees coming late because they need to wait for some hours to get their test.</p>\n\n\n\n<p>[00:26:04] <strong>Evangelia Pappa:</strong> At the moment, we will have this option and also if someone has symptoms of COVID like fever, or they have a difficulty breathing or a cough or they feel they have an issue or they test positive. They can contact immediately the Portuguese national health service. We have listed the telephones on our website too, and we will have someone available to assist them when they are outside of the venue and, also, they can call 1 1 2, that is the number for emergencies. At the moment, people that test positive need to be isolated. However, previously it was mandatory also for the high risk contacts. This limitation has been eliminated, it has been removed. So now only people that test positive for COVID will be required to be in isolation.</p>\n\n\n\n<p>At the same time another measure like the digital certificate that was required for entry into restaurants, bars places like that. Was required and now is no longer required. However, it is required if you&#8217;re traveling, like we said previously, and you need to cross the borders or you need to pick a flight or something like that. And also the capacity limits of closed spaces has been eliminated. Previously there was a capacity limit and according to the last measures, this does no longer exist. Looking at the situation right now seems like the pandemic is phasing beyond, things are improving daily.</p>\n\n\n\n<p>So we have the hope that if variation prevails among the others, it will be lot easier on people, and also more restrictions will be eliminated until we get to the event date.</p>\n\n\n\n<p>[00:27:49] <strong>Nathan Wrigley:</strong> Now, I know that we all love WordPress and we love attending WordPress speakers, presentations and so on, but another thing we love is the after-party. I suspect that this is a very large reason why many people attend these events. It&#8217;s just such good fun. Now that, I&#8217;m presuming, has been modified in its scope and in its limitations, and what have you. So just very briefly, the social side of things, how is that different now?</p>\n\n\n\n<p>[00:28:14] <strong>Bernhard Kau:</strong> Yeah, basically the same applies as for the conference days. So we would have foods and drinks served outside. So we make sure that&#8217;s if you eat or drink something and you cannot wear your mask at the same time, you do that outside. And for the party itself we have it inside, it&#8217;s in the same area as track one was the same day.</p>\n\n\n\n<p>So like after the closing remarks, we would move everything out and then this area would be for the after party. And it&#8217;s quite huge space, so there&#8217;s enough space for those who want to go inside and listen to music. And those who want to talk to other people, they would probably go outside because it&#8217;s quiet outside, and there they can also have drinks and food.</p>\n\n\n\n<p>[00:28:52] <strong>Nathan Wrigley:</strong> Okay. This section wasn&#8217;t a part of the show notes when I originally wrote down the questions, I was going to be asking you but, in the last couple of weeks, we&#8217;ve had really seismic events happening in Europe. On the Eastern side of Europe. We&#8217;ve had the events happening in the Ukraine. And I don&#8217;t know if there are any thoughts as to whether this will change anything, whether or not the event has any posture on that at all. I don&#8217;t really have a question around that. Just whether or not the Ukrainian situation has forced something to be changed on the WCEU side?</p>\n\n\n\n<p>[00:29:26] <strong>Evangelia Pappa:</strong> At the moment the war is not changing anything regarding the event. Location dates, restrictions remain the same for everyone. We can say how things might end up in the future. It will depend also, for example, in the Portuguese government, in case they have any restrictions for citizens from Russia for example. As things that are floating at the moment, and it might not change anything regarding the event.</p>\n\n\n\n<p>However, this is a very tough topic and being Europeans, we have a really big history of wars on this continent. And some of them are really recent. It definitely does not make us happy and it does affect everyone. Mentally, mostly, in the rest of the continent. As many of us have colleagues there, relatives, friends and we wake up and sleep with the news everyday.</p>\n\n\n\n<p>Talking about the WordPress side of things and the community. Both countries, Ukraine and Russia have active local workers, communities, and our organizing team in WordCamp Europe includes members from Ukraine and Russia? This is a very difficult period. One thing that makes us proud during this whole situation is to say that we have members of the organizing team that are offering their help actively and our hearts and minds at the moment are with our people over there.</p>\n\n\n\n<p>If we have any information about further restrictions that might be, we will definitely inform everyone through the website and the social media. At the moment, nothing is changing regarding the event.</p>\n\n\n\n<p>[00:31:03] <strong>Nathan Wrigley:</strong> Okay, moving on then, that&#8217;s the first part of our discussion. And this next part will probably be a little bit shorter, but nevertheless, equally important. After the event website had gone live with the organizing committee details and the speakers being announced and the sponsors and all of that. There was some conversation that arose, I believe, but I could be wrong about this, I believe it began on Twitter. Where questions were raised about the event. I&#8217;m not sure specifically around which aspect of the event, whether it was the speakers or whether it was the event organizers. Maybe it was both or one or the other, I&#8217;m not entirely sure.</p>\n\n\n\n<p>But there were questions raised about the diversity of the event. I know that upon those questions being raised, the response you gave was pretty swift, and there was a lot of soul searching going on. I don&#8217;t know who wants to answer it first, but really, do you want you to summarize what the concerns that members of the community were raising about WordCamp EU and the diversity of it.</p>\n\n\n\n<p>[00:32:08] <strong>Evangelia Pappa:</strong> It was a social media post on Twitter that started the whole conversation. And it was based on the diversity of the organizing team Which is something that was a really difficult discussion and a really difficult thing this year. You see this organizing team and this conference in 2022, it&#8217;s coming back after two years of lockdowns. It was really difficult to get it started to find people that were able to commit.</p>\n\n\n\n<p>So the problem that this Tweet was raising was that there was not any black person among the organizers. However, where I come from for example we don&#8217;t even say black, because it&#8217;s considered, a form of racism. When we saw that Tweet, it was really difficult for us.</p>\n\n\n\n<p>Nobody had reached out. Nobody asked why we don&#8217;t have people of skin color or why we have, for example only Europeans and North Americans or anything regarding diversity. But suddenly we are being called out on social media. It gives the team, the feeling of being chased unfairly.</p>\n\n\n\n<p>Europe has a different background and history regarding many things. Before we start a discussion about diversity, or inclusion, which is definitely important. If you do not discuss, we cannot fix anything. But you need to have some knowledge about how things worked out when we started organizing. How things are progressing during organizing the event.</p>\n\n\n\n<p>At the same time, you need to take a look at the background of the organizing team and also the background of Europe. Location, culture, demographics, history, and all this factors that can help identify what is the diversity we need to aim to. So definitely, seeing it from the point of view of someone that resides in the United States.</p>\n\n\n\n<p>It&#8217;s not a good thing to see an organizing team that doesn&#8217;t include a person of skin color. I&#8217;m not quite sure if I&#8217;m using the correct word, because I&#8217;m not a native speaker in English. So, I hope it is the correct word, but I don&#8217;t want to use the black color, because, where I come from, it&#8217;s not a nice thing to call people like that. I understand where the person that started the Tweet comes from, and I understand also the people that were replying on threads and the whole discussion. However, we should make a larger discussion to understand how diversity factors and what metrics are different in the US and in Europe and in Asia, for example. Because there is not any continent that doesn&#8217;t need to take care of diverse.</p>\n\n\n\n<p>[00:34:59] <strong>Nathan Wrigley:</strong> Bernhard, anything to add to that?</p>\n\n\n\n<p>[00:35:02] <strong>Bernhard Kau:</strong> Yeah. As I mentioned earlier, we had quite a tough time getting the organizing team together because many of the organizers have been on the organizing team in 2020 before we canceled the in-person events and went to an online event. You can also see on the 2020 page on the organizers page there&#8217;s the in-person team, and then there&#8217;s the online event team.</p>\n\n\n\n<p>And you can see that back then, it also was a quite diverse team. But it was really hard to convince all the organizers who&#8217;ve committed themselves in 2020 to rejoin the team. So we really had to find people who are willing to invest that huge amount of time into organizing and WordCamp Europe, and for us, diversity is not just dictated by skin color or by gender or something.</p>\n\n\n\n<p>It&#8217;s also by origin, from which country applicants are coming from also in terms of how experienced are people. We don&#8217;t want to be gatekeepers only inviting the same organizers over and over again. So we really want to have some experienced organizers, but we also want to welcome new organizers. And then it might be that you have to reach out to people.</p>\n\n\n\n<p>But for 2022, it was really hard to find people that were in the organizing team in 2020 to rejoin. And that was one of the many factors why we are not as diverse as we&#8217;ve been in the past. And it&#8217;s true that reaching out to people is important, but in these times it&#8217;s really hard. And also, many organizers weren&#8217;t really sure, and it was back in September, I would say when we asked people and back then the COVID situation was not as positive in quotes as today. So people were really not sure if WordCamp Europe in-person is going to happen at all. And if they would be able to help organizing it.</p>\n\n\n\n<p>[00:36:51] <strong>Evangelia Pappa:</strong> People are not able to commit at the moment. Not only their time, but it also costs some money. I know it doesn&#8217;t sound, really romantic. But being volunteers, we&#8217;re not being paid for the time that we offer while organizing. And at the same time we have to be present at the event. So this means accommodation. This means travel expenses. And even if someone wants to assist is not able to travel to the event and knows it in advance, then they know they will not be selected. This is one thing. Because, practically, there are funds, companies that can fund someone and help them do this trip, but not everyone knows it, or not everyone is willing to ask for this kind of help. And this is really important. At the same time, as Bernard said, feeling not safe, and also not believing that the event is going to be in person was one of the reasons that people were turning our invitations down, and this is totally understandable.</p>\n\n\n\n<p>During two years we had so many online events, not only WordPress related, but, we had so many online events. We did everything online, zoom meetings with the companies you work with, with clients with everyone. So, you were stuck on a display. People still when we started didn&#8217;t believe we are going to go for an in-person event.</p>\n\n\n\n<p>Frankly, they were saying, I don&#8217;t want to do an online event again. I don&#8217;t want to be part of it. I don&#8217;t want to commit myself, and then in the end we end up with an online event. And I understand that it was tiring for many people, online events have different duties than in person events, and it wasn&#8217;t so easy to get it going and get the ball rolling.</p>\n\n\n\n<p>[00:38:43] <strong>Nathan Wrigley:</strong> Thank you very much. So since that tweet was posted and this diversity debate began. Are you able to tell us the ways that you&#8217;ve interacted with those people? The lessons potentially that may have been learned, but also the things which you are now doing differently. Measures that affect this particular event, or perhaps you&#8217;ve put things on hold and you&#8217;ve got procedures, which might be different for the next WordCamp Europe, whether or not you&#8217;re both involved I don&#8217;t know, but things that would be done differently the next time around. So, essentially I&#8217;m wrapping that up all in the phrase of, are there any lessons that you&#8217;ve learned here?</p>\n\n\n\n<p>[00:39:22] <strong>Bernhard Kau:</strong> I think the lesson that the whole WordPress community learned is that diversity is important. And it&#8217;s something the whole community has to have an eye on. It&#8217;s not just the organizing team, and it&#8217;s something that can help an organizing team to solve because being a diverse team is not just posting a call for organizers form and waiting for people to respond.</p>\n\n\n\n<p>It&#8217;s how you promote the call for organizers. How do you maybe find people you invite directly into the organizing team? And there are some great resources and some great initiatives. There&#8217;s the diversity training program which targets more towards speakers. The same things can be applied to organizers as well.</p>\n\n\n\n<p>And I have been taking part in this training and many other organizers as well. So we really know how to make sure that the next organizing team is even more diverse as the current one. But for this event, we cannot change the organizing team. It was hard enough to get enough people. We also had help from some companies. Volunteering some employees to us. So we have enough people to get all the workload done we have in the organizing team. But for other things, it&#8217;s a bit easier, like for the call for speakers and call for volunteers there it&#8217;s easier to have a diverse group of people. And this is always something we kept in mind.</p>\n\n\n\n<p>So in the past we&#8217;ve increased the number in the gender ratio. But as I said earlier, diversity is not just dictated by gender. So we really want to have a very diverse group of speakers. So in terms of gender and experience and all of that. And the content team really focuses on that a lot and has focused a lot in the past. And the volunteers, I would say every year, you can see that the volunteers group is really diverse. We have people from all around the world because being an organizer, you need to be within some time zones. It&#8217;s really tough to have someone from, I don&#8217;t know, Australia in the organizing team, we had some people from that time zone back in 2019, which is really a challenge.</p>\n\n\n\n<p>But for volunteers it&#8217;s really easy to invite everyone to become a volunteer because they all have to travel to Porto and time zones are not a huge tissue. But for the organizing team, that&#8217;s really something that can be challenging.</p>\n\n\n\n<p>[00:41:42] <strong>Nathan Wrigley:</strong> Thank you has the debate on Twitter, has it led to a conversation? In other words, when that was mentioned on Twitter, presumably it was a calling out of something that people felt needed addressing. Did you engage with those people and ask for their opinion and what it was that they thought needed to be looked at? How has that conversation, that debate move forward over the last several weeks?</p>\n\n\n\n<p>[00:42:06] <strong>Evangelia Pappa:</strong> Regarding having a discussion with the people on Twitter. We don&#8217;t want to use the social media for such conversation as some of the social media, not good enough, and not the proper way of communication for such discussions. And the reason is for example, Twitter has a limitation of characters. It&#8217;s not easy to make a discussion over there for diversity. That is a huge topic and really important for the whole community. So we had to have another way to discuss this and move forward with a whole situation. You see, diversity means you belong here and you&#8217;re not the only one. So you give people the opportunity to representation and the feeling of inclusivity.</p>\n\n\n\n<p>It is one of the things that makes a community viable and creative. It means that people with different backgrounds are able to express themselves freely. They are able to stand behind their ideas. They have a voice. And this is very important. And it is a goal that takes time. It&#8217;s not a post a post on Twitter that, you know, can make things different, there is no a quick hack.</p>\n\n\n\n<p>We can only focus on the work that is needed to make it happen. And it takes time. It&#8217;s not going to happen from one day to the other. It takes time and we need to work on this. So we have asked for help from WordCamp central. We have asked for resources, the ones that Bernard mentioned previously, and we&#8217;d like to thank everyone for this help.</p>\n\n\n\n<p>And a great open discussion has been opened to the make WordPress website which is a discussion well to follow closely about diversity in WordPress events. This was the way, not WordCamp Europe, but WordPress community in general approached the people that felt underrepresented and opened this topic about WordCamp Europe, because it&#8217;s not only about WordCamp Europe it&#8217;s about all the WordCamps and also local events like meetups.</p>\n\n\n\n<p>[00:44:02] <strong>Nathan Wrigley:</strong> I think that I&#8217;ve asked all of the questions that I would like to ask. Just one quick thing. We were talking previously about hybrid events and the fact that people were possibly a little bit fed up of being online, but for those people who, for example, are unable to attend WordCamp Europe, is there a plan this time around to have any of the sessions broadcast live?</p>\n\n\n\n<p>In my parlance I&#8217;m terming that a hybrid event live mixed with online. Is that going to be happening at WordCamp Europe this year? Or is it just live with WordPress TV to look at them after the fact?</p>\n\n\n\n<p>[00:44:38] <strong>Bernhard Kau:</strong> We&#8217;ve been livestreaming WordCamp Europe, I think since 2017, when we were in Paris. Maybe even in Vienna. So we had live streams for a long time. What would make WordCamp Europe really a hybrid event is the opportunity to connect the online world with the offline world. So for example, we are planning to have in the Q and A after a session, someone taking questions from the online audience and asking the speakers onstage some questions from the online audience so they feel more connected to what&#8217;s happening in Portugal. We cannot have every aspect of the events being put into the online world as well, but we really try to make it more hybrid. So those were just watching on our websites. They can also participate in some way, and we are still figuring out in the many different ways how we can make as many aspects of the WordCamp Europe also available for the online world, but at least for the Q and A, this is a plan we already agreed on. So we would have questions from the online audience after the speakers onstage.</p>\n\n\n\n<p>[00:45:47] <strong>Nathan Wrigley:</strong> Lovely. Thank you very much. If anybody wanted to reach out to both of you, either of you, are you able to share the best place to do that? That could be a Twitter feed or it could be an email address, whatever you&#8217;re comfortable with. So I&#8217;ll start with Bernhard.</p>\n\n\n\n<p>[00:46:04] <strong>Bernhard Kau:</strong> I think that the best and easiest way is either by my personal block or through Twitter. You probably have to put that into the show notes, my exact Twitter handle. It&#8217;s second cowboy, but it&#8217;s K A U. So my my last name that&#8217;s my Twitter handle and yeah, my blog post and my block is listing as well. So that&#8217;s probably the best way to get in contact with me.</p>\n\n\n\n<p>[00:46:26] <strong>Nathan Wrigley:</strong> Thank you very much and Evangelia.</p>\n\n\n\n<p>[00:46:29] <strong>Evangelia Pappa:</strong> If someone needs to get in contact with us as organizers of WordCamp Europe, they can always find us at europe @ wordcamp dot org, which is the official email of WordCamp Europe. If someone needs to talk to us directly, social media I think is the best way at the moment. And. Twitter or Facebook or something like that.</p>\n\n\n\n<p>Mine is, Evangelia Pappa my handle on Twitter, so they can find me over there too.</p>\n\n\n\n<p>[00:46:55] <strong>Nathan Wrigley:</strong> I will make sure to put all of those into the show notes, which can be found on the WP Tavern website. Bernhard, Evangelia, thank you so much for talking to me about WordCamp Europe today. I really appreciate it.</p>\n\n\n\n<p>[00:47:09] <strong>Bernhard Kau:</strong> Thanks for having us.</p>\n\n\n\n<p>[00:47:10] <strong>Evangelia Pappa:</strong> Thank you for having us.</p>\n</div>\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}s:7:\"pubDate\";a:1:{i:0;a:5:{s:4:\"data\";s:31:\"Wed, 23 Mar 2022 14:00:00 +0000\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}}s:32:\"http://purl.org/dc/elements/1.1/\";a:1:{s:7:\"creator\";a:1:{i:0;a:5:{s:4:\"data\";s:14:\"Nathan Wrigley\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}}}}i:39;a:6:{s:4:\"data\";s:13:\"\n	\n	\n	\n	\n	\n	\n\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";s:5:\"child\";a:2:{s:0:\"\";a:5:{s:5:\"title\";a:1:{i:0;a:5:{s:4:\"data\";s:56:\"Post Status: This Week at WordPress.org (March 21, 2022)\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}s:4:\"guid\";a:1:{i:0;a:5:{s:4:\"data\";s:31:\"https://poststatus.com/?p=94894\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}s:4:\"link\";a:1:{i:0;a:5:{s:4:\"data\";s:64:\"https://poststatus.com/this-week-at-wordpress-org-march-21-2022/\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}s:11:\"description\";a:1:{i:0;a:5:{s:4:\"data\";s:8902:\"<p>Each week we are highlighting the news from WordPress.org that you don\'t want to miss.  If you or your company create products or services that use WordPress, we\'ve got the news you need to know. Be sure to share this resource with your product and project managers.</p>\n\n\n\n<h2 id=\"h-news\"><a href=\"http://wordpress.org/news\">News</a></h2>\n\n\n\n<ul><li><a href=\"https://wordpress.org/news/2022/03/the-month-in-wordpress-february-2022/\"></a><a href=\"https://wordpress.org/news/2022/03/wordpress-5-9-2-security-maintenance-release/\"></a><a href=\"https://wordpress.org/news/2022/03/episode-27-is-wordpress-made-for-me/\">WP Briefing: Episode 27: Is WordPress Made for Me?</a></li><li><a href=\"https://make.wordpress.org/project/2022/03/23/removal-of-the-zamir-plugin/\">Removal of the Zamir Plugin</a></li><li><a href=\"https://make.wordpress.org/plugins/2022/03/23/journal-entry-removal-of-the-zamir-plugin/\">Journal Entry: Removal of the Zamir Plugin</a></li></ul>\n\n\n.kt-block-spacer-_a09d8b-b0 .kt-divider{width:80%;}\n<div class=\"wp-block-kadence-spacer aligncenter kt-block-spacer-_a09d8b-b0\"><div class=\"kt-block-spacer kt-block-spacer-halign-center\"><hr class=\"kt-divider\" /></div></div>\n\n\n\n<div class=\"wp-block-columns\">\n<div class=\"wp-block-column\">\n<h2 id=\"h-core\"><a href=\"https://make.wordpress.org/core\">Core</a> </h2>\n\n\n\n<ul><li><a href=\"https://make.wordpress.org/core/2022/03/23/migrating-wordpress-e2e-tests-to-playwright/\">Migrating WordPress E2E tests to Playwright</a><a href=\"https://make.wordpress.org/core/2022/03/07/the-performance-lab-plugin-has-been-released/\"></a><a href=\"https://make.wordpress.org/core/2022/03/07/a-week-in-core-march-7-2022/\"></a><a href=\"https://make.wordpress.org/core/2022/03/14/a-week-in-core-march-14-2022/\"></a></li><li><a href=\"https://make.wordpress.org/core/2022/03/21/a-week-in-core-march-21-2022/\">A Week in Core – March 21, 2022</a></li><li><a href=\"https://make.wordpress.org/core/2022/03/15/bug-scrub-schedule-for-6-0/\">Bug Scrub Schedule for 6.0</a></li></ul>\n\n\n\n<h2 id=\"h-community\"><a href=\"https://make.wordpress.org/community\">Community</a></h2>\n\n\n\n<ul><li><a href=\"https://make.wordpress.org/community/2022/03/03/2022-community-team-goals-summary/\"></a><a href=\"https://make.wordpress.org/community/2022/03/14/meetup-organizer-newsletter-march-2022/\">Meetup Organizer Newsletter: March 2022</a></li><li><a href=\"https://make.wordpress.org/community/2022/03/23/return-to-events-blue-sky-thinking/\">Return to In-Person Events: Blue Sky Thinking</a></li><li><a href=\"https://make.wordpress.org/community/2022/03/17/discussion-revisiting-in-person-regional-wordcamps/\">Discussion: Revisiting In-person Regional WordCamps</a></li></ul>\n\n\n\n<h2 id=\"h-docs\"><a href=\"https://make.wordpress.org/docs\">Docs</a>:</h2>\n\n\n\n<ul><li><a href=\"https://make.wordpress.org/docs/2022/03/23/working-on-wordpress-release-6-0-selecting-trac-tickets-for-devnotes/\">Working on WordPress release 6.0 – Selecting Trac tickets for DevNotes</a></li></ul>\n\n\n\n<h3 id=\"h-support-articles\">Support Articles:</h3>\n\n\n\n<ul><li><a href=\"https://wordpress.org/support/article/submit-your-block-pattern-to-the-directory/\">Submit your Block Pattern to the Directory</a></li><li><a href=\"https://wordpress.org/support/article/post-date-block/\">Post Date Block</a></li><li><a href=\"https://wordpress.org/support/article/post-tags-block/\">Post Tags Block</a></li><li><a href=\"https://wordpress.org/support/article/post-categories-block/\">Post Categories Block</a></li><li><a href=\"https://wordpress.org/support/article/post-excerpt-block/\">Post Excerpt Block</a></li><li><a href=\"https://wordpress.org/support/article/post-title-block/\">Post Title Block</a></li></ul>\n\n\n\n<h2 id=\"h-meta\">Meta</h2>\n\n\n\n<ul><li><a href=\"https://make.wordpress.org/meta/2022/03/16/coming-soon-block-pattern-directory-submissions/\">Coming soon: Block Pattern Directory Submissions</a></li></ul>\n\n\n\n<h2 id=\"h-mobile\">Mobile</h2>\n\n\n\n<ul><li><a href=\"https://make.wordpress.org/mobile/2022/03/21/call-for-testing-wordpress-for-ios-19-5/\">Call for Testing: WordPress for iOS 19.5</a></li><li><a href=\"https://make.wordpress.org/mobile/2022/03/21/call-for-testing-wordpress-for-android-19-5/\">Call for Testing: WordPress for Android 19.5</a></li></ul>\n\n\n\n<h2 id=\"h-photos\">Photos</h2>\n\n\n\n<ul><li><a href=\"https://make.wordpress.org/photos/2022/03/23/announcement-photo-directory-team-reps-2022/\">Announcement: Photo Directory Team Reps 2022</a></li></ul>\n\n\n\n<h2 id=\"h-polyglots\">Polyglots</h2>\n\n\n\n<ul><li><a href=\"https://make.wordpress.org/polyglots/2022/03/22/polyglots-monthly-newsletter-march-2022/\">Polyglots Monthly Newsletter: March 2022</a></li></ul>\n</div>\n\n\n\n<div class=\"wp-block-column\">\n<h2 id=\"h-plugins\"><a href=\"https://make.wordpress.org/plugins\">Plugins</a></h2>\n\n\n\n<ul><li><a href=\"https://make.wordpress.org/updates/2022/02/22/plugin-review-team-21-february-2022/\"></a><a href=\"https://make.wordpress.org/updates/2022/02/28/plugin-review-team-update-28-feb-2022/\"></a><a href=\"https://make.wordpress.org/updates/2022/03/15/plugin-review-team-14-march-2022/\"></a><a href=\"https://make.wordpress.org/updates/2022/03/22/plugin-review-team-21-march-2022/\">Plugin Review Team: 21 March 2022</a></li></ul>\n\n\n\n<h2 id=\"h-project\"><a href=\"https://make.wordpress.org/project\">Project</a></h2>\n\n\n\n<ul><li><a href=\"https://make.wordpress.org/project/2022/03/16/proposal-to-remove-spam-dormant-five-for-the-future-pledges/\">Proposal to remove spam/dormant Five for the Future pledges</a></li></ul>\n\n\n\n<h2 id=\"h-themes\"><a href=\"https://make.wordpress.org/themes\">Themes</a></h2>\n\n\n\n<ul><li><a href=\"https://make.wordpress.org/updates/2022/03/02/themes-team-update-march-02-2022/\"></a><a href=\"https://make.wordpress.org/updates/2022/03/15/themes-team-update-march-15-2022/\"><a href=\"https://make.wordpress.org/updates/2022/03/22/themes-team-update-march-22-2022/\">Themes team update March 22, 2022</a></a></li></ul>\n\n\n\n<h2 id=\"h-training\"><a href=\"https://make.wordpress.org/training\">Training</a></h2>\n\n\n\n<ul><li><a href=\"https://make.wordpress.org/updates/2022/02/28/whats-new-on-learnwp-in-february-2022/\"></a><a href=\"https://make.wordpress.org/training/2022/03/03/march-2022-team-sprint/\">March 2022 Team Sprint</a></li><li><a href=\"https://make.wordpress.org/training/2022/01/31/faculty-program-structure-proposal/\">Faculty Program: Structure Proposal</a></li></ul>\n\n\n\n<h4 id=\"h-workshops\">Workshops</h4>\n\n\n\n<ul><li><a href=\"https://learn.wordpress.org/workshop/adding-a-site-tagline-to-block-themes/\">Adding a Site Tagline to Block Themes</a></li><li><a href=\"https://learn.wordpress.org/workshop/manage-settings-privacy/\">Manage Settings: Privacy</a></li></ul>\n\n\n\n<h4 id=\"h-social-learning-spaces\">Social Learning Spaces:</h4>\n\n\n\n<ul><li><a href=\"https://learn.wordpress.org/social-learning/\">Calendar</a></li></ul>\n\n\n\n<h2 id=\"h-support\">Support</h2>\n\n\n\n<ul><li><a href=\"https://make.wordpress.org/support/2022/03/health-check-troubleshooting-upcoming-release-of-version-1-5-0/\">Health Check & Troubleshooting – Upcoming release of version 1.5.0</a></li></ul>\n\n\n\n<h2 id=\"h-openverse\">Openverse</h2>\n\n\n\n<ul><li><a href=\"https://make.wordpress.org/openverse/2022/03/10/openverse-frontend-v3-1-1-release/\">Openverse Frontend v3.1.1 Release</a></li><li><a href=\"https://make.wordpress.org/openverse/2022/03/14/last-week-openverse-2022-03-07-2022-03-14/\"></a><a href=\"https://make.wordpress.org/openverse/2022/03/21/last-week-openverse-2022-03-14-2022-03-21/\">A week in Openverse: 2022-03-14 – 2022-03-21</a></li></ul>\n</div>\n</div>\n\n\n\n<div class=\"wp-block-spacer\"></div>\n\n\n\n<div class=\"wp-block-media-text alignwide is-stacked-on-mobile has-background\"><a href=\"https://poststatus.com/\"><img src=\"https://cdn.poststatus.com/wp-content/uploads/2021/09/vertical-post-status-logo-250.png\" alt=\"Post Status\" class=\"wp-image-85823 size-full\" /></a><div class=\"wp-block-media-text__content\">\n<p class=\"has-text-align-left has-normal-font-size\" id=\"h-get-ready-for-remote-work\">You — and <a href=\"https://poststatus.com/business-membership/\">your whole team</a> can <a href=\"https://poststatus.com/post-status-membership-club/\">Join Post Status</a> too!</p>\n\n\n\n<p class=\"has-text-align-left has-small-font-size\"><strong>Build your network. Learn with others. Find your next job — or your next hire.</strong> Read the <strong>Post Status</strong> <a href=\"https://poststatus.com/newsletter/\">newsletter</a>. <img src=\"https://s.w.org/images/core/emoji/13.1.0/72x72/2709.png\" alt=\"✉\" class=\"wp-smiley\" /> Listen to <a href=\"https://poststatus.com/podcasts/\">podcasts</a>. <img src=\"https://s.w.org/images/core/emoji/13.1.0/72x72/1f399.png\" alt=\"🎙\" class=\"wp-smiley\" /> Follow <a href=\"https://twitter.com/post_status/\">@Post_Status</a>. <img src=\"https://s.w.org/images/core/emoji/13.1.0/72x72/1f426.png\" alt=\"🐦\" class=\"wp-smiley\" /></p>\n</div></div>\n\n\n\n<div class=\"wp-block-spacer\"></div>\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}s:7:\"pubDate\";a:1:{i:0;a:5:{s:4:\"data\";s:31:\"Wed, 23 Mar 2022 14:00:00 +0000\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}}s:32:\"http://purl.org/dc/elements/1.1/\";a:1:{s:7:\"creator\";a:1:{i:0;a:5:{s:4:\"data\";s:18:\"Courtney Robertson\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}}}}i:40;a:6:{s:4:\"data\";s:13:\"\n	\n	\n	\n	\n	\n	\n\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";s:5:\"child\";a:2:{s:0:\"\";a:5:{s:5:\"title\";a:1:{i:0;a:5:{s:4:\"data\";s:85:\"WPTavern: WP Engine, Pantheon, and Others Drop Support for Russian Business Customers\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}s:4:\"guid\";a:1:{i:0;a:5:{s:4:\"data\";s:30:\"https://wptavern.com/?p=131723\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}s:4:\"link\";a:1:{i:0;a:5:{s:4:\"data\";s:94:\"https://wptavern.com/wp-engine-pantheon-and-others-drop-support-for-russian-business-customers\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}s:11:\"description\";a:1:{i:0;a:5:{s:4:\"data\";s:6742:\"<p>WordPress managed hosting company WP Engine has joined Acquia, Fastly, Gatsby, Netlify, and Pantheon to begin booting Russian companies off their platforms. </p>\n\n\n\n<p>In addition to the joint protest, each organization has also pledged support to the <a href=\"https://ooni.org/\">Open Observatory of Network Interference</a> (OONI), a non-profit that documents internet censorship around the world.</p>\n\n\n\n<p>&#8220;As part of that effort to increase our support, we are adopting a stronger stance against the actions of the Russian government while supporting the ideals we hold true as an Open Web company, which is why WP Engine has joined with other Open Web companies Acquia, Fastly, Gatsby, Netlify, and Pantheon to stand with Ukraine,&#8221; WP Engine said in a <a href=\"https://wpengine.com/blog/wp-engine-stands-with-ukraine/\">statement</a>. &#8220;WP Engine has ceased all business with Russian companies that were using our platform.&#8221;</p>\n\n\n\n<p>These stricter measures came after the company had already donated to Polish and Ukrainian humanitarian funds, matching employee funds.  WP Engine condemned Russia&#8217;s invasion in its first published statement on the matter:</p>\n\n\n\n<blockquote class=\"wp-block-quote\"><p>As the world watches in horror, Russia’s invasion of Ukraine continues to leave heart-wrenching destruction in its wake. It is truly shocking that in 2022, a major world power would launch an unprovoked attack on a sovereign nation, causing the largest humanitarian crisis in Europe since WWII.</p><p>As they face unimaginable hardships, we stand firmly with the Ukrainian people and condemn the actions of the Russian government in Ukraine.  </p></blockquote>\n\n\n\n<p>Similarly, Acquia <a href=\"https://twitter.com/acquia/status/1505997734909722625?ref_src=twsrc%5Etfw%7Ctwcamp%5Etweetembed%7Ctwterm%5E1505997734909722625%7Ctwgr%5E%7Ctwcon%5Es1_&ref_url=https%3A%2F%2Fwptavern.com%2Fwp-admin%2Fpost.php%3Fpost%3D131723action%3Dedit\">tweeted </a>earlier this week that the company &#8220;will not provide software or services to organizations based in Russia.&#8221;</p>\n\n\n\n<p>The coalition of organizations is sanctioning Russia in a similar way to Namecheap, and many other companies, that have <a href=\"https://news.ycombinator.com/item?id=30504812\">terminated service for Russian customers</a>. The world has never seen anything like it with the number of companies across every industry willingly sanctioning the Russian market without a government requirement to do so. Widespread outrage against Putin&#8217;s invasion of Ukraine has provoked a massive response from corporations and private enterprises.</p>\n\n\n\n<p>&#8220;The net effect of so many companies exiting or pausing operations in Russia means the government sanctions might almost become a moot point. “It’s a chicken and egg story,&#8221; Leo Feler, senior economist at UCLA Anderson School of Management, told <a href=\"https://time.com/6155725/corporations-war-russia-ukraine/\">TIME magazine</a>. &#8220;If enough businesses abandon the Russian market on their own, the Russian market is also going to shrink. You don’t need sanctions to do it if everyone self-sanctions.”</p>\n\n\n\n<p>In the world of open source software, individuals, companies, and projects are grappling with the ethical implications of staying neutral versus imposing some form of sanctions. One misguided attempt at &#8220;protestware&#8221; was included as a dependency for a popular npm package with malicious code that <a href=\"https://www.bleepingcomputer.com/news/security/big-sabotage-famous-npm-package-deletes-files-to-protest-ukraine-war/amp/\">deletes data by overwriting files for users based in Russia and Belarus</a>. People are desperate to make a difference for those suffering in Ukraine, but they don&#8217;t always know the most effective way to direct their efforts.</p>\n\n\n\n<p>The Open Source Initiative (OSI) has taken a firm stance on the immutability of the freedoms and protections that open source licensing confers. </p>\n\n\n\n<p>&#8220;Civil society has many non-violent ways at its disposal to resolve conflicts and it’s important to explore all possible avenues,&#8221; OSI Executive Director Stefano Maffulli <a href=\"https://opensource.org/newsletter/OSI-mar-2022\">said</a>. </p>\n\n\n\n<p>&#8220;When it comes to open source software, however, the&nbsp;<a href=\"https://opensource.org/osd\">Open Source Definition</a>&nbsp;is clear: There must be &#8216;no discrimination against persons or groups&#8217; and &#8216;no discrimination against fields of endeavor.\'&#8221;</p>\n\n\n\n<p>Maffulli elaborated on these thoughts in an interview with <a href=\"https://thenewstack.io/where-does-open-source-fit-into-russias-war-with-ukraine/\">The New Stack</a>, noting that limiting distribution is one option for protesting but that this could hurt Russian citizens more than “the Russian military and powerful elites who certainly have the means to develop workarounds.&#8221; </p>\n\n\n\n<p>Limiting distribution would likely be far more difficult than denying service to Russian businesses, which is why this tactic has been more readily adopted. Businesses are  using whatever means they have within their spheres of  influence to make an impact. </p>\n\n\n\n<p>The WordPress project stopped short of explicitly condemning the aggression and has focused more on the humanitarian crisis and supporting peacebuilders. The project produced a <a href=\"https://wordpress.org/news/2022/03/episode-26-matt-mullenweg-on-ukraine-community-and-wordpress/\">special edition of its WP Briefing podcast</a> to address the situation in Ukraine earlier this month.</p>\n\n\n\n<p>&#8220;The downstream humanitarian crises of the invasion are unimaginable,&#8221; WordPress co-creator Matt Mullenweg said.</p>\n\n\n\n<p>&#8220;And seeing destruction in the world we live in is confusing, disconcerting, and difficult.&#8221;</p>\n\n\n\n<p>Mullenweg invited the WordPress community to stand &#8220;with those in the world working to end conflict and working toward a world of peace, promise, and opportunity.&#8221;</p>\n\n\n\n<p>Many companies have followed this same approach with efforts aimed at providing relief for refugees and economic support for Ukrainians who are still fighting. WP Engine, Acquia, Fastly, Gatsby, Netlify, and Pantheon were compelled to go beyond their humanitarian efforts to put some pressure on Russia. It&#8217;s not yet clear whether disempowering Russian companies will have any bearing on the outcome of this conflict.</p>\n\n\n\n<p>After a nearly month long war that has left cities like Mariupol in ashes, with Russia&#8217;s war crimes on full display across media outlets around the world, companies are coming under more pressure to act. </p>\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}s:7:\"pubDate\";a:1:{i:0;a:5:{s:4:\"data\";s:31:\"Wed, 23 Mar 2022 03:25:25 +0000\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}}s:32:\"http://purl.org/dc/elements/1.1/\";a:1:{s:7:\"creator\";a:1:{i:0;a:5:{s:4:\"data\";s:13:\"Sarah Gooding\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}}}}i:41;a:6:{s:4:\"data\";s:13:\"\n	\n	\n	\n	\n	\n	\n\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";s:5:\"child\";a:2:{s:0:\"\";a:5:{s:5:\"title\";a:1:{i:0;a:5:{s:4:\"data\";s:87:\"WPTavern: Block Accidental Edits of Shared Content With the Lock Reusable Blocks Plugin\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}s:4:\"guid\";a:1:{i:0;a:5:{s:4:\"data\";s:30:\"https://wptavern.com/?p=131797\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}s:4:\"link\";a:1:{i:0;a:5:{s:4:\"data\";s:98:\"https://wptavern.com/block-accidental-edits-of-shared-content-with-the-lock-reusable-blocks-plugin\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}s:11:\"description\";a:1:{i:0;a:5:{s:4:\"data\";s:4091:\"<p class=\"has-drop-cap\">Over the weekend, web developer Marie Comet released the <a href=\"https://wordpress.org/plugins/lock-reusable-blocks/\">Lock Reusable Blocks</a> plugin. Since then, she has published a couple of more updates that polish that initial release. The extension blocks users from directly editing reusable blocks from the post-editing screen.</p>\n\n\n\n<p>Reusable blocks allow users to group one or more blocks in the post editor, save them, and reuse anywhere blocks are supported. Technically, they are &#8220;shared&#8221; or &#8220;synced.&#8221; If editing a reusable block in one location, all uses of it will share those changes.</p>\n\n\n\n<img />Creating a reusable block.\n\n\n\n<p>The problem with the feature is that it is not always clear when you are editing a reusable block. WordPress will display its name in the toolbar, list view, and breadcrumbs nav. However, the only clear message that it is a shared instance is in the sidebar panel, which only appears if open.</p>\n\n\n\n<p>Before WordPress 5.7, users had to click an &#8220;Edit&#8221; button to make changes to a reusable block. At least in that scenario, it was somewhat clear that the content was different from the main post or page content. However, 5.7 rolled out a &#8220;click-through&#8221; method for editing. The first click selects the wrapper element around the saved block, requiring a second click to edit any inner content. This change has made it far too easy to inadvertently edit global content.</p>\n\n\n\n<p>I am familiar enough with the editor that I doubt I would slip up with this problem. However, I still hand sites over to friends and family from time to time. Most never discover the feature, but those who do inevitably make these global changes when they did not intend to. I have also heard enough client-related horror stories from others to know it is a legitimate issue.</p>\n\n\n\n<p>There is an open ticket to <a href=\"https://github.com/WordPress/gutenberg/issues/32461\">bring a locking mechanism</a> to reusable blocks, and there has been a <a href=\"https://github.com/WordPress/gutenberg/pull/32710\">patch for it since June 2021</a>. However, there has not been much movement in the last several months. In the meantime, at least we have the Lock Reusable Blocks plugin.</p>\n\n\n\n<p>Comet&#8217;s solution takes a different approach from earlier versions of WordPress and the proposed patch. Instead of giving users the option to edit in-content, they are blocked from doing so altogether:</p>\n\n\n\n<img />Lock Reusable Blocks overlay and buttons.\n\n\n\n<p>The plugin grays out the reusable block and adds two buttons over the top when selected in the editor. The first button enables editing, but it does so by opening a new browser tab/window and taking the user to the editor for the block itself. This approach makes it clear that the content is separate from the post.</p>\n\n\n\n<p>WordPress&#8217;s reusable block management screen is hidden by default, but there are a few <a href=\"https://wordpress.org/plugins/search/reusable+blocks/\">plugins that enable it</a>.</p>\n\n\n\n<p>The plugin&#8217;s second button in the overlay allows users to convert the reusable block to regular blocks. Doing this takes it out of the global scope and can be safely edited without affecting other uses.</p>\n\n\n\n<p>I want to like the reusable blocks feature in WordPress. I understand how it could be one of the platform&#8217;s most powerful tools. However, its implementation has yet to live up to the potential it showed four years ago when under development in Gutenberg.</p>\n\n\n\n<p>If we could fix the accidental-editing issue and the longstanding problem with <a href=\"https://github.com/WordPress/gutenberg/issues/8288\">wide alignments not working</a> (<em>I could not write this post without at least noting that ticket</em>), it could start down the path of becoming the feature it was always meant to be.</p>\n\n\n\n<div class=\"wp-block-embed__wrapper\">\n<blockquote class=\"wp-embedded-content\"><a href=\"https://wordpress.org/plugins/lock-reusable-blocks/\">Lock Reusable Blocks</a></blockquote>\n</div>\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}s:7:\"pubDate\";a:1:{i:0;a:5:{s:4:\"data\";s:31:\"Wed, 23 Mar 2022 03:15:10 +0000\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}}s:32:\"http://purl.org/dc/elements/1.1/\";a:1:{s:7:\"creator\";a:1:{i:0;a:5:{s:4:\"data\";s:14:\"Justin Tadlock\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}}}}i:42;a:6:{s:4:\"data\";s:13:\"\n	\n	\n	\n	\n	\n	\n\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";s:5:\"child\";a:2:{s:0:\"\";a:5:{s:5:\"title\";a:1:{i:0;a:5:{s:4:\"data\";s:64:\"Akismet: How to Enable or Disable User Registration in WordPress\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}s:4:\"guid\";a:1:{i:0;a:5:{s:4:\"data\";s:31:\"http://blog.akismet.com/?p=2344\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}s:4:\"link\";a:1:{i:0;a:5:{s:4:\"data\";s:92:\"https://blog.akismet.com/2022/03/22/how-to-enable-or-disable-user-registration-in-wordpress/\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}s:11:\"description\";a:1:{i:0;a:5:{s:4:\"data\";s:12896:\"<p>WordPress offers a built-in user management and registration system. That means you can allow visitors to register on your website to receive updates, make purchases, or <a href=\"https://blog.akismet.com/2022/01/12/how-to-stop-comment-spam-in-wordpress/\">submit comments</a>. User registration is disabled by default, so you may need to turn it on.</p>\n\n\n\n<p>Fortunately, enabling user registration in WordPress is simple. Once you complete the process, you can share a registration link with visitors so they can sign up at any time. WordPress will take care of the rest. This includes saving user data, assigning roles, and submitting email confirmations.</p>\n\n\n\n<p>In this article, we’ll talk about when it makes sense to offer users the option to sign up on your website. Then we’ll show you how to enable and disable user registration.&nbsp;</p>\n\n\n\n<span id=\"more-2344\"></span>\n\n\n\n<h2>An introduction to WordPress user roles</h2>\n\n\n\n<p>Before we continue, it’s important to have some familiarity with the <a href=\"https://wordpress.org/support/article/roles-and-capabilities/\" target=\"_blank\" rel=\"noreferrer noopener\">six user roles</a> WordPress offers. Each user account is assigned a specific role, and as the administrator (the top user role), you have full control over assignment and permissions.</p>\n\n\n\n<p>The default WordPress user roles are:</p>\n\n\n\n<ol><li><strong>Super admin. </strong>This only exists for <a href=\"https://wordpress.org/support/article/create-a-network/\" target=\"_blank\" rel=\"noreferrer noopener\">WordPress Multisite networks</a>. This level gets administrative permissions on websites within the entire network.</li><li><strong>Administrator. </strong>With this role, you can modify any aspect of the website through your dashboard. You can also create, modify, and delete user accounts.</li><li><strong>Editor. </strong>This account gets to create and publish posts. It can also edit entries by other users.</li><li><strong>Author. </strong>The author user role can create and publish posts, but it only has access to content published under its own account.</li><li><strong>Contributor. </strong>The contributor user role can create posts, but it doesn’t get publishing permissions. An editor needs to review the content and publish it.</li><li><strong>Subscriber. </strong>This is the lowest user role. Subscribers don’t get to create, publish, or edit content. They simply have access to their own profiles.</li></ol>\n\n\n\n<p>The default WordPress user role system is designed primarily for blogging. You can expand on existing user roles with plugins or by modifying your WordPress setup. Depending on your choices, you might end up with dozens of available user roles.</p>\n\n\n\n<img />\n\n\n\n<p>When a visitor creates an account, they’re assigned a user role and a corresponding set of permissions. You have control over what role new users are assigned, and can change them if needed.</p>\n\n\n\n<h2>When to enable user registration in WordPress</h2>\n\n\n\n<p>By default, users won’t be able to register on a new WordPress website. This is primarily because a lot of sites won’t need this feature. If you’re running a one-author blog, for example, there’s little reason to provide this option. If your goal is to collect emails for marketing, there are plenty of choices that don’t require user registration.&nbsp;</p>\n\n\n\n<p>It does make sense under other circumstances, though. If you have a team of authors, you can enable registration and assign Author<em> </em>and Editor<em> </em>roles to specific users. For online stores, you can enable custom user roles like Customer<em> </em>and Shop Manager.</p>\n\n\n\n<p>Here’s the standard registration form:</p>\n\n\n\n<img />\n\n\n\n<p>There are few downsides to enabling user registrations. You can avoid most potential problems by not giving accounts access to more permissions than they need.</p>\n\n\n\n<p>Still, one issue you should consider is spam registrations. This is when bots or attackers register fake accounts on your website. They may do this so they can fill your comments sections with affiliate links, try to modify your content, or even steal user data.</p>\n\n\n\n<p>Fortunately, there are several ways to <a href=\"https://blog.akismet.com/2022/01/26/how-to-stop-user-spam-registrations-in-wordpress/\">prevent spam registrations</a> on your website. So you shouldn’t let that concern stop you from implementing this feature if it suits your needs.</p>\n\n\n\n<h2>How to enable user registration in WordPress</h2>\n\n\n\n<p>Enabling user registration in WordPress is simple. If you want to make it easy for visitors to register, you’ll also need to provide them a link to the signup page. Let’s see how you can do this in just a few steps:</p>\n\n\n\n<h3>Step 1: Enable the user registration feature</h3>\n\n\n\n<p>First, log in to your WordPress site and navigate to <strong>Settings → General</strong><em> </em>in your dashboard. Scroll down until you see the option that reads <strong>Membership</strong>. Tick the <strong>Anyone can register</strong> box.</p>\n\n\n\n<img />\n\n\n\n<p>Before you save your changes, take a look at the <strong>New User Default Role</strong><em> </em>option. By default, WordPress assigns the Subscriber<em> </em>user role to new accounts, but you can modify this depending on your needs.</p>\n\n\n\n<p>If you’re <a href=\"https://woocommerce.com/posts/a-guide-to-woocommerce-user-roles-permissions-and-security/\" target=\"_blank\" rel=\"noreferrer noopener\">using WooCommerce</a>, you might prefer to set the default role to Customer<em> </em>instead. That way, new users will be able to track their purchases through their profiles.</p>\n\n\n\n<h3>Step 2: Add a registration link to your website</h3>\n\n\n\n<p>Once you enable registration for your WordPress site, you’ll need to provide visitors with a link to the signup page. You can find this page by navigating to the following URL:</p>\n\n\n\n<p><em>yourwebsite.com/wp-login.php?action=register</em></p>\n\n\n\n<p>You have multiple options for adding this link to your website, but your best bet is to use the main navigation menu. To modify this menu, go to <strong>Appearance → Menus → Edit Menus</strong>. Next to <strong>Select a menu to edit</strong>, you’ll see a list of existing options.</p>\n\n\n\n<img />\n\n\n\n<p>One of those should be called something like “main navigation.” Select the primary menu and WordPress will show you the links it contains under <strong>Menu structure</strong>.</p>\n\n\n\n<img />\n\n\n\n<p>The above menu includes links to three pages, which are Homepage, Shop, and Checkout. To add a link to the registration page, select the <strong>Custom Links</strong><em> </em>tab in your left-hand panel.&nbsp;</p>\n\n\n\n<p>Then add your site’s registration link in the <strong>URL</strong><em> </em>field, and type something like “Sign up” in the <strong>Link text</strong><em> </em>field. Click on <strong>Add to Menu</strong>.</p>\n\n\n\n<img />\n\n\n\n<p>By default, any new links that you add to the menu will appear last. If your site design displays a horizontal menu, the Signup<em> </em>link will show up as the last entry on the right. If your navigation is vertical, the Signup link will appear at the bottom.</p>\n\n\n\n<img />\n\n\n\n<p>If you want to change the order, you can easily do so by dragging and dropping the menu items. Then click on <strong>Save menu</strong>,<em> </em>and that’s it. When you check out your website again, you should see a Sign Up<em> </em>option in the main navigation menu.</p>\n\n\n\n<img />\n\n\n\n<p>Keep in mind that you can use any text you want for the link to the user registration page. “Sign Up” is usually a safe bet, but you can also opt for “Register Now,” “Sign Up Now,” or other variants.</p>\n\n\n\n<h3>Step 3 (Optional): Customize your WordPress registration page</h3>\n\n\n\n<p>If you want your user registration process to be as clear and user-friendly as possible, you may want further customization options. In that case, your best choice is to use a plugin like <a href=\"https://wordpress.org/plugins/user-registration/\" target=\"_blank\" rel=\"noreferrer noopener\">User Registration</a>.</p>\n\n\n\n<p>With User Registration, you get access to a drag-and-drop builder that enables you to easily add new fields to your registration page. This plugin comes with a collection of pre-built fields. This includes options that let you choose your country, upload a profile picture, and more.</p>\n\n\n\n<p>After installing and activating the plugin, go to <strong>User Registration → User Registration</strong><em> </em>in your WordPress dashboard. The plugin will automatically generate a basic signup form, which you can select and edit.</p>\n\n\n\n<img />\n\n\n\n<p>User Registration will show you a preview of its basic registration form. You can use the menu to the left to select the fields you want to include. Then you can rearrange them on the right.</p>\n\n\n\n<img />\n\n\n\n<p>Additionally, if you select any field in the right-hand panel, the plugin will show you its customization settings (or <strong>Field Options</strong>) to the left. These settings enable you to choose which elements are required, as well as what labels and descriptions to include.</p>\n\n\n\n<img />\n\n\n\n<p>When you’re done tweaking your registration form, click on <strong>Update form</strong>. Then copy the shortcode above the form editor.</p>\n\n\n\n<img />\n\n\n\n<p>You can use that shortcode to embed the new registration form on any page on your website. Simply add a Shortcode<em> </em>block to your chosen page.</p>\n\n\n\n<img />\n\n\n\n<p>Publish the page, and it should look something like this on the front end:</p>\n\n\n\n<img />\n\n\n\n<p>Since you’re using a custom registration page, you’ll also need to update the Sign Up<em> </em>link in your main navigation menu. To do so, replace the link with the URL for this new page (for more details, refer back to Step 2.) Then, test the link on the front end of your site to ensure that it leads to the new registration page.</p>\n\n\n\n<h2>How to update user roles in WordPress</h2>\n\n\n\n<p>After a user registers, you might need to update their role manually. This may occur if you set the default role to Subscriber.</p>\n\n\n\n<p>To update a user’s role, go to <strong>Users → All Users</strong><em> </em>and locate the account you want to modify. If there’s a large number of users, you might need to search to find the right account.</p>\n\n\n\n<img />\n\n\n\n<p>When you’ve located the desired account, hover over it and click on <strong>Edit</strong>. That will open a new page for editing account settings. While you’re there, you can also manually update the Nickname, First Name, Last Name, and more.</p>\n\n\n\n<img />\n\n\n\n<p>Most importantly, you’ll need to use the drop-down menu next to <strong>Role</strong> to select a new permissions level for the account. After altering the user’s role, save your changes.</p>\n\n\n\n<h2>How to disable user registration in WordPress</h2>\n\n\n\n<p>Disabling user registration in WordPress is simple. If you’re having problems with your website due to an <a href=\"https://blog.akismet.com/2022/01/26/how-to-stop-user-spam-registrations-in-wordpress/\">influx of fake users</a> or you just want to disable registration temporarily, you can do it in a few clicks.&nbsp;</p>\n\n\n\n<p>Go to <strong>Settings → General</strong><em> </em>in your WordPress dashboard. Look for the option that reads <strong>Anyone can register</strong><em> </em>and deselect it.</p>\n\n\n\n<img />\n\n\n\n<p>After you disable the setting, save your changes. If you have a user registration link in your site’s main navigation menu, remember to remove it as well. That way, visitors won’t try to register while the option is turned off. If they attempt and fail to register, it may create confusion.</p>\n\n\n\n<h2>Creating a strong community through your WordPress website</h2>\n\n\n\n<p>WordPress makes it easy to enable user registration on your website. You also get full control over what roles to assign to new users. As the administrator, you can edit existing users, change their roles, and even delete them.</p>\n\n\n\n<p>Once you enable user registration in WordPress, you can link to your registration page anywhere on your website. A great place to add a registration URL is in your main navigation menu. Some plugins even enable you to <a href=\"https://blog.akismet.com/2022/03/18/how-to-create-a-custom-wordpress-user-registration-form/\">create fully-customized registration pages</a>, so you can ask users for pertinent information when they sign up to your site.</p>\n\n\n\n<p>Of course, the more users who join your website, the harder it can be to deal with spam. Fortunately, <a href=\"https://akismet.com/how/\">Akismet</a> can help keep your site spam free. That way, real users will be able to enjoy engaging with each other in the comments sections. <a href=\"https://akismet.com/plans/\">Sign up for an Akismet plan</a> and watch spam disappear!</p>\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}s:7:\"pubDate\";a:1:{i:0;a:5:{s:4:\"data\";s:31:\"Tue, 22 Mar 2022 19:49:57 +0000\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}}s:32:\"http://purl.org/dc/elements/1.1/\";a:1:{s:7:\"creator\";a:1:{i:0;a:5:{s:4:\"data\";s:8:\"Rob Pugh\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}}}}i:43;a:6:{s:4:\"data\";s:13:\"\n	\n	\n	\n	\n	\n	\n\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";s:5:\"child\";a:2:{s:0:\"\";a:5:{s:5:\"title\";a:1:{i:0;a:5:{s:4:\"data\";s:62:\"WPTavern: How to Build a Single-Product Sales Page with Blocks\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}s:4:\"guid\";a:1:{i:0;a:5:{s:4:\"data\";s:30:\"https://wptavern.com/?p=131024\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}s:4:\"link\";a:1:{i:0;a:5:{s:4:\"data\";s:73:\"https://wptavern.com/how-to-build-a-single-product-sales-page-with-blocks\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}s:11:\"description\";a:1:{i:0;a:5:{s:4:\"data\";s:4585:\"<p>In today&#8217;s edition of our <a href=\"https://wptavern.com/category/building-with-blocks\">Building with Blocks</a> series, we&#8217;re going to explore one example of building a single-product sales page. There is by no means one approach for building something like this. This particular example aims to demonstrate a fast way to start selling a single product online, while using free plugins and themes available on WordPress.org. </p>\n\n\n\n<p>Here&#8217;s what you need to build this simple page:</p>\n\n\n\n<ul><li>Theme: <a href=\"https://wordpress.org/themes/blank-canvas/\">Blank Canvas</a> </li><li>Plugins: <a href=\"https://wordpress.org/plugins/stripe-payments/\">Accept Stripe Payments</a> and <a href=\"https://wordpress.org/plugins/testimonial-wp-block/\">Testimonial Block</a></li><li><a href=\"https://stripe.com/\">Stripe Account</a></li></ul>\n\n\n\n<p>This five-minute video walks through the sale page setup:</p>\n\n\n\n<div class=\"wp-block-embed__wrapper\">\n\n</div>\n\n\n\n<h3>Step 1: Install Automattic&#8217;s <a href=\"https://wordpress.org/themes/blank-canvas/\">Blank Canvas</a> theme. </h3>\n\n\n\n<p>The reason I selected this theme is because it makes it easy to build a one-page website without all the extra unnecessary page elements. It has no header, navigation menus, or widgets by default, so you don&#8217;t have to figure out how to turn all that stuff off.</p>\n\n\n\n<p>First, create a new page and then select the theme&#8217;s &#8216;About me&#8217; pattern from the pattern explorer: </p>\n\n\n\n<img />\n\n\n\n<p>Replace the image with your product image and replace the text with product info. Customize the button text to &#8220;Buy Now&#8221; or whatever you want for the purchase button. </p>\n\n\n\n<p>Add testimonials below the product. If you search in the block inserter, you can find the <a href=\"https://wordpress.org/plugins/testimonial-wp-block/\">Testimonial Block</a> and install it from there. </p>\n\n\n\n<h3>Step 2: Install and Activate the <a href=\"https://wordpress.org/plugins/stripe-payments/\">Accept Stripe Payments</a> Plugin.</h3>\n\n\n\n<p>This plugin enables users to accept credit card payments via the Stripe payment gateway. Even those who have not established a business entity can use Stripe for a small project like this. Select &#8220;Individual/Sole proprietor&#8221; when activating a Stripe account.</p>\n\n\n\n<p>If you need PayPal or another gateway, just look for a block plugin that offers what you need. If I was setting up a full-blown e-commerce store with multiple products, I would probably use WooCommerce, Easy Digital Downloads, or another more complex plugin. Accept Stripe Payments seemed simpler for this project.</p>\n\n\n\n<p>The video does not show how to configure the plugin&#8217;s settings, but you will need to add your Stripe API keys and make a few selections for your one-product store.  </p>\n\n\n\n<h3>Step 3: Create a New Product and Link the Checkout Button.</h3>\n\n\n\n<p>Go to <strong>Stripe Payments >> Add New Products</strong>. Add a title, default currency, price,  variations, shipping cost, product URL (for digital products), and thank you page URL, if any of these are applicable to your product. The plugin includes support for setting the quantity available and enabling stock control. Make sure to select &#8220;Collect Both Billing And Shipping Addresses&#8221; for physical products that need to ship.</p>\n\n\n\n<p>I am not advocating using this specific commerce plugin. It&#8217;s just one I saw with a Stripe block that wasn&#8217;t necessarily aimed at providing a full e-commerce engine. A surprising number of plugins still only support shortcodes and have no block available. In this instance, even though the plugin includes a block, I didn&#8217;t want to have to re-style the button&#8217;s output. Each product provides a URL that you can paste into the block editor. Once your product is created, paste the product link on the checkout button&#8217;s text.</p>\n\n\n\n<p>The last step is to test out the purchasing process. You can use <a href=\"https://stripe.com/docs/keys\">Stripe &#8216;s Test API keys </a>and  test credit card numbers to make sure it is working before making it live. The checkout form launches in a modal window and customers will be redirected to a “Checkout Result” page after the credit card payment. This page can be further customized in the block editor.</p>\n\n\n\n<p>If you want to expand beyond this basic single-product website, the Accept Stripe Payments plugin allows you to add multiple products or do different things like collect donations or create “Authorize Only” products. </p>\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}s:7:\"pubDate\";a:1:{i:0;a:5:{s:4:\"data\";s:31:\"Tue, 22 Mar 2022 03:56:48 +0000\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}}s:32:\"http://purl.org/dc/elements/1.1/\";a:1:{s:7:\"creator\";a:1:{i:0;a:5:{s:4:\"data\";s:13:\"Sarah Gooding\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}}}}i:44;a:6:{s:4:\"data\";s:13:\"\n	\n	\n	\n	\n	\n	\n\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";s:5:\"child\";a:2:{s:0:\"\";a:5:{s:5:\"title\";a:1:{i:0;a:5:{s:4:\"data\";s:86:\"WPTavern: DeoThemes Launches Ona Creative, Another Well-Designed WordPress Block Theme\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}s:4:\"guid\";a:1:{i:0;a:5:{s:4:\"data\";s:30:\"https://wptavern.com/?p=131727\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}s:4:\"link\";a:1:{i:0;a:5:{s:4:\"data\";s:96:\"https://wptavern.com/deothemes-launches-ona-creative-another-well-designed-wordpress-block-theme\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}s:11:\"description\";a:1:{i:0;a:5:{s:4:\"data\";s:4901:\"<p class=\"has-drop-cap\">Yesterday, DeoThemes&#8217; latest block theme, <a href=\"https://wordpress.org/themes/ona-creative/\">Ona Creative</a>, landed in the WordPress directory. It is the second child of Ona, a theme I <a href=\"https://wptavern.com/ona-by-deothemes-just-raised-the-bar-for-wordpress-block-theme-design\">initially showcased</a> here on the Tavern in November 2021.</p>\n\n\n\n<p>When I first reviewed the Ona parent theme, WordPress 5.9 had yet to be released, and users were required to install the Gutenberg plugin to test it. Developers were still rapidly launching features in a push to get a production-ready version of the block-based templates and global styles features.</p>\n\n\n\n<p>Ona was unlike any other block theme submitted to the directory at that point. If not paying attention, one could mistake it as a classic theme. It was well-designed in its own right, regardless of the system under the hood. However, most block themes were bare-bones experiments for a system struggling to launch. Ona carried a promise that block themes did not need to suck all the life out of design to function.</p>\n\n\n\n<p>At the time, the theme had bugs that were not of its own making. Depending on a user&#8217;s site structure, default images could return a &#8220;404: Not Found&#8221; result. The Pattern block did not exist in either WordPress or Gutenberg, and themes had no surefire way of inserting dynamic data. However, Ona now uses this feature to create beautiful default templates.</p>\n\n\n\n<p>Not only does the Ona parent do this, but the Ona Creative child theme reuses and rearranges those patterns without needing to write nearly as much new code. The front page template adds a custom header but inserts two existing patterns to set its design apart from its parent:</p>\n\n\n\n<img />Ona Creative, partial front page template.\n\n\n\n<p>But, there are also some missed opportunities with Ona Creative. While it uses patterns from its parent theme, there are sections in its front page template that would have made perfect patterns themselves. Users may like the default posts Query block and want to use its layout on other pages.</p>\n\n\n\n<p>The following testimonial section definitely makes sense as a pattern:</p>\n\n\n\n<img />Testimonials section.\n\n\n\n<p>At this point, I am not sure if directly inserting most block code in theme templates is an ideal path. If it is good enough to be in a template, <em>why not make it reusable?</em> I have hardly seen cases where theme templates should not just be made up of one or more patterns.</p>\n\n\n\n<p>The most significant issue I have with Ona and Ona Creative is that they eschew the block-style system in favor of custom classes. For example, the theme has two classes that it adds to the Cover block in this section of its front-page template:</p>\n\n\n\n<img />Cover block selected in a pattern.\n\n\n\n<p>The first styles the inner border, and the second creates a hover effect that zooms in on the background. There are two ways for users to recreate this design on the Cover block elsewhere. Either copy and paste one of the blocks in the pattern or manually type the classes under the &#8220;Advanced&#8221; section of the block options sidebar.</p>\n\n\n\n<p>The same is true for the cursive handwriting style used in some sections. Users must manually add the <code>ona-alt-font</code> class instead of picking it from the design tools. I am willing to give a pass on this because font-family selection should be handled via the Font Family block control. However, this is not yet supported for blocks like Heading and Paragraph in WordPress.</p>\n\n\n\n<img />Adding handwriting/cursive text.\n\n\n\n<p>Both are cases of the old way of designing themes, requiring users to jump through hoops to recreate a specific look. Themers need to leave this way of thinking back in the classic era. The block system has a standardized block styles feature that allows users to select these classes visually. If they are registered via the theme, users can recreate that same design with literally any block that supports them.</p>\n\n\n\n<p>There is a simple question to ask when deciding whether to register a block style: <em>Is the class on a block in a pattern or template?</em>  Except in some rare use cases &#8212; usually involving headers and navigation &#8212; the answer is almost always that the custom class should be a block style.</p>\n\n\n\n<p>I may be a bit nit-picky about the implementation of some features. The space is still largely unexplored &#8212; Ona Creative is only #56 out of 58 block themes in the directory. This does not take away from how well-designed it is.</p>\n\n\n\n<p>And the one thing that DeoThemes continues to get right is the design. Ona Creative deserves to grace the front end of many WordPress sites. Its development team has kept up with changes to the block system, the typography is on-point, and it simply looks good.</p>\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}s:7:\"pubDate\";a:1:{i:0;a:5:{s:4:\"data\";s:31:\"Tue, 22 Mar 2022 02:35:02 +0000\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}}s:32:\"http://purl.org/dc/elements/1.1/\";a:1:{s:7:\"creator\";a:1:{i:0;a:5:{s:4:\"data\";s:14:\"Justin Tadlock\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}}}}i:45;a:6:{s:4:\"data\";s:13:\"\n	\n	\n	\n	\n	\n	\n\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";s:5:\"child\";a:2:{s:0:\"\";a:5:{s:5:\"title\";a:1:{i:0;a:5:{s:4:\"data\";s:115:\"Post Status: Post Status Excerpt (No. 51) — Comparing the Drupal and WordPress Communities with Amy June Hineline\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}s:4:\"guid\";a:1:{i:0;a:5:{s:4:\"data\";s:31:\"https://poststatus.com/?p=94432\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}s:4:\"link\";a:1:{i:0;a:5:{s:4:\"data\";s:119:\"https://poststatus.com/post-status-excerpt-no-51-comparing-the-drupal-and-wordpress-communities-with-amy-june-hineline/\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}s:11:\"description\";a:1:{i:0;a:5:{s:4:\"data\";s:30722:\"<h2 id=\"more-important-than-being-responsive-is-setting-expectations-dave-rodenbaugh\">&#8220;When it comes to contributing…. time is a true privilege&#8221; —Amy June Hineline</h2>\n\n\n\n<p class=\"has-drop-cap\">There are a lot of people in the <strong>WordPress</strong> community who also work (or previously worked) with <strong>Drupal</strong>, <strong>Joomla</strong>, and other open-source software projects. <strong>Amy June Hineline</strong> is Community Manager at <a href=\"https://t.co/1jey6pgCSr\" target=\"_blank\" rel=\"noreferrer noopener\">Opensource.com</a>. She is also a member of both the WordPress and Drupal communities. As <strong>DrupalCon 2022</strong> approaches, Amy June shares the lessons she thinks WordPress can learn from Drupal’s relationship with its contributors and open source. </p>\n\n\n\n<p><strong>Why This Is Important:</strong> Drupal and WordPress are both mature open source PHP/MySQL CMS platforms that emerged in the early 2000s. They share a common goal and have similar communities, but there are notable differences between them. There are opportunities for each community to learn from the other. </p>\n\n\n\n\n\n\n\n<p class=\"has-background\">Every week <strong><a href=\"https://poststatus.com/podcast/the-excerpt/\">Post Status Excerpt</a></strong> will brief you on important WordPress news — in about 15 minutes or less! Learn what\'s new in WordPress in a flash. <img src=\"https://s.w.org/images/core/emoji/13.1.0/72x72/26a1.png\" alt=\"⚡\" class=\"wp-smiley\" /><br /><br />You can listen to <a href=\"https://poststatus.com/podcast/the-excerpt/\">past episodes</a> of <strong>The Excerpt</strong>, <a href=\"https://poststatus.com/category/post-status-podcasts/\">browse all our podcasts</a>, and don’t forget to subscribe on <a href=\"https://open.spotify.com/show/1m3xwXbe0MG5BzFVPtB0A7\">Spotify</a>, Amazon Music, <a href=\"https://podcasts.google.com/feed/aHR0cHM6Ly9mZWVkcy5zaW1wbGVjYXN0LmNvbS8ySkU5c2M4UA\">Google Podcasts</a>, <a href=\"https://itunes.apple.com/us/podcast/post-status-draft-wordpress/id976403008\">iTunes</a>, <a href=\"https://castro.fm/podcast/c53552c6-1ee0-4fc4-9de4-08ed6bf1ee4d\">Castro</a>, <a href=\"https://www.youtube.com/c/PostStatus\">YouTube</a>, <a href=\"http://www.stitcher.com/podcast/krogsgard/post-status-draft-wordpress-podcast\">Stitcher</a>, <a href=\"https://player.fm/series/wordpress-post-status-podcasts\">Player.fm</a>, <a href=\"https://pca.st/05rR\">Pocket Casts</a>, <a href=\"https://wordpress-post-status-draft-podcast.simplecast.com/\">Simplecast</a>, or by <a href=\"https://feeds.simplecast.com/2JE9sc8P\">RSS</a>. <img src=\"https://s.w.org/images/core/emoji/13.1.0/72x72/1f3a7.png\" alt=\"🎧\" class=\"wp-smiley\" /></p>\n\n\n\n<h3 id=\"h-mentioned-in-the-show\"><img src=\"https://s.w.org/images/core/emoji/13.1.0/72x72/1f517.png\" alt=\"🔗\" class=\"wp-smiley\" /> Mentioned in the show:</h3>\n\n\n\n<ul><li><a href=\"https://github.com/shaal/DrupalPod\">Drupal Pod GitHub</a></li><li><a href=\"https://events.drupal.org/portland2022\">DrupalCon</a></li><li><a href=\"https://kanopi.com/\"><a href=\"https://t.co/1jey6pgCSr\" target=\"_blank\" rel=\"noreferrer noopener\">Opensource.com</a></a></li><li><a href=\"https://twitter.com/volkswagenchick\">Amy June</a> (Twitter)</li><li><a href=\"https://twitter.com/dimensionmedia\" target=\"_blank\" rel=\"noreferrer noopener\">David Bisset</a> (Twitter)</li><li><a href=\"https://twitter.com/post_status\" target=\"_blank\" rel=\"noreferrer noopener\">Post Status</a> (Twitter)</li></ul>\n\n\n.kt-block-spacer-_138506-a0 .kt-divider{width:80%;}\n<div class=\"wp-block-kadence-spacer aligncenter kt-block-spacer-_138506-a0\"><div class=\"kt-block-spacer kt-block-spacer-halign-center\"><hr class=\"kt-divider\" /></div></div>\n\n\n\n<h3 id=\"sponsor\"><img src=\"https://s.w.org/images/core/emoji/13.1.0/72x72/1f64f.png\" alt=\"🙏\" class=\"wp-smiley\" /> Sponsor: <a href=\"https://pagely.com/\">Pagely</a></h3>\n\n\n\n<p><strong>Pagely</strong> offers Top-Tier Managed WordPress hosting solutions for <strong>Enterprise</strong>, the<strong> Public Sector</strong>, and <strong>Media</strong> companies. We invented Managed WordPress and we never stopped raising the bar. Expect Extraordinary.</p>\n\n\n.kt-block-spacer-_2e6c92-dc .kt-divider{width:80%;}\n<div class=\"wp-block-kadence-spacer aligncenter kt-block-spacer-_2e6c92-dc\"><div class=\"kt-block-spacer kt-block-spacer-halign-center\"><hr class=\"kt-divider\" /></div></div>\n\n\n\n<h2 id=\"h-transcript\"><strong>Transcript</strong></h2>\n\n\n\n<p>Amy June</p>\n\n\n\n<p><strong>Amy June:</strong> So I have, um, some housekeeping to tell you my gardener has not made his appearance yet, so we may have all kinds of visitors. So my name is Amy, June Heinlein. Amy, June being one word, title, camel case. I\'d like to point that out because if you just yell Amy down the street, I probably won\'t turn around and answer</p>\n\n\n\n<p><strong>David Bisset:</strong> Me or June either probably goes.</p>\n\n\n\n<p><strong>Amy June:</strong> Exactly, exactly. Um, so I\'ve been working in open source since about 2016. I started in the Drupal community and then, um, a couple years later started in the WordPress community. I am a self-described non coder, but very prolific con contributor to both of those communities. Along with the accessibility community, specifically in Drupal, I am a very huge advocate.</p>\n\n\n\n<p>Reducing the barriers to non code contributions. Um, and in WordPress, that\'s not nearly as much of an issue because when I entered the WordPress space, um, WordPress is already a big ag advocate for lots of different kinds of things. Contributions. Um, many of them being non code. Um, recently I\'ve switched over and I\'m working in the wider open source community and I help curate articles for source.com.</p>\n\n\n\n<p>Um, and so I work with all sorts of different communities now, but my love is still in those, um, that content management system of WordPress and Drupal</p>\n\n\n\n<p><strong>David Bisset:</strong> So you were in Drupal first, so what got you into the WordPress space,</p>\n\n\n\n<p><strong>Amy June:</strong> took a job with canopy studios. They\'re an agency that does WordPress and Drupal. I suckered and the CEO into hiring me exclusively to give back to the community.</p>\n\n\n\n<p>Yeah, I could be her corporate citizenship. And, um, when I started a week, one on Monday, she says, oh, Hey, so we do WordPress. How would you like to go to work camp us on Friday? I was like, oh,</p>\n\n\n\n<p><strong>David Bisset:</strong> is it free? Do I get to miss work?</p>\n\n\n\n<p><strong>Amy June:</strong> Yeah, that was my first start. And let me tell you, the people I met there, I met you, I\'ve met everyone, you know, um, established relationships, but that\'s, that was my initial exposure to WordPress community was at WordCamp us.</p>\n\n\n\n<p>I had had the obligatory blog, you know, when my kids were little or my, or my girlfriend would get married, that kind of thing, but I never worked on WordPress. It was just, you know, just opening the blog and putting pictures up before.</p>\n\n\n\n<p><strong>David Bisset:</strong> So when it comes to contributions, It\'s big on advertising, uh, or getting people motivated to contribute and truthful to the same way from your experience, both being in Drupal and WordPress, how would you compare how they handle, um, their contribution events and recruiting?</p>\n\n\n\n<p><strong>Amy June:</strong> First off for the crowd of admirers listening at home, my space and both WordPress and Drupal is mostly in contributions, starting off in Drupal contributions. Um, it\'s very code centric. Um, it\'s all about the tools and the resources to get ramped up into contributing to. Core contributions. Um, so when I helped organize a Drupal contribution days at like the local and the regional, and even at the national level, which I do now, um, it\'s all about the tools and the processes and the mentoring that involves around, uh, revolves around code.</p>\n\n\n\n<p>Um, looking back at that first word camp us, I went to, um, in, in Nashville, uh, the. The big thing I noticed when I walked into contribution day was how there were all of these tables around contributions and code was only one of those tables where it was like the complete opposite from when you go to a contribution day at Drupal con.</p>\n\n\n\n<p>So you have marketing. You have translations, you have events, you have Drupal TV, you have all of these tables and one table for code. And at first I thought that was really. Different, you know, cause we all, when we\'re used to one thing and going into another, it takes us a little bit to wrap our head around things.</p>\n\n\n\n<p>But you know, I\'ve been advocating for non-covered contributions or lowering the barrier to code contributions in the Drupal space that walking into the word camp, us contribution space was like, wow, it\'s already set up where everyone can continue. I liked to go to camps and I like to organize, and I, you know, I enjoy the Drupal space.</p>\n\n\n\n<p>That\'s something that I took away from word camp us is when I did start. Going to more camps. Um, and the Drupal space and setting up contribution days was having, uh, issues available for non coders. You know, not just in the code, not just like documentation tasks, but Hey, we have a slide deck that this initiative team wants to work on, you know?</p>\n\n\n\n<p>Absolutely no code contributions for non coders. And I don\'t mean that in a reductive sense, just, you know, we all want to come to camps and we all want to contribute, you know, but there\'s, there\'s people who don\'t code. There\'s our marketers, there\'s our human resources. There\'s our salespeople, you know, there\'s our, um, there\'s our designers, you know, and giving them the space to be able to.</p>\n\n\n\n<p>Come to that extended day, you know, that day after camp and go to the, you know, go to the picnics and the, just the more activities to get involved with the whole community, I think is really valuable. And that\'s what that word word camp U S space showed me. And that was really inspiring to me. So when I sat down at the code table at WordCamp us, I didn\'t know how to contribute back as a non coder.</p>\n\n\n\n<p>So. That is something I think that the WordPress side could learn from the Drupal side is maybe providing some tools that would reduce the barrier to code contribution to people who don\'t historically code.</p>\n\n\n\n<p><strong>David Bisset:</strong> So you could code, you just were a little bit lost in like where to start,</p>\n\n\n\n<p><strong>Amy June:</strong> right. Or, you know, do I have to have a local environment set up, you know, do I have to do I have to use Vagrant?</p>\n\n\n\n<p>You know, all of these, like. Because those are kind of complex things. When you\'re maybe just new to WordPress, maybe you don\'t know how to set up the local environment. Maybe you don\'t know how to write a patch, you know, and having those resources really more human readable, or maybe having a tool that is browser-based versus locally based would help lower that barrier a little bit more.</p>\n\n\n\n<p><strong>David Bisset:</strong> What is Drupal pod?</p>\n\n\n\n<p><strong>Amy June:</strong> Drupal pod does it allows folks to spin up an environment. That\'s, browser-based spins up this environment online where you can test drive your Drupal site. It applies the merge requests. It provides an integrated development environment and IDE like vs code. So you can share the URL with like, I could spin up a Drupal pod site right now, share the URL with you.</p>\n\n\n\n<p>And we could both be participating on. Issue at the same time in real time, exploring and, uh, sort of reviewing each other\'s code and having an instance up online that way we wouldn\'t have to take the time to like, maybe get something like D dev or Lando or, you know, um, one of those, uh, like DVE up on our local machines it\'s right there and shareable with the URL.</p>\n\n\n\n<p><strong>David Bisset:</strong> Oh. So we can collaboratively. Test out a patch and in, and this is I\'m assuming this fairly quickly and without much technical know-how because it is an actual browser extension for Chrome or Firefox,</p>\n\n\n\n<p><strong>Amy June:</strong> right? It\'s for Chrome or Firefox. We don\'t have it working on anything else, but you can do a patch. You can do a fork, you can do a branch.</p>\n\n\n\n<p>Um,</p>\n\n\n\n<p><strong>David Bisset:</strong> it\'s all running on the cloud, that is pretty impressive.</p>\n\n\n\n<p>There\'s</p>\n\n\n\n<p><strong>Amy June:</strong> documentation on it. There it\'s still sort of our new tool. You know, this is something new that we\'re doing at Drupal con this year. We\'re, um, as, as mentors, we\'re learning the process. You know, this is, this is only the second year. We\'re really working on merger requests versus patching too.</p>\n\n\n\n<p>So there\'s a learning curve with mentors teaching this, but every year we really struggle with first time contributions and the tooling and the processes. So we\'re hoping with Drupal pod being browser-based a lot of those. Cumbersome tasks for onboarding or eliminated because it\'s a browser extension versus, you know, is it a windows machine?</p>\n\n\n\n<p>Are they running Linux? You know, uh, do we have to, you know, go against, you know, a VPN or some of these things that people have on their machines. So we\'re hoping. Having that browser-based really makes it just a whole lot easier. And then two, you know, instead of like having to peer share a local tool, you know, the bandwidth it takes to, you know, download an extension and just have something running browser-based versus downloading tools will alleviate a lot of those pains we have with, with, with, with internet, uh, during the event.</p>\n\n\n\n<p>I have a tool that I that\'s very near and dear to my heart called simply test, uh, dot Emmy. And that\'s another tool that\'s, browser-based where we, um, the environment\'s a little bit. In Drupal, as opposed to WordPress, you know, we have contributed modules that are kind of mirrored the plugin system, but a lot of them are free and you can test drive plugins.</p>\n\n\n\n<p>But also with simply test me, you can also test patches. And again, it\'s a browser-based environment that really reduces the barrier to contributions as well. I would love to see some of these browser based tools being extended further out into the wider CMS.</p>\n\n\n\n<p><strong>David Bisset:</strong> How do you compare the mentorship sides that you\'ve seen in your, in your observations between Drupal and WordPress?</p>\n\n\n\n<p><strong>Amy June:</strong> We do have one. Um, so we have a mentoring cohort where we have, you know, Drupal core, um, Mentoring leads where there\'s a group of us. There\'s maybe 10 of us that work on processes and documentation, and really leading the initiative all year long. Um, and with that, what that means is we. Have weekly meetings where we talk with other mentors, we\'ve run mentoring summits, where we do mentor the mentoring.</p>\n\n\n\n<p>Um, we run two flagship events, one being Drupal con us and the other one being Drupal con Europe. Um, if Drupal con Asia happens, we help with that one as well. And we really concentrate on those, uh, two or three, you know, uh, uh, continental events rather than the local and regional events because, um, the local regional load events, um, Uh, can be run, um, by the local and regional organizers, but at the slash ship events, we make sure that we have enough mentors to have a contribution day, be very successful.</p>\n\n\n\n<p>Um, and with that, we run first time contributor workshops. And again, you know, Drupal\'s a little bit more code centric. And so we run first time. Contributor meant first time contributor workshops, where we talk about tools. We talk about documentation. We talk about non code participation. We, um, go into demos of, you know, how do you do a merge request?</p>\n\n\n\n<p>How do you review a patch? How do you do issue queue triage? And these are all things that we teach all year long, um, to the other mentors who want to join in to our monthly meetings. And then as we get closer to events, we meet a little bit more often, like we\'re, you know, we\'re about a month and a half out from Drupal con in April.</p>\n\n\n\n<p>So we\'re starting to meet weekly. Um, really trying to. Discover who\'s coming to triple con you know, who\'s going to be around who\'s, you know, cause there\'s. There can be mentors for all sorts of different spaces. We have mentors that help when people arrive to the event, you know, making sure they make it to the right space because we have, you know, uh, a mentored contribution room.</p>\n\n\n\n<p>We have a first time mentor contribution room, and then we have just the general contribution space. So making sure have people that are welcoming and lead people in the right direction. And then people leading people in the right direction when they\'re ready to graduate and go into another room, you know, making sure we have.</p>\n\n\n\n<p>Table leads, you know, um, that people are, are, are paired up with, you know, folks of similar skill sets or passions. And then we always want to stress too, that you don\'t have to know everything to be a mentor. You just have to have the passion to be able to figure out how to get the answer yourself. You know, you don\'t have to know everything, but you have to kind of just know how to figure it out, you know?</p>\n\n\n\n<p>We always know a little bit more than someone else, you know, and, and we really try to, uh, encourage people to, if you\'ve contributed once you\'re qualified to be a mentor.</p>\n\n\n\n<p><strong>David Bisset:</strong> Oh yeah. That seems pretty, pretty a straightforward way of getting a lot more people on board that much more quickly and boosting their self-esteem too, because.</p>\n\n\n\n<p><strong>Amy June:</strong> Yeah. And then we, we, we try to be empowering as the event takes place. Like, you know, right now we\'re planning, Drupal con and our, our event is Monday through Thursday, but the mentored event is on Wednesday afternoon. So Monday and Tuesday, we have a booth to encourage people to sign up, to be a mentor.</p>\n\n\n\n<p>And then Monday afternoon, we have a couple of events that like how to triage issues or here\'s the tools or mentor the mentor. So we have a couple of, you know, we call them birds of a feather over there, you know, Box where we\'re sit down with the mentors and, and answer questions and really sort of get to know one another.</p>\n\n\n\n<p>And then that way they feel supported when we go into the main event too. So we, we really build up that empowerment as the week goes on.</p>\n\n\n\n<p><strong>David Bisset:</strong> You\'ve probably observed in the WordPress space. There\'s been a lot of discussion, especially recently, um, open-source contributions, uh, people having being compensated for their time, um, efforts or just playing, getting.</p>\n\n\n\n<p>How does Drupal handle giving credit or what\'s their credit system light?</p>\n\n\n\n<p><strong>Amy June:</strong> So I am a huge fan of incentives. Um, we don\'t all need them, but sometimes the agencies and the organizations we work for a need them, all of us, I would hope understand that, you know, if we use open source, open source depends on us, you know, and all of us have this idea of, we should contribute 10 to 20%.</p>\n\n\n\n<p>And we hope that our employers in our organizations, that we work for feel the same way. And you know, sometimes agencies need more than just corporate citizenship. And Drupal has this really robust incentive program where they have this marketplace where. When someone like, I\'m just going to use me as an example.</p>\n\n\n\n<p>When I get back to Drupal, I give, I concentrate and I work on a core issue and I get a credit for working on that core issue. I could get the credit because I opened the issue. I could get the credit because I contributed the solution. Or maybe I wrote a test for the issue, or maybe I, you know, designed a logo, any sort of thing.</p>\n\n\n\n<p>I could get a contribution. When the issue is closed, I have the choice of taking a box that gives an organization that I mark on my profile as my employer. I can give them attribution for the credit as well. So at the end of the year, Drupal has these stats of, you know, their top contributors, but also the agency.</p>\n\n\n\n<p>Who employed those top contributors, they have metrics of who contributed their own time and volunteered. And then they have this marketplace where a person looking to hire an agency. You go to this marketplace and the marketplace is your position on the marketplaces ranked on how much you give back to Drupal.</p>\n\n\n\n<p>And then their, their ranking is also. Broken down into, you know, a core credit gives you a little bit better ranking than if you work on like a contributed module or on a community module. And then the last couple of years, they\'ve also opened spaces for community projects. So say you run a camp like Drupal camp Asheville.</p>\n\n\n\n<p>Well, Drupal understands that there\'s more than code contributions. Some people are camp organizers and dedicate hundreds and thousands of hours of their lifetime organizing camps. And sometimes, you know, can a person\'s first. Exposure to communities at the local camp level. And that\'s just as important as code.</p>\n\n\n\n<p>And so we\'ve actually put those into the credit system as well. So people who are speaking at camps and training at camps and writing documentation for, you know, things like get pod or, you know, um, from, uh, doing podcasts. So they, they have this really robust and rich incentive program, which I think has really.</p>\n\n\n\n<p>Driven more organizations to pay for more of their employees times to give back to open source, because especially during the pandemic, we know that time is a privilege. As more of us are at home as caregivers, we don\'t have that luxury of, you know, quote unquote free time after our 40 hours a week. So we noticed a drop in the, the numbers of diverse based.</p>\n\n\n\n<p>Who are contributing to our projects because more of them are caregivers. You know, we definitely seen a drop in women contributing to our projects because you know, their home, their mothers, you know, and these are broad blanket statements. Of course ,</p>\n\n\n\n<p><strong>David Bisset:</strong> but that makes sense.</p>\n\n\n\n<p><strong>Amy June:</strong> But yeah, so.</p>\n\n\n\n<p>I know that the few agencies I\'ve really worked close with have seen that. And they\'ve added, you know, instead of only having, you know, one hour of community time a week, they\'ve added it to two or three because they seen that that time is a true privilege.</p>\n\n\n\n<p><strong>David Bisset:</strong> So if there was one thing that you could maybe based off of what Drupal\'s is doing on the lessons from it, what\'s one thing that you would heavily suggest for WordPress to make an adjustment to regarding contribution.</p>\n\n\n\n<p><strong>Amy June:</strong> Okay, so this is two, and I know you just said one, but there\'s two things that I really think I would really love to see on the code contribution side. The barriers really reduced like something like the browser-based solutions for helping contribute to core. And then also, like there is a little bit of a, of a program for, uh, incentivizing agents.</p>\n\n\n\n<p>Providing their employees around to contributions. There\'s the five for five. Is that what it\'s called five for the future? It\'s in a way that\'s sort of hidden, it needs to be more pronounced. So when people are looking for those, it needs to be incentivized more. Right. You know, like I said, like, I hate to, I hate to be like this incentivized program, but you know, has to be some sort of.</p>\n\n\n\n<p>In your face visual. Cause I know like I give back to WordPress and I have these little ticks on my profile, but there\'s no ticks on my company\'s profile. Right. They\'re only on mine and then not every camp I\'ve talked with or not every project I helped contribute to gives me a tick. So as much as I give, like say I, you know, the whole time I worked with a company where I, you know, donated 25% of my time for WordPress, I only have.</p>\n\n\n\n<p>Five kicks on my WordPress profile. So it\'s not, it\'s not very reflective of how much work I actually did for WordPress.</p>\n\n\n\n<p><strong>David Bisset:</strong> I see, I know we track, I know WordPress does track a kiss man at state of the word does show. I mean, we do have, we do know how many contributors. I guess are associated with companies because they do track number of employees per company, obviously automatic is the biggest, and then there\'s Yost and there\'s a few other ones, but it sounds like to me, this is an on Drupal site.</p>\n\n\n\n<p>It\'s more integrated into, into maybe not a leaderboard, but at least a kind of like an ongoing. System. I like the top 40 and music or something where</p>\n\n\n\n<p><strong>Amy June:</strong> it\'s, it\'s okay to say leaderboard. Like, I love seeing my name on that top 40 slide when it came up, you know,</p>\n\n\n\n<p><strong>David Bisset:</strong> is that cause any problems or any conflicts or any burnout, anything or is it just people just kind of accept the leaderboard and what the,</p>\n\n\n\n<p><strong>Amy June:</strong> I don\'t think so because, because th they also break it down into who\'s paid and who\'s not, you know, because there definitely is a.</p>\n\n\n\n<p>Uh, something to say about the, the non-paid contributions. There\'s a lot of people who give back on their own dime, you know, and they do break that down as well.</p>\n\n\n\n<p><strong>David Bisset:</strong> Yeah. So tell me, as we wrap things up here, tell me a little bit about this Drupal con that\'s coming up.</p>\n\n\n\n<p><strong>Amy June:</strong> Okay. So it is the last week in April, and it will be in Portland, Oregon in-person, which is very exciting</p>\n\n\n\n<p><strong>David Bisset:</strong> Is this the first in-person event for Drupal?</p>\n\n\n\n<p>No,</p>\n\n\n\n<p><strong>Amy June:</strong> I, I just got back from Florida Drupal camp. That was the first in-person Drupal event. Um, well, in, in north America anyway, we were the last triple event in north America. Um, and I think it was sort of funny that we were the first one coming back in 2020. Um, we\'re not quite sure how many people were going to expect, you know, people are still up in the air about the state of all of the things going on in the world, you know? So, um, we don\'t know whether or not to expect more people because people haven\'t seen one another or less people because of all of the things going on in the</p>\n\n\n\n<p><strong>David Bisset:</strong> world. Perfectly understandable. Everybody it\'s come back when you feel comfortable or come, when you feel comfortable.</p>\n\n\n\n<p>That\'s same thing for what I\'ll say for work camp us as well. No one\'s should be shaming. Anybody else or wondering why someone isn\'t physically. Um, it could be physical reasons. Emotional. Some people have been awhile.</p>\n\n\n\n<p><strong>Amy June:</strong> We\'re kind of mixing things up a little bit, you know, we\'re still doing summits and a lot of interactive sessions and contributions every day.</p>\n\n\n\n<p>Um, we\'re abiding by the local, uh, the local laws around vaccination and masks, you know, so whatever you know, Portland is doing at the time is what we\'re going to go by. As far as you know, our, our vaccination stuff. Um, I\'m really excited. I haven\'t seen a lot of these people in a long time. Um,</p>\n\n\n\n<p><strong>David Bisset:</strong> I\'m drawing a blank on his name now dries for&#8230; drees.</p>\n\n\n\n<p>Is he give his, uh, state of Drupal at this one. Oh,</p>\n\n\n\n<p><strong>Amy June:</strong> okay. Yeah. So actually the jury\'s note will be the only. Uh, streaming session. That\'s</p>\n\n\n\n<p><strong>David Bisset:</strong> where, that\'s how I remember it because whenever, whenever, and I believe it\'s free, I think pretty sure to just broadcast like that. Um, and that\'s, I don\'t miss that. Uh,</p>\n\n\n\n<p><strong>Amy June:</strong> yeah, you\'re right.</p>\n\n\n\n<p>I always forget about that one. Cause it\'s always been, but that, yeah, that\'ll be the only streaming event will be the teres. now,</p>\n\n\n\n<p><strong>David Bisset:</strong> because your Drupal concept will have so many tracks and it\'s how many days is it? Three. Wow. That\'s let\'s that\'s longer than a WordCamp. EWAS yeah, that\'s amazing. Yeah. I don\'t miss his, um, livestream.</p>\n\n\n\n<p>Keynotes usually lasts about an hour. Lots of just like how Matt does a state of the word. Uh, the Drupal version equivalent has a ton of information. I like the statistics that he shares, so I definitely will not be missing that. And I\'ll put a link in the show notes for the event, and specifically, as soon as I can figure it out.</p>\n\n\n\n<p>Where on the website or any blog posts that has that kind of link or to expect that, um, maybe on the calendar or something like that. I\'ll definitely put that in there as well. I, I honestly believe all of the open source. CMS is the WordPress, the Drupal\'s and the gym was in we\'re all kindred spirits in terms of opensource.</p>\n\n\n\n<p><strong>Amy June:</strong> Uh, I actually have the privilege of working on the contributor team with word camp us this year. So I\'m hoping to bring some of the ideas, um, with me and maybe start like a mentorship program too. So very excited</p>\n\n\n\n<p><strong>David Bisset:</strong> WordCamp US has always been. Open to trying new things. I remember in 2019 before the, that was the last one before the pandemic, we had an entire track just based off of community aspects of things like, you know, diversity planning, meetups, that sort of thing.</p>\n\n\n\n<p>I thought that went pretty well. And who\'s to say what we could have expanded that to, if we could have gone beyond 2019. Um, uninterrupted. Um, so I really would look forward to see, because it\'s a different landscape. Now. We haven\'t had word camps. Um, we haven\'t had physical work camps and more than two years, we, a lot of the momentum for contributions for WordPress came from live events.</p>\n\n\n\n<p>You know, in one way, we\'ve kinda been a little bit of, um, handicapped in terms of, of what we\'ve been used to. Get new contributions in or get fresh ideas, experimented with fleshed out. So I\'m really looking forward. And maybe we can talk about that later, as it\'s closer to where camp us, I would love to hear some of the things that are getting, going to be publicly announced and what some of the thinking has gone on behind it.</p>\n\n\n\n<p>So, yeah,</p>\n\n\n\n<p><strong>Amy June:</strong> and my Gardner came just on cue. Okay. Thanks a lot, David. I appreciate that.</p>\n\n\n\n<p><strong>David Bisset:</strong> No, thank you for voluntarily contributing your time and go talk to your. Okay. If I sit there, have a good night. Thank you. Have a good one.</p>\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}s:7:\"pubDate\";a:1:{i:0;a:5:{s:4:\"data\";s:31:\"Mon, 21 Mar 2022 15:00:43 +0000\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}}s:32:\"http://purl.org/dc/elements/1.1/\";a:1:{s:7:\"creator\";a:1:{i:0;a:5:{s:4:\"data\";s:12:\"David Bisset\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}}}}i:46;a:6:{s:4:\"data\";s:13:\"\n	\n	\n	\n	\n	\n	\n\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";s:5:\"child\";a:2:{s:0:\"\";a:5:{s:5:\"title\";a:1:{i:0;a:5:{s:4:\"data\";s:70:\"WordPress.org blog: WP Briefing: Episode 27: Is WordPress Made for Me?\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}s:4:\"guid\";a:1:{i:0;a:5:{s:4:\"data\";s:53:\"https://wordpress.org/news/?post_type=podcast&p=12451\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}s:4:\"link\";a:1:{i:0;a:5:{s:4:\"data\";s:71:\"https://wordpress.org/news/2022/03/episode-27-is-wordpress-made-for-me/\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}s:11:\"description\";a:1:{i:0;a:5:{s:4:\"data\";s:9761:\"<p>Who is WordPress actually made for? Join our host, WordPress Executive Director Josepha Haden Chomphosy, as she explores this controversial question and three things that can help find the answer.</p>\n\n\n\n<p><strong><em>H</em></strong><em><strong>ave a question you&#8217;d like answered? You can submit them to <a href=\"mailto:wpbriefing@wordpress.org\">wpbriefing@wordpress.org</a>, either written or as a voice recording.</strong></em> </p>\n\n\n\n<p>Hosts: <a href=\"https://profiles.wordpress.org/chanthaboune/\">Josepha Haden Chomphosy</a> <br />Editor:&nbsp;<a href=\"https://profiles.wordpress.org/dustinhartzler/\">Dustin Hartzler</a><br />Logo:&nbsp;<a href=\"https://profiles.wordpress.org/beafialho/\">Beatriz Fialho</a><br />Production:&nbsp;<a href=\"https://profiles.wordpress.org/santanainniss/\">Santana Inniss</a></p>\n\n\n\n<h2>References</h2>\n\n\n\n<ul><li><a href=\"https://europe.wordcamp.org/2022/call-for-volunteers/\">WordCamp Europe call for volunteers</a></li><li><a href=\"https://make.wordpress.org/photos/\">WordPress Photo Directory team</a></li><li><a href=\"https://www.unicefusa.org/stories/unicef-children-crossfire-ukraine-crisis/39542?utm_campaign=20220225_Emergencies&utm_medium=Organic&utm_source=UkraineWebStoryChildrenFeb2022&utm_content=LearnMoreUkraineWebStoryChildrenFeb2022&ms=Organic_PRL_2022_Emergencies_20220225_UkraineWebStoryChildrenFeb2022_LearnMoreUkraineWebStoryChildrenFeb2022_none_none&initialms=Organic_PRL_2022_Emergencies_20220225_UkraineWebStoryChildrenFeb2022_LearnMoreUkraineWebStoryChildrenFeb2022_none_none\">UNICEF</a></li><li><a href=\"https://www.doctorswithoutborders.org/what-we-do/countries/ukraine\">Médecins Sans Frontieres</a>&nbsp;</li><li><a href=\"https://www.icrc.org/en/where-we-work/europe-central-asia/ukraine\">International Committee of the Red Cross</a>&nbsp;</li><li><a href=\"https://help.rescue.org/donate/ukraine-acq?ms=gs_ppc_fy22_ukraine_mmus_feb&initialms=gs_ppc_fy22_ukraine_mmus_feb&gclid=CjwKCAiAjoeRBhAJEiwAYY3nDHNlEUUNRM4wKl1bY0ploy1RNl0M7G1OlLTqawZdg_XhrJ0TircZ_RoCfh8QAvD_BwE\">International Rescue Committee</a></li><li><a href=\"https://www.unrefugees.org/what-we-do/\">UN Refugee Agency</a>&nbsp;</li><li><a href=\"https://donate.wck.org/give/236738/#!/donation/checkout\">World Central Kitchen</a></li><li><a href=\"https://www.techtotherescue.org/tech/tech-for-ukraine\">Tech For Ukraine</a></li><li><a href=\"https://twitter.com/hashtag/wp4ukraine\">#WP4Ukraine</a></li></ul>\n\n\n\n<h2>Transcript </h2>\n\n\n<a class=\"wp-block-read-more\" href=\"https://wordpress.org/news/2022/03/episode-27-is-wordpress-made-for-me/\" target=\"_self\">Read more</a>\n\n\n<p><strong>Episode 27</strong></p>\n\n\n\n<p><strong>Josepha Haden Chomphosy [00:00:00]&nbsp;</strong></p>\n\n\n\n<p>Hello everyone, and welcome to the WordPress Briefing: the podcast where you can catch quick explanations of the ideas behind the WordPress open source project, some insight into the community that supports it, and get a small list of big things coming up in the next two weeks. I&#8217;m your host, Josepha Haden Chomphosy. Here we go!</p>\n\n\n\n<p>Today, we&#8217;re talking about who WordPress is built for. I was talking to a group of contributors last week and we encountered some questions around just who WordPress is built for. And it&#8217;s a question that you&#8217;ll find any time that you&#8217;re working on user testing or on triaging tickets, and especially when that comes up when you look at the big picture, roadmap sorts of things. The easiest answer for this question is, of course, everyone because WordPress&#8217; mission is to democratize publishing and that should be available to everyone.</p>\n\n\n\n<p><strong>Josepha Haden Chomphosy </strong><strong>[00:01:11]</strong></p>\n\n\n\n<p>However, everyone is a really big target and certainly doesn&#8217;t help get your mind around the people that you&#8217;re wanting to actually build it for, the people that you actually want to be able to use your product, your software on a day-to-day basis. So let&#8217;s take a look at the one question that can help us figure out who it&#8217;s built for today and how we get it to being something that&#8217;s built forever.</p>\n\n\n\n<p>Firstly, there&#8217;s a basic premise of open source that informs this thought. And that premise is that we are citizens of a community of contributors therefore the decisions are made by the people who show up. In general, I believe that to be true, though, I also believe that some basic qualifications are needed.</p>\n\n\n\n<p><strong>Josepha Haden Chomphosy [00:01:50]&nbsp;</strong></p>\n\n\n\n<p>So with that in mind, the one question that can help us figure out who a software is built for is this: how do your active contributors see themselves? I would bet that most contributors to open source software projects, like WordPress, are developers of some sort, it is sort of written right into the definition of the project.&nbsp;</p>\n\n\n\n<p>If you work on software, then you need developers. And what I love about WordPress, in particular, is that we do work to include contributors who are not developers. Yet it still remains true that there is a fairly high level of technical knowledge required to actively contribute.&nbsp;</p>\n\n\n\n<p><strong>Josepha Haden Chomphosy [00:2:25]&nbsp;</strong></p>\n\n\n\n<p>Which kind of brings us to the second half of the original question of how can we make sure that WordPress can be something that&#8217;s built for everyone? The answer to this one is easy to say, hard to do, and that is to make sure to include them as co-creators in the development process.&nbsp;</p>\n\n\n\n<p>We&#8217;ve talked about co-creators in open source before. It&#8217;s this idea that people who use the software every day are likely to know the biggest pain points. So if you want your software to be used by people who don&#8217;t know HTML, talk to a bunch of people who don&#8217;t know HTML about how it is to use your software.&nbsp;</p>\n\n\n\n<p>If you want your software to be mostly used by enterprise agencies, talk to enterprise agencies, but also ask them what their clients hate, because everyone has more than one stakeholder. And I know that I said this already, but it bears repeating that, obviously, this is all very easy to say and hard to do.&nbsp;</p>\n\n\n\n<p><strong>Josepha Haden Chomphosy [00:3:20]&nbsp;</strong></p>\n\n\n\n<p>So what is my best guess for the how-to-do part for WordPress? There are three things.&nbsp;</p>\n\n\n\n<p>The first is testing. This not only helps bring in new contributors and helps train future contributors, which I&#8217;ve talked about on the podcast before. But testing also gives us a higher chance of actionable feedback from folks who don&#8217;t necessarily spend time directly in the WordPress project.&nbsp;</p>\n\n\n\n<p>Frequently the feedback that we do get that is just kind of undirected and ad hoc is exactly that– it is undirected and ad hoc and is then hard to follow up on and make sure that we understand what was wrong and how we can help fix it. And so testing is important for that. And testing it turns out is important for a bunch of things. When you&#8217;re working in open source.&nbsp;</p>\n\n\n\n<p>The next thing is support. So checking in with support teams at hosts, as well as the hardworking support teams in the project. And that can really help us to get early indications of what difficulties exist now. They have routinely seen problems and issues that are raised in support forums, and from their everyday users that they are providing support to.&nbsp;</p>\n\n\n\n<p>That probably could be fixed in WordPress if we had a good understanding of just what was not going right, how many people really needed it to go better, and what our targets were to fix that particular problem.&nbsp;</p>\n\n\n\n<p><strong>Josepha Haden Chomphosy [00:4:45]&nbsp;</strong></p>\n\n\n\n<p>And the third thing is communication. I know that I&#8217;ve gone on record in many places as saying that most of our problems at the end of the day are communication problems. And I&#8217;m going on record about it again here in this podcast, establishing better communication patterns with users is key.&nbsp;</p>\n\n\n\n<p>That can be a multi-year project in itself. And even after that, it&#8217;s going to be an ongoing journey. But it is one of the many things that WordCamps and other WordPress events have given to us over the years, an opportunity to really hear from and see the struggles that people who are not building with WordPress every day, or literally building WordPress every day are actually having.</p>\n\n\n\n<p><strong>Josepha Haden Chomphosy [00:5:34]&nbsp;</strong></p>\n\n\n\n<p>So now that you&#8217;ve heard my small list of way too big things, that brings us to our regular small list of big things. The first thing is that WordCamp Europe is still looking for volunteers. If you&#8217;ve never done that before, I think it&#8217;s quite fun. You get to meet a lot of people and the team of organizers is super fun, but I&#8217;ll leave a link for you in the show notes.</p>\n\n\n\n<p>We also have a new code-free way to contribute through the photo directory. That team is just getting started and still is working toward building out its programs. So now&#8217;s a good time to drop in and just kind of see what they are up to. And finally, a reminder that we do have contributors who are affected by the war in Ukraine right now. I will reshare the list of humanitarian organizations in case you missed them a couple of weeks ago as well.&nbsp;</p>\n\n\n\n<p><strong>Josepha Haden Chomphosy [00:6:21]&nbsp;</strong></p>\n\n\n\n<p>And that my friends is your small list of big things. Thank you for tuning in today for this WordPress Briefing. I&#8217;m your host, Josepha Haden Chomphosy. I&#8217;ll see you again in a couple of weeks.</p>\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}s:7:\"pubDate\";a:1:{i:0;a:5:{s:4:\"data\";s:31:\"Mon, 21 Mar 2022 12:57:38 +0000\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}}s:32:\"http://purl.org/dc/elements/1.1/\";a:1:{s:7:\"creator\";a:1:{i:0;a:5:{s:4:\"data\";s:14:\"Santana Inniss\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}}}}i:47;a:6:{s:4:\"data\";s:13:\"\n	\n	\n	\n	\n	\n	\n\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";s:5:\"child\";a:2:{s:0:\"\";a:5:{s:5:\"title\";a:1:{i:0;a:5:{s:4:\"data\";s:125:\"Gutenberg Times: Block Pattern Directory, Export FSE Theme, Integration with BentoJS and Tailwind CSS – Weekend Edition 207\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}s:4:\"guid\";a:1:{i:0;a:5:{s:4:\"data\";s:35:\"https://gutenbergtimes.com/?p=20709\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}s:4:\"link\";a:1:{i:0;a:5:{s:4:\"data\";s:130:\"https://gutenbergtimes.com/block-pattern-directory-export-fse-theme-integration-with-bentojs-and-tailwind-css-weekend-edition-207/\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}s:11:\"description\";a:1:{i:0;a:5:{s:4:\"data\";s:24677:\"<p>Howdy, </p>\n\n\n\n<p>Thank you for keeping in touch between weekend editions. I am always grateful to read your comments and ideas. I learn so much. Keep &#8217;em coming👍 .</p>\n\n\n\n<p>I just finished testing the submission process for the block pattern directory. It&#8217;s a great experience. It showcases how the block editor can be used outside the content creation process. It is also a test case to for integrating Openverse into a media library and how to handle custom post types with the block editor. If you are eager to learn more about either of the topics the <a href=\"https://github.com/WordPress/pattern-directory/issues\">code is public and available on GitHub.</a></p>\n\n\n\n<p>I hope to see you at the <a href=\"https://www.meetup.com/wordpress-social-learning/events/284434154/\">Gutenberg Developer Hours on Tuesday</a>. </p>\n\n\n\n<p>Be well, </p>\n\n\n\n<p>Yours, 💕<br /><em>Birgit</em></p>\n\n\n\n\n<div class=\"wp-container-4 wp-block-group has-light-background-background-color has-background\"><div class=\"wp-block-group__inner-container\">\n<p><strong>Table of Contents</strong></p>\n\n\n\n<div class=\"wp-block-sortabrilliant-guidepost\"><ul><li><a href=\"https://gutenbergtimes.com/feed/#0-gutenberg-plugin-version-12-8\">Gutenberg Plugin Version 12.8 </a></li><li><a href=\"https://gutenbergtimes.com/feed/#1-gutenberg-for-nocode-site-builders-and-content-creators\">Gutenberg for #nocode site builders and Content Creators. </a></li><li><a href=\"https://gutenbergtimes.com/feed/#2-developing-blocks-and-for-the-block-editor\">Developing Blocks and for the block editor</a></li><li><a href=\"https://gutenbergtimes.com/feed/#3-developing-themes-for-gutenberg\">Developing Themes for Gutenberg</a></li><li><a href=\"https://gutenbergtimes.com/feed/#4-word-press-social-learning-events\">WordPress Social Learning Events</a></li></ul></div>\n</div></div>\n\n\n\n\n<h2 id=\"0-gutenberg-plugin-version-12-8\">Gutenberg Plugin Version 12.8 </h2>\n\n\n\n<p><strong>Hector Prieto c</strong>oordinated the release of the 12.8 version of the Gutenberg Feature Plugin. In his release notes <a href=\"https://make.wordpress.org/core/2022/03/16/whats-new-in-gutenberg-12-8-16-march/\"><strong>What’s new in Gutenberg 12.8? (16 March)</strong></a>, he highlights the following topics: </p>\n\n\n\n<ul><li><a href=\"https://make.wordpress.org/core/2022/03/16/whats-new-in-gutenberg-12-8-16-march/#highlight-1\">New Webfonts API</a></li><li><a href=\"https://make.wordpress.org/core/2022/03/16/whats-new-in-gutenberg-12-8-16-march/#highlight-2\">Swift inline insertion of internal links</a></li><li><a href=\"https://make.wordpress.org/core/2022/03/16/whats-new-in-gutenberg-12-8-16-march/#highlight-3\">Steps towards full visual theme creation</a></li><li><a href=\"https://make.wordpress.org/core/2022/03/16/whats-new-in-gutenberg-12-8-16-march/#highlight-4\">Iterating on placeholder and loading states</a></li></ul>\n\n\n\n<p>Many of the other changes are subtle, vital changes to the interface, to make the users feel more comfortable. </p>\n\n\n\n<p>As always, WPTavern&#8217;s <strong>Justin Tadlock</strong> wrote about it, too: <a href=\"https://wptavern.com/gutenberg-12-8-launches-the-web-fonts-api-improves-group-nesting-and-adds-keyboard-shortcut-for-links\"><strong>Gutenberg 12.8 Launches the Web Fonts API, Improves Group Nesting, and Adds Keyboard Shortcut for Links</strong></a></p>\n\n\n\n<p><strong>Mary Job</strong> and I recorded our <strong><a href=\"https://gutenbergtimes.com/podcast/gutenberg-changelog-63-webfonts-api-gutenberg-12-8/\">Gutenberg Changelog episode 63</a> </strong>last night and it should already travel to your podcast app. We really hope that we figured out the sound issues now, although technology wasn&#8217;t cooperating very well. We still had fun chatting about family and travel, off the record. </p>\n\n\n\n<a href=\"https://gutenbergtimes.com/podcast/gutenberg-changelog-63-webfonts-api-gutenberg-12-8/\"><img /></a>\n\n\n\n\n<p><strong>&nbsp;<a href=\"https://make.wordpress.org/core/handbook/references/keeping-up-with-gutenberg-index/\" target=\"_blank\" rel=\"noreferrer noopener\">&#8220;Keeping up with Gutenberg &#8211; Index 2022&#8221;</a>&nbsp;</strong><br />A chronological list of the WordPress Make Blog posts from various teams involved in Gutenberg development: Design, Theme Review Team, Core Editor, Core JS, Core CSS, Test and Meta team from Jan. 2021 on. Updated by yours truly.  <a href=\"https://make.wordpress.org/core/handbook/references/keeping-up-with-gutenberg-index/keeping-up-with-gutenberg-index-2020/\"><em>The index 2020 is here</em></a></p>\n\n\n\n\n<hr class=\"wp-block-separator is-style-wide\" />\n\n\n\n<h2 id=\"1-gutenberg-for-nocode-site-builders-and-content-creators\">Gutenberg for #nocode site builders and Content Creators. </h2>\n\n\n\n<p><strong><a href=\"https://twitter.com/bb____ross\">Beatriz Fiahlo</a></strong> is a product designer at Automattic and open-source contributor, among others she worked on the new <a href=\"https://wordpress.org/news/2022/02/a-new-wordpress-news/\">News theme on WordPress.org</a> and the site of the <a href=\"https://block-museum.com\">Block Museum of Art</a>. </p>\n\n\n\n<p>In her most recent post and video, <a href=\"https://automattic.design/2022/03/15/designing-a-theme-in-the-wordpress-editor/\"><strong>Designing a theme in the WordPress&nbsp;Editor</strong></a>, Fiahlo recounts how you can create a theme by just using the Site Editor.  &#8220;We’re finding that it’s more and more possible to design a fully-featured theme using just the Site Editor, skipping that Figma step entirely. This takes us from a rough idea to a working theme in just a matter of hours, and doesn’t require opening a code editor at all.&#8221; she wrote about the theme design process at Automattic. She also had a few tips along the way. </p>\n\n\n\n<hr class=\"wp-block-separator is-style-wide\" />\n\n\n\n<p>This week&#8217;s <a href=\"https://www.youtube.com/watch?v=w9AE90TRZgQ\"><strong>Gutenberg Block News</strong></a> show with <strong>Jamie Marsland l</strong>anded. First, Marsland demos the new theme export features. Go from modifying and existing theme via Styles,  to uploading it as a new theme in six steps:</p>\n\n\n\n<ol><li>how to modify a theme, </li><li>export it via the site editor, </li><li>make three minor changes,  </li><li>re-zip it and </li><li>upload it to a website and </li><li>activate it. </li></ol>\n\n\n\n<p>Check it out and learn about Marsland&#8217;s Theme of the Week, the review roast and more. </p>\n\n\n\n<a href=\"https://www.youtube.com/watch?v=w9AE90TRZgQ\"><img /></a>Still shot from <a href=\"https://www.youtube.com/watch?v=w9AE90TRZgQ\">WordPress Gutenberg News March 18th, by Jamie Marsland</a>\n\n\n\n\n<p><strong><a href=\"https://gutenbergtimes.com/need-a-zip-from-master/\">Need a plugin .zip from Gutenberg&#8217;s master branch?</a></strong><br />Gutenberg Times provides daily build for testing and review. <br />Have you been using it? Hit reply and let me know.</p>\n\n\n\n<p><img alt=\"GitHub all releases\" src=\"https://img.shields.io/github/downloads/bph/gutenberg/total?style=for-the-badge\" /></p>\n\n\n\n\n<hr class=\"wp-block-separator is-style-wide\" />\n\n\n\n<p><strong>Lesley Sim,</strong> founder of the Gutenberg first <a href=\"https://wordpress.org/plugins/newsletter-glue/\">Newsletter Glue plugin</a> and used her on the Gutenberg Times, published an in depth tutorial on how to <a href=\"https://newsletterglue.com/blog/build/paid-newsletter-paid-memberships-pro/\"><strong>build your own paid newsletter on WordPress with Paid Memberships Pro</strong></a>. If you ever wondered what it took to create a Substack-like tool for writers, educators and consultant, this could be your blueprint. </p>\n\n\n\n<hr class=\"wp-block-separator is-style-wide\" />\n\n\n\n<p>In the series Building Blocks, Justin Tadlock walks you through his tutorial <a href=\"https://wptavern.com/how-to-build-a-recipe-card-via-the-wordpress-block-editor\">H</a><strong><a href=\"https://wptavern.com/how-to-build-a-recipe-card-via-the-wordpress-block-editor\">ow To Build a Recipe Card via the WordPress Block Editor</a>.</strong> The end product is a pattern, created all with existing blocks and available to copy/paste into your site via a GitHub Gist the<em> <a href=\"https://gist.github.com/justintadlock/2948ca4470b5e2fe1ba70b9e999e91d2#file-wp-recipe-card-pattern-html\">wp-recipe-card-pattern.html</a></em></p>\n\n\n\n<hr class=\"wp-block-separator is-style-wide\" />\n\n\n\n<p><strong>Anne McCarthy</strong> started the 3rd round of <a href=\"https://make.wordpress.org/test/2022/03/16/fse-program-bring-your-questions-round-three/\"><strong>Full-Site Editing (FSE) Questions</strong></a>. &#8220;If possible, please focus questions specifically around WordPress 6.0 as those will be the most high impact to address ahead of this upcoming release.&#8221; she wrote. You can either submit your questions <a href=\"https://wordpressdotorg.survey.fm/fse-outreach-program-submit-fse-questions-round-three-1\">via the Survey Form</a> or leave a comment on the post by<strong>&nbsp;March 30th, 2022.</strong></p>\n\n\n\n<hr class=\"wp-block-separator is-style-wide\" />\n\n\n\n<p><strong>Alex Shiels</strong> from the Meta Team just announced that <a href=\"https://make.wordpress.org/meta/2022/03/16/coming-soon-block-pattern-directory-submissions/\"><strong>the Block Pattern Directory will soon be open for public submissions</strong></a>. You are invited to test the submission process before it goes live. You can create your block pattern using a stand-alone front-end block editor, using all core blocks, except theme blocks, for instance site title or tag) and dynamic, site related blocks, like a query loop. </p>\n\n\n\n<p>Openverse is integrated as media library, and you can use images released with the Creative Commons license &#8220;CC0 license, no attribution needed&#8221;, to keep everyone out of licensing troubles. </p>\n\n\n\n<p>Once you hit the submit button for your English block pattern, volunteer translators on the Polyglot team will make it available as well for other locales. </p>\n\n\n\n<a href=\"https://wordpress.org/patterns/\"><img /></a>First designers submitted <a href=\"https://wordpress.org/patterns/\">Block Patterns to the directory</a>: Carolina Nymark and Rich Tabor. \n\n\n\n<p>After the <a href=\"https://wordpress.org/photos/\">WordPress Photos Directory</a>, the <a href=\"https://wordpress.org/patterns/\">Block Pattern Directory</a> is another opportunity for creative people, non-developers to contribute to the WordPress community. </p>\n\n\n\n<p>Sarah Gooding on WPTavern wrote about it in her article: <a href=\"https://wptavern.com/wordpress-org-to-launch-pattern-creator-to-expand-pattern-directory\"><strong>WordPress.org to </strong></a><em><a href=\"https://wptavern.com/wordpress-org-to-launch-pattern-creator-to-expand-pattern-directory\"><strong>Launch Pattern Creator to Expand Pattern Directory</strong></a>. </em></p>\n\n\n\n<hr class=\"wp-block-separator is-style-wide\" />\n\n\n\n<p><strong>Jamie Marsland</strong> has <a href=\"https://www.youtube.com/watch?v=GnhSFvW6Q-o\"><strong>10 WordPress Gutenberg Block Editor Tips That Save You Time</strong></a>. From disabling the pre-publish step, over the List View to the Slash command, you&#8217;ll find a great array of tips and tricks for the new and power user alike in Marsland&#8217;s video. Personally, I also enjoyed the Mac Shortcut to get a list of Emojis to use in your content 😉.</p>\n\n\n\n<h2 id=\"2-developing-blocks-and-for-the-block-editor\">Developing Blocks and for the block editor</h2>\n\n\n\n<p><strong><a href=\"https://renemorozowich.com/where-wordpress-block-plugins-used/\">Where are WordPress Block Plugins used on my site?</a></strong> <strong>Rene Morozowich</strong> looked for the clues in the database and shares what sure discovered. She walks you through the process can code. </p>\n\n\n\n<p>If you are uncomfortable with raw database tables and SQL you can also install the  plugin <a href=\"https://wordpress.org/plugins/find-my-blocks/\">Find my Blocks</a>. This plugin provides you the list of used blocks, the post, and pages, you used them on and the unique identifier of each block. You can use the search in WP-Admin &gt; All Posts enter the unique identifier string into search box, and you will get a list of posts where you used a particular block. I described the process in <a href=\"https://github.com/WordPress/gutenberg/issues/28572#issuecomment-771092327\">detail on GitHub</a>, commenting on the tracking issue for Block Manager enhancements. </p>\n\n\n\n<hr class=\"wp-block-separator is-style-wide\" />\n\n\n\n<p><strong><a href=\"https://twitter.com/swissspidy\">Pascal Birchler</a></strong>, core contributor at Google, explored building Gutenberg Blocks with BentoJS components. His tutorial, <a href=\"https://bentojs.dev/documentation/guides/bento-gutenberg-blocks-guide/\">How to create WordPress Gutenberg blocks with BentoJS</a>, is part of the official BentoJS documentation. Birchler and <strong>Alain Schlesser</strong>, maintainer of WP-CLI are <a href=\"https://twitter.com/schlessera/status/1505110138662928384\">meeting up at CloudFest in Germany</a>, to explore the use of BentoJS with the block editor.</p>\n\n\n\n<p><em><a href=\"https://bentojs.dev/\">BentoJS website</a> | <a href=\"https://github.com/swissspidy/gutenberg-bento\">Pascal Birchler&#8217;s GitHub repo for the Gutenberg Carousel</a>. </em></p>\n\n\n\n<hr class=\"wp-block-separator is-style-wide\" />\n\n\n\n<p><strong><a href=\"https://twitter.com/m_munirkamal\">Munir Kamal</a></strong>, author of the Editor Plug plugin and founder of the Gutenberg Hub, posted a tutorial on <a href=\"https://gutenberghub.com/how-to-create-custom-block-category/\"><strong>How to create a Custom Block Category</strong></a>, a section in the Inserter that can hold your group of blocks. </p>\n\n\n\n<hr class=\"wp-block-separator is-style-wide\" />\n\n\n\n<p><a href=\"https://twitter.com/BenjaminRitner\"><strong>Ben Ritner</strong>,</a> founder of <a href=\"https://www.kadencewp.com/\"><em>Kadence Theme</em></a> and now part of Liquid Web and StellarWP, was this week&#8217;s guest on the <a href=\"https://www.youtube.com/watch?v=UuTynYwpKAM\"><strong>Torque Social Hour</strong></a> with DocPop and Nick Diego. </p>\n\n\n\n<p>The <a href=\"https://wordpress.org/plugins/kadence-blocks/\">Kadence blocks plugins</a> was available even before the block editor was merged with WordPress 5.0 and has now over 200,000 active installations. </p>\n\n\n\n<p>On the show, Ritner discussed the realities of a WordPress theme developer and listed a few major features that he found missing in Gutenberg, before Ritner would consider it a site builder. &#8220;How there is no responsiveness in any of the Core Blocks is blowing my mind. How are we working on full site editing and not handling that key aspect of web development?&#8221; </p>\n\n\n\n<p>Ritner also explained, why his team doesn&#8217;t yet consider making a child theme for the full-site editing experience. &#8220;It&#8217;s not ready yet&#8221;. Kadence created a design library early on, so there is no need for Block patterns in the theme. Once they create a child theme for full site editing, they will recreate some of their templates as Block Patterns. </p>\n\n\n\n<p>These are only a few insights you get from the show. It was a candid discussion that is well worth your time. </p>\n\n\n\n<p><strong>Speaking of responsiveness. </strong>The Gutenberg contributors have been tackling this for quite a while. You can follow along on these issues on GitHub, chime in and test. </p>\n\n\n\n<ul><li><a href=\"https://github.com/WordPress/gutenberg/issues/34641\"><strong>Responsive blocks &amp; intrinsic web design</strong></a> </li><li><a href=\"https://github.com/WordPress/gutenberg/issues/38167\"><strong>Add a Style Engine to manage rendering block styles</strong></a>. </li><li><a href=\"https://github.com/WordPress/gutenberg/issues/34345\"><strong>Typography Tools: Tracking tools</strong></a> </li></ul>\n\n\n\n<hr class=\"wp-block-separator is-style-wide\" />\n\n\n\n<h2 id=\"3-developing-themes-for-gutenberg\">Developing Themes for Gutenberg</h2>\n\n\n\n<p><strong>Justin Tadlock</strong> discovered a <a href=\"https://wptavern.com/new-plugin-for-writing-wordpress-theme-json-files-via-yaml\">New Plugin for Writing WordPress Theme JSON Files via YAML</a> by <strong>Sascha Paukner</strong>, a web developer from Berlin, Germany. In his article, Tadlock walks you through on how to use the <a href=\"https://wordpress.org/plugins/theme-yaml/\"><em>Theme YAML plugin.</em></a> For some developers YAML is an easier format than JSON. </p>\n\n\n\n<hr class=\"wp-block-separator is-style-wide\" />\n\n\n\n<p>It seems the feature of configuring the block editor via the theme.json file sparks great creativity for tooling. If you are searching for other tools check out this list: </p>\n\n\n\n<ul><li><strong>David Dwyer&#8217;s</strong> <a href=\"https://www.themegen.app/\"><strong>ThemeGen.app</strong></a>  with a browser interface to select all the desired options and generate your theme.json file. </li><li><strong>Carolina Nymark&#8217;s</strong> <a href=\"https://fullsiteediting.com/block-theme-generator/\"><strong>Block Theme Generator</strong></a></li></ul>\n\n\n\n<p>You also might be interested in our post <a href=\"https://gutenbergtimes.com/how-to-disable-theme-features-and-lock-block-templates-for-full-site-editing-in-wordpress/\">How to disable theme features and Lock Block Templates for Full-Site Editing in WordPress</a></p>\n\n\n\n<hr class=\"wp-block-separator is-style-wide\" />\n\n\n\n<p><strong>Misha Rudrastyh</strong> shared their insight on <a href=\"https://rudrastyh.com/gutenberg/learning-full-site-editing-with-kubrick-block-theme.html\"><strong>Learning Full Site Editing with Kubrick Block Theme</strong></a>. Riad Benguella rebuilt the long-time default theme as block theme. Rudrastyh&#8217;s walk explains how the pieces fit together. </p>\n\n\n\n<hr class=\"wp-block-separator is-style-wide\" />\n\n\n\n<p><strong>David Dwyer</strong> published a <a href=\"https://github.com/dgwyer/tailwind-blocks\">demo plugin</a> how he was able to integrate the create-block script with Tailwind CSS.  Say hello to <a href=\"https://github.com/dgwyer/tailwind-blocks\"><strong>&#8216;Tailwind Blocks&#8217;</strong></a>. The plugin started its existence with the recommended @wordpress/create-block script and auto enqueues all JS and CSS (including Tailwind styles).&nbsp;</p>\n\n\n\n<p>In this week&#8217;s Twitch stream, <strong>Ryan Welcher</strong> invited his follower &#8220;<a href=\"https://www.twitch.tv/videos/1428319101\"><strong>Let&#8217;s add Tailwind CSS to our custom blocks and create a create-block template for it.</strong></a>&#8221; </p>\n\n\n\n<hr class=\"wp-block-separator is-style-wide\" />\n\n\n\n<p><strong>Nyasha Green</strong> of MasterWP posted an <a href=\"https://masterwp.com/an-interview-with-anne-mccarthy-on-wordpresss-coolest-new-project-the-museum-of-block-art/\"><strong>interview with Anne McCarthy on WordPress’s coolest new project: the Museum of Block Art</strong></a>. Green wrote about her response to the museum: <em>&#8220;Speaking for myself the best thing about this project is that it reminds us that we are artists.&nbsp; Even those us of who are not designers, or the best at Front End work.&nbsp; We still create masterpieces in the form of code, websites, apps, etc.&nbsp; I think you have created that link that makes us go to ourselves, “Hey we are making&nbsp;art!” And I for one am very grateful for it.&nbsp;&#8220;</em> </p>\n\n\n\n<hr class=\"wp-block-separator is-style-wide\" />\n\n\n\n<p>Are you interested in <a href=\"https://buddy.works/webinars/how-automate-gutenberg-block-in-wp-projects\"><strong>Automating your Gutenberg Block development</strong>? </a>The next Buddy.works webinar will take place on March 23 at&nbsp; 17:00 PM UTC / 1 pm Eastern / 10am PT.</p>\n\n\n\n<p>With <strong>Grzegorz Ziolkowski</strong>, Open Sourcerer @ Automattic and <strong>Maciek Palmowski</strong>, WordPress Ambassador @ Buddy.&nbsp;</p>\n\n\n\n<p>You will learn&nbsp;</p>\n\n\n\n<ul><li>How to start WordPress block development</li><li>How to leverage JavaScript developer tools for WordPress plugin and block development</li></ul>\n\n\n\n<ul><li>How to automate your development workflow to maximize confidence in the codebase and monitor its health</li><li>How to configure a pipeline in Buddy to automate the development process</li></ul>\n\n\n\n<h2 id=\"4-word-press-social-learning-events\">WordPress Social Learning Events</h2>\n\n\n\n<p>If you are a developer working with code, the Gutenberg Developer Hours are for you. The next event will take place&nbsp;<a href=\"https://www.meetup.com/wordpress-social-learning/events/284434154/\">March 22nd, 2022 16:00 UTC / noon ET.</a></p>\n\n\n\n<a href=\"https://www.meetup.com/wordpress-social-learning/events/284434154/\"><img /></a><em>With Joni Halabi, Tammie Lister and Fabian Kägy</em>\n\n\n\n<hr class=\"wp-block-separator is-style-dots\" />\n\n\n\n<p><strong>March 22, 2022, at 3 am ET / 19:00 UTC</strong><br /><a href=\"https://www.meetup.com/wordpress-social-learning/events/284320854/\"><strong>Intro to Theme Blocks</strong></a>&nbsp;with Wes Theron</p>\n\n\n\n<p><strong>March 23, 2022, at 1pm ET / 17:00 UTC</strong><br /><a href=\"https://www.meetup.com/wordpress-social-learning/events/284383346/\"><strong>Builder Basics: Exploring Block Layout, Alignment, Dimensions, and Spacing</strong>&nbsp;</a>with Nick Diego</p>\n\n\n\n<p><strong>March 25, 2022, at 11 am EDT / 15:00 UTC </strong><br /><strong><a href=\"https://www.meetup.com/wordpress-social-learning/events/284679152/\">Block Theme Discussions: Custom Fonts</a></strong> with Daisy Olson</p>\n\n\n\n<p><strong>March 28, 2022, at 11 am ET / 15:00 UTC</strong><br /><strong><a href=\"https://www.meetup.com/wordpress-social-learning/events/284387767/\">Hello Blocks! Coding a custom block</a></strong>&nbsp;with Wes Theron and Ryan Welcher</p>\n\n\n\n<p><strong>March 29, 2022, at 3 pm ET / 20:00 UTC</strong><br /><strong><a href=\"https://www.meetup.com/wordpress-social-learning/events/284252760/\">Beginner’s Guide to Full Site Editing&nbsp;</a></strong>with Sarah Snow</p>\n\n\n\n<p><strong>April 1, 2022, 11 am EDT / 15:00 UTC </strong><br /><strong><a href=\"https://www.meetup.com/wordpress-social-learning/events/284700941/\">Block Theme Discussions: JSON Schema</a></strong> with Daisy Olsen </p>\n\n\n\n<p><strong>April 6, 2022, 2pm EDT / 18:00 UTC</strong> <br /><a href=\"https://www.meetup.com/wordpress-social-learning/events/284700789/\"><strong>Builder Basics: Designing with Columns, Group, and Row Blocks (Part 2)</strong></a> with Nick Diego</p>\n\n\n\n<p><strong>April 8, 2022, 11 am EDT / 15:00 UTC </strong><br /><a href=\"https://www.meetup.com/wordpress-social-learning/events/284701015/\"><strong>Block Theme Discussions: Supports in theme.json with Daisy Olsen </strong></a></p>\n\n\n\n<p><strong>April 12, 2022 2pm EDT 18:00 UTC</strong> <br /><strong><a href=\"https://www.meetup.com/wordpress-social-learning/events/284700822/\">Builder Basics: Headers and Footers in Full Site Editing</a></strong> w/ Nick Diego</p>\n\n\n\n<p><strong>April 15, 2022, 11 am EDT / 15:00 UTC</strong> <br /><strong><a href=\"https://www.meetup.com/wordpress-social-learning/events/284701295/\">Block Theme Discussions: Presets in theme.json</a></strong> with Daisy Olsen</p>\n\n\n\n<p>April 19, 2022 2pm EDT / 18:00 UTC <br /><strong><a href=\"https://www.meetup.com/wordpress-social-learning/events/284700867/\">Builder Basics: Exploring Block Layout, Alignment, and Dimensions </a>(Part 2)</strong></p>\n\n\n\n<hr class=\"wp-block-separator\" />\n\n\n\n<p><em>Featured image: DC Metro-ChinaTown platform by Sara Marcondes found on the WordPress photos directory </em></p>\n\n\n\n\n<hr class=\"wp-block-separator is-style-wide\" />\n\n\n\n<p class=\"has-text-align-left\"><strong>Don&#8217;t want to miss the next Weekend Edition? </strong></p>\n\n\n\n<form class=\"wp-block-newsletterglue-form ngl-form ngl-portrait\" action=\"https://gutenbergtimes.com/feed/\" method=\"post\"><div class=\"ngl-form-container\"><div class=\"ngl-form-field\"><label class=\"ngl-form-label\" for=\"ngl_email\"><br />Type in your Email address to subscribe.</label><div class=\"ngl-form-input\"><input type=\"email\" class=\"ngl-form-input-text\" name=\"ngl_email\" id=\"ngl_email\" /></div></div><button class=\"ngl-form-button\">Subscribe</button><p class=\"ngl-form-text\">We hate spam, too and won&#8217;t give your email address to anyone except Mailchimp to send out our Weekend Edition</p></div><div class=\"ngl-message-overlay\"><div class=\"ngl-message-svg-wrap\"></div><div class=\"ngl-message-overlay-text\">Thanks for subscribing.</div></div><input type=\"hidden\" name=\"ngl_list_id\" id=\"ngl_list_id\" value=\"26f81bd8ae\" /><input type=\"hidden\" name=\"ngl_double_optin\" id=\"ngl_double_optin\" value=\"yes\" /></form>\n\n\n\n<hr class=\"wp-block-separator is-style-wide\" />\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}s:7:\"pubDate\";a:1:{i:0;a:5:{s:4:\"data\";s:31:\"Sat, 19 Mar 2022 19:00:14 +0000\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}}s:32:\"http://purl.org/dc/elements/1.1/\";a:1:{s:7:\"creator\";a:1:{i:0;a:5:{s:4:\"data\";s:18:\"Birgit Pauli-Haack\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}}}}i:48;a:6:{s:4:\"data\";s:13:\"\n	\n	\n	\n	\n	\n	\n\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";s:5:\"child\";a:2:{s:0:\"\";a:5:{s:5:\"title\";a:1:{i:0;a:5:{s:4:\"data\";s:101:\"Gutenberg Times: Gutenberg Changelog #63 – Block Pattern Directory, WebFonts API and Gutenberg 12.8\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}s:4:\"guid\";a:1:{i:0;a:5:{s:4:\"data\";s:53:\"https://gutenbergtimes.com/?post_type=podcast&p=20755\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}s:4:\"link\";a:1:{i:0;a:5:{s:4:\"data\";s:86:\"https://gutenbergtimes.com/podcast/gutenberg-changelog-63-webfonts-api-gutenberg-12-8/\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}s:11:\"description\";a:1:{i:0;a:5:{s:4:\"data\";s:23103:\"<p>Birgit Pauli-Haack and Mary Job discuss Block Pattern Directory, WebFonts API and Gutenberg 12.8.</p>\n\n\n\n<ul><li>Music:&nbsp;<a href=\"https://soundcloud.com/xirclebox\">Homer Gaines</a></li><li>Editor:&nbsp;<a href=\"https://www.linkedin.com/in/sandy-reed/\">Sandy Reed</a></li><li>Logo:&nbsp;<a href=\"https://markuraine.com/\">Mark Uraine</a></li><li>Production:&nbsp;<a href=\"https://icodeforapurpose.com\">Birgit Pauli-Haack</a></li></ul>\n\n\n\n<span id=\"more-20755\"></span>\n\n\n\n<p><a href=\"https://gutenbergtimes.com/podcast/gutenberg-changelog-63-webfonts-api-gutenberg-12-8/#shownotes\">Show Notes</a> / <a href=\"https://gutenbergtimes.com/podcast/gutenberg-changelog-63-webfonts-api-gutenberg-12-8/#transcript\">Transcript</a></p>\n\n\n\n<p><strong>Subscribe to the&nbsp;<a href=\"https://gutenbergtimes.com/podcast/\">Gutenberg Changelog</a>&nbsp;podcast via your favorite podcast apps!</strong><br />🎙️&nbsp;<a href=\"https://open.spotify.com/show/620NwVKQJGdTupy36zYxvg?mc_cid=4b6c9f88fe\">Spotify</a>&nbsp;|&nbsp;<a href=\"https://podcasts.google.com/feed/aHR0cHM6Ly9ndXRlbmJlcmd0aW1lcy5jb20vZmVlZC9wb2RjYXN0\">Google</a>&nbsp;|&nbsp;<a href=\"https://podcasts.apple.com/us/podcast/gutenberg-changelog/id1469294475\">iTunes</a>&nbsp;|&nbsp;<a href=\"https://pca.st/podcast/f8445ec0-7508-0137-f267-1d245fc5f9cf\">PocketCasts</a>&nbsp;|&nbsp;<a href=\"https://www.stitcher.com/show/gutenberg-changelog\">Stitcher</a>&nbsp;|<br />🎙️&nbsp;<a href=\"https://www.podbean.com/podcast-detail/chi7j-9904a/Gutenberg-Changelog-Podcast\">Pod Bean</a>&nbsp;|&nbsp;<a href=\"https://castbox.fm/channel/Gutenberg-Changelog-id2173375\">CastBox</a>&nbsp;|&nbsp;<a href=\"https://www.podchaser.com/podcasts/gutenberg-changelog-878239/\">Podchaser</a>&nbsp;|&nbsp;<a href=\"https://gutenbergtimes.com/feed/podcast\">RSS Feed</a>&nbsp;</p>\n\n\n\n<p class=\"has-large-font-size\" id=\"shownotes\"><strong>Show Notes </strong></p>\n\n\n\n<h2>Announcements</h2>\n\n\n\n<ul><li><a href=\"https://make.wordpress.org/test/2022/03/16/fse-program-bring-your-questions-round-three/\">FSE Program: Bring your questions – Round Three</a></li><li><a href=\"https://make.wordpress.org/meta/2022/03/16/coming-soon-block-pattern-directory-submissions/\">Coming soon: Block Pattern Directory Submissions</a></li></ul>\n\n\n\n<h2>Community Contributions</h2>\n\n\n\n<ul><li><a href=\"https://github.com/dgwyer/tailwind-blocks\">Tailwind Blocks</a> by David Gwyer </li><li><a href=\"https://www.twitch.tv/videos/1428319101\">Let&#8217;s add Tailwind CSS to our custom blocks and create a create-block template for it</a> Twitch Stream with Ryan Welcher</li><li><a href=\"https://buddy.works/webinars/how-automate-gutenberg-block-in-wp-projects\">How to automate Gutenberg block development in WP projects</a> Buddy.works</li><li><a href=\"https://www.meetup.com/wordpress-social-learning/events/284434154/\">Gutenberg Developer Hours</a>&nbsp;<a href=\"https://www.meetup.com/wordpress-social-learning/events/284434154/\">March 22nd, 2022 16:00 UTC / noon ET.</a></li></ul>\n\n\n\n<h2>Gutenberg 12.8</h2>\n\n\n\n<ul><li><a href=\"https://make.wordpress.org/core/2022/03/16/whats-new-in-gutenberg-12-8-16-march/\">What’s new in Gutenberg 12.8? (16 March)</a> by Hector Prieto</li><li>Justin Tadlock <a href=\"https://wptavern.com/gutenberg-12-8-launches-the-web-fonts-api-improves-group-nesting-and-adds-keyboard-shortcut-for-links\">Gutenberg 12.8 Launches the Web Fonts API, Improves Group Nesting, and Adds Keyboard Shortcut for Links</a></li></ul>\n\n\n\n<p class=\"has-large-font-size\">Stay in Touch</p>\n\n\n\n<div class=\"wp-container-3 wp-block-group\"><div class=\"wp-block-group__inner-container\">\n<ul><li>Did you like this episode? <a href=\"https://lovethepodcast.com/gutenbergchangelog\"><strong>Please write us a review </strong></a></li><li>Ping us on Twitter or send DMs with questions. <a href=\"https://twitter.com/maryojob\">@maryojob </a>and <a href=\"https://twitter.com/bph\">@bph</a>.</li><li><em>If you have questions or suggestions, or news you want us to include, send them to <a href=\"mailto:changelog@gutenbergtimes.com\">changelog@gutenbergtimes.com</a>. </em></li><li><em>Please write us a review on iTunes! <a href=\"https://gutenbergtimes.com/itunes/\">(Click here to learn how)</a></em></li></ul>\n</div></div>\n\n\n\n<p class=\"has-large-font-size\" id=\"transcript\">Transcript</p>\n\n\n\n<p><em>Birgit Pauli-Haack</em>: Hello, and welcome to our 63rd episode of the Gutenberg Changelog podcast. Today we&#8217;ll talk about Block Pattern Directory, the Web Fonts API, and Gutenberg 12.8. I&#8217;m Birgit Pauli-Haack, curator at the Gutenberg Times and WordPress developer advocate. And I&#8217;m here with my co-host, Mary Job, WordPress advocate and support engineer at Paid Memberships Pro. Good evening, Mary. How are you today?</p>\n\n\n\n<p><em>Mary Job</em>: I&#8217;m doing very good, Birgit. Thank you. It&#8217;s almost 9:00 P.M. my time, so that&#8217;s great.</p>\n\n\n\n<p><em>Birgit Pauli-Haack</em>: Oh, Friday night, that&#8217;s what you do for fun, right?</p>\n\n\n\n<p><em>Mary Job</em>: Yes, this is&#8230; All right, so we have a couple of announcements. Anne McCarthy published a third round of questions about full site editing experience. Now that all features for full site editing are available in a better version, what are the questions you have? If you have them, please submit them via the survey form that we&#8217;re going to share once this episode is published. You can also find it on the Make WordPress Test blog.</p>\n\n\n\n<p><em>Birgit Pauli-Haack</em>: Awesome. Yeah. So there was a first round and a second round, and now this is the third round. And I think that it has gotten quite some improvements since the first round of questions, and the vision for full site editing becomes probably clearer and hopefully answer the questions that you have. So, Alex Shiels and the Meta team invite you to test the Block Pattern Directory, especially the submission. They have created the pattern creator page where you can then, completely with a block editor, create block patterns. So the block pattern creator page, Alex wrote, will allow designers and content creators to build, edit, and submit their best block patterns to the directory.</p>\n\n\n\n<p>Approved patterns will be added to the directory where they will be instantly available to the authors of millions of WordPress sites. So for Alex Shiels, I did some testing and also wrote a few notes for the documentation. And it&#8217;s not yet ready for you to submit dynamic blocks or patterns for dynamic blocks, like the ones that you use for templates or header, footer, or query loop. And another caveat is that all patterns need to be submitted in English before the translators then can make them available for different locales. That&#8217;s kind of, yeah, some that are two things you need to know before you start creating your patterns, but check it out.</p>\n\n\n\n<p>We will of course have links in the show note, or when you go to WordPress.org/meta, M-E-T-A forward slash, you see the latest page there is the invitation about the coming soon pattern submission. Only in this phase before it&#8217;s really public there is an approval process in there, but the team is actually working to make that instant so that there is no review process in there. But they&#8217;re also implementing a report process. So that&#8217;s really exciting that people can now submit their best patterns and other people can use it. There&#8217;s some great creativity going on as we saw with the block museum, block-museum.com. That came out two weeks ago. So there&#8217;s a lot of things happening on the block patterns.</p>\n\n\n\n<p><em>Mary Job</em>: I think this is a great idea, Birgit, because it&#8217;s going to open up a chance for people to contribute more to WordPress. This is also an opportunity for people who want to contribute. It&#8217;s a good one.&nbsp;</p>\n\n\n\n<h3><strong>Community Contributions</strong></h3>\n\n\n\n<p>And on community contributions, we have David Dwyer just published a demo plugin on how he was able to integrate the quick blocks with Tailwind CSS. We&#8217;re going to also put the link to this GitHub repository in the show notes to say hello to Tailwind blocks, it&#8217;s a streamlined way to develop blocks using Tailwind CSS. The plugin is scaffolded using the recommended at WordPress/script, block scripts and autos and CSS, including styles.</p>\n\n\n\n<p><em>Birgit Pauli-Haack</em>: Yeah. And I just wanted to add that Ryan Welcher this week did a live Twitch stream to create actually a template for the create block scaffolding tool for these tailwind styles. That&#8217;s also a link we will share in the show notes and let&#8217;s see how far he came with it.</p>\n\n\n\n<p><em>Mary Job</em>: Yeah.</p>\n\n\n\n<p><em>Birgit Pauli-Haack</em>: If you have a withdrawal from Grzegorz , and you are interested in automating your Gutenberg block development, put the next buddy works webinar on your calendar. It&#8217;s for March 23rd, at 1700 UTC, 1:00 PM Eastern, 10:00 AM Pacific. And it&#8217;s with Grzegorz Ziokowski, the open sorcerer at Automattic and Maciek Palmowski, WordPress ambassador at Buddy. And you will learn how to start a WebPress block development, how to leverage JavaScript developer tools for the WebPress plugin and block development and how to automate your development workflow and maximize confidence in the code and monitor itself. You also learn how to configure the pipeline of deployment with Buddy to automate the process. As always links are in the show notes and yeah, hopefully I can make it to see Grzegorz again.</p>\n\n\n\n<p><em>Mary Job</em>: Oh yes. That&#8217;d be good to see him again. I miss him already, even though we didn&#8217;t spend so much time together on the show. So the next Gutenberg developer hours would take place on March 22nd, at 1600 UTC. At noon Eastern, you can pick part in the fourth Gutenberg developer event and meet up with Fabian Kagy, Tammie Lister and Joni Halabi on the expert panel.</p>\n\n\n\n<h3><strong>What’s Released &#8211; WordPress 5.9.2 and Gutenberg 12.8</strong></h3>\n\n\n\n<p><em>Birgit Pauli-Haack</em>: Yes. Hope to see everybody there. So that brings us to the section of what&#8217;s released. And if you are on automatic updates of minor releases, WordPress 5.9.2 security and maintenance release has already landed on your site near you. And if you haven&#8217;t yet, update now, don&#8217;t wait.</p>\n\n\n\n<p><em>Mary Job</em>: Woo commerce release also the security and maintenance version, and you can automatically update from version 3.5 to 6.3. If you don&#8217;t get the plugin automatically, please update now.</p>\n\n\n\n<p><em>Birgit Pauli-Haack</em>: Don&#8217;t wait.</p>\n\n\n\n<p><em>Mary Job</em>: At all.</p>\n\n\n\n<p><em>Birgit Pauli-Haack</em>: Yeah. And that brings us to Gutenberg 12.8. Hector Prieto handles the 12.8 release from release candidate to the final release this week on Wednesday, March 16th. And so there are a few enhancements, not so much particular new features. It&#8217;s not an entirely spectacular release because it&#8217;s still does some bug fixing for 5.9, but we can start with the enhancements.&nbsp;</p>\n\n\n\n<h3><strong>Enhancements</strong></h3>\n\n\n\n<p>And the navigation block has now improved loading and place holder states. And it also has improved user interface feedback for the navigation block. So it makes it easier to handle that.</p>\n\n\n\n<p><em>Mary Job</em>: Yes, the media and text block also add announcements. You can now display the media where you are uploading the same way it works for the cover image and the other gallery images.</p>\n\n\n\n<p><em>Birgit Pauli-Haack</em>: Yeah. And that&#8217;s really interesting because then you can continue working and know that that&#8217;s uploaded. There&#8217;s also a link completer for inline links to post, and this is more for power users, but I think other people who use the keyboard quite a bit is so you can add a link to internal on your site pages and posts by just having two left square brackets in sequence. Yeah. Put them in. And then it brings up a search of modal where you can pick the page or the post that you want to link to.</p>\n\n\n\n<p>This is very interesting and it&#8217;s really for the power users and it doesn&#8217;t put more weight on the user interface. It has a nice balance and it doesn&#8217;t affect performance. So this is a great add on to the keyboard shortcuts that we know, too. It&#8217;s an auto completer so you can kind of select things from search. It&#8217;s similar, like the slash command where you put the forward slash and then for the inserter and this is just for the links. Check it out and try it out and see how it maybe improves your speed on linking things in. It takes the link. If you select it takes the title of the page as the link text. So that saves a lot of time.</p>\n\n\n\n<p><em>Mary Job</em>: Yes, I personally recommend if you haven&#8217;t, you should download full site. You use full site editing on the local site and practice with it and play with it, at least that&#8217;s what I&#8217;m doing before it becomes mainstream. It&#8217;s a good idea to get used to how it works, it&#8217;s sustainability, the future, WordPress, so there is no point waiting. You can test it out now and be part of the development process. The site editor also got an enhancement. You can now export app to your team expert, the theme.json file, your index, the PHP and style of CSS. This is great.</p>\n\n\n\n<p><em>Birgit Pauli-Haack</em>: Yeah. And it&#8217;s really interesting. Yeah. Now a non coder can actually create themes and with the site editor and then so under the three.menu on the right hand side and the sidebar where you also go to the code editor or change the top toolbar kind of thing, there&#8217;s also now in the site editor, a menu items that has export and you click on it and then it grabs everything into the theme.json, the index PHP, styles as all, and other files that are in the current theme and downloads it as a zip file to your hard drive. And then you could make just some changes on the styles CSS and give it a new name, zip it again, and upload it. That is kind of the first process of having these no code theme development or theme designers work with the site editor at that. It will be quite have an impact on the WordPress ecosystem.</p>\n\n\n\n<p>I also wanted to give a shout out to Jamie Marsland. Just before I headed into the recording of this Changelog, I saw his new Gutenberg block news show on YouTube. And he&#8217;s in his show from March 18th, he&#8217;s actually demoing the exact process on how to export and import the theme that you create with the site editor. So it&#8217;s a fantastic video and of course we link it in the show notes, but just should subscribe to Jamie Marsland&#8217;s YouTube channel because he comes out every Friday with this new news show and shows you a few things that are new in the WordPress in the block editor.</p>\n\n\n\n<p><em>Mary Job</em>: I think this is great because it means that you don&#8217;t have to recreate your design every time as a person who is no code. You don&#8217;t have to recreate your design every time you&#8217;re trying to build a site. You could just start with the templates that you already have and then take it from there.</p>\n\n\n\n<p><em>Birgit Pauli-Haack</em>: Exactly, exactly. It&#8217;s a great tooling for site builders that work with clients and that have that want to streamline their process. Yes.</p>\n\n\n\n<h3><strong>New APIs</strong></h3>\n\n\n\n<p>So what&#8217;s also in there and is the new webfonts API finally landed in Gutenberg then that has been in the works for quite a while. And does API is the first step in helping people to load fonts in a performance friendly and privacy friendly, future proof manner. Something that has been very difficult before and with the few weeks left until the WordPress 6.0 beta release, it would be really helpful to give it a wheel, test this API for your sites, especially theme developers, and also plug-in developers. The tooling still needs to be built. The UI is meant the user interface. So, but it&#8217;s definitely good to have it in there so it will land in WordPress 6.0. Yeah, go get the 12.8 and start working on it for testing on your site or others.</p>\n\n\n\n<p>What also is new in Gutenberg? And it doesn&#8217;t have any ramification for a user, but for contributors, it definitely makes life easier because the WordPress preference panel has been isolated into a package and then all the editors use the same preference panel. So there&#8217;s some code reuse and some streamlining of the editor handling. So the widget editor, the site editor, the post editor and the standalone editor can now use this preference panel exclusively. So that is definitely&#8230; So the preferences are the things like, do you want to have the two step publish process? Do you want the toolbar on top? They are which blocks are enabled or disabled. This is definitely a step towards something that has been on the wishlist of a lot of people using the editor that the choices that you make are not going to go away when you delete the cache off your browser or close the browser and it&#8217;s emptied. And when you come in again, it shows you the welcome guide again, and you have to do some of the preferences, put them in again.</p>\n\n\n\n<p>And having that in one package now is the first step to kind of, for the contributers to figure out how those choices can actually be persistent, like being in the user meta panel or something like that. So this is definitely a progression. I know that that has been on the wishlist for definitely three years, if not four, of many people, that those selections are actually persistent. There is a plugin actually out there by Mario Jensen, who has the preference all make them persistent in the user meta fields. I&#8217;ll share the link again in the show notes, just so those can kind of bridge the times waiting for that to land in core.</p>\n\n\n\n<p>We talked about the create block scripts before. There is another item in the Changelog that the script now supports more plugin held head of fields to add additional information to the plugin that comes out of it. So that is definitely an additional step there.</p>\n\n\n\n<p>Speaking of create blocks, there&#8217;s also a new confirmed problem for showing the plugin options. So you can type them in and also improve the custom project template configuration that how you integrate your own custom templates with the scaffolding tool. The release shows all the different ways how this works now. And I&#8217;m sure either Ryan Welcher or some other developer will walk us through what that exactly means, but for now, know it&#8217;s in the Gutenberg plugin, 12.8.</p>\n\n\n\n<p>Does that conclude our release today? Yes, it does. There are certainly a few code quality PRs that contributors might want to look at. And also for some tools, especially testing, there have been some changes there and build tool that just has some minor fixes. Yeah. So, that&#8217;s the end. Well, thank you. It was that big of a release as we had before, but anything that kind of jumped at you, Mary, that you want to talk about that we haven&#8217;t yet?</p>\n\n\n\n<p><em>Mary Job</em>: Oh, I think we&#8217;ve pretty much covered everything for this episode.</p>\n\n\n\n<p><em>Birgit Pauli-Haack</em>: Yes. And before we end the show, I want to remind everyone the Gutenberg Developer hours, the next one is on March 22nd, at 1600 UTC on Meetup for registration. And if you listen to this at a later date, I know a few people kind of binge listen to this, but kind of weeks later, so check out the Meetup group, WordPress Social Learning, because there are where the Gutenberg Developer events happen are announced. That&#8217;s also where other social learning discussions happen like Nick Diego does some builder building blocks series. Ryan Welcher does some create block tutorials, beginners ones, and then also for no code site builders, there are additional tutorials on there and discussions. All right.</p>\n\n\n\n<p><em>Mary Job</em>: Yes. And if you want to join in for my side of the continent, that will be 10:00 PM, 10 to 11, say between nine to 11:00 PM our time. You should definitely join in. I look forward to seeing you there. As always, the show notes are there.</p>\n\n\n\n<p><em>Birgit Pauli-Haack</em>: Oh, sorry.</p>\n\n\n\n<p><em>Mary Job</em>: Yeah.</p>\n\n\n\n<p><em>Birgit Pauli-Haack</em>: Good point. Thank you very much for pointing that out. So, I just want to recap the Gutenberg Developer hours are actually&#8230; We scheduled four events as a trial. There was a proposal at the core make blog in October, and we finally got it implemented to have four events trial. And as it turns out, we probably will have more events. So there will also be to better times for other time zones. Yeah. So for Europeans, it&#8217;s definitely relatively late and it&#8217;s also, I don&#8217;t even know what the time it would be for the Asia Pacific people, but we definitely will schedule different dates and also different time for different time zones, the future ones. We might take a break in April, but then in May, we will start out with new Gutenberg Developer hours in all different time zones.</p>\n\n\n\n<p>And if you are a practitioner, you work for an agency as a block developer or a site builder or build themes, and you want to be part of our expert panel that answers the questions from the audience, it&#8217;s totally audience driven event. So the people that attend, give us the questions sometimes ahead of time. We sort through them and then say, okay, these are all the questions for block development and these are all the questions for theme development. And these are all the questions that are more conceptual or architectural. And then we work through them and have a discussion about them amongst the panel or with the people in the audience. It&#8217;s a meeting style rather than a webinar style. So yeah. Join us either on March 22nd or when we have the next one on schedule. Sorry. Yeah.</p>\n\n\n\n<p><em>Mary Job</em>: That would be great. That would be great, Birgit because, so there&#8217;s a saying where I come from that it&#8217;s very difficult to please everyone. And I know that it commits is trying. Cracking time zone is very tricky, so we definitely understand, but we will do what we can to make it better and to be able to set everyone. As always the show notes for our episodes, they will be published GutenbergTimes.com/podcasts. And if you have questions or suggestions or news you want us to include, send them to <a href=\"mailto:Changelog@GutenbergTimes.com\">Changelog@GutenbergTimes.com</a>. That&#8217;s <a href=\"mailto:Changelog@GutenbergTimes.com\">Changelog@GutenbergTimes.com</a>.</p>\n\n\n\n<p><em>Birgit Pauli-Haack</em>: Wow. Thank you so much, Mary. And this is it for me. This is episode 63. And just in case you&#8217;re looking for it on the podcast website, you all have a great time and I&#8217;ll talk to you in two weeks. Thank you.</p>\n\n\n\n<p><em>Mary Job</em>: Thank you.</p>\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}s:7:\"pubDate\";a:1:{i:0;a:5:{s:4:\"data\";s:31:\"Sat, 19 Mar 2022 18:23:29 +0000\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}}s:32:\"http://purl.org/dc/elements/1.1/\";a:1:{s:7:\"creator\";a:1:{i:0;a:5:{s:4:\"data\";s:18:\"Birgit Pauli-Haack\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}}}}i:49;a:6:{s:4:\"data\";s:13:\"\n	\n	\n	\n	\n	\n	\n\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";s:5:\"child\";a:2:{s:0:\"\";a:5:{s:5:\"title\";a:1:{i:0;a:5:{s:4:\"data\";s:90:\"WPTavern: WordPress Community Team Reconsiders Guidelines for In-Person Regional WordCamps\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}s:4:\"guid\";a:1:{i:0;a:5:{s:4:\"data\";s:30:\"https://wptavern.com/?p=131608\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}s:4:\"link\";a:1:{i:0;a:5:{s:4:\"data\";s:101:\"https://wptavern.com/wordpress-community-team-reconsiders-guidelines-for-in-person-regional-wordcamps\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}s:11:\"description\";a:1:{i:0;a:5:{s:4:\"data\";s:6160:\"<p>The pandemic has dramatically slashed the number of in-person WordPress events that volunteers are organizing and events have been slow to start up again. This has caused the WordPress Community Team to reconsider the guidelines for hosting regional WordCamps.</p>\n\n\n\n<p>Historically, these guidelines have generated lengthy discussions, as many vocal opponents found them to be needlessly prohibitive. WordCamps began as local, city-based events, and organizers were not allowed to put together a regional WordCamp without jumping through a lot of extra requirements. These included having experienced event organizers that represent all WordPress communities in the region. The <a href=\"https://make.wordpress.org/community/handbook/wordcamp-organizer/become-an-organizer/regional-wordcamps/\">guidelines</a> state:</p>\n\n\n\n<blockquote class=\"wp-block-quote\"><p>Before applying to organize a regional WordCamp, there should be at least 3 cities in your region (but very possibly more) with a local group that meets monthly, and that have hosted at least one WordCamp. The size of your region (in geography and population) will affect the expected number of established communities.</p></blockquote>\n\n\n\n<p>In 2017, WordPress Community Support (WCS) <a href=\"https://wptavern.com/wordpress-community-support-shuts-down-wordcamp-netherlands-in-favor-of-city-based-wordcamps\">shut down WordCamp Netherlands</a> in favor of city-based WordCamps, sending the Dutch community <a href=\"https://twitter.com/roytanck/status/847365810506969089\">into</a> <a href=\"https://twitter.com/jrf_nl/status/847470162496241664\">an</a> <a href=\"https://twitter.com/nielsvr/status/847384382541148161\">uproar</a>. The region, which is roughly the size of Maryland, had successfully held six editions of WordCamp Netherlands before WCS decided not to approve its application. </p>\n\n\n\n<p>The camp was <a href=\"https://wptavern.com/wordcamp-netherlands-reinstated-for-2018\">reinstated in 2018</a> after organizers agreed to meet additional requirements in the guidelines outlined above. This was not without a significant struggle, as the project moved to shed its “one-size-fits-all” approach to WordPress events. WordCamp Netherlands is once again on the schedule for 2022 as an in-person event. </p>\n\n\n\n<p>In 2017, WordPress Community Manager Hugh Lashbrooke proposed the idea of <a href=\"https://make.wordpress.org/community/2017/11/10/discussion-micro-regional-wordcamps/\">micro-regional WordCamps</a>, which makes exceptions to the meetup requirements for regional camps in situations where neighboring cities share meetup organization responsibilities. The idea received widespread support, as it makes sense in certain instances.</p>\n\n\n\n<p>&#8220;Exception is the keyword here,&#8221; WordCamp Netherlands organizer Marcel Bootsman said at the time. &#8220;If these local communities are active and healthy, let them organize a WordCamp. Be happy with the fact that people want to organize.&#8221; </p>\n\n\n\n<p>WordPress is slowly coming around to this idea &#8211; that volunteer-run events thrive better with more flexible guidelines that allow for cultural and geographical differences.</p>\n\n\n\n<p>In 2020, the Community team <a href=\"https://make.wordpress.org/community/2020/03/24/community-events-in-the-time-of-covid-19/\">relaxed a number of guidelines</a>, including some for regional online WordCamps, in order to help keep communities connected during a difficult time.</p>\n\n\n\n<p>&#8220;This resulted in a bunch of online regional WordCamps in<a href=\"https://centroamerica.wordcamp.org/2021/\"> Centroamerica</a>,  <a href=\"https://greece.wordcamp.org/2021/\">Greece</a>, <a href=\"https://finland.wordcamp.org/2020/\">Finland</a>, <a href=\"https://india.wordcamp.org/2021/\">India</a>, <a rel=\"noreferrer noopener\" href=\"https://italia.wordcamp.org/2021/\" target=\"_blank\">Italy</a>, <a href=\"https://japan.wordcamp.org/2021/\">Japan</a>, <a rel=\"noreferrer noopener\" href=\"https://spain.wordcamp.org/2021/\" target=\"_blank\">Spain</a>, and Taiwan, among others,&#8221; Community Team Representative Hari Shanker said. &#8220;These events were quite successful in bringing together local communities even despite the challenges of the COVID-19 pandemic.&#8221;</p>\n\n\n\n<p>Now that WordPress events have taken a hard hit, the Community Team is considering loosening these restrictions for in-person regional events. </p>\n\n\n\n<p>&#8220;Some local communities have also approached WordCamp Central, expressing their interest in organizing regional events,&#8221; Shanker said. &#8220;At this time, our organizers are still encouraged to plan smaller city-based WordCamps over larger regional events (especially in the light of COVID restrictions that are still in place in many regions). However, I strongly feel that the Community Team should revisit the existing guidelines for regional events due to a renewed interest in the same.&#8221;</p>\n\n\n\n<p>Shanker is asking for feedback on the <a href=\"https://make.wordpress.org/community/2022/03/17/discussion-revisiting-in-person-regional-wordcamps/\">discussion</a> before April 4, 2022. A few contributors and organizers have already weighed in.</p>\n\n\n\n<p>&#8220;Switzerland is such a small country that having separate WordCamps for Geneva, Lausanne, Bern and Zurich seems to be unnecessarily complicated,&#8221; Mark Howells-Mead said. &#8220;By re-establishing WordCamp Switzerland – which takes place in a different city each time and which was organized as a regional event until 2015 – we can better ensure that the visibility of the event and repetitive work can be more efficiently organized.&#8221;</p>\n\n\n\n<p>Marcel Bootsman once again called on the Community Team to use common sense as a guide when evaluating whether a region is fit to host a WordCamp.</p>\n\n\n\n<p>&#8220;We’ve had quite a few discussions about regional WordCamps in The Netherlands,&#8221; Bootsman said. &#8220;Let me just say I’m happy WCNL is back on the agenda, and I hope regional/local (city based) WordCamps are evaluated according to the country geographical size, and the feedback of the people organizing them.&#8221;</p>\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}s:7:\"pubDate\";a:1:{i:0;a:5:{s:4:\"data\";s:31:\"Sat, 19 Mar 2022 04:44:09 +0000\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}}s:32:\"http://purl.org/dc/elements/1.1/\";a:1:{s:7:\"creator\";a:1:{i:0;a:5:{s:4:\"data\";s:13:\"Sarah Gooding\";s:7:\"attribs\";a:0:{}s:8:\"xml_base\";s:0:\"\";s:17:\"xml_base_explicit\";b:0;s:8:\"xml_lang\";s:0:\"\";}}}}}}}}}}}}}}}}s:4:\"type\";i:128;s:7:\"headers\";O:42:\"Requests_Utility_CaseInsensitiveDictionary\":1:{s:7:\"\0*\0data\";a:8:{s:6:\"server\";s:5:\"nginx\";s:4:\"date\";s:29:\"Tue, 05 Apr 2022 18:37:16 GMT\";s:12:\"content-type\";s:8:\"text/xml\";s:4:\"vary\";s:15:\"Accept-Encoding\";s:13:\"last-modified\";s:29:\"Tue, 05 Apr 2022 18:30:10 GMT\";s:15:\"x-frame-options\";s:10:\"SAMEORIGIN\";s:4:\"x-nc\";s:9:\"HIT ord 2\";s:16:\"content-encoding\";s:4:\"gzip\";}}s:5:\"build\";s:14:\"20211220193300\";}', 'no');
INSERT INTO `urotec_options` (`option_id`, `option_name`, `option_value`, `autoload`) VALUES
(464, '_transient_timeout_feed_mod_d117b5738fbd35bd8c0391cda1f2b5d9', '1649227036', 'no'),
(465, '_transient_feed_mod_d117b5738fbd35bd8c0391cda1f2b5d9', '1649183836', 'no'),
(466, '_transient_timeout_dash_v2_f69de0bbfe7eaa113146875f40c02000', '1649227036', 'no'),
(467, '_transient_dash_v2_f69de0bbfe7eaa113146875f40c02000', '<div class=\"rss-widget\"><ul><li><a class=\'rsswidget\' href=\'https://ru.wordpress.org/news/2021/12/highlights-from-state-of-the-word-2021/\'>Основные моменты выступления State of the Word 2021</a></li><li><a class=\'rsswidget\' href=\'https://ru.wordpress.org/news/2021/12/people-of-wordpress-devin-maeztri/\'>Люди WordPress: Девин Мейстри</a></li></ul></div><div class=\"rss-widget\"><ul><li><a class=\'rsswidget\' href=\'https://wordpress.org/news/2022/04/the-month-in-wordpress-march-2022/\'>WordPress.org blog: The Month in WordPress – March 2022</a></li><li><a class=\'rsswidget\' href=\'https://wptavern.com/fse-outreach-13-building-an-author-template-from-the-wordpress-site-editor\'>WPTavern: FSE Outreach #13: Building an Author Template from the WordPress Site Editor</a></li><li><a class=\'rsswidget\' href=\'https://wptavern.com/wordpress-com-makes-major-unannounced-pricing-changes-slashes-free-storage-limits\'>WPTavern: WordPress.com Makes Major Unannounced Pricing Changes, Slashes Free Storage Limits</a></li></ul></div>', 'no'),
(468, '_site_transient_timeout_wp_remote_block_patterns_9a2b220d96b3352215ebdab80c6b6574', '1649187663', 'no');
INSERT INTO `urotec_options` (`option_id`, `option_name`, `option_value`, `autoload`) VALUES
(469, '_site_transient_wp_remote_block_patterns_9a2b220d96b3352215ebdab80c6b6574', 'a:26:{i:0;O:8:\"stdClass\":7:{s:2:\"id\";i:4385;s:5:\"title\";O:8:\"stdClass\":1:{s:8:\"rendered\";s:103:\"Большой заголовок с выравниванием текста по левому краю\";}s:7:\"content\";O:8:\"stdClass\":2:{s:8:\"rendered\";s:1487:\"\n<div class=\"wp-block-cover alignfull has-background-dim-60 has-background-dim\" style=\"min-height:800px\"><img class=\"wp-block-cover__image-background\" alt=\"\" src=\"https://s.w.org/images/core/5.8/forest.jpg\" data-object-fit=\"cover\" /><div class=\"wp-block-cover__inner-container\">\n<h2 class=\"alignwide has-text-color\" style=\"color:#ffe074;font-size:64px\">Лес</h2>\n\n\n\n<div class=\"wp-container-624c8cd6f10e4 wp-block-columns alignwide\">\n<div class=\"wp-block-column\" style=\"flex-basis:55%\">\n<div style=\"height:330px\" aria-hidden=\"true\" class=\"wp-block-spacer\"></div>\n\n\n\n<p class=\"has-text-color\" style=\"color:#ffe074;font-size:12px;line-height:1.3\"><em>Даже ребенок знает, насколько ценен лес. Свежий, захватывающий дух запах деревьев. Эхо птиц, летящих над этим плотным массивом. Стабильный климат, устойчивая разнообразная жизнь и источник культуры. Тем не менее, леса и другие экосистемы висят на волоске и могут превратиться в пахотные земли, пастбища и плантации.</em></p>\n</div>\n\n\n\n<div class=\"wp-block-column\"></div>\n</div>\n<style>.wp-container-624c8cd6f10e4 {display: flex;gap: var( --wp--style--block-gap, 0.5em );flex-wrap: nowrap;align-items: center;}.wp-container-624c8cd6f10e4 > * { margin: 0; }</style></div></div>\n\";s:9:\"protected\";b:0;}s:4:\"meta\";O:8:\"stdClass\":6:{s:10:\"spay_email\";s:0:\"\";s:13:\"wpop_keywords\";s:0:\"\";s:16:\"wpop_description\";s:73:\"Изображение на обложке с цитатой сверху\";s:19:\"wpop_viewport_width\";i:1200;s:16:\"wpop_block_types\";a:0:{}s:11:\"wpop_locale\";s:5:\"ru_RU\";}s:14:\"category_slugs\";a:2:{i:0;s:8:\"featured\";i:1;s:6:\"header\";}s:13:\"keyword_slugs\";a:1:{i:0;s:4:\"core\";}s:15:\"pattern_content\";s:1866:\"<!-- wp:cover {\"url\":\"https://s.w.org/images/core/5.8/forest.jpg\",\"dimRatio\":60,\"minHeight\":800,\"align\":\"full\"} -->\n<div class=\"wp-block-cover alignfull has-background-dim-60 has-background-dim\" style=\"min-height:800px\"><img class=\"wp-block-cover__image-background\" alt=\"\" src=\"https://s.w.org/images/core/5.8/forest.jpg\" data-object-fit=\"cover\" /><div class=\"wp-block-cover__inner-container\"><!-- wp:heading {\"align\":\"wide\",\"style\":{\"color\":{\"text\":\"#ffe074\"},\"typography\":{\"fontSize\":\"64px\"}}} -->\n<h2 class=\"alignwide has-text-color\" style=\"color:#ffe074;font-size:64px\">Лес</h2>\n<!-- /wp:heading -->\n\n<!-- wp:columns {\"align\":\"wide\"} -->\n<div class=\"wp-block-columns alignwide\"><!-- wp:column {\"width\":\"55%\"} -->\n<div class=\"wp-block-column\" style=\"flex-basis:55%\"><!-- wp:spacer {\"height\":330} -->\n<div style=\"height:330px\" aria-hidden=\"true\" class=\"wp-block-spacer\"></div>\n<!-- /wp:spacer -->\n\n<!-- wp:paragraph {\"style\":{\"color\":{\"text\":\"#ffe074\"},\"typography\":{\"lineHeight\":\"1.3\",\"fontSize\":\"12px\"}}} -->\n<p class=\"has-text-color\" style=\"color:#ffe074;font-size:12px;line-height:1.3\"><em>Даже ребенок знает, насколько ценен лес. Свежий, захватывающий дух запах деревьев. Эхо птиц, летящих над этим плотным массивом. Стабильный климат, устойчивая разнообразная жизнь и источник культуры. Тем не менее, леса и другие экосистемы висят на волоске и могут превратиться в пахотные земли, пастбища и плантации.</em></p>\n<!-- /wp:paragraph --></div>\n<!-- /wp:column -->\n\n<!-- wp:column -->\n<div class=\"wp-block-column\"></div>\n<!-- /wp:column --></div>\n<!-- /wp:columns --></div></div>\n<!-- /wp:cover -->\";}i:1;O:8:\"stdClass\":7:{s:2:\"id\";i:4384;s:5:\"title\";O:8:\"stdClass\":1:{s:8:\"rendered\";s:69:\"Большой заголовок с текстом и кнопкой\";}s:7:\"content\";O:8:\"stdClass\":2:{s:8:\"rendered\";s:1584:\"\n<div class=\"wp-block-cover alignfull has-background-dim-40 has-background-dim has-parallax\" style=\"background-image:url(https://s.w.org/images/core/5.8/art-01.jpg);background-color:#000000;min-height:100vh\"><div class=\"wp-block-cover__inner-container\">\n<h2 class=\"alignwide has-white-color has-text-color\" style=\"font-size:48px;line-height:1.2\"><strong><em>За границей:</em></strong><br><strong><em>1500–1960</em></strong></h2>\n\n\n\n<div class=\"wp-container-624c8cd6f292f wp-block-columns alignwide\">\n<div class=\"wp-block-column\" style=\"flex-basis:60%\">\n<p class=\"has-text-color\" style=\"color:#ffffff\">Выставка о различных представлениях океана во времени, между шестнадцатым и двадцатым веками. Проходит в нашей открытой комнате на <em>этаже 2</em>.</p>\n\n\n\n<div class=\"wp-container-624c8cd6f25b4 wp-block-buttons\">\n<div class=\"wp-block-button is-style-outline\"><a class=\"wp-block-button__link has-text-color has-background no-border-radius\" style=\"background-color:#000000;color:#ffffff\">Посетить</a></div>\n</div>\n<style>.wp-container-624c8cd6f25b4 {display: flex;gap: var( --wp--style--block-gap, 0.5em );flex-wrap: wrap;align-items: center;}.wp-container-624c8cd6f25b4 > * { margin: 0; }</style></div>\n\n\n\n<div class=\"wp-block-column\"></div>\n</div>\n<style>.wp-container-624c8cd6f292f {display: flex;gap: var( --wp--style--block-gap, 0.5em );flex-wrap: nowrap;align-items: center;}.wp-container-624c8cd6f292f > * { margin: 0; }</style></div></div>\n\";s:9:\"protected\";b:0;}s:4:\"meta\";O:8:\"stdClass\":6:{s:10:\"spay_email\";s:0:\"\";s:13:\"wpop_keywords\";s:0:\"\";s:16:\"wpop_description\";s:124:\"Большой заголовок с фоновым изображением, текстом и кнопкой сверху.\";s:19:\"wpop_viewport_width\";i:1200;s:16:\"wpop_block_types\";a:0:{}s:11:\"wpop_locale\";s:5:\"ru_RU\";}s:14:\"category_slugs\";a:1:{i:0;s:6:\"header\";}s:13:\"keyword_slugs\";a:1:{i:0;s:4:\"core\";}s:15:\"pattern_content\";s:1972:\"<!-- wp:cover {\"url\":\"https://s.w.org/images/core/5.8/art-01.jpg\",\"hasParallax\":true,\"dimRatio\":40,\"customOverlayColor\":\"#000000\",\"minHeight\":100,\"minHeightUnit\":\"vh\",\"contentPosition\":\"center center\",\"align\":\"full\"} -->\n<div class=\"wp-block-cover alignfull has-background-dim-40 has-background-dim has-parallax\" style=\"background-image:url(https://s.w.org/images/core/5.8/art-01.jpg);background-color:#000000;min-height:100vh\"><div class=\"wp-block-cover__inner-container\"><!-- wp:heading {\"style\":{\"typography\":{\"fontSize\":\"48px\",\"lineHeight\":\"1.2\"}},\"className\":\"alignwide has-white-color has-text-color\"} -->\n<h2 class=\"alignwide has-white-color has-text-color\" style=\"font-size:48px;line-height:1.2\"><strong><em>За границей:</em></strong><br><strong><em>1500–1960</em></strong></h2>\n<!-- /wp:heading -->\n\n<!-- wp:columns {\"align\":\"wide\"} -->\n<div class=\"wp-block-columns alignwide\"><!-- wp:column {\"width\":\"60%\"} -->\n<div class=\"wp-block-column\" style=\"flex-basis:60%\"><!-- wp:paragraph {\"style\":{\"color\":{\"text\":\"#ffffff\"}}} -->\n<p class=\"has-text-color\" style=\"color:#ffffff\">Выставка о различных представлениях океана во времени, между шестнадцатым и двадцатым веками. Проходит в нашей открытой комнате на <em>этаже 2</em>.</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:buttons -->\n<div class=\"wp-block-buttons\"><!-- wp:button {\"borderRadius\":0,\"style\":{\"color\":{\"text\":\"#ffffff\",\"background\":\"#000000\"}},\"className\":\"is-style-outline\"} -->\n<div class=\"wp-block-button is-style-outline\"><a class=\"wp-block-button__link has-text-color has-background no-border-radius\" style=\"background-color:#000000;color:#ffffff\">Посетить</a></div>\n<!-- /wp:button --></div>\n<!-- /wp:buttons --></div>\n<!-- /wp:column -->\n\n<!-- wp:column -->\n<div class=\"wp-block-column\"></div>\n<!-- /wp:column --></div>\n<!-- /wp:columns --></div></div>\n<!-- /wp:cover -->\";}i:2;O:8:\"stdClass\":7:{s:2:\"id\";i:4395;s:5:\"title\";O:8:\"stdClass\":1:{s:8:\"rendered\";s:39:\"Два изображения в ряд\";}s:7:\"content\";O:8:\"stdClass\":2:{s:8:\"rendered\";s:728:\"\n<figure class=\"wp-block-gallery alignwide columns-2 is-cropped\"><ul class=\"blocks-gallery-grid\"><li class=\"blocks-gallery-item\"><figure><img src=\"https://s.w.org/images/core/5.8/nature-above-01.jpg\" alt=\"Вид с воздуха на волны, разбивающиеся о берег.\" data-full-url=\"https://s.w.org/images/core/5.8/nature-above-01.jpg\" data-link=\"#\" /></figure></li><li class=\"blocks-gallery-item\"><figure><img src=\"https://s.w.org/images/core/5.8/nature-above-02.jpg\" alt=\"Аэрофотоснимок поля. Дорога проходит через правый верхний угол.\" data-full-url=\"https://s.w.org/images/core/5.8/nature-above-02.jpg\" data-link=\"#\" /></figure></li></ul></figure>\n\";s:9:\"protected\";b:0;}s:4:\"meta\";O:8:\"stdClass\":6:{s:10:\"spay_email\";s:0:\"\";s:13:\"wpop_keywords\";s:0:\"\";s:16:\"wpop_description\";s:101:\"Галерея изображений с двумя изображениями для примера.\";s:19:\"wpop_viewport_width\";i:800;s:16:\"wpop_block_types\";a:0:{}s:11:\"wpop_locale\";s:5:\"ru_RU\";}s:14:\"category_slugs\";a:1:{i:0;s:7:\"gallery\";}s:13:\"keyword_slugs\";a:1:{i:0;s:4:\"core\";}s:15:\"pattern_content\";s:818:\"<!-- wp:gallery {\"ids\":[null,null],\"linkTo\":\"none\",\"align\":\"wide\"} -->\n<figure class=\"wp-block-gallery alignwide columns-2 is-cropped\"><ul class=\"blocks-gallery-grid\"><li class=\"blocks-gallery-item\"><figure><img src=\"https://s.w.org/images/core/5.8/nature-above-01.jpg\" alt=\"Вид с воздуха на волны, разбивающиеся о берег.\" data-full-url=\"https://s.w.org/images/core/5.8/nature-above-01.jpg\" data-link=\"#\" /></figure></li><li class=\"blocks-gallery-item\"><figure><img src=\"https://s.w.org/images/core/5.8/nature-above-02.jpg\" alt=\"Аэрофотоснимок поля. Дорога проходит через правый верхний угол.\" data-full-url=\"https://s.w.org/images/core/5.8/nature-above-02.jpg\" data-link=\"#\" /></figure></li></ul></figure>\n<!-- /wp:gallery -->\";}i:3;O:8:\"stdClass\":7:{s:2:\"id\";i:4380;s:5:\"title\";O:8:\"stdClass\":1:{s:8:\"rendered\";s:79:\"Два столбца текста со смещенным заголовком\";}s:7:\"content\";O:8:\"stdClass\":2:{s:8:\"rendered\";s:3215:\"\n<div class=\"wp-container-624c8cd700730 wp-block-group alignfull has-background\" style=\"background-color:#f2f0e9\">\n<div style=\"height:70px\" aria-hidden=\"true\" class=\"wp-block-spacer\"></div>\n\n\n\n<div class=\"wp-container-624c8cd700074 wp-block-columns alignwide are-vertically-aligned-center\">\n<div class=\"wp-block-column\" style=\"flex-basis:50%\">\n<p class=\"has-text-color\" style=\"color:#000000;font-size:30px;line-height:1.1\"><strong>Океанское вдохновение</strong></p>\n</div>\n\n\n\n<div class=\"wp-block-column\" style=\"flex-basis:50%\">\n<hr class=\"wp-block-separator has-text-color has-background is-style-wide\" style=\"background-color:#000000;color:#000000\" />\n</div>\n</div>\n<style>.wp-container-624c8cd700074 {display: flex;gap: var( --wp--style--block-gap, 0.5em );flex-wrap: nowrap;align-items: center;}.wp-container-624c8cd700074 > * { margin: 0; }</style>\n\n\n<div class=\"wp-container-624c8cd7003c8 wp-block-columns alignwide\">\n<div class=\"wp-block-column\"></div>\n\n\n\n<div class=\"wp-block-column\">\n<p class=\"has-text-color has-extra-small-font-size\" style=\"color:#000000\">Обмотав головы вуалью, женщины вышли на палубу. Теперь они неуклонно двигались вниз по реке, минуя темные силуэты кораблей на якоре, и Лондон представлял собой рой огней с нависшим над ним бледно-желтым куполом. Это были огни больших театров, огни длинных улиц, огни, указывающие на огромные площади домашнего уюта, огни, которые висели высоко в воздухе.</p>\n</div>\n\n\n\n<div class=\"wp-block-column\">\n<p class=\"has-text-color has-extra-small-font-size\" style=\"color:#000000\">Никакая тьма никогда не осядет на этих светильниках, поскольку никакая тьма не села на них сотни лет. Казалось ужасным, что город вечно пылает на одном и том же месте; ужасен, по крайней мере, для людей, отправляющихся в путешествие по морю и созерцающих его как ограниченный холм, вечно выжженный, вечно покрытый шрамами. С палубы корабля город казался как трусливая фигура, сидячий скряга.</p>\n</div>\n</div>\n<style>.wp-container-624c8cd7003c8 {display: flex;gap: var( --wp--style--block-gap, 0.5em );flex-wrap: nowrap;align-items: center;}.wp-container-624c8cd7003c8 > * { margin: 0; }</style>\n\n\n<div style=\"height:40px\" aria-hidden=\"true\" class=\"wp-block-spacer\"></div>\n</div>\n<style>.wp-container-624c8cd700730 .alignleft { float: left; margin-right: 2em; margin-left: 0; }.wp-container-624c8cd700730 .alignright { float: right; margin-left: 2em; margin-right: 0; }.wp-container-624c8cd700730 > * { margin-top: 0; margin-bottom: 0; }.wp-container-624c8cd700730 > * + * { margin-top: var( --wp--style--block-gap );  margin-bottom: 0; }</style>\";s:9:\"protected\";b:0;}s:4:\"meta\";O:8:\"stdClass\":6:{s:10:\"spay_email\";s:0:\"\";s:13:\"wpop_keywords\";s:0:\"\";s:16:\"wpop_description\";s:80:\"Два столбца текста со смещенным заголовком.\";s:19:\"wpop_viewport_width\";i:1200;s:16:\"wpop_block_types\";a:0:{}s:11:\"wpop_locale\";s:5:\"ru_RU\";}s:14:\"category_slugs\";a:2:{i:0;s:7:\"columns\";i:1;s:4:\"text\";}s:13:\"keyword_slugs\";a:1:{i:0;s:4:\"core\";}s:15:\"pattern_content\";s:3398:\"<!-- wp:group {\"align\":\"full\",\"style\":{\"color\":{\"background\":\"#f2f0e9\"}}} -->\n<div class=\"wp-block-group alignfull has-background\" style=\"background-color:#f2f0e9\"><!-- wp:spacer {\"height\":70} -->\n<div style=\"height:70px\" aria-hidden=\"true\" class=\"wp-block-spacer\"></div>\n<!-- /wp:spacer -->\n\n<!-- wp:columns {\"verticalAlignment\":\"center\",\"align\":\"wide\"} -->\n<div class=\"wp-block-columns alignwide are-vertically-aligned-center\"><!-- wp:column {\"width\":\"50%\"} -->\n<div class=\"wp-block-column\" style=\"flex-basis:50%\"><!-- wp:paragraph {\"style\":{\"typography\":{\"lineHeight\":\"1.1\",\"fontSize\":\"30px\"},\"color\":{\"text\":\"#000000\"}}} -->\n<p class=\"has-text-color\" style=\"color:#000000;font-size:30px;line-height:1.1\"><strong>Океанское вдохновение</strong></p>\n<!-- /wp:paragraph --></div>\n<!-- /wp:column -->\n\n<!-- wp:column {\"width\":\"50%\"} -->\n<div class=\"wp-block-column\" style=\"flex-basis:50%\"><!-- wp:separator {\"customColor\":\"#000000\",\"className\":\"is-style-wide\"} -->\n<hr class=\"wp-block-separator has-text-color has-background is-style-wide\" style=\"background-color:#000000;color:#000000\" />\n<!-- /wp:separator --></div>\n<!-- /wp:column --></div>\n<!-- /wp:columns -->\n\n<!-- wp:columns {\"align\":\"wide\"} -->\n<div class=\"wp-block-columns alignwide\"><!-- wp:column -->\n<div class=\"wp-block-column\"></div>\n<!-- /wp:column -->\n\n<!-- wp:column -->\n<div class=\"wp-block-column\"><!-- wp:paragraph {\"style\":{\"color\":{\"text\":\"#000000\"}},\"fontSize\":\"extra-small\"} -->\n<p class=\"has-text-color has-extra-small-font-size\" style=\"color:#000000\">Обмотав головы вуалью, женщины вышли на палубу. Теперь они неуклонно двигались вниз по реке, минуя темные силуэты кораблей на якоре, и Лондон представлял собой рой огней с нависшим над ним бледно-желтым куполом. Это были огни больших театров, огни длинных улиц, огни, указывающие на огромные площади домашнего уюта, огни, которые висели высоко в воздухе.</p>\n<!-- /wp:paragraph --></div>\n<!-- /wp:column -->\n\n<!-- wp:column -->\n<div class=\"wp-block-column\"><!-- wp:paragraph {\"style\":{\"color\":{\"text\":\"#000000\"}},\"fontSize\":\"extra-small\"} -->\n<p class=\"has-text-color has-extra-small-font-size\" style=\"color:#000000\">Никакая тьма никогда не осядет на этих светильниках, поскольку никакая тьма не села на них сотни лет. Казалось ужасным, что город вечно пылает на одном и том же месте; ужасен, по крайней мере, для людей, отправляющихся в путешествие по морю и созерцающих его как ограниченный холм, вечно выжженный, вечно покрытый шрамами. С палубы корабля город казался как трусливая фигура, сидячий скряга.</p>\n<!-- /wp:paragraph --></div>\n<!-- /wp:column --></div>\n<!-- /wp:columns -->\n\n<!-- wp:spacer {\"height\":40} -->\n<div style=\"height:40px\" aria-hidden=\"true\" class=\"wp-block-spacer\"></div>\n<!-- /wp:spacer --></div>\n<!-- /wp:group -->\";}i:4;O:8:\"stdClass\":7:{s:2:\"id\";i:4394;s:5:\"title\";O:8:\"stdClass\":1:{s:8:\"rendered\";s:56:\"Две колонки текста и заголовка\";}s:7:\"content\";O:8:\"stdClass\":2:{s:8:\"rendered\";s:2308:\"\n<h2 style=\"font-size:38px;line-height:1.4\"><strong>Путешествие началось и началось счастливо с мягкого голубого неба и спокойного моря.</strong></h2>\n\n\n\n<div class=\"wp-container-624c8cd70185e wp-block-columns\">\n<div class=\"wp-block-column\">\n<p style=\"font-size:18px\">Они последовали за ней на палубу. Весь дым и дома исчезли, и корабль оказался в открытом море, очень свежем и чистом, хотя и бледном в раннем свете. Они оставили Лондон сидеть в грязи. На горизонте сужалась очень тонкая линия тени, едва достаточная для того, чтобы выдержать бремя Парижа, которое, тем не менее, лежало на нем. Они были свободны от дорог, от человечества, и все они были взволнованы своей свободой.</p>\n</div>\n\n\n\n<div class=\"wp-block-column\">\n<p style=\"font-size:18px\">Корабль неуклонно продвигался сквозь небольшие волны, которые ударили по ней, а затем шипели, как бурлящая вода, оставляя с обеих сторон небольшую границу из пузырьков и пены. Бесцветное октябрьское небо над головой было тонко затянуто облаками, словно шлейфом от костра, а воздух был чудесно соленым и живым. На самом деле было слишком холодно, чтобы стоять на месте. Миссис Эмброуз взяла мужа за руку, и когда они двинулись прочь, по тому, как ее щека повернулась к его щеке, было видно, что у нее есть что сказать личное.</p>\n</div>\n</div>\n<style>.wp-container-624c8cd70185e {display: flex;gap: var( --wp--style--block-gap, 0.5em );flex-wrap: nowrap;align-items: center;}.wp-container-624c8cd70185e > * { margin: 0; }</style>\";s:9:\"protected\";b:0;}s:4:\"meta\";O:8:\"stdClass\":6:{s:10:\"spay_email\";s:0:\"\";s:13:\"wpop_keywords\";s:0:\"\";s:16:\"wpop_description\";s:94:\"Два столбца текста с длинным заголовком перед ними.\";s:19:\"wpop_viewport_width\";i:1200;s:16:\"wpop_block_types\";a:0:{}s:11:\"wpop_locale\";s:5:\"ru_RU\";}s:14:\"category_slugs\";a:2:{i:0;s:7:\"columns\";i:1;s:4:\"text\";}s:13:\"keyword_slugs\";a:1:{i:0;s:4:\"core\";}s:15:\"pattern_content\";s:2476:\"<!-- wp:heading {\"style\":{\"typography\":{\"fontSize\":38,\"lineHeight\":\"1.4\"}}} -->\n<h2 style=\"font-size:38px;line-height:1.4\"><strong>Путешествие началось и началось счастливо с мягкого голубого неба и спокойного моря.</strong></h2>\n<!-- /wp:heading -->\n\n<!-- wp:columns -->\n<div class=\"wp-block-columns\"><!-- wp:column -->\n<div class=\"wp-block-column\"><!-- wp:paragraph {\"style\":{\"typography\":{\"fontSize\":18}}} -->\n<p style=\"font-size:18px\">Они последовали за ней на палубу. Весь дым и дома исчезли, и корабль оказался в открытом море, очень свежем и чистом, хотя и бледном в раннем свете. Они оставили Лондон сидеть в грязи. На горизонте сужалась очень тонкая линия тени, едва достаточная для того, чтобы выдержать бремя Парижа, которое, тем не менее, лежало на нем. Они были свободны от дорог, от человечества, и все они были взволнованы своей свободой.</p>\n<!-- /wp:paragraph --></div>\n<!-- /wp:column -->\n\n<!-- wp:column -->\n<div class=\"wp-block-column\"><!-- wp:paragraph {\"style\":{\"typography\":{\"fontSize\":18}}} -->\n<p style=\"font-size:18px\">Корабль неуклонно продвигался сквозь небольшие волны, которые ударили по ней, а затем шипели, как бурлящая вода, оставляя с обеих сторон небольшую границу из пузырьков и пены. Бесцветное октябрьское небо над головой было тонко затянуто облаками, словно шлейфом от костра, а воздух был чудесно соленым и живым. На самом деле было слишком холодно, чтобы стоять на месте. Миссис Эмброуз взяла мужа за руку, и когда они двинулись прочь, по тому, как ее щека повернулась к его щеке, было видно, что у нее есть что сказать личное.</p>\n<!-- /wp:paragraph --></div>\n<!-- /wp:column --></div>\n<!-- /wp:columns -->\";}i:5;O:8:\"stdClass\":7:{s:2:\"id\";i:4387;s:5:\"title\";O:8:\"stdClass\":1:{s:8:\"rendered\";s:18:\"Заголовок\";}s:7:\"content\";O:8:\"stdClass\":2:{s:8:\"rendered\";s:703:\"\n<h2 class=\"alignwide\" id=\"we-re-a-studio-in-berlin-with-an-international-practice-in-architecture-urban-planning-and-interior-design-we-believe-in-sharing-knowledge-and-promoting-dialogue-to-increase-the-creative-potential-of-collaboration\" style=\"font-size:48px;line-height:1.1\">Мы &#8212; студия в Берлине с международной практикой в ​​области архитектуры, городского планирования и дизайна интерьеров. Мы верим в обмен знаниями и продвижение диалога для увеличения творческого потенциала сотрудничества.</h2>\n\";s:9:\"protected\";b:0;}s:4:\"meta\";O:8:\"stdClass\":6:{s:10:\"spay_email\";s:0:\"\";s:13:\"wpop_keywords\";s:0:\"\";s:16:\"wpop_description\";s:29:\"Текст заголовка\";s:19:\"wpop_viewport_width\";i:1200;s:16:\"wpop_block_types\";a:0:{}s:11:\"wpop_locale\";s:5:\"ru_RU\";}s:14:\"category_slugs\";a:2:{i:0;s:8:\"featured\";i:1;s:4:\"text\";}s:13:\"keyword_slugs\";a:1:{i:0;s:4:\"core\";}s:15:\"pattern_content\";s:815:\"<!-- wp:heading {\"align\":\"wide\",\"style\":{\"typography\":{\"fontSize\":\"48px\",\"lineHeight\":\"1.1\"}}} -->\n<h2 class=\"alignwide\" id=\"we-re-a-studio-in-berlin-with-an-international-practice-in-architecture-urban-planning-and-interior-design-we-believe-in-sharing-knowledge-and-promoting-dialogue-to-increase-the-creative-potential-of-collaboration\" style=\"font-size:48px;line-height:1.1\">Мы - студия в Берлине с международной практикой в ​​области архитектуры, городского планирования и дизайна интерьеров. Мы верим в обмен знаниями и продвижение диалога для увеличения творческого потенциала сотрудничества.</h2>\n<!-- /wp:heading -->\";}i:6;O:8:\"stdClass\":7:{s:2:\"id\";i:4381;s:5:\"title\";O:8:\"stdClass\":1:{s:8:\"rendered\";s:77:\"Медиа и текст в полноразмерном контейнере\";}s:7:\"content\";O:8:\"stdClass\":2:{s:8:\"rendered\";s:1737:\"\n<div class=\"wp-block-cover alignfull has-background-dim\" style=\"background-color:#ffffff;min-height:100vh\"><div class=\"wp-block-cover__inner-container\">\n<div class=\"wp-block-media-text alignwide is-stacked-on-mobile is-vertically-aligned-center is-image-fill\" style=\"grid-template-columns:56% auto\"><figure class=\"wp-block-media-text__media\" style=\"background-image:url(https://s.w.org/images/core/5.8/soil.jpg);background-position:50% 50%\"><img src=\"https://s.w.org/images/core/5.8/soil.jpg\" alt=\"Крупный план засохшей потрескавшейся земли.\" /></figure><div class=\"wp-block-media-text__content\">\n<h2 class=\"has-text-color\" style=\"color:#000000;font-size:32px\"><strong>В чем проблема?</strong></h2>\n\n\n\n<p class=\"has-text-color\" style=\"color:#000000;font-size:17px\">Сегодня деревья важнее, чем когда-либо прежде. Сообщается, что из деревьев изготовлено более 10 000 изделий. Посредством химии из скромной поленницы получаются химические вещества, пластмассы и ткани, о которых невозможно было даже представить, когда топор впервые срубил техасское дерево.</p>\n\n\n\n<div class=\"wp-container-624c8cd702f4b wp-block-buttons\">\n<div class=\"wp-block-button is-style-fill\"><a class=\"wp-block-button__link\">Узнать больше</a></div>\n</div>\n<style>.wp-container-624c8cd702f4b {display: flex;gap: var( --wp--style--block-gap, 0.5em );flex-wrap: wrap;align-items: center;}.wp-container-624c8cd702f4b > * { margin: 0; }</style></div></div>\n</div></div>\n\";s:9:\"protected\";b:0;}s:4:\"meta\";O:8:\"stdClass\":6:{s:10:\"spay_email\";s:0:\"\";s:13:\"wpop_keywords\";s:0:\"\";s:16:\"wpop_description\";s:130:\"Медиа и текстовый блок с изображением слева и текстом и кнопкой справа.\";s:19:\"wpop_viewport_width\";i:1200;s:16:\"wpop_block_types\";a:0:{}s:11:\"wpop_locale\";s:5:\"ru_RU\";}s:14:\"category_slugs\";a:1:{i:0;s:6:\"header\";}s:13:\"keyword_slugs\";a:1:{i:0;s:4:\"core\";}s:15:\"pattern_content\";s:2197:\"<!-- wp:cover {\"customOverlayColor\":\"#ffffff\",\"minHeight\":100,\"minHeightUnit\":\"vh\",\"contentPosition\":\"center center\",\"align\":\"full\"} -->\n<div class=\"wp-block-cover alignfull has-background-dim\" style=\"background-color:#ffffff;min-height:100vh\"><div class=\"wp-block-cover__inner-container\"><!-- wp:media-text {\"mediaLink\":\"https://s.w.org/images/core/5.8/soil.jpg\",\"mediaType\":\"image\",\"mediaWidth\":56,\"verticalAlignment\":\"center\",\"imageFill\":true} -->\n<div class=\"wp-block-media-text alignwide is-stacked-on-mobile is-vertically-aligned-center is-image-fill\" style=\"grid-template-columns:56% auto\"><figure class=\"wp-block-media-text__media\" style=\"background-image:url(https://s.w.org/images/core/5.8/soil.jpg);background-position:50% 50%\"><img src=\"https://s.w.org/images/core/5.8/soil.jpg\" alt=\"Крупный план засохшей потрескавшейся земли.\" /></figure><div class=\"wp-block-media-text__content\"><!-- wp:heading {\"style\":{\"typography\":{\"fontSize\":\"32px\"},\"color\":{\"text\":\"#000000\"}}} -->\n<h2 class=\"has-text-color\" style=\"color:#000000;font-size:32px\"><strong>В чем проблема?</strong></h2>\n<!-- /wp:heading -->\n\n<!-- wp:paragraph {\"style\":{\"typography\":{\"fontSize\":\"17px\"},\"color\":{\"text\":\"#000000\"}}} -->\n<p class=\"has-text-color\" style=\"color:#000000;font-size:17px\">Сегодня деревья важнее, чем когда-либо прежде. Сообщается, что из деревьев изготовлено более 10 000 изделий. Посредством химии из скромной поленницы получаются химические вещества, пластмассы и ткани, о которых невозможно было даже представить, когда топор впервые срубил техасское дерево.</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:buttons -->\n<div class=\"wp-block-buttons\"><!-- wp:button {\"className\":\"is-style-fill\"} -->\n<div class=\"wp-block-button is-style-fill\"><a class=\"wp-block-button__link\">Узнать больше</a></div>\n<!-- /wp:button --></div>\n<!-- /wp:buttons --></div></div>\n<!-- /wp:media-text --></div></div>\n<!-- /wp:cover -->\";}i:7;O:8:\"stdClass\":7:{s:2:\"id\";i:4383;s:5:\"title\";O:8:\"stdClass\":1:{s:8:\"rendered\";s:63:\"Медиа и текст с изображением слева\";}s:7:\"content\";O:8:\"stdClass\":2:{s:8:\"rendered\";s:644:\"\n<div class=\"wp-block-media-text alignfull is-stacked-on-mobile is-vertically-aligned-center\"><figure class=\"wp-block-media-text__media\"><img src=\"https://s.w.org/images/core/5.8/architecture-04.jpg\" alt=\"Крупный план, абстрактный вид архитектуры.\" /></figure><div class=\"wp-block-media-text__content\">\n<h3 class=\"has-text-align-center has-text-color\" style=\"color:#000000\"><strong>Открытые пространства</strong></h3>\n\n\n\n<p class=\"has-text-align-center has-extra-small-font-size\"><a href=\"#\">Посмотрите тематическое исследование ↗</a></p>\n</div></div>\n\";s:9:\"protected\";b:0;}s:4:\"meta\";O:8:\"stdClass\":6:{s:10:\"spay_email\";s:0:\"\";s:13:\"wpop_keywords\";s:0:\"\";s:16:\"wpop_description\";s:112:\"Медиа и текстовый блок с изображением слева и текстом справа.\";s:19:\"wpop_viewport_width\";i:1200;s:16:\"wpop_block_types\";a:0:{}s:11:\"wpop_locale\";s:5:\"ru_RU\";}s:14:\"category_slugs\";a:2:{i:0;s:8:\"featured\";i:1;s:6:\"header\";}s:13:\"keyword_slugs\";a:1:{i:0;s:4:\"core\";}s:15:\"pattern_content\";s:951:\"<!-- wp:media-text {\"align\":\"full\",\"mediaType\":\"image\",\"verticalAlignment\":\"center\"} -->\n<div class=\"wp-block-media-text alignfull is-stacked-on-mobile is-vertically-aligned-center\"><figure class=\"wp-block-media-text__media\"><img src=\"https://s.w.org/images/core/5.8/architecture-04.jpg\" alt=\"Крупный план, абстрактный вид архитектуры.\" /></figure><div class=\"wp-block-media-text__content\"><!-- wp:heading {\"textAlign\":\"center\",\"level\":3,\"style\":{\"color\":{\"text\":\"#000000\"}}} -->\n<h3 class=\"has-text-align-center has-text-color\" style=\"color:#000000\"><strong>Открытые пространства</strong></h3>\n<!-- /wp:heading -->\n\n<!-- wp:paragraph {\"align\":\"center\",\"fontSize\":\"extra-small\"} -->\n<p class=\"has-text-align-center has-extra-small-font-size\"><a href=\"#\">Посмотрите тематическое исследование ↗</a></p>\n<!-- /wp:paragraph --></div></div>\n<!-- /wp:media-text -->\";}i:8;O:8:\"stdClass\":7:{s:2:\"id\";i:4382;s:5:\"title\";O:8:\"stdClass\":1:{s:8:\"rendered\";s:65:\"Медиа и текст с изображением справа\";}s:7:\"content\";O:8:\"stdClass\":2:{s:8:\"rendered\";s:830:\"\n<div class=\"wp-block-media-text alignfull has-media-on-the-right is-stacked-on-mobile is-vertically-aligned-center is-style-default\" style=\"grid-template-columns:auto 56%\"><figure class=\"wp-block-media-text__media\"><img src=\"https://s.w.org/images/core/5.8/art-02.jpg\" alt=\"Зелено-коричневый сельский пейзаж, ведущий в ярко-синий океан и слегка облачное небо, выполненный масляными красками.\" /></figure><div class=\"wp-block-media-text__content\">\n<h2 class=\"has-text-color\" style=\"color:#000000\"><strong>Берег синего моря</strong></h2>\n\n\n\n<p class=\"has-text-color\" style=\"color:#636363;font-size:17px;line-height:1.1\">Элеонора Харрис&nbsp;(Американка, 1901-1942)</p>\n</div></div>\n\n\n\n<p></p>\n\";s:9:\"protected\";b:0;}s:4:\"meta\";O:8:\"stdClass\":6:{s:10:\"spay_email\";s:0:\"\";s:13:\"wpop_keywords\";s:0:\"\";s:16:\"wpop_description\";s:112:\"Медиа и текстовый блок с изображением справа и текстом слева.\";s:19:\"wpop_viewport_width\";i:1200;s:16:\"wpop_block_types\";a:0:{}s:11:\"wpop_locale\";s:5:\"ru_RU\";}s:14:\"category_slugs\";a:1:{i:0;s:6:\"header\";}s:13:\"keyword_slugs\";a:1:{i:0;s:4:\"core\";}s:15:\"pattern_content\";s:1283:\"<!-- wp:media-text {\"align\":\"full\",\"mediaPosition\":\"right\",\"mediaLink\":\"#\",\"mediaType\":\"image\",\"mediaWidth\":56,\"verticalAlignment\":\"center\",\"className\":\"is-style-default\"} -->\n<div class=\"wp-block-media-text alignfull has-media-on-the-right is-stacked-on-mobile is-vertically-aligned-center is-style-default\" style=\"grid-template-columns:auto 56%\"><figure class=\"wp-block-media-text__media\"><img src=\"https://s.w.org/images/core/5.8/art-02.jpg\" alt=\"Зелено-коричневый сельский пейзаж, ведущий в ярко-синий океан и слегка облачное небо, выполненный масляными красками.\" /></figure><div class=\"wp-block-media-text__content\"><!-- wp:heading {\"style\":{\"color\":{\"text\":\"#000000\"}}} -->\n<h2 class=\"has-text-color\" style=\"color:#000000\"><strong>Берег синего моря</strong></h2>\n<!-- /wp:heading -->\n\n<!-- wp:paragraph {\"style\":{\"typography\":{\"lineHeight\":\"1.1\",\"fontSize\":\"17px\"},\"color\":{\"text\":\"#636363\"}}} -->\n<p class=\"has-text-color\" style=\"color:#636363;font-size:17px;line-height:1.1\">Элеонора Харрис&nbsp;(Американка, 1901-1942)</p>\n<!-- /wp:paragraph --></div></div>\n<!-- /wp:media-text -->\n\n<!-- wp:paragraph -->\n<p></p>\n<!-- /wp:paragraph -->\";}i:9;O:8:\"stdClass\":7:{s:2:\"id\";i:4379;s:5:\"title\";O:8:\"stdClass\":1:{s:8:\"rendered\";s:69:\"Три колонки с изображениями и текстом\";}s:7:\"content\";O:8:\"stdClass\":2:{s:8:\"rendered\";s:4372:\"\n<div class=\"wp-container-624c8cd705f1a wp-block-group alignfull has-background\" style=\"background-color:#f8f4e4\">\n<div class=\"wp-container-624c8cd7054a5 wp-block-columns alignwide\">\n<div class=\"wp-block-column\">\n<div style=\"height:100px\" aria-hidden=\"true\" class=\"wp-block-spacer\"></div>\n\n\n\n<h6 class=\"has-text-color\" id=\"ecosystem\" style=\"color:#000000\">ЭКОСИСТЕМА</h6>\n\n\n\n<p class=\"has-text-color\" style=\"color:#000000;font-size:5vw;line-height:1.1\"><strong>Положительный рост.</strong></p>\n\n\n\n<div style=\"height:5px\" aria-hidden=\"true\" class=\"wp-block-spacer\"></div>\n</div>\n</div>\n<style>.wp-container-624c8cd7054a5 {display: flex;gap: var( --wp--style--block-gap, 0.5em );flex-wrap: nowrap;align-items: center;}.wp-container-624c8cd7054a5 > * { margin: 0; }</style>\n\n\n<div class=\"wp-container-624c8cd70589f wp-block-columns alignwide\">\n<div class=\"wp-block-column\" style=\"flex-basis:33.38%\">\n<p class=\"has-text-color has-extra-small-font-size\" style=\"color:#000000\"><em>Природа</em> в обычном смысле слова относится к сущностям, неизменным человеком; космос, воздух, река, лист. <em>Искусство</em> применяется к смеси его воли с теми же вещами, как в доме, канале, статуе, картине. Но его операции, взятые вместе, настолько незначительны, это небольшое измельчение, выпечка, заплатка и стирка, что в таком грандиозном впечатлении, как мир, в человеческом сознании, они не меняют результата.</p>\n</div>\n\n\n\n<div class=\"wp-block-column\" style=\"flex-basis:33%\">\n<div style=\"height:100px\" aria-hidden=\"true\" class=\"wp-block-spacer\"></div>\n\n\n\n<figure class=\"wp-block-image size-large\"><img src=\"https://s.w.org/images/core/5.8/outside-01.jpg\" alt=\"Солнце садится сквозь густой лес деревьев.\" /></figure>\n</div>\n\n\n\n<div class=\"wp-block-column\" style=\"flex-basis:33.62%\">\n<figure class=\"wp-block-image size-large\"><img src=\"https://s.w.org/images/core/5.8/outside-02.jpg\" alt=\"Ветровые турбины, стоящие на травянистой равнине, против голубого неба.\" /></figure>\n</div>\n</div>\n<style>.wp-container-624c8cd70589f {display: flex;gap: var( --wp--style--block-gap, 0.5em );flex-wrap: nowrap;align-items: center;}.wp-container-624c8cd70589f > * { margin: 0; }</style>\n\n\n<div class=\"wp-container-624c8cd705c0d wp-block-columns alignwide\">\n<div class=\"wp-block-column\" style=\"flex-basis:67%\">\n<div class=\"wp-block-image\"><figure class=\"alignright size-large\"><img src=\"https://s.w.org/images/core/5.8/outside-03.jpg\" alt=\"Солнце светит над гребнем, спускающимся к берегу. Вдалеке по дороге едет машина.\" /></figure></div>\n</div>\n\n\n\n<div class=\"wp-block-column is-vertically-aligned-center\" style=\"flex-basis:33%\">\n<p class=\"has-text-color has-extra-small-font-size\" style=\"color:#000000\">Несомненно, у нас нет вопросов, на которые невозможно ответить. Мы должны доверять совершенству творения настолько, чтобы верить в то, что какое бы любопытство ни пробудил в наших умах порядок вещей, порядок вещей может удовлетворить. Состояние каждого человека &#8212; это иероглифическое решение тех вопросов, которые он задавал.</p>\n</div>\n</div>\n<style>.wp-container-624c8cd705c0d {display: flex;gap: var( --wp--style--block-gap, 0.5em );flex-wrap: nowrap;align-items: center;}.wp-container-624c8cd705c0d > * { margin: 0; }</style></div>\n<style>.wp-container-624c8cd705f1a .alignleft { float: left; margin-right: 2em; margin-left: 0; }.wp-container-624c8cd705f1a .alignright { float: right; margin-left: 2em; margin-right: 0; }.wp-container-624c8cd705f1a > * { margin-top: 0; margin-bottom: 0; }.wp-container-624c8cd705f1a > * + * { margin-top: var( --wp--style--block-gap );  margin-bottom: 0; }</style>\";s:9:\"protected\";b:0;}s:4:\"meta\";O:8:\"stdClass\":6:{s:10:\"spay_email\";s:0:\"\";s:13:\"wpop_keywords\";s:0:\"\";s:16:\"wpop_description\";s:142:\"Три столбца с изображениями и текстом с интервалом по вертикали для смещения.\";s:19:\"wpop_viewport_width\";i:1200;s:16:\"wpop_block_types\";a:0:{}s:11:\"wpop_locale\";s:5:\"ru_RU\";}s:14:\"category_slugs\";a:2:{i:0;s:7:\"columns\";i:1;s:8:\"featured\";}s:13:\"keyword_slugs\";a:1:{i:0;s:4:\"core\";}s:15:\"pattern_content\";s:4759:\"<!-- wp:group {\"align\":\"full\",\"style\":{\"color\":{\"background\":\"#f8f4e4\"}}} -->\n<div class=\"wp-block-group alignfull has-background\" style=\"background-color:#f8f4e4\"><!-- wp:columns {\"align\":\"wide\"} -->\n<div class=\"wp-block-columns alignwide\"><!-- wp:column -->\n<div class=\"wp-block-column\"><!-- wp:spacer -->\n<div style=\"height:100px\" aria-hidden=\"true\" class=\"wp-block-spacer\"></div>\n<!-- /wp:spacer -->\n\n<!-- wp:heading {\"level\":6,\"style\":{\"color\":{\"text\":\"#000000\"}}} -->\n<h6 class=\"has-text-color\" id=\"ecosystem\" style=\"color:#000000\">ЭКОСИСТЕМА</h6>\n<!-- /wp:heading -->\n\n<!-- wp:paragraph {\"style\":{\"typography\":{\"lineHeight\":\"1.1\",\"fontSize\":\"5vw\"},\"color\":{\"text\":\"#000000\"}}} -->\n<p class=\"has-text-color\" style=\"color:#000000;font-size:5vw;line-height:1.1\"><strong>Положительный рост.</strong></p>\n<!-- /wp:paragraph -->\n\n<!-- wp:spacer {\"height\":\"5px\"} -->\n<div style=\"height:5px\" aria-hidden=\"true\" class=\"wp-block-spacer\"></div>\n<!-- /wp:spacer --></div>\n<!-- /wp:column --></div>\n<!-- /wp:columns -->\n\n<!-- wp:columns {\"align\":\"wide\"} -->\n<div class=\"wp-block-columns alignwide\"><!-- wp:column {\"width\":\"33.38%\"} -->\n<div class=\"wp-block-column\" style=\"flex-basis:33.38%\"><!-- wp:paragraph {\"style\":{\"color\":{\"text\":\"#000000\"}},\"fontSize\":\"extra-small\"} -->\n<p class=\"has-text-color has-extra-small-font-size\" style=\"color:#000000\"><em>Природа</em> в обычном смысле слова относится к сущностям, неизменным человеком; космос, воздух, река, лист. <em>Искусство</em> применяется к смеси его воли с теми же вещами, как в доме, канале, статуе, картине. Но его операции, взятые вместе, настолько незначительны, это небольшое измельчение, выпечка, заплатка и стирка, что в таком грандиозном впечатлении, как мир, в человеческом сознании, они не меняют результата.</p>\n<!-- /wp:paragraph --></div>\n<!-- /wp:column -->\n\n<!-- wp:column {\"width\":\"33%\"} -->\n<div class=\"wp-block-column\" style=\"flex-basis:33%\"><!-- wp:spacer -->\n<div style=\"height:100px\" aria-hidden=\"true\" class=\"wp-block-spacer\"></div>\n<!-- /wp:spacer -->\n\n<!-- wp:image {\"sizeSlug\":\"large\",\"linkDestination\":\"none\"} -->\n<figure class=\"wp-block-image size-large\"><img src=\"https://s.w.org/images/core/5.8/outside-01.jpg\" alt=\"Солнце садится сквозь густой лес деревьев.\" /></figure>\n<!-- /wp:image --></div>\n<!-- /wp:column -->\n\n<!-- wp:column {\"width\":\"33.62%\"} -->\n<div class=\"wp-block-column\" style=\"flex-basis:33.62%\"><!-- wp:image {\"sizeSlug\":\"large\",\"linkDestination\":\"none\"} -->\n<figure class=\"wp-block-image size-large\"><img src=\"https://s.w.org/images/core/5.8/outside-02.jpg\" alt=\"Ветровые турбины, стоящие на травянистой равнине, против голубого неба.\" /></figure>\n<!-- /wp:image --></div>\n<!-- /wp:column --></div>\n<!-- /wp:columns -->\n\n<!-- wp:columns {\"align\":\"wide\"} -->\n<div class=\"wp-block-columns alignwide\"><!-- wp:column {\"width\":\"67%\"} -->\n<div class=\"wp-block-column\" style=\"flex-basis:67%\"><!-- wp:image {\"align\":\"right\",\"sizeSlug\":\"large\",\"linkDestination\":\"none\"} -->\n<div class=\"wp-block-image\"><figure class=\"alignright size-large\"><img src=\"https://s.w.org/images/core/5.8/outside-03.jpg\" alt=\"Солнце светит над гребнем, спускающимся к берегу. Вдалеке по дороге едет машина.\" /></figure></div>\n<!-- /wp:image --></div>\n<!-- /wp:column -->\n\n<!-- wp:column {\"verticalAlignment\":\"center\",\"width\":\"33%\"} -->\n<div class=\"wp-block-column is-vertically-aligned-center\" style=\"flex-basis:33%\"><!-- wp:paragraph {\"style\":{\"color\":{\"text\":\"#000000\"}},\"fontSize\":\"extra-small\"} -->\n<p class=\"has-text-color has-extra-small-font-size\" style=\"color:#000000\">Несомненно, у нас нет вопросов, на которые невозможно ответить. Мы должны доверять совершенству творения настолько, чтобы верить в то, что какое бы любопытство ни пробудил в наших умах порядок вещей, порядок вещей может удовлетворить. Состояние каждого человека - это иероглифическое решение тех вопросов, которые он задавал.</p>\n<!-- /wp:paragraph --></div>\n<!-- /wp:column --></div>\n<!-- /wp:columns --></div>\n<!-- /wp:group -->\";}i:10;O:8:\"stdClass\":7:{s:2:\"id\";i:4377;s:5:\"title\";O:8:\"stdClass\":1:{s:8:\"rendered\";s:74:\"Три колонки со смещенными изображениями\";}s:7:\"content\";O:8:\"stdClass\":2:{s:8:\"rendered\";s:1434:\"\n<div class=\"wp-container-624c8cd7072c6 wp-block-columns alignwide\">\n<div class=\"wp-block-column\" style=\"flex-basis:25%\">\n<figure class=\"wp-block-image size-large is-style-default\"><img src=\"https://s.w.org/images/core/5.8/architecture-01.jpg\" alt=\"Крупный план, абстрактный вид геометрической архитектуры.\" /></figure>\n</div>\n\n\n\n<div class=\"wp-block-column\" style=\"flex-basis:25%\">\n<div style=\"height:500px\" aria-hidden=\"true\" class=\"wp-block-spacer\"></div>\n\n\n\n<div style=\"height:150px\" aria-hidden=\"true\" class=\"wp-block-spacer\"></div>\n\n\n\n<figure class=\"wp-block-image size-large\"><img src=\"https://s.w.org/images/core/5.8/architecture-02.jpg\" alt=\"Крупным планом вид окна белого здания под углом.\" /></figure>\n</div>\n\n\n\n<div class=\"wp-block-column\" style=\"flex-basis:45%\">\n<figure class=\"wp-block-image size-large is-style-default\"><img src=\"https://s.w.org/images/core/5.8/architecture-03.jpg\" alt=\"Крупный план угла белого геометрического здания с острыми и скругленными углами.\" /></figure>\n\n\n\n<div style=\"height:285px\" aria-hidden=\"true\" class=\"wp-block-spacer\"></div>\n</div>\n</div>\n<style>.wp-container-624c8cd7072c6 {display: flex;gap: var( --wp--style--block-gap, 0.5em );flex-wrap: nowrap;align-items: center;}.wp-container-624c8cd7072c6 > * { margin: 0; }</style>\";s:9:\"protected\";b:0;}s:4:\"meta\";O:8:\"stdClass\":6:{s:10:\"spay_email\";s:0:\"\";s:13:\"wpop_keywords\";s:0:\"\";s:16:\"wpop_description\";s:75:\"Три колонки со смещенными изображениями.\";s:19:\"wpop_viewport_width\";i:1200;s:16:\"wpop_block_types\";a:0:{}s:11:\"wpop_locale\";s:5:\"ru_RU\";}s:14:\"category_slugs\";a:2:{i:0;s:7:\"gallery\";i:1;s:6:\"images\";}s:13:\"keyword_slugs\";a:1:{i:0;s:4:\"core\";}s:15:\"pattern_content\";s:1898:\"<!-- wp:columns {\"align\":\"wide\"} -->\n<div class=\"wp-block-columns alignwide\"><!-- wp:column {\"width\":\"25%\"} -->\n<div class=\"wp-block-column\" style=\"flex-basis:25%\"><!-- wp:image {\"sizeSlug\":\"large\",\"linkDestination\":\"none\",\"className\":\"is-style-default\"} -->\n<figure class=\"wp-block-image size-large is-style-default\"><img src=\"https://s.w.org/images/core/5.8/architecture-01.jpg\" alt=\"Крупный план, абстрактный вид геометрической архитектуры.\" /></figure>\n<!-- /wp:image --></div>\n<!-- /wp:column -->\n\n<!-- wp:column {\"width\":\"25%\"} -->\n<div class=\"wp-block-column\" style=\"flex-basis:25%\"><!-- wp:spacer {\"height\":500} -->\n<div style=\"height:500px\" aria-hidden=\"true\" class=\"wp-block-spacer\"></div>\n<!-- /wp:spacer -->\n\n<!-- wp:spacer {\"height\":150} -->\n<div style=\"height:150px\" aria-hidden=\"true\" class=\"wp-block-spacer\"></div>\n<!-- /wp:spacer -->\n\n<!-- wp:image {\"sizeSlug\":\"large\",\"linkDestination\":\"none\"} -->\n<figure class=\"wp-block-image size-large\"><img src=\"https://s.w.org/images/core/5.8/architecture-02.jpg\" alt=\"Крупным планом вид окна белого здания под углом.\" /></figure>\n<!-- /wp:image --></div>\n<!-- /wp:column -->\n\n<!-- wp:column {\"width\":\"45%\"} -->\n<div class=\"wp-block-column\" style=\"flex-basis:45%\"><!-- wp:image {\"sizeSlug\":\"large\",\"linkDestination\":\"none\",\"className\":\"is-style-default\"} -->\n<figure class=\"wp-block-image size-large is-style-default\"><img src=\"https://s.w.org/images/core/5.8/architecture-03.jpg\" alt=\"Крупный план угла белого геометрического здания с острыми и скругленными углами.\" /></figure>\n<!-- /wp:image -->\n\n<!-- wp:spacer {\"height\":285} -->\n<div style=\"height:285px\" aria-hidden=\"true\" class=\"wp-block-spacer\"></div>\n<!-- /wp:spacer --></div>\n<!-- /wp:column --></div>\n<!-- /wp:columns -->\";}i:11;O:8:\"stdClass\":7:{s:2:\"id\";i:4378;s:5:\"title\";O:8:\"stdClass\":1:{s:8:\"rendered\";s:34:\"Три колонки текста\";}s:7:\"content\";O:8:\"stdClass\":2:{s:8:\"rendered\";s:1253:\"\n<div class=\"wp-container-624c8cd7082dc wp-block-columns alignfull has-text-color has-background\" style=\"background-color:#ffffff;color:#000000\">\n<div class=\"wp-block-column\">\n<h3 style=\"font-size:24px;line-height:1.3\"><strong><a href=\"http://wordpress.org\">Виртуальный тур ↗</a></strong></h3>\n\n\n\n<p>Примите участие в виртуальной экскурсии по музею. Идеально подходит для школ и мероприятий.</p>\n</div>\n\n\n\n<div class=\"wp-block-column\">\n<h3 style=\"font-size:24px;line-height:1.3\"><strong><a href=\"https://wordpress.org\">Текущие шоу ↗</a></strong></h3>\n\n\n\n<p>Будьте в курсе и смотрите наши текущие выставки здесь.</p>\n</div>\n\n\n\n<div class=\"wp-block-column\">\n<h3 style=\"font-size:24px;line-height:1.3\"><strong><a href=\"https://wordpress.org\">Полезная информация ↗</a></strong></h3>\n\n\n\n<p>Узнайте о времени работы, ценах на билеты и скидках.</p>\n</div>\n</div>\n<style>.wp-container-624c8cd7082dc {display: flex;gap: var( --wp--style--block-gap, 0.5em );flex-wrap: nowrap;align-items: center;}.wp-container-624c8cd7082dc > * { margin: 0; }</style>\";s:9:\"protected\";b:0;}s:4:\"meta\";O:8:\"stdClass\":6:{s:10:\"spay_email\";s:0:\"\";s:13:\"wpop_keywords\";s:0:\"\";s:16:\"wpop_description\";s:35:\"Три колонки текста.\";s:19:\"wpop_viewport_width\";i:1200;s:16:\"wpop_block_types\";a:0:{}s:11:\"wpop_locale\";s:5:\"ru_RU\";}s:14:\"category_slugs\";a:3:{i:0;s:7:\"columns\";i:1;s:8:\"featured\";i:2;s:4:\"text\";}s:13:\"keyword_slugs\";a:1:{i:0;s:4:\"core\";}s:15:\"pattern_content\";s:1736:\"<!-- wp:columns {\"align\":\"full\",\"style\":{\"color\":{\"text\":\"#000000\",\"background\":\"#ffffff\"}}} -->\n<div class=\"wp-block-columns alignfull has-text-color has-background\" style=\"background-color:#ffffff;color:#000000\"><!-- wp:column -->\n<div class=\"wp-block-column\"><!-- wp:heading {\"level\":3,\"style\":{\"typography\":{\"fontSize\":\"24px\",\"lineHeight\":\"1.3\"}}} -->\n<h3 style=\"font-size:24px;line-height:1.3\"><strong><a href=\"http://wordpress.org\">Виртуальный тур ↗</a></strong></h3>\n<!-- /wp:heading -->\n\n<!-- wp:paragraph -->\n<p>Примите участие в виртуальной экскурсии по музею. Идеально подходит для школ и мероприятий.</p>\n<!-- /wp:paragraph --></div>\n<!-- /wp:column -->\n\n<!-- wp:column -->\n<div class=\"wp-block-column\"><!-- wp:heading {\"level\":3,\"style\":{\"typography\":{\"fontSize\":\"24px\",\"lineHeight\":\"1.3\"}}} -->\n<h3 style=\"font-size:24px;line-height:1.3\"><strong><a href=\"https://wordpress.org\">Текущие шоу ↗</a></strong></h3>\n<!-- /wp:heading -->\n\n<!-- wp:paragraph -->\n<p>Будьте в курсе и смотрите наши текущие выставки здесь.</p>\n<!-- /wp:paragraph --></div>\n<!-- /wp:column -->\n\n<!-- wp:column -->\n<div class=\"wp-block-column\"><!-- wp:heading {\"level\":3,\"style\":{\"typography\":{\"fontSize\":\"24px\",\"lineHeight\":\"1.3\"}}} -->\n<h3 style=\"font-size:24px;line-height:1.3\"><strong><a href=\"https://wordpress.org\">Полезная информация ↗</a></strong></h3>\n<!-- /wp:heading -->\n\n<!-- wp:paragraph -->\n<p>Узнайте о времени работы, ценах на билеты и скидках.</p>\n<!-- /wp:paragraph --></div>\n<!-- /wp:column --></div>\n<!-- /wp:columns -->\";}i:12;O:8:\"stdClass\":7:{s:2:\"id\";i:4391;s:5:\"title\";O:8:\"stdClass\":1:{s:8:\"rendered\";s:12:\"Цитата\";}s:7:\"content\";O:8:\"stdClass\":2:{s:8:\"rendered\";s:771:\"\n<hr class=\"wp-block-separator is-style-default\" />\n\n\n\n<div class=\"wp-block-image is-style-rounded\"><figure class=\"aligncenter size-large is-resized\"><img loading=\"lazy\" src=\"https://s.w.org/images/core/5.8/portrait.jpg\" alt=\"Боковой профиль женщины в коричневой водолазке и белой сумке. Она смотрит с закрытыми глазами.\" width=\"150\" height=\"150\" /></figure></div>\n\n\n\n<blockquote class=\"wp-block-quote has-text-align-center is-style-large\"><p>«Участие заставляет меня чувствовать, что я полезен планете».</p><cite>&#8212; Анна Вонг,<em>Волонтер</em></cite></blockquote>\n\n\n\n<hr class=\"wp-block-separator is-style-default\" />\n\";s:9:\"protected\";b:0;}s:4:\"meta\";O:8:\"stdClass\":6:{s:10:\"spay_email\";s:0:\"\";s:13:\"wpop_keywords\";s:0:\"\";s:16:\"wpop_description\";s:0:\"\";s:19:\"wpop_viewport_width\";i:800;s:16:\"wpop_block_types\";a:0:{}s:11:\"wpop_locale\";s:5:\"ru_RU\";}s:14:\"category_slugs\";a:1:{i:0;s:4:\"text\";}s:13:\"keyword_slugs\";a:1:{i:0;s:4:\"core\";}s:15:\"pattern_content\";s:1139:\"<!-- wp:separator {\"className\":\"is-style-default\"} -->\n<hr class=\"wp-block-separator is-style-default\" />\n<!-- /wp:separator -->\n\n<!-- wp:image {\"align\":\"center\",\"width\":150,\"height\":150,\"sizeSlug\":\"large\",\"linkDestination\":\"none\",\"className\":\"is-style-rounded\"} -->\n<div class=\"wp-block-image is-style-rounded\"><figure class=\"aligncenter size-large is-resized\"><img src=\"https://s.w.org/images/core/5.8/portrait.jpg\" alt=\"Боковой профиль женщины в коричневой водолазке и белой сумке. Она смотрит с закрытыми глазами.\" width=\"150\" height=\"150\" /></figure></div>\n<!-- /wp:image -->\n\n<!-- wp:quote {\"align\":\"center\",\"className\":\"is-style-large\"} -->\n<blockquote class=\"wp-block-quote has-text-align-center is-style-large\"><p>«Участие заставляет меня чувствовать, что я полезен планете».</p><cite>- Анна Вонг,<em>Волонтер</em></cite></blockquote>\n<!-- /wp:quote -->\n\n<!-- wp:separator {\"className\":\"is-style-default\"} -->\n<hr class=\"wp-block-separator is-style-default\" />\n<!-- /wp:separator -->\";}i:13;O:8:\"stdClass\":7:{s:2:\"id\";i:184;s:5:\"title\";O:8:\"stdClass\":1:{s:8:\"rendered\";s:7:\"Heading\";}s:7:\"content\";O:8:\"stdClass\":2:{s:8:\"rendered\";s:509:\"\n<h2 class=\"alignwide\" id=\"we-re-a-studio-in-berlin-with-an-international-practice-in-architecture-urban-planning-and-interior-design-we-believe-in-sharing-knowledge-and-promoting-dialogue-to-increase-the-creative-potential-of-collaboration\" style=\"font-size:48px;line-height:1.1\">We&#8217;re a studio in Berlin with an international practice in architecture, urban planning and interior design. We believe in sharing knowledge and promoting dialogue to increase the creative potential of collaboration.</h2>\n\";s:9:\"protected\";b:0;}s:4:\"meta\";O:8:\"stdClass\":6:{s:10:\"spay_email\";s:0:\"\";s:13:\"wpop_keywords\";s:17:\"large text, title\";s:16:\"wpop_description\";s:12:\"Heading text\";s:19:\"wpop_viewport_width\";i:1200;s:16:\"wpop_block_types\";a:1:{i:0;s:12:\"core/heading\";}s:11:\"wpop_locale\";s:5:\"en_US\";}s:14:\"category_slugs\";a:2:{i:0;s:8:\"featured\";i:1;s:4:\"text\";}s:13:\"keyword_slugs\";a:1:{i:0;s:4:\"core\";}s:15:\"pattern_content\";s:621:\"<!-- wp:heading {\"align\":\"wide\",\"style\":{\"typography\":{\"fontSize\":\"48px\",\"lineHeight\":\"1.1\"}}} -->\n<h2 class=\"alignwide\" id=\"we-re-a-studio-in-berlin-with-an-international-practice-in-architecture-urban-planning-and-interior-design-we-believe-in-sharing-knowledge-and-promoting-dialogue-to-increase-the-creative-potential-of-collaboration\" style=\"font-size:48px;line-height:1.1\">We\'re a studio in Berlin with an international practice in architecture, urban planning and interior design. We believe in sharing knowledge and promoting dialogue to increase the creative potential of collaboration.</h2>\n<!-- /wp:heading -->\";}i:14;O:8:\"stdClass\":7:{s:2:\"id\";i:185;s:5:\"title\";O:8:\"stdClass\":1:{s:8:\"rendered\";s:35:\"Large header with left-aligned text\";}s:7:\"content\";O:8:\"stdClass\":2:{s:8:\"rendered\";s:1231:\"\n<div class=\"wp-block-cover alignfull has-background-dim-60 has-background-dim\" style=\"min-height:800px\"><img class=\"wp-block-cover__image-background\" alt=\"\" src=\"https://s.w.org/images/core/5.8/forest.jpg\" data-object-fit=\"cover\" /><div class=\"wp-block-cover__inner-container\">\n<h2 class=\"alignwide has-text-color\" style=\"color:#ffe074;font-size:64px\">Forest.</h2>\n\n\n\n<div class=\"wp-container-624c8cd70a4ce wp-block-columns alignwide\">\n<div class=\"wp-block-column\" style=\"flex-basis:55%\">\n<div style=\"height:330px\" aria-hidden=\"true\" class=\"wp-block-spacer\"></div>\n\n\n\n<p class=\"has-text-color\" style=\"color:#ffe074;font-size:12px;line-height:1.3\"><em>Even a child knows how valuable the forest is. The fresh, breathtaking smell of trees. Echoing birds flying above that dense magnitude. A stable climate, a sustainable diverse life and a source of culture. Yet, forests and other ecosystems hang in the balance, threatened to become croplands, pasture, and plantations.</em></p>\n</div>\n\n\n\n<div class=\"wp-block-column\"></div>\n</div>\n<style>.wp-container-624c8cd70a4ce {display: flex;gap: var( --wp--style--block-gap, 0.5em );flex-wrap: nowrap;align-items: center;}.wp-container-624c8cd70a4ce > * { margin: 0; }</style></div></div>\n\";s:9:\"protected\";b:0;}s:4:\"meta\";O:8:\"stdClass\":6:{s:10:\"spay_email\";s:0:\"\";s:13:\"wpop_keywords\";s:0:\"\";s:16:\"wpop_description\";s:29:\"Cover image with quote on top\";s:19:\"wpop_viewport_width\";i:1200;s:16:\"wpop_block_types\";a:0:{}s:11:\"wpop_locale\";s:5:\"en_US\";}s:14:\"category_slugs\";a:2:{i:0;s:8:\"featured\";i:1;s:6:\"header\";}s:13:\"keyword_slugs\";a:1:{i:0;s:4:\"core\";}s:15:\"pattern_content\";s:1610:\"<!-- wp:cover {\"url\":\"https://s.w.org/images/core/5.8/forest.jpg\",\"dimRatio\":60,\"minHeight\":800,\"align\":\"full\"} -->\n<div class=\"wp-block-cover alignfull has-background-dim-60 has-background-dim\" style=\"min-height:800px\"><img class=\"wp-block-cover__image-background\" alt=\"\" src=\"https://s.w.org/images/core/5.8/forest.jpg\" data-object-fit=\"cover\" /><div class=\"wp-block-cover__inner-container\"><!-- wp:heading {\"align\":\"wide\",\"style\":{\"color\":{\"text\":\"#ffe074\"},\"typography\":{\"fontSize\":\"64px\"}}} -->\n<h2 class=\"alignwide has-text-color\" style=\"color:#ffe074;font-size:64px\">Forest.</h2>\n<!-- /wp:heading -->\n\n<!-- wp:columns {\"align\":\"wide\"} -->\n<div class=\"wp-block-columns alignwide\"><!-- wp:column {\"width\":\"55%\"} -->\n<div class=\"wp-block-column\" style=\"flex-basis:55%\"><!-- wp:spacer {\"height\":330} -->\n<div style=\"height:330px\" aria-hidden=\"true\" class=\"wp-block-spacer\"></div>\n<!-- /wp:spacer -->\n\n<!-- wp:paragraph {\"style\":{\"color\":{\"text\":\"#ffe074\"},\"typography\":{\"lineHeight\":\"1.3\",\"fontSize\":\"12px\"}}} -->\n<p class=\"has-text-color\" style=\"color:#ffe074;font-size:12px;line-height:1.3\"><em>Even a child knows how valuable the forest is. The fresh, breathtaking smell of trees. Echoing birds flying above that dense magnitude. A stable climate, a sustainable diverse life and a source of culture. Yet, forests and other ecosystems hang in the balance, threatened to become croplands, pasture, and plantations.</em></p>\n<!-- /wp:paragraph --></div>\n<!-- /wp:column -->\n\n<!-- wp:column -->\n<div class=\"wp-block-column\"></div>\n<!-- /wp:column --></div>\n<!-- /wp:columns --></div></div>\n<!-- /wp:cover -->\";}i:15;O:8:\"stdClass\":7:{s:2:\"id\";i:186;s:5:\"title\";O:8:\"stdClass\":1:{s:8:\"rendered\";s:35:\"Large header with text and a button\";}s:7:\"content\";O:8:\"stdClass\":2:{s:8:\"rendered\";s:1477:\"\n<div class=\"wp-block-cover alignfull has-background-dim-40 has-background-dim has-parallax\" style=\"background-image:url(https://s.w.org/images/core/5.8/art-01.jpg);background-color:#000000;min-height:100vh\"><div class=\"wp-block-cover__inner-container\">\n<h2 class=\"alignwide has-white-color has-text-color\" style=\"font-size:48px;line-height:1.2\"><strong><em>Overseas:</em></strong><br><strong><em>1500 — 1960</em></strong></h2>\n\n\n\n<div class=\"wp-container-624c8cd70b617 wp-block-columns alignwide\">\n<div class=\"wp-block-column\" style=\"flex-basis:60%\">\n<p class=\"has-text-color\" style=\"color:#ffffff\">An exhibition about the different representations of the ocean throughout time, between the sixteenth and the twentieth century. Taking place in our Open Room in <em>Floor 2</em>.</p>\n\n\n\n<div class=\"wp-container-624c8cd70b2e4 wp-block-buttons\">\n<div class=\"wp-block-button is-style-outline\"><a class=\"wp-block-button__link has-text-color has-background no-border-radius\" style=\"background-color:#000000;color:#ffffff\">Visit</a></div>\n</div>\n<style>.wp-container-624c8cd70b2e4 {display: flex;gap: var( --wp--style--block-gap, 0.5em );flex-wrap: wrap;align-items: center;}.wp-container-624c8cd70b2e4 > * { margin: 0; }</style></div>\n\n\n\n<div class=\"wp-block-column\"></div>\n</div>\n<style>.wp-container-624c8cd70b617 {display: flex;gap: var( --wp--style--block-gap, 0.5em );flex-wrap: nowrap;align-items: center;}.wp-container-624c8cd70b617 > * { margin: 0; }</style></div></div>\n\";s:9:\"protected\";b:0;}s:4:\"meta\";O:8:\"stdClass\":6:{s:10:\"spay_email\";s:0:\"\";s:13:\"wpop_keywords\";s:0:\"\";s:16:\"wpop_description\";s:62:\"Large header with background image and text and button on top.\";s:19:\"wpop_viewport_width\";i:1200;s:16:\"wpop_block_types\";a:0:{}s:11:\"wpop_locale\";s:5:\"en_US\";}s:14:\"category_slugs\";a:1:{i:0;s:6:\"header\";}s:13:\"keyword_slugs\";a:1:{i:0;s:4:\"core\";}s:15:\"pattern_content\";s:1865:\"<!-- wp:cover {\"url\":\"https://s.w.org/images/core/5.8/art-01.jpg\",\"hasParallax\":true,\"dimRatio\":40,\"customOverlayColor\":\"#000000\",\"minHeight\":100,\"minHeightUnit\":\"vh\",\"contentPosition\":\"center center\",\"align\":\"full\"} -->\n<div class=\"wp-block-cover alignfull has-background-dim-40 has-background-dim has-parallax\" style=\"background-image:url(https://s.w.org/images/core/5.8/art-01.jpg);background-color:#000000;min-height:100vh\"><div class=\"wp-block-cover__inner-container\"><!-- wp:heading {\"style\":{\"typography\":{\"fontSize\":\"48px\",\"lineHeight\":\"1.2\"}},\"className\":\"alignwide has-white-color has-text-color\"} -->\n<h2 class=\"alignwide has-white-color has-text-color\" style=\"font-size:48px;line-height:1.2\"><strong><em>Overseas:</em></strong><br><strong><em>1500 — 1960</em></strong></h2>\n<!-- /wp:heading -->\n\n<!-- wp:columns {\"align\":\"wide\"} -->\n<div class=\"wp-block-columns alignwide\"><!-- wp:column {\"width\":\"60%\"} -->\n<div class=\"wp-block-column\" style=\"flex-basis:60%\"><!-- wp:paragraph {\"style\":{\"color\":{\"text\":\"#ffffff\"}}} -->\n<p class=\"has-text-color\" style=\"color:#ffffff\">An exhibition about the different representations of the ocean throughout time, between the sixteenth and the twentieth century. Taking place in our Open Room in <em>Floor 2</em>.</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:buttons -->\n<div class=\"wp-block-buttons\"><!-- wp:button {\"borderRadius\":0,\"style\":{\"color\":{\"text\":\"#ffffff\",\"background\":\"#000000\"}},\"className\":\"is-style-outline\"} -->\n<div class=\"wp-block-button is-style-outline\"><a class=\"wp-block-button__link has-text-color has-background no-border-radius\" style=\"background-color:#000000;color:#ffffff\">Visit</a></div>\n<!-- /wp:button --></div>\n<!-- /wp:buttons --></div>\n<!-- /wp:column -->\n\n<!-- wp:column -->\n<div class=\"wp-block-column\"></div>\n<!-- /wp:column --></div>\n<!-- /wp:columns --></div></div>\n<!-- /wp:cover -->\";}i:16;O:8:\"stdClass\":7:{s:2:\"id\";i:196;s:5:\"title\";O:8:\"stdClass\":1:{s:8:\"rendered\";s:41:\"Media and text in a full height container\";}s:7:\"content\";O:8:\"stdClass\":2:{s:8:\"rendered\";s:1404:\"\n<div class=\"wp-block-cover alignfull has-background-dim\" style=\"background-color:#ffffff;min-height:100vh\"><div class=\"wp-block-cover__inner-container\">\n<div class=\"wp-block-media-text alignwide is-stacked-on-mobile is-vertically-aligned-center is-image-fill\" style=\"grid-template-columns:56% auto\"><figure class=\"wp-block-media-text__media\" style=\"background-image:url(https://s.w.org/images/core/5.8/soil.jpg);background-position:50% 50%\"><img src=\"https://s.w.org/images/core/5.8/soil.jpg\" alt=\"Close-up of dried, cracked earth.\" /></figure><div class=\"wp-block-media-text__content\">\n<h2 class=\"has-text-color\" style=\"color:#000000;font-size:32px\"><strong>What&#8217;s the problem?</strong></h2>\n\n\n\n<p class=\"has-text-color\" style=\"color:#000000;font-size:17px\">Trees are more important today than ever before. More than 10,000 products are reportedly made from trees. Through chemistry, the humble woodpile is yielding chemicals, plastics and fabrics that were beyond comprehension when an axe first felled a Texas tree.</p>\n\n\n\n<div class=\"wp-container-624c8cd70c908 wp-block-buttons\">\n<div class=\"wp-block-button is-style-fill\"><a class=\"wp-block-button__link\">Learn more</a></div>\n</div>\n<style>.wp-container-624c8cd70c908 {display: flex;gap: var( --wp--style--block-gap, 0.5em );flex-wrap: wrap;align-items: center;}.wp-container-624c8cd70c908 > * { margin: 0; }</style></div></div>\n</div></div>\n\";s:9:\"protected\";b:0;}s:4:\"meta\";O:8:\"stdClass\":6:{s:10:\"spay_email\";s:0:\"\";s:13:\"wpop_keywords\";s:0:\"\";s:16:\"wpop_description\";s:77:\"Media and text block with image to the left and text and button to the right.\";s:19:\"wpop_viewport_width\";i:1200;s:16:\"wpop_block_types\";a:0:{}s:11:\"wpop_locale\";s:5:\"en_US\";}s:14:\"category_slugs\";a:1:{i:0;s:6:\"header\";}s:13:\"keyword_slugs\";a:1:{i:0;s:4:\"core\";}s:15:\"pattern_content\";s:1858:\"<!-- wp:cover {\"customOverlayColor\":\"#ffffff\",\"minHeight\":100,\"minHeightUnit\":\"vh\",\"contentPosition\":\"center center\",\"align\":\"full\"} -->\n<div class=\"wp-block-cover alignfull has-background-dim\" style=\"background-color:#ffffff;min-height:100vh\"><div class=\"wp-block-cover__inner-container\"><!-- wp:media-text {\"mediaLink\":\"https://s.w.org/images/core/5.8/soil.jpg\",\"mediaType\":\"image\",\"mediaWidth\":56,\"verticalAlignment\":\"center\",\"imageFill\":true} -->\n<div class=\"wp-block-media-text alignwide is-stacked-on-mobile is-vertically-aligned-center is-image-fill\" style=\"grid-template-columns:56% auto\"><figure class=\"wp-block-media-text__media\" style=\"background-image:url(https://s.w.org/images/core/5.8/soil.jpg);background-position:50% 50%\"><img src=\"https://s.w.org/images/core/5.8/soil.jpg\" alt=\"Close-up of dried, cracked earth.\" /></figure><div class=\"wp-block-media-text__content\"><!-- wp:heading {\"style\":{\"typography\":{\"fontSize\":\"32px\"},\"color\":{\"text\":\"#000000\"}}} -->\n<h2 class=\"has-text-color\" style=\"color:#000000;font-size:32px\"><strong>What\'s the problem?</strong></h2>\n<!-- /wp:heading -->\n\n<!-- wp:paragraph {\"style\":{\"typography\":{\"fontSize\":\"17px\"},\"color\":{\"text\":\"#000000\"}}} -->\n<p class=\"has-text-color\" style=\"color:#000000;font-size:17px\">Trees are more important today than ever before. More than 10,000 products are reportedly made from trees. Through chemistry, the humble woodpile is yielding chemicals, plastics and fabrics that were beyond comprehension when an axe first felled a Texas tree.</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:buttons -->\n<div class=\"wp-block-buttons\"><!-- wp:button {\"className\":\"is-style-fill\"} -->\n<div class=\"wp-block-button is-style-fill\"><a class=\"wp-block-button__link\">Learn more</a></div>\n<!-- /wp:button --></div>\n<!-- /wp:buttons --></div></div>\n<!-- /wp:media-text --></div></div>\n<!-- /wp:cover -->\";}i:17;O:8:\"stdClass\":7:{s:2:\"id\";i:192;s:5:\"title\";O:8:\"stdClass\":1:{s:8:\"rendered\";s:37:\"Media and text with image on the left\";}s:7:\"content\";O:8:\"stdClass\":2:{s:8:\"rendered\";s:520:\"\n<div class=\"wp-block-media-text alignfull is-stacked-on-mobile is-vertically-aligned-center\"><figure class=\"wp-block-media-text__media\"><img src=\"https://s.w.org/images/core/5.8/architecture-04.jpg\" alt=\"Close-up, abstract view of architecture.\" /></figure><div class=\"wp-block-media-text__content\">\n<h3 class=\"has-text-align-center has-text-color\" style=\"color:#000000\"><strong>Open Spaces</strong></h3>\n\n\n\n<p class=\"has-text-align-center has-extra-small-font-size\"><a href=\"#\">See case study ↗</a></p>\n</div></div>\n\";s:9:\"protected\";b:0;}s:4:\"meta\";O:8:\"stdClass\":6:{s:10:\"spay_email\";s:0:\"\";s:13:\"wpop_keywords\";s:0:\"\";s:16:\"wpop_description\";s:66:\"Media and text block with image to the left and text to the right.\";s:19:\"wpop_viewport_width\";i:1200;s:16:\"wpop_block_types\";a:0:{}s:11:\"wpop_locale\";s:5:\"en_US\";}s:14:\"category_slugs\";a:2:{i:0;s:8:\"featured\";i:1;s:6:\"header\";}s:13:\"keyword_slugs\";a:1:{i:0;s:4:\"core\";}s:15:\"pattern_content\";s:827:\"<!-- wp:media-text {\"align\":\"full\",\"mediaType\":\"image\",\"verticalAlignment\":\"center\"} -->\n<div class=\"wp-block-media-text alignfull is-stacked-on-mobile is-vertically-aligned-center\"><figure class=\"wp-block-media-text__media\"><img src=\"https://s.w.org/images/core/5.8/architecture-04.jpg\" alt=\"Close-up, abstract view of architecture.\" /></figure><div class=\"wp-block-media-text__content\"><!-- wp:heading {\"textAlign\":\"center\",\"level\":3,\"style\":{\"color\":{\"text\":\"#000000\"}}} -->\n<h3 class=\"has-text-align-center has-text-color\" style=\"color:#000000\"><strong>Open Spaces</strong></h3>\n<!-- /wp:heading -->\n\n<!-- wp:paragraph {\"align\":\"center\",\"fontSize\":\"extra-small\"} -->\n<p class=\"has-text-align-center has-extra-small-font-size\"><a href=\"#\">See case study ↗</a></p>\n<!-- /wp:paragraph --></div></div>\n<!-- /wp:media-text -->\";}i:18;O:8:\"stdClass\":7:{s:2:\"id\";i:195;s:5:\"title\";O:8:\"stdClass\":1:{s:8:\"rendered\";s:38:\"Media and text with image on the right\";}s:7:\"content\";O:8:\"stdClass\":2:{s:8:\"rendered\";s:685:\"\n<div class=\"wp-block-media-text alignfull has-media-on-the-right is-stacked-on-mobile is-vertically-aligned-center is-style-default\" style=\"grid-template-columns:auto 56%\"><figure class=\"wp-block-media-text__media\"><img src=\"https://s.w.org/images/core/5.8/art-02.jpg\" alt=\"A green and brown rural landscape leading into a bright blue ocean and slightly cloudy sky, done in oil paints.\" /></figure><div class=\"wp-block-media-text__content\">\n<h2 class=\"has-text-color\" style=\"color:#000000\"><strong>Shore with Blue Sea</strong></h2>\n\n\n\n<p class=\"has-text-color\" style=\"color:#636363;font-size:17px;line-height:1.1\">Eleanor Harris&nbsp;(American, 1901-1942)</p>\n</div></div>\n\n\n\n<p></p>\n\";s:9:\"protected\";b:0;}s:4:\"meta\";O:8:\"stdClass\":6:{s:10:\"spay_email\";s:0:\"\";s:13:\"wpop_keywords\";s:0:\"\";s:16:\"wpop_description\";s:66:\"Media and text block with image to the right and text to the left.\";s:19:\"wpop_viewport_width\";i:1200;s:16:\"wpop_block_types\";a:0:{}s:11:\"wpop_locale\";s:5:\"en_US\";}s:14:\"category_slugs\";a:1:{i:0;s:6:\"header\";}s:13:\"keyword_slugs\";a:1:{i:0;s:4:\"core\";}s:15:\"pattern_content\";s:1138:\"<!-- wp:media-text {\"align\":\"full\",\"mediaPosition\":\"right\",\"mediaLink\":\"#\",\"mediaType\":\"image\",\"mediaWidth\":56,\"verticalAlignment\":\"center\",\"className\":\"is-style-default\"} -->\n<div class=\"wp-block-media-text alignfull has-media-on-the-right is-stacked-on-mobile is-vertically-aligned-center is-style-default\" style=\"grid-template-columns:auto 56%\"><figure class=\"wp-block-media-text__media\"><img src=\"https://s.w.org/images/core/5.8/art-02.jpg\" alt=\"A green and brown rural landscape leading into a bright blue ocean and slightly cloudy sky, done in oil paints.\" /></figure><div class=\"wp-block-media-text__content\"><!-- wp:heading {\"style\":{\"color\":{\"text\":\"#000000\"}}} -->\n<h2 class=\"has-text-color\" style=\"color:#000000\"><strong>Shore with Blue Sea</strong></h2>\n<!-- /wp:heading -->\n\n<!-- wp:paragraph {\"style\":{\"typography\":{\"lineHeight\":\"1.1\",\"fontSize\":\"17px\"},\"color\":{\"text\":\"#636363\"}}} -->\n<p class=\"has-text-color\" style=\"color:#636363;font-size:17px;line-height:1.1\">Eleanor Harris&nbsp;(American, 1901-1942)</p>\n<!-- /wp:paragraph --></div></div>\n<!-- /wp:media-text -->\n\n<!-- wp:paragraph -->\n<p></p>\n<!-- /wp:paragraph -->\";}i:19;O:8:\"stdClass\":7:{s:2:\"id\";i:27;s:5:\"title\";O:8:\"stdClass\":1:{s:8:\"rendered\";s:5:\"Quote\";}s:7:\"content\";O:8:\"stdClass\":2:{s:8:\"rendered\";s:654:\"\n<hr class=\"wp-block-separator is-style-default\" />\n\n\n\n<div class=\"wp-block-image is-style-rounded\"><figure class=\"aligncenter size-large is-resized\"><img loading=\"lazy\" src=\"https://s.w.org/images/core/5.8/portrait.jpg\" alt=\"A side profile of a woman in a russet-colored turtleneck and white bag. She looks up with her eyes closed.\" width=\"150\" height=\"150\" /></figure></div>\n\n\n\n<blockquote class=\"wp-block-quote has-text-align-center is-style-large\"><p>&#171;Contributing makes me feel like I&#8217;m being useful to the planet.&#187;</p><cite>— Anna Wong, <em>Volunteer</em></cite></blockquote>\n\n\n\n<hr class=\"wp-block-separator is-style-default\" />\n\";s:9:\"protected\";b:0;}s:4:\"meta\";O:8:\"stdClass\":6:{s:10:\"spay_email\";s:0:\"\";s:13:\"wpop_keywords\";s:0:\"\";s:16:\"wpop_description\";s:0:\"\";s:19:\"wpop_viewport_width\";i:800;s:16:\"wpop_block_types\";a:1:{i:0;s:10:\"core/quote\";}s:11:\"wpop_locale\";s:5:\"en_US\";}s:14:\"category_slugs\";a:1:{i:0;s:4:\"text\";}s:13:\"keyword_slugs\";a:1:{i:0;s:4:\"core\";}s:15:\"pattern_content\";s:1012:\"<!-- wp:separator {\"className\":\"is-style-default\"} -->\n<hr class=\"wp-block-separator is-style-default\" />\n<!-- /wp:separator -->\n\n<!-- wp:image {\"align\":\"center\",\"width\":150,\"height\":150,\"sizeSlug\":\"large\",\"linkDestination\":\"none\",\"className\":\"is-style-rounded\"} -->\n<div class=\"wp-block-image is-style-rounded\"><figure class=\"aligncenter size-large is-resized\"><img src=\"https://s.w.org/images/core/5.8/portrait.jpg\" alt=\"A side profile of a woman in a russet-colored turtleneck and white bag. She looks up with her eyes closed.\" width=\"150\" height=\"150\" /></figure></div>\n<!-- /wp:image -->\n\n<!-- wp:quote {\"align\":\"center\",\"className\":\"is-style-large\"} -->\n<blockquote class=\"wp-block-quote has-text-align-center is-style-large\"><p>\"Contributing makes me feel like I\'m being useful to the planet.\"</p><cite>— Anna Wong, <em>Volunteer</em></cite></blockquote>\n<!-- /wp:quote -->\n\n<!-- wp:separator {\"className\":\"is-style-default\"} -->\n<hr class=\"wp-block-separator is-style-default\" />\n<!-- /wp:separator -->\";}i:20;O:8:\"stdClass\":7:{s:2:\"id\";i:200;s:5:\"title\";O:8:\"stdClass\":1:{s:8:\"rendered\";s:21:\"Three columns of text\";}s:7:\"content\";O:8:\"stdClass\":2:{s:8:\"rendered\";s:1013:\"\n<div class=\"wp-container-624c8cd70f6ee wp-block-columns alignfull has-text-color has-background\" style=\"background-color:#ffffff;color:#000000\">\n<div class=\"wp-block-column\">\n<h3 style=\"font-size:24px;line-height:1.3\"><strong><a href=\"http://wordpress.org\">Virtual Tour ↗</a></strong></h3>\n\n\n\n<p>Get a virtual tour of the museum. Ideal for schools and events.</p>\n</div>\n\n\n\n<div class=\"wp-block-column\">\n<h3 style=\"font-size:24px;line-height:1.3\"><strong><a href=\"https://wordpress.org\">Current Shows ↗</a></strong></h3>\n\n\n\n<p>Stay updated and see our current exhibitions here.</p>\n</div>\n\n\n\n<div class=\"wp-block-column\">\n<h3 style=\"font-size:24px;line-height:1.3\"><strong><a href=\"https://wordpress.org\">Useful Info ↗</a></strong></h3>\n\n\n\n<p>Get to know our opening times, ticket prices and discounts.</p>\n</div>\n</div>\n<style>.wp-container-624c8cd70f6ee {display: flex;gap: var( --wp--style--block-gap, 0.5em );flex-wrap: nowrap;align-items: center;}.wp-container-624c8cd70f6ee > * { margin: 0; }</style>\";s:9:\"protected\";b:0;}s:4:\"meta\";O:8:\"stdClass\":6:{s:10:\"spay_email\";s:0:\"\";s:13:\"wpop_keywords\";s:0:\"\";s:16:\"wpop_description\";s:22:\"Three columns of text.\";s:19:\"wpop_viewport_width\";i:1200;s:16:\"wpop_block_types\";a:0:{}s:11:\"wpop_locale\";s:5:\"en_US\";}s:14:\"category_slugs\";a:3:{i:0;s:7:\"columns\";i:1;s:8:\"featured\";i:2;s:4:\"text\";}s:13:\"keyword_slugs\";a:1:{i:0;s:4:\"core\";}s:15:\"pattern_content\";s:1496:\"<!-- wp:columns {\"align\":\"full\",\"style\":{\"color\":{\"text\":\"#000000\",\"background\":\"#ffffff\"}}} -->\n<div class=\"wp-block-columns alignfull has-text-color has-background\" style=\"background-color:#ffffff;color:#000000\"><!-- wp:column -->\n<div class=\"wp-block-column\"><!-- wp:heading {\"level\":3,\"style\":{\"typography\":{\"fontSize\":\"24px\",\"lineHeight\":\"1.3\"}}} -->\n<h3 style=\"font-size:24px;line-height:1.3\"><strong><a href=\"http://wordpress.org\">Virtual Tour ↗</a></strong></h3>\n<!-- /wp:heading -->\n\n<!-- wp:paragraph -->\n<p>Get a virtual tour of the museum. Ideal for schools and events.</p>\n<!-- /wp:paragraph --></div>\n<!-- /wp:column -->\n\n<!-- wp:column -->\n<div class=\"wp-block-column\"><!-- wp:heading {\"level\":3,\"style\":{\"typography\":{\"fontSize\":\"24px\",\"lineHeight\":\"1.3\"}}} -->\n<h3 style=\"font-size:24px;line-height:1.3\"><strong><a href=\"https://wordpress.org\">Current Shows ↗</a></strong></h3>\n<!-- /wp:heading -->\n\n<!-- wp:paragraph -->\n<p>Stay updated and see our current exhibitions here.</p>\n<!-- /wp:paragraph --></div>\n<!-- /wp:column -->\n\n<!-- wp:column -->\n<div class=\"wp-block-column\"><!-- wp:heading {\"level\":3,\"style\":{\"typography\":{\"fontSize\":\"24px\",\"lineHeight\":\"1.3\"}}} -->\n<h3 style=\"font-size:24px;line-height:1.3\"><strong><a href=\"https://wordpress.org\">Useful Info ↗</a></strong></h3>\n<!-- /wp:heading -->\n\n<!-- wp:paragraph -->\n<p>Get to know our opening times, ticket prices and discounts.</p>\n<!-- /wp:paragraph --></div>\n<!-- /wp:column --></div>\n<!-- /wp:columns -->\";}i:21;O:8:\"stdClass\":7:{s:2:\"id\";i:199;s:5:\"title\";O:8:\"stdClass\":1:{s:8:\"rendered\";s:34:\"Three columns with images and text\";}s:7:\"content\";O:8:\"stdClass\":2:{s:8:\"rendered\";s:3603:\"\n<div class=\"wp-container-624c8cd7112bf wp-block-group alignfull has-background\" style=\"background-color:#f8f4e4\">\n<div class=\"wp-container-624c8cd710804 wp-block-columns alignwide\">\n<div class=\"wp-block-column\">\n<div style=\"height:100px\" aria-hidden=\"true\" class=\"wp-block-spacer\"></div>\n\n\n\n<h6 class=\"has-text-color\" id=\"ecosystem\" style=\"color:#000000\">ECOSYSTEM</h6>\n\n\n\n<p class=\"has-text-color\" style=\"color:#000000;font-size:5vw;line-height:1.1\"><strong>Positive growth.</strong></p>\n\n\n\n<div style=\"height:5px\" aria-hidden=\"true\" class=\"wp-block-spacer\"></div>\n</div>\n</div>\n<style>.wp-container-624c8cd710804 {display: flex;gap: var( --wp--style--block-gap, 0.5em );flex-wrap: nowrap;align-items: center;}.wp-container-624c8cd710804 > * { margin: 0; }</style>\n\n\n<div class=\"wp-container-624c8cd710bd2 wp-block-columns alignwide\">\n<div class=\"wp-block-column\" style=\"flex-basis:33.38%\">\n<p class=\"has-text-color has-extra-small-font-size\" style=\"color:#000000\"><em>Nature</em>, in the common sense, refers to essences unchanged by man; space, the air, the river, the leaf.&nbsp;<em>Art</em>&nbsp;is applied to the mixture of his will with the same things, as in a house, a canal, a statue, a picture. But his operations taken together are so insignificant, a little chipping, baking, patching, and washing, that in an impression so grand as that of the world on the human mind, they do not vary the result.</p>\n</div>\n\n\n\n<div class=\"wp-block-column\" style=\"flex-basis:33%\">\n<div style=\"height:100px\" aria-hidden=\"true\" class=\"wp-block-spacer\"></div>\n\n\n\n<figure class=\"wp-block-image size-large\"><img src=\"https://s.w.org/images/core/5.8/outside-01.jpg\" alt=\"The sun setting through a dense forest.\" /></figure>\n</div>\n\n\n\n<div class=\"wp-block-column\" style=\"flex-basis:33.62%\">\n<figure class=\"wp-block-image size-large\"><img src=\"https://s.w.org/images/core/5.8/outside-02.jpg\" alt=\"Wind turbines standing on a grassy plain, against a blue sky.\" /></figure>\n</div>\n</div>\n<style>.wp-container-624c8cd710bd2 {display: flex;gap: var( --wp--style--block-gap, 0.5em );flex-wrap: nowrap;align-items: center;}.wp-container-624c8cd710bd2 > * { margin: 0; }</style>\n\n\n<div class=\"wp-container-624c8cd710f79 wp-block-columns alignwide\">\n<div class=\"wp-block-column\" style=\"flex-basis:67%\">\n<div class=\"wp-block-image\"><figure class=\"alignright size-large\"><img src=\"https://s.w.org/images/core/5.8/outside-03.jpg\" alt=\"The sun shining over a ridge leading down into the shore. In the distance, a car drives down a road.\" /></figure></div>\n</div>\n\n\n\n<div class=\"wp-block-column is-vertically-aligned-center\" style=\"flex-basis:33%\">\n<p class=\"has-text-color has-extra-small-font-size\" style=\"color:#000000\">Undoubtedly we have no questions to ask which are unanswerable. We must trust the perfection of the creation so far, as to believe that whatever curiosity the order of things has awakened in our minds, the order of things can satisfy. Every man&#8217;s condition is a solution in hieroglyphic to those inquiries he would put.</p>\n</div>\n</div>\n<style>.wp-container-624c8cd710f79 {display: flex;gap: var( --wp--style--block-gap, 0.5em );flex-wrap: nowrap;align-items: center;}.wp-container-624c8cd710f79 > * { margin: 0; }</style></div>\n<style>.wp-container-624c8cd7112bf .alignleft { float: left; margin-right: 2em; margin-left: 0; }.wp-container-624c8cd7112bf .alignright { float: right; margin-left: 2em; margin-right: 0; }.wp-container-624c8cd7112bf > * { margin-top: 0; margin-bottom: 0; }.wp-container-624c8cd7112bf > * + * { margin-top: var( --wp--style--block-gap );  margin-bottom: 0; }</style>\";s:9:\"protected\";b:0;}s:4:\"meta\";O:8:\"stdClass\":6:{s:10:\"spay_email\";s:0:\"\";s:13:\"wpop_keywords\";s:0:\"\";s:16:\"wpop_description\";s:77:\"Three columns with images and text, with vertical spacing for an offset look.\";s:19:\"wpop_viewport_width\";i:1200;s:16:\"wpop_block_types\";a:0:{}s:11:\"wpop_locale\";s:5:\"en_US\";}s:14:\"category_slugs\";a:2:{i:0;s:7:\"columns\";i:1;s:8:\"featured\";}s:13:\"keyword_slugs\";a:1:{i:0;s:4:\"core\";}s:15:\"pattern_content\";s:3990:\"<!-- wp:group {\"align\":\"full\",\"style\":{\"color\":{\"background\":\"#f8f4e4\"}}} -->\n<div class=\"wp-block-group alignfull has-background\" style=\"background-color:#f8f4e4\"><!-- wp:columns {\"align\":\"wide\"} -->\n<div class=\"wp-block-columns alignwide\"><!-- wp:column -->\n<div class=\"wp-block-column\"><!-- wp:spacer -->\n<div style=\"height:100px\" aria-hidden=\"true\" class=\"wp-block-spacer\"></div>\n<!-- /wp:spacer -->\n\n<!-- wp:heading {\"level\":6,\"style\":{\"color\":{\"text\":\"#000000\"}}} -->\n<h6 class=\"has-text-color\" id=\"ecosystem\" style=\"color:#000000\">ECOSYSTEM</h6>\n<!-- /wp:heading -->\n\n<!-- wp:paragraph {\"style\":{\"typography\":{\"lineHeight\":\"1.1\",\"fontSize\":\"5vw\"},\"color\":{\"text\":\"#000000\"}}} -->\n<p class=\"has-text-color\" style=\"color:#000000;font-size:5vw;line-height:1.1\"><strong>Positive growth.</strong></p>\n<!-- /wp:paragraph -->\n\n<!-- wp:spacer {\"height\":\"5px\"} -->\n<div style=\"height:5px\" aria-hidden=\"true\" class=\"wp-block-spacer\"></div>\n<!-- /wp:spacer --></div>\n<!-- /wp:column --></div>\n<!-- /wp:columns -->\n\n<!-- wp:columns {\"align\":\"wide\"} -->\n<div class=\"wp-block-columns alignwide\"><!-- wp:column {\"width\":\"33.38%\"} -->\n<div class=\"wp-block-column\" style=\"flex-basis:33.38%\"><!-- wp:paragraph {\"style\":{\"color\":{\"text\":\"#000000\"}},\"fontSize\":\"extra-small\"} -->\n<p class=\"has-text-color has-extra-small-font-size\" style=\"color:#000000\"><em>Nature</em>, in the common sense, refers to essences unchanged by man; space, the air, the river, the leaf.&nbsp;<em>Art</em>&nbsp;is applied to the mixture of his will with the same things, as in a house, a canal, a statue, a picture. But his operations taken together are so insignificant, a little chipping, baking, patching, and washing, that in an impression so grand as that of the world on the human mind, they do not vary the result.</p>\n<!-- /wp:paragraph --></div>\n<!-- /wp:column -->\n\n<!-- wp:column {\"width\":\"33%\"} -->\n<div class=\"wp-block-column\" style=\"flex-basis:33%\"><!-- wp:spacer -->\n<div style=\"height:100px\" aria-hidden=\"true\" class=\"wp-block-spacer\"></div>\n<!-- /wp:spacer -->\n\n<!-- wp:image {\"sizeSlug\":\"large\",\"linkDestination\":\"none\"} -->\n<figure class=\"wp-block-image size-large\"><img src=\"https://s.w.org/images/core/5.8/outside-01.jpg\" alt=\"The sun setting through a dense forest.\" /></figure>\n<!-- /wp:image --></div>\n<!-- /wp:column -->\n\n<!-- wp:column {\"width\":\"33.62%\"} -->\n<div class=\"wp-block-column\" style=\"flex-basis:33.62%\"><!-- wp:image {\"sizeSlug\":\"large\",\"linkDestination\":\"none\"} -->\n<figure class=\"wp-block-image size-large\"><img src=\"https://s.w.org/images/core/5.8/outside-02.jpg\" alt=\"Wind turbines standing on a grassy plain, against a blue sky.\" /></figure>\n<!-- /wp:image --></div>\n<!-- /wp:column --></div>\n<!-- /wp:columns -->\n\n<!-- wp:columns {\"align\":\"wide\"} -->\n<div class=\"wp-block-columns alignwide\"><!-- wp:column {\"width\":\"67%\"} -->\n<div class=\"wp-block-column\" style=\"flex-basis:67%\"><!-- wp:image {\"align\":\"right\",\"sizeSlug\":\"large\",\"linkDestination\":\"none\"} -->\n<div class=\"wp-block-image\"><figure class=\"alignright size-large\"><img src=\"https://s.w.org/images/core/5.8/outside-03.jpg\" alt=\"The sun shining over a ridge leading down into the shore. In the distance, a car drives down a road.\" /></figure></div>\n<!-- /wp:image --></div>\n<!-- /wp:column -->\n\n<!-- wp:column {\"verticalAlignment\":\"center\",\"width\":\"33%\"} -->\n<div class=\"wp-block-column is-vertically-aligned-center\" style=\"flex-basis:33%\"><!-- wp:paragraph {\"style\":{\"color\":{\"text\":\"#000000\"}},\"fontSize\":\"extra-small\"} -->\n<p class=\"has-text-color has-extra-small-font-size\" style=\"color:#000000\">Undoubtedly we have no questions to ask which are unanswerable. We must trust the perfection of the creation so far, as to believe that whatever curiosity the order of things has awakened in our minds, the order of things can satisfy. Every man\'s condition is a solution in hieroglyphic to those inquiries he would put.</p>\n<!-- /wp:paragraph --></div>\n<!-- /wp:column --></div>\n<!-- /wp:columns --></div>\n<!-- /wp:group -->\";}i:22;O:8:\"stdClass\":7:{s:2:\"id\";i:201;s:5:\"title\";O:8:\"stdClass\":1:{s:8:\"rendered\";s:32:\"Three columns with offset images\";}s:7:\"content\";O:8:\"stdClass\":2:{s:8:\"rendered\";s:1289:\"\n<div class=\"wp-container-624c8cd712675 wp-block-columns alignwide\">\n<div class=\"wp-block-column\" style=\"flex-basis:25%\">\n<figure class=\"wp-block-image size-large is-style-default\"><img src=\"https://s.w.org/images/core/5.8/architecture-01.jpg\" alt=\"Close-up, abstract view of geometric architecture.\" /></figure>\n</div>\n\n\n\n<div class=\"wp-block-column\" style=\"flex-basis:25%\">\n<div style=\"height:500px\" aria-hidden=\"true\" class=\"wp-block-spacer\"></div>\n\n\n\n<div style=\"height:150px\" aria-hidden=\"true\" class=\"wp-block-spacer\"></div>\n\n\n\n<figure class=\"wp-block-image size-large\"><img src=\"https://s.w.org/images/core/5.8/architecture-02.jpg\" alt=\"Close-up, angled view of a window on a white building.\" /></figure>\n</div>\n\n\n\n<div class=\"wp-block-column\" style=\"flex-basis:45%\">\n<figure class=\"wp-block-image size-large is-style-default\"><img src=\"https://s.w.org/images/core/5.8/architecture-03.jpg\" alt=\"Close-up of the corner of a white, geometric building with both sharp points and round corners.\" /></figure>\n\n\n\n<div style=\"height:285px\" aria-hidden=\"true\" class=\"wp-block-spacer\"></div>\n</div>\n</div>\n<style>.wp-container-624c8cd712675 {display: flex;gap: var( --wp--style--block-gap, 0.5em );flex-wrap: nowrap;align-items: center;}.wp-container-624c8cd712675 > * { margin: 0; }</style>\";s:9:\"protected\";b:0;}s:4:\"meta\";O:8:\"stdClass\":6:{s:10:\"spay_email\";s:0:\"\";s:13:\"wpop_keywords\";s:0:\"\";s:16:\"wpop_description\";s:33:\"Three columns with offset images.\";s:19:\"wpop_viewport_width\";i:1200;s:16:\"wpop_block_types\";a:0:{}s:11:\"wpop_locale\";s:5:\"en_US\";}s:14:\"category_slugs\";a:2:{i:0;s:7:\"gallery\";i:1;s:6:\"images\";}s:13:\"keyword_slugs\";a:1:{i:0;s:4:\"core\";}s:15:\"pattern_content\";s:1753:\"<!-- wp:columns {\"align\":\"wide\"} -->\n<div class=\"wp-block-columns alignwide\"><!-- wp:column {\"width\":\"25%\"} -->\n<div class=\"wp-block-column\" style=\"flex-basis:25%\"><!-- wp:image {\"sizeSlug\":\"large\",\"linkDestination\":\"none\",\"className\":\"is-style-default\"} -->\n<figure class=\"wp-block-image size-large is-style-default\"><img src=\"https://s.w.org/images/core/5.8/architecture-01.jpg\" alt=\"Close-up, abstract view of geometric architecture.\" /></figure>\n<!-- /wp:image --></div>\n<!-- /wp:column -->\n\n<!-- wp:column {\"width\":\"25%\"} -->\n<div class=\"wp-block-column\" style=\"flex-basis:25%\"><!-- wp:spacer {\"height\":500} -->\n<div style=\"height:500px\" aria-hidden=\"true\" class=\"wp-block-spacer\"></div>\n<!-- /wp:spacer -->\n\n<!-- wp:spacer {\"height\":150} -->\n<div style=\"height:150px\" aria-hidden=\"true\" class=\"wp-block-spacer\"></div>\n<!-- /wp:spacer -->\n\n<!-- wp:image {\"sizeSlug\":\"large\",\"linkDestination\":\"none\"} -->\n<figure class=\"wp-block-image size-large\"><img src=\"https://s.w.org/images/core/5.8/architecture-02.jpg\" alt=\"Close-up, angled view of a window on a white building.\" /></figure>\n<!-- /wp:image --></div>\n<!-- /wp:column -->\n\n<!-- wp:column {\"width\":\"45%\"} -->\n<div class=\"wp-block-column\" style=\"flex-basis:45%\"><!-- wp:image {\"sizeSlug\":\"large\",\"linkDestination\":\"none\",\"className\":\"is-style-default\"} -->\n<figure class=\"wp-block-image size-large is-style-default\"><img src=\"https://s.w.org/images/core/5.8/architecture-03.jpg\" alt=\"Close-up of the corner of a white, geometric building with both sharp points and round corners.\" /></figure>\n<!-- /wp:image -->\n\n<!-- wp:spacer {\"height\":285} -->\n<div style=\"height:285px\" aria-hidden=\"true\" class=\"wp-block-spacer\"></div>\n<!-- /wp:spacer --></div>\n<!-- /wp:column --></div>\n<!-- /wp:columns -->\";}i:23;O:8:\"stdClass\":7:{s:2:\"id\";i:29;s:5:\"title\";O:8:\"stdClass\":1:{s:8:\"rendered\";s:29:\"Two columns of text and title\";}s:7:\"content\";O:8:\"stdClass\":2:{s:8:\"rendered\";s:1549:\"\n<h2 style=\"font-size:38px;line-height:1.4\"><strong>The voyage had begun, and had begun happily with a soft blue sky, and a calm sea.</strong></h2>\n\n\n\n<div class=\"wp-container-624c8cd713683 wp-block-columns\">\n<div class=\"wp-block-column\">\n<p style=\"font-size:18px\">They followed her on to the deck. All the smoke and the houses had disappeared, and the ship was out in a wide space of sea very fresh and clear though pale in the early light. They had left London sitting on its mud. A very thin line of shadow tapered on the horizon, scarcely thick enough to stand the burden of Paris, which nevertheless rested upon it. They were free of roads, free of mankind, and the same exhilaration at their freedom ran through them all.</p>\n</div>\n\n\n\n<div class=\"wp-block-column\">\n<p style=\"font-size:18px\">The ship was making her way steadily through small waves which slapped her and then fizzled like effervescing water, leaving a little border of bubbles and foam on either side. The colourless October sky above was thinly clouded as if by the trail of wood-fire smoke, and the air was wonderfully salt and brisk. Indeed it was too cold to stand still. Mrs. Ambrose drew her arm within her husband&#8217;s, and as they moved off it could be seen from the way in which her sloping cheek turned up to his that she had something private to communicate.</p>\n</div>\n</div>\n<style>.wp-container-624c8cd713683 {display: flex;gap: var( --wp--style--block-gap, 0.5em );flex-wrap: nowrap;align-items: center;}.wp-container-624c8cd713683 > * { margin: 0; }</style>\";s:9:\"protected\";b:0;}s:4:\"meta\";O:8:\"stdClass\":6:{s:10:\"spay_email\";s:0:\"\";s:13:\"wpop_keywords\";s:0:\"\";s:16:\"wpop_description\";s:47:\"Two columns of text preceded by a long heading.\";s:19:\"wpop_viewport_width\";i:1200;s:16:\"wpop_block_types\";a:0:{}s:11:\"wpop_locale\";s:5:\"en_US\";}s:14:\"category_slugs\";a:2:{i:0;s:7:\"columns\";i:1;s:4:\"text\";}s:13:\"keyword_slugs\";a:1:{i:0;s:4:\"core\";}s:15:\"pattern_content\";s:1711:\"<!-- wp:heading {\"style\":{\"typography\":{\"fontSize\":38,\"lineHeight\":\"1.4\"}}} -->\n<h2 style=\"font-size:38px;line-height:1.4\"><strong>The voyage had begun, and had begun happily with a soft blue sky, and a calm sea.</strong></h2>\n<!-- /wp:heading -->\n\n<!-- wp:columns -->\n<div class=\"wp-block-columns\"><!-- wp:column -->\n<div class=\"wp-block-column\"><!-- wp:paragraph {\"style\":{\"typography\":{\"fontSize\":18}}} -->\n<p style=\"font-size:18px\">They followed her on to the deck. All the smoke and the houses had disappeared, and the ship was out in a wide space of sea very fresh and clear though pale in the early light. They had left London sitting on its mud. A very thin line of shadow tapered on the horizon, scarcely thick enough to stand the burden of Paris, which nevertheless rested upon it. They were free of roads, free of mankind, and the same exhilaration at their freedom ran through them all.</p>\n<!-- /wp:paragraph --></div>\n<!-- /wp:column -->\n\n<!-- wp:column -->\n<div class=\"wp-block-column\"><!-- wp:paragraph {\"style\":{\"typography\":{\"fontSize\":18}}} -->\n<p style=\"font-size:18px\">The ship was making her way steadily through small waves which slapped her and then fizzled like effervescing water, leaving a little border of bubbles and foam on either side. The colourless October sky above was thinly clouded as if by the trail of wood-fire smoke, and the air was wonderfully salt and brisk. Indeed it was too cold to stand still. Mrs. Ambrose drew her arm within her husband\'s, and as they moved off it could be seen from the way in which her sloping cheek turned up to his that she had something private to communicate.</p>\n<!-- /wp:paragraph --></div>\n<!-- /wp:column --></div>\n<!-- /wp:columns -->\";}i:24;O:8:\"stdClass\":7:{s:2:\"id\";i:197;s:5:\"title\";O:8:\"stdClass\":1:{s:8:\"rendered\";s:39:\"Two columns of text with offset heading\";}s:7:\"content\";O:8:\"stdClass\":2:{s:8:\"rendered\";s:2654:\"\n<div class=\"wp-container-624c8cd714b6e wp-block-group alignfull has-background\" style=\"background-color:#f2f0e9\">\n<div style=\"height:70px\" aria-hidden=\"true\" class=\"wp-block-spacer\"></div>\n\n\n\n<div class=\"wp-container-624c8cd7144fa wp-block-columns alignwide are-vertically-aligned-center\">\n<div class=\"wp-block-column\" style=\"flex-basis:50%\">\n<p class=\"has-text-color\" style=\"color:#000000;font-size:30px;line-height:1.1\"><strong>Oceanic Inspiration</strong></p>\n</div>\n\n\n\n<div class=\"wp-block-column\" style=\"flex-basis:50%\">\n<hr class=\"wp-block-separator has-text-color has-background is-style-wide\" style=\"background-color:#000000;color:#000000\" />\n</div>\n</div>\n<style>.wp-container-624c8cd7144fa {display: flex;gap: var( --wp--style--block-gap, 0.5em );flex-wrap: nowrap;align-items: center;}.wp-container-624c8cd7144fa > * { margin: 0; }</style>\n\n\n<div class=\"wp-container-624c8cd714850 wp-block-columns alignwide\">\n<div class=\"wp-block-column\"></div>\n\n\n\n<div class=\"wp-block-column\">\n<p class=\"has-text-color has-extra-small-font-size\" style=\"color:#000000\">Winding veils round their heads, the women walked on deck. They were now moving steadily down the river, passing the dark shapes of ships at anchor, and London was a swarm of lights with a pale yellow canopy drooping above it. There were the lights of the great theatres, the lights of the long streets, lights that indicated huge squares of domestic comfort, lights that hung high in air.</p>\n</div>\n\n\n\n<div class=\"wp-block-column\">\n<p class=\"has-text-color has-extra-small-font-size\" style=\"color:#000000\">No darkness would ever settle upon those lamps, as no darkness had settled upon them for hundreds of years. It seemed dreadful that the town should blaze for ever in the same spot; dreadful at least to people going away to adventure upon the sea, and beholding it as a circumscribed mound, eternally burnt, eternally scarred. From the deck of the ship the great city appeared a crouched and cowardly figure, a sedentary miser.</p>\n</div>\n</div>\n<style>.wp-container-624c8cd714850 {display: flex;gap: var( --wp--style--block-gap, 0.5em );flex-wrap: nowrap;align-items: center;}.wp-container-624c8cd714850 > * { margin: 0; }</style>\n\n\n<div style=\"height:40px\" aria-hidden=\"true\" class=\"wp-block-spacer\"></div>\n</div>\n<style>.wp-container-624c8cd714b6e .alignleft { float: left; margin-right: 2em; margin-left: 0; }.wp-container-624c8cd714b6e .alignright { float: right; margin-left: 2em; margin-right: 0; }.wp-container-624c8cd714b6e > * { margin-top: 0; margin-bottom: 0; }.wp-container-624c8cd714b6e > * + * { margin-top: var( --wp--style--block-gap );  margin-bottom: 0; }</style>\";s:9:\"protected\";b:0;}s:4:\"meta\";O:8:\"stdClass\":6:{s:10:\"spay_email\";s:0:\"\";s:13:\"wpop_keywords\";s:0:\"\";s:16:\"wpop_description\";s:43:\"Two columns of text with an offset heading.\";s:19:\"wpop_viewport_width\";i:1200;s:16:\"wpop_block_types\";a:0:{}s:11:\"wpop_locale\";s:5:\"en_US\";}s:14:\"category_slugs\";a:2:{i:0;s:7:\"columns\";i:1;s:4:\"text\";}s:13:\"keyword_slugs\";a:1:{i:0;s:4:\"core\";}s:15:\"pattern_content\";s:2837:\"<!-- wp:group {\"align\":\"full\",\"style\":{\"color\":{\"background\":\"#f2f0e9\"}}} -->\n<div class=\"wp-block-group alignfull has-background\" style=\"background-color:#f2f0e9\"><!-- wp:spacer {\"height\":70} -->\n<div style=\"height:70px\" aria-hidden=\"true\" class=\"wp-block-spacer\"></div>\n<!-- /wp:spacer -->\n\n<!-- wp:columns {\"verticalAlignment\":\"center\",\"align\":\"wide\"} -->\n<div class=\"wp-block-columns alignwide are-vertically-aligned-center\"><!-- wp:column {\"width\":\"50%\"} -->\n<div class=\"wp-block-column\" style=\"flex-basis:50%\"><!-- wp:paragraph {\"style\":{\"typography\":{\"lineHeight\":\"1.1\",\"fontSize\":\"30px\"},\"color\":{\"text\":\"#000000\"}}} -->\n<p class=\"has-text-color\" style=\"color:#000000;font-size:30px;line-height:1.1\"><strong>Oceanic Inspiration</strong></p>\n<!-- /wp:paragraph --></div>\n<!-- /wp:column -->\n\n<!-- wp:column {\"width\":\"50%\"} -->\n<div class=\"wp-block-column\" style=\"flex-basis:50%\"><!-- wp:separator {\"customColor\":\"#000000\",\"className\":\"is-style-wide\"} -->\n<hr class=\"wp-block-separator has-text-color has-background is-style-wide\" style=\"background-color:#000000;color:#000000\" />\n<!-- /wp:separator --></div>\n<!-- /wp:column --></div>\n<!-- /wp:columns -->\n\n<!-- wp:columns {\"align\":\"wide\"} -->\n<div class=\"wp-block-columns alignwide\"><!-- wp:column -->\n<div class=\"wp-block-column\"></div>\n<!-- /wp:column -->\n\n<!-- wp:column -->\n<div class=\"wp-block-column\"><!-- wp:paragraph {\"style\":{\"color\":{\"text\":\"#000000\"}},\"fontSize\":\"extra-small\"} -->\n<p class=\"has-text-color has-extra-small-font-size\" style=\"color:#000000\">Winding veils round their heads, the women walked on deck. They were now moving steadily down the river, passing the dark shapes of ships at anchor, and London was a swarm of lights with a pale yellow canopy drooping above it. There were the lights of the great theatres, the lights of the long streets, lights that indicated huge squares of domestic comfort, lights that hung high in air.</p>\n<!-- /wp:paragraph --></div>\n<!-- /wp:column -->\n\n<!-- wp:column -->\n<div class=\"wp-block-column\"><!-- wp:paragraph {\"style\":{\"color\":{\"text\":\"#000000\"}},\"fontSize\":\"extra-small\"} -->\n<p class=\"has-text-color has-extra-small-font-size\" style=\"color:#000000\">No darkness would ever settle upon those lamps, as no darkness had settled upon them for hundreds of years. It seemed dreadful that the town should blaze for ever in the same spot; dreadful at least to people going away to adventure upon the sea, and beholding it as a circumscribed mound, eternally burnt, eternally scarred. From the deck of the ship the great city appeared a crouched and cowardly figure, a sedentary miser.</p>\n<!-- /wp:paragraph --></div>\n<!-- /wp:column --></div>\n<!-- /wp:columns -->\n\n<!-- wp:spacer {\"height\":40} -->\n<div style=\"height:40px\" aria-hidden=\"true\" class=\"wp-block-spacer\"></div>\n<!-- /wp:spacer --></div>\n<!-- /wp:group -->\";}i:25;O:8:\"stdClass\":7:{s:2:\"id\";i:19;s:5:\"title\";O:8:\"stdClass\":1:{s:8:\"rendered\";s:23:\"Two images side by side\";}s:7:\"content\";O:8:\"stdClass\":2:{s:8:\"rendered\";s:647:\"\n<figure class=\"wp-block-gallery alignwide columns-2 is-cropped\"><ul class=\"blocks-gallery-grid\"><li class=\"blocks-gallery-item\"><figure><img src=\"https://s.w.org/images/core/5.8/nature-above-01.jpg\" alt=\"An aerial view of waves crashing against a shore.\" data-full-url=\"https://s.w.org/images/core/5.8/nature-above-01.jpg\" data-link=\"#\" /></figure></li><li class=\"blocks-gallery-item\"><figure><img src=\"https://s.w.org/images/core/5.8/nature-above-02.jpg\" alt=\"An aerial view of a field. A road runs through the upper right corner.\" data-full-url=\"https://s.w.org/images/core/5.8/nature-above-02.jpg\" data-link=\"#\" /></figure></li></ul></figure>\n\";s:9:\"protected\";b:0;}s:4:\"meta\";O:8:\"stdClass\":6:{s:10:\"spay_email\";s:0:\"\";s:13:\"wpop_keywords\";s:0:\"\";s:16:\"wpop_description\";s:41:\"An image gallery with two example images.\";s:19:\"wpop_viewport_width\";i:800;s:16:\"wpop_block_types\";a:0:{}s:11:\"wpop_locale\";s:5:\"en_US\";}s:14:\"category_slugs\";a:1:{i:0;s:7:\"gallery\";}s:13:\"keyword_slugs\";a:1:{i:0;s:4:\"core\";}s:15:\"pattern_content\";s:737:\"<!-- wp:gallery {\"ids\":[null,null],\"linkTo\":\"none\",\"align\":\"wide\"} -->\n<figure class=\"wp-block-gallery alignwide columns-2 is-cropped\"><ul class=\"blocks-gallery-grid\"><li class=\"blocks-gallery-item\"><figure><img src=\"https://s.w.org/images/core/5.8/nature-above-01.jpg\" alt=\"An aerial view of waves crashing against a shore.\" data-full-url=\"https://s.w.org/images/core/5.8/nature-above-01.jpg\" data-link=\"#\" /></figure></li><li class=\"blocks-gallery-item\"><figure><img src=\"https://s.w.org/images/core/5.8/nature-above-02.jpg\" alt=\"An aerial view of a field. A road runs through the upper right corner.\" data-full-url=\"https://s.w.org/images/core/5.8/nature-above-02.jpg\" data-link=\"#\" /></figure></li></ul></figure>\n<!-- /wp:gallery -->\";}}', 'no');
INSERT INTO `urotec_options` (`option_id`, `option_name`, `option_value`, `autoload`) VALUES
(470, '_site_transient_timeout_wp_remote_block_patterns_9c64b6249697996d8e205e5ef979dcff', '1649187664', 'no');
INSERT INTO `urotec_options` (`option_id`, `option_name`, `option_value`, `autoload`) VALUES
(471, '_site_transient_wp_remote_block_patterns_9c64b6249697996d8e205e5ef979dcff', 'a:28:{i:0;O:8:\"stdClass\":7:{s:2:\"id\";i:4349;s:5:\"title\";O:8:\"stdClass\":1:{s:8:\"rendered\";s:49:\"Анонс и детали мероприятия\";}s:7:\"content\";O:8:\"stdClass\":2:{s:8:\"rendered\";s:2392:\"\n<div class=\"wp-elements-624c8c9f234e2 wp-container-624c8c9f234ca wp-block-group alignfull has-black-color has-text-color has-background has-link-color\" style=\"background-color:#d2cdc7\">\n<div style=\"height:50px\" aria-hidden=\"true\" class=\"wp-block-spacer\"></div>\n\n\n\n<h2 class=\"alignwide\" style=\"font-size:46px;font-weight:400;line-height:1.1\">ЭЛЕН ДЮМА<br><em>ФРАГМЕНТЫ</em></h2>\n\n\n\n<h3 class=\"alignwide\" style=\"font-size:46px;font-weight:400;line-height:1.1\">20/4 &#8212; 9/9/2021<br>ЮЖНАЯ ЛОНДОНСКАЯ ХУДОЖЕСТВЕННАЯ ГАЛЕРЕЯ</h3>\n\n\n\n<div style=\"height:50px\" aria-hidden=\"true\" class=\"wp-block-spacer\"></div>\n\n\n\n<div class=\"wp-container-624c8c9f22e2f wp-block-columns alignwide\">\n<div class=\"wp-block-column\" style=\"flex-basis:25%\"></div>\n\n\n\n<div class=\"wp-block-column\" style=\"flex-basis:75%\">\n<figure class=\"wp-block-image size-full\"><img src=\"https://mywptesting.site/wp-content/uploads/2021/06/Histoire_naturelle_..._-fragments-_-_Upper_cover_C108eee15-1.jpg\" alt=\"\" class=\"wp-image-3173\" /></figure>\n</div>\n</div>\n<style>.wp-container-624c8c9f22e2f {display: flex;gap: var( --wp--style--block-gap, 0.5em );flex-wrap: nowrap;align-items: center;}.wp-container-624c8c9f22e2f > * { margin: 0; }</style>\n\n\n<div style=\"height:50px\" aria-hidden=\"true\" class=\"wp-block-spacer\"></div>\n\n\n\n<div class=\"wp-container-624c8c9f231ab wp-block-columns alignwide\">\n<div class=\"wp-block-column\">\n<p style=\"font-size:25px\">ПОДРОБНЕЕ НА: WP.ORG · +44 21 1234 5678</p>\n</div>\n\n\n\n<div class=\"wp-block-column\">\n<p class=\"has-text-align-right\" style=\"font-size:25px\">INSTAGRAM · <a href=\"#\">БИЛЕТЫ</a></p>\n</div>\n</div>\n<style>.wp-container-624c8c9f231ab {display: flex;gap: var( --wp--style--block-gap, 0.5em );flex-wrap: nowrap;align-items: center;}.wp-container-624c8c9f231ab > * { margin: 0; }</style>\n\n\n<div style=\"height:50px\" aria-hidden=\"true\" class=\"wp-block-spacer\"></div>\n</div>\n<style>.wp-container-624c8c9f234ca .alignleft { float: left; margin-right: 2em; margin-left: 0; }.wp-container-624c8c9f234ca .alignright { float: right; margin-left: 2em; margin-right: 0; }.wp-container-624c8c9f234ca > * { margin-top: 0; margin-bottom: 0; }.wp-container-624c8c9f234ca > * + * { margin-top: var( --wp--style--block-gap );  margin-bottom: 0; }</style><style>.wp-elements-624c8c9f234e2 a{color: var(--wp--preset--color--black);}</style>\n\";s:9:\"protected\";b:0;}s:4:\"meta\";O:8:\"stdClass\":6:{s:10:\"spay_email\";s:0:\"\";s:13:\"wpop_keywords\";s:0:\"\";s:16:\"wpop_description\";s:0:\"\";s:19:\"wpop_viewport_width\";i:800;s:16:\"wpop_block_types\";a:0:{}s:11:\"wpop_locale\";s:5:\"ru_RU\";}s:14:\"category_slugs\";a:3:{i:0;s:8:\"featured\";i:1;s:6:\"images\";i:2;s:4:\"text\";}s:13:\"keyword_slugs\";a:0:{}s:15:\"pattern_content\";s:2699:\"<!-- wp:group {\"align\":\"full\",\"style\":{\"color\":{\"background\":\"#d2cdc7\"},\"elements\":{\"link\":{\"color\":{\"text\":\"var:preset|color|black\"}}}},\"textColor\":\"black\"} -->\n<div class=\"wp-block-group alignfull has-black-color has-text-color has-background has-link-color\" style=\"background-color:#d2cdc7\"><!-- wp:spacer {\"height\":50} -->\n<div style=\"height:50px\" aria-hidden=\"true\" class=\"wp-block-spacer\"></div>\n<!-- /wp:spacer -->\n\n<!-- wp:heading {\"align\":\"wide\",\"style\":{\"typography\":{\"fontSize\":\"46px\",\"lineHeight\":\"1.1\",\"fontWeight\":\"400\"}}} -->\n<h2 class=\"alignwide\" style=\"font-size:46px;font-weight:400;line-height:1.1\">ЭЛЕН ДЮМА<br><em>ФРАГМЕНТЫ</em></h2>\n<!-- /wp:heading -->\n\n<!-- wp:heading {\"level\":3,\"align\":\"wide\",\"style\":{\"typography\":{\"fontSize\":\"46px\",\"lineHeight\":\"1.1\",\"fontWeight\":\"400\"}}} -->\n<h3 class=\"alignwide\" style=\"font-size:46px;font-weight:400;line-height:1.1\">20/4 - 9/9/2021<br>ЮЖНАЯ ЛОНДОНСКАЯ ХУДОЖЕСТВЕННАЯ ГАЛЕРЕЯ</h3>\n<!-- /wp:heading -->\n\n<!-- wp:spacer {\"height\":50} -->\n<div style=\"height:50px\" aria-hidden=\"true\" class=\"wp-block-spacer\"></div>\n<!-- /wp:spacer -->\n\n<!-- wp:columns {\"align\":\"wide\"} -->\n<div class=\"wp-block-columns alignwide\"><!-- wp:column {\"width\":\"25%\"} -->\n<div class=\"wp-block-column\" style=\"flex-basis:25%\"></div>\n<!-- /wp:column -->\n\n<!-- wp:column {\"width\":\"75%\"} -->\n<div class=\"wp-block-column\" style=\"flex-basis:75%\"><!-- wp:image {\"id\":3173,\"sizeSlug\":\"full\",\"linkDestination\":\"none\"} -->\n<figure class=\"wp-block-image size-full\"><img src=\"https://mywptesting.site/wp-content/uploads/2021/06/Histoire_naturelle_..._-fragments-_-_Upper_cover_C108eee15-1.jpg\" alt=\"\" class=\"wp-image-3173\" /></figure>\n<!-- /wp:image --></div>\n<!-- /wp:column --></div>\n<!-- /wp:columns -->\n\n<!-- wp:spacer {\"height\":50} -->\n<div style=\"height:50px\" aria-hidden=\"true\" class=\"wp-block-spacer\"></div>\n<!-- /wp:spacer -->\n\n<!-- wp:columns {\"align\":\"wide\"} -->\n<div class=\"wp-block-columns alignwide\"><!-- wp:column -->\n<div class=\"wp-block-column\"><!-- wp:paragraph {\"style\":{\"typography\":{\"fontSize\":\"25px\"}}} -->\n<p style=\"font-size:25px\">ПОДРОБНЕЕ НА: WP.ORG · +44 21 1234 5678</p>\n<!-- /wp:paragraph --></div>\n<!-- /wp:column -->\n\n<!-- wp:column -->\n<div class=\"wp-block-column\"><!-- wp:paragraph {\"align\":\"right\",\"style\":{\"typography\":{\"fontSize\":\"25px\"}}} -->\n<p class=\"has-text-align-right\" style=\"font-size:25px\">INSTAGRAM · <a href=\"#\">БИЛЕТЫ</a></p>\n<!-- /wp:paragraph --></div>\n<!-- /wp:column --></div>\n<!-- /wp:columns -->\n\n<!-- wp:spacer {\"height\":50} -->\n<div style=\"height:50px\" aria-hidden=\"true\" class=\"wp-block-spacer\"></div>\n<!-- /wp:spacer --></div>\n<!-- /wp:group -->\";}i:1;O:8:\"stdClass\":7:{s:2:\"id\";i:4385;s:5:\"title\";O:8:\"stdClass\":1:{s:8:\"rendered\";s:103:\"Большой заголовок с выравниванием текста по левому краю\";}s:7:\"content\";O:8:\"stdClass\":2:{s:8:\"rendered\";s:1487:\"\n<div class=\"wp-block-cover alignfull has-background-dim-60 has-background-dim\" style=\"min-height:800px\"><img class=\"wp-block-cover__image-background\" alt=\"\" src=\"https://s.w.org/images/core/5.8/forest.jpg\" data-object-fit=\"cover\" /><div class=\"wp-block-cover__inner-container\">\n<h2 class=\"alignwide has-text-color\" style=\"color:#ffe074;font-size:64px\">Лес</h2>\n\n\n\n<div class=\"wp-container-624c8c9f24bc4 wp-block-columns alignwide\">\n<div class=\"wp-block-column\" style=\"flex-basis:55%\">\n<div style=\"height:330px\" aria-hidden=\"true\" class=\"wp-block-spacer\"></div>\n\n\n\n<p class=\"has-text-color\" style=\"color:#ffe074;font-size:12px;line-height:1.3\"><em>Даже ребенок знает, насколько ценен лес. Свежий, захватывающий дух запах деревьев. Эхо птиц, летящих над этим плотным массивом. Стабильный климат, устойчивая разнообразная жизнь и источник культуры. Тем не менее, леса и другие экосистемы висят на волоске и могут превратиться в пахотные земли, пастбища и плантации.</em></p>\n</div>\n\n\n\n<div class=\"wp-block-column\"></div>\n</div>\n<style>.wp-container-624c8c9f24bc4 {display: flex;gap: var( --wp--style--block-gap, 0.5em );flex-wrap: nowrap;align-items: center;}.wp-container-624c8c9f24bc4 > * { margin: 0; }</style></div></div>\n\";s:9:\"protected\";b:0;}s:4:\"meta\";O:8:\"stdClass\":6:{s:10:\"spay_email\";s:0:\"\";s:13:\"wpop_keywords\";s:0:\"\";s:16:\"wpop_description\";s:73:\"Изображение на обложке с цитатой сверху\";s:19:\"wpop_viewport_width\";i:1200;s:16:\"wpop_block_types\";a:0:{}s:11:\"wpop_locale\";s:5:\"ru_RU\";}s:14:\"category_slugs\";a:2:{i:0;s:8:\"featured\";i:1;s:6:\"header\";}s:13:\"keyword_slugs\";a:1:{i:0;s:4:\"core\";}s:15:\"pattern_content\";s:1866:\"<!-- wp:cover {\"url\":\"https://s.w.org/images/core/5.8/forest.jpg\",\"dimRatio\":60,\"minHeight\":800,\"align\":\"full\"} -->\n<div class=\"wp-block-cover alignfull has-background-dim-60 has-background-dim\" style=\"min-height:800px\"><img class=\"wp-block-cover__image-background\" alt=\"\" src=\"https://s.w.org/images/core/5.8/forest.jpg\" data-object-fit=\"cover\" /><div class=\"wp-block-cover__inner-container\"><!-- wp:heading {\"align\":\"wide\",\"style\":{\"color\":{\"text\":\"#ffe074\"},\"typography\":{\"fontSize\":\"64px\"}}} -->\n<h2 class=\"alignwide has-text-color\" style=\"color:#ffe074;font-size:64px\">Лес</h2>\n<!-- /wp:heading -->\n\n<!-- wp:columns {\"align\":\"wide\"} -->\n<div class=\"wp-block-columns alignwide\"><!-- wp:column {\"width\":\"55%\"} -->\n<div class=\"wp-block-column\" style=\"flex-basis:55%\"><!-- wp:spacer {\"height\":330} -->\n<div style=\"height:330px\" aria-hidden=\"true\" class=\"wp-block-spacer\"></div>\n<!-- /wp:spacer -->\n\n<!-- wp:paragraph {\"style\":{\"color\":{\"text\":\"#ffe074\"},\"typography\":{\"lineHeight\":\"1.3\",\"fontSize\":\"12px\"}}} -->\n<p class=\"has-text-color\" style=\"color:#ffe074;font-size:12px;line-height:1.3\"><em>Даже ребенок знает, насколько ценен лес. Свежий, захватывающий дух запах деревьев. Эхо птиц, летящих над этим плотным массивом. Стабильный климат, устойчивая разнообразная жизнь и источник культуры. Тем не менее, леса и другие экосистемы висят на волоске и могут превратиться в пахотные земли, пастбища и плантации.</em></p>\n<!-- /wp:paragraph --></div>\n<!-- /wp:column -->\n\n<!-- wp:column -->\n<div class=\"wp-block-column\"></div>\n<!-- /wp:column --></div>\n<!-- /wp:columns --></div></div>\n<!-- /wp:cover -->\";}i:2;O:8:\"stdClass\":7:{s:2:\"id\";i:4387;s:5:\"title\";O:8:\"stdClass\":1:{s:8:\"rendered\";s:18:\"Заголовок\";}s:7:\"content\";O:8:\"stdClass\":2:{s:8:\"rendered\";s:703:\"\n<h2 class=\"alignwide\" id=\"we-re-a-studio-in-berlin-with-an-international-practice-in-architecture-urban-planning-and-interior-design-we-believe-in-sharing-knowledge-and-promoting-dialogue-to-increase-the-creative-potential-of-collaboration\" style=\"font-size:48px;line-height:1.1\">Мы &#8212; студия в Берлине с международной практикой в ​​области архитектуры, городского планирования и дизайна интерьеров. Мы верим в обмен знаниями и продвижение диалога для увеличения творческого потенциала сотрудничества.</h2>\n\";s:9:\"protected\";b:0;}s:4:\"meta\";O:8:\"stdClass\":6:{s:10:\"spay_email\";s:0:\"\";s:13:\"wpop_keywords\";s:0:\"\";s:16:\"wpop_description\";s:29:\"Текст заголовка\";s:19:\"wpop_viewport_width\";i:1200;s:16:\"wpop_block_types\";a:0:{}s:11:\"wpop_locale\";s:5:\"ru_RU\";}s:14:\"category_slugs\";a:2:{i:0;s:8:\"featured\";i:1;s:4:\"text\";}s:13:\"keyword_slugs\";a:1:{i:0;s:4:\"core\";}s:15:\"pattern_content\";s:815:\"<!-- wp:heading {\"align\":\"wide\",\"style\":{\"typography\":{\"fontSize\":\"48px\",\"lineHeight\":\"1.1\"}}} -->\n<h2 class=\"alignwide\" id=\"we-re-a-studio-in-berlin-with-an-international-practice-in-architecture-urban-planning-and-interior-design-we-believe-in-sharing-knowledge-and-promoting-dialogue-to-increase-the-creative-potential-of-collaboration\" style=\"font-size:48px;line-height:1.1\">Мы - студия в Берлине с международной практикой в ​​области архитектуры, городского планирования и дизайна интерьеров. Мы верим в обмен знаниями и продвижение диалога для увеличения творческого потенциала сотрудничества.</h2>\n<!-- /wp:heading -->\";}i:3;O:8:\"stdClass\":7:{s:2:\"id\";i:4336;s:5:\"title\";O:8:\"stdClass\":1:{s:8:\"rendered\";s:52:\"Изображение и цитата на фоне\";}s:7:\"content\";O:8:\"stdClass\":2:{s:8:\"rendered\";s:3042:\"\n<div class=\"wp-block-media-text alignwide has-media-on-the-right is-stacked-on-mobile is-vertically-aligned-center has-background\" style=\"background-color:#f1f5c7\"><figure class=\"wp-block-media-text__media\"><img loading=\"lazy\" width=\"1024\" height=\"1024\" src=\"https://s.w.org/patterns/files/2021/06/pear-1-1024x1024.png\" alt=\"\" class=\"wp-image-5263 size-full\" srcset=\"https://s.w.org/patterns/files/2021/06/pear-1-1024x1024.png 1024w, https://s.w.org/patterns/files/2021/06/pear-1-300x300.png 300w, https://s.w.org/patterns/files/2021/06/pear-1-150x150.png 150w, https://s.w.org/patterns/files/2021/06/pear-1-768x768.png 768w, https://s.w.org/patterns/files/2021/06/pear-1.png 1300w\" sizes=\"(max-width: 1024px) 100vw, 1024px\" /></figure><div class=\"wp-block-media-text__content\">\n<div class=\"wp-container-624c8c9f263d5 wp-block-group\" style=\"padding-top:2em;padding-right:2em;padding-bottom:2em;padding-left:2em\">\n<p style=\"font-size:36px;line-height:1.2\"><strong>Даже в самых горьких фруктах есть сладость.</strong></p>\n\n\n\n<p class=\"has-extra-small-font-size\">&#8212; Терри О&#8217;Нил</p>\n</div>\n<style>.wp-container-624c8c9f263d5 .alignleft { float: left; margin-right: 2em; margin-left: 0; }.wp-container-624c8c9f263d5 .alignright { float: right; margin-left: 2em; margin-right: 0; }.wp-container-624c8c9f263d5 > * { margin-top: 0; margin-bottom: 0; }.wp-container-624c8c9f263d5 > * + * { margin-top: var( --wp--style--block-gap );  margin-bottom: 0; }</style></div></div>\n\n\n\n<div class=\"wp-block-media-text alignwide is-stacked-on-mobile is-vertically-aligned-center has-background\" style=\"background-color:#fffdea\"><figure class=\"wp-block-media-text__media\"><img loading=\"lazy\" width=\"1024\" height=\"1024\" src=\"https://s.w.org/patterns/files/2021/06/pear-half-1024x1024.png\" alt=\"\" class=\"wp-image-673 size-full\" srcset=\"https://s.w.org/patterns/files/2021/06/pear-half-1024x1024.png 1024w, https://s.w.org/patterns/files/2021/06/pear-half-300x300.png 300w, https://s.w.org/patterns/files/2021/06/pear-half-150x150.png 150w, https://s.w.org/patterns/files/2021/06/pear-half-768x768.png 768w, https://s.w.org/patterns/files/2021/06/pear-half.png 1300w\" sizes=\"(max-width: 1024px) 100vw, 1024px\" /></figure><div class=\"wp-block-media-text__content\">\n<div class=\"wp-container-624c8c9f26786 wp-block-group\" style=\"padding-top:2em;padding-right:2em;padding-bottom:2em;padding-left:2em\">\n<p style=\"font-size:36px;line-height:1.2\"><strong>Наилучшие плоды приносят медленнорастущие деревья.</strong></p>\n\n\n\n<p class=\"has-extra-small-font-size\">&#8212; Мольер</p>\n</div>\n<style>.wp-container-624c8c9f26786 .alignleft { float: left; margin-right: 2em; margin-left: 0; }.wp-container-624c8c9f26786 .alignright { float: right; margin-left: 2em; margin-right: 0; }.wp-container-624c8c9f26786 > * { margin-top: 0; margin-bottom: 0; }.wp-container-624c8c9f26786 > * + * { margin-top: var( --wp--style--block-gap );  margin-bottom: 0; }</style></div></div>\n\";s:9:\"protected\";b:0;}s:4:\"meta\";O:8:\"stdClass\":6:{s:10:\"spay_email\";s:0:\"\";s:13:\"wpop_keywords\";s:0:\"\";s:16:\"wpop_description\";s:347:\"Два медиа и текстовых блока. Верхний имеет бледно-зеленый фон. Текст находится слева и содержит цитату, а изображение - справа. В следующем блоке внизу есть изображение слева и цитата справа.\";s:19:\"wpop_viewport_width\";i:800;s:16:\"wpop_block_types\";a:0:{}s:11:\"wpop_locale\";s:5:\"ru_RU\";}s:14:\"category_slugs\";a:3:{i:0;s:8:\"featured\";i:1;s:6:\"images\";i:2;s:4:\"text\";}s:13:\"keyword_slugs\";a:0:{}s:15:\"pattern_content\";s:2491:\"<!-- wp:media-text {\"mediaPosition\":\"right\",\"mediaId\":5263,\"mediaLink\":\"https://wordpress.org/patterns/pattern/image-and-quote-on-a-background/pear-3/\",\"mediaType\":\"image\",\"verticalAlignment\":\"center\",\"style\":{\"color\":{\"background\":\"#f1f5c7\"}}} -->\n<div class=\"wp-block-media-text alignwide has-media-on-the-right is-stacked-on-mobile is-vertically-aligned-center has-background\" style=\"background-color:#f1f5c7\"><figure class=\"wp-block-media-text__media\"><img src=\"https://s.w.org/patterns/files/2021/06/pear-1-1024x1024.png\" alt=\"\" class=\"wp-image-5263 size-full\" /></figure><div class=\"wp-block-media-text__content\"><!-- wp:group {\"style\":{\"spacing\":{\"padding\":{\"top\":\"2em\",\"right\":\"2em\",\"bottom\":\"2em\",\"left\":\"2em\"}}}} -->\n<div class=\"wp-block-group\" style=\"padding-top:2em;padding-right:2em;padding-bottom:2em;padding-left:2em\"><!-- wp:paragraph {\"style\":{\"typography\":{\"lineHeight\":\"1.2\",\"fontSize\":\"36px\"}}} -->\n<p style=\"font-size:36px;line-height:1.2\"><strong>Даже в самых горьких фруктах есть сладость.</strong></p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph {\"fontSize\":\"extra-small\"} -->\n<p class=\"has-extra-small-font-size\">- Терри О\'Нил</p>\n<!-- /wp:paragraph --></div>\n<!-- /wp:group --></div></div>\n<!-- /wp:media-text -->\n\n<!-- wp:media-text {\"mediaId\":673,\"mediaLink\":\"https://wordpress.org/patterns/pear-half/\",\"mediaType\":\"image\",\"verticalAlignment\":\"center\",\"style\":{\"color\":{\"background\":\"#fffdea\"}}} -->\n<div class=\"wp-block-media-text alignwide is-stacked-on-mobile is-vertically-aligned-center has-background\" style=\"background-color:#fffdea\"><figure class=\"wp-block-media-text__media\"><img src=\"https://s.w.org/patterns/files/2021/06/pear-half-1024x1024.png\" alt=\"\" class=\"wp-image-673 size-full\" /></figure><div class=\"wp-block-media-text__content\"><!-- wp:group {\"style\":{\"spacing\":{\"padding\":{\"top\":\"2em\",\"right\":\"2em\",\"bottom\":\"2em\",\"left\":\"2em\"}}}} -->\n<div class=\"wp-block-group\" style=\"padding-top:2em;padding-right:2em;padding-bottom:2em;padding-left:2em\"><!-- wp:paragraph {\"style\":{\"typography\":{\"lineHeight\":\"1.2\",\"fontSize\":\"36px\"}}} -->\n<p style=\"font-size:36px;line-height:1.2\"><strong>Наилучшие плоды приносят медленнорастущие деревья.</strong></p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph {\"fontSize\":\"extra-small\"} -->\n<p class=\"has-extra-small-font-size\">- Мольер</p>\n<!-- /wp:paragraph --></div>\n<!-- /wp:group --></div></div>\n<!-- /wp:media-text -->\";}i:4;O:8:\"stdClass\":7:{s:2:\"id\";i:4353;s:5:\"title\";O:8:\"stdClass\":1:{s:8:\"rendered\";s:77:\"Изображение на сплошном цвете с описанием\";}s:7:\"content\";O:8:\"stdClass\":2:{s:8:\"rendered\";s:2111:\"\n<div class=\"wp-container-624c8c9f27cfd wp-block-columns alignfull\">\n<div class=\"wp-block-column\" style=\"flex-basis:50%\">\n<div class=\"wp-block-cover has-background-dim\" style=\"background-color:#f6f6f6;min-height:600px\"><div class=\"wp-block-cover__inner-container\">\n<div class=\"wp-block-image\"><figure class=\"aligncenter size-medium\"><img loading=\"lazy\" width=\"263\" height=\"300\" src=\"https://s.w.org/patterns/files/2021/06/wire-sculpture-263x300.jpg\" alt=\"\" class=\"wp-image-571\" srcset=\"https://s.w.org/patterns/files/2021/06/wire-sculpture-263x300.jpg 263w, https://s.w.org/patterns/files/2021/06/wire-sculpture-898x1024.jpg 898w, https://s.w.org/patterns/files/2021/06/wire-sculpture-768x875.jpg 768w, https://s.w.org/patterns/files/2021/06/wire-sculpture-1347x1536.jpg 1347w, https://s.w.org/patterns/files/2021/06/wire-sculpture.jpg 1658w\" sizes=\"(max-width: 263px) 100vw, 263px\" /></figure></div>\n</div></div>\n</div>\n\n\n\n<div class=\"wp-block-column is-vertically-aligned-center\" style=\"padding-top:1em;padding-right:1em;padding-bottom:1em;padding-left:1em\">\n<div class=\"wp-container-624c8c9f27a26 wp-block-columns\">\n<div class=\"wp-block-column\" style=\"flex-basis:320px\">\n<p class=\"has-small-font-size\" style=\"line-height:1.6\"><strong>Самолет</strong></p>\n\n\n\n<p class=\"has-small-font-size\" style=\"line-height:1.6\">Медная проволока, деревянная основа. Я создал это произведение в конце 2008 года. В этой работе я стремился передать как промышленную тяжесть самолета, так и то, что вы чувствуете себя как на облаке, находясь в нем.</p>\n</div>\n</div>\n<style>.wp-container-624c8c9f27a26 {display: flex;gap: var( --wp--style--block-gap, 0.5em );flex-wrap: nowrap;align-items: center;}.wp-container-624c8c9f27a26 > * { margin: 0; }</style></div>\n</div>\n<style>.wp-container-624c8c9f27cfd {display: flex;gap: var( --wp--style--block-gap, 0.5em );flex-wrap: nowrap;align-items: center;}.wp-container-624c8c9f27cfd > * { margin: 0; }</style>\";s:9:\"protected\";b:0;}s:4:\"meta\";O:8:\"stdClass\":6:{s:10:\"spay_email\";s:0:\"\";s:13:\"wpop_keywords\";s:0:\"\";s:16:\"wpop_description\";s:78:\"Изображение на сплошном цвете с описанием.\";s:19:\"wpop_viewport_width\";i:1200;s:16:\"wpop_block_types\";a:0:{}s:11:\"wpop_locale\";s:5:\"ru_RU\";}s:14:\"category_slugs\";a:3:{i:0;s:8:\"featured\";i:1;s:6:\"images\";i:2;s:4:\"text\";}s:13:\"keyword_slugs\";a:0:{}s:15:\"pattern_content\";s:2009:\"<!-- wp:columns {\"align\":\"full\"} -->\n<div class=\"wp-block-columns alignfull\"><!-- wp:column {\"width\":\"50%\"} -->\n<div class=\"wp-block-column\" style=\"flex-basis:50%\"><!-- wp:cover {\"customOverlayColor\":\"#f6f6f6\",\"minHeight\":600} -->\n<div class=\"wp-block-cover has-background-dim\" style=\"background-color:#f6f6f6;min-height:600px\"><div class=\"wp-block-cover__inner-container\"><!-- wp:image {\"align\":\"center\",\"id\":571,\"sizeSlug\":\"medium\",\"linkDestination\":\"none\"} -->\n<div class=\"wp-block-image\"><figure class=\"aligncenter size-medium\"><img src=\"https://s.w.org/patterns/files/2021/06/wire-sculpture-263x300.jpg\" alt=\"\" class=\"wp-image-571\" /></figure></div>\n<!-- /wp:image --></div></div>\n<!-- /wp:cover --></div>\n<!-- /wp:column -->\n\n<!-- wp:column {\"verticalAlignment\":\"center\",\"style\":{\"spacing\":{\"padding\":{\"top\":\"1em\",\"right\":\"1em\",\"bottom\":\"1em\",\"left\":\"1em\"}}}} -->\n<div class=\"wp-block-column is-vertically-aligned-center\" style=\"padding-top:1em;padding-right:1em;padding-bottom:1em;padding-left:1em\"><!-- wp:columns -->\n<div class=\"wp-block-columns\"><!-- wp:column {\"width\":\"320px\"} -->\n<div class=\"wp-block-column\" style=\"flex-basis:320px\"><!-- wp:paragraph {\"style\":{\"typography\":{\"lineHeight\":\"1.6\"}},\"fontSize\":\"small\"} -->\n<p class=\"has-small-font-size\" style=\"line-height:1.6\"><strong>Самолет</strong></p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph {\"style\":{\"typography\":{\"lineHeight\":\"1.6\"}},\"fontSize\":\"small\"} -->\n<p class=\"has-small-font-size\" style=\"line-height:1.6\">Медная проволока, деревянная основа. Я создал это произведение в конце 2008 года. В этой работе я стремился передать как промышленную тяжесть самолета, так и то, что вы чувствуете себя как на облаке, находясь в нем.</p>\n<!-- /wp:paragraph --></div>\n<!-- /wp:column --></div>\n<!-- /wp:columns --></div>\n<!-- /wp:column --></div>\n<!-- /wp:columns -->\";}i:5;O:8:\"stdClass\":7:{s:2:\"id\";i:4361;s:5:\"title\";O:8:\"stdClass\":1:{s:8:\"rendered\";s:71:\"Изображение с описанием внизу и справа\";}s:7:\"content\";O:8:\"stdClass\":2:{s:8:\"rendered\";s:1729:\"\n<div class=\"wp-container-624c8c9f28d41 wp-block-columns\">\n<div class=\"wp-block-column\" style=\"flex-basis:10%\"></div>\n\n\n\n<div class=\"wp-block-column\">\n<figure class=\"wp-block-image size-large\"><img loading=\"lazy\" width=\"1024\" height=\"1024\" src=\"https://s.w.org/patterns/files/2021/06/image-from-rawpixel-id-539759-jpeg-1-1024x1024.jpg\" alt=\"Иллюстрация Купидона. Винтаж.\" class=\"wp-image-522\" srcset=\"https://s.w.org/patterns/files/2021/06/image-from-rawpixel-id-539759-jpeg-1-1024x1024.jpg 1024w, https://s.w.org/patterns/files/2021/06/image-from-rawpixel-id-539759-jpeg-1-300x300.jpg 300w, https://s.w.org/patterns/files/2021/06/image-from-rawpixel-id-539759-jpeg-1-150x150.jpg 150w, https://s.w.org/patterns/files/2021/06/image-from-rawpixel-id-539759-jpeg-1-768x768.jpg 768w, https://s.w.org/patterns/files/2021/06/image-from-rawpixel-id-539759-jpeg-1.jpg 1510w\" sizes=\"(max-width: 1024px) 100vw, 1024px\" /></figure>\n</div>\n\n\n\n<div class=\"wp-block-column\"></div>\n\n\n\n<div class=\"wp-block-column\" style=\"flex-basis:10%\"></div>\n</div>\n<style>.wp-container-624c8c9f28d41 {display: flex;gap: var( --wp--style--block-gap, 0.5em );flex-wrap: nowrap;align-items: center;}.wp-container-624c8c9f28d41 > * { margin: 0; }</style>\n\n\n<div class=\"wp-container-624c8c9f29042 wp-block-columns\">\n<div class=\"wp-block-column\"></div>\n\n\n\n<div class=\"wp-block-column\">\n<p style=\"font-size:14px\"><strong>Полет Купидона</strong><br>Жикле, 48 x 48 дюймов, архивная бумага.</p>\n</div>\n</div>\n<style>.wp-container-624c8c9f29042 {display: flex;gap: var( --wp--style--block-gap, 0.5em );flex-wrap: nowrap;align-items: center;}.wp-container-624c8c9f29042 > * { margin: 0; }</style>\n\n\n<p></p>\n\";s:9:\"protected\";b:0;}s:4:\"meta\";O:8:\"stdClass\":6:{s:10:\"spay_email\";s:0:\"\";s:13:\"wpop_keywords\";s:0:\"\";s:16:\"wpop_description\";s:72:\"Изображение с описанием внизу и справа.\";s:19:\"wpop_viewport_width\";i:1200;s:16:\"wpop_block_types\";a:0:{}s:11:\"wpop_locale\";s:5:\"ru_RU\";}s:14:\"category_slugs\";a:2:{i:0;s:8:\"featured\";i:1;s:6:\"images\";}s:13:\"keyword_slugs\";a:0:{}s:15:\"pattern_content\";s:1300:\"<!-- wp:columns -->\n<div class=\"wp-block-columns\"><!-- wp:column {\"width\":\"10%\"} -->\n<div class=\"wp-block-column\" style=\"flex-basis:10%\"></div>\n<!-- /wp:column -->\n\n<!-- wp:column -->\n<div class=\"wp-block-column\"><!-- wp:image {\"id\":522,\"sizeSlug\":\"large\",\"linkDestination\":\"none\"} -->\n<figure class=\"wp-block-image size-large\"><img src=\"https://s.w.org/patterns/files/2021/06/image-from-rawpixel-id-539759-jpeg-1-1024x1024.jpg\" alt=\"Иллюстрация Купидона. Винтаж.\" class=\"wp-image-522\" /></figure>\n<!-- /wp:image --></div>\n<!-- /wp:column -->\n\n<!-- wp:column -->\n<div class=\"wp-block-column\"></div>\n<!-- /wp:column -->\n\n<!-- wp:column {\"width\":\"10%\"} -->\n<div class=\"wp-block-column\" style=\"flex-basis:10%\"></div>\n<!-- /wp:column --></div>\n<!-- /wp:columns -->\n\n<!-- wp:columns -->\n<div class=\"wp-block-columns\"><!-- wp:column -->\n<div class=\"wp-block-column\"></div>\n<!-- /wp:column -->\n\n<!-- wp:column -->\n<div class=\"wp-block-column\"><!-- wp:paragraph {\"style\":{\"typography\":{\"fontSize\":\"14px\"}}} -->\n<p style=\"font-size:14px\"><strong>Полет Купидона</strong><br>Жикле, 48 x 48 дюймов, архивная бумага.</p>\n<!-- /wp:paragraph --></div>\n<!-- /wp:column --></div>\n<!-- /wp:columns -->\n\n<!-- wp:paragraph -->\n<p></p>\n<!-- /wp:paragraph -->\";}i:6;O:8:\"stdClass\":7:{s:2:\"id\";i:4383;s:5:\"title\";O:8:\"stdClass\":1:{s:8:\"rendered\";s:63:\"Медиа и текст с изображением слева\";}s:7:\"content\";O:8:\"stdClass\":2:{s:8:\"rendered\";s:644:\"\n<div class=\"wp-block-media-text alignfull is-stacked-on-mobile is-vertically-aligned-center\"><figure class=\"wp-block-media-text__media\"><img src=\"https://s.w.org/images/core/5.8/architecture-04.jpg\" alt=\"Крупный план, абстрактный вид архитектуры.\" /></figure><div class=\"wp-block-media-text__content\">\n<h3 class=\"has-text-align-center has-text-color\" style=\"color:#000000\"><strong>Открытые пространства</strong></h3>\n\n\n\n<p class=\"has-text-align-center has-extra-small-font-size\"><a href=\"#\">Посмотрите тематическое исследование ↗</a></p>\n</div></div>\n\";s:9:\"protected\";b:0;}s:4:\"meta\";O:8:\"stdClass\":6:{s:10:\"spay_email\";s:0:\"\";s:13:\"wpop_keywords\";s:0:\"\";s:16:\"wpop_description\";s:112:\"Медиа и текстовый блок с изображением слева и текстом справа.\";s:19:\"wpop_viewport_width\";i:1200;s:16:\"wpop_block_types\";a:0:{}s:11:\"wpop_locale\";s:5:\"ru_RU\";}s:14:\"category_slugs\";a:2:{i:0;s:8:\"featured\";i:1;s:6:\"header\";}s:13:\"keyword_slugs\";a:1:{i:0;s:4:\"core\";}s:15:\"pattern_content\";s:951:\"<!-- wp:media-text {\"align\":\"full\",\"mediaType\":\"image\",\"verticalAlignment\":\"center\"} -->\n<div class=\"wp-block-media-text alignfull is-stacked-on-mobile is-vertically-aligned-center\"><figure class=\"wp-block-media-text__media\"><img src=\"https://s.w.org/images/core/5.8/architecture-04.jpg\" alt=\"Крупный план, абстрактный вид архитектуры.\" /></figure><div class=\"wp-block-media-text__content\"><!-- wp:heading {\"textAlign\":\"center\",\"level\":3,\"style\":{\"color\":{\"text\":\"#000000\"}}} -->\n<h3 class=\"has-text-align-center has-text-color\" style=\"color:#000000\"><strong>Открытые пространства</strong></h3>\n<!-- /wp:heading -->\n\n<!-- wp:paragraph {\"align\":\"center\",\"fontSize\":\"extra-small\"} -->\n<p class=\"has-text-align-center has-extra-small-font-size\"><a href=\"#\">Посмотрите тематическое исследование ↗</a></p>\n<!-- /wp:paragraph --></div></div>\n<!-- /wp:media-text -->\";}i:7;O:8:\"stdClass\":7:{s:2:\"id\";i:4368;s:5:\"title\";O:8:\"stdClass\":1:{s:8:\"rendered\";s:45:\"Подробности мероприятия\";}s:7:\"content\";O:8:\"stdClass\":2:{s:8:\"rendered\";s:1916:\"\n<figure class=\"wp-block-image alignwide size-full\"><img loading=\"lazy\" width=\"2560\" height=\"1227\" src=\"https://s.w.org/patterns/files/2021/06/Group-17-scaled.jpg\" alt=\"Изображение женщины, которую лебеди несут по воздуху.\" class=\"wp-image-501\" srcset=\"https://s.w.org/patterns/files/2021/06/Group-17-scaled.jpg 2560w, https://s.w.org/patterns/files/2021/06/Group-17-300x144.jpg 300w, https://s.w.org/patterns/files/2021/06/Group-17-1024x491.jpg 1024w, https://s.w.org/patterns/files/2021/06/Group-17-768x368.jpg 768w, https://s.w.org/patterns/files/2021/06/Group-17-1536x736.jpg 1536w, https://s.w.org/patterns/files/2021/06/Group-17-2048x981.jpg 2048w\" sizes=\"(max-width: 2560px) 100vw, 2560px\" /></figure>\n\n\n\n<div class=\"wp-container-624c8c9f2ae73 wp-block-columns alignwide are-vertically-aligned-center\">\n<div class=\"wp-block-column is-vertically-aligned-center\">\n<p style=\"line-height:2\"><strong>Место:</strong><br>ул. Лизюкова 1, Воронеж</p>\n</div>\n\n\n\n<div class=\"wp-block-column is-vertically-aligned-center\">\n<p style=\"line-height:2\"><strong>Время:</strong><br>24 октября 2021 г.</p>\n</div>\n\n\n\n<div class=\"wp-block-column is-vertically-aligned-center\">\n<div class=\"wp-container-624c8c9f2aba7 wp-block-buttons\">\n<div class=\"wp-block-button has-custom-width wp-block-button__width-100\"><a class=\"wp-block-button__link has-text-color has-background\" style=\"background-color:#262626;color:#efefef\">Приобрести билеты</a></div>\n</div>\n<style>.wp-container-624c8c9f2aba7 {display: flex;gap: var( --wp--style--block-gap, 0.5em );flex-wrap: wrap;align-items: center;}.wp-container-624c8c9f2aba7 > * { margin: 0; }</style></div>\n</div>\n<style>.wp-container-624c8c9f2ae73 {display: flex;gap: var( --wp--style--block-gap, 0.5em );flex-wrap: nowrap;align-items: center;}.wp-container-624c8c9f2ae73 > * { margin: 0; }</style>\";s:9:\"protected\";b:0;}s:4:\"meta\";O:8:\"stdClass\":6:{s:10:\"spay_email\";s:0:\"\";s:13:\"wpop_keywords\";s:0:\"\";s:16:\"wpop_description\";s:46:\"Подробности мероприятия.\";s:19:\"wpop_viewport_width\";i:1200;s:16:\"wpop_block_types\";a:0:{}s:11:\"wpop_locale\";s:5:\"ru_RU\";}s:14:\"category_slugs\";a:2:{i:0;s:8:\"featured\";i:1;s:4:\"text\";}s:13:\"keyword_slugs\";a:0:{}s:15:\"pattern_content\";s:1717:\"<!-- wp:image {\"align\":\"wide\",\"id\":501,\"sizeSlug\":\"full\",\"linkDestination\":\"none\"} -->\n<figure class=\"wp-block-image alignwide size-full\"><img src=\"https://s.w.org/patterns/files/2021/06/Group-17-scaled.jpg\" alt=\"Изображение женщины, которую лебеди несут по воздуху.\" class=\"wp-image-501\" /></figure>\n<!-- /wp:image -->\n\n<!-- wp:columns {\"verticalAlignment\":\"center\",\"align\":\"wide\"} -->\n<div class=\"wp-block-columns alignwide are-vertically-aligned-center\"><!-- wp:column {\"verticalAlignment\":\"center\"} -->\n<div class=\"wp-block-column is-vertically-aligned-center\"><!-- wp:paragraph {\"style\":{\"typography\":{\"lineHeight\":\"2\"}}} -->\n<p style=\"line-height:2\"><strong>Место:</strong><br>ул. Лизюкова 1, Воронеж</p>\n<!-- /wp:paragraph --></div>\n<!-- /wp:column -->\n\n<!-- wp:column {\"verticalAlignment\":\"center\"} -->\n<div class=\"wp-block-column is-vertically-aligned-center\"><!-- wp:paragraph {\"style\":{\"typography\":{\"lineHeight\":\"2\"}}} -->\n<p style=\"line-height:2\"><strong>Время:</strong><br>24 октября 2021 г.</p>\n<!-- /wp:paragraph --></div>\n<!-- /wp:column -->\n\n<!-- wp:column {\"verticalAlignment\":\"center\"} -->\n<div class=\"wp-block-column is-vertically-aligned-center\"><!-- wp:buttons -->\n<div class=\"wp-block-buttons\"><!-- wp:button {\"width\":100,\"style\":{\"color\":{\"background\":\"#262626\",\"text\":\"#efefef\"}}} -->\n<div class=\"wp-block-button has-custom-width wp-block-button__width-100\"><a class=\"wp-block-button__link has-text-color has-background\" style=\"background-color:#262626;color:#efefef\">Приобрести билеты</a></div>\n<!-- /wp:button --></div>\n<!-- /wp:buttons --></div>\n<!-- /wp:column --></div>\n<!-- /wp:columns -->\";}i:8;O:8:\"stdClass\":7:{s:2:\"id\";i:4327;s:5:\"title\";O:8:\"stdClass\":1:{s:8:\"rendered\";s:47:\"Простой призыв к действию\";}s:7:\"content\";O:8:\"stdClass\":2:{s:8:\"rendered\";s:1478:\"\n<div class=\"wp-container-624c8c9f2c018 wp-block-group alignfull has-text-color has-background\" style=\"background-color:#ffffff;color:#000000\">\n<div style=\"height:64px\" aria-hidden=\"true\" class=\"wp-block-spacer\"></div>\n\n\n\n<p class=\"has-text-align-center has-small-font-size\" style=\"line-height:.9\"><strong>СВЯЖИТЕСЬ С НАМИ!</strong></p>\n\n\n\n<h2 class=\"has-text-align-center\" id=\"schedule-a-visit\" style=\"font-size:59px;line-height:1.15\"><strong>Запланировать визит</strong></h2>\n\n\n\n<div class=\"wp-container-624c8c9f2bd3c wp-block-buttons\">\n<div class=\"wp-block-button has-custom-width wp-block-button__width-50\"><a class=\"wp-block-button__link has-text-color has-background\" style=\"border-radius:50px;background-color:#000000;color:#ffffff\">Свяжитесь с нами</a></div>\n</div>\n<style>.wp-container-624c8c9f2bd3c {display: flex;gap: var( --wp--style--block-gap, 0.5em );flex-wrap: wrap;align-items: center;justify-content: center;}.wp-container-624c8c9f2bd3c > * { margin: 0; }</style>\n\n\n<div style=\"height:64px\" aria-hidden=\"true\" class=\"wp-block-spacer\"></div>\n</div>\n<style>.wp-container-624c8c9f2c018 .alignleft { float: left; margin-right: 2em; margin-left: 0; }.wp-container-624c8c9f2c018 .alignright { float: right; margin-left: 2em; margin-right: 0; }.wp-container-624c8c9f2c018 > * { margin-top: 0; margin-bottom: 0; }.wp-container-624c8c9f2c018 > * + * { margin-top: var( --wp--style--block-gap );  margin-bottom: 0; }</style>\";s:9:\"protected\";b:0;}s:4:\"meta\";O:8:\"stdClass\":6:{s:10:\"spay_email\";s:0:\"\";s:13:\"wpop_keywords\";s:0:\"\";s:16:\"wpop_description\";s:153:\"Контейнер с белым фоном. Внутри находится центрированный абзац, заголовок и кнопка.\";s:19:\"wpop_viewport_width\";i:800;s:16:\"wpop_block_types\";a:0:{}s:11:\"wpop_locale\";s:5:\"ru_RU\";}s:14:\"category_slugs\";a:2:{i:0;s:7:\"buttons\";i:1;s:8:\"featured\";}s:13:\"keyword_slugs\";a:0:{}s:15:\"pattern_content\";s:1566:\"<!-- wp:group {\"align\":\"full\",\"style\":{\"color\":{\"text\":\"#000000\",\"background\":\"#ffffff\"}}} -->\n<div class=\"wp-block-group alignfull has-text-color has-background\" style=\"background-color:#ffffff;color:#000000\"><!-- wp:spacer {\"height\":64} -->\n<div style=\"height:64px\" aria-hidden=\"true\" class=\"wp-block-spacer\"></div>\n<!-- /wp:spacer -->\n\n<!-- wp:paragraph {\"align\":\"center\",\"style\":{\"typography\":{\"lineHeight\":\".9\"}},\"fontSize\":\"small\"} -->\n<p class=\"has-text-align-center has-small-font-size\" style=\"line-height:.9\"><strong>СВЯЖИТЕСЬ С НАМИ!</strong></p>\n<!-- /wp:paragraph -->\n\n<!-- wp:heading {\"textAlign\":\"center\",\"style\":{\"typography\":{\"fontSize\":59,\"lineHeight\":\"1.15\"}}} -->\n<h2 class=\"has-text-align-center\" id=\"schedule-a-visit\" style=\"font-size:59px;line-height:1.15\"><strong>Запланировать визит</strong></h2>\n<!-- /wp:heading -->\n\n<!-- wp:buttons {\"layout\":{\"type\":\"flex\",\"justifyContent\":\"center\",\"orientation\":\"horizontal\"}} -->\n<div class=\"wp-block-buttons\"><!-- wp:button {\"width\":50,\"style\":{\"color\":{\"background\":\"#000000\",\"text\":\"#ffffff\"},\"border\":{\"radius\":\"50px\"}}} -->\n<div class=\"wp-block-button has-custom-width wp-block-button__width-50\"><a class=\"wp-block-button__link has-text-color has-background\" style=\"border-radius:50px;background-color:#000000;color:#ffffff\">Свяжитесь с нами</a></div>\n<!-- /wp:button --></div>\n<!-- /wp:buttons -->\n\n<!-- wp:spacer {\"height\":64} -->\n<div style=\"height:64px\" aria-hidden=\"true\" class=\"wp-block-spacer\"></div>\n<!-- /wp:spacer --></div>\n<!-- /wp:group -->\";}i:9;O:8:\"stdClass\":7:{s:2:\"id\";i:4360;s:5:\"title\";O:8:\"stdClass\":1:{s:8:\"rendered\";s:66:\"Смещенные изображения с описаниями.\";}s:7:\"content\";O:8:\"stdClass\":2:{s:8:\"rendered\";s:1923:\"\n<div class=\"wp-container-624c8c9f2cf7a wp-block-columns\">\n<div class=\"wp-block-column\">\n<figure class=\"wp-block-image size-large\"><img loading=\"lazy\" width=\"793\" height=\"1024\" src=\"https://s.w.org/patterns/files/2021/06/Iris-793x1024.jpg\" alt=\"\" class=\"wp-image-525\" srcset=\"https://s.w.org/patterns/files/2021/06/Iris-793x1024.jpg 793w, https://s.w.org/patterns/files/2021/06/Iris-232x300.jpg 232w, https://s.w.org/patterns/files/2021/06/Iris-768x992.jpg 768w, https://s.w.org/patterns/files/2021/06/Iris-1189x1536.jpg 1189w, https://s.w.org/patterns/files/2021/06/Iris-1586x2048.jpg 1586w, https://s.w.org/patterns/files/2021/06/Iris.jpg 1920w\" sizes=\"(max-width: 793px) 100vw, 793px\" /></figure>\n\n\n\n<p style=\"font-size:14px\"><strong>Белые ирисы</strong><br>Огава Кадзумаса</p>\n</div>\n\n\n\n<div class=\"wp-block-column\">\n<div style=\"height:100px\" aria-hidden=\"true\" class=\"wp-block-spacer\"></div>\n\n\n\n<p style=\"font-size:14px\"><strong>Цветение вишни</strong><br>Огава Кадзумаса</p>\n\n\n\n<figure class=\"wp-block-image size-large\"><img loading=\"lazy\" width=\"707\" height=\"1024\" src=\"https://s.w.org/patterns/files/2021/06/Cherry-Blossom-707x1024.jpg\" alt=\"\" class=\"wp-image-524\" srcset=\"https://s.w.org/patterns/files/2021/06/Cherry-Blossom-707x1024.jpg 707w, https://s.w.org/patterns/files/2021/06/Cherry-Blossom-207x300.jpg 207w, https://s.w.org/patterns/files/2021/06/Cherry-Blossom-768x1112.jpg 768w, https://s.w.org/patterns/files/2021/06/Cherry-Blossom-1061x1536.jpg 1061w, https://s.w.org/patterns/files/2021/06/Cherry-Blossom-1414x2048.jpg 1414w, https://s.w.org/patterns/files/2021/06/Cherry-Blossom-scaled.jpg 1768w\" sizes=\"(max-width: 707px) 100vw, 707px\" /></figure>\n</div>\n</div>\n<style>.wp-container-624c8c9f2cf7a {display: flex;gap: var( --wp--style--block-gap, 0.5em );flex-wrap: nowrap;align-items: center;}.wp-container-624c8c9f2cf7a > * { margin: 0; }</style>\";s:9:\"protected\";b:0;}s:4:\"meta\";O:8:\"stdClass\":6:{s:10:\"spay_email\";s:0:\"\";s:13:\"wpop_keywords\";s:0:\"\";s:16:\"wpop_description\";s:66:\"Смещенные изображения с описаниями.\";s:19:\"wpop_viewport_width\";i:1200;s:16:\"wpop_block_types\";a:0:{}s:11:\"wpop_locale\";s:5:\"ru_RU\";}s:14:\"category_slugs\";a:3:{i:0;s:8:\"featured\";i:1;s:7:\"gallery\";i:2;s:6:\"images\";}s:13:\"keyword_slugs\";a:0:{}s:15:\"pattern_content\";s:1227:\"<!-- wp:columns -->\n<div class=\"wp-block-columns\"><!-- wp:column -->\n<div class=\"wp-block-column\"><!-- wp:image {\"id\":525,\"sizeSlug\":\"large\",\"linkDestination\":\"none\"} -->\n<figure class=\"wp-block-image size-large\"><img src=\"https://s.w.org/patterns/files/2021/06/Iris-793x1024.jpg\" alt=\"\" class=\"wp-image-525\" /></figure>\n<!-- /wp:image -->\n\n<!-- wp:paragraph {\"style\":{\"typography\":{\"fontSize\":\"14px\"}}} -->\n<p style=\"font-size:14px\"><strong>Белые ирисы</strong><br>Огава Кадзумаса</p>\n<!-- /wp:paragraph --></div>\n<!-- /wp:column -->\n\n<!-- wp:column -->\n<div class=\"wp-block-column\"><!-- wp:spacer -->\n<div style=\"height:100px\" aria-hidden=\"true\" class=\"wp-block-spacer\"></div>\n<!-- /wp:spacer -->\n\n<!-- wp:paragraph {\"style\":{\"typography\":{\"fontSize\":\"14px\"}}} -->\n<p style=\"font-size:14px\"><strong>Цветение вишни</strong><br>Огава Кадзумаса</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:image {\"id\":524,\"sizeSlug\":\"large\",\"linkDestination\":\"none\"} -->\n<figure class=\"wp-block-image size-large\"><img src=\"https://s.w.org/patterns/files/2021/06/Cherry-Blossom-707x1024.jpg\" alt=\"\" class=\"wp-image-524\" /></figure>\n<!-- /wp:image --></div>\n<!-- /wp:column --></div>\n<!-- /wp:columns -->\";}i:10;O:8:\"stdClass\":7:{s:2:\"id\";i:4346;s:5:\"title\";O:8:\"stdClass\":1:{s:8:\"rendered\";s:14:\"Событие\";}s:7:\"content\";O:8:\"stdClass\":2:{s:8:\"rendered\";s:2141:\"\n<div class=\"wp-elements-624c8c9f2dfcb wp-block-media-text alignfull has-media-on-the-right is-stacked-on-mobile is-vertically-aligned-top has-text-color has-background has-link-color\" style=\"background-color:#121c1c;color:#fffdc7;grid-template-columns:auto 60%\"><figure class=\"wp-block-media-text__media\"><img loading=\"lazy\" width=\"1024\" height=\"1024\" src=\"https://s.w.org/patterns/files/2021/06/image-from-rawpixel-id-430289-jpeg-1-1024x1024.jpg\" alt=\"\" class=\"wp-image-590 size-full\" srcset=\"https://s.w.org/patterns/files/2021/06/image-from-rawpixel-id-430289-jpeg-1-1024x1024.jpg 1024w, https://s.w.org/patterns/files/2021/06/image-from-rawpixel-id-430289-jpeg-1-300x300.jpg 300w, https://s.w.org/patterns/files/2021/06/image-from-rawpixel-id-430289-jpeg-1-150x150.jpg 150w, https://s.w.org/patterns/files/2021/06/image-from-rawpixel-id-430289-jpeg-1-768x768.jpg 768w, https://s.w.org/patterns/files/2021/06/image-from-rawpixel-id-430289-jpeg-1-1536x1536.jpg 1536w, https://s.w.org/patterns/files/2021/06/image-from-rawpixel-id-430289-jpeg-1.jpg 1572w\" sizes=\"(max-width: 1024px) 100vw, 1024px\" /></figure><div class=\"wp-block-media-text__content\">\n<div class=\"wp-elements-624c8c9f2dfae wp-container-624c8c9f2dfa4 wp-block-group has-link-color\" style=\"padding-top:2em;padding-right:2em;padding-bottom:2em;padding-left:2em\">\n<h2 style=\"font-size:48px;font-weight:700;line-height:1.15\">Вечеринка <br>Открытия</h2>\n\n\n\n<p class=\"wp-elements-624c8c9f2dc96 has-text-color has-link-color\" style=\"color:#fffdc7\"><strong><a href=\"#\">RSVP →</a></strong></p>\n<style>.wp-elements-624c8c9f2dc96 a{color: #fffdc7;}</style>\n</div>\n<style>.wp-container-624c8c9f2dfa4 .alignleft { float: left; margin-right: 2em; margin-left: 0; }.wp-container-624c8c9f2dfa4 .alignright { float: right; margin-left: 2em; margin-right: 0; }.wp-container-624c8c9f2dfa4 > * { margin-top: 0; margin-bottom: 0; }.wp-container-624c8c9f2dfa4 > * + * { margin-top: var( --wp--style--block-gap );  margin-bottom: 0; }</style><style>.wp-elements-624c8c9f2dfae a{color: #fffdc7;}</style>\n</div></div>\n<style>.wp-elements-624c8c9f2dfcb a{color: #fffdc7;}</style>\n\";s:9:\"protected\";b:0;}s:4:\"meta\";O:8:\"stdClass\":6:{s:10:\"spay_email\";s:0:\"\";s:13:\"wpop_keywords\";s:0:\"\";s:16:\"wpop_description\";s:0:\"\";s:19:\"wpop_viewport_width\";i:800;s:16:\"wpop_block_types\";a:0:{}s:11:\"wpop_locale\";s:5:\"ru_RU\";}s:14:\"category_slugs\";a:3:{i:0;s:8:\"featured\";i:1;s:6:\"header\";i:2;s:6:\"images\";}s:13:\"keyword_slugs\";a:0:{}s:15:\"pattern_content\";s:1614:\"<!-- wp:media-text {\"align\":\"full\",\"mediaPosition\":\"right\",\"mediaId\":590,\"mediaLink\":\"https://wordpress.org/patterns/image-from-rawpixel-id-430289-jpeg-1/\",\"mediaType\":\"image\",\"mediaWidth\":60,\"verticalAlignment\":\"top\",\"style\":{\"color\":{\"background\":\"#121c1c\",\"text\":\"#fffdc7\"},\"elements\":{\"link\":{\"color\":{\"text\":\"#fffdc7\"}}}}} -->\n<div class=\"wp-block-media-text alignfull has-media-on-the-right is-stacked-on-mobile is-vertically-aligned-top has-text-color has-background has-link-color\" style=\"background-color:#121c1c;color:#fffdc7;grid-template-columns:auto 60%\"><figure class=\"wp-block-media-text__media\"><img src=\"https://s.w.org/patterns/files/2021/06/image-from-rawpixel-id-430289-jpeg-1-1024x1024.jpg\" alt=\"\" class=\"wp-image-590 size-full\" /></figure><div class=\"wp-block-media-text__content\"><!-- wp:group {\"style\":{\"spacing\":{\"padding\":{\"top\":\"2em\",\"right\":\"2em\",\"bottom\":\"2em\",\"left\":\"2em\"}},\"elements\":{\"link\":{\"color\":{\"text\":\"#fffdc7\"}}}}} -->\n<div class=\"wp-block-group has-link-color\" style=\"padding-top:2em;padding-right:2em;padding-bottom:2em;padding-left:2em\"><!-- wp:heading {\"style\":{\"typography\":{\"fontWeight\":\"700\",\"fontSize\":\"48px\",\"lineHeight\":\"1.15\"}}} -->\n<h2 style=\"font-size:48px;font-weight:700;line-height:1.15\">Вечеринка <br>Открытия</h2>\n<!-- /wp:heading -->\n\n<!-- wp:paragraph {\"style\":{\"elements\":{\"link\":{\"color\":{\"text\":\"#fffdc7\"}}},\"color\":{\"text\":\"#fffdc7\"}}} -->\n<p class=\"has-text-color has-link-color\" style=\"color:#fffdc7\"><strong><a href=\"#\">RSVP →</a></strong></p>\n<!-- /wp:paragraph --></div>\n<!-- /wp:group --></div></div>\n<!-- /wp:media-text -->\";}i:11;O:8:\"stdClass\":7:{s:2:\"id\";i:4335;s:5:\"title\";O:8:\"stdClass\":1:{s:8:\"rendered\";s:21:\"Таблица цен\";}s:7:\"content\";O:8:\"stdClass\":2:{s:8:\"rendered\";s:4569:\"\n<div class=\"wp-container-624c8c9f2fa8a wp-block-columns alignwide\">\n<div class=\"wp-elements-624c8c9f2eff2 wp-block-column has-text-color has-background has-link-color\" style=\"background-color:#ffe97d;color:#000000;padding-top:2em;padding-right:2em;padding-bottom:2em;padding-left:2em\">\n<h2 id=\"single\" style=\"font-size:40px\"><strong>Индивидуальный</strong></h2>\n\n\n\n<p class=\"has-normal-font-size\" style=\"line-height:1.5\"><strong>Обогатите наше растущее сообщество.</strong></p>\n\n\n\n<hr class=\"wp-block-separator has-text-color has-background is-style-wide\" style=\"background-color:#000000;color:#000000\" />\n\n\n\n<ul class=\"has-normal-font-size\"><li>Общие скидки на вход и членство для одного взрослого</li><li>Один бесплатный билет на каждую специальную выставку</li><li>Два одноразовых гостевых пропуска в год</li></ul>\n\n\n\n<div class=\"wp-container-624c8c9f2efda wp-block-buttons alignfull\">\n<div class=\"wp-block-button has-custom-width wp-block-button__width-100\"><a class=\"wp-block-button__link has-white-color has-text-color has-background no-border-radius\" style=\"background-color:#000000\">$110 в год</a></div>\n</div>\n<style>.wp-container-624c8c9f2efda {display: flex;gap: var( --wp--style--block-gap, 0.5em );flex-wrap: wrap;align-items: center;justify-content: center;}.wp-container-624c8c9f2efda > * { margin: 0; }</style></div>\n<style>.wp-elements-624c8c9f2eff2 a{color: #000000;}</style>\n\n\n\n<div class=\"wp-elements-624c8c9f2f3a4 wp-block-column has-text-color has-background has-link-color\" style=\"background-color:#d1d1e1;color:#000000;padding-top:2em;padding-right:2em;padding-bottom:2em;padding-left:2em\">\n<h2 id=\"family\" style=\"font-size:40px\"><strong>Cемья</strong></h2>\n\n\n\n<p class=\"has-normal-font-size\" style=\"line-height:1.5\"><strong>Поддержите специальные выставки.</strong></p>\n\n\n\n<hr class=\"wp-block-separator is-style-wide\" />\n\n\n\n<ul class=\"has-normal-font-size\"><li>Общий входной билет и скидки для двух взрослых.</li><li>Четыре бесплатных билета на одну специальную выставку.</li><li>Четыре одноразовых гостевых пропуска в год</li></ul>\n\n\n\n<div class=\"wp-container-624c8c9f2f38b wp-block-buttons alignfull\">\n<div class=\"wp-block-button has-custom-width wp-block-button__width-100 is-style-fill\"><a class=\"wp-block-button__link has-white-color has-text-color has-background no-border-radius\" style=\"background-color:#000000\">$200 в год</a></div>\n</div>\n<style>.wp-container-624c8c9f2f38b {display: flex;gap: var( --wp--style--block-gap, 0.5em );flex-wrap: wrap;align-items: center;justify-content: center;}.wp-container-624c8c9f2f38b > * { margin: 0; }</style></div>\n<style>.wp-elements-624c8c9f2f3a4 a{color: #000000;}</style>\n\n\n\n<div class=\"wp-elements-624c8c9f2f767 wp-block-column has-text-color has-background has-link-color\" style=\"background-color:#c0ebf1;color:#000000;padding-top:2em;padding-right:2em;padding-bottom:2em;padding-left:2em\">\n<h2 id=\"patron\" style=\"font-size:40px\"><strong>Спонсор</strong></h2>\n\n\n\n<p class=\"has-normal-font-size\"><strong>Поднимите поддержку до следующего уровня.</strong></p>\n\n\n\n<hr class=\"wp-block-separator is-style-wide\" />\n\n\n\n<ul class=\"has-normal-font-size\"><li>Общий входной билет и скидки для двух взрослых.</li><li>Пять бесплатных билетов на одну специальную выставку.</li><li>Шесть одноразовых гостевых пропусков в год</li></ul>\n\n\n\n<div class=\"wp-container-624c8c9f2f751 wp-block-buttons alignfull\">\n<div class=\"wp-block-button has-custom-width wp-block-button__width-100\"><a class=\"wp-block-button__link has-white-color has-text-color has-background no-border-radius\" style=\"background-color:#000000\">$400 в год</a></div>\n</div>\n<style>.wp-container-624c8c9f2f751 {display: flex;gap: var( --wp--style--block-gap, 0.5em );flex-wrap: wrap;align-items: center;justify-content: center;}.wp-container-624c8c9f2f751 > * { margin: 0; }</style></div>\n<style>.wp-elements-624c8c9f2f767 a{color: #000000;}</style>\n</div>\n<style>.wp-container-624c8c9f2fa8a {display: flex;gap: var( --wp--style--block-gap, 0.5em );flex-wrap: nowrap;align-items: center;}.wp-container-624c8c9f2fa8a > * { margin: 0; }</style>\";s:9:\"protected\";b:0;}s:4:\"meta\";O:8:\"stdClass\":6:{s:10:\"spay_email\";s:0:\"\";s:13:\"wpop_keywords\";s:0:\"\";s:16:\"wpop_description\";s:407:\"Три столбца одинаковой ширины настроены как таблица цен. Левый имеет желтый фон, средний имеет светло-фиолетовый фон, правый имеет голубой фон. Каждый столбец содержит заголовок, подзаголовок, разделитель, список и кнопку.\";s:19:\"wpop_viewport_width\";i:800;s:16:\"wpop_block_types\";a:0:{}s:11:\"wpop_locale\";s:5:\"ru_RU\";}s:14:\"category_slugs\";a:3:{i:0;s:7:\"buttons\";i:1;s:7:\"columns\";i:2;s:8:\"featured\";}s:13:\"keyword_slugs\";a:0:{}s:15:\"pattern_content\";s:5909:\"<!-- wp:columns {\"align\":\"wide\"} -->\n<div class=\"wp-block-columns alignwide\"><!-- wp:column {\"style\":{\"color\":{\"background\":\"#ffe97d\",\"text\":\"#000000\"},\"elements\":{\"link\":{\"color\":{\"text\":\"#000000\"}}},\"spacing\":{\"padding\":{\"top\":\"2em\",\"right\":\"2em\",\"bottom\":\"2em\",\"left\":\"2em\"}}}} -->\n<div class=\"wp-block-column has-text-color has-background has-link-color\" style=\"background-color:#ffe97d;color:#000000;padding-top:2em;padding-right:2em;padding-bottom:2em;padding-left:2em\"><!-- wp:heading {\"style\":{\"typography\":{\"fontSize\":\"40px\"}}} -->\n<h2 id=\"single\" style=\"font-size:40px\"><strong>Индивидуальный</strong></h2>\n<!-- /wp:heading -->\n\n<!-- wp:paragraph {\"style\":{\"typography\":{\"lineHeight\":\"1.5\"}},\"fontSize\":\"normal\"} -->\n<p class=\"has-normal-font-size\" style=\"line-height:1.5\"><strong>Обогатите наше растущее сообщество.</strong></p>\n<!-- /wp:paragraph -->\n\n<!-- wp:separator {\"customColor\":\"#000000\",\"className\":\"is-style-wide\"} -->\n<hr class=\"wp-block-separator has-text-color has-background is-style-wide\" style=\"background-color:#000000;color:#000000\" />\n<!-- /wp:separator -->\n\n<!-- wp:list {\"fontSize\":\"normal\"} -->\n<ul class=\"has-normal-font-size\"><li>Общие скидки на вход и членство для одного взрослого</li><li>Один бесплатный билет на каждую специальную выставку</li><li>Два одноразовых гостевых пропуска в год</li></ul>\n<!-- /wp:list -->\n\n<!-- wp:buttons {\"align\":\"full\",\"layout\":{\"type\":\"flex\",\"justifyContent\":\"center\",\"orientation\":\"horizontal\"}} -->\n<div class=\"wp-block-buttons alignfull\"><!-- wp:button {\"textColor\":\"white\",\"width\":100,\"style\":{\"color\":{\"background\":\"#000000\"},\"border\":{\"radius\":0}}} -->\n<div class=\"wp-block-button has-custom-width wp-block-button__width-100\"><a class=\"wp-block-button__link has-white-color has-text-color has-background no-border-radius\" style=\"background-color:#000000\">$110 в год</a></div>\n<!-- /wp:button --></div>\n<!-- /wp:buttons --></div>\n<!-- /wp:column -->\n\n<!-- wp:column {\"style\":{\"color\":{\"background\":\"#d1d1e1\",\"text\":\"#000000\"},\"elements\":{\"link\":{\"color\":{\"text\":\"#000000\"}}},\"spacing\":{\"padding\":{\"top\":\"2em\",\"right\":\"2em\",\"bottom\":\"2em\",\"left\":\"2em\"}}}} -->\n<div class=\"wp-block-column has-text-color has-background has-link-color\" style=\"background-color:#d1d1e1;color:#000000;padding-top:2em;padding-right:2em;padding-bottom:2em;padding-left:2em\"><!-- wp:heading {\"style\":{\"typography\":{\"fontSize\":\"40px\"}}} -->\n<h2 id=\"family\" style=\"font-size:40px\"><strong>Cемья</strong></h2>\n<!-- /wp:heading -->\n\n<!-- wp:paragraph {\"style\":{\"typography\":{\"lineHeight\":\"1.5\"}},\"fontSize\":\"normal\"} -->\n<p class=\"has-normal-font-size\" style=\"line-height:1.5\"><strong>Поддержите специальные выставки.</strong></p>\n<!-- /wp:paragraph -->\n\n<!-- wp:separator {\"className\":\"is-style-wide\"} -->\n<hr class=\"wp-block-separator is-style-wide\" />\n<!-- /wp:separator -->\n\n<!-- wp:list {\"fontSize\":\"normal\"} -->\n<ul class=\"has-normal-font-size\"><li>Общий входной билет и скидки для двух взрослых.</li><li>Четыре бесплатных билета на одну специальную выставку.</li><li>Четыре одноразовых гостевых пропуска в год</li></ul>\n<!-- /wp:list -->\n\n<!-- wp:buttons {\"align\":\"full\",\"layout\":{\"type\":\"flex\",\"justifyContent\":\"center\",\"orientation\":\"horizontal\"}} -->\n<div class=\"wp-block-buttons alignfull\"><!-- wp:button {\"textColor\":\"white\",\"width\":100,\"style\":{\"color\":{\"background\":\"#000000\"},\"border\":{\"radius\":0}},\"className\":\"is-style-fill\"} -->\n<div class=\"wp-block-button has-custom-width wp-block-button__width-100 is-style-fill\"><a class=\"wp-block-button__link has-white-color has-text-color has-background no-border-radius\" style=\"background-color:#000000\">$200 в год</a></div>\n<!-- /wp:button --></div>\n<!-- /wp:buttons --></div>\n<!-- /wp:column -->\n\n<!-- wp:column {\"style\":{\"color\":{\"background\":\"#c0ebf1\",\"text\":\"#000000\"},\"elements\":{\"link\":{\"color\":{\"text\":\"#000000\"}}},\"spacing\":{\"padding\":{\"top\":\"2em\",\"right\":\"2em\",\"bottom\":\"2em\",\"left\":\"2em\"}}}} -->\n<div class=\"wp-block-column has-text-color has-background has-link-color\" style=\"background-color:#c0ebf1;color:#000000;padding-top:2em;padding-right:2em;padding-bottom:2em;padding-left:2em\"><!-- wp:heading {\"style\":{\"typography\":{\"fontSize\":\"40px\"}}} -->\n<h2 id=\"patron\" style=\"font-size:40px\"><strong>Спонсор</strong></h2>\n<!-- /wp:heading -->\n\n<!-- wp:paragraph {\"fontSize\":\"normal\"} -->\n<p class=\"has-normal-font-size\"><strong>Поднимите поддержку до следующего уровня.</strong></p>\n<!-- /wp:paragraph -->\n\n<!-- wp:separator {\"className\":\"is-style-wide\"} -->\n<hr class=\"wp-block-separator is-style-wide\" />\n<!-- /wp:separator -->\n\n<!-- wp:list {\"fontSize\":\"normal\"} -->\n<ul class=\"has-normal-font-size\"><li>Общий входной билет и скидки для двух взрослых.</li><li>Пять бесплатных билетов на одну специальную выставку.</li><li>Шесть одноразовых гостевых пропусков в год</li></ul>\n<!-- /wp:list -->\n\n<!-- wp:buttons {\"align\":\"full\",\"layout\":{\"type\":\"flex\",\"justifyContent\":\"center\",\"orientation\":\"horizontal\"}} -->\n<div class=\"wp-block-buttons alignfull\"><!-- wp:button {\"textColor\":\"white\",\"width\":100,\"style\":{\"color\":{\"background\":\"#000000\"},\"border\":{\"radius\":0}}} -->\n<div class=\"wp-block-button has-custom-width wp-block-button__width-100\"><a class=\"wp-block-button__link has-white-color has-text-color has-background no-border-radius\" style=\"background-color:#000000\">$400 в год</a></div>\n<!-- /wp:button --></div>\n<!-- /wp:buttons --></div>\n<!-- /wp:column --></div>\n<!-- /wp:columns -->\";}i:12;O:8:\"stdClass\":7:{s:2:\"id\";i:4379;s:5:\"title\";O:8:\"stdClass\":1:{s:8:\"rendered\";s:69:\"Три колонки с изображениями и текстом\";}s:7:\"content\";O:8:\"stdClass\":2:{s:8:\"rendered\";s:4372:\"\n<div class=\"wp-container-624c8c9f31a7a wp-block-group alignfull has-background\" style=\"background-color:#f8f4e4\">\n<div class=\"wp-container-624c8c9f3102f wp-block-columns alignwide\">\n<div class=\"wp-block-column\">\n<div style=\"height:100px\" aria-hidden=\"true\" class=\"wp-block-spacer\"></div>\n\n\n\n<h6 class=\"has-text-color\" id=\"ecosystem\" style=\"color:#000000\">ЭКОСИСТЕМА</h6>\n\n\n\n<p class=\"has-text-color\" style=\"color:#000000;font-size:5vw;line-height:1.1\"><strong>Положительный рост.</strong></p>\n\n\n\n<div style=\"height:5px\" aria-hidden=\"true\" class=\"wp-block-spacer\"></div>\n</div>\n</div>\n<style>.wp-container-624c8c9f3102f {display: flex;gap: var( --wp--style--block-gap, 0.5em );flex-wrap: nowrap;align-items: center;}.wp-container-624c8c9f3102f > * { margin: 0; }</style>\n\n\n<div class=\"wp-container-624c8c9f313f6 wp-block-columns alignwide\">\n<div class=\"wp-block-column\" style=\"flex-basis:33.38%\">\n<p class=\"has-text-color has-extra-small-font-size\" style=\"color:#000000\"><em>Природа</em> в обычном смысле слова относится к сущностям, неизменным человеком; космос, воздух, река, лист. <em>Искусство</em> применяется к смеси его воли с теми же вещами, как в доме, канале, статуе, картине. Но его операции, взятые вместе, настолько незначительны, это небольшое измельчение, выпечка, заплатка и стирка, что в таком грандиозном впечатлении, как мир, в человеческом сознании, они не меняют результата.</p>\n</div>\n\n\n\n<div class=\"wp-block-column\" style=\"flex-basis:33%\">\n<div style=\"height:100px\" aria-hidden=\"true\" class=\"wp-block-spacer\"></div>\n\n\n\n<figure class=\"wp-block-image size-large\"><img src=\"https://s.w.org/images/core/5.8/outside-01.jpg\" alt=\"Солнце садится сквозь густой лес деревьев.\" /></figure>\n</div>\n\n\n\n<div class=\"wp-block-column\" style=\"flex-basis:33.62%\">\n<figure class=\"wp-block-image size-large\"><img src=\"https://s.w.org/images/core/5.8/outside-02.jpg\" alt=\"Ветровые турбины, стоящие на травянистой равнине, против голубого неба.\" /></figure>\n</div>\n</div>\n<style>.wp-container-624c8c9f313f6 {display: flex;gap: var( --wp--style--block-gap, 0.5em );flex-wrap: nowrap;align-items: center;}.wp-container-624c8c9f313f6 > * { margin: 0; }</style>\n\n\n<div class=\"wp-container-624c8c9f31780 wp-block-columns alignwide\">\n<div class=\"wp-block-column\" style=\"flex-basis:67%\">\n<div class=\"wp-block-image\"><figure class=\"alignright size-large\"><img src=\"https://s.w.org/images/core/5.8/outside-03.jpg\" alt=\"Солнце светит над гребнем, спускающимся к берегу. Вдалеке по дороге едет машина.\" /></figure></div>\n</div>\n\n\n\n<div class=\"wp-block-column is-vertically-aligned-center\" style=\"flex-basis:33%\">\n<p class=\"has-text-color has-extra-small-font-size\" style=\"color:#000000\">Несомненно, у нас нет вопросов, на которые невозможно ответить. Мы должны доверять совершенству творения настолько, чтобы верить в то, что какое бы любопытство ни пробудил в наших умах порядок вещей, порядок вещей может удовлетворить. Состояние каждого человека &#8212; это иероглифическое решение тех вопросов, которые он задавал.</p>\n</div>\n</div>\n<style>.wp-container-624c8c9f31780 {display: flex;gap: var( --wp--style--block-gap, 0.5em );flex-wrap: nowrap;align-items: center;}.wp-container-624c8c9f31780 > * { margin: 0; }</style></div>\n<style>.wp-container-624c8c9f31a7a .alignleft { float: left; margin-right: 2em; margin-left: 0; }.wp-container-624c8c9f31a7a .alignright { float: right; margin-left: 2em; margin-right: 0; }.wp-container-624c8c9f31a7a > * { margin-top: 0; margin-bottom: 0; }.wp-container-624c8c9f31a7a > * + * { margin-top: var( --wp--style--block-gap );  margin-bottom: 0; }</style>\";s:9:\"protected\";b:0;}s:4:\"meta\";O:8:\"stdClass\":6:{s:10:\"spay_email\";s:0:\"\";s:13:\"wpop_keywords\";s:0:\"\";s:16:\"wpop_description\";s:142:\"Три столбца с изображениями и текстом с интервалом по вертикали для смещения.\";s:19:\"wpop_viewport_width\";i:1200;s:16:\"wpop_block_types\";a:0:{}s:11:\"wpop_locale\";s:5:\"ru_RU\";}s:14:\"category_slugs\";a:2:{i:0;s:7:\"columns\";i:1;s:8:\"featured\";}s:13:\"keyword_slugs\";a:1:{i:0;s:4:\"core\";}s:15:\"pattern_content\";s:4759:\"<!-- wp:group {\"align\":\"full\",\"style\":{\"color\":{\"background\":\"#f8f4e4\"}}} -->\n<div class=\"wp-block-group alignfull has-background\" style=\"background-color:#f8f4e4\"><!-- wp:columns {\"align\":\"wide\"} -->\n<div class=\"wp-block-columns alignwide\"><!-- wp:column -->\n<div class=\"wp-block-column\"><!-- wp:spacer -->\n<div style=\"height:100px\" aria-hidden=\"true\" class=\"wp-block-spacer\"></div>\n<!-- /wp:spacer -->\n\n<!-- wp:heading {\"level\":6,\"style\":{\"color\":{\"text\":\"#000000\"}}} -->\n<h6 class=\"has-text-color\" id=\"ecosystem\" style=\"color:#000000\">ЭКОСИСТЕМА</h6>\n<!-- /wp:heading -->\n\n<!-- wp:paragraph {\"style\":{\"typography\":{\"lineHeight\":\"1.1\",\"fontSize\":\"5vw\"},\"color\":{\"text\":\"#000000\"}}} -->\n<p class=\"has-text-color\" style=\"color:#000000;font-size:5vw;line-height:1.1\"><strong>Положительный рост.</strong></p>\n<!-- /wp:paragraph -->\n\n<!-- wp:spacer {\"height\":\"5px\"} -->\n<div style=\"height:5px\" aria-hidden=\"true\" class=\"wp-block-spacer\"></div>\n<!-- /wp:spacer --></div>\n<!-- /wp:column --></div>\n<!-- /wp:columns -->\n\n<!-- wp:columns {\"align\":\"wide\"} -->\n<div class=\"wp-block-columns alignwide\"><!-- wp:column {\"width\":\"33.38%\"} -->\n<div class=\"wp-block-column\" style=\"flex-basis:33.38%\"><!-- wp:paragraph {\"style\":{\"color\":{\"text\":\"#000000\"}},\"fontSize\":\"extra-small\"} -->\n<p class=\"has-text-color has-extra-small-font-size\" style=\"color:#000000\"><em>Природа</em> в обычном смысле слова относится к сущностям, неизменным человеком; космос, воздух, река, лист. <em>Искусство</em> применяется к смеси его воли с теми же вещами, как в доме, канале, статуе, картине. Но его операции, взятые вместе, настолько незначительны, это небольшое измельчение, выпечка, заплатка и стирка, что в таком грандиозном впечатлении, как мир, в человеческом сознании, они не меняют результата.</p>\n<!-- /wp:paragraph --></div>\n<!-- /wp:column -->\n\n<!-- wp:column {\"width\":\"33%\"} -->\n<div class=\"wp-block-column\" style=\"flex-basis:33%\"><!-- wp:spacer -->\n<div style=\"height:100px\" aria-hidden=\"true\" class=\"wp-block-spacer\"></div>\n<!-- /wp:spacer -->\n\n<!-- wp:image {\"sizeSlug\":\"large\",\"linkDestination\":\"none\"} -->\n<figure class=\"wp-block-image size-large\"><img src=\"https://s.w.org/images/core/5.8/outside-01.jpg\" alt=\"Солнце садится сквозь густой лес деревьев.\" /></figure>\n<!-- /wp:image --></div>\n<!-- /wp:column -->\n\n<!-- wp:column {\"width\":\"33.62%\"} -->\n<div class=\"wp-block-column\" style=\"flex-basis:33.62%\"><!-- wp:image {\"sizeSlug\":\"large\",\"linkDestination\":\"none\"} -->\n<figure class=\"wp-block-image size-large\"><img src=\"https://s.w.org/images/core/5.8/outside-02.jpg\" alt=\"Ветровые турбины, стоящие на травянистой равнине, против голубого неба.\" /></figure>\n<!-- /wp:image --></div>\n<!-- /wp:column --></div>\n<!-- /wp:columns -->\n\n<!-- wp:columns {\"align\":\"wide\"} -->\n<div class=\"wp-block-columns alignwide\"><!-- wp:column {\"width\":\"67%\"} -->\n<div class=\"wp-block-column\" style=\"flex-basis:67%\"><!-- wp:image {\"align\":\"right\",\"sizeSlug\":\"large\",\"linkDestination\":\"none\"} -->\n<div class=\"wp-block-image\"><figure class=\"alignright size-large\"><img src=\"https://s.w.org/images/core/5.8/outside-03.jpg\" alt=\"Солнце светит над гребнем, спускающимся к берегу. Вдалеке по дороге едет машина.\" /></figure></div>\n<!-- /wp:image --></div>\n<!-- /wp:column -->\n\n<!-- wp:column {\"verticalAlignment\":\"center\",\"width\":\"33%\"} -->\n<div class=\"wp-block-column is-vertically-aligned-center\" style=\"flex-basis:33%\"><!-- wp:paragraph {\"style\":{\"color\":{\"text\":\"#000000\"}},\"fontSize\":\"extra-small\"} -->\n<p class=\"has-text-color has-extra-small-font-size\" style=\"color:#000000\">Несомненно, у нас нет вопросов, на которые невозможно ответить. Мы должны доверять совершенству творения настолько, чтобы верить в то, что какое бы любопытство ни пробудил в наших умах порядок вещей, порядок вещей может удовлетворить. Состояние каждого человека - это иероглифическое решение тех вопросов, которые он задавал.</p>\n<!-- /wp:paragraph --></div>\n<!-- /wp:column --></div>\n<!-- /wp:columns --></div>\n<!-- /wp:group -->\";}i:13;O:8:\"stdClass\":7:{s:2:\"id\";i:4378;s:5:\"title\";O:8:\"stdClass\":1:{s:8:\"rendered\";s:34:\"Три колонки текста\";}s:7:\"content\";O:8:\"stdClass\":2:{s:8:\"rendered\";s:1253:\"\n<div class=\"wp-container-624c8c9f32ddb wp-block-columns alignfull has-text-color has-background\" style=\"background-color:#ffffff;color:#000000\">\n<div class=\"wp-block-column\">\n<h3 style=\"font-size:24px;line-height:1.3\"><strong><a href=\"http://wordpress.org\">Виртуальный тур ↗</a></strong></h3>\n\n\n\n<p>Примите участие в виртуальной экскурсии по музею. Идеально подходит для школ и мероприятий.</p>\n</div>\n\n\n\n<div class=\"wp-block-column\">\n<h3 style=\"font-size:24px;line-height:1.3\"><strong><a href=\"https://wordpress.org\">Текущие шоу ↗</a></strong></h3>\n\n\n\n<p>Будьте в курсе и смотрите наши текущие выставки здесь.</p>\n</div>\n\n\n\n<div class=\"wp-block-column\">\n<h3 style=\"font-size:24px;line-height:1.3\"><strong><a href=\"https://wordpress.org\">Полезная информация ↗</a></strong></h3>\n\n\n\n<p>Узнайте о времени работы, ценах на билеты и скидках.</p>\n</div>\n</div>\n<style>.wp-container-624c8c9f32ddb {display: flex;gap: var( --wp--style--block-gap, 0.5em );flex-wrap: nowrap;align-items: center;}.wp-container-624c8c9f32ddb > * { margin: 0; }</style>\";s:9:\"protected\";b:0;}s:4:\"meta\";O:8:\"stdClass\":6:{s:10:\"spay_email\";s:0:\"\";s:13:\"wpop_keywords\";s:0:\"\";s:16:\"wpop_description\";s:35:\"Три колонки текста.\";s:19:\"wpop_viewport_width\";i:1200;s:16:\"wpop_block_types\";a:0:{}s:11:\"wpop_locale\";s:5:\"ru_RU\";}s:14:\"category_slugs\";a:3:{i:0;s:7:\"columns\";i:1;s:8:\"featured\";i:2;s:4:\"text\";}s:13:\"keyword_slugs\";a:1:{i:0;s:4:\"core\";}s:15:\"pattern_content\";s:1736:\"<!-- wp:columns {\"align\":\"full\",\"style\":{\"color\":{\"text\":\"#000000\",\"background\":\"#ffffff\"}}} -->\n<div class=\"wp-block-columns alignfull has-text-color has-background\" style=\"background-color:#ffffff;color:#000000\"><!-- wp:column -->\n<div class=\"wp-block-column\"><!-- wp:heading {\"level\":3,\"style\":{\"typography\":{\"fontSize\":\"24px\",\"lineHeight\":\"1.3\"}}} -->\n<h3 style=\"font-size:24px;line-height:1.3\"><strong><a href=\"http://wordpress.org\">Виртуальный тур ↗</a></strong></h3>\n<!-- /wp:heading -->\n\n<!-- wp:paragraph -->\n<p>Примите участие в виртуальной экскурсии по музею. Идеально подходит для школ и мероприятий.</p>\n<!-- /wp:paragraph --></div>\n<!-- /wp:column -->\n\n<!-- wp:column -->\n<div class=\"wp-block-column\"><!-- wp:heading {\"level\":3,\"style\":{\"typography\":{\"fontSize\":\"24px\",\"lineHeight\":\"1.3\"}}} -->\n<h3 style=\"font-size:24px;line-height:1.3\"><strong><a href=\"https://wordpress.org\">Текущие шоу ↗</a></strong></h3>\n<!-- /wp:heading -->\n\n<!-- wp:paragraph -->\n<p>Будьте в курсе и смотрите наши текущие выставки здесь.</p>\n<!-- /wp:paragraph --></div>\n<!-- /wp:column -->\n\n<!-- wp:column -->\n<div class=\"wp-block-column\"><!-- wp:heading {\"level\":3,\"style\":{\"typography\":{\"fontSize\":\"24px\",\"lineHeight\":\"1.3\"}}} -->\n<h3 style=\"font-size:24px;line-height:1.3\"><strong><a href=\"https://wordpress.org\">Полезная информация ↗</a></strong></h3>\n<!-- /wp:heading -->\n\n<!-- wp:paragraph -->\n<p>Узнайте о времени работы, ценах на билеты и скидках.</p>\n<!-- /wp:paragraph --></div>\n<!-- /wp:column --></div>\n<!-- /wp:columns -->\";}i:14;O:8:\"stdClass\":7:{s:2:\"id\";i:591;s:5:\"title\";O:8:\"stdClass\":1:{s:8:\"rendered\";s:5:\"Event\";}s:7:\"content\";O:8:\"stdClass\":2:{s:8:\"rendered\";s:2119:\"\n<div class=\"wp-elements-624c8c9f33d4c wp-block-media-text alignfull has-media-on-the-right is-stacked-on-mobile is-vertically-aligned-top has-text-color has-background has-link-color\" style=\"background-color:#121c1c;color:#fffdc7;grid-template-columns:auto 60%\"><figure class=\"wp-block-media-text__media\"><img loading=\"lazy\" width=\"1024\" height=\"1024\" src=\"https://s.w.org/patterns/files/2021/06/image-from-rawpixel-id-430289-jpeg-1-1024x1024.jpg\" alt=\"\" class=\"wp-image-590 size-full\" srcset=\"https://s.w.org/patterns/files/2021/06/image-from-rawpixel-id-430289-jpeg-1-1024x1024.jpg 1024w, https://s.w.org/patterns/files/2021/06/image-from-rawpixel-id-430289-jpeg-1-300x300.jpg 300w, https://s.w.org/patterns/files/2021/06/image-from-rawpixel-id-430289-jpeg-1-150x150.jpg 150w, https://s.w.org/patterns/files/2021/06/image-from-rawpixel-id-430289-jpeg-1-768x768.jpg 768w, https://s.w.org/patterns/files/2021/06/image-from-rawpixel-id-430289-jpeg-1-1536x1536.jpg 1536w, https://s.w.org/patterns/files/2021/06/image-from-rawpixel-id-430289-jpeg-1.jpg 1572w\" sizes=\"(max-width: 1024px) 100vw, 1024px\" /></figure><div class=\"wp-block-media-text__content\">\n<div class=\"wp-elements-624c8c9f33d2e wp-container-624c8c9f33d23 wp-block-group has-link-color\" style=\"padding-top:2em;padding-right:2em;padding-bottom:2em;padding-left:2em\">\n<h2 style=\"font-size:48px;font-weight:700;line-height:1.15\">Opening <br>Party</h2>\n\n\n\n<p class=\"wp-elements-624c8c9f339cf has-text-color has-link-color\" style=\"color:#fffdc7\"><strong><a href=\"#\">RSVP →</a></strong></p>\n<style>.wp-elements-624c8c9f339cf a{color: #fffdc7;}</style>\n</div>\n<style>.wp-container-624c8c9f33d23 .alignleft { float: left; margin-right: 2em; margin-left: 0; }.wp-container-624c8c9f33d23 .alignright { float: right; margin-left: 2em; margin-right: 0; }.wp-container-624c8c9f33d23 > * { margin-top: 0; margin-bottom: 0; }.wp-container-624c8c9f33d23 > * + * { margin-top: var( --wp--style--block-gap );  margin-bottom: 0; }</style><style>.wp-elements-624c8c9f33d2e a{color: #fffdc7;}</style>\n</div></div>\n<style>.wp-elements-624c8c9f33d4c a{color: #fffdc7;}</style>\n\";s:9:\"protected\";b:0;}s:4:\"meta\";O:8:\"stdClass\":6:{s:10:\"spay_email\";s:0:\"\";s:13:\"wpop_keywords\";s:0:\"\";s:16:\"wpop_description\";s:0:\"\";s:19:\"wpop_viewport_width\";i:800;s:16:\"wpop_block_types\";a:0:{}s:11:\"wpop_locale\";s:5:\"en_US\";}s:14:\"category_slugs\";a:3:{i:0;s:8:\"featured\";i:1;s:6:\"header\";i:2;s:6:\"images\";}s:13:\"keyword_slugs\";a:0:{}s:15:\"pattern_content\";s:1592:\"<!-- wp:media-text {\"align\":\"full\",\"mediaPosition\":\"right\",\"mediaId\":590,\"mediaLink\":\"https://wordpress.org/patterns/image-from-rawpixel-id-430289-jpeg-1/\",\"mediaType\":\"image\",\"mediaWidth\":60,\"verticalAlignment\":\"top\",\"style\":{\"color\":{\"background\":\"#121c1c\",\"text\":\"#fffdc7\"},\"elements\":{\"link\":{\"color\":{\"text\":\"#fffdc7\"}}}}} -->\n<div class=\"wp-block-media-text alignfull has-media-on-the-right is-stacked-on-mobile is-vertically-aligned-top has-text-color has-background has-link-color\" style=\"background-color:#121c1c;color:#fffdc7;grid-template-columns:auto 60%\"><figure class=\"wp-block-media-text__media\"><img src=\"https://s.w.org/patterns/files/2021/06/image-from-rawpixel-id-430289-jpeg-1-1024x1024.jpg\" alt=\"\" class=\"wp-image-590 size-full\" /></figure><div class=\"wp-block-media-text__content\"><!-- wp:group {\"style\":{\"spacing\":{\"padding\":{\"top\":\"2em\",\"right\":\"2em\",\"bottom\":\"2em\",\"left\":\"2em\"}},\"elements\":{\"link\":{\"color\":{\"text\":\"#fffdc7\"}}}}} -->\n<div class=\"wp-block-group has-link-color\" style=\"padding-top:2em;padding-right:2em;padding-bottom:2em;padding-left:2em\"><!-- wp:heading {\"style\":{\"typography\":{\"fontWeight\":\"700\",\"fontSize\":\"48px\",\"lineHeight\":\"1.15\"}}} -->\n<h2 style=\"font-size:48px;font-weight:700;line-height:1.15\">Opening <br>Party</h2>\n<!-- /wp:heading -->\n\n<!-- wp:paragraph {\"style\":{\"elements\":{\"link\":{\"color\":{\"text\":\"#fffdc7\"}}},\"color\":{\"text\":\"#fffdc7\"}}} -->\n<p class=\"has-text-color has-link-color\" style=\"color:#fffdc7\"><strong><a href=\"#\">RSVP →</a></strong></p>\n<!-- /wp:paragraph --></div>\n<!-- /wp:group --></div></div>\n<!-- /wp:media-text -->\";}i:15;O:8:\"stdClass\":7:{s:2:\"id\";i:566;s:5:\"title\";O:8:\"stdClass\":1:{s:8:\"rendered\";s:30:\"Event announcement and details\";}s:7:\"content\";O:8:\"stdClass\":2:{s:8:\"rendered\";s:2309:\"\n<div class=\"wp-elements-624c8c9f356f2 wp-container-624c8c9f356e1 wp-block-group alignfull has-black-color has-text-color has-background has-link-color\" style=\"background-color:#d2cdc7\">\n<div style=\"height:50px\" aria-hidden=\"true\" class=\"wp-block-spacer\"></div>\n\n\n\n<h2 class=\"alignwide\" style=\"font-size:46px;font-weight:400;line-height:1.1\">HÉLÈNE DUMAS<br><em>FRAGMENTS</em></h2>\n\n\n\n<h3 class=\"alignwide\" style=\"font-size:46px;font-weight:400;line-height:1.1\">20/4 — 9/9/2021<br>SOUTH LONDON ART GALLERY</h3>\n\n\n\n<div style=\"height:50px\" aria-hidden=\"true\" class=\"wp-block-spacer\"></div>\n\n\n\n<div class=\"wp-container-624c8c9f34de6 wp-block-columns alignwide\">\n<div class=\"wp-block-column\" style=\"flex-basis:25%\"></div>\n\n\n\n<div class=\"wp-block-column\" style=\"flex-basis:75%\">\n<figure class=\"wp-block-image size-full\"><img src=\"https://mywptesting.site/wp-content/uploads/2021/06/Histoire_naturelle_..._-fragments-_-_Upper_cover_C108eee15-1.jpg\" alt=\"\" class=\"wp-image-3173\" /></figure>\n</div>\n</div>\n<style>.wp-container-624c8c9f34de6 {display: flex;gap: var( --wp--style--block-gap, 0.5em );flex-wrap: nowrap;align-items: center;}.wp-container-624c8c9f34de6 > * { margin: 0; }</style>\n\n\n<div style=\"height:50px\" aria-hidden=\"true\" class=\"wp-block-spacer\"></div>\n\n\n\n<div class=\"wp-container-624c8c9f3524e wp-block-columns alignwide\">\n<div class=\"wp-block-column\">\n<p style=\"font-size:25px\">MORE INFO AT: WP.ORG · +44 21 1234 5678</p>\n</div>\n\n\n\n<div class=\"wp-block-column\">\n<p class=\"has-text-align-right\" style=\"font-size:25px\">INSTAGRAM · <a href=\"#\">TICKETS</a></p>\n</div>\n</div>\n<style>.wp-container-624c8c9f3524e {display: flex;gap: var( --wp--style--block-gap, 0.5em );flex-wrap: nowrap;align-items: center;}.wp-container-624c8c9f3524e > * { margin: 0; }</style>\n\n\n<div style=\"height:50px\" aria-hidden=\"true\" class=\"wp-block-spacer\"></div>\n</div>\n<style>.wp-container-624c8c9f356e1 .alignleft { float: left; margin-right: 2em; margin-left: 0; }.wp-container-624c8c9f356e1 .alignright { float: right; margin-left: 2em; margin-right: 0; }.wp-container-624c8c9f356e1 > * { margin-top: 0; margin-bottom: 0; }.wp-container-624c8c9f356e1 > * + * { margin-top: var( --wp--style--block-gap );  margin-bottom: 0; }</style><style>.wp-elements-624c8c9f356f2 a{color: var(--wp--preset--color--black);}</style>\n\";s:9:\"protected\";b:0;}s:4:\"meta\";O:8:\"stdClass\":6:{s:10:\"spay_email\";s:0:\"\";s:13:\"wpop_keywords\";s:0:\"\";s:16:\"wpop_description\";s:0:\"\";s:19:\"wpop_viewport_width\";i:800;s:16:\"wpop_block_types\";a:0:{}s:11:\"wpop_locale\";s:5:\"en_US\";}s:14:\"category_slugs\";a:3:{i:0;s:8:\"featured\";i:1;s:6:\"images\";i:2;s:4:\"text\";}s:13:\"keyword_slugs\";a:0:{}s:15:\"pattern_content\";s:2622:\"<!-- wp:group {\"align\":\"full\",\"style\":{\"color\":{\"background\":\"#d2cdc7\"},\"elements\":{\"link\":{\"color\":{\"text\":\"var:preset|color|black\"}}}},\"textColor\":\"black\"} -->\n<div class=\"wp-block-group alignfull has-black-color has-text-color has-background has-link-color\" style=\"background-color:#d2cdc7\"><!-- wp:spacer {\"height\":50} -->\n<div style=\"height:50px\" aria-hidden=\"true\" class=\"wp-block-spacer\"></div>\n<!-- /wp:spacer -->\n\n<!-- wp:heading {\"align\":\"wide\",\"style\":{\"typography\":{\"fontSize\":\"46px\",\"lineHeight\":\"1.1\",\"fontWeight\":\"400\"}}} -->\n<h2 class=\"alignwide\" style=\"font-size:46px;font-weight:400;line-height:1.1\">HÉLÈNE DUMAS<br><em>FRAGMENTS</em></h2>\n<!-- /wp:heading -->\n\n<!-- wp:heading {\"level\":3,\"align\":\"wide\",\"style\":{\"typography\":{\"fontSize\":\"46px\",\"lineHeight\":\"1.1\",\"fontWeight\":\"400\"}}} -->\n<h3 class=\"alignwide\" style=\"font-size:46px;font-weight:400;line-height:1.1\">20/4 — 9/9/2021<br>SOUTH LONDON ART GALLERY</h3>\n<!-- /wp:heading -->\n\n<!-- wp:spacer {\"height\":50} -->\n<div style=\"height:50px\" aria-hidden=\"true\" class=\"wp-block-spacer\"></div>\n<!-- /wp:spacer -->\n\n<!-- wp:columns {\"align\":\"wide\"} -->\n<div class=\"wp-block-columns alignwide\"><!-- wp:column {\"width\":\"25%\"} -->\n<div class=\"wp-block-column\" style=\"flex-basis:25%\"></div>\n<!-- /wp:column -->\n\n<!-- wp:column {\"width\":\"75%\"} -->\n<div class=\"wp-block-column\" style=\"flex-basis:75%\"><!-- wp:image {\"id\":3173,\"sizeSlug\":\"full\",\"linkDestination\":\"none\"} -->\n<figure class=\"wp-block-image size-full\"><img src=\"https://mywptesting.site/wp-content/uploads/2021/06/Histoire_naturelle_..._-fragments-_-_Upper_cover_C108eee15-1.jpg\" alt=\"\" class=\"wp-image-3173\" /></figure>\n<!-- /wp:image --></div>\n<!-- /wp:column --></div>\n<!-- /wp:columns -->\n\n<!-- wp:spacer {\"height\":50} -->\n<div style=\"height:50px\" aria-hidden=\"true\" class=\"wp-block-spacer\"></div>\n<!-- /wp:spacer -->\n\n<!-- wp:columns {\"align\":\"wide\"} -->\n<div class=\"wp-block-columns alignwide\"><!-- wp:column -->\n<div class=\"wp-block-column\"><!-- wp:paragraph {\"style\":{\"typography\":{\"fontSize\":\"25px\"}}} -->\n<p style=\"font-size:25px\">MORE INFO AT: WP.ORG · +44 21 1234 5678</p>\n<!-- /wp:paragraph --></div>\n<!-- /wp:column -->\n\n<!-- wp:column -->\n<div class=\"wp-block-column\"><!-- wp:paragraph {\"align\":\"right\",\"style\":{\"typography\":{\"fontSize\":\"25px\"}}} -->\n<p class=\"has-text-align-right\" style=\"font-size:25px\">INSTAGRAM · <a href=\"#\">TICKETS</a></p>\n<!-- /wp:paragraph --></div>\n<!-- /wp:column --></div>\n<!-- /wp:columns -->\n\n<!-- wp:spacer {\"height\":50} -->\n<div style=\"height:50px\" aria-hidden=\"true\" class=\"wp-block-spacer\"></div>\n<!-- /wp:spacer --></div>\n<!-- /wp:group -->\";}i:16;O:8:\"stdClass\":7:{s:2:\"id\";i:502;s:5:\"title\";O:8:\"stdClass\":1:{s:8:\"rendered\";s:13:\"Event details\";}s:7:\"content\";O:8:\"stdClass\":2:{s:8:\"rendered\";s:1823:\"\n<figure class=\"wp-block-image alignwide size-full\"><img loading=\"lazy\" width=\"2560\" height=\"1227\" src=\"https://s.w.org/patterns/files/2021/06/Group-17-scaled.jpg\" alt=\"Image of a woman being carried through the air by swans.\" class=\"wp-image-501\" srcset=\"https://s.w.org/patterns/files/2021/06/Group-17-scaled.jpg 2560w, https://s.w.org/patterns/files/2021/06/Group-17-300x144.jpg 300w, https://s.w.org/patterns/files/2021/06/Group-17-1024x491.jpg 1024w, https://s.w.org/patterns/files/2021/06/Group-17-768x368.jpg 768w, https://s.w.org/patterns/files/2021/06/Group-17-1536x736.jpg 1536w, https://s.w.org/patterns/files/2021/06/Group-17-2048x981.jpg 2048w\" sizes=\"(max-width: 2560px) 100vw, 2560px\" /></figure>\n\n\n\n<div class=\"wp-container-624c8c9f36e7e wp-block-columns alignwide are-vertically-aligned-center\">\n<div class=\"wp-block-column is-vertically-aligned-center\">\n<p style=\"line-height:2\"><strong>Location:</strong><br>82 Main St. Brooklyn, NY</p>\n</div>\n\n\n\n<div class=\"wp-block-column is-vertically-aligned-center\">\n<p style=\"line-height:2\"><strong>Date:</strong><br>October 24, 2021</p>\n</div>\n\n\n\n<div class=\"wp-block-column is-vertically-aligned-center\">\n<div class=\"wp-container-624c8c9f36b3a wp-block-buttons\">\n<div class=\"wp-block-button has-custom-width wp-block-button__width-100\"><a class=\"wp-block-button__link has-text-color has-background\" style=\"background-color:#262626;color:#efefef\">Purchase Tickets</a></div>\n</div>\n<style>.wp-container-624c8c9f36b3a {display: flex;gap: var( --wp--style--block-gap, 0.5em );flex-wrap: wrap;align-items: center;}.wp-container-624c8c9f36b3a > * { margin: 0; }</style></div>\n</div>\n<style>.wp-container-624c8c9f36e7e {display: flex;gap: var( --wp--style--block-gap, 0.5em );flex-wrap: nowrap;align-items: center;}.wp-container-624c8c9f36e7e > * { margin: 0; }</style>\";s:9:\"protected\";b:0;}s:4:\"meta\";O:8:\"stdClass\":6:{s:10:\"spay_email\";s:0:\"\";s:13:\"wpop_keywords\";s:0:\"\";s:16:\"wpop_description\";s:14:\"Event details.\";s:19:\"wpop_viewport_width\";i:1200;s:16:\"wpop_block_types\";a:0:{}s:11:\"wpop_locale\";s:5:\"en_US\";}s:14:\"category_slugs\";a:2:{i:0;s:8:\"featured\";i:1;s:4:\"text\";}s:13:\"keyword_slugs\";a:0:{}s:15:\"pattern_content\";s:1624:\"<!-- wp:image {\"align\":\"wide\",\"id\":501,\"sizeSlug\":\"full\",\"linkDestination\":\"none\"} -->\n<figure class=\"wp-block-image alignwide size-full\"><img src=\"https://s.w.org/patterns/files/2021/06/Group-17-scaled.jpg\" alt=\"Image of a woman being carried through the air by swans.\" class=\"wp-image-501\" /></figure>\n<!-- /wp:image -->\n\n<!-- wp:columns {\"verticalAlignment\":\"center\",\"align\":\"wide\"} -->\n<div class=\"wp-block-columns alignwide are-vertically-aligned-center\"><!-- wp:column {\"verticalAlignment\":\"center\"} -->\n<div class=\"wp-block-column is-vertically-aligned-center\"><!-- wp:paragraph {\"style\":{\"typography\":{\"lineHeight\":\"2\"}}} -->\n<p style=\"line-height:2\"><strong>Location:</strong><br>82 Main St. Brooklyn, NY</p>\n<!-- /wp:paragraph --></div>\n<!-- /wp:column -->\n\n<!-- wp:column {\"verticalAlignment\":\"center\"} -->\n<div class=\"wp-block-column is-vertically-aligned-center\"><!-- wp:paragraph {\"style\":{\"typography\":{\"lineHeight\":\"2\"}}} -->\n<p style=\"line-height:2\"><strong>Date:</strong><br>October 24, 2021</p>\n<!-- /wp:paragraph --></div>\n<!-- /wp:column -->\n\n<!-- wp:column {\"verticalAlignment\":\"center\"} -->\n<div class=\"wp-block-column is-vertically-aligned-center\"><!-- wp:buttons -->\n<div class=\"wp-block-buttons\"><!-- wp:button {\"width\":100,\"style\":{\"color\":{\"background\":\"#262626\",\"text\":\"#efefef\"}}} -->\n<div class=\"wp-block-button has-custom-width wp-block-button__width-100\"><a class=\"wp-block-button__link has-text-color has-background\" style=\"background-color:#262626;color:#efefef\">Purchase Tickets</a></div>\n<!-- /wp:button --></div>\n<!-- /wp:buttons --></div>\n<!-- /wp:column --></div>\n<!-- /wp:columns -->\";}i:17;O:8:\"stdClass\":7:{s:2:\"id\";i:184;s:5:\"title\";O:8:\"stdClass\":1:{s:8:\"rendered\";s:7:\"Heading\";}s:7:\"content\";O:8:\"stdClass\":2:{s:8:\"rendered\";s:509:\"\n<h2 class=\"alignwide\" id=\"we-re-a-studio-in-berlin-with-an-international-practice-in-architecture-urban-planning-and-interior-design-we-believe-in-sharing-knowledge-and-promoting-dialogue-to-increase-the-creative-potential-of-collaboration\" style=\"font-size:48px;line-height:1.1\">We&#8217;re a studio in Berlin with an international practice in architecture, urban planning and interior design. We believe in sharing knowledge and promoting dialogue to increase the creative potential of collaboration.</h2>\n\";s:9:\"protected\";b:0;}s:4:\"meta\";O:8:\"stdClass\":6:{s:10:\"spay_email\";s:0:\"\";s:13:\"wpop_keywords\";s:17:\"large text, title\";s:16:\"wpop_description\";s:12:\"Heading text\";s:19:\"wpop_viewport_width\";i:1200;s:16:\"wpop_block_types\";a:1:{i:0;s:12:\"core/heading\";}s:11:\"wpop_locale\";s:5:\"en_US\";}s:14:\"category_slugs\";a:2:{i:0;s:8:\"featured\";i:1;s:4:\"text\";}s:13:\"keyword_slugs\";a:1:{i:0;s:4:\"core\";}s:15:\"pattern_content\";s:621:\"<!-- wp:heading {\"align\":\"wide\",\"style\":{\"typography\":{\"fontSize\":\"48px\",\"lineHeight\":\"1.1\"}}} -->\n<h2 class=\"alignwide\" id=\"we-re-a-studio-in-berlin-with-an-international-practice-in-architecture-urban-planning-and-interior-design-we-believe-in-sharing-knowledge-and-promoting-dialogue-to-increase-the-creative-potential-of-collaboration\" style=\"font-size:48px;line-height:1.1\">We\'re a studio in Berlin with an international practice in architecture, urban planning and interior design. We believe in sharing knowledge and promoting dialogue to increase the creative potential of collaboration.</h2>\n<!-- /wp:heading -->\";}i:18;O:8:\"stdClass\":7:{s:2:\"id\";i:669;s:5:\"title\";O:8:\"stdClass\":1:{s:8:\"rendered\";s:31:\"Image and quote on a background\";}s:7:\"content\";O:8:\"stdClass\":2:{s:8:\"rendered\";s:2943:\"\n<div class=\"wp-block-media-text alignwide has-media-on-the-right is-stacked-on-mobile is-vertically-aligned-center has-background\" style=\"background-color:#f1f5c7\"><figure class=\"wp-block-media-text__media\"><img loading=\"lazy\" width=\"1024\" height=\"1024\" src=\"https://s.w.org/patterns/files/2021/06/pear-1-1024x1024.png\" alt=\"\" class=\"wp-image-5263 size-full\" srcset=\"https://s.w.org/patterns/files/2021/06/pear-1-1024x1024.png 1024w, https://s.w.org/patterns/files/2021/06/pear-1-300x300.png 300w, https://s.w.org/patterns/files/2021/06/pear-1-150x150.png 150w, https://s.w.org/patterns/files/2021/06/pear-1-768x768.png 768w, https://s.w.org/patterns/files/2021/06/pear-1.png 1300w\" sizes=\"(max-width: 1024px) 100vw, 1024px\" /></figure><div class=\"wp-block-media-text__content\">\n<div class=\"wp-container-624c8c9f38815 wp-block-group\" style=\"padding-top:2em;padding-right:2em;padding-bottom:2em;padding-left:2em\">\n<p style=\"font-size:36px;line-height:1.2\"><strong>Even the bitterest fruit has sugar in it.</strong></p>\n\n\n\n<p class=\"has-extra-small-font-size\">– Terry a O&#8217;Neal</p>\n</div>\n<style>.wp-container-624c8c9f38815 .alignleft { float: left; margin-right: 2em; margin-left: 0; }.wp-container-624c8c9f38815 .alignright { float: right; margin-left: 2em; margin-right: 0; }.wp-container-624c8c9f38815 > * { margin-top: 0; margin-bottom: 0; }.wp-container-624c8c9f38815 > * + * { margin-top: var( --wp--style--block-gap );  margin-bottom: 0; }</style></div></div>\n\n\n\n<div class=\"wp-block-media-text alignwide is-stacked-on-mobile is-vertically-aligned-center has-background\" style=\"background-color:#fffdea\"><figure class=\"wp-block-media-text__media\"><img loading=\"lazy\" width=\"1024\" height=\"1024\" src=\"https://s.w.org/patterns/files/2021/06/pear-half-1024x1024.png\" alt=\"\" class=\"wp-image-673 size-full\" srcset=\"https://s.w.org/patterns/files/2021/06/pear-half-1024x1024.png 1024w, https://s.w.org/patterns/files/2021/06/pear-half-300x300.png 300w, https://s.w.org/patterns/files/2021/06/pear-half-150x150.png 150w, https://s.w.org/patterns/files/2021/06/pear-half-768x768.png 768w, https://s.w.org/patterns/files/2021/06/pear-half.png 1300w\" sizes=\"(max-width: 1024px) 100vw, 1024px\" /></figure><div class=\"wp-block-media-text__content\">\n<div class=\"wp-container-624c8c9f38b69 wp-block-group\" style=\"padding-top:2em;padding-right:2em;padding-bottom:2em;padding-left:2em\">\n<p style=\"font-size:36px;line-height:1.2\"><strong>The trees that are slow to grow bear the best fruit.</strong></p>\n\n\n\n<p class=\"has-extra-small-font-size\">– Molière</p>\n</div>\n<style>.wp-container-624c8c9f38b69 .alignleft { float: left; margin-right: 2em; margin-left: 0; }.wp-container-624c8c9f38b69 .alignright { float: right; margin-left: 2em; margin-right: 0; }.wp-container-624c8c9f38b69 > * { margin-top: 0; margin-bottom: 0; }.wp-container-624c8c9f38b69 > * + * { margin-top: var( --wp--style--block-gap );  margin-bottom: 0; }</style></div></div>\n\";s:9:\"protected\";b:0;}s:4:\"meta\";O:8:\"stdClass\":6:{s:10:\"spay_email\";s:0:\"\";s:13:\"wpop_keywords\";s:0:\"\";s:16:\"wpop_description\";s:221:\"Two media and text blocks. The top one has a pale green background. The text is on the left and contains a quote, and the image is on the right. The next block underneath has the image on the left, and quote on the right.\";s:19:\"wpop_viewport_width\";i:800;s:16:\"wpop_block_types\";a:0:{}s:11:\"wpop_locale\";s:5:\"en_US\";}s:14:\"category_slugs\";a:3:{i:0;s:8:\"featured\";i:1;s:6:\"images\";i:2;s:4:\"text\";}s:13:\"keyword_slugs\";a:0:{}s:15:\"pattern_content\";s:2404:\"<!-- wp:media-text {\"mediaPosition\":\"right\",\"mediaId\":5263,\"mediaLink\":\"https://wordpress.org/patterns/pattern/image-and-quote-on-a-background/pear-3/\",\"mediaType\":\"image\",\"verticalAlignment\":\"center\",\"style\":{\"color\":{\"background\":\"#f1f5c7\"}}} -->\n<div class=\"wp-block-media-text alignwide has-media-on-the-right is-stacked-on-mobile is-vertically-aligned-center has-background\" style=\"background-color:#f1f5c7\"><figure class=\"wp-block-media-text__media\"><img src=\"https://s.w.org/patterns/files/2021/06/pear-1-1024x1024.png\" alt=\"\" class=\"wp-image-5263 size-full\" /></figure><div class=\"wp-block-media-text__content\"><!-- wp:group {\"style\":{\"spacing\":{\"padding\":{\"top\":\"2em\",\"right\":\"2em\",\"bottom\":\"2em\",\"left\":\"2em\"}}}} -->\n<div class=\"wp-block-group\" style=\"padding-top:2em;padding-right:2em;padding-bottom:2em;padding-left:2em\"><!-- wp:paragraph {\"style\":{\"typography\":{\"lineHeight\":\"1.2\",\"fontSize\":\"36px\"}}} -->\n<p style=\"font-size:36px;line-height:1.2\"><strong>Even the bitterest fruit has sugar in it.</strong></p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph {\"fontSize\":\"extra-small\"} -->\n<p class=\"has-extra-small-font-size\">– Terry a O\'Neal</p>\n<!-- /wp:paragraph --></div>\n<!-- /wp:group --></div></div>\n<!-- /wp:media-text -->\n\n<!-- wp:media-text {\"mediaId\":673,\"mediaLink\":\"https://wordpress.org/patterns/pear-half/\",\"mediaType\":\"image\",\"verticalAlignment\":\"center\",\"style\":{\"color\":{\"background\":\"#fffdea\"}}} -->\n<div class=\"wp-block-media-text alignwide is-stacked-on-mobile is-vertically-aligned-center has-background\" style=\"background-color:#fffdea\"><figure class=\"wp-block-media-text__media\"><img src=\"https://s.w.org/patterns/files/2021/06/pear-half-1024x1024.png\" alt=\"\" class=\"wp-image-673 size-full\" /></figure><div class=\"wp-block-media-text__content\"><!-- wp:group {\"style\":{\"spacing\":{\"padding\":{\"top\":\"2em\",\"right\":\"2em\",\"bottom\":\"2em\",\"left\":\"2em\"}}}} -->\n<div class=\"wp-block-group\" style=\"padding-top:2em;padding-right:2em;padding-bottom:2em;padding-left:2em\"><!-- wp:paragraph {\"style\":{\"typography\":{\"lineHeight\":\"1.2\",\"fontSize\":\"36px\"}}} -->\n<p style=\"font-size:36px;line-height:1.2\"><strong>The trees that are slow to grow bear the best fruit.</strong></p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph {\"fontSize\":\"extra-small\"} -->\n<p class=\"has-extra-small-font-size\">– Molière</p>\n<!-- /wp:paragraph --></div>\n<!-- /wp:group --></div></div>\n<!-- /wp:media-text -->\";}i:19;O:8:\"stdClass\":7:{s:2:\"id\";i:573;s:5:\"title\";O:8:\"stdClass\":1:{s:8:\"rendered\";s:37:\"Image on solid color with description\";}s:7:\"content\";O:8:\"stdClass\":2:{s:8:\"rendered\";s:1928:\"\n<div class=\"wp-container-624c8c9f3a215 wp-block-columns alignfull\">\n<div class=\"wp-block-column\" style=\"flex-basis:50%\">\n<div class=\"wp-block-cover has-background-dim\" style=\"background-color:#f6f6f6;min-height:600px\"><div class=\"wp-block-cover__inner-container\">\n<div class=\"wp-block-image\"><figure class=\"aligncenter size-medium\"><img loading=\"lazy\" width=\"263\" height=\"300\" src=\"https://s.w.org/patterns/files/2021/06/wire-sculpture-263x300.jpg\" alt=\"\" class=\"wp-image-571\" srcset=\"https://s.w.org/patterns/files/2021/06/wire-sculpture-263x300.jpg 263w, https://s.w.org/patterns/files/2021/06/wire-sculpture-898x1024.jpg 898w, https://s.w.org/patterns/files/2021/06/wire-sculpture-768x875.jpg 768w, https://s.w.org/patterns/files/2021/06/wire-sculpture-1347x1536.jpg 1347w, https://s.w.org/patterns/files/2021/06/wire-sculpture.jpg 1658w\" sizes=\"(max-width: 263px) 100vw, 263px\" /></figure></div>\n</div></div>\n</div>\n\n\n\n<div class=\"wp-block-column is-vertically-aligned-center\" style=\"padding-top:1em;padding-right:1em;padding-bottom:1em;padding-left:1em\">\n<div class=\"wp-container-624c8c9f39ebf wp-block-columns\">\n<div class=\"wp-block-column\" style=\"flex-basis:320px\">\n<p class=\"has-small-font-size\" style=\"line-height:1.6\"><strong>Airplane</strong></p>\n\n\n\n<p class=\"has-small-font-size\" style=\"line-height:1.6\">Copper wire, wood base. I created this piece in late 2008. For this work, I aimed to convey both the industrial heaviness of an airplane, but also the cloudlike floating quality you feel when you’re in one.</p>\n</div>\n</div>\n<style>.wp-container-624c8c9f39ebf {display: flex;gap: var( --wp--style--block-gap, 0.5em );flex-wrap: nowrap;align-items: center;}.wp-container-624c8c9f39ebf > * { margin: 0; }</style></div>\n</div>\n<style>.wp-container-624c8c9f3a215 {display: flex;gap: var( --wp--style--block-gap, 0.5em );flex-wrap: nowrap;align-items: center;}.wp-container-624c8c9f3a215 > * { margin: 0; }</style>\";s:9:\"protected\";b:0;}s:4:\"meta\";O:8:\"stdClass\":6:{s:10:\"spay_email\";s:0:\"\";s:13:\"wpop_keywords\";s:0:\"\";s:16:\"wpop_description\";s:38:\"Image on solid color with description.\";s:19:\"wpop_viewport_width\";i:1200;s:16:\"wpop_block_types\";a:0:{}s:11:\"wpop_locale\";s:5:\"en_US\";}s:14:\"category_slugs\";a:3:{i:0;s:8:\"featured\";i:1;s:6:\"images\";i:2;s:4:\"text\";}s:13:\"keyword_slugs\";a:0:{}s:15:\"pattern_content\";s:1826:\"<!-- wp:columns {\"align\":\"full\"} -->\n<div class=\"wp-block-columns alignfull\"><!-- wp:column {\"width\":\"50%\"} -->\n<div class=\"wp-block-column\" style=\"flex-basis:50%\"><!-- wp:cover {\"customOverlayColor\":\"#f6f6f6\",\"minHeight\":600} -->\n<div class=\"wp-block-cover has-background-dim\" style=\"background-color:#f6f6f6;min-height:600px\"><div class=\"wp-block-cover__inner-container\"><!-- wp:image {\"align\":\"center\",\"id\":571,\"sizeSlug\":\"medium\",\"linkDestination\":\"none\"} -->\n<div class=\"wp-block-image\"><figure class=\"aligncenter size-medium\"><img src=\"https://s.w.org/patterns/files/2021/06/wire-sculpture-263x300.jpg\" alt=\"\" class=\"wp-image-571\" /></figure></div>\n<!-- /wp:image --></div></div>\n<!-- /wp:cover --></div>\n<!-- /wp:column -->\n\n<!-- wp:column {\"verticalAlignment\":\"center\",\"style\":{\"spacing\":{\"padding\":{\"top\":\"1em\",\"right\":\"1em\",\"bottom\":\"1em\",\"left\":\"1em\"}}}} -->\n<div class=\"wp-block-column is-vertically-aligned-center\" style=\"padding-top:1em;padding-right:1em;padding-bottom:1em;padding-left:1em\"><!-- wp:columns -->\n<div class=\"wp-block-columns\"><!-- wp:column {\"width\":\"320px\"} -->\n<div class=\"wp-block-column\" style=\"flex-basis:320px\"><!-- wp:paragraph {\"style\":{\"typography\":{\"lineHeight\":\"1.6\"}},\"fontSize\":\"small\"} -->\n<p class=\"has-small-font-size\" style=\"line-height:1.6\"><strong>Airplane</strong></p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph {\"style\":{\"typography\":{\"lineHeight\":\"1.6\"}},\"fontSize\":\"small\"} -->\n<p class=\"has-small-font-size\" style=\"line-height:1.6\">Copper wire, wood base. I created this piece in late 2008. For this work, I aimed to convey both the industrial heaviness of an airplane, but also the cloudlike floating quality you feel when you’re in one.</p>\n<!-- /wp:paragraph --></div>\n<!-- /wp:column --></div>\n<!-- /wp:columns --></div>\n<!-- /wp:column --></div>\n<!-- /wp:columns -->\";}i:20;O:8:\"stdClass\":7:{s:2:\"id\";i:521;s:5:\"title\";O:8:\"stdClass\":1:{s:8:\"rendered\";s:45:\"Image with description below and to the right\";}s:7:\"content\";O:8:\"stdClass\":2:{s:8:\"rendered\";s:1670:\"\n<div class=\"wp-container-624c8c9f3b31d wp-block-columns\">\n<div class=\"wp-block-column\" style=\"flex-basis:10%\"></div>\n\n\n\n<div class=\"wp-block-column\">\n<figure class=\"wp-block-image size-large\"><img loading=\"lazy\" width=\"1024\" height=\"1024\" src=\"https://s.w.org/patterns/files/2021/06/image-from-rawpixel-id-539759-jpeg-1-1024x1024.jpg\" alt=\"Vintage Cupid Illustration\" class=\"wp-image-522\" srcset=\"https://s.w.org/patterns/files/2021/06/image-from-rawpixel-id-539759-jpeg-1-1024x1024.jpg 1024w, https://s.w.org/patterns/files/2021/06/image-from-rawpixel-id-539759-jpeg-1-300x300.jpg 300w, https://s.w.org/patterns/files/2021/06/image-from-rawpixel-id-539759-jpeg-1-150x150.jpg 150w, https://s.w.org/patterns/files/2021/06/image-from-rawpixel-id-539759-jpeg-1-768x768.jpg 768w, https://s.w.org/patterns/files/2021/06/image-from-rawpixel-id-539759-jpeg-1.jpg 1510w\" sizes=\"(max-width: 1024px) 100vw, 1024px\" /></figure>\n</div>\n\n\n\n<div class=\"wp-block-column\"></div>\n\n\n\n<div class=\"wp-block-column\" style=\"flex-basis:10%\"></div>\n</div>\n<style>.wp-container-624c8c9f3b31d {display: flex;gap: var( --wp--style--block-gap, 0.5em );flex-wrap: nowrap;align-items: center;}.wp-container-624c8c9f3b31d > * { margin: 0; }</style>\n\n\n<div class=\"wp-container-624c8c9f3b68a wp-block-columns\">\n<div class=\"wp-block-column\"></div>\n\n\n\n<div class=\"wp-block-column\">\n<p style=\"font-size:14px\"><strong>Cupid in Flight</strong><br>48” x 48” Giclee print on archival paper.</p>\n</div>\n</div>\n<style>.wp-container-624c8c9f3b68a {display: flex;gap: var( --wp--style--block-gap, 0.5em );flex-wrap: nowrap;align-items: center;}.wp-container-624c8c9f3b68a > * { margin: 0; }</style>\n\n\n<p></p>\n\";s:9:\"protected\";b:0;}s:4:\"meta\";O:8:\"stdClass\":6:{s:10:\"spay_email\";s:0:\"\";s:13:\"wpop_keywords\";s:0:\"\";s:16:\"wpop_description\";s:46:\"Image with description below and to the right.\";s:19:\"wpop_viewport_width\";i:1200;s:16:\"wpop_block_types\";a:0:{}s:11:\"wpop_locale\";s:5:\"en_US\";}s:14:\"category_slugs\";a:2:{i:0;s:8:\"featured\";i:1;s:6:\"images\";}s:13:\"keyword_slugs\";a:0:{}s:15:\"pattern_content\";s:1241:\"<!-- wp:columns -->\n<div class=\"wp-block-columns\"><!-- wp:column {\"width\":\"10%\"} -->\n<div class=\"wp-block-column\" style=\"flex-basis:10%\"></div>\n<!-- /wp:column -->\n\n<!-- wp:column -->\n<div class=\"wp-block-column\"><!-- wp:image {\"id\":522,\"sizeSlug\":\"large\",\"linkDestination\":\"none\"} -->\n<figure class=\"wp-block-image size-large\"><img src=\"https://s.w.org/patterns/files/2021/06/image-from-rawpixel-id-539759-jpeg-1-1024x1024.jpg\" alt=\"Vintage Cupid Illustration\" class=\"wp-image-522\" /></figure>\n<!-- /wp:image --></div>\n<!-- /wp:column -->\n\n<!-- wp:column -->\n<div class=\"wp-block-column\"></div>\n<!-- /wp:column -->\n\n<!-- wp:column {\"width\":\"10%\"} -->\n<div class=\"wp-block-column\" style=\"flex-basis:10%\"></div>\n<!-- /wp:column --></div>\n<!-- /wp:columns -->\n\n<!-- wp:columns -->\n<div class=\"wp-block-columns\"><!-- wp:column -->\n<div class=\"wp-block-column\"></div>\n<!-- /wp:column -->\n\n<!-- wp:column -->\n<div class=\"wp-block-column\"><!-- wp:paragraph {\"style\":{\"typography\":{\"fontSize\":\"14px\"}}} -->\n<p style=\"font-size:14px\"><strong>Cupid in Flight</strong><br>48” x 48” Giclee print on archival paper.</p>\n<!-- /wp:paragraph --></div>\n<!-- /wp:column --></div>\n<!-- /wp:columns -->\n\n<!-- wp:paragraph -->\n<p></p>\n<!-- /wp:paragraph -->\";}i:21;O:8:\"stdClass\":7:{s:2:\"id\";i:185;s:5:\"title\";O:8:\"stdClass\":1:{s:8:\"rendered\";s:35:\"Large header with left-aligned text\";}s:7:\"content\";O:8:\"stdClass\":2:{s:8:\"rendered\";s:1231:\"\n<div class=\"wp-block-cover alignfull has-background-dim-60 has-background-dim\" style=\"min-height:800px\"><img class=\"wp-block-cover__image-background\" alt=\"\" src=\"https://s.w.org/images/core/5.8/forest.jpg\" data-object-fit=\"cover\" /><div class=\"wp-block-cover__inner-container\">\n<h2 class=\"alignwide has-text-color\" style=\"color:#ffe074;font-size:64px\">Forest.</h2>\n\n\n\n<div class=\"wp-container-624c8c9f3c671 wp-block-columns alignwide\">\n<div class=\"wp-block-column\" style=\"flex-basis:55%\">\n<div style=\"height:330px\" aria-hidden=\"true\" class=\"wp-block-spacer\"></div>\n\n\n\n<p class=\"has-text-color\" style=\"color:#ffe074;font-size:12px;line-height:1.3\"><em>Even a child knows how valuable the forest is. The fresh, breathtaking smell of trees. Echoing birds flying above that dense magnitude. A stable climate, a sustainable diverse life and a source of culture. Yet, forests and other ecosystems hang in the balance, threatened to become croplands, pasture, and plantations.</em></p>\n</div>\n\n\n\n<div class=\"wp-block-column\"></div>\n</div>\n<style>.wp-container-624c8c9f3c671 {display: flex;gap: var( --wp--style--block-gap, 0.5em );flex-wrap: nowrap;align-items: center;}.wp-container-624c8c9f3c671 > * { margin: 0; }</style></div></div>\n\";s:9:\"protected\";b:0;}s:4:\"meta\";O:8:\"stdClass\":6:{s:10:\"spay_email\";s:0:\"\";s:13:\"wpop_keywords\";s:0:\"\";s:16:\"wpop_description\";s:29:\"Cover image with quote on top\";s:19:\"wpop_viewport_width\";i:1200;s:16:\"wpop_block_types\";a:0:{}s:11:\"wpop_locale\";s:5:\"en_US\";}s:14:\"category_slugs\";a:2:{i:0;s:8:\"featured\";i:1;s:6:\"header\";}s:13:\"keyword_slugs\";a:1:{i:0;s:4:\"core\";}s:15:\"pattern_content\";s:1610:\"<!-- wp:cover {\"url\":\"https://s.w.org/images/core/5.8/forest.jpg\",\"dimRatio\":60,\"minHeight\":800,\"align\":\"full\"} -->\n<div class=\"wp-block-cover alignfull has-background-dim-60 has-background-dim\" style=\"min-height:800px\"><img class=\"wp-block-cover__image-background\" alt=\"\" src=\"https://s.w.org/images/core/5.8/forest.jpg\" data-object-fit=\"cover\" /><div class=\"wp-block-cover__inner-container\"><!-- wp:heading {\"align\":\"wide\",\"style\":{\"color\":{\"text\":\"#ffe074\"},\"typography\":{\"fontSize\":\"64px\"}}} -->\n<h2 class=\"alignwide has-text-color\" style=\"color:#ffe074;font-size:64px\">Forest.</h2>\n<!-- /wp:heading -->\n\n<!-- wp:columns {\"align\":\"wide\"} -->\n<div class=\"wp-block-columns alignwide\"><!-- wp:column {\"width\":\"55%\"} -->\n<div class=\"wp-block-column\" style=\"flex-basis:55%\"><!-- wp:spacer {\"height\":330} -->\n<div style=\"height:330px\" aria-hidden=\"true\" class=\"wp-block-spacer\"></div>\n<!-- /wp:spacer -->\n\n<!-- wp:paragraph {\"style\":{\"color\":{\"text\":\"#ffe074\"},\"typography\":{\"lineHeight\":\"1.3\",\"fontSize\":\"12px\"}}} -->\n<p class=\"has-text-color\" style=\"color:#ffe074;font-size:12px;line-height:1.3\"><em>Even a child knows how valuable the forest is. The fresh, breathtaking smell of trees. Echoing birds flying above that dense magnitude. A stable climate, a sustainable diverse life and a source of culture. Yet, forests and other ecosystems hang in the balance, threatened to become croplands, pasture, and plantations.</em></p>\n<!-- /wp:paragraph --></div>\n<!-- /wp:column -->\n\n<!-- wp:column -->\n<div class=\"wp-block-column\"></div>\n<!-- /wp:column --></div>\n<!-- /wp:columns --></div></div>\n<!-- /wp:cover -->\";}i:22;O:8:\"stdClass\":7:{s:2:\"id\";i:192;s:5:\"title\";O:8:\"stdClass\":1:{s:8:\"rendered\";s:37:\"Media and text with image on the left\";}s:7:\"content\";O:8:\"stdClass\":2:{s:8:\"rendered\";s:520:\"\n<div class=\"wp-block-media-text alignfull is-stacked-on-mobile is-vertically-aligned-center\"><figure class=\"wp-block-media-text__media\"><img src=\"https://s.w.org/images/core/5.8/architecture-04.jpg\" alt=\"Close-up, abstract view of architecture.\" /></figure><div class=\"wp-block-media-text__content\">\n<h3 class=\"has-text-align-center has-text-color\" style=\"color:#000000\"><strong>Open Spaces</strong></h3>\n\n\n\n<p class=\"has-text-align-center has-extra-small-font-size\"><a href=\"#\">See case study ↗</a></p>\n</div></div>\n\";s:9:\"protected\";b:0;}s:4:\"meta\";O:8:\"stdClass\":6:{s:10:\"spay_email\";s:0:\"\";s:13:\"wpop_keywords\";s:0:\"\";s:16:\"wpop_description\";s:66:\"Media and text block with image to the left and text to the right.\";s:19:\"wpop_viewport_width\";i:1200;s:16:\"wpop_block_types\";a:0:{}s:11:\"wpop_locale\";s:5:\"en_US\";}s:14:\"category_slugs\";a:2:{i:0;s:8:\"featured\";i:1;s:6:\"header\";}s:13:\"keyword_slugs\";a:1:{i:0;s:4:\"core\";}s:15:\"pattern_content\";s:827:\"<!-- wp:media-text {\"align\":\"full\",\"mediaType\":\"image\",\"verticalAlignment\":\"center\"} -->\n<div class=\"wp-block-media-text alignfull is-stacked-on-mobile is-vertically-aligned-center\"><figure class=\"wp-block-media-text__media\"><img src=\"https://s.w.org/images/core/5.8/architecture-04.jpg\" alt=\"Close-up, abstract view of architecture.\" /></figure><div class=\"wp-block-media-text__content\"><!-- wp:heading {\"textAlign\":\"center\",\"level\":3,\"style\":{\"color\":{\"text\":\"#000000\"}}} -->\n<h3 class=\"has-text-align-center has-text-color\" style=\"color:#000000\"><strong>Open Spaces</strong></h3>\n<!-- /wp:heading -->\n\n<!-- wp:paragraph {\"align\":\"center\",\"fontSize\":\"extra-small\"} -->\n<p class=\"has-text-align-center has-extra-small-font-size\"><a href=\"#\">See case study ↗</a></p>\n<!-- /wp:paragraph --></div></div>\n<!-- /wp:media-text -->\";}i:23;O:8:\"stdClass\":7:{s:2:\"id\";i:526;s:5:\"title\";O:8:\"stdClass\":1:{s:8:\"rendered\";s:32:\"Offset images with descriptions.\";}s:7:\"content\";O:8:\"stdClass\":2:{s:8:\"rendered\";s:1871:\"\n<div class=\"wp-container-624c8c9f3e0f8 wp-block-columns\">\n<div class=\"wp-block-column\">\n<figure class=\"wp-block-image size-large\"><img loading=\"lazy\" width=\"793\" height=\"1024\" src=\"https://s.w.org/patterns/files/2021/06/Iris-793x1024.jpg\" alt=\"\" class=\"wp-image-525\" srcset=\"https://s.w.org/patterns/files/2021/06/Iris-793x1024.jpg 793w, https://s.w.org/patterns/files/2021/06/Iris-232x300.jpg 232w, https://s.w.org/patterns/files/2021/06/Iris-768x992.jpg 768w, https://s.w.org/patterns/files/2021/06/Iris-1189x1536.jpg 1189w, https://s.w.org/patterns/files/2021/06/Iris-1586x2048.jpg 1586w, https://s.w.org/patterns/files/2021/06/Iris.jpg 1920w\" sizes=\"(max-width: 793px) 100vw, 793px\" /></figure>\n\n\n\n<p style=\"font-size:14px\"><strong>White Irises</strong><br>Ogawa Kazumasa</p>\n</div>\n\n\n\n<div class=\"wp-block-column\">\n<div style=\"height:100px\" aria-hidden=\"true\" class=\"wp-block-spacer\"></div>\n\n\n\n<p style=\"font-size:14px\"><strong>Cherry Blossom</strong><br>Ogawa Kazumasa</p>\n\n\n\n<figure class=\"wp-block-image size-large\"><img loading=\"lazy\" width=\"707\" height=\"1024\" src=\"https://s.w.org/patterns/files/2021/06/Cherry-Blossom-707x1024.jpg\" alt=\"\" class=\"wp-image-524\" srcset=\"https://s.w.org/patterns/files/2021/06/Cherry-Blossom-707x1024.jpg 707w, https://s.w.org/patterns/files/2021/06/Cherry-Blossom-207x300.jpg 207w, https://s.w.org/patterns/files/2021/06/Cherry-Blossom-768x1112.jpg 768w, https://s.w.org/patterns/files/2021/06/Cherry-Blossom-1061x1536.jpg 1061w, https://s.w.org/patterns/files/2021/06/Cherry-Blossom-1414x2048.jpg 1414w, https://s.w.org/patterns/files/2021/06/Cherry-Blossom-scaled.jpg 1768w\" sizes=\"(max-width: 707px) 100vw, 707px\" /></figure>\n</div>\n</div>\n<style>.wp-container-624c8c9f3e0f8 {display: flex;gap: var( --wp--style--block-gap, 0.5em );flex-wrap: nowrap;align-items: center;}.wp-container-624c8c9f3e0f8 > * { margin: 0; }</style>\";s:9:\"protected\";b:0;}s:4:\"meta\";O:8:\"stdClass\":6:{s:10:\"spay_email\";s:0:\"\";s:13:\"wpop_keywords\";s:0:\"\";s:16:\"wpop_description\";s:32:\"Offset images with descriptions.\";s:19:\"wpop_viewport_width\";i:1200;s:16:\"wpop_block_types\";a:0:{}s:11:\"wpop_locale\";s:5:\"en_US\";}s:14:\"category_slugs\";a:3:{i:0;s:8:\"featured\";i:1;s:7:\"gallery\";i:2;s:6:\"images\";}s:13:\"keyword_slugs\";a:0:{}s:15:\"pattern_content\";s:1175:\"<!-- wp:columns -->\n<div class=\"wp-block-columns\"><!-- wp:column -->\n<div class=\"wp-block-column\"><!-- wp:image {\"id\":525,\"sizeSlug\":\"large\",\"linkDestination\":\"none\"} -->\n<figure class=\"wp-block-image size-large\"><img src=\"https://s.w.org/patterns/files/2021/06/Iris-793x1024.jpg\" alt=\"\" class=\"wp-image-525\" /></figure>\n<!-- /wp:image -->\n\n<!-- wp:paragraph {\"style\":{\"typography\":{\"fontSize\":\"14px\"}}} -->\n<p style=\"font-size:14px\"><strong>White Irises</strong><br>Ogawa Kazumasa</p>\n<!-- /wp:paragraph --></div>\n<!-- /wp:column -->\n\n<!-- wp:column -->\n<div class=\"wp-block-column\"><!-- wp:spacer -->\n<div style=\"height:100px\" aria-hidden=\"true\" class=\"wp-block-spacer\"></div>\n<!-- /wp:spacer -->\n\n<!-- wp:paragraph {\"style\":{\"typography\":{\"fontSize\":\"14px\"}}} -->\n<p style=\"font-size:14px\"><strong>Cherry Blossom</strong><br>Ogawa Kazumasa</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:image {\"id\":524,\"sizeSlug\":\"large\",\"linkDestination\":\"none\"} -->\n<figure class=\"wp-block-image size-large\"><img src=\"https://s.w.org/patterns/files/2021/06/Cherry-Blossom-707x1024.jpg\" alt=\"\" class=\"wp-image-524\" /></figure>\n<!-- /wp:image --></div>\n<!-- /wp:column --></div>\n<!-- /wp:columns -->\";}i:24;O:8:\"stdClass\":7:{s:2:\"id\";i:678;s:5:\"title\";O:8:\"stdClass\":1:{s:8:\"rendered\";s:13:\"Pricing table\";}s:7:\"content\";O:8:\"stdClass\":2:{s:8:\"rendered\";s:4000:\"\n<div class=\"wp-container-624c8c9f3fe8f wp-block-columns alignwide\">\n<div class=\"wp-elements-624c8c9f3f38e wp-block-column has-text-color has-background has-link-color\" style=\"background-color:#ffe97d;color:#000000;padding-top:2em;padding-right:2em;padding-bottom:2em;padding-left:2em\">\n<h2 id=\"single\" style=\"font-size:40px\"><strong>Single</strong></h2>\n\n\n\n<p class=\"has-normal-font-size\" style=\"line-height:1.5\"><strong>Enrich our growing community.</strong> </p>\n\n\n\n<hr class=\"wp-block-separator has-text-color has-background is-style-wide\" style=\"background-color:#000000;color:#000000\" />\n\n\n\n<ul class=\"has-normal-font-size\"><li>General admission and member discounts for one adult</li><li>One free ticket per special exhibition</li><li>Two single-use guest passes per year</li></ul>\n\n\n\n<div class=\"wp-container-624c8c9f3f376 wp-block-buttons alignfull\">\n<div class=\"wp-block-button has-custom-width wp-block-button__width-100\"><a class=\"wp-block-button__link has-white-color has-text-color has-background no-border-radius\" style=\"background-color:#000000\">$110 / year</a></div>\n</div>\n<style>.wp-container-624c8c9f3f376 {display: flex;gap: var( --wp--style--block-gap, 0.5em );flex-wrap: wrap;align-items: center;justify-content: center;}.wp-container-624c8c9f3f376 > * { margin: 0; }</style></div>\n<style>.wp-elements-624c8c9f3f38e a{color: #000000;}</style>\n\n\n\n<div class=\"wp-elements-624c8c9f3f722 wp-block-column has-text-color has-background has-link-color\" style=\"background-color:#d1d1e1;color:#000000;padding-top:2em;padding-right:2em;padding-bottom:2em;padding-left:2em\">\n<h2 id=\"family\" style=\"font-size:40px\"><strong>Family</strong></h2>\n\n\n\n<p class=\"has-normal-font-size\" style=\"line-height:1.5\"><strong>Support special exhibitions.</strong></p>\n\n\n\n<hr class=\"wp-block-separator is-style-wide\" />\n\n\n\n<ul class=\"has-normal-font-size\"><li>General admission and member discounts for two adults</li><li>Four free tickets per special exhibition</li><li>Four single-use guest passes per year</li></ul>\n\n\n\n<div class=\"wp-container-624c8c9f3f70a wp-block-buttons alignfull\">\n<div class=\"wp-block-button has-custom-width wp-block-button__width-100 is-style-fill\"><a class=\"wp-block-button__link has-white-color has-text-color has-background no-border-radius\" style=\"background-color:#000000\">$200 / year</a></div>\n</div>\n<style>.wp-container-624c8c9f3f70a {display: flex;gap: var( --wp--style--block-gap, 0.5em );flex-wrap: wrap;align-items: center;justify-content: center;}.wp-container-624c8c9f3f70a > * { margin: 0; }</style></div>\n<style>.wp-elements-624c8c9f3f722 a{color: #000000;}</style>\n\n\n\n<div class=\"wp-elements-624c8c9f3fadf wp-block-column has-text-color has-background has-link-color\" style=\"background-color:#c0ebf1;color:#000000;padding-top:2em;padding-right:2em;padding-bottom:2em;padding-left:2em\">\n<h2 id=\"patron\" style=\"font-size:40px\"><strong>Patron</strong></h2>\n\n\n\n<p class=\"has-normal-font-size\"><strong>Take support to the next level.</strong></p>\n\n\n\n<hr class=\"wp-block-separator is-style-wide\" />\n\n\n\n<ul class=\"has-normal-font-size\"><li>General admission and member discounts for two adults</li><li>Five free tickets per special exhibition</li><li>Six single-use guest passes per year</li></ul>\n\n\n\n<div class=\"wp-container-624c8c9f3fac9 wp-block-buttons alignfull\">\n<div class=\"wp-block-button has-custom-width wp-block-button__width-100\"><a class=\"wp-block-button__link has-white-color has-text-color has-background no-border-radius\" style=\"background-color:#000000\">$400 / year</a></div>\n</div>\n<style>.wp-container-624c8c9f3fac9 {display: flex;gap: var( --wp--style--block-gap, 0.5em );flex-wrap: wrap;align-items: center;justify-content: center;}.wp-container-624c8c9f3fac9 > * { margin: 0; }</style></div>\n<style>.wp-elements-624c8c9f3fadf a{color: #000000;}</style>\n</div>\n<style>.wp-container-624c8c9f3fe8f {display: flex;gap: var( --wp--style--block-gap, 0.5em );flex-wrap: nowrap;align-items: center;}.wp-container-624c8c9f3fe8f > * { margin: 0; }</style>\";s:9:\"protected\";b:0;}s:4:\"meta\";O:8:\"stdClass\":6:{s:10:\"spay_email\";s:0:\"\";s:13:\"wpop_keywords\";s:0:\"\";s:16:\"wpop_description\";s:272:\"Three equal-width columns set up as a pricing table. The left column has a yellow background, the middle column has a light purple background, and the right column has a light blue background. Each column contains a heading, subheading, separator, list, and then a button.\";s:19:\"wpop_viewport_width\";i:800;s:16:\"wpop_block_types\";a:0:{}s:11:\"wpop_locale\";s:5:\"en_US\";}s:14:\"category_slugs\";a:3:{i:0;s:7:\"buttons\";i:1;s:7:\"columns\";i:2;s:8:\"featured\";}s:13:\"keyword_slugs\";a:0:{}s:15:\"pattern_content\";s:5340:\"<!-- wp:columns {\"align\":\"wide\"} -->\n<div class=\"wp-block-columns alignwide\"><!-- wp:column {\"style\":{\"color\":{\"background\":\"#ffe97d\",\"text\":\"#000000\"},\"elements\":{\"link\":{\"color\":{\"text\":\"#000000\"}}},\"spacing\":{\"padding\":{\"top\":\"2em\",\"right\":\"2em\",\"bottom\":\"2em\",\"left\":\"2em\"}}}} -->\n<div class=\"wp-block-column has-text-color has-background has-link-color\" style=\"background-color:#ffe97d;color:#000000;padding-top:2em;padding-right:2em;padding-bottom:2em;padding-left:2em\"><!-- wp:heading {\"style\":{\"typography\":{\"fontSize\":\"40px\"}}} -->\n<h2 id=\"single\" style=\"font-size:40px\"><strong>Single</strong></h2>\n<!-- /wp:heading -->\n\n<!-- wp:paragraph {\"style\":{\"typography\":{\"lineHeight\":\"1.5\"}},\"fontSize\":\"normal\"} -->\n<p class=\"has-normal-font-size\" style=\"line-height:1.5\"><strong>Enrich our growing community.</strong> </p>\n<!-- /wp:paragraph -->\n\n<!-- wp:separator {\"customColor\":\"#000000\",\"className\":\"is-style-wide\"} -->\n<hr class=\"wp-block-separator has-text-color has-background is-style-wide\" style=\"background-color:#000000;color:#000000\" />\n<!-- /wp:separator -->\n\n<!-- wp:list {\"fontSize\":\"normal\"} -->\n<ul class=\"has-normal-font-size\"><li>General admission and member discounts for one adult</li><li>One free ticket per special exhibition</li><li>Two single-use guest passes per year</li></ul>\n<!-- /wp:list -->\n\n<!-- wp:buttons {\"align\":\"full\",\"layout\":{\"type\":\"flex\",\"justifyContent\":\"center\",\"orientation\":\"horizontal\"}} -->\n<div class=\"wp-block-buttons alignfull\"><!-- wp:button {\"textColor\":\"white\",\"width\":100,\"style\":{\"color\":{\"background\":\"#000000\"},\"border\":{\"radius\":0}}} -->\n<div class=\"wp-block-button has-custom-width wp-block-button__width-100\"><a class=\"wp-block-button__link has-white-color has-text-color has-background no-border-radius\" style=\"background-color:#000000\">$110 / year</a></div>\n<!-- /wp:button --></div>\n<!-- /wp:buttons --></div>\n<!-- /wp:column -->\n\n<!-- wp:column {\"style\":{\"color\":{\"background\":\"#d1d1e1\",\"text\":\"#000000\"},\"elements\":{\"link\":{\"color\":{\"text\":\"#000000\"}}},\"spacing\":{\"padding\":{\"top\":\"2em\",\"right\":\"2em\",\"bottom\":\"2em\",\"left\":\"2em\"}}}} -->\n<div class=\"wp-block-column has-text-color has-background has-link-color\" style=\"background-color:#d1d1e1;color:#000000;padding-top:2em;padding-right:2em;padding-bottom:2em;padding-left:2em\"><!-- wp:heading {\"style\":{\"typography\":{\"fontSize\":\"40px\"}}} -->\n<h2 id=\"family\" style=\"font-size:40px\"><strong>Family</strong></h2>\n<!-- /wp:heading -->\n\n<!-- wp:paragraph {\"style\":{\"typography\":{\"lineHeight\":\"1.5\"}},\"fontSize\":\"normal\"} -->\n<p class=\"has-normal-font-size\" style=\"line-height:1.5\"><strong>Support special exhibitions.</strong></p>\n<!-- /wp:paragraph -->\n\n<!-- wp:separator {\"className\":\"is-style-wide\"} -->\n<hr class=\"wp-block-separator is-style-wide\" />\n<!-- /wp:separator -->\n\n<!-- wp:list {\"fontSize\":\"normal\"} -->\n<ul class=\"has-normal-font-size\"><li>General admission and member discounts for two adults</li><li>Four free tickets per special exhibition</li><li>Four single-use guest passes per year</li></ul>\n<!-- /wp:list -->\n\n<!-- wp:buttons {\"align\":\"full\",\"layout\":{\"type\":\"flex\",\"justifyContent\":\"center\",\"orientation\":\"horizontal\"}} -->\n<div class=\"wp-block-buttons alignfull\"><!-- wp:button {\"textColor\":\"white\",\"width\":100,\"style\":{\"color\":{\"background\":\"#000000\"},\"border\":{\"radius\":0}},\"className\":\"is-style-fill\"} -->\n<div class=\"wp-block-button has-custom-width wp-block-button__width-100 is-style-fill\"><a class=\"wp-block-button__link has-white-color has-text-color has-background no-border-radius\" style=\"background-color:#000000\">$200 / year</a></div>\n<!-- /wp:button --></div>\n<!-- /wp:buttons --></div>\n<!-- /wp:column -->\n\n<!-- wp:column {\"style\":{\"color\":{\"background\":\"#c0ebf1\",\"text\":\"#000000\"},\"elements\":{\"link\":{\"color\":{\"text\":\"#000000\"}}},\"spacing\":{\"padding\":{\"top\":\"2em\",\"right\":\"2em\",\"bottom\":\"2em\",\"left\":\"2em\"}}}} -->\n<div class=\"wp-block-column has-text-color has-background has-link-color\" style=\"background-color:#c0ebf1;color:#000000;padding-top:2em;padding-right:2em;padding-bottom:2em;padding-left:2em\"><!-- wp:heading {\"style\":{\"typography\":{\"fontSize\":\"40px\"}}} -->\n<h2 id=\"patron\" style=\"font-size:40px\"><strong>Patron</strong></h2>\n<!-- /wp:heading -->\n\n<!-- wp:paragraph {\"fontSize\":\"normal\"} -->\n<p class=\"has-normal-font-size\"><strong>Take support to the next level.</strong></p>\n<!-- /wp:paragraph -->\n\n<!-- wp:separator {\"className\":\"is-style-wide\"} -->\n<hr class=\"wp-block-separator is-style-wide\" />\n<!-- /wp:separator -->\n\n<!-- wp:list {\"fontSize\":\"normal\"} -->\n<ul class=\"has-normal-font-size\"><li>General admission and member discounts for two adults</li><li>Five free tickets per special exhibition</li><li>Six single-use guest passes per year</li></ul>\n<!-- /wp:list -->\n\n<!-- wp:buttons {\"align\":\"full\",\"layout\":{\"type\":\"flex\",\"justifyContent\":\"center\",\"orientation\":\"horizontal\"}} -->\n<div class=\"wp-block-buttons alignfull\"><!-- wp:button {\"textColor\":\"white\",\"width\":100,\"style\":{\"color\":{\"background\":\"#000000\"},\"border\":{\"radius\":0}}} -->\n<div class=\"wp-block-button has-custom-width wp-block-button__width-100\"><a class=\"wp-block-button__link has-white-color has-text-color has-background no-border-radius\" style=\"background-color:#000000\">$400 / year</a></div>\n<!-- /wp:button --></div>\n<!-- /wp:buttons --></div>\n<!-- /wp:column --></div>\n<!-- /wp:columns -->\";}i:25;O:8:\"stdClass\":7:{s:2:\"id\";i:732;s:5:\"title\";O:8:\"stdClass\":1:{s:8:\"rendered\";s:21:\"Simple call to action\";}s:7:\"content\";O:8:\"stdClass\":2:{s:8:\"rendered\";s:1418:\"\n<div class=\"wp-container-624c8c9f41802 wp-block-group alignfull has-text-color has-background\" style=\"background-color:#ffffff;color:#000000\">\n<div style=\"height:64px\" aria-hidden=\"true\" class=\"wp-block-spacer\"></div>\n\n\n\n<p class=\"has-text-align-center has-small-font-size\" style=\"line-height:.9\"><strong>GET IN TOUCH</strong></p>\n\n\n\n<h2 class=\"has-text-align-center\" id=\"schedule-a-visit\" style=\"font-size:59px;line-height:1.15\"><strong>Schedule a Visit</strong></h2>\n\n\n\n<div class=\"wp-container-624c8c9f414bd wp-block-buttons\">\n<div class=\"wp-block-button has-custom-width wp-block-button__width-50\"><a class=\"wp-block-button__link has-text-color has-background\" style=\"border-radius:50px;background-color:#000000;color:#ffffff\">Contact us</a></div>\n</div>\n<style>.wp-container-624c8c9f414bd {display: flex;gap: var( --wp--style--block-gap, 0.5em );flex-wrap: wrap;align-items: center;justify-content: center;}.wp-container-624c8c9f414bd > * { margin: 0; }</style>\n\n\n<div style=\"height:64px\" aria-hidden=\"true\" class=\"wp-block-spacer\"></div>\n</div>\n<style>.wp-container-624c8c9f41802 .alignleft { float: left; margin-right: 2em; margin-left: 0; }.wp-container-624c8c9f41802 .alignright { float: right; margin-left: 2em; margin-right: 0; }.wp-container-624c8c9f41802 > * { margin-top: 0; margin-bottom: 0; }.wp-container-624c8c9f41802 > * + * { margin-top: var( --wp--style--block-gap );  margin-bottom: 0; }</style>\";s:9:\"protected\";b:0;}s:4:\"meta\";O:8:\"stdClass\":6:{s:10:\"spay_email\";s:0:\"\";s:13:\"wpop_keywords\";s:0:\"\";s:16:\"wpop_description\";s:89:\"A container with a white background. Inside is a centered paragraph, heading, and button.\";s:19:\"wpop_viewport_width\";i:800;s:16:\"wpop_block_types\";a:0:{}s:11:\"wpop_locale\";s:5:\"en_US\";}s:14:\"category_slugs\";a:2:{i:0;s:7:\"buttons\";i:1;s:8:\"featured\";}s:13:\"keyword_slugs\";a:0:{}s:15:\"pattern_content\";s:1506:\"<!-- wp:group {\"align\":\"full\",\"style\":{\"color\":{\"text\":\"#000000\",\"background\":\"#ffffff\"}}} -->\n<div class=\"wp-block-group alignfull has-text-color has-background\" style=\"background-color:#ffffff;color:#000000\"><!-- wp:spacer {\"height\":64} -->\n<div style=\"height:64px\" aria-hidden=\"true\" class=\"wp-block-spacer\"></div>\n<!-- /wp:spacer -->\n\n<!-- wp:paragraph {\"align\":\"center\",\"style\":{\"typography\":{\"lineHeight\":\".9\"}},\"fontSize\":\"small\"} -->\n<p class=\"has-text-align-center has-small-font-size\" style=\"line-height:.9\"><strong>GET IN TOUCH</strong></p>\n<!-- /wp:paragraph -->\n\n<!-- wp:heading {\"textAlign\":\"center\",\"style\":{\"typography\":{\"fontSize\":59,\"lineHeight\":\"1.15\"}}} -->\n<h2 class=\"has-text-align-center\" id=\"schedule-a-visit\" style=\"font-size:59px;line-height:1.15\"><strong>Schedule a Visit</strong></h2>\n<!-- /wp:heading -->\n\n<!-- wp:buttons {\"layout\":{\"type\":\"flex\",\"justifyContent\":\"center\",\"orientation\":\"horizontal\"}} -->\n<div class=\"wp-block-buttons\"><!-- wp:button {\"width\":50,\"style\":{\"color\":{\"background\":\"#000000\",\"text\":\"#ffffff\"},\"border\":{\"radius\":\"50px\"}}} -->\n<div class=\"wp-block-button has-custom-width wp-block-button__width-50\"><a class=\"wp-block-button__link has-text-color has-background\" style=\"border-radius:50px;background-color:#000000;color:#ffffff\">Contact us</a></div>\n<!-- /wp:button --></div>\n<!-- /wp:buttons -->\n\n<!-- wp:spacer {\"height\":64} -->\n<div style=\"height:64px\" aria-hidden=\"true\" class=\"wp-block-spacer\"></div>\n<!-- /wp:spacer --></div>\n<!-- /wp:group -->\";}i:26;O:8:\"stdClass\":7:{s:2:\"id\";i:200;s:5:\"title\";O:8:\"stdClass\":1:{s:8:\"rendered\";s:21:\"Three columns of text\";}s:7:\"content\";O:8:\"stdClass\":2:{s:8:\"rendered\";s:1013:\"\n<div class=\"wp-container-624c8c9f4280d wp-block-columns alignfull has-text-color has-background\" style=\"background-color:#ffffff;color:#000000\">\n<div class=\"wp-block-column\">\n<h3 style=\"font-size:24px;line-height:1.3\"><strong><a href=\"http://wordpress.org\">Virtual Tour ↗</a></strong></h3>\n\n\n\n<p>Get a virtual tour of the museum. Ideal for schools and events.</p>\n</div>\n\n\n\n<div class=\"wp-block-column\">\n<h3 style=\"font-size:24px;line-height:1.3\"><strong><a href=\"https://wordpress.org\">Current Shows ↗</a></strong></h3>\n\n\n\n<p>Stay updated and see our current exhibitions here.</p>\n</div>\n\n\n\n<div class=\"wp-block-column\">\n<h3 style=\"font-size:24px;line-height:1.3\"><strong><a href=\"https://wordpress.org\">Useful Info ↗</a></strong></h3>\n\n\n\n<p>Get to know our opening times, ticket prices and discounts.</p>\n</div>\n</div>\n<style>.wp-container-624c8c9f4280d {display: flex;gap: var( --wp--style--block-gap, 0.5em );flex-wrap: nowrap;align-items: center;}.wp-container-624c8c9f4280d > * { margin: 0; }</style>\";s:9:\"protected\";b:0;}s:4:\"meta\";O:8:\"stdClass\":6:{s:10:\"spay_email\";s:0:\"\";s:13:\"wpop_keywords\";s:0:\"\";s:16:\"wpop_description\";s:22:\"Three columns of text.\";s:19:\"wpop_viewport_width\";i:1200;s:16:\"wpop_block_types\";a:0:{}s:11:\"wpop_locale\";s:5:\"en_US\";}s:14:\"category_slugs\";a:3:{i:0;s:7:\"columns\";i:1;s:8:\"featured\";i:2;s:4:\"text\";}s:13:\"keyword_slugs\";a:1:{i:0;s:4:\"core\";}s:15:\"pattern_content\";s:1496:\"<!-- wp:columns {\"align\":\"full\",\"style\":{\"color\":{\"text\":\"#000000\",\"background\":\"#ffffff\"}}} -->\n<div class=\"wp-block-columns alignfull has-text-color has-background\" style=\"background-color:#ffffff;color:#000000\"><!-- wp:column -->\n<div class=\"wp-block-column\"><!-- wp:heading {\"level\":3,\"style\":{\"typography\":{\"fontSize\":\"24px\",\"lineHeight\":\"1.3\"}}} -->\n<h3 style=\"font-size:24px;line-height:1.3\"><strong><a href=\"http://wordpress.org\">Virtual Tour ↗</a></strong></h3>\n<!-- /wp:heading -->\n\n<!-- wp:paragraph -->\n<p>Get a virtual tour of the museum. Ideal for schools and events.</p>\n<!-- /wp:paragraph --></div>\n<!-- /wp:column -->\n\n<!-- wp:column -->\n<div class=\"wp-block-column\"><!-- wp:heading {\"level\":3,\"style\":{\"typography\":{\"fontSize\":\"24px\",\"lineHeight\":\"1.3\"}}} -->\n<h3 style=\"font-size:24px;line-height:1.3\"><strong><a href=\"https://wordpress.org\">Current Shows ↗</a></strong></h3>\n<!-- /wp:heading -->\n\n<!-- wp:paragraph -->\n<p>Stay updated and see our current exhibitions here.</p>\n<!-- /wp:paragraph --></div>\n<!-- /wp:column -->\n\n<!-- wp:column -->\n<div class=\"wp-block-column\"><!-- wp:heading {\"level\":3,\"style\":{\"typography\":{\"fontSize\":\"24px\",\"lineHeight\":\"1.3\"}}} -->\n<h3 style=\"font-size:24px;line-height:1.3\"><strong><a href=\"https://wordpress.org\">Useful Info ↗</a></strong></h3>\n<!-- /wp:heading -->\n\n<!-- wp:paragraph -->\n<p>Get to know our opening times, ticket prices and discounts.</p>\n<!-- /wp:paragraph --></div>\n<!-- /wp:column --></div>\n<!-- /wp:columns -->\";}i:27;O:8:\"stdClass\":7:{s:2:\"id\";i:199;s:5:\"title\";O:8:\"stdClass\":1:{s:8:\"rendered\";s:34:\"Three columns with images and text\";}s:7:\"content\";O:8:\"stdClass\":2:{s:8:\"rendered\";s:3603:\"\n<div class=\"wp-container-624c8c9f442fb wp-block-group alignfull has-background\" style=\"background-color:#f8f4e4\">\n<div class=\"wp-container-624c8c9f438d6 wp-block-columns alignwide\">\n<div class=\"wp-block-column\">\n<div style=\"height:100px\" aria-hidden=\"true\" class=\"wp-block-spacer\"></div>\n\n\n\n<h6 class=\"has-text-color\" id=\"ecosystem\" style=\"color:#000000\">ECOSYSTEM</h6>\n\n\n\n<p class=\"has-text-color\" style=\"color:#000000;font-size:5vw;line-height:1.1\"><strong>Positive growth.</strong></p>\n\n\n\n<div style=\"height:5px\" aria-hidden=\"true\" class=\"wp-block-spacer\"></div>\n</div>\n</div>\n<style>.wp-container-624c8c9f438d6 {display: flex;gap: var( --wp--style--block-gap, 0.5em );flex-wrap: nowrap;align-items: center;}.wp-container-624c8c9f438d6 > * { margin: 0; }</style>\n\n\n<div class=\"wp-container-624c8c9f43c85 wp-block-columns alignwide\">\n<div class=\"wp-block-column\" style=\"flex-basis:33.38%\">\n<p class=\"has-text-color has-extra-small-font-size\" style=\"color:#000000\"><em>Nature</em>, in the common sense, refers to essences unchanged by man; space, the air, the river, the leaf.&nbsp;<em>Art</em>&nbsp;is applied to the mixture of his will with the same things, as in a house, a canal, a statue, a picture. But his operations taken together are so insignificant, a little chipping, baking, patching, and washing, that in an impression so grand as that of the world on the human mind, they do not vary the result.</p>\n</div>\n\n\n\n<div class=\"wp-block-column\" style=\"flex-basis:33%\">\n<div style=\"height:100px\" aria-hidden=\"true\" class=\"wp-block-spacer\"></div>\n\n\n\n<figure class=\"wp-block-image size-large\"><img src=\"https://s.w.org/images/core/5.8/outside-01.jpg\" alt=\"The sun setting through a dense forest.\" /></figure>\n</div>\n\n\n\n<div class=\"wp-block-column\" style=\"flex-basis:33.62%\">\n<figure class=\"wp-block-image size-large\"><img src=\"https://s.w.org/images/core/5.8/outside-02.jpg\" alt=\"Wind turbines standing on a grassy plain, against a blue sky.\" /></figure>\n</div>\n</div>\n<style>.wp-container-624c8c9f43c85 {display: flex;gap: var( --wp--style--block-gap, 0.5em );flex-wrap: nowrap;align-items: center;}.wp-container-624c8c9f43c85 > * { margin: 0; }</style>\n\n\n<div class=\"wp-container-624c8c9f4400b wp-block-columns alignwide\">\n<div class=\"wp-block-column\" style=\"flex-basis:67%\">\n<div class=\"wp-block-image\"><figure class=\"alignright size-large\"><img src=\"https://s.w.org/images/core/5.8/outside-03.jpg\" alt=\"The sun shining over a ridge leading down into the shore. In the distance, a car drives down a road.\" /></figure></div>\n</div>\n\n\n\n<div class=\"wp-block-column is-vertically-aligned-center\" style=\"flex-basis:33%\">\n<p class=\"has-text-color has-extra-small-font-size\" style=\"color:#000000\">Undoubtedly we have no questions to ask which are unanswerable. We must trust the perfection of the creation so far, as to believe that whatever curiosity the order of things has awakened in our minds, the order of things can satisfy. Every man&#8217;s condition is a solution in hieroglyphic to those inquiries he would put.</p>\n</div>\n</div>\n<style>.wp-container-624c8c9f4400b {display: flex;gap: var( --wp--style--block-gap, 0.5em );flex-wrap: nowrap;align-items: center;}.wp-container-624c8c9f4400b > * { margin: 0; }</style></div>\n<style>.wp-container-624c8c9f442fb .alignleft { float: left; margin-right: 2em; margin-left: 0; }.wp-container-624c8c9f442fb .alignright { float: right; margin-left: 2em; margin-right: 0; }.wp-container-624c8c9f442fb > * { margin-top: 0; margin-bottom: 0; }.wp-container-624c8c9f442fb > * + * { margin-top: var( --wp--style--block-gap );  margin-bottom: 0; }</style>\";s:9:\"protected\";b:0;}s:4:\"meta\";O:8:\"stdClass\":6:{s:10:\"spay_email\";s:0:\"\";s:13:\"wpop_keywords\";s:0:\"\";s:16:\"wpop_description\";s:77:\"Three columns with images and text, with vertical spacing for an offset look.\";s:19:\"wpop_viewport_width\";i:1200;s:16:\"wpop_block_types\";a:0:{}s:11:\"wpop_locale\";s:5:\"en_US\";}s:14:\"category_slugs\";a:2:{i:0;s:7:\"columns\";i:1;s:8:\"featured\";}s:13:\"keyword_slugs\";a:1:{i:0;s:4:\"core\";}s:15:\"pattern_content\";s:3990:\"<!-- wp:group {\"align\":\"full\",\"style\":{\"color\":{\"background\":\"#f8f4e4\"}}} -->\n<div class=\"wp-block-group alignfull has-background\" style=\"background-color:#f8f4e4\"><!-- wp:columns {\"align\":\"wide\"} -->\n<div class=\"wp-block-columns alignwide\"><!-- wp:column -->\n<div class=\"wp-block-column\"><!-- wp:spacer -->\n<div style=\"height:100px\" aria-hidden=\"true\" class=\"wp-block-spacer\"></div>\n<!-- /wp:spacer -->\n\n<!-- wp:heading {\"level\":6,\"style\":{\"color\":{\"text\":\"#000000\"}}} -->\n<h6 class=\"has-text-color\" id=\"ecosystem\" style=\"color:#000000\">ECOSYSTEM</h6>\n<!-- /wp:heading -->\n\n<!-- wp:paragraph {\"style\":{\"typography\":{\"lineHeight\":\"1.1\",\"fontSize\":\"5vw\"},\"color\":{\"text\":\"#000000\"}}} -->\n<p class=\"has-text-color\" style=\"color:#000000;font-size:5vw;line-height:1.1\"><strong>Positive growth.</strong></p>\n<!-- /wp:paragraph -->\n\n<!-- wp:spacer {\"height\":\"5px\"} -->\n<div style=\"height:5px\" aria-hidden=\"true\" class=\"wp-block-spacer\"></div>\n<!-- /wp:spacer --></div>\n<!-- /wp:column --></div>\n<!-- /wp:columns -->\n\n<!-- wp:columns {\"align\":\"wide\"} -->\n<div class=\"wp-block-columns alignwide\"><!-- wp:column {\"width\":\"33.38%\"} -->\n<div class=\"wp-block-column\" style=\"flex-basis:33.38%\"><!-- wp:paragraph {\"style\":{\"color\":{\"text\":\"#000000\"}},\"fontSize\":\"extra-small\"} -->\n<p class=\"has-text-color has-extra-small-font-size\" style=\"color:#000000\"><em>Nature</em>, in the common sense, refers to essences unchanged by man; space, the air, the river, the leaf.&nbsp;<em>Art</em>&nbsp;is applied to the mixture of his will with the same things, as in a house, a canal, a statue, a picture. But his operations taken together are so insignificant, a little chipping, baking, patching, and washing, that in an impression so grand as that of the world on the human mind, they do not vary the result.</p>\n<!-- /wp:paragraph --></div>\n<!-- /wp:column -->\n\n<!-- wp:column {\"width\":\"33%\"} -->\n<div class=\"wp-block-column\" style=\"flex-basis:33%\"><!-- wp:spacer -->\n<div style=\"height:100px\" aria-hidden=\"true\" class=\"wp-block-spacer\"></div>\n<!-- /wp:spacer -->\n\n<!-- wp:image {\"sizeSlug\":\"large\",\"linkDestination\":\"none\"} -->\n<figure class=\"wp-block-image size-large\"><img src=\"https://s.w.org/images/core/5.8/outside-01.jpg\" alt=\"The sun setting through a dense forest.\" /></figure>\n<!-- /wp:image --></div>\n<!-- /wp:column -->\n\n<!-- wp:column {\"width\":\"33.62%\"} -->\n<div class=\"wp-block-column\" style=\"flex-basis:33.62%\"><!-- wp:image {\"sizeSlug\":\"large\",\"linkDestination\":\"none\"} -->\n<figure class=\"wp-block-image size-large\"><img src=\"https://s.w.org/images/core/5.8/outside-02.jpg\" alt=\"Wind turbines standing on a grassy plain, against a blue sky.\" /></figure>\n<!-- /wp:image --></div>\n<!-- /wp:column --></div>\n<!-- /wp:columns -->\n\n<!-- wp:columns {\"align\":\"wide\"} -->\n<div class=\"wp-block-columns alignwide\"><!-- wp:column {\"width\":\"67%\"} -->\n<div class=\"wp-block-column\" style=\"flex-basis:67%\"><!-- wp:image {\"align\":\"right\",\"sizeSlug\":\"large\",\"linkDestination\":\"none\"} -->\n<div class=\"wp-block-image\"><figure class=\"alignright size-large\"><img src=\"https://s.w.org/images/core/5.8/outside-03.jpg\" alt=\"The sun shining over a ridge leading down into the shore. In the distance, a car drives down a road.\" /></figure></div>\n<!-- /wp:image --></div>\n<!-- /wp:column -->\n\n<!-- wp:column {\"verticalAlignment\":\"center\",\"width\":\"33%\"} -->\n<div class=\"wp-block-column is-vertically-aligned-center\" style=\"flex-basis:33%\"><!-- wp:paragraph {\"style\":{\"color\":{\"text\":\"#000000\"}},\"fontSize\":\"extra-small\"} -->\n<p class=\"has-text-color has-extra-small-font-size\" style=\"color:#000000\">Undoubtedly we have no questions to ask which are unanswerable. We must trust the perfection of the creation so far, as to believe that whatever curiosity the order of things has awakened in our minds, the order of things can satisfy. Every man\'s condition is a solution in hieroglyphic to those inquiries he would put.</p>\n<!-- /wp:paragraph --></div>\n<!-- /wp:column --></div>\n<!-- /wp:columns --></div>\n<!-- /wp:group -->\";}}', 'no');
INSERT INTO `urotec_options` (`option_id`, `option_name`, `option_value`, `autoload`) VALUES
(472, '_site_transient_timeout_theme_roots', '1649185864', 'no'),
(473, '_site_transient_theme_roots', 'a:1:{s:4:\"mega\";s:7:\"/themes\";}', 'no'),
(474, 'options_текст-мод_3', '<h3>Урорек является наиболее безопасным препаратом для пациентов с СНМП/ДГПЖ и сопутствующими сердечно-сосудистыми заболеваниями<sup>3</sup></h3>\r\n<ul>\r\n 	<li>Безопасность доказана в  пострегистрационных клинических исследованиях (в т.ч. у пациентов с сопутствующими заболеваниями сердечно-сосудистой системы) <sup>7,8</sup></li>\r\n 	<li>Риск развития сердечно-сосудистых осложнений <sup>5</sup> и ортостатической гипотензии минимален <sup>6,9</sup></li>\r\n 	<li>Не усиливает действие препаратов для лечения артериальной гипертонии при одновременном применении и не требует снижения дозы <sup>8</sup></li>\r\n 	<li>Отсутствие жизнеугрожающих побочных эффектов, таких как фибрилляция предсердий, аритмия <sup>6,9</sup></li>\r\n 	<li>Лучшие результаты по переносимости в классе альфа-адреноблокаторов <sup>3,7</sup></li>\r\n</ul>', 'no'),
(475, '_options_текст-мод_3', 'field_624c8c8ba268e', 'no');

-- --------------------------------------------------------

--
-- Table structure for table `urotec_postmeta`
--

CREATE TABLE `urotec_postmeta` (
  `meta_id` bigint(20) UNSIGNED NOT NULL,
  `post_id` bigint(20) UNSIGNED NOT NULL DEFAULT '0',
  `meta_key` varchar(255) COLLATE utf8mb4_unicode_520_ci DEFAULT NULL,
  `meta_value` longtext COLLATE utf8mb4_unicode_520_ci
) ENGINE=InnoDB DEFAULT CHARSET=utf8mb4 COLLATE=utf8mb4_unicode_520_ci;

--
-- Dumping data for table `urotec_postmeta`
--

INSERT INTO `urotec_postmeta` (`meta_id`, `post_id`, `meta_key`, `meta_value`) VALUES
(1, 2, '_wp_page_template', 'default'),
(2, 3, '_wp_page_template', 'default'),
(3, 2, '_edit_lock', '1649185426:1'),
(4, 8, '_edit_last', '1'),
(5, 8, '_edit_lock', '1648658202:1'),
(6, 13, '_wp_attached_file', '2022/03/head-img.png'),
(7, 13, '_wp_attachment_metadata', 'a:5:{s:5:\"width\";i:567;s:6:\"height\";i:355;s:4:\"file\";s:20:\"2022/03/head-img.png\";s:5:\"sizes\";a:5:{s:6:\"medium\";a:4:{s:4:\"file\";s:20:\"head-img-300x188.png\";s:5:\"width\";i:300;s:6:\"height\";i:188;s:9:\"mime-type\";s:9:\"image/png\";}s:9:\"thumbnail\";a:4:{s:4:\"file\";s:20:\"head-img-150x150.png\";s:5:\"width\";i:150;s:6:\"height\";i:150;s:9:\"mime-type\";s:9:\"image/png\";}s:3:\"mob\";a:4:{s:4:\"file\";s:20:\"head-img-480x301.png\";s:5:\"width\";i:480;s:6:\"height\";i:301;s:9:\"mime-type\";s:9:\"image/png\";}s:8:\"500х500\";a:4:{s:4:\"file\";s:20:\"head-img-500x355.png\";s:5:\"width\";i:500;s:6:\"height\";i:355;s:9:\"mime-type\";s:9:\"image/png\";}s:8:\"330х660\";a:4:{s:4:\"file\";s:20:\"head-img-330x355.png\";s:5:\"width\";i:330;s:6:\"height\";i:355;s:9:\"mime-type\";s:9:\"image/png\";}}s:10:\"image_meta\";a:12:{s:8:\"aperture\";s:1:\"0\";s:6:\"credit\";s:0:\"\";s:6:\"camera\";s:0:\"\";s:7:\"caption\";s:0:\"\";s:17:\"created_timestamp\";s:1:\"0\";s:9:\"copyright\";s:0:\"\";s:12:\"focal_length\";s:1:\"0\";s:3:\"iso\";s:1:\"0\";s:13:\"shutter_speed\";s:1:\"0\";s:5:\"title\";s:0:\"\";s:11:\"orientation\";s:1:\"0\";s:8:\"keywords\";a:0:{}}}'),
(8, 2, '_edit_last', '1'),
(9, 2, 'заголовок-1', 'УРОРЕК – оригинальный<sup>10</sup> альфа-адреноблокатор'),
(10, 2, '_заголовок-1', 'field_62435bd26f29f'),
(11, 2, 'текст-1', '<div class=\"headerBlock__body\">\r\n<p>Силодозин (действующее вещество препарата Урорек) обладает максимальной уроселективностью в&nbsp;своем классе, что обеспечивает его уродинамическую эффективность и&nbsp;высокую безопасность<sup>4</sup></p>\r\n</div>\r\n<div class=\"headerBlock__footer\">\r\n<p><strong>Показания к применению: </strong><br/>Лечение симптомов доброкачественной гиперплазии предстательной железы<sup>6</sup></p>\r\n</div>'),
(12, 2, '_текст-1', 'field_62435c0c6f2a0'),
(13, 2, 'изображение-1', '13'),
(14, 2, '_изображение-1', 'field_62435c8b6f2a1'),
(15, 14, 'заголовок-1', 'УРОРЕК – оригинальный<sup>10</sup> альфа-адреноблокатор'),
(16, 14, '_заголовок-1', 'field_62435bd26f29f'),
(17, 14, 'текст-1', '<div class=\"headerBlock__body\">\r\n<p>Силодозин (действующее вещество препарата Урорек) обладает максимальной уроселективностью в&nbsp;своем классе, что обеспечивает его уродинамическую эффективность и&nbsp;высокую безопасность<sup>4</sup></p>\r\n</div>\r\n<div class=\"headerBlock__footer\">\r\n<p><strong>Показания к применению: </strong><br/>Лечение симптомов доброкачественной гиперплазии предстательной железы<sup>6</sup></p>\r\n</div>'),
(18, 14, '_текст-1', 'field_62435c0c6f2a0'),
(19, 14, 'изображение-1', '13'),
(20, 14, '_изображение-1', 'field_62435c8b6f2a1'),
(21, 16, 'заголовок-1', 'УРОРЕК – оригинальный<sup>10</sup> альфа-адреноблокатор'),
(22, 16, '_заголовок-1', 'field_62435bd26f29f'),
(23, 16, 'текст-1', '<div class=\"headerBlock__body\">\r\n<p>Силодозин (действующее вещество препарата Урорек) обладает максимальной уроселективностью в&nbsp;своем классе, что обеспечивает его уродинамическую эффективность и&nbsp;высокую безопасность<sup>4</sup></p>\r\n</div>\r\n<div class=\"headerBlock__footer\">\r\n<p><strong>Показания к применению: </strong><br/>Лечение симптомов доброкачественной гиперплазии предстательной железы<sup>6</sup></p>\r\n</div>'),
(24, 16, '_текст-1', 'field_62435c0c6f2a0'),
(25, 16, 'изображение-1', '13'),
(26, 16, '_изображение-1', 'field_62435c8b6f2a1'),
(27, 17, '_wp_attached_file', '2022/03/head-bg.jpg'),
(28, 17, '_wp_attachment_metadata', 'a:5:{s:5:\"width\";i:1920;s:6:\"height\";i:800;s:4:\"file\";s:19:\"2022/03/head-bg.jpg\";s:5:\"sizes\";a:13:{s:6:\"medium\";a:4:{s:4:\"file\";s:19:\"head-bg-300x125.jpg\";s:5:\"width\";i:300;s:6:\"height\";i:125;s:9:\"mime-type\";s:10:\"image/jpeg\";}s:5:\"large\";a:4:{s:4:\"file\";s:20:\"head-bg-1024x427.jpg\";s:5:\"width\";i:1024;s:6:\"height\";i:427;s:9:\"mime-type\";s:10:\"image/jpeg\";}s:9:\"thumbnail\";a:4:{s:4:\"file\";s:19:\"head-bg-150x150.jpg\";s:5:\"width\";i:150;s:6:\"height\";i:150;s:9:\"mime-type\";s:10:\"image/jpeg\";}s:12:\"medium_large\";a:4:{s:4:\"file\";s:19:\"head-bg-768x320.jpg\";s:5:\"width\";i:768;s:6:\"height\";i:320;s:9:\"mime-type\";s:10:\"image/jpeg\";}s:9:\"1536x1536\";a:4:{s:4:\"file\";s:20:\"head-bg-1536x640.jpg\";s:5:\"width\";i:1536;s:6:\"height\";i:640;s:9:\"mime-type\";s:10:\"image/jpeg\";}i:2;a:4:{s:4:\"file\";s:20:\"head-bg-1400x583.jpg\";s:5:\"width\";i:1400;s:6:\"height\";i:583;s:9:\"mime-type\";s:10:\"image/jpeg\";}s:8:\"1200*800\";a:4:{s:4:\"file\";s:20:\"head-bg-1200x500.jpg\";s:5:\"width\";i:1200;s:6:\"height\";i:500;s:9:\"mime-type\";s:10:\"image/jpeg\";}s:3:\"mob\";a:4:{s:4:\"file\";s:19:\"head-bg-480x200.jpg\";s:5:\"width\";i:480;s:6:\"height\";i:200;s:9:\"mime-type\";s:10:\"image/jpeg\";}s:12:\"mob-vertical\";a:4:{s:4:\"file\";s:19:\"head-bg-576x800.jpg\";s:5:\"width\";i:576;s:6:\"height\";i:800;s:9:\"mime-type\";s:10:\"image/jpeg\";}s:3:\"adv\";a:4:{s:4:\"file\";s:19:\"head-bg-680x792.jpg\";s:5:\"width\";i:680;s:6:\"height\";i:792;s:9:\"mime-type\";s:10:\"image/jpeg\";}s:8:\"500х500\";a:4:{s:4:\"file\";s:19:\"head-bg-500x500.jpg\";s:5:\"width\";i:500;s:6:\"height\";i:500;s:9:\"mime-type\";s:10:\"image/jpeg\";}s:8:\"330х660\";a:4:{s:4:\"file\";s:19:\"head-bg-330x660.jpg\";s:5:\"width\";i:330;s:6:\"height\";i:660;s:9:\"mime-type\";s:10:\"image/jpeg\";}s:8:\"680х530\";a:4:{s:4:\"file\";s:19:\"head-bg-680x530.jpg\";s:5:\"width\";i:680;s:6:\"height\";i:530;s:9:\"mime-type\";s:10:\"image/jpeg\";}}s:10:\"image_meta\";a:12:{s:8:\"aperture\";s:1:\"0\";s:6:\"credit\";s:0:\"\";s:6:\"camera\";s:0:\"\";s:7:\"caption\";s:0:\"\";s:17:\"created_timestamp\";s:1:\"0\";s:9:\"copyright\";s:0:\"\";s:12:\"focal_length\";s:1:\"0\";s:3:\"iso\";s:1:\"0\";s:13:\"shutter_speed\";s:1:\"0\";s:5:\"title\";s:0:\"\";s:11:\"orientation\";s:1:\"0\";s:8:\"keywords\";a:0:{}}}'),
(29, 2, 'фон-1', '17'),
(30, 2, '_фон-1', 'field_62435db92ea96'),
(31, 18, 'заголовок-1', 'УРОРЕК – оригинальный<sup>10</sup> альфа-адреноблокатор'),
(32, 18, '_заголовок-1', 'field_62435bd26f29f'),
(33, 18, 'текст-1', '<div class=\"headerBlock__body\">\r\n<p>Силодозин (действующее вещество препарата Урорек) обладает максимальной уроселективностью в&nbsp;своем классе, что обеспечивает его уродинамическую эффективность и&nbsp;высокую безопасность<sup>4</sup></p>\r\n</div>\r\n<div class=\"headerBlock__footer\">\r\n<p><strong>Показания к применению: </strong><br/>Лечение симптомов доброкачественной гиперплазии предстательной железы<sup>6</sup></p>\r\n</div>'),
(34, 18, '_текст-1', 'field_62435c0c6f2a0'),
(35, 18, 'изображение-1', '13'),
(36, 18, '_изображение-1', 'field_62435c8b6f2a1'),
(37, 18, 'фон-1', '17'),
(38, 18, '_фон-1', 'field_62435db92ea96'),
(39, 20, 'заголовок-1', 'УРОРЕК – оригинальный<sup>10</sup> альфа-адреноблокатор'),
(40, 20, '_заголовок-1', 'field_62435bd26f29f'),
(41, 20, 'текст-1', '<div class=\"headerBlock__body\">\r\n<p>Силодозин (действующее вещество препарата Урорек) обладает максимальной уроселективностью в&nbsp;своем классе, что обеспечивает его уродинамическую эффективность и&nbsp;высокую безопасность<sup>4</sup></p>\r\n</div>\r\n<div class=\"headerBlock__footer\">\r\n<p><strong>Показания к применению: </strong><br/>Лечение симптомов доброкачественной гиперплазии предстательной железы<sup>6</sup></p>\r\n</div>'),
(42, 20, '_текст-1', 'field_62435c0c6f2a0'),
(43, 20, 'изображение-1', '13'),
(44, 20, '_изображение-1', 'field_62435c8b6f2a1'),
(45, 20, 'фон-1', '17'),
(46, 20, '_фон-1', 'field_62435db92ea96'),
(47, 21, '_edit_last', '1'),
(48, 21, '_edit_lock', '1648720272:1'),
(49, 31, '_wp_attached_file', '2022/03/adv-i-1.svg'),
(50, 31, '_wp_attachment_metadata', 'a:2:{s:5:\"width\";d:80;s:6:\"height\";d:81;}'),
(51, 32, '_wp_attached_file', '2022/03/adv-i-2.svg'),
(52, 32, '_wp_attachment_metadata', 'a:2:{s:5:\"width\";d:64;s:6:\"height\";d:81;}'),
(53, 33, '_wp_attached_file', '2022/03/adv-i-3.svg'),
(54, 33, '_wp_attachment_metadata', 'a:2:{s:5:\"width\";d:80;s:6:\"height\";d:81;}'),
(55, 34, '_wp_attached_file', '2022/03/dad.png'),
(56, 34, '_wp_attachment_metadata', 'a:5:{s:5:\"width\";i:811;s:6:\"height\";i:680;s:4:\"file\";s:15:\"2022/03/dad.png\";s:5:\"sizes\";a:9:{s:6:\"medium\";a:4:{s:4:\"file\";s:15:\"dad-300x252.png\";s:5:\"width\";i:300;s:6:\"height\";i:252;s:9:\"mime-type\";s:9:\"image/png\";}s:9:\"thumbnail\";a:4:{s:4:\"file\";s:15:\"dad-150x150.png\";s:5:\"width\";i:150;s:6:\"height\";i:150;s:9:\"mime-type\";s:9:\"image/png\";}s:12:\"medium_large\";a:4:{s:4:\"file\";s:15:\"dad-768x644.png\";s:5:\"width\";i:768;s:6:\"height\";i:644;s:9:\"mime-type\";s:9:\"image/png\";}s:3:\"mob\";a:4:{s:4:\"file\";s:15:\"dad-480x402.png\";s:5:\"width\";i:480;s:6:\"height\";i:402;s:9:\"mime-type\";s:9:\"image/png\";}s:12:\"mob-vertical\";a:4:{s:4:\"file\";s:15:\"dad-576x680.png\";s:5:\"width\";i:576;s:6:\"height\";i:680;s:9:\"mime-type\";s:9:\"image/png\";}s:3:\"adv\";a:4:{s:4:\"file\";s:15:\"dad-680x680.png\";s:5:\"width\";i:680;s:6:\"height\";i:680;s:9:\"mime-type\";s:9:\"image/png\";}s:8:\"500х500\";a:4:{s:4:\"file\";s:15:\"dad-500x500.png\";s:5:\"width\";i:500;s:6:\"height\";i:500;s:9:\"mime-type\";s:9:\"image/png\";}s:8:\"330х660\";a:4:{s:4:\"file\";s:15:\"dad-330x660.png\";s:5:\"width\";i:330;s:6:\"height\";i:660;s:9:\"mime-type\";s:9:\"image/png\";}s:8:\"680х530\";a:4:{s:4:\"file\";s:15:\"dad-680x530.png\";s:5:\"width\";i:680;s:6:\"height\";i:530;s:9:\"mime-type\";s:9:\"image/png\";}}s:10:\"image_meta\";a:12:{s:8:\"aperture\";s:1:\"0\";s:6:\"credit\";s:0:\"\";s:6:\"camera\";s:0:\"\";s:7:\"caption\";s:0:\"\";s:17:\"created_timestamp\";s:1:\"0\";s:9:\"copyright\";s:0:\"\";s:12:\"focal_length\";s:1:\"0\";s:3:\"iso\";s:1:\"0\";s:13:\"shutter_speed\";s:1:\"0\";s:5:\"title\";s:0:\"\";s:11:\"orientation\";s:1:\"0\";s:8:\"keywords\";a:0:{}}}'),
(57, 2, 'заголовок-2', 'Ключевые преимущества препарата Урорек'),
(58, 2, '_заголовок-2', 'field_6243606295196'),
(59, 2, 'список-2', 'Единственный оригинальный препарат из&nbsp;группы альфа1-адреноблокаторов, не&nbsp;имеющий генериков в&nbsp;РФ<sup>1</sup>'),
(60, 2, '_список-2', 'field_6243608195197'),
(61, 2, 'картинка_с_текстом_0_изображение', '31'),
(62, 2, '_картинка_с_текстом_0_изображение', 'field_624363d095199'),
(63, 2, 'картинка_с_текстом_0_описание', 'Обширная доказательная база собственных пострегистрационных клинических исследований<sup>2</sup>'),
(64, 2, '_картинка_с_текстом_0_описание', 'field_624363e59519a'),
(65, 2, 'картинка_с_текстом_1_изображение', '32'),
(66, 2, '_картинка_с_текстом_1_изображение', 'field_624363d095199'),
(67, 2, 'картинка_с_текстом_1_описание', 'Отсутствие риска замены препарата Урорек в&nbsp;аптеке (единственный препарат с&nbsp;действующим веществом силодозин)<sup>1</sup>'),
(68, 2, '_картинка_с_текстом_1_описание', 'field_624363e59519a'),
(69, 2, 'картинка_с_текстом_2_изображение', '33'),
(70, 2, '_картинка_с_текстом_2_изображение', 'field_624363d095199'),
(71, 2, 'картинка_с_текстом_2_описание', 'Большинство пациентов предпочитают принимать оригинальные препараты<sup>3</sup>'),
(72, 2, '_картинка_с_текстом_2_описание', 'field_624363e59519a'),
(73, 2, 'картинка_с_текстом', '3'),
(74, 2, '_картинка_с_текстом', 'field_624363b995198'),
(75, 2, 'второй_список', '<li>Клинические преимущества препарата Урорек (силодозин) определяются максимальной уроселективностью в&nbsp;классе альфа-адреноблокаторов<sup>4</sup></li>\r\n\r\n<li>Урорек&nbsp;&mdash; альфа-адреноблокатор последнего поколения, который эффективен в&nbsp;отношении всех СНМП (накопления, опорожнения, постмиктурических).<sup>12,13</sup> При этом Урорек обладает минимальным риском развития нежелательных явлений со&nbsp;стороны сердечно-сосудистой системы, в&nbsp;том числе&nbsp;у&nbsp;пациентов, принимающих антигипертензивные препараты<sup>46,8</sup> <small> <span>СНМП </span>симптомы нижних мочевыводящих путей</small></li>'),
(76, 2, '_второй_список', 'field_6243640e05eda'),
(77, 2, 'заголовок2-2', 'Максимальная уроселективность силодозина в&nbsp;классе альфа-адреноблокаторов обуславливает его уродинамическую эффективность и&nbsp;высокий профиль безопасности<sup>4</sup>'),
(78, 2, '_заголовок2-2', 'field_6243644705edb'),
(79, 2, 'текст3', '<ul>\r\n<li>Урорек значительно улучшает клинические проявления и&nbsp;качество жизни у&nbsp;всех пациентов с&nbsp;СНМП/ДГПЖ, в&nbsp;том числе с&nbsp;тяжелым течением<sup>11</sup>\r\n<a href=\"#modal-call-first\" class=\"link-modal-js\">Узнать больше...</a></li>\r\n\r\n<li>Урорек является препаратом выбора для пациентов с&nbsp;СНМП/ДГПЖ и&nbsp;сопутствующими сердечно-сосудистыми заболеваниями<sup>3</sup> \r\n<a href=\"#modal-call-second\" class=\"link-modal-js\">Узнать больше...</a></li>\r\n</ul>\r\n<small> <span>ДГПЖ </span>доброкачественная гиперплазия предстательной железы</small>'),
(80, 2, '_текст3', 'field_6243647405edc'),
(81, 2, 'изображение-2', '34'),
(82, 2, '_изображение-2', 'field_624364dd05edd'),
(83, 35, 'заголовок-1', 'УРОРЕК – оригинальный<sup>10</sup> альфа-адреноблокатор'),
(84, 35, '_заголовок-1', 'field_62435bd26f29f'),
(85, 35, 'текст-1', '<div class=\"headerBlock__body\">\r\n<p>Силодозин (действующее вещество препарата Урорек) обладает максимальной уроселективностью в&nbsp;своем классе, что обеспечивает его уродинамическую эффективность и&nbsp;высокую безопасность<sup>4</sup></p>\r\n</div>\r\n<div class=\"headerBlock__footer\">\r\n<p><strong>Показания к применению: </strong><br/>Лечение симптомов доброкачественной гиперплазии предстательной железы<sup>6</sup></p>\r\n</div>'),
(86, 35, '_текст-1', 'field_62435c0c6f2a0'),
(87, 35, 'изображение-1', '13'),
(88, 35, '_изображение-1', 'field_62435c8b6f2a1'),
(89, 35, 'фон-1', '17'),
(90, 35, '_фон-1', 'field_62435db92ea96'),
(91, 35, 'заголовок-2', ''),
(92, 35, '_заголовок-2', 'field_6243606295196'),
(93, 35, 'список-2', 'Единственный оригинальный препарат из&nbsp;группы альфа1-адреноблокаторов, не&nbsp;имеющий генериков в&nbsp;РФ<sup>1</sup>'),
(94, 35, '_список-2', 'field_6243608195197'),
(95, 35, 'картинка_с_текстом_0_изображение', '31'),
(96, 35, '_картинка_с_текстом_0_изображение', 'field_624363d095199'),
(97, 35, 'картинка_с_текстом_0_описание', 'Обширная доказательная база собственных пострегистрационных клинических исследований<sup>2</sup>'),
(98, 35, '_картинка_с_текстом_0_описание', 'field_624363e59519a'),
(99, 35, 'картинка_с_текстом_1_изображение', '32'),
(100, 35, '_картинка_с_текстом_1_изображение', 'field_624363d095199'),
(101, 35, 'картинка_с_текстом_1_описание', 'Отсутствие риска замены препарата Урорек в&nbsp;аптеке (единственный препарат с&nbsp;действующим веществом силодозин)<sup>1</sup>'),
(102, 35, '_картинка_с_текстом_1_описание', 'field_624363e59519a'),
(103, 35, 'картинка_с_текстом_2_изображение', '33'),
(104, 35, '_картинка_с_текстом_2_изображение', 'field_624363d095199'),
(105, 35, 'картинка_с_текстом_2_описание', 'Большинство пациентов предпочитают принимать оригинальные препараты<sup>3</sup>'),
(106, 35, '_картинка_с_текстом_2_описание', 'field_624363e59519a'),
(107, 35, 'картинка_с_текстом', '3'),
(108, 35, '_картинка_с_текстом', 'field_624363b995198'),
(109, 35, 'второй_список', '<li>Клинические преимущества препарата Урорек (силодозин) определяются максимальной уроселективностью в&nbsp;классе альфа-адреноблокаторов<sup>4</sup></li>\r\n\r\n<li>Урорек&nbsp;&mdash; альфа-адреноблокатор последнего поколения, который эффективен в&nbsp;отношении всех СНМП (накопления, опорожнения, постмиктурических).<sup>12,13</sup> При этом Урорек обладает минимальным риском развития нежелательных явлений со&nbsp;стороны сердечно-сосудистой системы, в&nbsp;том числе&nbsp;у&nbsp;пациентов, принимающих антигипертензивные препараты<sup>46,8</sup> <small> <span>СНМП </span>симптомы нижних мочевыводящих путей</small></li>'),
(110, 35, '_второй_список', 'field_6243640e05eda'),
(111, 35, 'заголовок2-2', 'Максимальная уроселективность силодозина в&nbsp;классе альфа-адреноблокаторов обуславливает его уродинамическую эффективность и&nbsp;высокий профиль безопасности<sup>4</sup>'),
(112, 35, '_заголовок2-2', 'field_6243644705edb'),
(113, 35, 'текст3', '<ul>\r\n<li>Урорек значительно улучшает клинические проявления и&nbsp;качество жизни у&nbsp;всех пациентов с&nbsp;СНМП/ДГПЖ, в&nbsp;том числе с&nbsp;тяжелым течением<sup>11</sup><a href=\"#\">Узнать больше...</a></li>\r\n\r\n<li>Урорек является препаратом выбора для пациентов с&nbsp;СНМП/ДГПЖ и&nbsp;сопутствующими сердечно-сосудистыми заболеваниями<sup>3</sup> <a href=\"#\">Узнать больше...</a></li>\r\n</ul>\r\n<small> <span>ДГПЖ </span>доброкачественная гиперплазия предстательной железы</small>'),
(114, 35, '_текст3', 'field_6243647405edc'),
(115, 35, 'изображение-2', '34'),
(116, 35, '_изображение-2', 'field_624364dd05edd'),
(117, 36, 'заголовок-1', 'УРОРЕК – оригинальный<sup>10</sup> альфа-адреноблокатор'),
(118, 36, '_заголовок-1', 'field_62435bd26f29f'),
(119, 36, 'текст-1', '<div class=\"headerBlock__body\">\r\n<p>Силодозин (действующее вещество препарата Урорек) обладает максимальной уроселективностью в&nbsp;своем классе, что обеспечивает его уродинамическую эффективность и&nbsp;высокую безопасность<sup>4</sup></p>\r\n</div>\r\n<div class=\"headerBlock__footer\">\r\n<p><strong>Показания к применению: </strong><br/>Лечение симптомов доброкачественной гиперплазии предстательной железы<sup>6</sup></p>\r\n</div>'),
(120, 36, '_текст-1', 'field_62435c0c6f2a0'),
(121, 36, 'изображение-1', '13'),
(122, 36, '_изображение-1', 'field_62435c8b6f2a1'),
(123, 36, 'фон-1', '17'),
(124, 36, '_фон-1', 'field_62435db92ea96'),
(125, 36, 'заголовок-2', ''),
(126, 36, '_заголовок-2', 'field_6243606295196'),
(127, 36, 'список-2', 'Единственный оригинальный препарат из&nbsp;группы альфа1-адреноблокаторов, не&nbsp;имеющий генериков в&nbsp;РФ<sup>1</sup>'),
(128, 36, '_список-2', 'field_6243608195197'),
(129, 36, 'картинка_с_текстом_0_изображение', '31'),
(130, 36, '_картинка_с_текстом_0_изображение', 'field_624363d095199'),
(131, 36, 'картинка_с_текстом_0_описание', 'Обширная доказательная база собственных пострегистрационных клинических исследований<sup>2</sup>'),
(132, 36, '_картинка_с_текстом_0_описание', 'field_624363e59519a'),
(133, 36, 'картинка_с_текстом_1_изображение', '32'),
(134, 36, '_картинка_с_текстом_1_изображение', 'field_624363d095199'),
(135, 36, 'картинка_с_текстом_1_описание', 'Отсутствие риска замены препарата Урорек в&nbsp;аптеке (единственный препарат с&nbsp;действующим веществом силодозин)<sup>1</sup>'),
(136, 36, '_картинка_с_текстом_1_описание', 'field_624363e59519a'),
(137, 36, 'картинка_с_текстом_2_изображение', '33'),
(138, 36, '_картинка_с_текстом_2_изображение', 'field_624363d095199'),
(139, 36, 'картинка_с_текстом_2_описание', 'Большинство пациентов предпочитают принимать оригинальные препараты<sup>3</sup>'),
(140, 36, '_картинка_с_текстом_2_описание', 'field_624363e59519a'),
(141, 36, 'картинка_с_текстом', '3'),
(142, 36, '_картинка_с_текстом', 'field_624363b995198'),
(143, 36, 'второй_список', '<li>Клинические преимущества препарата Урорек (силодозин) определяются максимальной уроселективностью в&nbsp;классе альфа-адреноблокаторов<sup>4</sup></li>\r\n\r\n<li>Урорек&nbsp;&mdash; альфа-адреноблокатор последнего поколения, который эффективен в&nbsp;отношении всех СНМП (накопления, опорожнения, постмиктурических).<sup>12,13</sup> При этом Урорек обладает минимальным риском развития нежелательных явлений со&nbsp;стороны сердечно-сосудистой системы, в&nbsp;том числе&nbsp;у&nbsp;пациентов, принимающих антигипертензивные препараты<sup>46,8</sup> <small> <span>СНМП </span>симптомы нижних мочевыводящих путей</small></li>'),
(144, 36, '_второй_список', 'field_6243640e05eda'),
(145, 36, 'заголовок2-2', 'Максимальная уроселективность силодозина в&nbsp;классе альфа-адреноблокаторов обуславливает его уродинамическую эффективность и&nbsp;высокий профиль безопасности<sup>4</sup>'),
(146, 36, '_заголовок2-2', 'field_6243644705edb'),
(147, 36, 'текст3', '<ul>\r\n<li>Урорек значительно улучшает клинические проявления и&nbsp;качество жизни у&nbsp;всех пациентов с&nbsp;СНМП/ДГПЖ, в&nbsp;том числе с&nbsp;тяжелым течением<sup>11</sup><a href=\"#\">Узнать больше...</a></li>\r\n\r\n<li>Урорек является препаратом выбора для пациентов с&nbsp;СНМП/ДГПЖ и&nbsp;сопутствующими сердечно-сосудистыми заболеваниями<sup>3</sup> <a href=\"#\">Узнать больше...</a></li>\r\n</ul>\r\n<small> <span>ДГПЖ </span>доброкачественная гиперплазия предстательной железы</small>'),
(148, 36, '_текст3', 'field_6243647405edc'),
(149, 36, 'изображение-2', '34'),
(150, 36, '_изображение-2', 'field_624364dd05edd'),
(151, 37, 'заголовок-1', 'УРОРЕК – оригинальный<sup>10</sup> альфа-адреноблокатор'),
(152, 37, '_заголовок-1', 'field_62435bd26f29f'),
(153, 37, 'текст-1', '<div class=\"headerBlock__body\">\r\n<p>Силодозин (действующее вещество препарата Урорек) обладает максимальной уроселективностью в&nbsp;своем классе, что обеспечивает его уродинамическую эффективность и&nbsp;высокую безопасность<sup>4</sup></p>\r\n</div>\r\n<div class=\"headerBlock__footer\">\r\n<p><strong>Показания к применению: </strong><br/>Лечение симптомов доброкачественной гиперплазии предстательной железы<sup>6</sup></p>\r\n</div>'),
(154, 37, '_текст-1', 'field_62435c0c6f2a0'),
(155, 37, 'изображение-1', '13'),
(156, 37, '_изображение-1', 'field_62435c8b6f2a1'),
(157, 37, 'фон-1', '17'),
(158, 37, '_фон-1', 'field_62435db92ea96'),
(159, 37, 'заголовок-2', ''),
(160, 37, '_заголовок-2', 'field_6243606295196'),
(161, 37, 'список-2', 'Единственный оригинальный препарат из&nbsp;группы альфа1-адреноблокаторов, не&nbsp;имеющий генериков в&nbsp;РФ<sup>1</sup>'),
(162, 37, '_список-2', 'field_6243608195197'),
(163, 37, 'картинка_с_текстом_0_изображение', '31'),
(164, 37, '_картинка_с_текстом_0_изображение', 'field_624363d095199'),
(165, 37, 'картинка_с_текстом_0_описание', 'Обширная доказательная база собственных пострегистрационных клинических исследований<sup>2</sup>'),
(166, 37, '_картинка_с_текстом_0_описание', 'field_624363e59519a'),
(167, 37, 'картинка_с_текстом_1_изображение', '32'),
(168, 37, '_картинка_с_текстом_1_изображение', 'field_624363d095199'),
(169, 37, 'картинка_с_текстом_1_описание', 'Отсутствие риска замены препарата Урорек в&nbsp;аптеке (единственный препарат с&nbsp;действующим веществом силодозин)<sup>1</sup>'),
(170, 37, '_картинка_с_текстом_1_описание', 'field_624363e59519a'),
(171, 37, 'картинка_с_текстом_2_изображение', '33'),
(172, 37, '_картинка_с_текстом_2_изображение', 'field_624363d095199'),
(173, 37, 'картинка_с_текстом_2_описание', 'Большинство пациентов предпочитают принимать оригинальные препараты<sup>3</sup>'),
(174, 37, '_картинка_с_текстом_2_описание', 'field_624363e59519a'),
(175, 37, 'картинка_с_текстом', '3'),
(176, 37, '_картинка_с_текстом', 'field_624363b995198'),
(177, 37, 'второй_список', '<li>Клинические преимущества препарата Урорек (силодозин) определяются максимальной уроселективностью в&nbsp;классе альфа-адреноблокаторов<sup>4</sup></li>\r\n\r\n<li>Урорек&nbsp;&mdash; альфа-адреноблокатор последнего поколения, который эффективен в&nbsp;отношении всех СНМП (накопления, опорожнения, постмиктурических).<sup>12,13</sup> При этом Урорек обладает минимальным риском развития нежелательных явлений со&nbsp;стороны сердечно-сосудистой системы, в&nbsp;том числе&nbsp;у&nbsp;пациентов, принимающих антигипертензивные препараты<sup>46,8</sup> <small> <span>СНМП </span>симптомы нижних мочевыводящих путей</small></li>'),
(178, 37, '_второй_список', 'field_6243640e05eda'),
(179, 37, 'заголовок2-2', 'Максимальная уроселективность силодозина в&nbsp;классе альфа-адреноблокаторов обуславливает его уродинамическую эффективность и&nbsp;высокий профиль безопасности<sup>4</sup>'),
(180, 37, '_заголовок2-2', 'field_6243644705edb'),
(181, 37, 'текст3', '<ul>\r\n<li>Урорек значительно улучшает клинические проявления и&nbsp;качество жизни у&nbsp;всех пациентов с&nbsp;СНМП/ДГПЖ, в&nbsp;том числе с&nbsp;тяжелым течением<sup>11</sup><a href=\"#\">Узнать больше...</a></li>\r\n\r\n<li>Урорек является препаратом выбора для пациентов с&nbsp;СНМП/ДГПЖ и&nbsp;сопутствующими сердечно-сосудистыми заболеваниями<sup>3</sup> <a href=\"#\">Узнать больше...</a></li>\r\n</ul>\r\n<small> <span>ДГПЖ </span>доброкачественная гиперплазия предстательной железы</small>'),
(182, 37, '_текст3', 'field_6243647405edc'),
(183, 37, 'изображение-2', '34'),
(184, 37, '_изображение-2', 'field_624364dd05edd'),
(185, 38, 'заголовок-1', 'УРОРЕК – оригинальный<sup>10</sup> альфа-адреноблокатор'),
(186, 38, '_заголовок-1', 'field_62435bd26f29f'),
(187, 38, 'текст-1', '<div class=\"headerBlock__body\">\r\n<p>Силодозин (действующее вещество препарата Урорек) обладает максимальной уроселективностью в&nbsp;своем классе, что обеспечивает его уродинамическую эффективность и&nbsp;высокую безопасность<sup>4</sup></p>\r\n</div>\r\n<div class=\"headerBlock__footer\">\r\n<p><strong>Показания к применению: </strong><br/>Лечение симптомов доброкачественной гиперплазии предстательной железы<sup>6</sup></p>\r\n</div>'),
(188, 38, '_текст-1', 'field_62435c0c6f2a0'),
(189, 38, 'изображение-1', '13'),
(190, 38, '_изображение-1', 'field_62435c8b6f2a1'),
(191, 38, 'фон-1', '17'),
(192, 38, '_фон-1', 'field_62435db92ea96'),
(193, 38, 'заголовок-2', 'Ключевые преимущества препарата Урорек'),
(194, 38, '_заголовок-2', 'field_6243606295196'),
(195, 38, 'список-2', 'Единственный оригинальный препарат из&nbsp;группы альфа1-адреноблокаторов, не&nbsp;имеющий генериков в&nbsp;РФ<sup>1</sup>'),
(196, 38, '_список-2', 'field_6243608195197'),
(197, 38, 'картинка_с_текстом_0_изображение', '31'),
(198, 38, '_картинка_с_текстом_0_изображение', 'field_624363d095199'),
(199, 38, 'картинка_с_текстом_0_описание', 'Обширная доказательная база собственных пострегистрационных клинических исследований<sup>2</sup>'),
(200, 38, '_картинка_с_текстом_0_описание', 'field_624363e59519a'),
(201, 38, 'картинка_с_текстом_1_изображение', '32'),
(202, 38, '_картинка_с_текстом_1_изображение', 'field_624363d095199'),
(203, 38, 'картинка_с_текстом_1_описание', 'Отсутствие риска замены препарата Урорек в&nbsp;аптеке (единственный препарат с&nbsp;действующим веществом силодозин)<sup>1</sup>'),
(204, 38, '_картинка_с_текстом_1_описание', 'field_624363e59519a'),
(205, 38, 'картинка_с_текстом_2_изображение', '33'),
(206, 38, '_картинка_с_текстом_2_изображение', 'field_624363d095199'),
(207, 38, 'картинка_с_текстом_2_описание', 'Большинство пациентов предпочитают принимать оригинальные препараты<sup>3</sup>'),
(208, 38, '_картинка_с_текстом_2_описание', 'field_624363e59519a'),
(209, 38, 'картинка_с_текстом', '3'),
(210, 38, '_картинка_с_текстом', 'field_624363b995198'),
(211, 38, 'второй_список', '<li>Клинические преимущества препарата Урорек (силодозин) определяются максимальной уроселективностью в&nbsp;классе альфа-адреноблокаторов<sup>4</sup></li>\r\n\r\n<li>Урорек&nbsp;&mdash; альфа-адреноблокатор последнего поколения, который эффективен в&nbsp;отношении всех СНМП (накопления, опорожнения, постмиктурических).<sup>12,13</sup> При этом Урорек обладает минимальным риском развития нежелательных явлений со&nbsp;стороны сердечно-сосудистой системы, в&nbsp;том числе&nbsp;у&nbsp;пациентов, принимающих антигипертензивные препараты<sup>46,8</sup> <small> <span>СНМП </span>симптомы нижних мочевыводящих путей</small></li>'),
(212, 38, '_второй_список', 'field_6243640e05eda'),
(213, 38, 'заголовок2-2', 'Максимальная уроселективность силодозина в&nbsp;классе альфа-адреноблокаторов обуславливает его уродинамическую эффективность и&nbsp;высокий профиль безопасности<sup>4</sup>'),
(214, 38, '_заголовок2-2', 'field_6243644705edb'),
(215, 38, 'текст3', '<ul>\r\n<li>Урорек значительно улучшает клинические проявления и&nbsp;качество жизни у&nbsp;всех пациентов с&nbsp;СНМП/ДГПЖ, в&nbsp;том числе с&nbsp;тяжелым течением<sup>11</sup><a href=\"#\">Узнать больше...</a></li>\r\n\r\n<li>Урорек является препаратом выбора для пациентов с&nbsp;СНМП/ДГПЖ и&nbsp;сопутствующими сердечно-сосудистыми заболеваниями<sup>3</sup> <a href=\"#\">Узнать больше...</a></li>\r\n</ul>\r\n<small> <span>ДГПЖ </span>доброкачественная гиперплазия предстательной железы</small>'),
(216, 38, '_текст3', 'field_6243647405edc'),
(217, 38, 'изображение-2', '34'),
(218, 38, '_изображение-2', 'field_624364dd05edd'),
(219, 2, 'текст_в_подвале', '<h2> Максимальная уроселективность в&nbsp;классе  альфа-адреноблокаторов<sup>4</sup></h2>\r\n<div class=\"h3\"> Почему это важно? <a href=\"#modal-call-3\" class=\"link-modal-js\">Подробнее</a></div>'),
(220, 2, '_текст_в_подвале', 'field_62436daf1f6d9'),
(221, 38, 'текст_в_подвале', '<h2> Максимальная уроселективность в&nbsp;классе  альфа-адреноблокаторов<sup>4</sup></h2>\r\n<div class=\"h3\"> Почему это важно? <a href=\"#\">Подробнее</a></div>'),
(222, 38, '_текст_в_подвале', 'field_62436daf1f6d9'),
(223, 40, 'заголовок-1', 'УРОРЕК – оригинальный<sup>10</sup> альфа-адреноблокатор'),
(224, 40, '_заголовок-1', 'field_62435bd26f29f'),
(225, 40, 'текст-1', '<div class=\"headerBlock__body\">\r\n<p>Силодозин (действующее вещество препарата Урорек) обладает максимальной уроселективностью в&nbsp;своем классе, что обеспечивает его уродинамическую эффективность и&nbsp;высокую безопасность<sup>4</sup></p>\r\n</div>\r\n<div class=\"headerBlock__footer\">\r\n<p><strong>Показания к применению: </strong><br/>Лечение симптомов доброкачественной гиперплазии предстательной железы<sup>6</sup></p>\r\n</div>'),
(226, 40, '_текст-1', 'field_62435c0c6f2a0'),
(227, 40, 'изображение-1', '13'),
(228, 40, '_изображение-1', 'field_62435c8b6f2a1'),
(229, 40, 'фон-1', '17'),
(230, 40, '_фон-1', 'field_62435db92ea96'),
(231, 40, 'заголовок-2', 'Ключевые преимущества препарата Урорек'),
(232, 40, '_заголовок-2', 'field_6243606295196'),
(233, 40, 'список-2', 'Единственный оригинальный препарат из&nbsp;группы альфа1-адреноблокаторов, не&nbsp;имеющий генериков в&nbsp;РФ<sup>1</sup>'),
(234, 40, '_список-2', 'field_6243608195197'),
(235, 40, 'картинка_с_текстом_0_изображение', '31'),
(236, 40, '_картинка_с_текстом_0_изображение', 'field_624363d095199'),
(237, 40, 'картинка_с_текстом_0_описание', 'Обширная доказательная база собственных пострегистрационных клинических исследований<sup>2</sup>'),
(238, 40, '_картинка_с_текстом_0_описание', 'field_624363e59519a'),
(239, 40, 'картинка_с_текстом_1_изображение', '32'),
(240, 40, '_картинка_с_текстом_1_изображение', 'field_624363d095199'),
(241, 40, 'картинка_с_текстом_1_описание', 'Отсутствие риска замены препарата Урорек в&nbsp;аптеке (единственный препарат с&nbsp;действующим веществом силодозин)<sup>1</sup>'),
(242, 40, '_картинка_с_текстом_1_описание', 'field_624363e59519a'),
(243, 40, 'картинка_с_текстом_2_изображение', '33'),
(244, 40, '_картинка_с_текстом_2_изображение', 'field_624363d095199'),
(245, 40, 'картинка_с_текстом_2_описание', 'Большинство пациентов предпочитают принимать оригинальные препараты<sup>3</sup>'),
(246, 40, '_картинка_с_текстом_2_описание', 'field_624363e59519a'),
(247, 40, 'картинка_с_текстом', '3'),
(248, 40, '_картинка_с_текстом', 'field_624363b995198'),
(249, 40, 'второй_список', '<li>Клинические преимущества препарата Урорек (силодозин) определяются максимальной уроселективностью в&nbsp;классе альфа-адреноблокаторов<sup>4</sup></li>\r\n\r\n<li>Урорек&nbsp;&mdash; альфа-адреноблокатор последнего поколения, который эффективен в&nbsp;отношении всех СНМП (накопления, опорожнения, постмиктурических).<sup>12,13</sup> При этом Урорек обладает минимальным риском развития нежелательных явлений со&nbsp;стороны сердечно-сосудистой системы, в&nbsp;том числе&nbsp;у&nbsp;пациентов, принимающих антигипертензивные препараты<sup>46,8</sup> <small> <span>СНМП </span>симптомы нижних мочевыводящих путей</small></li>'),
(250, 40, '_второй_список', 'field_6243640e05eda'),
(251, 40, 'заголовок2-2', 'Максимальная уроселективность силодозина в&nbsp;классе альфа-адреноблокаторов обуславливает его уродинамическую эффективность и&nbsp;высокий профиль безопасности<sup>4</sup>'),
(252, 40, '_заголовок2-2', 'field_6243644705edb'),
(253, 40, 'текст3', '<ul>\r\n<li>Урорек значительно улучшает клинические проявления и&nbsp;качество жизни у&nbsp;всех пациентов с&nbsp;СНМП/ДГПЖ, в&nbsp;том числе с&nbsp;тяжелым течением<sup>11</sup><a href=\"#\">Узнать больше...</a></li>\r\n\r\n<li>Урорек является препаратом выбора для пациентов с&nbsp;СНМП/ДГПЖ и&nbsp;сопутствующими сердечно-сосудистыми заболеваниями<sup>3</sup> <a href=\"#\">Узнать больше...</a></li>\r\n</ul>\r\n<small> <span>ДГПЖ </span>доброкачественная гиперплазия предстательной железы</small>'),
(254, 40, '_текст3', 'field_6243647405edc'),
(255, 40, 'изображение-2', '34'),
(256, 40, '_изображение-2', 'field_624364dd05edd'),
(257, 40, 'текст_в_подвале', '<h2> Максимальная уроселективность в&nbsp;классе  альфа-адреноблокаторов<sup>4</sup></h2>\r\n<div class=\"h3\"> Почему это важно? <a href=\"#\">Подробнее</a></div>'),
(258, 40, '_текст_в_подвале', 'field_62436daf1f6d9'),
(259, 42, '_edit_last', '1'),
(260, 42, '_edit_lock', '1648587858:1'),
(261, 51, '_wp_attached_file', '2022/03/catalog-img-1.png'),
(262, 51, '_wp_attachment_metadata', 'a:5:{s:5:\"width\";i:263;s:6:\"height\";i:188;s:4:\"file\";s:25:\"2022/03/catalog-img-1.png\";s:5:\"sizes\";a:1:{s:9:\"thumbnail\";a:4:{s:4:\"file\";s:25:\"catalog-img-1-150x150.png\";s:5:\"width\";i:150;s:6:\"height\";i:150;s:9:\"mime-type\";s:9:\"image/png\";}}s:10:\"image_meta\";a:12:{s:8:\"aperture\";s:1:\"0\";s:6:\"credit\";s:0:\"\";s:6:\"camera\";s:0:\"\";s:7:\"caption\";s:0:\"\";s:17:\"created_timestamp\";s:1:\"0\";s:9:\"copyright\";s:0:\"\";s:12:\"focal_length\";s:1:\"0\";s:3:\"iso\";s:1:\"0\";s:13:\"shutter_speed\";s:1:\"0\";s:5:\"title\";s:0:\"\";s:11:\"orientation\";s:1:\"0\";s:8:\"keywords\";a:0:{}}}'),
(263, 52, '_wp_attached_file', '2022/03/catalog-img-3.png'),
(264, 52, '_wp_attachment_metadata', 'a:5:{s:5:\"width\";i:263;s:6:\"height\";i:188;s:4:\"file\";s:25:\"2022/03/catalog-img-3.png\";s:5:\"sizes\";a:1:{s:9:\"thumbnail\";a:4:{s:4:\"file\";s:25:\"catalog-img-3-150x150.png\";s:5:\"width\";i:150;s:6:\"height\";i:150;s:9:\"mime-type\";s:9:\"image/png\";}}s:10:\"image_meta\";a:12:{s:8:\"aperture\";s:1:\"0\";s:6:\"credit\";s:0:\"\";s:6:\"camera\";s:0:\"\";s:7:\"caption\";s:0:\"\";s:17:\"created_timestamp\";s:1:\"0\";s:9:\"copyright\";s:0:\"\";s:12:\"focal_length\";s:1:\"0\";s:3:\"iso\";s:1:\"0\";s:13:\"shutter_speed\";s:1:\"0\";s:5:\"title\";s:0:\"\";s:11:\"orientation\";s:1:\"0\";s:8:\"keywords\";a:0:{}}}'),
(265, 53, '_wp_attached_file', '2022/03/catalog-img-2.png'),
(266, 53, '_wp_attachment_metadata', 'a:5:{s:5:\"width\";i:263;s:6:\"height\";i:188;s:4:\"file\";s:25:\"2022/03/catalog-img-2.png\";s:5:\"sizes\";a:1:{s:9:\"thumbnail\";a:4:{s:4:\"file\";s:25:\"catalog-img-2-150x150.png\";s:5:\"width\";i:150;s:6:\"height\";i:150;s:9:\"mime-type\";s:9:\"image/png\";}}s:10:\"image_meta\";a:12:{s:8:\"aperture\";s:1:\"0\";s:6:\"credit\";s:0:\"\";s:6:\"camera\";s:0:\"\";s:7:\"caption\";s:0:\"\";s:17:\"created_timestamp\";s:1:\"0\";s:9:\"copyright\";s:0:\"\";s:12:\"focal_length\";s:1:\"0\";s:3:\"iso\";s:1:\"0\";s:13:\"shutter_speed\";s:1:\"0\";s:5:\"title\";s:0:\"\";s:11:\"orientation\";s:1:\"0\";s:8:\"keywords\";a:0:{}}}'),
(267, 2, 'заголовок-3', 'Форма выпуска препарата Урорек'),
(268, 2, '_заголовок-3', 'field_62436efee98e7'),
(269, 2, 'текст-3', '<p class=\"section-descr\"><span>8мг </span>- рекомендуемая доза для лечения симптомов ДГПЖ<sup>6</sup>*</p>\r\n					<p class=\"section-note col-md-10\">*Более подробные сведения о&nbsp;препарате, особенностях применения, побочных действиях и&nbsp;др. &mdash;&nbsp;смотрите инструкцию по&nbsp;медицинскому применению лекарственного препарата Урорек, РУ&nbsp;ЛСР-005971/10 от&nbsp;25.06.2010 </p>'),
(270, 2, '_текст-3', 'field_62436f60e98e8'),
(271, 2, 'товар_0_название', 'Урорек 8мг №30'),
(272, 2, '_товар_0_название', 'field_62436fcce98ea'),
(273, 2, 'товар_0_описание', 'Упаковка, рассчитанная на&nbsp;1&nbsp;месяц лечения&nbsp;/ для старта терапии'),
(274, 2, '_товар_0_описание', 'field_62436fe1e98eb'),
(275, 2, 'товар_0_лицензия', 'РУ: ЛСР-005971/10 от 25.06.2010'),
(276, 2, '_товар_0_лицензия', 'field_62436ff0e98ec'),
(277, 2, 'товар_0_изображение', '51'),
(278, 2, '_товар_0_изображение', 'field_62437045e98ed'),
(279, 2, 'товар_1_название', 'Урорек 8мг №90'),
(280, 2, '_товар_1_название', 'field_62436fcce98ea'),
(281, 2, 'товар_1_описание', 'Выгодная упаковка, рассчитанная на&nbsp;3&nbsp;месяца лечения. Самая доступная стоимость 1&nbsp;дня терапии препаратом Урорек&nbsp;<sup>27</sup>'),
(282, 2, '_товар_1_описание', 'field_62436fe1e98eb'),
(283, 2, 'товар_1_лицензия', 'РУ: ЛСР-005971/10 от 25.06.2010'),
(284, 2, '_товар_1_лицензия', 'field_62436ff0e98ec'),
(285, 2, 'товар_1_изображение', '53'),
(286, 2, '_товар_1_изображение', 'field_62437045e98ed'),
(287, 2, 'товар_2_название', 'Урорек 4мг №30'),
(288, 2, '_товар_2_название', 'field_62436fcce98ea'),
(289, 2, 'товар_2_описание', '4&nbsp;мг&nbsp;&mdash; стартовая доза для лечения симптомов ДГПЖ у&nbsp;пациентов с&nbsp;почечной недостаточностью средней степени тяжести<sup>6</sup>'),
(290, 2, '_товар_2_описание', 'field_62436fe1e98eb'),
(291, 2, 'товар_2_лицензия', 'РУ: ЛСР-005971/10 от 25.06.2010'),
(292, 2, '_товар_2_лицензия', 'field_62436ff0e98ec'),
(293, 2, 'товар_2_изображение', '52'),
(294, 2, '_товар_2_изображение', 'field_62437045e98ed'),
(295, 2, 'товар', '3'),
(296, 2, '_товар', 'field_62436fbde98e9'),
(297, 54, 'заголовок-1', 'УРОРЕК – оригинальный<sup>10</sup> альфа-адреноблокатор'),
(298, 54, '_заголовок-1', 'field_62435bd26f29f'),
(299, 54, 'текст-1', '<div class=\"headerBlock__body\">\r\n<p>Силодозин (действующее вещество препарата Урорек) обладает максимальной уроселективностью в&nbsp;своем классе, что обеспечивает его уродинамическую эффективность и&nbsp;высокую безопасность<sup>4</sup></p>\r\n</div>\r\n<div class=\"headerBlock__footer\">\r\n<p><strong>Показания к применению: </strong><br/>Лечение симптомов доброкачественной гиперплазии предстательной железы<sup>6</sup></p>\r\n</div>'),
(300, 54, '_текст-1', 'field_62435c0c6f2a0'),
(301, 54, 'изображение-1', '13'),
(302, 54, '_изображение-1', 'field_62435c8b6f2a1'),
(303, 54, 'фон-1', '17'),
(304, 54, '_фон-1', 'field_62435db92ea96'),
(305, 54, 'заголовок-2', 'Ключевые преимущества препарата Урорек'),
(306, 54, '_заголовок-2', 'field_6243606295196'),
(307, 54, 'список-2', 'Единственный оригинальный препарат из&nbsp;группы альфа1-адреноблокаторов, не&nbsp;имеющий генериков в&nbsp;РФ<sup>1</sup>'),
(308, 54, '_список-2', 'field_6243608195197'),
(309, 54, 'картинка_с_текстом_0_изображение', '31'),
(310, 54, '_картинка_с_текстом_0_изображение', 'field_624363d095199'),
(311, 54, 'картинка_с_текстом_0_описание', 'Обширная доказательная база собственных пострегистрационных клинических исследований<sup>2</sup>'),
(312, 54, '_картинка_с_текстом_0_описание', 'field_624363e59519a'),
(313, 54, 'картинка_с_текстом_1_изображение', '32'),
(314, 54, '_картинка_с_текстом_1_изображение', 'field_624363d095199'),
(315, 54, 'картинка_с_текстом_1_описание', 'Отсутствие риска замены препарата Урорек в&nbsp;аптеке (единственный препарат с&nbsp;действующим веществом силодозин)<sup>1</sup>'),
(316, 54, '_картинка_с_текстом_1_описание', 'field_624363e59519a'),
(317, 54, 'картинка_с_текстом_2_изображение', '33'),
(318, 54, '_картинка_с_текстом_2_изображение', 'field_624363d095199'),
(319, 54, 'картинка_с_текстом_2_описание', 'Большинство пациентов предпочитают принимать оригинальные препараты<sup>3</sup>'),
(320, 54, '_картинка_с_текстом_2_описание', 'field_624363e59519a'),
(321, 54, 'картинка_с_текстом', '3'),
(322, 54, '_картинка_с_текстом', 'field_624363b995198'),
(323, 54, 'второй_список', '<li>Клинические преимущества препарата Урорек (силодозин) определяются максимальной уроселективностью в&nbsp;классе альфа-адреноблокаторов<sup>4</sup></li>\r\n\r\n<li>Урорек&nbsp;&mdash; альфа-адреноблокатор последнего поколения, который эффективен в&nbsp;отношении всех СНМП (накопления, опорожнения, постмиктурических).<sup>12,13</sup> При этом Урорек обладает минимальным риском развития нежелательных явлений со&nbsp;стороны сердечно-сосудистой системы, в&nbsp;том числе&nbsp;у&nbsp;пациентов, принимающих антигипертензивные препараты<sup>46,8</sup> <small> <span>СНМП </span>симптомы нижних мочевыводящих путей</small></li>'),
(324, 54, '_второй_список', 'field_6243640e05eda'),
(325, 54, 'заголовок2-2', 'Максимальная уроселективность силодозина в&nbsp;классе альфа-адреноблокаторов обуславливает его уродинамическую эффективность и&nbsp;высокий профиль безопасности<sup>4</sup>'),
(326, 54, '_заголовок2-2', 'field_6243644705edb'),
(327, 54, 'текст3', '<ul>\r\n<li>Урорек значительно улучшает клинические проявления и&nbsp;качество жизни у&nbsp;всех пациентов с&nbsp;СНМП/ДГПЖ, в&nbsp;том числе с&nbsp;тяжелым течением<sup>11</sup><a href=\"#\">Узнать больше...</a></li>\r\n\r\n<li>Урорек является препаратом выбора для пациентов с&nbsp;СНМП/ДГПЖ и&nbsp;сопутствующими сердечно-сосудистыми заболеваниями<sup>3</sup> <a href=\"#\">Узнать больше...</a></li>\r\n</ul>\r\n<small> <span>ДГПЖ </span>доброкачественная гиперплазия предстательной железы</small>'),
(328, 54, '_текст3', 'field_6243647405edc'),
(329, 54, 'изображение-2', '34'),
(330, 54, '_изображение-2', 'field_624364dd05edd'),
(331, 54, 'текст_в_подвале', '<h2> Максимальная уроселективность в&nbsp;классе  альфа-адреноблокаторов<sup>4</sup></h2>\r\n<div class=\"h3\"> Почему это важно? <a href=\"#\">Подробнее</a></div>'),
(332, 54, '_текст_в_подвале', 'field_62436daf1f6d9'),
(333, 54, 'заголовок-3', 'Форма выпуска препарата Урорек'),
(334, 54, '_заголовок-3', 'field_62436efee98e7'),
(335, 54, 'текст-3', '<p class=\"section-descr\"><span>8мг </span>- рекомендуемая доза для лечения симптомов ДГПЖ<sup>6</sup>*</p>\r\n					<p class=\"section-note col-md-10\">*Более подробные сведения о&nbsp;препарате, особенностях применения, побочных действиях и&nbsp;др. &mdash;&nbsp;смотрите инструкцию по&nbsp;медицинскому применению лекарственного препарата Урорек, РУ&nbsp;ЛСР-005971/10 от&nbsp;25.06.2010 </p>'),
(336, 54, '_текст-3', 'field_62436f60e98e8'),
(337, 54, 'товар_0_название', 'Урорек 8мг №30'),
(338, 54, '_товар_0_название', 'field_62436fcce98ea'),
(339, 54, 'товар_0_описание', 'Упаковка, рассчитанная на&nbsp;1&nbsp;месяц лечения&nbsp;/ для старта терапии'),
(340, 54, '_товар_0_описание', 'field_62436fe1e98eb'),
(341, 54, 'товар_0_лицензия', 'РУ: ЛСР-005971/10 от 25.06.2010'),
(342, 54, '_товар_0_лицензия', 'field_62436ff0e98ec'),
(343, 54, 'товар_0_изображение', '51'),
(344, 54, '_товар_0_изображение', 'field_62437045e98ed'),
(345, 54, 'товар_1_название', 'Урорек 8мг №90'),
(346, 54, '_товар_1_название', 'field_62436fcce98ea'),
(347, 54, 'товар_1_описание', 'Выгодная упаковка, рассчитанная на&nbsp;3&nbsp;месяца лечения. Самая доступная стоимость 1&nbsp;дня терапии препаратом Урорек&nbsp;<sup>27</sup>'),
(348, 54, '_товар_1_описание', 'field_62436fe1e98eb'),
(349, 54, 'товар_1_лицензия', 'РУ: ЛСР-005971/10 от&nbsp;25.06.2010'),
(350, 54, '_товар_1_лицензия', 'field_62436ff0e98ec'),
(351, 54, 'товар_1_изображение', '53'),
(352, 54, '_товар_1_изображение', 'field_62437045e98ed'),
(353, 54, 'товар_2_название', 'Урорек 4мг №30'),
(354, 54, '_товар_2_название', 'field_62436fcce98ea'),
(355, 54, 'товар_2_описание', '4&nbsp;мг&nbsp;&mdash; стартовая упаковка для лечения симптомов ДГПЖ у&nbsp;пациентов с&nbsp;почечной недостаточностью средней степени тяжести<sup>6</sup>'),
(356, 54, '_товар_2_описание', 'field_62436fe1e98eb'),
(357, 54, 'товар_2_лицензия', 'РУ: ЛСР-005971/10 от&nbsp;25.06.2010'),
(358, 54, '_товар_2_лицензия', 'field_62436ff0e98ec'),
(359, 54, 'товар_2_изображение', '52'),
(360, 54, '_товар_2_изображение', 'field_62437045e98ed'),
(361, 54, 'товар', '3'),
(362, 54, '_товар', 'field_62436fbde98e9'),
(363, 55, 'заголовок-1', 'УРОРЕК – оригинальный<sup>10</sup> альфа-адреноблокатор'),
(364, 55, '_заголовок-1', 'field_62435bd26f29f'),
(365, 55, 'текст-1', '<div class=\"headerBlock__body\">\r\n<p>Силодозин (действующее вещество препарата Урорек) обладает максимальной уроселективностью в&nbsp;своем классе, что обеспечивает его уродинамическую эффективность и&nbsp;высокую безопасность<sup>4</sup></p>\r\n</div>\r\n<div class=\"headerBlock__footer\">\r\n<p><strong>Показания к применению: </strong><br/>Лечение симптомов доброкачественной гиперплазии предстательной железы<sup>6</sup></p>\r\n</div>'),
(366, 55, '_текст-1', 'field_62435c0c6f2a0'),
(367, 55, 'изображение-1', '13'),
(368, 55, '_изображение-1', 'field_62435c8b6f2a1'),
(369, 55, 'фон-1', '17'),
(370, 55, '_фон-1', 'field_62435db92ea96'),
(371, 55, 'заголовок-2', 'Ключевые преимущества препарата Урорек'),
(372, 55, '_заголовок-2', 'field_6243606295196'),
(373, 55, 'список-2', 'Единственный оригинальный препарат из&nbsp;группы альфа1-адреноблокаторов, не&nbsp;имеющий генериков в&nbsp;РФ<sup>1</sup>'),
(374, 55, '_список-2', 'field_6243608195197'),
(375, 55, 'картинка_с_текстом_0_изображение', '31'),
(376, 55, '_картинка_с_текстом_0_изображение', 'field_624363d095199'),
(377, 55, 'картинка_с_текстом_0_описание', 'Обширная доказательная база собственных пострегистрационных клинических исследований<sup>2</sup>'),
(378, 55, '_картинка_с_текстом_0_описание', 'field_624363e59519a'),
(379, 55, 'картинка_с_текстом_1_изображение', '32'),
(380, 55, '_картинка_с_текстом_1_изображение', 'field_624363d095199'),
(381, 55, 'картинка_с_текстом_1_описание', 'Отсутствие риска замены препарата Урорек в&nbsp;аптеке (единственный препарат с&nbsp;действующим веществом силодозин)<sup>1</sup>'),
(382, 55, '_картинка_с_текстом_1_описание', 'field_624363e59519a'),
(383, 55, 'картинка_с_текстом_2_изображение', '33'),
(384, 55, '_картинка_с_текстом_2_изображение', 'field_624363d095199'),
(385, 55, 'картинка_с_текстом_2_описание', 'Большинство пациентов предпочитают принимать оригинальные препараты<sup>3</sup>'),
(386, 55, '_картинка_с_текстом_2_описание', 'field_624363e59519a'),
(387, 55, 'картинка_с_текстом', '3'),
(388, 55, '_картинка_с_текстом', 'field_624363b995198'),
(389, 55, 'второй_список', '<li>Клинические преимущества препарата Урорек (силодозин) определяются максимальной уроселективностью в&nbsp;классе альфа-адреноблокаторов<sup>4</sup></li>\r\n\r\n<li>Урорек&nbsp;&mdash; альфа-адреноблокатор последнего поколения, который эффективен в&nbsp;отношении всех СНМП (накопления, опорожнения, постмиктурических).<sup>12,13</sup> При этом Урорек обладает минимальным риском развития нежелательных явлений со&nbsp;стороны сердечно-сосудистой системы, в&nbsp;том числе&nbsp;у&nbsp;пациентов, принимающих антигипертензивные препараты<sup>46,8</sup> <small> <span>СНМП </span>симптомы нижних мочевыводящих путей</small></li>'),
(390, 55, '_второй_список', 'field_6243640e05eda'),
(391, 55, 'заголовок2-2', 'Максимальная уроселективность силодозина в&nbsp;классе альфа-адреноблокаторов обуславливает его уродинамическую эффективность и&nbsp;высокий профиль безопасности<sup>4</sup>'),
(392, 55, '_заголовок2-2', 'field_6243644705edb'),
(393, 55, 'текст3', '<ul>\r\n<li>Урорек значительно улучшает клинические проявления и&nbsp;качество жизни у&nbsp;всех пациентов с&nbsp;СНМП/ДГПЖ, в&nbsp;том числе с&nbsp;тяжелым течением<sup>11</sup><a href=\"#\">Узнать больше...</a></li>\r\n\r\n<li>Урорек является препаратом выбора для пациентов с&nbsp;СНМП/ДГПЖ и&nbsp;сопутствующими сердечно-сосудистыми заболеваниями<sup>3</sup> <a href=\"#\">Узнать больше...</a></li>\r\n</ul>\r\n<small> <span>ДГПЖ </span>доброкачественная гиперплазия предстательной железы</small>'),
(394, 55, '_текст3', 'field_6243647405edc'),
(395, 55, 'изображение-2', '34'),
(396, 55, '_изображение-2', 'field_624364dd05edd'),
(397, 55, 'текст_в_подвале', '<h2> Максимальная уроселективность в&nbsp;классе  альфа-адреноблокаторов<sup>4</sup></h2>\r\n<div class=\"h3\"> Почему это важно? <a href=\"#\">Подробнее</a></div>'),
(398, 55, '_текст_в_подвале', 'field_62436daf1f6d9'),
(399, 55, 'заголовок-3', 'Форма выпуска препарата Урорек'),
(400, 55, '_заголовок-3', 'field_62436efee98e7'),
(401, 55, 'текст-3', '<p class=\"section-descr\"><span>8мг </span>- рекомендуемая доза для лечения симптомов ДГПЖ<sup>6</sup>*</p>\r\n					<p class=\"section-note col-md-10\">*Более подробные сведения о&nbsp;препарате, особенностях применения, побочных действиях и&nbsp;др. &mdash;&nbsp;смотрите инструкцию по&nbsp;медицинскому применению лекарственного препарата Урорек, РУ&nbsp;ЛСР-005971/10 от&nbsp;25.06.2010 </p>'),
(402, 55, '_текст-3', 'field_62436f60e98e8'),
(403, 55, 'товар_0_название', 'Урорек 8мг №30'),
(404, 55, '_товар_0_название', 'field_62436fcce98ea'),
(405, 55, 'товар_0_описание', 'Упаковка, рассчитанная на&nbsp;1&nbsp;месяц лечения&nbsp;/ для старта терапии'),
(406, 55, '_товар_0_описание', 'field_62436fe1e98eb'),
(407, 55, 'товар_0_лицензия', 'РУ: ЛСР-005971/10 от 25.06.2010'),
(408, 55, '_товар_0_лицензия', 'field_62436ff0e98ec'),
(409, 55, 'товар_0_изображение', '51'),
(410, 55, '_товар_0_изображение', 'field_62437045e98ed'),
(411, 55, 'товар_1_название', 'Урорек 8мг №90'),
(412, 55, '_товар_1_название', 'field_62436fcce98ea'),
(413, 55, 'товар_1_описание', 'Выгодная упаковка, рассчитанная на&nbsp;3&nbsp;месяца лечения. Самая доступная стоимость 1&nbsp;дня терапии препаратом Урорек&nbsp;<sup>27</sup>'),
(414, 55, '_товар_1_описание', 'field_62436fe1e98eb'),
(415, 55, 'товар_1_лицензия', 'РУ: ЛСР-005971/10 от&nbsp;25.06.2010'),
(416, 55, '_товар_1_лицензия', 'field_62436ff0e98ec'),
(417, 55, 'товар_1_изображение', '53'),
(418, 55, '_товар_1_изображение', 'field_62437045e98ed'),
(419, 55, 'товар_2_название', 'Урорек 4мг №30'),
(420, 55, '_товар_2_название', 'field_62436fcce98ea'),
(421, 55, 'товар_2_описание', '4&nbsp;мг&nbsp;&mdash; стартовая упаковка для лечения симптомов ДГПЖ у&nbsp;пациентов с&nbsp;почечной недостаточностью средней степени тяжести<sup>6</sup>'),
(422, 55, '_товар_2_описание', 'field_62436fe1e98eb'),
(423, 55, 'товар_2_лицензия', 'РУ: ЛСР-005971/10 от&nbsp;25.06.2010'),
(424, 55, '_товар_2_лицензия', 'field_62436ff0e98ec'),
(425, 55, 'товар_2_изображение', '52'),
(426, 55, '_товар_2_изображение', 'field_62437045e98ed'),
(427, 55, 'товар', '3'),
(428, 55, '_товар', 'field_62436fbde98e9'),
(429, 56, 'заголовок-1', 'УРОРЕК – оригинальный<sup>10</sup> альфа-адреноблокатор'),
(430, 56, '_заголовок-1', 'field_62435bd26f29f');
INSERT INTO `urotec_postmeta` (`meta_id`, `post_id`, `meta_key`, `meta_value`) VALUES
(431, 56, 'текст-1', '<div class=\"headerBlock__body\">\r\n<p>Силодозин (действующее вещество препарата Урорек) обладает максимальной уроселективностью в&nbsp;своем классе, что обеспечивает его уродинамическую эффективность и&nbsp;высокую безопасность<sup>4</sup></p>\r\n</div>\r\n<div class=\"headerBlock__footer\">\r\n<p><strong>Показания к применению: </strong><br/>Лечение симптомов доброкачественной гиперплазии предстательной железы<sup>6</sup></p>\r\n</div>'),
(432, 56, '_текст-1', 'field_62435c0c6f2a0'),
(433, 56, 'изображение-1', '13'),
(434, 56, '_изображение-1', 'field_62435c8b6f2a1'),
(435, 56, 'фон-1', '17'),
(436, 56, '_фон-1', 'field_62435db92ea96'),
(437, 56, 'заголовок-2', 'Ключевые преимущества препарата Урорек'),
(438, 56, '_заголовок-2', 'field_6243606295196'),
(439, 56, 'список-2', 'Единственный оригинальный препарат из&nbsp;группы альфа1-адреноблокаторов, не&nbsp;имеющий генериков в&nbsp;РФ<sup>1</sup>'),
(440, 56, '_список-2', 'field_6243608195197'),
(441, 56, 'картинка_с_текстом_0_изображение', '31'),
(442, 56, '_картинка_с_текстом_0_изображение', 'field_624363d095199'),
(443, 56, 'картинка_с_текстом_0_описание', 'Обширная доказательная база собственных пострегистрационных клинических исследований<sup>2</sup>'),
(444, 56, '_картинка_с_текстом_0_описание', 'field_624363e59519a'),
(445, 56, 'картинка_с_текстом_1_изображение', '32'),
(446, 56, '_картинка_с_текстом_1_изображение', 'field_624363d095199'),
(447, 56, 'картинка_с_текстом_1_описание', 'Отсутствие риска замены препарата Урорек в&nbsp;аптеке (единственный препарат с&nbsp;действующим веществом силодозин)<sup>1</sup>'),
(448, 56, '_картинка_с_текстом_1_описание', 'field_624363e59519a'),
(449, 56, 'картинка_с_текстом_2_изображение', '33'),
(450, 56, '_картинка_с_текстом_2_изображение', 'field_624363d095199'),
(451, 56, 'картинка_с_текстом_2_описание', 'Большинство пациентов предпочитают принимать оригинальные препараты<sup>3</sup>'),
(452, 56, '_картинка_с_текстом_2_описание', 'field_624363e59519a'),
(453, 56, 'картинка_с_текстом', '3'),
(454, 56, '_картинка_с_текстом', 'field_624363b995198'),
(455, 56, 'второй_список', '<li>Клинические преимущества препарата Урорек (силодозин) определяются максимальной уроселективностью в&nbsp;классе альфа-адреноблокаторов<sup>4</sup></li>\r\n\r\n<li>Урорек&nbsp;&mdash; альфа-адреноблокатор последнего поколения, который эффективен в&nbsp;отношении всех СНМП (накопления, опорожнения, постмиктурических).<sup>12,13</sup> При этом Урорек обладает минимальным риском развития нежелательных явлений со&nbsp;стороны сердечно-сосудистой системы, в&nbsp;том числе&nbsp;у&nbsp;пациентов, принимающих антигипертензивные препараты<sup>46,8</sup> <small> <span>СНМП </span>симптомы нижних мочевыводящих путей</small></li>'),
(456, 56, '_второй_список', 'field_6243640e05eda'),
(457, 56, 'заголовок2-2', 'Максимальная уроселективность силодозина в&nbsp;классе альфа-адреноблокаторов обуславливает его уродинамическую эффективность и&nbsp;высокий профиль безопасности<sup>4</sup>'),
(458, 56, '_заголовок2-2', 'field_6243644705edb'),
(459, 56, 'текст3', '<ul>\r\n<li>Урорек значительно улучшает клинические проявления и&nbsp;качество жизни у&nbsp;всех пациентов с&nbsp;СНМП/ДГПЖ, в&nbsp;том числе с&nbsp;тяжелым течением<sup>11</sup><a href=\"#\">Узнать больше...</a></li>\r\n\r\n<li>Урорек является препаратом выбора для пациентов с&nbsp;СНМП/ДГПЖ и&nbsp;сопутствующими сердечно-сосудистыми заболеваниями<sup>3</sup> <a href=\"#\">Узнать больше...</a></li>\r\n</ul>\r\n<small> <span>ДГПЖ </span>доброкачественная гиперплазия предстательной железы</small>'),
(460, 56, '_текст3', 'field_6243647405edc'),
(461, 56, 'изображение-2', '34'),
(462, 56, '_изображение-2', 'field_624364dd05edd'),
(463, 56, 'текст_в_подвале', '<h2> Максимальная уроселективность в&nbsp;классе  альфа-адреноблокаторов<sup>4</sup></h2>\r\n<div class=\"h3\"> Почему это важно? <a href=\"#\">Подробнее</a></div>'),
(464, 56, '_текст_в_подвале', 'field_62436daf1f6d9'),
(465, 56, 'заголовок-3', 'Форма выпуска препарата Урорек'),
(466, 56, '_заголовок-3', 'field_62436efee98e7'),
(467, 56, 'текст-3', '<p class=\"section-descr\"><span>8мг </span>- рекомендуемая доза для лечения симптомов ДГПЖ<sup>6</sup>*</p>\r\n					<p class=\"section-note col-md-10\">*Более подробные сведения о&nbsp;препарате, особенностях применения, побочных действиях и&nbsp;др. &mdash;&nbsp;смотрите инструкцию по&nbsp;медицинскому применению лекарственного препарата Урорек, РУ&nbsp;ЛСР-005971/10 от&nbsp;25.06.2010 </p>'),
(468, 56, '_текст-3', 'field_62436f60e98e8'),
(469, 56, 'товар_0_название', 'Урорек 8мг №30'),
(470, 56, '_товар_0_название', 'field_62436fcce98ea'),
(471, 56, 'товар_0_описание', 'Упаковка, рассчитанная на&nbsp;1&nbsp;месяц лечения&nbsp;/ для старта терапии'),
(472, 56, '_товар_0_описание', 'field_62436fe1e98eb'),
(473, 56, 'товар_0_лицензия', 'РУ: ЛСР-005971/10 от 25.06.2010'),
(474, 56, '_товар_0_лицензия', 'field_62436ff0e98ec'),
(475, 56, 'товар_0_изображение', '51'),
(476, 56, '_товар_0_изображение', 'field_62437045e98ed'),
(477, 56, 'товар_1_название', 'Урорек 8мг №90'),
(478, 56, '_товар_1_название', 'field_62436fcce98ea'),
(479, 56, 'товар_1_описание', 'Выгодная упаковка, рассчитанная на&nbsp;3&nbsp;месяца лечения. Самая доступная стоимость 1&nbsp;дня терапии препаратом Урорек&nbsp;<sup>27</sup>'),
(480, 56, '_товар_1_описание', 'field_62436fe1e98eb'),
(481, 56, 'товар_1_лицензия', 'РУ: ЛСР-005971/10 от&nbsp;25.06.2010'),
(482, 56, '_товар_1_лицензия', 'field_62436ff0e98ec'),
(483, 56, 'товар_1_изображение', '53'),
(484, 56, '_товар_1_изображение', 'field_62437045e98ed'),
(485, 56, 'товар_2_название', 'Урорек 4мг №30'),
(486, 56, '_товар_2_название', 'field_62436fcce98ea'),
(487, 56, 'товар_2_описание', '4&nbsp;мг&nbsp;&mdash; стартовая упаковка для лечения симптомов ДГПЖ у&nbsp;пациентов с&nbsp;почечной недостаточностью средней степени тяжести<sup>6</sup>'),
(488, 56, '_товар_2_описание', 'field_62436fe1e98eb'),
(489, 56, 'товар_2_лицензия', 'РУ: ЛСР-005971/10 от&nbsp;25.06.2010'),
(490, 56, '_товар_2_лицензия', 'field_62436ff0e98ec'),
(491, 56, 'товар_2_изображение', '52'),
(492, 56, '_товар_2_изображение', 'field_62437045e98ed'),
(493, 56, 'товар', '3'),
(494, 56, '_товар', 'field_62436fbde98e9'),
(495, 58, 'заголовок-1', 'УРОРЕК – оригинальный<sup>10</sup> альфа-адреноблокатор'),
(496, 58, '_заголовок-1', 'field_62435bd26f29f'),
(497, 58, 'текст-1', '<div class=\"headerBlock__body\">\r\n<p>Силодозин (действующее вещество препарата Урорек) обладает максимальной уроселективностью в&nbsp;своем классе, что обеспечивает его уродинамическую эффективность и&nbsp;высокую безопасность<sup>4</sup></p>\r\n</div>\r\n<div class=\"headerBlock__footer\">\r\n<p><strong>Показания к применению: </strong><br/>Лечение симптомов доброкачественной гиперплазии предстательной железы<sup>6</sup></p>\r\n</div>'),
(498, 58, '_текст-1', 'field_62435c0c6f2a0'),
(499, 58, 'изображение-1', '13'),
(500, 58, '_изображение-1', 'field_62435c8b6f2a1'),
(501, 58, 'фон-1', '17'),
(502, 58, '_фон-1', 'field_62435db92ea96'),
(503, 58, 'заголовок-2', 'Ключевые преимущества препарата Урорек'),
(504, 58, '_заголовок-2', 'field_6243606295196'),
(505, 58, 'список-2', 'Единственный оригинальный препарат из&nbsp;группы альфа1-адреноблокаторов, не&nbsp;имеющий генериков в&nbsp;РФ<sup>1</sup>'),
(506, 58, '_список-2', 'field_6243608195197'),
(507, 58, 'картинка_с_текстом_0_изображение', '31'),
(508, 58, '_картинка_с_текстом_0_изображение', 'field_624363d095199'),
(509, 58, 'картинка_с_текстом_0_описание', 'Обширная доказательная база собственных пострегистрационных клинических исследований<sup>2</sup>'),
(510, 58, '_картинка_с_текстом_0_описание', 'field_624363e59519a'),
(511, 58, 'картинка_с_текстом_1_изображение', '32'),
(512, 58, '_картинка_с_текстом_1_изображение', 'field_624363d095199'),
(513, 58, 'картинка_с_текстом_1_описание', 'Отсутствие риска замены препарата Урорек в&nbsp;аптеке (единственный препарат с&nbsp;действующим веществом силодозин)<sup>1</sup>'),
(514, 58, '_картинка_с_текстом_1_описание', 'field_624363e59519a'),
(515, 58, 'картинка_с_текстом_2_изображение', '33'),
(516, 58, '_картинка_с_текстом_2_изображение', 'field_624363d095199'),
(517, 58, 'картинка_с_текстом_2_описание', 'Большинство пациентов предпочитают принимать оригинальные препараты<sup>3</sup>'),
(518, 58, '_картинка_с_текстом_2_описание', 'field_624363e59519a'),
(519, 58, 'картинка_с_текстом', '3'),
(520, 58, '_картинка_с_текстом', 'field_624363b995198'),
(521, 58, 'второй_список', '<li>Клинические преимущества препарата Урорек (силодозин) определяются максимальной уроселективностью в&nbsp;классе альфа-адреноблокаторов<sup>4</sup></li>\r\n\r\n<li>Урорек&nbsp;&mdash; альфа-адреноблокатор последнего поколения, который эффективен в&nbsp;отношении всех СНМП (накопления, опорожнения, постмиктурических).<sup>12,13</sup> При этом Урорек обладает минимальным риском развития нежелательных явлений со&nbsp;стороны сердечно-сосудистой системы, в&nbsp;том числе&nbsp;у&nbsp;пациентов, принимающих антигипертензивные препараты<sup>46,8</sup> <small> <span>СНМП </span>симптомы нижних мочевыводящих путей</small></li>'),
(522, 58, '_второй_список', 'field_6243640e05eda'),
(523, 58, 'заголовок2-2', 'Максимальная уроселективность силодозина в&nbsp;классе альфа-адреноблокаторов обуславливает его уродинамическую эффективность и&nbsp;высокий профиль безопасности<sup>4</sup>'),
(524, 58, '_заголовок2-2', 'field_6243644705edb'),
(525, 58, 'текст3', '<ul>\r\n<li>Урорек значительно улучшает клинические проявления и&nbsp;качество жизни у&nbsp;всех пациентов с&nbsp;СНМП/ДГПЖ, в&nbsp;том числе с&nbsp;тяжелым течением<sup>11</sup><a href=\"#\">Узнать больше...</a></li>\r\n\r\n<li>Урорек является препаратом выбора для пациентов с&nbsp;СНМП/ДГПЖ и&nbsp;сопутствующими сердечно-сосудистыми заболеваниями<sup>3</sup> <a href=\"#\">Узнать больше...</a></li>\r\n</ul>\r\n<small> <span>ДГПЖ </span>доброкачественная гиперплазия предстательной железы</small>'),
(526, 58, '_текст3', 'field_6243647405edc'),
(527, 58, 'изображение-2', '34'),
(528, 58, '_изображение-2', 'field_624364dd05edd'),
(529, 58, 'текст_в_подвале', '<h2> Максимальная уроселективность в&nbsp;классе  альфа-адреноблокаторов<sup>4</sup></h2>\r\n<div class=\"h3\"> Почему это важно? <a href=\"#\">Подробнее</a></div>'),
(530, 58, '_текст_в_подвале', 'field_62436daf1f6d9'),
(531, 58, 'заголовок-3', 'Форма выпуска препарата Урорек'),
(532, 58, '_заголовок-3', 'field_62436efee98e7'),
(533, 58, 'текст-3', '<p class=\"section-descr\"><span>8мг </span>- рекомендуемая доза для лечения симптомов ДГПЖ<sup>6</sup>*</p>\r\n					<p class=\"section-note col-md-10\">*Более подробные сведения о&nbsp;препарате, особенностях применения, побочных действиях и&nbsp;др. &mdash;&nbsp;смотрите инструкцию по&nbsp;медицинскому применению лекарственного препарата Урорек, РУ&nbsp;ЛСР-005971/10 от&nbsp;25.06.2010 </p>'),
(534, 58, '_текст-3', 'field_62436f60e98e8'),
(535, 58, 'товар_0_название', 'Урорек 8мг №30'),
(536, 58, '_товар_0_название', 'field_62436fcce98ea'),
(537, 58, 'товар_0_описание', 'Упаковка, рассчитанная на&nbsp;1&nbsp;месяц лечения&nbsp;/ для старта терапии'),
(538, 58, '_товар_0_описание', 'field_62436fe1e98eb'),
(539, 58, 'товар_0_лицензия', 'РУ: ЛСР-005971/10 от 25.06.2010'),
(540, 58, '_товар_0_лицензия', 'field_62436ff0e98ec'),
(541, 58, 'товар_0_изображение', '51'),
(542, 58, '_товар_0_изображение', 'field_62437045e98ed'),
(543, 58, 'товар_1_название', 'Урорек 8мг №90'),
(544, 58, '_товар_1_название', 'field_62436fcce98ea'),
(545, 58, 'товар_1_описание', 'Выгодная упаковка, рассчитанная на&nbsp;3&nbsp;месяца лечения. Самая доступная стоимость 1&nbsp;дня терапии препаратом Урорек&nbsp;<sup>27</sup>'),
(546, 58, '_товар_1_описание', 'field_62436fe1e98eb'),
(547, 58, 'товар_1_лицензия', 'РУ: ЛСР-005971/10 от&nbsp;25.06.2010'),
(548, 58, '_товар_1_лицензия', 'field_62436ff0e98ec'),
(549, 58, 'товар_1_изображение', '53'),
(550, 58, '_товар_1_изображение', 'field_62437045e98ed'),
(551, 58, 'товар_2_название', 'Урорек 4мг №30'),
(552, 58, '_товар_2_название', 'field_62436fcce98ea'),
(553, 58, 'товар_2_описание', '4&nbsp;мг&nbsp;&mdash; стартовая упаковка для лечения симптомов ДГПЖ у&nbsp;пациентов с&nbsp;почечной недостаточностью средней степени тяжести<sup>6</sup>'),
(554, 58, '_товар_2_описание', 'field_62436fe1e98eb'),
(555, 58, 'товар_2_лицензия', 'РУ: ЛСР-005971/10 от&nbsp;25.06.2010'),
(556, 58, '_товар_2_лицензия', 'field_62436ff0e98ec'),
(557, 58, 'товар_2_изображение', '52'),
(558, 58, '_товар_2_изображение', 'field_62437045e98ed'),
(559, 58, 'товар', '3'),
(560, 58, '_товар', 'field_62436fbde98e9'),
(561, 59, '_edit_last', '1'),
(562, 59, '_edit_lock', '1648832275:1'),
(563, 63, '_wp_attached_file', '2022/03/tobuy-img-1.png'),
(564, 63, '_wp_attachment_metadata', 'a:5:{s:5:\"width\";i:171;s:6:\"height\";i:56;s:4:\"file\";s:23:\"2022/03/tobuy-img-1.png\";s:5:\"sizes\";a:1:{s:9:\"thumbnail\";a:4:{s:4:\"file\";s:22:\"tobuy-img-1-150x56.png\";s:5:\"width\";i:150;s:6:\"height\";i:56;s:9:\"mime-type\";s:9:\"image/png\";}}s:10:\"image_meta\";a:12:{s:8:\"aperture\";s:1:\"0\";s:6:\"credit\";s:0:\"\";s:6:\"camera\";s:0:\"\";s:7:\"caption\";s:0:\"\";s:17:\"created_timestamp\";s:1:\"0\";s:9:\"copyright\";s:0:\"\";s:12:\"focal_length\";s:1:\"0\";s:3:\"iso\";s:1:\"0\";s:13:\"shutter_speed\";s:1:\"0\";s:5:\"title\";s:0:\"\";s:11:\"orientation\";s:1:\"0\";s:8:\"keywords\";a:0:{}}}'),
(565, 64, '_wp_attached_file', '2022/03/tobuy-img-2.png'),
(566, 64, '_wp_attachment_metadata', 'a:5:{s:5:\"width\";i:76;s:6:\"height\";i:73;s:4:\"file\";s:23:\"2022/03/tobuy-img-2.png\";s:5:\"sizes\";a:0:{}s:10:\"image_meta\";a:12:{s:8:\"aperture\";s:1:\"0\";s:6:\"credit\";s:0:\"\";s:6:\"camera\";s:0:\"\";s:7:\"caption\";s:0:\"\";s:17:\"created_timestamp\";s:1:\"0\";s:9:\"copyright\";s:0:\"\";s:12:\"focal_length\";s:1:\"0\";s:3:\"iso\";s:1:\"0\";s:13:\"shutter_speed\";s:1:\"0\";s:5:\"title\";s:0:\"\";s:11:\"orientation\";s:1:\"0\";s:8:\"keywords\";a:0:{}}}'),
(567, 65, '_wp_attached_file', '2022/03/tobuy-img-3.png'),
(568, 65, '_wp_attachment_metadata', 'a:5:{s:5:\"width\";i:158;s:6:\"height\";i:26;s:4:\"file\";s:23:\"2022/03/tobuy-img-3.png\";s:5:\"sizes\";a:1:{s:9:\"thumbnail\";a:4:{s:4:\"file\";s:22:\"tobuy-img-3-150x26.png\";s:5:\"width\";i:150;s:6:\"height\";i:26;s:9:\"mime-type\";s:9:\"image/png\";}}s:10:\"image_meta\";a:12:{s:8:\"aperture\";s:1:\"0\";s:6:\"credit\";s:0:\"\";s:6:\"camera\";s:0:\"\";s:7:\"caption\";s:0:\"\";s:17:\"created_timestamp\";s:1:\"0\";s:9:\"copyright\";s:0:\"\";s:12:\"focal_length\";s:1:\"0\";s:3:\"iso\";s:1:\"0\";s:13:\"shutter_speed\";s:1:\"0\";s:5:\"title\";s:0:\"\";s:11:\"orientation\";s:1:\"0\";s:8:\"keywords\";a:0:{}}}'),
(569, 66, '_wp_attached_file', '2022/03/tobuy-img-4.png'),
(570, 66, '_wp_attachment_metadata', 'a:5:{s:5:\"width\";i:182;s:6:\"height\";i:56;s:4:\"file\";s:23:\"2022/03/tobuy-img-4.png\";s:5:\"sizes\";a:1:{s:9:\"thumbnail\";a:4:{s:4:\"file\";s:22:\"tobuy-img-4-150x56.png\";s:5:\"width\";i:150;s:6:\"height\";i:56;s:9:\"mime-type\";s:9:\"image/png\";}}s:10:\"image_meta\";a:12:{s:8:\"aperture\";s:1:\"0\";s:6:\"credit\";s:0:\"\";s:6:\"camera\";s:0:\"\";s:7:\"caption\";s:0:\"\";s:17:\"created_timestamp\";s:1:\"0\";s:9:\"copyright\";s:0:\"\";s:12:\"focal_length\";s:1:\"0\";s:3:\"iso\";s:1:\"0\";s:13:\"shutter_speed\";s:1:\"0\";s:5:\"title\";s:0:\"\";s:11:\"orientation\";s:1:\"0\";s:8:\"keywords\";a:0:{}}}'),
(571, 67, '_wp_attached_file', '2022/03/tobuy-img-5.png'),
(572, 67, '_wp_attachment_metadata', 'a:5:{s:5:\"width\";i:165;s:6:\"height\";i:74;s:4:\"file\";s:23:\"2022/03/tobuy-img-5.png\";s:5:\"sizes\";a:1:{s:9:\"thumbnail\";a:4:{s:4:\"file\";s:22:\"tobuy-img-5-150x74.png\";s:5:\"width\";i:150;s:6:\"height\";i:74;s:9:\"mime-type\";s:9:\"image/png\";}}s:10:\"image_meta\";a:12:{s:8:\"aperture\";s:1:\"0\";s:6:\"credit\";s:0:\"\";s:6:\"camera\";s:0:\"\";s:7:\"caption\";s:0:\"\";s:17:\"created_timestamp\";s:1:\"0\";s:9:\"copyright\";s:0:\"\";s:12:\"focal_length\";s:1:\"0\";s:3:\"iso\";s:1:\"0\";s:13:\"shutter_speed\";s:1:\"0\";s:5:\"title\";s:0:\"\";s:11:\"orientation\";s:1:\"0\";s:8:\"keywords\";a:0:{}}}'),
(573, 68, '_wp_attached_file', '2022/03/tobuy-img-6.png'),
(574, 68, '_wp_attachment_metadata', 'a:5:{s:5:\"width\";i:171;s:6:\"height\";i:49;s:4:\"file\";s:23:\"2022/03/tobuy-img-6.png\";s:5:\"sizes\";a:1:{s:9:\"thumbnail\";a:4:{s:4:\"file\";s:22:\"tobuy-img-6-150x49.png\";s:5:\"width\";i:150;s:6:\"height\";i:49;s:9:\"mime-type\";s:9:\"image/png\";}}s:10:\"image_meta\";a:12:{s:8:\"aperture\";s:1:\"0\";s:6:\"credit\";s:0:\"\";s:6:\"camera\";s:0:\"\";s:7:\"caption\";s:0:\"\";s:17:\"created_timestamp\";s:1:\"0\";s:9:\"copyright\";s:0:\"\";s:12:\"focal_length\";s:1:\"0\";s:3:\"iso\";s:1:\"0\";s:13:\"shutter_speed\";s:1:\"0\";s:5:\"title\";s:0:\"\";s:11:\"orientation\";s:1:\"0\";s:8:\"keywords\";a:0:{}}}'),
(575, 69, '_wp_attached_file', '2022/03/tobuy-img-7.png'),
(576, 69, '_wp_attachment_metadata', 'a:5:{s:5:\"width\";i:169;s:6:\"height\";i:46;s:4:\"file\";s:23:\"2022/03/tobuy-img-7.png\";s:5:\"sizes\";a:1:{s:9:\"thumbnail\";a:4:{s:4:\"file\";s:22:\"tobuy-img-7-150x46.png\";s:5:\"width\";i:150;s:6:\"height\";i:46;s:9:\"mime-type\";s:9:\"image/png\";}}s:10:\"image_meta\";a:12:{s:8:\"aperture\";s:1:\"0\";s:6:\"credit\";s:0:\"\";s:6:\"camera\";s:0:\"\";s:7:\"caption\";s:0:\"\";s:17:\"created_timestamp\";s:1:\"0\";s:9:\"copyright\";s:0:\"\";s:12:\"focal_length\";s:1:\"0\";s:3:\"iso\";s:1:\"0\";s:13:\"shutter_speed\";s:1:\"0\";s:5:\"title\";s:0:\"\";s:11:\"orientation\";s:1:\"0\";s:8:\"keywords\";a:0:{}}}'),
(577, 70, '_wp_attached_file', '2022/03/tobuy-img-8.png'),
(578, 70, '_wp_attachment_metadata', 'a:5:{s:5:\"width\";i:143;s:6:\"height\";i:60;s:4:\"file\";s:23:\"2022/03/tobuy-img-8.png\";s:5:\"sizes\";a:0:{}s:10:\"image_meta\";a:12:{s:8:\"aperture\";s:1:\"0\";s:6:\"credit\";s:0:\"\";s:6:\"camera\";s:0:\"\";s:7:\"caption\";s:0:\"\";s:17:\"created_timestamp\";s:1:\"0\";s:9:\"copyright\";s:0:\"\";s:12:\"focal_length\";s:1:\"0\";s:3:\"iso\";s:1:\"0\";s:13:\"shutter_speed\";s:1:\"0\";s:5:\"title\";s:0:\"\";s:11:\"orientation\";s:1:\"0\";s:8:\"keywords\";a:0:{}}}'),
(579, 71, '_wp_attached_file', '2022/03/tobuy-img-9.png'),
(580, 71, '_wp_attachment_metadata', 'a:5:{s:5:\"width\";i:143;s:6:\"height\";i:61;s:4:\"file\";s:23:\"2022/03/tobuy-img-9.png\";s:5:\"sizes\";a:0:{}s:10:\"image_meta\";a:12:{s:8:\"aperture\";s:1:\"0\";s:6:\"credit\";s:0:\"\";s:6:\"camera\";s:0:\"\";s:7:\"caption\";s:0:\"\";s:17:\"created_timestamp\";s:1:\"0\";s:9:\"copyright\";s:0:\"\";s:12:\"focal_length\";s:1:\"0\";s:3:\"iso\";s:1:\"0\";s:13:\"shutter_speed\";s:1:\"0\";s:5:\"title\";s:0:\"\";s:11:\"orientation\";s:1:\"0\";s:8:\"keywords\";a:0:{}}}'),
(581, 72, '_wp_attached_file', '2022/03/tobuy-img-10.png'),
(582, 72, '_wp_attachment_metadata', 'a:5:{s:5:\"width\";i:73;s:6:\"height\";i:74;s:4:\"file\";s:24:\"2022/03/tobuy-img-10.png\";s:5:\"sizes\";a:0:{}s:10:\"image_meta\";a:12:{s:8:\"aperture\";s:1:\"0\";s:6:\"credit\";s:0:\"\";s:6:\"camera\";s:0:\"\";s:7:\"caption\";s:0:\"\";s:17:\"created_timestamp\";s:1:\"0\";s:9:\"copyright\";s:0:\"\";s:12:\"focal_length\";s:1:\"0\";s:3:\"iso\";s:1:\"0\";s:13:\"shutter_speed\";s:1:\"0\";s:5:\"title\";s:0:\"\";s:11:\"orientation\";s:1:\"0\";s:8:\"keywords\";a:0:{}}}'),
(583, 73, '_wp_attached_file', '2022/03/tobuy-img-11.png'),
(584, 73, '_wp_attachment_metadata', 'a:5:{s:5:\"width\";i:153;s:6:\"height\";i:64;s:4:\"file\";s:24:\"2022/03/tobuy-img-11.png\";s:5:\"sizes\";a:1:{s:9:\"thumbnail\";a:4:{s:4:\"file\";s:23:\"tobuy-img-11-150x64.png\";s:5:\"width\";i:150;s:6:\"height\";i:64;s:9:\"mime-type\";s:9:\"image/png\";}}s:10:\"image_meta\";a:12:{s:8:\"aperture\";s:1:\"0\";s:6:\"credit\";s:0:\"\";s:6:\"camera\";s:0:\"\";s:7:\"caption\";s:0:\"\";s:17:\"created_timestamp\";s:1:\"0\";s:9:\"copyright\";s:0:\"\";s:12:\"focal_length\";s:1:\"0\";s:3:\"iso\";s:1:\"0\";s:13:\"shutter_speed\";s:1:\"0\";s:5:\"title\";s:0:\"\";s:11:\"orientation\";s:1:\"0\";s:8:\"keywords\";a:0:{}}}'),
(585, 74, '_wp_attached_file', '2022/03/tobuy-img-12.png'),
(586, 74, '_wp_attachment_metadata', 'a:5:{s:5:\"width\";i:132;s:6:\"height\";i:75;s:4:\"file\";s:24:\"2022/03/tobuy-img-12.png\";s:5:\"sizes\";a:0:{}s:10:\"image_meta\";a:12:{s:8:\"aperture\";s:1:\"0\";s:6:\"credit\";s:0:\"\";s:6:\"camera\";s:0:\"\";s:7:\"caption\";s:0:\"\";s:17:\"created_timestamp\";s:1:\"0\";s:9:\"copyright\";s:0:\"\";s:12:\"focal_length\";s:1:\"0\";s:3:\"iso\";s:1:\"0\";s:13:\"shutter_speed\";s:1:\"0\";s:5:\"title\";s:0:\"\";s:11:\"orientation\";s:1:\"0\";s:8:\"keywords\";a:0:{}}}'),
(587, 2, 'заголовок-4', 'Где купить'),
(588, 2, '_заголовок-4', 'field_624374f73d8bd'),
(589, 2, 'изображения', 'a:12:{i:0;s:2:\"63\";i:1;s:2:\"64\";i:2;s:2:\"65\";i:3;s:2:\"66\";i:4;s:2:\"67\";i:5;s:2:\"68\";i:6;s:2:\"69\";i:7;s:2:\"70\";i:8;s:2:\"71\";i:9;s:2:\"72\";i:10;s:2:\"73\";i:11;s:2:\"74\";}'),
(590, 2, '_изображения', 'field_624375093d8be'),
(591, 75, 'заголовок-1', 'УРОРЕК – оригинальный<sup>10</sup> альфа-адреноблокатор'),
(592, 75, '_заголовок-1', 'field_62435bd26f29f'),
(593, 75, 'текст-1', '<div class=\"headerBlock__body\">\r\n<p>Силодозин (действующее вещество препарата Урорек) обладает максимальной уроселективностью в&nbsp;своем классе, что обеспечивает его уродинамическую эффективность и&nbsp;высокую безопасность<sup>4</sup></p>\r\n</div>\r\n<div class=\"headerBlock__footer\">\r\n<p><strong>Показания к применению: </strong><br/>Лечение симптомов доброкачественной гиперплазии предстательной железы<sup>6</sup></p>\r\n</div>'),
(594, 75, '_текст-1', 'field_62435c0c6f2a0'),
(595, 75, 'изображение-1', '13'),
(596, 75, '_изображение-1', 'field_62435c8b6f2a1'),
(597, 75, 'фон-1', '17'),
(598, 75, '_фон-1', 'field_62435db92ea96'),
(599, 75, 'заголовок-2', 'Ключевые преимущества препарата Урорек'),
(600, 75, '_заголовок-2', 'field_6243606295196'),
(601, 75, 'список-2', 'Единственный оригинальный препарат из&nbsp;группы альфа1-адреноблокаторов, не&nbsp;имеющий генериков в&nbsp;РФ<sup>1</sup>'),
(602, 75, '_список-2', 'field_6243608195197'),
(603, 75, 'картинка_с_текстом_0_изображение', '31'),
(604, 75, '_картинка_с_текстом_0_изображение', 'field_624363d095199'),
(605, 75, 'картинка_с_текстом_0_описание', 'Обширная доказательная база собственных пострегистрационных клинических исследований<sup>2</sup>'),
(606, 75, '_картинка_с_текстом_0_описание', 'field_624363e59519a'),
(607, 75, 'картинка_с_текстом_1_изображение', '32'),
(608, 75, '_картинка_с_текстом_1_изображение', 'field_624363d095199'),
(609, 75, 'картинка_с_текстом_1_описание', 'Отсутствие риска замены препарата Урорек в&nbsp;аптеке (единственный препарат с&nbsp;действующим веществом силодозин)<sup>1</sup>'),
(610, 75, '_картинка_с_текстом_1_описание', 'field_624363e59519a'),
(611, 75, 'картинка_с_текстом_2_изображение', '33'),
(612, 75, '_картинка_с_текстом_2_изображение', 'field_624363d095199'),
(613, 75, 'картинка_с_текстом_2_описание', 'Большинство пациентов предпочитают принимать оригинальные препараты<sup>3</sup>'),
(614, 75, '_картинка_с_текстом_2_описание', 'field_624363e59519a'),
(615, 75, 'картинка_с_текстом', '3'),
(616, 75, '_картинка_с_текстом', 'field_624363b995198'),
(617, 75, 'второй_список', '<li>Клинические преимущества препарата Урорек (силодозин) определяются максимальной уроселективностью в&nbsp;классе альфа-адреноблокаторов<sup>4</sup></li>\r\n\r\n<li>Урорек&nbsp;&mdash; альфа-адреноблокатор последнего поколения, который эффективен в&nbsp;отношении всех СНМП (накопления, опорожнения, постмиктурических).<sup>12,13</sup> При этом Урорек обладает минимальным риском развития нежелательных явлений со&nbsp;стороны сердечно-сосудистой системы, в&nbsp;том числе&nbsp;у&nbsp;пациентов, принимающих антигипертензивные препараты<sup>46,8</sup> <small> <span>СНМП </span>симптомы нижних мочевыводящих путей</small></li>'),
(618, 75, '_второй_список', 'field_6243640e05eda'),
(619, 75, 'заголовок2-2', 'Максимальная уроселективность силодозина в&nbsp;классе альфа-адреноблокаторов обуславливает его уродинамическую эффективность и&nbsp;высокий профиль безопасности<sup>4</sup>'),
(620, 75, '_заголовок2-2', 'field_6243644705edb'),
(621, 75, 'текст3', '<ul>\r\n<li>Урорек значительно улучшает клинические проявления и&nbsp;качество жизни у&nbsp;всех пациентов с&nbsp;СНМП/ДГПЖ, в&nbsp;том числе с&nbsp;тяжелым течением<sup>11</sup><a href=\"#\">Узнать больше...</a></li>\r\n\r\n<li>Урорек является препаратом выбора для пациентов с&nbsp;СНМП/ДГПЖ и&nbsp;сопутствующими сердечно-сосудистыми заболеваниями<sup>3</sup> <a href=\"#\">Узнать больше...</a></li>\r\n</ul>\r\n<small> <span>ДГПЖ </span>доброкачественная гиперплазия предстательной железы</small>'),
(622, 75, '_текст3', 'field_6243647405edc'),
(623, 75, 'изображение-2', '34'),
(624, 75, '_изображение-2', 'field_624364dd05edd'),
(625, 75, 'текст_в_подвале', '<h2> Максимальная уроселективность в&nbsp;классе  альфа-адреноблокаторов<sup>4</sup></h2>\r\n<div class=\"h3\"> Почему это важно? <a href=\"#\">Подробнее</a></div>'),
(626, 75, '_текст_в_подвале', 'field_62436daf1f6d9'),
(627, 75, 'заголовок-3', 'Форма выпуска препарата Урорек'),
(628, 75, '_заголовок-3', 'field_62436efee98e7'),
(629, 75, 'текст-3', '<p class=\"section-descr\"><span>8мг </span>- рекомендуемая доза для лечения симптомов ДГПЖ<sup>6</sup>*</p>\r\n					<p class=\"section-note col-md-10\">*Более подробные сведения о&nbsp;препарате, особенностях применения, побочных действиях и&nbsp;др. &mdash;&nbsp;смотрите инструкцию по&nbsp;медицинскому применению лекарственного препарата Урорек, РУ&nbsp;ЛСР-005971/10 от&nbsp;25.06.2010 </p>'),
(630, 75, '_текст-3', 'field_62436f60e98e8'),
(631, 75, 'товар_0_название', 'Урорек 8мг №30'),
(632, 75, '_товар_0_название', 'field_62436fcce98ea'),
(633, 75, 'товар_0_описание', 'Упаковка, рассчитанная на&nbsp;1&nbsp;месяц лечения&nbsp;/ для старта терапии'),
(634, 75, '_товар_0_описание', 'field_62436fe1e98eb'),
(635, 75, 'товар_0_лицензия', 'РУ: ЛСР-005971/10 от 25.06.2010'),
(636, 75, '_товар_0_лицензия', 'field_62436ff0e98ec'),
(637, 75, 'товар_0_изображение', '51'),
(638, 75, '_товар_0_изображение', 'field_62437045e98ed'),
(639, 75, 'товар_1_название', 'Урорек 8мг №90'),
(640, 75, '_товар_1_название', 'field_62436fcce98ea'),
(641, 75, 'товар_1_описание', 'Выгодная упаковка, рассчитанная на&nbsp;3&nbsp;месяца лечения. Самая доступная стоимость 1&nbsp;дня терапии препаратом Урорек&nbsp;<sup>27</sup>'),
(642, 75, '_товар_1_описание', 'field_62436fe1e98eb'),
(643, 75, 'товар_1_лицензия', 'РУ: ЛСР-005971/10 от 25.06.2010'),
(644, 75, '_товар_1_лицензия', 'field_62436ff0e98ec'),
(645, 75, 'товар_1_изображение', '53'),
(646, 75, '_товар_1_изображение', 'field_62437045e98ed'),
(647, 75, 'товар_2_название', 'Урорек 4мг №30'),
(648, 75, '_товар_2_название', 'field_62436fcce98ea'),
(649, 75, 'товар_2_описание', '4&nbsp;мг&nbsp;&mdash; стартовая упаковка для лечения симптомов ДГПЖ у&nbsp;пациентов с&nbsp;почечной недостаточностью средней степени тяжести<sup>6</sup>'),
(650, 75, '_товар_2_описание', 'field_62436fe1e98eb'),
(651, 75, 'товар_2_лицензия', 'РУ: ЛСР-005971/10 от 25.06.2010'),
(652, 75, '_товар_2_лицензия', 'field_62436ff0e98ec'),
(653, 75, 'товар_2_изображение', '52'),
(654, 75, '_товар_2_изображение', 'field_62437045e98ed'),
(655, 75, 'товар', '3'),
(656, 75, '_товар', 'field_62436fbde98e9'),
(657, 75, 'заголовок-4', 'Где купить'),
(658, 75, '_заголовок-4', 'field_624374f73d8bd'),
(659, 75, 'изображения', 'a:12:{i:0;s:2:\"63\";i:1;s:2:\"64\";i:2;s:2:\"65\";i:3;s:2:\"66\";i:4;s:2:\"67\";i:5;s:2:\"68\";i:6;s:2:\"69\";i:7;s:2:\"70\";i:8;s:2:\"71\";i:9;s:2:\"72\";i:10;s:2:\"73\";i:11;s:2:\"74\";}'),
(660, 75, '_изображения', 'field_624375093d8be'),
(661, 2, 'изображения-4', 'a:12:{i:0;s:2:\"63\";i:1;s:2:\"64\";i:2;s:2:\"65\";i:3;s:2:\"66\";i:4;s:2:\"67\";i:5;s:2:\"68\";i:6;s:2:\"69\";i:7;s:2:\"70\";i:8;s:2:\"71\";i:9;s:2:\"72\";i:10;s:2:\"73\";i:11;s:2:\"74\";}'),
(662, 2, '_изображения-4', 'field_624375093d8be'),
(663, 76, 'заголовок-1', 'УРОРЕК – оригинальный<sup>10</sup> альфа-адреноблокатор'),
(664, 76, '_заголовок-1', 'field_62435bd26f29f'),
(665, 76, 'текст-1', '<div class=\"headerBlock__body\">\r\n<p>Силодозин (действующее вещество препарата Урорек) обладает максимальной уроселективностью в&nbsp;своем классе, что обеспечивает его уродинамическую эффективность и&nbsp;высокую безопасность<sup>4</sup></p>\r\n</div>\r\n<div class=\"headerBlock__footer\">\r\n<p><strong>Показания к применению: </strong><br/>Лечение симптомов доброкачественной гиперплазии предстательной железы<sup>6</sup></p>\r\n</div>'),
(666, 76, '_текст-1', 'field_62435c0c6f2a0'),
(667, 76, 'изображение-1', '13'),
(668, 76, '_изображение-1', 'field_62435c8b6f2a1'),
(669, 76, 'фон-1', '17'),
(670, 76, '_фон-1', 'field_62435db92ea96'),
(671, 76, 'заголовок-2', 'Ключевые преимущества препарата Урорек'),
(672, 76, '_заголовок-2', 'field_6243606295196'),
(673, 76, 'список-2', 'Единственный оригинальный препарат из&nbsp;группы альфа1-адреноблокаторов, не&nbsp;имеющий генериков в&nbsp;РФ<sup>1</sup>'),
(674, 76, '_список-2', 'field_6243608195197'),
(675, 76, 'картинка_с_текстом_0_изображение', '31'),
(676, 76, '_картинка_с_текстом_0_изображение', 'field_624363d095199'),
(677, 76, 'картинка_с_текстом_0_описание', 'Обширная доказательная база собственных пострегистрационных клинических исследований<sup>2</sup>'),
(678, 76, '_картинка_с_текстом_0_описание', 'field_624363e59519a'),
(679, 76, 'картинка_с_текстом_1_изображение', '32'),
(680, 76, '_картинка_с_текстом_1_изображение', 'field_624363d095199'),
(681, 76, 'картинка_с_текстом_1_описание', 'Отсутствие риска замены препарата Урорек в&nbsp;аптеке (единственный препарат с&nbsp;действующим веществом силодозин)<sup>1</sup>'),
(682, 76, '_картинка_с_текстом_1_описание', 'field_624363e59519a'),
(683, 76, 'картинка_с_текстом_2_изображение', '33'),
(684, 76, '_картинка_с_текстом_2_изображение', 'field_624363d095199'),
(685, 76, 'картинка_с_текстом_2_описание', 'Большинство пациентов предпочитают принимать оригинальные препараты<sup>3</sup>'),
(686, 76, '_картинка_с_текстом_2_описание', 'field_624363e59519a'),
(687, 76, 'картинка_с_текстом', '3'),
(688, 76, '_картинка_с_текстом', 'field_624363b995198'),
(689, 76, 'второй_список', '<li>Клинические преимущества препарата Урорек (силодозин) определяются максимальной уроселективностью в&nbsp;классе альфа-адреноблокаторов<sup>4</sup></li>\r\n\r\n<li>Урорек&nbsp;&mdash; альфа-адреноблокатор последнего поколения, который эффективен в&nbsp;отношении всех СНМП (накопления, опорожнения, постмиктурических).<sup>12,13</sup> При этом Урорек обладает минимальным риском развития нежелательных явлений со&nbsp;стороны сердечно-сосудистой системы, в&nbsp;том числе&nbsp;у&nbsp;пациентов, принимающих антигипертензивные препараты<sup>46,8</sup> <small> <span>СНМП </span>симптомы нижних мочевыводящих путей</small></li>'),
(690, 76, '_второй_список', 'field_6243640e05eda'),
(691, 76, 'заголовок2-2', 'Максимальная уроселективность силодозина в&nbsp;классе альфа-адреноблокаторов обуславливает его уродинамическую эффективность и&nbsp;высокий профиль безопасности<sup>4</sup>'),
(692, 76, '_заголовок2-2', 'field_6243644705edb'),
(693, 76, 'текст3', '<ul>\r\n<li>Урорек значительно улучшает клинические проявления и&nbsp;качество жизни у&nbsp;всех пациентов с&nbsp;СНМП/ДГПЖ, в&nbsp;том числе с&nbsp;тяжелым течением<sup>11</sup><a href=\"#\">Узнать больше...</a></li>\r\n\r\n<li>Урорек является препаратом выбора для пациентов с&nbsp;СНМП/ДГПЖ и&nbsp;сопутствующими сердечно-сосудистыми заболеваниями<sup>3</sup> <a href=\"#\">Узнать больше...</a></li>\r\n</ul>\r\n<small> <span>ДГПЖ </span>доброкачественная гиперплазия предстательной железы</small>'),
(694, 76, '_текст3', 'field_6243647405edc'),
(695, 76, 'изображение-2', '34'),
(696, 76, '_изображение-2', 'field_624364dd05edd'),
(697, 76, 'текст_в_подвале', '<h2> Максимальная уроселективность в&nbsp;классе  альфа-адреноблокаторов<sup>4</sup></h2>\r\n<div class=\"h3\"> Почему это важно? <a href=\"#\">Подробнее</a></div>'),
(698, 76, '_текст_в_подвале', 'field_62436daf1f6d9'),
(699, 76, 'заголовок-3', 'Форма выпуска препарата Урорек'),
(700, 76, '_заголовок-3', 'field_62436efee98e7'),
(701, 76, 'текст-3', '<p class=\"section-descr\"><span>8мг </span>- рекомендуемая доза для лечения симптомов ДГПЖ<sup>6</sup>*</p>\r\n					<p class=\"section-note col-md-10\">*Более подробные сведения о&nbsp;препарате, особенностях применения, побочных действиях и&nbsp;др. &mdash;&nbsp;смотрите инструкцию по&nbsp;медицинскому применению лекарственного препарата Урорек, РУ&nbsp;ЛСР-005971/10 от&nbsp;25.06.2010 </p>'),
(702, 76, '_текст-3', 'field_62436f60e98e8'),
(703, 76, 'товар_0_название', 'Урорек 8мг №30'),
(704, 76, '_товар_0_название', 'field_62436fcce98ea'),
(705, 76, 'товар_0_описание', 'Упаковка, рассчитанная на&nbsp;1&nbsp;месяц лечения&nbsp;/ для старта терапии'),
(706, 76, '_товар_0_описание', 'field_62436fe1e98eb'),
(707, 76, 'товар_0_лицензия', 'РУ: ЛСР-005971/10 от 25.06.2010'),
(708, 76, '_товар_0_лицензия', 'field_62436ff0e98ec'),
(709, 76, 'товар_0_изображение', '51'),
(710, 76, '_товар_0_изображение', 'field_62437045e98ed'),
(711, 76, 'товар_1_название', 'Урорек 8мг №90'),
(712, 76, '_товар_1_название', 'field_62436fcce98ea'),
(713, 76, 'товар_1_описание', 'Выгодная упаковка, рассчитанная на&nbsp;3&nbsp;месяца лечения. Самая доступная стоимость 1&nbsp;дня терапии препаратом Урорек&nbsp;<sup>27</sup>'),
(714, 76, '_товар_1_описание', 'field_62436fe1e98eb'),
(715, 76, 'товар_1_лицензия', 'РУ: ЛСР-005971/10 от 25.06.2010'),
(716, 76, '_товар_1_лицензия', 'field_62436ff0e98ec'),
(717, 76, 'товар_1_изображение', '53'),
(718, 76, '_товар_1_изображение', 'field_62437045e98ed'),
(719, 76, 'товар_2_название', 'Урорек 4мг №30'),
(720, 76, '_товар_2_название', 'field_62436fcce98ea'),
(721, 76, 'товар_2_описание', '4&nbsp;мг&nbsp;&mdash; стартовая упаковка для лечения симптомов ДГПЖ у&nbsp;пациентов с&nbsp;почечной недостаточностью средней степени тяжести<sup>6</sup>'),
(722, 76, '_товар_2_описание', 'field_62436fe1e98eb'),
(723, 76, 'товар_2_лицензия', 'РУ: ЛСР-005971/10 от 25.06.2010'),
(724, 76, '_товар_2_лицензия', 'field_62436ff0e98ec'),
(725, 76, 'товар_2_изображение', '52'),
(726, 76, '_товар_2_изображение', 'field_62437045e98ed'),
(727, 76, 'товар', '3'),
(728, 76, '_товар', 'field_62436fbde98e9'),
(729, 76, 'заголовок-4', 'Где купить'),
(730, 76, '_заголовок-4', 'field_624374f73d8bd'),
(731, 76, 'изображения', 'a:12:{i:0;s:2:\"63\";i:1;s:2:\"64\";i:2;s:2:\"65\";i:3;s:2:\"66\";i:4;s:2:\"67\";i:5;s:2:\"68\";i:6;s:2:\"69\";i:7;s:2:\"70\";i:8;s:2:\"71\";i:9;s:2:\"72\";i:10;s:2:\"73\";i:11;s:2:\"74\";}'),
(732, 76, '_изображения', 'field_624375093d8be'),
(733, 76, 'изображения-4', 'a:12:{i:0;s:2:\"63\";i:1;s:2:\"64\";i:2;s:2:\"65\";i:3;s:2:\"66\";i:4;s:2:\"67\";i:5;s:2:\"68\";i:6;s:2:\"69\";i:7;s:2:\"70\";i:8;s:2:\"71\";i:9;s:2:\"72\";i:10;s:2:\"73\";i:11;s:2:\"74\";}'),
(734, 76, '_изображения-4', 'field_624375093d8be'),
(735, 77, 'заголовок-1', 'УРОРЕК – оригинальный<sup>10</sup> альфа-адреноблокатор'),
(736, 77, '_заголовок-1', 'field_62435bd26f29f'),
(737, 77, 'текст-1', '<div class=\"headerBlock__body\">\r\n<p>Силодозин (действующее вещество препарата Урорек) обладает максимальной уроселективностью в&nbsp;своем классе, что обеспечивает его уродинамическую эффективность и&nbsp;высокую безопасность<sup>4</sup></p>\r\n</div>\r\n<div class=\"headerBlock__footer\">\r\n<p><strong>Показания к применению: </strong><br/>Лечение симптомов доброкачественной гиперплазии предстательной железы<sup>6</sup></p>\r\n</div>'),
(738, 77, '_текст-1', 'field_62435c0c6f2a0'),
(739, 77, 'изображение-1', '13'),
(740, 77, '_изображение-1', 'field_62435c8b6f2a1'),
(741, 77, 'фон-1', '17'),
(742, 77, '_фон-1', 'field_62435db92ea96'),
(743, 77, 'заголовок-2', 'Ключевые преимущества препарата Урорек'),
(744, 77, '_заголовок-2', 'field_6243606295196'),
(745, 77, 'список-2', 'Единственный оригинальный препарат из&nbsp;группы альфа1-адреноблокаторов, не&nbsp;имеющий генериков в&nbsp;РФ<sup>1</sup>'),
(746, 77, '_список-2', 'field_6243608195197'),
(747, 77, 'картинка_с_текстом_0_изображение', '31'),
(748, 77, '_картинка_с_текстом_0_изображение', 'field_624363d095199'),
(749, 77, 'картинка_с_текстом_0_описание', 'Обширная доказательная база собственных пострегистрационных клинических исследований<sup>2</sup>'),
(750, 77, '_картинка_с_текстом_0_описание', 'field_624363e59519a'),
(751, 77, 'картинка_с_текстом_1_изображение', '32'),
(752, 77, '_картинка_с_текстом_1_изображение', 'field_624363d095199'),
(753, 77, 'картинка_с_текстом_1_описание', 'Отсутствие риска замены препарата Урорек в&nbsp;аптеке (единственный препарат с&nbsp;действующим веществом силодозин)<sup>1</sup>'),
(754, 77, '_картинка_с_текстом_1_описание', 'field_624363e59519a'),
(755, 77, 'картинка_с_текстом_2_изображение', '33'),
(756, 77, '_картинка_с_текстом_2_изображение', 'field_624363d095199'),
(757, 77, 'картинка_с_текстом_2_описание', 'Большинство пациентов предпочитают принимать оригинальные препараты<sup>3</sup>'),
(758, 77, '_картинка_с_текстом_2_описание', 'field_624363e59519a'),
(759, 77, 'картинка_с_текстом', '3'),
(760, 77, '_картинка_с_текстом', 'field_624363b995198'),
(761, 77, 'второй_список', '<li>Клинические преимущества препарата Урорек (силодозин) определяются максимальной уроселективностью в&nbsp;классе альфа-адреноблокаторов<sup>4</sup></li>\r\n\r\n<li>Урорек&nbsp;&mdash; альфа-адреноблокатор последнего поколения, который эффективен в&nbsp;отношении всех СНМП (накопления, опорожнения, постмиктурических).<sup>12,13</sup> При этом Урорек обладает минимальным риском развития нежелательных явлений со&nbsp;стороны сердечно-сосудистой системы, в&nbsp;том числе&nbsp;у&nbsp;пациентов, принимающих антигипертензивные препараты<sup>46,8</sup> <small> <span>СНМП </span>симптомы нижних мочевыводящих путей</small></li>'),
(762, 77, '_второй_список', 'field_6243640e05eda'),
(763, 77, 'заголовок2-2', 'Максимальная уроселективность силодозина в&nbsp;классе альфа-адреноблокаторов обуславливает его уродинамическую эффективность и&nbsp;высокий профиль безопасности<sup>4</sup>'),
(764, 77, '_заголовок2-2', 'field_6243644705edb'),
(765, 77, 'текст3', '<ul>\r\n<li>Урорек значительно улучшает клинические проявления и&nbsp;качество жизни у&nbsp;всех пациентов с&nbsp;СНМП/ДГПЖ, в&nbsp;том числе с&nbsp;тяжелым течением<sup>11</sup><a href=\"#\">Узнать больше...</a></li>\r\n\r\n<li>Урорек является препаратом выбора для пациентов с&nbsp;СНМП/ДГПЖ и&nbsp;сопутствующими сердечно-сосудистыми заболеваниями<sup>3</sup> <a href=\"#\">Узнать больше...</a></li>\r\n</ul>\r\n<small> <span>ДГПЖ </span>доброкачественная гиперплазия предстательной железы</small>'),
(766, 77, '_текст3', 'field_6243647405edc'),
(767, 77, 'изображение-2', '34'),
(768, 77, '_изображение-2', 'field_624364dd05edd'),
(769, 77, 'текст_в_подвале', '<h2> Максимальная уроселективность в&nbsp;классе  альфа-адреноблокаторов<sup>4</sup></h2>\r\n<div class=\"h3\"> Почему это важно? <a href=\"#\">Подробнее</a></div>'),
(770, 77, '_текст_в_подвале', 'field_62436daf1f6d9'),
(771, 77, 'заголовок-3', 'Форма выпуска препарата Урорек'),
(772, 77, '_заголовок-3', 'field_62436efee98e7'),
(773, 77, 'текст-3', '<p class=\"section-descr\"><span>8мг </span>- рекомендуемая доза для лечения симптомов ДГПЖ<sup>6</sup>*</p>\r\n					<p class=\"section-note col-md-10\">*Более подробные сведения о&nbsp;препарате, особенностях применения, побочных действиях и&nbsp;др. &mdash;&nbsp;смотрите инструкцию по&nbsp;медицинскому применению лекарственного препарата Урорек, РУ&nbsp;ЛСР-005971/10 от&nbsp;25.06.2010 </p>'),
(774, 77, '_текст-3', 'field_62436f60e98e8'),
(775, 77, 'товар_0_название', 'Урорек 8мг №30'),
(776, 77, '_товар_0_название', 'field_62436fcce98ea'),
(777, 77, 'товар_0_описание', 'Упаковка, рассчитанная на&nbsp;1&nbsp;месяц лечения&nbsp;/ для старта терапии'),
(778, 77, '_товар_0_описание', 'field_62436fe1e98eb'),
(779, 77, 'товар_0_лицензия', 'РУ: ЛСР-005971/10 от 25.06.2010'),
(780, 77, '_товар_0_лицензия', 'field_62436ff0e98ec'),
(781, 77, 'товар_0_изображение', '51'),
(782, 77, '_товар_0_изображение', 'field_62437045e98ed'),
(783, 77, 'товар_1_название', 'Урорек 8мг №90'),
(784, 77, '_товар_1_название', 'field_62436fcce98ea'),
(785, 77, 'товар_1_описание', 'Выгодная упаковка, рассчитанная на&nbsp;3&nbsp;месяца лечения. Самая доступная стоимость 1&nbsp;дня терапии препаратом Урорек&nbsp;<sup>27</sup>'),
(786, 77, '_товар_1_описание', 'field_62436fe1e98eb'),
(787, 77, 'товар_1_лицензия', 'РУ: ЛСР-005971/10 от 25.06.2010'),
(788, 77, '_товар_1_лицензия', 'field_62436ff0e98ec'),
(789, 77, 'товар_1_изображение', '53'),
(790, 77, '_товар_1_изображение', 'field_62437045e98ed'),
(791, 77, 'товар_2_название', 'Урорек 4мг №30'),
(792, 77, '_товар_2_название', 'field_62436fcce98ea'),
(793, 77, 'товар_2_описание', '4&nbsp;мг&nbsp;&mdash; стартовая упаковка для лечения симптомов ДГПЖ у&nbsp;пациентов с&nbsp;почечной недостаточностью средней степени тяжести<sup>6</sup>'),
(794, 77, '_товар_2_описание', 'field_62436fe1e98eb'),
(795, 77, 'товар_2_лицензия', 'РУ: ЛСР-005971/10 от 25.06.2010'),
(796, 77, '_товар_2_лицензия', 'field_62436ff0e98ec'),
(797, 77, 'товар_2_изображение', '52'),
(798, 77, '_товар_2_изображение', 'field_62437045e98ed'),
(799, 77, 'товар', '3'),
(800, 77, '_товар', 'field_62436fbde98e9'),
(801, 77, 'заголовок-4', 'Где купить'),
(802, 77, '_заголовок-4', 'field_624374f73d8bd'),
(803, 77, 'изображения', 'a:12:{i:0;s:2:\"63\";i:1;s:2:\"64\";i:2;s:2:\"65\";i:3;s:2:\"66\";i:4;s:2:\"67\";i:5;s:2:\"68\";i:6;s:2:\"69\";i:7;s:2:\"70\";i:8;s:2:\"71\";i:9;s:2:\"72\";i:10;s:2:\"73\";i:11;s:2:\"74\";}'),
(804, 77, '_изображения', 'field_624375093d8be'),
(805, 77, 'изображения-4', 'a:12:{i:0;s:2:\"63\";i:1;s:2:\"64\";i:2;s:2:\"65\";i:3;s:2:\"66\";i:4;s:2:\"67\";i:5;s:2:\"68\";i:6;s:2:\"69\";i:7;s:2:\"70\";i:8;s:2:\"71\";i:9;s:2:\"72\";i:10;s:2:\"73\";i:11;s:2:\"74\";}'),
(806, 77, '_изображения-4', 'field_624375093d8be'),
(807, 78, '_edit_last', '1'),
(808, 78, '_edit_lock', '1648627945:1'),
(809, 83, '_wp_attached_file', '2022/03/method-i-1.svg'),
(810, 83, '_wp_attachment_metadata', 'a:2:{s:5:\"width\";d:41;s:6:\"height\";d:40;}'),
(811, 84, '_wp_attached_file', '2022/03/method-i-2.svg'),
(812, 84, '_wp_attachment_metadata', 'a:2:{s:5:\"width\";d:41;s:6:\"height\";d:40;}'),
(813, 85, '_wp_attached_file', '2022/03/method-i-3.svg'),
(814, 85, '_wp_attachment_metadata', 'a:2:{s:5:\"width\";d:40;s:6:\"height\";d:40;}'),
(815, 86, '_wp_attached_file', '2022/03/method-i-4.svg'),
(816, 86, '_wp_attachment_metadata', 'a:2:{s:5:\"width\";d:41;s:6:\"height\";d:40;}'),
(817, 87, '_wp_attached_file', '2022/03/method-i-5.svg'),
(818, 87, '_wp_attachment_metadata', 'a:2:{s:5:\"width\";d:41;s:6:\"height\";d:40;}'),
(819, 2, 'заголовок-5', 'Способ применения*<sup>6</sup>'),
(820, 2, '_заголовок-5', 'field_624379bd4756d'),
(821, 2, 'иконки', 'a:5:{i:0;s:2:\"83\";i:1;s:2:\"84\";i:2;s:2:\"85\";i:3;s:2:\"86\";i:4;s:2:\"87\";}'),
(822, 2, '_иконки', 'field_624379f24756e'),
(823, 2, 'текст-5', 'У пациентов с легкой почечной недостаточностью (клиренс креатинина ≥ 50 — ≤ 80 мл/мин) коррекция дозы не требуется. Для лечения пациентов с почечной недостаточностью средней степени тяжести (клиренс креатинина ≥ 30 — < 50 мл/мин) рекомендуется в течение первой недели принимать начальную дозу по 4 мг в сутки, при хорошей индивидуальной переносимости доза может быть увеличена до 8 мг в сутки. Применение препарата для пациентов с тяжелой почечной недостаточностью (клиренс креатинина < 30 мл / мин) не рекомендуется'),
(824, 2, '_текст-5', 'field_62437a374756f'),
(825, 2, 'текст_под_кнопкой', '*Более подробные сведения о&nbsp;препарате, особенностях применения, побочных действиях и&nbsp;др. &mdash;&nbsp;см. инструкцию по&nbsp;медицинскому применению лекарственного препарата Урорек, РУ&nbsp;ЛСР-005971/10 от&nbsp;25.06.2010'),
(826, 2, '_текст_под_кнопкой', 'field_62437a7c47570'),
(827, 88, 'заголовок-1', 'УРОРЕК – оригинальный<sup>10</sup> альфа-адреноблокатор'),
(828, 88, '_заголовок-1', 'field_62435bd26f29f'),
(829, 88, 'текст-1', '<div class=\"headerBlock__body\">\r\n<p>Силодозин (действующее вещество препарата Урорек) обладает максимальной уроселективностью в&nbsp;своем классе, что обеспечивает его уродинамическую эффективность и&nbsp;высокую безопасность<sup>4</sup></p>\r\n</div>\r\n<div class=\"headerBlock__footer\">\r\n<p><strong>Показания к применению: </strong><br/>Лечение симптомов доброкачественной гиперплазии предстательной железы<sup>6</sup></p>\r\n</div>'),
(830, 88, '_текст-1', 'field_62435c0c6f2a0'),
(831, 88, 'изображение-1', '13'),
(832, 88, '_изображение-1', 'field_62435c8b6f2a1'),
(833, 88, 'фон-1', '17'),
(834, 88, '_фон-1', 'field_62435db92ea96'),
(835, 88, 'заголовок-2', 'Ключевые преимущества препарата Урорек'),
(836, 88, '_заголовок-2', 'field_6243606295196'),
(837, 88, 'список-2', 'Единственный оригинальный препарат из&nbsp;группы альфа1-адреноблокаторов, не&nbsp;имеющий генериков в&nbsp;РФ<sup>1</sup>'),
(838, 88, '_список-2', 'field_6243608195197'),
(839, 88, 'картинка_с_текстом_0_изображение', '31'),
(840, 88, '_картинка_с_текстом_0_изображение', 'field_624363d095199'),
(841, 88, 'картинка_с_текстом_0_описание', 'Обширная доказательная база собственных пострегистрационных клинических исследований<sup>2</sup>'),
(842, 88, '_картинка_с_текстом_0_описание', 'field_624363e59519a'),
(843, 88, 'картинка_с_текстом_1_изображение', '32'),
(844, 88, '_картинка_с_текстом_1_изображение', 'field_624363d095199'),
(845, 88, 'картинка_с_текстом_1_описание', 'Отсутствие риска замены препарата Урорек в&nbsp;аптеке (единственный препарат с&nbsp;действующим веществом силодозин)<sup>1</sup>'),
(846, 88, '_картинка_с_текстом_1_описание', 'field_624363e59519a'),
(847, 88, 'картинка_с_текстом_2_изображение', '33'),
(848, 88, '_картинка_с_текстом_2_изображение', 'field_624363d095199'),
(849, 88, 'картинка_с_текстом_2_описание', 'Большинство пациентов предпочитают принимать оригинальные препараты<sup>3</sup>'),
(850, 88, '_картинка_с_текстом_2_описание', 'field_624363e59519a'),
(851, 88, 'картинка_с_текстом', '3'),
(852, 88, '_картинка_с_текстом', 'field_624363b995198'),
(853, 88, 'второй_список', '<li>Клинические преимущества препарата Урорек (силодозин) определяются максимальной уроселективностью в&nbsp;классе альфа-адреноблокаторов<sup>4</sup></li>\r\n\r\n<li>Урорек&nbsp;&mdash; альфа-адреноблокатор последнего поколения, который эффективен в&nbsp;отношении всех СНМП (накопления, опорожнения, постмиктурических).<sup>12,13</sup> При этом Урорек обладает минимальным риском развития нежелательных явлений со&nbsp;стороны сердечно-сосудистой системы, в&nbsp;том числе&nbsp;у&nbsp;пациентов, принимающих антигипертензивные препараты<sup>46,8</sup> <small> <span>СНМП </span>симптомы нижних мочевыводящих путей</small></li>'),
(854, 88, '_второй_список', 'field_6243640e05eda'),
(855, 88, 'заголовок2-2', 'Максимальная уроселективность силодозина в&nbsp;классе альфа-адреноблокаторов обуславливает его уродинамическую эффективность и&nbsp;высокий профиль безопасности<sup>4</sup>'),
(856, 88, '_заголовок2-2', 'field_6243644705edb'),
(857, 88, 'текст3', '<ul>\r\n<li>Урорек значительно улучшает клинические проявления и&nbsp;качество жизни у&nbsp;всех пациентов с&nbsp;СНМП/ДГПЖ, в&nbsp;том числе с&nbsp;тяжелым течением<sup>11</sup><a href=\"#\">Узнать больше...</a></li>\r\n\r\n<li>Урорек является препаратом выбора для пациентов с&nbsp;СНМП/ДГПЖ и&nbsp;сопутствующими сердечно-сосудистыми заболеваниями<sup>3</sup> <a href=\"#\">Узнать больше...</a></li>\r\n</ul>\r\n<small> <span>ДГПЖ </span>доброкачественная гиперплазия предстательной железы</small>'),
(858, 88, '_текст3', 'field_6243647405edc'),
(859, 88, 'изображение-2', '34'),
(860, 88, '_изображение-2', 'field_624364dd05edd'),
(861, 88, 'текст_в_подвале', '<h2> Максимальная уроселективность в&nbsp;классе  альфа-адреноблокаторов<sup>4</sup></h2>\r\n<div class=\"h3\"> Почему это важно? <a href=\"#\">Подробнее</a></div>'),
(862, 88, '_текст_в_подвале', 'field_62436daf1f6d9'),
(863, 88, 'заголовок-3', 'Форма выпуска препарата Урорек'),
(864, 88, '_заголовок-3', 'field_62436efee98e7'),
(865, 88, 'текст-3', '<p class=\"section-descr\"><span>8мг </span>- рекомендуемая доза для лечения симптомов ДГПЖ<sup>6</sup>*</p>\r\n					<p class=\"section-note col-md-10\">*Более подробные сведения о&nbsp;препарате, особенностях применения, побочных действиях и&nbsp;др. &mdash;&nbsp;смотрите инструкцию по&nbsp;медицинскому применению лекарственного препарата Урорек, РУ&nbsp;ЛСР-005971/10 от&nbsp;25.06.2010 </p>'),
(866, 88, '_текст-3', 'field_62436f60e98e8'),
(867, 88, 'товар_0_название', 'Урорек 8мг №30'),
(868, 88, '_товар_0_название', 'field_62436fcce98ea'),
(869, 88, 'товар_0_описание', 'Упаковка, рассчитанная на&nbsp;1&nbsp;месяц лечения&nbsp;/ для старта терапии'),
(870, 88, '_товар_0_описание', 'field_62436fe1e98eb'),
(871, 88, 'товар_0_лицензия', 'РУ: ЛСР-005971/10 от 25.06.2010'),
(872, 88, '_товар_0_лицензия', 'field_62436ff0e98ec'),
(873, 88, 'товар_0_изображение', '51'),
(874, 88, '_товар_0_изображение', 'field_62437045e98ed'),
(875, 88, 'товар_1_название', 'Урорек 8мг №90'),
(876, 88, '_товар_1_название', 'field_62436fcce98ea'),
(877, 88, 'товар_1_описание', 'Выгодная упаковка, рассчитанная на&nbsp;3&nbsp;месяца лечения. Самая доступная стоимость 1&nbsp;дня терапии препаратом Урорек&nbsp;<sup>27</sup>'),
(878, 88, '_товар_1_описание', 'field_62436fe1e98eb'),
(879, 88, 'товар_1_лицензия', 'РУ: ЛСР-005971/10 от 25.06.2010'),
(880, 88, '_товар_1_лицензия', 'field_62436ff0e98ec'),
(881, 88, 'товар_1_изображение', '53'),
(882, 88, '_товар_1_изображение', 'field_62437045e98ed'),
(883, 88, 'товар_2_название', 'Урорек 4мг №30'),
(884, 88, '_товар_2_название', 'field_62436fcce98ea'),
(885, 88, 'товар_2_описание', '4&nbsp;мг&nbsp;&mdash; стартовая упаковка для лечения симптомов ДГПЖ у&nbsp;пациентов с&nbsp;почечной недостаточностью средней степени тяжести<sup>6</sup>'),
(886, 88, '_товар_2_описание', 'field_62436fe1e98eb'),
(887, 88, 'товар_2_лицензия', 'РУ: ЛСР-005971/10 от 25.06.2010'),
(888, 88, '_товар_2_лицензия', 'field_62436ff0e98ec'),
(889, 88, 'товар_2_изображение', '52'),
(890, 88, '_товар_2_изображение', 'field_62437045e98ed'),
(891, 88, 'товар', '3'),
(892, 88, '_товар', 'field_62436fbde98e9'),
(893, 88, 'заголовок-4', 'Где купить'),
(894, 88, '_заголовок-4', 'field_624374f73d8bd'),
(895, 88, 'изображения', 'a:12:{i:0;s:2:\"63\";i:1;s:2:\"64\";i:2;s:2:\"65\";i:3;s:2:\"66\";i:4;s:2:\"67\";i:5;s:2:\"68\";i:6;s:2:\"69\";i:7;s:2:\"70\";i:8;s:2:\"71\";i:9;s:2:\"72\";i:10;s:2:\"73\";i:11;s:2:\"74\";}'),
(896, 88, '_изображения', 'field_624375093d8be'),
(897, 88, 'изображения-4', 'a:12:{i:0;s:2:\"63\";i:1;s:2:\"64\";i:2;s:2:\"65\";i:3;s:2:\"66\";i:4;s:2:\"67\";i:5;s:2:\"68\";i:6;s:2:\"69\";i:7;s:2:\"70\";i:8;s:2:\"71\";i:9;s:2:\"72\";i:10;s:2:\"73\";i:11;s:2:\"74\";}');
INSERT INTO `urotec_postmeta` (`meta_id`, `post_id`, `meta_key`, `meta_value`) VALUES
(898, 88, '_изображения-4', 'field_624375093d8be'),
(899, 88, 'заголовок-5', 'Способ применения*<sup>6</sup>'),
(900, 88, '_заголовок-5', 'field_624379bd4756d'),
(901, 88, 'иконки', 'a:5:{i:0;s:2:\"83\";i:1;s:2:\"84\";i:2;s:2:\"85\";i:3;s:2:\"86\";i:4;s:2:\"87\";}'),
(902, 88, '_иконки', 'field_624379f24756e'),
(903, 88, 'текст-5', 'У пациентов с легкой почечной недостаточностью (клиренс креатинина ≥ 50 — ≤ 80 мл/мин) коррекция дозы не требуется. Для лечения пациентов с почечной недостаточностью средней степени тяжести (клиренс креатинина ≥ 30 — < 50 мл/мин) рекомендуется в течение первой недели принимать начальную дозу по 4 мг в сутки, при хорошей индивидуальной переносимости доза может быть увеличена до 8 мг в сутки. Применение препарата для пациентов с тяжелой почечной недостаточностью (клиренс креатинина < 30 мл / мин) не рекомендуется'),
(904, 88, '_текст-5', 'field_62437a374756f'),
(905, 88, 'текст_под_кнопкой', '*Более подробные сведения о&nbsp;препарате, особенностях применения, побочных действиях и&nbsp;др. &mdash;&nbsp;см. инструкцию по&nbsp;медицинскому применению лекарственного препарата Урорек, РУ&nbsp;ЛСР-005971/10 от&nbsp;25.06.2010'),
(906, 88, '_текст_под_кнопкой', 'field_62437a7c47570'),
(907, 89, 'заголовок-1', 'УРОРЕК – оригинальный<sup>10</sup> альфа-адреноблокатор'),
(908, 89, '_заголовок-1', 'field_62435bd26f29f'),
(909, 89, 'текст-1', '<div class=\"headerBlock__body\">\r\n<p>Силодозин (действующее вещество препарата Урорек) обладает максимальной уроселективностью в&nbsp;своем классе, что обеспечивает его уродинамическую эффективность и&nbsp;высокую безопасность<sup>4</sup></p>\r\n</div>\r\n<div class=\"headerBlock__footer\">\r\n<p><strong>Показания к применению: </strong><br/>Лечение симптомов доброкачественной гиперплазии предстательной железы<sup>6</sup></p>\r\n</div>'),
(910, 89, '_текст-1', 'field_62435c0c6f2a0'),
(911, 89, 'изображение-1', '13'),
(912, 89, '_изображение-1', 'field_62435c8b6f2a1'),
(913, 89, 'фон-1', '17'),
(914, 89, '_фон-1', 'field_62435db92ea96'),
(915, 89, 'заголовок-2', 'Ключевые преимущества препарата Урорек'),
(916, 89, '_заголовок-2', 'field_6243606295196'),
(917, 89, 'список-2', 'Единственный оригинальный препарат из&nbsp;группы альфа1-адреноблокаторов, не&nbsp;имеющий генериков в&nbsp;РФ<sup>1</sup>'),
(918, 89, '_список-2', 'field_6243608195197'),
(919, 89, 'картинка_с_текстом_0_изображение', '31'),
(920, 89, '_картинка_с_текстом_0_изображение', 'field_624363d095199'),
(921, 89, 'картинка_с_текстом_0_описание', 'Обширная доказательная база собственных пострегистрационных клинических исследований<sup>2</sup>'),
(922, 89, '_картинка_с_текстом_0_описание', 'field_624363e59519a'),
(923, 89, 'картинка_с_текстом_1_изображение', '32'),
(924, 89, '_картинка_с_текстом_1_изображение', 'field_624363d095199'),
(925, 89, 'картинка_с_текстом_1_описание', 'Отсутствие риска замены препарата Урорек в&nbsp;аптеке (единственный препарат с&nbsp;действующим веществом силодозин)<sup>1</sup>'),
(926, 89, '_картинка_с_текстом_1_описание', 'field_624363e59519a'),
(927, 89, 'картинка_с_текстом_2_изображение', '33'),
(928, 89, '_картинка_с_текстом_2_изображение', 'field_624363d095199'),
(929, 89, 'картинка_с_текстом_2_описание', 'Большинство пациентов предпочитают принимать оригинальные препараты<sup>3</sup>'),
(930, 89, '_картинка_с_текстом_2_описание', 'field_624363e59519a'),
(931, 89, 'картинка_с_текстом', '3'),
(932, 89, '_картинка_с_текстом', 'field_624363b995198'),
(933, 89, 'второй_список', '<li>Клинические преимущества препарата Урорек (силодозин) определяются максимальной уроселективностью в&nbsp;классе альфа-адреноблокаторов<sup>4</sup></li>\r\n\r\n<li>Урорек&nbsp;&mdash; альфа-адреноблокатор последнего поколения, который эффективен в&nbsp;отношении всех СНМП (накопления, опорожнения, постмиктурических).<sup>12,13</sup> При этом Урорек обладает минимальным риском развития нежелательных явлений со&nbsp;стороны сердечно-сосудистой системы, в&nbsp;том числе&nbsp;у&nbsp;пациентов, принимающих антигипертензивные препараты<sup>46,8</sup> <small> <span>СНМП </span>симптомы нижних мочевыводящих путей</small></li>'),
(934, 89, '_второй_список', 'field_6243640e05eda'),
(935, 89, 'заголовок2-2', 'Максимальная уроселективность силодозина в&nbsp;классе альфа-адреноблокаторов обуславливает его уродинамическую эффективность и&nbsp;высокий профиль безопасности<sup>4</sup>'),
(936, 89, '_заголовок2-2', 'field_6243644705edb'),
(937, 89, 'текст3', '<ul>\r\n<li>Урорек значительно улучшает клинические проявления и&nbsp;качество жизни у&nbsp;всех пациентов с&nbsp;СНМП/ДГПЖ, в&nbsp;том числе с&nbsp;тяжелым течением<sup>11</sup><a href=\"#\">Узнать больше...</a></li>\r\n\r\n<li>Урорек является препаратом выбора для пациентов с&nbsp;СНМП/ДГПЖ и&nbsp;сопутствующими сердечно-сосудистыми заболеваниями<sup>3</sup> <a href=\"#\">Узнать больше...</a></li>\r\n</ul>\r\n<small> <span>ДГПЖ </span>доброкачественная гиперплазия предстательной железы</small>'),
(938, 89, '_текст3', 'field_6243647405edc'),
(939, 89, 'изображение-2', '34'),
(940, 89, '_изображение-2', 'field_624364dd05edd'),
(941, 89, 'текст_в_подвале', '<h2> Максимальная уроселективность в&nbsp;классе  альфа-адреноблокаторов<sup>4</sup></h2>\r\n<div class=\"h3\"> Почему это важно? <a href=\"#\">Подробнее</a></div>'),
(942, 89, '_текст_в_подвале', 'field_62436daf1f6d9'),
(943, 89, 'заголовок-3', 'Форма выпуска препарата Урорек'),
(944, 89, '_заголовок-3', 'field_62436efee98e7'),
(945, 89, 'текст-3', '<p class=\"section-descr\"><span>8мг </span>- рекомендуемая доза для лечения симптомов ДГПЖ<sup>6</sup>*</p>\r\n					<p class=\"section-note col-md-10\">*Более подробные сведения о&nbsp;препарате, особенностях применения, побочных действиях и&nbsp;др. &mdash;&nbsp;смотрите инструкцию по&nbsp;медицинскому применению лекарственного препарата Урорек, РУ&nbsp;ЛСР-005971/10 от&nbsp;25.06.2010 </p>'),
(946, 89, '_текст-3', 'field_62436f60e98e8'),
(947, 89, 'товар_0_название', 'Урорек 8мг №30'),
(948, 89, '_товар_0_название', 'field_62436fcce98ea'),
(949, 89, 'товар_0_описание', 'Упаковка, рассчитанная на&nbsp;1&nbsp;месяц лечения&nbsp;/ для старта терапии'),
(950, 89, '_товар_0_описание', 'field_62436fe1e98eb'),
(951, 89, 'товар_0_лицензия', 'РУ: ЛСР-005971/10 от 25.06.2010'),
(952, 89, '_товар_0_лицензия', 'field_62436ff0e98ec'),
(953, 89, 'товар_0_изображение', '51'),
(954, 89, '_товар_0_изображение', 'field_62437045e98ed'),
(955, 89, 'товар_1_название', 'Урорек 8мг №90'),
(956, 89, '_товар_1_название', 'field_62436fcce98ea'),
(957, 89, 'товар_1_описание', 'Выгодная упаковка, рассчитанная на&nbsp;3&nbsp;месяца лечения. Самая доступная стоимость 1&nbsp;дня терапии препаратом Урорек&nbsp;<sup>27</sup>'),
(958, 89, '_товар_1_описание', 'field_62436fe1e98eb'),
(959, 89, 'товар_1_лицензия', 'РУ: ЛСР-005971/10 от 25.06.2010'),
(960, 89, '_товар_1_лицензия', 'field_62436ff0e98ec'),
(961, 89, 'товар_1_изображение', '53'),
(962, 89, '_товар_1_изображение', 'field_62437045e98ed'),
(963, 89, 'товар_2_название', 'Урорек 4мг №30'),
(964, 89, '_товар_2_название', 'field_62436fcce98ea'),
(965, 89, 'товар_2_описание', '4&nbsp;мг&nbsp;&mdash; стартовая упаковка для лечения симптомов ДГПЖ у&nbsp;пациентов с&nbsp;почечной недостаточностью средней степени тяжести<sup>6</sup>'),
(966, 89, '_товар_2_описание', 'field_62436fe1e98eb'),
(967, 89, 'товар_2_лицензия', 'РУ: ЛСР-005971/10 от 25.06.2010'),
(968, 89, '_товар_2_лицензия', 'field_62436ff0e98ec'),
(969, 89, 'товар_2_изображение', '52'),
(970, 89, '_товар_2_изображение', 'field_62437045e98ed'),
(971, 89, 'товар', '3'),
(972, 89, '_товар', 'field_62436fbde98e9'),
(973, 89, 'заголовок-4', 'Где купить'),
(974, 89, '_заголовок-4', 'field_624374f73d8bd'),
(975, 89, 'изображения', 'a:12:{i:0;s:2:\"63\";i:1;s:2:\"64\";i:2;s:2:\"65\";i:3;s:2:\"66\";i:4;s:2:\"67\";i:5;s:2:\"68\";i:6;s:2:\"69\";i:7;s:2:\"70\";i:8;s:2:\"71\";i:9;s:2:\"72\";i:10;s:2:\"73\";i:11;s:2:\"74\";}'),
(976, 89, '_изображения', 'field_624375093d8be'),
(977, 89, 'изображения-4', 'a:12:{i:0;s:2:\"63\";i:1;s:2:\"64\";i:2;s:2:\"65\";i:3;s:2:\"66\";i:4;s:2:\"67\";i:5;s:2:\"68\";i:6;s:2:\"69\";i:7;s:2:\"70\";i:8;s:2:\"71\";i:9;s:2:\"72\";i:10;s:2:\"73\";i:11;s:2:\"74\";}'),
(978, 89, '_изображения-4', 'field_624375093d8be'),
(979, 89, 'заголовок-5', 'Способ применения*<sup>6</sup>'),
(980, 89, '_заголовок-5', 'field_624379bd4756d'),
(981, 89, 'иконки', 'a:5:{i:0;s:2:\"83\";i:1;s:2:\"84\";i:2;s:2:\"85\";i:3;s:2:\"86\";i:4;s:2:\"87\";}'),
(982, 89, '_иконки', 'field_624379f24756e'),
(983, 89, 'текст-5', 'У пациентов с легкой почечной недостаточностью (клиренс креатинина ≥ 50 — ≤ 80 мл/мин) коррекция дозы не требуется. Для лечения пациентов с почечной недостаточностью средней степени тяжести (клиренс креатинина ≥ 30 — < 50 мл/мин) рекомендуется в течение первой недели принимать начальную дозу по 4 мг в сутки, при хорошей индивидуальной переносимости доза может быть увеличена до 8 мг в сутки. Применение препарата для пациентов с тяжелой почечной недостаточностью (клиренс креатинина < 30 мл / мин) не рекомендуется'),
(984, 89, '_текст-5', 'field_62437a374756f'),
(985, 89, 'текст_под_кнопкой', '*Более подробные сведения о&nbsp;препарате, особенностях применения, побочных действиях и&nbsp;др. &mdash;&nbsp;см. инструкцию по&nbsp;медицинскому применению лекарственного препарата Урорек, РУ&nbsp;ЛСР-005971/10 от&nbsp;25.06.2010'),
(986, 89, '_текст_под_кнопкой', 'field_62437a7c47570'),
(987, 90, 'заголовок-1', 'УРОРЕК – оригинальный<sup>10</sup> альфа-адреноблокатор'),
(988, 90, '_заголовок-1', 'field_62435bd26f29f'),
(989, 90, 'текст-1', '<div class=\"headerBlock__body\">\r\n<p>Силодозин (действующее вещество препарата Урорек) обладает максимальной уроселективностью в&nbsp;своем классе, что обеспечивает его уродинамическую эффективность и&nbsp;высокую безопасность<sup>4</sup></p>\r\n</div>\r\n<div class=\"headerBlock__footer\">\r\n<p><strong>Показания к применению: </strong><br/>Лечение симптомов доброкачественной гиперплазии предстательной железы<sup>6</sup></p>\r\n</div>'),
(990, 90, '_текст-1', 'field_62435c0c6f2a0'),
(991, 90, 'изображение-1', '13'),
(992, 90, '_изображение-1', 'field_62435c8b6f2a1'),
(993, 90, 'фон-1', '17'),
(994, 90, '_фон-1', 'field_62435db92ea96'),
(995, 90, 'заголовок-2', 'Ключевые преимущества препарата Урорек'),
(996, 90, '_заголовок-2', 'field_6243606295196'),
(997, 90, 'список-2', 'Единственный оригинальный препарат из&nbsp;группы альфа1-адреноблокаторов, не&nbsp;имеющий генериков в&nbsp;РФ<sup>1</sup>'),
(998, 90, '_список-2', 'field_6243608195197'),
(999, 90, 'картинка_с_текстом_0_изображение', '31'),
(1000, 90, '_картинка_с_текстом_0_изображение', 'field_624363d095199'),
(1001, 90, 'картинка_с_текстом_0_описание', 'Обширная доказательная база собственных пострегистрационных клинических исследований<sup>2</sup>'),
(1002, 90, '_картинка_с_текстом_0_описание', 'field_624363e59519a'),
(1003, 90, 'картинка_с_текстом_1_изображение', '32'),
(1004, 90, '_картинка_с_текстом_1_изображение', 'field_624363d095199'),
(1005, 90, 'картинка_с_текстом_1_описание', 'Отсутствие риска замены препарата Урорек в&nbsp;аптеке (единственный препарат с&nbsp;действующим веществом силодозин)<sup>1</sup>'),
(1006, 90, '_картинка_с_текстом_1_описание', 'field_624363e59519a'),
(1007, 90, 'картинка_с_текстом_2_изображение', '33'),
(1008, 90, '_картинка_с_текстом_2_изображение', 'field_624363d095199'),
(1009, 90, 'картинка_с_текстом_2_описание', 'Большинство пациентов предпочитают принимать оригинальные препараты<sup>3</sup>'),
(1010, 90, '_картинка_с_текстом_2_описание', 'field_624363e59519a'),
(1011, 90, 'картинка_с_текстом', '3'),
(1012, 90, '_картинка_с_текстом', 'field_624363b995198'),
(1013, 90, 'второй_список', '<li>Клинические преимущества препарата Урорек (силодозин) определяются максимальной уроселективностью в&nbsp;классе альфа-адреноблокаторов<sup>4</sup></li>\r\n\r\n<li>Урорек&nbsp;&mdash; альфа-адреноблокатор последнего поколения, который эффективен в&nbsp;отношении всех СНМП (накопления, опорожнения, постмиктурических).<sup>12,13</sup> При этом Урорек обладает минимальным риском развития нежелательных явлений со&nbsp;стороны сердечно-сосудистой системы, в&nbsp;том числе&nbsp;у&nbsp;пациентов, принимающих антигипертензивные препараты<sup>46,8</sup> <small> <span>СНМП </span>симптомы нижних мочевыводящих путей</small></li>'),
(1014, 90, '_второй_список', 'field_6243640e05eda'),
(1015, 90, 'заголовок2-2', 'Максимальная уроселективность силодозина в&nbsp;классе альфа-адреноблокаторов обуславливает его уродинамическую эффективность и&nbsp;высокий профиль безопасности<sup>4</sup>'),
(1016, 90, '_заголовок2-2', 'field_6243644705edb'),
(1017, 90, 'текст3', '<ul>\r\n<li>Урорек значительно улучшает клинические проявления и&nbsp;качество жизни у&nbsp;всех пациентов с&nbsp;СНМП/ДГПЖ, в&nbsp;том числе с&nbsp;тяжелым течением<sup>11</sup><a href=\"#\">Узнать больше...</a></li>\r\n\r\n<li>Урорек является препаратом выбора для пациентов с&nbsp;СНМП/ДГПЖ и&nbsp;сопутствующими сердечно-сосудистыми заболеваниями<sup>3</sup> <a href=\"#\">Узнать больше...</a></li>\r\n</ul>\r\n<small> <span>ДГПЖ </span>доброкачественная гиперплазия предстательной железы</small>'),
(1018, 90, '_текст3', 'field_6243647405edc'),
(1019, 90, 'изображение-2', '34'),
(1020, 90, '_изображение-2', 'field_624364dd05edd'),
(1021, 90, 'текст_в_подвале', '<h2> Максимальная уроселективность в&nbsp;классе  альфа-адреноблокаторов<sup>4</sup></h2>\r\n<div class=\"h3\"> Почему это важно? <a href=\"#\">Подробнее</a></div>'),
(1022, 90, '_текст_в_подвале', 'field_62436daf1f6d9'),
(1023, 90, 'заголовок-3', 'Форма выпуска препарата Урорек'),
(1024, 90, '_заголовок-3', 'field_62436efee98e7'),
(1025, 90, 'текст-3', '<p class=\"section-descr\"><span>8мг </span>- рекомендуемая доза для лечения симптомов ДГПЖ<sup>6</sup>*</p>\r\n					<p class=\"section-note col-md-10\">*Более подробные сведения о&nbsp;препарате, особенностях применения, побочных действиях и&nbsp;др. &mdash;&nbsp;смотрите инструкцию по&nbsp;медицинскому применению лекарственного препарата Урорек, РУ&nbsp;ЛСР-005971/10 от&nbsp;25.06.2010 </p>'),
(1026, 90, '_текст-3', 'field_62436f60e98e8'),
(1027, 90, 'товар_0_название', 'Урорек 8мг №30'),
(1028, 90, '_товар_0_название', 'field_62436fcce98ea'),
(1029, 90, 'товар_0_описание', 'Упаковка, рассчитанная на&nbsp;1&nbsp;месяц лечения&nbsp;/ для старта терапии'),
(1030, 90, '_товар_0_описание', 'field_62436fe1e98eb'),
(1031, 90, 'товар_0_лицензия', 'РУ: ЛСР-005971/10 от 25.06.2010'),
(1032, 90, '_товар_0_лицензия', 'field_62436ff0e98ec'),
(1033, 90, 'товар_0_изображение', '51'),
(1034, 90, '_товар_0_изображение', 'field_62437045e98ed'),
(1035, 90, 'товар_1_название', 'Урорек 8мг №90'),
(1036, 90, '_товар_1_название', 'field_62436fcce98ea'),
(1037, 90, 'товар_1_описание', 'Выгодная упаковка, рассчитанная на&nbsp;3&nbsp;месяца лечения. Самая доступная стоимость 1&nbsp;дня терапии препаратом Урорек&nbsp;<sup>27</sup>'),
(1038, 90, '_товар_1_описание', 'field_62436fe1e98eb'),
(1039, 90, 'товар_1_лицензия', 'РУ: ЛСР-005971/10 от 25.06.2010'),
(1040, 90, '_товар_1_лицензия', 'field_62436ff0e98ec'),
(1041, 90, 'товар_1_изображение', '53'),
(1042, 90, '_товар_1_изображение', 'field_62437045e98ed'),
(1043, 90, 'товар_2_название', 'Урорек 4мг №30'),
(1044, 90, '_товар_2_название', 'field_62436fcce98ea'),
(1045, 90, 'товар_2_описание', '4&nbsp;мг&nbsp;&mdash; стартовая упаковка для лечения симптомов ДГПЖ у&nbsp;пациентов с&nbsp;почечной недостаточностью средней степени тяжести<sup>6</sup>'),
(1046, 90, '_товар_2_описание', 'field_62436fe1e98eb'),
(1047, 90, 'товар_2_лицензия', 'РУ: ЛСР-005971/10 от 25.06.2010'),
(1048, 90, '_товар_2_лицензия', 'field_62436ff0e98ec'),
(1049, 90, 'товар_2_изображение', '52'),
(1050, 90, '_товар_2_изображение', 'field_62437045e98ed'),
(1051, 90, 'товар', '3'),
(1052, 90, '_товар', 'field_62436fbde98e9'),
(1053, 90, 'заголовок-4', 'Где купить'),
(1054, 90, '_заголовок-4', 'field_624374f73d8bd'),
(1055, 90, 'изображения', 'a:12:{i:0;s:2:\"63\";i:1;s:2:\"64\";i:2;s:2:\"65\";i:3;s:2:\"66\";i:4;s:2:\"67\";i:5;s:2:\"68\";i:6;s:2:\"69\";i:7;s:2:\"70\";i:8;s:2:\"71\";i:9;s:2:\"72\";i:10;s:2:\"73\";i:11;s:2:\"74\";}'),
(1056, 90, '_изображения', 'field_624375093d8be'),
(1057, 90, 'изображения-4', 'a:12:{i:0;s:2:\"63\";i:1;s:2:\"64\";i:2;s:2:\"65\";i:3;s:2:\"66\";i:4;s:2:\"67\";i:5;s:2:\"68\";i:6;s:2:\"69\";i:7;s:2:\"70\";i:8;s:2:\"71\";i:9;s:2:\"72\";i:10;s:2:\"73\";i:11;s:2:\"74\";}'),
(1058, 90, '_изображения-4', 'field_624375093d8be'),
(1059, 90, 'заголовок-5', 'Способ применения*<sup>6</sup>'),
(1060, 90, '_заголовок-5', 'field_624379bd4756d'),
(1061, 90, 'иконки', 'a:5:{i:0;s:2:\"83\";i:1;s:2:\"84\";i:2;s:2:\"85\";i:3;s:2:\"86\";i:4;s:2:\"87\";}'),
(1062, 90, '_иконки', 'field_624379f24756e'),
(1063, 90, 'текст-5', 'У пациентов с легкой почечной недостаточностью (клиренс креатинина ≥ 50 — ≤ 80 мл/мин) коррекция дозы не требуется. Для лечения пациентов с почечной недостаточностью средней степени тяжести (клиренс креатинина ≥ 30 — < 50 мл/мин) рекомендуется в течение первой недели принимать начальную дозу по 4 мг в сутки, при хорошей индивидуальной переносимости доза может быть увеличена до 8 мг в сутки. Применение препарата для пациентов с тяжелой почечной недостаточностью (клиренс креатинина < 30 мл / мин) не рекомендуется'),
(1064, 90, '_текст-5', 'field_62437a374756f'),
(1065, 90, 'текст_под_кнопкой', '*Более подробные сведения о&nbsp;препарате, особенностях применения, побочных действиях и&nbsp;др. &mdash;&nbsp;см. инструкцию по&nbsp;медицинскому применению лекарственного препарата Урорек, РУ&nbsp;ЛСР-005971/10 от&nbsp;25.06.2010'),
(1066, 90, '_текст_под_кнопкой', 'field_62437a7c47570'),
(1067, 91, '_edit_last', '1'),
(1068, 91, '_edit_lock', '1648629583:1'),
(1069, 2, 'заголовок-6', 'Препарат Урорек (силодозин) включен в&nbsp;российские и&nbsp;международные клинические рекомендации и&nbsp;стандарты для лечения ряда урологических заболеваний:'),
(1070, 2, '_заголовок-6', 'field_6244117c68bd0'),
(1071, 2, 'список-6_0_ссылка', 'a:3:{s:5:\"title\";s:68:\"Российские клинические рекомендации\";s:3:\"url\";s:1:\"#\";s:6:\"target\";s:0:\"\";}'),
(1072, 2, '_список-6_0_ссылка', 'field_624411ce68bd2'),
(1073, 2, 'список-6_0_описание', '«Доброкачественная гиперплазия предстательной железы», 2020<sup>28</sup>'),
(1074, 2, '_список-6_0_описание', 'field_6244121168bd3'),
(1075, 2, 'список-6_1_ссылка', 'a:3:{s:5:\"title\";s:70:\"Европейские клинические рекомендации\";s:3:\"url\";s:1:\"#\";s:6:\"target\";s:0:\"\";}'),
(1076, 2, '_список-6_1_ссылка', 'field_624411ce68bd2'),
(1077, 2, 'список-6_1_описание', 'глава «Консервативное лечение ненейрогенных симптомов нарушенного мочеиспускания у мужчин, включая доброкачественную простатическую обструкцию», 2021<sup>29</sup>'),
(1078, 2, '_список-6_1_описание', 'field_6244121168bd3'),
(1079, 2, 'список-6_2_ссылка', 'a:3:{s:5:\"title\";s:154:\"Стандарт первичной медико-санитарной помощи при гиперплазии предстательной железы\";s:3:\"url\";s:1:\"#\";s:6:\"target\";s:0:\"\";}'),
(1080, 2, '_список-6_2_ссылка', 'field_624411ce68bd2'),
(1081, 2, 'список-6_2_описание', '09.11.2012<sup>30</sup> / Обновлён 13.04.2015\r\n'),
(1082, 2, '_список-6_2_описание', 'field_6244121168bd3'),
(1083, 2, 'список-6_3_ссылка', 'a:3:{s:5:\"title\";s:122:\"Стандарт специализированной медицинской помощи при задержке мочи\";s:3:\"url\";s:1:\"#\";s:6:\"target\";s:0:\"\";}'),
(1084, 2, '_список-6_3_ссылка', 'field_624411ce68bd2'),
(1085, 2, 'список-6_3_описание', '29.01.2013<sup>31</sup> / Обновлён 06.05.2015\r\n'),
(1086, 2, '_список-6_3_описание', 'field_6244121168bd3'),
(1087, 2, 'список-6_4_ссылка', 'a:3:{s:5:\"title\";s:133:\"Стандарт первичной медико-санитарной помощи при хроническом простатите\";s:3:\"url\";s:1:\"#\";s:6:\"target\";s:0:\"\";}'),
(1088, 2, '_список-6_4_ссылка', 'field_624411ce68bd2'),
(1089, 2, 'список-6_4_описание', '09.11.2012<sup>32</sup> / Обновлён 13.04.2015\r\n'),
(1090, 2, '_список-6_4_описание', 'field_6244121168bd3'),
(1091, 2, 'список-6_5_ссылка', 'a:3:{s:5:\"title\";s:168:\"Стандарт специализированной медицинской помощи при остром простатите, орхите, эпидидимите\";s:3:\"url\";s:1:\"#\";s:6:\"target\";s:0:\"\";}'),
(1092, 2, '_список-6_5_ссылка', 'field_624411ce68bd2'),
(1093, 2, 'список-6_5_описание', '09.11.2012<sup>33</sup> / Обновлён 27.05.2015'),
(1094, 2, '_список-6_5_описание', 'field_6244121168bd3'),
(1095, 2, 'список-6', '6'),
(1096, 2, '_список-6', 'field_624411be68bd1'),
(1097, 96, 'заголовок-1', 'УРОРЕК – оригинальный<sup>10</sup> альфа-адреноблокатор'),
(1098, 96, '_заголовок-1', 'field_62435bd26f29f'),
(1099, 96, 'текст-1', '<div class=\"headerBlock__body\">\r\n<p>Силодозин (действующее вещество препарата Урорек) обладает максимальной уроселективностью в&nbsp;своем классе, что обеспечивает его уродинамическую эффективность и&nbsp;высокую безопасность<sup>4</sup></p>\r\n</div>\r\n<div class=\"headerBlock__footer\">\r\n<p><strong>Показания к применению: </strong><br/>Лечение симптомов доброкачественной гиперплазии предстательной железы<sup>6</sup></p>\r\n</div>'),
(1100, 96, '_текст-1', 'field_62435c0c6f2a0'),
(1101, 96, 'изображение-1', '13'),
(1102, 96, '_изображение-1', 'field_62435c8b6f2a1'),
(1103, 96, 'фон-1', '17'),
(1104, 96, '_фон-1', 'field_62435db92ea96'),
(1105, 96, 'заголовок-2', 'Ключевые преимущества препарата Урорек'),
(1106, 96, '_заголовок-2', 'field_6243606295196'),
(1107, 96, 'список-2', 'Единственный оригинальный препарат из&nbsp;группы альфа1-адреноблокаторов, не&nbsp;имеющий генериков в&nbsp;РФ<sup>1</sup>'),
(1108, 96, '_список-2', 'field_6243608195197'),
(1109, 96, 'картинка_с_текстом_0_изображение', '31'),
(1110, 96, '_картинка_с_текстом_0_изображение', 'field_624363d095199'),
(1111, 96, 'картинка_с_текстом_0_описание', 'Обширная доказательная база собственных пострегистрационных клинических исследований<sup>2</sup>'),
(1112, 96, '_картинка_с_текстом_0_описание', 'field_624363e59519a'),
(1113, 96, 'картинка_с_текстом_1_изображение', '32'),
(1114, 96, '_картинка_с_текстом_1_изображение', 'field_624363d095199'),
(1115, 96, 'картинка_с_текстом_1_описание', 'Отсутствие риска замены препарата Урорек в&nbsp;аптеке (единственный препарат с&nbsp;действующим веществом силодозин)<sup>1</sup>'),
(1116, 96, '_картинка_с_текстом_1_описание', 'field_624363e59519a'),
(1117, 96, 'картинка_с_текстом_2_изображение', '33'),
(1118, 96, '_картинка_с_текстом_2_изображение', 'field_624363d095199'),
(1119, 96, 'картинка_с_текстом_2_описание', 'Большинство пациентов предпочитают принимать оригинальные препараты<sup>3</sup>'),
(1120, 96, '_картинка_с_текстом_2_описание', 'field_624363e59519a'),
(1121, 96, 'картинка_с_текстом', '3'),
(1122, 96, '_картинка_с_текстом', 'field_624363b995198'),
(1123, 96, 'второй_список', '<li>Клинические преимущества препарата Урорек (силодозин) определяются максимальной уроселективностью в&nbsp;классе альфа-адреноблокаторов<sup>4</sup></li>\r\n\r\n<li>Урорек&nbsp;&mdash; альфа-адреноблокатор последнего поколения, который эффективен в&nbsp;отношении всех СНМП (накопления, опорожнения, постмиктурических).<sup>12,13</sup> При этом Урорек обладает минимальным риском развития нежелательных явлений со&nbsp;стороны сердечно-сосудистой системы, в&nbsp;том числе&nbsp;у&nbsp;пациентов, принимающих антигипертензивные препараты<sup>46,8</sup> <small> <span>СНМП </span>симптомы нижних мочевыводящих путей</small></li>'),
(1124, 96, '_второй_список', 'field_6243640e05eda'),
(1125, 96, 'заголовок2-2', 'Максимальная уроселективность силодозина в&nbsp;классе альфа-адреноблокаторов обуславливает его уродинамическую эффективность и&nbsp;высокий профиль безопасности<sup>4</sup>'),
(1126, 96, '_заголовок2-2', 'field_6243644705edb'),
(1127, 96, 'текст3', '<ul>\r\n<li>Урорек значительно улучшает клинические проявления и&nbsp;качество жизни у&nbsp;всех пациентов с&nbsp;СНМП/ДГПЖ, в&nbsp;том числе с&nbsp;тяжелым течением<sup>11</sup><a href=\"#\">Узнать больше...</a></li>\r\n\r\n<li>Урорек является препаратом выбора для пациентов с&nbsp;СНМП/ДГПЖ и&nbsp;сопутствующими сердечно-сосудистыми заболеваниями<sup>3</sup> <a href=\"#\">Узнать больше...</a></li>\r\n</ul>\r\n<small> <span>ДГПЖ </span>доброкачественная гиперплазия предстательной железы</small>'),
(1128, 96, '_текст3', 'field_6243647405edc'),
(1129, 96, 'изображение-2', '34'),
(1130, 96, '_изображение-2', 'field_624364dd05edd'),
(1131, 96, 'текст_в_подвале', '<h2> Максимальная уроселективность в&nbsp;классе  альфа-адреноблокаторов<sup>4</sup></h2>\r\n<div class=\"h3\"> Почему это важно? <a href=\"#\">Подробнее</a></div>'),
(1132, 96, '_текст_в_подвале', 'field_62436daf1f6d9'),
(1133, 96, 'заголовок-3', 'Форма выпуска препарата Урорек'),
(1134, 96, '_заголовок-3', 'field_62436efee98e7'),
(1135, 96, 'текст-3', '<p class=\"section-descr\"><span>8мг </span>- рекомендуемая доза для лечения симптомов ДГПЖ<sup>6</sup>*</p>\r\n					<p class=\"section-note col-md-10\">*Более подробные сведения о&nbsp;препарате, особенностях применения, побочных действиях и&nbsp;др. &mdash;&nbsp;смотрите инструкцию по&nbsp;медицинскому применению лекарственного препарата Урорек, РУ&nbsp;ЛСР-005971/10 от&nbsp;25.06.2010 </p>'),
(1136, 96, '_текст-3', 'field_62436f60e98e8'),
(1137, 96, 'товар_0_название', 'Урорек 8мг №30'),
(1138, 96, '_товар_0_название', 'field_62436fcce98ea'),
(1139, 96, 'товар_0_описание', 'Упаковка, рассчитанная на&nbsp;1&nbsp;месяц лечения&nbsp;/ для старта терапии'),
(1140, 96, '_товар_0_описание', 'field_62436fe1e98eb'),
(1141, 96, 'товар_0_лицензия', 'РУ: ЛСР-005971/10 от 25.06.2010'),
(1142, 96, '_товар_0_лицензия', 'field_62436ff0e98ec'),
(1143, 96, 'товар_0_изображение', '51'),
(1144, 96, '_товар_0_изображение', 'field_62437045e98ed'),
(1145, 96, 'товар_1_название', 'Урорек 8мг №90'),
(1146, 96, '_товар_1_название', 'field_62436fcce98ea'),
(1147, 96, 'товар_1_описание', 'Выгодная упаковка, рассчитанная на&nbsp;3&nbsp;месяца лечения. Самая доступная стоимость 1&nbsp;дня терапии препаратом Урорек&nbsp;<sup>27</sup>'),
(1148, 96, '_товар_1_описание', 'field_62436fe1e98eb'),
(1149, 96, 'товар_1_лицензия', 'РУ: ЛСР-005971/10 от 25.06.2010'),
(1150, 96, '_товар_1_лицензия', 'field_62436ff0e98ec'),
(1151, 96, 'товар_1_изображение', '53'),
(1152, 96, '_товар_1_изображение', 'field_62437045e98ed'),
(1153, 96, 'товар_2_название', 'Урорек 4мг №30'),
(1154, 96, '_товар_2_название', 'field_62436fcce98ea'),
(1155, 96, 'товар_2_описание', '4&nbsp;мг&nbsp;&mdash; стартовая упаковка для лечения симптомов ДГПЖ у&nbsp;пациентов с&nbsp;почечной недостаточностью средней степени тяжести<sup>6</sup>'),
(1156, 96, '_товар_2_описание', 'field_62436fe1e98eb'),
(1157, 96, 'товар_2_лицензия', 'РУ: ЛСР-005971/10 от 25.06.2010'),
(1158, 96, '_товар_2_лицензия', 'field_62436ff0e98ec'),
(1159, 96, 'товар_2_изображение', '52'),
(1160, 96, '_товар_2_изображение', 'field_62437045e98ed'),
(1161, 96, 'товар', '3'),
(1162, 96, '_товар', 'field_62436fbde98e9'),
(1163, 96, 'заголовок-4', 'Где купить'),
(1164, 96, '_заголовок-4', 'field_624374f73d8bd'),
(1165, 96, 'изображения', 'a:12:{i:0;s:2:\"63\";i:1;s:2:\"64\";i:2;s:2:\"65\";i:3;s:2:\"66\";i:4;s:2:\"67\";i:5;s:2:\"68\";i:6;s:2:\"69\";i:7;s:2:\"70\";i:8;s:2:\"71\";i:9;s:2:\"72\";i:10;s:2:\"73\";i:11;s:2:\"74\";}'),
(1166, 96, '_изображения', 'field_624375093d8be'),
(1167, 96, 'изображения-4', 'a:12:{i:0;s:2:\"63\";i:1;s:2:\"64\";i:2;s:2:\"65\";i:3;s:2:\"66\";i:4;s:2:\"67\";i:5;s:2:\"68\";i:6;s:2:\"69\";i:7;s:2:\"70\";i:8;s:2:\"71\";i:9;s:2:\"72\";i:10;s:2:\"73\";i:11;s:2:\"74\";}'),
(1168, 96, '_изображения-4', 'field_624375093d8be'),
(1169, 96, 'заголовок-5', 'Способ применения*<sup>6</sup>'),
(1170, 96, '_заголовок-5', 'field_624379bd4756d'),
(1171, 96, 'иконки', 'a:5:{i:0;s:2:\"83\";i:1;s:2:\"84\";i:2;s:2:\"85\";i:3;s:2:\"86\";i:4;s:2:\"87\";}'),
(1172, 96, '_иконки', 'field_624379f24756e'),
(1173, 96, 'текст-5', 'У пациентов с легкой почечной недостаточностью (клиренс креатинина ≥ 50 — ≤ 80 мл/мин) коррекция дозы не требуется. Для лечения пациентов с почечной недостаточностью средней степени тяжести (клиренс креатинина ≥ 30 — < 50 мл/мин) рекомендуется в течение первой недели принимать начальную дозу по 4 мг в сутки, при хорошей индивидуальной переносимости доза может быть увеличена до 8 мг в сутки. Применение препарата для пациентов с тяжелой почечной недостаточностью (клиренс креатинина < 30 мл / мин) не рекомендуется'),
(1174, 96, '_текст-5', 'field_62437a374756f'),
(1175, 96, 'текст_под_кнопкой', '*Более подробные сведения о&nbsp;препарате, особенностях применения, побочных действиях и&nbsp;др. &mdash;&nbsp;см. инструкцию по&nbsp;медицинскому применению лекарственного препарата Урорек, РУ&nbsp;ЛСР-005971/10 от&nbsp;25.06.2010'),
(1176, 96, '_текст_под_кнопкой', 'field_62437a7c47570'),
(1177, 96, 'заголовок-6', 'Препарат Урорек (силодозин) включен в&nbsp;российские и&nbsp;международные клинические рекомендации и&nbsp;стандарты для лечения ряда урологических заболеваний:'),
(1178, 96, '_заголовок-6', 'field_6244117c68bd0'),
(1179, 96, 'список-6_0_ссылка', 'a:3:{s:5:\"title\";s:68:\"Российские клинические рекомендации\";s:3:\"url\";s:1:\"#\";s:6:\"target\";s:0:\"\";}'),
(1180, 96, '_список-6_0_ссылка', 'field_624411ce68bd2'),
(1181, 96, 'список-6_0_описание', '«Доброкачественная гиперплазия предстательной железы», 2020<sup>28</sup>'),
(1182, 96, '_список-6_0_описание', 'field_6244121168bd3'),
(1183, 96, 'список-6_1_ссылка', 'a:3:{s:5:\"title\";s:70:\"Европейские клинические рекомендации\";s:3:\"url\";s:1:\"#\";s:6:\"target\";s:0:\"\";}'),
(1184, 96, '_список-6_1_ссылка', 'field_624411ce68bd2'),
(1185, 96, 'список-6_1_описание', 'глава «Консервативное лечение ненейрогенных симптомов нарушенного мочеиспускания у мужчин, включая доброкачественную простатическую обструкцию», 2021<sup>29</sup>'),
(1186, 96, '_список-6_1_описание', 'field_6244121168bd3'),
(1187, 96, 'список-6_2_ссылка', 'a:3:{s:5:\"title\";s:154:\"Стандарт первичной медико-санитарной помощи при гиперплазии предстательной железы\";s:3:\"url\";s:1:\"#\";s:6:\"target\";s:0:\"\";}'),
(1188, 96, '_список-6_2_ссылка', 'field_624411ce68bd2'),
(1189, 96, 'список-6_2_описание', '09.11.2012<sup>30</sup> / Обновлён 13.04.2015\r\n'),
(1190, 96, '_список-6_2_описание', 'field_6244121168bd3'),
(1191, 96, 'список-6_3_ссылка', 'a:3:{s:5:\"title\";s:122:\"Стандарт специализированной медицинской помощи при задержке мочи\";s:3:\"url\";s:1:\"#\";s:6:\"target\";s:0:\"\";}'),
(1192, 96, '_список-6_3_ссылка', 'field_624411ce68bd2'),
(1193, 96, 'список-6_3_описание', '29.01.2013<sup>31</sup> / Обновлён 06.05.2015\r\n'),
(1194, 96, '_список-6_3_описание', 'field_6244121168bd3'),
(1195, 96, 'список-6_4_ссылка', 'a:3:{s:5:\"title\";s:133:\"Стандарт первичной медико-санитарной помощи при хроническом простатите\";s:3:\"url\";s:1:\"#\";s:6:\"target\";s:0:\"\";}'),
(1196, 96, '_список-6_4_ссылка', 'field_624411ce68bd2'),
(1197, 96, 'список-6_4_описание', '09.11.2012<sup>32</sup> / Обновлён 13.04.2015\r\n'),
(1198, 96, '_список-6_4_описание', 'field_6244121168bd3'),
(1199, 96, 'список-6_5_ссылка', 'a:3:{s:5:\"title\";s:168:\"Стандарт специализированной медицинской помощи при остром простатите, орхите, эпидидимите\";s:3:\"url\";s:1:\"#\";s:6:\"target\";s:0:\"\";}'),
(1200, 96, '_список-6_5_ссылка', 'field_624411ce68bd2'),
(1201, 96, 'список-6_5_описание', '09.11.2012<sup>33</sup> / Обновлён 27.05.2015'),
(1202, 96, '_список-6_5_описание', 'field_6244121168bd3'),
(1203, 96, 'список-6', '6'),
(1204, 96, '_список-6', 'field_624411be68bd1'),
(1205, 97, 'заголовок-1', 'УРОРЕК – оригинальный<sup>10</sup> альфа-адреноблокатор'),
(1206, 97, '_заголовок-1', 'field_62435bd26f29f'),
(1207, 97, 'текст-1', '<div class=\"headerBlock__body\">\r\n<p>Силодозин (действующее вещество препарата Урорек) обладает максимальной уроселективностью в&nbsp;своем классе, что обеспечивает его уродинамическую эффективность и&nbsp;высокую безопасность<sup>4</sup></p>\r\n</div>\r\n<div class=\"headerBlock__footer\">\r\n<p><strong>Показания к применению: </strong><br/>Лечение симптомов доброкачественной гиперплазии предстательной железы<sup>6</sup></p>\r\n</div>'),
(1208, 97, '_текст-1', 'field_62435c0c6f2a0'),
(1209, 97, 'изображение-1', '13'),
(1210, 97, '_изображение-1', 'field_62435c8b6f2a1'),
(1211, 97, 'фон-1', '17'),
(1212, 97, '_фон-1', 'field_62435db92ea96'),
(1213, 97, 'заголовок-2', 'Ключевые преимущества препарата Урорек'),
(1214, 97, '_заголовок-2', 'field_6243606295196'),
(1215, 97, 'список-2', 'Единственный оригинальный препарат из&nbsp;группы альфа1-адреноблокаторов, не&nbsp;имеющий генериков в&nbsp;РФ<sup>1</sup>'),
(1216, 97, '_список-2', 'field_6243608195197'),
(1217, 97, 'картинка_с_текстом_0_изображение', '31'),
(1218, 97, '_картинка_с_текстом_0_изображение', 'field_624363d095199'),
(1219, 97, 'картинка_с_текстом_0_описание', 'Обширная доказательная база собственных пострегистрационных клинических исследований<sup>2</sup>'),
(1220, 97, '_картинка_с_текстом_0_описание', 'field_624363e59519a'),
(1221, 97, 'картинка_с_текстом_1_изображение', '32'),
(1222, 97, '_картинка_с_текстом_1_изображение', 'field_624363d095199'),
(1223, 97, 'картинка_с_текстом_1_описание', 'Отсутствие риска замены препарата Урорек в&nbsp;аптеке (единственный препарат с&nbsp;действующим веществом силодозин)<sup>1</sup>'),
(1224, 97, '_картинка_с_текстом_1_описание', 'field_624363e59519a'),
(1225, 97, 'картинка_с_текстом_2_изображение', '33'),
(1226, 97, '_картинка_с_текстом_2_изображение', 'field_624363d095199'),
(1227, 97, 'картинка_с_текстом_2_описание', 'Большинство пациентов предпочитают принимать оригинальные препараты<sup>3</sup>'),
(1228, 97, '_картинка_с_текстом_2_описание', 'field_624363e59519a'),
(1229, 97, 'картинка_с_текстом', '3'),
(1230, 97, '_картинка_с_текстом', 'field_624363b995198'),
(1231, 97, 'второй_список', '<li>Клинические преимущества препарата Урорек (силодозин) определяются максимальной уроселективностью в&nbsp;классе альфа-адреноблокаторов<sup>4</sup></li>\r\n\r\n<li>Урорек&nbsp;&mdash; альфа-адреноблокатор последнего поколения, который эффективен в&nbsp;отношении всех СНМП (накопления, опорожнения, постмиктурических).<sup>12,13</sup> При этом Урорек обладает минимальным риском развития нежелательных явлений со&nbsp;стороны сердечно-сосудистой системы, в&nbsp;том числе&nbsp;у&nbsp;пациентов, принимающих антигипертензивные препараты<sup>46,8</sup> <small> <span>СНМП </span>симптомы нижних мочевыводящих путей</small></li>'),
(1232, 97, '_второй_список', 'field_6243640e05eda'),
(1233, 97, 'заголовок2-2', 'Максимальная уроселективность силодозина в&nbsp;классе альфа-адреноблокаторов обуславливает его уродинамическую эффективность и&nbsp;высокий профиль безопасности<sup>4</sup>'),
(1234, 97, '_заголовок2-2', 'field_6243644705edb'),
(1235, 97, 'текст3', '<ul>\r\n<li>Урорек значительно улучшает клинические проявления и&nbsp;качество жизни у&nbsp;всех пациентов с&nbsp;СНМП/ДГПЖ, в&nbsp;том числе с&nbsp;тяжелым течением<sup>11</sup><a href=\"#\">Узнать больше...</a></li>\r\n\r\n<li>Урорек является препаратом выбора для пациентов с&nbsp;СНМП/ДГПЖ и&nbsp;сопутствующими сердечно-сосудистыми заболеваниями<sup>3</sup> <a href=\"#\">Узнать больше...</a></li>\r\n</ul>\r\n<small> <span>ДГПЖ </span>доброкачественная гиперплазия предстательной железы</small>'),
(1236, 97, '_текст3', 'field_6243647405edc'),
(1237, 97, 'изображение-2', '34'),
(1238, 97, '_изображение-2', 'field_624364dd05edd'),
(1239, 97, 'текст_в_подвале', '<h2> Максимальная уроселективность в&nbsp;классе  альфа-адреноблокаторов<sup>4</sup></h2>\r\n<div class=\"h3\"> Почему это важно? <a href=\"#\">Подробнее</a></div>'),
(1240, 97, '_текст_в_подвале', 'field_62436daf1f6d9'),
(1241, 97, 'заголовок-3', 'Форма выпуска препарата Урорек'),
(1242, 97, '_заголовок-3', 'field_62436efee98e7'),
(1243, 97, 'текст-3', '<p class=\"section-descr\"><span>8мг </span>- рекомендуемая доза для лечения симптомов ДГПЖ<sup>6</sup>*</p>\r\n					<p class=\"section-note col-md-10\">*Более подробные сведения о&nbsp;препарате, особенностях применения, побочных действиях и&nbsp;др. &mdash;&nbsp;смотрите инструкцию по&nbsp;медицинскому применению лекарственного препарата Урорек, РУ&nbsp;ЛСР-005971/10 от&nbsp;25.06.2010 </p>'),
(1244, 97, '_текст-3', 'field_62436f60e98e8'),
(1245, 97, 'товар_0_название', 'Урорек 8мг №30'),
(1246, 97, '_товар_0_название', 'field_62436fcce98ea'),
(1247, 97, 'товар_0_описание', 'Упаковка, рассчитанная на&nbsp;1&nbsp;месяц лечения&nbsp;/ для старта терапии'),
(1248, 97, '_товар_0_описание', 'field_62436fe1e98eb'),
(1249, 97, 'товар_0_лицензия', 'РУ: ЛСР-005971/10 от 25.06.2010'),
(1250, 97, '_товар_0_лицензия', 'field_62436ff0e98ec'),
(1251, 97, 'товар_0_изображение', '51'),
(1252, 97, '_товар_0_изображение', 'field_62437045e98ed'),
(1253, 97, 'товар_1_название', 'Урорек 8мг №90'),
(1254, 97, '_товар_1_название', 'field_62436fcce98ea'),
(1255, 97, 'товар_1_описание', 'Выгодная упаковка, рассчитанная на&nbsp;3&nbsp;месяца лечения. Самая доступная стоимость 1&nbsp;дня терапии препаратом Урорек&nbsp;<sup>27</sup>'),
(1256, 97, '_товар_1_описание', 'field_62436fe1e98eb'),
(1257, 97, 'товар_1_лицензия', 'РУ: ЛСР-005971/10 от 25.06.2010'),
(1258, 97, '_товар_1_лицензия', 'field_62436ff0e98ec'),
(1259, 97, 'товар_1_изображение', '53'),
(1260, 97, '_товар_1_изображение', 'field_62437045e98ed'),
(1261, 97, 'товар_2_название', 'Урорек 4мг №30'),
(1262, 97, '_товар_2_название', 'field_62436fcce98ea'),
(1263, 97, 'товар_2_описание', '4&nbsp;мг&nbsp;&mdash; стартовая упаковка для лечения симптомов ДГПЖ у&nbsp;пациентов с&nbsp;почечной недостаточностью средней степени тяжести<sup>6</sup>'),
(1264, 97, '_товар_2_описание', 'field_62436fe1e98eb'),
(1265, 97, 'товар_2_лицензия', 'РУ: ЛСР-005971/10 от 25.06.2010'),
(1266, 97, '_товар_2_лицензия', 'field_62436ff0e98ec'),
(1267, 97, 'товар_2_изображение', '52'),
(1268, 97, '_товар_2_изображение', 'field_62437045e98ed'),
(1269, 97, 'товар', '3'),
(1270, 97, '_товар', 'field_62436fbde98e9'),
(1271, 97, 'заголовок-4', 'Где купить'),
(1272, 97, '_заголовок-4', 'field_624374f73d8bd'),
(1273, 97, 'изображения', 'a:12:{i:0;s:2:\"63\";i:1;s:2:\"64\";i:2;s:2:\"65\";i:3;s:2:\"66\";i:4;s:2:\"67\";i:5;s:2:\"68\";i:6;s:2:\"69\";i:7;s:2:\"70\";i:8;s:2:\"71\";i:9;s:2:\"72\";i:10;s:2:\"73\";i:11;s:2:\"74\";}'),
(1274, 97, '_изображения', 'field_624375093d8be'),
(1275, 97, 'изображения-4', 'a:12:{i:0;s:2:\"63\";i:1;s:2:\"64\";i:2;s:2:\"65\";i:3;s:2:\"66\";i:4;s:2:\"67\";i:5;s:2:\"68\";i:6;s:2:\"69\";i:7;s:2:\"70\";i:8;s:2:\"71\";i:9;s:2:\"72\";i:10;s:2:\"73\";i:11;s:2:\"74\";}'),
(1276, 97, '_изображения-4', 'field_624375093d8be'),
(1277, 97, 'заголовок-5', 'Способ применения*<sup>6</sup>'),
(1278, 97, '_заголовок-5', 'field_624379bd4756d'),
(1279, 97, 'иконки', 'a:5:{i:0;s:2:\"83\";i:1;s:2:\"84\";i:2;s:2:\"85\";i:3;s:2:\"86\";i:4;s:2:\"87\";}'),
(1280, 97, '_иконки', 'field_624379f24756e'),
(1281, 97, 'текст-5', 'У пациентов с легкой почечной недостаточностью (клиренс креатинина ≥ 50 — ≤ 80 мл/мин) коррекция дозы не требуется. Для лечения пациентов с почечной недостаточностью средней степени тяжести (клиренс креатинина ≥ 30 — < 50 мл/мин) рекомендуется в течение первой недели принимать начальную дозу по 4 мг в сутки, при хорошей индивидуальной переносимости доза может быть увеличена до 8 мг в сутки. Применение препарата для пациентов с тяжелой почечной недостаточностью (клиренс креатинина < 30 мл / мин) не рекомендуется'),
(1282, 97, '_текст-5', 'field_62437a374756f'),
(1283, 97, 'текст_под_кнопкой', '*Более подробные сведения о&nbsp;препарате, особенностях применения, побочных действиях и&nbsp;др. &mdash;&nbsp;см. инструкцию по&nbsp;медицинскому применению лекарственного препарата Урорек, РУ&nbsp;ЛСР-005971/10 от&nbsp;25.06.2010'),
(1284, 97, '_текст_под_кнопкой', 'field_62437a7c47570'),
(1285, 97, 'заголовок-6', 'Препарат Урорек (силодозин) включен в&nbsp;российские и&nbsp;международные клинические рекомендации и&nbsp;стандарты для лечения ряда урологических заболеваний:'),
(1286, 97, '_заголовок-6', 'field_6244117c68bd0'),
(1287, 97, 'список-6_0_ссылка', 'a:3:{s:5:\"title\";s:68:\"Российские клинические рекомендации\";s:3:\"url\";s:1:\"#\";s:6:\"target\";s:0:\"\";}'),
(1288, 97, '_список-6_0_ссылка', 'field_624411ce68bd2'),
(1289, 97, 'список-6_0_описание', '«Доброкачественная гиперплазия предстательной железы», 2020<sup>28</sup>'),
(1290, 97, '_список-6_0_описание', 'field_6244121168bd3'),
(1291, 97, 'список-6_1_ссылка', 'a:3:{s:5:\"title\";s:70:\"Европейские клинические рекомендации\";s:3:\"url\";s:1:\"#\";s:6:\"target\";s:0:\"\";}'),
(1292, 97, '_список-6_1_ссылка', 'field_624411ce68bd2'),
(1293, 97, 'список-6_1_описание', 'глава «Консервативное лечение ненейрогенных симптомов нарушенного мочеиспускания у мужчин, включая доброкачественную простатическую обструкцию», 2021<sup>29</sup>'),
(1294, 97, '_список-6_1_описание', 'field_6244121168bd3'),
(1295, 97, 'список-6_2_ссылка', 'a:3:{s:5:\"title\";s:154:\"Стандарт первичной медико-санитарной помощи при гиперплазии предстательной железы\";s:3:\"url\";s:1:\"#\";s:6:\"target\";s:0:\"\";}'),
(1296, 97, '_список-6_2_ссылка', 'field_624411ce68bd2'),
(1297, 97, 'список-6_2_описание', '09.11.2012<sup>30</sup> / Обновлён 13.04.2015\r\n'),
(1298, 97, '_список-6_2_описание', 'field_6244121168bd3'),
(1299, 97, 'список-6_3_ссылка', 'a:3:{s:5:\"title\";s:122:\"Стандарт специализированной медицинской помощи при задержке мочи\";s:3:\"url\";s:1:\"#\";s:6:\"target\";s:0:\"\";}'),
(1300, 97, '_список-6_3_ссылка', 'field_624411ce68bd2'),
(1301, 97, 'список-6_3_описание', '29.01.2013<sup>31</sup> / Обновлён 06.05.2015\r\n'),
(1302, 97, '_список-6_3_описание', 'field_6244121168bd3'),
(1303, 97, 'список-6_4_ссылка', 'a:3:{s:5:\"title\";s:133:\"Стандарт первичной медико-санитарной помощи при хроническом простатите\";s:3:\"url\";s:1:\"#\";s:6:\"target\";s:0:\"\";}'),
(1304, 97, '_список-6_4_ссылка', 'field_624411ce68bd2'),
(1305, 97, 'список-6_4_описание', '09.11.2012<sup>32</sup> / Обновлён 13.04.2015\r\n'),
(1306, 97, '_список-6_4_описание', 'field_6244121168bd3'),
(1307, 97, 'список-6_5_ссылка', 'a:3:{s:5:\"title\";s:168:\"Стандарт специализированной медицинской помощи при остром простатите, орхите, эпидидимите\";s:3:\"url\";s:1:\"#\";s:6:\"target\";s:0:\"\";}'),
(1308, 97, '_список-6_5_ссылка', 'field_624411ce68bd2'),
(1309, 97, 'список-6_5_описание', '09.11.2012<sup>33</sup> / Обновлён 27.05.2015'),
(1310, 97, '_список-6_5_описание', 'field_6244121168bd3'),
(1311, 97, 'список-6', '6'),
(1312, 97, '_список-6', 'field_624411be68bd1'),
(1313, 98, '_edit_last', '1'),
(1314, 98, '_edit_lock', '1648636367:1'),
(1315, 105, '_wp_attached_file', '2022/03/countries-img-1.png'),
(1316, 105, '_wp_attachment_metadata', 'a:5:{s:5:\"width\";i:191;s:6:\"height\";i:120;s:4:\"file\";s:27:\"2022/03/countries-img-1.png\";s:5:\"sizes\";a:1:{s:9:\"thumbnail\";a:4:{s:4:\"file\";s:27:\"countries-img-1-150x120.png\";s:5:\"width\";i:150;s:6:\"height\";i:120;s:9:\"mime-type\";s:9:\"image/png\";}}s:10:\"image_meta\";a:12:{s:8:\"aperture\";s:1:\"0\";s:6:\"credit\";s:0:\"\";s:6:\"camera\";s:0:\"\";s:7:\"caption\";s:0:\"\";s:17:\"created_timestamp\";s:1:\"0\";s:9:\"copyright\";s:0:\"\";s:12:\"focal_length\";s:1:\"0\";s:3:\"iso\";s:1:\"0\";s:13:\"shutter_speed\";s:1:\"0\";s:5:\"title\";s:0:\"\";s:11:\"orientation\";s:1:\"0\";s:8:\"keywords\";a:0:{}}}'),
(1317, 106, '_wp_attached_file', '2022/03/countries-img-2.png'),
(1318, 106, '_wp_attachment_metadata', 'a:5:{s:5:\"width\";i:190;s:6:\"height\";i:120;s:4:\"file\";s:27:\"2022/03/countries-img-2.png\";s:5:\"sizes\";a:1:{s:9:\"thumbnail\";a:4:{s:4:\"file\";s:27:\"countries-img-2-150x120.png\";s:5:\"width\";i:150;s:6:\"height\";i:120;s:9:\"mime-type\";s:9:\"image/png\";}}s:10:\"image_meta\";a:12:{s:8:\"aperture\";s:1:\"0\";s:6:\"credit\";s:0:\"\";s:6:\"camera\";s:0:\"\";s:7:\"caption\";s:0:\"\";s:17:\"created_timestamp\";s:1:\"0\";s:9:\"copyright\";s:0:\"\";s:12:\"focal_length\";s:1:\"0\";s:3:\"iso\";s:1:\"0\";s:13:\"shutter_speed\";s:1:\"0\";s:5:\"title\";s:0:\"\";s:11:\"orientation\";s:1:\"0\";s:8:\"keywords\";a:0:{}}}'),
(1319, 107, '_wp_attached_file', '2022/03/countries-img-3.png'),
(1320, 107, '_wp_attachment_metadata', 'a:5:{s:5:\"width\";i:190;s:6:\"height\";i:120;s:4:\"file\";s:27:\"2022/03/countries-img-3.png\";s:5:\"sizes\";a:1:{s:9:\"thumbnail\";a:4:{s:4:\"file\";s:27:\"countries-img-3-150x120.png\";s:5:\"width\";i:150;s:6:\"height\";i:120;s:9:\"mime-type\";s:9:\"image/png\";}}s:10:\"image_meta\";a:12:{s:8:\"aperture\";s:1:\"0\";s:6:\"credit\";s:0:\"\";s:6:\"camera\";s:0:\"\";s:7:\"caption\";s:0:\"\";s:17:\"created_timestamp\";s:1:\"0\";s:9:\"copyright\";s:0:\"\";s:12:\"focal_length\";s:1:\"0\";s:3:\"iso\";s:1:\"0\";s:13:\"shutter_speed\";s:1:\"0\";s:5:\"title\";s:0:\"\";s:11:\"orientation\";s:1:\"0\";s:8:\"keywords\";a:0:{}}}'),
(1321, 108, '_wp_attached_file', '2022/03/countries-img-4.png'),
(1322, 108, '_wp_attachment_metadata', 'a:5:{s:5:\"width\";i:190;s:6:\"height\";i:120;s:4:\"file\";s:27:\"2022/03/countries-img-4.png\";s:5:\"sizes\";a:1:{s:9:\"thumbnail\";a:4:{s:4:\"file\";s:27:\"countries-img-4-150x120.png\";s:5:\"width\";i:150;s:6:\"height\";i:120;s:9:\"mime-type\";s:9:\"image/png\";}}s:10:\"image_meta\";a:12:{s:8:\"aperture\";s:1:\"0\";s:6:\"credit\";s:0:\"\";s:6:\"camera\";s:0:\"\";s:7:\"caption\";s:0:\"\";s:17:\"created_timestamp\";s:1:\"0\";s:9:\"copyright\";s:0:\"\";s:12:\"focal_length\";s:1:\"0\";s:3:\"iso\";s:1:\"0\";s:13:\"shutter_speed\";s:1:\"0\";s:5:\"title\";s:0:\"\";s:11:\"orientation\";s:1:\"0\";s:8:\"keywords\";a:0:{}}}'),
(1323, 2, 'заголовок-7', 'Препарат Урорек (силодозин) зарегистрирован и&nbsp;применяется в&nbsp;разных странах мира <br>\r\nОдобрен ЕМА*<sup>34</sup> и&nbsp;FDA**<sup>35</sup>'),
(1324, 2, '_заголовок-7', 'field_624417e3b6088'),
(1325, 2, 'текст', '<p class=\"sOtherCountries__agency\"><span>EMA</span> Европейское медицинское агентство</p>\r\n<p class=\"sOtherCountries__agency\"><span>FDA</span> Управление по&nbsp;санитарному надзору за&nbsp;качеством пищевых продуктов и&nbsp;медикаментов, США</p>'),
(1326, 2, '_текст', 'field_6244182bb6089'),
(1327, 2, 'страны_0_флаг', '105'),
(1328, 2, '_страны_0_флаг', 'field_62441880b608b'),
(1329, 2, 'страны_0_название', 'Япония'),
(1330, 2, '_страны_0_название', 'field_62441899b608c'),
(1331, 2, 'страны_0_год', '2006<sup>36,37</sup>'),
(1332, 2, '_страны_0_год', 'field_624418aab608d'),
(1333, 2, 'страны_1_флаг', '106'),
(1334, 2, '_страны_1_флаг', 'field_62441880b608b'),
(1335, 2, 'страны_1_название', 'США'),
(1336, 2, '_страны_1_название', 'field_62441899b608c'),
(1337, 2, 'страны_1_год', '2008<sup>35</sup>'),
(1338, 2, '_страны_1_год', 'field_624418aab608d'),
(1339, 2, 'страны_2_флаг', '107'),
(1340, 2, '_страны_2_флаг', 'field_62441880b608b'),
(1341, 2, 'страны_2_название', 'Страны ЕС'),
(1342, 2, '_страны_2_название', 'field_62441899b608c'),
(1343, 2, 'страны_2_год', '2010<sup>34</sup>'),
(1344, 2, '_страны_2_год', 'field_624418aab608d'),
(1345, 2, 'страны_3_флаг', '108'),
(1346, 2, '_страны_3_флаг', 'field_62441880b608b'),
(1347, 2, 'страны_3_название', 'Россия'),
(1348, 2, '_страны_3_название', 'field_62441899b608c'),
(1349, 2, 'страны_3_год', '2010<sup>1</sup>'),
(1350, 2, '_страны_3_год', 'field_624418aab608d'),
(1351, 2, 'страны', '4'),
(1352, 2, '_страны', 'field_62441847b608a'),
(1353, 110, 'заголовок-1', 'УРОРЕК – оригинальный<sup>10</sup> альфа-адреноблокатор'),
(1354, 110, '_заголовок-1', 'field_62435bd26f29f'),
(1355, 110, 'текст-1', '<div class=\"headerBlock__body\">\r\n<p>Силодозин (действующее вещество препарата Урорек) обладает максимальной уроселективностью в&nbsp;своем классе, что обеспечивает его уродинамическую эффективность и&nbsp;высокую безопасность<sup>4</sup></p>\r\n</div>\r\n<div class=\"headerBlock__footer\">\r\n<p><strong>Показания к применению: </strong><br/>Лечение симптомов доброкачественной гиперплазии предстательной железы<sup>6</sup></p>\r\n</div>'),
(1356, 110, '_текст-1', 'field_62435c0c6f2a0'),
(1357, 110, 'изображение-1', '13'),
(1358, 110, '_изображение-1', 'field_62435c8b6f2a1'),
(1359, 110, 'фон-1', '17'),
(1360, 110, '_фон-1', 'field_62435db92ea96'),
(1361, 110, 'заголовок-2', 'Ключевые преимущества препарата Урорек'),
(1362, 110, '_заголовок-2', 'field_6243606295196'),
(1363, 110, 'список-2', 'Единственный оригинальный препарат из&nbsp;группы альфа1-адреноблокаторов, не&nbsp;имеющий генериков в&nbsp;РФ<sup>1</sup>'),
(1364, 110, '_список-2', 'field_6243608195197'),
(1365, 110, 'картинка_с_текстом_0_изображение', '31'),
(1366, 110, '_картинка_с_текстом_0_изображение', 'field_624363d095199'),
(1367, 110, 'картинка_с_текстом_0_описание', 'Обширная доказательная база собственных пострегистрационных клинических исследований<sup>2</sup>'),
(1368, 110, '_картинка_с_текстом_0_описание', 'field_624363e59519a'),
(1369, 110, 'картинка_с_текстом_1_изображение', '32'),
(1370, 110, '_картинка_с_текстом_1_изображение', 'field_624363d095199'),
(1371, 110, 'картинка_с_текстом_1_описание', 'Отсутствие риска замены препарата Урорек в&nbsp;аптеке (единственный препарат с&nbsp;действующим веществом силодозин)<sup>1</sup>'),
(1372, 110, '_картинка_с_текстом_1_описание', 'field_624363e59519a'),
(1373, 110, 'картинка_с_текстом_2_изображение', '33'),
(1374, 110, '_картинка_с_текстом_2_изображение', 'field_624363d095199'),
(1375, 110, 'картинка_с_текстом_2_описание', 'Большинство пациентов предпочитают принимать оригинальные препараты<sup>3</sup>'),
(1376, 110, '_картинка_с_текстом_2_описание', 'field_624363e59519a'),
(1377, 110, 'картинка_с_текстом', '3'),
(1378, 110, '_картинка_с_текстом', 'field_624363b995198'),
(1379, 110, 'второй_список', '<li>Клинические преимущества препарата Урорек (силодозин) определяются максимальной уроселективностью в&nbsp;классе альфа-адреноблокаторов<sup>4</sup></li>\r\n\r\n<li>Урорек&nbsp;&mdash; альфа-адреноблокатор последнего поколения, который эффективен в&nbsp;отношении всех СНМП (накопления, опорожнения, постмиктурических).<sup>12,13</sup> При этом Урорек обладает минимальным риском развития нежелательных явлений со&nbsp;стороны сердечно-сосудистой системы, в&nbsp;том числе&nbsp;у&nbsp;пациентов, принимающих антигипертензивные препараты<sup>46,8</sup> <small> <span>СНМП </span>симптомы нижних мочевыводящих путей</small></li>'),
(1380, 110, '_второй_список', 'field_6243640e05eda'),
(1381, 110, 'заголовок2-2', 'Максимальная уроселективность силодозина в&nbsp;классе альфа-адреноблокаторов обуславливает его уродинамическую эффективность и&nbsp;высокий профиль безопасности<sup>4</sup>'),
(1382, 110, '_заголовок2-2', 'field_6243644705edb');
INSERT INTO `urotec_postmeta` (`meta_id`, `post_id`, `meta_key`, `meta_value`) VALUES
(1383, 110, 'текст3', '<ul>\r\n<li>Урорек значительно улучшает клинические проявления и&nbsp;качество жизни у&nbsp;всех пациентов с&nbsp;СНМП/ДГПЖ, в&nbsp;том числе с&nbsp;тяжелым течением<sup>11</sup><a href=\"#\">Узнать больше...</a></li>\r\n\r\n<li>Урорек является препаратом выбора для пациентов с&nbsp;СНМП/ДГПЖ и&nbsp;сопутствующими сердечно-сосудистыми заболеваниями<sup>3</sup> <a href=\"#\">Узнать больше...</a></li>\r\n</ul>\r\n<small> <span>ДГПЖ </span>доброкачественная гиперплазия предстательной железы</small>'),
(1384, 110, '_текст3', 'field_6243647405edc'),
(1385, 110, 'изображение-2', '34'),
(1386, 110, '_изображение-2', 'field_624364dd05edd'),
(1387, 110, 'текст_в_подвале', '<h2> Максимальная уроселективность в&nbsp;классе  альфа-адреноблокаторов<sup>4</sup></h2>\r\n<div class=\"h3\"> Почему это важно? <a href=\"#\">Подробнее</a></div>'),
(1388, 110, '_текст_в_подвале', 'field_62436daf1f6d9'),
(1389, 110, 'заголовок-3', 'Форма выпуска препарата Урорек'),
(1390, 110, '_заголовок-3', 'field_62436efee98e7'),
(1391, 110, 'текст-3', '<p class=\"section-descr\"><span>8мг </span>- рекомендуемая доза для лечения симптомов ДГПЖ<sup>6</sup>*</p>\r\n					<p class=\"section-note col-md-10\">*Более подробные сведения о&nbsp;препарате, особенностях применения, побочных действиях и&nbsp;др. &mdash;&nbsp;смотрите инструкцию по&nbsp;медицинскому применению лекарственного препарата Урорек, РУ&nbsp;ЛСР-005971/10 от&nbsp;25.06.2010 </p>'),
(1392, 110, '_текст-3', 'field_62436f60e98e8'),
(1393, 110, 'товар_0_название', 'Урорек 8мг №30'),
(1394, 110, '_товар_0_название', 'field_62436fcce98ea'),
(1395, 110, 'товар_0_описание', 'Упаковка, рассчитанная на&nbsp;1&nbsp;месяц лечения&nbsp;/ для старта терапии'),
(1396, 110, '_товар_0_описание', 'field_62436fe1e98eb'),
(1397, 110, 'товар_0_лицензия', 'РУ: ЛСР-005971/10 от 25.06.2010'),
(1398, 110, '_товар_0_лицензия', 'field_62436ff0e98ec'),
(1399, 110, 'товар_0_изображение', '51'),
(1400, 110, '_товар_0_изображение', 'field_62437045e98ed'),
(1401, 110, 'товар_1_название', 'Урорек 8мг №90'),
(1402, 110, '_товар_1_название', 'field_62436fcce98ea'),
(1403, 110, 'товар_1_описание', 'Выгодная упаковка, рассчитанная на&nbsp;3&nbsp;месяца лечения. Самая доступная стоимость 1&nbsp;дня терапии препаратом Урорек&nbsp;<sup>27</sup>'),
(1404, 110, '_товар_1_описание', 'field_62436fe1e98eb'),
(1405, 110, 'товар_1_лицензия', 'РУ: ЛСР-005971/10 от 25.06.2010'),
(1406, 110, '_товар_1_лицензия', 'field_62436ff0e98ec'),
(1407, 110, 'товар_1_изображение', '53'),
(1408, 110, '_товар_1_изображение', 'field_62437045e98ed'),
(1409, 110, 'товар_2_название', 'Урорек 4мг №30'),
(1410, 110, '_товар_2_название', 'field_62436fcce98ea'),
(1411, 110, 'товар_2_описание', '4&nbsp;мг&nbsp;&mdash; стартовая упаковка для лечения симптомов ДГПЖ у&nbsp;пациентов с&nbsp;почечной недостаточностью средней степени тяжести<sup>6</sup>'),
(1412, 110, '_товар_2_описание', 'field_62436fe1e98eb'),
(1413, 110, 'товар_2_лицензия', 'РУ: ЛСР-005971/10 от 25.06.2010'),
(1414, 110, '_товар_2_лицензия', 'field_62436ff0e98ec'),
(1415, 110, 'товар_2_изображение', '52'),
(1416, 110, '_товар_2_изображение', 'field_62437045e98ed'),
(1417, 110, 'товар', '3'),
(1418, 110, '_товар', 'field_62436fbde98e9'),
(1419, 110, 'заголовок-4', 'Где купить'),
(1420, 110, '_заголовок-4', 'field_624374f73d8bd'),
(1421, 110, 'изображения', 'a:12:{i:0;s:2:\"63\";i:1;s:2:\"64\";i:2;s:2:\"65\";i:3;s:2:\"66\";i:4;s:2:\"67\";i:5;s:2:\"68\";i:6;s:2:\"69\";i:7;s:2:\"70\";i:8;s:2:\"71\";i:9;s:2:\"72\";i:10;s:2:\"73\";i:11;s:2:\"74\";}'),
(1422, 110, '_изображения', 'field_624375093d8be'),
(1423, 110, 'изображения-4', 'a:12:{i:0;s:2:\"63\";i:1;s:2:\"64\";i:2;s:2:\"65\";i:3;s:2:\"66\";i:4;s:2:\"67\";i:5;s:2:\"68\";i:6;s:2:\"69\";i:7;s:2:\"70\";i:8;s:2:\"71\";i:9;s:2:\"72\";i:10;s:2:\"73\";i:11;s:2:\"74\";}'),
(1424, 110, '_изображения-4', 'field_624375093d8be'),
(1425, 110, 'заголовок-5', 'Способ применения*<sup>6</sup>'),
(1426, 110, '_заголовок-5', 'field_624379bd4756d'),
(1427, 110, 'иконки', 'a:5:{i:0;s:2:\"83\";i:1;s:2:\"84\";i:2;s:2:\"85\";i:3;s:2:\"86\";i:4;s:2:\"87\";}'),
(1428, 110, '_иконки', 'field_624379f24756e'),
(1429, 110, 'текст-5', 'У пациентов с легкой почечной недостаточностью (клиренс креатинина ≥ 50 — ≤ 80 мл/мин) коррекция дозы не требуется. Для лечения пациентов с почечной недостаточностью средней степени тяжести (клиренс креатинина ≥ 30 — < 50 мл/мин) рекомендуется в течение первой недели принимать начальную дозу по 4 мг в сутки, при хорошей индивидуальной переносимости доза может быть увеличена до 8 мг в сутки. Применение препарата для пациентов с тяжелой почечной недостаточностью (клиренс креатинина < 30 мл / мин) не рекомендуется'),
(1430, 110, '_текст-5', 'field_62437a374756f'),
(1431, 110, 'текст_под_кнопкой', '*Более подробные сведения о&nbsp;препарате, особенностях применения, побочных действиях и&nbsp;др. &mdash;&nbsp;см. инструкцию по&nbsp;медицинскому применению лекарственного препарата Урорек, РУ&nbsp;ЛСР-005971/10 от&nbsp;25.06.2010'),
(1432, 110, '_текст_под_кнопкой', 'field_62437a7c47570'),
(1433, 110, 'заголовок-6', 'Препарат Урорек (силодозин) включен в&nbsp;российские и&nbsp;международные клинические рекомендации и&nbsp;стандарты для лечения ряда урологических заболеваний:'),
(1434, 110, '_заголовок-6', 'field_6244117c68bd0'),
(1435, 110, 'список-6_0_ссылка', 'a:3:{s:5:\"title\";s:68:\"Российские клинические рекомендации\";s:3:\"url\";s:1:\"#\";s:6:\"target\";s:0:\"\";}'),
(1436, 110, '_список-6_0_ссылка', 'field_624411ce68bd2'),
(1437, 110, 'список-6_0_описание', '«Доброкачественная гиперплазия предстательной железы», 2020<sup>28</sup>'),
(1438, 110, '_список-6_0_описание', 'field_6244121168bd3'),
(1439, 110, 'список-6_1_ссылка', 'a:3:{s:5:\"title\";s:70:\"Европейские клинические рекомендации\";s:3:\"url\";s:1:\"#\";s:6:\"target\";s:0:\"\";}'),
(1440, 110, '_список-6_1_ссылка', 'field_624411ce68bd2'),
(1441, 110, 'список-6_1_описание', 'глава «Консервативное лечение ненейрогенных симптомов нарушенного мочеиспускания у мужчин, включая доброкачественную простатическую обструкцию», 2021<sup>29</sup>'),
(1442, 110, '_список-6_1_описание', 'field_6244121168bd3'),
(1443, 110, 'список-6_2_ссылка', 'a:3:{s:5:\"title\";s:154:\"Стандарт первичной медико-санитарной помощи при гиперплазии предстательной железы\";s:3:\"url\";s:1:\"#\";s:6:\"target\";s:0:\"\";}'),
(1444, 110, '_список-6_2_ссылка', 'field_624411ce68bd2'),
(1445, 110, 'список-6_2_описание', '09.11.2012<sup>30</sup> / Обновлён 13.04.2015\r\n'),
(1446, 110, '_список-6_2_описание', 'field_6244121168bd3'),
(1447, 110, 'список-6_3_ссылка', 'a:3:{s:5:\"title\";s:122:\"Стандарт специализированной медицинской помощи при задержке мочи\";s:3:\"url\";s:1:\"#\";s:6:\"target\";s:0:\"\";}'),
(1448, 110, '_список-6_3_ссылка', 'field_624411ce68bd2'),
(1449, 110, 'список-6_3_описание', '29.01.2013<sup>31</sup> / Обновлён 06.05.2015\r\n'),
(1450, 110, '_список-6_3_описание', 'field_6244121168bd3'),
(1451, 110, 'список-6_4_ссылка', 'a:3:{s:5:\"title\";s:133:\"Стандарт первичной медико-санитарной помощи при хроническом простатите\";s:3:\"url\";s:1:\"#\";s:6:\"target\";s:0:\"\";}'),
(1452, 110, '_список-6_4_ссылка', 'field_624411ce68bd2'),
(1453, 110, 'список-6_4_описание', '09.11.2012<sup>32</sup> / Обновлён 13.04.2015\r\n'),
(1454, 110, '_список-6_4_описание', 'field_6244121168bd3'),
(1455, 110, 'список-6_5_ссылка', 'a:3:{s:5:\"title\";s:168:\"Стандарт специализированной медицинской помощи при остром простатите, орхите, эпидидимите\";s:3:\"url\";s:1:\"#\";s:6:\"target\";s:0:\"\";}'),
(1456, 110, '_список-6_5_ссылка', 'field_624411ce68bd2'),
(1457, 110, 'список-6_5_описание', '09.11.2012<sup>33</sup> / Обновлён 27.05.2015'),
(1458, 110, '_список-6_5_описание', 'field_6244121168bd3'),
(1459, 110, 'список-6', '6'),
(1460, 110, '_список-6', 'field_624411be68bd1'),
(1461, 110, 'заголовок-7', 'Препарат Урорек (силодозин) зарегистрирован и&nbsp;применяется в&nbsp;разных странах мира Одобрен ЕМА*<sup>34</sup> и&nbsp;FDA**<sup>35</sup>'),
(1462, 110, '_заголовок-7', 'field_624417e3b6088'),
(1463, 110, 'текст', '<p class=\"sOtherCountries__agency\"><span>EMA</span> Европейское медицинское агентство</p>\r\n<p class=\"sOtherCountries__agency\"><span>FDA</span> Управление по&nbsp;санитарному надзору за&nbsp;качеством пищевых продуктов и&nbsp;медикаментов, США</p>'),
(1464, 110, '_текст', 'field_6244182bb6089'),
(1465, 110, 'страны_0_флаг', '105'),
(1466, 110, '_страны_0_флаг', 'field_62441880b608b'),
(1467, 110, 'страны_0_название', ''),
(1468, 110, '_страны_0_название', 'field_62441899b608c'),
(1469, 110, 'страны_0_год', ''),
(1470, 110, '_страны_0_год', 'field_624418aab608d'),
(1471, 110, 'страны_1_флаг', '106'),
(1472, 110, '_страны_1_флаг', 'field_62441880b608b'),
(1473, 110, 'страны_1_название', ''),
(1474, 110, '_страны_1_название', 'field_62441899b608c'),
(1475, 110, 'страны_1_год', ''),
(1476, 110, '_страны_1_год', 'field_624418aab608d'),
(1477, 110, 'страны_2_флаг', '107'),
(1478, 110, '_страны_2_флаг', 'field_62441880b608b'),
(1479, 110, 'страны_2_название', ''),
(1480, 110, '_страны_2_название', 'field_62441899b608c'),
(1481, 110, 'страны_2_год', ''),
(1482, 110, '_страны_2_год', 'field_624418aab608d'),
(1483, 110, 'страны_3_флаг', '108'),
(1484, 110, '_страны_3_флаг', 'field_62441880b608b'),
(1485, 110, 'страны_3_название', ''),
(1486, 110, '_страны_3_название', 'field_62441899b608c'),
(1487, 110, 'страны_3_год', ''),
(1488, 110, '_страны_3_год', 'field_624418aab608d'),
(1489, 110, 'страны', '4'),
(1490, 110, '_страны', 'field_62441847b608a'),
(1491, 2, 'текст-7', '<p class=\"sOtherCountries__agency\"><span>EMA</span> Европейское медицинское агентство</p>\r\n<p class=\"sOtherCountries__agency\"><span>FDA</span> Управление по&nbsp;санитарному надзору за&nbsp;качеством пищевых продуктов и&nbsp;медикаментов, США</p>'),
(1492, 2, '_текст-7', 'field_6244182bb6089'),
(1493, 2, 'текст-7-1', 'Производство препарата Урорек, поставляемого в&nbsp;Россию, осуществляется в&nbsp;Италии с&nbsp;использованием субстанции из&nbsp;Японии, в&nbsp;соответствии с&nbsp;необходимыми требованиями к&nbsp;производству и&nbsp;контролю качества<sup>6,1</sup>'),
(1494, 2, '_текст-7-1', 'field_62441a5acf03c'),
(1495, 111, 'заголовок-1', 'УРОРЕК – оригинальный<sup>10</sup> альфа-адреноблокатор'),
(1496, 111, '_заголовок-1', 'field_62435bd26f29f'),
(1497, 111, 'текст-1', '<div class=\"headerBlock__body\">\r\n<p>Силодозин (действующее вещество препарата Урорек) обладает максимальной уроселективностью в&nbsp;своем классе, что обеспечивает его уродинамическую эффективность и&nbsp;высокую безопасность<sup>4</sup></p>\r\n</div>\r\n<div class=\"headerBlock__footer\">\r\n<p><strong>Показания к применению: </strong><br/>Лечение симптомов доброкачественной гиперплазии предстательной железы<sup>6</sup></p>\r\n</div>'),
(1498, 111, '_текст-1', 'field_62435c0c6f2a0'),
(1499, 111, 'изображение-1', '13'),
(1500, 111, '_изображение-1', 'field_62435c8b6f2a1'),
(1501, 111, 'фон-1', '17'),
(1502, 111, '_фон-1', 'field_62435db92ea96'),
(1503, 111, 'заголовок-2', 'Ключевые преимущества препарата Урорек'),
(1504, 111, '_заголовок-2', 'field_6243606295196'),
(1505, 111, 'список-2', 'Единственный оригинальный препарат из&nbsp;группы альфа1-адреноблокаторов, не&nbsp;имеющий генериков в&nbsp;РФ<sup>1</sup>'),
(1506, 111, '_список-2', 'field_6243608195197'),
(1507, 111, 'картинка_с_текстом_0_изображение', '31'),
(1508, 111, '_картинка_с_текстом_0_изображение', 'field_624363d095199'),
(1509, 111, 'картинка_с_текстом_0_описание', 'Обширная доказательная база собственных пострегистрационных клинических исследований<sup>2</sup>'),
(1510, 111, '_картинка_с_текстом_0_описание', 'field_624363e59519a'),
(1511, 111, 'картинка_с_текстом_1_изображение', '32'),
(1512, 111, '_картинка_с_текстом_1_изображение', 'field_624363d095199'),
(1513, 111, 'картинка_с_текстом_1_описание', 'Отсутствие риска замены препарата Урорек в&nbsp;аптеке (единственный препарат с&nbsp;действующим веществом силодозин)<sup>1</sup>'),
(1514, 111, '_картинка_с_текстом_1_описание', 'field_624363e59519a'),
(1515, 111, 'картинка_с_текстом_2_изображение', '33'),
(1516, 111, '_картинка_с_текстом_2_изображение', 'field_624363d095199'),
(1517, 111, 'картинка_с_текстом_2_описание', 'Большинство пациентов предпочитают принимать оригинальные препараты<sup>3</sup>'),
(1518, 111, '_картинка_с_текстом_2_описание', 'field_624363e59519a'),
(1519, 111, 'картинка_с_текстом', '3'),
(1520, 111, '_картинка_с_текстом', 'field_624363b995198'),
(1521, 111, 'второй_список', '<li>Клинические преимущества препарата Урорек (силодозин) определяются максимальной уроселективностью в&nbsp;классе альфа-адреноблокаторов<sup>4</sup></li>\r\n\r\n<li>Урорек&nbsp;&mdash; альфа-адреноблокатор последнего поколения, который эффективен в&nbsp;отношении всех СНМП (накопления, опорожнения, постмиктурических).<sup>12,13</sup> При этом Урорек обладает минимальным риском развития нежелательных явлений со&nbsp;стороны сердечно-сосудистой системы, в&nbsp;том числе&nbsp;у&nbsp;пациентов, принимающих антигипертензивные препараты<sup>46,8</sup> <small> <span>СНМП </span>симптомы нижних мочевыводящих путей</small></li>'),
(1522, 111, '_второй_список', 'field_6243640e05eda'),
(1523, 111, 'заголовок2-2', 'Максимальная уроселективность силодозина в&nbsp;классе альфа-адреноблокаторов обуславливает его уродинамическую эффективность и&nbsp;высокий профиль безопасности<sup>4</sup>'),
(1524, 111, '_заголовок2-2', 'field_6243644705edb'),
(1525, 111, 'текст3', '<ul>\r\n<li>Урорек значительно улучшает клинические проявления и&nbsp;качество жизни у&nbsp;всех пациентов с&nbsp;СНМП/ДГПЖ, в&nbsp;том числе с&nbsp;тяжелым течением<sup>11</sup><a href=\"#\">Узнать больше...</a></li>\r\n\r\n<li>Урорек является препаратом выбора для пациентов с&nbsp;СНМП/ДГПЖ и&nbsp;сопутствующими сердечно-сосудистыми заболеваниями<sup>3</sup> <a href=\"#\">Узнать больше...</a></li>\r\n</ul>\r\n<small> <span>ДГПЖ </span>доброкачественная гиперплазия предстательной железы</small>'),
(1526, 111, '_текст3', 'field_6243647405edc'),
(1527, 111, 'изображение-2', '34'),
(1528, 111, '_изображение-2', 'field_624364dd05edd'),
(1529, 111, 'текст_в_подвале', '<h2> Максимальная уроселективность в&nbsp;классе  альфа-адреноблокаторов<sup>4</sup></h2>\r\n<div class=\"h3\"> Почему это важно? <a href=\"#\">Подробнее</a></div>'),
(1530, 111, '_текст_в_подвале', 'field_62436daf1f6d9'),
(1531, 111, 'заголовок-3', 'Форма выпуска препарата Урорек'),
(1532, 111, '_заголовок-3', 'field_62436efee98e7'),
(1533, 111, 'текст-3', '<p class=\"section-descr\"><span>8мг </span>- рекомендуемая доза для лечения симптомов ДГПЖ<sup>6</sup>*</p>\r\n					<p class=\"section-note col-md-10\">*Более подробные сведения о&nbsp;препарате, особенностях применения, побочных действиях и&nbsp;др. &mdash;&nbsp;смотрите инструкцию по&nbsp;медицинскому применению лекарственного препарата Урорек, РУ&nbsp;ЛСР-005971/10 от&nbsp;25.06.2010 </p>'),
(1534, 111, '_текст-3', 'field_62436f60e98e8'),
(1535, 111, 'товар_0_название', 'Урорек 8мг №30'),
(1536, 111, '_товар_0_название', 'field_62436fcce98ea'),
(1537, 111, 'товар_0_описание', 'Упаковка, рассчитанная на&nbsp;1&nbsp;месяц лечения&nbsp;/ для старта терапии'),
(1538, 111, '_товар_0_описание', 'field_62436fe1e98eb'),
(1539, 111, 'товар_0_лицензия', 'РУ: ЛСР-005971/10 от 25.06.2010'),
(1540, 111, '_товар_0_лицензия', 'field_62436ff0e98ec'),
(1541, 111, 'товар_0_изображение', '51'),
(1542, 111, '_товар_0_изображение', 'field_62437045e98ed'),
(1543, 111, 'товар_1_название', 'Урорек 8мг №90'),
(1544, 111, '_товар_1_название', 'field_62436fcce98ea'),
(1545, 111, 'товар_1_описание', 'Выгодная упаковка, рассчитанная на&nbsp;3&nbsp;месяца лечения. Самая доступная стоимость 1&nbsp;дня терапии препаратом Урорек&nbsp;<sup>27</sup>'),
(1546, 111, '_товар_1_описание', 'field_62436fe1e98eb'),
(1547, 111, 'товар_1_лицензия', 'РУ: ЛСР-005971/10 от 25.06.2010'),
(1548, 111, '_товар_1_лицензия', 'field_62436ff0e98ec'),
(1549, 111, 'товар_1_изображение', '53'),
(1550, 111, '_товар_1_изображение', 'field_62437045e98ed'),
(1551, 111, 'товар_2_название', 'Урорек 4мг №30'),
(1552, 111, '_товар_2_название', 'field_62436fcce98ea'),
(1553, 111, 'товар_2_описание', '4&nbsp;мг&nbsp;&mdash; стартовая упаковка для лечения симптомов ДГПЖ у&nbsp;пациентов с&nbsp;почечной недостаточностью средней степени тяжести<sup>6</sup>'),
(1554, 111, '_товар_2_описание', 'field_62436fe1e98eb'),
(1555, 111, 'товар_2_лицензия', 'РУ: ЛСР-005971/10 от 25.06.2010'),
(1556, 111, '_товар_2_лицензия', 'field_62436ff0e98ec'),
(1557, 111, 'товар_2_изображение', '52'),
(1558, 111, '_товар_2_изображение', 'field_62437045e98ed'),
(1559, 111, 'товар', '3'),
(1560, 111, '_товар', 'field_62436fbde98e9'),
(1561, 111, 'заголовок-4', 'Где купить'),
(1562, 111, '_заголовок-4', 'field_624374f73d8bd'),
(1563, 111, 'изображения', 'a:12:{i:0;s:2:\"63\";i:1;s:2:\"64\";i:2;s:2:\"65\";i:3;s:2:\"66\";i:4;s:2:\"67\";i:5;s:2:\"68\";i:6;s:2:\"69\";i:7;s:2:\"70\";i:8;s:2:\"71\";i:9;s:2:\"72\";i:10;s:2:\"73\";i:11;s:2:\"74\";}'),
(1564, 111, '_изображения', 'field_624375093d8be'),
(1565, 111, 'изображения-4', 'a:12:{i:0;s:2:\"63\";i:1;s:2:\"64\";i:2;s:2:\"65\";i:3;s:2:\"66\";i:4;s:2:\"67\";i:5;s:2:\"68\";i:6;s:2:\"69\";i:7;s:2:\"70\";i:8;s:2:\"71\";i:9;s:2:\"72\";i:10;s:2:\"73\";i:11;s:2:\"74\";}'),
(1566, 111, '_изображения-4', 'field_624375093d8be'),
(1567, 111, 'заголовок-5', 'Способ применения*<sup>6</sup>'),
(1568, 111, '_заголовок-5', 'field_624379bd4756d'),
(1569, 111, 'иконки', 'a:5:{i:0;s:2:\"83\";i:1;s:2:\"84\";i:2;s:2:\"85\";i:3;s:2:\"86\";i:4;s:2:\"87\";}'),
(1570, 111, '_иконки', 'field_624379f24756e'),
(1571, 111, 'текст-5', 'У пациентов с легкой почечной недостаточностью (клиренс креатинина ≥ 50 — ≤ 80 мл/мин) коррекция дозы не требуется. Для лечения пациентов с почечной недостаточностью средней степени тяжести (клиренс креатинина ≥ 30 — < 50 мл/мин) рекомендуется в течение первой недели принимать начальную дозу по 4 мг в сутки, при хорошей индивидуальной переносимости доза может быть увеличена до 8 мг в сутки. Применение препарата для пациентов с тяжелой почечной недостаточностью (клиренс креатинина < 30 мл / мин) не рекомендуется'),
(1572, 111, '_текст-5', 'field_62437a374756f'),
(1573, 111, 'текст_под_кнопкой', '*Более подробные сведения о&nbsp;препарате, особенностях применения, побочных действиях и&nbsp;др. &mdash;&nbsp;см. инструкцию по&nbsp;медицинскому применению лекарственного препарата Урорек, РУ&nbsp;ЛСР-005971/10 от&nbsp;25.06.2010'),
(1574, 111, '_текст_под_кнопкой', 'field_62437a7c47570'),
(1575, 111, 'заголовок-6', 'Препарат Урорек (силодозин) включен в&nbsp;российские и&nbsp;международные клинические рекомендации и&nbsp;стандарты для лечения ряда урологических заболеваний:'),
(1576, 111, '_заголовок-6', 'field_6244117c68bd0'),
(1577, 111, 'список-6_0_ссылка', 'a:3:{s:5:\"title\";s:68:\"Российские клинические рекомендации\";s:3:\"url\";s:1:\"#\";s:6:\"target\";s:0:\"\";}'),
(1578, 111, '_список-6_0_ссылка', 'field_624411ce68bd2'),
(1579, 111, 'список-6_0_описание', '«Доброкачественная гиперплазия предстательной железы», 2020<sup>28</sup>'),
(1580, 111, '_список-6_0_описание', 'field_6244121168bd3'),
(1581, 111, 'список-6_1_ссылка', 'a:3:{s:5:\"title\";s:70:\"Европейские клинические рекомендации\";s:3:\"url\";s:1:\"#\";s:6:\"target\";s:0:\"\";}'),
(1582, 111, '_список-6_1_ссылка', 'field_624411ce68bd2'),
(1583, 111, 'список-6_1_описание', 'глава «Консервативное лечение ненейрогенных симптомов нарушенного мочеиспускания у мужчин, включая доброкачественную простатическую обструкцию», 2021<sup>29</sup>'),
(1584, 111, '_список-6_1_описание', 'field_6244121168bd3'),
(1585, 111, 'список-6_2_ссылка', 'a:3:{s:5:\"title\";s:154:\"Стандарт первичной медико-санитарной помощи при гиперплазии предстательной железы\";s:3:\"url\";s:1:\"#\";s:6:\"target\";s:0:\"\";}'),
(1586, 111, '_список-6_2_ссылка', 'field_624411ce68bd2'),
(1587, 111, 'список-6_2_описание', '09.11.2012<sup>30</sup> / Обновлён 13.04.2015\r\n'),
(1588, 111, '_список-6_2_описание', 'field_6244121168bd3'),
(1589, 111, 'список-6_3_ссылка', 'a:3:{s:5:\"title\";s:122:\"Стандарт специализированной медицинской помощи при задержке мочи\";s:3:\"url\";s:1:\"#\";s:6:\"target\";s:0:\"\";}'),
(1590, 111, '_список-6_3_ссылка', 'field_624411ce68bd2'),
(1591, 111, 'список-6_3_описание', '29.01.2013<sup>31</sup> / Обновлён 06.05.2015\r\n'),
(1592, 111, '_список-6_3_описание', 'field_6244121168bd3'),
(1593, 111, 'список-6_4_ссылка', 'a:3:{s:5:\"title\";s:133:\"Стандарт первичной медико-санитарной помощи при хроническом простатите\";s:3:\"url\";s:1:\"#\";s:6:\"target\";s:0:\"\";}'),
(1594, 111, '_список-6_4_ссылка', 'field_624411ce68bd2'),
(1595, 111, 'список-6_4_описание', '09.11.2012<sup>32</sup> / Обновлён 13.04.2015\r\n'),
(1596, 111, '_список-6_4_описание', 'field_6244121168bd3'),
(1597, 111, 'список-6_5_ссылка', 'a:3:{s:5:\"title\";s:168:\"Стандарт специализированной медицинской помощи при остром простатите, орхите, эпидидимите\";s:3:\"url\";s:1:\"#\";s:6:\"target\";s:0:\"\";}'),
(1598, 111, '_список-6_5_ссылка', 'field_624411ce68bd2'),
(1599, 111, 'список-6_5_описание', '09.11.2012<sup>33</sup> / Обновлён 27.05.2015'),
(1600, 111, '_список-6_5_описание', 'field_6244121168bd3'),
(1601, 111, 'список-6', '6'),
(1602, 111, '_список-6', 'field_624411be68bd1'),
(1603, 111, 'заголовок-7', 'Препарат Урорек (силодозин) зарегистрирован и&nbsp;применяется в&nbsp;разных странах мира Одобрен ЕМА*<sup>34</sup> и&nbsp;FDA**<sup>35</sup>'),
(1604, 111, '_заголовок-7', 'field_624417e3b6088'),
(1605, 111, 'текст', '<p class=\"sOtherCountries__agency\"><span>EMA</span> Европейское медицинское агентство</p>\r\n<p class=\"sOtherCountries__agency\"><span>FDA</span> Управление по&nbsp;санитарному надзору за&nbsp;качеством пищевых продуктов и&nbsp;медикаментов, США</p>'),
(1606, 111, '_текст', 'field_6244182bb6089'),
(1607, 111, 'страны_0_флаг', '105'),
(1608, 111, '_страны_0_флаг', 'field_62441880b608b'),
(1609, 111, 'страны_0_название', 'Япония'),
(1610, 111, '_страны_0_название', 'field_62441899b608c'),
(1611, 111, 'страны_0_год', '2006<sup>36,37</sup>'),
(1612, 111, '_страны_0_год', 'field_624418aab608d'),
(1613, 111, 'страны_1_флаг', '106'),
(1614, 111, '_страны_1_флаг', 'field_62441880b608b'),
(1615, 111, 'страны_1_название', 'США'),
(1616, 111, '_страны_1_название', 'field_62441899b608c'),
(1617, 111, 'страны_1_год', '2008<sup>35</sup>'),
(1618, 111, '_страны_1_год', 'field_624418aab608d'),
(1619, 111, 'страны_2_флаг', '107'),
(1620, 111, '_страны_2_флаг', 'field_62441880b608b'),
(1621, 111, 'страны_2_название', 'Страны ЕС'),
(1622, 111, '_страны_2_название', 'field_62441899b608c'),
(1623, 111, 'страны_2_год', '2010<sup>34</sup>'),
(1624, 111, '_страны_2_год', 'field_624418aab608d'),
(1625, 111, 'страны_3_флаг', '108'),
(1626, 111, '_страны_3_флаг', 'field_62441880b608b'),
(1627, 111, 'страны_3_название', 'Россия'),
(1628, 111, '_страны_3_название', 'field_62441899b608c'),
(1629, 111, 'страны_3_год', '2010<sup>1</sup>'),
(1630, 111, '_страны_3_год', 'field_624418aab608d'),
(1631, 111, 'страны', '4'),
(1632, 111, '_страны', 'field_62441847b608a'),
(1633, 111, 'текст-7', '<p class=\"sOtherCountries__agency\"><span>EMA</span> Европейское медицинское агентство</p>\r\n<p class=\"sOtherCountries__agency\"><span>FDA</span> Управление по&nbsp;санитарному надзору за&nbsp;качеством пищевых продуктов и&nbsp;медикаментов, США</p>'),
(1634, 111, '_текст-7', 'field_6244182bb6089'),
(1635, 111, 'текст-7-1', '&nbsp;\r\n<p class=\"sOtherCountries__agency\">EMA Европейское медицинское агентство</p>\r\n<p class=\"sOtherCountries__agency\">FDA Управление по санитарному надзору за качеством пищевых продуктов и медикаментов, США</p>'),
(1636, 111, '_текст-7-1', 'field_62441a5acf03c'),
(1637, 112, 'заголовок-1', 'УРОРЕК – оригинальный<sup>10</sup> альфа-адреноблокатор'),
(1638, 112, '_заголовок-1', 'field_62435bd26f29f'),
(1639, 112, 'текст-1', '<div class=\"headerBlock__body\">\r\n<p>Силодозин (действующее вещество препарата Урорек) обладает максимальной уроселективностью в&nbsp;своем классе, что обеспечивает его уродинамическую эффективность и&nbsp;высокую безопасность<sup>4</sup></p>\r\n</div>\r\n<div class=\"headerBlock__footer\">\r\n<p><strong>Показания к применению: </strong><br/>Лечение симптомов доброкачественной гиперплазии предстательной железы<sup>6</sup></p>\r\n</div>'),
(1640, 112, '_текст-1', 'field_62435c0c6f2a0'),
(1641, 112, 'изображение-1', '13'),
(1642, 112, '_изображение-1', 'field_62435c8b6f2a1'),
(1643, 112, 'фон-1', '17'),
(1644, 112, '_фон-1', 'field_62435db92ea96'),
(1645, 112, 'заголовок-2', 'Ключевые преимущества препарата Урорек'),
(1646, 112, '_заголовок-2', 'field_6243606295196'),
(1647, 112, 'список-2', 'Единственный оригинальный препарат из&nbsp;группы альфа1-адреноблокаторов, не&nbsp;имеющий генериков в&nbsp;РФ<sup>1</sup>'),
(1648, 112, '_список-2', 'field_6243608195197'),
(1649, 112, 'картинка_с_текстом_0_изображение', '31'),
(1650, 112, '_картинка_с_текстом_0_изображение', 'field_624363d095199'),
(1651, 112, 'картинка_с_текстом_0_описание', 'Обширная доказательная база собственных пострегистрационных клинических исследований<sup>2</sup>'),
(1652, 112, '_картинка_с_текстом_0_описание', 'field_624363e59519a'),
(1653, 112, 'картинка_с_текстом_1_изображение', '32'),
(1654, 112, '_картинка_с_текстом_1_изображение', 'field_624363d095199'),
(1655, 112, 'картинка_с_текстом_1_описание', 'Отсутствие риска замены препарата Урорек в&nbsp;аптеке (единственный препарат с&nbsp;действующим веществом силодозин)<sup>1</sup>'),
(1656, 112, '_картинка_с_текстом_1_описание', 'field_624363e59519a'),
(1657, 112, 'картинка_с_текстом_2_изображение', '33'),
(1658, 112, '_картинка_с_текстом_2_изображение', 'field_624363d095199'),
(1659, 112, 'картинка_с_текстом_2_описание', 'Большинство пациентов предпочитают принимать оригинальные препараты<sup>3</sup>'),
(1660, 112, '_картинка_с_текстом_2_описание', 'field_624363e59519a'),
(1661, 112, 'картинка_с_текстом', '3'),
(1662, 112, '_картинка_с_текстом', 'field_624363b995198'),
(1663, 112, 'второй_список', '<li>Клинические преимущества препарата Урорек (силодозин) определяются максимальной уроселективностью в&nbsp;классе альфа-адреноблокаторов<sup>4</sup></li>\r\n\r\n<li>Урорек&nbsp;&mdash; альфа-адреноблокатор последнего поколения, который эффективен в&nbsp;отношении всех СНМП (накопления, опорожнения, постмиктурических).<sup>12,13</sup> При этом Урорек обладает минимальным риском развития нежелательных явлений со&nbsp;стороны сердечно-сосудистой системы, в&nbsp;том числе&nbsp;у&nbsp;пациентов, принимающих антигипертензивные препараты<sup>46,8</sup> <small> <span>СНМП </span>симптомы нижних мочевыводящих путей</small></li>'),
(1664, 112, '_второй_список', 'field_6243640e05eda'),
(1665, 112, 'заголовок2-2', 'Максимальная уроселективность силодозина в&nbsp;классе альфа-адреноблокаторов обуславливает его уродинамическую эффективность и&nbsp;высокий профиль безопасности<sup>4</sup>'),
(1666, 112, '_заголовок2-2', 'field_6243644705edb'),
(1667, 112, 'текст3', '<ul>\r\n<li>Урорек значительно улучшает клинические проявления и&nbsp;качество жизни у&nbsp;всех пациентов с&nbsp;СНМП/ДГПЖ, в&nbsp;том числе с&nbsp;тяжелым течением<sup>11</sup><a href=\"#\">Узнать больше...</a></li>\r\n\r\n<li>Урорек является препаратом выбора для пациентов с&nbsp;СНМП/ДГПЖ и&nbsp;сопутствующими сердечно-сосудистыми заболеваниями<sup>3</sup> <a href=\"#\">Узнать больше...</a></li>\r\n</ul>\r\n<small> <span>ДГПЖ </span>доброкачественная гиперплазия предстательной железы</small>'),
(1668, 112, '_текст3', 'field_6243647405edc'),
(1669, 112, 'изображение-2', '34'),
(1670, 112, '_изображение-2', 'field_624364dd05edd'),
(1671, 112, 'текст_в_подвале', '<h2> Максимальная уроселективность в&nbsp;классе  альфа-адреноблокаторов<sup>4</sup></h2>\r\n<div class=\"h3\"> Почему это важно? <a href=\"#\">Подробнее</a></div>'),
(1672, 112, '_текст_в_подвале', 'field_62436daf1f6d9'),
(1673, 112, 'заголовок-3', 'Форма выпуска препарата Урорек'),
(1674, 112, '_заголовок-3', 'field_62436efee98e7'),
(1675, 112, 'текст-3', '<p class=\"section-descr\"><span>8мг </span>- рекомендуемая доза для лечения симптомов ДГПЖ<sup>6</sup>*</p>\r\n					<p class=\"section-note col-md-10\">*Более подробные сведения о&nbsp;препарате, особенностях применения, побочных действиях и&nbsp;др. &mdash;&nbsp;смотрите инструкцию по&nbsp;медицинскому применению лекарственного препарата Урорек, РУ&nbsp;ЛСР-005971/10 от&nbsp;25.06.2010 </p>'),
(1676, 112, '_текст-3', 'field_62436f60e98e8'),
(1677, 112, 'товар_0_название', 'Урорек 8мг №30'),
(1678, 112, '_товар_0_название', 'field_62436fcce98ea'),
(1679, 112, 'товар_0_описание', 'Упаковка, рассчитанная на&nbsp;1&nbsp;месяц лечения&nbsp;/ для старта терапии'),
(1680, 112, '_товар_0_описание', 'field_62436fe1e98eb'),
(1681, 112, 'товар_0_лицензия', 'РУ: ЛСР-005971/10 от 25.06.2010'),
(1682, 112, '_товар_0_лицензия', 'field_62436ff0e98ec'),
(1683, 112, 'товар_0_изображение', '51'),
(1684, 112, '_товар_0_изображение', 'field_62437045e98ed'),
(1685, 112, 'товар_1_название', 'Урорек 8мг №90'),
(1686, 112, '_товар_1_название', 'field_62436fcce98ea'),
(1687, 112, 'товар_1_описание', 'Выгодная упаковка, рассчитанная на&nbsp;3&nbsp;месяца лечения. Самая доступная стоимость 1&nbsp;дня терапии препаратом Урорек&nbsp;<sup>27</sup>'),
(1688, 112, '_товар_1_описание', 'field_62436fe1e98eb'),
(1689, 112, 'товар_1_лицензия', 'РУ: ЛСР-005971/10 от 25.06.2010'),
(1690, 112, '_товар_1_лицензия', 'field_62436ff0e98ec'),
(1691, 112, 'товар_1_изображение', '53'),
(1692, 112, '_товар_1_изображение', 'field_62437045e98ed'),
(1693, 112, 'товар_2_название', 'Урорек 4мг №30'),
(1694, 112, '_товар_2_название', 'field_62436fcce98ea'),
(1695, 112, 'товар_2_описание', '4&nbsp;мг&nbsp;&mdash; стартовая упаковка для лечения симптомов ДГПЖ у&nbsp;пациентов с&nbsp;почечной недостаточностью средней степени тяжести<sup>6</sup>'),
(1696, 112, '_товар_2_описание', 'field_62436fe1e98eb'),
(1697, 112, 'товар_2_лицензия', 'РУ: ЛСР-005971/10 от 25.06.2010'),
(1698, 112, '_товар_2_лицензия', 'field_62436ff0e98ec'),
(1699, 112, 'товар_2_изображение', '52'),
(1700, 112, '_товар_2_изображение', 'field_62437045e98ed'),
(1701, 112, 'товар', '3'),
(1702, 112, '_товар', 'field_62436fbde98e9'),
(1703, 112, 'заголовок-4', 'Где купить'),
(1704, 112, '_заголовок-4', 'field_624374f73d8bd'),
(1705, 112, 'изображения', 'a:12:{i:0;s:2:\"63\";i:1;s:2:\"64\";i:2;s:2:\"65\";i:3;s:2:\"66\";i:4;s:2:\"67\";i:5;s:2:\"68\";i:6;s:2:\"69\";i:7;s:2:\"70\";i:8;s:2:\"71\";i:9;s:2:\"72\";i:10;s:2:\"73\";i:11;s:2:\"74\";}'),
(1706, 112, '_изображения', 'field_624375093d8be'),
(1707, 112, 'изображения-4', 'a:12:{i:0;s:2:\"63\";i:1;s:2:\"64\";i:2;s:2:\"65\";i:3;s:2:\"66\";i:4;s:2:\"67\";i:5;s:2:\"68\";i:6;s:2:\"69\";i:7;s:2:\"70\";i:8;s:2:\"71\";i:9;s:2:\"72\";i:10;s:2:\"73\";i:11;s:2:\"74\";}'),
(1708, 112, '_изображения-4', 'field_624375093d8be'),
(1709, 112, 'заголовок-5', 'Способ применения*<sup>6</sup>'),
(1710, 112, '_заголовок-5', 'field_624379bd4756d'),
(1711, 112, 'иконки', 'a:5:{i:0;s:2:\"83\";i:1;s:2:\"84\";i:2;s:2:\"85\";i:3;s:2:\"86\";i:4;s:2:\"87\";}'),
(1712, 112, '_иконки', 'field_624379f24756e'),
(1713, 112, 'текст-5', 'У пациентов с легкой почечной недостаточностью (клиренс креатинина ≥ 50 — ≤ 80 мл/мин) коррекция дозы не требуется. Для лечения пациентов с почечной недостаточностью средней степени тяжести (клиренс креатинина ≥ 30 — < 50 мл/мин) рекомендуется в течение первой недели принимать начальную дозу по 4 мг в сутки, при хорошей индивидуальной переносимости доза может быть увеличена до 8 мг в сутки. Применение препарата для пациентов с тяжелой почечной недостаточностью (клиренс креатинина < 30 мл / мин) не рекомендуется'),
(1714, 112, '_текст-5', 'field_62437a374756f'),
(1715, 112, 'текст_под_кнопкой', '*Более подробные сведения о&nbsp;препарате, особенностях применения, побочных действиях и&nbsp;др. &mdash;&nbsp;см. инструкцию по&nbsp;медицинскому применению лекарственного препарата Урорек, РУ&nbsp;ЛСР-005971/10 от&nbsp;25.06.2010'),
(1716, 112, '_текст_под_кнопкой', 'field_62437a7c47570'),
(1717, 112, 'заголовок-6', 'Препарат Урорек (силодозин) включен в&nbsp;российские и&nbsp;международные клинические рекомендации и&nbsp;стандарты для лечения ряда урологических заболеваний:'),
(1718, 112, '_заголовок-6', 'field_6244117c68bd0'),
(1719, 112, 'список-6_0_ссылка', 'a:3:{s:5:\"title\";s:68:\"Российские клинические рекомендации\";s:3:\"url\";s:1:\"#\";s:6:\"target\";s:0:\"\";}'),
(1720, 112, '_список-6_0_ссылка', 'field_624411ce68bd2'),
(1721, 112, 'список-6_0_описание', '«Доброкачественная гиперплазия предстательной железы», 2020<sup>28</sup>'),
(1722, 112, '_список-6_0_описание', 'field_6244121168bd3'),
(1723, 112, 'список-6_1_ссылка', 'a:3:{s:5:\"title\";s:70:\"Европейские клинические рекомендации\";s:3:\"url\";s:1:\"#\";s:6:\"target\";s:0:\"\";}'),
(1724, 112, '_список-6_1_ссылка', 'field_624411ce68bd2'),
(1725, 112, 'список-6_1_описание', 'глава «Консервативное лечение ненейрогенных симптомов нарушенного мочеиспускания у мужчин, включая доброкачественную простатическую обструкцию», 2021<sup>29</sup>'),
(1726, 112, '_список-6_1_описание', 'field_6244121168bd3'),
(1727, 112, 'список-6_2_ссылка', 'a:3:{s:5:\"title\";s:154:\"Стандарт первичной медико-санитарной помощи при гиперплазии предстательной железы\";s:3:\"url\";s:1:\"#\";s:6:\"target\";s:0:\"\";}'),
(1728, 112, '_список-6_2_ссылка', 'field_624411ce68bd2'),
(1729, 112, 'список-6_2_описание', '09.11.2012<sup>30</sup> / Обновлён 13.04.2015\r\n'),
(1730, 112, '_список-6_2_описание', 'field_6244121168bd3'),
(1731, 112, 'список-6_3_ссылка', 'a:3:{s:5:\"title\";s:122:\"Стандарт специализированной медицинской помощи при задержке мочи\";s:3:\"url\";s:1:\"#\";s:6:\"target\";s:0:\"\";}'),
(1732, 112, '_список-6_3_ссылка', 'field_624411ce68bd2'),
(1733, 112, 'список-6_3_описание', '29.01.2013<sup>31</sup> / Обновлён 06.05.2015\r\n'),
(1734, 112, '_список-6_3_описание', 'field_6244121168bd3'),
(1735, 112, 'список-6_4_ссылка', 'a:3:{s:5:\"title\";s:133:\"Стандарт первичной медико-санитарной помощи при хроническом простатите\";s:3:\"url\";s:1:\"#\";s:6:\"target\";s:0:\"\";}'),
(1736, 112, '_список-6_4_ссылка', 'field_624411ce68bd2'),
(1737, 112, 'список-6_4_описание', '09.11.2012<sup>32</sup> / Обновлён 13.04.2015\r\n'),
(1738, 112, '_список-6_4_описание', 'field_6244121168bd3'),
(1739, 112, 'список-6_5_ссылка', 'a:3:{s:5:\"title\";s:168:\"Стандарт специализированной медицинской помощи при остром простатите, орхите, эпидидимите\";s:3:\"url\";s:1:\"#\";s:6:\"target\";s:0:\"\";}'),
(1740, 112, '_список-6_5_ссылка', 'field_624411ce68bd2'),
(1741, 112, 'список-6_5_описание', '09.11.2012<sup>33</sup> / Обновлён 27.05.2015'),
(1742, 112, '_список-6_5_описание', 'field_6244121168bd3'),
(1743, 112, 'список-6', '6'),
(1744, 112, '_список-6', 'field_624411be68bd1'),
(1745, 112, 'заголовок-7', 'Препарат Урорек (силодозин) зарегистрирован и&nbsp;применяется в&nbsp;разных странах мира Одобрен ЕМА*<sup>34</sup> и&nbsp;FDA**<sup>35</sup>'),
(1746, 112, '_заголовок-7', 'field_624417e3b6088'),
(1747, 112, 'текст', '<p class=\"sOtherCountries__agency\"><span>EMA</span> Европейское медицинское агентство</p>\r\n<p class=\"sOtherCountries__agency\"><span>FDA</span> Управление по&nbsp;санитарному надзору за&nbsp;качеством пищевых продуктов и&nbsp;медикаментов, США</p>'),
(1748, 112, '_текст', 'field_6244182bb6089'),
(1749, 112, 'страны_0_флаг', '105'),
(1750, 112, '_страны_0_флаг', 'field_62441880b608b'),
(1751, 112, 'страны_0_название', 'Япония'),
(1752, 112, '_страны_0_название', 'field_62441899b608c'),
(1753, 112, 'страны_0_год', '2006<sup>36,37</sup>'),
(1754, 112, '_страны_0_год', 'field_624418aab608d'),
(1755, 112, 'страны_1_флаг', '106'),
(1756, 112, '_страны_1_флаг', 'field_62441880b608b'),
(1757, 112, 'страны_1_название', 'США'),
(1758, 112, '_страны_1_название', 'field_62441899b608c'),
(1759, 112, 'страны_1_год', '2008<sup>35</sup>'),
(1760, 112, '_страны_1_год', 'field_624418aab608d'),
(1761, 112, 'страны_2_флаг', '107'),
(1762, 112, '_страны_2_флаг', 'field_62441880b608b'),
(1763, 112, 'страны_2_название', 'Страны ЕС'),
(1764, 112, '_страны_2_название', 'field_62441899b608c'),
(1765, 112, 'страны_2_год', '2010<sup>34</sup>'),
(1766, 112, '_страны_2_год', 'field_624418aab608d'),
(1767, 112, 'страны_3_флаг', '108'),
(1768, 112, '_страны_3_флаг', 'field_62441880b608b'),
(1769, 112, 'страны_3_название', 'Россия'),
(1770, 112, '_страны_3_название', 'field_62441899b608c'),
(1771, 112, 'страны_3_год', '2010<sup>1</sup>'),
(1772, 112, '_страны_3_год', 'field_624418aab608d'),
(1773, 112, 'страны', '4'),
(1774, 112, '_страны', 'field_62441847b608a'),
(1775, 112, 'текст-7', '<p class=\"sOtherCountries__agency\"><span>EMA</span> Европейское медицинское агентство</p>\r\n<p class=\"sOtherCountries__agency\"><span>FDA</span> Управление по&nbsp;санитарному надзору за&nbsp;качеством пищевых продуктов и&nbsp;медикаментов, США</p>'),
(1776, 112, '_текст-7', 'field_6244182bb6089'),
(1777, 112, 'текст-7-1', '&nbsp;\r\n<p class=\"sOtherCountries__agency\">EMA Европейское медицинское агентство</p>\r\n<p class=\"sOtherCountries__agency\">FDA Управление по санитарному надзору за качеством пищевых продуктов и медикаментов, США</p>'),
(1778, 112, '_текст-7-1', 'field_62441a5acf03c'),
(1779, 113, 'заголовок-1', 'УРОРЕК – оригинальный<sup>10</sup> альфа-адреноблокатор'),
(1780, 113, '_заголовок-1', 'field_62435bd26f29f'),
(1781, 113, 'текст-1', '<div class=\"headerBlock__body\">\r\n<p>Силодозин (действующее вещество препарата Урорек) обладает максимальной уроселективностью в&nbsp;своем классе, что обеспечивает его уродинамическую эффективность и&nbsp;высокую безопасность<sup>4</sup></p>\r\n</div>\r\n<div class=\"headerBlock__footer\">\r\n<p><strong>Показания к применению: </strong><br/>Лечение симптомов доброкачественной гиперплазии предстательной железы<sup>6</sup></p>\r\n</div>'),
(1782, 113, '_текст-1', 'field_62435c0c6f2a0'),
(1783, 113, 'изображение-1', '13'),
(1784, 113, '_изображение-1', 'field_62435c8b6f2a1'),
(1785, 113, 'фон-1', '17'),
(1786, 113, '_фон-1', 'field_62435db92ea96'),
(1787, 113, 'заголовок-2', 'Ключевые преимущества препарата Урорек'),
(1788, 113, '_заголовок-2', 'field_6243606295196'),
(1789, 113, 'список-2', 'Единственный оригинальный препарат из&nbsp;группы альфа1-адреноблокаторов, не&nbsp;имеющий генериков в&nbsp;РФ<sup>1</sup>'),
(1790, 113, '_список-2', 'field_6243608195197'),
(1791, 113, 'картинка_с_текстом_0_изображение', '31'),
(1792, 113, '_картинка_с_текстом_0_изображение', 'field_624363d095199'),
(1793, 113, 'картинка_с_текстом_0_описание', 'Обширная доказательная база собственных пострегистрационных клинических исследований<sup>2</sup>'),
(1794, 113, '_картинка_с_текстом_0_описание', 'field_624363e59519a'),
(1795, 113, 'картинка_с_текстом_1_изображение', '32'),
(1796, 113, '_картинка_с_текстом_1_изображение', 'field_624363d095199'),
(1797, 113, 'картинка_с_текстом_1_описание', 'Отсутствие риска замены препарата Урорек в&nbsp;аптеке (единственный препарат с&nbsp;действующим веществом силодозин)<sup>1</sup>'),
(1798, 113, '_картинка_с_текстом_1_описание', 'field_624363e59519a'),
(1799, 113, 'картинка_с_текстом_2_изображение', '33'),
(1800, 113, '_картинка_с_текстом_2_изображение', 'field_624363d095199'),
(1801, 113, 'картинка_с_текстом_2_описание', 'Большинство пациентов предпочитают принимать оригинальные препараты<sup>3</sup>'),
(1802, 113, '_картинка_с_текстом_2_описание', 'field_624363e59519a'),
(1803, 113, 'картинка_с_текстом', '3'),
(1804, 113, '_картинка_с_текстом', 'field_624363b995198'),
(1805, 113, 'второй_список', '<li>Клинические преимущества препарата Урорек (силодозин) определяются максимальной уроселективностью в&nbsp;классе альфа-адреноблокаторов<sup>4</sup></li>\r\n\r\n<li>Урорек&nbsp;&mdash; альфа-адреноблокатор последнего поколения, который эффективен в&nbsp;отношении всех СНМП (накопления, опорожнения, постмиктурических).<sup>12,13</sup> При этом Урорек обладает минимальным риском развития нежелательных явлений со&nbsp;стороны сердечно-сосудистой системы, в&nbsp;том числе&nbsp;у&nbsp;пациентов, принимающих антигипертензивные препараты<sup>46,8</sup> <small> <span>СНМП </span>симптомы нижних мочевыводящих путей</small></li>'),
(1806, 113, '_второй_список', 'field_6243640e05eda'),
(1807, 113, 'заголовок2-2', 'Максимальная уроселективность силодозина в&nbsp;классе альфа-адреноблокаторов обуславливает его уродинамическую эффективность и&nbsp;высокий профиль безопасности<sup>4</sup>'),
(1808, 113, '_заголовок2-2', 'field_6243644705edb'),
(1809, 113, 'текст3', '<ul>\r\n<li>Урорек значительно улучшает клинические проявления и&nbsp;качество жизни у&nbsp;всех пациентов с&nbsp;СНМП/ДГПЖ, в&nbsp;том числе с&nbsp;тяжелым течением<sup>11</sup><a href=\"#\">Узнать больше...</a></li>\r\n\r\n<li>Урорек является препаратом выбора для пациентов с&nbsp;СНМП/ДГПЖ и&nbsp;сопутствующими сердечно-сосудистыми заболеваниями<sup>3</sup> <a href=\"#\">Узнать больше...</a></li>\r\n</ul>\r\n<small> <span>ДГПЖ </span>доброкачественная гиперплазия предстательной железы</small>'),
(1810, 113, '_текст3', 'field_6243647405edc'),
(1811, 113, 'изображение-2', '34'),
(1812, 113, '_изображение-2', 'field_624364dd05edd'),
(1813, 113, 'текст_в_подвале', '<h2> Максимальная уроселективность в&nbsp;классе  альфа-адреноблокаторов<sup>4</sup></h2>\r\n<div class=\"h3\"> Почему это важно? <a href=\"#\">Подробнее</a></div>'),
(1814, 113, '_текст_в_подвале', 'field_62436daf1f6d9'),
(1815, 113, 'заголовок-3', 'Форма выпуска препарата Урорек'),
(1816, 113, '_заголовок-3', 'field_62436efee98e7'),
(1817, 113, 'текст-3', '<p class=\"section-descr\"><span>8мг </span>- рекомендуемая доза для лечения симптомов ДГПЖ<sup>6</sup>*</p>\r\n					<p class=\"section-note col-md-10\">*Более подробные сведения о&nbsp;препарате, особенностях применения, побочных действиях и&nbsp;др. &mdash;&nbsp;смотрите инструкцию по&nbsp;медицинскому применению лекарственного препарата Урорек, РУ&nbsp;ЛСР-005971/10 от&nbsp;25.06.2010 </p>'),
(1818, 113, '_текст-3', 'field_62436f60e98e8'),
(1819, 113, 'товар_0_название', 'Урорек 8мг №30'),
(1820, 113, '_товар_0_название', 'field_62436fcce98ea'),
(1821, 113, 'товар_0_описание', 'Упаковка, рассчитанная на&nbsp;1&nbsp;месяц лечения&nbsp;/ для старта терапии'),
(1822, 113, '_товар_0_описание', 'field_62436fe1e98eb'),
(1823, 113, 'товар_0_лицензия', 'РУ: ЛСР-005971/10 от 25.06.2010'),
(1824, 113, '_товар_0_лицензия', 'field_62436ff0e98ec'),
(1825, 113, 'товар_0_изображение', '51'),
(1826, 113, '_товар_0_изображение', 'field_62437045e98ed'),
(1827, 113, 'товар_1_название', 'Урорек 8мг №90'),
(1828, 113, '_товар_1_название', 'field_62436fcce98ea'),
(1829, 113, 'товар_1_описание', 'Выгодная упаковка, рассчитанная на&nbsp;3&nbsp;месяца лечения. Самая доступная стоимость 1&nbsp;дня терапии препаратом Урорек&nbsp;<sup>27</sup>'),
(1830, 113, '_товар_1_описание', 'field_62436fe1e98eb'),
(1831, 113, 'товар_1_лицензия', 'РУ: ЛСР-005971/10 от 25.06.2010'),
(1832, 113, '_товар_1_лицензия', 'field_62436ff0e98ec'),
(1833, 113, 'товар_1_изображение', '53'),
(1834, 113, '_товар_1_изображение', 'field_62437045e98ed'),
(1835, 113, 'товар_2_название', 'Урорек 4мг №30'),
(1836, 113, '_товар_2_название', 'field_62436fcce98ea'),
(1837, 113, 'товар_2_описание', '4&nbsp;мг&nbsp;&mdash; стартовая упаковка для лечения симптомов ДГПЖ у&nbsp;пациентов с&nbsp;почечной недостаточностью средней степени тяжести<sup>6</sup>'),
(1838, 113, '_товар_2_описание', 'field_62436fe1e98eb'),
(1839, 113, 'товар_2_лицензия', 'РУ: ЛСР-005971/10 от 25.06.2010'),
(1840, 113, '_товар_2_лицензия', 'field_62436ff0e98ec'),
(1841, 113, 'товар_2_изображение', '52'),
(1842, 113, '_товар_2_изображение', 'field_62437045e98ed'),
(1843, 113, 'товар', '3'),
(1844, 113, '_товар', 'field_62436fbde98e9'),
(1845, 113, 'заголовок-4', 'Где купить'),
(1846, 113, '_заголовок-4', 'field_624374f73d8bd'),
(1847, 113, 'изображения', 'a:12:{i:0;s:2:\"63\";i:1;s:2:\"64\";i:2;s:2:\"65\";i:3;s:2:\"66\";i:4;s:2:\"67\";i:5;s:2:\"68\";i:6;s:2:\"69\";i:7;s:2:\"70\";i:8;s:2:\"71\";i:9;s:2:\"72\";i:10;s:2:\"73\";i:11;s:2:\"74\";}'),
(1848, 113, '_изображения', 'field_624375093d8be'),
(1849, 113, 'изображения-4', 'a:12:{i:0;s:2:\"63\";i:1;s:2:\"64\";i:2;s:2:\"65\";i:3;s:2:\"66\";i:4;s:2:\"67\";i:5;s:2:\"68\";i:6;s:2:\"69\";i:7;s:2:\"70\";i:8;s:2:\"71\";i:9;s:2:\"72\";i:10;s:2:\"73\";i:11;s:2:\"74\";}'),
(1850, 113, '_изображения-4', 'field_624375093d8be'),
(1851, 113, 'заголовок-5', 'Способ применения*<sup>6</sup>'),
(1852, 113, '_заголовок-5', 'field_624379bd4756d'),
(1853, 113, 'иконки', 'a:5:{i:0;s:2:\"83\";i:1;s:2:\"84\";i:2;s:2:\"85\";i:3;s:2:\"86\";i:4;s:2:\"87\";}'),
(1854, 113, '_иконки', 'field_624379f24756e'),
(1855, 113, 'текст-5', 'У пациентов с легкой почечной недостаточностью (клиренс креатинина ≥ 50 — ≤ 80 мл/мин) коррекция дозы не требуется. Для лечения пациентов с почечной недостаточностью средней степени тяжести (клиренс креатинина ≥ 30 — < 50 мл/мин) рекомендуется в течение первой недели принимать начальную дозу по 4 мг в сутки, при хорошей индивидуальной переносимости доза может быть увеличена до 8 мг в сутки. Применение препарата для пациентов с тяжелой почечной недостаточностью (клиренс креатинина < 30 мл / мин) не рекомендуется'),
(1856, 113, '_текст-5', 'field_62437a374756f'),
(1857, 113, 'текст_под_кнопкой', '*Более подробные сведения о&nbsp;препарате, особенностях применения, побочных действиях и&nbsp;др. &mdash;&nbsp;см. инструкцию по&nbsp;медицинскому применению лекарственного препарата Урорек, РУ&nbsp;ЛСР-005971/10 от&nbsp;25.06.2010'),
(1858, 113, '_текст_под_кнопкой', 'field_62437a7c47570'),
(1859, 113, 'заголовок-6', 'Препарат Урорек (силодозин) включен в&nbsp;российские и&nbsp;международные клинические рекомендации и&nbsp;стандарты для лечения ряда урологических заболеваний:'),
(1860, 113, '_заголовок-6', 'field_6244117c68bd0'),
(1861, 113, 'список-6_0_ссылка', 'a:3:{s:5:\"title\";s:68:\"Российские клинические рекомендации\";s:3:\"url\";s:1:\"#\";s:6:\"target\";s:0:\"\";}'),
(1862, 113, '_список-6_0_ссылка', 'field_624411ce68bd2'),
(1863, 113, 'список-6_0_описание', '«Доброкачественная гиперплазия предстательной железы», 2020<sup>28</sup>'),
(1864, 113, '_список-6_0_описание', 'field_6244121168bd3'),
(1865, 113, 'список-6_1_ссылка', 'a:3:{s:5:\"title\";s:70:\"Европейские клинические рекомендации\";s:3:\"url\";s:1:\"#\";s:6:\"target\";s:0:\"\";}'),
(1866, 113, '_список-6_1_ссылка', 'field_624411ce68bd2'),
(1867, 113, 'список-6_1_описание', 'глава «Консервативное лечение ненейрогенных симптомов нарушенного мочеиспускания у мужчин, включая доброкачественную простатическую обструкцию», 2021<sup>29</sup>'),
(1868, 113, '_список-6_1_описание', 'field_6244121168bd3'),
(1869, 113, 'список-6_2_ссылка', 'a:3:{s:5:\"title\";s:154:\"Стандарт первичной медико-санитарной помощи при гиперплазии предстательной железы\";s:3:\"url\";s:1:\"#\";s:6:\"target\";s:0:\"\";}'),
(1870, 113, '_список-6_2_ссылка', 'field_624411ce68bd2'),
(1871, 113, 'список-6_2_описание', '09.11.2012<sup>30</sup> / Обновлён 13.04.2015\r\n'),
(1872, 113, '_список-6_2_описание', 'field_6244121168bd3'),
(1873, 113, 'список-6_3_ссылка', 'a:3:{s:5:\"title\";s:122:\"Стандарт специализированной медицинской помощи при задержке мочи\";s:3:\"url\";s:1:\"#\";s:6:\"target\";s:0:\"\";}'),
(1874, 113, '_список-6_3_ссылка', 'field_624411ce68bd2'),
(1875, 113, 'список-6_3_описание', '29.01.2013<sup>31</sup> / Обновлён 06.05.2015\r\n'),
(1876, 113, '_список-6_3_описание', 'field_6244121168bd3'),
(1877, 113, 'список-6_4_ссылка', 'a:3:{s:5:\"title\";s:133:\"Стандарт первичной медико-санитарной помощи при хроническом простатите\";s:3:\"url\";s:1:\"#\";s:6:\"target\";s:0:\"\";}'),
(1878, 113, '_список-6_4_ссылка', 'field_624411ce68bd2'),
(1879, 113, 'список-6_4_описание', '09.11.2012<sup>32</sup> / Обновлён 13.04.2015\r\n'),
(1880, 113, '_список-6_4_описание', 'field_6244121168bd3'),
(1881, 113, 'список-6_5_ссылка', 'a:3:{s:5:\"title\";s:168:\"Стандарт специализированной медицинской помощи при остром простатите, орхите, эпидидимите\";s:3:\"url\";s:1:\"#\";s:6:\"target\";s:0:\"\";}'),
(1882, 113, '_список-6_5_ссылка', 'field_624411ce68bd2'),
(1883, 113, 'список-6_5_описание', '09.11.2012<sup>33</sup> / Обновлён 27.05.2015'),
(1884, 113, '_список-6_5_описание', 'field_6244121168bd3'),
(1885, 113, 'список-6', '6'),
(1886, 113, '_список-6', 'field_624411be68bd1'),
(1887, 113, 'заголовок-7', 'Препарат Урорек (силодозин) зарегистрирован и&nbsp;применяется в&nbsp;разных странах мира Одобрен ЕМА*<sup>34</sup> и&nbsp;FDA**<sup>35</sup>'),
(1888, 113, '_заголовок-7', 'field_624417e3b6088'),
(1889, 113, 'текст', '<p class=\"sOtherCountries__agency\"><span>EMA</span> Европейское медицинское агентство</p>\r\n<p class=\"sOtherCountries__agency\"><span>FDA</span> Управление по&nbsp;санитарному надзору за&nbsp;качеством пищевых продуктов и&nbsp;медикаментов, США</p>'),
(1890, 113, '_текст', 'field_6244182bb6089'),
(1891, 113, 'страны_0_флаг', '105'),
(1892, 113, '_страны_0_флаг', 'field_62441880b608b'),
(1893, 113, 'страны_0_название', 'Япония'),
(1894, 113, '_страны_0_название', 'field_62441899b608c'),
(1895, 113, 'страны_0_год', '2006<sup>36,37</sup>'),
(1896, 113, '_страны_0_год', 'field_624418aab608d'),
(1897, 113, 'страны_1_флаг', '106'),
(1898, 113, '_страны_1_флаг', 'field_62441880b608b'),
(1899, 113, 'страны_1_название', 'США'),
(1900, 113, '_страны_1_название', 'field_62441899b608c'),
(1901, 113, 'страны_1_год', '2008<sup>35</sup>'),
(1902, 113, '_страны_1_год', 'field_624418aab608d'),
(1903, 113, 'страны_2_флаг', '107'),
(1904, 113, '_страны_2_флаг', 'field_62441880b608b'),
(1905, 113, 'страны_2_название', 'Страны ЕС'),
(1906, 113, '_страны_2_название', 'field_62441899b608c'),
(1907, 113, 'страны_2_год', '2010<sup>34</sup>'),
(1908, 113, '_страны_2_год', 'field_624418aab608d'),
(1909, 113, 'страны_3_флаг', '108'),
(1910, 113, '_страны_3_флаг', 'field_62441880b608b'),
(1911, 113, 'страны_3_название', 'Россия'),
(1912, 113, '_страны_3_название', 'field_62441899b608c'),
(1913, 113, 'страны_3_год', '2010<sup>1</sup>'),
(1914, 113, '_страны_3_год', 'field_624418aab608d'),
(1915, 113, 'страны', '4'),
(1916, 113, '_страны', 'field_62441847b608a'),
(1917, 113, 'текст-7', '<p class=\"sOtherCountries__agency\"><span>EMA</span> Европейское медицинское агентство</p>\r\n<p class=\"sOtherCountries__agency\"><span>FDA</span> Управление по&nbsp;санитарному надзору за&nbsp;качеством пищевых продуктов и&nbsp;медикаментов, США</p>'),
(1918, 113, '_текст-7', 'field_6244182bb6089'),
(1919, 113, 'текст-7-1', 'Производство препарата Урорек, поставляемого в&nbsp;Россию, осуществляется в&nbsp;Италии с&nbsp;использованием субстанции из&nbsp;Японии, в&nbsp;соответствии с&nbsp;необходимыми требованиями к&nbsp;производству и&nbsp;контролю качества<sup>6,1</sup>'),
(1920, 113, '_текст-7-1', 'field_62441a5acf03c'),
(1921, 115, 'заголовок-1', 'УРОРЕК – оригинальный<sup>10</sup> альфа-адреноблокатор'),
(1922, 115, '_заголовок-1', 'field_62435bd26f29f');
INSERT INTO `urotec_postmeta` (`meta_id`, `post_id`, `meta_key`, `meta_value`) VALUES
(1923, 115, 'текст-1', '<div class=\"headerBlock__body\">\r\n<p>Силодозин (действующее вещество препарата Урорек) обладает максимальной уроселективностью в&nbsp;своем классе, что обеспечивает его уродинамическую эффективность и&nbsp;высокую безопасность<sup>4</sup></p>\r\n</div>\r\n<div class=\"headerBlock__footer\">\r\n<p><strong>Показания к применению: </strong><br/>Лечение симптомов доброкачественной гиперплазии предстательной железы<sup>6</sup></p>\r\n</div>'),
(1924, 115, '_текст-1', 'field_62435c0c6f2a0'),
(1925, 115, 'изображение-1', '13'),
(1926, 115, '_изображение-1', 'field_62435c8b6f2a1'),
(1927, 115, 'фон-1', '17'),
(1928, 115, '_фон-1', 'field_62435db92ea96'),
(1929, 115, 'заголовок-2', 'Ключевые преимущества препарата Урорек'),
(1930, 115, '_заголовок-2', 'field_6243606295196'),
(1931, 115, 'список-2', 'Единственный оригинальный препарат из&nbsp;группы альфа1-адреноблокаторов, не&nbsp;имеющий генериков в&nbsp;РФ<sup>1</sup>'),
(1932, 115, '_список-2', 'field_6243608195197'),
(1933, 115, 'картинка_с_текстом_0_изображение', '31'),
(1934, 115, '_картинка_с_текстом_0_изображение', 'field_624363d095199'),
(1935, 115, 'картинка_с_текстом_0_описание', 'Обширная доказательная база собственных пострегистрационных клинических исследований<sup>2</sup>'),
(1936, 115, '_картинка_с_текстом_0_описание', 'field_624363e59519a'),
(1937, 115, 'картинка_с_текстом_1_изображение', '32'),
(1938, 115, '_картинка_с_текстом_1_изображение', 'field_624363d095199'),
(1939, 115, 'картинка_с_текстом_1_описание', 'Отсутствие риска замены препарата Урорек в&nbsp;аптеке (единственный препарат с&nbsp;действующим веществом силодозин)<sup>1</sup>'),
(1940, 115, '_картинка_с_текстом_1_описание', 'field_624363e59519a'),
(1941, 115, 'картинка_с_текстом_2_изображение', '33'),
(1942, 115, '_картинка_с_текстом_2_изображение', 'field_624363d095199'),
(1943, 115, 'картинка_с_текстом_2_описание', 'Большинство пациентов предпочитают принимать оригинальные препараты<sup>3</sup>'),
(1944, 115, '_картинка_с_текстом_2_описание', 'field_624363e59519a'),
(1945, 115, 'картинка_с_текстом', '3'),
(1946, 115, '_картинка_с_текстом', 'field_624363b995198'),
(1947, 115, 'второй_список', '<li>Клинические преимущества препарата Урорек (силодозин) определяются максимальной уроселективностью в&nbsp;классе альфа-адреноблокаторов<sup>4</sup></li>\r\n\r\n<li>Урорек&nbsp;&mdash; альфа-адреноблокатор последнего поколения, который эффективен в&nbsp;отношении всех СНМП (накопления, опорожнения, постмиктурических).<sup>12,13</sup> При этом Урорек обладает минимальным риском развития нежелательных явлений со&nbsp;стороны сердечно-сосудистой системы, в&nbsp;том числе&nbsp;у&nbsp;пациентов, принимающих антигипертензивные препараты<sup>46,8</sup> <small> <span>СНМП </span>симптомы нижних мочевыводящих путей</small></li>'),
(1948, 115, '_второй_список', 'field_6243640e05eda'),
(1949, 115, 'заголовок2-2', 'Максимальная уроселективность силодозина в&nbsp;классе альфа-адреноблокаторов обуславливает его уродинамическую эффективность и&nbsp;высокий профиль безопасности<sup>4</sup>'),
(1950, 115, '_заголовок2-2', 'field_6243644705edb'),
(1951, 115, 'текст3', '<ul>\r\n<li>Урорек значительно улучшает клинические проявления и&nbsp;качество жизни у&nbsp;всех пациентов с&nbsp;СНМП/ДГПЖ, в&nbsp;том числе с&nbsp;тяжелым течением<sup>11</sup><a href=\"#\">Узнать больше...</a></li>\r\n\r\n<li>Урорек является препаратом выбора для пациентов с&nbsp;СНМП/ДГПЖ и&nbsp;сопутствующими сердечно-сосудистыми заболеваниями<sup>3</sup> <a href=\"#\">Узнать больше...</a></li>\r\n</ul>\r\n<small> <span>ДГПЖ </span>доброкачественная гиперплазия предстательной железы</small>'),
(1952, 115, '_текст3', 'field_6243647405edc'),
(1953, 115, 'изображение-2', '34'),
(1954, 115, '_изображение-2', 'field_624364dd05edd'),
(1955, 115, 'текст_в_подвале', '<h2> Максимальная уроселективность в&nbsp;классе  альфа-адреноблокаторов<sup>4</sup></h2>\r\n<div class=\"h3\"> Почему это важно? <a href=\"#\">Подробнее</a></div>'),
(1956, 115, '_текст_в_подвале', 'field_62436daf1f6d9'),
(1957, 115, 'заголовок-3', 'Форма выпуска препарата Урорек'),
(1958, 115, '_заголовок-3', 'field_62436efee98e7'),
(1959, 115, 'текст-3', '<p class=\"section-descr\"><span>8мг </span>- рекомендуемая доза для лечения симптомов ДГПЖ<sup>6</sup>*</p>\r\n					<p class=\"section-note col-md-10\">*Более подробные сведения о&nbsp;препарате, особенностях применения, побочных действиях и&nbsp;др. &mdash;&nbsp;смотрите инструкцию по&nbsp;медицинскому применению лекарственного препарата Урорек, РУ&nbsp;ЛСР-005971/10 от&nbsp;25.06.2010 </p>'),
(1960, 115, '_текст-3', 'field_62436f60e98e8'),
(1961, 115, 'товар_0_название', 'Урорек 8мг №30'),
(1962, 115, '_товар_0_название', 'field_62436fcce98ea'),
(1963, 115, 'товар_0_описание', 'Упаковка, рассчитанная на&nbsp;1&nbsp;месяц лечения&nbsp;/ для старта терапии'),
(1964, 115, '_товар_0_описание', 'field_62436fe1e98eb'),
(1965, 115, 'товар_0_лицензия', 'РУ: ЛСР-005971/10 от 25.06.2010'),
(1966, 115, '_товар_0_лицензия', 'field_62436ff0e98ec'),
(1967, 115, 'товар_0_изображение', '51'),
(1968, 115, '_товар_0_изображение', 'field_62437045e98ed'),
(1969, 115, 'товар_1_название', 'Урорек 8мг №90'),
(1970, 115, '_товар_1_название', 'field_62436fcce98ea'),
(1971, 115, 'товар_1_описание', 'Выгодная упаковка, рассчитанная на&nbsp;3&nbsp;месяца лечения. Самая доступная стоимость 1&nbsp;дня терапии препаратом Урорек&nbsp;<sup>27</sup>'),
(1972, 115, '_товар_1_описание', 'field_62436fe1e98eb'),
(1973, 115, 'товар_1_лицензия', 'РУ: ЛСР-005971/10 от 25.06.2010'),
(1974, 115, '_товар_1_лицензия', 'field_62436ff0e98ec'),
(1975, 115, 'товар_1_изображение', '53'),
(1976, 115, '_товар_1_изображение', 'field_62437045e98ed'),
(1977, 115, 'товар_2_название', 'Урорек 4мг №30'),
(1978, 115, '_товар_2_название', 'field_62436fcce98ea'),
(1979, 115, 'товар_2_описание', '4&nbsp;мг&nbsp;&mdash; стартовая упаковка для лечения симптомов ДГПЖ у&nbsp;пациентов с&nbsp;почечной недостаточностью средней степени тяжести<sup>6</sup>'),
(1980, 115, '_товар_2_описание', 'field_62436fe1e98eb'),
(1981, 115, 'товар_2_лицензия', 'РУ: ЛСР-005971/10 от 25.06.2010'),
(1982, 115, '_товар_2_лицензия', 'field_62436ff0e98ec'),
(1983, 115, 'товар_2_изображение', '52'),
(1984, 115, '_товар_2_изображение', 'field_62437045e98ed'),
(1985, 115, 'товар', '3'),
(1986, 115, '_товар', 'field_62436fbde98e9'),
(1987, 115, 'заголовок-4', 'Где купить'),
(1988, 115, '_заголовок-4', 'field_624374f73d8bd'),
(1989, 115, 'изображения', 'a:12:{i:0;s:2:\"63\";i:1;s:2:\"64\";i:2;s:2:\"65\";i:3;s:2:\"66\";i:4;s:2:\"67\";i:5;s:2:\"68\";i:6;s:2:\"69\";i:7;s:2:\"70\";i:8;s:2:\"71\";i:9;s:2:\"72\";i:10;s:2:\"73\";i:11;s:2:\"74\";}'),
(1990, 115, '_изображения', 'field_624375093d8be'),
(1991, 115, 'изображения-4', 'a:12:{i:0;s:2:\"63\";i:1;s:2:\"64\";i:2;s:2:\"65\";i:3;s:2:\"66\";i:4;s:2:\"67\";i:5;s:2:\"68\";i:6;s:2:\"69\";i:7;s:2:\"70\";i:8;s:2:\"71\";i:9;s:2:\"72\";i:10;s:2:\"73\";i:11;s:2:\"74\";}'),
(1992, 115, '_изображения-4', 'field_624375093d8be'),
(1993, 115, 'заголовок-5', 'Способ применения*<sup>6</sup>'),
(1994, 115, '_заголовок-5', 'field_624379bd4756d'),
(1995, 115, 'иконки', 'a:5:{i:0;s:2:\"83\";i:1;s:2:\"84\";i:2;s:2:\"85\";i:3;s:2:\"86\";i:4;s:2:\"87\";}'),
(1996, 115, '_иконки', 'field_624379f24756e'),
(1997, 115, 'текст-5', 'У пациентов с легкой почечной недостаточностью (клиренс креатинина ≥ 50 — ≤ 80 мл/мин) коррекция дозы не требуется. Для лечения пациентов с почечной недостаточностью средней степени тяжести (клиренс креатинина ≥ 30 — < 50 мл/мин) рекомендуется в течение первой недели принимать начальную дозу по 4 мг в сутки, при хорошей индивидуальной переносимости доза может быть увеличена до 8 мг в сутки. Применение препарата для пациентов с тяжелой почечной недостаточностью (клиренс креатинина < 30 мл / мин) не рекомендуется'),
(1998, 115, '_текст-5', 'field_62437a374756f'),
(1999, 115, 'текст_под_кнопкой', '*Более подробные сведения о&nbsp;препарате, особенностях применения, побочных действиях и&nbsp;др. &mdash;&nbsp;см. инструкцию по&nbsp;медицинскому применению лекарственного препарата Урорек, РУ&nbsp;ЛСР-005971/10 от&nbsp;25.06.2010'),
(2000, 115, '_текст_под_кнопкой', 'field_62437a7c47570'),
(2001, 115, 'заголовок-6', 'Препарат Урорек (силодозин) включен в&nbsp;российские и&nbsp;международные клинические рекомендации и&nbsp;стандарты для лечения ряда урологических заболеваний:'),
(2002, 115, '_заголовок-6', 'field_6244117c68bd0'),
(2003, 115, 'список-6_0_ссылка', 'a:3:{s:5:\"title\";s:68:\"Российские клинические рекомендации\";s:3:\"url\";s:1:\"#\";s:6:\"target\";s:0:\"\";}'),
(2004, 115, '_список-6_0_ссылка', 'field_624411ce68bd2'),
(2005, 115, 'список-6_0_описание', '«Доброкачественная гиперплазия предстательной железы», 2020<sup>28</sup>'),
(2006, 115, '_список-6_0_описание', 'field_6244121168bd3'),
(2007, 115, 'список-6_1_ссылка', 'a:3:{s:5:\"title\";s:70:\"Европейские клинические рекомендации\";s:3:\"url\";s:1:\"#\";s:6:\"target\";s:0:\"\";}'),
(2008, 115, '_список-6_1_ссылка', 'field_624411ce68bd2'),
(2009, 115, 'список-6_1_описание', 'глава «Консервативное лечение ненейрогенных симптомов нарушенного мочеиспускания у мужчин, включая доброкачественную простатическую обструкцию», 2021<sup>29</sup>'),
(2010, 115, '_список-6_1_описание', 'field_6244121168bd3'),
(2011, 115, 'список-6_2_ссылка', 'a:3:{s:5:\"title\";s:154:\"Стандарт первичной медико-санитарной помощи при гиперплазии предстательной железы\";s:3:\"url\";s:1:\"#\";s:6:\"target\";s:0:\"\";}'),
(2012, 115, '_список-6_2_ссылка', 'field_624411ce68bd2'),
(2013, 115, 'список-6_2_описание', '09.11.2012<sup>30</sup> / Обновлён 13.04.2015\r\n'),
(2014, 115, '_список-6_2_описание', 'field_6244121168bd3'),
(2015, 115, 'список-6_3_ссылка', 'a:3:{s:5:\"title\";s:122:\"Стандарт специализированной медицинской помощи при задержке мочи\";s:3:\"url\";s:1:\"#\";s:6:\"target\";s:0:\"\";}'),
(2016, 115, '_список-6_3_ссылка', 'field_624411ce68bd2'),
(2017, 115, 'список-6_3_описание', '29.01.2013<sup>31</sup> / Обновлён 06.05.2015\r\n'),
(2018, 115, '_список-6_3_описание', 'field_6244121168bd3'),
(2019, 115, 'список-6_4_ссылка', 'a:3:{s:5:\"title\";s:133:\"Стандарт первичной медико-санитарной помощи при хроническом простатите\";s:3:\"url\";s:1:\"#\";s:6:\"target\";s:0:\"\";}'),
(2020, 115, '_список-6_4_ссылка', 'field_624411ce68bd2'),
(2021, 115, 'список-6_4_описание', '09.11.2012<sup>32</sup> / Обновлён 13.04.2015\r\n'),
(2022, 115, '_список-6_4_описание', 'field_6244121168bd3'),
(2023, 115, 'список-6_5_ссылка', 'a:3:{s:5:\"title\";s:168:\"Стандарт специализированной медицинской помощи при остром простатите, орхите, эпидидимите\";s:3:\"url\";s:1:\"#\";s:6:\"target\";s:0:\"\";}'),
(2024, 115, '_список-6_5_ссылка', 'field_624411ce68bd2'),
(2025, 115, 'список-6_5_описание', '09.11.2012<sup>33</sup> / Обновлён 27.05.2015'),
(2026, 115, '_список-6_5_описание', 'field_6244121168bd3'),
(2027, 115, 'список-6', '6'),
(2028, 115, '_список-6', 'field_624411be68bd1'),
(2029, 115, 'заголовок-7', 'Препарат Урорек (силодозин) зарегистрирован и&nbsp;применяется в&nbsp;разных странах мира Одобрен ЕМА*<sup>34</sup> и&nbsp;FDA**<sup>35</sup>'),
(2030, 115, '_заголовок-7', 'field_624417e3b6088'),
(2031, 115, 'текст', '<p class=\"sOtherCountries__agency\"><span>EMA</span> Европейское медицинское агентство</p>\r\n<p class=\"sOtherCountries__agency\"><span>FDA</span> Управление по&nbsp;санитарному надзору за&nbsp;качеством пищевых продуктов и&nbsp;медикаментов, США</p>'),
(2032, 115, '_текст', 'field_6244182bb6089'),
(2033, 115, 'страны_0_флаг', '105'),
(2034, 115, '_страны_0_флаг', 'field_62441880b608b'),
(2035, 115, 'страны_0_название', 'Япония'),
(2036, 115, '_страны_0_название', 'field_62441899b608c'),
(2037, 115, 'страны_0_год', '2006<sup>36,37</sup>'),
(2038, 115, '_страны_0_год', 'field_624418aab608d'),
(2039, 115, 'страны_1_флаг', '106'),
(2040, 115, '_страны_1_флаг', 'field_62441880b608b'),
(2041, 115, 'страны_1_название', 'США'),
(2042, 115, '_страны_1_название', 'field_62441899b608c'),
(2043, 115, 'страны_1_год', '2008<sup>35</sup>'),
(2044, 115, '_страны_1_год', 'field_624418aab608d'),
(2045, 115, 'страны_2_флаг', '107'),
(2046, 115, '_страны_2_флаг', 'field_62441880b608b'),
(2047, 115, 'страны_2_название', 'Страны ЕС'),
(2048, 115, '_страны_2_название', 'field_62441899b608c'),
(2049, 115, 'страны_2_год', '2010<sup>34</sup>'),
(2050, 115, '_страны_2_год', 'field_624418aab608d'),
(2051, 115, 'страны_3_флаг', '108'),
(2052, 115, '_страны_3_флаг', 'field_62441880b608b'),
(2053, 115, 'страны_3_название', 'Россия'),
(2054, 115, '_страны_3_название', 'field_62441899b608c'),
(2055, 115, 'страны_3_год', '2010<sup>1</sup>'),
(2056, 115, '_страны_3_год', 'field_624418aab608d'),
(2057, 115, 'страны', '4'),
(2058, 115, '_страны', 'field_62441847b608a'),
(2059, 115, 'текст-7', '<p class=\"sOtherCountries__agency\"><span>EMA</span> Европейское медицинское агентство</p>\r\n<p class=\"sOtherCountries__agency\"><span>FDA</span> Управление по&nbsp;санитарному надзору за&nbsp;качеством пищевых продуктов и&nbsp;медикаментов, США</p>'),
(2060, 115, '_текст-7', 'field_6244182bb6089'),
(2061, 115, 'текст-7-1', 'Производство препарата Урорек, поставляемого в&nbsp;Россию, осуществляется в&nbsp;Италии с&nbsp;использованием субстанции из&nbsp;Японии, в&nbsp;соответствии с&nbsp;необходимыми требованиями к&nbsp;производству и&nbsp;контролю качества<sup>6,1</sup>'),
(2062, 115, '_текст-7-1', 'field_62441a5acf03c'),
(2063, 117, '_edit_last', '1'),
(2064, 117, '_edit_lock', '1648636788:1'),
(2065, 122, '_wp_attached_file', '2022/03/about-img.png'),
(2066, 122, '_wp_attachment_metadata', 'a:5:{s:5:\"width\";i:594;s:6:\"height\";i:696;s:4:\"file\";s:21:\"2022/03/about-img.png\";s:5:\"sizes\";a:3:{s:6:\"medium\";a:4:{s:4:\"file\";s:21:\"about-img-256x300.png\";s:5:\"width\";i:256;s:6:\"height\";i:300;s:9:\"mime-type\";s:9:\"image/png\";}s:9:\"thumbnail\";a:4:{s:4:\"file\";s:21:\"about-img-150x150.png\";s:5:\"width\";i:150;s:6:\"height\";i:150;s:9:\"mime-type\";s:9:\"image/png\";}s:8:\"500х500\";a:4:{s:4:\"file\";s:21:\"about-img-500x500.png\";s:5:\"width\";i:500;s:6:\"height\";i:500;s:9:\"mime-type\";s:9:\"image/png\";}}s:10:\"image_meta\";a:12:{s:8:\"aperture\";s:1:\"0\";s:6:\"credit\";s:0:\"\";s:6:\"camera\";s:0:\"\";s:7:\"caption\";s:0:\"\";s:17:\"created_timestamp\";s:1:\"0\";s:9:\"copyright\";s:0:\"\";s:12:\"focal_length\";s:1:\"0\";s:3:\"iso\";s:1:\"0\";s:13:\"shutter_speed\";s:1:\"0\";s:5:\"title\";s:0:\"\";s:11:\"orientation\";s:1:\"0\";s:8:\"keywords\";a:0:{}}}'),
(2067, 123, '_wp_attached_file', '2022/03/symptoms-i-1.png'),
(2068, 123, '_wp_attachment_metadata', 'a:5:{s:5:\"width\";i:52;s:6:\"height\";i:52;s:4:\"file\";s:24:\"2022/03/symptoms-i-1.png\";s:5:\"sizes\";a:0:{}s:10:\"image_meta\";a:12:{s:8:\"aperture\";s:1:\"0\";s:6:\"credit\";s:0:\"\";s:6:\"camera\";s:0:\"\";s:7:\"caption\";s:0:\"\";s:17:\"created_timestamp\";s:1:\"0\";s:9:\"copyright\";s:0:\"\";s:12:\"focal_length\";s:1:\"0\";s:3:\"iso\";s:1:\"0\";s:13:\"shutter_speed\";s:1:\"0\";s:5:\"title\";s:0:\"\";s:11:\"orientation\";s:1:\"0\";s:8:\"keywords\";a:0:{}}}'),
(2069, 124, '_wp_attached_file', '2022/03/symptoms-i-2.png'),
(2070, 124, '_wp_attachment_metadata', 'a:5:{s:5:\"width\";i:50;s:6:\"height\";i:51;s:4:\"file\";s:24:\"2022/03/symptoms-i-2.png\";s:5:\"sizes\";a:0:{}s:10:\"image_meta\";a:12:{s:8:\"aperture\";s:1:\"0\";s:6:\"credit\";s:0:\"\";s:6:\"camera\";s:0:\"\";s:7:\"caption\";s:0:\"\";s:17:\"created_timestamp\";s:1:\"0\";s:9:\"copyright\";s:0:\"\";s:12:\"focal_length\";s:1:\"0\";s:3:\"iso\";s:1:\"0\";s:13:\"shutter_speed\";s:1:\"0\";s:5:\"title\";s:0:\"\";s:11:\"orientation\";s:1:\"0\";s:8:\"keywords\";a:0:{}}}'),
(2071, 125, '_wp_attached_file', '2022/03/symptoms-i-3.png'),
(2072, 125, '_wp_attachment_metadata', 'a:5:{s:5:\"width\";i:53;s:6:\"height\";i:53;s:4:\"file\";s:24:\"2022/03/symptoms-i-3.png\";s:5:\"sizes\";a:0:{}s:10:\"image_meta\";a:12:{s:8:\"aperture\";s:1:\"0\";s:6:\"credit\";s:0:\"\";s:6:\"camera\";s:0:\"\";s:7:\"caption\";s:0:\"\";s:17:\"created_timestamp\";s:1:\"0\";s:9:\"copyright\";s:0:\"\";s:12:\"focal_length\";s:1:\"0\";s:3:\"iso\";s:1:\"0\";s:13:\"shutter_speed\";s:1:\"0\";s:5:\"title\";s:0:\"\";s:11:\"orientation\";s:1:\"0\";s:8:\"keywords\";a:0:{}}}'),
(2073, 126, '_wp_attached_file', '2022/03/symptoms-i-4.png'),
(2074, 126, '_wp_attachment_metadata', 'a:5:{s:5:\"width\";i:53;s:6:\"height\";i:53;s:4:\"file\";s:24:\"2022/03/symptoms-i-4.png\";s:5:\"sizes\";a:0:{}s:10:\"image_meta\";a:12:{s:8:\"aperture\";s:1:\"0\";s:6:\"credit\";s:0:\"\";s:6:\"camera\";s:0:\"\";s:7:\"caption\";s:0:\"\";s:17:\"created_timestamp\";s:1:\"0\";s:9:\"copyright\";s:0:\"\";s:12:\"focal_length\";s:1:\"0\";s:3:\"iso\";s:1:\"0\";s:13:\"shutter_speed\";s:1:\"0\";s:5:\"title\";s:0:\"\";s:11:\"orientation\";s:1:\"0\";s:8:\"keywords\";a:0:{}}}'),
(2075, 127, '_wp_attached_file', '2022/03/symptoms-i-5.png'),
(2076, 127, '_wp_attachment_metadata', 'a:5:{s:5:\"width\";i:46;s:6:\"height\";i:46;s:4:\"file\";s:24:\"2022/03/symptoms-i-5.png\";s:5:\"sizes\";a:0:{}s:10:\"image_meta\";a:12:{s:8:\"aperture\";s:1:\"0\";s:6:\"credit\";s:0:\"\";s:6:\"camera\";s:0:\"\";s:7:\"caption\";s:0:\"\";s:17:\"created_timestamp\";s:1:\"0\";s:9:\"copyright\";s:0:\"\";s:12:\"focal_length\";s:1:\"0\";s:3:\"iso\";s:1:\"0\";s:13:\"shutter_speed\";s:1:\"0\";s:5:\"title\";s:0:\"\";s:11:\"orientation\";s:1:\"0\";s:8:\"keywords\";a:0:{}}}'),
(2077, 128, '_wp_attached_file', '2022/03/symptoms-i-6.png'),
(2078, 128, '_wp_attachment_metadata', 'a:5:{s:5:\"width\";i:51;s:6:\"height\";i:51;s:4:\"file\";s:24:\"2022/03/symptoms-i-6.png\";s:5:\"sizes\";a:0:{}s:10:\"image_meta\";a:12:{s:8:\"aperture\";s:1:\"0\";s:6:\"credit\";s:0:\"\";s:6:\"camera\";s:0:\"\";s:7:\"caption\";s:0:\"\";s:17:\"created_timestamp\";s:1:\"0\";s:9:\"copyright\";s:0:\"\";s:12:\"focal_length\";s:1:\"0\";s:3:\"iso\";s:1:\"0\";s:13:\"shutter_speed\";s:1:\"0\";s:5:\"title\";s:0:\"\";s:11:\"orientation\";s:1:\"0\";s:8:\"keywords\";a:0:{}}}'),
(2079, 2, 'заголовок-8', 'О проблеме'),
(2080, 2, '_заголовок-8', 'field_624431d91624d'),
(2081, 2, 'текст-8', 'Доброкачественная гиперплазия предстательной железы (ДГПЖ), или как ее еще называют, аденома простаты, как правило, возникает у мужчин старше 50 лет и характеризуется наличием симптомов нижних мочевыводящих путей (СНМП), увеличением предстательной железы или ее части, и нарушением оттока мочи из мочевого пузыря вследствие инфравезикальной обструкции.<sup>38</sup>\r\n\r\nРаспространенность ДГПЖ увеличивается с возрастом. Так, клинически значимая ДГПЖ проявляется у 13% мужчин в возрасте старше 50 лет, у 34% мужчин в возрасте 60 лет и у 43% в возрасте 70 лет.<sup>39</sup>\r\n\r\n<img class=\"alignnone wp-image-122 size-full\" src=\"http://0026urotec.loc:8888/wp-content/uploads/2022/03/about-img.png\" alt=\"\" width=\"594\" height=\"696\" />'),
(2082, 2, '_текст-8', 'field_624431f11624e'),
(2083, 2, 'текст-8-1', 'Наличие СНМП может быть ассоциировано с&nbsp;тяжелыми хроническими заболеваниями, такими как заболевания сердца, сахарный диабет, артериальная гипертензия и&nbsp;депрессия<sup>40</sup>'),
(2084, 2, '_текст-8-1', 'field_6244320b26db3'),
(2085, 2, 'иконки-8', 'a:6:{i:0;s:3:\"123\";i:1;s:3:\"124\";i:2;s:3:\"125\";i:3;s:3:\"126\";i:4;s:3:\"127\";i:5;s:3:\"128\";}'),
(2086, 2, '_иконки-8', 'field_6244322d26db4'),
(2087, 129, 'заголовок-1', 'УРОРЕК – оригинальный<sup>10</sup> альфа-адреноблокатор'),
(2088, 129, '_заголовок-1', 'field_62435bd26f29f'),
(2089, 129, 'текст-1', '<div class=\"headerBlock__body\">\r\n<p>Силодозин (действующее вещество препарата Урорек) обладает максимальной уроселективностью в&nbsp;своем классе, что обеспечивает его уродинамическую эффективность и&nbsp;высокую безопасность<sup>4</sup></p>\r\n</div>\r\n<div class=\"headerBlock__footer\">\r\n<p><strong>Показания к применению: </strong><br/>Лечение симптомов доброкачественной гиперплазии предстательной железы<sup>6</sup></p>\r\n</div>'),
(2090, 129, '_текст-1', 'field_62435c0c6f2a0'),
(2091, 129, 'изображение-1', '13'),
(2092, 129, '_изображение-1', 'field_62435c8b6f2a1'),
(2093, 129, 'фон-1', '17'),
(2094, 129, '_фон-1', 'field_62435db92ea96'),
(2095, 129, 'заголовок-2', 'Ключевые преимущества препарата Урорек'),
(2096, 129, '_заголовок-2', 'field_6243606295196'),
(2097, 129, 'список-2', 'Единственный оригинальный препарат из&nbsp;группы альфа1-адреноблокаторов, не&nbsp;имеющий генериков в&nbsp;РФ<sup>1</sup>'),
(2098, 129, '_список-2', 'field_6243608195197'),
(2099, 129, 'картинка_с_текстом_0_изображение', '31'),
(2100, 129, '_картинка_с_текстом_0_изображение', 'field_624363d095199'),
(2101, 129, 'картинка_с_текстом_0_описание', 'Обширная доказательная база собственных пострегистрационных клинических исследований<sup>2</sup>'),
(2102, 129, '_картинка_с_текстом_0_описание', 'field_624363e59519a'),
(2103, 129, 'картинка_с_текстом_1_изображение', '32'),
(2104, 129, '_картинка_с_текстом_1_изображение', 'field_624363d095199'),
(2105, 129, 'картинка_с_текстом_1_описание', 'Отсутствие риска замены препарата Урорек в&nbsp;аптеке (единственный препарат с&nbsp;действующим веществом силодозин)<sup>1</sup>'),
(2106, 129, '_картинка_с_текстом_1_описание', 'field_624363e59519a'),
(2107, 129, 'картинка_с_текстом_2_изображение', '33'),
(2108, 129, '_картинка_с_текстом_2_изображение', 'field_624363d095199'),
(2109, 129, 'картинка_с_текстом_2_описание', 'Большинство пациентов предпочитают принимать оригинальные препараты<sup>3</sup>'),
(2110, 129, '_картинка_с_текстом_2_описание', 'field_624363e59519a'),
(2111, 129, 'картинка_с_текстом', '3'),
(2112, 129, '_картинка_с_текстом', 'field_624363b995198'),
(2113, 129, 'второй_список', '<li>Клинические преимущества препарата Урорек (силодозин) определяются максимальной уроселективностью в&nbsp;классе альфа-адреноблокаторов<sup>4</sup></li>\r\n\r\n<li>Урорек&nbsp;&mdash; альфа-адреноблокатор последнего поколения, который эффективен в&nbsp;отношении всех СНМП (накопления, опорожнения, постмиктурических).<sup>12,13</sup> При этом Урорек обладает минимальным риском развития нежелательных явлений со&nbsp;стороны сердечно-сосудистой системы, в&nbsp;том числе&nbsp;у&nbsp;пациентов, принимающих антигипертензивные препараты<sup>46,8</sup> <small> <span>СНМП </span>симптомы нижних мочевыводящих путей</small></li>'),
(2114, 129, '_второй_список', 'field_6243640e05eda'),
(2115, 129, 'заголовок2-2', 'Максимальная уроселективность силодозина в&nbsp;классе альфа-адреноблокаторов обуславливает его уродинамическую эффективность и&nbsp;высокий профиль безопасности<sup>4</sup>'),
(2116, 129, '_заголовок2-2', 'field_6243644705edb'),
(2117, 129, 'текст3', '<ul>\r\n<li>Урорек значительно улучшает клинические проявления и&nbsp;качество жизни у&nbsp;всех пациентов с&nbsp;СНМП/ДГПЖ, в&nbsp;том числе с&nbsp;тяжелым течением<sup>11</sup><a href=\"#\">Узнать больше...</a></li>\r\n\r\n<li>Урорек является препаратом выбора для пациентов с&nbsp;СНМП/ДГПЖ и&nbsp;сопутствующими сердечно-сосудистыми заболеваниями<sup>3</sup> <a href=\"#\">Узнать больше...</a></li>\r\n</ul>\r\n<small> <span>ДГПЖ </span>доброкачественная гиперплазия предстательной железы</small>'),
(2118, 129, '_текст3', 'field_6243647405edc'),
(2119, 129, 'изображение-2', '34'),
(2120, 129, '_изображение-2', 'field_624364dd05edd'),
(2121, 129, 'текст_в_подвале', '<h2> Максимальная уроселективность в&nbsp;классе  альфа-адреноблокаторов<sup>4</sup></h2>\r\n<div class=\"h3\"> Почему это важно? <a href=\"#\">Подробнее</a></div>'),
(2122, 129, '_текст_в_подвале', 'field_62436daf1f6d9'),
(2123, 129, 'заголовок-3', 'Форма выпуска препарата Урорек'),
(2124, 129, '_заголовок-3', 'field_62436efee98e7'),
(2125, 129, 'текст-3', '<p class=\"section-descr\"><span>8мг </span>- рекомендуемая доза для лечения симптомов ДГПЖ<sup>6</sup>*</p>\r\n					<p class=\"section-note col-md-10\">*Более подробные сведения о&nbsp;препарате, особенностях применения, побочных действиях и&nbsp;др. &mdash;&nbsp;смотрите инструкцию по&nbsp;медицинскому применению лекарственного препарата Урорек, РУ&nbsp;ЛСР-005971/10 от&nbsp;25.06.2010 </p>'),
(2126, 129, '_текст-3', 'field_62436f60e98e8'),
(2127, 129, 'товар_0_название', 'Урорек 8мг №30'),
(2128, 129, '_товар_0_название', 'field_62436fcce98ea'),
(2129, 129, 'товар_0_описание', 'Упаковка, рассчитанная на&nbsp;1&nbsp;месяц лечения&nbsp;/ для старта терапии'),
(2130, 129, '_товар_0_описание', 'field_62436fe1e98eb'),
(2131, 129, 'товар_0_лицензия', 'РУ: ЛСР-005971/10 от 25.06.2010'),
(2132, 129, '_товар_0_лицензия', 'field_62436ff0e98ec'),
(2133, 129, 'товар_0_изображение', '51'),
(2134, 129, '_товар_0_изображение', 'field_62437045e98ed'),
(2135, 129, 'товар_1_название', 'Урорек 8мг №90'),
(2136, 129, '_товар_1_название', 'field_62436fcce98ea'),
(2137, 129, 'товар_1_описание', 'Выгодная упаковка, рассчитанная на&nbsp;3&nbsp;месяца лечения. Самая доступная стоимость 1&nbsp;дня терапии препаратом Урорек&nbsp;<sup>27</sup>'),
(2138, 129, '_товар_1_описание', 'field_62436fe1e98eb'),
(2139, 129, 'товар_1_лицензия', 'РУ: ЛСР-005971/10 от 25.06.2010'),
(2140, 129, '_товар_1_лицензия', 'field_62436ff0e98ec'),
(2141, 129, 'товар_1_изображение', '53'),
(2142, 129, '_товар_1_изображение', 'field_62437045e98ed'),
(2143, 129, 'товар_2_название', 'Урорек 4мг №30'),
(2144, 129, '_товар_2_название', 'field_62436fcce98ea'),
(2145, 129, 'товар_2_описание', '4&nbsp;мг&nbsp;&mdash; стартовая упаковка для лечения симптомов ДГПЖ у&nbsp;пациентов с&nbsp;почечной недостаточностью средней степени тяжести<sup>6</sup>'),
(2146, 129, '_товар_2_описание', 'field_62436fe1e98eb'),
(2147, 129, 'товар_2_лицензия', 'РУ: ЛСР-005971/10 от 25.06.2010'),
(2148, 129, '_товар_2_лицензия', 'field_62436ff0e98ec'),
(2149, 129, 'товар_2_изображение', '52'),
(2150, 129, '_товар_2_изображение', 'field_62437045e98ed'),
(2151, 129, 'товар', '3'),
(2152, 129, '_товар', 'field_62436fbde98e9'),
(2153, 129, 'заголовок-4', 'Где купить'),
(2154, 129, '_заголовок-4', 'field_624374f73d8bd'),
(2155, 129, 'изображения', 'a:12:{i:0;s:2:\"63\";i:1;s:2:\"64\";i:2;s:2:\"65\";i:3;s:2:\"66\";i:4;s:2:\"67\";i:5;s:2:\"68\";i:6;s:2:\"69\";i:7;s:2:\"70\";i:8;s:2:\"71\";i:9;s:2:\"72\";i:10;s:2:\"73\";i:11;s:2:\"74\";}'),
(2156, 129, '_изображения', 'field_624375093d8be'),
(2157, 129, 'изображения-4', 'a:12:{i:0;s:2:\"63\";i:1;s:2:\"64\";i:2;s:2:\"65\";i:3;s:2:\"66\";i:4;s:2:\"67\";i:5;s:2:\"68\";i:6;s:2:\"69\";i:7;s:2:\"70\";i:8;s:2:\"71\";i:9;s:2:\"72\";i:10;s:2:\"73\";i:11;s:2:\"74\";}'),
(2158, 129, '_изображения-4', 'field_624375093d8be'),
(2159, 129, 'заголовок-5', 'Способ применения*<sup>6</sup>'),
(2160, 129, '_заголовок-5', 'field_624379bd4756d'),
(2161, 129, 'иконки', 'a:5:{i:0;s:2:\"83\";i:1;s:2:\"84\";i:2;s:2:\"85\";i:3;s:2:\"86\";i:4;s:2:\"87\";}'),
(2162, 129, '_иконки', 'field_624379f24756e'),
(2163, 129, 'текст-5', 'У пациентов с легкой почечной недостаточностью (клиренс креатинина ≥ 50 — ≤ 80 мл/мин) коррекция дозы не требуется. Для лечения пациентов с почечной недостаточностью средней степени тяжести (клиренс креатинина ≥ 30 — < 50 мл/мин) рекомендуется в течение первой недели принимать начальную дозу по 4 мг в сутки, при хорошей индивидуальной переносимости доза может быть увеличена до 8 мг в сутки. Применение препарата для пациентов с тяжелой почечной недостаточностью (клиренс креатинина < 30 мл / мин) не рекомендуется'),
(2164, 129, '_текст-5', 'field_62437a374756f'),
(2165, 129, 'текст_под_кнопкой', '*Более подробные сведения о&nbsp;препарате, особенностях применения, побочных действиях и&nbsp;др. &mdash;&nbsp;см. инструкцию по&nbsp;медицинскому применению лекарственного препарата Урорек, РУ&nbsp;ЛСР-005971/10 от&nbsp;25.06.2010'),
(2166, 129, '_текст_под_кнопкой', 'field_62437a7c47570'),
(2167, 129, 'заголовок-6', 'Препарат Урорек (силодозин) включен в&nbsp;российские и&nbsp;международные клинические рекомендации и&nbsp;стандарты для лечения ряда урологических заболеваний:'),
(2168, 129, '_заголовок-6', 'field_6244117c68bd0'),
(2169, 129, 'список-6_0_ссылка', 'a:3:{s:5:\"title\";s:68:\"Российские клинические рекомендации\";s:3:\"url\";s:1:\"#\";s:6:\"target\";s:0:\"\";}'),
(2170, 129, '_список-6_0_ссылка', 'field_624411ce68bd2'),
(2171, 129, 'список-6_0_описание', '«Доброкачественная гиперплазия предстательной железы», 2020<sup>28</sup>'),
(2172, 129, '_список-6_0_описание', 'field_6244121168bd3'),
(2173, 129, 'список-6_1_ссылка', 'a:3:{s:5:\"title\";s:70:\"Европейские клинические рекомендации\";s:3:\"url\";s:1:\"#\";s:6:\"target\";s:0:\"\";}'),
(2174, 129, '_список-6_1_ссылка', 'field_624411ce68bd2'),
(2175, 129, 'список-6_1_описание', 'глава «Консервативное лечение ненейрогенных симптомов нарушенного мочеиспускания у мужчин, включая доброкачественную простатическую обструкцию», 2021<sup>29</sup>'),
(2176, 129, '_список-6_1_описание', 'field_6244121168bd3'),
(2177, 129, 'список-6_2_ссылка', 'a:3:{s:5:\"title\";s:154:\"Стандарт первичной медико-санитарной помощи при гиперплазии предстательной железы\";s:3:\"url\";s:1:\"#\";s:6:\"target\";s:0:\"\";}'),
(2178, 129, '_список-6_2_ссылка', 'field_624411ce68bd2'),
(2179, 129, 'список-6_2_описание', '09.11.2012<sup>30</sup> / Обновлён 13.04.2015\r\n'),
(2180, 129, '_список-6_2_описание', 'field_6244121168bd3'),
(2181, 129, 'список-6_3_ссылка', 'a:3:{s:5:\"title\";s:122:\"Стандарт специализированной медицинской помощи при задержке мочи\";s:3:\"url\";s:1:\"#\";s:6:\"target\";s:0:\"\";}'),
(2182, 129, '_список-6_3_ссылка', 'field_624411ce68bd2'),
(2183, 129, 'список-6_3_описание', '29.01.2013<sup>31</sup> / Обновлён 06.05.2015\r\n'),
(2184, 129, '_список-6_3_описание', 'field_6244121168bd3'),
(2185, 129, 'список-6_4_ссылка', 'a:3:{s:5:\"title\";s:133:\"Стандарт первичной медико-санитарной помощи при хроническом простатите\";s:3:\"url\";s:1:\"#\";s:6:\"target\";s:0:\"\";}'),
(2186, 129, '_список-6_4_ссылка', 'field_624411ce68bd2'),
(2187, 129, 'список-6_4_описание', '09.11.2012<sup>32</sup> / Обновлён 13.04.2015\r\n'),
(2188, 129, '_список-6_4_описание', 'field_6244121168bd3'),
(2189, 129, 'список-6_5_ссылка', 'a:3:{s:5:\"title\";s:168:\"Стандарт специализированной медицинской помощи при остром простатите, орхите, эпидидимите\";s:3:\"url\";s:1:\"#\";s:6:\"target\";s:0:\"\";}'),
(2190, 129, '_список-6_5_ссылка', 'field_624411ce68bd2'),
(2191, 129, 'список-6_5_описание', '09.11.2012<sup>33</sup> / Обновлён 27.05.2015'),
(2192, 129, '_список-6_5_описание', 'field_6244121168bd3'),
(2193, 129, 'список-6', '6'),
(2194, 129, '_список-6', 'field_624411be68bd1'),
(2195, 129, 'заголовок-7', 'Препарат Урорек (силодозин) зарегистрирован и&nbsp;применяется в&nbsp;разных странах мира Одобрен ЕМА*<sup>34</sup> и&nbsp;FDA**<sup>35</sup>'),
(2196, 129, '_заголовок-7', 'field_624417e3b6088'),
(2197, 129, 'текст', '<p class=\"sOtherCountries__agency\"><span>EMA</span> Европейское медицинское агентство</p>\r\n<p class=\"sOtherCountries__agency\"><span>FDA</span> Управление по&nbsp;санитарному надзору за&nbsp;качеством пищевых продуктов и&nbsp;медикаментов, США</p>'),
(2198, 129, '_текст', 'field_6244182bb6089'),
(2199, 129, 'страны_0_флаг', '105'),
(2200, 129, '_страны_0_флаг', 'field_62441880b608b'),
(2201, 129, 'страны_0_название', 'Япония'),
(2202, 129, '_страны_0_название', 'field_62441899b608c'),
(2203, 129, 'страны_0_год', '2006<sup>36,37</sup>'),
(2204, 129, '_страны_0_год', 'field_624418aab608d'),
(2205, 129, 'страны_1_флаг', '106'),
(2206, 129, '_страны_1_флаг', 'field_62441880b608b'),
(2207, 129, 'страны_1_название', 'США'),
(2208, 129, '_страны_1_название', 'field_62441899b608c'),
(2209, 129, 'страны_1_год', '2008<sup>35</sup>'),
(2210, 129, '_страны_1_год', 'field_624418aab608d'),
(2211, 129, 'страны_2_флаг', '107'),
(2212, 129, '_страны_2_флаг', 'field_62441880b608b'),
(2213, 129, 'страны_2_название', 'Страны ЕС'),
(2214, 129, '_страны_2_название', 'field_62441899b608c'),
(2215, 129, 'страны_2_год', '2010<sup>34</sup>'),
(2216, 129, '_страны_2_год', 'field_624418aab608d'),
(2217, 129, 'страны_3_флаг', '108'),
(2218, 129, '_страны_3_флаг', 'field_62441880b608b'),
(2219, 129, 'страны_3_название', 'Россия'),
(2220, 129, '_страны_3_название', 'field_62441899b608c'),
(2221, 129, 'страны_3_год', '2010<sup>1</sup>'),
(2222, 129, '_страны_3_год', 'field_624418aab608d'),
(2223, 129, 'страны', '4'),
(2224, 129, '_страны', 'field_62441847b608a'),
(2225, 129, 'текст-7', '<p class=\"sOtherCountries__agency\"><span>EMA</span> Европейское медицинское агентство</p>\r\n<p class=\"sOtherCountries__agency\"><span>FDA</span> Управление по&nbsp;санитарному надзору за&nbsp;качеством пищевых продуктов и&nbsp;медикаментов, США</p>'),
(2226, 129, '_текст-7', 'field_6244182bb6089'),
(2227, 129, 'текст-7-1', 'Производство препарата Урорек, поставляемого в&nbsp;Россию, осуществляется в&nbsp;Италии с&nbsp;использованием субстанции из&nbsp;Японии, в&nbsp;соответствии с&nbsp;необходимыми требованиями к&nbsp;производству и&nbsp;контролю качества<sup>6,1</sup>'),
(2228, 129, '_текст-7-1', 'field_62441a5acf03c'),
(2229, 129, 'заголовок-8', 'О проблеме'),
(2230, 129, '_заголовок-8', 'field_624431d91624d'),
(2231, 129, 'текст-8', 'Доброкачественная гиперплазия предстательной железы (ДГПЖ), или как ее еще называют, аденома простаты, как правило, возникает у мужчин старше 50 лет и характеризуется наличием симптомов нижних мочевыводящих путей (СНМП), увеличением предстательной железы или ее части, и нарушением оттока мочи из мочевого пузыря вследствие инфравезикальной обструкции.<sup>38</sup>\r\n\r\nРаспространенность ДГПЖ увеличивается с возрастом. Так, клинически значимая ДГПЖ проявляется у 13% мужчин в возрасте старше 50 лет, у 34% мужчин в возрасте 60 лет и у 43% в возрасте 70 лет.<sup>39</sup>\r\n\r\n&nbsp;\r\n\r\n<img class=\"alignnone size-medium wp-image-122\" src=\"http://0026urotec.loc:8888/wp-content/uploads/2022/03/about-img-256x300.png\" alt=\"\" width=\"256\" height=\"300\" />'),
(2232, 129, '_текст-8', 'field_624431f11624e'),
(2233, 129, 'текст-8-1', ''),
(2234, 129, '_текст-8-1', 'field_6244320b26db3'),
(2235, 129, 'иконки-8', 'a:6:{i:0;s:3:\"123\";i:1;s:3:\"124\";i:2;s:3:\"125\";i:3;s:3:\"126\";i:4;s:3:\"127\";i:5;s:3:\"128\";}'),
(2236, 129, '_иконки-8', 'field_6244322d26db4'),
(2237, 130, 'заголовок-1', 'УРОРЕК – оригинальный<sup>10</sup> альфа-адреноблокатор'),
(2238, 130, '_заголовок-1', 'field_62435bd26f29f'),
(2239, 130, 'текст-1', '<div class=\"headerBlock__body\">\r\n<p>Силодозин (действующее вещество препарата Урорек) обладает максимальной уроселективностью в&nbsp;своем классе, что обеспечивает его уродинамическую эффективность и&nbsp;высокую безопасность<sup>4</sup></p>\r\n</div>\r\n<div class=\"headerBlock__footer\">\r\n<p><strong>Показания к применению: </strong><br/>Лечение симптомов доброкачественной гиперплазии предстательной железы<sup>6</sup></p>\r\n</div>'),
(2240, 130, '_текст-1', 'field_62435c0c6f2a0'),
(2241, 130, 'изображение-1', '13'),
(2242, 130, '_изображение-1', 'field_62435c8b6f2a1'),
(2243, 130, 'фон-1', '17'),
(2244, 130, '_фон-1', 'field_62435db92ea96'),
(2245, 130, 'заголовок-2', 'Ключевые преимущества препарата Урорек'),
(2246, 130, '_заголовок-2', 'field_6243606295196'),
(2247, 130, 'список-2', 'Единственный оригинальный препарат из&nbsp;группы альфа1-адреноблокаторов, не&nbsp;имеющий генериков в&nbsp;РФ<sup>1</sup>'),
(2248, 130, '_список-2', 'field_6243608195197'),
(2249, 130, 'картинка_с_текстом_0_изображение', '31'),
(2250, 130, '_картинка_с_текстом_0_изображение', 'field_624363d095199'),
(2251, 130, 'картинка_с_текстом_0_описание', 'Обширная доказательная база собственных пострегистрационных клинических исследований<sup>2</sup>'),
(2252, 130, '_картинка_с_текстом_0_описание', 'field_624363e59519a'),
(2253, 130, 'картинка_с_текстом_1_изображение', '32'),
(2254, 130, '_картинка_с_текстом_1_изображение', 'field_624363d095199'),
(2255, 130, 'картинка_с_текстом_1_описание', 'Отсутствие риска замены препарата Урорек в&nbsp;аптеке (единственный препарат с&nbsp;действующим веществом силодозин)<sup>1</sup>'),
(2256, 130, '_картинка_с_текстом_1_описание', 'field_624363e59519a'),
(2257, 130, 'картинка_с_текстом_2_изображение', '33'),
(2258, 130, '_картинка_с_текстом_2_изображение', 'field_624363d095199'),
(2259, 130, 'картинка_с_текстом_2_описание', 'Большинство пациентов предпочитают принимать оригинальные препараты<sup>3</sup>'),
(2260, 130, '_картинка_с_текстом_2_описание', 'field_624363e59519a'),
(2261, 130, 'картинка_с_текстом', '3'),
(2262, 130, '_картинка_с_текстом', 'field_624363b995198'),
(2263, 130, 'второй_список', '<li>Клинические преимущества препарата Урорек (силодозин) определяются максимальной уроселективностью в&nbsp;классе альфа-адреноблокаторов<sup>4</sup></li>\r\n\r\n<li>Урорек&nbsp;&mdash; альфа-адреноблокатор последнего поколения, который эффективен в&nbsp;отношении всех СНМП (накопления, опорожнения, постмиктурических).<sup>12,13</sup> При этом Урорек обладает минимальным риском развития нежелательных явлений со&nbsp;стороны сердечно-сосудистой системы, в&nbsp;том числе&nbsp;у&nbsp;пациентов, принимающих антигипертензивные препараты<sup>46,8</sup> <small> <span>СНМП </span>симптомы нижних мочевыводящих путей</small></li>'),
(2264, 130, '_второй_список', 'field_6243640e05eda'),
(2265, 130, 'заголовок2-2', 'Максимальная уроселективность силодозина в&nbsp;классе альфа-адреноблокаторов обуславливает его уродинамическую эффективность и&nbsp;высокий профиль безопасности<sup>4</sup>'),
(2266, 130, '_заголовок2-2', 'field_6243644705edb'),
(2267, 130, 'текст3', '<ul>\r\n<li>Урорек значительно улучшает клинические проявления и&nbsp;качество жизни у&nbsp;всех пациентов с&nbsp;СНМП/ДГПЖ, в&nbsp;том числе с&nbsp;тяжелым течением<sup>11</sup><a href=\"#\">Узнать больше...</a></li>\r\n\r\n<li>Урорек является препаратом выбора для пациентов с&nbsp;СНМП/ДГПЖ и&nbsp;сопутствующими сердечно-сосудистыми заболеваниями<sup>3</sup> <a href=\"#\">Узнать больше...</a></li>\r\n</ul>\r\n<small> <span>ДГПЖ </span>доброкачественная гиперплазия предстательной железы</small>'),
(2268, 130, '_текст3', 'field_6243647405edc'),
(2269, 130, 'изображение-2', '34'),
(2270, 130, '_изображение-2', 'field_624364dd05edd'),
(2271, 130, 'текст_в_подвале', '<h2> Максимальная уроселективность в&nbsp;классе  альфа-адреноблокаторов<sup>4</sup></h2>\r\n<div class=\"h3\"> Почему это важно? <a href=\"#\">Подробнее</a></div>'),
(2272, 130, '_текст_в_подвале', 'field_62436daf1f6d9'),
(2273, 130, 'заголовок-3', 'Форма выпуска препарата Урорек'),
(2274, 130, '_заголовок-3', 'field_62436efee98e7'),
(2275, 130, 'текст-3', '<p class=\"section-descr\"><span>8мг </span>- рекомендуемая доза для лечения симптомов ДГПЖ<sup>6</sup>*</p>\r\n					<p class=\"section-note col-md-10\">*Более подробные сведения о&nbsp;препарате, особенностях применения, побочных действиях и&nbsp;др. &mdash;&nbsp;смотрите инструкцию по&nbsp;медицинскому применению лекарственного препарата Урорек, РУ&nbsp;ЛСР-005971/10 от&nbsp;25.06.2010 </p>'),
(2276, 130, '_текст-3', 'field_62436f60e98e8'),
(2277, 130, 'товар_0_название', 'Урорек 8мг №30'),
(2278, 130, '_товар_0_название', 'field_62436fcce98ea'),
(2279, 130, 'товар_0_описание', 'Упаковка, рассчитанная на&nbsp;1&nbsp;месяц лечения&nbsp;/ для старта терапии'),
(2280, 130, '_товар_0_описание', 'field_62436fe1e98eb'),
(2281, 130, 'товар_0_лицензия', 'РУ: ЛСР-005971/10 от 25.06.2010'),
(2282, 130, '_товар_0_лицензия', 'field_62436ff0e98ec'),
(2283, 130, 'товар_0_изображение', '51'),
(2284, 130, '_товар_0_изображение', 'field_62437045e98ed'),
(2285, 130, 'товар_1_название', 'Урорек 8мг №90'),
(2286, 130, '_товар_1_название', 'field_62436fcce98ea'),
(2287, 130, 'товар_1_описание', 'Выгодная упаковка, рассчитанная на&nbsp;3&nbsp;месяца лечения. Самая доступная стоимость 1&nbsp;дня терапии препаратом Урорек&nbsp;<sup>27</sup>'),
(2288, 130, '_товар_1_описание', 'field_62436fe1e98eb'),
(2289, 130, 'товар_1_лицензия', 'РУ: ЛСР-005971/10 от 25.06.2010'),
(2290, 130, '_товар_1_лицензия', 'field_62436ff0e98ec'),
(2291, 130, 'товар_1_изображение', '53'),
(2292, 130, '_товар_1_изображение', 'field_62437045e98ed'),
(2293, 130, 'товар_2_название', 'Урорек 4мг №30'),
(2294, 130, '_товар_2_название', 'field_62436fcce98ea'),
(2295, 130, 'товар_2_описание', '4&nbsp;мг&nbsp;&mdash; стартовая упаковка для лечения симптомов ДГПЖ у&nbsp;пациентов с&nbsp;почечной недостаточностью средней степени тяжести<sup>6</sup>'),
(2296, 130, '_товар_2_описание', 'field_62436fe1e98eb'),
(2297, 130, 'товар_2_лицензия', 'РУ: ЛСР-005971/10 от 25.06.2010'),
(2298, 130, '_товар_2_лицензия', 'field_62436ff0e98ec'),
(2299, 130, 'товар_2_изображение', '52'),
(2300, 130, '_товар_2_изображение', 'field_62437045e98ed'),
(2301, 130, 'товар', '3'),
(2302, 130, '_товар', 'field_62436fbde98e9'),
(2303, 130, 'заголовок-4', 'Где купить'),
(2304, 130, '_заголовок-4', 'field_624374f73d8bd'),
(2305, 130, 'изображения', 'a:12:{i:0;s:2:\"63\";i:1;s:2:\"64\";i:2;s:2:\"65\";i:3;s:2:\"66\";i:4;s:2:\"67\";i:5;s:2:\"68\";i:6;s:2:\"69\";i:7;s:2:\"70\";i:8;s:2:\"71\";i:9;s:2:\"72\";i:10;s:2:\"73\";i:11;s:2:\"74\";}'),
(2306, 130, '_изображения', 'field_624375093d8be'),
(2307, 130, 'изображения-4', 'a:12:{i:0;s:2:\"63\";i:1;s:2:\"64\";i:2;s:2:\"65\";i:3;s:2:\"66\";i:4;s:2:\"67\";i:5;s:2:\"68\";i:6;s:2:\"69\";i:7;s:2:\"70\";i:8;s:2:\"71\";i:9;s:2:\"72\";i:10;s:2:\"73\";i:11;s:2:\"74\";}'),
(2308, 130, '_изображения-4', 'field_624375093d8be'),
(2309, 130, 'заголовок-5', 'Способ применения*<sup>6</sup>'),
(2310, 130, '_заголовок-5', 'field_624379bd4756d'),
(2311, 130, 'иконки', 'a:5:{i:0;s:2:\"83\";i:1;s:2:\"84\";i:2;s:2:\"85\";i:3;s:2:\"86\";i:4;s:2:\"87\";}'),
(2312, 130, '_иконки', 'field_624379f24756e'),
(2313, 130, 'текст-5', 'У пациентов с легкой почечной недостаточностью (клиренс креатинина ≥ 50 — ≤ 80 мл/мин) коррекция дозы не требуется. Для лечения пациентов с почечной недостаточностью средней степени тяжести (клиренс креатинина ≥ 30 — < 50 мл/мин) рекомендуется в течение первой недели принимать начальную дозу по 4 мг в сутки, при хорошей индивидуальной переносимости доза может быть увеличена до 8 мг в сутки. Применение препарата для пациентов с тяжелой почечной недостаточностью (клиренс креатинина < 30 мл / мин) не рекомендуется'),
(2314, 130, '_текст-5', 'field_62437a374756f'),
(2315, 130, 'текст_под_кнопкой', '*Более подробные сведения о&nbsp;препарате, особенностях применения, побочных действиях и&nbsp;др. &mdash;&nbsp;см. инструкцию по&nbsp;медицинскому применению лекарственного препарата Урорек, РУ&nbsp;ЛСР-005971/10 от&nbsp;25.06.2010'),
(2316, 130, '_текст_под_кнопкой', 'field_62437a7c47570'),
(2317, 130, 'заголовок-6', 'Препарат Урорек (силодозин) включен в&nbsp;российские и&nbsp;международные клинические рекомендации и&nbsp;стандарты для лечения ряда урологических заболеваний:'),
(2318, 130, '_заголовок-6', 'field_6244117c68bd0'),
(2319, 130, 'список-6_0_ссылка', 'a:3:{s:5:\"title\";s:68:\"Российские клинические рекомендации\";s:3:\"url\";s:1:\"#\";s:6:\"target\";s:0:\"\";}'),
(2320, 130, '_список-6_0_ссылка', 'field_624411ce68bd2'),
(2321, 130, 'список-6_0_описание', '«Доброкачественная гиперплазия предстательной железы», 2020<sup>28</sup>'),
(2322, 130, '_список-6_0_описание', 'field_6244121168bd3'),
(2323, 130, 'список-6_1_ссылка', 'a:3:{s:5:\"title\";s:70:\"Европейские клинические рекомендации\";s:3:\"url\";s:1:\"#\";s:6:\"target\";s:0:\"\";}'),
(2324, 130, '_список-6_1_ссылка', 'field_624411ce68bd2'),
(2325, 130, 'список-6_1_описание', 'глава «Консервативное лечение ненейрогенных симптомов нарушенного мочеиспускания у мужчин, включая доброкачественную простатическую обструкцию», 2021<sup>29</sup>'),
(2326, 130, '_список-6_1_описание', 'field_6244121168bd3'),
(2327, 130, 'список-6_2_ссылка', 'a:3:{s:5:\"title\";s:154:\"Стандарт первичной медико-санитарной помощи при гиперплазии предстательной железы\";s:3:\"url\";s:1:\"#\";s:6:\"target\";s:0:\"\";}'),
(2328, 130, '_список-6_2_ссылка', 'field_624411ce68bd2'),
(2329, 130, 'список-6_2_описание', '09.11.2012<sup>30</sup> / Обновлён 13.04.2015\r\n'),
(2330, 130, '_список-6_2_описание', 'field_6244121168bd3'),
(2331, 130, 'список-6_3_ссылка', 'a:3:{s:5:\"title\";s:122:\"Стандарт специализированной медицинской помощи при задержке мочи\";s:3:\"url\";s:1:\"#\";s:6:\"target\";s:0:\"\";}'),
(2332, 130, '_список-6_3_ссылка', 'field_624411ce68bd2'),
(2333, 130, 'список-6_3_описание', '29.01.2013<sup>31</sup> / Обновлён 06.05.2015\r\n'),
(2334, 130, '_список-6_3_описание', 'field_6244121168bd3'),
(2335, 130, 'список-6_4_ссылка', 'a:3:{s:5:\"title\";s:133:\"Стандарт первичной медико-санитарной помощи при хроническом простатите\";s:3:\"url\";s:1:\"#\";s:6:\"target\";s:0:\"\";}'),
(2336, 130, '_список-6_4_ссылка', 'field_624411ce68bd2'),
(2337, 130, 'список-6_4_описание', '09.11.2012<sup>32</sup> / Обновлён 13.04.2015\r\n'),
(2338, 130, '_список-6_4_описание', 'field_6244121168bd3'),
(2339, 130, 'список-6_5_ссылка', 'a:3:{s:5:\"title\";s:168:\"Стандарт специализированной медицинской помощи при остром простатите, орхите, эпидидимите\";s:3:\"url\";s:1:\"#\";s:6:\"target\";s:0:\"\";}'),
(2340, 130, '_список-6_5_ссылка', 'field_624411ce68bd2'),
(2341, 130, 'список-6_5_описание', '09.11.2012<sup>33</sup> / Обновлён 27.05.2015'),
(2342, 130, '_список-6_5_описание', 'field_6244121168bd3'),
(2343, 130, 'список-6', '6'),
(2344, 130, '_список-6', 'field_624411be68bd1'),
(2345, 130, 'заголовок-7', 'Препарат Урорек (силодозин) зарегистрирован и&nbsp;применяется в&nbsp;разных странах мира Одобрен ЕМА*<sup>34</sup> и&nbsp;FDA**<sup>35</sup>'),
(2346, 130, '_заголовок-7', 'field_624417e3b6088'),
(2347, 130, 'текст', '<p class=\"sOtherCountries__agency\"><span>EMA</span> Европейское медицинское агентство</p>\r\n<p class=\"sOtherCountries__agency\"><span>FDA</span> Управление по&nbsp;санитарному надзору за&nbsp;качеством пищевых продуктов и&nbsp;медикаментов, США</p>'),
(2348, 130, '_текст', 'field_6244182bb6089'),
(2349, 130, 'страны_0_флаг', '105'),
(2350, 130, '_страны_0_флаг', 'field_62441880b608b'),
(2351, 130, 'страны_0_название', 'Япония'),
(2352, 130, '_страны_0_название', 'field_62441899b608c'),
(2353, 130, 'страны_0_год', '2006<sup>36,37</sup>'),
(2354, 130, '_страны_0_год', 'field_624418aab608d'),
(2355, 130, 'страны_1_флаг', '106'),
(2356, 130, '_страны_1_флаг', 'field_62441880b608b'),
(2357, 130, 'страны_1_название', 'США'),
(2358, 130, '_страны_1_название', 'field_62441899b608c'),
(2359, 130, 'страны_1_год', '2008<sup>35</sup>'),
(2360, 130, '_страны_1_год', 'field_624418aab608d'),
(2361, 130, 'страны_2_флаг', '107'),
(2362, 130, '_страны_2_флаг', 'field_62441880b608b'),
(2363, 130, 'страны_2_название', 'Страны ЕС'),
(2364, 130, '_страны_2_название', 'field_62441899b608c'),
(2365, 130, 'страны_2_год', '2010<sup>34</sup>'),
(2366, 130, '_страны_2_год', 'field_624418aab608d'),
(2367, 130, 'страны_3_флаг', '108'),
(2368, 130, '_страны_3_флаг', 'field_62441880b608b'),
(2369, 130, 'страны_3_название', 'Россия'),
(2370, 130, '_страны_3_название', 'field_62441899b608c'),
(2371, 130, 'страны_3_год', '2010<sup>1</sup>'),
(2372, 130, '_страны_3_год', 'field_624418aab608d'),
(2373, 130, 'страны', '4'),
(2374, 130, '_страны', 'field_62441847b608a'),
(2375, 130, 'текст-7', '<p class=\"sOtherCountries__agency\"><span>EMA</span> Европейское медицинское агентство</p>\r\n<p class=\"sOtherCountries__agency\"><span>FDA</span> Управление по&nbsp;санитарному надзору за&nbsp;качеством пищевых продуктов и&nbsp;медикаментов, США</p>'),
(2376, 130, '_текст-7', 'field_6244182bb6089'),
(2377, 130, 'текст-7-1', 'Производство препарата Урорек, поставляемого в&nbsp;Россию, осуществляется в&nbsp;Италии с&nbsp;использованием субстанции из&nbsp;Японии, в&nbsp;соответствии с&nbsp;необходимыми требованиями к&nbsp;производству и&nbsp;контролю качества<sup>6,1</sup>'),
(2378, 130, '_текст-7-1', 'field_62441a5acf03c'),
(2379, 130, 'заголовок-8', 'О проблеме'),
(2380, 130, '_заголовок-8', 'field_624431d91624d'),
(2381, 130, 'текст-8', 'Доброкачественная гиперплазия предстательной железы (ДГПЖ), или как ее еще называют, аденома простаты, как правило, возникает у мужчин старше 50 лет и характеризуется наличием симптомов нижних мочевыводящих путей (СНМП), увеличением предстательной железы или ее части, и нарушением оттока мочи из мочевого пузыря вследствие инфравезикальной обструкции.<sup>38</sup>\r\n\r\nРаспространенность ДГПЖ увеличивается с возрастом. Так, клинически значимая ДГПЖ проявляется у 13% мужчин в возрасте старше 50 лет, у 34% мужчин в возрасте 60 лет и у 43% в возрасте 70 лет.<sup>39</sup>\r\n\r\n&nbsp;\r\n\r\n<img class=\"alignnone size-medium wp-image-122\" src=\"http://0026urotec.loc:8888/wp-content/uploads/2022/03/about-img-256x300.png\" alt=\"\" width=\"256\" height=\"300\" />'),
(2382, 130, '_текст-8', 'field_624431f11624e'),
(2383, 130, 'текст-8-1', 'Наличие СНМП может быть ассоциировано с&nbsp;тяжелыми хроническими заболеваниями, такими как заболевания сердца, сахарный диабет, артериальная гипертензия и&nbsp;депрессия<sup>40</sup>'),
(2384, 130, '_текст-8-1', 'field_6244320b26db3'),
(2385, 130, 'иконки-8', 'a:6:{i:0;s:3:\"123\";i:1;s:3:\"124\";i:2;s:3:\"125\";i:3;s:3:\"126\";i:4;s:3:\"127\";i:5;s:3:\"128\";}'),
(2386, 130, '_иконки-8', 'field_6244322d26db4'),
(2387, 2, 'текст-8-2', '<h3>Симптомы доброкачественной гиперплазии предстательной железы</h3>\r\nСимптомы нарушенного мочеиспускания являются частой жалобой у взрослых мужчин. Они оказывают серьезное негативное влияние на качество жизни. При ДГПЖ предстательная железа увеличивается в размерах, оказывая давление на нижние мочевые пути. В результате развиваются следующие симптомы:<sup>41</sup>'),
(2388, 2, '_текст-8-2', 'field_6244335fe2373'),
(2389, 132, 'заголовок-1', 'УРОРЕК – оригинальный<sup>10</sup> альфа-адреноблокатор'),
(2390, 132, '_заголовок-1', 'field_62435bd26f29f'),
(2391, 132, 'текст-1', '<div class=\"headerBlock__body\">\r\n<p>Силодозин (действующее вещество препарата Урорек) обладает максимальной уроселективностью в&nbsp;своем классе, что обеспечивает его уродинамическую эффективность и&nbsp;высокую безопасность<sup>4</sup></p>\r\n</div>\r\n<div class=\"headerBlock__footer\">\r\n<p><strong>Показания к применению: </strong><br/>Лечение симптомов доброкачественной гиперплазии предстательной железы<sup>6</sup></p>\r\n</div>'),
(2392, 132, '_текст-1', 'field_62435c0c6f2a0'),
(2393, 132, 'изображение-1', '13'),
(2394, 132, '_изображение-1', 'field_62435c8b6f2a1'),
(2395, 132, 'фон-1', '17'),
(2396, 132, '_фон-1', 'field_62435db92ea96'),
(2397, 132, 'заголовок-2', 'Ключевые преимущества препарата Урорек'),
(2398, 132, '_заголовок-2', 'field_6243606295196'),
(2399, 132, 'список-2', 'Единственный оригинальный препарат из&nbsp;группы альфа1-адреноблокаторов, не&nbsp;имеющий генериков в&nbsp;РФ<sup>1</sup>'),
(2400, 132, '_список-2', 'field_6243608195197'),
(2401, 132, 'картинка_с_текстом_0_изображение', '31'),
(2402, 132, '_картинка_с_текстом_0_изображение', 'field_624363d095199'),
(2403, 132, 'картинка_с_текстом_0_описание', 'Обширная доказательная база собственных пострегистрационных клинических исследований<sup>2</sup>');
INSERT INTO `urotec_postmeta` (`meta_id`, `post_id`, `meta_key`, `meta_value`) VALUES
(2404, 132, '_картинка_с_текстом_0_описание', 'field_624363e59519a'),
(2405, 132, 'картинка_с_текстом_1_изображение', '32'),
(2406, 132, '_картинка_с_текстом_1_изображение', 'field_624363d095199'),
(2407, 132, 'картинка_с_текстом_1_описание', 'Отсутствие риска замены препарата Урорек в&nbsp;аптеке (единственный препарат с&nbsp;действующим веществом силодозин)<sup>1</sup>'),
(2408, 132, '_картинка_с_текстом_1_описание', 'field_624363e59519a'),
(2409, 132, 'картинка_с_текстом_2_изображение', '33'),
(2410, 132, '_картинка_с_текстом_2_изображение', 'field_624363d095199'),
(2411, 132, 'картинка_с_текстом_2_описание', 'Большинство пациентов предпочитают принимать оригинальные препараты<sup>3</sup>'),
(2412, 132, '_картинка_с_текстом_2_описание', 'field_624363e59519a'),
(2413, 132, 'картинка_с_текстом', '3'),
(2414, 132, '_картинка_с_текстом', 'field_624363b995198'),
(2415, 132, 'второй_список', '<li>Клинические преимущества препарата Урорек (силодозин) определяются максимальной уроселективностью в&nbsp;классе альфа-адреноблокаторов<sup>4</sup></li>\r\n\r\n<li>Урорек&nbsp;&mdash; альфа-адреноблокатор последнего поколения, который эффективен в&nbsp;отношении всех СНМП (накопления, опорожнения, постмиктурических).<sup>12,13</sup> При этом Урорек обладает минимальным риском развития нежелательных явлений со&nbsp;стороны сердечно-сосудистой системы, в&nbsp;том числе&nbsp;у&nbsp;пациентов, принимающих антигипертензивные препараты<sup>46,8</sup> <small> <span>СНМП </span>симптомы нижних мочевыводящих путей</small></li>'),
(2416, 132, '_второй_список', 'field_6243640e05eda'),
(2417, 132, 'заголовок2-2', 'Максимальная уроселективность силодозина в&nbsp;классе альфа-адреноблокаторов обуславливает его уродинамическую эффективность и&nbsp;высокий профиль безопасности<sup>4</sup>'),
(2418, 132, '_заголовок2-2', 'field_6243644705edb'),
(2419, 132, 'текст3', '<ul>\r\n<li>Урорек значительно улучшает клинические проявления и&nbsp;качество жизни у&nbsp;всех пациентов с&nbsp;СНМП/ДГПЖ, в&nbsp;том числе с&nbsp;тяжелым течением<sup>11</sup><a href=\"#\">Узнать больше...</a></li>\r\n\r\n<li>Урорек является препаратом выбора для пациентов с&nbsp;СНМП/ДГПЖ и&nbsp;сопутствующими сердечно-сосудистыми заболеваниями<sup>3</sup> <a href=\"#\">Узнать больше...</a></li>\r\n</ul>\r\n<small> <span>ДГПЖ </span>доброкачественная гиперплазия предстательной железы</small>'),
(2420, 132, '_текст3', 'field_6243647405edc'),
(2421, 132, 'изображение-2', '34'),
(2422, 132, '_изображение-2', 'field_624364dd05edd'),
(2423, 132, 'текст_в_подвале', '<h2> Максимальная уроселективность в&nbsp;классе  альфа-адреноблокаторов<sup>4</sup></h2>\r\n<div class=\"h3\"> Почему это важно? <a href=\"#\">Подробнее</a></div>'),
(2424, 132, '_текст_в_подвале', 'field_62436daf1f6d9'),
(2425, 132, 'заголовок-3', 'Форма выпуска препарата Урорек'),
(2426, 132, '_заголовок-3', 'field_62436efee98e7'),
(2427, 132, 'текст-3', '<p class=\"section-descr\"><span>8мг </span>- рекомендуемая доза для лечения симптомов ДГПЖ<sup>6</sup>*</p>\r\n					<p class=\"section-note col-md-10\">*Более подробные сведения о&nbsp;препарате, особенностях применения, побочных действиях и&nbsp;др. &mdash;&nbsp;смотрите инструкцию по&nbsp;медицинскому применению лекарственного препарата Урорек, РУ&nbsp;ЛСР-005971/10 от&nbsp;25.06.2010 </p>'),
(2428, 132, '_текст-3', 'field_62436f60e98e8'),
(2429, 132, 'товар_0_название', 'Урорек 8мг №30'),
(2430, 132, '_товар_0_название', 'field_62436fcce98ea'),
(2431, 132, 'товар_0_описание', 'Упаковка, рассчитанная на&nbsp;1&nbsp;месяц лечения&nbsp;/ для старта терапии'),
(2432, 132, '_товар_0_описание', 'field_62436fe1e98eb'),
(2433, 132, 'товар_0_лицензия', 'РУ: ЛСР-005971/10 от 25.06.2010'),
(2434, 132, '_товар_0_лицензия', 'field_62436ff0e98ec'),
(2435, 132, 'товар_0_изображение', '51'),
(2436, 132, '_товар_0_изображение', 'field_62437045e98ed'),
(2437, 132, 'товар_1_название', 'Урорек 8мг №90'),
(2438, 132, '_товар_1_название', 'field_62436fcce98ea'),
(2439, 132, 'товар_1_описание', 'Выгодная упаковка, рассчитанная на&nbsp;3&nbsp;месяца лечения. Самая доступная стоимость 1&nbsp;дня терапии препаратом Урорек&nbsp;<sup>27</sup>'),
(2440, 132, '_товар_1_описание', 'field_62436fe1e98eb'),
(2441, 132, 'товар_1_лицензия', 'РУ: ЛСР-005971/10 от 25.06.2010'),
(2442, 132, '_товар_1_лицензия', 'field_62436ff0e98ec'),
(2443, 132, 'товар_1_изображение', '53'),
(2444, 132, '_товар_1_изображение', 'field_62437045e98ed'),
(2445, 132, 'товар_2_название', 'Урорек 4мг №30'),
(2446, 132, '_товар_2_название', 'field_62436fcce98ea'),
(2447, 132, 'товар_2_описание', '4&nbsp;мг&nbsp;&mdash; стартовая упаковка для лечения симптомов ДГПЖ у&nbsp;пациентов с&nbsp;почечной недостаточностью средней степени тяжести<sup>6</sup>'),
(2448, 132, '_товар_2_описание', 'field_62436fe1e98eb'),
(2449, 132, 'товар_2_лицензия', 'РУ: ЛСР-005971/10 от 25.06.2010'),
(2450, 132, '_товар_2_лицензия', 'field_62436ff0e98ec'),
(2451, 132, 'товар_2_изображение', '52'),
(2452, 132, '_товар_2_изображение', 'field_62437045e98ed'),
(2453, 132, 'товар', '3'),
(2454, 132, '_товар', 'field_62436fbde98e9'),
(2455, 132, 'заголовок-4', 'Где купить'),
(2456, 132, '_заголовок-4', 'field_624374f73d8bd'),
(2457, 132, 'изображения', 'a:12:{i:0;s:2:\"63\";i:1;s:2:\"64\";i:2;s:2:\"65\";i:3;s:2:\"66\";i:4;s:2:\"67\";i:5;s:2:\"68\";i:6;s:2:\"69\";i:7;s:2:\"70\";i:8;s:2:\"71\";i:9;s:2:\"72\";i:10;s:2:\"73\";i:11;s:2:\"74\";}'),
(2458, 132, '_изображения', 'field_624375093d8be'),
(2459, 132, 'изображения-4', 'a:12:{i:0;s:2:\"63\";i:1;s:2:\"64\";i:2;s:2:\"65\";i:3;s:2:\"66\";i:4;s:2:\"67\";i:5;s:2:\"68\";i:6;s:2:\"69\";i:7;s:2:\"70\";i:8;s:2:\"71\";i:9;s:2:\"72\";i:10;s:2:\"73\";i:11;s:2:\"74\";}'),
(2460, 132, '_изображения-4', 'field_624375093d8be'),
(2461, 132, 'заголовок-5', 'Способ применения*<sup>6</sup>'),
(2462, 132, '_заголовок-5', 'field_624379bd4756d'),
(2463, 132, 'иконки', 'a:5:{i:0;s:2:\"83\";i:1;s:2:\"84\";i:2;s:2:\"85\";i:3;s:2:\"86\";i:4;s:2:\"87\";}'),
(2464, 132, '_иконки', 'field_624379f24756e'),
(2465, 132, 'текст-5', 'У пациентов с легкой почечной недостаточностью (клиренс креатинина ≥ 50 — ≤ 80 мл/мин) коррекция дозы не требуется. Для лечения пациентов с почечной недостаточностью средней степени тяжести (клиренс креатинина ≥ 30 — < 50 мл/мин) рекомендуется в течение первой недели принимать начальную дозу по 4 мг в сутки, при хорошей индивидуальной переносимости доза может быть увеличена до 8 мг в сутки. Применение препарата для пациентов с тяжелой почечной недостаточностью (клиренс креатинина < 30 мл / мин) не рекомендуется'),
(2466, 132, '_текст-5', 'field_62437a374756f'),
(2467, 132, 'текст_под_кнопкой', '*Более подробные сведения о&nbsp;препарате, особенностях применения, побочных действиях и&nbsp;др. &mdash;&nbsp;см. инструкцию по&nbsp;медицинскому применению лекарственного препарата Урорек, РУ&nbsp;ЛСР-005971/10 от&nbsp;25.06.2010'),
(2468, 132, '_текст_под_кнопкой', 'field_62437a7c47570'),
(2469, 132, 'заголовок-6', 'Препарат Урорек (силодозин) включен в&nbsp;российские и&nbsp;международные клинические рекомендации и&nbsp;стандарты для лечения ряда урологических заболеваний:'),
(2470, 132, '_заголовок-6', 'field_6244117c68bd0'),
(2471, 132, 'список-6_0_ссылка', 'a:3:{s:5:\"title\";s:68:\"Российские клинические рекомендации\";s:3:\"url\";s:1:\"#\";s:6:\"target\";s:0:\"\";}'),
(2472, 132, '_список-6_0_ссылка', 'field_624411ce68bd2'),
(2473, 132, 'список-6_0_описание', '«Доброкачественная гиперплазия предстательной железы», 2020<sup>28</sup>'),
(2474, 132, '_список-6_0_описание', 'field_6244121168bd3'),
(2475, 132, 'список-6_1_ссылка', 'a:3:{s:5:\"title\";s:70:\"Европейские клинические рекомендации\";s:3:\"url\";s:1:\"#\";s:6:\"target\";s:0:\"\";}'),
(2476, 132, '_список-6_1_ссылка', 'field_624411ce68bd2'),
(2477, 132, 'список-6_1_описание', 'глава «Консервативное лечение ненейрогенных симптомов нарушенного мочеиспускания у мужчин, включая доброкачественную простатическую обструкцию», 2021<sup>29</sup>'),
(2478, 132, '_список-6_1_описание', 'field_6244121168bd3'),
(2479, 132, 'список-6_2_ссылка', 'a:3:{s:5:\"title\";s:154:\"Стандарт первичной медико-санитарной помощи при гиперплазии предстательной железы\";s:3:\"url\";s:1:\"#\";s:6:\"target\";s:0:\"\";}'),
(2480, 132, '_список-6_2_ссылка', 'field_624411ce68bd2'),
(2481, 132, 'список-6_2_описание', '09.11.2012<sup>30</sup> / Обновлён 13.04.2015\r\n'),
(2482, 132, '_список-6_2_описание', 'field_6244121168bd3'),
(2483, 132, 'список-6_3_ссылка', 'a:3:{s:5:\"title\";s:122:\"Стандарт специализированной медицинской помощи при задержке мочи\";s:3:\"url\";s:1:\"#\";s:6:\"target\";s:0:\"\";}'),
(2484, 132, '_список-6_3_ссылка', 'field_624411ce68bd2'),
(2485, 132, 'список-6_3_описание', '29.01.2013<sup>31</sup> / Обновлён 06.05.2015\r\n'),
(2486, 132, '_список-6_3_описание', 'field_6244121168bd3'),
(2487, 132, 'список-6_4_ссылка', 'a:3:{s:5:\"title\";s:133:\"Стандарт первичной медико-санитарной помощи при хроническом простатите\";s:3:\"url\";s:1:\"#\";s:6:\"target\";s:0:\"\";}'),
(2488, 132, '_список-6_4_ссылка', 'field_624411ce68bd2'),
(2489, 132, 'список-6_4_описание', '09.11.2012<sup>32</sup> / Обновлён 13.04.2015\r\n'),
(2490, 132, '_список-6_4_описание', 'field_6244121168bd3'),
(2491, 132, 'список-6_5_ссылка', 'a:3:{s:5:\"title\";s:168:\"Стандарт специализированной медицинской помощи при остром простатите, орхите, эпидидимите\";s:3:\"url\";s:1:\"#\";s:6:\"target\";s:0:\"\";}'),
(2492, 132, '_список-6_5_ссылка', 'field_624411ce68bd2'),
(2493, 132, 'список-6_5_описание', '09.11.2012<sup>33</sup> / Обновлён 27.05.2015'),
(2494, 132, '_список-6_5_описание', 'field_6244121168bd3'),
(2495, 132, 'список-6', '6'),
(2496, 132, '_список-6', 'field_624411be68bd1'),
(2497, 132, 'заголовок-7', 'Препарат Урорек (силодозин) зарегистрирован и&nbsp;применяется в&nbsp;разных странах мира Одобрен ЕМА*<sup>34</sup> и&nbsp;FDA**<sup>35</sup>'),
(2498, 132, '_заголовок-7', 'field_624417e3b6088'),
(2499, 132, 'текст', '<p class=\"sOtherCountries__agency\"><span>EMA</span> Европейское медицинское агентство</p>\r\n<p class=\"sOtherCountries__agency\"><span>FDA</span> Управление по&nbsp;санитарному надзору за&nbsp;качеством пищевых продуктов и&nbsp;медикаментов, США</p>'),
(2500, 132, '_текст', 'field_6244182bb6089'),
(2501, 132, 'страны_0_флаг', '105'),
(2502, 132, '_страны_0_флаг', 'field_62441880b608b'),
(2503, 132, 'страны_0_название', 'Япония'),
(2504, 132, '_страны_0_название', 'field_62441899b608c'),
(2505, 132, 'страны_0_год', '2006<sup>36,37</sup>'),
(2506, 132, '_страны_0_год', 'field_624418aab608d'),
(2507, 132, 'страны_1_флаг', '106'),
(2508, 132, '_страны_1_флаг', 'field_62441880b608b'),
(2509, 132, 'страны_1_название', 'США'),
(2510, 132, '_страны_1_название', 'field_62441899b608c'),
(2511, 132, 'страны_1_год', '2008<sup>35</sup>'),
(2512, 132, '_страны_1_год', 'field_624418aab608d'),
(2513, 132, 'страны_2_флаг', '107'),
(2514, 132, '_страны_2_флаг', 'field_62441880b608b'),
(2515, 132, 'страны_2_название', 'Страны ЕС'),
(2516, 132, '_страны_2_название', 'field_62441899b608c'),
(2517, 132, 'страны_2_год', '2010<sup>34</sup>'),
(2518, 132, '_страны_2_год', 'field_624418aab608d'),
(2519, 132, 'страны_3_флаг', '108'),
(2520, 132, '_страны_3_флаг', 'field_62441880b608b'),
(2521, 132, 'страны_3_название', 'Россия'),
(2522, 132, '_страны_3_название', 'field_62441899b608c'),
(2523, 132, 'страны_3_год', '2010<sup>1</sup>'),
(2524, 132, '_страны_3_год', 'field_624418aab608d'),
(2525, 132, 'страны', '4'),
(2526, 132, '_страны', 'field_62441847b608a'),
(2527, 132, 'текст-7', '<p class=\"sOtherCountries__agency\"><span>EMA</span> Европейское медицинское агентство</p>\r\n<p class=\"sOtherCountries__agency\"><span>FDA</span> Управление по&nbsp;санитарному надзору за&nbsp;качеством пищевых продуктов и&nbsp;медикаментов, США</p>'),
(2528, 132, '_текст-7', 'field_6244182bb6089'),
(2529, 132, 'текст-7-1', 'Производство препарата Урорек, поставляемого в&nbsp;Россию, осуществляется в&nbsp;Италии с&nbsp;использованием субстанции из&nbsp;Японии, в&nbsp;соответствии с&nbsp;необходимыми требованиями к&nbsp;производству и&nbsp;контролю качества<sup>6,1</sup>'),
(2530, 132, '_текст-7-1', 'field_62441a5acf03c'),
(2531, 132, 'заголовок-8', 'О проблеме'),
(2532, 132, '_заголовок-8', 'field_624431d91624d'),
(2533, 132, 'текст-8', 'Доброкачественная гиперплазия предстательной железы (ДГПЖ), или как ее еще называют, аденома простаты, как правило, возникает у мужчин старше 50 лет и характеризуется наличием симптомов нижних мочевыводящих путей (СНМП), увеличением предстательной железы или ее части, и нарушением оттока мочи из мочевого пузыря вследствие инфравезикальной обструкции.<sup>38</sup>\r\n\r\nРаспространенность ДГПЖ увеличивается с возрастом. Так, клинически значимая ДГПЖ проявляется у 13% мужчин в возрасте старше 50 лет, у 34% мужчин в возрасте 60 лет и у 43% в возрасте 70 лет.<sup>39</sup>\r\n\r\n&nbsp;\r\n\r\n<img class=\"alignnone size-medium wp-image-122\" src=\"http://0026urotec.loc:8888/wp-content/uploads/2022/03/about-img-256x300.png\" alt=\"\" width=\"256\" height=\"300\" />'),
(2534, 132, '_текст-8', 'field_624431f11624e'),
(2535, 132, 'текст-8-1', 'Наличие СНМП может быть ассоциировано с&nbsp;тяжелыми хроническими заболеваниями, такими как заболевания сердца, сахарный диабет, артериальная гипертензия и&nbsp;депрессия<sup>40</sup>'),
(2536, 132, '_текст-8-1', 'field_6244320b26db3'),
(2537, 132, 'иконки-8', 'a:6:{i:0;s:3:\"123\";i:1;s:3:\"124\";i:2;s:3:\"125\";i:3;s:3:\"126\";i:4;s:3:\"127\";i:5;s:3:\"128\";}'),
(2538, 132, '_иконки-8', 'field_6244322d26db4'),
(2539, 132, 'текст-8-2', '<h3>Симптомы доброкачественной гиперплазии предстательной железы</h3>\r\nСимптомы нарушенного мочеиспускания являются частой жалобой у взрослых мужчин. Они оказывают серьезное негативное влияние на качество жизни. При ДГПЖ предстательная железа увеличивается в размерах, оказывая давление на нижние мочевые пути. В результате развиваются следующие симптомы:<sup>41</sup>'),
(2540, 132, '_текст-8-2', 'field_6244335fe2373'),
(2541, 133, 'заголовок-1', 'УРОРЕК – оригинальный<sup>10</sup> альфа-адреноблокатор'),
(2542, 133, '_заголовок-1', 'field_62435bd26f29f'),
(2543, 133, 'текст-1', '<div class=\"headerBlock__body\">\r\n<p>Силодозин (действующее вещество препарата Урорек) обладает максимальной уроселективностью в&nbsp;своем классе, что обеспечивает его уродинамическую эффективность и&nbsp;высокую безопасность<sup>4</sup></p>\r\n</div>\r\n<div class=\"headerBlock__footer\">\r\n<p><strong>Показания к применению: </strong><br/>Лечение симптомов доброкачественной гиперплазии предстательной железы<sup>6</sup></p>\r\n</div>'),
(2544, 133, '_текст-1', 'field_62435c0c6f2a0'),
(2545, 133, 'изображение-1', '13'),
(2546, 133, '_изображение-1', 'field_62435c8b6f2a1'),
(2547, 133, 'фон-1', '17'),
(2548, 133, '_фон-1', 'field_62435db92ea96'),
(2549, 133, 'заголовок-2', 'Ключевые преимущества препарата Урорек'),
(2550, 133, '_заголовок-2', 'field_6243606295196'),
(2551, 133, 'список-2', 'Единственный оригинальный препарат из&nbsp;группы альфа1-адреноблокаторов, не&nbsp;имеющий генериков в&nbsp;РФ<sup>1</sup>'),
(2552, 133, '_список-2', 'field_6243608195197'),
(2553, 133, 'картинка_с_текстом_0_изображение', '31'),
(2554, 133, '_картинка_с_текстом_0_изображение', 'field_624363d095199'),
(2555, 133, 'картинка_с_текстом_0_описание', 'Обширная доказательная база собственных пострегистрационных клинических исследований<sup>2</sup>'),
(2556, 133, '_картинка_с_текстом_0_описание', 'field_624363e59519a'),
(2557, 133, 'картинка_с_текстом_1_изображение', '32'),
(2558, 133, '_картинка_с_текстом_1_изображение', 'field_624363d095199'),
(2559, 133, 'картинка_с_текстом_1_описание', 'Отсутствие риска замены препарата Урорек в&nbsp;аптеке (единственный препарат с&nbsp;действующим веществом силодозин)<sup>1</sup>'),
(2560, 133, '_картинка_с_текстом_1_описание', 'field_624363e59519a'),
(2561, 133, 'картинка_с_текстом_2_изображение', '33'),
(2562, 133, '_картинка_с_текстом_2_изображение', 'field_624363d095199'),
(2563, 133, 'картинка_с_текстом_2_описание', 'Большинство пациентов предпочитают принимать оригинальные препараты<sup>3</sup>'),
(2564, 133, '_картинка_с_текстом_2_описание', 'field_624363e59519a'),
(2565, 133, 'картинка_с_текстом', '3'),
(2566, 133, '_картинка_с_текстом', 'field_624363b995198'),
(2567, 133, 'второй_список', '<li>Клинические преимущества препарата Урорек (силодозин) определяются максимальной уроселективностью в&nbsp;классе альфа-адреноблокаторов<sup>4</sup></li>\r\n\r\n<li>Урорек&nbsp;&mdash; альфа-адреноблокатор последнего поколения, который эффективен в&nbsp;отношении всех СНМП (накопления, опорожнения, постмиктурических).<sup>12,13</sup> При этом Урорек обладает минимальным риском развития нежелательных явлений со&nbsp;стороны сердечно-сосудистой системы, в&nbsp;том числе&nbsp;у&nbsp;пациентов, принимающих антигипертензивные препараты<sup>46,8</sup> <small> <span>СНМП </span>симптомы нижних мочевыводящих путей</small></li>'),
(2568, 133, '_второй_список', 'field_6243640e05eda'),
(2569, 133, 'заголовок2-2', 'Максимальная уроселективность силодозина в&nbsp;классе альфа-адреноблокаторов обуславливает его уродинамическую эффективность и&nbsp;высокий профиль безопасности<sup>4</sup>'),
(2570, 133, '_заголовок2-2', 'field_6243644705edb'),
(2571, 133, 'текст3', '<ul>\r\n<li>Урорек значительно улучшает клинические проявления и&nbsp;качество жизни у&nbsp;всех пациентов с&nbsp;СНМП/ДГПЖ, в&nbsp;том числе с&nbsp;тяжелым течением<sup>11</sup><a href=\"#\">Узнать больше...</a></li>\r\n\r\n<li>Урорек является препаратом выбора для пациентов с&nbsp;СНМП/ДГПЖ и&nbsp;сопутствующими сердечно-сосудистыми заболеваниями<sup>3</sup> <a href=\"#\">Узнать больше...</a></li>\r\n</ul>\r\n<small> <span>ДГПЖ </span>доброкачественная гиперплазия предстательной железы</small>'),
(2572, 133, '_текст3', 'field_6243647405edc'),
(2573, 133, 'изображение-2', '34'),
(2574, 133, '_изображение-2', 'field_624364dd05edd'),
(2575, 133, 'текст_в_подвале', '<h2> Максимальная уроселективность в&nbsp;классе  альфа-адреноблокаторов<sup>4</sup></h2>\r\n<div class=\"h3\"> Почему это важно? <a href=\"#\">Подробнее</a></div>'),
(2576, 133, '_текст_в_подвале', 'field_62436daf1f6d9'),
(2577, 133, 'заголовок-3', 'Форма выпуска препарата Урорек'),
(2578, 133, '_заголовок-3', 'field_62436efee98e7'),
(2579, 133, 'текст-3', '<p class=\"section-descr\"><span>8мг </span>- рекомендуемая доза для лечения симптомов ДГПЖ<sup>6</sup>*</p>\r\n					<p class=\"section-note col-md-10\">*Более подробные сведения о&nbsp;препарате, особенностях применения, побочных действиях и&nbsp;др. &mdash;&nbsp;смотрите инструкцию по&nbsp;медицинскому применению лекарственного препарата Урорек, РУ&nbsp;ЛСР-005971/10 от&nbsp;25.06.2010 </p>'),
(2580, 133, '_текст-3', 'field_62436f60e98e8'),
(2581, 133, 'товар_0_название', 'Урорек 8мг №30'),
(2582, 133, '_товар_0_название', 'field_62436fcce98ea'),
(2583, 133, 'товар_0_описание', 'Упаковка, рассчитанная на&nbsp;1&nbsp;месяц лечения&nbsp;/ для старта терапии'),
(2584, 133, '_товар_0_описание', 'field_62436fe1e98eb'),
(2585, 133, 'товар_0_лицензия', 'РУ: ЛСР-005971/10 от 25.06.2010'),
(2586, 133, '_товар_0_лицензия', 'field_62436ff0e98ec'),
(2587, 133, 'товар_0_изображение', '51'),
(2588, 133, '_товар_0_изображение', 'field_62437045e98ed'),
(2589, 133, 'товар_1_название', 'Урорек 8мг №90'),
(2590, 133, '_товар_1_название', 'field_62436fcce98ea'),
(2591, 133, 'товар_1_описание', 'Выгодная упаковка, рассчитанная на&nbsp;3&nbsp;месяца лечения. Самая доступная стоимость 1&nbsp;дня терапии препаратом Урорек&nbsp;<sup>27</sup>'),
(2592, 133, '_товар_1_описание', 'field_62436fe1e98eb'),
(2593, 133, 'товар_1_лицензия', 'РУ: ЛСР-005971/10 от 25.06.2010'),
(2594, 133, '_товар_1_лицензия', 'field_62436ff0e98ec'),
(2595, 133, 'товар_1_изображение', '53'),
(2596, 133, '_товар_1_изображение', 'field_62437045e98ed'),
(2597, 133, 'товар_2_название', 'Урорек 4мг №30'),
(2598, 133, '_товар_2_название', 'field_62436fcce98ea'),
(2599, 133, 'товар_2_описание', '4&nbsp;мг&nbsp;&mdash; стартовая упаковка для лечения симптомов ДГПЖ у&nbsp;пациентов с&nbsp;почечной недостаточностью средней степени тяжести<sup>6</sup>'),
(2600, 133, '_товар_2_описание', 'field_62436fe1e98eb'),
(2601, 133, 'товар_2_лицензия', 'РУ: ЛСР-005971/10 от 25.06.2010'),
(2602, 133, '_товар_2_лицензия', 'field_62436ff0e98ec'),
(2603, 133, 'товар_2_изображение', '52'),
(2604, 133, '_товар_2_изображение', 'field_62437045e98ed'),
(2605, 133, 'товар', '3'),
(2606, 133, '_товар', 'field_62436fbde98e9'),
(2607, 133, 'заголовок-4', 'Где купить'),
(2608, 133, '_заголовок-4', 'field_624374f73d8bd'),
(2609, 133, 'изображения', 'a:12:{i:0;s:2:\"63\";i:1;s:2:\"64\";i:2;s:2:\"65\";i:3;s:2:\"66\";i:4;s:2:\"67\";i:5;s:2:\"68\";i:6;s:2:\"69\";i:7;s:2:\"70\";i:8;s:2:\"71\";i:9;s:2:\"72\";i:10;s:2:\"73\";i:11;s:2:\"74\";}'),
(2610, 133, '_изображения', 'field_624375093d8be'),
(2611, 133, 'изображения-4', 'a:12:{i:0;s:2:\"63\";i:1;s:2:\"64\";i:2;s:2:\"65\";i:3;s:2:\"66\";i:4;s:2:\"67\";i:5;s:2:\"68\";i:6;s:2:\"69\";i:7;s:2:\"70\";i:8;s:2:\"71\";i:9;s:2:\"72\";i:10;s:2:\"73\";i:11;s:2:\"74\";}'),
(2612, 133, '_изображения-4', 'field_624375093d8be'),
(2613, 133, 'заголовок-5', 'Способ применения*<sup>6</sup>'),
(2614, 133, '_заголовок-5', 'field_624379bd4756d'),
(2615, 133, 'иконки', 'a:5:{i:0;s:2:\"83\";i:1;s:2:\"84\";i:2;s:2:\"85\";i:3;s:2:\"86\";i:4;s:2:\"87\";}'),
(2616, 133, '_иконки', 'field_624379f24756e'),
(2617, 133, 'текст-5', 'У пациентов с легкой почечной недостаточностью (клиренс креатинина ≥ 50 — ≤ 80 мл/мин) коррекция дозы не требуется. Для лечения пациентов с почечной недостаточностью средней степени тяжести (клиренс креатинина ≥ 30 — < 50 мл/мин) рекомендуется в течение первой недели принимать начальную дозу по 4 мг в сутки, при хорошей индивидуальной переносимости доза может быть увеличена до 8 мг в сутки. Применение препарата для пациентов с тяжелой почечной недостаточностью (клиренс креатинина < 30 мл / мин) не рекомендуется'),
(2618, 133, '_текст-5', 'field_62437a374756f'),
(2619, 133, 'текст_под_кнопкой', '*Более подробные сведения о&nbsp;препарате, особенностях применения, побочных действиях и&nbsp;др. &mdash;&nbsp;см. инструкцию по&nbsp;медицинскому применению лекарственного препарата Урорек, РУ&nbsp;ЛСР-005971/10 от&nbsp;25.06.2010'),
(2620, 133, '_текст_под_кнопкой', 'field_62437a7c47570'),
(2621, 133, 'заголовок-6', 'Препарат Урорек (силодозин) включен в&nbsp;российские и&nbsp;международные клинические рекомендации и&nbsp;стандарты для лечения ряда урологических заболеваний:'),
(2622, 133, '_заголовок-6', 'field_6244117c68bd0'),
(2623, 133, 'список-6_0_ссылка', 'a:3:{s:5:\"title\";s:68:\"Российские клинические рекомендации\";s:3:\"url\";s:1:\"#\";s:6:\"target\";s:0:\"\";}'),
(2624, 133, '_список-6_0_ссылка', 'field_624411ce68bd2'),
(2625, 133, 'список-6_0_описание', '«Доброкачественная гиперплазия предстательной железы», 2020<sup>28</sup>'),
(2626, 133, '_список-6_0_описание', 'field_6244121168bd3'),
(2627, 133, 'список-6_1_ссылка', 'a:3:{s:5:\"title\";s:70:\"Европейские клинические рекомендации\";s:3:\"url\";s:1:\"#\";s:6:\"target\";s:0:\"\";}'),
(2628, 133, '_список-6_1_ссылка', 'field_624411ce68bd2'),
(2629, 133, 'список-6_1_описание', 'глава «Консервативное лечение ненейрогенных симптомов нарушенного мочеиспускания у мужчин, включая доброкачественную простатическую обструкцию», 2021<sup>29</sup>'),
(2630, 133, '_список-6_1_описание', 'field_6244121168bd3'),
(2631, 133, 'список-6_2_ссылка', 'a:3:{s:5:\"title\";s:154:\"Стандарт первичной медико-санитарной помощи при гиперплазии предстательной железы\";s:3:\"url\";s:1:\"#\";s:6:\"target\";s:0:\"\";}'),
(2632, 133, '_список-6_2_ссылка', 'field_624411ce68bd2'),
(2633, 133, 'список-6_2_описание', '09.11.2012<sup>30</sup> / Обновлён 13.04.2015\r\n'),
(2634, 133, '_список-6_2_описание', 'field_6244121168bd3'),
(2635, 133, 'список-6_3_ссылка', 'a:3:{s:5:\"title\";s:122:\"Стандарт специализированной медицинской помощи при задержке мочи\";s:3:\"url\";s:1:\"#\";s:6:\"target\";s:0:\"\";}'),
(2636, 133, '_список-6_3_ссылка', 'field_624411ce68bd2'),
(2637, 133, 'список-6_3_описание', '29.01.2013<sup>31</sup> / Обновлён 06.05.2015\r\n'),
(2638, 133, '_список-6_3_описание', 'field_6244121168bd3'),
(2639, 133, 'список-6_4_ссылка', 'a:3:{s:5:\"title\";s:133:\"Стандарт первичной медико-санитарной помощи при хроническом простатите\";s:3:\"url\";s:1:\"#\";s:6:\"target\";s:0:\"\";}'),
(2640, 133, '_список-6_4_ссылка', 'field_624411ce68bd2'),
(2641, 133, 'список-6_4_описание', '09.11.2012<sup>32</sup> / Обновлён 13.04.2015\r\n'),
(2642, 133, '_список-6_4_описание', 'field_6244121168bd3'),
(2643, 133, 'список-6_5_ссылка', 'a:3:{s:5:\"title\";s:168:\"Стандарт специализированной медицинской помощи при остром простатите, орхите, эпидидимите\";s:3:\"url\";s:1:\"#\";s:6:\"target\";s:0:\"\";}'),
(2644, 133, '_список-6_5_ссылка', 'field_624411ce68bd2'),
(2645, 133, 'список-6_5_описание', '09.11.2012<sup>33</sup> / Обновлён 27.05.2015'),
(2646, 133, '_список-6_5_описание', 'field_6244121168bd3'),
(2647, 133, 'список-6', '6'),
(2648, 133, '_список-6', 'field_624411be68bd1'),
(2649, 133, 'заголовок-7', 'Препарат Урорек (силодозин) зарегистрирован и&nbsp;применяется в&nbsp;разных странах мира Одобрен ЕМА*<sup>34</sup> и&nbsp;FDA**<sup>35</sup>'),
(2650, 133, '_заголовок-7', 'field_624417e3b6088'),
(2651, 133, 'текст', '<p class=\"sOtherCountries__agency\"><span>EMA</span> Европейское медицинское агентство</p>\r\n<p class=\"sOtherCountries__agency\"><span>FDA</span> Управление по&nbsp;санитарному надзору за&nbsp;качеством пищевых продуктов и&nbsp;медикаментов, США</p>'),
(2652, 133, '_текст', 'field_6244182bb6089'),
(2653, 133, 'страны_0_флаг', '105'),
(2654, 133, '_страны_0_флаг', 'field_62441880b608b'),
(2655, 133, 'страны_0_название', 'Япония'),
(2656, 133, '_страны_0_название', 'field_62441899b608c'),
(2657, 133, 'страны_0_год', '2006<sup>36,37</sup>'),
(2658, 133, '_страны_0_год', 'field_624418aab608d'),
(2659, 133, 'страны_1_флаг', '106'),
(2660, 133, '_страны_1_флаг', 'field_62441880b608b'),
(2661, 133, 'страны_1_название', 'США'),
(2662, 133, '_страны_1_название', 'field_62441899b608c'),
(2663, 133, 'страны_1_год', '2008<sup>35</sup>'),
(2664, 133, '_страны_1_год', 'field_624418aab608d'),
(2665, 133, 'страны_2_флаг', '107'),
(2666, 133, '_страны_2_флаг', 'field_62441880b608b'),
(2667, 133, 'страны_2_название', 'Страны ЕС'),
(2668, 133, '_страны_2_название', 'field_62441899b608c'),
(2669, 133, 'страны_2_год', '2010<sup>34</sup>'),
(2670, 133, '_страны_2_год', 'field_624418aab608d'),
(2671, 133, 'страны_3_флаг', '108'),
(2672, 133, '_страны_3_флаг', 'field_62441880b608b'),
(2673, 133, 'страны_3_название', 'Россия'),
(2674, 133, '_страны_3_название', 'field_62441899b608c'),
(2675, 133, 'страны_3_год', '2010<sup>1</sup>'),
(2676, 133, '_страны_3_год', 'field_624418aab608d'),
(2677, 133, 'страны', '4'),
(2678, 133, '_страны', 'field_62441847b608a'),
(2679, 133, 'текст-7', '<p class=\"sOtherCountries__agency\"><span>EMA</span> Европейское медицинское агентство</p>\r\n<p class=\"sOtherCountries__agency\"><span>FDA</span> Управление по&nbsp;санитарному надзору за&nbsp;качеством пищевых продуктов и&nbsp;медикаментов, США</p>'),
(2680, 133, '_текст-7', 'field_6244182bb6089'),
(2681, 133, 'текст-7-1', 'Производство препарата Урорек, поставляемого в&nbsp;Россию, осуществляется в&nbsp;Италии с&nbsp;использованием субстанции из&nbsp;Японии, в&nbsp;соответствии с&nbsp;необходимыми требованиями к&nbsp;производству и&nbsp;контролю качества<sup>6,1</sup>'),
(2682, 133, '_текст-7-1', 'field_62441a5acf03c'),
(2683, 133, 'заголовок-8', 'О проблеме'),
(2684, 133, '_заголовок-8', 'field_624431d91624d'),
(2685, 133, 'текст-8', 'Доброкачественная гиперплазия предстательной железы (ДГПЖ), или как ее еще называют, аденома простаты, как правило, возникает у мужчин старше 50 лет и характеризуется наличием симптомов нижних мочевыводящих путей (СНМП), увеличением предстательной железы или ее части, и нарушением оттока мочи из мочевого пузыря вследствие инфравезикальной обструкции.<sup>38</sup>\r\n\r\nРаспространенность ДГПЖ увеличивается с возрастом. Так, клинически значимая ДГПЖ проявляется у 13% мужчин в возрасте старше 50 лет, у 34% мужчин в возрасте 60 лет и у 43% в возрасте 70 лет.<sup>39</sup>\r\n\r\n&nbsp;\r\n\r\n<img class=\"alignnone wp-image-122 size-full\" src=\"http://0026urotec.loc:8888/wp-content/uploads/2022/03/about-img.png\" alt=\"\" width=\"594\" height=\"696\" />'),
(2686, 133, '_текст-8', 'field_624431f11624e'),
(2687, 133, 'текст-8-1', 'Наличие СНМП может быть ассоциировано с&nbsp;тяжелыми хроническими заболеваниями, такими как заболевания сердца, сахарный диабет, артериальная гипертензия и&nbsp;депрессия<sup>40</sup>'),
(2688, 133, '_текст-8-1', 'field_6244320b26db3'),
(2689, 133, 'иконки-8', 'a:6:{i:0;s:3:\"123\";i:1;s:3:\"124\";i:2;s:3:\"125\";i:3;s:3:\"126\";i:4;s:3:\"127\";i:5;s:3:\"128\";}'),
(2690, 133, '_иконки-8', 'field_6244322d26db4'),
(2691, 133, 'текст-8-2', '<h3>Симптомы доброкачественной гиперплазии предстательной железы</h3>\r\nСимптомы нарушенного мочеиспускания являются частой жалобой у взрослых мужчин. Они оказывают серьезное негативное влияние на качество жизни. При ДГПЖ предстательная железа увеличивается в размерах, оказывая давление на нижние мочевые пути. В результате развиваются следующие симптомы:<sup>41</sup>'),
(2692, 133, '_текст-8-2', 'field_6244335fe2373'),
(2693, 135, '_edit_last', '1'),
(2694, 135, '_edit_lock', '1648642044:1'),
(2695, 140, 'заголовок-1', 'УРОРЕК – оригинальный<sup>10</sup> альфа-адреноблокатор'),
(2696, 140, '_заголовок-1', 'field_62435bd26f29f'),
(2697, 140, 'текст-1', '<div class=\"headerBlock__body\">\r\n<p>Силодозин (действующее вещество препарата Урорек) обладает максимальной уроселективностью в&nbsp;своем классе, что обеспечивает его уродинамическую эффективность и&nbsp;высокую безопасность<sup>4</sup></p>\r\n</div>\r\n<div class=\"headerBlock__footer\">\r\n<p><strong>Показания к применению: </strong><br/>Лечение симптомов доброкачественной гиперплазии предстательной железы<sup>6</sup></p>\r\n</div>'),
(2698, 140, '_текст-1', 'field_62435c0c6f2a0'),
(2699, 140, 'изображение-1', '13'),
(2700, 140, '_изображение-1', 'field_62435c8b6f2a1'),
(2701, 140, 'фон-1', '17'),
(2702, 140, '_фон-1', 'field_62435db92ea96'),
(2703, 140, 'заголовок-2', 'Ключевые преимущества препарата Урорек'),
(2704, 140, '_заголовок-2', 'field_6243606295196'),
(2705, 140, 'список-2', 'Единственный оригинальный препарат из&nbsp;группы альфа1-адреноблокаторов, не&nbsp;имеющий генериков в&nbsp;РФ<sup>1</sup>'),
(2706, 140, '_список-2', 'field_6243608195197'),
(2707, 140, 'картинка_с_текстом_0_изображение', '31'),
(2708, 140, '_картинка_с_текстом_0_изображение', 'field_624363d095199'),
(2709, 140, 'картинка_с_текстом_0_описание', 'Обширная доказательная база собственных пострегистрационных клинических исследований<sup>2</sup>'),
(2710, 140, '_картинка_с_текстом_0_описание', 'field_624363e59519a'),
(2711, 140, 'картинка_с_текстом_1_изображение', '32'),
(2712, 140, '_картинка_с_текстом_1_изображение', 'field_624363d095199'),
(2713, 140, 'картинка_с_текстом_1_описание', 'Отсутствие риска замены препарата Урорек в&nbsp;аптеке (единственный препарат с&nbsp;действующим веществом силодозин)<sup>1</sup>'),
(2714, 140, '_картинка_с_текстом_1_описание', 'field_624363e59519a'),
(2715, 140, 'картинка_с_текстом_2_изображение', '33'),
(2716, 140, '_картинка_с_текстом_2_изображение', 'field_624363d095199'),
(2717, 140, 'картинка_с_текстом_2_описание', 'Большинство пациентов предпочитают принимать оригинальные препараты<sup>3</sup>'),
(2718, 140, '_картинка_с_текстом_2_описание', 'field_624363e59519a'),
(2719, 140, 'картинка_с_текстом', '3'),
(2720, 140, '_картинка_с_текстом', 'field_624363b995198'),
(2721, 140, 'второй_список', '<li>Клинические преимущества препарата Урорек (силодозин) определяются максимальной уроселективностью в&nbsp;классе альфа-адреноблокаторов<sup>4</sup></li>\r\n\r\n<li>Урорек&nbsp;&mdash; альфа-адреноблокатор последнего поколения, который эффективен в&nbsp;отношении всех СНМП (накопления, опорожнения, постмиктурических).<sup>12,13</sup> При этом Урорек обладает минимальным риском развития нежелательных явлений со&nbsp;стороны сердечно-сосудистой системы, в&nbsp;том числе&nbsp;у&nbsp;пациентов, принимающих антигипертензивные препараты<sup>46,8</sup> <small> <span>СНМП </span>симптомы нижних мочевыводящих путей</small></li>'),
(2722, 140, '_второй_список', 'field_6243640e05eda'),
(2723, 140, 'заголовок2-2', 'Максимальная уроселективность силодозина в&nbsp;классе альфа-адреноблокаторов обуславливает его уродинамическую эффективность и&nbsp;высокий профиль безопасности<sup>4</sup>'),
(2724, 140, '_заголовок2-2', 'field_6243644705edb'),
(2725, 140, 'текст3', '<ul>\r\n<li>Урорек значительно улучшает клинические проявления и&nbsp;качество жизни у&nbsp;всех пациентов с&nbsp;СНМП/ДГПЖ, в&nbsp;том числе с&nbsp;тяжелым течением<sup>11</sup><a href=\"#\">Узнать больше...</a></li>\r\n\r\n<li>Урорек является препаратом выбора для пациентов с&nbsp;СНМП/ДГПЖ и&nbsp;сопутствующими сердечно-сосудистыми заболеваниями<sup>3</sup> <a href=\"#\">Узнать больше...</a></li>\r\n</ul>\r\n<small> <span>ДГПЖ </span>доброкачественная гиперплазия предстательной железы</small>'),
(2726, 140, '_текст3', 'field_6243647405edc'),
(2727, 140, 'изображение-2', '34'),
(2728, 140, '_изображение-2', 'field_624364dd05edd'),
(2729, 140, 'текст_в_подвале', '<h2> Максимальная уроселективность в&nbsp;классе  альфа-адреноблокаторов<sup>4</sup></h2>\r\n<div class=\"h3\"> Почему это важно? <a href=\"#\">Подробнее</a></div>'),
(2730, 140, '_текст_в_подвале', 'field_62436daf1f6d9'),
(2731, 140, 'заголовок-3', 'Форма выпуска препарата Урорек'),
(2732, 140, '_заголовок-3', 'field_62436efee98e7'),
(2733, 140, 'текст-3', '<p class=\"section-descr\"><span>8мг </span>- рекомендуемая доза для лечения симптомов ДГПЖ<sup>6</sup>*</p>\r\n					<p class=\"section-note col-md-10\">*Более подробные сведения о&nbsp;препарате, особенностях применения, побочных действиях и&nbsp;др. &mdash;&nbsp;смотрите инструкцию по&nbsp;медицинскому применению лекарственного препарата Урорек, РУ&nbsp;ЛСР-005971/10 от&nbsp;25.06.2010 </p>'),
(2734, 140, '_текст-3', 'field_62436f60e98e8'),
(2735, 140, 'товар_0_название', 'Урорек 8мг №30'),
(2736, 140, '_товар_0_название', 'field_62436fcce98ea'),
(2737, 140, 'товар_0_описание', 'Упаковка, рассчитанная на&nbsp;1&nbsp;месяц лечения&nbsp;/ для старта терапии'),
(2738, 140, '_товар_0_описание', 'field_62436fe1e98eb'),
(2739, 140, 'товар_0_лицензия', 'РУ: ЛСР-005971/10 от 25.06.2010'),
(2740, 140, '_товар_0_лицензия', 'field_62436ff0e98ec'),
(2741, 140, 'товар_0_изображение', '51'),
(2742, 140, '_товар_0_изображение', 'field_62437045e98ed'),
(2743, 140, 'товар_1_название', 'Урорек 8мг №90'),
(2744, 140, '_товар_1_название', 'field_62436fcce98ea'),
(2745, 140, 'товар_1_описание', 'Выгодная упаковка, рассчитанная на&nbsp;3&nbsp;месяца лечения. Самая доступная стоимость 1&nbsp;дня терапии препаратом Урорек&nbsp;<sup>27</sup>'),
(2746, 140, '_товар_1_описание', 'field_62436fe1e98eb'),
(2747, 140, 'товар_1_лицензия', 'РУ: ЛСР-005971/10 от 25.06.2010'),
(2748, 140, '_товар_1_лицензия', 'field_62436ff0e98ec'),
(2749, 140, 'товар_1_изображение', '53'),
(2750, 140, '_товар_1_изображение', 'field_62437045e98ed'),
(2751, 140, 'товар_2_название', 'Урорек 4мг №30'),
(2752, 140, '_товар_2_название', 'field_62436fcce98ea'),
(2753, 140, 'товар_2_описание', '4&nbsp;мг&nbsp;&mdash; стартовая упаковка для лечения симптомов ДГПЖ у&nbsp;пациентов с&nbsp;почечной недостаточностью средней степени тяжести<sup>6</sup>'),
(2754, 140, '_товар_2_описание', 'field_62436fe1e98eb'),
(2755, 140, 'товар_2_лицензия', 'РУ: ЛСР-005971/10 от 25.06.2010'),
(2756, 140, '_товар_2_лицензия', 'field_62436ff0e98ec'),
(2757, 140, 'товар_2_изображение', '52'),
(2758, 140, '_товар_2_изображение', 'field_62437045e98ed'),
(2759, 140, 'товар', '3'),
(2760, 140, '_товар', 'field_62436fbde98e9'),
(2761, 140, 'заголовок-4', 'Где купить'),
(2762, 140, '_заголовок-4', 'field_624374f73d8bd'),
(2763, 140, 'изображения', 'a:12:{i:0;s:2:\"63\";i:1;s:2:\"64\";i:2;s:2:\"65\";i:3;s:2:\"66\";i:4;s:2:\"67\";i:5;s:2:\"68\";i:6;s:2:\"69\";i:7;s:2:\"70\";i:8;s:2:\"71\";i:9;s:2:\"72\";i:10;s:2:\"73\";i:11;s:2:\"74\";}'),
(2764, 140, '_изображения', 'field_624375093d8be'),
(2765, 140, 'изображения-4', 'a:12:{i:0;s:2:\"63\";i:1;s:2:\"64\";i:2;s:2:\"65\";i:3;s:2:\"66\";i:4;s:2:\"67\";i:5;s:2:\"68\";i:6;s:2:\"69\";i:7;s:2:\"70\";i:8;s:2:\"71\";i:9;s:2:\"72\";i:10;s:2:\"73\";i:11;s:2:\"74\";}'),
(2766, 140, '_изображения-4', 'field_624375093d8be'),
(2767, 140, 'заголовок-5', 'Способ применения*<sup>6</sup>'),
(2768, 140, '_заголовок-5', 'field_624379bd4756d'),
(2769, 140, 'иконки', 'a:5:{i:0;s:2:\"83\";i:1;s:2:\"84\";i:2;s:2:\"85\";i:3;s:2:\"86\";i:4;s:2:\"87\";}'),
(2770, 140, '_иконки', 'field_624379f24756e'),
(2771, 140, 'текст-5', 'У пациентов с легкой почечной недостаточностью (клиренс креатинина ≥ 50 — ≤ 80 мл/мин) коррекция дозы не требуется. Для лечения пациентов с почечной недостаточностью средней степени тяжести (клиренс креатинина ≥ 30 — < 50 мл/мин) рекомендуется в течение первой недели принимать начальную дозу по 4 мг в сутки, при хорошей индивидуальной переносимости доза может быть увеличена до 8 мг в сутки. Применение препарата для пациентов с тяжелой почечной недостаточностью (клиренс креатинина < 30 мл / мин) не рекомендуется'),
(2772, 140, '_текст-5', 'field_62437a374756f'),
(2773, 140, 'текст_под_кнопкой', '*Более подробные сведения о&nbsp;препарате, особенностях применения, побочных действиях и&nbsp;др. &mdash;&nbsp;см. инструкцию по&nbsp;медицинскому применению лекарственного препарата Урорек, РУ&nbsp;ЛСР-005971/10 от&nbsp;25.06.2010'),
(2774, 140, '_текст_под_кнопкой', 'field_62437a7c47570'),
(2775, 140, 'заголовок-6', 'Препарат Урорек (силодозин) включен в&nbsp;российские и&nbsp;международные клинические рекомендации и&nbsp;стандарты для лечения ряда урологических заболеваний:'),
(2776, 140, '_заголовок-6', 'field_6244117c68bd0'),
(2777, 140, 'список-6_0_ссылка', 'a:3:{s:5:\"title\";s:68:\"Российские клинические рекомендации\";s:3:\"url\";s:1:\"#\";s:6:\"target\";s:0:\"\";}'),
(2778, 140, '_список-6_0_ссылка', 'field_624411ce68bd2'),
(2779, 140, 'список-6_0_описание', '«Доброкачественная гиперплазия предстательной железы», 2020<sup>28</sup>'),
(2780, 140, '_список-6_0_описание', 'field_6244121168bd3'),
(2781, 140, 'список-6_1_ссылка', 'a:3:{s:5:\"title\";s:70:\"Европейские клинические рекомендации\";s:3:\"url\";s:1:\"#\";s:6:\"target\";s:0:\"\";}'),
(2782, 140, '_список-6_1_ссылка', 'field_624411ce68bd2'),
(2783, 140, 'список-6_1_описание', 'глава «Консервативное лечение ненейрогенных симптомов нарушенного мочеиспускания у мужчин, включая доброкачественную простатическую обструкцию», 2021<sup>29</sup>'),
(2784, 140, '_список-6_1_описание', 'field_6244121168bd3'),
(2785, 140, 'список-6_2_ссылка', 'a:3:{s:5:\"title\";s:154:\"Стандарт первичной медико-санитарной помощи при гиперплазии предстательной железы\";s:3:\"url\";s:1:\"#\";s:6:\"target\";s:0:\"\";}'),
(2786, 140, '_список-6_2_ссылка', 'field_624411ce68bd2'),
(2787, 140, 'список-6_2_описание', '09.11.2012<sup>30</sup> / Обновлён 13.04.2015\r\n'),
(2788, 140, '_список-6_2_описание', 'field_6244121168bd3'),
(2789, 140, 'список-6_3_ссылка', 'a:3:{s:5:\"title\";s:122:\"Стандарт специализированной медицинской помощи при задержке мочи\";s:3:\"url\";s:1:\"#\";s:6:\"target\";s:0:\"\";}'),
(2790, 140, '_список-6_3_ссылка', 'field_624411ce68bd2'),
(2791, 140, 'список-6_3_описание', '29.01.2013<sup>31</sup> / Обновлён 06.05.2015\r\n'),
(2792, 140, '_список-6_3_описание', 'field_6244121168bd3'),
(2793, 140, 'список-6_4_ссылка', 'a:3:{s:5:\"title\";s:133:\"Стандарт первичной медико-санитарной помощи при хроническом простатите\";s:3:\"url\";s:1:\"#\";s:6:\"target\";s:0:\"\";}'),
(2794, 140, '_список-6_4_ссылка', 'field_624411ce68bd2'),
(2795, 140, 'список-6_4_описание', '09.11.2012<sup>32</sup> / Обновлён 13.04.2015\r\n'),
(2796, 140, '_список-6_4_описание', 'field_6244121168bd3'),
(2797, 140, 'список-6_5_ссылка', 'a:3:{s:5:\"title\";s:168:\"Стандарт специализированной медицинской помощи при остром простатите, орхите, эпидидимите\";s:3:\"url\";s:1:\"#\";s:6:\"target\";s:0:\"\";}'),
(2798, 140, '_список-6_5_ссылка', 'field_624411ce68bd2'),
(2799, 140, 'список-6_5_описание', '09.11.2012<sup>33</sup> / Обновлён 27.05.2015'),
(2800, 140, '_список-6_5_описание', 'field_6244121168bd3'),
(2801, 140, 'список-6', '6'),
(2802, 140, '_список-6', 'field_624411be68bd1'),
(2803, 140, 'заголовок-7', 'Препарат Урорек (силодозин) зарегистрирован и&nbsp;применяется в&nbsp;разных странах мира Одобрен ЕМА*<sup>34</sup> и&nbsp;FDA**<sup>35</sup>'),
(2804, 140, '_заголовок-7', 'field_624417e3b6088'),
(2805, 140, 'текст', '<p class=\"sOtherCountries__agency\"><span>EMA</span> Европейское медицинское агентство</p>\r\n<p class=\"sOtherCountries__agency\"><span>FDA</span> Управление по&nbsp;санитарному надзору за&nbsp;качеством пищевых продуктов и&nbsp;медикаментов, США</p>'),
(2806, 140, '_текст', 'field_6244182bb6089'),
(2807, 140, 'страны_0_флаг', '105'),
(2808, 140, '_страны_0_флаг', 'field_62441880b608b'),
(2809, 140, 'страны_0_название', 'Япония'),
(2810, 140, '_страны_0_название', 'field_62441899b608c'),
(2811, 140, 'страны_0_год', '2006<sup>36,37</sup>'),
(2812, 140, '_страны_0_год', 'field_624418aab608d'),
(2813, 140, 'страны_1_флаг', '106'),
(2814, 140, '_страны_1_флаг', 'field_62441880b608b'),
(2815, 140, 'страны_1_название', 'США'),
(2816, 140, '_страны_1_название', 'field_62441899b608c'),
(2817, 140, 'страны_1_год', '2008<sup>35</sup>'),
(2818, 140, '_страны_1_год', 'field_624418aab608d'),
(2819, 140, 'страны_2_флаг', '107'),
(2820, 140, '_страны_2_флаг', 'field_62441880b608b'),
(2821, 140, 'страны_2_название', 'Страны ЕС'),
(2822, 140, '_страны_2_название', 'field_62441899b608c'),
(2823, 140, 'страны_2_год', '2010<sup>34</sup>'),
(2824, 140, '_страны_2_год', 'field_624418aab608d'),
(2825, 140, 'страны_3_флаг', '108'),
(2826, 140, '_страны_3_флаг', 'field_62441880b608b'),
(2827, 140, 'страны_3_название', 'Россия'),
(2828, 140, '_страны_3_название', 'field_62441899b608c'),
(2829, 140, 'страны_3_год', '2010<sup>1</sup>'),
(2830, 140, '_страны_3_год', 'field_624418aab608d'),
(2831, 140, 'страны', '4'),
(2832, 140, '_страны', 'field_62441847b608a'),
(2833, 140, 'текст-7', '<p class=\"sOtherCountries__agency\"><span>EMA</span> Европейское медицинское агентство</p>\r\n<p class=\"sOtherCountries__agency\"><span>FDA</span> Управление по&nbsp;санитарному надзору за&nbsp;качеством пищевых продуктов и&nbsp;медикаментов, США</p>'),
(2834, 140, '_текст-7', 'field_6244182bb6089'),
(2835, 140, 'текст-7-1', 'Производство препарата Урорек, поставляемого в&nbsp;Россию, осуществляется в&nbsp;Италии с&nbsp;использованием субстанции из&nbsp;Японии, в&nbsp;соответствии с&nbsp;необходимыми требованиями к&nbsp;производству и&nbsp;контролю качества<sup>6,1</sup>'),
(2836, 140, '_текст-7-1', 'field_62441a5acf03c'),
(2837, 140, 'заголовок-8', 'О проблеме'),
(2838, 140, '_заголовок-8', 'field_624431d91624d'),
(2839, 140, 'текст-8', 'Доброкачественная гиперплазия предстательной железы (ДГПЖ), или как ее еще называют, аденома простаты, как правило, возникает у мужчин старше 50 лет и характеризуется наличием симптомов нижних мочевыводящих путей (СНМП), увеличением предстательной железы или ее части, и нарушением оттока мочи из мочевого пузыря вследствие инфравезикальной обструкции.<sup>38</sup>\r\n\r\nРаспространенность ДГПЖ увеличивается с возрастом. Так, клинически значимая ДГПЖ проявляется у 13% мужчин в возрасте старше 50 лет, у 34% мужчин в возрасте 60 лет и у 43% в возрасте 70 лет.<sup>39</sup>\r\n\r\n&nbsp;\r\n\r\n[caption id=\"attachment_122\" align=\"alignnone\" width=\"594\"]<img class=\"wp-image-122 size-full\" src=\"http://0026urotec.loc:8888/wp-content/uploads/2022/03/about-img.png\" alt=\"мужик\" width=\"594\" height=\"696\" /> Федя[/caption]'),
(2840, 140, '_текст-8', 'field_624431f11624e'),
(2841, 140, 'текст-8-1', 'Наличие СНМП может быть ассоциировано с&nbsp;тяжелыми хроническими заболеваниями, такими как заболевания сердца, сахарный диабет, артериальная гипертензия и&nbsp;депрессия<sup>40</sup>'),
(2842, 140, '_текст-8-1', 'field_6244320b26db3'),
(2843, 140, 'иконки-8', 'a:6:{i:0;s:3:\"123\";i:1;s:3:\"124\";i:2;s:3:\"125\";i:3;s:3:\"126\";i:4;s:3:\"127\";i:5;s:3:\"128\";}'),
(2844, 140, '_иконки-8', 'field_6244322d26db4'),
(2845, 140, 'текст-8-2', '<h3>Симптомы доброкачественной гиперплазии предстательной железы</h3>\r\nСимптомы нарушенного мочеиспускания являются частой жалобой у взрослых мужчин. Они оказывают серьезное негативное влияние на качество жизни. При ДГПЖ предстательная железа увеличивается в размерах, оказывая давление на нижние мочевые пути. В результате развиваются следующие симптомы:<sup>41</sup>'),
(2846, 140, '_текст-8-2', 'field_6244335fe2373'),
(2847, 141, '_wp_attached_file', '2022/03/complex-img-1.png'),
(2848, 141, '_wp_attachment_metadata', 'a:5:{s:5:\"width\";i:85;s:6:\"height\";i:188;s:4:\"file\";s:25:\"2022/03/complex-img-1.png\";s:5:\"sizes\";a:1:{s:9:\"thumbnail\";a:4:{s:4:\"file\";s:24:\"complex-img-1-85x150.png\";s:5:\"width\";i:85;s:6:\"height\";i:150;s:9:\"mime-type\";s:9:\"image/png\";}}s:10:\"image_meta\";a:12:{s:8:\"aperture\";s:1:\"0\";s:6:\"credit\";s:0:\"\";s:6:\"camera\";s:0:\"\";s:7:\"caption\";s:0:\"\";s:17:\"created_timestamp\";s:1:\"0\";s:9:\"copyright\";s:0:\"\";s:12:\"focal_length\";s:1:\"0\";s:3:\"iso\";s:1:\"0\";s:13:\"shutter_speed\";s:1:\"0\";s:5:\"title\";s:0:\"\";s:11:\"orientation\";s:1:\"0\";s:8:\"keywords\";a:0:{}}}'),
(2849, 142, '_wp_attached_file', '2022/03/complex-img-2.png'),
(2850, 142, '_wp_attachment_metadata', 'a:5:{s:5:\"width\";i:234;s:6:\"height\";i:117;s:4:\"file\";s:25:\"2022/03/complex-img-2.png\";s:5:\"sizes\";a:1:{s:9:\"thumbnail\";a:4:{s:4:\"file\";s:25:\"complex-img-2-150x117.png\";s:5:\"width\";i:150;s:6:\"height\";i:117;s:9:\"mime-type\";s:9:\"image/png\";}}s:10:\"image_meta\";a:12:{s:8:\"aperture\";s:1:\"0\";s:6:\"credit\";s:0:\"\";s:6:\"camera\";s:0:\"\";s:7:\"caption\";s:0:\"\";s:17:\"created_timestamp\";s:1:\"0\";s:9:\"copyright\";s:0:\"\";s:12:\"focal_length\";s:1:\"0\";s:3:\"iso\";s:1:\"0\";s:13:\"shutter_speed\";s:1:\"0\";s:5:\"title\";s:0:\"\";s:11:\"orientation\";s:1:\"0\";s:8:\"keywords\";a:0:{}}}'),
(2851, 143, '_wp_attached_file', '2022/03/complex-img-3.png'),
(2852, 143, '_wp_attachment_metadata', 'a:5:{s:5:\"width\";i:133;s:6:\"height\";i:181;s:4:\"file\";s:25:\"2022/03/complex-img-3.png\";s:5:\"sizes\";a:1:{s:9:\"thumbnail\";a:4:{s:4:\"file\";s:25:\"complex-img-3-133x150.png\";s:5:\"width\";i:133;s:6:\"height\";i:150;s:9:\"mime-type\";s:9:\"image/png\";}}s:10:\"image_meta\";a:12:{s:8:\"aperture\";s:1:\"0\";s:6:\"credit\";s:0:\"\";s:6:\"camera\";s:0:\"\";s:7:\"caption\";s:0:\"\";s:17:\"created_timestamp\";s:1:\"0\";s:9:\"copyright\";s:0:\"\";s:12:\"focal_length\";s:1:\"0\";s:3:\"iso\";s:1:\"0\";s:13:\"shutter_speed\";s:1:\"0\";s:5:\"title\";s:0:\"\";s:11:\"orientation\";s:1:\"0\";s:8:\"keywords\";a:0:{}}}'),
(2853, 144, '_wp_attached_file', '2022/03/complex-img-4.png'),
(2854, 144, '_wp_attachment_metadata', 'a:5:{s:5:\"width\";i:94;s:6:\"height\";i:179;s:4:\"file\";s:25:\"2022/03/complex-img-4.png\";s:5:\"sizes\";a:1:{s:9:\"thumbnail\";a:4:{s:4:\"file\";s:24:\"complex-img-4-94x150.png\";s:5:\"width\";i:94;s:6:\"height\";i:150;s:9:\"mime-type\";s:9:\"image/png\";}}s:10:\"image_meta\";a:12:{s:8:\"aperture\";s:1:\"0\";s:6:\"credit\";s:0:\"\";s:6:\"camera\";s:0:\"\";s:7:\"caption\";s:0:\"\";s:17:\"created_timestamp\";s:1:\"0\";s:9:\"copyright\";s:0:\"\";s:12:\"focal_length\";s:1:\"0\";s:3:\"iso\";s:1:\"0\";s:13:\"shutter_speed\";s:1:\"0\";s:5:\"title\";s:0:\"\";s:11:\"orientation\";s:1:\"0\";s:8:\"keywords\";a:0:{}}}'),
(2855, 145, '_wp_attached_file', '2022/03/complex-img-5.png'),
(2856, 145, '_wp_attachment_metadata', 'a:5:{s:5:\"width\";i:69;s:6:\"height\";i:189;s:4:\"file\";s:25:\"2022/03/complex-img-5.png\";s:5:\"sizes\";a:1:{s:9:\"thumbnail\";a:4:{s:4:\"file\";s:24:\"complex-img-5-69x150.png\";s:5:\"width\";i:69;s:6:\"height\";i:150;s:9:\"mime-type\";s:9:\"image/png\";}}s:10:\"image_meta\";a:12:{s:8:\"aperture\";s:1:\"0\";s:6:\"credit\";s:0:\"\";s:6:\"camera\";s:0:\"\";s:7:\"caption\";s:0:\"\";s:17:\"created_timestamp\";s:1:\"0\";s:9:\"copyright\";s:0:\"\";s:12:\"focal_length\";s:1:\"0\";s:3:\"iso\";s:1:\"0\";s:13:\"shutter_speed\";s:1:\"0\";s:5:\"title\";s:0:\"\";s:11:\"orientation\";s:1:\"0\";s:8:\"keywords\";a:0:{}}}'),
(2857, 146, '_wp_attached_file', '2022/03/complex-img-6.png'),
(2858, 146, '_wp_attachment_metadata', 'a:5:{s:5:\"width\";i:146;s:6:\"height\";i:99;s:4:\"file\";s:25:\"2022/03/complex-img-6.png\";s:5:\"sizes\";a:0:{}s:10:\"image_meta\";a:12:{s:8:\"aperture\";s:1:\"0\";s:6:\"credit\";s:0:\"\";s:6:\"camera\";s:0:\"\";s:7:\"caption\";s:0:\"\";s:17:\"created_timestamp\";s:1:\"0\";s:9:\"copyright\";s:0:\"\";s:12:\"focal_length\";s:1:\"0\";s:3:\"iso\";s:1:\"0\";s:13:\"shutter_speed\";s:1:\"0\";s:5:\"title\";s:0:\"\";s:11:\"orientation\";s:1:\"0\";s:8:\"keywords\";a:0:{}}}'),
(2859, 2, 'заголовок-9', 'Осложнения ДГПЖ<sup>38</sup>'),
(2860, 2, '_заголовок-9', 'field_6244377a52263'),
(2861, 2, 'изображения-9', 'a:6:{i:0;s:3:\"141\";i:1;s:3:\"142\";i:2;s:3:\"143\";i:3;s:3:\"144\";i:4;s:3:\"145\";i:5;s:3:\"146\";}'),
(2862, 2, '_изображения-9', 'field_6244379652264'),
(2863, 147, 'заголовок-1', 'УРОРЕК – оригинальный<sup>10</sup> альфа-адреноблокатор'),
(2864, 147, '_заголовок-1', 'field_62435bd26f29f'),
(2865, 147, 'текст-1', '<div class=\"headerBlock__body\">\r\n<p>Силодозин (действующее вещество препарата Урорек) обладает максимальной уроселективностью в&nbsp;своем классе, что обеспечивает его уродинамическую эффективность и&nbsp;высокую безопасность<sup>4</sup></p>\r\n</div>\r\n<div class=\"headerBlock__footer\">\r\n<p><strong>Показания к применению: </strong><br/>Лечение симптомов доброкачественной гиперплазии предстательной железы<sup>6</sup></p>\r\n</div>'),
(2866, 147, '_текст-1', 'field_62435c0c6f2a0'),
(2867, 147, 'изображение-1', '13'),
(2868, 147, '_изображение-1', 'field_62435c8b6f2a1'),
(2869, 147, 'фон-1', '17'),
(2870, 147, '_фон-1', 'field_62435db92ea96'),
(2871, 147, 'заголовок-2', 'Ключевые преимущества препарата Урорек'),
(2872, 147, '_заголовок-2', 'field_6243606295196'),
(2873, 147, 'список-2', 'Единственный оригинальный препарат из&nbsp;группы альфа1-адреноблокаторов, не&nbsp;имеющий генериков в&nbsp;РФ<sup>1</sup>'),
(2874, 147, '_список-2', 'field_6243608195197'),
(2875, 147, 'картинка_с_текстом_0_изображение', '31'),
(2876, 147, '_картинка_с_текстом_0_изображение', 'field_624363d095199'),
(2877, 147, 'картинка_с_текстом_0_описание', 'Обширная доказательная база собственных пострегистрационных клинических исследований<sup>2</sup>');
INSERT INTO `urotec_postmeta` (`meta_id`, `post_id`, `meta_key`, `meta_value`) VALUES
(2878, 147, '_картинка_с_текстом_0_описание', 'field_624363e59519a'),
(2879, 147, 'картинка_с_текстом_1_изображение', '32'),
(2880, 147, '_картинка_с_текстом_1_изображение', 'field_624363d095199'),
(2881, 147, 'картинка_с_текстом_1_описание', 'Отсутствие риска замены препарата Урорек в&nbsp;аптеке (единственный препарат с&nbsp;действующим веществом силодозин)<sup>1</sup>'),
(2882, 147, '_картинка_с_текстом_1_описание', 'field_624363e59519a'),
(2883, 147, 'картинка_с_текстом_2_изображение', '33'),
(2884, 147, '_картинка_с_текстом_2_изображение', 'field_624363d095199'),
(2885, 147, 'картинка_с_текстом_2_описание', 'Большинство пациентов предпочитают принимать оригинальные препараты<sup>3</sup>'),
(2886, 147, '_картинка_с_текстом_2_описание', 'field_624363e59519a'),
(2887, 147, 'картинка_с_текстом', '3'),
(2888, 147, '_картинка_с_текстом', 'field_624363b995198'),
(2889, 147, 'второй_список', '<li>Клинические преимущества препарата Урорек (силодозин) определяются максимальной уроселективностью в&nbsp;классе альфа-адреноблокаторов<sup>4</sup></li>\r\n\r\n<li>Урорек&nbsp;&mdash; альфа-адреноблокатор последнего поколения, который эффективен в&nbsp;отношении всех СНМП (накопления, опорожнения, постмиктурических).<sup>12,13</sup> При этом Урорек обладает минимальным риском развития нежелательных явлений со&nbsp;стороны сердечно-сосудистой системы, в&nbsp;том числе&nbsp;у&nbsp;пациентов, принимающих антигипертензивные препараты<sup>46,8</sup> <small> <span>СНМП </span>симптомы нижних мочевыводящих путей</small></li>'),
(2890, 147, '_второй_список', 'field_6243640e05eda'),
(2891, 147, 'заголовок2-2', 'Максимальная уроселективность силодозина в&nbsp;классе альфа-адреноблокаторов обуславливает его уродинамическую эффективность и&nbsp;высокий профиль безопасности<sup>4</sup>'),
(2892, 147, '_заголовок2-2', 'field_6243644705edb'),
(2893, 147, 'текст3', '<ul>\r\n<li>Урорек значительно улучшает клинические проявления и&nbsp;качество жизни у&nbsp;всех пациентов с&nbsp;СНМП/ДГПЖ, в&nbsp;том числе с&nbsp;тяжелым течением<sup>11</sup><a href=\"#\">Узнать больше...</a></li>\r\n\r\n<li>Урорек является препаратом выбора для пациентов с&nbsp;СНМП/ДГПЖ и&nbsp;сопутствующими сердечно-сосудистыми заболеваниями<sup>3</sup> <a href=\"#\">Узнать больше...</a></li>\r\n</ul>\r\n<small> <span>ДГПЖ </span>доброкачественная гиперплазия предстательной железы</small>'),
(2894, 147, '_текст3', 'field_6243647405edc'),
(2895, 147, 'изображение-2', '34'),
(2896, 147, '_изображение-2', 'field_624364dd05edd'),
(2897, 147, 'текст_в_подвале', '<h2> Максимальная уроселективность в&nbsp;классе  альфа-адреноблокаторов<sup>4</sup></h2>\r\n<div class=\"h3\"> Почему это важно? <a href=\"#\">Подробнее</a></div>'),
(2898, 147, '_текст_в_подвале', 'field_62436daf1f6d9'),
(2899, 147, 'заголовок-3', 'Форма выпуска препарата Урорек'),
(2900, 147, '_заголовок-3', 'field_62436efee98e7'),
(2901, 147, 'текст-3', '<p class=\"section-descr\"><span>8мг </span>- рекомендуемая доза для лечения симптомов ДГПЖ<sup>6</sup>*</p>\r\n					<p class=\"section-note col-md-10\">*Более подробные сведения о&nbsp;препарате, особенностях применения, побочных действиях и&nbsp;др. &mdash;&nbsp;смотрите инструкцию по&nbsp;медицинскому применению лекарственного препарата Урорек, РУ&nbsp;ЛСР-005971/10 от&nbsp;25.06.2010 </p>'),
(2902, 147, '_текст-3', 'field_62436f60e98e8'),
(2903, 147, 'товар_0_название', 'Урорек 8мг №30'),
(2904, 147, '_товар_0_название', 'field_62436fcce98ea'),
(2905, 147, 'товар_0_описание', 'Упаковка, рассчитанная на&nbsp;1&nbsp;месяц лечения&nbsp;/ для старта терапии'),
(2906, 147, '_товар_0_описание', 'field_62436fe1e98eb'),
(2907, 147, 'товар_0_лицензия', 'РУ: ЛСР-005971/10 от 25.06.2010'),
(2908, 147, '_товар_0_лицензия', 'field_62436ff0e98ec'),
(2909, 147, 'товар_0_изображение', '51'),
(2910, 147, '_товар_0_изображение', 'field_62437045e98ed'),
(2911, 147, 'товар_1_название', 'Урорек 8мг №90'),
(2912, 147, '_товар_1_название', 'field_62436fcce98ea'),
(2913, 147, 'товар_1_описание', 'Выгодная упаковка, рассчитанная на&nbsp;3&nbsp;месяца лечения. Самая доступная стоимость 1&nbsp;дня терапии препаратом Урорек&nbsp;<sup>27</sup>'),
(2914, 147, '_товар_1_описание', 'field_62436fe1e98eb'),
(2915, 147, 'товар_1_лицензия', 'РУ: ЛСР-005971/10 от 25.06.2010'),
(2916, 147, '_товар_1_лицензия', 'field_62436ff0e98ec'),
(2917, 147, 'товар_1_изображение', '53'),
(2918, 147, '_товар_1_изображение', 'field_62437045e98ed'),
(2919, 147, 'товар_2_название', 'Урорек 4мг №30'),
(2920, 147, '_товар_2_название', 'field_62436fcce98ea'),
(2921, 147, 'товар_2_описание', '4&nbsp;мг&nbsp;&mdash; стартовая упаковка для лечения симптомов ДГПЖ у&nbsp;пациентов с&nbsp;почечной недостаточностью средней степени тяжести<sup>6</sup>'),
(2922, 147, '_товар_2_описание', 'field_62436fe1e98eb'),
(2923, 147, 'товар_2_лицензия', 'РУ: ЛСР-005971/10 от 25.06.2010'),
(2924, 147, '_товар_2_лицензия', 'field_62436ff0e98ec'),
(2925, 147, 'товар_2_изображение', '52'),
(2926, 147, '_товар_2_изображение', 'field_62437045e98ed'),
(2927, 147, 'товар', '3'),
(2928, 147, '_товар', 'field_62436fbde98e9'),
(2929, 147, 'заголовок-4', 'Где купить'),
(2930, 147, '_заголовок-4', 'field_624374f73d8bd'),
(2931, 147, 'изображения', 'a:12:{i:0;s:2:\"63\";i:1;s:2:\"64\";i:2;s:2:\"65\";i:3;s:2:\"66\";i:4;s:2:\"67\";i:5;s:2:\"68\";i:6;s:2:\"69\";i:7;s:2:\"70\";i:8;s:2:\"71\";i:9;s:2:\"72\";i:10;s:2:\"73\";i:11;s:2:\"74\";}'),
(2932, 147, '_изображения', 'field_624375093d8be'),
(2933, 147, 'изображения-4', 'a:12:{i:0;s:2:\"63\";i:1;s:2:\"64\";i:2;s:2:\"65\";i:3;s:2:\"66\";i:4;s:2:\"67\";i:5;s:2:\"68\";i:6;s:2:\"69\";i:7;s:2:\"70\";i:8;s:2:\"71\";i:9;s:2:\"72\";i:10;s:2:\"73\";i:11;s:2:\"74\";}'),
(2934, 147, '_изображения-4', 'field_624375093d8be'),
(2935, 147, 'заголовок-5', 'Способ применения*<sup>6</sup>'),
(2936, 147, '_заголовок-5', 'field_624379bd4756d'),
(2937, 147, 'иконки', 'a:5:{i:0;s:2:\"83\";i:1;s:2:\"84\";i:2;s:2:\"85\";i:3;s:2:\"86\";i:4;s:2:\"87\";}'),
(2938, 147, '_иконки', 'field_624379f24756e'),
(2939, 147, 'текст-5', 'У пациентов с легкой почечной недостаточностью (клиренс креатинина ≥ 50 — ≤ 80 мл/мин) коррекция дозы не требуется. Для лечения пациентов с почечной недостаточностью средней степени тяжести (клиренс креатинина ≥ 30 — < 50 мл/мин) рекомендуется в течение первой недели принимать начальную дозу по 4 мг в сутки, при хорошей индивидуальной переносимости доза может быть увеличена до 8 мг в сутки. Применение препарата для пациентов с тяжелой почечной недостаточностью (клиренс креатинина < 30 мл / мин) не рекомендуется'),
(2940, 147, '_текст-5', 'field_62437a374756f'),
(2941, 147, 'текст_под_кнопкой', '*Более подробные сведения о&nbsp;препарате, особенностях применения, побочных действиях и&nbsp;др. &mdash;&nbsp;см. инструкцию по&nbsp;медицинскому применению лекарственного препарата Урорек, РУ&nbsp;ЛСР-005971/10 от&nbsp;25.06.2010'),
(2942, 147, '_текст_под_кнопкой', 'field_62437a7c47570'),
(2943, 147, 'заголовок-6', 'Препарат Урорек (силодозин) включен в&nbsp;российские и&nbsp;международные клинические рекомендации и&nbsp;стандарты для лечения ряда урологических заболеваний:'),
(2944, 147, '_заголовок-6', 'field_6244117c68bd0'),
(2945, 147, 'список-6_0_ссылка', 'a:3:{s:5:\"title\";s:68:\"Российские клинические рекомендации\";s:3:\"url\";s:1:\"#\";s:6:\"target\";s:0:\"\";}'),
(2946, 147, '_список-6_0_ссылка', 'field_624411ce68bd2'),
(2947, 147, 'список-6_0_описание', '«Доброкачественная гиперплазия предстательной железы», 2020<sup>28</sup>'),
(2948, 147, '_список-6_0_описание', 'field_6244121168bd3'),
(2949, 147, 'список-6_1_ссылка', 'a:3:{s:5:\"title\";s:70:\"Европейские клинические рекомендации\";s:3:\"url\";s:1:\"#\";s:6:\"target\";s:0:\"\";}'),
(2950, 147, '_список-6_1_ссылка', 'field_624411ce68bd2'),
(2951, 147, 'список-6_1_описание', 'глава «Консервативное лечение ненейрогенных симптомов нарушенного мочеиспускания у мужчин, включая доброкачественную простатическую обструкцию», 2021<sup>29</sup>'),
(2952, 147, '_список-6_1_описание', 'field_6244121168bd3'),
(2953, 147, 'список-6_2_ссылка', 'a:3:{s:5:\"title\";s:154:\"Стандарт первичной медико-санитарной помощи при гиперплазии предстательной железы\";s:3:\"url\";s:1:\"#\";s:6:\"target\";s:0:\"\";}'),
(2954, 147, '_список-6_2_ссылка', 'field_624411ce68bd2'),
(2955, 147, 'список-6_2_описание', '09.11.2012<sup>30</sup> / Обновлён 13.04.2015\r\n'),
(2956, 147, '_список-6_2_описание', 'field_6244121168bd3'),
(2957, 147, 'список-6_3_ссылка', 'a:3:{s:5:\"title\";s:122:\"Стандарт специализированной медицинской помощи при задержке мочи\";s:3:\"url\";s:1:\"#\";s:6:\"target\";s:0:\"\";}'),
(2958, 147, '_список-6_3_ссылка', 'field_624411ce68bd2'),
(2959, 147, 'список-6_3_описание', '29.01.2013<sup>31</sup> / Обновлён 06.05.2015\r\n'),
(2960, 147, '_список-6_3_описание', 'field_6244121168bd3'),
(2961, 147, 'список-6_4_ссылка', 'a:3:{s:5:\"title\";s:133:\"Стандарт первичной медико-санитарной помощи при хроническом простатите\";s:3:\"url\";s:1:\"#\";s:6:\"target\";s:0:\"\";}'),
(2962, 147, '_список-6_4_ссылка', 'field_624411ce68bd2'),
(2963, 147, 'список-6_4_описание', '09.11.2012<sup>32</sup> / Обновлён 13.04.2015\r\n'),
(2964, 147, '_список-6_4_описание', 'field_6244121168bd3'),
(2965, 147, 'список-6_5_ссылка', 'a:3:{s:5:\"title\";s:168:\"Стандарт специализированной медицинской помощи при остром простатите, орхите, эпидидимите\";s:3:\"url\";s:1:\"#\";s:6:\"target\";s:0:\"\";}'),
(2966, 147, '_список-6_5_ссылка', 'field_624411ce68bd2'),
(2967, 147, 'список-6_5_описание', '09.11.2012<sup>33</sup> / Обновлён 27.05.2015'),
(2968, 147, '_список-6_5_описание', 'field_6244121168bd3'),
(2969, 147, 'список-6', '6'),
(2970, 147, '_список-6', 'field_624411be68bd1'),
(2971, 147, 'заголовок-7', 'Препарат Урорек (силодозин) зарегистрирован и&nbsp;применяется в&nbsp;разных странах мира Одобрен ЕМА*<sup>34</sup> и&nbsp;FDA**<sup>35</sup>'),
(2972, 147, '_заголовок-7', 'field_624417e3b6088'),
(2973, 147, 'текст', '<p class=\"sOtherCountries__agency\"><span>EMA</span> Европейское медицинское агентство</p>\r\n<p class=\"sOtherCountries__agency\"><span>FDA</span> Управление по&nbsp;санитарному надзору за&nbsp;качеством пищевых продуктов и&nbsp;медикаментов, США</p>'),
(2974, 147, '_текст', 'field_6244182bb6089'),
(2975, 147, 'страны_0_флаг', '105'),
(2976, 147, '_страны_0_флаг', 'field_62441880b608b'),
(2977, 147, 'страны_0_название', 'Япония'),
(2978, 147, '_страны_0_название', 'field_62441899b608c'),
(2979, 147, 'страны_0_год', '2006<sup>36,37</sup>'),
(2980, 147, '_страны_0_год', 'field_624418aab608d'),
(2981, 147, 'страны_1_флаг', '106'),
(2982, 147, '_страны_1_флаг', 'field_62441880b608b'),
(2983, 147, 'страны_1_название', 'США'),
(2984, 147, '_страны_1_название', 'field_62441899b608c'),
(2985, 147, 'страны_1_год', '2008<sup>35</sup>'),
(2986, 147, '_страны_1_год', 'field_624418aab608d'),
(2987, 147, 'страны_2_флаг', '107'),
(2988, 147, '_страны_2_флаг', 'field_62441880b608b'),
(2989, 147, 'страны_2_название', 'Страны ЕС'),
(2990, 147, '_страны_2_название', 'field_62441899b608c'),
(2991, 147, 'страны_2_год', '2010<sup>34</sup>'),
(2992, 147, '_страны_2_год', 'field_624418aab608d'),
(2993, 147, 'страны_3_флаг', '108'),
(2994, 147, '_страны_3_флаг', 'field_62441880b608b'),
(2995, 147, 'страны_3_название', 'Россия'),
(2996, 147, '_страны_3_название', 'field_62441899b608c'),
(2997, 147, 'страны_3_год', '2010<sup>1</sup>'),
(2998, 147, '_страны_3_год', 'field_624418aab608d'),
(2999, 147, 'страны', '4'),
(3000, 147, '_страны', 'field_62441847b608a'),
(3001, 147, 'текст-7', '<p class=\"sOtherCountries__agency\"><span>EMA</span> Европейское медицинское агентство</p>\r\n<p class=\"sOtherCountries__agency\"><span>FDA</span> Управление по&nbsp;санитарному надзору за&nbsp;качеством пищевых продуктов и&nbsp;медикаментов, США</p>'),
(3002, 147, '_текст-7', 'field_6244182bb6089'),
(3003, 147, 'текст-7-1', 'Производство препарата Урорек, поставляемого в&nbsp;Россию, осуществляется в&nbsp;Италии с&nbsp;использованием субстанции из&nbsp;Японии, в&nbsp;соответствии с&nbsp;необходимыми требованиями к&nbsp;производству и&nbsp;контролю качества<sup>6,1</sup>'),
(3004, 147, '_текст-7-1', 'field_62441a5acf03c'),
(3005, 147, 'заголовок-8', 'О проблеме'),
(3006, 147, '_заголовок-8', 'field_624431d91624d'),
(3007, 147, 'текст-8', 'Доброкачественная гиперплазия предстательной железы (ДГПЖ), или как ее еще называют, аденома простаты, как правило, возникает у мужчин старше 50 лет и характеризуется наличием симптомов нижних мочевыводящих путей (СНМП), увеличением предстательной железы или ее части, и нарушением оттока мочи из мочевого пузыря вследствие инфравезикальной обструкции.<sup>38</sup>\r\n\r\nРаспространенность ДГПЖ увеличивается с возрастом. Так, клинически значимая ДГПЖ проявляется у 13% мужчин в возрасте старше 50 лет, у 34% мужчин в возрасте 60 лет и у 43% в возрасте 70 лет.<sup>39</sup>\r\n\r\n&nbsp;\r\n\r\n[caption id=\"attachment_122\" align=\"alignnone\" width=\"594\"]<img class=\"wp-image-122 size-full\" src=\"http://0026urotec.loc:8888/wp-content/uploads/2022/03/about-img.png\" alt=\"мужик\" width=\"594\" height=\"696\" /> Федя[/caption]'),
(3008, 147, '_текст-8', 'field_624431f11624e'),
(3009, 147, 'текст-8-1', 'Наличие СНМП может быть ассоциировано с&nbsp;тяжелыми хроническими заболеваниями, такими как заболевания сердца, сахарный диабет, артериальная гипертензия и&nbsp;депрессия<sup>40</sup>'),
(3010, 147, '_текст-8-1', 'field_6244320b26db3'),
(3011, 147, 'иконки-8', 'a:6:{i:0;s:3:\"123\";i:1;s:3:\"124\";i:2;s:3:\"125\";i:3;s:3:\"126\";i:4;s:3:\"127\";i:5;s:3:\"128\";}'),
(3012, 147, '_иконки-8', 'field_6244322d26db4'),
(3013, 147, 'текст-8-2', '<h3>Симптомы доброкачественной гиперплазии предстательной железы</h3>\r\nСимптомы нарушенного мочеиспускания являются частой жалобой у взрослых мужчин. Они оказывают серьезное негативное влияние на качество жизни. При ДГПЖ предстательная железа увеличивается в размерах, оказывая давление на нижние мочевые пути. В результате развиваются следующие симптомы:<sup>41</sup>'),
(3014, 147, '_текст-8-2', 'field_6244335fe2373'),
(3015, 147, 'заголовок-9', 'Осложнения ДГПЖ<sup>38</sup>'),
(3016, 147, '_заголовок-9', 'field_6244377a52263'),
(3017, 147, 'изображения-9', 'a:6:{i:0;s:3:\"141\";i:1;s:3:\"142\";i:2;s:3:\"143\";i:3;s:3:\"144\";i:4;s:3:\"145\";i:5;s:3:\"146\";}'),
(3018, 147, '_изображения-9', 'field_6244379652264'),
(3019, 149, 'заголовок-1', 'УРОРЕК – оригинальный<sup>10</sup> альфа-адреноблокатор'),
(3020, 149, '_заголовок-1', 'field_62435bd26f29f'),
(3021, 149, 'текст-1', '<div class=\"headerBlock__body\">\r\n<p>Силодозин (действующее вещество препарата Урорек) обладает максимальной уроселективностью в&nbsp;своем классе, что обеспечивает его уродинамическую эффективность и&nbsp;высокую безопасность<sup>4</sup></p>\r\n</div>\r\n<div class=\"headerBlock__footer\">\r\n<p><strong>Показания к применению: </strong><br/>Лечение симптомов доброкачественной гиперплазии предстательной железы<sup>6</sup></p>\r\n</div>'),
(3022, 149, '_текст-1', 'field_62435c0c6f2a0'),
(3023, 149, 'изображение-1', '13'),
(3024, 149, '_изображение-1', 'field_62435c8b6f2a1'),
(3025, 149, 'фон-1', '17'),
(3026, 149, '_фон-1', 'field_62435db92ea96'),
(3027, 149, 'заголовок-2', 'Ключевые преимущества препарата Урорек'),
(3028, 149, '_заголовок-2', 'field_6243606295196'),
(3029, 149, 'список-2', 'Единственный оригинальный препарат из&nbsp;группы альфа1-адреноблокаторов, не&nbsp;имеющий генериков в&nbsp;РФ<sup>1</sup>'),
(3030, 149, '_список-2', 'field_6243608195197'),
(3031, 149, 'картинка_с_текстом_0_изображение', '31'),
(3032, 149, '_картинка_с_текстом_0_изображение', 'field_624363d095199'),
(3033, 149, 'картинка_с_текстом_0_описание', 'Обширная доказательная база собственных пострегистрационных клинических исследований<sup>2</sup>'),
(3034, 149, '_картинка_с_текстом_0_описание', 'field_624363e59519a'),
(3035, 149, 'картинка_с_текстом_1_изображение', '32'),
(3036, 149, '_картинка_с_текстом_1_изображение', 'field_624363d095199'),
(3037, 149, 'картинка_с_текстом_1_описание', 'Отсутствие риска замены препарата Урорек в&nbsp;аптеке (единственный препарат с&nbsp;действующим веществом силодозин)<sup>1</sup>'),
(3038, 149, '_картинка_с_текстом_1_описание', 'field_624363e59519a'),
(3039, 149, 'картинка_с_текстом_2_изображение', '33'),
(3040, 149, '_картинка_с_текстом_2_изображение', 'field_624363d095199'),
(3041, 149, 'картинка_с_текстом_2_описание', 'Большинство пациентов предпочитают принимать оригинальные препараты<sup>3</sup>'),
(3042, 149, '_картинка_с_текстом_2_описание', 'field_624363e59519a'),
(3043, 149, 'картинка_с_текстом', '3'),
(3044, 149, '_картинка_с_текстом', 'field_624363b995198'),
(3045, 149, 'второй_список', '<li>Клинические преимущества препарата Урорек (силодозин) определяются максимальной уроселективностью в&nbsp;классе альфа-адреноблокаторов<sup>4</sup></li>\r\n\r\n<li>Урорек&nbsp;&mdash; альфа-адреноблокатор последнего поколения, который эффективен в&nbsp;отношении всех СНМП (накопления, опорожнения, постмиктурических).<sup>12,13</sup> При этом Урорек обладает минимальным риском развития нежелательных явлений со&nbsp;стороны сердечно-сосудистой системы, в&nbsp;том числе&nbsp;у&nbsp;пациентов, принимающих антигипертензивные препараты<sup>46,8</sup> <small> <span>СНМП </span>симптомы нижних мочевыводящих путей</small></li>'),
(3046, 149, '_второй_список', 'field_6243640e05eda'),
(3047, 149, 'заголовок2-2', 'Максимальная уроселективность силодозина в&nbsp;классе альфа-адреноблокаторов обуславливает его уродинамическую эффективность и&nbsp;высокий профиль безопасности<sup>4</sup>'),
(3048, 149, '_заголовок2-2', 'field_6243644705edb'),
(3049, 149, 'текст3', '<ul>\r\n<li>Урорек значительно улучшает клинические проявления и&nbsp;качество жизни у&nbsp;всех пациентов с&nbsp;СНМП/ДГПЖ, в&nbsp;том числе с&nbsp;тяжелым течением<sup>11</sup><a href=\"#\">Узнать больше...</a></li>\r\n\r\n<li>Урорек является препаратом выбора для пациентов с&nbsp;СНМП/ДГПЖ и&nbsp;сопутствующими сердечно-сосудистыми заболеваниями<sup>3</sup> <a href=\"#\">Узнать больше...</a></li>\r\n</ul>\r\n<small> <span>ДГПЖ </span>доброкачественная гиперплазия предстательной железы</small>'),
(3050, 149, '_текст3', 'field_6243647405edc'),
(3051, 149, 'изображение-2', '34'),
(3052, 149, '_изображение-2', 'field_624364dd05edd'),
(3053, 149, 'текст_в_подвале', '<h2> Максимальная уроселективность в&nbsp;классе  альфа-адреноблокаторов<sup>4</sup></h2>\r\n<div class=\"h3\"> Почему это важно? <a href=\"#\">Подробнее</a></div>'),
(3054, 149, '_текст_в_подвале', 'field_62436daf1f6d9'),
(3055, 149, 'заголовок-3', 'Форма выпуска препарата Урорек'),
(3056, 149, '_заголовок-3', 'field_62436efee98e7'),
(3057, 149, 'текст-3', '<p class=\"section-descr\"><span>8мг </span>- рекомендуемая доза для лечения симптомов ДГПЖ<sup>6</sup>*</p>\r\n					<p class=\"section-note col-md-10\">*Более подробные сведения о&nbsp;препарате, особенностях применения, побочных действиях и&nbsp;др. &mdash;&nbsp;смотрите инструкцию по&nbsp;медицинскому применению лекарственного препарата Урорек, РУ&nbsp;ЛСР-005971/10 от&nbsp;25.06.2010 </p>'),
(3058, 149, '_текст-3', 'field_62436f60e98e8'),
(3059, 149, 'товар_0_название', 'Урорек 8мг №30'),
(3060, 149, '_товар_0_название', 'field_62436fcce98ea'),
(3061, 149, 'товар_0_описание', 'Упаковка, рассчитанная на&nbsp;1&nbsp;месяц лечения&nbsp;/ для старта терапии'),
(3062, 149, '_товар_0_описание', 'field_62436fe1e98eb'),
(3063, 149, 'товар_0_лицензия', 'РУ: ЛСР-005971/10 от 25.06.2010'),
(3064, 149, '_товар_0_лицензия', 'field_62436ff0e98ec'),
(3065, 149, 'товар_0_изображение', '51'),
(3066, 149, '_товар_0_изображение', 'field_62437045e98ed'),
(3067, 149, 'товар_1_название', 'Урорек 8мг №90'),
(3068, 149, '_товар_1_название', 'field_62436fcce98ea'),
(3069, 149, 'товар_1_описание', 'Выгодная упаковка, рассчитанная на&nbsp;3&nbsp;месяца лечения. Самая доступная стоимость 1&nbsp;дня терапии препаратом Урорек&nbsp;<sup>27</sup>'),
(3070, 149, '_товар_1_описание', 'field_62436fe1e98eb'),
(3071, 149, 'товар_1_лицензия', 'РУ: ЛСР-005971/10 от 25.06.2010'),
(3072, 149, '_товар_1_лицензия', 'field_62436ff0e98ec'),
(3073, 149, 'товар_1_изображение', '53'),
(3074, 149, '_товар_1_изображение', 'field_62437045e98ed'),
(3075, 149, 'товар_2_название', 'Урорек 4мг №30'),
(3076, 149, '_товар_2_название', 'field_62436fcce98ea'),
(3077, 149, 'товар_2_описание', '4&nbsp;мг&nbsp;&mdash; стартовая упаковка для лечения симптомов ДГПЖ у&nbsp;пациентов с&nbsp;почечной недостаточностью средней степени тяжести<sup>6</sup>'),
(3078, 149, '_товар_2_описание', 'field_62436fe1e98eb'),
(3079, 149, 'товар_2_лицензия', 'РУ: ЛСР-005971/10 от 25.06.2010'),
(3080, 149, '_товар_2_лицензия', 'field_62436ff0e98ec'),
(3081, 149, 'товар_2_изображение', '52'),
(3082, 149, '_товар_2_изображение', 'field_62437045e98ed'),
(3083, 149, 'товар', '3'),
(3084, 149, '_товар', 'field_62436fbde98e9'),
(3085, 149, 'заголовок-4', 'Где купить'),
(3086, 149, '_заголовок-4', 'field_624374f73d8bd'),
(3087, 149, 'изображения', 'a:12:{i:0;s:2:\"63\";i:1;s:2:\"64\";i:2;s:2:\"65\";i:3;s:2:\"66\";i:4;s:2:\"67\";i:5;s:2:\"68\";i:6;s:2:\"69\";i:7;s:2:\"70\";i:8;s:2:\"71\";i:9;s:2:\"72\";i:10;s:2:\"73\";i:11;s:2:\"74\";}'),
(3088, 149, '_изображения', 'field_624375093d8be'),
(3089, 149, 'изображения-4', 'a:12:{i:0;s:2:\"63\";i:1;s:2:\"64\";i:2;s:2:\"65\";i:3;s:2:\"66\";i:4;s:2:\"67\";i:5;s:2:\"68\";i:6;s:2:\"69\";i:7;s:2:\"70\";i:8;s:2:\"71\";i:9;s:2:\"72\";i:10;s:2:\"73\";i:11;s:2:\"74\";}'),
(3090, 149, '_изображения-4', 'field_624375093d8be'),
(3091, 149, 'заголовок-5', 'Способ применения*<sup>6</sup>'),
(3092, 149, '_заголовок-5', 'field_624379bd4756d'),
(3093, 149, 'иконки', 'a:5:{i:0;s:2:\"83\";i:1;s:2:\"84\";i:2;s:2:\"85\";i:3;s:2:\"86\";i:4;s:2:\"87\";}'),
(3094, 149, '_иконки', 'field_624379f24756e'),
(3095, 149, 'текст-5', 'У пациентов с легкой почечной недостаточностью (клиренс креатинина ≥ 50 — ≤ 80 мл/мин) коррекция дозы не требуется. Для лечения пациентов с почечной недостаточностью средней степени тяжести (клиренс креатинина ≥ 30 — < 50 мл/мин) рекомендуется в течение первой недели принимать начальную дозу по 4 мг в сутки, при хорошей индивидуальной переносимости доза может быть увеличена до 8 мг в сутки. Применение препарата для пациентов с тяжелой почечной недостаточностью (клиренс креатинина < 30 мл / мин) не рекомендуется'),
(3096, 149, '_текст-5', 'field_62437a374756f'),
(3097, 149, 'текст_под_кнопкой', '*Более подробные сведения о&nbsp;препарате, особенностях применения, побочных действиях и&nbsp;др. &mdash;&nbsp;см. инструкцию по&nbsp;медицинскому применению лекарственного препарата Урорек, РУ&nbsp;ЛСР-005971/10 от&nbsp;25.06.2010'),
(3098, 149, '_текст_под_кнопкой', 'field_62437a7c47570'),
(3099, 149, 'заголовок-6', 'Препарат Урорек (силодозин) включен в&nbsp;российские и&nbsp;международные клинические рекомендации и&nbsp;стандарты для лечения ряда урологических заболеваний:'),
(3100, 149, '_заголовок-6', 'field_6244117c68bd0'),
(3101, 149, 'список-6_0_ссылка', 'a:3:{s:5:\"title\";s:68:\"Российские клинические рекомендации\";s:3:\"url\";s:1:\"#\";s:6:\"target\";s:0:\"\";}'),
(3102, 149, '_список-6_0_ссылка', 'field_624411ce68bd2'),
(3103, 149, 'список-6_0_описание', '«Доброкачественная гиперплазия предстательной железы», 2020<sup>28</sup>'),
(3104, 149, '_список-6_0_описание', 'field_6244121168bd3'),
(3105, 149, 'список-6_1_ссылка', 'a:3:{s:5:\"title\";s:70:\"Европейские клинические рекомендации\";s:3:\"url\";s:1:\"#\";s:6:\"target\";s:0:\"\";}'),
(3106, 149, '_список-6_1_ссылка', 'field_624411ce68bd2'),
(3107, 149, 'список-6_1_описание', 'глава «Консервативное лечение ненейрогенных симптомов нарушенного мочеиспускания у мужчин, включая доброкачественную простатическую обструкцию», 2021<sup>29</sup>'),
(3108, 149, '_список-6_1_описание', 'field_6244121168bd3'),
(3109, 149, 'список-6_2_ссылка', 'a:3:{s:5:\"title\";s:154:\"Стандарт первичной медико-санитарной помощи при гиперплазии предстательной железы\";s:3:\"url\";s:1:\"#\";s:6:\"target\";s:0:\"\";}'),
(3110, 149, '_список-6_2_ссылка', 'field_624411ce68bd2'),
(3111, 149, 'список-6_2_описание', '09.11.2012<sup>30</sup> / Обновлён 13.04.2015\r\n'),
(3112, 149, '_список-6_2_описание', 'field_6244121168bd3'),
(3113, 149, 'список-6_3_ссылка', 'a:3:{s:5:\"title\";s:122:\"Стандарт специализированной медицинской помощи при задержке мочи\";s:3:\"url\";s:1:\"#\";s:6:\"target\";s:0:\"\";}'),
(3114, 149, '_список-6_3_ссылка', 'field_624411ce68bd2'),
(3115, 149, 'список-6_3_описание', '29.01.2013<sup>31</sup> / Обновлён 06.05.2015\r\n'),
(3116, 149, '_список-6_3_описание', 'field_6244121168bd3'),
(3117, 149, 'список-6_4_ссылка', 'a:3:{s:5:\"title\";s:133:\"Стандарт первичной медико-санитарной помощи при хроническом простатите\";s:3:\"url\";s:1:\"#\";s:6:\"target\";s:0:\"\";}'),
(3118, 149, '_список-6_4_ссылка', 'field_624411ce68bd2'),
(3119, 149, 'список-6_4_описание', '09.11.2012<sup>32</sup> / Обновлён 13.04.2015\r\n'),
(3120, 149, '_список-6_4_описание', 'field_6244121168bd3'),
(3121, 149, 'список-6_5_ссылка', 'a:3:{s:5:\"title\";s:168:\"Стандарт специализированной медицинской помощи при остром простатите, орхите, эпидидимите\";s:3:\"url\";s:1:\"#\";s:6:\"target\";s:0:\"\";}'),
(3122, 149, '_список-6_5_ссылка', 'field_624411ce68bd2'),
(3123, 149, 'список-6_5_описание', '09.11.2012<sup>33</sup> / Обновлён 27.05.2015'),
(3124, 149, '_список-6_5_описание', 'field_6244121168bd3'),
(3125, 149, 'список-6', '6'),
(3126, 149, '_список-6', 'field_624411be68bd1'),
(3127, 149, 'заголовок-7', 'Препарат Урорек (силодозин) зарегистрирован и&nbsp;применяется в&nbsp;разных странах мира Одобрен ЕМА*<sup>34</sup> и&nbsp;FDA**<sup>35</sup>'),
(3128, 149, '_заголовок-7', 'field_624417e3b6088'),
(3129, 149, 'текст', '<p class=\"sOtherCountries__agency\"><span>EMA</span> Европейское медицинское агентство</p>\r\n<p class=\"sOtherCountries__agency\"><span>FDA</span> Управление по&nbsp;санитарному надзору за&nbsp;качеством пищевых продуктов и&nbsp;медикаментов, США</p>'),
(3130, 149, '_текст', 'field_6244182bb6089'),
(3131, 149, 'страны_0_флаг', '105'),
(3132, 149, '_страны_0_флаг', 'field_62441880b608b'),
(3133, 149, 'страны_0_название', 'Япония'),
(3134, 149, '_страны_0_название', 'field_62441899b608c'),
(3135, 149, 'страны_0_год', '2006<sup>36,37</sup>'),
(3136, 149, '_страны_0_год', 'field_624418aab608d'),
(3137, 149, 'страны_1_флаг', '106'),
(3138, 149, '_страны_1_флаг', 'field_62441880b608b'),
(3139, 149, 'страны_1_название', 'США'),
(3140, 149, '_страны_1_название', 'field_62441899b608c'),
(3141, 149, 'страны_1_год', '2008<sup>35</sup>'),
(3142, 149, '_страны_1_год', 'field_624418aab608d'),
(3143, 149, 'страны_2_флаг', '107'),
(3144, 149, '_страны_2_флаг', 'field_62441880b608b'),
(3145, 149, 'страны_2_название', 'Страны ЕС'),
(3146, 149, '_страны_2_название', 'field_62441899b608c'),
(3147, 149, 'страны_2_год', '2010<sup>34</sup>'),
(3148, 149, '_страны_2_год', 'field_624418aab608d'),
(3149, 149, 'страны_3_флаг', '108'),
(3150, 149, '_страны_3_флаг', 'field_62441880b608b'),
(3151, 149, 'страны_3_название', 'Россия'),
(3152, 149, '_страны_3_название', 'field_62441899b608c'),
(3153, 149, 'страны_3_год', '2010<sup>1</sup>'),
(3154, 149, '_страны_3_год', 'field_624418aab608d'),
(3155, 149, 'страны', '4'),
(3156, 149, '_страны', 'field_62441847b608a'),
(3157, 149, 'текст-7', '<p class=\"sOtherCountries__agency\"><span>EMA</span> Европейское медицинское агентство</p>\r\n<p class=\"sOtherCountries__agency\"><span>FDA</span> Управление по&nbsp;санитарному надзору за&nbsp;качеством пищевых продуктов и&nbsp;медикаментов, США</p>'),
(3158, 149, '_текст-7', 'field_6244182bb6089'),
(3159, 149, 'текст-7-1', 'Производство препарата Урорек, поставляемого в&nbsp;Россию, осуществляется в&nbsp;Италии с&nbsp;использованием субстанции из&nbsp;Японии, в&nbsp;соответствии с&nbsp;необходимыми требованиями к&nbsp;производству и&nbsp;контролю качества<sup>6,1</sup>'),
(3160, 149, '_текст-7-1', 'field_62441a5acf03c'),
(3161, 149, 'заголовок-8', 'О проблеме'),
(3162, 149, '_заголовок-8', 'field_624431d91624d'),
(3163, 149, 'текст-8', 'Доброкачественная гиперплазия предстательной железы (ДГПЖ), или как ее еще называют, аденома простаты, как правило, возникает у мужчин старше 50 лет и характеризуется наличием симптомов нижних мочевыводящих путей (СНМП), увеличением предстательной железы или ее части, и нарушением оттока мочи из мочевого пузыря вследствие инфравезикальной обструкции.<sup>38</sup>\r\n\r\nРаспространенность ДГПЖ увеличивается с возрастом. Так, клинически значимая ДГПЖ проявляется у 13% мужчин в возрасте старше 50 лет, у 34% мужчин в возрасте 60 лет и у 43% в возрасте 70 лет.<sup>39</sup>\r\n\r\n&nbsp;\r\n\r\n[caption id=\"attachment_122\" align=\"alignnone\" width=\"594\"]<img class=\"wp-image-122 size-full\" src=\"http://0026urotec.loc:8888/wp-content/uploads/2022/03/about-img.png\" alt=\"мужик\" width=\"594\" height=\"696\" /> Федя[/caption]'),
(3164, 149, '_текст-8', 'field_624431f11624e'),
(3165, 149, 'текст-8-1', 'Наличие СНМП может быть ассоциировано с&nbsp;тяжелыми хроническими заболеваниями, такими как заболевания сердца, сахарный диабет, артериальная гипертензия и&nbsp;депрессия<sup>40</sup>'),
(3166, 149, '_текст-8-1', 'field_6244320b26db3'),
(3167, 149, 'иконки-8', 'a:6:{i:0;s:3:\"123\";i:1;s:3:\"124\";i:2;s:3:\"125\";i:3;s:3:\"126\";i:4;s:3:\"127\";i:5;s:3:\"128\";}'),
(3168, 149, '_иконки-8', 'field_6244322d26db4'),
(3169, 149, 'текст-8-2', '<h3>Симптомы доброкачественной гиперплазии предстательной железы</h3>\r\nСимптомы нарушенного мочеиспускания являются частой жалобой у взрослых мужчин. Они оказывают серьезное негативное влияние на качество жизни. При ДГПЖ предстательная железа увеличивается в размерах, оказывая давление на нижние мочевые пути. В результате развиваются следующие симптомы:<sup>41</sup>'),
(3170, 149, '_текст-8-2', 'field_6244335fe2373'),
(3171, 149, 'заголовок-9', 'Осложнения ДГПЖ<sup>38</sup>'),
(3172, 149, '_заголовок-9', 'field_6244377a52263'),
(3173, 149, 'изображения-9', 'a:6:{i:0;s:3:\"141\";i:1;s:3:\"142\";i:2;s:3:\"143\";i:3;s:3:\"144\";i:4;s:3:\"145\";i:5;s:3:\"146\";}'),
(3174, 149, '_изображения-9', 'field_6244379652264'),
(3175, 150, '_edit_last', '1'),
(3176, 150, '_edit_lock', '1648642720:1'),
(3177, 2, 'заголовок-10', 'Медикаментозное лечение СНМП/ДГПЖ'),
(3178, 2, '_заголовок-10', 'field_6244489614262'),
(3179, 2, 'текст-10', 'Антагонисты альфа1-адренорецепторов (альфа-адреноблокаторы) и&nbsp;ингибиторы 5&nbsp;альфа1-редуктазы (ингибиторы 5-АР) являются группами лекарственных препаратов, которые в&nbsp;настоящее время утверждены для лечения ДГПЖ. Обе группы препаратов обеспечивают надлежащее ослабление симптомов, но&nbsp;&alpha;&mdash;блокаторы обладают довольно быстрым началом действия, а&nbsp;ингибиторам 5-АР требуется несколько месяцев для получения терапевтического эффекта.<sup>42</sup>'),
(3180, 2, '_текст-10', 'field_624448ce14263'),
(3181, 2, 'карточки-10_0_заголовок', 'Альфа-адреноблокаторы'),
(3182, 2, '_карточки-10_0_заголовок', 'field_624448fc14265'),
(3183, 2, 'карточки-10_0_текст', 'представляют собой наиболее эффективный класс лекарственных препаратов, характеризующийся хорошим профилем безопасности и высокой комплаентностью, применяющийся для облегчения СНМП, связанных с ДГПЖ: они снимают спазм гладкой мускулатуры предстательной железы и шейки мочевого пузыря<sup>42</sup>'),
(3184, 2, '_карточки-10_0_текст', 'field_6244490c14266'),
(3185, 2, 'карточки-10_1_заголовок', 'Ингибиторы 5-АР'),
(3186, 2, '_карточки-10_1_заголовок', 'field_624448fc14265'),
(3187, 2, 'карточки-10_1_текст', 'приводят к редукции железистой ткани и к снижению размера предстательной железы: они блокируют конверсию тестостерона в дигидротестостерон, который стимулирует рост предстательной железы<sup>43,44</sup>.Назначаются при большом объеме предстательной железы. Для получения значимого клинического эффекта требуется несколько месяцев применения<sup>45</sup>\r\n'),
(3188, 2, '_карточки-10_1_текст', 'field_6244490c14266'),
(3189, 2, 'карточки-10', '2'),
(3190, 2, '_карточки-10', 'field_624448e214264'),
(3191, 2, 'видео', '<iframe width=\"560\" height=\"315\" src=\"https://www.youtube.com/embed/3DrU3pFXSsY\" title=\"YouTube video player\" frameborder=\"0\" allow=\"accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture\" allowfullscreen></iframe>'),
(3192, 2, '_видео', 'field_6244492214267'),
(3193, 157, 'заголовок-1', 'УРОРЕК – оригинальный<sup>10</sup> альфа-адреноблокатор'),
(3194, 157, '_заголовок-1', 'field_62435bd26f29f'),
(3195, 157, 'текст-1', '<div class=\"headerBlock__body\">\r\n<p>Силодозин (действующее вещество препарата Урорек) обладает максимальной уроселективностью в&nbsp;своем классе, что обеспечивает его уродинамическую эффективность и&nbsp;высокую безопасность<sup>4</sup></p>\r\n</div>\r\n<div class=\"headerBlock__footer\">\r\n<p><strong>Показания к применению: </strong><br/>Лечение симптомов доброкачественной гиперплазии предстательной железы<sup>6</sup></p>\r\n</div>'),
(3196, 157, '_текст-1', 'field_62435c0c6f2a0'),
(3197, 157, 'изображение-1', '13'),
(3198, 157, '_изображение-1', 'field_62435c8b6f2a1'),
(3199, 157, 'фон-1', '17'),
(3200, 157, '_фон-1', 'field_62435db92ea96'),
(3201, 157, 'заголовок-2', 'Ключевые преимущества препарата Урорек'),
(3202, 157, '_заголовок-2', 'field_6243606295196'),
(3203, 157, 'список-2', 'Единственный оригинальный препарат из&nbsp;группы альфа1-адреноблокаторов, не&nbsp;имеющий генериков в&nbsp;РФ<sup>1</sup>'),
(3204, 157, '_список-2', 'field_6243608195197'),
(3205, 157, 'картинка_с_текстом_0_изображение', '31'),
(3206, 157, '_картинка_с_текстом_0_изображение', 'field_624363d095199'),
(3207, 157, 'картинка_с_текстом_0_описание', 'Обширная доказательная база собственных пострегистрационных клинических исследований<sup>2</sup>'),
(3208, 157, '_картинка_с_текстом_0_описание', 'field_624363e59519a'),
(3209, 157, 'картинка_с_текстом_1_изображение', '32'),
(3210, 157, '_картинка_с_текстом_1_изображение', 'field_624363d095199'),
(3211, 157, 'картинка_с_текстом_1_описание', 'Отсутствие риска замены препарата Урорек в&nbsp;аптеке (единственный препарат с&nbsp;действующим веществом силодозин)<sup>1</sup>'),
(3212, 157, '_картинка_с_текстом_1_описание', 'field_624363e59519a'),
(3213, 157, 'картинка_с_текстом_2_изображение', '33'),
(3214, 157, '_картинка_с_текстом_2_изображение', 'field_624363d095199'),
(3215, 157, 'картинка_с_текстом_2_описание', 'Большинство пациентов предпочитают принимать оригинальные препараты<sup>3</sup>'),
(3216, 157, '_картинка_с_текстом_2_описание', 'field_624363e59519a'),
(3217, 157, 'картинка_с_текстом', '3'),
(3218, 157, '_картинка_с_текстом', 'field_624363b995198'),
(3219, 157, 'второй_список', '<li>Клинические преимущества препарата Урорек (силодозин) определяются максимальной уроселективностью в&nbsp;классе альфа-адреноблокаторов<sup>4</sup></li>\r\n\r\n<li>Урорек&nbsp;&mdash; альфа-адреноблокатор последнего поколения, который эффективен в&nbsp;отношении всех СНМП (накопления, опорожнения, постмиктурических).<sup>12,13</sup> При этом Урорек обладает минимальным риском развития нежелательных явлений со&nbsp;стороны сердечно-сосудистой системы, в&nbsp;том числе&nbsp;у&nbsp;пациентов, принимающих антигипертензивные препараты<sup>46,8</sup> <small> <span>СНМП </span>симптомы нижних мочевыводящих путей</small></li>'),
(3220, 157, '_второй_список', 'field_6243640e05eda'),
(3221, 157, 'заголовок2-2', 'Максимальная уроселективность силодозина в&nbsp;классе альфа-адреноблокаторов обуславливает его уродинамическую эффективность и&nbsp;высокий профиль безопасности<sup>4</sup>'),
(3222, 157, '_заголовок2-2', 'field_6243644705edb'),
(3223, 157, 'текст3', '<ul>\r\n<li>Урорек значительно улучшает клинические проявления и&nbsp;качество жизни у&nbsp;всех пациентов с&nbsp;СНМП/ДГПЖ, в&nbsp;том числе с&nbsp;тяжелым течением<sup>11</sup><a href=\"#\">Узнать больше...</a></li>\r\n\r\n<li>Урорек является препаратом выбора для пациентов с&nbsp;СНМП/ДГПЖ и&nbsp;сопутствующими сердечно-сосудистыми заболеваниями<sup>3</sup> <a href=\"#\">Узнать больше...</a></li>\r\n</ul>\r\n<small> <span>ДГПЖ </span>доброкачественная гиперплазия предстательной железы</small>'),
(3224, 157, '_текст3', 'field_6243647405edc'),
(3225, 157, 'изображение-2', '34'),
(3226, 157, '_изображение-2', 'field_624364dd05edd'),
(3227, 157, 'текст_в_подвале', '<h2> Максимальная уроселективность в&nbsp;классе  альфа-адреноблокаторов<sup>4</sup></h2>\r\n<div class=\"h3\"> Почему это важно? <a href=\"#\">Подробнее</a></div>'),
(3228, 157, '_текст_в_подвале', 'field_62436daf1f6d9'),
(3229, 157, 'заголовок-3', 'Форма выпуска препарата Урорек'),
(3230, 157, '_заголовок-3', 'field_62436efee98e7'),
(3231, 157, 'текст-3', '<p class=\"section-descr\"><span>8мг </span>- рекомендуемая доза для лечения симптомов ДГПЖ<sup>6</sup>*</p>\r\n					<p class=\"section-note col-md-10\">*Более подробные сведения о&nbsp;препарате, особенностях применения, побочных действиях и&nbsp;др. &mdash;&nbsp;смотрите инструкцию по&nbsp;медицинскому применению лекарственного препарата Урорек, РУ&nbsp;ЛСР-005971/10 от&nbsp;25.06.2010 </p>'),
(3232, 157, '_текст-3', 'field_62436f60e98e8'),
(3233, 157, 'товар_0_название', 'Урорек 8мг №30'),
(3234, 157, '_товар_0_название', 'field_62436fcce98ea'),
(3235, 157, 'товар_0_описание', 'Упаковка, рассчитанная на&nbsp;1&nbsp;месяц лечения&nbsp;/ для старта терапии'),
(3236, 157, '_товар_0_описание', 'field_62436fe1e98eb'),
(3237, 157, 'товар_0_лицензия', 'РУ: ЛСР-005971/10 от 25.06.2010'),
(3238, 157, '_товар_0_лицензия', 'field_62436ff0e98ec'),
(3239, 157, 'товар_0_изображение', '51'),
(3240, 157, '_товар_0_изображение', 'field_62437045e98ed'),
(3241, 157, 'товар_1_название', 'Урорек 8мг №90'),
(3242, 157, '_товар_1_название', 'field_62436fcce98ea'),
(3243, 157, 'товар_1_описание', 'Выгодная упаковка, рассчитанная на&nbsp;3&nbsp;месяца лечения. Самая доступная стоимость 1&nbsp;дня терапии препаратом Урорек&nbsp;<sup>27</sup>'),
(3244, 157, '_товар_1_описание', 'field_62436fe1e98eb'),
(3245, 157, 'товар_1_лицензия', 'РУ: ЛСР-005971/10 от 25.06.2010'),
(3246, 157, '_товар_1_лицензия', 'field_62436ff0e98ec'),
(3247, 157, 'товар_1_изображение', '53'),
(3248, 157, '_товар_1_изображение', 'field_62437045e98ed'),
(3249, 157, 'товар_2_название', 'Урорек 4мг №30'),
(3250, 157, '_товар_2_название', 'field_62436fcce98ea'),
(3251, 157, 'товар_2_описание', '4&nbsp;мг&nbsp;&mdash; стартовая упаковка для лечения симптомов ДГПЖ у&nbsp;пациентов с&nbsp;почечной недостаточностью средней степени тяжести<sup>6</sup>'),
(3252, 157, '_товар_2_описание', 'field_62436fe1e98eb'),
(3253, 157, 'товар_2_лицензия', 'РУ: ЛСР-005971/10 от 25.06.2010'),
(3254, 157, '_товар_2_лицензия', 'field_62436ff0e98ec'),
(3255, 157, 'товар_2_изображение', '52'),
(3256, 157, '_товар_2_изображение', 'field_62437045e98ed'),
(3257, 157, 'товар', '3'),
(3258, 157, '_товар', 'field_62436fbde98e9'),
(3259, 157, 'заголовок-4', 'Где купить'),
(3260, 157, '_заголовок-4', 'field_624374f73d8bd'),
(3261, 157, 'изображения', 'a:12:{i:0;s:2:\"63\";i:1;s:2:\"64\";i:2;s:2:\"65\";i:3;s:2:\"66\";i:4;s:2:\"67\";i:5;s:2:\"68\";i:6;s:2:\"69\";i:7;s:2:\"70\";i:8;s:2:\"71\";i:9;s:2:\"72\";i:10;s:2:\"73\";i:11;s:2:\"74\";}'),
(3262, 157, '_изображения', 'field_624375093d8be'),
(3263, 157, 'изображения-4', 'a:12:{i:0;s:2:\"63\";i:1;s:2:\"64\";i:2;s:2:\"65\";i:3;s:2:\"66\";i:4;s:2:\"67\";i:5;s:2:\"68\";i:6;s:2:\"69\";i:7;s:2:\"70\";i:8;s:2:\"71\";i:9;s:2:\"72\";i:10;s:2:\"73\";i:11;s:2:\"74\";}'),
(3264, 157, '_изображения-4', 'field_624375093d8be'),
(3265, 157, 'заголовок-5', 'Способ применения*<sup>6</sup>'),
(3266, 157, '_заголовок-5', 'field_624379bd4756d'),
(3267, 157, 'иконки', 'a:5:{i:0;s:2:\"83\";i:1;s:2:\"84\";i:2;s:2:\"85\";i:3;s:2:\"86\";i:4;s:2:\"87\";}'),
(3268, 157, '_иконки', 'field_624379f24756e'),
(3269, 157, 'текст-5', 'У пациентов с легкой почечной недостаточностью (клиренс креатинина ≥ 50 — ≤ 80 мл/мин) коррекция дозы не требуется. Для лечения пациентов с почечной недостаточностью средней степени тяжести (клиренс креатинина ≥ 30 — < 50 мл/мин) рекомендуется в течение первой недели принимать начальную дозу по 4 мг в сутки, при хорошей индивидуальной переносимости доза может быть увеличена до 8 мг в сутки. Применение препарата для пациентов с тяжелой почечной недостаточностью (клиренс креатинина < 30 мл / мин) не рекомендуется'),
(3270, 157, '_текст-5', 'field_62437a374756f'),
(3271, 157, 'текст_под_кнопкой', '*Более подробные сведения о&nbsp;препарате, особенностях применения, побочных действиях и&nbsp;др. &mdash;&nbsp;см. инструкцию по&nbsp;медицинскому применению лекарственного препарата Урорек, РУ&nbsp;ЛСР-005971/10 от&nbsp;25.06.2010'),
(3272, 157, '_текст_под_кнопкой', 'field_62437a7c47570'),
(3273, 157, 'заголовок-6', 'Препарат Урорек (силодозин) включен в&nbsp;российские и&nbsp;международные клинические рекомендации и&nbsp;стандарты для лечения ряда урологических заболеваний:'),
(3274, 157, '_заголовок-6', 'field_6244117c68bd0'),
(3275, 157, 'список-6_0_ссылка', 'a:3:{s:5:\"title\";s:68:\"Российские клинические рекомендации\";s:3:\"url\";s:1:\"#\";s:6:\"target\";s:0:\"\";}'),
(3276, 157, '_список-6_0_ссылка', 'field_624411ce68bd2'),
(3277, 157, 'список-6_0_описание', '«Доброкачественная гиперплазия предстательной железы», 2020<sup>28</sup>'),
(3278, 157, '_список-6_0_описание', 'field_6244121168bd3'),
(3279, 157, 'список-6_1_ссылка', 'a:3:{s:5:\"title\";s:70:\"Европейские клинические рекомендации\";s:3:\"url\";s:1:\"#\";s:6:\"target\";s:0:\"\";}'),
(3280, 157, '_список-6_1_ссылка', 'field_624411ce68bd2'),
(3281, 157, 'список-6_1_описание', 'глава «Консервативное лечение ненейрогенных симптомов нарушенного мочеиспускания у мужчин, включая доброкачественную простатическую обструкцию», 2021<sup>29</sup>'),
(3282, 157, '_список-6_1_описание', 'field_6244121168bd3'),
(3283, 157, 'список-6_2_ссылка', 'a:3:{s:5:\"title\";s:154:\"Стандарт первичной медико-санитарной помощи при гиперплазии предстательной железы\";s:3:\"url\";s:1:\"#\";s:6:\"target\";s:0:\"\";}'),
(3284, 157, '_список-6_2_ссылка', 'field_624411ce68bd2'),
(3285, 157, 'список-6_2_описание', '09.11.2012<sup>30</sup> / Обновлён 13.04.2015\r\n'),
(3286, 157, '_список-6_2_описание', 'field_6244121168bd3'),
(3287, 157, 'список-6_3_ссылка', 'a:3:{s:5:\"title\";s:122:\"Стандарт специализированной медицинской помощи при задержке мочи\";s:3:\"url\";s:1:\"#\";s:6:\"target\";s:0:\"\";}'),
(3288, 157, '_список-6_3_ссылка', 'field_624411ce68bd2'),
(3289, 157, 'список-6_3_описание', '29.01.2013<sup>31</sup> / Обновлён 06.05.2015\r\n'),
(3290, 157, '_список-6_3_описание', 'field_6244121168bd3'),
(3291, 157, 'список-6_4_ссылка', 'a:3:{s:5:\"title\";s:133:\"Стандарт первичной медико-санитарной помощи при хроническом простатите\";s:3:\"url\";s:1:\"#\";s:6:\"target\";s:0:\"\";}'),
(3292, 157, '_список-6_4_ссылка', 'field_624411ce68bd2'),
(3293, 157, 'список-6_4_описание', '09.11.2012<sup>32</sup> / Обновлён 13.04.2015\r\n'),
(3294, 157, '_список-6_4_описание', 'field_6244121168bd3'),
(3295, 157, 'список-6_5_ссылка', 'a:3:{s:5:\"title\";s:168:\"Стандарт специализированной медицинской помощи при остром простатите, орхите, эпидидимите\";s:3:\"url\";s:1:\"#\";s:6:\"target\";s:0:\"\";}'),
(3296, 157, '_список-6_5_ссылка', 'field_624411ce68bd2'),
(3297, 157, 'список-6_5_описание', '09.11.2012<sup>33</sup> / Обновлён 27.05.2015'),
(3298, 157, '_список-6_5_описание', 'field_6244121168bd3'),
(3299, 157, 'список-6', '6'),
(3300, 157, '_список-6', 'field_624411be68bd1'),
(3301, 157, 'заголовок-7', 'Препарат Урорек (силодозин) зарегистрирован и&nbsp;применяется в&nbsp;разных странах мира Одобрен ЕМА*<sup>34</sup> и&nbsp;FDA**<sup>35</sup>'),
(3302, 157, '_заголовок-7', 'field_624417e3b6088'),
(3303, 157, 'текст', '<p class=\"sOtherCountries__agency\"><span>EMA</span> Европейское медицинское агентство</p>\r\n<p class=\"sOtherCountries__agency\"><span>FDA</span> Управление по&nbsp;санитарному надзору за&nbsp;качеством пищевых продуктов и&nbsp;медикаментов, США</p>'),
(3304, 157, '_текст', 'field_6244182bb6089'),
(3305, 157, 'страны_0_флаг', '105'),
(3306, 157, '_страны_0_флаг', 'field_62441880b608b'),
(3307, 157, 'страны_0_название', 'Япония'),
(3308, 157, '_страны_0_название', 'field_62441899b608c'),
(3309, 157, 'страны_0_год', '2006<sup>36,37</sup>'),
(3310, 157, '_страны_0_год', 'field_624418aab608d'),
(3311, 157, 'страны_1_флаг', '106'),
(3312, 157, '_страны_1_флаг', 'field_62441880b608b'),
(3313, 157, 'страны_1_название', 'США'),
(3314, 157, '_страны_1_название', 'field_62441899b608c'),
(3315, 157, 'страны_1_год', '2008<sup>35</sup>'),
(3316, 157, '_страны_1_год', 'field_624418aab608d'),
(3317, 157, 'страны_2_флаг', '107'),
(3318, 157, '_страны_2_флаг', 'field_62441880b608b'),
(3319, 157, 'страны_2_название', 'Страны ЕС'),
(3320, 157, '_страны_2_название', 'field_62441899b608c'),
(3321, 157, 'страны_2_год', '2010<sup>34</sup>'),
(3322, 157, '_страны_2_год', 'field_624418aab608d'),
(3323, 157, 'страны_3_флаг', '108'),
(3324, 157, '_страны_3_флаг', 'field_62441880b608b'),
(3325, 157, 'страны_3_название', 'Россия'),
(3326, 157, '_страны_3_название', 'field_62441899b608c'),
(3327, 157, 'страны_3_год', '2010<sup>1</sup>'),
(3328, 157, '_страны_3_год', 'field_624418aab608d'),
(3329, 157, 'страны', '4'),
(3330, 157, '_страны', 'field_62441847b608a'),
(3331, 157, 'текст-7', '<p class=\"sOtherCountries__agency\"><span>EMA</span> Европейское медицинское агентство</p>\r\n<p class=\"sOtherCountries__agency\"><span>FDA</span> Управление по&nbsp;санитарному надзору за&nbsp;качеством пищевых продуктов и&nbsp;медикаментов, США</p>'),
(3332, 157, '_текст-7', 'field_6244182bb6089'),
(3333, 157, 'текст-7-1', 'Производство препарата Урорек, поставляемого в&nbsp;Россию, осуществляется в&nbsp;Италии с&nbsp;использованием субстанции из&nbsp;Японии, в&nbsp;соответствии с&nbsp;необходимыми требованиями к&nbsp;производству и&nbsp;контролю качества<sup>6,1</sup>'),
(3334, 157, '_текст-7-1', 'field_62441a5acf03c'),
(3335, 157, 'заголовок-8', 'О проблеме'),
(3336, 157, '_заголовок-8', 'field_624431d91624d'),
(3337, 157, 'текст-8', 'Доброкачественная гиперплазия предстательной железы (ДГПЖ), или как ее еще называют, аденома простаты, как правило, возникает у мужчин старше 50 лет и характеризуется наличием симптомов нижних мочевыводящих путей (СНМП), увеличением предстательной железы или ее части, и нарушением оттока мочи из мочевого пузыря вследствие инфравезикальной обструкции.<sup>38</sup>\r\n\r\nРаспространенность ДГПЖ увеличивается с возрастом. Так, клинически значимая ДГПЖ проявляется у 13% мужчин в возрасте старше 50 лет, у 34% мужчин в возрасте 60 лет и у 43% в возрасте 70 лет.<sup>39</sup>\r\n\r\n&nbsp;\r\n\r\n[caption id=\"attachment_122\" align=\"alignnone\" width=\"594\"]<img class=\"wp-image-122 size-full\" src=\"http://0026urotec.loc:8888/wp-content/uploads/2022/03/about-img.png\" alt=\"мужик\" width=\"594\" height=\"696\" /> Федя[/caption]'),
(3338, 157, '_текст-8', 'field_624431f11624e'),
(3339, 157, 'текст-8-1', 'Наличие СНМП может быть ассоциировано с&nbsp;тяжелыми хроническими заболеваниями, такими как заболевания сердца, сахарный диабет, артериальная гипертензия и&nbsp;депрессия<sup>40</sup>'),
(3340, 157, '_текст-8-1', 'field_6244320b26db3'),
(3341, 157, 'иконки-8', 'a:6:{i:0;s:3:\"123\";i:1;s:3:\"124\";i:2;s:3:\"125\";i:3;s:3:\"126\";i:4;s:3:\"127\";i:5;s:3:\"128\";}'),
(3342, 157, '_иконки-8', 'field_6244322d26db4'),
(3343, 157, 'текст-8-2', '<h3>Симптомы доброкачественной гиперплазии предстательной железы</h3>\r\nСимптомы нарушенного мочеиспускания являются частой жалобой у взрослых мужчин. Они оказывают серьезное негативное влияние на качество жизни. При ДГПЖ предстательная железа увеличивается в размерах, оказывая давление на нижние мочевые пути. В результате развиваются следующие симптомы:<sup>41</sup>'),
(3344, 157, '_текст-8-2', 'field_6244335fe2373'),
(3345, 157, 'заголовок-9', 'Осложнения ДГПЖ<sup>38</sup>'),
(3346, 157, '_заголовок-9', 'field_6244377a52263'),
(3347, 157, 'изображения-9', 'a:6:{i:0;s:3:\"141\";i:1;s:3:\"142\";i:2;s:3:\"143\";i:3;s:3:\"144\";i:4;s:3:\"145\";i:5;s:3:\"146\";}'),
(3348, 157, '_изображения-9', 'field_6244379652264'),
(3349, 157, 'заголовок-10', 'Медикаментозное лечение СНМП/ДГПЖ'),
(3350, 157, '_заголовок-10', 'field_6244489614262'),
(3351, 157, 'текст-10', 'Антагонисты альфа1-адренорецепторов (альфа-адреноблокаторы) и&nbsp;ингибиторы 5&nbsp;альфа1-редуктазы (ингибиторы 5-АР) являются группами лекарственных препаратов, которые в&nbsp;настоящее время утверждены для лечения ДГПЖ. Обе группы препаратов обеспечивают надлежащее ослабление симптомов, но&nbsp;&alpha;&mdash;блокаторы обладают довольно быстрым началом действия, а&nbsp;ингибиторам 5-АР требуется несколько месяцев для получения терапевтического эффекта.<sup>42</sup>'),
(3352, 157, '_текст-10', 'field_624448ce14263'),
(3353, 157, 'карточки-10_0_заголовок', 'Альфа-адреноблокаторы'),
(3354, 157, '_карточки-10_0_заголовок', 'field_624448fc14265'),
(3355, 157, 'карточки-10_0_текст', '\r\nпредставляют собой наиболее эффективный класс лекарственных препаратов, характеризующийся хорошим профилем безопасности и высокой комплаентностью, применяющийся для облегчения СНМП, связанных с ДГПЖ: они снимают спазм гладкой мускулатуры предстательной железы и шейки мочевого пузыря42'),
(3356, 157, '_карточки-10_0_текст', 'field_6244490c14266'),
(3357, 157, 'карточки-10_1_заголовок', 'Ингибиторы 5-АР —'),
(3358, 157, '_карточки-10_1_заголовок', 'field_624448fc14265'),
(3359, 157, 'карточки-10_1_текст', '\r\nприводят к редукции железистой ткани и к снижению размера предстательной железы: они блокируют конверсию тестостерона в дигидротестостерон, который стимулирует рост предстательной железы43,44.Назначаются при большом объеме предстательной железы. Для получения значимого клинического эффекта требуется несколько месяцев применения45\r\n'),
(3360, 157, '_карточки-10_1_текст', 'field_6244490c14266'),
(3361, 157, 'карточки-10', '2'),
(3362, 157, '_карточки-10', 'field_624448e214264'),
(3363, 157, 'видео', '<iframe width=\"560\" height=\"315\" src=\"https://www.youtube.com/embed/3DrU3pFXSsY\" title=\"YouTube video player\" frameborder=\"0\" allow=\"accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture\" allowfullscreen></iframe>'),
(3364, 157, '_видео', 'field_6244492214267'),
(3365, 159, '_edit_last', '1'),
(3366, 159, '_edit_lock', '1648647021:1'),
(3367, 165, 'заголовок-1', 'УРОРЕК – оригинальный<sup>10</sup> альфа-адреноблокатор'),
(3368, 165, '_заголовок-1', 'field_62435bd26f29f');
INSERT INTO `urotec_postmeta` (`meta_id`, `post_id`, `meta_key`, `meta_value`) VALUES
(3369, 165, 'текст-1', '<div class=\"headerBlock__body\">\r\n<p>Силодозин (действующее вещество препарата Урорек) обладает максимальной уроселективностью в&nbsp;своем классе, что обеспечивает его уродинамическую эффективность и&nbsp;высокую безопасность<sup>4</sup></p>\r\n</div>\r\n<div class=\"headerBlock__footer\">\r\n<p><strong>Показания к применению: </strong><br/>Лечение симптомов доброкачественной гиперплазии предстательной железы<sup>6</sup></p>\r\n</div>'),
(3370, 165, '_текст-1', 'field_62435c0c6f2a0'),
(3371, 165, 'изображение-1', '13'),
(3372, 165, '_изображение-1', 'field_62435c8b6f2a1'),
(3373, 165, 'фон-1', '17'),
(3374, 165, '_фон-1', 'field_62435db92ea96'),
(3375, 165, 'заголовок-2', 'Ключевые преимущества препарата Урорек'),
(3376, 165, '_заголовок-2', 'field_6243606295196'),
(3377, 165, 'список-2', 'Единственный оригинальный препарат из&nbsp;группы альфа1-адреноблокаторов, не&nbsp;имеющий генериков в&nbsp;РФ<sup>1</sup>'),
(3378, 165, '_список-2', 'field_6243608195197'),
(3379, 165, 'картинка_с_текстом_0_изображение', '31'),
(3380, 165, '_картинка_с_текстом_0_изображение', 'field_624363d095199'),
(3381, 165, 'картинка_с_текстом_0_описание', 'Обширная доказательная база собственных пострегистрационных клинических исследований<sup>2</sup>'),
(3382, 165, '_картинка_с_текстом_0_описание', 'field_624363e59519a'),
(3383, 165, 'картинка_с_текстом_1_изображение', '32'),
(3384, 165, '_картинка_с_текстом_1_изображение', 'field_624363d095199'),
(3385, 165, 'картинка_с_текстом_1_описание', 'Отсутствие риска замены препарата Урорек в&nbsp;аптеке (единственный препарат с&nbsp;действующим веществом силодозин)<sup>1</sup>'),
(3386, 165, '_картинка_с_текстом_1_описание', 'field_624363e59519a'),
(3387, 165, 'картинка_с_текстом_2_изображение', '33'),
(3388, 165, '_картинка_с_текстом_2_изображение', 'field_624363d095199'),
(3389, 165, 'картинка_с_текстом_2_описание', 'Большинство пациентов предпочитают принимать оригинальные препараты<sup>3</sup>'),
(3390, 165, '_картинка_с_текстом_2_описание', 'field_624363e59519a'),
(3391, 165, 'картинка_с_текстом', '3'),
(3392, 165, '_картинка_с_текстом', 'field_624363b995198'),
(3393, 165, 'второй_список', '<li>Клинические преимущества препарата Урорек (силодозин) определяются максимальной уроселективностью в&nbsp;классе альфа-адреноблокаторов<sup>4</sup></li>\r\n\r\n<li>Урорек&nbsp;&mdash; альфа-адреноблокатор последнего поколения, который эффективен в&nbsp;отношении всех СНМП (накопления, опорожнения, постмиктурических).<sup>12,13</sup> При этом Урорек обладает минимальным риском развития нежелательных явлений со&nbsp;стороны сердечно-сосудистой системы, в&nbsp;том числе&nbsp;у&nbsp;пациентов, принимающих антигипертензивные препараты<sup>46,8</sup> <small> <span>СНМП </span>симптомы нижних мочевыводящих путей</small></li>'),
(3394, 165, '_второй_список', 'field_6243640e05eda'),
(3395, 165, 'заголовок2-2', 'Максимальная уроселективность силодозина в&nbsp;классе альфа-адреноблокаторов обуславливает его уродинамическую эффективность и&nbsp;высокий профиль безопасности<sup>4</sup>'),
(3396, 165, '_заголовок2-2', 'field_6243644705edb'),
(3397, 165, 'текст3', '<ul>\r\n<li>Урорек значительно улучшает клинические проявления и&nbsp;качество жизни у&nbsp;всех пациентов с&nbsp;СНМП/ДГПЖ, в&nbsp;том числе с&nbsp;тяжелым течением<sup>11</sup><a href=\"#\">Узнать больше...</a></li>\r\n\r\n<li>Урорек является препаратом выбора для пациентов с&nbsp;СНМП/ДГПЖ и&nbsp;сопутствующими сердечно-сосудистыми заболеваниями<sup>3</sup> <a href=\"#\">Узнать больше...</a></li>\r\n</ul>\r\n<small> <span>ДГПЖ </span>доброкачественная гиперплазия предстательной железы</small>'),
(3398, 165, '_текст3', 'field_6243647405edc'),
(3399, 165, 'изображение-2', '34'),
(3400, 165, '_изображение-2', 'field_624364dd05edd'),
(3401, 165, 'текст_в_подвале', '<h2> Максимальная уроселективность в&nbsp;классе  альфа-адреноблокаторов<sup>4</sup></h2>\r\n<div class=\"h3\"> Почему это важно? <a href=\"#\">Подробнее</a></div>'),
(3402, 165, '_текст_в_подвале', 'field_62436daf1f6d9'),
(3403, 165, 'заголовок-3', 'Форма выпуска препарата Урорек'),
(3404, 165, '_заголовок-3', 'field_62436efee98e7'),
(3405, 165, 'текст-3', '<p class=\"section-descr\"><span>8мг </span>- рекомендуемая доза для лечения симптомов ДГПЖ<sup>6</sup>*</p>\r\n					<p class=\"section-note col-md-10\">*Более подробные сведения о&nbsp;препарате, особенностях применения, побочных действиях и&nbsp;др. &mdash;&nbsp;смотрите инструкцию по&nbsp;медицинскому применению лекарственного препарата Урорек, РУ&nbsp;ЛСР-005971/10 от&nbsp;25.06.2010 </p>'),
(3406, 165, '_текст-3', 'field_62436f60e98e8'),
(3407, 165, 'товар_0_название', 'Урорек 8мг №30'),
(3408, 165, '_товар_0_название', 'field_62436fcce98ea'),
(3409, 165, 'товар_0_описание', 'Упаковка, рассчитанная на&nbsp;1&nbsp;месяц лечения&nbsp;/ для старта терапии'),
(3410, 165, '_товар_0_описание', 'field_62436fe1e98eb'),
(3411, 165, 'товар_0_лицензия', 'РУ: ЛСР-005971/10 от 25.06.2010'),
(3412, 165, '_товар_0_лицензия', 'field_62436ff0e98ec'),
(3413, 165, 'товар_0_изображение', '51'),
(3414, 165, '_товар_0_изображение', 'field_62437045e98ed'),
(3415, 165, 'товар_1_название', 'Урорек 8мг №90'),
(3416, 165, '_товар_1_название', 'field_62436fcce98ea'),
(3417, 165, 'товар_1_описание', 'Выгодная упаковка, рассчитанная на&nbsp;3&nbsp;месяца лечения. Самая доступная стоимость 1&nbsp;дня терапии препаратом Урорек&nbsp;<sup>27</sup>'),
(3418, 165, '_товар_1_описание', 'field_62436fe1e98eb'),
(3419, 165, 'товар_1_лицензия', 'РУ: ЛСР-005971/10 от 25.06.2010'),
(3420, 165, '_товар_1_лицензия', 'field_62436ff0e98ec'),
(3421, 165, 'товар_1_изображение', '53'),
(3422, 165, '_товар_1_изображение', 'field_62437045e98ed'),
(3423, 165, 'товар_2_название', 'Урорек 4мг №30'),
(3424, 165, '_товар_2_название', 'field_62436fcce98ea'),
(3425, 165, 'товар_2_описание', '4&nbsp;мг&nbsp;&mdash; стартовая упаковка для лечения симптомов ДГПЖ у&nbsp;пациентов с&nbsp;почечной недостаточностью средней степени тяжести<sup>6</sup>'),
(3426, 165, '_товар_2_описание', 'field_62436fe1e98eb'),
(3427, 165, 'товар_2_лицензия', 'РУ: ЛСР-005971/10 от 25.06.2010'),
(3428, 165, '_товар_2_лицензия', 'field_62436ff0e98ec'),
(3429, 165, 'товар_2_изображение', '52'),
(3430, 165, '_товар_2_изображение', 'field_62437045e98ed'),
(3431, 165, 'товар', '3'),
(3432, 165, '_товар', 'field_62436fbde98e9'),
(3433, 165, 'заголовок-4', 'Где купить'),
(3434, 165, '_заголовок-4', 'field_624374f73d8bd'),
(3435, 165, 'изображения', 'a:12:{i:0;s:2:\"63\";i:1;s:2:\"64\";i:2;s:2:\"65\";i:3;s:2:\"66\";i:4;s:2:\"67\";i:5;s:2:\"68\";i:6;s:2:\"69\";i:7;s:2:\"70\";i:8;s:2:\"71\";i:9;s:2:\"72\";i:10;s:2:\"73\";i:11;s:2:\"74\";}'),
(3436, 165, '_изображения', 'field_624375093d8be'),
(3437, 165, 'изображения-4', 'a:12:{i:0;s:2:\"63\";i:1;s:2:\"64\";i:2;s:2:\"65\";i:3;s:2:\"66\";i:4;s:2:\"67\";i:5;s:2:\"68\";i:6;s:2:\"69\";i:7;s:2:\"70\";i:8;s:2:\"71\";i:9;s:2:\"72\";i:10;s:2:\"73\";i:11;s:2:\"74\";}'),
(3438, 165, '_изображения-4', 'field_624375093d8be'),
(3439, 165, 'заголовок-5', 'Способ применения*<sup>6</sup>'),
(3440, 165, '_заголовок-5', 'field_624379bd4756d'),
(3441, 165, 'иконки', 'a:5:{i:0;s:2:\"83\";i:1;s:2:\"84\";i:2;s:2:\"85\";i:3;s:2:\"86\";i:4;s:2:\"87\";}'),
(3442, 165, '_иконки', 'field_624379f24756e'),
(3443, 165, 'текст-5', 'У пациентов с легкой почечной недостаточностью (клиренс креатинина ≥ 50 — ≤ 80 мл/мин) коррекция дозы не требуется. Для лечения пациентов с почечной недостаточностью средней степени тяжести (клиренс креатинина ≥ 30 — < 50 мл/мин) рекомендуется в течение первой недели принимать начальную дозу по 4 мг в сутки, при хорошей индивидуальной переносимости доза может быть увеличена до 8 мг в сутки. Применение препарата для пациентов с тяжелой почечной недостаточностью (клиренс креатинина < 30 мл / мин) не рекомендуется'),
(3444, 165, '_текст-5', 'field_62437a374756f'),
(3445, 165, 'текст_под_кнопкой', '*Более подробные сведения о&nbsp;препарате, особенностях применения, побочных действиях и&nbsp;др. &mdash;&nbsp;см. инструкцию по&nbsp;медицинскому применению лекарственного препарата Урорек, РУ&nbsp;ЛСР-005971/10 от&nbsp;25.06.2010'),
(3446, 165, '_текст_под_кнопкой', 'field_62437a7c47570'),
(3447, 165, 'заголовок-6', 'Препарат Урорек (силодозин) включен в&nbsp;российские и&nbsp;международные клинические рекомендации и&nbsp;стандарты для лечения ряда урологических заболеваний:'),
(3448, 165, '_заголовок-6', 'field_6244117c68bd0'),
(3449, 165, 'список-6_0_ссылка', 'a:3:{s:5:\"title\";s:68:\"Российские клинические рекомендации\";s:3:\"url\";s:1:\"#\";s:6:\"target\";s:0:\"\";}'),
(3450, 165, '_список-6_0_ссылка', 'field_624411ce68bd2'),
(3451, 165, 'список-6_0_описание', '«Доброкачественная гиперплазия предстательной железы», 2020<sup>28</sup>'),
(3452, 165, '_список-6_0_описание', 'field_6244121168bd3'),
(3453, 165, 'список-6_1_ссылка', 'a:3:{s:5:\"title\";s:70:\"Европейские клинические рекомендации\";s:3:\"url\";s:1:\"#\";s:6:\"target\";s:0:\"\";}'),
(3454, 165, '_список-6_1_ссылка', 'field_624411ce68bd2'),
(3455, 165, 'список-6_1_описание', 'глава «Консервативное лечение ненейрогенных симптомов нарушенного мочеиспускания у мужчин, включая доброкачественную простатическую обструкцию», 2021<sup>29</sup>'),
(3456, 165, '_список-6_1_описание', 'field_6244121168bd3'),
(3457, 165, 'список-6_2_ссылка', 'a:3:{s:5:\"title\";s:154:\"Стандарт первичной медико-санитарной помощи при гиперплазии предстательной железы\";s:3:\"url\";s:1:\"#\";s:6:\"target\";s:0:\"\";}'),
(3458, 165, '_список-6_2_ссылка', 'field_624411ce68bd2'),
(3459, 165, 'список-6_2_описание', '09.11.2012<sup>30</sup> / Обновлён 13.04.2015\r\n'),
(3460, 165, '_список-6_2_описание', 'field_6244121168bd3'),
(3461, 165, 'список-6_3_ссылка', 'a:3:{s:5:\"title\";s:122:\"Стандарт специализированной медицинской помощи при задержке мочи\";s:3:\"url\";s:1:\"#\";s:6:\"target\";s:0:\"\";}'),
(3462, 165, '_список-6_3_ссылка', 'field_624411ce68bd2'),
(3463, 165, 'список-6_3_описание', '29.01.2013<sup>31</sup> / Обновлён 06.05.2015\r\n'),
(3464, 165, '_список-6_3_описание', 'field_6244121168bd3'),
(3465, 165, 'список-6_4_ссылка', 'a:3:{s:5:\"title\";s:133:\"Стандарт первичной медико-санитарной помощи при хроническом простатите\";s:3:\"url\";s:1:\"#\";s:6:\"target\";s:0:\"\";}'),
(3466, 165, '_список-6_4_ссылка', 'field_624411ce68bd2'),
(3467, 165, 'список-6_4_описание', '09.11.2012<sup>32</sup> / Обновлён 13.04.2015\r\n'),
(3468, 165, '_список-6_4_описание', 'field_6244121168bd3'),
(3469, 165, 'список-6_5_ссылка', 'a:3:{s:5:\"title\";s:168:\"Стандарт специализированной медицинской помощи при остром простатите, орхите, эпидидимите\";s:3:\"url\";s:1:\"#\";s:6:\"target\";s:0:\"\";}'),
(3470, 165, '_список-6_5_ссылка', 'field_624411ce68bd2'),
(3471, 165, 'список-6_5_описание', '09.11.2012<sup>33</sup> / Обновлён 27.05.2015'),
(3472, 165, '_список-6_5_описание', 'field_6244121168bd3'),
(3473, 165, 'список-6', '6'),
(3474, 165, '_список-6', 'field_624411be68bd1'),
(3475, 165, 'заголовок-7', 'Препарат Урорек (силодозин) зарегистрирован и&nbsp;применяется в&nbsp;разных странах мира Одобрен ЕМА*<sup>34</sup> и&nbsp;FDA**<sup>35</sup>'),
(3476, 165, '_заголовок-7', 'field_624417e3b6088'),
(3477, 165, 'текст', '<p class=\"sOtherCountries__agency\"><span>EMA</span> Европейское медицинское агентство</p>\r\n<p class=\"sOtherCountries__agency\"><span>FDA</span> Управление по&nbsp;санитарному надзору за&nbsp;качеством пищевых продуктов и&nbsp;медикаментов, США</p>'),
(3478, 165, '_текст', 'field_6244182bb6089'),
(3479, 165, 'страны_0_флаг', '105'),
(3480, 165, '_страны_0_флаг', 'field_62441880b608b'),
(3481, 165, 'страны_0_название', 'Япония'),
(3482, 165, '_страны_0_название', 'field_62441899b608c'),
(3483, 165, 'страны_0_год', '2006<sup>36,37</sup>'),
(3484, 165, '_страны_0_год', 'field_624418aab608d'),
(3485, 165, 'страны_1_флаг', '106'),
(3486, 165, '_страны_1_флаг', 'field_62441880b608b'),
(3487, 165, 'страны_1_название', 'США'),
(3488, 165, '_страны_1_название', 'field_62441899b608c'),
(3489, 165, 'страны_1_год', '2008<sup>35</sup>'),
(3490, 165, '_страны_1_год', 'field_624418aab608d'),
(3491, 165, 'страны_2_флаг', '107'),
(3492, 165, '_страны_2_флаг', 'field_62441880b608b'),
(3493, 165, 'страны_2_название', 'Страны ЕС'),
(3494, 165, '_страны_2_название', 'field_62441899b608c'),
(3495, 165, 'страны_2_год', '2010<sup>34</sup>'),
(3496, 165, '_страны_2_год', 'field_624418aab608d'),
(3497, 165, 'страны_3_флаг', '108'),
(3498, 165, '_страны_3_флаг', 'field_62441880b608b'),
(3499, 165, 'страны_3_название', 'Россия'),
(3500, 165, '_страны_3_название', 'field_62441899b608c'),
(3501, 165, 'страны_3_год', '2010<sup>1</sup>'),
(3502, 165, '_страны_3_год', 'field_624418aab608d'),
(3503, 165, 'страны', '4'),
(3504, 165, '_страны', 'field_62441847b608a'),
(3505, 165, 'текст-7', '<p class=\"sOtherCountries__agency\"><span>EMA</span> Европейское медицинское агентство</p>\r\n<p class=\"sOtherCountries__agency\"><span>FDA</span> Управление по&nbsp;санитарному надзору за&nbsp;качеством пищевых продуктов и&nbsp;медикаментов, США</p>'),
(3506, 165, '_текст-7', 'field_6244182bb6089'),
(3507, 165, 'текст-7-1', 'Производство препарата Урорек, поставляемого в&nbsp;Россию, осуществляется в&nbsp;Италии с&nbsp;использованием субстанции из&nbsp;Японии, в&nbsp;соответствии с&nbsp;необходимыми требованиями к&nbsp;производству и&nbsp;контролю качества<sup>6,1</sup>'),
(3508, 165, '_текст-7-1', 'field_62441a5acf03c'),
(3509, 165, 'заголовок-8', 'О проблеме'),
(3510, 165, '_заголовок-8', 'field_624431d91624d'),
(3511, 165, 'текст-8', 'Доброкачественная гиперплазия предстательной железы (ДГПЖ), или как ее еще называют, аденома простаты, как правило, возникает у мужчин старше 50 лет и характеризуется наличием симптомов нижних мочевыводящих путей (СНМП), увеличением предстательной железы или ее части, и нарушением оттока мочи из мочевого пузыря вследствие инфравезикальной обструкции.<sup>38</sup>\r\n\r\nРаспространенность ДГПЖ увеличивается с возрастом. Так, клинически значимая ДГПЖ проявляется у 13% мужчин в возрасте старше 50 лет, у 34% мужчин в возрасте 60 лет и у 43% в возрасте 70 лет.<sup>39</sup>\r\n\r\n&nbsp;\r\n\r\n[caption id=\"attachment_122\" align=\"alignnone\" width=\"594\"]<img class=\"wp-image-122 size-full\" src=\"http://0026urotec.loc:8888/wp-content/uploads/2022/03/about-img.png\" alt=\"мужик\" width=\"594\" height=\"696\" /> Федя[/caption]'),
(3512, 165, '_текст-8', 'field_624431f11624e'),
(3513, 165, 'текст-8-1', 'Наличие СНМП может быть ассоциировано с&nbsp;тяжелыми хроническими заболеваниями, такими как заболевания сердца, сахарный диабет, артериальная гипертензия и&nbsp;депрессия<sup>40</sup>'),
(3514, 165, '_текст-8-1', 'field_6244320b26db3'),
(3515, 165, 'иконки-8', 'a:6:{i:0;s:3:\"123\";i:1;s:3:\"124\";i:2;s:3:\"125\";i:3;s:3:\"126\";i:4;s:3:\"127\";i:5;s:3:\"128\";}'),
(3516, 165, '_иконки-8', 'field_6244322d26db4'),
(3517, 165, 'текст-8-2', '<h3>Симптомы доброкачественной гиперплазии предстательной железы</h3>\r\nСимптомы нарушенного мочеиспускания являются частой жалобой у взрослых мужчин. Они оказывают серьезное негативное влияние на качество жизни. При ДГПЖ предстательная железа увеличивается в размерах, оказывая давление на нижние мочевые пути. В результате развиваются следующие симптомы:<sup>41</sup>'),
(3518, 165, '_текст-8-2', 'field_6244335fe2373'),
(3519, 165, 'заголовок-9', 'Осложнения ДГПЖ<sup>38</sup>'),
(3520, 165, '_заголовок-9', 'field_6244377a52263'),
(3521, 165, 'изображения-9', 'a:6:{i:0;s:3:\"141\";i:1;s:3:\"142\";i:2;s:3:\"143\";i:3;s:3:\"144\";i:4;s:3:\"145\";i:5;s:3:\"146\";}'),
(3522, 165, '_изображения-9', 'field_6244379652264'),
(3523, 165, 'заголовок-10', 'Медикаментозное лечение СНМП/ДГПЖ'),
(3524, 165, '_заголовок-10', 'field_6244489614262'),
(3525, 165, 'текст-10', 'Антагонисты альфа1-адренорецепторов (альфа-адреноблокаторы) и&nbsp;ингибиторы 5&nbsp;альфа1-редуктазы (ингибиторы 5-АР) являются группами лекарственных препаратов, которые в&nbsp;настоящее время утверждены для лечения ДГПЖ. Обе группы препаратов обеспечивают надлежащее ослабление симптомов, но&nbsp;&alpha;&mdash;блокаторы обладают довольно быстрым началом действия, а&nbsp;ингибиторам 5-АР требуется несколько месяцев для получения терапевтического эффекта.<sup>42</sup>'),
(3526, 165, '_текст-10', 'field_624448ce14263'),
(3527, 165, 'карточки-10_0_заголовок', 'Альфа-адреноблокаторы'),
(3528, 165, '_карточки-10_0_заголовок', 'field_624448fc14265'),
(3529, 165, 'карточки-10_0_текст', '\r\nпредставляют собой наиболее эффективный класс лекарственных препаратов, характеризующийся хорошим профилем безопасности и высокой комплаентностью, применяющийся для облегчения СНМП, связанных с ДГПЖ: они снимают спазм гладкой мускулатуры предстательной железы и шейки мочевого пузыря42'),
(3530, 165, '_карточки-10_0_текст', 'field_6244490c14266'),
(3531, 165, 'карточки-10_1_заголовок', 'Ингибиторы 5-АР —'),
(3532, 165, '_карточки-10_1_заголовок', 'field_624448fc14265'),
(3533, 165, 'карточки-10_1_текст', '\r\nприводят к редукции железистой ткани и к снижению размера предстательной железы: они блокируют конверсию тестостерона в дигидротестостерон, который стимулирует рост предстательной железы43,44.Назначаются при большом объеме предстательной железы. Для получения значимого клинического эффекта требуется несколько месяцев применения45\r\n'),
(3534, 165, '_карточки-10_1_текст', 'field_6244490c14266'),
(3535, 165, 'карточки-10', '2'),
(3536, 165, '_карточки-10', 'field_624448e214264'),
(3537, 165, 'видео', '<iframe width=\"560\" height=\"315\" src=\"https://www.youtube.com/embed/3DrU3pFXSsY\" title=\"YouTube video player\" frameborder=\"0\" allow=\"accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture\" allowfullscreen></iframe>'),
(3538, 165, '_видео', 'field_6244492214267'),
(3539, 2, 'заголовок-11', 'Часто задаваемые вопросы'),
(3540, 2, '_заголовок-11', 'field_62444b33e25d6'),
(3541, 2, 'вопросы_0_заголовок', 'Почему при приеме препарата Урорек у некоторых пациентов развивается нарушение эякуляции?'),
(3542, 2, '_вопросы_0_заголовок', 'field_62444b58e25d8'),
(3543, 2, 'вопросы_0_текст', 'Урорек — высокоселективный препарат, то есть преимущественно действует на альфа1А-адренорецепторы, которые находятся в нижних мочевых путях, предстательной железе и семенных пузырьках. Поэтому эффект развивается уже через 2–6 часов после приёма первой дозы препарата Урорек<sup>14</sup> при минимальным количестве нежелательных явлений.<sup>5</sup>\r\n\r\nНаиболее частый побочный эффект при приеме препарата Урорек — нарушение эякуляции<sup>46</sup>. Это может быть связано как с забросом эякулята при семяизвержении вместо уретры в мочевой пузырь, так и со снижением или отсутствием семенной жидкости во время эякуляции<sup>29</sup>. Силодозин снижает тонус гладкомышечных клеток семенных пузырьков, простаты и шейки мочевого пузыря, поэтому не происходит выброс семени. Этот эффект свойственен всем уроселективным альфа-адреноблокаторам<sup>53</sup> и самостоятельно исчезает после прекращения приема препарата.<sup>6</sup>\r\n\r\nЧастота эякуляторной дисфункции прямо пропорционально связана с улучшением СНМП и скорости мочеиспускания и подтверждает эффективность альфа-адреноблокатора: чем выше эффективность, тем выше частота встречаемости эякуляторной дисфункции.<sup>29</sup>\r\n\r\nНарушение эякуляции не влияет на сексуальную функцию<sup>52</sup>, не воспринимается как беспокоящий симптом подавляющим большинством пациентов и не требует отмены терапии.<sup>46</sup>'),
(3544, 2, '_вопросы_0_текст', 'field_62444b66e25d9'),
(3545, 2, 'вопросы_1_заголовок', 'Можно ли принимать Урорек при артериальной гипертензии и ишемический болезни сердца (ИБС)?'),
(3546, 2, '_вопросы_1_заголовок', 'field_62444b58e25d8'),
(3547, 2, 'вопросы_1_текст', 'Согласно инструкции по медицинскому применению, противопоказаний для применения лекарственного препарата Урорек у пациентов с СНМП/ДГПЖ и сопутствующими сердечно-сосудистыми заболеваниями нет.<sup>3</sup> Урорек не оказывает влияния на частоту сердечных сокращений (ЧСС), систолическое артериальное давление (САД) и диастолическое артериальное давление (ДАД).<sup>9</sup> Силодозин — не вызывает клинически значимого снижения артериального давления (АД)<sup>46</sup>, не усиливает действие антигипертензивных препаратов и не требует снижения дозы при одновременном приеме.<sup>7</sup> В соответствии с дизайном клинического исследования многие пациенты получали сопутствующую терапию антигипертензивными препаратами (в основном, средствами, воздействующими на ренин-ангиотензиновую систему, бета-блокаторами, антагонистами кальция и диуретиками) без повышения частоты ортостатической гипотензии.<sup>6</sup>\r\n\r\nПри приеме препарата Урорек наиболее низкий риск развития сердечно-сосудистых осложнений.<sup>5</sup>'),
(3548, 2, '_вопросы_1_текст', 'field_62444b66e25d9'),
(3549, 2, 'вопросы_2_заголовок', 'Можно ли принимать Урорек пациенту с ортостатической гипотензией в анамнезе?'),
(3550, 2, '_вопросы_2_заголовок', 'field_62444b58e25d8'),
(3551, 2, 'вопросы_2_текст', 'Повышенная селективность силодозина к альфа1A-адренорецепторам по сравнению с альфа1B-адренорецепторами выражается в пониженном риске развития сердечно-сосудистых осложнений.<sup>4</sup> Благодаря этому частота ортостатической гипотензии на фоне его приема сравнима с таковой при приеме плацебо.<sup>45,9</sup>\r\n\r\nВ отличие от других альфа-адреноблокаторов (например, все формы тамсулозина<sup>47,48</sup>), Урорек не противопоказан к приему у пациентов с ортостатической гипотензией в анамнезе. Тем не менее, пациентам с ортостатической гипотензией в анамнезе не рекомендуется принимать любые альфа-адреноблокаторы, в т.ч. Урорек.<sup>6</sup>'),
(3552, 2, '_вопросы_2_текст', 'field_62444b66e25d9'),
(3553, 2, 'вопросы_3_заголовок', 'Как долго можно принимать Урорек?'),
(3554, 2, '_вопросы_3_заголовок', 'field_62444b58e25d8'),
(3555, 2, 'вопросы_3_текст', 'Учитывая прогрессирующий характер течения доброкачественной гиперплазии предстательной железы, медикаментозную терапию следует проводить длительно (иногда в течение всей жизни пациента).<sup>49</sup>'),
(3556, 2, '_вопросы_3_текст', 'field_62444b66e25d9'),
(3557, 2, 'вопросы_4_заголовок', 'Пациенты жалуются на заложенность носа при лечении альфа-адреноблокаторами. Есть ли у препарата Урорек такое побочное действие?'),
(3558, 2, '_вопросы_4_заголовок', 'field_62444b58e25d8'),
(3559, 2, 'вопросы_4_текст', 'Заложенность носа — это возможный побочный эффект для всех альфа-адреноблокаторов. При приеме препарата Урорек он может возникать примерно в 1% случаев.<sup>46</sup>'),
(3560, 2, '_вопросы_4_текст', 'field_62444b66e25d9'),
(3561, 2, 'вопросы_5_заголовок', 'Можно ли начинать лечение препаратом Урорек с дозы 4 мг в сутки?'),
(3562, 2, '_вопросы_5_заголовок', 'field_62444b58e25d8'),
(3563, 2, 'вопросы_5_текст', 'Согласно инструкции по медицинскому применению лекарственного препарата Урорек, доза 8 мг в сутки рекомендована для лечения пациентов с СНМП/ДГПЖ. Титрование дозы при применении силодозина не требуется.\r\n\r\nУрорек 4 мг — это специальная доза для лечения пациентов с почечной недостаточностью средней степени тяжести (клиренс креатинина ≥ 30 до &lt; 50 мл/мин). Рекомендуется в течение первой недели принимать начальную дозу по 4 мг в сутки, далее при хорошей переносимости доза может быть увеличена до 8 мг в сутки.<sup>6</sup>*\r\n\r\n<small><strong>*Более подробные сведения о препарате, особенностях применения, побочных действиях и др. — см. инструкцию по медицинскому применению лекарственного препарата Урорек, РУ ЛСР-005971/10 от 25.06.2010</strong></small>'),
(3564, 2, '_вопросы_5_текст', 'field_62444b66e25d9'),
(3565, 2, 'вопросы_6_заголовок', 'Влияет ли Урорек на течение ДГПЖ или только снимает симптомы нижних мочевыводящих путей?'),
(3566, 2, '_вопросы_6_заголовок', 'field_62444b58e25d8'),
(3567, 2, 'вопросы_6_текст', 'Помимо субъективных симптомов, ДГПЖ вызывает прогрессирующее морфологическое ремоделирование мочевого пузыря с риском развития серьезных функциональных нарушений. Лечение должно не только купировать субъективные симптомы, но и включать профилактику патологического ремоделирования мочевого пузыря.<sup>161</sup>\r\n\r\nСилодозин, действующее вещество препарата Урорек, в сравнении с другими альфа-адреноблокаторами более эффективно влияет на инфравезикальную обструкцию (ИВО), что оказывает влияние на предотвращение патологического прогрессирования ремоделирования мочевого пузыря и риск развития серьезных функциональных нарушений.<sup>50,51</sup>'),
(3568, 2, '_вопросы_6_текст', 'field_62444b66e25d9'),
(3569, 2, 'вопросы_7_заголовок', 'Доступен ли Урорек по льготному отпуску?'),
(3570, 2, '_вопросы_7_заголовок', 'field_62444b58e25d8'),
(3571, 2, 'вопросы_7_текст', 'Урорек (силодозин) не включен в список жизненно важных лекарственных препаратов (ЖНВЛП)<sup>1</sup> и не входит в перечень препаратов для льготного обеспечения граждан по федеральному льготному списку.'),
(3572, 2, '_вопросы_7_текст', 'field_62444b66e25d9'),
(3573, 2, 'вопросы', '8'),
(3574, 2, '_вопросы', 'field_62444b49e25d7'),
(3575, 166, 'заголовок-1', 'УРОРЕК – оригинальный<sup>10</sup> альфа-адреноблокатор'),
(3576, 166, '_заголовок-1', 'field_62435bd26f29f'),
(3577, 166, 'текст-1', '<div class=\"headerBlock__body\">\r\n<p>Силодозин (действующее вещество препарата Урорек) обладает максимальной уроселективностью в&nbsp;своем классе, что обеспечивает его уродинамическую эффективность и&nbsp;высокую безопасность<sup>4</sup></p>\r\n</div>\r\n<div class=\"headerBlock__footer\">\r\n<p><strong>Показания к применению: </strong><br/>Лечение симптомов доброкачественной гиперплазии предстательной железы<sup>6</sup></p>\r\n</div>'),
(3578, 166, '_текст-1', 'field_62435c0c6f2a0'),
(3579, 166, 'изображение-1', '13'),
(3580, 166, '_изображение-1', 'field_62435c8b6f2a1'),
(3581, 166, 'фон-1', '17'),
(3582, 166, '_фон-1', 'field_62435db92ea96'),
(3583, 166, 'заголовок-2', 'Ключевые преимущества препарата Урорек'),
(3584, 166, '_заголовок-2', 'field_6243606295196'),
(3585, 166, 'список-2', 'Единственный оригинальный препарат из&nbsp;группы альфа1-адреноблокаторов, не&nbsp;имеющий генериков в&nbsp;РФ<sup>1</sup>'),
(3586, 166, '_список-2', 'field_6243608195197'),
(3587, 166, 'картинка_с_текстом_0_изображение', '31'),
(3588, 166, '_картинка_с_текстом_0_изображение', 'field_624363d095199'),
(3589, 166, 'картинка_с_текстом_0_описание', 'Обширная доказательная база собственных пострегистрационных клинических исследований<sup>2</sup>'),
(3590, 166, '_картинка_с_текстом_0_описание', 'field_624363e59519a'),
(3591, 166, 'картинка_с_текстом_1_изображение', '32'),
(3592, 166, '_картинка_с_текстом_1_изображение', 'field_624363d095199'),
(3593, 166, 'картинка_с_текстом_1_описание', 'Отсутствие риска замены препарата Урорек в&nbsp;аптеке (единственный препарат с&nbsp;действующим веществом силодозин)<sup>1</sup>'),
(3594, 166, '_картинка_с_текстом_1_описание', 'field_624363e59519a'),
(3595, 166, 'картинка_с_текстом_2_изображение', '33'),
(3596, 166, '_картинка_с_текстом_2_изображение', 'field_624363d095199'),
(3597, 166, 'картинка_с_текстом_2_описание', 'Большинство пациентов предпочитают принимать оригинальные препараты<sup>3</sup>'),
(3598, 166, '_картинка_с_текстом_2_описание', 'field_624363e59519a'),
(3599, 166, 'картинка_с_текстом', '3'),
(3600, 166, '_картинка_с_текстом', 'field_624363b995198'),
(3601, 166, 'второй_список', '<li>Клинические преимущества препарата Урорек (силодозин) определяются максимальной уроселективностью в&nbsp;классе альфа-адреноблокаторов<sup>4</sup></li>\r\n\r\n<li>Урорек&nbsp;&mdash; альфа-адреноблокатор последнего поколения, который эффективен в&nbsp;отношении всех СНМП (накопления, опорожнения, постмиктурических).<sup>12,13</sup> При этом Урорек обладает минимальным риском развития нежелательных явлений со&nbsp;стороны сердечно-сосудистой системы, в&nbsp;том числе&nbsp;у&nbsp;пациентов, принимающих антигипертензивные препараты<sup>46,8</sup> <small> <span>СНМП </span>симптомы нижних мочевыводящих путей</small></li>'),
(3602, 166, '_второй_список', 'field_6243640e05eda'),
(3603, 166, 'заголовок2-2', 'Максимальная уроселективность силодозина в&nbsp;классе альфа-адреноблокаторов обуславливает его уродинамическую эффективность и&nbsp;высокий профиль безопасности<sup>4</sup>'),
(3604, 166, '_заголовок2-2', 'field_6243644705edb'),
(3605, 166, 'текст3', '<ul>\r\n<li>Урорек значительно улучшает клинические проявления и&nbsp;качество жизни у&nbsp;всех пациентов с&nbsp;СНМП/ДГПЖ, в&nbsp;том числе с&nbsp;тяжелым течением<sup>11</sup><a href=\"#\">Узнать больше...</a></li>\r\n\r\n<li>Урорек является препаратом выбора для пациентов с&nbsp;СНМП/ДГПЖ и&nbsp;сопутствующими сердечно-сосудистыми заболеваниями<sup>3</sup> <a href=\"#\">Узнать больше...</a></li>\r\n</ul>\r\n<small> <span>ДГПЖ </span>доброкачественная гиперплазия предстательной железы</small>'),
(3606, 166, '_текст3', 'field_6243647405edc'),
(3607, 166, 'изображение-2', '34'),
(3608, 166, '_изображение-2', 'field_624364dd05edd'),
(3609, 166, 'текст_в_подвале', '<h2> Максимальная уроселективность в&nbsp;классе  альфа-адреноблокаторов<sup>4</sup></h2>\r\n<div class=\"h3\"> Почему это важно? <a href=\"#\">Подробнее</a></div>'),
(3610, 166, '_текст_в_подвале', 'field_62436daf1f6d9'),
(3611, 166, 'заголовок-3', 'Форма выпуска препарата Урорек'),
(3612, 166, '_заголовок-3', 'field_62436efee98e7'),
(3613, 166, 'текст-3', '<p class=\"section-descr\"><span>8мг </span>- рекомендуемая доза для лечения симптомов ДГПЖ<sup>6</sup>*</p>\r\n					<p class=\"section-note col-md-10\">*Более подробные сведения о&nbsp;препарате, особенностях применения, побочных действиях и&nbsp;др. &mdash;&nbsp;смотрите инструкцию по&nbsp;медицинскому применению лекарственного препарата Урорек, РУ&nbsp;ЛСР-005971/10 от&nbsp;25.06.2010 </p>'),
(3614, 166, '_текст-3', 'field_62436f60e98e8'),
(3615, 166, 'товар_0_название', 'Урорек 8мг №30'),
(3616, 166, '_товар_0_название', 'field_62436fcce98ea'),
(3617, 166, 'товар_0_описание', 'Упаковка, рассчитанная на&nbsp;1&nbsp;месяц лечения&nbsp;/ для старта терапии'),
(3618, 166, '_товар_0_описание', 'field_62436fe1e98eb'),
(3619, 166, 'товар_0_лицензия', 'РУ: ЛСР-005971/10 от 25.06.2010'),
(3620, 166, '_товар_0_лицензия', 'field_62436ff0e98ec'),
(3621, 166, 'товар_0_изображение', '51'),
(3622, 166, '_товар_0_изображение', 'field_62437045e98ed'),
(3623, 166, 'товар_1_название', 'Урорек 8мг №90'),
(3624, 166, '_товар_1_название', 'field_62436fcce98ea'),
(3625, 166, 'товар_1_описание', 'Выгодная упаковка, рассчитанная на&nbsp;3&nbsp;месяца лечения. Самая доступная стоимость 1&nbsp;дня терапии препаратом Урорек&nbsp;<sup>27</sup>'),
(3626, 166, '_товар_1_описание', 'field_62436fe1e98eb'),
(3627, 166, 'товар_1_лицензия', 'РУ: ЛСР-005971/10 от 25.06.2010'),
(3628, 166, '_товар_1_лицензия', 'field_62436ff0e98ec'),
(3629, 166, 'товар_1_изображение', '53'),
(3630, 166, '_товар_1_изображение', 'field_62437045e98ed'),
(3631, 166, 'товар_2_название', 'Урорек 4мг №30'),
(3632, 166, '_товар_2_название', 'field_62436fcce98ea'),
(3633, 166, 'товар_2_описание', '4&nbsp;мг&nbsp;&mdash; стартовая упаковка для лечения симптомов ДГПЖ у&nbsp;пациентов с&nbsp;почечной недостаточностью средней степени тяжести<sup>6</sup>'),
(3634, 166, '_товар_2_описание', 'field_62436fe1e98eb'),
(3635, 166, 'товар_2_лицензия', 'РУ: ЛСР-005971/10 от 25.06.2010'),
(3636, 166, '_товар_2_лицензия', 'field_62436ff0e98ec'),
(3637, 166, 'товар_2_изображение', '52'),
(3638, 166, '_товар_2_изображение', 'field_62437045e98ed'),
(3639, 166, 'товар', '3'),
(3640, 166, '_товар', 'field_62436fbde98e9'),
(3641, 166, 'заголовок-4', 'Где купить'),
(3642, 166, '_заголовок-4', 'field_624374f73d8bd'),
(3643, 166, 'изображения', 'a:12:{i:0;s:2:\"63\";i:1;s:2:\"64\";i:2;s:2:\"65\";i:3;s:2:\"66\";i:4;s:2:\"67\";i:5;s:2:\"68\";i:6;s:2:\"69\";i:7;s:2:\"70\";i:8;s:2:\"71\";i:9;s:2:\"72\";i:10;s:2:\"73\";i:11;s:2:\"74\";}'),
(3644, 166, '_изображения', 'field_624375093d8be'),
(3645, 166, 'изображения-4', 'a:12:{i:0;s:2:\"63\";i:1;s:2:\"64\";i:2;s:2:\"65\";i:3;s:2:\"66\";i:4;s:2:\"67\";i:5;s:2:\"68\";i:6;s:2:\"69\";i:7;s:2:\"70\";i:8;s:2:\"71\";i:9;s:2:\"72\";i:10;s:2:\"73\";i:11;s:2:\"74\";}'),
(3646, 166, '_изображения-4', 'field_624375093d8be'),
(3647, 166, 'заголовок-5', 'Способ применения*<sup>6</sup>'),
(3648, 166, '_заголовок-5', 'field_624379bd4756d'),
(3649, 166, 'иконки', 'a:5:{i:0;s:2:\"83\";i:1;s:2:\"84\";i:2;s:2:\"85\";i:3;s:2:\"86\";i:4;s:2:\"87\";}'),
(3650, 166, '_иконки', 'field_624379f24756e'),
(3651, 166, 'текст-5', 'У пациентов с легкой почечной недостаточностью (клиренс креатинина ≥ 50 — ≤ 80 мл/мин) коррекция дозы не требуется. Для лечения пациентов с почечной недостаточностью средней степени тяжести (клиренс креатинина ≥ 30 — < 50 мл/мин) рекомендуется в течение первой недели принимать начальную дозу по 4 мг в сутки, при хорошей индивидуальной переносимости доза может быть увеличена до 8 мг в сутки. Применение препарата для пациентов с тяжелой почечной недостаточностью (клиренс креатинина < 30 мл / мин) не рекомендуется'),
(3652, 166, '_текст-5', 'field_62437a374756f'),
(3653, 166, 'текст_под_кнопкой', '*Более подробные сведения о&nbsp;препарате, особенностях применения, побочных действиях и&nbsp;др. &mdash;&nbsp;см. инструкцию по&nbsp;медицинскому применению лекарственного препарата Урорек, РУ&nbsp;ЛСР-005971/10 от&nbsp;25.06.2010'),
(3654, 166, '_текст_под_кнопкой', 'field_62437a7c47570'),
(3655, 166, 'заголовок-6', 'Препарат Урорек (силодозин) включен в&nbsp;российские и&nbsp;международные клинические рекомендации и&nbsp;стандарты для лечения ряда урологических заболеваний:'),
(3656, 166, '_заголовок-6', 'field_6244117c68bd0'),
(3657, 166, 'список-6_0_ссылка', 'a:3:{s:5:\"title\";s:68:\"Российские клинические рекомендации\";s:3:\"url\";s:1:\"#\";s:6:\"target\";s:0:\"\";}'),
(3658, 166, '_список-6_0_ссылка', 'field_624411ce68bd2'),
(3659, 166, 'список-6_0_описание', '«Доброкачественная гиперплазия предстательной железы», 2020<sup>28</sup>'),
(3660, 166, '_список-6_0_описание', 'field_6244121168bd3'),
(3661, 166, 'список-6_1_ссылка', 'a:3:{s:5:\"title\";s:70:\"Европейские клинические рекомендации\";s:3:\"url\";s:1:\"#\";s:6:\"target\";s:0:\"\";}'),
(3662, 166, '_список-6_1_ссылка', 'field_624411ce68bd2'),
(3663, 166, 'список-6_1_описание', 'глава «Консервативное лечение ненейрогенных симптомов нарушенного мочеиспускания у мужчин, включая доброкачественную простатическую обструкцию», 2021<sup>29</sup>'),
(3664, 166, '_список-6_1_описание', 'field_6244121168bd3'),
(3665, 166, 'список-6_2_ссылка', 'a:3:{s:5:\"title\";s:154:\"Стандарт первичной медико-санитарной помощи при гиперплазии предстательной железы\";s:3:\"url\";s:1:\"#\";s:6:\"target\";s:0:\"\";}'),
(3666, 166, '_список-6_2_ссылка', 'field_624411ce68bd2'),
(3667, 166, 'список-6_2_описание', '09.11.2012<sup>30</sup> / Обновлён 13.04.2015\r\n'),
(3668, 166, '_список-6_2_описание', 'field_6244121168bd3'),
(3669, 166, 'список-6_3_ссылка', 'a:3:{s:5:\"title\";s:122:\"Стандарт специализированной медицинской помощи при задержке мочи\";s:3:\"url\";s:1:\"#\";s:6:\"target\";s:0:\"\";}'),
(3670, 166, '_список-6_3_ссылка', 'field_624411ce68bd2'),
(3671, 166, 'список-6_3_описание', '29.01.2013<sup>31</sup> / Обновлён 06.05.2015\r\n'),
(3672, 166, '_список-6_3_описание', 'field_6244121168bd3'),
(3673, 166, 'список-6_4_ссылка', 'a:3:{s:5:\"title\";s:133:\"Стандарт первичной медико-санитарной помощи при хроническом простатите\";s:3:\"url\";s:1:\"#\";s:6:\"target\";s:0:\"\";}'),
(3674, 166, '_список-6_4_ссылка', 'field_624411ce68bd2'),
(3675, 166, 'список-6_4_описание', '09.11.2012<sup>32</sup> / Обновлён 13.04.2015\r\n'),
(3676, 166, '_список-6_4_описание', 'field_6244121168bd3'),
(3677, 166, 'список-6_5_ссылка', 'a:3:{s:5:\"title\";s:168:\"Стандарт специализированной медицинской помощи при остром простатите, орхите, эпидидимите\";s:3:\"url\";s:1:\"#\";s:6:\"target\";s:0:\"\";}'),
(3678, 166, '_список-6_5_ссылка', 'field_624411ce68bd2'),
(3679, 166, 'список-6_5_описание', '09.11.2012<sup>33</sup> / Обновлён 27.05.2015'),
(3680, 166, '_список-6_5_описание', 'field_6244121168bd3'),
(3681, 166, 'список-6', '6'),
(3682, 166, '_список-6', 'field_624411be68bd1'),
(3683, 166, 'заголовок-7', 'Препарат Урорек (силодозин) зарегистрирован и&nbsp;применяется в&nbsp;разных странах мира Одобрен ЕМА*<sup>34</sup> и&nbsp;FDA**<sup>35</sup>'),
(3684, 166, '_заголовок-7', 'field_624417e3b6088'),
(3685, 166, 'текст', '<p class=\"sOtherCountries__agency\"><span>EMA</span> Европейское медицинское агентство</p>\r\n<p class=\"sOtherCountries__agency\"><span>FDA</span> Управление по&nbsp;санитарному надзору за&nbsp;качеством пищевых продуктов и&nbsp;медикаментов, США</p>'),
(3686, 166, '_текст', 'field_6244182bb6089'),
(3687, 166, 'страны_0_флаг', '105'),
(3688, 166, '_страны_0_флаг', 'field_62441880b608b'),
(3689, 166, 'страны_0_название', 'Япония'),
(3690, 166, '_страны_0_название', 'field_62441899b608c'),
(3691, 166, 'страны_0_год', '2006<sup>36,37</sup>'),
(3692, 166, '_страны_0_год', 'field_624418aab608d'),
(3693, 166, 'страны_1_флаг', '106'),
(3694, 166, '_страны_1_флаг', 'field_62441880b608b'),
(3695, 166, 'страны_1_название', 'США'),
(3696, 166, '_страны_1_название', 'field_62441899b608c'),
(3697, 166, 'страны_1_год', '2008<sup>35</sup>'),
(3698, 166, '_страны_1_год', 'field_624418aab608d'),
(3699, 166, 'страны_2_флаг', '107'),
(3700, 166, '_страны_2_флаг', 'field_62441880b608b'),
(3701, 166, 'страны_2_название', 'Страны ЕС'),
(3702, 166, '_страны_2_название', 'field_62441899b608c'),
(3703, 166, 'страны_2_год', '2010<sup>34</sup>'),
(3704, 166, '_страны_2_год', 'field_624418aab608d'),
(3705, 166, 'страны_3_флаг', '108'),
(3706, 166, '_страны_3_флаг', 'field_62441880b608b'),
(3707, 166, 'страны_3_название', 'Россия'),
(3708, 166, '_страны_3_название', 'field_62441899b608c'),
(3709, 166, 'страны_3_год', '2010<sup>1</sup>'),
(3710, 166, '_страны_3_год', 'field_624418aab608d'),
(3711, 166, 'страны', '4'),
(3712, 166, '_страны', 'field_62441847b608a'),
(3713, 166, 'текст-7', '<p class=\"sOtherCountries__agency\"><span>EMA</span> Европейское медицинское агентство</p>\r\n<p class=\"sOtherCountries__agency\"><span>FDA</span> Управление по&nbsp;санитарному надзору за&nbsp;качеством пищевых продуктов и&nbsp;медикаментов, США</p>'),
(3714, 166, '_текст-7', 'field_6244182bb6089'),
(3715, 166, 'текст-7-1', 'Производство препарата Урорек, поставляемого в&nbsp;Россию, осуществляется в&nbsp;Италии с&nbsp;использованием субстанции из&nbsp;Японии, в&nbsp;соответствии с&nbsp;необходимыми требованиями к&nbsp;производству и&nbsp;контролю качества<sup>6,1</sup>'),
(3716, 166, '_текст-7-1', 'field_62441a5acf03c'),
(3717, 166, 'заголовок-8', 'О проблеме'),
(3718, 166, '_заголовок-8', 'field_624431d91624d'),
(3719, 166, 'текст-8', 'Доброкачественная гиперплазия предстательной железы (ДГПЖ), или как ее еще называют, аденома простаты, как правило, возникает у мужчин старше 50 лет и характеризуется наличием симптомов нижних мочевыводящих путей (СНМП), увеличением предстательной железы или ее части, и нарушением оттока мочи из мочевого пузыря вследствие инфравезикальной обструкции.<sup>38</sup>\r\n\r\nРаспространенность ДГПЖ увеличивается с возрастом. Так, клинически значимая ДГПЖ проявляется у 13% мужчин в возрасте старше 50 лет, у 34% мужчин в возрасте 60 лет и у 43% в возрасте 70 лет.<sup>39</sup>\r\n\r\n&nbsp;\r\n\r\n[caption id=\"attachment_122\" align=\"alignnone\" width=\"594\"]<img class=\"wp-image-122 size-full\" src=\"http://0026urotec.loc:8888/wp-content/uploads/2022/03/about-img.png\" alt=\"мужик\" width=\"594\" height=\"696\" /> Федя[/caption]'),
(3720, 166, '_текст-8', 'field_624431f11624e'),
(3721, 166, 'текст-8-1', 'Наличие СНМП может быть ассоциировано с&nbsp;тяжелыми хроническими заболеваниями, такими как заболевания сердца, сахарный диабет, артериальная гипертензия и&nbsp;депрессия<sup>40</sup>'),
(3722, 166, '_текст-8-1', 'field_6244320b26db3'),
(3723, 166, 'иконки-8', 'a:6:{i:0;s:3:\"123\";i:1;s:3:\"124\";i:2;s:3:\"125\";i:3;s:3:\"126\";i:4;s:3:\"127\";i:5;s:3:\"128\";}'),
(3724, 166, '_иконки-8', 'field_6244322d26db4'),
(3725, 166, 'текст-8-2', '<h3>Симптомы доброкачественной гиперплазии предстательной железы</h3>\r\nСимптомы нарушенного мочеиспускания являются частой жалобой у взрослых мужчин. Они оказывают серьезное негативное влияние на качество жизни. При ДГПЖ предстательная железа увеличивается в размерах, оказывая давление на нижние мочевые пути. В результате развиваются следующие симптомы:<sup>41</sup>'),
(3726, 166, '_текст-8-2', 'field_6244335fe2373'),
(3727, 166, 'заголовок-9', 'Осложнения ДГПЖ<sup>38</sup>'),
(3728, 166, '_заголовок-9', 'field_6244377a52263'),
(3729, 166, 'изображения-9', 'a:6:{i:0;s:3:\"141\";i:1;s:3:\"142\";i:2;s:3:\"143\";i:3;s:3:\"144\";i:4;s:3:\"145\";i:5;s:3:\"146\";}'),
(3730, 166, '_изображения-9', 'field_6244379652264'),
(3731, 166, 'заголовок-10', 'Медикаментозное лечение СНМП/ДГПЖ'),
(3732, 166, '_заголовок-10', 'field_6244489614262'),
(3733, 166, 'текст-10', 'Антагонисты альфа1-адренорецепторов (альфа-адреноблокаторы) и&nbsp;ингибиторы 5&nbsp;альфа1-редуктазы (ингибиторы 5-АР) являются группами лекарственных препаратов, которые в&nbsp;настоящее время утверждены для лечения ДГПЖ. Обе группы препаратов обеспечивают надлежащее ослабление симптомов, но&nbsp;&alpha;&mdash;блокаторы обладают довольно быстрым началом действия, а&nbsp;ингибиторам 5-АР требуется несколько месяцев для получения терапевтического эффекта.<sup>42</sup>'),
(3734, 166, '_текст-10', 'field_624448ce14263'),
(3735, 166, 'карточки-10_0_заголовок', 'Альфа-адреноблокаторы'),
(3736, 166, '_карточки-10_0_заголовок', 'field_624448fc14265'),
(3737, 166, 'карточки-10_0_текст', 'представляют собой наиболее эффективный класс лекарственных препаратов, характеризующийся хорошим профилем безопасности и высокой комплаентностью, применяющийся для облегчения СНМП, связанных с ДГПЖ: они снимают спазм гладкой мускулатуры предстательной железы и шейки мочевого пузыря42'),
(3738, 166, '_карточки-10_0_текст', 'field_6244490c14266'),
(3739, 166, 'карточки-10_1_заголовок', 'Ингибиторы 5-АР —'),
(3740, 166, '_карточки-10_1_заголовок', 'field_624448fc14265'),
(3741, 166, 'карточки-10_1_текст', 'приводят к редукции железистой ткани и к снижению размера предстательной железы: они блокируют конверсию тестостерона в дигидротестостерон, который стимулирует рост предстательной железы43,44.Назначаются при большом объеме предстательной железы. Для получения значимого клинического эффекта требуется несколько месяцев применения45\r\n'),
(3742, 166, '_карточки-10_1_текст', 'field_6244490c14266'),
(3743, 166, 'карточки-10', '2'),
(3744, 166, '_карточки-10', 'field_624448e214264'),
(3745, 166, 'видео', '<iframe width=\"560\" height=\"315\" src=\"https://www.youtube.com/embed/3DrU3pFXSsY\" title=\"YouTube video player\" frameborder=\"0\" allow=\"accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture\" allowfullscreen></iframe>'),
(3746, 166, '_видео', 'field_6244492214267'),
(3747, 166, 'заголовок-11', 'Часто задаваемые вопросы'),
(3748, 166, '_заголовок-11', 'field_62444b33e25d6'),
(3749, 166, 'вопросы_0_заголовок', 'Почему при приеме препарата Урорек у некоторых пациентов развивается нарушение эякуляции?'),
(3750, 166, '_вопросы_0_заголовок', 'field_62444b58e25d8'),
(3751, 166, 'вопросы_0_текст', 'Урорек — высокоселективный препарат, то есть преимущественно действует на альфа1А-адренорецепторы, которые находятся в нижних мочевых путях, предстательной железе и семенных пузырьках. Поэтому эффект развивается уже через 2–6 часов после приёма первой дозы препарата Урорек<sup>14</sup> при минимальным количестве нежелательных явлений.<sup>5</sup>\r\n\r\nНаиболее частый побочный эффект при приеме препарата Урорек — нарушение эякуляции<sup>46</sup>. Это может быть связано как с забросом эякулята при семяизвержении вместо уретры в мочевой пузырь, так и со снижением или отсутствием семенной жидкости во время эякуляции<sup>29</sup>. Силодозин снижает тонус гладкомышечных клеток семенных пузырьков, простаты и шейки мочевого пузыря, поэтому не происходит выброс семени. Этот эффект свойственен всем уроселективным альфа-адреноблокаторам<sup>53</sup> и самостоятельно исчезает после прекращения приема препарата.<sup>6</sup>\r\n\r\nЧастота эякуляторной дисфункции прямо пропорционально связана с улучшением СНМП и скорости мочеиспускания и подтверждает эффективность альфа-адреноблокатора: чем выше эффективность, тем выше частота встречаемости эякуляторной дисфункции.<sup>29</sup>\r\n\r\nНарушение эякуляции не влияет на сексуальную функцию<sup>52</sup>, не воспринимается как беспокоящий симптом подавляющим большинством пациентов и не требует отмены терапии.<sup>46</sup>'),
(3752, 166, '_вопросы_0_текст', 'field_62444b66e25d9'),
(3753, 166, 'вопросы_1_заголовок', 'Можно ли принимать Урорек при артериальной гипертензии и ишемический болезни сердца (ИБС)?'),
(3754, 166, '_вопросы_1_заголовок', 'field_62444b58e25d8'),
(3755, 166, 'вопросы_1_текст', 'Согласно инструкции по медицинскому применению, противопоказаний для применения лекарственного препарата Урорек у пациентов с СНМП/ДГПЖ и сопутствующими сердечно-сосудистыми заболеваниями нет.<sup>3</sup> Урорек не оказывает влияния на частоту сердечных сокращений (ЧСС), систолическое артериальное давление (САД) и диастолическое артериальное давление (ДАД).<sup>9</sup> Силодозин — не вызывает клинически значимого снижения артериального давления (АД)<sup>46</sup>, не усиливает действие антигипертензивных препаратов и не требует снижения дозы при одновременном приеме.<sup>7</sup> В соответствии с дизайном клинического исследования многие пациенты получали сопутствующую терапию антигипертензивными препаратами (в основном, средствами, воздействующими на ренин-ангиотензиновую систему, бета-блокаторами, антагонистами кальция и диуретиками) без повышения частоты ортостатической гипотензии.<sup>6</sup>\r\n\r\nПри приеме препарата Урорек наиболее низкий риск развития сердечно-сосудистых осложнений.<sup>5</sup>'),
(3756, 166, '_вопросы_1_текст', 'field_62444b66e25d9'),
(3757, 166, 'вопросы_2_заголовок', 'Можно ли принимать Урорек пациенту с ортостатической гипотензией в анамнезе?'),
(3758, 166, '_вопросы_2_заголовок', 'field_62444b58e25d8'),
(3759, 166, 'вопросы_2_текст', 'Повышенная селективность силодозина к альфа1A-адренорецепторам по сравнению с альфа1B-адренорецепторами выражается в пониженном риске развития сердечно-сосудистых осложнений.<sup>4</sup> Благодаря этому частота ортостатической гипотензии на фоне его приема сравнима с таковой при приеме плацебо.<sup>45,9</sup>\r\n\r\nВ отличие от других альфа-адреноблокаторов (например, все формы тамсулозина<sup>47,48</sup>), Урорек не противопоказан к приему у пациентов с ортостатической гипотензией в анамнезе. Тем не менее, пациентам с ортостатической гипотензией в анамнезе не рекомендуется принимать любые альфа-адреноблокаторы, в т.ч. Урорек.<sup>6</sup>'),
(3760, 166, '_вопросы_2_текст', 'field_62444b66e25d9'),
(3761, 166, 'вопросы_3_заголовок', 'Как долго можно принимать Урорек?'),
(3762, 166, '_вопросы_3_заголовок', 'field_62444b58e25d8'),
(3763, 166, 'вопросы_3_текст', 'Учитывая прогрессирующий характер течения доброкачественной гиперплазии предстательной железы, медикаментозную терапию следует проводить длительно (иногда в течение всей жизни пациента).<sup>49</sup>'),
(3764, 166, '_вопросы_3_текст', 'field_62444b66e25d9'),
(3765, 166, 'вопросы_4_заголовок', 'Пациенты жалуются на заложенность носа при лечении альфа-адреноблокаторами. Есть ли у препарата Урорек такое побочное действие?'),
(3766, 166, '_вопросы_4_заголовок', 'field_62444b58e25d8'),
(3767, 166, 'вопросы_4_текст', 'Заложенность носа — это возможный побочный эффект для всех альфа-адреноблокаторов. При приеме препарата Урорек он может возникать примерно в 1% случаев.<sup>46</sup>'),
(3768, 166, '_вопросы_4_текст', 'field_62444b66e25d9'),
(3769, 166, 'вопросы_5_заголовок', 'Можно ли начинать лечение препаратом Урорек с дозы 4 мг в сутки?'),
(3770, 166, '_вопросы_5_заголовок', 'field_62444b58e25d8'),
(3771, 166, 'вопросы_5_текст', 'Согласно инструкции по медицинскому применению лекарственного препарата Урорек, доза 8 мг в сутки рекомендована для лечения пациентов с СНМП/ДГПЖ. Титрование дозы при применении силодозина не требуется.\r\n\r\nУрорек 4 мг — это специальная доза для лечения пациентов с почечной недостаточностью средней степени тяжести (клиренс креатинина ≥ 30 до &lt; 50 мл/мин). Рекомендуется в течение первой недели принимать начальную дозу по 4 мг в сутки, далее при хорошей переносимости доза может быть увеличена до 8 мг в сутки.<sup>6</sup>**Более подробные сведения о препарате, особенностях применения, побочных действиях и др. — см. инструкцию по медицинскому применению лекарственного препарата Урорек, РУ ЛСР-005971/10 от 25.06.2010'),
(3772, 166, '_вопросы_5_текст', 'field_62444b66e25d9'),
(3773, 166, 'вопросы_6_заголовок', 'Влияет ли Урорек на течение ДГПЖ или только снимает симптомы нижних мочевыводящих путей?'),
(3774, 166, '_вопросы_6_заголовок', 'field_62444b58e25d8'),
(3775, 166, 'вопросы_6_текст', 'Помимо субъективных симптомов, ДГПЖ вызывает прогрессирующее морфологическое ремоделирование мочевого пузыря с риском развития серьезных функциональных нарушений. Лечение должно не только купировать субъективные симптомы, но и включать профилактику патологического ремоделирования мочевого пузыря.<sup>161</sup>\r\n\r\nСилодозин, действующее вещество препарата Урорек, в сравнении с другими альфа-адреноблокаторами более эффективно влияет на инфравезикальную обструкцию (ИВО), что оказывает влияние на предотвращение патологического прогрессирования ремоделирования мочевого пузыря и риск развития серьезных функциональных нарушений.<sup>50,51</sup>'),
(3776, 166, '_вопросы_6_текст', 'field_62444b66e25d9'),
(3777, 166, 'вопросы_7_заголовок', 'Доступен ли Урорек по льготному отпуску?'),
(3778, 166, '_вопросы_7_заголовок', 'field_62444b58e25d8'),
(3779, 166, 'вопросы_7_текст', 'Урорек (силодозин) не включен в список жизненно важных лекарственных препаратов (ЖНВЛП)<sup>1</sup> и не входит в перечень препаратов для льготного обеспечения граждан по федеральному льготному списку.'),
(3780, 166, '_вопросы_7_текст', 'field_62444b66e25d9'),
(3781, 166, 'вопросы', '8'),
(3782, 166, '_вопросы', 'field_62444b49e25d7'),
(3783, 167, 'заголовок-1', 'УРОРЕК – оригинальный<sup>10</sup> альфа-адреноблокатор'),
(3784, 167, '_заголовок-1', 'field_62435bd26f29f');
INSERT INTO `urotec_postmeta` (`meta_id`, `post_id`, `meta_key`, `meta_value`) VALUES
(3785, 167, 'текст-1', '<div class=\"headerBlock__body\">\r\n<p>Силодозин (действующее вещество препарата Урорек) обладает максимальной уроселективностью в&nbsp;своем классе, что обеспечивает его уродинамическую эффективность и&nbsp;высокую безопасность<sup>4</sup></p>\r\n</div>\r\n<div class=\"headerBlock__footer\">\r\n<p><strong>Показания к применению: </strong><br/>Лечение симптомов доброкачественной гиперплазии предстательной железы<sup>6</sup></p>\r\n</div>'),
(3786, 167, '_текст-1', 'field_62435c0c6f2a0'),
(3787, 167, 'изображение-1', '13'),
(3788, 167, '_изображение-1', 'field_62435c8b6f2a1'),
(3789, 167, 'фон-1', '17'),
(3790, 167, '_фон-1', 'field_62435db92ea96'),
(3791, 167, 'заголовок-2', 'Ключевые преимущества препарата Урорек'),
(3792, 167, '_заголовок-2', 'field_6243606295196'),
(3793, 167, 'список-2', 'Единственный оригинальный препарат из&nbsp;группы альфа1-адреноблокаторов, не&nbsp;имеющий генериков в&nbsp;РФ<sup>1</sup>'),
(3794, 167, '_список-2', 'field_6243608195197'),
(3795, 167, 'картинка_с_текстом_0_изображение', '31'),
(3796, 167, '_картинка_с_текстом_0_изображение', 'field_624363d095199'),
(3797, 167, 'картинка_с_текстом_0_описание', 'Обширная доказательная база собственных пострегистрационных клинических исследований<sup>2</sup>'),
(3798, 167, '_картинка_с_текстом_0_описание', 'field_624363e59519a'),
(3799, 167, 'картинка_с_текстом_1_изображение', '32'),
(3800, 167, '_картинка_с_текстом_1_изображение', 'field_624363d095199'),
(3801, 167, 'картинка_с_текстом_1_описание', 'Отсутствие риска замены препарата Урорек в&nbsp;аптеке (единственный препарат с&nbsp;действующим веществом силодозин)<sup>1</sup>'),
(3802, 167, '_картинка_с_текстом_1_описание', 'field_624363e59519a'),
(3803, 167, 'картинка_с_текстом_2_изображение', '33'),
(3804, 167, '_картинка_с_текстом_2_изображение', 'field_624363d095199'),
(3805, 167, 'картинка_с_текстом_2_описание', 'Большинство пациентов предпочитают принимать оригинальные препараты<sup>3</sup>'),
(3806, 167, '_картинка_с_текстом_2_описание', 'field_624363e59519a'),
(3807, 167, 'картинка_с_текстом', '3'),
(3808, 167, '_картинка_с_текстом', 'field_624363b995198'),
(3809, 167, 'второй_список', '<li>Клинические преимущества препарата Урорек (силодозин) определяются максимальной уроселективностью в&nbsp;классе альфа-адреноблокаторов<sup>4</sup></li>\r\n\r\n<li>Урорек&nbsp;&mdash; альфа-адреноблокатор последнего поколения, который эффективен в&nbsp;отношении всех СНМП (накопления, опорожнения, постмиктурических).<sup>12,13</sup> При этом Урорек обладает минимальным риском развития нежелательных явлений со&nbsp;стороны сердечно-сосудистой системы, в&nbsp;том числе&nbsp;у&nbsp;пациентов, принимающих антигипертензивные препараты<sup>46,8</sup> <small> <span>СНМП </span>симптомы нижних мочевыводящих путей</small></li>'),
(3810, 167, '_второй_список', 'field_6243640e05eda'),
(3811, 167, 'заголовок2-2', 'Максимальная уроселективность силодозина в&nbsp;классе альфа-адреноблокаторов обуславливает его уродинамическую эффективность и&nbsp;высокий профиль безопасности<sup>4</sup>'),
(3812, 167, '_заголовок2-2', 'field_6243644705edb'),
(3813, 167, 'текст3', '<ul>\r\n<li>Урорек значительно улучшает клинические проявления и&nbsp;качество жизни у&nbsp;всех пациентов с&nbsp;СНМП/ДГПЖ, в&nbsp;том числе с&nbsp;тяжелым течением<sup>11</sup><a href=\"#\">Узнать больше...</a></li>\r\n\r\n<li>Урорек является препаратом выбора для пациентов с&nbsp;СНМП/ДГПЖ и&nbsp;сопутствующими сердечно-сосудистыми заболеваниями<sup>3</sup> <a href=\"#\">Узнать больше...</a></li>\r\n</ul>\r\n<small> <span>ДГПЖ </span>доброкачественная гиперплазия предстательной железы</small>'),
(3814, 167, '_текст3', 'field_6243647405edc'),
(3815, 167, 'изображение-2', '34'),
(3816, 167, '_изображение-2', 'field_624364dd05edd'),
(3817, 167, 'текст_в_подвале', '<h2> Максимальная уроселективность в&nbsp;классе  альфа-адреноблокаторов<sup>4</sup></h2>\r\n<div class=\"h3\"> Почему это важно? <a href=\"#\">Подробнее</a></div>'),
(3818, 167, '_текст_в_подвале', 'field_62436daf1f6d9'),
(3819, 167, 'заголовок-3', 'Форма выпуска препарата Урорек'),
(3820, 167, '_заголовок-3', 'field_62436efee98e7'),
(3821, 167, 'текст-3', '<p class=\"section-descr\"><span>8мг </span>- рекомендуемая доза для лечения симптомов ДГПЖ<sup>6</sup>*</p>\r\n					<p class=\"section-note col-md-10\">*Более подробные сведения о&nbsp;препарате, особенностях применения, побочных действиях и&nbsp;др. &mdash;&nbsp;смотрите инструкцию по&nbsp;медицинскому применению лекарственного препарата Урорек, РУ&nbsp;ЛСР-005971/10 от&nbsp;25.06.2010 </p>'),
(3822, 167, '_текст-3', 'field_62436f60e98e8'),
(3823, 167, 'товар_0_название', 'Урорек 8мг №30'),
(3824, 167, '_товар_0_название', 'field_62436fcce98ea'),
(3825, 167, 'товар_0_описание', 'Упаковка, рассчитанная на&nbsp;1&nbsp;месяц лечения&nbsp;/ для старта терапии'),
(3826, 167, '_товар_0_описание', 'field_62436fe1e98eb'),
(3827, 167, 'товар_0_лицензия', 'РУ: ЛСР-005971/10 от 25.06.2010'),
(3828, 167, '_товар_0_лицензия', 'field_62436ff0e98ec'),
(3829, 167, 'товар_0_изображение', '51'),
(3830, 167, '_товар_0_изображение', 'field_62437045e98ed'),
(3831, 167, 'товар_1_название', 'Урорек 8мг №90'),
(3832, 167, '_товар_1_название', 'field_62436fcce98ea'),
(3833, 167, 'товар_1_описание', 'Выгодная упаковка, рассчитанная на&nbsp;3&nbsp;месяца лечения. Самая доступная стоимость 1&nbsp;дня терапии препаратом Урорек&nbsp;<sup>27</sup>'),
(3834, 167, '_товар_1_описание', 'field_62436fe1e98eb'),
(3835, 167, 'товар_1_лицензия', 'РУ: ЛСР-005971/10 от 25.06.2010'),
(3836, 167, '_товар_1_лицензия', 'field_62436ff0e98ec'),
(3837, 167, 'товар_1_изображение', '53'),
(3838, 167, '_товар_1_изображение', 'field_62437045e98ed'),
(3839, 167, 'товар_2_название', 'Урорек 4мг №30'),
(3840, 167, '_товар_2_название', 'field_62436fcce98ea'),
(3841, 167, 'товар_2_описание', '4&nbsp;мг&nbsp;&mdash; стартовая упаковка для лечения симптомов ДГПЖ у&nbsp;пациентов с&nbsp;почечной недостаточностью средней степени тяжести<sup>6</sup>'),
(3842, 167, '_товар_2_описание', 'field_62436fe1e98eb'),
(3843, 167, 'товар_2_лицензия', 'РУ: ЛСР-005971/10 от 25.06.2010'),
(3844, 167, '_товар_2_лицензия', 'field_62436ff0e98ec'),
(3845, 167, 'товар_2_изображение', '52'),
(3846, 167, '_товар_2_изображение', 'field_62437045e98ed'),
(3847, 167, 'товар', '3'),
(3848, 167, '_товар', 'field_62436fbde98e9'),
(3849, 167, 'заголовок-4', 'Где купить'),
(3850, 167, '_заголовок-4', 'field_624374f73d8bd'),
(3851, 167, 'изображения', 'a:12:{i:0;s:2:\"63\";i:1;s:2:\"64\";i:2;s:2:\"65\";i:3;s:2:\"66\";i:4;s:2:\"67\";i:5;s:2:\"68\";i:6;s:2:\"69\";i:7;s:2:\"70\";i:8;s:2:\"71\";i:9;s:2:\"72\";i:10;s:2:\"73\";i:11;s:2:\"74\";}'),
(3852, 167, '_изображения', 'field_624375093d8be'),
(3853, 167, 'изображения-4', 'a:12:{i:0;s:2:\"63\";i:1;s:2:\"64\";i:2;s:2:\"65\";i:3;s:2:\"66\";i:4;s:2:\"67\";i:5;s:2:\"68\";i:6;s:2:\"69\";i:7;s:2:\"70\";i:8;s:2:\"71\";i:9;s:2:\"72\";i:10;s:2:\"73\";i:11;s:2:\"74\";}'),
(3854, 167, '_изображения-4', 'field_624375093d8be'),
(3855, 167, 'заголовок-5', 'Способ применения*<sup>6</sup>'),
(3856, 167, '_заголовок-5', 'field_624379bd4756d'),
(3857, 167, 'иконки', 'a:5:{i:0;s:2:\"83\";i:1;s:2:\"84\";i:2;s:2:\"85\";i:3;s:2:\"86\";i:4;s:2:\"87\";}'),
(3858, 167, '_иконки', 'field_624379f24756e'),
(3859, 167, 'текст-5', 'У пациентов с легкой почечной недостаточностью (клиренс креатинина ≥ 50 — ≤ 80 мл/мин) коррекция дозы не требуется. Для лечения пациентов с почечной недостаточностью средней степени тяжести (клиренс креатинина ≥ 30 — < 50 мл/мин) рекомендуется в течение первой недели принимать начальную дозу по 4 мг в сутки, при хорошей индивидуальной переносимости доза может быть увеличена до 8 мг в сутки. Применение препарата для пациентов с тяжелой почечной недостаточностью (клиренс креатинина < 30 мл / мин) не рекомендуется'),
(3860, 167, '_текст-5', 'field_62437a374756f'),
(3861, 167, 'текст_под_кнопкой', '*Более подробные сведения о&nbsp;препарате, особенностях применения, побочных действиях и&nbsp;др. &mdash;&nbsp;см. инструкцию по&nbsp;медицинскому применению лекарственного препарата Урорек, РУ&nbsp;ЛСР-005971/10 от&nbsp;25.06.2010'),
(3862, 167, '_текст_под_кнопкой', 'field_62437a7c47570'),
(3863, 167, 'заголовок-6', 'Препарат Урорек (силодозин) включен в&nbsp;российские и&nbsp;международные клинические рекомендации и&nbsp;стандарты для лечения ряда урологических заболеваний:'),
(3864, 167, '_заголовок-6', 'field_6244117c68bd0'),
(3865, 167, 'список-6_0_ссылка', 'a:3:{s:5:\"title\";s:68:\"Российские клинические рекомендации\";s:3:\"url\";s:1:\"#\";s:6:\"target\";s:0:\"\";}'),
(3866, 167, '_список-6_0_ссылка', 'field_624411ce68bd2'),
(3867, 167, 'список-6_0_описание', '«Доброкачественная гиперплазия предстательной железы», 2020<sup>28</sup>'),
(3868, 167, '_список-6_0_описание', 'field_6244121168bd3'),
(3869, 167, 'список-6_1_ссылка', 'a:3:{s:5:\"title\";s:70:\"Европейские клинические рекомендации\";s:3:\"url\";s:1:\"#\";s:6:\"target\";s:0:\"\";}'),
(3870, 167, '_список-6_1_ссылка', 'field_624411ce68bd2'),
(3871, 167, 'список-6_1_описание', 'глава «Консервативное лечение ненейрогенных симптомов нарушенного мочеиспускания у мужчин, включая доброкачественную простатическую обструкцию», 2021<sup>29</sup>'),
(3872, 167, '_список-6_1_описание', 'field_6244121168bd3'),
(3873, 167, 'список-6_2_ссылка', 'a:3:{s:5:\"title\";s:154:\"Стандарт первичной медико-санитарной помощи при гиперплазии предстательной железы\";s:3:\"url\";s:1:\"#\";s:6:\"target\";s:0:\"\";}'),
(3874, 167, '_список-6_2_ссылка', 'field_624411ce68bd2'),
(3875, 167, 'список-6_2_описание', '09.11.2012<sup>30</sup> / Обновлён 13.04.2015\r\n'),
(3876, 167, '_список-6_2_описание', 'field_6244121168bd3'),
(3877, 167, 'список-6_3_ссылка', 'a:3:{s:5:\"title\";s:122:\"Стандарт специализированной медицинской помощи при задержке мочи\";s:3:\"url\";s:1:\"#\";s:6:\"target\";s:0:\"\";}'),
(3878, 167, '_список-6_3_ссылка', 'field_624411ce68bd2'),
(3879, 167, 'список-6_3_описание', '29.01.2013<sup>31</sup> / Обновлён 06.05.2015\r\n'),
(3880, 167, '_список-6_3_описание', 'field_6244121168bd3'),
(3881, 167, 'список-6_4_ссылка', 'a:3:{s:5:\"title\";s:133:\"Стандарт первичной медико-санитарной помощи при хроническом простатите\";s:3:\"url\";s:1:\"#\";s:6:\"target\";s:0:\"\";}'),
(3882, 167, '_список-6_4_ссылка', 'field_624411ce68bd2'),
(3883, 167, 'список-6_4_описание', '09.11.2012<sup>32</sup> / Обновлён 13.04.2015\r\n'),
(3884, 167, '_список-6_4_описание', 'field_6244121168bd3'),
(3885, 167, 'список-6_5_ссылка', 'a:3:{s:5:\"title\";s:168:\"Стандарт специализированной медицинской помощи при остром простатите, орхите, эпидидимите\";s:3:\"url\";s:1:\"#\";s:6:\"target\";s:0:\"\";}'),
(3886, 167, '_список-6_5_ссылка', 'field_624411ce68bd2'),
(3887, 167, 'список-6_5_описание', '09.11.2012<sup>33</sup> / Обновлён 27.05.2015'),
(3888, 167, '_список-6_5_описание', 'field_6244121168bd3'),
(3889, 167, 'список-6', '6'),
(3890, 167, '_список-6', 'field_624411be68bd1'),
(3891, 167, 'заголовок-7', 'Препарат Урорек (силодозин) зарегистрирован и&nbsp;применяется в&nbsp;разных странах мира Одобрен ЕМА*<sup>34</sup> и&nbsp;FDA**<sup>35</sup>'),
(3892, 167, '_заголовок-7', 'field_624417e3b6088'),
(3893, 167, 'текст', '<p class=\"sOtherCountries__agency\"><span>EMA</span> Европейское медицинское агентство</p>\r\n<p class=\"sOtherCountries__agency\"><span>FDA</span> Управление по&nbsp;санитарному надзору за&nbsp;качеством пищевых продуктов и&nbsp;медикаментов, США</p>'),
(3894, 167, '_текст', 'field_6244182bb6089'),
(3895, 167, 'страны_0_флаг', '105'),
(3896, 167, '_страны_0_флаг', 'field_62441880b608b'),
(3897, 167, 'страны_0_название', 'Япония'),
(3898, 167, '_страны_0_название', 'field_62441899b608c'),
(3899, 167, 'страны_0_год', '2006<sup>36,37</sup>'),
(3900, 167, '_страны_0_год', 'field_624418aab608d'),
(3901, 167, 'страны_1_флаг', '106'),
(3902, 167, '_страны_1_флаг', 'field_62441880b608b'),
(3903, 167, 'страны_1_название', 'США'),
(3904, 167, '_страны_1_название', 'field_62441899b608c'),
(3905, 167, 'страны_1_год', '2008<sup>35</sup>'),
(3906, 167, '_страны_1_год', 'field_624418aab608d'),
(3907, 167, 'страны_2_флаг', '107'),
(3908, 167, '_страны_2_флаг', 'field_62441880b608b'),
(3909, 167, 'страны_2_название', 'Страны ЕС'),
(3910, 167, '_страны_2_название', 'field_62441899b608c'),
(3911, 167, 'страны_2_год', '2010<sup>34</sup>'),
(3912, 167, '_страны_2_год', 'field_624418aab608d'),
(3913, 167, 'страны_3_флаг', '108'),
(3914, 167, '_страны_3_флаг', 'field_62441880b608b'),
(3915, 167, 'страны_3_название', 'Россия'),
(3916, 167, '_страны_3_название', 'field_62441899b608c'),
(3917, 167, 'страны_3_год', '2010<sup>1</sup>'),
(3918, 167, '_страны_3_год', 'field_624418aab608d'),
(3919, 167, 'страны', '4'),
(3920, 167, '_страны', 'field_62441847b608a'),
(3921, 167, 'текст-7', '<p class=\"sOtherCountries__agency\"><span>EMA</span> Европейское медицинское агентство</p>\r\n<p class=\"sOtherCountries__agency\"><span>FDA</span> Управление по&nbsp;санитарному надзору за&nbsp;качеством пищевых продуктов и&nbsp;медикаментов, США</p>'),
(3922, 167, '_текст-7', 'field_6244182bb6089'),
(3923, 167, 'текст-7-1', 'Производство препарата Урорек, поставляемого в&nbsp;Россию, осуществляется в&nbsp;Италии с&nbsp;использованием субстанции из&nbsp;Японии, в&nbsp;соответствии с&nbsp;необходимыми требованиями к&nbsp;производству и&nbsp;контролю качества<sup>6,1</sup>'),
(3924, 167, '_текст-7-1', 'field_62441a5acf03c'),
(3925, 167, 'заголовок-8', 'О проблеме'),
(3926, 167, '_заголовок-8', 'field_624431d91624d'),
(3927, 167, 'текст-8', 'Доброкачественная гиперплазия предстательной железы (ДГПЖ), или как ее еще называют, аденома простаты, как правило, возникает у мужчин старше 50 лет и характеризуется наличием симптомов нижних мочевыводящих путей (СНМП), увеличением предстательной железы или ее части, и нарушением оттока мочи из мочевого пузыря вследствие инфравезикальной обструкции.<sup>38</sup>\r\n\r\nРаспространенность ДГПЖ увеличивается с возрастом. Так, клинически значимая ДГПЖ проявляется у 13% мужчин в возрасте старше 50 лет, у 34% мужчин в возрасте 60 лет и у 43% в возрасте 70 лет.<sup>39</sup>\r\n\r\n&nbsp;\r\n\r\n[caption id=\"attachment_122\" align=\"alignnone\" width=\"594\"]<img class=\"wp-image-122 size-full\" src=\"http://0026urotec.loc:8888/wp-content/uploads/2022/03/about-img.png\" alt=\"мужик\" width=\"594\" height=\"696\" /> Федя[/caption]'),
(3928, 167, '_текст-8', 'field_624431f11624e'),
(3929, 167, 'текст-8-1', 'Наличие СНМП может быть ассоциировано с&nbsp;тяжелыми хроническими заболеваниями, такими как заболевания сердца, сахарный диабет, артериальная гипертензия и&nbsp;депрессия<sup>40</sup>'),
(3930, 167, '_текст-8-1', 'field_6244320b26db3'),
(3931, 167, 'иконки-8', 'a:6:{i:0;s:3:\"123\";i:1;s:3:\"124\";i:2;s:3:\"125\";i:3;s:3:\"126\";i:4;s:3:\"127\";i:5;s:3:\"128\";}'),
(3932, 167, '_иконки-8', 'field_6244322d26db4'),
(3933, 167, 'текст-8-2', '<h3>Симптомы доброкачественной гиперплазии предстательной железы</h3>\r\nСимптомы нарушенного мочеиспускания являются частой жалобой у взрослых мужчин. Они оказывают серьезное негативное влияние на качество жизни. При ДГПЖ предстательная железа увеличивается в размерах, оказывая давление на нижние мочевые пути. В результате развиваются следующие симптомы:<sup>41</sup>'),
(3934, 167, '_текст-8-2', 'field_6244335fe2373'),
(3935, 167, 'заголовок-9', 'Осложнения ДГПЖ<sup>38</sup>'),
(3936, 167, '_заголовок-9', 'field_6244377a52263'),
(3937, 167, 'изображения-9', 'a:6:{i:0;s:3:\"141\";i:1;s:3:\"142\";i:2;s:3:\"143\";i:3;s:3:\"144\";i:4;s:3:\"145\";i:5;s:3:\"146\";}'),
(3938, 167, '_изображения-9', 'field_6244379652264'),
(3939, 167, 'заголовок-10', 'Медикаментозное лечение СНМП/ДГПЖ'),
(3940, 167, '_заголовок-10', 'field_6244489614262'),
(3941, 167, 'текст-10', 'Антагонисты альфа1-адренорецепторов (альфа-адреноблокаторы) и&nbsp;ингибиторы 5&nbsp;альфа1-редуктазы (ингибиторы 5-АР) являются группами лекарственных препаратов, которые в&nbsp;настоящее время утверждены для лечения ДГПЖ. Обе группы препаратов обеспечивают надлежащее ослабление симптомов, но&nbsp;&alpha;&mdash;блокаторы обладают довольно быстрым началом действия, а&nbsp;ингибиторам 5-АР требуется несколько месяцев для получения терапевтического эффекта.<sup>42</sup>'),
(3942, 167, '_текст-10', 'field_624448ce14263'),
(3943, 167, 'карточки-10_0_заголовок', 'Альфа-адреноблокаторы'),
(3944, 167, '_карточки-10_0_заголовок', 'field_624448fc14265'),
(3945, 167, 'карточки-10_0_текст', 'представляют собой наиболее эффективный класс лекарственных препаратов, характеризующийся хорошим профилем безопасности и высокой комплаентностью, применяющийся для облегчения СНМП, связанных с ДГПЖ: они снимают спазм гладкой мускулатуры предстательной железы и шейки мочевого пузыря42'),
(3946, 167, '_карточки-10_0_текст', 'field_6244490c14266'),
(3947, 167, 'карточки-10_1_заголовок', 'Ингибиторы 5-АР —'),
(3948, 167, '_карточки-10_1_заголовок', 'field_624448fc14265'),
(3949, 167, 'карточки-10_1_текст', 'приводят к редукции железистой ткани и к снижению размера предстательной железы: они блокируют конверсию тестостерона в дигидротестостерон, который стимулирует рост предстательной железы43,44.Назначаются при большом объеме предстательной железы. Для получения значимого клинического эффекта требуется несколько месяцев применения45\r\n'),
(3950, 167, '_карточки-10_1_текст', 'field_6244490c14266'),
(3951, 167, 'карточки-10', '2'),
(3952, 167, '_карточки-10', 'field_624448e214264'),
(3953, 167, 'видео', '<iframe width=\"560\" height=\"315\" src=\"https://www.youtube.com/embed/3DrU3pFXSsY\" title=\"YouTube video player\" frameborder=\"0\" allow=\"accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture\" allowfullscreen></iframe>'),
(3954, 167, '_видео', 'field_6244492214267'),
(3955, 167, 'заголовок-11', 'Часто задаваемые вопросы'),
(3956, 167, '_заголовок-11', 'field_62444b33e25d6'),
(3957, 167, 'вопросы_0_заголовок', 'Почему при приеме препарата Урорек у некоторых пациентов развивается нарушение эякуляции?'),
(3958, 167, '_вопросы_0_заголовок', 'field_62444b58e25d8'),
(3959, 167, 'вопросы_0_текст', 'Урорек — высокоселективный препарат, то есть преимущественно действует на альфа1А-адренорецепторы, которые находятся в нижних мочевых путях, предстательной железе и семенных пузырьках. Поэтому эффект развивается уже через 2–6 часов после приёма первой дозы препарата Урорек<sup>14</sup> при минимальным количестве нежелательных явлений.<sup>5</sup>\r\n\r\nНаиболее частый побочный эффект при приеме препарата Урорек — нарушение эякуляции<sup>46</sup>. Это может быть связано как с забросом эякулята при семяизвержении вместо уретры в мочевой пузырь, так и со снижением или отсутствием семенной жидкости во время эякуляции<sup>29</sup>. Силодозин снижает тонус гладкомышечных клеток семенных пузырьков, простаты и шейки мочевого пузыря, поэтому не происходит выброс семени. Этот эффект свойственен всем уроселективным альфа-адреноблокаторам<sup>53</sup> и самостоятельно исчезает после прекращения приема препарата.<sup>6</sup>\r\n\r\nЧастота эякуляторной дисфункции прямо пропорционально связана с улучшением СНМП и скорости мочеиспускания и подтверждает эффективность альфа-адреноблокатора: чем выше эффективность, тем выше частота встречаемости эякуляторной дисфункции.<sup>29</sup>\r\n\r\nНарушение эякуляции не влияет на сексуальную функцию<sup>52</sup>, не воспринимается как беспокоящий симптом подавляющим большинством пациентов и не требует отмены терапии.<sup>46</sup>'),
(3960, 167, '_вопросы_0_текст', 'field_62444b66e25d9'),
(3961, 167, 'вопросы_1_заголовок', 'Можно ли принимать Урорек при артериальной гипертензии и ишемический болезни сердца (ИБС)?'),
(3962, 167, '_вопросы_1_заголовок', 'field_62444b58e25d8'),
(3963, 167, 'вопросы_1_текст', 'Согласно инструкции по медицинскому применению, противопоказаний для применения лекарственного препарата Урорек у пациентов с СНМП/ДГПЖ и сопутствующими сердечно-сосудистыми заболеваниями нет.<sup>3</sup> Урорек не оказывает влияния на частоту сердечных сокращений (ЧСС), систолическое артериальное давление (САД) и диастолическое артериальное давление (ДАД).<sup>9</sup> Силодозин — не вызывает клинически значимого снижения артериального давления (АД)<sup>46</sup>, не усиливает действие антигипертензивных препаратов и не требует снижения дозы при одновременном приеме.<sup>7</sup> В соответствии с дизайном клинического исследования многие пациенты получали сопутствующую терапию антигипертензивными препаратами (в основном, средствами, воздействующими на ренин-ангиотензиновую систему, бета-блокаторами, антагонистами кальция и диуретиками) без повышения частоты ортостатической гипотензии.<sup>6</sup>\r\n\r\nПри приеме препарата Урорек наиболее низкий риск развития сердечно-сосудистых осложнений.<sup>5</sup>'),
(3964, 167, '_вопросы_1_текст', 'field_62444b66e25d9'),
(3965, 167, 'вопросы_2_заголовок', 'Можно ли принимать Урорек пациенту с ортостатической гипотензией в анамнезе?'),
(3966, 167, '_вопросы_2_заголовок', 'field_62444b58e25d8'),
(3967, 167, 'вопросы_2_текст', 'Повышенная селективность силодозина к альфа1A-адренорецепторам по сравнению с альфа1B-адренорецепторами выражается в пониженном риске развития сердечно-сосудистых осложнений.<sup>4</sup> Благодаря этому частота ортостатической гипотензии на фоне его приема сравнима с таковой при приеме плацебо.<sup>45,9</sup>\r\n\r\nВ отличие от других альфа-адреноблокаторов (например, все формы тамсулозина<sup>47,48</sup>), Урорек не противопоказан к приему у пациентов с ортостатической гипотензией в анамнезе. Тем не менее, пациентам с ортостатической гипотензией в анамнезе не рекомендуется принимать любые альфа-адреноблокаторы, в т.ч. Урорек.<sup>6</sup>'),
(3968, 167, '_вопросы_2_текст', 'field_62444b66e25d9'),
(3969, 167, 'вопросы_3_заголовок', 'Как долго можно принимать Урорек?'),
(3970, 167, '_вопросы_3_заголовок', 'field_62444b58e25d8'),
(3971, 167, 'вопросы_3_текст', 'Учитывая прогрессирующий характер течения доброкачественной гиперплазии предстательной железы, медикаментозную терапию следует проводить длительно (иногда в течение всей жизни пациента).<sup>49</sup>'),
(3972, 167, '_вопросы_3_текст', 'field_62444b66e25d9'),
(3973, 167, 'вопросы_4_заголовок', 'Пациенты жалуются на заложенность носа при лечении альфа-адреноблокаторами. Есть ли у препарата Урорек такое побочное действие?'),
(3974, 167, '_вопросы_4_заголовок', 'field_62444b58e25d8'),
(3975, 167, 'вопросы_4_текст', 'Заложенность носа — это возможный побочный эффект для всех альфа-адреноблокаторов. При приеме препарата Урорек он может возникать примерно в 1% случаев.<sup>46</sup>'),
(3976, 167, '_вопросы_4_текст', 'field_62444b66e25d9'),
(3977, 167, 'вопросы_5_заголовок', 'Можно ли начинать лечение препаратом Урорек с дозы 4 мг в сутки?'),
(3978, 167, '_вопросы_5_заголовок', 'field_62444b58e25d8'),
(3979, 167, 'вопросы_5_текст', 'Согласно инструкции по медицинскому применению лекарственного препарата Урорек, доза 8 мг в сутки рекомендована для лечения пациентов с СНМП/ДГПЖ. Титрование дозы при применении силодозина не требуется.\r\n\r\nУрорек 4 мг — это специальная доза для лечения пациентов с почечной недостаточностью средней степени тяжести (клиренс креатинина ≥ 30 до &lt; 50 мл/мин). Рекомендуется в течение первой недели принимать начальную дозу по 4 мг в сутки, далее при хорошей переносимости доза может быть увеличена до 8 мг в сутки.<sup>6</sup>**Более подробные сведения о препарате, особенностях применения, побочных действиях и др. — см. инструкцию по медицинскому применению лекарственного препарата Урорек, РУ ЛСР-005971/10 от 25.06.2010'),
(3980, 167, '_вопросы_5_текст', 'field_62444b66e25d9'),
(3981, 167, 'вопросы_6_заголовок', 'Влияет ли Урорек на течение ДГПЖ или только снимает симптомы нижних мочевыводящих путей?'),
(3982, 167, '_вопросы_6_заголовок', 'field_62444b58e25d8'),
(3983, 167, 'вопросы_6_текст', 'Помимо субъективных симптомов, ДГПЖ вызывает прогрессирующее морфологическое ремоделирование мочевого пузыря с риском развития серьезных функциональных нарушений. Лечение должно не только купировать субъективные симптомы, но и включать профилактику патологического ремоделирования мочевого пузыря.<sup>161</sup>\r\n\r\nСилодозин, действующее вещество препарата Урорек, в сравнении с другими альфа-адреноблокаторами более эффективно влияет на инфравезикальную обструкцию (ИВО), что оказывает влияние на предотвращение патологического прогрессирования ремоделирования мочевого пузыря и риск развития серьезных функциональных нарушений.<sup>50,51</sup>'),
(3984, 167, '_вопросы_6_текст', 'field_62444b66e25d9'),
(3985, 167, 'вопросы_7_заголовок', 'Доступен ли Урорек по льготному отпуску?'),
(3986, 167, '_вопросы_7_заголовок', 'field_62444b58e25d8'),
(3987, 167, 'вопросы_7_текст', 'Урорек (силодозин) не включен в список жизненно важных лекарственных препаратов (ЖНВЛП)<sup>1</sup> и не входит в перечень препаратов для льготного обеспечения граждан по федеральному льготному списку.'),
(3988, 167, '_вопросы_7_текст', 'field_62444b66e25d9'),
(3989, 167, 'вопросы', '8'),
(3990, 167, '_вопросы', 'field_62444b49e25d7'),
(3991, 168, '_edit_last', '1'),
(3992, 168, '_edit_lock', '1649184168:1'),
(3993, 176, '_wp_attached_file', '2022/03/logo.svg'),
(3994, 176, '_wp_attachment_metadata', 'a:2:{s:5:\"width\";d:95;s:6:\"height\";d:19;}'),
(3995, 177, '_wp_attached_file', '2022/03/recordati-logo.png'),
(3996, 177, '_wp_attachment_metadata', 'a:5:{s:5:\"width\";i:115;s:6:\"height\";i:38;s:4:\"file\";s:26:\"2022/03/recordati-logo.png\";s:5:\"sizes\";a:0:{}s:10:\"image_meta\";a:12:{s:8:\"aperture\";s:1:\"0\";s:6:\"credit\";s:0:\"\";s:6:\"camera\";s:0:\"\";s:7:\"caption\";s:0:\"\";s:17:\"created_timestamp\";s:1:\"0\";s:9:\"copyright\";s:0:\"\";s:12:\"focal_length\";s:1:\"0\";s:3:\"iso\";s:1:\"0\";s:13:\"shutter_speed\";s:1:\"0\";s:5:\"title\";s:0:\"\";s:11:\"orientation\";s:1:\"0\";s:8:\"keywords\";a:0:{}}}'),
(3997, 178, '_menu_item_type', 'custom'),
(3998, 178, '_menu_item_menu_item_parent', '0'),
(3999, 178, '_menu_item_object_id', '178'),
(4000, 178, '_menu_item_object', 'custom'),
(4001, 178, '_menu_item_target', ''),
(4002, 178, '_menu_item_classes', 'a:1:{i:0;s:0:\"\";}'),
(4003, 178, '_menu_item_xfn', ''),
(4004, 178, '_menu_item_url', '#sAbout'),
(4006, 179, '_menu_item_type', 'custom'),
(4007, 179, '_menu_item_menu_item_parent', '0'),
(4008, 179, '_menu_item_object_id', '179'),
(4009, 179, '_menu_item_object', 'custom'),
(4010, 179, '_menu_item_target', ''),
(4011, 179, '_menu_item_classes', 'a:1:{i:0;s:0:\"\";}'),
(4012, 179, '_menu_item_xfn', ''),
(4013, 179, '_menu_item_url', '#sWhereBuy'),
(4015, 180, '_menu_item_type', 'custom'),
(4016, 180, '_menu_item_menu_item_parent', '0'),
(4017, 180, '_menu_item_object_id', '180'),
(4018, 180, '_menu_item_object', 'custom'),
(4019, 180, '_menu_item_target', ''),
(4020, 180, '_menu_item_classes', 'a:1:{i:0;s:0:\"\";}'),
(4021, 180, '_menu_item_xfn', ''),
(4022, 180, '_menu_item_url', '#sFAQ'),
(4033, 182, '_menu_item_type', 'custom'),
(4034, 182, '_menu_item_menu_item_parent', '0'),
(4035, 182, '_menu_item_object_id', '182'),
(4036, 182, '_menu_item_object', 'custom'),
(4037, 182, '_menu_item_target', ''),
(4038, 182, '_menu_item_classes', 'a:1:{i:0;s:0:\"\";}'),
(4039, 182, '_menu_item_xfn', ''),
(4040, 182, '_menu_item_url', '#'),
(4060, 185, 'заголовок-1', 'УРОРЕК – оригинальный<sup>10</sup> альфа-адреноблокатор'),
(4061, 185, '_заголовок-1', 'field_62435bd26f29f'),
(4062, 185, 'текст-1', '<div class=\"headerBlock__body\">\r\n<p>Силодозин (действующее вещество препарата Урорек) обладает максимальной уроселективностью в&nbsp;своем классе, что обеспечивает его уродинамическую эффективность и&nbsp;высокую безопасность<sup>4</sup></p>\r\n</div>\r\n<div class=\"headerBlock__footer\">\r\n<p><strong>Показания к применению: </strong><br/>Лечение симптомов доброкачественной гиперплазии предстательной железы<sup>6</sup></p>\r\n</div>'),
(4063, 185, '_текст-1', 'field_62435c0c6f2a0'),
(4064, 185, 'изображение-1', '13'),
(4065, 185, '_изображение-1', 'field_62435c8b6f2a1'),
(4066, 185, 'фон-1', '17'),
(4067, 185, '_фон-1', 'field_62435db92ea96'),
(4068, 185, 'заголовок-2', 'Ключевые преимущества препарата Урорек'),
(4069, 185, '_заголовок-2', 'field_6243606295196'),
(4070, 185, 'список-2', 'Единственный оригинальный препарат из&nbsp;группы альфа1-адреноблокаторов, не&nbsp;имеющий генериков в&nbsp;РФ<sup>1</sup>'),
(4071, 185, '_список-2', 'field_6243608195197'),
(4072, 185, 'картинка_с_текстом_0_изображение', '31'),
(4073, 185, '_картинка_с_текстом_0_изображение', 'field_624363d095199'),
(4074, 185, 'картинка_с_текстом_0_описание', 'Обширная доказательная база собственных пострегистрационных клинических исследований<sup>2</sup>'),
(4075, 185, '_картинка_с_текстом_0_описание', 'field_624363e59519a'),
(4076, 185, 'картинка_с_текстом_1_изображение', '32'),
(4077, 185, '_картинка_с_текстом_1_изображение', 'field_624363d095199'),
(4078, 185, 'картинка_с_текстом_1_описание', 'Отсутствие риска замены препарата Урорек в&nbsp;аптеке (единственный препарат с&nbsp;действующим веществом силодозин)<sup>1</sup>'),
(4079, 185, '_картинка_с_текстом_1_описание', 'field_624363e59519a'),
(4080, 185, 'картинка_с_текстом_2_изображение', '33'),
(4081, 185, '_картинка_с_текстом_2_изображение', 'field_624363d095199'),
(4082, 185, 'картинка_с_текстом_2_описание', 'Большинство пациентов предпочитают принимать оригинальные препараты<sup>3</sup>'),
(4083, 185, '_картинка_с_текстом_2_описание', 'field_624363e59519a'),
(4084, 185, 'картинка_с_текстом', '3'),
(4085, 185, '_картинка_с_текстом', 'field_624363b995198'),
(4086, 185, 'второй_список', '<li>Клинические преимущества препарата Урорек (силодозин) определяются максимальной уроселективностью в&nbsp;классе альфа-адреноблокаторов<sup>4</sup></li>\r\n\r\n<li>Урорек&nbsp;&mdash; альфа-адреноблокатор последнего поколения, который эффективен в&nbsp;отношении всех СНМП (накопления, опорожнения, постмиктурических).<sup>12,13</sup> При этом Урорек обладает минимальным риском развития нежелательных явлений со&nbsp;стороны сердечно-сосудистой системы, в&nbsp;том числе&nbsp;у&nbsp;пациентов, принимающих антигипертензивные препараты<sup>46,8</sup> <small> <span>СНМП </span>симптомы нижних мочевыводящих путей</small></li>'),
(4087, 185, '_второй_список', 'field_6243640e05eda'),
(4088, 185, 'заголовок2-2', 'Максимальная уроселективность силодозина в&nbsp;классе альфа-адреноблокаторов обуславливает его уродинамическую эффективность и&nbsp;высокий профиль безопасности<sup>4</sup>'),
(4089, 185, '_заголовок2-2', 'field_6243644705edb'),
(4090, 185, 'текст3', '<ul>\r\n<li>Урорек значительно улучшает клинические проявления и&nbsp;качество жизни у&nbsp;всех пациентов с&nbsp;СНМП/ДГПЖ, в&nbsp;том числе с&nbsp;тяжелым течением<sup>11</sup><a href=\"#\">Узнать больше...</a></li>\r\n\r\n<li>Урорек является препаратом выбора для пациентов с&nbsp;СНМП/ДГПЖ и&nbsp;сопутствующими сердечно-сосудистыми заболеваниями<sup>3</sup> <a href=\"#\">Узнать больше...</a></li>\r\n</ul>\r\n<small> <span>ДГПЖ </span>доброкачественная гиперплазия предстательной железы</small>'),
(4091, 185, '_текст3', 'field_6243647405edc'),
(4092, 185, 'изображение-2', '34'),
(4093, 185, '_изображение-2', 'field_624364dd05edd'),
(4094, 185, 'текст_в_подвале', '<h2> Максимальная уроселективность в&nbsp;классе  альфа-адреноблокаторов<sup>4</sup></h2>\r\n<div class=\"h3\"> Почему это важно? <a href=\"#\">Подробнее</a></div>'),
(4095, 185, '_текст_в_подвале', 'field_62436daf1f6d9'),
(4096, 185, 'заголовок-3', 'Форма выпуска препарата Урорек'),
(4097, 185, '_заголовок-3', 'field_62436efee98e7'),
(4098, 185, 'текст-3', '<p class=\"section-descr\"><span>8мг </span>- рекомендуемая доза для лечения симптомов ДГПЖ<sup>6</sup>*</p>\r\n					<p class=\"section-note col-md-10\">*Более подробные сведения о&nbsp;препарате, особенностях применения, побочных действиях и&nbsp;др. &mdash;&nbsp;смотрите инструкцию по&nbsp;медицинскому применению лекарственного препарата Урорек, РУ&nbsp;ЛСР-005971/10 от&nbsp;25.06.2010 </p>'),
(4099, 185, '_текст-3', 'field_62436f60e98e8'),
(4100, 185, 'товар_0_название', 'Урорек 8мг №30'),
(4101, 185, '_товар_0_название', 'field_62436fcce98ea'),
(4102, 185, 'товар_0_описание', 'Упаковка, рассчитанная на&nbsp;1&nbsp;месяц лечения&nbsp;/ для старта терапии'),
(4103, 185, '_товар_0_описание', 'field_62436fe1e98eb'),
(4104, 185, 'товар_0_лицензия', 'РУ: ЛСР-005971/10 от 25.06.2010'),
(4105, 185, '_товар_0_лицензия', 'field_62436ff0e98ec'),
(4106, 185, 'товар_0_изображение', '51'),
(4107, 185, '_товар_0_изображение', 'field_62437045e98ed'),
(4108, 185, 'товар_1_название', 'Урорек 8мг №90'),
(4109, 185, '_товар_1_название', 'field_62436fcce98ea'),
(4110, 185, 'товар_1_описание', 'Выгодная упаковка, рассчитанная на&nbsp;3&nbsp;месяца лечения. Самая доступная стоимость 1&nbsp;дня терапии препаратом Урорек&nbsp;<sup>27</sup>'),
(4111, 185, '_товар_1_описание', 'field_62436fe1e98eb'),
(4112, 185, 'товар_1_лицензия', 'РУ: ЛСР-005971/10 от 25.06.2010'),
(4113, 185, '_товар_1_лицензия', 'field_62436ff0e98ec'),
(4114, 185, 'товар_1_изображение', '53'),
(4115, 185, '_товар_1_изображение', 'field_62437045e98ed'),
(4116, 185, 'товар_2_название', 'Урорек 4мг №30'),
(4117, 185, '_товар_2_название', 'field_62436fcce98ea'),
(4118, 185, 'товар_2_описание', '4&nbsp;мг&nbsp;&mdash; стартовая упаковка для лечения симптомов ДГПЖ у&nbsp;пациентов с&nbsp;почечной недостаточностью средней степени тяжести<sup>6</sup>'),
(4119, 185, '_товар_2_описание', 'field_62436fe1e98eb'),
(4120, 185, 'товар_2_лицензия', 'РУ: ЛСР-005971/10 от 25.06.2010'),
(4121, 185, '_товар_2_лицензия', 'field_62436ff0e98ec'),
(4122, 185, 'товар_2_изображение', '52'),
(4123, 185, '_товар_2_изображение', 'field_62437045e98ed'),
(4124, 185, 'товар', '3'),
(4125, 185, '_товар', 'field_62436fbde98e9'),
(4126, 185, 'заголовок-4', 'Где купить'),
(4127, 185, '_заголовок-4', 'field_624374f73d8bd'),
(4128, 185, 'изображения', 'a:12:{i:0;s:2:\"63\";i:1;s:2:\"64\";i:2;s:2:\"65\";i:3;s:2:\"66\";i:4;s:2:\"67\";i:5;s:2:\"68\";i:6;s:2:\"69\";i:7;s:2:\"70\";i:8;s:2:\"71\";i:9;s:2:\"72\";i:10;s:2:\"73\";i:11;s:2:\"74\";}'),
(4129, 185, '_изображения', 'field_624375093d8be'),
(4130, 185, 'изображения-4', 'a:12:{i:0;s:2:\"63\";i:1;s:2:\"64\";i:2;s:2:\"65\";i:3;s:2:\"66\";i:4;s:2:\"67\";i:5;s:2:\"68\";i:6;s:2:\"69\";i:7;s:2:\"70\";i:8;s:2:\"71\";i:9;s:2:\"72\";i:10;s:2:\"73\";i:11;s:2:\"74\";}'),
(4131, 185, '_изображения-4', 'field_624375093d8be'),
(4132, 185, 'заголовок-5', 'Способ применения*<sup>6</sup>'),
(4133, 185, '_заголовок-5', 'field_624379bd4756d'),
(4134, 185, 'иконки', 'a:5:{i:0;s:2:\"83\";i:1;s:2:\"84\";i:2;s:2:\"85\";i:3;s:2:\"86\";i:4;s:2:\"87\";}'),
(4135, 185, '_иконки', 'field_624379f24756e'),
(4136, 185, 'текст-5', 'У пациентов с легкой почечной недостаточностью (клиренс креатинина ≥ 50 — ≤ 80 мл/мин) коррекция дозы не требуется. Для лечения пациентов с почечной недостаточностью средней степени тяжести (клиренс креатинина ≥ 30 — < 50 мл/мин) рекомендуется в течение первой недели принимать начальную дозу по 4 мг в сутки, при хорошей индивидуальной переносимости доза может быть увеличена до 8 мг в сутки. Применение препарата для пациентов с тяжелой почечной недостаточностью (клиренс креатинина < 30 мл / мин) не рекомендуется'),
(4137, 185, '_текст-5', 'field_62437a374756f'),
(4138, 185, 'текст_под_кнопкой', '*Более подробные сведения о&nbsp;препарате, особенностях применения, побочных действиях и&nbsp;др. &mdash;&nbsp;см. инструкцию по&nbsp;медицинскому применению лекарственного препарата Урорек, РУ&nbsp;ЛСР-005971/10 от&nbsp;25.06.2010'),
(4139, 185, '_текст_под_кнопкой', 'field_62437a7c47570'),
(4140, 185, 'заголовок-6', 'Препарат Урорек (силодозин) включен в&nbsp;российские и&nbsp;международные клинические рекомендации и&nbsp;стандарты для лечения ряда урологических заболеваний:'),
(4141, 185, '_заголовок-6', 'field_6244117c68bd0'),
(4142, 185, 'список-6_0_ссылка', 'a:3:{s:5:\"title\";s:68:\"Российские клинические рекомендации\";s:3:\"url\";s:1:\"#\";s:6:\"target\";s:0:\"\";}'),
(4143, 185, '_список-6_0_ссылка', 'field_624411ce68bd2'),
(4144, 185, 'список-6_0_описание', '«Доброкачественная гиперплазия предстательной железы», 2020<sup>28</sup>'),
(4145, 185, '_список-6_0_описание', 'field_6244121168bd3'),
(4146, 185, 'список-6_1_ссылка', 'a:3:{s:5:\"title\";s:70:\"Европейские клинические рекомендации\";s:3:\"url\";s:1:\"#\";s:6:\"target\";s:0:\"\";}'),
(4147, 185, '_список-6_1_ссылка', 'field_624411ce68bd2'),
(4148, 185, 'список-6_1_описание', 'глава «Консервативное лечение ненейрогенных симптомов нарушенного мочеиспускания у мужчин, включая доброкачественную простатическую обструкцию», 2021<sup>29</sup>'),
(4149, 185, '_список-6_1_описание', 'field_6244121168bd3'),
(4150, 185, 'список-6_2_ссылка', 'a:3:{s:5:\"title\";s:154:\"Стандарт первичной медико-санитарной помощи при гиперплазии предстательной железы\";s:3:\"url\";s:1:\"#\";s:6:\"target\";s:0:\"\";}'),
(4151, 185, '_список-6_2_ссылка', 'field_624411ce68bd2'),
(4152, 185, 'список-6_2_описание', '09.11.2012<sup>30</sup> / Обновлён 13.04.2015\r\n'),
(4153, 185, '_список-6_2_описание', 'field_6244121168bd3'),
(4154, 185, 'список-6_3_ссылка', 'a:3:{s:5:\"title\";s:122:\"Стандарт специализированной медицинской помощи при задержке мочи\";s:3:\"url\";s:1:\"#\";s:6:\"target\";s:0:\"\";}'),
(4155, 185, '_список-6_3_ссылка', 'field_624411ce68bd2'),
(4156, 185, 'список-6_3_описание', '29.01.2013<sup>31</sup> / Обновлён 06.05.2015\r\n'),
(4157, 185, '_список-6_3_описание', 'field_6244121168bd3'),
(4158, 185, 'список-6_4_ссылка', 'a:3:{s:5:\"title\";s:133:\"Стандарт первичной медико-санитарной помощи при хроническом простатите\";s:3:\"url\";s:1:\"#\";s:6:\"target\";s:0:\"\";}'),
(4159, 185, '_список-6_4_ссылка', 'field_624411ce68bd2'),
(4160, 185, 'список-6_4_описание', '09.11.2012<sup>32</sup> / Обновлён 13.04.2015\r\n'),
(4161, 185, '_список-6_4_описание', 'field_6244121168bd3'),
(4162, 185, 'список-6_5_ссылка', 'a:3:{s:5:\"title\";s:168:\"Стандарт специализированной медицинской помощи при остром простатите, орхите, эпидидимите\";s:3:\"url\";s:1:\"#\";s:6:\"target\";s:0:\"\";}'),
(4163, 185, '_список-6_5_ссылка', 'field_624411ce68bd2'),
(4164, 185, 'список-6_5_описание', '09.11.2012<sup>33</sup> / Обновлён 27.05.2015'),
(4165, 185, '_список-6_5_описание', 'field_6244121168bd3'),
(4166, 185, 'список-6', '6'),
(4167, 185, '_список-6', 'field_624411be68bd1'),
(4168, 185, 'заголовок-7', 'Препарат Урорек (силодозин) зарегистрирован и&nbsp;применяется в&nbsp;разных странах мира Одобрен ЕМА*<sup>34</sup> и&nbsp;FDA**<sup>35</sup>'),
(4169, 185, '_заголовок-7', 'field_624417e3b6088'),
(4170, 185, 'текст', '<p class=\"sOtherCountries__agency\"><span>EMA</span> Европейское медицинское агентство</p>\r\n<p class=\"sOtherCountries__agency\"><span>FDA</span> Управление по&nbsp;санитарному надзору за&nbsp;качеством пищевых продуктов и&nbsp;медикаментов, США</p>'),
(4171, 185, '_текст', 'field_6244182bb6089'),
(4172, 185, 'страны_0_флаг', '105'),
(4173, 185, '_страны_0_флаг', 'field_62441880b608b'),
(4174, 185, 'страны_0_название', 'Япония'),
(4175, 185, '_страны_0_название', 'field_62441899b608c'),
(4176, 185, 'страны_0_год', '2006<sup>36,37</sup>'),
(4177, 185, '_страны_0_год', 'field_624418aab608d'),
(4178, 185, 'страны_1_флаг', '106'),
(4179, 185, '_страны_1_флаг', 'field_62441880b608b'),
(4180, 185, 'страны_1_название', 'США'),
(4181, 185, '_страны_1_название', 'field_62441899b608c'),
(4182, 185, 'страны_1_год', '2008<sup>35</sup>'),
(4183, 185, '_страны_1_год', 'field_624418aab608d'),
(4184, 185, 'страны_2_флаг', '107'),
(4185, 185, '_страны_2_флаг', 'field_62441880b608b'),
(4186, 185, 'страны_2_название', 'Страны ЕС'),
(4187, 185, '_страны_2_название', 'field_62441899b608c'),
(4188, 185, 'страны_2_год', '2010<sup>34</sup>'),
(4189, 185, '_страны_2_год', 'field_624418aab608d'),
(4190, 185, 'страны_3_флаг', '108'),
(4191, 185, '_страны_3_флаг', 'field_62441880b608b'),
(4192, 185, 'страны_3_название', 'Россия'),
(4193, 185, '_страны_3_название', 'field_62441899b608c'),
(4194, 185, 'страны_3_год', '2010<sup>1</sup>'),
(4195, 185, '_страны_3_год', 'field_624418aab608d'),
(4196, 185, 'страны', '4'),
(4197, 185, '_страны', 'field_62441847b608a'),
(4198, 185, 'текст-7', '<p class=\"sOtherCountries__agency\"><span>EMA</span> Европейское медицинское агентство</p>\r\n<p class=\"sOtherCountries__agency\"><span>FDA</span> Управление по&nbsp;санитарному надзору за&nbsp;качеством пищевых продуктов и&nbsp;медикаментов, США</p>'),
(4199, 185, '_текст-7', 'field_6244182bb6089'),
(4200, 185, 'текст-7-1', 'Производство препарата Урорек, поставляемого в&nbsp;Россию, осуществляется в&nbsp;Италии с&nbsp;использованием субстанции из&nbsp;Японии, в&nbsp;соответствии с&nbsp;необходимыми требованиями к&nbsp;производству и&nbsp;контролю качества<sup>6,1</sup>'),
(4201, 185, '_текст-7-1', 'field_62441a5acf03c'),
(4202, 185, 'заголовок-8', 'О проблеме'),
(4203, 185, '_заголовок-8', 'field_624431d91624d'),
(4204, 185, 'текст-8', 'Доброкачественная гиперплазия предстательной железы (ДГПЖ), или как ее еще называют, аденома простаты, как правило, возникает у мужчин старше 50 лет и характеризуется наличием симптомов нижних мочевыводящих путей (СНМП), увеличением предстательной железы или ее части, и нарушением оттока мочи из мочевого пузыря вследствие инфравезикальной обструкции.<sup>38</sup>\r\n\r\nРаспространенность ДГПЖ увеличивается с возрастом. Так, клинически значимая ДГПЖ проявляется у 13% мужчин в возрасте старше 50 лет, у 34% мужчин в возрасте 60 лет и у 43% в возрасте 70 лет.<sup>39</sup>\r\n\r\n&nbsp;\r\n\r\n[caption id=\"attachment_122\" align=\"alignnone\" width=\"594\"]<img class=\"wp-image-122 size-full\" src=\"http://0026urotec.loc:8888/wp-content/uploads/2022/03/about-img.png\" alt=\"мужик\" width=\"594\" height=\"696\" /> Федя[/caption]'),
(4205, 185, '_текст-8', 'field_624431f11624e'),
(4206, 185, 'текст-8-1', 'Наличие СНМП может быть ассоциировано с&nbsp;тяжелыми хроническими заболеваниями, такими как заболевания сердца, сахарный диабет, артериальная гипертензия и&nbsp;депрессия<sup>40</sup>'),
(4207, 185, '_текст-8-1', 'field_6244320b26db3'),
(4208, 185, 'иконки-8', 'a:6:{i:0;s:3:\"123\";i:1;s:3:\"124\";i:2;s:3:\"125\";i:3;s:3:\"126\";i:4;s:3:\"127\";i:5;s:3:\"128\";}'),
(4209, 185, '_иконки-8', 'field_6244322d26db4'),
(4210, 185, 'текст-8-2', '<h3>Симптомы доброкачественной гиперплазии предстательной железы</h3>\r\nСимптомы нарушенного мочеиспускания являются частой жалобой у взрослых мужчин. Они оказывают серьезное негативное влияние на качество жизни. При ДГПЖ предстательная железа увеличивается в размерах, оказывая давление на нижние мочевые пути. В результате развиваются следующие симптомы:<sup>41</sup>'),
(4211, 185, '_текст-8-2', 'field_6244335fe2373'),
(4212, 185, 'заголовок-9', 'Осложнения ДГПЖ<sup>38</sup>'),
(4213, 185, '_заголовок-9', 'field_6244377a52263'),
(4214, 185, 'изображения-9', 'a:6:{i:0;s:3:\"141\";i:1;s:3:\"142\";i:2;s:3:\"143\";i:3;s:3:\"144\";i:4;s:3:\"145\";i:5;s:3:\"146\";}'),
(4215, 185, '_изображения-9', 'field_6244379652264'),
(4216, 185, 'заголовок-10', 'Медикаментозное лечение СНМП/ДГПЖ'),
(4217, 185, '_заголовок-10', 'field_6244489614262'),
(4218, 185, 'текст-10', 'Антагонисты альфа1-адренорецепторов (альфа-адреноблокаторы) и&nbsp;ингибиторы 5&nbsp;альфа1-редуктазы (ингибиторы 5-АР) являются группами лекарственных препаратов, которые в&nbsp;настоящее время утверждены для лечения ДГПЖ. Обе группы препаратов обеспечивают надлежащее ослабление симптомов, но&nbsp;&alpha;&mdash;блокаторы обладают довольно быстрым началом действия, а&nbsp;ингибиторам 5-АР требуется несколько месяцев для получения терапевтического эффекта.<sup>42</sup>'),
(4219, 185, '_текст-10', 'field_624448ce14263'),
(4220, 185, 'карточки-10_0_заголовок', 'Альфа-адреноблокаторы'),
(4221, 185, '_карточки-10_0_заголовок', 'field_624448fc14265'),
(4222, 185, 'карточки-10_0_текст', 'представляют собой наиболее эффективный класс лекарственных препаратов, характеризующийся хорошим профилем безопасности и высокой комплаентностью, применяющийся для облегчения СНМП, связанных с ДГПЖ: они снимают спазм гладкой мускулатуры предстательной железы и шейки мочевого пузыря42'),
(4223, 185, '_карточки-10_0_текст', 'field_6244490c14266'),
(4224, 185, 'карточки-10_1_заголовок', 'Ингибиторы 5-АР —'),
(4225, 185, '_карточки-10_1_заголовок', 'field_624448fc14265'),
(4226, 185, 'карточки-10_1_текст', 'приводят к редукции железистой ткани и к снижению размера предстательной железы: они блокируют конверсию тестостерона в дигидротестостерон, который стимулирует рост предстательной железы43,44.Назначаются при большом объеме предстательной железы. Для получения значимого клинического эффекта требуется несколько месяцев применения45\r\n'),
(4227, 185, '_карточки-10_1_текст', 'field_6244490c14266'),
(4228, 185, 'карточки-10', '2'),
(4229, 185, '_карточки-10', 'field_624448e214264'),
(4230, 185, 'видео', '<iframe width=\"560\" height=\"315\" src=\"https://www.youtube.com/embed/3DrU3pFXSsY\" title=\"YouTube video player\" frameborder=\"0\" allow=\"accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture\" allowfullscreen></iframe>'),
(4231, 185, '_видео', 'field_6244492214267'),
(4232, 185, 'заголовок-11', 'Часто задаваемые вопросы'),
(4233, 185, '_заголовок-11', 'field_62444b33e25d6'),
(4234, 185, 'вопросы_0_заголовок', 'Почему при приеме препарата Урорек у некоторых пациентов развивается нарушение эякуляции?'),
(4235, 185, '_вопросы_0_заголовок', 'field_62444b58e25d8'),
(4236, 185, 'вопросы_0_текст', 'Урорек — высокоселективный препарат, то есть преимущественно действует на альфа1А-адренорецепторы, которые находятся в нижних мочевых путях, предстательной железе и семенных пузырьках. Поэтому эффект развивается уже через 2–6 часов после приёма первой дозы препарата Урорек<sup>14</sup> при минимальным количестве нежелательных явлений.<sup>5</sup>\r\n\r\nНаиболее частый побочный эффект при приеме препарата Урорек — нарушение эякуляции<sup>46</sup>. Это может быть связано как с забросом эякулята при семяизвержении вместо уретры в мочевой пузырь, так и со снижением или отсутствием семенной жидкости во время эякуляции<sup>29</sup>. Силодозин снижает тонус гладкомышечных клеток семенных пузырьков, простаты и шейки мочевого пузыря, поэтому не происходит выброс семени. Этот эффект свойственен всем уроселективным альфа-адреноблокаторам<sup>53</sup> и самостоятельно исчезает после прекращения приема препарата.<sup>6</sup>\r\n\r\nЧастота эякуляторной дисфункции прямо пропорционально связана с улучшением СНМП и скорости мочеиспускания и подтверждает эффективность альфа-адреноблокатора: чем выше эффективность, тем выше частота встречаемости эякуляторной дисфункции.<sup>29</sup>\r\n\r\nНарушение эякуляции не влияет на сексуальную функцию<sup>52</sup>, не воспринимается как беспокоящий симптом подавляющим большинством пациентов и не требует отмены терапии.<sup>46</sup>'),
(4237, 185, '_вопросы_0_текст', 'field_62444b66e25d9'),
(4238, 185, 'вопросы_1_заголовок', 'Можно ли принимать Урорек при артериальной гипертензии и ишемический болезни сердца (ИБС)?'),
(4239, 185, '_вопросы_1_заголовок', 'field_62444b58e25d8'),
(4240, 185, 'вопросы_1_текст', 'Согласно инструкции по медицинскому применению, противопоказаний для применения лекарственного препарата Урорек у пациентов с СНМП/ДГПЖ и сопутствующими сердечно-сосудистыми заболеваниями нет.<sup>3</sup> Урорек не оказывает влияния на частоту сердечных сокращений (ЧСС), систолическое артериальное давление (САД) и диастолическое артериальное давление (ДАД).<sup>9</sup> Силодозин — не вызывает клинически значимого снижения артериального давления (АД)<sup>46</sup>, не усиливает действие антигипертензивных препаратов и не требует снижения дозы при одновременном приеме.<sup>7</sup> В соответствии с дизайном клинического исследования многие пациенты получали сопутствующую терапию антигипертензивными препаратами (в основном, средствами, воздействующими на ренин-ангиотензиновую систему, бета-блокаторами, антагонистами кальция и диуретиками) без повышения частоты ортостатической гипотензии.<sup>6</sup>\r\n\r\nПри приеме препарата Урорек наиболее низкий риск развития сердечно-сосудистых осложнений.<sup>5</sup>'),
(4241, 185, '_вопросы_1_текст', 'field_62444b66e25d9'),
(4242, 185, 'вопросы_2_заголовок', 'Можно ли принимать Урорек пациенту с ортостатической гипотензией в анамнезе?'),
(4243, 185, '_вопросы_2_заголовок', 'field_62444b58e25d8'),
(4244, 185, 'вопросы_2_текст', 'Повышенная селективность силодозина к альфа1A-адренорецепторам по сравнению с альфа1B-адренорецепторами выражается в пониженном риске развития сердечно-сосудистых осложнений.<sup>4</sup> Благодаря этому частота ортостатической гипотензии на фоне его приема сравнима с таковой при приеме плацебо.<sup>45,9</sup>\r\n\r\nВ отличие от других альфа-адреноблокаторов (например, все формы тамсулозина<sup>47,48</sup>), Урорек не противопоказан к приему у пациентов с ортостатической гипотензией в анамнезе. Тем не менее, пациентам с ортостатической гипотензией в анамнезе не рекомендуется принимать любые альфа-адреноблокаторы, в т.ч. Урорек.<sup>6</sup>'),
(4245, 185, '_вопросы_2_текст', 'field_62444b66e25d9'),
(4246, 185, 'вопросы_3_заголовок', 'Как долго можно принимать Урорек?'),
(4247, 185, '_вопросы_3_заголовок', 'field_62444b58e25d8'),
(4248, 185, 'вопросы_3_текст', 'Учитывая прогрессирующий характер течения доброкачественной гиперплазии предстательной железы, медикаментозную терапию следует проводить длительно (иногда в течение всей жизни пациента).<sup>49</sup>'),
(4249, 185, '_вопросы_3_текст', 'field_62444b66e25d9'),
(4250, 185, 'вопросы_4_заголовок', 'Пациенты жалуются на заложенность носа при лечении альфа-адреноблокаторами. Есть ли у препарата Урорек такое побочное действие?'),
(4251, 185, '_вопросы_4_заголовок', 'field_62444b58e25d8'),
(4252, 185, 'вопросы_4_текст', 'Заложенность носа — это возможный побочный эффект для всех альфа-адреноблокаторов. При приеме препарата Урорек он может возникать примерно в 1% случаев.<sup>46</sup>'),
(4253, 185, '_вопросы_4_текст', 'field_62444b66e25d9'),
(4254, 185, 'вопросы_5_заголовок', 'Можно ли начинать лечение препаратом Урорек с дозы 4 мг в сутки?'),
(4255, 185, '_вопросы_5_заголовок', 'field_62444b58e25d8');
INSERT INTO `urotec_postmeta` (`meta_id`, `post_id`, `meta_key`, `meta_value`) VALUES
(4256, 185, 'вопросы_5_текст', 'Согласно инструкции по медицинскому применению лекарственного препарата Урорек, доза 8 мг в сутки рекомендована для лечения пациентов с СНМП/ДГПЖ. Титрование дозы при применении силодозина не требуется.\r\n\r\nУрорек 4 мг — это специальная доза для лечения пациентов с почечной недостаточностью средней степени тяжести (клиренс креатинина ≥ 30 до &lt; 50 мл/мин). Рекомендуется в течение первой недели принимать начальную дозу по 4 мг в сутки, далее при хорошей переносимости доза может быть увеличена до 8 мг в сутки.<sup>6</sup>**Более подробные сведения о препарате, особенностях применения, побочных действиях и др. — см. инструкцию по медицинскому применению лекарственного препарата Урорек, РУ ЛСР-005971/10 от 25.06.2010'),
(4257, 185, '_вопросы_5_текст', 'field_62444b66e25d9'),
(4258, 185, 'вопросы_6_заголовок', 'Влияет ли Урорек на течение ДГПЖ или только снимает симптомы нижних мочевыводящих путей?'),
(4259, 185, '_вопросы_6_заголовок', 'field_62444b58e25d8'),
(4260, 185, 'вопросы_6_текст', 'Помимо субъективных симптомов, ДГПЖ вызывает прогрессирующее морфологическое ремоделирование мочевого пузыря с риском развития серьезных функциональных нарушений. Лечение должно не только купировать субъективные симптомы, но и включать профилактику патологического ремоделирования мочевого пузыря.<sup>161</sup>\r\n\r\nСилодозин, действующее вещество препарата Урорек, в сравнении с другими альфа-адреноблокаторами более эффективно влияет на инфравезикальную обструкцию (ИВО), что оказывает влияние на предотвращение патологического прогрессирования ремоделирования мочевого пузыря и риск развития серьезных функциональных нарушений.<sup>50,51</sup>'),
(4261, 185, '_вопросы_6_текст', 'field_62444b66e25d9'),
(4262, 185, 'вопросы_7_заголовок', 'Доступен ли Урорек по льготному отпуску?'),
(4263, 185, '_вопросы_7_заголовок', 'field_62444b58e25d8'),
(4264, 185, 'вопросы_7_текст', 'Урорек (силодозин) не включен в список жизненно важных лекарственных препаратов (ЖНВЛП)<sup>1</sup> и не входит в перечень препаратов для льготного обеспечения граждан по федеральному льготному списку.'),
(4265, 185, '_вопросы_7_текст', 'field_62444b66e25d9'),
(4266, 185, 'вопросы', '8'),
(4267, 185, '_вопросы', 'field_62444b49e25d7'),
(4295, 1, '_edit_lock', '1648663305:1'),
(4296, 190, '_wp_attached_file', '2022/03/unsplash_lQGJCMY5qcM.jpg'),
(4297, 190, '_wp_attachment_metadata', 'a:5:{s:5:\"width\";i:639;s:6:\"height\";i:335;s:4:\"file\";s:32:\"2022/03/unsplash_lQGJCMY5qcM.jpg\";s:5:\"sizes\";a:2:{s:6:\"medium\";a:4:{s:4:\"file\";s:32:\"unsplash_lQGJCMY5qcM-300x157.jpg\";s:5:\"width\";i:300;s:6:\"height\";i:157;s:9:\"mime-type\";s:10:\"image/jpeg\";}s:9:\"thumbnail\";a:4:{s:4:\"file\";s:32:\"unsplash_lQGJCMY5qcM-150x150.jpg\";s:5:\"width\";i:150;s:6:\"height\";i:150;s:9:\"mime-type\";s:10:\"image/jpeg\";}}s:10:\"image_meta\";a:12:{s:8:\"aperture\";s:1:\"0\";s:6:\"credit\";s:0:\"\";s:6:\"camera\";s:0:\"\";s:7:\"caption\";s:0:\"\";s:17:\"created_timestamp\";s:1:\"0\";s:9:\"copyright\";s:0:\"\";s:12:\"focal_length\";s:1:\"0\";s:3:\"iso\";s:1:\"0\";s:13:\"shutter_speed\";s:1:\"0\";s:5:\"title\";s:0:\"\";s:11:\"orientation\";s:1:\"0\";s:8:\"keywords\";a:0:{}}}'),
(4300, 192, '_wp_attached_file', '2022/03/unsplash_lQGJCMY5qcM-1.jpg'),
(4301, 192, '_wp_attachment_metadata', 'a:5:{s:5:\"width\";i:639;s:6:\"height\";i:335;s:4:\"file\";s:34:\"2022/03/unsplash_lQGJCMY5qcM-1.jpg\";s:5:\"sizes\";a:2:{s:6:\"medium\";a:4:{s:4:\"file\";s:34:\"unsplash_lQGJCMY5qcM-1-300x157.jpg\";s:5:\"width\";i:300;s:6:\"height\";i:157;s:9:\"mime-type\";s:10:\"image/jpeg\";}s:9:\"thumbnail\";a:4:{s:4:\"file\";s:34:\"unsplash_lQGJCMY5qcM-1-150x150.jpg\";s:5:\"width\";i:150;s:6:\"height\";i:150;s:9:\"mime-type\";s:10:\"image/jpeg\";}}s:10:\"image_meta\";a:12:{s:8:\"aperture\";s:1:\"0\";s:6:\"credit\";s:0:\"\";s:6:\"camera\";s:0:\"\";s:7:\"caption\";s:0:\"\";s:17:\"created_timestamp\";s:1:\"0\";s:9:\"copyright\";s:0:\"\";s:12:\"focal_length\";s:1:\"0\";s:3:\"iso\";s:1:\"0\";s:13:\"shutter_speed\";s:1:\"0\";s:5:\"title\";s:0:\"\";s:11:\"orientation\";s:1:\"0\";s:8:\"keywords\";a:0:{}}}'),
(4304, 1, '_thumbnail_id', '196'),
(4305, 1, 'wbcr_wp_old_slug', '%d0%bf%d1%80%d0%b8%d0%b2%d0%b5%d1%82-%d0%bc%d0%b8%d1%80'),
(4306, 178, 'wbcr_wp_old_slug', '%d0%be-%d0%bf%d1%80%d0%be%d0%b1%d0%bb%d0%b5%d0%bc%d0%b5'),
(4307, 179, 'wbcr_wp_old_slug', '%d0%b3%d0%b4%d0%b5-%d0%ba%d1%83%d0%bf%d0%b8%d1%82%d1%8c'),
(4308, 180, 'wbcr_wp_old_slug', '%d0%b2%d0%be%d0%bf%d1%80%d0%be%d1%81%d1%8b-%d0%b8-%d0%be%d1%82%d0%b2%d0%b5%d1%82%d1%8b'),
(4310, 182, 'wbcr_wp_old_slug', '%d0%bf%d0%be%d0%bb%d0%b8%d1%82%d0%b8%d0%ba%d0%b0-%d0%ba%d0%be%d0%bd%d1%84%d0%b8%d0%b4%d0%b5%d0%bd%d1%86%d0%b8%d0%b0%d0%bb%d1%8c%d0%bd%d0%be%d1%81%d1%82%d0%b8-2'),
(4313, 193, '_thumbnail_id', '192'),
(4314, 193, 'wbcr_wp_old_slug', '%d0%bf%d1%80%d0%b8%d0%b2%d0%b5%d1%82-%d0%bc%d0%b8%d1%80'),
(4315, 193, '_dp_original', '1'),
(4316, 193, '_edit_lock', '1648661100:1'),
(4321, 196, '_wp_attached_file', '2022/03/art-4.jpg'),
(4322, 196, '_wp_attachment_metadata', 'a:5:{s:5:\"width\";i:1000;s:6:\"height\";i:667;s:4:\"file\";s:17:\"2022/03/art-4.jpg\";s:5:\"sizes\";a:5:{s:6:\"medium\";a:4:{s:4:\"file\";s:17:\"art-4-300x200.jpg\";s:5:\"width\";i:300;s:6:\"height\";i:200;s:9:\"mime-type\";s:10:\"image/jpeg\";}s:9:\"thumbnail\";a:4:{s:4:\"file\";s:17:\"art-4-150x150.jpg\";s:5:\"width\";i:150;s:6:\"height\";i:150;s:9:\"mime-type\";s:10:\"image/jpeg\";}s:12:\"medium_large\";a:4:{s:4:\"file\";s:17:\"art-4-768x512.jpg\";s:5:\"width\";i:768;s:6:\"height\";i:512;s:9:\"mime-type\";s:10:\"image/jpeg\";}s:3:\"adv\";a:4:{s:4:\"file\";s:17:\"art-4-680x667.jpg\";s:5:\"width\";i:680;s:6:\"height\";i:667;s:9:\"mime-type\";s:10:\"image/jpeg\";}s:3:\"art\";a:4:{s:4:\"file\";s:17:\"art-4-640x340.jpg\";s:5:\"width\";i:640;s:6:\"height\";i:340;s:9:\"mime-type\";s:10:\"image/jpeg\";}}s:10:\"image_meta\";a:12:{s:8:\"aperture\";s:1:\"0\";s:6:\"credit\";s:0:\"\";s:6:\"camera\";s:0:\"\";s:7:\"caption\";s:0:\"\";s:17:\"created_timestamp\";s:1:\"0\";s:9:\"copyright\";s:0:\"\";s:12:\"focal_length\";s:1:\"0\";s:3:\"iso\";s:1:\"0\";s:13:\"shutter_speed\";s:1:\"0\";s:5:\"title\";s:0:\"\";s:11:\"orientation\";s:1:\"0\";s:8:\"keywords\";a:0:{}}}'),
(4325, 197, '_thumbnail_id', '198'),
(4326, 197, 'wbcr_wp_old_slug', '%d0%bf%d1%80%d0%b8%d0%b2%d0%b5%d1%82-%d0%bc%d0%b8%d1%80'),
(4328, 197, '_dp_original', '193'),
(4329, 197, '_edit_lock', '1648663285:1'),
(4330, 198, '_wp_attached_file', '2022/03/art-5.jpg'),
(4331, 198, '_wp_attachment_metadata', 'a:5:{s:5:\"width\";i:1000;s:6:\"height\";i:667;s:4:\"file\";s:17:\"2022/03/art-5.jpg\";s:5:\"sizes\";a:5:{s:6:\"medium\";a:4:{s:4:\"file\";s:17:\"art-5-300x200.jpg\";s:5:\"width\";i:300;s:6:\"height\";i:200;s:9:\"mime-type\";s:10:\"image/jpeg\";}s:9:\"thumbnail\";a:4:{s:4:\"file\";s:17:\"art-5-150x150.jpg\";s:5:\"width\";i:150;s:6:\"height\";i:150;s:9:\"mime-type\";s:10:\"image/jpeg\";}s:12:\"medium_large\";a:4:{s:4:\"file\";s:17:\"art-5-768x512.jpg\";s:5:\"width\";i:768;s:6:\"height\";i:512;s:9:\"mime-type\";s:10:\"image/jpeg\";}s:3:\"adv\";a:4:{s:4:\"file\";s:17:\"art-5-680x667.jpg\";s:5:\"width\";i:680;s:6:\"height\";i:667;s:9:\"mime-type\";s:10:\"image/jpeg\";}s:3:\"art\";a:4:{s:4:\"file\";s:17:\"art-5-640x340.jpg\";s:5:\"width\";i:640;s:6:\"height\";i:340;s:9:\"mime-type\";s:10:\"image/jpeg\";}}s:10:\"image_meta\";a:12:{s:8:\"aperture\";s:1:\"0\";s:6:\"credit\";s:0:\"\";s:6:\"camera\";s:0:\"\";s:7:\"caption\";s:0:\"\";s:17:\"created_timestamp\";s:1:\"0\";s:9:\"copyright\";s:0:\"\";s:12:\"focal_length\";s:1:\"0\";s:3:\"iso\";s:1:\"0\";s:13:\"shutter_speed\";s:1:\"0\";s:5:\"title\";s:0:\"\";s:11:\"orientation\";s:1:\"0\";s:8:\"keywords\";a:0:{}}}'),
(4334, 200, '_edit_lock', '1648730869:1'),
(4335, 200, '_wp_page_template', 'articals.php'),
(4336, 202, '_thumbnail_id', '198'),
(4337, 202, 'wbcr_wp_old_slug', '%d0%bf%d1%80%d0%b8%d0%b2%d0%b5%d1%82-%d0%bc%d0%b8%d1%80'),
(4339, 202, '_dp_original', '197'),
(4340, 203, '_thumbnail_id', '192'),
(4341, 203, 'wbcr_wp_old_slug', '%d0%bf%d1%80%d0%b8%d0%b2%d0%b5%d1%82-%d0%bc%d0%b8%d1%80'),
(4343, 203, '_dp_original', '193'),
(4344, 204, '_thumbnail_id', '196'),
(4345, 204, 'wbcr_wp_old_slug', '%d0%bf%d1%80%d0%b8%d0%b2%d0%b5%d1%82-%d0%bc%d0%b8%d1%80'),
(4346, 204, '_dp_original', '1'),
(4347, 205, '_thumbnail_id', '198'),
(4348, 205, 'wbcr_wp_old_slug', '%d0%bf%d1%80%d0%b8%d0%b2%d0%b5%d1%82-%d0%bc%d0%b8%d1%80'),
(4350, 205, '_dp_original', '202'),
(4351, 206, '_thumbnail_id', '192'),
(4352, 206, 'wbcr_wp_old_slug', '%d0%bf%d1%80%d0%b8%d0%b2%d0%b5%d1%82-%d0%bc%d0%b8%d1%80'),
(4354, 206, '_dp_original', '203'),
(4355, 207, '_thumbnail_id', '196'),
(4356, 207, 'wbcr_wp_old_slug', '%d0%bf%d1%80%d0%b8%d0%b2%d0%b5%d1%82-%d0%bc%d0%b8%d1%80'),
(4358, 207, '_dp_original', '204'),
(4359, 208, '_thumbnail_id', '198'),
(4360, 208, 'wbcr_wp_old_slug', '%d0%bf%d1%80%d0%b8%d0%b2%d0%b5%d1%82-%d0%bc%d0%b8%d1%80'),
(4362, 208, '_dp_original', '197'),
(4363, 209, '_thumbnail_id', '192'),
(4364, 209, 'wbcr_wp_old_slug', '%d0%bf%d1%80%d0%b8%d0%b2%d0%b5%d1%82-%d0%bc%d0%b8%d1%80'),
(4366, 209, '_dp_original', '193'),
(4367, 210, '_thumbnail_id', '196'),
(4368, 210, 'wbcr_wp_old_slug', '%d0%bf%d1%80%d0%b8%d0%b2%d0%b5%d1%82-%d0%bc%d0%b8%d1%80'),
(4369, 210, '_dp_original', '1'),
(4370, 207, '_edit_last', '1'),
(4373, 207, '_edit_lock', '1648663637:1'),
(4374, 208, '_edit_last', '1'),
(4377, 208, '_edit_lock', '1648663645:1'),
(4378, 209, '_edit_last', '1'),
(4381, 209, '_edit_lock', '1648663656:1'),
(4382, 210, '_edit_last', '1'),
(4385, 210, '_edit_lock', '1648663662:1'),
(4386, 205, '_edit_last', '1'),
(4389, 205, '_edit_lock', '1648663668:1'),
(4390, 206, '_edit_last', '1'),
(4393, 206, '_edit_lock', '1648663674:1'),
(4394, 202, '_edit_last', '1'),
(4397, 202, '_edit_lock', '1648663678:1'),
(4398, 203, '_edit_last', '1'),
(4401, 203, '_edit_lock', '1648663684:1'),
(4402, 204, '_edit_last', '1'),
(4405, 204, '_edit_lock', '1648663691:1'),
(4406, 222, '_menu_item_type', 'post_type'),
(4407, 222, '_menu_item_menu_item_parent', '0'),
(4408, 222, '_menu_item_object_id', '200'),
(4409, 222, '_menu_item_object', 'page'),
(4410, 222, '_menu_item_target', ''),
(4411, 222, '_menu_item_classes', 'a:1:{i:0;s:0:\"\";}'),
(4412, 222, '_menu_item_xfn', ''),
(4413, 222, '_menu_item_url', ''),
(4415, 223, 'заголовок-1', 'УРОРЕК – оригинальный<sup>10</sup> альфа-адреноблокатор'),
(4416, 223, '_заголовок-1', 'field_62435bd26f29f'),
(4417, 223, 'текст-1', '<div class=\"headerBlock__body\">\r\n<p>Силодозин (действующее вещество препарата Урорек) обладает максимальной уроселективностью в&nbsp;своем классе, что обеспечивает его уродинамическую эффективность и&nbsp;высокую безопасность<sup>4</sup></p>\r\n</div>\r\n<div class=\"headerBlock__footer\">\r\n<p><strong>Показания к применению: </strong><br/>Лечение симптомов доброкачественной гиперплазии предстательной железы<sup>6</sup></p>\r\n</div>'),
(4418, 223, '_текст-1', 'field_62435c0c6f2a0'),
(4419, 223, 'изображение-1', '13'),
(4420, 223, '_изображение-1', 'field_62435c8b6f2a1'),
(4421, 223, 'фон-1', '17'),
(4422, 223, '_фон-1', 'field_62435db92ea96'),
(4423, 223, 'заголовок-2', 'Ключевые преимущества препарата Урорек'),
(4424, 223, '_заголовок-2', 'field_6243606295196'),
(4425, 223, 'список-2', 'Единственный оригинальный препарат из&nbsp;группы альфа1-адреноблокаторов, не&nbsp;имеющий генериков в&nbsp;РФ<sup>1</sup>'),
(4426, 223, '_список-2', 'field_6243608195197'),
(4427, 223, 'картинка_с_текстом_0_изображение', '31'),
(4428, 223, '_картинка_с_текстом_0_изображение', 'field_624363d095199'),
(4429, 223, 'картинка_с_текстом_0_описание', 'Обширная доказательная база собственных пострегистрационных клинических исследований<sup>2</sup>'),
(4430, 223, '_картинка_с_текстом_0_описание', 'field_624363e59519a'),
(4431, 223, 'картинка_с_текстом_1_изображение', '32'),
(4432, 223, '_картинка_с_текстом_1_изображение', 'field_624363d095199'),
(4433, 223, 'картинка_с_текстом_1_описание', 'Отсутствие риска замены препарата Урорек в&nbsp;аптеке (единственный препарат с&nbsp;действующим веществом силодозин)<sup>1</sup>'),
(4434, 223, '_картинка_с_текстом_1_описание', 'field_624363e59519a'),
(4435, 223, 'картинка_с_текстом_2_изображение', '33'),
(4436, 223, '_картинка_с_текстом_2_изображение', 'field_624363d095199'),
(4437, 223, 'картинка_с_текстом_2_описание', 'Большинство пациентов предпочитают принимать оригинальные препараты<sup>3</sup>'),
(4438, 223, '_картинка_с_текстом_2_описание', 'field_624363e59519a'),
(4439, 223, 'картинка_с_текстом', '3'),
(4440, 223, '_картинка_с_текстом', 'field_624363b995198'),
(4441, 223, 'второй_список', '<li>Клинические преимущества препарата Урорек (силодозин) определяются максимальной уроселективностью в&nbsp;классе альфа-адреноблокаторов<sup>4</sup></li>\r\n\r\n<li>Урорек&nbsp;&mdash; альфа-адреноблокатор последнего поколения, который эффективен в&nbsp;отношении всех СНМП (накопления, опорожнения, постмиктурических).<sup>12,13</sup> При этом Урорек обладает минимальным риском развития нежелательных явлений со&nbsp;стороны сердечно-сосудистой системы, в&nbsp;том числе&nbsp;у&nbsp;пациентов, принимающих антигипертензивные препараты<sup>46,8</sup> <small> <span>СНМП </span>симптомы нижних мочевыводящих путей</small></li>'),
(4442, 223, '_второй_список', 'field_6243640e05eda'),
(4443, 223, 'заголовок2-2', 'Максимальная уроселективность силодозина в&nbsp;классе альфа-адреноблокаторов обуславливает его уродинамическую эффективность и&nbsp;высокий профиль безопасности<sup>4</sup>'),
(4444, 223, '_заголовок2-2', 'field_6243644705edb'),
(4445, 223, 'текст3', '<ul>\r\n<li>Урорек значительно улучшает клинические проявления и&nbsp;качество жизни у&nbsp;всех пациентов с&nbsp;СНМП/ДГПЖ, в&nbsp;том числе с&nbsp;тяжелым течением<sup>11</sup><a href=\"#\">Узнать больше...</a></li>\r\n\r\n<li>Урорек является препаратом выбора для пациентов с&nbsp;СНМП/ДГПЖ и&nbsp;сопутствующими сердечно-сосудистыми заболеваниями<sup>3</sup> <a href=\"#\">Узнать больше...</a></li>\r\n</ul>\r\n<small> <span>ДГПЖ </span>доброкачественная гиперплазия предстательной железы</small>'),
(4446, 223, '_текст3', 'field_6243647405edc'),
(4447, 223, 'изображение-2', '34'),
(4448, 223, '_изображение-2', 'field_624364dd05edd'),
(4449, 223, 'текст_в_подвале', '<h2> Максимальная уроселективность в&nbsp;классе  альфа-адреноблокаторов<sup>4</sup></h2>\r\n<div class=\"h3\"> Почему это важно? <a href=\"#\">Подробнее</a></div>'),
(4450, 223, '_текст_в_подвале', 'field_62436daf1f6d9'),
(4451, 223, 'заголовок-3', 'Форма выпуска препарата Урорек'),
(4452, 223, '_заголовок-3', 'field_62436efee98e7'),
(4453, 223, 'текст-3', '<p class=\"section-descr\"><span>8мг </span>- рекомендуемая доза для лечения симптомов ДГПЖ<sup>6</sup>*</p>\r\n					<p class=\"section-note col-md-10\">*Более подробные сведения о&nbsp;препарате, особенностях применения, побочных действиях и&nbsp;др. &mdash;&nbsp;смотрите инструкцию по&nbsp;медицинскому применению лекарственного препарата Урорек, РУ&nbsp;ЛСР-005971/10 от&nbsp;25.06.2010 </p>'),
(4454, 223, '_текст-3', 'field_62436f60e98e8'),
(4455, 223, 'товар_0_название', 'Урорек 8мг №30'),
(4456, 223, '_товар_0_название', 'field_62436fcce98ea'),
(4457, 223, 'товар_0_описание', 'Упаковка, рассчитанная на&nbsp;1&nbsp;месяц лечения&nbsp;/ для старта терапии'),
(4458, 223, '_товар_0_описание', 'field_62436fe1e98eb'),
(4459, 223, 'товар_0_лицензия', 'РУ: ЛСР-005971/10 от 25.06.2010'),
(4460, 223, '_товар_0_лицензия', 'field_62436ff0e98ec'),
(4461, 223, 'товар_0_изображение', '51'),
(4462, 223, '_товар_0_изображение', 'field_62437045e98ed'),
(4463, 223, 'товар_1_название', 'Урорек 8мг №90'),
(4464, 223, '_товар_1_название', 'field_62436fcce98ea'),
(4465, 223, 'товар_1_описание', 'Выгодная упаковка, рассчитанная на&nbsp;3&nbsp;месяца лечения. Самая доступная стоимость 1&nbsp;дня терапии препаратом Урорек&nbsp;<sup>27</sup>'),
(4466, 223, '_товар_1_описание', 'field_62436fe1e98eb'),
(4467, 223, 'товар_1_лицензия', 'РУ: ЛСР-005971/10 от 25.06.2010'),
(4468, 223, '_товар_1_лицензия', 'field_62436ff0e98ec'),
(4469, 223, 'товар_1_изображение', '53'),
(4470, 223, '_товар_1_изображение', 'field_62437045e98ed'),
(4471, 223, 'товар_2_название', 'Урорек 4мг №30'),
(4472, 223, '_товар_2_название', 'field_62436fcce98ea'),
(4473, 223, 'товар_2_описание', '4&nbsp;мг&nbsp;&mdash; стартовая упаковка для лечения симптомов ДГПЖ у&nbsp;пациентов с&nbsp;почечной недостаточностью средней степени тяжести<sup>6</sup>'),
(4474, 223, '_товар_2_описание', 'field_62436fe1e98eb'),
(4475, 223, 'товар_2_лицензия', 'РУ: ЛСР-005971/10 от 25.06.2010'),
(4476, 223, '_товар_2_лицензия', 'field_62436ff0e98ec'),
(4477, 223, 'товар_2_изображение', '52'),
(4478, 223, '_товар_2_изображение', 'field_62437045e98ed'),
(4479, 223, 'товар', '3'),
(4480, 223, '_товар', 'field_62436fbde98e9'),
(4481, 223, 'заголовок-4', 'Где купить'),
(4482, 223, '_заголовок-4', 'field_624374f73d8bd'),
(4483, 223, 'изображения', 'a:12:{i:0;s:2:\"63\";i:1;s:2:\"64\";i:2;s:2:\"65\";i:3;s:2:\"66\";i:4;s:2:\"67\";i:5;s:2:\"68\";i:6;s:2:\"69\";i:7;s:2:\"70\";i:8;s:2:\"71\";i:9;s:2:\"72\";i:10;s:2:\"73\";i:11;s:2:\"74\";}'),
(4484, 223, '_изображения', 'field_624375093d8be'),
(4485, 223, 'изображения-4', 'a:12:{i:0;s:2:\"63\";i:1;s:2:\"64\";i:2;s:2:\"65\";i:3;s:2:\"66\";i:4;s:2:\"67\";i:5;s:2:\"68\";i:6;s:2:\"69\";i:7;s:2:\"70\";i:8;s:2:\"71\";i:9;s:2:\"72\";i:10;s:2:\"73\";i:11;s:2:\"74\";}'),
(4486, 223, '_изображения-4', 'field_624375093d8be'),
(4487, 223, 'заголовок-5', 'Способ применения*<sup>6</sup>'),
(4488, 223, '_заголовок-5', 'field_624379bd4756d'),
(4489, 223, 'иконки', 'a:5:{i:0;s:2:\"83\";i:1;s:2:\"84\";i:2;s:2:\"85\";i:3;s:2:\"86\";i:4;s:2:\"87\";}'),
(4490, 223, '_иконки', 'field_624379f24756e'),
(4491, 223, 'текст-5', 'У пациентов с легкой почечной недостаточностью (клиренс креатинина ≥ 50 — ≤ 80 мл/мин) коррекция дозы не требуется. Для лечения пациентов с почечной недостаточностью средней степени тяжести (клиренс креатинина ≥ 30 — < 50 мл/мин) рекомендуется в течение первой недели принимать начальную дозу по 4 мг в сутки, при хорошей индивидуальной переносимости доза может быть увеличена до 8 мг в сутки. Применение препарата для пациентов с тяжелой почечной недостаточностью (клиренс креатинина < 30 мл / мин) не рекомендуется'),
(4492, 223, '_текст-5', 'field_62437a374756f'),
(4493, 223, 'текст_под_кнопкой', '*Более подробные сведения о&nbsp;препарате, особенностях применения, побочных действиях и&nbsp;др. &mdash;&nbsp;см. инструкцию по&nbsp;медицинскому применению лекарственного препарата Урорек, РУ&nbsp;ЛСР-005971/10 от&nbsp;25.06.2010'),
(4494, 223, '_текст_под_кнопкой', 'field_62437a7c47570'),
(4495, 223, 'заголовок-6', 'Препарат Урорек (силодозин) включен в&nbsp;российские и&nbsp;международные клинические рекомендации и&nbsp;стандарты для лечения ряда урологических заболеваний:'),
(4496, 223, '_заголовок-6', 'field_6244117c68bd0'),
(4497, 223, 'список-6_0_ссылка', 'a:3:{s:5:\"title\";s:68:\"Российские клинические рекомендации\";s:3:\"url\";s:1:\"#\";s:6:\"target\";s:0:\"\";}'),
(4498, 223, '_список-6_0_ссылка', 'field_624411ce68bd2'),
(4499, 223, 'список-6_0_описание', '«Доброкачественная гиперплазия предстательной железы», 2020<sup>28</sup>'),
(4500, 223, '_список-6_0_описание', 'field_6244121168bd3'),
(4501, 223, 'список-6_1_ссылка', 'a:3:{s:5:\"title\";s:70:\"Европейские клинические рекомендации\";s:3:\"url\";s:1:\"#\";s:6:\"target\";s:0:\"\";}'),
(4502, 223, '_список-6_1_ссылка', 'field_624411ce68bd2'),
(4503, 223, 'список-6_1_описание', 'глава «Консервативное лечение ненейрогенных симптомов нарушенного мочеиспускания у мужчин, включая доброкачественную простатическую обструкцию», 2021<sup>29</sup>'),
(4504, 223, '_список-6_1_описание', 'field_6244121168bd3'),
(4505, 223, 'список-6_2_ссылка', 'a:3:{s:5:\"title\";s:154:\"Стандарт первичной медико-санитарной помощи при гиперплазии предстательной железы\";s:3:\"url\";s:1:\"#\";s:6:\"target\";s:0:\"\";}'),
(4506, 223, '_список-6_2_ссылка', 'field_624411ce68bd2'),
(4507, 223, 'список-6_2_описание', '09.11.2012<sup>30</sup> / Обновлён 13.04.2015\r\n'),
(4508, 223, '_список-6_2_описание', 'field_6244121168bd3'),
(4509, 223, 'список-6_3_ссылка', 'a:3:{s:5:\"title\";s:122:\"Стандарт специализированной медицинской помощи при задержке мочи\";s:3:\"url\";s:1:\"#\";s:6:\"target\";s:0:\"\";}'),
(4510, 223, '_список-6_3_ссылка', 'field_624411ce68bd2'),
(4511, 223, 'список-6_3_описание', '29.01.2013<sup>31</sup> / Обновлён 06.05.2015\r\n'),
(4512, 223, '_список-6_3_описание', 'field_6244121168bd3'),
(4513, 223, 'список-6_4_ссылка', 'a:3:{s:5:\"title\";s:133:\"Стандарт первичной медико-санитарной помощи при хроническом простатите\";s:3:\"url\";s:1:\"#\";s:6:\"target\";s:0:\"\";}'),
(4514, 223, '_список-6_4_ссылка', 'field_624411ce68bd2'),
(4515, 223, 'список-6_4_описание', '09.11.2012<sup>32</sup> / Обновлён 13.04.2015\r\n'),
(4516, 223, '_список-6_4_описание', 'field_6244121168bd3'),
(4517, 223, 'список-6_5_ссылка', 'a:3:{s:5:\"title\";s:168:\"Стандарт специализированной медицинской помощи при остром простатите, орхите, эпидидимите\";s:3:\"url\";s:1:\"#\";s:6:\"target\";s:0:\"\";}'),
(4518, 223, '_список-6_5_ссылка', 'field_624411ce68bd2'),
(4519, 223, 'список-6_5_описание', '09.11.2012<sup>33</sup> / Обновлён 27.05.2015'),
(4520, 223, '_список-6_5_описание', 'field_6244121168bd3'),
(4521, 223, 'список-6', '6'),
(4522, 223, '_список-6', 'field_624411be68bd1'),
(4523, 223, 'заголовок-7', 'Препарат Урорек (силодозин) зарегистрирован и&nbsp;применяется в&nbsp;разных странах мира Одобрен ЕМА*<sup>34</sup> и&nbsp;FDA**<sup>35</sup>'),
(4524, 223, '_заголовок-7', 'field_624417e3b6088'),
(4525, 223, 'текст', '<p class=\"sOtherCountries__agency\"><span>EMA</span> Европейское медицинское агентство</p>\r\n<p class=\"sOtherCountries__agency\"><span>FDA</span> Управление по&nbsp;санитарному надзору за&nbsp;качеством пищевых продуктов и&nbsp;медикаментов, США</p>'),
(4526, 223, '_текст', 'field_6244182bb6089'),
(4527, 223, 'страны_0_флаг', '105'),
(4528, 223, '_страны_0_флаг', 'field_62441880b608b'),
(4529, 223, 'страны_0_название', 'Япония'),
(4530, 223, '_страны_0_название', 'field_62441899b608c'),
(4531, 223, 'страны_0_год', '2006<sup>36,37</sup>'),
(4532, 223, '_страны_0_год', 'field_624418aab608d'),
(4533, 223, 'страны_1_флаг', '106'),
(4534, 223, '_страны_1_флаг', 'field_62441880b608b'),
(4535, 223, 'страны_1_название', 'США'),
(4536, 223, '_страны_1_название', 'field_62441899b608c'),
(4537, 223, 'страны_1_год', '2008<sup>35</sup>'),
(4538, 223, '_страны_1_год', 'field_624418aab608d'),
(4539, 223, 'страны_2_флаг', '107'),
(4540, 223, '_страны_2_флаг', 'field_62441880b608b'),
(4541, 223, 'страны_2_название', 'Страны ЕС'),
(4542, 223, '_страны_2_название', 'field_62441899b608c'),
(4543, 223, 'страны_2_год', '2010<sup>34</sup>'),
(4544, 223, '_страны_2_год', 'field_624418aab608d'),
(4545, 223, 'страны_3_флаг', '108'),
(4546, 223, '_страны_3_флаг', 'field_62441880b608b'),
(4547, 223, 'страны_3_название', 'Россия'),
(4548, 223, '_страны_3_название', 'field_62441899b608c'),
(4549, 223, 'страны_3_год', '2010<sup>1</sup>'),
(4550, 223, '_страны_3_год', 'field_624418aab608d'),
(4551, 223, 'страны', '4'),
(4552, 223, '_страны', 'field_62441847b608a'),
(4553, 223, 'текст-7', '<p class=\"sOtherCountries__agency\"><span>EMA</span> Европейское медицинское агентство</p>\r\n<p class=\"sOtherCountries__agency\"><span>FDA</span> Управление по&nbsp;санитарному надзору за&nbsp;качеством пищевых продуктов и&nbsp;медикаментов, США</p>'),
(4554, 223, '_текст-7', 'field_6244182bb6089'),
(4555, 223, 'текст-7-1', 'Производство препарата Урорек, поставляемого в&nbsp;Россию, осуществляется в&nbsp;Италии с&nbsp;использованием субстанции из&nbsp;Японии, в&nbsp;соответствии с&nbsp;необходимыми требованиями к&nbsp;производству и&nbsp;контролю качества<sup>6,1</sup>'),
(4556, 223, '_текст-7-1', 'field_62441a5acf03c'),
(4557, 223, 'заголовок-8', 'О проблеме'),
(4558, 223, '_заголовок-8', 'field_624431d91624d'),
(4559, 223, 'текст-8', 'Доброкачественная гиперплазия предстательной железы (ДГПЖ), или как ее еще называют, аденома простаты, как правило, возникает у мужчин старше 50 лет и характеризуется наличием симптомов нижних мочевыводящих путей (СНМП), увеличением предстательной железы или ее части, и нарушением оттока мочи из мочевого пузыря вследствие инфравезикальной обструкции.<sup>38</sup>\r\n\r\nРаспространенность ДГПЖ увеличивается с возрастом. Так, клинически значимая ДГПЖ проявляется у 13% мужчин в возрасте старше 50 лет, у 34% мужчин в возрасте 60 лет и у 43% в возрасте 70 лет.<sup>39</sup>\r\n\r\n&nbsp;\r\n\r\n<img class=\"alignnone wp-image-122 size-full\" src=\"http://0026urotec.loc:8888/wp-content/uploads/2022/03/about-img.png\" alt=\"\" width=\"594\" height=\"696\" />'),
(4560, 223, '_текст-8', 'field_624431f11624e'),
(4561, 223, 'текст-8-1', 'Наличие СНМП может быть ассоциировано с&nbsp;тяжелыми хроническими заболеваниями, такими как заболевания сердца, сахарный диабет, артериальная гипертензия и&nbsp;депрессия<sup>40</sup>'),
(4562, 223, '_текст-8-1', 'field_6244320b26db3'),
(4563, 223, 'иконки-8', 'a:6:{i:0;s:3:\"123\";i:1;s:3:\"124\";i:2;s:3:\"125\";i:3;s:3:\"126\";i:4;s:3:\"127\";i:5;s:3:\"128\";}'),
(4564, 223, '_иконки-8', 'field_6244322d26db4'),
(4565, 223, 'текст-8-2', '<h3>Симптомы доброкачественной гиперплазии предстательной железы</h3>\r\nСимптомы нарушенного мочеиспускания являются частой жалобой у взрослых мужчин. Они оказывают серьезное негативное влияние на качество жизни. При ДГПЖ предстательная железа увеличивается в размерах, оказывая давление на нижние мочевые пути. В результате развиваются следующие симптомы:<sup>41</sup>'),
(4566, 223, '_текст-8-2', 'field_6244335fe2373'),
(4567, 223, 'заголовок-9', 'Осложнения ДГПЖ<sup>38</sup>'),
(4568, 223, '_заголовок-9', 'field_6244377a52263'),
(4569, 223, 'изображения-9', 'a:6:{i:0;s:3:\"141\";i:1;s:3:\"142\";i:2;s:3:\"143\";i:3;s:3:\"144\";i:4;s:3:\"145\";i:5;s:3:\"146\";}'),
(4570, 223, '_изображения-9', 'field_6244379652264'),
(4571, 223, 'заголовок-10', 'Медикаментозное лечение СНМП/ДГПЖ'),
(4572, 223, '_заголовок-10', 'field_6244489614262'),
(4573, 223, 'текст-10', 'Антагонисты альфа1-адренорецепторов (альфа-адреноблокаторы) и&nbsp;ингибиторы 5&nbsp;альфа1-редуктазы (ингибиторы 5-АР) являются группами лекарственных препаратов, которые в&nbsp;настоящее время утверждены для лечения ДГПЖ. Обе группы препаратов обеспечивают надлежащее ослабление симптомов, но&nbsp;&alpha;&mdash;блокаторы обладают довольно быстрым началом действия, а&nbsp;ингибиторам 5-АР требуется несколько месяцев для получения терапевтического эффекта.<sup>42</sup>'),
(4574, 223, '_текст-10', 'field_624448ce14263'),
(4575, 223, 'карточки-10_0_заголовок', 'Альфа-адреноблокаторы'),
(4576, 223, '_карточки-10_0_заголовок', 'field_624448fc14265'),
(4577, 223, 'карточки-10_0_текст', 'представляют собой наиболее эффективный класс лекарственных препаратов, характеризующийся хорошим профилем безопасности и высокой комплаентностью, применяющийся для облегчения СНМП, связанных с ДГПЖ: они снимают спазм гладкой мускулатуры предстательной железы и шейки мочевого пузыря42'),
(4578, 223, '_карточки-10_0_текст', 'field_6244490c14266'),
(4579, 223, 'карточки-10_1_заголовок', 'Ингибиторы 5-АР —'),
(4580, 223, '_карточки-10_1_заголовок', 'field_624448fc14265'),
(4581, 223, 'карточки-10_1_текст', 'приводят к редукции железистой ткани и к снижению размера предстательной железы: они блокируют конверсию тестостерона в дигидротестостерон, который стимулирует рост предстательной железы43,44.Назначаются при большом объеме предстательной железы. Для получения значимого клинического эффекта требуется несколько месяцев применения45\r\n'),
(4582, 223, '_карточки-10_1_текст', 'field_6244490c14266'),
(4583, 223, 'карточки-10', '2'),
(4584, 223, '_карточки-10', 'field_624448e214264'),
(4585, 223, 'видео', '<iframe width=\"560\" height=\"315\" src=\"https://www.youtube.com/embed/3DrU3pFXSsY\" title=\"YouTube video player\" frameborder=\"0\" allow=\"accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture\" allowfullscreen></iframe>'),
(4586, 223, '_видео', 'field_6244492214267'),
(4587, 223, 'заголовок-11', 'Часто задаваемые вопросы'),
(4588, 223, '_заголовок-11', 'field_62444b33e25d6'),
(4589, 223, 'вопросы_0_заголовок', 'Почему при приеме препарата Урорек у некоторых пациентов развивается нарушение эякуляции?'),
(4590, 223, '_вопросы_0_заголовок', 'field_62444b58e25d8'),
(4591, 223, 'вопросы_0_текст', 'Урорек — высокоселективный препарат, то есть преимущественно действует на альфа1А-адренорецепторы, которые находятся в нижних мочевых путях, предстательной железе и семенных пузырьках. Поэтому эффект развивается уже через 2–6 часов после приёма первой дозы препарата Урорек<sup>14</sup> при минимальным количестве нежелательных явлений.<sup>5</sup>\r\n\r\nНаиболее частый побочный эффект при приеме препарата Урорек — нарушение эякуляции<sup>46</sup>. Это может быть связано как с забросом эякулята при семяизвержении вместо уретры в мочевой пузырь, так и со снижением или отсутствием семенной жидкости во время эякуляции<sup>29</sup>. Силодозин снижает тонус гладкомышечных клеток семенных пузырьков, простаты и шейки мочевого пузыря, поэтому не происходит выброс семени. Этот эффект свойственен всем уроселективным альфа-адреноблокаторам<sup>53</sup> и самостоятельно исчезает после прекращения приема препарата.<sup>6</sup>\r\n\r\nЧастота эякуляторной дисфункции прямо пропорционально связана с улучшением СНМП и скорости мочеиспускания и подтверждает эффективность альфа-адреноблокатора: чем выше эффективность, тем выше частота встречаемости эякуляторной дисфункции.<sup>29</sup>\r\n\r\nНарушение эякуляции не влияет на сексуальную функцию<sup>52</sup>, не воспринимается как беспокоящий симптом подавляющим большинством пациентов и не требует отмены терапии.<sup>46</sup>'),
(4592, 223, '_вопросы_0_текст', 'field_62444b66e25d9'),
(4593, 223, 'вопросы_1_заголовок', 'Можно ли принимать Урорек при артериальной гипертензии и ишемический болезни сердца (ИБС)?'),
(4594, 223, '_вопросы_1_заголовок', 'field_62444b58e25d8'),
(4595, 223, 'вопросы_1_текст', 'Согласно инструкции по медицинскому применению, противопоказаний для применения лекарственного препарата Урорек у пациентов с СНМП/ДГПЖ и сопутствующими сердечно-сосудистыми заболеваниями нет.<sup>3</sup> Урорек не оказывает влияния на частоту сердечных сокращений (ЧСС), систолическое артериальное давление (САД) и диастолическое артериальное давление (ДАД).<sup>9</sup> Силодозин — не вызывает клинически значимого снижения артериального давления (АД)<sup>46</sup>, не усиливает действие антигипертензивных препаратов и не требует снижения дозы при одновременном приеме.<sup>7</sup> В соответствии с дизайном клинического исследования многие пациенты получали сопутствующую терапию антигипертензивными препаратами (в основном, средствами, воздействующими на ренин-ангиотензиновую систему, бета-блокаторами, антагонистами кальция и диуретиками) без повышения частоты ортостатической гипотензии.<sup>6</sup>\r\n\r\nПри приеме препарата Урорек наиболее низкий риск развития сердечно-сосудистых осложнений.<sup>5</sup>'),
(4596, 223, '_вопросы_1_текст', 'field_62444b66e25d9'),
(4597, 223, 'вопросы_2_заголовок', 'Можно ли принимать Урорек пациенту с ортостатической гипотензией в анамнезе?'),
(4598, 223, '_вопросы_2_заголовок', 'field_62444b58e25d8'),
(4599, 223, 'вопросы_2_текст', 'Повышенная селективность силодозина к альфа1A-адренорецепторам по сравнению с альфа1B-адренорецепторами выражается в пониженном риске развития сердечно-сосудистых осложнений.<sup>4</sup> Благодаря этому частота ортостатической гипотензии на фоне его приема сравнима с таковой при приеме плацебо.<sup>45,9</sup>\r\n\r\nВ отличие от других альфа-адреноблокаторов (например, все формы тамсулозина<sup>47,48</sup>), Урорек не противопоказан к приему у пациентов с ортостатической гипотензией в анамнезе. Тем не менее, пациентам с ортостатической гипотензией в анамнезе не рекомендуется принимать любые альфа-адреноблокаторы, в т.ч. Урорек.<sup>6</sup>'),
(4600, 223, '_вопросы_2_текст', 'field_62444b66e25d9'),
(4601, 223, 'вопросы_3_заголовок', 'Как долго можно принимать Урорек?'),
(4602, 223, '_вопросы_3_заголовок', 'field_62444b58e25d8'),
(4603, 223, 'вопросы_3_текст', 'Учитывая прогрессирующий характер течения доброкачественной гиперплазии предстательной железы, медикаментозную терапию следует проводить длительно (иногда в течение всей жизни пациента).<sup>49</sup>'),
(4604, 223, '_вопросы_3_текст', 'field_62444b66e25d9'),
(4605, 223, 'вопросы_4_заголовок', 'Пациенты жалуются на заложенность носа при лечении альфа-адреноблокаторами. Есть ли у препарата Урорек такое побочное действие?'),
(4606, 223, '_вопросы_4_заголовок', 'field_62444b58e25d8'),
(4607, 223, 'вопросы_4_текст', 'Заложенность носа — это возможный побочный эффект для всех альфа-адреноблокаторов. При приеме препарата Урорек он может возникать примерно в 1% случаев.<sup>46</sup>'),
(4608, 223, '_вопросы_4_текст', 'field_62444b66e25d9'),
(4609, 223, 'вопросы_5_заголовок', 'Можно ли начинать лечение препаратом Урорек с дозы 4 мг в сутки?'),
(4610, 223, '_вопросы_5_заголовок', 'field_62444b58e25d8'),
(4611, 223, 'вопросы_5_текст', 'Согласно инструкции по медицинскому применению лекарственного препарата Урорек, доза 8 мг в сутки рекомендована для лечения пациентов с СНМП/ДГПЖ. Титрование дозы при применении силодозина не требуется.\r\n\r\nУрорек 4 мг — это специальная доза для лечения пациентов с почечной недостаточностью средней степени тяжести (клиренс креатинина ≥ 30 до &lt; 50 мл/мин). Рекомендуется в течение первой недели принимать начальную дозу по 4 мг в сутки, далее при хорошей переносимости доза может быть увеличена до 8 мг в сутки.<sup>6</sup>**Более подробные сведения о препарате, особенностях применения, побочных действиях и др. — см. инструкцию по медицинскому применению лекарственного препарата Урорек, РУ ЛСР-005971/10 от 25.06.2010'),
(4612, 223, '_вопросы_5_текст', 'field_62444b66e25d9'),
(4613, 223, 'вопросы_6_заголовок', 'Влияет ли Урорек на течение ДГПЖ или только снимает симптомы нижних мочевыводящих путей?'),
(4614, 223, '_вопросы_6_заголовок', 'field_62444b58e25d8'),
(4615, 223, 'вопросы_6_текст', 'Помимо субъективных симптомов, ДГПЖ вызывает прогрессирующее морфологическое ремоделирование мочевого пузыря с риском развития серьезных функциональных нарушений. Лечение должно не только купировать субъективные симптомы, но и включать профилактику патологического ремоделирования мочевого пузыря.<sup>161</sup>\r\n\r\nСилодозин, действующее вещество препарата Урорек, в сравнении с другими альфа-адреноблокаторами более эффективно влияет на инфравезикальную обструкцию (ИВО), что оказывает влияние на предотвращение патологического прогрессирования ремоделирования мочевого пузыря и риск развития серьезных функциональных нарушений.<sup>50,51</sup>'),
(4616, 223, '_вопросы_6_текст', 'field_62444b66e25d9'),
(4617, 223, 'вопросы_7_заголовок', 'Доступен ли Урорек по льготному отпуску?'),
(4618, 223, '_вопросы_7_заголовок', 'field_62444b58e25d8'),
(4619, 223, 'вопросы_7_текст', 'Урорек (силодозин) не включен в список жизненно важных лекарственных препаратов (ЖНВЛП)<sup>1</sup> и не входит в перечень препаратов для льготного обеспечения граждан по федеральному льготному списку.'),
(4620, 223, '_вопросы_7_текст', 'field_62444b66e25d9'),
(4621, 223, 'вопросы', '8'),
(4622, 223, '_вопросы', 'field_62444b49e25d7'),
(4623, 178, '_wp_old_date', '2022-03-30'),
(4624, 179, '_wp_old_date', '2022-03-30'),
(4625, 180, '_wp_old_date', '2022-03-30'),
(4626, 222, '_wp_old_date', '2022-03-30'),
(4627, 224, 'заголовок-1', 'УРОРЕК – оригинальный<sup>10</sup> альфа-адреноблокатор'),
(4628, 224, '_заголовок-1', 'field_62435bd26f29f'),
(4629, 224, 'текст-1', '<div class=\"headerBlock__body\">\r\n<p>Силодозин (действующее вещество препарата Урорек) обладает максимальной уроселективностью в&nbsp;своем классе, что обеспечивает его уродинамическую эффективность и&nbsp;высокую безопасность<sup>4</sup></p>\r\n</div>\r\n<div class=\"headerBlock__footer\">\r\n<p><strong>Показания к применению: </strong><br/>Лечение симптомов доброкачественной гиперплазии предстательной железы<sup>6</sup></p>\r\n</div>'),
(4630, 224, '_текст-1', 'field_62435c0c6f2a0'),
(4631, 224, 'изображение-1', '13'),
(4632, 224, '_изображение-1', 'field_62435c8b6f2a1'),
(4633, 224, 'фон-1', '17'),
(4634, 224, '_фон-1', 'field_62435db92ea96'),
(4635, 224, 'заголовок-2', 'Ключевые преимущества препарата Урорек'),
(4636, 224, '_заголовок-2', 'field_6243606295196'),
(4637, 224, 'список-2', 'Единственный оригинальный препарат из&nbsp;группы альфа1-адреноблокаторов, не&nbsp;имеющий генериков в&nbsp;РФ<sup>1</sup>'),
(4638, 224, '_список-2', 'field_6243608195197'),
(4639, 224, 'картинка_с_текстом_0_изображение', '31'),
(4640, 224, '_картинка_с_текстом_0_изображение', 'field_624363d095199'),
(4641, 224, 'картинка_с_текстом_0_описание', 'Обширная доказательная база собственных пострегистрационных клинических исследований<sup>2</sup>'),
(4642, 224, '_картинка_с_текстом_0_описание', 'field_624363e59519a'),
(4643, 224, 'картинка_с_текстом_1_изображение', '32'),
(4644, 224, '_картинка_с_текстом_1_изображение', 'field_624363d095199'),
(4645, 224, 'картинка_с_текстом_1_описание', 'Отсутствие риска замены препарата Урорек в&nbsp;аптеке (единственный препарат с&nbsp;действующим веществом силодозин)<sup>1</sup>'),
(4646, 224, '_картинка_с_текстом_1_описание', 'field_624363e59519a'),
(4647, 224, 'картинка_с_текстом_2_изображение', '33'),
(4648, 224, '_картинка_с_текстом_2_изображение', 'field_624363d095199'),
(4649, 224, 'картинка_с_текстом_2_описание', 'Большинство пациентов предпочитают принимать оригинальные препараты<sup>3</sup>'),
(4650, 224, '_картинка_с_текстом_2_описание', 'field_624363e59519a'),
(4651, 224, 'картинка_с_текстом', '3'),
(4652, 224, '_картинка_с_текстом', 'field_624363b995198'),
(4653, 224, 'второй_список', '<li>Клинические преимущества препарата Урорек (силодозин) определяются максимальной уроселективностью в&nbsp;классе альфа-адреноблокаторов<sup>4</sup></li>\r\n\r\n<li>Урорек&nbsp;&mdash; альфа-адреноблокатор последнего поколения, который эффективен в&nbsp;отношении всех СНМП (накопления, опорожнения, постмиктурических).<sup>12,13</sup> При этом Урорек обладает минимальным риском развития нежелательных явлений со&nbsp;стороны сердечно-сосудистой системы, в&nbsp;том числе&nbsp;у&nbsp;пациентов, принимающих антигипертензивные препараты<sup>46,8</sup> <small> <span>СНМП </span>симптомы нижних мочевыводящих путей</small></li>'),
(4654, 224, '_второй_список', 'field_6243640e05eda'),
(4655, 224, 'заголовок2-2', 'Максимальная уроселективность силодозина в&nbsp;классе альфа-адреноблокаторов обуславливает его уродинамическую эффективность и&nbsp;высокий профиль безопасности<sup>4</sup>'),
(4656, 224, '_заголовок2-2', 'field_6243644705edb'),
(4657, 224, 'текст3', '<ul>\r\n<li>Урорек значительно улучшает клинические проявления и&nbsp;качество жизни у&nbsp;всех пациентов с&nbsp;СНМП/ДГПЖ, в&nbsp;том числе с&nbsp;тяжелым течением<sup>11</sup>\r\n<a href=\"#modal-call-first\" class=\"link-modal-js\">Узнать больше...</a></li>\r\n\r\n<li>Урорек является препаратом выбора для пациентов с&nbsp;СНМП/ДГПЖ и&nbsp;сопутствующими сердечно-сосудистыми заболеваниями<sup>3</sup> \r\n<a href=\"#modal-call-second\" class=\"link-modal-js\">Узнать больше...</a></li>\r\n</ul>\r\n<small> <span>ДГПЖ </span>доброкачественная гиперплазия предстательной железы</small>'),
(4658, 224, '_текст3', 'field_6243647405edc'),
(4659, 224, 'изображение-2', '34'),
(4660, 224, '_изображение-2', 'field_624364dd05edd'),
(4661, 224, 'текст_в_подвале', '<h2> Максимальная уроселективность в&nbsp;классе  альфа-адреноблокаторов<sup>4</sup></h2>\r\n<div class=\"h3\"> Почему это важно? <a href=\"#\">Подробнее</a></div>'),
(4662, 224, '_текст_в_подвале', 'field_62436daf1f6d9'),
(4663, 224, 'заголовок-3', 'Форма выпуска препарата Урорек'),
(4664, 224, '_заголовок-3', 'field_62436efee98e7'),
(4665, 224, 'текст-3', '<p class=\"section-descr\"><span>8мг </span>- рекомендуемая доза для лечения симптомов ДГПЖ<sup>6</sup>*</p>\r\n					<p class=\"section-note col-md-10\">*Более подробные сведения о&nbsp;препарате, особенностях применения, побочных действиях и&nbsp;др. &mdash;&nbsp;смотрите инструкцию по&nbsp;медицинскому применению лекарственного препарата Урорек, РУ&nbsp;ЛСР-005971/10 от&nbsp;25.06.2010 </p>'),
(4666, 224, '_текст-3', 'field_62436f60e98e8'),
(4667, 224, 'товар_0_название', 'Урорек 8мг №30'),
(4668, 224, '_товар_0_название', 'field_62436fcce98ea'),
(4669, 224, 'товар_0_описание', 'Упаковка, рассчитанная на&nbsp;1&nbsp;месяц лечения&nbsp;/ для старта терапии'),
(4670, 224, '_товар_0_описание', 'field_62436fe1e98eb'),
(4671, 224, 'товар_0_лицензия', 'РУ: ЛСР-005971/10 от 25.06.2010'),
(4672, 224, '_товар_0_лицензия', 'field_62436ff0e98ec'),
(4673, 224, 'товар_0_изображение', '51'),
(4674, 224, '_товар_0_изображение', 'field_62437045e98ed'),
(4675, 224, 'товар_1_название', 'Урорек 8мг №90'),
(4676, 224, '_товар_1_название', 'field_62436fcce98ea'),
(4677, 224, 'товар_1_описание', 'Выгодная упаковка, рассчитанная на&nbsp;3&nbsp;месяца лечения. Самая доступная стоимость 1&nbsp;дня терапии препаратом Урорек&nbsp;<sup>27</sup>'),
(4678, 224, '_товар_1_описание', 'field_62436fe1e98eb'),
(4679, 224, 'товар_1_лицензия', 'РУ: ЛСР-005971/10 от 25.06.2010'),
(4680, 224, '_товар_1_лицензия', 'field_62436ff0e98ec'),
(4681, 224, 'товар_1_изображение', '53'),
(4682, 224, '_товар_1_изображение', 'field_62437045e98ed'),
(4683, 224, 'товар_2_название', 'Урорек 4мг №30'),
(4684, 224, '_товар_2_название', 'field_62436fcce98ea'),
(4685, 224, 'товар_2_описание', '4&nbsp;мг&nbsp;&mdash; стартовая упаковка для лечения симптомов ДГПЖ у&nbsp;пациентов с&nbsp;почечной недостаточностью средней степени тяжести<sup>6</sup>'),
(4686, 224, '_товар_2_описание', 'field_62436fe1e98eb'),
(4687, 224, 'товар_2_лицензия', 'РУ: ЛСР-005971/10 от 25.06.2010'),
(4688, 224, '_товар_2_лицензия', 'field_62436ff0e98ec'),
(4689, 224, 'товар_2_изображение', '52'),
(4690, 224, '_товар_2_изображение', 'field_62437045e98ed'),
(4691, 224, 'товар', '3'),
(4692, 224, '_товар', 'field_62436fbde98e9'),
(4693, 224, 'заголовок-4', 'Где купить'),
(4694, 224, '_заголовок-4', 'field_624374f73d8bd'),
(4695, 224, 'изображения', 'a:12:{i:0;s:2:\"63\";i:1;s:2:\"64\";i:2;s:2:\"65\";i:3;s:2:\"66\";i:4;s:2:\"67\";i:5;s:2:\"68\";i:6;s:2:\"69\";i:7;s:2:\"70\";i:8;s:2:\"71\";i:9;s:2:\"72\";i:10;s:2:\"73\";i:11;s:2:\"74\";}'),
(4696, 224, '_изображения', 'field_624375093d8be'),
(4697, 224, 'изображения-4', 'a:12:{i:0;s:2:\"63\";i:1;s:2:\"64\";i:2;s:2:\"65\";i:3;s:2:\"66\";i:4;s:2:\"67\";i:5;s:2:\"68\";i:6;s:2:\"69\";i:7;s:2:\"70\";i:8;s:2:\"71\";i:9;s:2:\"72\";i:10;s:2:\"73\";i:11;s:2:\"74\";}'),
(4698, 224, '_изображения-4', 'field_624375093d8be'),
(4699, 224, 'заголовок-5', 'Способ применения*<sup>6</sup>'),
(4700, 224, '_заголовок-5', 'field_624379bd4756d'),
(4701, 224, 'иконки', 'a:5:{i:0;s:2:\"83\";i:1;s:2:\"84\";i:2;s:2:\"85\";i:3;s:2:\"86\";i:4;s:2:\"87\";}'),
(4702, 224, '_иконки', 'field_624379f24756e'),
(4703, 224, 'текст-5', 'У пациентов с легкой почечной недостаточностью (клиренс креатинина ≥ 50 — ≤ 80 мл/мин) коррекция дозы не требуется. Для лечения пациентов с почечной недостаточностью средней степени тяжести (клиренс креатинина ≥ 30 — < 50 мл/мин) рекомендуется в течение первой недели принимать начальную дозу по 4 мг в сутки, при хорошей индивидуальной переносимости доза может быть увеличена до 8 мг в сутки. Применение препарата для пациентов с тяжелой почечной недостаточностью (клиренс креатинина < 30 мл / мин) не рекомендуется'),
(4704, 224, '_текст-5', 'field_62437a374756f'),
(4705, 224, 'текст_под_кнопкой', '*Более подробные сведения о&nbsp;препарате, особенностях применения, побочных действиях и&nbsp;др. &mdash;&nbsp;см. инструкцию по&nbsp;медицинскому применению лекарственного препарата Урорек, РУ&nbsp;ЛСР-005971/10 от&nbsp;25.06.2010'),
(4706, 224, '_текст_под_кнопкой', 'field_62437a7c47570'),
(4707, 224, 'заголовок-6', 'Препарат Урорек (силодозин) включен в&nbsp;российские и&nbsp;международные клинические рекомендации и&nbsp;стандарты для лечения ряда урологических заболеваний:'),
(4708, 224, '_заголовок-6', 'field_6244117c68bd0'),
(4709, 224, 'список-6_0_ссылка', 'a:3:{s:5:\"title\";s:68:\"Российские клинические рекомендации\";s:3:\"url\";s:1:\"#\";s:6:\"target\";s:0:\"\";}'),
(4710, 224, '_список-6_0_ссылка', 'field_624411ce68bd2'),
(4711, 224, 'список-6_0_описание', '«Доброкачественная гиперплазия предстательной железы», 2020<sup>28</sup>'),
(4712, 224, '_список-6_0_описание', 'field_6244121168bd3'),
(4713, 224, 'список-6_1_ссылка', 'a:3:{s:5:\"title\";s:70:\"Европейские клинические рекомендации\";s:3:\"url\";s:1:\"#\";s:6:\"target\";s:0:\"\";}'),
(4714, 224, '_список-6_1_ссылка', 'field_624411ce68bd2'),
(4715, 224, 'список-6_1_описание', 'глава «Консервативное лечение ненейрогенных симптомов нарушенного мочеиспускания у мужчин, включая доброкачественную простатическую обструкцию», 2021<sup>29</sup>'),
(4716, 224, '_список-6_1_описание', 'field_6244121168bd3'),
(4717, 224, 'список-6_2_ссылка', 'a:3:{s:5:\"title\";s:154:\"Стандарт первичной медико-санитарной помощи при гиперплазии предстательной железы\";s:3:\"url\";s:1:\"#\";s:6:\"target\";s:0:\"\";}'),
(4718, 224, '_список-6_2_ссылка', 'field_624411ce68bd2'),
(4719, 224, 'список-6_2_описание', '09.11.2012<sup>30</sup> / Обновлён 13.04.2015\r\n'),
(4720, 224, '_список-6_2_описание', 'field_6244121168bd3'),
(4721, 224, 'список-6_3_ссылка', 'a:3:{s:5:\"title\";s:122:\"Стандарт специализированной медицинской помощи при задержке мочи\";s:3:\"url\";s:1:\"#\";s:6:\"target\";s:0:\"\";}'),
(4722, 224, '_список-6_3_ссылка', 'field_624411ce68bd2'),
(4723, 224, 'список-6_3_описание', '29.01.2013<sup>31</sup> / Обновлён 06.05.2015\r\n'),
(4724, 224, '_список-6_3_описание', 'field_6244121168bd3'),
(4725, 224, 'список-6_4_ссылка', 'a:3:{s:5:\"title\";s:133:\"Стандарт первичной медико-санитарной помощи при хроническом простатите\";s:3:\"url\";s:1:\"#\";s:6:\"target\";s:0:\"\";}'),
(4726, 224, '_список-6_4_ссылка', 'field_624411ce68bd2'),
(4727, 224, 'список-6_4_описание', '09.11.2012<sup>32</sup> / Обновлён 13.04.2015\r\n'),
(4728, 224, '_список-6_4_описание', 'field_6244121168bd3'),
(4729, 224, 'список-6_5_ссылка', 'a:3:{s:5:\"title\";s:168:\"Стандарт специализированной медицинской помощи при остром простатите, орхите, эпидидимите\";s:3:\"url\";s:1:\"#\";s:6:\"target\";s:0:\"\";}'),
(4730, 224, '_список-6_5_ссылка', 'field_624411ce68bd2'),
(4731, 224, 'список-6_5_описание', '09.11.2012<sup>33</sup> / Обновлён 27.05.2015'),
(4732, 224, '_список-6_5_описание', 'field_6244121168bd3'),
(4733, 224, 'список-6', '6'),
(4734, 224, '_список-6', 'field_624411be68bd1'),
(4735, 224, 'заголовок-7', 'Препарат Урорек (силодозин) зарегистрирован и&nbsp;применяется в&nbsp;разных странах мира Одобрен ЕМА*<sup>34</sup> и&nbsp;FDA**<sup>35</sup>'),
(4736, 224, '_заголовок-7', 'field_624417e3b6088'),
(4737, 224, 'текст', '<p class=\"sOtherCountries__agency\"><span>EMA</span> Европейское медицинское агентство</p>\r\n<p class=\"sOtherCountries__agency\"><span>FDA</span> Управление по&nbsp;санитарному надзору за&nbsp;качеством пищевых продуктов и&nbsp;медикаментов, США</p>'),
(4738, 224, '_текст', 'field_6244182bb6089'),
(4739, 224, 'страны_0_флаг', '105'),
(4740, 224, '_страны_0_флаг', 'field_62441880b608b'),
(4741, 224, 'страны_0_название', 'Япония'),
(4742, 224, '_страны_0_название', 'field_62441899b608c'),
(4743, 224, 'страны_0_год', '2006<sup>36,37</sup>'),
(4744, 224, '_страны_0_год', 'field_624418aab608d'),
(4745, 224, 'страны_1_флаг', '106'),
(4746, 224, '_страны_1_флаг', 'field_62441880b608b'),
(4747, 224, 'страны_1_название', 'США'),
(4748, 224, '_страны_1_название', 'field_62441899b608c'),
(4749, 224, 'страны_1_год', '2008<sup>35</sup>'),
(4750, 224, '_страны_1_год', 'field_624418aab608d'),
(4751, 224, 'страны_2_флаг', '107'),
(4752, 224, '_страны_2_флаг', 'field_62441880b608b'),
(4753, 224, 'страны_2_название', 'Страны ЕС'),
(4754, 224, '_страны_2_название', 'field_62441899b608c'),
(4755, 224, 'страны_2_год', '2010<sup>34</sup>'),
(4756, 224, '_страны_2_год', 'field_624418aab608d'),
(4757, 224, 'страны_3_флаг', '108'),
(4758, 224, '_страны_3_флаг', 'field_62441880b608b'),
(4759, 224, 'страны_3_название', 'Россия'),
(4760, 224, '_страны_3_название', 'field_62441899b608c'),
(4761, 224, 'страны_3_год', '2010<sup>1</sup>'),
(4762, 224, '_страны_3_год', 'field_624418aab608d'),
(4763, 224, 'страны', '4'),
(4764, 224, '_страны', 'field_62441847b608a'),
(4765, 224, 'текст-7', '<p class=\"sOtherCountries__agency\"><span>EMA</span> Европейское медицинское агентство</p>\r\n<p class=\"sOtherCountries__agency\"><span>FDA</span> Управление по&nbsp;санитарному надзору за&nbsp;качеством пищевых продуктов и&nbsp;медикаментов, США</p>'),
(4766, 224, '_текст-7', 'field_6244182bb6089'),
(4767, 224, 'текст-7-1', 'Производство препарата Урорек, поставляемого в&nbsp;Россию, осуществляется в&nbsp;Италии с&nbsp;использованием субстанции из&nbsp;Японии, в&nbsp;соответствии с&nbsp;необходимыми требованиями к&nbsp;производству и&nbsp;контролю качества<sup>6,1</sup>'),
(4768, 224, '_текст-7-1', 'field_62441a5acf03c'),
(4769, 224, 'заголовок-8', 'О проблеме'),
(4770, 224, '_заголовок-8', 'field_624431d91624d'),
(4771, 224, 'текст-8', 'Доброкачественная гиперплазия предстательной железы (ДГПЖ), или как ее еще называют, аденома простаты, как правило, возникает у мужчин старше 50 лет и характеризуется наличием симптомов нижних мочевыводящих путей (СНМП), увеличением предстательной железы или ее части, и нарушением оттока мочи из мочевого пузыря вследствие инфравезикальной обструкции.<sup>38</sup>\r\n\r\nРаспространенность ДГПЖ увеличивается с возрастом. Так, клинически значимая ДГПЖ проявляется у 13% мужчин в возрасте старше 50 лет, у 34% мужчин в возрасте 60 лет и у 43% в возрасте 70 лет.<sup>39</sup>\r\n\r\n&nbsp;\r\n\r\n<img class=\"alignnone wp-image-122 size-full\" src=\"http://0026urotec.loc:8888/wp-content/uploads/2022/03/about-img.png\" alt=\"\" width=\"594\" height=\"696\" />'),
(4772, 224, '_текст-8', 'field_624431f11624e'),
(4773, 224, 'текст-8-1', 'Наличие СНМП может быть ассоциировано с&nbsp;тяжелыми хроническими заболеваниями, такими как заболевания сердца, сахарный диабет, артериальная гипертензия и&nbsp;депрессия<sup>40</sup>'),
(4774, 224, '_текст-8-1', 'field_6244320b26db3'),
(4775, 224, 'иконки-8', 'a:6:{i:0;s:3:\"123\";i:1;s:3:\"124\";i:2;s:3:\"125\";i:3;s:3:\"126\";i:4;s:3:\"127\";i:5;s:3:\"128\";}'),
(4776, 224, '_иконки-8', 'field_6244322d26db4');
INSERT INTO `urotec_postmeta` (`meta_id`, `post_id`, `meta_key`, `meta_value`) VALUES
(4777, 224, 'текст-8-2', '<h3>Симптомы доброкачественной гиперплазии предстательной железы</h3>\r\nСимптомы нарушенного мочеиспускания являются частой жалобой у взрослых мужчин. Они оказывают серьезное негативное влияние на качество жизни. При ДГПЖ предстательная железа увеличивается в размерах, оказывая давление на нижние мочевые пути. В результате развиваются следующие симптомы:<sup>41</sup>'),
(4778, 224, '_текст-8-2', 'field_6244335fe2373'),
(4779, 224, 'заголовок-9', 'Осложнения ДГПЖ<sup>38</sup>'),
(4780, 224, '_заголовок-9', 'field_6244377a52263'),
(4781, 224, 'изображения-9', 'a:6:{i:0;s:3:\"141\";i:1;s:3:\"142\";i:2;s:3:\"143\";i:3;s:3:\"144\";i:4;s:3:\"145\";i:5;s:3:\"146\";}'),
(4782, 224, '_изображения-9', 'field_6244379652264'),
(4783, 224, 'заголовок-10', 'Медикаментозное лечение СНМП/ДГПЖ'),
(4784, 224, '_заголовок-10', 'field_6244489614262'),
(4785, 224, 'текст-10', 'Антагонисты альфа1-адренорецепторов (альфа-адреноблокаторы) и&nbsp;ингибиторы 5&nbsp;альфа1-редуктазы (ингибиторы 5-АР) являются группами лекарственных препаратов, которые в&nbsp;настоящее время утверждены для лечения ДГПЖ. Обе группы препаратов обеспечивают надлежащее ослабление симптомов, но&nbsp;&alpha;&mdash;блокаторы обладают довольно быстрым началом действия, а&nbsp;ингибиторам 5-АР требуется несколько месяцев для получения терапевтического эффекта.<sup>42</sup>'),
(4786, 224, '_текст-10', 'field_624448ce14263'),
(4787, 224, 'карточки-10_0_заголовок', 'Альфа-адреноблокаторы'),
(4788, 224, '_карточки-10_0_заголовок', 'field_624448fc14265'),
(4789, 224, 'карточки-10_0_текст', 'представляют собой наиболее эффективный класс лекарственных препаратов, характеризующийся хорошим профилем безопасности и высокой комплаентностью, применяющийся для облегчения СНМП, связанных с ДГПЖ: они снимают спазм гладкой мускулатуры предстательной железы и шейки мочевого пузыря42'),
(4790, 224, '_карточки-10_0_текст', 'field_6244490c14266'),
(4791, 224, 'карточки-10_1_заголовок', 'Ингибиторы 5-АР —'),
(4792, 224, '_карточки-10_1_заголовок', 'field_624448fc14265'),
(4793, 224, 'карточки-10_1_текст', 'приводят к редукции железистой ткани и к снижению размера предстательной железы: они блокируют конверсию тестостерона в дигидротестостерон, который стимулирует рост предстательной железы43,44.Назначаются при большом объеме предстательной железы. Для получения значимого клинического эффекта требуется несколько месяцев применения45\r\n'),
(4794, 224, '_карточки-10_1_текст', 'field_6244490c14266'),
(4795, 224, 'карточки-10', '2'),
(4796, 224, '_карточки-10', 'field_624448e214264'),
(4797, 224, 'видео', '<iframe width=\"560\" height=\"315\" src=\"https://www.youtube.com/embed/3DrU3pFXSsY\" title=\"YouTube video player\" frameborder=\"0\" allow=\"accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture\" allowfullscreen></iframe>'),
(4798, 224, '_видео', 'field_6244492214267'),
(4799, 224, 'заголовок-11', 'Часто задаваемые вопросы'),
(4800, 224, '_заголовок-11', 'field_62444b33e25d6'),
(4801, 224, 'вопросы_0_заголовок', 'Почему при приеме препарата Урорек у некоторых пациентов развивается нарушение эякуляции?'),
(4802, 224, '_вопросы_0_заголовок', 'field_62444b58e25d8'),
(4803, 224, 'вопросы_0_текст', 'Урорек — высокоселективный препарат, то есть преимущественно действует на альфа1А-адренорецепторы, которые находятся в нижних мочевых путях, предстательной железе и семенных пузырьках. Поэтому эффект развивается уже через 2–6 часов после приёма первой дозы препарата Урорек<sup>14</sup> при минимальным количестве нежелательных явлений.<sup>5</sup>\r\n\r\nНаиболее частый побочный эффект при приеме препарата Урорек — нарушение эякуляции<sup>46</sup>. Это может быть связано как с забросом эякулята при семяизвержении вместо уретры в мочевой пузырь, так и со снижением или отсутствием семенной жидкости во время эякуляции<sup>29</sup>. Силодозин снижает тонус гладкомышечных клеток семенных пузырьков, простаты и шейки мочевого пузыря, поэтому не происходит выброс семени. Этот эффект свойственен всем уроселективным альфа-адреноблокаторам<sup>53</sup> и самостоятельно исчезает после прекращения приема препарата.<sup>6</sup>\r\n\r\nЧастота эякуляторной дисфункции прямо пропорционально связана с улучшением СНМП и скорости мочеиспускания и подтверждает эффективность альфа-адреноблокатора: чем выше эффективность, тем выше частота встречаемости эякуляторной дисфункции.<sup>29</sup>\r\n\r\nНарушение эякуляции не влияет на сексуальную функцию<sup>52</sup>, не воспринимается как беспокоящий симптом подавляющим большинством пациентов и не требует отмены терапии.<sup>46</sup>'),
(4804, 224, '_вопросы_0_текст', 'field_62444b66e25d9'),
(4805, 224, 'вопросы_1_заголовок', 'Можно ли принимать Урорек при артериальной гипертензии и ишемический болезни сердца (ИБС)?'),
(4806, 224, '_вопросы_1_заголовок', 'field_62444b58e25d8'),
(4807, 224, 'вопросы_1_текст', 'Согласно инструкции по медицинскому применению, противопоказаний для применения лекарственного препарата Урорек у пациентов с СНМП/ДГПЖ и сопутствующими сердечно-сосудистыми заболеваниями нет.<sup>3</sup> Урорек не оказывает влияния на частоту сердечных сокращений (ЧСС), систолическое артериальное давление (САД) и диастолическое артериальное давление (ДАД).<sup>9</sup> Силодозин — не вызывает клинически значимого снижения артериального давления (АД)<sup>46</sup>, не усиливает действие антигипертензивных препаратов и не требует снижения дозы при одновременном приеме.<sup>7</sup> В соответствии с дизайном клинического исследования многие пациенты получали сопутствующую терапию антигипертензивными препаратами (в основном, средствами, воздействующими на ренин-ангиотензиновую систему, бета-блокаторами, антагонистами кальция и диуретиками) без повышения частоты ортостатической гипотензии.<sup>6</sup>\r\n\r\nПри приеме препарата Урорек наиболее низкий риск развития сердечно-сосудистых осложнений.<sup>5</sup>'),
(4808, 224, '_вопросы_1_текст', 'field_62444b66e25d9'),
(4809, 224, 'вопросы_2_заголовок', 'Можно ли принимать Урорек пациенту с ортостатической гипотензией в анамнезе?'),
(4810, 224, '_вопросы_2_заголовок', 'field_62444b58e25d8'),
(4811, 224, 'вопросы_2_текст', 'Повышенная селективность силодозина к альфа1A-адренорецепторам по сравнению с альфа1B-адренорецепторами выражается в пониженном риске развития сердечно-сосудистых осложнений.<sup>4</sup> Благодаря этому частота ортостатической гипотензии на фоне его приема сравнима с таковой при приеме плацебо.<sup>45,9</sup>\r\n\r\nВ отличие от других альфа-адреноблокаторов (например, все формы тамсулозина<sup>47,48</sup>), Урорек не противопоказан к приему у пациентов с ортостатической гипотензией в анамнезе. Тем не менее, пациентам с ортостатической гипотензией в анамнезе не рекомендуется принимать любые альфа-адреноблокаторы, в т.ч. Урорек.<sup>6</sup>'),
(4812, 224, '_вопросы_2_текст', 'field_62444b66e25d9'),
(4813, 224, 'вопросы_3_заголовок', 'Как долго можно принимать Урорек?'),
(4814, 224, '_вопросы_3_заголовок', 'field_62444b58e25d8'),
(4815, 224, 'вопросы_3_текст', 'Учитывая прогрессирующий характер течения доброкачественной гиперплазии предстательной железы, медикаментозную терапию следует проводить длительно (иногда в течение всей жизни пациента).<sup>49</sup>'),
(4816, 224, '_вопросы_3_текст', 'field_62444b66e25d9'),
(4817, 224, 'вопросы_4_заголовок', 'Пациенты жалуются на заложенность носа при лечении альфа-адреноблокаторами. Есть ли у препарата Урорек такое побочное действие?'),
(4818, 224, '_вопросы_4_заголовок', 'field_62444b58e25d8'),
(4819, 224, 'вопросы_4_текст', 'Заложенность носа — это возможный побочный эффект для всех альфа-адреноблокаторов. При приеме препарата Урорек он может возникать примерно в 1% случаев.<sup>46</sup>'),
(4820, 224, '_вопросы_4_текст', 'field_62444b66e25d9'),
(4821, 224, 'вопросы_5_заголовок', 'Можно ли начинать лечение препаратом Урорек с дозы 4 мг в сутки?'),
(4822, 224, '_вопросы_5_заголовок', 'field_62444b58e25d8'),
(4823, 224, 'вопросы_5_текст', 'Согласно инструкции по медицинскому применению лекарственного препарата Урорек, доза 8 мг в сутки рекомендована для лечения пациентов с СНМП/ДГПЖ. Титрование дозы при применении силодозина не требуется.\r\n\r\nУрорек 4 мг — это специальная доза для лечения пациентов с почечной недостаточностью средней степени тяжести (клиренс креатинина ≥ 30 до &lt; 50 мл/мин). Рекомендуется в течение первой недели принимать начальную дозу по 4 мг в сутки, далее при хорошей переносимости доза может быть увеличена до 8 мг в сутки.<sup>6</sup>**Более подробные сведения о препарате, особенностях применения, побочных действиях и др. — см. инструкцию по медицинскому применению лекарственного препарата Урорек, РУ ЛСР-005971/10 от 25.06.2010'),
(4824, 224, '_вопросы_5_текст', 'field_62444b66e25d9'),
(4825, 224, 'вопросы_6_заголовок', 'Влияет ли Урорек на течение ДГПЖ или только снимает симптомы нижних мочевыводящих путей?'),
(4826, 224, '_вопросы_6_заголовок', 'field_62444b58e25d8'),
(4827, 224, 'вопросы_6_текст', 'Помимо субъективных симптомов, ДГПЖ вызывает прогрессирующее морфологическое ремоделирование мочевого пузыря с риском развития серьезных функциональных нарушений. Лечение должно не только купировать субъективные симптомы, но и включать профилактику патологического ремоделирования мочевого пузыря.<sup>161</sup>\r\n\r\nСилодозин, действующее вещество препарата Урорек, в сравнении с другими альфа-адреноблокаторами более эффективно влияет на инфравезикальную обструкцию (ИВО), что оказывает влияние на предотвращение патологического прогрессирования ремоделирования мочевого пузыря и риск развития серьезных функциональных нарушений.<sup>50,51</sup>'),
(4828, 224, '_вопросы_6_текст', 'field_62444b66e25d9'),
(4829, 224, 'вопросы_7_заголовок', 'Доступен ли Урорек по льготному отпуску?'),
(4830, 224, '_вопросы_7_заголовок', 'field_62444b58e25d8'),
(4831, 224, 'вопросы_7_текст', 'Урорек (силодозин) не включен в список жизненно важных лекарственных препаратов (ЖНВЛП)<sup>1</sup> и не входит в перечень препаратов для льготного обеспечения граждан по федеральному льготному списку.'),
(4832, 224, '_вопросы_7_текст', 'field_62444b66e25d9'),
(4833, 224, 'вопросы', '8'),
(4834, 224, '_вопросы', 'field_62444b49e25d7'),
(4835, 225, 'заголовок-1', 'УРОРЕК – оригинальный<sup>10</sup> альфа-адреноблокатор'),
(4836, 225, '_заголовок-1', 'field_62435bd26f29f'),
(4837, 225, 'текст-1', '<div class=\"headerBlock__body\">\r\n<p>Силодозин (действующее вещество препарата Урорек) обладает максимальной уроселективностью в&nbsp;своем классе, что обеспечивает его уродинамическую эффективность и&nbsp;высокую безопасность<sup>4</sup></p>\r\n</div>\r\n<div class=\"headerBlock__footer\">\r\n<p><strong>Показания к применению: </strong><br/>Лечение симптомов доброкачественной гиперплазии предстательной железы<sup>6</sup></p>\r\n</div>'),
(4838, 225, '_текст-1', 'field_62435c0c6f2a0'),
(4839, 225, 'изображение-1', '13'),
(4840, 225, '_изображение-1', 'field_62435c8b6f2a1'),
(4841, 225, 'фон-1', '17'),
(4842, 225, '_фон-1', 'field_62435db92ea96'),
(4843, 225, 'заголовок-2', 'Ключевые преимущества препарата Урорек'),
(4844, 225, '_заголовок-2', 'field_6243606295196'),
(4845, 225, 'список-2', 'Единственный оригинальный препарат из&nbsp;группы альфа1-адреноблокаторов, не&nbsp;имеющий генериков в&nbsp;РФ<sup>1</sup>'),
(4846, 225, '_список-2', 'field_6243608195197'),
(4847, 225, 'картинка_с_текстом_0_изображение', '31'),
(4848, 225, '_картинка_с_текстом_0_изображение', 'field_624363d095199'),
(4849, 225, 'картинка_с_текстом_0_описание', 'Обширная доказательная база собственных пострегистрационных клинических исследований<sup>2</sup>'),
(4850, 225, '_картинка_с_текстом_0_описание', 'field_624363e59519a'),
(4851, 225, 'картинка_с_текстом_1_изображение', '32'),
(4852, 225, '_картинка_с_текстом_1_изображение', 'field_624363d095199'),
(4853, 225, 'картинка_с_текстом_1_описание', 'Отсутствие риска замены препарата Урорек в&nbsp;аптеке (единственный препарат с&nbsp;действующим веществом силодозин)<sup>1</sup>'),
(4854, 225, '_картинка_с_текстом_1_описание', 'field_624363e59519a'),
(4855, 225, 'картинка_с_текстом_2_изображение', '33'),
(4856, 225, '_картинка_с_текстом_2_изображение', 'field_624363d095199'),
(4857, 225, 'картинка_с_текстом_2_описание', 'Большинство пациентов предпочитают принимать оригинальные препараты<sup>3</sup>'),
(4858, 225, '_картинка_с_текстом_2_описание', 'field_624363e59519a'),
(4859, 225, 'картинка_с_текстом', '3'),
(4860, 225, '_картинка_с_текстом', 'field_624363b995198'),
(4861, 225, 'второй_список', '<li>Клинические преимущества препарата Урорек (силодозин) определяются максимальной уроселективностью в&nbsp;классе альфа-адреноблокаторов<sup>4</sup></li>\r\n\r\n<li>Урорек&nbsp;&mdash; альфа-адреноблокатор последнего поколения, который эффективен в&nbsp;отношении всех СНМП (накопления, опорожнения, постмиктурических).<sup>12,13</sup> При этом Урорек обладает минимальным риском развития нежелательных явлений со&nbsp;стороны сердечно-сосудистой системы, в&nbsp;том числе&nbsp;у&nbsp;пациентов, принимающих антигипертензивные препараты<sup>46,8</sup> <small> <span>СНМП </span>симптомы нижних мочевыводящих путей</small></li>'),
(4862, 225, '_второй_список', 'field_6243640e05eda'),
(4863, 225, 'заголовок2-2', 'Максимальная уроселективность силодозина в&nbsp;классе альфа-адреноблокаторов обуславливает его уродинамическую эффективность и&nbsp;высокий профиль безопасности<sup>4</sup>'),
(4864, 225, '_заголовок2-2', 'field_6243644705edb'),
(4865, 225, 'текст3', '<ul>\r\n<li>Урорек значительно улучшает клинические проявления и&nbsp;качество жизни у&nbsp;всех пациентов с&nbsp;СНМП/ДГПЖ, в&nbsp;том числе с&nbsp;тяжелым течением<sup>11</sup>\r\n<a href=\"#modal-call-first\" class=\"link-modal-js\">Узнать больше...</a></li>\r\n\r\n<li>Урорек является препаратом выбора для пациентов с&nbsp;СНМП/ДГПЖ и&nbsp;сопутствующими сердечно-сосудистыми заболеваниями<sup>3</sup> \r\n<a href=\"#modal-call-second\" class=\"link-modal-js\">Узнать больше...</a></li>\r\n</ul>\r\n<small> <span>ДГПЖ </span>доброкачественная гиперплазия предстательной железы</small>'),
(4866, 225, '_текст3', 'field_6243647405edc'),
(4867, 225, 'изображение-2', '34'),
(4868, 225, '_изображение-2', 'field_624364dd05edd'),
(4869, 225, 'текст_в_подвале', '<h2> Максимальная уроселективность в&nbsp;классе  альфа-адреноблокаторов<sup>4</sup></h2>\r\n<div class=\"h3\"> Почему это важно? <a href=\"#\">Подробнее</a></div>'),
(4870, 225, '_текст_в_подвале', 'field_62436daf1f6d9'),
(4871, 225, 'заголовок-3', 'Форма выпуска препарата Урорек'),
(4872, 225, '_заголовок-3', 'field_62436efee98e7'),
(4873, 225, 'текст-3', '<p class=\"section-descr\"><span>8мг </span>- рекомендуемая доза для лечения симптомов ДГПЖ<sup>6</sup>*</p>\r\n					<p class=\"section-note col-md-10\">*Более подробные сведения о&nbsp;препарате, особенностях применения, побочных действиях и&nbsp;др. &mdash;&nbsp;смотрите инструкцию по&nbsp;медицинскому применению лекарственного препарата Урорек, РУ&nbsp;ЛСР-005971/10 от&nbsp;25.06.2010 </p>'),
(4874, 225, '_текст-3', 'field_62436f60e98e8'),
(4875, 225, 'товар_0_название', 'Урорек 8мг №30'),
(4876, 225, '_товар_0_название', 'field_62436fcce98ea'),
(4877, 225, 'товар_0_описание', 'Упаковка, рассчитанная на&nbsp;1&nbsp;месяц лечения&nbsp;/ для старта терапии'),
(4878, 225, '_товар_0_описание', 'field_62436fe1e98eb'),
(4879, 225, 'товар_0_лицензия', 'РУ: ЛСР-005971/10 от 25.06.2010'),
(4880, 225, '_товар_0_лицензия', 'field_62436ff0e98ec'),
(4881, 225, 'товар_0_изображение', '51'),
(4882, 225, '_товар_0_изображение', 'field_62437045e98ed'),
(4883, 225, 'товар_1_название', 'Урорек 8мг №90'),
(4884, 225, '_товар_1_название', 'field_62436fcce98ea'),
(4885, 225, 'товар_1_описание', 'Выгодная упаковка, рассчитанная на&nbsp;3&nbsp;месяца лечения. Самая доступная стоимость 1&nbsp;дня терапии препаратом Урорек&nbsp;<sup>27</sup>'),
(4886, 225, '_товар_1_описание', 'field_62436fe1e98eb'),
(4887, 225, 'товар_1_лицензия', 'РУ: ЛСР-005971/10 от 25.06.2010'),
(4888, 225, '_товар_1_лицензия', 'field_62436ff0e98ec'),
(4889, 225, 'товар_1_изображение', '53'),
(4890, 225, '_товар_1_изображение', 'field_62437045e98ed'),
(4891, 225, 'товар_2_название', 'Урорек 4мг №30'),
(4892, 225, '_товар_2_название', 'field_62436fcce98ea'),
(4893, 225, 'товар_2_описание', '4&nbsp;мг&nbsp;&mdash; стартовая упаковка для лечения симптомов ДГПЖ у&nbsp;пациентов с&nbsp;почечной недостаточностью средней степени тяжести<sup>6</sup>'),
(4894, 225, '_товар_2_описание', 'field_62436fe1e98eb'),
(4895, 225, 'товар_2_лицензия', 'РУ: ЛСР-005971/10 от 25.06.2010'),
(4896, 225, '_товар_2_лицензия', 'field_62436ff0e98ec'),
(4897, 225, 'товар_2_изображение', '52'),
(4898, 225, '_товар_2_изображение', 'field_62437045e98ed'),
(4899, 225, 'товар', '3'),
(4900, 225, '_товар', 'field_62436fbde98e9'),
(4901, 225, 'заголовок-4', 'Где купить'),
(4902, 225, '_заголовок-4', 'field_624374f73d8bd'),
(4903, 225, 'изображения', 'a:12:{i:0;s:2:\"63\";i:1;s:2:\"64\";i:2;s:2:\"65\";i:3;s:2:\"66\";i:4;s:2:\"67\";i:5;s:2:\"68\";i:6;s:2:\"69\";i:7;s:2:\"70\";i:8;s:2:\"71\";i:9;s:2:\"72\";i:10;s:2:\"73\";i:11;s:2:\"74\";}'),
(4904, 225, '_изображения', 'field_624375093d8be'),
(4905, 225, 'изображения-4', 'a:12:{i:0;s:2:\"63\";i:1;s:2:\"64\";i:2;s:2:\"65\";i:3;s:2:\"66\";i:4;s:2:\"67\";i:5;s:2:\"68\";i:6;s:2:\"69\";i:7;s:2:\"70\";i:8;s:2:\"71\";i:9;s:2:\"72\";i:10;s:2:\"73\";i:11;s:2:\"74\";}'),
(4906, 225, '_изображения-4', 'field_624375093d8be'),
(4907, 225, 'заголовок-5', 'Способ применения*<sup>6</sup>'),
(4908, 225, '_заголовок-5', 'field_624379bd4756d'),
(4909, 225, 'иконки', 'a:5:{i:0;s:2:\"83\";i:1;s:2:\"84\";i:2;s:2:\"85\";i:3;s:2:\"86\";i:4;s:2:\"87\";}'),
(4910, 225, '_иконки', 'field_624379f24756e'),
(4911, 225, 'текст-5', 'У пациентов с легкой почечной недостаточностью (клиренс креатинина ≥ 50 — ≤ 80 мл/мин) коррекция дозы не требуется. Для лечения пациентов с почечной недостаточностью средней степени тяжести (клиренс креатинина ≥ 30 — < 50 мл/мин) рекомендуется в течение первой недели принимать начальную дозу по 4 мг в сутки, при хорошей индивидуальной переносимости доза может быть увеличена до 8 мг в сутки. Применение препарата для пациентов с тяжелой почечной недостаточностью (клиренс креатинина < 30 мл / мин) не рекомендуется'),
(4912, 225, '_текст-5', 'field_62437a374756f'),
(4913, 225, 'текст_под_кнопкой', '*Более подробные сведения о&nbsp;препарате, особенностях применения, побочных действиях и&nbsp;др. &mdash;&nbsp;см. инструкцию по&nbsp;медицинскому применению лекарственного препарата Урорек, РУ&nbsp;ЛСР-005971/10 от&nbsp;25.06.2010'),
(4914, 225, '_текст_под_кнопкой', 'field_62437a7c47570'),
(4915, 225, 'заголовок-6', 'Препарат Урорек (силодозин) включен в&nbsp;российские и&nbsp;международные клинические рекомендации и&nbsp;стандарты для лечения ряда урологических заболеваний:'),
(4916, 225, '_заголовок-6', 'field_6244117c68bd0'),
(4917, 225, 'список-6_0_ссылка', 'a:3:{s:5:\"title\";s:68:\"Российские клинические рекомендации\";s:3:\"url\";s:1:\"#\";s:6:\"target\";s:0:\"\";}'),
(4918, 225, '_список-6_0_ссылка', 'field_624411ce68bd2'),
(4919, 225, 'список-6_0_описание', '«Доброкачественная гиперплазия предстательной железы», 2020<sup>28</sup>'),
(4920, 225, '_список-6_0_описание', 'field_6244121168bd3'),
(4921, 225, 'список-6_1_ссылка', 'a:3:{s:5:\"title\";s:70:\"Европейские клинические рекомендации\";s:3:\"url\";s:1:\"#\";s:6:\"target\";s:0:\"\";}'),
(4922, 225, '_список-6_1_ссылка', 'field_624411ce68bd2'),
(4923, 225, 'список-6_1_описание', 'глава «Консервативное лечение ненейрогенных симптомов нарушенного мочеиспускания у мужчин, включая доброкачественную простатическую обструкцию», 2021<sup>29</sup>'),
(4924, 225, '_список-6_1_описание', 'field_6244121168bd3'),
(4925, 225, 'список-6_2_ссылка', 'a:3:{s:5:\"title\";s:154:\"Стандарт первичной медико-санитарной помощи при гиперплазии предстательной железы\";s:3:\"url\";s:1:\"#\";s:6:\"target\";s:0:\"\";}'),
(4926, 225, '_список-6_2_ссылка', 'field_624411ce68bd2'),
(4927, 225, 'список-6_2_описание', '09.11.2012<sup>30</sup> / Обновлён 13.04.2015\r\n'),
(4928, 225, '_список-6_2_описание', 'field_6244121168bd3'),
(4929, 225, 'список-6_3_ссылка', 'a:3:{s:5:\"title\";s:122:\"Стандарт специализированной медицинской помощи при задержке мочи\";s:3:\"url\";s:1:\"#\";s:6:\"target\";s:0:\"\";}'),
(4930, 225, '_список-6_3_ссылка', 'field_624411ce68bd2'),
(4931, 225, 'список-6_3_описание', '29.01.2013<sup>31</sup> / Обновлён 06.05.2015\r\n'),
(4932, 225, '_список-6_3_описание', 'field_6244121168bd3'),
(4933, 225, 'список-6_4_ссылка', 'a:3:{s:5:\"title\";s:133:\"Стандарт первичной медико-санитарной помощи при хроническом простатите\";s:3:\"url\";s:1:\"#\";s:6:\"target\";s:0:\"\";}'),
(4934, 225, '_список-6_4_ссылка', 'field_624411ce68bd2'),
(4935, 225, 'список-6_4_описание', '09.11.2012<sup>32</sup> / Обновлён 13.04.2015\r\n'),
(4936, 225, '_список-6_4_описание', 'field_6244121168bd3'),
(4937, 225, 'список-6_5_ссылка', 'a:3:{s:5:\"title\";s:168:\"Стандарт специализированной медицинской помощи при остром простатите, орхите, эпидидимите\";s:3:\"url\";s:1:\"#\";s:6:\"target\";s:0:\"\";}'),
(4938, 225, '_список-6_5_ссылка', 'field_624411ce68bd2'),
(4939, 225, 'список-6_5_описание', '09.11.2012<sup>33</sup> / Обновлён 27.05.2015'),
(4940, 225, '_список-6_5_описание', 'field_6244121168bd3'),
(4941, 225, 'список-6', '6'),
(4942, 225, '_список-6', 'field_624411be68bd1'),
(4943, 225, 'заголовок-7', 'Препарат Урорек (силодозин) зарегистрирован и&nbsp;применяется в&nbsp;разных странах мира Одобрен ЕМА*<sup>34</sup> и&nbsp;FDA**<sup>35</sup>'),
(4944, 225, '_заголовок-7', 'field_624417e3b6088'),
(4945, 225, 'текст', '<p class=\"sOtherCountries__agency\"><span>EMA</span> Европейское медицинское агентство</p>\r\n<p class=\"sOtherCountries__agency\"><span>FDA</span> Управление по&nbsp;санитарному надзору за&nbsp;качеством пищевых продуктов и&nbsp;медикаментов, США</p>'),
(4946, 225, '_текст', 'field_6244182bb6089'),
(4947, 225, 'страны_0_флаг', '105'),
(4948, 225, '_страны_0_флаг', 'field_62441880b608b'),
(4949, 225, 'страны_0_название', 'Япония'),
(4950, 225, '_страны_0_название', 'field_62441899b608c'),
(4951, 225, 'страны_0_год', '2006<sup>36,37</sup>'),
(4952, 225, '_страны_0_год', 'field_624418aab608d'),
(4953, 225, 'страны_1_флаг', '106'),
(4954, 225, '_страны_1_флаг', 'field_62441880b608b'),
(4955, 225, 'страны_1_название', 'США'),
(4956, 225, '_страны_1_название', 'field_62441899b608c'),
(4957, 225, 'страны_1_год', '2008<sup>35</sup>'),
(4958, 225, '_страны_1_год', 'field_624418aab608d'),
(4959, 225, 'страны_2_флаг', '107'),
(4960, 225, '_страны_2_флаг', 'field_62441880b608b'),
(4961, 225, 'страны_2_название', 'Страны ЕС'),
(4962, 225, '_страны_2_название', 'field_62441899b608c'),
(4963, 225, 'страны_2_год', '2010<sup>34</sup>'),
(4964, 225, '_страны_2_год', 'field_624418aab608d'),
(4965, 225, 'страны_3_флаг', '108'),
(4966, 225, '_страны_3_флаг', 'field_62441880b608b'),
(4967, 225, 'страны_3_название', 'Россия'),
(4968, 225, '_страны_3_название', 'field_62441899b608c'),
(4969, 225, 'страны_3_год', '2010<sup>1</sup>'),
(4970, 225, '_страны_3_год', 'field_624418aab608d'),
(4971, 225, 'страны', '4'),
(4972, 225, '_страны', 'field_62441847b608a'),
(4973, 225, 'текст-7', '<p class=\"sOtherCountries__agency\"><span>EMA</span> Европейское медицинское агентство</p>\r\n<p class=\"sOtherCountries__agency\"><span>FDA</span> Управление по&nbsp;санитарному надзору за&nbsp;качеством пищевых продуктов и&nbsp;медикаментов, США</p>'),
(4974, 225, '_текст-7', 'field_6244182bb6089'),
(4975, 225, 'текст-7-1', 'Производство препарата Урорек, поставляемого в&nbsp;Россию, осуществляется в&nbsp;Италии с&nbsp;использованием субстанции из&nbsp;Японии, в&nbsp;соответствии с&nbsp;необходимыми требованиями к&nbsp;производству и&nbsp;контролю качества<sup>6,1</sup>'),
(4976, 225, '_текст-7-1', 'field_62441a5acf03c'),
(4977, 225, 'заголовок-8', 'О проблеме'),
(4978, 225, '_заголовок-8', 'field_624431d91624d'),
(4979, 225, 'текст-8', 'Доброкачественная гиперплазия предстательной железы (ДГПЖ), или как ее еще называют, аденома простаты, как правило, возникает у мужчин старше 50 лет и характеризуется наличием симптомов нижних мочевыводящих путей (СНМП), увеличением предстательной железы или ее части, и нарушением оттока мочи из мочевого пузыря вследствие инфравезикальной обструкции.<sup>38</sup>\r\n\r\nРаспространенность ДГПЖ увеличивается с возрастом. Так, клинически значимая ДГПЖ проявляется у 13% мужчин в возрасте старше 50 лет, у 34% мужчин в возрасте 60 лет и у 43% в возрасте 70 лет.<sup>39</sup>\r\n\r\n&nbsp;\r\n\r\n<img class=\"alignnone wp-image-122 size-full\" src=\"http://0026urotec.loc:8888/wp-content/uploads/2022/03/about-img.png\" alt=\"\" width=\"594\" height=\"696\" />'),
(4980, 225, '_текст-8', 'field_624431f11624e'),
(4981, 225, 'текст-8-1', 'Наличие СНМП может быть ассоциировано с&nbsp;тяжелыми хроническими заболеваниями, такими как заболевания сердца, сахарный диабет, артериальная гипертензия и&nbsp;депрессия<sup>40</sup>'),
(4982, 225, '_текст-8-1', 'field_6244320b26db3'),
(4983, 225, 'иконки-8', 'a:6:{i:0;s:3:\"123\";i:1;s:3:\"124\";i:2;s:3:\"125\";i:3;s:3:\"126\";i:4;s:3:\"127\";i:5;s:3:\"128\";}'),
(4984, 225, '_иконки-8', 'field_6244322d26db4'),
(4985, 225, 'текст-8-2', '<h3>Симптомы доброкачественной гиперплазии предстательной железы</h3>\r\nСимптомы нарушенного мочеиспускания являются частой жалобой у взрослых мужчин. Они оказывают серьезное негативное влияние на качество жизни. При ДГПЖ предстательная железа увеличивается в размерах, оказывая давление на нижние мочевые пути. В результате развиваются следующие симптомы:<sup>41</sup>'),
(4986, 225, '_текст-8-2', 'field_6244335fe2373'),
(4987, 225, 'заголовок-9', 'Осложнения ДГПЖ<sup>38</sup>'),
(4988, 225, '_заголовок-9', 'field_6244377a52263'),
(4989, 225, 'изображения-9', 'a:6:{i:0;s:3:\"141\";i:1;s:3:\"142\";i:2;s:3:\"143\";i:3;s:3:\"144\";i:4;s:3:\"145\";i:5;s:3:\"146\";}'),
(4990, 225, '_изображения-9', 'field_6244379652264'),
(4991, 225, 'заголовок-10', 'Медикаментозное лечение СНМП/ДГПЖ'),
(4992, 225, '_заголовок-10', 'field_6244489614262'),
(4993, 225, 'текст-10', 'Антагонисты альфа1-адренорецепторов (альфа-адреноблокаторы) и&nbsp;ингибиторы 5&nbsp;альфа1-редуктазы (ингибиторы 5-АР) являются группами лекарственных препаратов, которые в&nbsp;настоящее время утверждены для лечения ДГПЖ. Обе группы препаратов обеспечивают надлежащее ослабление симптомов, но&nbsp;&alpha;&mdash;блокаторы обладают довольно быстрым началом действия, а&nbsp;ингибиторам 5-АР требуется несколько месяцев для получения терапевтического эффекта.<sup>42</sup>'),
(4994, 225, '_текст-10', 'field_624448ce14263'),
(4995, 225, 'карточки-10_0_заголовок', 'Альфа-адреноблокаторы'),
(4996, 225, '_карточки-10_0_заголовок', 'field_624448fc14265'),
(4997, 225, 'карточки-10_0_текст', 'представляют собой наиболее эффективный класс лекарственных препаратов, характеризующийся хорошим профилем безопасности и высокой комплаентностью, применяющийся для облегчения СНМП, связанных с ДГПЖ: они снимают спазм гладкой мускулатуры предстательной железы и шейки мочевого пузыря42'),
(4998, 225, '_карточки-10_0_текст', 'field_6244490c14266'),
(4999, 225, 'карточки-10_1_заголовок', 'Ингибиторы 5-АР —'),
(5000, 225, '_карточки-10_1_заголовок', 'field_624448fc14265'),
(5001, 225, 'карточки-10_1_текст', 'приводят к редукции железистой ткани и к снижению размера предстательной железы: они блокируют конверсию тестостерона в дигидротестостерон, который стимулирует рост предстательной железы43,44.Назначаются при большом объеме предстательной железы. Для получения значимого клинического эффекта требуется несколько месяцев применения45\r\n'),
(5002, 225, '_карточки-10_1_текст', 'field_6244490c14266'),
(5003, 225, 'карточки-10', '2'),
(5004, 225, '_карточки-10', 'field_624448e214264'),
(5005, 225, 'видео', '<iframe width=\"560\" height=\"315\" src=\"https://www.youtube.com/embed/3DrU3pFXSsY\" title=\"YouTube video player\" frameborder=\"0\" allow=\"accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture\" allowfullscreen></iframe>'),
(5006, 225, '_видео', 'field_6244492214267'),
(5007, 225, 'заголовок-11', 'Часто задаваемые вопросы'),
(5008, 225, '_заголовок-11', 'field_62444b33e25d6'),
(5009, 225, 'вопросы_0_заголовок', 'Почему при приеме препарата Урорек у некоторых пациентов развивается нарушение эякуляции?'),
(5010, 225, '_вопросы_0_заголовок', 'field_62444b58e25d8'),
(5011, 225, 'вопросы_0_текст', 'Урорек — высокоселективный препарат, то есть преимущественно действует на альфа1А-адренорецепторы, которые находятся в нижних мочевых путях, предстательной железе и семенных пузырьках. Поэтому эффект развивается уже через 2–6 часов после приёма первой дозы препарата Урорек<sup>14</sup> при минимальным количестве нежелательных явлений.<sup>5</sup>\r\n\r\nНаиболее частый побочный эффект при приеме препарата Урорек — нарушение эякуляции<sup>46</sup>. Это может быть связано как с забросом эякулята при семяизвержении вместо уретры в мочевой пузырь, так и со снижением или отсутствием семенной жидкости во время эякуляции<sup>29</sup>. Силодозин снижает тонус гладкомышечных клеток семенных пузырьков, простаты и шейки мочевого пузыря, поэтому не происходит выброс семени. Этот эффект свойственен всем уроселективным альфа-адреноблокаторам<sup>53</sup> и самостоятельно исчезает после прекращения приема препарата.<sup>6</sup>\r\n\r\nЧастота эякуляторной дисфункции прямо пропорционально связана с улучшением СНМП и скорости мочеиспускания и подтверждает эффективность альфа-адреноблокатора: чем выше эффективность, тем выше частота встречаемости эякуляторной дисфункции.<sup>29</sup>\r\n\r\nНарушение эякуляции не влияет на сексуальную функцию<sup>52</sup>, не воспринимается как беспокоящий симптом подавляющим большинством пациентов и не требует отмены терапии.<sup>46</sup>'),
(5012, 225, '_вопросы_0_текст', 'field_62444b66e25d9'),
(5013, 225, 'вопросы_1_заголовок', 'Можно ли принимать Урорек при артериальной гипертензии и ишемический болезни сердца (ИБС)?'),
(5014, 225, '_вопросы_1_заголовок', 'field_62444b58e25d8'),
(5015, 225, 'вопросы_1_текст', 'Согласно инструкции по медицинскому применению, противопоказаний для применения лекарственного препарата Урорек у пациентов с СНМП/ДГПЖ и сопутствующими сердечно-сосудистыми заболеваниями нет.<sup>3</sup> Урорек не оказывает влияния на частоту сердечных сокращений (ЧСС), систолическое артериальное давление (САД) и диастолическое артериальное давление (ДАД).<sup>9</sup> Силодозин — не вызывает клинически значимого снижения артериального давления (АД)<sup>46</sup>, не усиливает действие антигипертензивных препаратов и не требует снижения дозы при одновременном приеме.<sup>7</sup> В соответствии с дизайном клинического исследования многие пациенты получали сопутствующую терапию антигипертензивными препаратами (в основном, средствами, воздействующими на ренин-ангиотензиновую систему, бета-блокаторами, антагонистами кальция и диуретиками) без повышения частоты ортостатической гипотензии.<sup>6</sup>\r\n\r\nПри приеме препарата Урорек наиболее низкий риск развития сердечно-сосудистых осложнений.<sup>5</sup>'),
(5016, 225, '_вопросы_1_текст', 'field_62444b66e25d9'),
(5017, 225, 'вопросы_2_заголовок', 'Можно ли принимать Урорек пациенту с ортостатической гипотензией в анамнезе?'),
(5018, 225, '_вопросы_2_заголовок', 'field_62444b58e25d8'),
(5019, 225, 'вопросы_2_текст', 'Повышенная селективность силодозина к альфа1A-адренорецепторам по сравнению с альфа1B-адренорецепторами выражается в пониженном риске развития сердечно-сосудистых осложнений.<sup>4</sup> Благодаря этому частота ортостатической гипотензии на фоне его приема сравнима с таковой при приеме плацебо.<sup>45,9</sup>\r\n\r\nВ отличие от других альфа-адреноблокаторов (например, все формы тамсулозина<sup>47,48</sup>), Урорек не противопоказан к приему у пациентов с ортостатической гипотензией в анамнезе. Тем не менее, пациентам с ортостатической гипотензией в анамнезе не рекомендуется принимать любые альфа-адреноблокаторы, в т.ч. Урорек.<sup>6</sup>'),
(5020, 225, '_вопросы_2_текст', 'field_62444b66e25d9'),
(5021, 225, 'вопросы_3_заголовок', 'Как долго можно принимать Урорек?'),
(5022, 225, '_вопросы_3_заголовок', 'field_62444b58e25d8'),
(5023, 225, 'вопросы_3_текст', 'Учитывая прогрессирующий характер течения доброкачественной гиперплазии предстательной железы, медикаментозную терапию следует проводить длительно (иногда в течение всей жизни пациента).<sup>49</sup>'),
(5024, 225, '_вопросы_3_текст', 'field_62444b66e25d9'),
(5025, 225, 'вопросы_4_заголовок', 'Пациенты жалуются на заложенность носа при лечении альфа-адреноблокаторами. Есть ли у препарата Урорек такое побочное действие?'),
(5026, 225, '_вопросы_4_заголовок', 'field_62444b58e25d8'),
(5027, 225, 'вопросы_4_текст', 'Заложенность носа — это возможный побочный эффект для всех альфа-адреноблокаторов. При приеме препарата Урорек он может возникать примерно в 1% случаев.<sup>46</sup>'),
(5028, 225, '_вопросы_4_текст', 'field_62444b66e25d9'),
(5029, 225, 'вопросы_5_заголовок', 'Можно ли начинать лечение препаратом Урорек с дозы 4 мг в сутки?'),
(5030, 225, '_вопросы_5_заголовок', 'field_62444b58e25d8'),
(5031, 225, 'вопросы_5_текст', 'Согласно инструкции по медицинскому применению лекарственного препарата Урорек, доза 8 мг в сутки рекомендована для лечения пациентов с СНМП/ДГПЖ. Титрование дозы при применении силодозина не требуется.\r\n\r\nУрорек 4 мг — это специальная доза для лечения пациентов с почечной недостаточностью средней степени тяжести (клиренс креатинина ≥ 30 до &lt; 50 мл/мин). Рекомендуется в течение первой недели принимать начальную дозу по 4 мг в сутки, далее при хорошей переносимости доза может быть увеличена до 8 мг в сутки.<sup>6</sup>**Более подробные сведения о препарате, особенностях применения, побочных действиях и др. — см. инструкцию по медицинскому применению лекарственного препарата Урорек, РУ ЛСР-005971/10 от 25.06.2010'),
(5032, 225, '_вопросы_5_текст', 'field_62444b66e25d9'),
(5033, 225, 'вопросы_6_заголовок', 'Влияет ли Урорек на течение ДГПЖ или только снимает симптомы нижних мочевыводящих путей?'),
(5034, 225, '_вопросы_6_заголовок', 'field_62444b58e25d8'),
(5035, 225, 'вопросы_6_текст', 'Помимо субъективных симптомов, ДГПЖ вызывает прогрессирующее морфологическое ремоделирование мочевого пузыря с риском развития серьезных функциональных нарушений. Лечение должно не только купировать субъективные симптомы, но и включать профилактику патологического ремоделирования мочевого пузыря.<sup>161</sup>\r\n\r\nСилодозин, действующее вещество препарата Урорек, в сравнении с другими альфа-адреноблокаторами более эффективно влияет на инфравезикальную обструкцию (ИВО), что оказывает влияние на предотвращение патологического прогрессирования ремоделирования мочевого пузыря и риск развития серьезных функциональных нарушений.<sup>50,51</sup>'),
(5036, 225, '_вопросы_6_текст', 'field_62444b66e25d9'),
(5037, 225, 'вопросы_7_заголовок', 'Доступен ли Урорек по льготному отпуску?'),
(5038, 225, '_вопросы_7_заголовок', 'field_62444b58e25d8'),
(5039, 225, 'вопросы_7_текст', 'Урорек (силодозин) не включен в список жизненно важных лекарственных препаратов (ЖНВЛП)<sup>1</sup> и не входит в перечень препаратов для льготного обеспечения граждан по федеральному льготному списку.'),
(5040, 225, '_вопросы_7_текст', 'field_62444b66e25d9'),
(5041, 225, 'вопросы', '8'),
(5042, 225, '_вопросы', 'field_62444b49e25d7'),
(5043, 226, 'заголовок-1', 'УРОРЕК – оригинальный<sup>10</sup> альфа-адреноблокатор'),
(5044, 226, '_заголовок-1', 'field_62435bd26f29f'),
(5045, 226, 'текст-1', '<div class=\"headerBlock__body\">\r\n<p>Силодозин (действующее вещество препарата Урорек) обладает максимальной уроселективностью в&nbsp;своем классе, что обеспечивает его уродинамическую эффективность и&nbsp;высокую безопасность<sup>4</sup></p>\r\n</div>\r\n<div class=\"headerBlock__footer\">\r\n<p><strong>Показания к применению: </strong><br/>Лечение симптомов доброкачественной гиперплазии предстательной железы<sup>6</sup></p>\r\n</div>'),
(5046, 226, '_текст-1', 'field_62435c0c6f2a0'),
(5047, 226, 'изображение-1', '13'),
(5048, 226, '_изображение-1', 'field_62435c8b6f2a1'),
(5049, 226, 'фон-1', '17'),
(5050, 226, '_фон-1', 'field_62435db92ea96'),
(5051, 226, 'заголовок-2', 'Ключевые преимущества препарата Урорек'),
(5052, 226, '_заголовок-2', 'field_6243606295196'),
(5053, 226, 'список-2', 'Единственный оригинальный препарат из&nbsp;группы альфа1-адреноблокаторов, не&nbsp;имеющий генериков в&nbsp;РФ<sup>1</sup>'),
(5054, 226, '_список-2', 'field_6243608195197'),
(5055, 226, 'картинка_с_текстом_0_изображение', '31'),
(5056, 226, '_картинка_с_текстом_0_изображение', 'field_624363d095199'),
(5057, 226, 'картинка_с_текстом_0_описание', 'Обширная доказательная база собственных пострегистрационных клинических исследований<sup>2</sup>'),
(5058, 226, '_картинка_с_текстом_0_описание', 'field_624363e59519a'),
(5059, 226, 'картинка_с_текстом_1_изображение', '32'),
(5060, 226, '_картинка_с_текстом_1_изображение', 'field_624363d095199'),
(5061, 226, 'картинка_с_текстом_1_описание', 'Отсутствие риска замены препарата Урорек в&nbsp;аптеке (единственный препарат с&nbsp;действующим веществом силодозин)<sup>1</sup>'),
(5062, 226, '_картинка_с_текстом_1_описание', 'field_624363e59519a'),
(5063, 226, 'картинка_с_текстом_2_изображение', '33'),
(5064, 226, '_картинка_с_текстом_2_изображение', 'field_624363d095199'),
(5065, 226, 'картинка_с_текстом_2_описание', 'Большинство пациентов предпочитают принимать оригинальные препараты<sup>3</sup>'),
(5066, 226, '_картинка_с_текстом_2_описание', 'field_624363e59519a'),
(5067, 226, 'картинка_с_текстом', '3'),
(5068, 226, '_картинка_с_текстом', 'field_624363b995198'),
(5069, 226, 'второй_список', '<li>Клинические преимущества препарата Урорек (силодозин) определяются максимальной уроселективностью в&nbsp;классе альфа-адреноблокаторов<sup>4</sup></li>\r\n\r\n<li>Урорек&nbsp;&mdash; альфа-адреноблокатор последнего поколения, который эффективен в&nbsp;отношении всех СНМП (накопления, опорожнения, постмиктурических).<sup>12,13</sup> При этом Урорек обладает минимальным риском развития нежелательных явлений со&nbsp;стороны сердечно-сосудистой системы, в&nbsp;том числе&nbsp;у&nbsp;пациентов, принимающих антигипертензивные препараты<sup>46,8</sup> <small> <span>СНМП </span>симптомы нижних мочевыводящих путей</small></li>'),
(5070, 226, '_второй_список', 'field_6243640e05eda'),
(5071, 226, 'заголовок2-2', 'Максимальная уроселективность силодозина в&nbsp;классе альфа-адреноблокаторов обуславливает его уродинамическую эффективность и&nbsp;высокий профиль безопасности<sup>4</sup>'),
(5072, 226, '_заголовок2-2', 'field_6243644705edb'),
(5073, 226, 'текст3', '<ul>\r\n<li>Урорек значительно улучшает клинические проявления и&nbsp;качество жизни у&nbsp;всех пациентов с&nbsp;СНМП/ДГПЖ, в&nbsp;том числе с&nbsp;тяжелым течением<sup>11</sup>\r\n<a href=\"#modal-call-first\" class=\"link-modal-js\">Узнать больше...</a></li>\r\n\r\n<li>Урорек является препаратом выбора для пациентов с&nbsp;СНМП/ДГПЖ и&nbsp;сопутствующими сердечно-сосудистыми заболеваниями<sup>3</sup> \r\n<a href=\"#modal-call-second\" class=\"link-modal-js\">Узнать больше...</a></li>\r\n</ul>\r\n<small> <span>ДГПЖ </span>доброкачественная гиперплазия предстательной железы</small>'),
(5074, 226, '_текст3', 'field_6243647405edc'),
(5075, 226, 'изображение-2', '34'),
(5076, 226, '_изображение-2', 'field_624364dd05edd'),
(5077, 226, 'текст_в_подвале', '<h2> Максимальная уроселективность в&nbsp;классе  альфа-адреноблокаторов<sup>4</sup></h2>\r\n<div class=\"h3\"> Почему это важно? <a href=\"#modal-call-second\" class=\"link-modal-js\">Подробнее</a></div>'),
(5078, 226, '_текст_в_подвале', 'field_62436daf1f6d9'),
(5079, 226, 'заголовок-3', 'Форма выпуска препарата Урорек'),
(5080, 226, '_заголовок-3', 'field_62436efee98e7'),
(5081, 226, 'текст-3', '<p class=\"section-descr\"><span>8мг </span>- рекомендуемая доза для лечения симптомов ДГПЖ<sup>6</sup>*</p>\r\n					<p class=\"section-note col-md-10\">*Более подробные сведения о&nbsp;препарате, особенностях применения, побочных действиях и&nbsp;др. &mdash;&nbsp;смотрите инструкцию по&nbsp;медицинскому применению лекарственного препарата Урорек, РУ&nbsp;ЛСР-005971/10 от&nbsp;25.06.2010 </p>'),
(5082, 226, '_текст-3', 'field_62436f60e98e8'),
(5083, 226, 'товар_0_название', 'Урорек 8мг №30'),
(5084, 226, '_товар_0_название', 'field_62436fcce98ea'),
(5085, 226, 'товар_0_описание', 'Упаковка, рассчитанная на&nbsp;1&nbsp;месяц лечения&nbsp;/ для старта терапии'),
(5086, 226, '_товар_0_описание', 'field_62436fe1e98eb'),
(5087, 226, 'товар_0_лицензия', 'РУ: ЛСР-005971/10 от 25.06.2010'),
(5088, 226, '_товар_0_лицензия', 'field_62436ff0e98ec'),
(5089, 226, 'товар_0_изображение', '51'),
(5090, 226, '_товар_0_изображение', 'field_62437045e98ed'),
(5091, 226, 'товар_1_название', 'Урорек 8мг №90'),
(5092, 226, '_товар_1_название', 'field_62436fcce98ea'),
(5093, 226, 'товар_1_описание', 'Выгодная упаковка, рассчитанная на&nbsp;3&nbsp;месяца лечения. Самая доступная стоимость 1&nbsp;дня терапии препаратом Урорек&nbsp;<sup>27</sup>'),
(5094, 226, '_товар_1_описание', 'field_62436fe1e98eb'),
(5095, 226, 'товар_1_лицензия', 'РУ: ЛСР-005971/10 от 25.06.2010'),
(5096, 226, '_товар_1_лицензия', 'field_62436ff0e98ec'),
(5097, 226, 'товар_1_изображение', '53'),
(5098, 226, '_товар_1_изображение', 'field_62437045e98ed'),
(5099, 226, 'товар_2_название', 'Урорек 4мг №30'),
(5100, 226, '_товар_2_название', 'field_62436fcce98ea'),
(5101, 226, 'товар_2_описание', '4&nbsp;мг&nbsp;&mdash; стартовая упаковка для лечения симптомов ДГПЖ у&nbsp;пациентов с&nbsp;почечной недостаточностью средней степени тяжести<sup>6</sup>'),
(5102, 226, '_товар_2_описание', 'field_62436fe1e98eb'),
(5103, 226, 'товар_2_лицензия', 'РУ: ЛСР-005971/10 от 25.06.2010'),
(5104, 226, '_товар_2_лицензия', 'field_62436ff0e98ec'),
(5105, 226, 'товар_2_изображение', '52'),
(5106, 226, '_товар_2_изображение', 'field_62437045e98ed'),
(5107, 226, 'товар', '3'),
(5108, 226, '_товар', 'field_62436fbde98e9'),
(5109, 226, 'заголовок-4', 'Где купить'),
(5110, 226, '_заголовок-4', 'field_624374f73d8bd'),
(5111, 226, 'изображения', 'a:12:{i:0;s:2:\"63\";i:1;s:2:\"64\";i:2;s:2:\"65\";i:3;s:2:\"66\";i:4;s:2:\"67\";i:5;s:2:\"68\";i:6;s:2:\"69\";i:7;s:2:\"70\";i:8;s:2:\"71\";i:9;s:2:\"72\";i:10;s:2:\"73\";i:11;s:2:\"74\";}'),
(5112, 226, '_изображения', 'field_624375093d8be'),
(5113, 226, 'изображения-4', 'a:12:{i:0;s:2:\"63\";i:1;s:2:\"64\";i:2;s:2:\"65\";i:3;s:2:\"66\";i:4;s:2:\"67\";i:5;s:2:\"68\";i:6;s:2:\"69\";i:7;s:2:\"70\";i:8;s:2:\"71\";i:9;s:2:\"72\";i:10;s:2:\"73\";i:11;s:2:\"74\";}'),
(5114, 226, '_изображения-4', 'field_624375093d8be'),
(5115, 226, 'заголовок-5', 'Способ применения*<sup>6</sup>'),
(5116, 226, '_заголовок-5', 'field_624379bd4756d'),
(5117, 226, 'иконки', 'a:5:{i:0;s:2:\"83\";i:1;s:2:\"84\";i:2;s:2:\"85\";i:3;s:2:\"86\";i:4;s:2:\"87\";}'),
(5118, 226, '_иконки', 'field_624379f24756e'),
(5119, 226, 'текст-5', 'У пациентов с легкой почечной недостаточностью (клиренс креатинина ≥ 50 — ≤ 80 мл/мин) коррекция дозы не требуется. Для лечения пациентов с почечной недостаточностью средней степени тяжести (клиренс креатинина ≥ 30 — < 50 мл/мин) рекомендуется в течение первой недели принимать начальную дозу по 4 мг в сутки, при хорошей индивидуальной переносимости доза может быть увеличена до 8 мг в сутки. Применение препарата для пациентов с тяжелой почечной недостаточностью (клиренс креатинина < 30 мл / мин) не рекомендуется'),
(5120, 226, '_текст-5', 'field_62437a374756f'),
(5121, 226, 'текст_под_кнопкой', '*Более подробные сведения о&nbsp;препарате, особенностях применения, побочных действиях и&nbsp;др. &mdash;&nbsp;см. инструкцию по&nbsp;медицинскому применению лекарственного препарата Урорек, РУ&nbsp;ЛСР-005971/10 от&nbsp;25.06.2010'),
(5122, 226, '_текст_под_кнопкой', 'field_62437a7c47570'),
(5123, 226, 'заголовок-6', 'Препарат Урорек (силодозин) включен в&nbsp;российские и&nbsp;международные клинические рекомендации и&nbsp;стандарты для лечения ряда урологических заболеваний:'),
(5124, 226, '_заголовок-6', 'field_6244117c68bd0'),
(5125, 226, 'список-6_0_ссылка', 'a:3:{s:5:\"title\";s:68:\"Российские клинические рекомендации\";s:3:\"url\";s:1:\"#\";s:6:\"target\";s:0:\"\";}'),
(5126, 226, '_список-6_0_ссылка', 'field_624411ce68bd2'),
(5127, 226, 'список-6_0_описание', '«Доброкачественная гиперплазия предстательной железы», 2020<sup>28</sup>'),
(5128, 226, '_список-6_0_описание', 'field_6244121168bd3'),
(5129, 226, 'список-6_1_ссылка', 'a:3:{s:5:\"title\";s:70:\"Европейские клинические рекомендации\";s:3:\"url\";s:1:\"#\";s:6:\"target\";s:0:\"\";}'),
(5130, 226, '_список-6_1_ссылка', 'field_624411ce68bd2'),
(5131, 226, 'список-6_1_описание', 'глава «Консервативное лечение ненейрогенных симптомов нарушенного мочеиспускания у мужчин, включая доброкачественную простатическую обструкцию», 2021<sup>29</sup>'),
(5132, 226, '_список-6_1_описание', 'field_6244121168bd3'),
(5133, 226, 'список-6_2_ссылка', 'a:3:{s:5:\"title\";s:154:\"Стандарт первичной медико-санитарной помощи при гиперплазии предстательной железы\";s:3:\"url\";s:1:\"#\";s:6:\"target\";s:0:\"\";}'),
(5134, 226, '_список-6_2_ссылка', 'field_624411ce68bd2'),
(5135, 226, 'список-6_2_описание', '09.11.2012<sup>30</sup> / Обновлён 13.04.2015\r\n'),
(5136, 226, '_список-6_2_описание', 'field_6244121168bd3'),
(5137, 226, 'список-6_3_ссылка', 'a:3:{s:5:\"title\";s:122:\"Стандарт специализированной медицинской помощи при задержке мочи\";s:3:\"url\";s:1:\"#\";s:6:\"target\";s:0:\"\";}'),
(5138, 226, '_список-6_3_ссылка', 'field_624411ce68bd2'),
(5139, 226, 'список-6_3_описание', '29.01.2013<sup>31</sup> / Обновлён 06.05.2015\r\n'),
(5140, 226, '_список-6_3_описание', 'field_6244121168bd3'),
(5141, 226, 'список-6_4_ссылка', 'a:3:{s:5:\"title\";s:133:\"Стандарт первичной медико-санитарной помощи при хроническом простатите\";s:3:\"url\";s:1:\"#\";s:6:\"target\";s:0:\"\";}'),
(5142, 226, '_список-6_4_ссылка', 'field_624411ce68bd2'),
(5143, 226, 'список-6_4_описание', '09.11.2012<sup>32</sup> / Обновлён 13.04.2015\r\n'),
(5144, 226, '_список-6_4_описание', 'field_6244121168bd3'),
(5145, 226, 'список-6_5_ссылка', 'a:3:{s:5:\"title\";s:168:\"Стандарт специализированной медицинской помощи при остром простатите, орхите, эпидидимите\";s:3:\"url\";s:1:\"#\";s:6:\"target\";s:0:\"\";}'),
(5146, 226, '_список-6_5_ссылка', 'field_624411ce68bd2'),
(5147, 226, 'список-6_5_описание', '09.11.2012<sup>33</sup> / Обновлён 27.05.2015'),
(5148, 226, '_список-6_5_описание', 'field_6244121168bd3'),
(5149, 226, 'список-6', '6'),
(5150, 226, '_список-6', 'field_624411be68bd1'),
(5151, 226, 'заголовок-7', 'Препарат Урорек (силодозин) зарегистрирован и&nbsp;применяется в&nbsp;разных странах мира Одобрен ЕМА*<sup>34</sup> и&nbsp;FDA**<sup>35</sup>'),
(5152, 226, '_заголовок-7', 'field_624417e3b6088'),
(5153, 226, 'текст', '<p class=\"sOtherCountries__agency\"><span>EMA</span> Европейское медицинское агентство</p>\r\n<p class=\"sOtherCountries__agency\"><span>FDA</span> Управление по&nbsp;санитарному надзору за&nbsp;качеством пищевых продуктов и&nbsp;медикаментов, США</p>'),
(5154, 226, '_текст', 'field_6244182bb6089'),
(5155, 226, 'страны_0_флаг', '105'),
(5156, 226, '_страны_0_флаг', 'field_62441880b608b'),
(5157, 226, 'страны_0_название', 'Япония'),
(5158, 226, '_страны_0_название', 'field_62441899b608c'),
(5159, 226, 'страны_0_год', '2006<sup>36,37</sup>'),
(5160, 226, '_страны_0_год', 'field_624418aab608d'),
(5161, 226, 'страны_1_флаг', '106'),
(5162, 226, '_страны_1_флаг', 'field_62441880b608b'),
(5163, 226, 'страны_1_название', 'США'),
(5164, 226, '_страны_1_название', 'field_62441899b608c'),
(5165, 226, 'страны_1_год', '2008<sup>35</sup>'),
(5166, 226, '_страны_1_год', 'field_624418aab608d'),
(5167, 226, 'страны_2_флаг', '107'),
(5168, 226, '_страны_2_флаг', 'field_62441880b608b'),
(5169, 226, 'страны_2_название', 'Страны ЕС'),
(5170, 226, '_страны_2_название', 'field_62441899b608c'),
(5171, 226, 'страны_2_год', '2010<sup>34</sup>'),
(5172, 226, '_страны_2_год', 'field_624418aab608d'),
(5173, 226, 'страны_3_флаг', '108'),
(5174, 226, '_страны_3_флаг', 'field_62441880b608b'),
(5175, 226, 'страны_3_название', 'Россия'),
(5176, 226, '_страны_3_название', 'field_62441899b608c'),
(5177, 226, 'страны_3_год', '2010<sup>1</sup>'),
(5178, 226, '_страны_3_год', 'field_624418aab608d'),
(5179, 226, 'страны', '4'),
(5180, 226, '_страны', 'field_62441847b608a'),
(5181, 226, 'текст-7', '<p class=\"sOtherCountries__agency\"><span>EMA</span> Европейское медицинское агентство</p>\r\n<p class=\"sOtherCountries__agency\"><span>FDA</span> Управление по&nbsp;санитарному надзору за&nbsp;качеством пищевых продуктов и&nbsp;медикаментов, США</p>'),
(5182, 226, '_текст-7', 'field_6244182bb6089'),
(5183, 226, 'текст-7-1', 'Производство препарата Урорек, поставляемого в&nbsp;Россию, осуществляется в&nbsp;Италии с&nbsp;использованием субстанции из&nbsp;Японии, в&nbsp;соответствии с&nbsp;необходимыми требованиями к&nbsp;производству и&nbsp;контролю качества<sup>6,1</sup>'),
(5184, 226, '_текст-7-1', 'field_62441a5acf03c'),
(5185, 226, 'заголовок-8', 'О проблеме'),
(5186, 226, '_заголовок-8', 'field_624431d91624d'),
(5187, 226, 'текст-8', 'Доброкачественная гиперплазия предстательной железы (ДГПЖ), или как ее еще называют, аденома простаты, как правило, возникает у мужчин старше 50 лет и характеризуется наличием симптомов нижних мочевыводящих путей (СНМП), увеличением предстательной железы или ее части, и нарушением оттока мочи из мочевого пузыря вследствие инфравезикальной обструкции.<sup>38</sup>\r\n\r\nРаспространенность ДГПЖ увеличивается с возрастом. Так, клинически значимая ДГПЖ проявляется у 13% мужчин в возрасте старше 50 лет, у 34% мужчин в возрасте 60 лет и у 43% в возрасте 70 лет.<sup>39</sup>\r\n\r\n&nbsp;\r\n\r\n<img class=\"alignnone wp-image-122 size-full\" src=\"http://0026urotec.loc:8888/wp-content/uploads/2022/03/about-img.png\" alt=\"\" width=\"594\" height=\"696\" />'),
(5188, 226, '_текст-8', 'field_624431f11624e'),
(5189, 226, 'текст-8-1', 'Наличие СНМП может быть ассоциировано с&nbsp;тяжелыми хроническими заболеваниями, такими как заболевания сердца, сахарный диабет, артериальная гипертензия и&nbsp;депрессия<sup>40</sup>'),
(5190, 226, '_текст-8-1', 'field_6244320b26db3'),
(5191, 226, 'иконки-8', 'a:6:{i:0;s:3:\"123\";i:1;s:3:\"124\";i:2;s:3:\"125\";i:3;s:3:\"126\";i:4;s:3:\"127\";i:5;s:3:\"128\";}'),
(5192, 226, '_иконки-8', 'field_6244322d26db4');
INSERT INTO `urotec_postmeta` (`meta_id`, `post_id`, `meta_key`, `meta_value`) VALUES
(5193, 226, 'текст-8-2', '<h3>Симптомы доброкачественной гиперплазии предстательной железы</h3>\r\nСимптомы нарушенного мочеиспускания являются частой жалобой у взрослых мужчин. Они оказывают серьезное негативное влияние на качество жизни. При ДГПЖ предстательная железа увеличивается в размерах, оказывая давление на нижние мочевые пути. В результате развиваются следующие симптомы:<sup>41</sup>'),
(5194, 226, '_текст-8-2', 'field_6244335fe2373'),
(5195, 226, 'заголовок-9', 'Осложнения ДГПЖ<sup>38</sup>'),
(5196, 226, '_заголовок-9', 'field_6244377a52263'),
(5197, 226, 'изображения-9', 'a:6:{i:0;s:3:\"141\";i:1;s:3:\"142\";i:2;s:3:\"143\";i:3;s:3:\"144\";i:4;s:3:\"145\";i:5;s:3:\"146\";}'),
(5198, 226, '_изображения-9', 'field_6244379652264'),
(5199, 226, 'заголовок-10', 'Медикаментозное лечение СНМП/ДГПЖ'),
(5200, 226, '_заголовок-10', 'field_6244489614262'),
(5201, 226, 'текст-10', 'Антагонисты альфа1-адренорецепторов (альфа-адреноблокаторы) и&nbsp;ингибиторы 5&nbsp;альфа1-редуктазы (ингибиторы 5-АР) являются группами лекарственных препаратов, которые в&nbsp;настоящее время утверждены для лечения ДГПЖ. Обе группы препаратов обеспечивают надлежащее ослабление симптомов, но&nbsp;&alpha;&mdash;блокаторы обладают довольно быстрым началом действия, а&nbsp;ингибиторам 5-АР требуется несколько месяцев для получения терапевтического эффекта.<sup>42</sup>'),
(5202, 226, '_текст-10', 'field_624448ce14263'),
(5203, 226, 'карточки-10_0_заголовок', 'Альфа-адреноблокаторы'),
(5204, 226, '_карточки-10_0_заголовок', 'field_624448fc14265'),
(5205, 226, 'карточки-10_0_текст', 'представляют собой наиболее эффективный класс лекарственных препаратов, характеризующийся хорошим профилем безопасности и высокой комплаентностью, применяющийся для облегчения СНМП, связанных с ДГПЖ: они снимают спазм гладкой мускулатуры предстательной железы и шейки мочевого пузыря42'),
(5206, 226, '_карточки-10_0_текст', 'field_6244490c14266'),
(5207, 226, 'карточки-10_1_заголовок', 'Ингибиторы 5-АР —'),
(5208, 226, '_карточки-10_1_заголовок', 'field_624448fc14265'),
(5209, 226, 'карточки-10_1_текст', 'приводят к редукции железистой ткани и к снижению размера предстательной железы: они блокируют конверсию тестостерона в дигидротестостерон, который стимулирует рост предстательной железы43,44.Назначаются при большом объеме предстательной железы. Для получения значимого клинического эффекта требуется несколько месяцев применения45\r\n'),
(5210, 226, '_карточки-10_1_текст', 'field_6244490c14266'),
(5211, 226, 'карточки-10', '2'),
(5212, 226, '_карточки-10', 'field_624448e214264'),
(5213, 226, 'видео', '<iframe width=\"560\" height=\"315\" src=\"https://www.youtube.com/embed/3DrU3pFXSsY\" title=\"YouTube video player\" frameborder=\"0\" allow=\"accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture\" allowfullscreen></iframe>'),
(5214, 226, '_видео', 'field_6244492214267'),
(5215, 226, 'заголовок-11', 'Часто задаваемые вопросы'),
(5216, 226, '_заголовок-11', 'field_62444b33e25d6'),
(5217, 226, 'вопросы_0_заголовок', 'Почему при приеме препарата Урорек у некоторых пациентов развивается нарушение эякуляции?'),
(5218, 226, '_вопросы_0_заголовок', 'field_62444b58e25d8'),
(5219, 226, 'вопросы_0_текст', 'Урорек — высокоселективный препарат, то есть преимущественно действует на альфа1А-адренорецепторы, которые находятся в нижних мочевых путях, предстательной железе и семенных пузырьках. Поэтому эффект развивается уже через 2–6 часов после приёма первой дозы препарата Урорек<sup>14</sup> при минимальным количестве нежелательных явлений.<sup>5</sup>\r\n\r\nНаиболее частый побочный эффект при приеме препарата Урорек — нарушение эякуляции<sup>46</sup>. Это может быть связано как с забросом эякулята при семяизвержении вместо уретры в мочевой пузырь, так и со снижением или отсутствием семенной жидкости во время эякуляции<sup>29</sup>. Силодозин снижает тонус гладкомышечных клеток семенных пузырьков, простаты и шейки мочевого пузыря, поэтому не происходит выброс семени. Этот эффект свойственен всем уроселективным альфа-адреноблокаторам<sup>53</sup> и самостоятельно исчезает после прекращения приема препарата.<sup>6</sup>\r\n\r\nЧастота эякуляторной дисфункции прямо пропорционально связана с улучшением СНМП и скорости мочеиспускания и подтверждает эффективность альфа-адреноблокатора: чем выше эффективность, тем выше частота встречаемости эякуляторной дисфункции.<sup>29</sup>\r\n\r\nНарушение эякуляции не влияет на сексуальную функцию<sup>52</sup>, не воспринимается как беспокоящий симптом подавляющим большинством пациентов и не требует отмены терапии.<sup>46</sup>'),
(5220, 226, '_вопросы_0_текст', 'field_62444b66e25d9'),
(5221, 226, 'вопросы_1_заголовок', 'Можно ли принимать Урорек при артериальной гипертензии и ишемический болезни сердца (ИБС)?'),
(5222, 226, '_вопросы_1_заголовок', 'field_62444b58e25d8'),
(5223, 226, 'вопросы_1_текст', 'Согласно инструкции по медицинскому применению, противопоказаний для применения лекарственного препарата Урорек у пациентов с СНМП/ДГПЖ и сопутствующими сердечно-сосудистыми заболеваниями нет.<sup>3</sup> Урорек не оказывает влияния на частоту сердечных сокращений (ЧСС), систолическое артериальное давление (САД) и диастолическое артериальное давление (ДАД).<sup>9</sup> Силодозин — не вызывает клинически значимого снижения артериального давления (АД)<sup>46</sup>, не усиливает действие антигипертензивных препаратов и не требует снижения дозы при одновременном приеме.<sup>7</sup> В соответствии с дизайном клинического исследования многие пациенты получали сопутствующую терапию антигипертензивными препаратами (в основном, средствами, воздействующими на ренин-ангиотензиновую систему, бета-блокаторами, антагонистами кальция и диуретиками) без повышения частоты ортостатической гипотензии.<sup>6</sup>\r\n\r\nПри приеме препарата Урорек наиболее низкий риск развития сердечно-сосудистых осложнений.<sup>5</sup>'),
(5224, 226, '_вопросы_1_текст', 'field_62444b66e25d9'),
(5225, 226, 'вопросы_2_заголовок', 'Можно ли принимать Урорек пациенту с ортостатической гипотензией в анамнезе?'),
(5226, 226, '_вопросы_2_заголовок', 'field_62444b58e25d8'),
(5227, 226, 'вопросы_2_текст', 'Повышенная селективность силодозина к альфа1A-адренорецепторам по сравнению с альфа1B-адренорецепторами выражается в пониженном риске развития сердечно-сосудистых осложнений.<sup>4</sup> Благодаря этому частота ортостатической гипотензии на фоне его приема сравнима с таковой при приеме плацебо.<sup>45,9</sup>\r\n\r\nВ отличие от других альфа-адреноблокаторов (например, все формы тамсулозина<sup>47,48</sup>), Урорек не противопоказан к приему у пациентов с ортостатической гипотензией в анамнезе. Тем не менее, пациентам с ортостатической гипотензией в анамнезе не рекомендуется принимать любые альфа-адреноблокаторы, в т.ч. Урорек.<sup>6</sup>'),
(5228, 226, '_вопросы_2_текст', 'field_62444b66e25d9'),
(5229, 226, 'вопросы_3_заголовок', 'Как долго можно принимать Урорек?'),
(5230, 226, '_вопросы_3_заголовок', 'field_62444b58e25d8'),
(5231, 226, 'вопросы_3_текст', 'Учитывая прогрессирующий характер течения доброкачественной гиперплазии предстательной железы, медикаментозную терапию следует проводить длительно (иногда в течение всей жизни пациента).<sup>49</sup>'),
(5232, 226, '_вопросы_3_текст', 'field_62444b66e25d9'),
(5233, 226, 'вопросы_4_заголовок', 'Пациенты жалуются на заложенность носа при лечении альфа-адреноблокаторами. Есть ли у препарата Урорек такое побочное действие?'),
(5234, 226, '_вопросы_4_заголовок', 'field_62444b58e25d8'),
(5235, 226, 'вопросы_4_текст', 'Заложенность носа — это возможный побочный эффект для всех альфа-адреноблокаторов. При приеме препарата Урорек он может возникать примерно в 1% случаев.<sup>46</sup>'),
(5236, 226, '_вопросы_4_текст', 'field_62444b66e25d9'),
(5237, 226, 'вопросы_5_заголовок', 'Можно ли начинать лечение препаратом Урорек с дозы 4 мг в сутки?'),
(5238, 226, '_вопросы_5_заголовок', 'field_62444b58e25d8'),
(5239, 226, 'вопросы_5_текст', 'Согласно инструкции по медицинскому применению лекарственного препарата Урорек, доза 8 мг в сутки рекомендована для лечения пациентов с СНМП/ДГПЖ. Титрование дозы при применении силодозина не требуется.\r\n\r\nУрорек 4 мг — это специальная доза для лечения пациентов с почечной недостаточностью средней степени тяжести (клиренс креатинина ≥ 30 до &lt; 50 мл/мин). Рекомендуется в течение первой недели принимать начальную дозу по 4 мг в сутки, далее при хорошей переносимости доза может быть увеличена до 8 мг в сутки.<sup>6</sup>**Более подробные сведения о препарате, особенностях применения, побочных действиях и др. — см. инструкцию по медицинскому применению лекарственного препарата Урорек, РУ ЛСР-005971/10 от 25.06.2010'),
(5240, 226, '_вопросы_5_текст', 'field_62444b66e25d9'),
(5241, 226, 'вопросы_6_заголовок', 'Влияет ли Урорек на течение ДГПЖ или только снимает симптомы нижних мочевыводящих путей?'),
(5242, 226, '_вопросы_6_заголовок', 'field_62444b58e25d8'),
(5243, 226, 'вопросы_6_текст', 'Помимо субъективных симптомов, ДГПЖ вызывает прогрессирующее морфологическое ремоделирование мочевого пузыря с риском развития серьезных функциональных нарушений. Лечение должно не только купировать субъективные симптомы, но и включать профилактику патологического ремоделирования мочевого пузыря.<sup>161</sup>\r\n\r\nСилодозин, действующее вещество препарата Урорек, в сравнении с другими альфа-адреноблокаторами более эффективно влияет на инфравезикальную обструкцию (ИВО), что оказывает влияние на предотвращение патологического прогрессирования ремоделирования мочевого пузыря и риск развития серьезных функциональных нарушений.<sup>50,51</sup>'),
(5244, 226, '_вопросы_6_текст', 'field_62444b66e25d9'),
(5245, 226, 'вопросы_7_заголовок', 'Доступен ли Урорек по льготному отпуску?'),
(5246, 226, '_вопросы_7_заголовок', 'field_62444b58e25d8'),
(5247, 226, 'вопросы_7_текст', 'Урорек (силодозин) не включен в список жизненно важных лекарственных препаратов (ЖНВЛП)<sup>1</sup> и не входит в перечень препаратов для льготного обеспечения граждан по федеральному льготному списку.'),
(5248, 226, '_вопросы_7_текст', 'field_62444b66e25d9'),
(5249, 226, 'вопросы', '8'),
(5250, 226, '_вопросы', 'field_62444b49e25d7'),
(5251, 237, '_wp_attached_file', '2022/03/modal-row-img-1.png'),
(5252, 237, '_wp_attachment_metadata', 'a:5:{s:5:\"width\";i:256;s:6:\"height\";i:153;s:4:\"file\";s:27:\"2022/03/modal-row-img-1.png\";s:5:\"sizes\";a:1:{s:9:\"thumbnail\";a:4:{s:4:\"file\";s:27:\"modal-row-img-1-150x150.png\";s:5:\"width\";i:150;s:6:\"height\";i:150;s:9:\"mime-type\";s:9:\"image/png\";}}s:10:\"image_meta\";a:12:{s:8:\"aperture\";s:1:\"0\";s:6:\"credit\";s:0:\"\";s:6:\"camera\";s:0:\"\";s:7:\"caption\";s:0:\"\";s:17:\"created_timestamp\";s:1:\"0\";s:9:\"copyright\";s:0:\"\";s:12:\"focal_length\";s:1:\"0\";s:3:\"iso\";s:1:\"0\";s:13:\"shutter_speed\";s:1:\"0\";s:5:\"title\";s:0:\"\";s:11:\"orientation\";s:1:\"0\";s:8:\"keywords\";a:0:{}}}'),
(5253, 238, '_wp_attached_file', '2022/03/modal-row-img-2.png'),
(5254, 238, '_wp_attachment_metadata', 'a:5:{s:5:\"width\";i:256;s:6:\"height\";i:153;s:4:\"file\";s:27:\"2022/03/modal-row-img-2.png\";s:5:\"sizes\";a:1:{s:9:\"thumbnail\";a:4:{s:4:\"file\";s:27:\"modal-row-img-2-150x150.png\";s:5:\"width\";i:150;s:6:\"height\";i:150;s:9:\"mime-type\";s:9:\"image/png\";}}s:10:\"image_meta\";a:12:{s:8:\"aperture\";s:1:\"0\";s:6:\"credit\";s:0:\"\";s:6:\"camera\";s:0:\"\";s:7:\"caption\";s:0:\"\";s:17:\"created_timestamp\";s:1:\"0\";s:9:\"copyright\";s:0:\"\";s:12:\"focal_length\";s:1:\"0\";s:3:\"iso\";s:1:\"0\";s:13:\"shutter_speed\";s:1:\"0\";s:5:\"title\";s:0:\"\";s:11:\"orientation\";s:1:\"0\";s:8:\"keywords\";a:0:{}}}'),
(5255, 239, '_wp_attached_file', '2022/03/modal-row-img-3.png'),
(5256, 239, '_wp_attachment_metadata', 'a:5:{s:5:\"width\";i:256;s:6:\"height\";i:153;s:4:\"file\";s:27:\"2022/03/modal-row-img-3.png\";s:5:\"sizes\";a:1:{s:9:\"thumbnail\";a:4:{s:4:\"file\";s:27:\"modal-row-img-3-150x150.png\";s:5:\"width\";i:150;s:6:\"height\";i:150;s:9:\"mime-type\";s:9:\"image/png\";}}s:10:\"image_meta\";a:12:{s:8:\"aperture\";s:1:\"0\";s:6:\"credit\";s:0:\"\";s:6:\"camera\";s:0:\"\";s:7:\"caption\";s:0:\"\";s:17:\"created_timestamp\";s:1:\"0\";s:9:\"copyright\";s:0:\"\";s:12:\"focal_length\";s:1:\"0\";s:3:\"iso\";s:1:\"0\";s:13:\"shutter_speed\";s:1:\"0\";s:5:\"title\";s:0:\"\";s:11:\"orientation\";s:1:\"0\";s:8:\"keywords\";a:0:{}}}'),
(5257, 182, '_wp_old_date', '2022-03-30'),
(5259, 240, '_edit_lock', '1648731096:1'),
(5260, 240, '_wp_page_template', 'artical.php'),
(5264, 245, '_menu_item_type', 'post_type'),
(5265, 245, '_menu_item_menu_item_parent', '0'),
(5266, 245, '_menu_item_object_id', '240'),
(5267, 245, '_menu_item_object', 'page'),
(5268, 245, '_menu_item_target', ''),
(5269, 245, '_menu_item_classes', 'a:1:{i:0;s:0:\"\";}'),
(5270, 245, '_menu_item_xfn', ''),
(5271, 245, '_menu_item_url', ''),
(5272, 246, 'заголовок-1', 'УРОРЕК – оригинальный<sup>10</sup> альфа-адреноблокатор'),
(5273, 246, '_заголовок-1', 'field_62435bd26f29f'),
(5274, 246, 'текст-1', '<div class=\"headerBlock__body\">\r\n<p>Силодозин (действующее вещество препарата Урорек) обладает максимальной уроселективностью в&nbsp;своем классе, что обеспечивает его уродинамическую эффективность и&nbsp;высокую безопасность<sup>4</sup></p>\r\n</div>\r\n<div class=\"headerBlock__footer\">\r\n<p><strong>Показания к применению: </strong><br/>Лечение симптомов доброкачественной гиперплазии предстательной железы<sup>6</sup></p>\r\n</div>'),
(5275, 246, '_текст-1', 'field_62435c0c6f2a0'),
(5276, 246, 'изображение-1', '13'),
(5277, 246, '_изображение-1', 'field_62435c8b6f2a1'),
(5278, 246, 'фон-1', '17'),
(5279, 246, '_фон-1', 'field_62435db92ea96'),
(5280, 246, 'заголовок-2', 'Ключевые преимущества препарата Урорек'),
(5281, 246, '_заголовок-2', 'field_6243606295196'),
(5282, 246, 'список-2', 'Единственный оригинальный препарат из&nbsp;группы альфа1-адреноблокаторов, не&nbsp;имеющий генериков в&nbsp;РФ<sup>1</sup>'),
(5283, 246, '_список-2', 'field_6243608195197'),
(5284, 246, 'картинка_с_текстом_0_изображение', '31'),
(5285, 246, '_картинка_с_текстом_0_изображение', 'field_624363d095199'),
(5286, 246, 'картинка_с_текстом_0_описание', 'Обширная доказательная база собственных пострегистрационных клинических исследований<sup>2</sup>'),
(5287, 246, '_картинка_с_текстом_0_описание', 'field_624363e59519a'),
(5288, 246, 'картинка_с_текстом_1_изображение', '32'),
(5289, 246, '_картинка_с_текстом_1_изображение', 'field_624363d095199'),
(5290, 246, 'картинка_с_текстом_1_описание', 'Отсутствие риска замены препарата Урорек в&nbsp;аптеке (единственный препарат с&nbsp;действующим веществом силодозин)<sup>1</sup>'),
(5291, 246, '_картинка_с_текстом_1_описание', 'field_624363e59519a'),
(5292, 246, 'картинка_с_текстом_2_изображение', '33'),
(5293, 246, '_картинка_с_текстом_2_изображение', 'field_624363d095199'),
(5294, 246, 'картинка_с_текстом_2_описание', 'Большинство пациентов предпочитают принимать оригинальные препараты<sup>3</sup>'),
(5295, 246, '_картинка_с_текстом_2_описание', 'field_624363e59519a'),
(5296, 246, 'картинка_с_текстом', '3'),
(5297, 246, '_картинка_с_текстом', 'field_624363b995198'),
(5298, 246, 'второй_список', '<li>Клинические преимущества препарата Урорек (силодозин) определяются максимальной уроселективностью в&nbsp;классе альфа-адреноблокаторов<sup>4</sup></li>\r\n\r\n<li>Урорек&nbsp;&mdash; альфа-адреноблокатор последнего поколения, который эффективен в&nbsp;отношении всех СНМП (накопления, опорожнения, постмиктурических).<sup>12,13</sup> При этом Урорек обладает минимальным риском развития нежелательных явлений со&nbsp;стороны сердечно-сосудистой системы, в&nbsp;том числе&nbsp;у&nbsp;пациентов, принимающих антигипертензивные препараты<sup>46,8</sup> <small> <span>СНМП </span>симптомы нижних мочевыводящих путей</small></li>'),
(5299, 246, '_второй_список', 'field_6243640e05eda'),
(5300, 246, 'заголовок2-2', 'Максимальная уроселективность силодозина в&nbsp;классе альфа-адреноблокаторов обуславливает его уродинамическую эффективность и&nbsp;высокий профиль безопасности<sup>4</sup>'),
(5301, 246, '_заголовок2-2', 'field_6243644705edb'),
(5302, 246, 'текст3', '<ul>\r\n<li>Урорек значительно улучшает клинические проявления и&nbsp;качество жизни у&nbsp;всех пациентов с&nbsp;СНМП/ДГПЖ, в&nbsp;том числе с&nbsp;тяжелым течением<sup>11</sup>\r\n<a href=\"#modal-call-first\" class=\"link-modal-js\">Узнать больше...</a></li>\r\n\r\n<li>Урорек является препаратом выбора для пациентов с&nbsp;СНМП/ДГПЖ и&nbsp;сопутствующими сердечно-сосудистыми заболеваниями<sup>3</sup> \r\n<a href=\"#modal-call-second\" class=\"link-modal-js\">Узнать больше...</a></li>\r\n</ul>\r\n<small> <span>ДГПЖ </span>доброкачественная гиперплазия предстательной железы</small>'),
(5303, 246, '_текст3', 'field_6243647405edc'),
(5304, 246, 'изображение-2', '34'),
(5305, 246, '_изображение-2', 'field_624364dd05edd'),
(5306, 246, 'текст_в_подвале', '<h2> Максимальная уроселективность в&nbsp;классе  альфа-адреноблокаторов<sup>4</sup></h2>\r\n<div class=\"h3\"> Почему это важно? <a href=\"#modal-call-second\" class=\"link-modal-js\">Подробнее</a></div>'),
(5307, 246, '_текст_в_подвале', 'field_62436daf1f6d9'),
(5308, 246, 'заголовок-3', 'Форма выпуска препарата Урорек'),
(5309, 246, '_заголовок-3', 'field_62436efee98e7'),
(5310, 246, 'текст-3', '<p class=\"section-descr\"><span>8мг </span>- рекомендуемая доза для лечения симптомов ДГПЖ<sup>6</sup>*</p>\r\n					<p class=\"section-note col-md-10\">*Более подробные сведения о&nbsp;препарате, особенностях применения, побочных действиях и&nbsp;др. &mdash;&nbsp;смотрите инструкцию по&nbsp;медицинскому применению лекарственного препарата Урорек, РУ&nbsp;ЛСР-005971/10 от&nbsp;25.06.2010 </p>'),
(5311, 246, '_текст-3', 'field_62436f60e98e8'),
(5312, 246, 'товар_0_название', 'Урорек 8мг №30'),
(5313, 246, '_товар_0_название', 'field_62436fcce98ea'),
(5314, 246, 'товар_0_описание', 'Упаковка, рассчитанная на&nbsp;1&nbsp;месяц лечения&nbsp;/ для старта терапии'),
(5315, 246, '_товар_0_описание', 'field_62436fe1e98eb'),
(5316, 246, 'товар_0_лицензия', 'РУ: ЛСР-005971/10 от 25.06.2010'),
(5317, 246, '_товар_0_лицензия', 'field_62436ff0e98ec'),
(5318, 246, 'товар_0_изображение', '51'),
(5319, 246, '_товар_0_изображение', 'field_62437045e98ed'),
(5320, 246, 'товар_1_название', 'Урорек 8мг №90'),
(5321, 246, '_товар_1_название', 'field_62436fcce98ea'),
(5322, 246, 'товар_1_описание', 'Выгодная упаковка, рассчитанная на&nbsp;3&nbsp;месяца лечения. Самая доступная стоимость 1&nbsp;дня терапии препаратом Урорек&nbsp;<sup>27</sup>'),
(5323, 246, '_товар_1_описание', 'field_62436fe1e98eb'),
(5324, 246, 'товар_1_лицензия', 'РУ: ЛСР-005971/10 от 25.06.2010'),
(5325, 246, '_товар_1_лицензия', 'field_62436ff0e98ec'),
(5326, 246, 'товар_1_изображение', '53'),
(5327, 246, '_товар_1_изображение', 'field_62437045e98ed'),
(5328, 246, 'товар_2_название', 'Урорек 4мг №30'),
(5329, 246, '_товар_2_название', 'field_62436fcce98ea'),
(5330, 246, 'товар_2_описание', '4&nbsp;мг&nbsp;&mdash; стартовая доза для лечения симптомов ДГПЖ у&nbsp;пациентов с&nbsp;почечной недостаточностью средней степени тяжести<sup>6</sup>'),
(5331, 246, '_товар_2_описание', 'field_62436fe1e98eb'),
(5332, 246, 'товар_2_лицензия', 'РУ: ЛСР-005971/10 от 25.06.2010'),
(5333, 246, '_товар_2_лицензия', 'field_62436ff0e98ec'),
(5334, 246, 'товар_2_изображение', '52'),
(5335, 246, '_товар_2_изображение', 'field_62437045e98ed'),
(5336, 246, 'товар', '3'),
(5337, 246, '_товар', 'field_62436fbde98e9'),
(5338, 246, 'заголовок-4', 'Где купить'),
(5339, 246, '_заголовок-4', 'field_624374f73d8bd'),
(5340, 246, 'изображения', 'a:12:{i:0;s:2:\"63\";i:1;s:2:\"64\";i:2;s:2:\"65\";i:3;s:2:\"66\";i:4;s:2:\"67\";i:5;s:2:\"68\";i:6;s:2:\"69\";i:7;s:2:\"70\";i:8;s:2:\"71\";i:9;s:2:\"72\";i:10;s:2:\"73\";i:11;s:2:\"74\";}'),
(5341, 246, '_изображения', 'field_624375093d8be'),
(5342, 246, 'изображения-4', 'a:12:{i:0;s:2:\"63\";i:1;s:2:\"64\";i:2;s:2:\"65\";i:3;s:2:\"66\";i:4;s:2:\"67\";i:5;s:2:\"68\";i:6;s:2:\"69\";i:7;s:2:\"70\";i:8;s:2:\"71\";i:9;s:2:\"72\";i:10;s:2:\"73\";i:11;s:2:\"74\";}'),
(5343, 246, '_изображения-4', 'field_624375093d8be'),
(5344, 246, 'заголовок-5', 'Способ применения*<sup>6</sup>'),
(5345, 246, '_заголовок-5', 'field_624379bd4756d'),
(5346, 246, 'иконки', 'a:5:{i:0;s:2:\"83\";i:1;s:2:\"84\";i:2;s:2:\"85\";i:3;s:2:\"86\";i:4;s:2:\"87\";}'),
(5347, 246, '_иконки', 'field_624379f24756e'),
(5348, 246, 'текст-5', 'У пациентов с легкой почечной недостаточностью (клиренс креатинина ≥ 50 — ≤ 80 мл/мин) коррекция дозы не требуется. Для лечения пациентов с почечной недостаточностью средней степени тяжести (клиренс креатинина ≥ 30 — < 50 мл/мин) рекомендуется в течение первой недели принимать начальную дозу по 4 мг в сутки, при хорошей индивидуальной переносимости доза может быть увеличена до 8 мг в сутки. Применение препарата для пациентов с тяжелой почечной недостаточностью (клиренс креатинина < 30 мл / мин) не рекомендуется'),
(5349, 246, '_текст-5', 'field_62437a374756f'),
(5350, 246, 'текст_под_кнопкой', '*Более подробные сведения о&nbsp;препарате, особенностях применения, побочных действиях и&nbsp;др. &mdash;&nbsp;см. инструкцию по&nbsp;медицинскому применению лекарственного препарата Урорек, РУ&nbsp;ЛСР-005971/10 от&nbsp;25.06.2010'),
(5351, 246, '_текст_под_кнопкой', 'field_62437a7c47570'),
(5352, 246, 'заголовок-6', 'Препарат Урорек (силодозин) включен в&nbsp;российские и&nbsp;международные клинические рекомендации и&nbsp;стандарты для лечения ряда урологических заболеваний:'),
(5353, 246, '_заголовок-6', 'field_6244117c68bd0'),
(5354, 246, 'список-6_0_ссылка', 'a:3:{s:5:\"title\";s:68:\"Российские клинические рекомендации\";s:3:\"url\";s:1:\"#\";s:6:\"target\";s:0:\"\";}'),
(5355, 246, '_список-6_0_ссылка', 'field_624411ce68bd2'),
(5356, 246, 'список-6_0_описание', '«Доброкачественная гиперплазия предстательной железы», 2020<sup>28</sup>'),
(5357, 246, '_список-6_0_описание', 'field_6244121168bd3'),
(5358, 246, 'список-6_1_ссылка', 'a:3:{s:5:\"title\";s:70:\"Европейские клинические рекомендации\";s:3:\"url\";s:1:\"#\";s:6:\"target\";s:0:\"\";}'),
(5359, 246, '_список-6_1_ссылка', 'field_624411ce68bd2'),
(5360, 246, 'список-6_1_описание', 'глава «Консервативное лечение ненейрогенных симптомов нарушенного мочеиспускания у мужчин, включая доброкачественную простатическую обструкцию», 2021<sup>29</sup>'),
(5361, 246, '_список-6_1_описание', 'field_6244121168bd3'),
(5362, 246, 'список-6_2_ссылка', 'a:3:{s:5:\"title\";s:154:\"Стандарт первичной медико-санитарной помощи при гиперплазии предстательной железы\";s:3:\"url\";s:1:\"#\";s:6:\"target\";s:0:\"\";}'),
(5363, 246, '_список-6_2_ссылка', 'field_624411ce68bd2'),
(5364, 246, 'список-6_2_описание', '09.11.2012<sup>30</sup> / Обновлён 13.04.2015\r\n'),
(5365, 246, '_список-6_2_описание', 'field_6244121168bd3'),
(5366, 246, 'список-6_3_ссылка', 'a:3:{s:5:\"title\";s:122:\"Стандарт специализированной медицинской помощи при задержке мочи\";s:3:\"url\";s:1:\"#\";s:6:\"target\";s:0:\"\";}'),
(5367, 246, '_список-6_3_ссылка', 'field_624411ce68bd2'),
(5368, 246, 'список-6_3_описание', '29.01.2013<sup>31</sup> / Обновлён 06.05.2015\r\n'),
(5369, 246, '_список-6_3_описание', 'field_6244121168bd3'),
(5370, 246, 'список-6_4_ссылка', 'a:3:{s:5:\"title\";s:133:\"Стандарт первичной медико-санитарной помощи при хроническом простатите\";s:3:\"url\";s:1:\"#\";s:6:\"target\";s:0:\"\";}'),
(5371, 246, '_список-6_4_ссылка', 'field_624411ce68bd2'),
(5372, 246, 'список-6_4_описание', '09.11.2012<sup>32</sup> / Обновлён 13.04.2015\r\n'),
(5373, 246, '_список-6_4_описание', 'field_6244121168bd3'),
(5374, 246, 'список-6_5_ссылка', 'a:3:{s:5:\"title\";s:168:\"Стандарт специализированной медицинской помощи при остром простатите, орхите, эпидидимите\";s:3:\"url\";s:1:\"#\";s:6:\"target\";s:0:\"\";}'),
(5375, 246, '_список-6_5_ссылка', 'field_624411ce68bd2'),
(5376, 246, 'список-6_5_описание', '09.11.2012<sup>33</sup> / Обновлён 27.05.2015'),
(5377, 246, '_список-6_5_описание', 'field_6244121168bd3'),
(5378, 246, 'список-6', '6'),
(5379, 246, '_список-6', 'field_624411be68bd1'),
(5380, 246, 'заголовок-7', 'Препарат Урорек (силодозин) зарегистрирован и&nbsp;применяется в&nbsp;разных странах мира Одобрен ЕМА*<sup>34</sup> и&nbsp;FDA**<sup>35</sup>'),
(5381, 246, '_заголовок-7', 'field_624417e3b6088'),
(5382, 246, 'текст', '<p class=\"sOtherCountries__agency\"><span>EMA</span> Европейское медицинское агентство</p>\r\n<p class=\"sOtherCountries__agency\"><span>FDA</span> Управление по&nbsp;санитарному надзору за&nbsp;качеством пищевых продуктов и&nbsp;медикаментов, США</p>'),
(5383, 246, '_текст', 'field_6244182bb6089'),
(5384, 246, 'страны_0_флаг', '105'),
(5385, 246, '_страны_0_флаг', 'field_62441880b608b'),
(5386, 246, 'страны_0_название', 'Япония'),
(5387, 246, '_страны_0_название', 'field_62441899b608c'),
(5388, 246, 'страны_0_год', '2006<sup>36,37</sup>'),
(5389, 246, '_страны_0_год', 'field_624418aab608d'),
(5390, 246, 'страны_1_флаг', '106'),
(5391, 246, '_страны_1_флаг', 'field_62441880b608b'),
(5392, 246, 'страны_1_название', 'США'),
(5393, 246, '_страны_1_название', 'field_62441899b608c'),
(5394, 246, 'страны_1_год', '2008<sup>35</sup>'),
(5395, 246, '_страны_1_год', 'field_624418aab608d'),
(5396, 246, 'страны_2_флаг', '107'),
(5397, 246, '_страны_2_флаг', 'field_62441880b608b'),
(5398, 246, 'страны_2_название', 'Страны ЕС'),
(5399, 246, '_страны_2_название', 'field_62441899b608c'),
(5400, 246, 'страны_2_год', '2010<sup>34</sup>'),
(5401, 246, '_страны_2_год', 'field_624418aab608d'),
(5402, 246, 'страны_3_флаг', '108'),
(5403, 246, '_страны_3_флаг', 'field_62441880b608b'),
(5404, 246, 'страны_3_название', 'Россия'),
(5405, 246, '_страны_3_название', 'field_62441899b608c'),
(5406, 246, 'страны_3_год', '2010<sup>1</sup>'),
(5407, 246, '_страны_3_год', 'field_624418aab608d'),
(5408, 246, 'страны', '4'),
(5409, 246, '_страны', 'field_62441847b608a'),
(5410, 246, 'текст-7', '<p class=\"sOtherCountries__agency\"><span>EMA</span> Европейское медицинское агентство</p>\r\n<p class=\"sOtherCountries__agency\"><span>FDA</span> Управление по&nbsp;санитарному надзору за&nbsp;качеством пищевых продуктов и&nbsp;медикаментов, США</p>'),
(5411, 246, '_текст-7', 'field_6244182bb6089'),
(5412, 246, 'текст-7-1', 'Производство препарата Урорек, поставляемого в&nbsp;Россию, осуществляется в&nbsp;Италии с&nbsp;использованием субстанции из&nbsp;Японии, в&nbsp;соответствии с&nbsp;необходимыми требованиями к&nbsp;производству и&nbsp;контролю качества<sup>6,1</sup>'),
(5413, 246, '_текст-7-1', 'field_62441a5acf03c'),
(5414, 246, 'заголовок-8', 'О проблеме'),
(5415, 246, '_заголовок-8', 'field_624431d91624d'),
(5416, 246, 'текст-8', 'Доброкачественная гиперплазия предстательной железы (ДГПЖ), или как ее еще называют, аденома простаты, как правило, возникает у мужчин старше 50 лет и характеризуется наличием симптомов нижних мочевыводящих путей (СНМП), увеличением предстательной железы или ее части, и нарушением оттока мочи из мочевого пузыря вследствие инфравезикальной обструкции.<sup>38</sup>\r\n\r\nРаспространенность ДГПЖ увеличивается с возрастом. Так, клинически значимая ДГПЖ проявляется у 13% мужчин в возрасте старше 50 лет, у 34% мужчин в возрасте 60 лет и у 43% в возрасте 70 лет.<sup>39</sup>\r\n\r\n&nbsp;\r\n\r\n<img class=\"alignnone wp-image-122 size-full\" src=\"http://0026urotec.loc:8888/wp-content/uploads/2022/03/about-img.png\" alt=\"\" width=\"594\" height=\"696\" />'),
(5417, 246, '_текст-8', 'field_624431f11624e'),
(5418, 246, 'текст-8-1', 'Наличие СНМП может быть ассоциировано с&nbsp;тяжелыми хроническими заболеваниями, такими как заболевания сердца, сахарный диабет, артериальная гипертензия и&nbsp;депрессия<sup>40</sup>'),
(5419, 246, '_текст-8-1', 'field_6244320b26db3'),
(5420, 246, 'иконки-8', 'a:6:{i:0;s:3:\"123\";i:1;s:3:\"124\";i:2;s:3:\"125\";i:3;s:3:\"126\";i:4;s:3:\"127\";i:5;s:3:\"128\";}'),
(5421, 246, '_иконки-8', 'field_6244322d26db4'),
(5422, 246, 'текст-8-2', '<h3>Симптомы доброкачественной гиперплазии предстательной железы</h3>\r\nСимптомы нарушенного мочеиспускания являются частой жалобой у взрослых мужчин. Они оказывают серьезное негативное влияние на качество жизни. При ДГПЖ предстательная железа увеличивается в размерах, оказывая давление на нижние мочевые пути. В результате развиваются следующие симптомы:<sup>41</sup>'),
(5423, 246, '_текст-8-2', 'field_6244335fe2373'),
(5424, 246, 'заголовок-9', 'Осложнения ДГПЖ<sup>38</sup>'),
(5425, 246, '_заголовок-9', 'field_6244377a52263'),
(5426, 246, 'изображения-9', 'a:6:{i:0;s:3:\"141\";i:1;s:3:\"142\";i:2;s:3:\"143\";i:3;s:3:\"144\";i:4;s:3:\"145\";i:5;s:3:\"146\";}'),
(5427, 246, '_изображения-9', 'field_6244379652264'),
(5428, 246, 'заголовок-10', 'Медикаментозное лечение СНМП/ДГПЖ'),
(5429, 246, '_заголовок-10', 'field_6244489614262'),
(5430, 246, 'текст-10', 'Антагонисты альфа1-адренорецепторов (альфа-адреноблокаторы) и&nbsp;ингибиторы 5&nbsp;альфа1-редуктазы (ингибиторы 5-АР) являются группами лекарственных препаратов, которые в&nbsp;настоящее время утверждены для лечения ДГПЖ. Обе группы препаратов обеспечивают надлежащее ослабление симптомов, но&nbsp;&alpha;&mdash;блокаторы обладают довольно быстрым началом действия, а&nbsp;ингибиторам 5-АР требуется несколько месяцев для получения терапевтического эффекта.<sup>42</sup>'),
(5431, 246, '_текст-10', 'field_624448ce14263'),
(5432, 246, 'карточки-10_0_заголовок', 'Альфа-адреноблокаторы'),
(5433, 246, '_карточки-10_0_заголовок', 'field_624448fc14265'),
(5434, 246, 'карточки-10_0_текст', 'представляют собой наиболее эффективный класс лекарственных препаратов, характеризующийся хорошим профилем безопасности и высокой комплаентностью, применяющийся для облегчения СНМП, связанных с ДГПЖ: они снимают спазм гладкой мускулатуры предстательной железы и шейки мочевого пузыря42'),
(5435, 246, '_карточки-10_0_текст', 'field_6244490c14266'),
(5436, 246, 'карточки-10_1_заголовок', 'Ингибиторы 5-АР —'),
(5437, 246, '_карточки-10_1_заголовок', 'field_624448fc14265'),
(5438, 246, 'карточки-10_1_текст', 'приводят к редукции железистой ткани и к снижению размера предстательной железы: они блокируют конверсию тестостерона в дигидротестостерон, который стимулирует рост предстательной железы43,44.Назначаются при большом объеме предстательной железы. Для получения значимого клинического эффекта требуется несколько месяцев применения45\r\n'),
(5439, 246, '_карточки-10_1_текст', 'field_6244490c14266'),
(5440, 246, 'карточки-10', '2'),
(5441, 246, '_карточки-10', 'field_624448e214264'),
(5442, 246, 'видео', '<iframe width=\"560\" height=\"315\" src=\"https://www.youtube.com/embed/3DrU3pFXSsY\" title=\"YouTube video player\" frameborder=\"0\" allow=\"accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture\" allowfullscreen></iframe>'),
(5443, 246, '_видео', 'field_6244492214267'),
(5444, 246, 'заголовок-11', 'Часто задаваемые вопросы'),
(5445, 246, '_заголовок-11', 'field_62444b33e25d6'),
(5446, 246, 'вопросы_0_заголовок', 'Почему при приеме препарата Урорек у некоторых пациентов развивается нарушение эякуляции?'),
(5447, 246, '_вопросы_0_заголовок', 'field_62444b58e25d8'),
(5448, 246, 'вопросы_0_текст', 'Урорек — высокоселективный препарат, то есть преимущественно действует на альфа1А-адренорецепторы, которые находятся в нижних мочевых путях, предстательной железе и семенных пузырьках. Поэтому эффект развивается уже через 2–6 часов после приёма первой дозы препарата Урорек<sup>14</sup> при минимальным количестве нежелательных явлений.<sup>5</sup>\r\n\r\nНаиболее частый побочный эффект при приеме препарата Урорек — нарушение эякуляции<sup>46</sup>. Это может быть связано как с забросом эякулята при семяизвержении вместо уретры в мочевой пузырь, так и со снижением или отсутствием семенной жидкости во время эякуляции<sup>29</sup>. Силодозин снижает тонус гладкомышечных клеток семенных пузырьков, простаты и шейки мочевого пузыря, поэтому не происходит выброс семени. Этот эффект свойственен всем уроселективным альфа-адреноблокаторам<sup>53</sup> и самостоятельно исчезает после прекращения приема препарата.<sup>6</sup>\r\n\r\nЧастота эякуляторной дисфункции прямо пропорционально связана с улучшением СНМП и скорости мочеиспускания и подтверждает эффективность альфа-адреноблокатора: чем выше эффективность, тем выше частота встречаемости эякуляторной дисфункции.<sup>29</sup>\r\n\r\nНарушение эякуляции не влияет на сексуальную функцию<sup>52</sup>, не воспринимается как беспокоящий симптом подавляющим большинством пациентов и не требует отмены терапии.<sup>46</sup>'),
(5449, 246, '_вопросы_0_текст', 'field_62444b66e25d9'),
(5450, 246, 'вопросы_1_заголовок', 'Можно ли принимать Урорек при артериальной гипертензии и ишемический болезни сердца (ИБС)?'),
(5451, 246, '_вопросы_1_заголовок', 'field_62444b58e25d8'),
(5452, 246, 'вопросы_1_текст', 'Согласно инструкции по медицинскому применению, противопоказаний для применения лекарственного препарата Урорек у пациентов с СНМП/ДГПЖ и сопутствующими сердечно-сосудистыми заболеваниями нет.<sup>3</sup> Урорек не оказывает влияния на частоту сердечных сокращений (ЧСС), систолическое артериальное давление (САД) и диастолическое артериальное давление (ДАД).<sup>9</sup> Силодозин — не вызывает клинически значимого снижения артериального давления (АД)<sup>46</sup>, не усиливает действие антигипертензивных препаратов и не требует снижения дозы при одновременном приеме.<sup>7</sup> В соответствии с дизайном клинического исследования многие пациенты получали сопутствующую терапию антигипертензивными препаратами (в основном, средствами, воздействующими на ренин-ангиотензиновую систему, бета-блокаторами, антагонистами кальция и диуретиками) без повышения частоты ортостатической гипотензии.<sup>6</sup>\r\n\r\nПри приеме препарата Урорек наиболее низкий риск развития сердечно-сосудистых осложнений.<sup>5</sup>'),
(5453, 246, '_вопросы_1_текст', 'field_62444b66e25d9'),
(5454, 246, 'вопросы_2_заголовок', 'Можно ли принимать Урорек пациенту с ортостатической гипотензией в анамнезе?'),
(5455, 246, '_вопросы_2_заголовок', 'field_62444b58e25d8'),
(5456, 246, 'вопросы_2_текст', 'Повышенная селективность силодозина к альфа1A-адренорецепторам по сравнению с альфа1B-адренорецепторами выражается в пониженном риске развития сердечно-сосудистых осложнений.<sup>4</sup> Благодаря этому частота ортостатической гипотензии на фоне его приема сравнима с таковой при приеме плацебо.<sup>45,9</sup>\r\n\r\nВ отличие от других альфа-адреноблокаторов (например, все формы тамсулозина<sup>47,48</sup>), Урорек не противопоказан к приему у пациентов с ортостатической гипотензией в анамнезе. Тем не менее, пациентам с ортостатической гипотензией в анамнезе не рекомендуется принимать любые альфа-адреноблокаторы, в т.ч. Урорек.<sup>6</sup>'),
(5457, 246, '_вопросы_2_текст', 'field_62444b66e25d9'),
(5458, 246, 'вопросы_3_заголовок', 'Как долго можно принимать Урорек?'),
(5459, 246, '_вопросы_3_заголовок', 'field_62444b58e25d8'),
(5460, 246, 'вопросы_3_текст', 'Учитывая прогрессирующий характер течения доброкачественной гиперплазии предстательной железы, медикаментозную терапию следует проводить длительно (иногда в течение всей жизни пациента).<sup>49</sup>'),
(5461, 246, '_вопросы_3_текст', 'field_62444b66e25d9'),
(5462, 246, 'вопросы_4_заголовок', 'Пациенты жалуются на заложенность носа при лечении альфа-адреноблокаторами. Есть ли у препарата Урорек такое побочное действие?'),
(5463, 246, '_вопросы_4_заголовок', 'field_62444b58e25d8'),
(5464, 246, 'вопросы_4_текст', 'Заложенность носа — это возможный побочный эффект для всех альфа-адреноблокаторов. При приеме препарата Урорек он может возникать примерно в 1% случаев.<sup>46</sup>'),
(5465, 246, '_вопросы_4_текст', 'field_62444b66e25d9'),
(5466, 246, 'вопросы_5_заголовок', 'Можно ли начинать лечение препаратом Урорек с дозы 4 мг в сутки?'),
(5467, 246, '_вопросы_5_заголовок', 'field_62444b58e25d8'),
(5468, 246, 'вопросы_5_текст', 'Согласно инструкции по медицинскому применению лекарственного препарата Урорек, доза 8 мг в сутки рекомендована для лечения пациентов с СНМП/ДГПЖ. Титрование дозы при применении силодозина не требуется.\r\n\r\nУрорек 4 мг — это специальная доза для лечения пациентов с почечной недостаточностью средней степени тяжести (клиренс креатинина ≥ 30 до &lt; 50 мл/мин). Рекомендуется в течение первой недели принимать начальную дозу по 4 мг в сутки, далее при хорошей переносимости доза может быть увеличена до 8 мг в сутки.<sup>6</sup>**Более подробные сведения о препарате, особенностях применения, побочных действиях и др. — см. инструкцию по медицинскому применению лекарственного препарата Урорек, РУ ЛСР-005971/10 от 25.06.2010'),
(5469, 246, '_вопросы_5_текст', 'field_62444b66e25d9'),
(5470, 246, 'вопросы_6_заголовок', 'Влияет ли Урорек на течение ДГПЖ или только снимает симптомы нижних мочевыводящих путей?'),
(5471, 246, '_вопросы_6_заголовок', 'field_62444b58e25d8'),
(5472, 246, 'вопросы_6_текст', 'Помимо субъективных симптомов, ДГПЖ вызывает прогрессирующее морфологическое ремоделирование мочевого пузыря с риском развития серьезных функциональных нарушений. Лечение должно не только купировать субъективные симптомы, но и включать профилактику патологического ремоделирования мочевого пузыря.<sup>161</sup>\r\n\r\nСилодозин, действующее вещество препарата Урорек, в сравнении с другими альфа-адреноблокаторами более эффективно влияет на инфравезикальную обструкцию (ИВО), что оказывает влияние на предотвращение патологического прогрессирования ремоделирования мочевого пузыря и риск развития серьезных функциональных нарушений.<sup>50,51</sup>'),
(5473, 246, '_вопросы_6_текст', 'field_62444b66e25d9'),
(5474, 246, 'вопросы_7_заголовок', 'Доступен ли Урорек по льготному отпуску?'),
(5475, 246, '_вопросы_7_заголовок', 'field_62444b58e25d8'),
(5476, 246, 'вопросы_7_текст', 'Урорек (силодозин) не включен в список жизненно важных лекарственных препаратов (ЖНВЛП)<sup>1</sup> и не входит в перечень препаратов для льготного обеспечения граждан по федеральному льготному списку.'),
(5477, 246, '_вопросы_7_текст', 'field_62444b66e25d9'),
(5478, 246, 'вопросы', '8'),
(5479, 246, '_вопросы', 'field_62444b49e25d7'),
(5480, 247, 'заголовок-1', 'УРОРЕК – оригинальный<sup>10</sup> альфа-адреноблокатор'),
(5481, 247, '_заголовок-1', 'field_62435bd26f29f'),
(5482, 247, 'текст-1', '<div class=\"headerBlock__body\">\r\n<p>Силодозин (действующее вещество препарата Урорек) обладает максимальной уроселективностью в&nbsp;своем классе, что обеспечивает его уродинамическую эффективность и&nbsp;высокую безопасность<sup>4</sup></p>\r\n</div>\r\n<div class=\"headerBlock__footer\">\r\n<p><strong>Показания к применению: </strong><br/>Лечение симптомов доброкачественной гиперплазии предстательной железы<sup>6</sup></p>\r\n</div>'),
(5483, 247, '_текст-1', 'field_62435c0c6f2a0'),
(5484, 247, 'изображение-1', '13'),
(5485, 247, '_изображение-1', 'field_62435c8b6f2a1'),
(5486, 247, 'фон-1', '17'),
(5487, 247, '_фон-1', 'field_62435db92ea96'),
(5488, 247, 'заголовок-2', 'Ключевые преимущества препарата Урорек'),
(5489, 247, '_заголовок-2', 'field_6243606295196'),
(5490, 247, 'список-2', 'Единственный оригинальный препарат из&nbsp;группы альфа1-адреноблокаторов, не&nbsp;имеющий генериков в&nbsp;РФ<sup>1</sup>'),
(5491, 247, '_список-2', 'field_6243608195197'),
(5492, 247, 'картинка_с_текстом_0_изображение', '31'),
(5493, 247, '_картинка_с_текстом_0_изображение', 'field_624363d095199'),
(5494, 247, 'картинка_с_текстом_0_описание', 'Обширная доказательная база собственных пострегистрационных клинических исследований<sup>2</sup>'),
(5495, 247, '_картинка_с_текстом_0_описание', 'field_624363e59519a'),
(5496, 247, 'картинка_с_текстом_1_изображение', '32'),
(5497, 247, '_картинка_с_текстом_1_изображение', 'field_624363d095199'),
(5498, 247, 'картинка_с_текстом_1_описание', 'Отсутствие риска замены препарата Урорек в&nbsp;аптеке (единственный препарат с&nbsp;действующим веществом силодозин)<sup>1</sup>'),
(5499, 247, '_картинка_с_текстом_1_описание', 'field_624363e59519a'),
(5500, 247, 'картинка_с_текстом_2_изображение', '33'),
(5501, 247, '_картинка_с_текстом_2_изображение', 'field_624363d095199'),
(5502, 247, 'картинка_с_текстом_2_описание', 'Большинство пациентов предпочитают принимать оригинальные препараты<sup>3</sup>'),
(5503, 247, '_картинка_с_текстом_2_описание', 'field_624363e59519a'),
(5504, 247, 'картинка_с_текстом', '3'),
(5505, 247, '_картинка_с_текстом', 'field_624363b995198'),
(5506, 247, 'второй_список', '<li>Клинические преимущества препарата Урорек (силодозин) определяются максимальной уроселективностью в&nbsp;классе альфа-адреноблокаторов<sup>4</sup></li>\r\n\r\n<li>Урорек&nbsp;&mdash; альфа-адреноблокатор последнего поколения, который эффективен в&nbsp;отношении всех СНМП (накопления, опорожнения, постмиктурических).<sup>12,13</sup> При этом Урорек обладает минимальным риском развития нежелательных явлений со&nbsp;стороны сердечно-сосудистой системы, в&nbsp;том числе&nbsp;у&nbsp;пациентов, принимающих антигипертензивные препараты<sup>46,8</sup> <small> <span>СНМП </span>симптомы нижних мочевыводящих путей</small></li>'),
(5507, 247, '_второй_список', 'field_6243640e05eda'),
(5508, 247, 'заголовок2-2', 'Максимальная уроселективность силодозина в&nbsp;классе альфа-адреноблокаторов обуславливает его уродинамическую эффективность и&nbsp;высокий профиль безопасности<sup>4</sup>'),
(5509, 247, '_заголовок2-2', 'field_6243644705edb'),
(5510, 247, 'текст3', '<ul>\r\n<li>Урорек значительно улучшает клинические проявления и&nbsp;качество жизни у&nbsp;всех пациентов с&nbsp;СНМП/ДГПЖ, в&nbsp;том числе с&nbsp;тяжелым течением<sup>11</sup>\r\n<a href=\"#modal-call-first\" class=\"link-modal-js\">Узнать больше...</a></li>\r\n\r\n<li>Урорек является препаратом выбора для пациентов с&nbsp;СНМП/ДГПЖ и&nbsp;сопутствующими сердечно-сосудистыми заболеваниями<sup>3</sup> \r\n<a href=\"#modal-call-second\" class=\"link-modal-js\">Узнать больше...</a></li>\r\n</ul>\r\n<small> <span>ДГПЖ </span>доброкачественная гиперплазия предстательной железы</small>'),
(5511, 247, '_текст3', 'field_6243647405edc'),
(5512, 247, 'изображение-2', '34'),
(5513, 247, '_изображение-2', 'field_624364dd05edd'),
(5514, 247, 'текст_в_подвале', '<h2> Максимальная уроселективность в&nbsp;классе  альфа-адреноблокаторов<sup>4</sup></h2>\r\n<div class=\"h3\"> Почему это важно? <a href=\"#modal-call-second\" class=\"link-modal-js\">Подробнее</a></div>'),
(5515, 247, '_текст_в_подвале', 'field_62436daf1f6d9'),
(5516, 247, 'заголовок-3', 'Форма выпуска препарата Урорек'),
(5517, 247, '_заголовок-3', 'field_62436efee98e7'),
(5518, 247, 'текст-3', '<p class=\"section-descr\"><span>8мг </span>- рекомендуемая доза для лечения симптомов ДГПЖ<sup>6</sup>*</p>\r\n					<p class=\"section-note col-md-10\">*Более подробные сведения о&nbsp;препарате, особенностях применения, побочных действиях и&nbsp;др. &mdash;&nbsp;смотрите инструкцию по&nbsp;медицинскому применению лекарственного препарата Урорек, РУ&nbsp;ЛСР-005971/10 от&nbsp;25.06.2010 </p>'),
(5519, 247, '_текст-3', 'field_62436f60e98e8'),
(5520, 247, 'товар_0_название', 'Урорек 8мг №30'),
(5521, 247, '_товар_0_название', 'field_62436fcce98ea'),
(5522, 247, 'товар_0_описание', 'Упаковка, рассчитанная на&nbsp;1&nbsp;месяц лечения&nbsp;/ для старта терапии'),
(5523, 247, '_товар_0_описание', 'field_62436fe1e98eb'),
(5524, 247, 'товар_0_лицензия', 'РУ: ЛСР-005971/10 от 25.06.2010'),
(5525, 247, '_товар_0_лицензия', 'field_62436ff0e98ec'),
(5526, 247, 'товар_0_изображение', '51'),
(5527, 247, '_товар_0_изображение', 'field_62437045e98ed'),
(5528, 247, 'товар_1_название', 'Урорек 8мг №90'),
(5529, 247, '_товар_1_название', 'field_62436fcce98ea'),
(5530, 247, 'товар_1_описание', 'Выгодная упаковка, рассчитанная на&nbsp;3&nbsp;месяца лечения. Самая доступная стоимость 1&nbsp;дня терапии препаратом Урорек&nbsp;<sup>27</sup>'),
(5531, 247, '_товар_1_описание', 'field_62436fe1e98eb'),
(5532, 247, 'товар_1_лицензия', 'РУ: ЛСР-005971/10 от 25.06.2010'),
(5533, 247, '_товар_1_лицензия', 'field_62436ff0e98ec'),
(5534, 247, 'товар_1_изображение', '53'),
(5535, 247, '_товар_1_изображение', 'field_62437045e98ed'),
(5536, 247, 'товар_2_название', 'Урорек 4мг №30'),
(5537, 247, '_товар_2_название', 'field_62436fcce98ea'),
(5538, 247, 'товар_2_описание', '4&nbsp;мг&nbsp;&mdash; стартовая доза для лечения симптомов ДГПЖ у&nbsp;пациентов с&nbsp;почечной недостаточностью средней степени тяжести<sup>6</sup>'),
(5539, 247, '_товар_2_описание', 'field_62436fe1e98eb'),
(5540, 247, 'товар_2_лицензия', 'РУ: ЛСР-005971/10 от 25.06.2010'),
(5541, 247, '_товар_2_лицензия', 'field_62436ff0e98ec'),
(5542, 247, 'товар_2_изображение', '52'),
(5543, 247, '_товар_2_изображение', 'field_62437045e98ed'),
(5544, 247, 'товар', '3'),
(5545, 247, '_товар', 'field_62436fbde98e9'),
(5546, 247, 'заголовок-4', 'Где купить'),
(5547, 247, '_заголовок-4', 'field_624374f73d8bd'),
(5548, 247, 'изображения', 'a:12:{i:0;s:2:\"63\";i:1;s:2:\"64\";i:2;s:2:\"65\";i:3;s:2:\"66\";i:4;s:2:\"67\";i:5;s:2:\"68\";i:6;s:2:\"69\";i:7;s:2:\"70\";i:8;s:2:\"71\";i:9;s:2:\"72\";i:10;s:2:\"73\";i:11;s:2:\"74\";}'),
(5549, 247, '_изображения', 'field_624375093d8be'),
(5550, 247, 'изображения-4', 'a:12:{i:0;s:2:\"63\";i:1;s:2:\"64\";i:2;s:2:\"65\";i:3;s:2:\"66\";i:4;s:2:\"67\";i:5;s:2:\"68\";i:6;s:2:\"69\";i:7;s:2:\"70\";i:8;s:2:\"71\";i:9;s:2:\"72\";i:10;s:2:\"73\";i:11;s:2:\"74\";}'),
(5551, 247, '_изображения-4', 'field_624375093d8be'),
(5552, 247, 'заголовок-5', 'Способ применения*<sup>6</sup>'),
(5553, 247, '_заголовок-5', 'field_624379bd4756d'),
(5554, 247, 'иконки', 'a:5:{i:0;s:2:\"83\";i:1;s:2:\"84\";i:2;s:2:\"85\";i:3;s:2:\"86\";i:4;s:2:\"87\";}'),
(5555, 247, '_иконки', 'field_624379f24756e'),
(5556, 247, 'текст-5', 'У пациентов с легкой почечной недостаточностью (клиренс креатинина ≥ 50 — ≤ 80 мл/мин) коррекция дозы не требуется. Для лечения пациентов с почечной недостаточностью средней степени тяжести (клиренс креатинина ≥ 30 — < 50 мл/мин) рекомендуется в течение первой недели принимать начальную дозу по 4 мг в сутки, при хорошей индивидуальной переносимости доза может быть увеличена до 8 мг в сутки. Применение препарата для пациентов с тяжелой почечной недостаточностью (клиренс креатинина < 30 мл / мин) не рекомендуется'),
(5557, 247, '_текст-5', 'field_62437a374756f'),
(5558, 247, 'текст_под_кнопкой', '*Более подробные сведения о&nbsp;препарате, особенностях применения, побочных действиях и&nbsp;др. &mdash;&nbsp;см. инструкцию по&nbsp;медицинскому применению лекарственного препарата Урорек, РУ&nbsp;ЛСР-005971/10 от&nbsp;25.06.2010'),
(5559, 247, '_текст_под_кнопкой', 'field_62437a7c47570'),
(5560, 247, 'заголовок-6', 'Препарат Урорек (силодозин) включен в&nbsp;российские и&nbsp;международные клинические рекомендации и&nbsp;стандарты для лечения ряда урологических заболеваний:'),
(5561, 247, '_заголовок-6', 'field_6244117c68bd0'),
(5562, 247, 'список-6_0_ссылка', 'a:3:{s:5:\"title\";s:68:\"Российские клинические рекомендации\";s:3:\"url\";s:1:\"#\";s:6:\"target\";s:0:\"\";}'),
(5563, 247, '_список-6_0_ссылка', 'field_624411ce68bd2'),
(5564, 247, 'список-6_0_описание', '«Доброкачественная гиперплазия предстательной железы», 2020<sup>28</sup>'),
(5565, 247, '_список-6_0_описание', 'field_6244121168bd3'),
(5566, 247, 'список-6_1_ссылка', 'a:3:{s:5:\"title\";s:70:\"Европейские клинические рекомендации\";s:3:\"url\";s:1:\"#\";s:6:\"target\";s:0:\"\";}'),
(5567, 247, '_список-6_1_ссылка', 'field_624411ce68bd2'),
(5568, 247, 'список-6_1_описание', 'глава «Консервативное лечение ненейрогенных симптомов нарушенного мочеиспускания у мужчин, включая доброкачественную простатическую обструкцию», 2021<sup>29</sup>'),
(5569, 247, '_список-6_1_описание', 'field_6244121168bd3'),
(5570, 247, 'список-6_2_ссылка', 'a:3:{s:5:\"title\";s:154:\"Стандарт первичной медико-санитарной помощи при гиперплазии предстательной железы\";s:3:\"url\";s:1:\"#\";s:6:\"target\";s:0:\"\";}'),
(5571, 247, '_список-6_2_ссылка', 'field_624411ce68bd2'),
(5572, 247, 'список-6_2_описание', '09.11.2012<sup>30</sup> / Обновлён 13.04.2015\r\n'),
(5573, 247, '_список-6_2_описание', 'field_6244121168bd3'),
(5574, 247, 'список-6_3_ссылка', 'a:3:{s:5:\"title\";s:122:\"Стандарт специализированной медицинской помощи при задержке мочи\";s:3:\"url\";s:1:\"#\";s:6:\"target\";s:0:\"\";}'),
(5575, 247, '_список-6_3_ссылка', 'field_624411ce68bd2'),
(5576, 247, 'список-6_3_описание', '29.01.2013<sup>31</sup> / Обновлён 06.05.2015\r\n'),
(5577, 247, '_список-6_3_описание', 'field_6244121168bd3'),
(5578, 247, 'список-6_4_ссылка', 'a:3:{s:5:\"title\";s:133:\"Стандарт первичной медико-санитарной помощи при хроническом простатите\";s:3:\"url\";s:1:\"#\";s:6:\"target\";s:0:\"\";}'),
(5579, 247, '_список-6_4_ссылка', 'field_624411ce68bd2'),
(5580, 247, 'список-6_4_описание', '09.11.2012<sup>32</sup> / Обновлён 13.04.2015\r\n'),
(5581, 247, '_список-6_4_описание', 'field_6244121168bd3'),
(5582, 247, 'список-6_5_ссылка', 'a:3:{s:5:\"title\";s:168:\"Стандарт специализированной медицинской помощи при остром простатите, орхите, эпидидимите\";s:3:\"url\";s:1:\"#\";s:6:\"target\";s:0:\"\";}'),
(5583, 247, '_список-6_5_ссылка', 'field_624411ce68bd2'),
(5584, 247, 'список-6_5_описание', '09.11.2012<sup>33</sup> / Обновлён 27.05.2015'),
(5585, 247, '_список-6_5_описание', 'field_6244121168bd3'),
(5586, 247, 'список-6', '6'),
(5587, 247, '_список-6', 'field_624411be68bd1'),
(5588, 247, 'заголовок-7', 'Препарат Урорек (силодозин) зарегистрирован и&nbsp;применяется в&nbsp;разных странах мира Одобрен ЕМА*<sup>34</sup> и&nbsp;FDA**<sup>35</sup>'),
(5589, 247, '_заголовок-7', 'field_624417e3b6088'),
(5590, 247, 'текст', '<p class=\"sOtherCountries__agency\"><span>EMA</span> Европейское медицинское агентство</p>\r\n<p class=\"sOtherCountries__agency\"><span>FDA</span> Управление по&nbsp;санитарному надзору за&nbsp;качеством пищевых продуктов и&nbsp;медикаментов, США</p>'),
(5591, 247, '_текст', 'field_6244182bb6089'),
(5592, 247, 'страны_0_флаг', '105'),
(5593, 247, '_страны_0_флаг', 'field_62441880b608b'),
(5594, 247, 'страны_0_название', 'Япония'),
(5595, 247, '_страны_0_название', 'field_62441899b608c'),
(5596, 247, 'страны_0_год', '2006<sup>36,37</sup>'),
(5597, 247, '_страны_0_год', 'field_624418aab608d'),
(5598, 247, 'страны_1_флаг', '106'),
(5599, 247, '_страны_1_флаг', 'field_62441880b608b'),
(5600, 247, 'страны_1_название', 'США'),
(5601, 247, '_страны_1_название', 'field_62441899b608c'),
(5602, 247, 'страны_1_год', '2008<sup>35</sup>'),
(5603, 247, '_страны_1_год', 'field_624418aab608d'),
(5604, 247, 'страны_2_флаг', '107'),
(5605, 247, '_страны_2_флаг', 'field_62441880b608b'),
(5606, 247, 'страны_2_название', 'Страны ЕС');
INSERT INTO `urotec_postmeta` (`meta_id`, `post_id`, `meta_key`, `meta_value`) VALUES
(5607, 247, '_страны_2_название', 'field_62441899b608c'),
(5608, 247, 'страны_2_год', '2010<sup>34</sup>'),
(5609, 247, '_страны_2_год', 'field_624418aab608d'),
(5610, 247, 'страны_3_флаг', '108'),
(5611, 247, '_страны_3_флаг', 'field_62441880b608b'),
(5612, 247, 'страны_3_название', 'Россия'),
(5613, 247, '_страны_3_название', 'field_62441899b608c'),
(5614, 247, 'страны_3_год', '2010<sup>1</sup>'),
(5615, 247, '_страны_3_год', 'field_624418aab608d'),
(5616, 247, 'страны', '4'),
(5617, 247, '_страны', 'field_62441847b608a'),
(5618, 247, 'текст-7', '<p class=\"sOtherCountries__agency\"><span>EMA</span> Европейское медицинское агентство</p>\r\n<p class=\"sOtherCountries__agency\"><span>FDA</span> Управление по&nbsp;санитарному надзору за&nbsp;качеством пищевых продуктов и&nbsp;медикаментов, США</p>'),
(5619, 247, '_текст-7', 'field_6244182bb6089'),
(5620, 247, 'текст-7-1', 'Производство препарата Урорек, поставляемого в&nbsp;Россию, осуществляется в&nbsp;Италии с&nbsp;использованием субстанции из&nbsp;Японии, в&nbsp;соответствии с&nbsp;необходимыми требованиями к&nbsp;производству и&nbsp;контролю качества<sup>6,1</sup>'),
(5621, 247, '_текст-7-1', 'field_62441a5acf03c'),
(5622, 247, 'заголовок-8', 'О проблеме'),
(5623, 247, '_заголовок-8', 'field_624431d91624d'),
(5624, 247, 'текст-8', 'Доброкачественная гиперплазия предстательной железы (ДГПЖ), или как ее еще называют, аденома простаты, как правило, возникает у мужчин старше 50 лет и характеризуется наличием симптомов нижних мочевыводящих путей (СНМП), увеличением предстательной железы или ее части, и нарушением оттока мочи из мочевого пузыря вследствие инфравезикальной обструкции.<sup>38</sup>\r\n\r\nРаспространенность ДГПЖ увеличивается с возрастом. Так, клинически значимая ДГПЖ проявляется у 13% мужчин в возрасте старше 50 лет, у 34% мужчин в возрасте 60 лет и у 43% в возрасте 70 лет.<sup>39</sup>\r\n\r\n&nbsp;\r\n\r\n<img class=\"alignnone wp-image-122 size-full\" src=\"http://0026urotec.loc:8888/wp-content/uploads/2022/03/about-img.png\" alt=\"\" width=\"594\" height=\"696\" />'),
(5625, 247, '_текст-8', 'field_624431f11624e'),
(5626, 247, 'текст-8-1', 'Наличие СНМП может быть ассоциировано с&nbsp;тяжелыми хроническими заболеваниями, такими как заболевания сердца, сахарный диабет, артериальная гипертензия и&nbsp;депрессия<sup>40</sup>'),
(5627, 247, '_текст-8-1', 'field_6244320b26db3'),
(5628, 247, 'иконки-8', 'a:6:{i:0;s:3:\"123\";i:1;s:3:\"124\";i:2;s:3:\"125\";i:3;s:3:\"126\";i:4;s:3:\"127\";i:5;s:3:\"128\";}'),
(5629, 247, '_иконки-8', 'field_6244322d26db4'),
(5630, 247, 'текст-8-2', '<h3>Симптомы доброкачественной гиперплазии предстательной железы</h3>\r\nСимптомы нарушенного мочеиспускания являются частой жалобой у взрослых мужчин. Они оказывают серьезное негативное влияние на качество жизни. При ДГПЖ предстательная железа увеличивается в размерах, оказывая давление на нижние мочевые пути. В результате развиваются следующие симптомы:<sup>41</sup>'),
(5631, 247, '_текст-8-2', 'field_6244335fe2373'),
(5632, 247, 'заголовок-9', 'Осложнения ДГПЖ<sup>38</sup>'),
(5633, 247, '_заголовок-9', 'field_6244377a52263'),
(5634, 247, 'изображения-9', 'a:6:{i:0;s:3:\"141\";i:1;s:3:\"142\";i:2;s:3:\"143\";i:3;s:3:\"144\";i:4;s:3:\"145\";i:5;s:3:\"146\";}'),
(5635, 247, '_изображения-9', 'field_6244379652264'),
(5636, 247, 'заголовок-10', 'Медикаментозное лечение СНМП/ДГПЖ'),
(5637, 247, '_заголовок-10', 'field_6244489614262'),
(5638, 247, 'текст-10', 'Антагонисты альфа1-адренорецепторов (альфа-адреноблокаторы) и&nbsp;ингибиторы 5&nbsp;альфа1-редуктазы (ингибиторы 5-АР) являются группами лекарственных препаратов, которые в&nbsp;настоящее время утверждены для лечения ДГПЖ. Обе группы препаратов обеспечивают надлежащее ослабление симптомов, но&nbsp;&alpha;&mdash;блокаторы обладают довольно быстрым началом действия, а&nbsp;ингибиторам 5-АР требуется несколько месяцев для получения терапевтического эффекта.<sup>42</sup>'),
(5639, 247, '_текст-10', 'field_624448ce14263'),
(5640, 247, 'карточки-10_0_заголовок', 'Альфа-адреноблокаторы'),
(5641, 247, '_карточки-10_0_заголовок', 'field_624448fc14265'),
(5642, 247, 'карточки-10_0_текст', 'представляют собой наиболее эффективный класс лекарственных препаратов, характеризующийся хорошим профилем безопасности и высокой комплаентностью, применяющийся для облегчения СНМП, связанных с ДГПЖ: они снимают спазм гладкой мускулатуры предстательной железы и шейки мочевого пузыря42'),
(5643, 247, '_карточки-10_0_текст', 'field_6244490c14266'),
(5644, 247, 'карточки-10_1_заголовок', 'Ингибиторы 5-АР —'),
(5645, 247, '_карточки-10_1_заголовок', 'field_624448fc14265'),
(5646, 247, 'карточки-10_1_текст', 'приводят к редукции железистой ткани и к снижению размера предстательной железы: они блокируют конверсию тестостерона в дигидротестостерон, который стимулирует рост предстательной железы43,44.Назначаются при большом объеме предстательной железы. Для получения значимого клинического эффекта требуется несколько месяцев применения45\r\n'),
(5647, 247, '_карточки-10_1_текст', 'field_6244490c14266'),
(5648, 247, 'карточки-10', '2'),
(5649, 247, '_карточки-10', 'field_624448e214264'),
(5650, 247, 'видео', '<iframe width=\"560\" height=\"315\" src=\"https://www.youtube.com/embed/3DrU3pFXSsY\" title=\"YouTube video player\" frameborder=\"0\" allow=\"accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture\" allowfullscreen></iframe>'),
(5651, 247, '_видео', 'field_6244492214267'),
(5652, 247, 'заголовок-11', 'Часто задаваемые вопросы'),
(5653, 247, '_заголовок-11', 'field_62444b33e25d6'),
(5654, 247, 'вопросы_0_заголовок', 'Почему при приеме препарата Урорек у некоторых пациентов развивается нарушение эякуляции?'),
(5655, 247, '_вопросы_0_заголовок', 'field_62444b58e25d8'),
(5656, 247, 'вопросы_0_текст', 'Урорек — высокоселективный препарат, то есть преимущественно действует на альфа1А-адренорецепторы, которые находятся в нижних мочевых путях, предстательной железе и семенных пузырьках. Поэтому эффект развивается уже через 2–6 часов после приёма первой дозы препарата Урорек<sup>14</sup> при минимальным количестве нежелательных явлений.<sup>5</sup>\r\n\r\nНаиболее частый побочный эффект при приеме препарата Урорек — нарушение эякуляции<sup>46</sup>. Это может быть связано как с забросом эякулята при семяизвержении вместо уретры в мочевой пузырь, так и со снижением или отсутствием семенной жидкости во время эякуляции<sup>29</sup>. Силодозин снижает тонус гладкомышечных клеток семенных пузырьков, простаты и шейки мочевого пузыря, поэтому не происходит выброс семени. Этот эффект свойственен всем уроселективным альфа-адреноблокаторам<sup>53</sup> и самостоятельно исчезает после прекращения приема препарата.<sup>6</sup>\r\n\r\nЧастота эякуляторной дисфункции прямо пропорционально связана с улучшением СНМП и скорости мочеиспускания и подтверждает эффективность альфа-адреноблокатора: чем выше эффективность, тем выше частота встречаемости эякуляторной дисфункции.<sup>29</sup>\r\n\r\nНарушение эякуляции не влияет на сексуальную функцию<sup>52</sup>, не воспринимается как беспокоящий симптом подавляющим большинством пациентов и не требует отмены терапии.<sup>46</sup>'),
(5657, 247, '_вопросы_0_текст', 'field_62444b66e25d9'),
(5658, 247, 'вопросы_1_заголовок', 'Можно ли принимать Урорек при артериальной гипертензии и ишемический болезни сердца (ИБС)?'),
(5659, 247, '_вопросы_1_заголовок', 'field_62444b58e25d8'),
(5660, 247, 'вопросы_1_текст', 'Согласно инструкции по медицинскому применению, противопоказаний для применения лекарственного препарата Урорек у пациентов с СНМП/ДГПЖ и сопутствующими сердечно-сосудистыми заболеваниями нет.<sup>3</sup> Урорек не оказывает влияния на частоту сердечных сокращений (ЧСС), систолическое артериальное давление (САД) и диастолическое артериальное давление (ДАД).<sup>9</sup> Силодозин — не вызывает клинически значимого снижения артериального давления (АД)<sup>46</sup>, не усиливает действие антигипертензивных препаратов и не требует снижения дозы при одновременном приеме.<sup>7</sup> В соответствии с дизайном клинического исследования многие пациенты получали сопутствующую терапию антигипертензивными препаратами (в основном, средствами, воздействующими на ренин-ангиотензиновую систему, бета-блокаторами, антагонистами кальция и диуретиками) без повышения частоты ортостатической гипотензии.<sup>6</sup>\r\n\r\nПри приеме препарата Урорек наиболее низкий риск развития сердечно-сосудистых осложнений.<sup>5</sup>'),
(5661, 247, '_вопросы_1_текст', 'field_62444b66e25d9'),
(5662, 247, 'вопросы_2_заголовок', 'Можно ли принимать Урорек пациенту с ортостатической гипотензией в анамнезе?'),
(5663, 247, '_вопросы_2_заголовок', 'field_62444b58e25d8'),
(5664, 247, 'вопросы_2_текст', 'Повышенная селективность силодозина к альфа1A-адренорецепторам по сравнению с альфа1B-адренорецепторами выражается в пониженном риске развития сердечно-сосудистых осложнений.<sup>4</sup> Благодаря этому частота ортостатической гипотензии на фоне его приема сравнима с таковой при приеме плацебо.<sup>45,9</sup>\r\n\r\nВ отличие от других альфа-адреноблокаторов (например, все формы тамсулозина<sup>47,48</sup>), Урорек не противопоказан к приему у пациентов с ортостатической гипотензией в анамнезе. Тем не менее, пациентам с ортостатической гипотензией в анамнезе не рекомендуется принимать любые альфа-адреноблокаторы, в т.ч. Урорек.<sup>6</sup>'),
(5665, 247, '_вопросы_2_текст', 'field_62444b66e25d9'),
(5666, 247, 'вопросы_3_заголовок', 'Как долго можно принимать Урорек?'),
(5667, 247, '_вопросы_3_заголовок', 'field_62444b58e25d8'),
(5668, 247, 'вопросы_3_текст', 'Учитывая прогрессирующий характер течения доброкачественной гиперплазии предстательной железы, медикаментозную терапию следует проводить длительно (иногда в течение всей жизни пациента).<sup>49</sup>'),
(5669, 247, '_вопросы_3_текст', 'field_62444b66e25d9'),
(5670, 247, 'вопросы_4_заголовок', 'Пациенты жалуются на заложенность носа при лечении альфа-адреноблокаторами. Есть ли у препарата Урорек такое побочное действие?'),
(5671, 247, '_вопросы_4_заголовок', 'field_62444b58e25d8'),
(5672, 247, 'вопросы_4_текст', 'Заложенность носа — это возможный побочный эффект для всех альфа-адреноблокаторов. При приеме препарата Урорек он может возникать примерно в 1% случаев.<sup>46</sup>'),
(5673, 247, '_вопросы_4_текст', 'field_62444b66e25d9'),
(5674, 247, 'вопросы_5_заголовок', 'Можно ли начинать лечение препаратом Урорек с дозы 4 мг в сутки?'),
(5675, 247, '_вопросы_5_заголовок', 'field_62444b58e25d8'),
(5676, 247, 'вопросы_5_текст', 'Согласно инструкции по медицинскому применению лекарственного препарата Урорек, доза 8 мг в сутки рекомендована для лечения пациентов с СНМП/ДГПЖ. Титрование дозы при применении силодозина не требуется.\r\n\r\nУрорек 4 мг — это специальная доза для лечения пациентов с почечной недостаточностью средней степени тяжести (клиренс креатинина ≥ 30 до &lt; 50 мл/мин). Рекомендуется в течение первой недели принимать начальную дозу по 4 мг в сутки, далее при хорошей переносимости доза может быть увеличена до 8 мг в сутки.<sup>6</sup>**Более подробные сведения о препарате, особенностях применения, побочных действиях и др. — см. инструкцию по медицинскому применению лекарственного препарата Урорек, РУ ЛСР-005971/10 от 25.06.2010'),
(5677, 247, '_вопросы_5_текст', 'field_62444b66e25d9'),
(5678, 247, 'вопросы_6_заголовок', 'Влияет ли Урорек на течение ДГПЖ или только снимает симптомы нижних мочевыводящих путей?'),
(5679, 247, '_вопросы_6_заголовок', 'field_62444b58e25d8'),
(5680, 247, 'вопросы_6_текст', 'Помимо субъективных симптомов, ДГПЖ вызывает прогрессирующее морфологическое ремоделирование мочевого пузыря с риском развития серьезных функциональных нарушений. Лечение должно не только купировать субъективные симптомы, но и включать профилактику патологического ремоделирования мочевого пузыря.<sup>161</sup>\r\n\r\nСилодозин, действующее вещество препарата Урорек, в сравнении с другими альфа-адреноблокаторами более эффективно влияет на инфравезикальную обструкцию (ИВО), что оказывает влияние на предотвращение патологического прогрессирования ремоделирования мочевого пузыря и риск развития серьезных функциональных нарушений.<sup>50,51</sup>'),
(5681, 247, '_вопросы_6_текст', 'field_62444b66e25d9'),
(5682, 247, 'вопросы_7_заголовок', 'Доступен ли Урорек по льготному отпуску?'),
(5683, 247, '_вопросы_7_заголовок', 'field_62444b58e25d8'),
(5684, 247, 'вопросы_7_текст', 'Урорек (силодозин) не включен в список жизненно важных лекарственных препаратов (ЖНВЛП)<sup>1</sup> и не входит в перечень препаратов для льготного обеспечения граждан по федеральному льготному списку.'),
(5685, 247, '_вопросы_7_текст', 'field_62444b66e25d9'),
(5686, 247, 'вопросы', '8'),
(5687, 247, '_вопросы', 'field_62444b49e25d7'),
(5688, 248, 'заголовок-1', 'УРОРЕК – оригинальный<sup>10</sup> альфа-адреноблокатор'),
(5689, 248, '_заголовок-1', 'field_62435bd26f29f'),
(5690, 248, 'текст-1', '<div class=\"headerBlock__body\">\r\n<p>Силодозин (действующее вещество препарата Урорек) обладает максимальной уроселективностью в&nbsp;своем классе, что обеспечивает его уродинамическую эффективность и&nbsp;высокую безопасность<sup>4</sup></p>\r\n</div>\r\n<div class=\"headerBlock__footer\">\r\n<p><strong>Показания к применению: </strong><br/>Лечение симптомов доброкачественной гиперплазии предстательной железы<sup>6</sup></p>\r\n</div>'),
(5691, 248, '_текст-1', 'field_62435c0c6f2a0'),
(5692, 248, 'изображение-1', '13'),
(5693, 248, '_изображение-1', 'field_62435c8b6f2a1'),
(5694, 248, 'фон-1', '17'),
(5695, 248, '_фон-1', 'field_62435db92ea96'),
(5696, 248, 'заголовок-2', 'Ключевые преимущества препарата Урорек'),
(5697, 248, '_заголовок-2', 'field_6243606295196'),
(5698, 248, 'список-2', 'Единственный оригинальный препарат из&nbsp;группы альфа1-адреноблокаторов, не&nbsp;имеющий генериков в&nbsp;РФ<sup>1</sup>'),
(5699, 248, '_список-2', 'field_6243608195197'),
(5700, 248, 'картинка_с_текстом_0_изображение', '31'),
(5701, 248, '_картинка_с_текстом_0_изображение', 'field_624363d095199'),
(5702, 248, 'картинка_с_текстом_0_описание', 'Обширная доказательная база собственных пострегистрационных клинических исследований<sup>2</sup>'),
(5703, 248, '_картинка_с_текстом_0_описание', 'field_624363e59519a'),
(5704, 248, 'картинка_с_текстом_1_изображение', '32'),
(5705, 248, '_картинка_с_текстом_1_изображение', 'field_624363d095199'),
(5706, 248, 'картинка_с_текстом_1_описание', 'Отсутствие риска замены препарата Урорек в&nbsp;аптеке (единственный препарат с&nbsp;действующим веществом силодозин)<sup>1</sup>'),
(5707, 248, '_картинка_с_текстом_1_описание', 'field_624363e59519a'),
(5708, 248, 'картинка_с_текстом_2_изображение', '33'),
(5709, 248, '_картинка_с_текстом_2_изображение', 'field_624363d095199'),
(5710, 248, 'картинка_с_текстом_2_описание', 'Большинство пациентов предпочитают принимать оригинальные препараты<sup>3</sup>'),
(5711, 248, '_картинка_с_текстом_2_описание', 'field_624363e59519a'),
(5712, 248, 'картинка_с_текстом', '3'),
(5713, 248, '_картинка_с_текстом', 'field_624363b995198'),
(5714, 248, 'второй_список', '<li>Клинические преимущества препарата Урорек (силодозин) определяются максимальной уроселективностью в&nbsp;классе альфа-адреноблокаторов<sup>4</sup></li>\r\n\r\n<li>Урорек&nbsp;&mdash; альфа-адреноблокатор последнего поколения, который эффективен в&nbsp;отношении всех СНМП (накопления, опорожнения, постмиктурических).<sup>12,13</sup> При этом Урорек обладает минимальным риском развития нежелательных явлений со&nbsp;стороны сердечно-сосудистой системы, в&nbsp;том числе&nbsp;у&nbsp;пациентов, принимающих антигипертензивные препараты<sup>46,8</sup> <small> <span>СНМП </span>симптомы нижних мочевыводящих путей</small></li>'),
(5715, 248, '_второй_список', 'field_6243640e05eda'),
(5716, 248, 'заголовок2-2', 'Максимальная уроселективность силодозина в&nbsp;классе альфа-адреноблокаторов обуславливает его уродинамическую эффективность и&nbsp;высокий профиль безопасности<sup>4</sup>'),
(5717, 248, '_заголовок2-2', 'field_6243644705edb'),
(5718, 248, 'текст3', '<ul>\r\n<li>Урорек значительно улучшает клинические проявления и&nbsp;качество жизни у&nbsp;всех пациентов с&nbsp;СНМП/ДГПЖ, в&nbsp;том числе с&nbsp;тяжелым течением<sup>11</sup>\r\n<a href=\"#modal-call-first\" class=\"link-modal-js\">Узнать больше...</a></li>\r\n\r\n<li>Урорек является препаратом выбора для пациентов с&nbsp;СНМП/ДГПЖ и&nbsp;сопутствующими сердечно-сосудистыми заболеваниями<sup>3</sup> \r\n<a href=\"#modal-call-second\" class=\"link-modal-js\">Узнать больше...</a></li>\r\n</ul>\r\n<small> <span>ДГПЖ </span>доброкачественная гиперплазия предстательной железы</small>'),
(5719, 248, '_текст3', 'field_6243647405edc'),
(5720, 248, 'изображение-2', '34'),
(5721, 248, '_изображение-2', 'field_624364dd05edd'),
(5722, 248, 'текст_в_подвале', '<h2> Максимальная уроселективность в&nbsp;классе  альфа-адреноблокаторов<sup>4</sup></h2>\r\n<div class=\"h3\"> Почему это важно? <a href=\"#modal-call-second\" class=\"link-modal-js\">Подробнее</a></div>'),
(5723, 248, '_текст_в_подвале', 'field_62436daf1f6d9'),
(5724, 248, 'заголовок-3', 'Форма выпуска препарата Урорек'),
(5725, 248, '_заголовок-3', 'field_62436efee98e7'),
(5726, 248, 'текст-3', '<p class=\"section-descr\"><span>8мг </span>- рекомендуемая доза для лечения симптомов ДГПЖ<sup>6</sup>*</p>\r\n					<p class=\"section-note col-md-10\">*Более подробные сведения о&nbsp;препарате, особенностях применения, побочных действиях и&nbsp;др. &mdash;&nbsp;смотрите инструкцию по&nbsp;медицинскому применению лекарственного препарата Урорек, РУ&nbsp;ЛСР-005971/10 от&nbsp;25.06.2010 </p>'),
(5727, 248, '_текст-3', 'field_62436f60e98e8'),
(5728, 248, 'товар_0_название', 'Урорек 8мг №30'),
(5729, 248, '_товар_0_название', 'field_62436fcce98ea'),
(5730, 248, 'товар_0_описание', 'Упаковка, рассчитанная на&nbsp;1&nbsp;месяц лечения&nbsp;/ для старта терапии'),
(5731, 248, '_товар_0_описание', 'field_62436fe1e98eb'),
(5732, 248, 'товар_0_лицензия', 'РУ: ЛСР-005971/10 от 25.06.2010'),
(5733, 248, '_товар_0_лицензия', 'field_62436ff0e98ec'),
(5734, 248, 'товар_0_изображение', '51'),
(5735, 248, '_товар_0_изображение', 'field_62437045e98ed'),
(5736, 248, 'товар_1_название', 'Урорек 8мг №90'),
(5737, 248, '_товар_1_название', 'field_62436fcce98ea'),
(5738, 248, 'товар_1_описание', 'Выгодная упаковка, рассчитанная на&nbsp;3&nbsp;месяца лечения. Самая доступная стоимость 1&nbsp;дня терапии препаратом Урорек&nbsp;<sup>27</sup>'),
(5739, 248, '_товар_1_описание', 'field_62436fe1e98eb'),
(5740, 248, 'товар_1_лицензия', 'РУ: ЛСР-005971/10 от 25.06.2010'),
(5741, 248, '_товар_1_лицензия', 'field_62436ff0e98ec'),
(5742, 248, 'товар_1_изображение', '53'),
(5743, 248, '_товар_1_изображение', 'field_62437045e98ed'),
(5744, 248, 'товар_2_название', 'Урорек 4мг №30'),
(5745, 248, '_товар_2_название', 'field_62436fcce98ea'),
(5746, 248, 'товар_2_описание', '4&nbsp;мг&nbsp;&mdash; стартовая доза для лечения симптомов ДГПЖ у&nbsp;пациентов с&nbsp;почечной недостаточностью средней степени тяжести<sup>6</sup>'),
(5747, 248, '_товар_2_описание', 'field_62436fe1e98eb'),
(5748, 248, 'товар_2_лицензия', 'РУ: ЛСР-005971/10 от 25.06.2010'),
(5749, 248, '_товар_2_лицензия', 'field_62436ff0e98ec'),
(5750, 248, 'товар_2_изображение', '52'),
(5751, 248, '_товар_2_изображение', 'field_62437045e98ed'),
(5752, 248, 'товар', '3'),
(5753, 248, '_товар', 'field_62436fbde98e9'),
(5754, 248, 'заголовок-4', 'Где купить'),
(5755, 248, '_заголовок-4', 'field_624374f73d8bd'),
(5756, 248, 'изображения', 'a:12:{i:0;s:2:\"63\";i:1;s:2:\"64\";i:2;s:2:\"65\";i:3;s:2:\"66\";i:4;s:2:\"67\";i:5;s:2:\"68\";i:6;s:2:\"69\";i:7;s:2:\"70\";i:8;s:2:\"71\";i:9;s:2:\"72\";i:10;s:2:\"73\";i:11;s:2:\"74\";}'),
(5757, 248, '_изображения', 'field_624375093d8be'),
(5758, 248, 'изображения-4', 'a:12:{i:0;s:2:\"63\";i:1;s:2:\"64\";i:2;s:2:\"65\";i:3;s:2:\"66\";i:4;s:2:\"67\";i:5;s:2:\"68\";i:6;s:2:\"69\";i:7;s:2:\"70\";i:8;s:2:\"71\";i:9;s:2:\"72\";i:10;s:2:\"73\";i:11;s:2:\"74\";}'),
(5759, 248, '_изображения-4', 'field_624375093d8be'),
(5760, 248, 'заголовок-5', 'Способ применения*<sup>6</sup>'),
(5761, 248, '_заголовок-5', 'field_624379bd4756d'),
(5762, 248, 'иконки', 'a:5:{i:0;s:2:\"83\";i:1;s:2:\"84\";i:2;s:2:\"85\";i:3;s:2:\"86\";i:4;s:2:\"87\";}'),
(5763, 248, '_иконки', 'field_624379f24756e'),
(5764, 248, 'текст-5', 'У пациентов с легкой почечной недостаточностью (клиренс креатинина ≥ 50 — ≤ 80 мл/мин) коррекция дозы не требуется. Для лечения пациентов с почечной недостаточностью средней степени тяжести (клиренс креатинина ≥ 30 — < 50 мл/мин) рекомендуется в течение первой недели принимать начальную дозу по 4 мг в сутки, при хорошей индивидуальной переносимости доза может быть увеличена до 8 мг в сутки. Применение препарата для пациентов с тяжелой почечной недостаточностью (клиренс креатинина < 30 мл / мин) не рекомендуется'),
(5765, 248, '_текст-5', 'field_62437a374756f'),
(5766, 248, 'текст_под_кнопкой', '*Более подробные сведения о&nbsp;препарате, особенностях применения, побочных действиях и&nbsp;др. &mdash;&nbsp;см. инструкцию по&nbsp;медицинскому применению лекарственного препарата Урорек, РУ&nbsp;ЛСР-005971/10 от&nbsp;25.06.2010'),
(5767, 248, '_текст_под_кнопкой', 'field_62437a7c47570'),
(5768, 248, 'заголовок-6', 'Препарат Урорек (силодозин) включен в&nbsp;российские и&nbsp;международные клинические рекомендации и&nbsp;стандарты для лечения ряда урологических заболеваний:'),
(5769, 248, '_заголовок-6', 'field_6244117c68bd0'),
(5770, 248, 'список-6_0_ссылка', 'a:3:{s:5:\"title\";s:68:\"Российские клинические рекомендации\";s:3:\"url\";s:1:\"#\";s:6:\"target\";s:0:\"\";}'),
(5771, 248, '_список-6_0_ссылка', 'field_624411ce68bd2'),
(5772, 248, 'список-6_0_описание', '«Доброкачественная гиперплазия предстательной железы», 2020<sup>28</sup>'),
(5773, 248, '_список-6_0_описание', 'field_6244121168bd3'),
(5774, 248, 'список-6_1_ссылка', 'a:3:{s:5:\"title\";s:70:\"Европейские клинические рекомендации\";s:3:\"url\";s:1:\"#\";s:6:\"target\";s:0:\"\";}'),
(5775, 248, '_список-6_1_ссылка', 'field_624411ce68bd2'),
(5776, 248, 'список-6_1_описание', 'глава «Консервативное лечение ненейрогенных симптомов нарушенного мочеиспускания у мужчин, включая доброкачественную простатическую обструкцию», 2021<sup>29</sup>'),
(5777, 248, '_список-6_1_описание', 'field_6244121168bd3'),
(5778, 248, 'список-6_2_ссылка', 'a:3:{s:5:\"title\";s:154:\"Стандарт первичной медико-санитарной помощи при гиперплазии предстательной железы\";s:3:\"url\";s:1:\"#\";s:6:\"target\";s:0:\"\";}'),
(5779, 248, '_список-6_2_ссылка', 'field_624411ce68bd2'),
(5780, 248, 'список-6_2_описание', '09.11.2012<sup>30</sup> / Обновлён 13.04.2015\r\n'),
(5781, 248, '_список-6_2_описание', 'field_6244121168bd3'),
(5782, 248, 'список-6_3_ссылка', 'a:3:{s:5:\"title\";s:122:\"Стандарт специализированной медицинской помощи при задержке мочи\";s:3:\"url\";s:1:\"#\";s:6:\"target\";s:0:\"\";}'),
(5783, 248, '_список-6_3_ссылка', 'field_624411ce68bd2'),
(5784, 248, 'список-6_3_описание', '29.01.2013<sup>31</sup> / Обновлён 06.05.2015\r\n'),
(5785, 248, '_список-6_3_описание', 'field_6244121168bd3'),
(5786, 248, 'список-6_4_ссылка', 'a:3:{s:5:\"title\";s:133:\"Стандарт первичной медико-санитарной помощи при хроническом простатите\";s:3:\"url\";s:1:\"#\";s:6:\"target\";s:0:\"\";}'),
(5787, 248, '_список-6_4_ссылка', 'field_624411ce68bd2'),
(5788, 248, 'список-6_4_описание', '09.11.2012<sup>32</sup> / Обновлён 13.04.2015\r\n'),
(5789, 248, '_список-6_4_описание', 'field_6244121168bd3'),
(5790, 248, 'список-6_5_ссылка', 'a:3:{s:5:\"title\";s:168:\"Стандарт специализированной медицинской помощи при остром простатите, орхите, эпидидимите\";s:3:\"url\";s:1:\"#\";s:6:\"target\";s:0:\"\";}'),
(5791, 248, '_список-6_5_ссылка', 'field_624411ce68bd2'),
(5792, 248, 'список-6_5_описание', '09.11.2012<sup>33</sup> / Обновлён 27.05.2015'),
(5793, 248, '_список-6_5_описание', 'field_6244121168bd3'),
(5794, 248, 'список-6', '6'),
(5795, 248, '_список-6', 'field_624411be68bd1'),
(5796, 248, 'заголовок-7', 'Препарат Урорек (силодозин) зарегистрирован и&nbsp;применяется в&nbsp;разных странах мира Одобрен ЕМА*<sup>34</sup> и&nbsp;FDA**<sup>35</sup>'),
(5797, 248, '_заголовок-7', 'field_624417e3b6088'),
(5798, 248, 'текст', '<p class=\"sOtherCountries__agency\"><span>EMA</span> Европейское медицинское агентство</p>\r\n<p class=\"sOtherCountries__agency\"><span>FDA</span> Управление по&nbsp;санитарному надзору за&nbsp;качеством пищевых продуктов и&nbsp;медикаментов, США</p>'),
(5799, 248, '_текст', 'field_6244182bb6089'),
(5800, 248, 'страны_0_флаг', '105'),
(5801, 248, '_страны_0_флаг', 'field_62441880b608b'),
(5802, 248, 'страны_0_название', 'Япония'),
(5803, 248, '_страны_0_название', 'field_62441899b608c'),
(5804, 248, 'страны_0_год', '2006<sup>36,37</sup>'),
(5805, 248, '_страны_0_год', 'field_624418aab608d'),
(5806, 248, 'страны_1_флаг', '106'),
(5807, 248, '_страны_1_флаг', 'field_62441880b608b'),
(5808, 248, 'страны_1_название', 'США'),
(5809, 248, '_страны_1_название', 'field_62441899b608c'),
(5810, 248, 'страны_1_год', '2008<sup>35</sup>'),
(5811, 248, '_страны_1_год', 'field_624418aab608d'),
(5812, 248, 'страны_2_флаг', '107'),
(5813, 248, '_страны_2_флаг', 'field_62441880b608b'),
(5814, 248, 'страны_2_название', 'Страны ЕС'),
(5815, 248, '_страны_2_название', 'field_62441899b608c'),
(5816, 248, 'страны_2_год', '2010<sup>34</sup>'),
(5817, 248, '_страны_2_год', 'field_624418aab608d'),
(5818, 248, 'страны_3_флаг', '108'),
(5819, 248, '_страны_3_флаг', 'field_62441880b608b'),
(5820, 248, 'страны_3_название', 'Россия'),
(5821, 248, '_страны_3_название', 'field_62441899b608c'),
(5822, 248, 'страны_3_год', '2010<sup>1</sup>'),
(5823, 248, '_страны_3_год', 'field_624418aab608d'),
(5824, 248, 'страны', '4'),
(5825, 248, '_страны', 'field_62441847b608a'),
(5826, 248, 'текст-7', '<p class=\"sOtherCountries__agency\"><span>EMA</span> Европейское медицинское агентство</p>\r\n<p class=\"sOtherCountries__agency\"><span>FDA</span> Управление по&nbsp;санитарному надзору за&nbsp;качеством пищевых продуктов и&nbsp;медикаментов, США</p>'),
(5827, 248, '_текст-7', 'field_6244182bb6089'),
(5828, 248, 'текст-7-1', 'Производство препарата Урорек, поставляемого в&nbsp;Россию, осуществляется в&nbsp;Италии с&nbsp;использованием субстанции из&nbsp;Японии, в&nbsp;соответствии с&nbsp;необходимыми требованиями к&nbsp;производству и&nbsp;контролю качества<sup>6,1</sup>'),
(5829, 248, '_текст-7-1', 'field_62441a5acf03c'),
(5830, 248, 'заголовок-8', 'О проблеме'),
(5831, 248, '_заголовок-8', 'field_624431d91624d'),
(5832, 248, 'текст-8', 'Доброкачественная гиперплазия предстательной железы (ДГПЖ), или как ее еще называют, аденома простаты, как правило, возникает у мужчин старше 50 лет и характеризуется наличием симптомов нижних мочевыводящих путей (СНМП), увеличением предстательной железы или ее части, и нарушением оттока мочи из мочевого пузыря вследствие инфравезикальной обструкции.<sup>38</sup>\r\n\r\nРаспространенность ДГПЖ увеличивается с возрастом. Так, клинически значимая ДГПЖ проявляется у 13% мужчин в возрасте старше 50 лет, у 34% мужчин в возрасте 60 лет и у 43% в возрасте 70 лет.<sup>39</sup>\r\n\r\n&nbsp;\r\n\r\n<img class=\"alignnone wp-image-122 size-full\" src=\"http://0026urotec.loc:8888/wp-content/uploads/2022/03/about-img.png\" alt=\"\" width=\"594\" height=\"696\" />'),
(5833, 248, '_текст-8', 'field_624431f11624e'),
(5834, 248, 'текст-8-1', 'Наличие СНМП может быть ассоциировано с&nbsp;тяжелыми хроническими заболеваниями, такими как заболевания сердца, сахарный диабет, артериальная гипертензия и&nbsp;депрессия<sup>40</sup>'),
(5835, 248, '_текст-8-1', 'field_6244320b26db3'),
(5836, 248, 'иконки-8', 'a:6:{i:0;s:3:\"123\";i:1;s:3:\"124\";i:2;s:3:\"125\";i:3;s:3:\"126\";i:4;s:3:\"127\";i:5;s:3:\"128\";}'),
(5837, 248, '_иконки-8', 'field_6244322d26db4'),
(5838, 248, 'текст-8-2', '<h3>Симптомы доброкачественной гиперплазии предстательной железы</h3>\r\nСимптомы нарушенного мочеиспускания являются частой жалобой у взрослых мужчин. Они оказывают серьезное негативное влияние на качество жизни. При ДГПЖ предстательная железа увеличивается в размерах, оказывая давление на нижние мочевые пути. В результате развиваются следующие симптомы:<sup>41</sup>'),
(5839, 248, '_текст-8-2', 'field_6244335fe2373'),
(5840, 248, 'заголовок-9', 'Осложнения ДГПЖ<sup>38</sup>'),
(5841, 248, '_заголовок-9', 'field_6244377a52263'),
(5842, 248, 'изображения-9', 'a:6:{i:0;s:3:\"141\";i:1;s:3:\"142\";i:2;s:3:\"143\";i:3;s:3:\"144\";i:4;s:3:\"145\";i:5;s:3:\"146\";}'),
(5843, 248, '_изображения-9', 'field_6244379652264'),
(5844, 248, 'заголовок-10', 'Медикаментозное лечение СНМП/ДГПЖ'),
(5845, 248, '_заголовок-10', 'field_6244489614262'),
(5846, 248, 'текст-10', 'Антагонисты альфа1-адренорецепторов (альфа-адреноблокаторы) и&nbsp;ингибиторы 5&nbsp;альфа1-редуктазы (ингибиторы 5-АР) являются группами лекарственных препаратов, которые в&nbsp;настоящее время утверждены для лечения ДГПЖ. Обе группы препаратов обеспечивают надлежащее ослабление симптомов, но&nbsp;&alpha;&mdash;блокаторы обладают довольно быстрым началом действия, а&nbsp;ингибиторам 5-АР требуется несколько месяцев для получения терапевтического эффекта.<sup>42</sup>'),
(5847, 248, '_текст-10', 'field_624448ce14263'),
(5848, 248, 'карточки-10_0_заголовок', 'Альфа-адреноблокаторы'),
(5849, 248, '_карточки-10_0_заголовок', 'field_624448fc14265'),
(5850, 248, 'карточки-10_0_текст', 'представляют собой наиболее эффективный класс лекарственных препаратов, характеризующийся хорошим профилем безопасности и высокой комплаентностью, применяющийся для облегчения СНМП, связанных с ДГПЖ: они снимают спазм гладкой мускулатуры предстательной железы и шейки мочевого пузыря<sup>42</sup>'),
(5851, 248, '_карточки-10_0_текст', 'field_6244490c14266'),
(5852, 248, 'карточки-10_1_заголовок', 'Ингибиторы 5-АР'),
(5853, 248, '_карточки-10_1_заголовок', 'field_624448fc14265'),
(5854, 248, 'карточки-10_1_текст', 'приводят к редукции железистой ткани и к снижению размера предстательной железы: они блокируют конверсию тестостерона в дигидротестостерон, который стимулирует рост предстательной железы<sup>43,44</sup>.Назначаются при большом объеме предстательной железы. Для получения значимого клинического эффекта требуется несколько месяцев применения<sup>45</sup>\r\n'),
(5855, 248, '_карточки-10_1_текст', 'field_6244490c14266'),
(5856, 248, 'карточки-10', '2'),
(5857, 248, '_карточки-10', 'field_624448e214264'),
(5858, 248, 'видео', '<iframe width=\"560\" height=\"315\" src=\"https://www.youtube.com/embed/3DrU3pFXSsY\" title=\"YouTube video player\" frameborder=\"0\" allow=\"accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture\" allowfullscreen></iframe>'),
(5859, 248, '_видео', 'field_6244492214267'),
(5860, 248, 'заголовок-11', 'Часто задаваемые вопросы'),
(5861, 248, '_заголовок-11', 'field_62444b33e25d6'),
(5862, 248, 'вопросы_0_заголовок', 'Почему при приеме препарата Урорек у некоторых пациентов развивается нарушение эякуляции?'),
(5863, 248, '_вопросы_0_заголовок', 'field_62444b58e25d8'),
(5864, 248, 'вопросы_0_текст', 'Урорек — высокоселективный препарат, то есть преимущественно действует на альфа1А-адренорецепторы, которые находятся в нижних мочевых путях, предстательной железе и семенных пузырьках. Поэтому эффект развивается уже через 2–6 часов после приёма первой дозы препарата Урорек<sup>14</sup> при минимальным количестве нежелательных явлений.<sup>5</sup>\r\n\r\nНаиболее частый побочный эффект при приеме препарата Урорек — нарушение эякуляции<sup>46</sup>. Это может быть связано как с забросом эякулята при семяизвержении вместо уретры в мочевой пузырь, так и со снижением или отсутствием семенной жидкости во время эякуляции<sup>29</sup>. Силодозин снижает тонус гладкомышечных клеток семенных пузырьков, простаты и шейки мочевого пузыря, поэтому не происходит выброс семени. Этот эффект свойственен всем уроселективным альфа-адреноблокаторам<sup>53</sup> и самостоятельно исчезает после прекращения приема препарата.<sup>6</sup>\r\n\r\nЧастота эякуляторной дисфункции прямо пропорционально связана с улучшением СНМП и скорости мочеиспускания и подтверждает эффективность альфа-адреноблокатора: чем выше эффективность, тем выше частота встречаемости эякуляторной дисфункции.<sup>29</sup>\r\n\r\nНарушение эякуляции не влияет на сексуальную функцию<sup>52</sup>, не воспринимается как беспокоящий симптом подавляющим большинством пациентов и не требует отмены терапии.<sup>46</sup>'),
(5865, 248, '_вопросы_0_текст', 'field_62444b66e25d9'),
(5866, 248, 'вопросы_1_заголовок', 'Можно ли принимать Урорек при артериальной гипертензии и ишемический болезни сердца (ИБС)?'),
(5867, 248, '_вопросы_1_заголовок', 'field_62444b58e25d8'),
(5868, 248, 'вопросы_1_текст', 'Согласно инструкции по медицинскому применению, противопоказаний для применения лекарственного препарата Урорек у пациентов с СНМП/ДГПЖ и сопутствующими сердечно-сосудистыми заболеваниями нет.<sup>3</sup> Урорек не оказывает влияния на частоту сердечных сокращений (ЧСС), систолическое артериальное давление (САД) и диастолическое артериальное давление (ДАД).<sup>9</sup> Силодозин — не вызывает клинически значимого снижения артериального давления (АД)<sup>46</sup>, не усиливает действие антигипертензивных препаратов и не требует снижения дозы при одновременном приеме.<sup>7</sup> В соответствии с дизайном клинического исследования многие пациенты получали сопутствующую терапию антигипертензивными препаратами (в основном, средствами, воздействующими на ренин-ангиотензиновую систему, бета-блокаторами, антагонистами кальция и диуретиками) без повышения частоты ортостатической гипотензии.<sup>6</sup>\r\n\r\nПри приеме препарата Урорек наиболее низкий риск развития сердечно-сосудистых осложнений.<sup>5</sup>'),
(5869, 248, '_вопросы_1_текст', 'field_62444b66e25d9'),
(5870, 248, 'вопросы_2_заголовок', 'Можно ли принимать Урорек пациенту с ортостатической гипотензией в анамнезе?'),
(5871, 248, '_вопросы_2_заголовок', 'field_62444b58e25d8'),
(5872, 248, 'вопросы_2_текст', 'Повышенная селективность силодозина к альфа1A-адренорецепторам по сравнению с альфа1B-адренорецепторами выражается в пониженном риске развития сердечно-сосудистых осложнений.<sup>4</sup> Благодаря этому частота ортостатической гипотензии на фоне его приема сравнима с таковой при приеме плацебо.<sup>45,9</sup>\r\n\r\nВ отличие от других альфа-адреноблокаторов (например, все формы тамсулозина<sup>47,48</sup>), Урорек не противопоказан к приему у пациентов с ортостатической гипотензией в анамнезе. Тем не менее, пациентам с ортостатической гипотензией в анамнезе не рекомендуется принимать любые альфа-адреноблокаторы, в т.ч. Урорек.<sup>6</sup>'),
(5873, 248, '_вопросы_2_текст', 'field_62444b66e25d9'),
(5874, 248, 'вопросы_3_заголовок', 'Как долго можно принимать Урорек?'),
(5875, 248, '_вопросы_3_заголовок', 'field_62444b58e25d8'),
(5876, 248, 'вопросы_3_текст', 'Учитывая прогрессирующий характер течения доброкачественной гиперплазии предстательной железы, медикаментозную терапию следует проводить длительно (иногда в течение всей жизни пациента).<sup>49</sup>'),
(5877, 248, '_вопросы_3_текст', 'field_62444b66e25d9'),
(5878, 248, 'вопросы_4_заголовок', 'Пациенты жалуются на заложенность носа при лечении альфа-адреноблокаторами. Есть ли у препарата Урорек такое побочное действие?'),
(5879, 248, '_вопросы_4_заголовок', 'field_62444b58e25d8'),
(5880, 248, 'вопросы_4_текст', 'Заложенность носа — это возможный побочный эффект для всех альфа-адреноблокаторов. При приеме препарата Урорек он может возникать примерно в 1% случаев.<sup>46</sup>'),
(5881, 248, '_вопросы_4_текст', 'field_62444b66e25d9'),
(5882, 248, 'вопросы_5_заголовок', 'Можно ли начинать лечение препаратом Урорек с дозы 4 мг в сутки?'),
(5883, 248, '_вопросы_5_заголовок', 'field_62444b58e25d8'),
(5884, 248, 'вопросы_5_текст', 'Согласно инструкции по медицинскому применению лекарственного препарата Урорек, доза 8 мг в сутки рекомендована для лечения пациентов с СНМП/ДГПЖ. Титрование дозы при применении силодозина не требуется.\r\n\r\nУрорек 4 мг — это специальная доза для лечения пациентов с почечной недостаточностью средней степени тяжести (клиренс креатинина ≥ 30 до &lt; 50 мл/мин). Рекомендуется в течение первой недели принимать начальную дозу по 4 мг в сутки, далее при хорошей переносимости доза может быть увеличена до 8 мг в сутки.<sup>6</sup>**Более подробные сведения о препарате, особенностях применения, побочных действиях и др. — см. инструкцию по медицинскому применению лекарственного препарата Урорек, РУ ЛСР-005971/10 от 25.06.2010'),
(5885, 248, '_вопросы_5_текст', 'field_62444b66e25d9'),
(5886, 248, 'вопросы_6_заголовок', 'Влияет ли Урорек на течение ДГПЖ или только снимает симптомы нижних мочевыводящих путей?'),
(5887, 248, '_вопросы_6_заголовок', 'field_62444b58e25d8'),
(5888, 248, 'вопросы_6_текст', 'Помимо субъективных симптомов, ДГПЖ вызывает прогрессирующее морфологическое ремоделирование мочевого пузыря с риском развития серьезных функциональных нарушений. Лечение должно не только купировать субъективные симптомы, но и включать профилактику патологического ремоделирования мочевого пузыря.<sup>161</sup>\r\n\r\nСилодозин, действующее вещество препарата Урорек, в сравнении с другими альфа-адреноблокаторами более эффективно влияет на инфравезикальную обструкцию (ИВО), что оказывает влияние на предотвращение патологического прогрессирования ремоделирования мочевого пузыря и риск развития серьезных функциональных нарушений.<sup>50,51</sup>'),
(5889, 248, '_вопросы_6_текст', 'field_62444b66e25d9'),
(5890, 248, 'вопросы_7_заголовок', 'Доступен ли Урорек по льготному отпуску?'),
(5891, 248, '_вопросы_7_заголовок', 'field_62444b58e25d8'),
(5892, 248, 'вопросы_7_текст', 'Урорек (силодозин) не включен в список жизненно важных лекарственных препаратов (ЖНВЛП)<sup>1</sup> и не входит в перечень препаратов для льготного обеспечения граждан по федеральному льготному списку.'),
(5893, 248, '_вопросы_7_текст', 'field_62444b66e25d9'),
(5894, 248, 'вопросы', '8'),
(5895, 248, '_вопросы', 'field_62444b49e25d7'),
(5896, 249, 'заголовок-1', 'УРОРЕК – оригинальный<sup>10</sup> альфа-адреноблокатор'),
(5897, 249, '_заголовок-1', 'field_62435bd26f29f'),
(5898, 249, 'текст-1', '<div class=\"headerBlock__body\">\r\n<p>Силодозин (действующее вещество препарата Урорек) обладает максимальной уроселективностью в&nbsp;своем классе, что обеспечивает его уродинамическую эффективность и&nbsp;высокую безопасность<sup>4</sup></p>\r\n</div>\r\n<div class=\"headerBlock__footer\">\r\n<p><strong>Показания к применению: </strong><br/>Лечение симптомов доброкачественной гиперплазии предстательной железы<sup>6</sup></p>\r\n</div>'),
(5899, 249, '_текст-1', 'field_62435c0c6f2a0'),
(5900, 249, 'изображение-1', '13'),
(5901, 249, '_изображение-1', 'field_62435c8b6f2a1'),
(5902, 249, 'фон-1', '17'),
(5903, 249, '_фон-1', 'field_62435db92ea96'),
(5904, 249, 'заголовок-2', 'Ключевые преимущества препарата Урорек'),
(5905, 249, '_заголовок-2', 'field_6243606295196'),
(5906, 249, 'список-2', 'Единственный оригинальный препарат из&nbsp;группы альфа1-адреноблокаторов, не&nbsp;имеющий генериков в&nbsp;РФ<sup>1</sup>'),
(5907, 249, '_список-2', 'field_6243608195197'),
(5908, 249, 'картинка_с_текстом_0_изображение', '31'),
(5909, 249, '_картинка_с_текстом_0_изображение', 'field_624363d095199'),
(5910, 249, 'картинка_с_текстом_0_описание', 'Обширная доказательная база собственных пострегистрационных клинических исследований<sup>2</sup>'),
(5911, 249, '_картинка_с_текстом_0_описание', 'field_624363e59519a'),
(5912, 249, 'картинка_с_текстом_1_изображение', '32'),
(5913, 249, '_картинка_с_текстом_1_изображение', 'field_624363d095199'),
(5914, 249, 'картинка_с_текстом_1_описание', 'Отсутствие риска замены препарата Урорек в&nbsp;аптеке (единственный препарат с&nbsp;действующим веществом силодозин)<sup>1</sup>'),
(5915, 249, '_картинка_с_текстом_1_описание', 'field_624363e59519a'),
(5916, 249, 'картинка_с_текстом_2_изображение', '33'),
(5917, 249, '_картинка_с_текстом_2_изображение', 'field_624363d095199'),
(5918, 249, 'картинка_с_текстом_2_описание', 'Большинство пациентов предпочитают принимать оригинальные препараты<sup>3</sup>'),
(5919, 249, '_картинка_с_текстом_2_описание', 'field_624363e59519a'),
(5920, 249, 'картинка_с_текстом', '3'),
(5921, 249, '_картинка_с_текстом', 'field_624363b995198'),
(5922, 249, 'второй_список', '<li>Клинические преимущества препарата Урорек (силодозин) определяются максимальной уроселективностью в&nbsp;классе альфа-адреноблокаторов<sup>4</sup></li>\r\n\r\n<li>Урорек&nbsp;&mdash; альфа-адреноблокатор последнего поколения, который эффективен в&nbsp;отношении всех СНМП (накопления, опорожнения, постмиктурических).<sup>12,13</sup> При этом Урорек обладает минимальным риском развития нежелательных явлений со&nbsp;стороны сердечно-сосудистой системы, в&nbsp;том числе&nbsp;у&nbsp;пациентов, принимающих антигипертензивные препараты<sup>46,8</sup> <small> <span>СНМП </span>симптомы нижних мочевыводящих путей</small></li>'),
(5923, 249, '_второй_список', 'field_6243640e05eda'),
(5924, 249, 'заголовок2-2', 'Максимальная уроселективность силодозина в&nbsp;классе альфа-адреноблокаторов обуславливает его уродинамическую эффективность и&nbsp;высокий профиль безопасности<sup>4</sup>'),
(5925, 249, '_заголовок2-2', 'field_6243644705edb'),
(5926, 249, 'текст3', '<ul>\r\n<li>Урорек значительно улучшает клинические проявления и&nbsp;качество жизни у&nbsp;всех пациентов с&nbsp;СНМП/ДГПЖ, в&nbsp;том числе с&nbsp;тяжелым течением<sup>11</sup>\r\n<a href=\"#modal-call-first\" class=\"link-modal-js\">Узнать больше...</a></li>\r\n\r\n<li>Урорек является препаратом выбора для пациентов с&nbsp;СНМП/ДГПЖ и&nbsp;сопутствующими сердечно-сосудистыми заболеваниями<sup>3</sup> \r\n<a href=\"#modal-call-second\" class=\"link-modal-js\">Узнать больше...</a></li>\r\n</ul>\r\n<small> <span>ДГПЖ </span>доброкачественная гиперплазия предстательной железы</small>'),
(5927, 249, '_текст3', 'field_6243647405edc'),
(5928, 249, 'изображение-2', '34'),
(5929, 249, '_изображение-2', 'field_624364dd05edd'),
(5930, 249, 'текст_в_подвале', '<h2> Максимальная уроселективность в&nbsp;классе  альфа-адреноблокаторов<sup>4</sup></h2>\r\n<div class=\"h3\"> Почему это важно? <a href=\"#modal-call-second\" class=\"link-modal-js\">Подробнее</a></div>'),
(5931, 249, '_текст_в_подвале', 'field_62436daf1f6d9'),
(5932, 249, 'заголовок-3', 'Форма выпуска препарата Урорек'),
(5933, 249, '_заголовок-3', 'field_62436efee98e7'),
(5934, 249, 'текст-3', '<p class=\"section-descr\"><span>8мг </span>- рекомендуемая доза для лечения симптомов ДГПЖ<sup>6</sup>*</p>\r\n					<p class=\"section-note col-md-10\">*Более подробные сведения о&nbsp;препарате, особенностях применения, побочных действиях и&nbsp;др. &mdash;&nbsp;смотрите инструкцию по&nbsp;медицинскому применению лекарственного препарата Урорек, РУ&nbsp;ЛСР-005971/10 от&nbsp;25.06.2010 </p>'),
(5935, 249, '_текст-3', 'field_62436f60e98e8'),
(5936, 249, 'товар_0_название', 'Урорек 8мг №30'),
(5937, 249, '_товар_0_название', 'field_62436fcce98ea'),
(5938, 249, 'товар_0_описание', 'Упаковка, рассчитанная на&nbsp;1&nbsp;месяц лечения&nbsp;/ для старта терапии'),
(5939, 249, '_товар_0_описание', 'field_62436fe1e98eb'),
(5940, 249, 'товар_0_лицензия', 'РУ: ЛСР-005971/10 от 25.06.2010'),
(5941, 249, '_товар_0_лицензия', 'field_62436ff0e98ec'),
(5942, 249, 'товар_0_изображение', '51'),
(5943, 249, '_товар_0_изображение', 'field_62437045e98ed'),
(5944, 249, 'товар_1_название', 'Урорек 8мг №90'),
(5945, 249, '_товар_1_название', 'field_62436fcce98ea'),
(5946, 249, 'товар_1_описание', 'Выгодная упаковка, рассчитанная на&nbsp;3&nbsp;месяца лечения. Самая доступная стоимость 1&nbsp;дня терапии препаратом Урорек&nbsp;<sup>27</sup>'),
(5947, 249, '_товар_1_описание', 'field_62436fe1e98eb'),
(5948, 249, 'товар_1_лицензия', 'РУ: ЛСР-005971/10 от 25.06.2010'),
(5949, 249, '_товар_1_лицензия', 'field_62436ff0e98ec'),
(5950, 249, 'товар_1_изображение', '53'),
(5951, 249, '_товар_1_изображение', 'field_62437045e98ed'),
(5952, 249, 'товар_2_название', 'Урорек 4мг №30'),
(5953, 249, '_товар_2_название', 'field_62436fcce98ea'),
(5954, 249, 'товар_2_описание', '4&nbsp;мг&nbsp;&mdash; стартовая доза для лечения симптомов ДГПЖ у&nbsp;пациентов с&nbsp;почечной недостаточностью средней степени тяжести<sup>6</sup>'),
(5955, 249, '_товар_2_описание', 'field_62436fe1e98eb'),
(5956, 249, 'товар_2_лицензия', 'РУ: ЛСР-005971/10 от 25.06.2010'),
(5957, 249, '_товар_2_лицензия', 'field_62436ff0e98ec'),
(5958, 249, 'товар_2_изображение', '52'),
(5959, 249, '_товар_2_изображение', 'field_62437045e98ed'),
(5960, 249, 'товар', '3'),
(5961, 249, '_товар', 'field_62436fbde98e9'),
(5962, 249, 'заголовок-4', 'Где купить'),
(5963, 249, '_заголовок-4', 'field_624374f73d8bd'),
(5964, 249, 'изображения', 'a:12:{i:0;s:2:\"63\";i:1;s:2:\"64\";i:2;s:2:\"65\";i:3;s:2:\"66\";i:4;s:2:\"67\";i:5;s:2:\"68\";i:6;s:2:\"69\";i:7;s:2:\"70\";i:8;s:2:\"71\";i:9;s:2:\"72\";i:10;s:2:\"73\";i:11;s:2:\"74\";}'),
(5965, 249, '_изображения', 'field_624375093d8be'),
(5966, 249, 'изображения-4', 'a:12:{i:0;s:2:\"63\";i:1;s:2:\"64\";i:2;s:2:\"65\";i:3;s:2:\"66\";i:4;s:2:\"67\";i:5;s:2:\"68\";i:6;s:2:\"69\";i:7;s:2:\"70\";i:8;s:2:\"71\";i:9;s:2:\"72\";i:10;s:2:\"73\";i:11;s:2:\"74\";}'),
(5967, 249, '_изображения-4', 'field_624375093d8be'),
(5968, 249, 'заголовок-5', 'Способ применения*<sup>6</sup>'),
(5969, 249, '_заголовок-5', 'field_624379bd4756d'),
(5970, 249, 'иконки', 'a:5:{i:0;s:2:\"83\";i:1;s:2:\"84\";i:2;s:2:\"85\";i:3;s:2:\"86\";i:4;s:2:\"87\";}'),
(5971, 249, '_иконки', 'field_624379f24756e'),
(5972, 249, 'текст-5', 'У пациентов с легкой почечной недостаточностью (клиренс креатинина ≥ 50 — ≤ 80 мл/мин) коррекция дозы не требуется. Для лечения пациентов с почечной недостаточностью средней степени тяжести (клиренс креатинина ≥ 30 — < 50 мл/мин) рекомендуется в течение первой недели принимать начальную дозу по 4 мг в сутки, при хорошей индивидуальной переносимости доза может быть увеличена до 8 мг в сутки. Применение препарата для пациентов с тяжелой почечной недостаточностью (клиренс креатинина < 30 мл / мин) не рекомендуется'),
(5973, 249, '_текст-5', 'field_62437a374756f'),
(5974, 249, 'текст_под_кнопкой', '*Более подробные сведения о&nbsp;препарате, особенностях применения, побочных действиях и&nbsp;др. &mdash;&nbsp;см. инструкцию по&nbsp;медицинскому применению лекарственного препарата Урорек, РУ&nbsp;ЛСР-005971/10 от&nbsp;25.06.2010'),
(5975, 249, '_текст_под_кнопкой', 'field_62437a7c47570'),
(5976, 249, 'заголовок-6', 'Препарат Урорек (силодозин) включен в&nbsp;российские и&nbsp;международные клинические рекомендации и&nbsp;стандарты для лечения ряда урологических заболеваний:'),
(5977, 249, '_заголовок-6', 'field_6244117c68bd0'),
(5978, 249, 'список-6_0_ссылка', 'a:3:{s:5:\"title\";s:68:\"Российские клинические рекомендации\";s:3:\"url\";s:1:\"#\";s:6:\"target\";s:0:\"\";}'),
(5979, 249, '_список-6_0_ссылка', 'field_624411ce68bd2'),
(5980, 249, 'список-6_0_описание', '«Доброкачественная гиперплазия предстательной железы», 2020<sup>28</sup>'),
(5981, 249, '_список-6_0_описание', 'field_6244121168bd3'),
(5982, 249, 'список-6_1_ссылка', 'a:3:{s:5:\"title\";s:70:\"Европейские клинические рекомендации\";s:3:\"url\";s:1:\"#\";s:6:\"target\";s:0:\"\";}'),
(5983, 249, '_список-6_1_ссылка', 'field_624411ce68bd2'),
(5984, 249, 'список-6_1_описание', 'глава «Консервативное лечение ненейрогенных симптомов нарушенного мочеиспускания у мужчин, включая доброкачественную простатическую обструкцию», 2021<sup>29</sup>'),
(5985, 249, '_список-6_1_описание', 'field_6244121168bd3'),
(5986, 249, 'список-6_2_ссылка', 'a:3:{s:5:\"title\";s:154:\"Стандарт первичной медико-санитарной помощи при гиперплазии предстательной железы\";s:3:\"url\";s:1:\"#\";s:6:\"target\";s:0:\"\";}'),
(5987, 249, '_список-6_2_ссылка', 'field_624411ce68bd2'),
(5988, 249, 'список-6_2_описание', '09.11.2012<sup>30</sup> / Обновлён 13.04.2015\r\n'),
(5989, 249, '_список-6_2_описание', 'field_6244121168bd3'),
(5990, 249, 'список-6_3_ссылка', 'a:3:{s:5:\"title\";s:122:\"Стандарт специализированной медицинской помощи при задержке мочи\";s:3:\"url\";s:1:\"#\";s:6:\"target\";s:0:\"\";}'),
(5991, 249, '_список-6_3_ссылка', 'field_624411ce68bd2'),
(5992, 249, 'список-6_3_описание', '29.01.2013<sup>31</sup> / Обновлён 06.05.2015\r\n'),
(5993, 249, '_список-6_3_описание', 'field_6244121168bd3'),
(5994, 249, 'список-6_4_ссылка', 'a:3:{s:5:\"title\";s:133:\"Стандарт первичной медико-санитарной помощи при хроническом простатите\";s:3:\"url\";s:1:\"#\";s:6:\"target\";s:0:\"\";}'),
(5995, 249, '_список-6_4_ссылка', 'field_624411ce68bd2'),
(5996, 249, 'список-6_4_описание', '09.11.2012<sup>32</sup> / Обновлён 13.04.2015\r\n'),
(5997, 249, '_список-6_4_описание', 'field_6244121168bd3'),
(5998, 249, 'список-6_5_ссылка', 'a:3:{s:5:\"title\";s:168:\"Стандарт специализированной медицинской помощи при остром простатите, орхите, эпидидимите\";s:3:\"url\";s:1:\"#\";s:6:\"target\";s:0:\"\";}'),
(5999, 249, '_список-6_5_ссылка', 'field_624411ce68bd2'),
(6000, 249, 'список-6_5_описание', '09.11.2012<sup>33</sup> / Обновлён 27.05.2015'),
(6001, 249, '_список-6_5_описание', 'field_6244121168bd3'),
(6002, 249, 'список-6', '6'),
(6003, 249, '_список-6', 'field_624411be68bd1'),
(6004, 249, 'заголовок-7', 'Препарат Урорек (силодозин) зарегистрирован и&nbsp;применяется в&nbsp;разных странах мира Одобрен ЕМА*<sup>34</sup> и&nbsp;FDA**<sup>35</sup>'),
(6005, 249, '_заголовок-7', 'field_624417e3b6088'),
(6006, 249, 'текст', '<p class=\"sOtherCountries__agency\"><span>EMA</span> Европейское медицинское агентство</p>\r\n<p class=\"sOtherCountries__agency\"><span>FDA</span> Управление по&nbsp;санитарному надзору за&nbsp;качеством пищевых продуктов и&nbsp;медикаментов, США</p>'),
(6007, 249, '_текст', 'field_6244182bb6089'),
(6008, 249, 'страны_0_флаг', '105'),
(6009, 249, '_страны_0_флаг', 'field_62441880b608b'),
(6010, 249, 'страны_0_название', 'Япония'),
(6011, 249, '_страны_0_название', 'field_62441899b608c'),
(6012, 249, 'страны_0_год', '2006<sup>36,37</sup>'),
(6013, 249, '_страны_0_год', 'field_624418aab608d'),
(6014, 249, 'страны_1_флаг', '106'),
(6015, 249, '_страны_1_флаг', 'field_62441880b608b'),
(6016, 249, 'страны_1_название', 'США'),
(6017, 249, '_страны_1_название', 'field_62441899b608c'),
(6018, 249, 'страны_1_год', '2008<sup>35</sup>'),
(6019, 249, '_страны_1_год', 'field_624418aab608d'),
(6020, 249, 'страны_2_флаг', '107'),
(6021, 249, '_страны_2_флаг', 'field_62441880b608b'),
(6022, 249, 'страны_2_название', 'Страны ЕС'),
(6023, 249, '_страны_2_название', 'field_62441899b608c'),
(6024, 249, 'страны_2_год', '2010<sup>34</sup>');
INSERT INTO `urotec_postmeta` (`meta_id`, `post_id`, `meta_key`, `meta_value`) VALUES
(6025, 249, '_страны_2_год', 'field_624418aab608d'),
(6026, 249, 'страны_3_флаг', '108'),
(6027, 249, '_страны_3_флаг', 'field_62441880b608b'),
(6028, 249, 'страны_3_название', 'Россия'),
(6029, 249, '_страны_3_название', 'field_62441899b608c'),
(6030, 249, 'страны_3_год', '2010<sup>1</sup>'),
(6031, 249, '_страны_3_год', 'field_624418aab608d'),
(6032, 249, 'страны', '4'),
(6033, 249, '_страны', 'field_62441847b608a'),
(6034, 249, 'текст-7', '<p class=\"sOtherCountries__agency\"><span>EMA</span> Европейское медицинское агентство</p>\r\n<p class=\"sOtherCountries__agency\"><span>FDA</span> Управление по&nbsp;санитарному надзору за&nbsp;качеством пищевых продуктов и&nbsp;медикаментов, США</p>'),
(6035, 249, '_текст-7', 'field_6244182bb6089'),
(6036, 249, 'текст-7-1', 'Производство препарата Урорек, поставляемого в&nbsp;Россию, осуществляется в&nbsp;Италии с&nbsp;использованием субстанции из&nbsp;Японии, в&nbsp;соответствии с&nbsp;необходимыми требованиями к&nbsp;производству и&nbsp;контролю качества<sup>6,1</sup>'),
(6037, 249, '_текст-7-1', 'field_62441a5acf03c'),
(6038, 249, 'заголовок-8', 'О проблеме'),
(6039, 249, '_заголовок-8', 'field_624431d91624d'),
(6040, 249, 'текст-8', 'Доброкачественная гиперплазия предстательной железы (ДГПЖ), или как ее еще называют, аденома простаты, как правило, возникает у мужчин старше 50 лет и характеризуется наличием симптомов нижних мочевыводящих путей (СНМП), увеличением предстательной железы или ее части, и нарушением оттока мочи из мочевого пузыря вследствие инфравезикальной обструкции.<sup>38</sup>\r\n\r\nРаспространенность ДГПЖ увеличивается с возрастом. Так, клинически значимая ДГПЖ проявляется у 13% мужчин в возрасте старше 50 лет, у 34% мужчин в возрасте 60 лет и у 43% в возрасте 70 лет.<sup>39</sup>\r\n\r\n&nbsp;\r\n\r\n<img class=\"alignnone wp-image-122 size-full\" src=\"http://0026urotec.loc:8888/wp-content/uploads/2022/03/about-img.png\" alt=\"\" width=\"594\" height=\"696\" />'),
(6041, 249, '_текст-8', 'field_624431f11624e'),
(6042, 249, 'текст-8-1', 'Наличие СНМП может быть ассоциировано с&nbsp;тяжелыми хроническими заболеваниями, такими как заболевания сердца, сахарный диабет, артериальная гипертензия и&nbsp;депрессия<sup>40</sup>'),
(6043, 249, '_текст-8-1', 'field_6244320b26db3'),
(6044, 249, 'иконки-8', 'a:6:{i:0;s:3:\"123\";i:1;s:3:\"124\";i:2;s:3:\"125\";i:3;s:3:\"126\";i:4;s:3:\"127\";i:5;s:3:\"128\";}'),
(6045, 249, '_иконки-8', 'field_6244322d26db4'),
(6046, 249, 'текст-8-2', '<h3>Симптомы доброкачественной гиперплазии предстательной железы</h3>\r\nСимптомы нарушенного мочеиспускания являются частой жалобой у взрослых мужчин. Они оказывают серьезное негативное влияние на качество жизни. При ДГПЖ предстательная железа увеличивается в размерах, оказывая давление на нижние мочевые пути. В результате развиваются следующие симптомы:<sup>41</sup>'),
(6047, 249, '_текст-8-2', 'field_6244335fe2373'),
(6048, 249, 'заголовок-9', 'Осложнения ДГПЖ<sup>38</sup>'),
(6049, 249, '_заголовок-9', 'field_6244377a52263'),
(6050, 249, 'изображения-9', 'a:6:{i:0;s:3:\"141\";i:1;s:3:\"142\";i:2;s:3:\"143\";i:3;s:3:\"144\";i:4;s:3:\"145\";i:5;s:3:\"146\";}'),
(6051, 249, '_изображения-9', 'field_6244379652264'),
(6052, 249, 'заголовок-10', 'Медикаментозное лечение СНМП/ДГПЖ'),
(6053, 249, '_заголовок-10', 'field_6244489614262'),
(6054, 249, 'текст-10', 'Антагонисты альфа1-адренорецепторов (альфа-адреноблокаторы) и&nbsp;ингибиторы 5&nbsp;альфа1-редуктазы (ингибиторы 5-АР) являются группами лекарственных препаратов, которые в&nbsp;настоящее время утверждены для лечения ДГПЖ. Обе группы препаратов обеспечивают надлежащее ослабление симптомов, но&nbsp;&alpha;&mdash;блокаторы обладают довольно быстрым началом действия, а&nbsp;ингибиторам 5-АР требуется несколько месяцев для получения терапевтического эффекта.<sup>42</sup>'),
(6055, 249, '_текст-10', 'field_624448ce14263'),
(6056, 249, 'карточки-10_0_заголовок', 'Альфа-адреноблокаторы'),
(6057, 249, '_карточки-10_0_заголовок', 'field_624448fc14265'),
(6058, 249, 'карточки-10_0_текст', 'представляют собой наиболее эффективный класс лекарственных препаратов, характеризующийся хорошим профилем безопасности и высокой комплаентностью, применяющийся для облегчения СНМП, связанных с ДГПЖ: они снимают спазм гладкой мускулатуры предстательной железы и шейки мочевого пузыря<sup>42</sup>'),
(6059, 249, '_карточки-10_0_текст', 'field_6244490c14266'),
(6060, 249, 'карточки-10_1_заголовок', 'Ингибиторы 5-АР'),
(6061, 249, '_карточки-10_1_заголовок', 'field_624448fc14265'),
(6062, 249, 'карточки-10_1_текст', 'приводят к редукции железистой ткани и к снижению размера предстательной железы: они блокируют конверсию тестостерона в дигидротестостерон, который стимулирует рост предстательной железы<sup>43,44</sup>.Назначаются при большом объеме предстательной железы. Для получения значимого клинического эффекта требуется несколько месяцев применения<sup>45</sup>\r\n'),
(6063, 249, '_карточки-10_1_текст', 'field_6244490c14266'),
(6064, 249, 'карточки-10', '2'),
(6065, 249, '_карточки-10', 'field_624448e214264'),
(6066, 249, 'видео', '<iframe width=\"560\" height=\"315\" src=\"https://www.youtube.com/embed/3DrU3pFXSsY\" title=\"YouTube video player\" frameborder=\"0\" allow=\"accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture\" allowfullscreen></iframe>'),
(6067, 249, '_видео', 'field_6244492214267'),
(6068, 249, 'заголовок-11', 'Часто задаваемые вопросы'),
(6069, 249, '_заголовок-11', 'field_62444b33e25d6'),
(6070, 249, 'вопросы_0_заголовок', 'Почему при приеме препарата Урорек у некоторых пациентов развивается нарушение эякуляции?'),
(6071, 249, '_вопросы_0_заголовок', 'field_62444b58e25d8'),
(6072, 249, 'вопросы_0_текст', 'Урорек — высокоселективный препарат, то есть преимущественно действует на альфа1А-адренорецепторы, которые находятся в нижних мочевых путях, предстательной железе и семенных пузырьках. Поэтому эффект развивается уже через 2–6 часов после приёма первой дозы препарата Урорек<sup>14</sup> при минимальным количестве нежелательных явлений.<sup>5</sup>\r\n\r\nНаиболее частый побочный эффект при приеме препарата Урорек — нарушение эякуляции<sup>46</sup>. Это может быть связано как с забросом эякулята при семяизвержении вместо уретры в мочевой пузырь, так и со снижением или отсутствием семенной жидкости во время эякуляции<sup>29</sup>. Силодозин снижает тонус гладкомышечных клеток семенных пузырьков, простаты и шейки мочевого пузыря, поэтому не происходит выброс семени. Этот эффект свойственен всем уроселективным альфа-адреноблокаторам<sup>53</sup> и самостоятельно исчезает после прекращения приема препарата.<sup>6</sup>\r\n\r\nЧастота эякуляторной дисфункции прямо пропорционально связана с улучшением СНМП и скорости мочеиспускания и подтверждает эффективность альфа-адреноблокатора: чем выше эффективность, тем выше частота встречаемости эякуляторной дисфункции.<sup>29</sup>\r\n\r\nНарушение эякуляции не влияет на сексуальную функцию<sup>52</sup>, не воспринимается как беспокоящий симптом подавляющим большинством пациентов и не требует отмены терапии.<sup>46</sup>'),
(6073, 249, '_вопросы_0_текст', 'field_62444b66e25d9'),
(6074, 249, 'вопросы_1_заголовок', 'Можно ли принимать Урорек при артериальной гипертензии и ишемический болезни сердца (ИБС)?'),
(6075, 249, '_вопросы_1_заголовок', 'field_62444b58e25d8'),
(6076, 249, 'вопросы_1_текст', 'Согласно инструкции по медицинскому применению, противопоказаний для применения лекарственного препарата Урорек у пациентов с СНМП/ДГПЖ и сопутствующими сердечно-сосудистыми заболеваниями нет.<sup>3</sup> Урорек не оказывает влияния на частоту сердечных сокращений (ЧСС), систолическое артериальное давление (САД) и диастолическое артериальное давление (ДАД).<sup>9</sup> Силодозин — не вызывает клинически значимого снижения артериального давления (АД)<sup>46</sup>, не усиливает действие антигипертензивных препаратов и не требует снижения дозы при одновременном приеме.<sup>7</sup> В соответствии с дизайном клинического исследования многие пациенты получали сопутствующую терапию антигипертензивными препаратами (в основном, средствами, воздействующими на ренин-ангиотензиновую систему, бета-блокаторами, антагонистами кальция и диуретиками) без повышения частоты ортостатической гипотензии.<sup>6</sup>\r\n\r\nПри приеме препарата Урорек наиболее низкий риск развития сердечно-сосудистых осложнений.<sup>5</sup>'),
(6077, 249, '_вопросы_1_текст', 'field_62444b66e25d9'),
(6078, 249, 'вопросы_2_заголовок', 'Можно ли принимать Урорек пациенту с ортостатической гипотензией в анамнезе?'),
(6079, 249, '_вопросы_2_заголовок', 'field_62444b58e25d8'),
(6080, 249, 'вопросы_2_текст', 'Повышенная селективность силодозина к альфа1A-адренорецепторам по сравнению с альфа1B-адренорецепторами выражается в пониженном риске развития сердечно-сосудистых осложнений.<sup>4</sup> Благодаря этому частота ортостатической гипотензии на фоне его приема сравнима с таковой при приеме плацебо.<sup>45,9</sup>\r\n\r\nВ отличие от других альфа-адреноблокаторов (например, все формы тамсулозина<sup>47,48</sup>), Урорек не противопоказан к приему у пациентов с ортостатической гипотензией в анамнезе. Тем не менее, пациентам с ортостатической гипотензией в анамнезе не рекомендуется принимать любые альфа-адреноблокаторы, в т.ч. Урорек.<sup>6</sup>'),
(6081, 249, '_вопросы_2_текст', 'field_62444b66e25d9'),
(6082, 249, 'вопросы_3_заголовок', 'Как долго можно принимать Урорек?'),
(6083, 249, '_вопросы_3_заголовок', 'field_62444b58e25d8'),
(6084, 249, 'вопросы_3_текст', 'Учитывая прогрессирующий характер течения доброкачественной гиперплазии предстательной железы, медикаментозную терапию следует проводить длительно (иногда в течение всей жизни пациента).<sup>49</sup>'),
(6085, 249, '_вопросы_3_текст', 'field_62444b66e25d9'),
(6086, 249, 'вопросы_4_заголовок', 'Пациенты жалуются на заложенность носа при лечении альфа-адреноблокаторами. Есть ли у препарата Урорек такое побочное действие?'),
(6087, 249, '_вопросы_4_заголовок', 'field_62444b58e25d8'),
(6088, 249, 'вопросы_4_текст', 'Заложенность носа — это возможный побочный эффект для всех альфа-адреноблокаторов. При приеме препарата Урорек он может возникать примерно в 1% случаев.<sup>46</sup>'),
(6089, 249, '_вопросы_4_текст', 'field_62444b66e25d9'),
(6090, 249, 'вопросы_5_заголовок', 'Можно ли начинать лечение препаратом Урорек с дозы 4 мг в сутки?'),
(6091, 249, '_вопросы_5_заголовок', 'field_62444b58e25d8'),
(6092, 249, 'вопросы_5_текст', 'Согласно инструкции по медицинскому применению лекарственного препарата Урорек, доза 8 мг в сутки рекомендована для лечения пациентов с СНМП/ДГПЖ. Титрование дозы при применении силодозина не требуется.\r\n\r\nУрорек 4 мг — это специальная доза для лечения пациентов с почечной недостаточностью средней степени тяжести (клиренс креатинина ≥ 30 до &lt; 50 мл/мин). Рекомендуется в течение первой недели принимать начальную дозу по 4 мг в сутки, далее при хорошей переносимости доза может быть увеличена до 8 мг в сутки.<sup>6</sup>*\r\n\r\n<small><strong>*Более подробные сведения о препарате, особенностях применения, побочных действиях и др. — см. инструкцию по медицинскому применению лекарственного препарата Урорек, РУ ЛСР-005971/10 от 25.06.2010</strong></small>'),
(6093, 249, '_вопросы_5_текст', 'field_62444b66e25d9'),
(6094, 249, 'вопросы_6_заголовок', 'Влияет ли Урорек на течение ДГПЖ или только снимает симптомы нижних мочевыводящих путей?'),
(6095, 249, '_вопросы_6_заголовок', 'field_62444b58e25d8'),
(6096, 249, 'вопросы_6_текст', 'Помимо субъективных симптомов, ДГПЖ вызывает прогрессирующее морфологическое ремоделирование мочевого пузыря с риском развития серьезных функциональных нарушений. Лечение должно не только купировать субъективные симптомы, но и включать профилактику патологического ремоделирования мочевого пузыря.<sup>161</sup>\r\n\r\nСилодозин, действующее вещество препарата Урорек, в сравнении с другими альфа-адреноблокаторами более эффективно влияет на инфравезикальную обструкцию (ИВО), что оказывает влияние на предотвращение патологического прогрессирования ремоделирования мочевого пузыря и риск развития серьезных функциональных нарушений.<sup>50,51</sup>'),
(6097, 249, '_вопросы_6_текст', 'field_62444b66e25d9'),
(6098, 249, 'вопросы_7_заголовок', 'Доступен ли Урорек по льготному отпуску?'),
(6099, 249, '_вопросы_7_заголовок', 'field_62444b58e25d8'),
(6100, 249, 'вопросы_7_текст', 'Урорек (силодозин) не включен в список жизненно важных лекарственных препаратов (ЖНВЛП)<sup>1</sup> и не входит в перечень препаратов для льготного обеспечения граждан по федеральному льготному списку.'),
(6101, 249, '_вопросы_7_текст', 'field_62444b66e25d9'),
(6102, 249, 'вопросы', '8'),
(6103, 249, '_вопросы', 'field_62444b49e25d7'),
(6104, 250, 'заголовок-1', 'УРОРЕК – оригинальный<sup>10</sup> альфа-адреноблокатор'),
(6105, 250, '_заголовок-1', 'field_62435bd26f29f'),
(6106, 250, 'текст-1', '<div class=\"headerBlock__body\">\r\n<p>Силодозин (действующее вещество препарата Урорек) обладает максимальной уроселективностью в&nbsp;своем классе, что обеспечивает его уродинамическую эффективность и&nbsp;высокую безопасность<sup>4</sup></p>\r\n</div>\r\n<div class=\"headerBlock__footer\">\r\n<p><strong>Показания к применению: </strong><br/>Лечение симптомов доброкачественной гиперплазии предстательной железы<sup>6</sup></p>\r\n</div>'),
(6107, 250, '_текст-1', 'field_62435c0c6f2a0'),
(6108, 250, 'изображение-1', '13'),
(6109, 250, '_изображение-1', 'field_62435c8b6f2a1'),
(6110, 250, 'фон-1', '17'),
(6111, 250, '_фон-1', 'field_62435db92ea96'),
(6112, 250, 'заголовок-2', 'Ключевые преимущества препарата Урорек'),
(6113, 250, '_заголовок-2', 'field_6243606295196'),
(6114, 250, 'список-2', 'Единственный оригинальный препарат из&nbsp;группы альфа1-адреноблокаторов, не&nbsp;имеющий генериков в&nbsp;РФ<sup>1</sup>'),
(6115, 250, '_список-2', 'field_6243608195197'),
(6116, 250, 'картинка_с_текстом_0_изображение', '31'),
(6117, 250, '_картинка_с_текстом_0_изображение', 'field_624363d095199'),
(6118, 250, 'картинка_с_текстом_0_описание', 'Обширная доказательная база собственных пострегистрационных клинических исследований<sup>2</sup>'),
(6119, 250, '_картинка_с_текстом_0_описание', 'field_624363e59519a'),
(6120, 250, 'картинка_с_текстом_1_изображение', '32'),
(6121, 250, '_картинка_с_текстом_1_изображение', 'field_624363d095199'),
(6122, 250, 'картинка_с_текстом_1_описание', 'Отсутствие риска замены препарата Урорек в&nbsp;аптеке (единственный препарат с&nbsp;действующим веществом силодозин)<sup>1</sup>'),
(6123, 250, '_картинка_с_текстом_1_описание', 'field_624363e59519a'),
(6124, 250, 'картинка_с_текстом_2_изображение', '33'),
(6125, 250, '_картинка_с_текстом_2_изображение', 'field_624363d095199'),
(6126, 250, 'картинка_с_текстом_2_описание', 'Большинство пациентов предпочитают принимать оригинальные препараты<sup>3</sup>'),
(6127, 250, '_картинка_с_текстом_2_описание', 'field_624363e59519a'),
(6128, 250, 'картинка_с_текстом', '3'),
(6129, 250, '_картинка_с_текстом', 'field_624363b995198'),
(6130, 250, 'второй_список', '<li>Клинические преимущества препарата Урорек (силодозин) определяются максимальной уроселективностью в&nbsp;классе альфа-адреноблокаторов<sup>4</sup></li>\r\n\r\n<li>Урорек&nbsp;&mdash; альфа-адреноблокатор последнего поколения, который эффективен в&nbsp;отношении всех СНМП (накопления, опорожнения, постмиктурических).<sup>12,13</sup> При этом Урорек обладает минимальным риском развития нежелательных явлений со&nbsp;стороны сердечно-сосудистой системы, в&nbsp;том числе&nbsp;у&nbsp;пациентов, принимающих антигипертензивные препараты<sup>46,8</sup> <small> <span>СНМП </span>симптомы нижних мочевыводящих путей</small></li>'),
(6131, 250, '_второй_список', 'field_6243640e05eda'),
(6132, 250, 'заголовок2-2', 'Максимальная уроселективность силодозина в&nbsp;классе альфа-адреноблокаторов обуславливает его уродинамическую эффективность и&nbsp;высокий профиль безопасности<sup>4</sup>'),
(6133, 250, '_заголовок2-2', 'field_6243644705edb'),
(6134, 250, 'текст3', '<ul>\r\n<li>Урорек значительно улучшает клинические проявления и&nbsp;качество жизни у&nbsp;всех пациентов с&nbsp;СНМП/ДГПЖ, в&nbsp;том числе с&nbsp;тяжелым течением<sup>11</sup>\r\n<a href=\"#modal-call-first\" class=\"link-modal-js\">Узнать больше...</a></li>\r\n\r\n<li>Урорек является препаратом выбора для пациентов с&nbsp;СНМП/ДГПЖ и&nbsp;сопутствующими сердечно-сосудистыми заболеваниями<sup>3</sup> \r\n<a href=\"#modal-call-second\" class=\"link-modal-js\">Узнать больше...</a></li>\r\n</ul>\r\n<small> <span>ДГПЖ </span>доброкачественная гиперплазия предстательной железы</small>'),
(6135, 250, '_текст3', 'field_6243647405edc'),
(6136, 250, 'изображение-2', '34'),
(6137, 250, '_изображение-2', 'field_624364dd05edd'),
(6138, 250, 'текст_в_подвале', '<h2> Максимальная уроселективность в&nbsp;классе  альфа-адреноблокаторов<sup>4</sup></h2>\r\n<div class=\"h3\"> Почему это важно? <a href=\"#modal-call-second\" class=\"link-modal-js\">Подробнее</a></div>'),
(6139, 250, '_текст_в_подвале', 'field_62436daf1f6d9'),
(6140, 250, 'заголовок-3', 'Форма выпуска препарата Урорек'),
(6141, 250, '_заголовок-3', 'field_62436efee98e7'),
(6142, 250, 'текст-3', '<p class=\"section-descr\"><span>8мг </span>- рекомендуемая доза для лечения симптомов ДГПЖ<sup>6</sup>*</p>\r\n					<p class=\"section-note col-md-10\">*Более подробные сведения о&nbsp;препарате, особенностях применения, побочных действиях и&nbsp;др. &mdash;&nbsp;смотрите инструкцию по&nbsp;медицинскому применению лекарственного препарата Урорек, РУ&nbsp;ЛСР-005971/10 от&nbsp;25.06.2010 </p>'),
(6143, 250, '_текст-3', 'field_62436f60e98e8'),
(6144, 250, 'товар_0_название', 'Урорек 8мг №30'),
(6145, 250, '_товар_0_название', 'field_62436fcce98ea'),
(6146, 250, 'товар_0_описание', 'Упаковка, рассчитанная на&nbsp;1&nbsp;месяц лечения&nbsp;/ для старта терапии'),
(6147, 250, '_товар_0_описание', 'field_62436fe1e98eb'),
(6148, 250, 'товар_0_лицензия', 'РУ: ЛСР-005971/10 от 25.06.2010'),
(6149, 250, '_товар_0_лицензия', 'field_62436ff0e98ec'),
(6150, 250, 'товар_0_изображение', '51'),
(6151, 250, '_товар_0_изображение', 'field_62437045e98ed'),
(6152, 250, 'товар_1_название', 'Урорек 8мг №90'),
(6153, 250, '_товар_1_название', 'field_62436fcce98ea'),
(6154, 250, 'товар_1_описание', 'Выгодная упаковка, рассчитанная на&nbsp;3&nbsp;месяца лечения. Самая доступная стоимость 1&nbsp;дня терапии препаратом Урорек&nbsp;<sup>27</sup>'),
(6155, 250, '_товар_1_описание', 'field_62436fe1e98eb'),
(6156, 250, 'товар_1_лицензия', 'РУ: ЛСР-005971/10 от 25.06.2010'),
(6157, 250, '_товар_1_лицензия', 'field_62436ff0e98ec'),
(6158, 250, 'товар_1_изображение', '53'),
(6159, 250, '_товар_1_изображение', 'field_62437045e98ed'),
(6160, 250, 'товар_2_название', 'Урорек 4мг №30'),
(6161, 250, '_товар_2_название', 'field_62436fcce98ea'),
(6162, 250, 'товар_2_описание', '4&nbsp;мг&nbsp;&mdash; стартовая доза для лечения симптомов ДГПЖ у&nbsp;пациентов с&nbsp;почечной недостаточностью средней степени тяжести<sup>6</sup>'),
(6163, 250, '_товар_2_описание', 'field_62436fe1e98eb'),
(6164, 250, 'товар_2_лицензия', 'РУ: ЛСР-005971/10 от 25.06.2010'),
(6165, 250, '_товар_2_лицензия', 'field_62436ff0e98ec'),
(6166, 250, 'товар_2_изображение', '52'),
(6167, 250, '_товар_2_изображение', 'field_62437045e98ed'),
(6168, 250, 'товар', '3'),
(6169, 250, '_товар', 'field_62436fbde98e9'),
(6170, 250, 'заголовок-4', 'Где купить'),
(6171, 250, '_заголовок-4', 'field_624374f73d8bd'),
(6172, 250, 'изображения', 'a:12:{i:0;s:2:\"63\";i:1;s:2:\"64\";i:2;s:2:\"65\";i:3;s:2:\"66\";i:4;s:2:\"67\";i:5;s:2:\"68\";i:6;s:2:\"69\";i:7;s:2:\"70\";i:8;s:2:\"71\";i:9;s:2:\"72\";i:10;s:2:\"73\";i:11;s:2:\"74\";}'),
(6173, 250, '_изображения', 'field_624375093d8be'),
(6174, 250, 'изображения-4', 'a:12:{i:0;s:2:\"63\";i:1;s:2:\"64\";i:2;s:2:\"65\";i:3;s:2:\"66\";i:4;s:2:\"67\";i:5;s:2:\"68\";i:6;s:2:\"69\";i:7;s:2:\"70\";i:8;s:2:\"71\";i:9;s:2:\"72\";i:10;s:2:\"73\";i:11;s:2:\"74\";}'),
(6175, 250, '_изображения-4', 'field_624375093d8be'),
(6176, 250, 'заголовок-5', 'Способ применения*<sup>6</sup>'),
(6177, 250, '_заголовок-5', 'field_624379bd4756d'),
(6178, 250, 'иконки', 'a:5:{i:0;s:2:\"83\";i:1;s:2:\"84\";i:2;s:2:\"85\";i:3;s:2:\"86\";i:4;s:2:\"87\";}'),
(6179, 250, '_иконки', 'field_624379f24756e'),
(6180, 250, 'текст-5', 'У пациентов с легкой почечной недостаточностью (клиренс креатинина ≥ 50 — ≤ 80 мл/мин) коррекция дозы не требуется. Для лечения пациентов с почечной недостаточностью средней степени тяжести (клиренс креатинина ≥ 30 — < 50 мл/мин) рекомендуется в течение первой недели принимать начальную дозу по 4 мг в сутки, при хорошей индивидуальной переносимости доза может быть увеличена до 8 мг в сутки. Применение препарата для пациентов с тяжелой почечной недостаточностью (клиренс креатинина < 30 мл / мин) не рекомендуется'),
(6181, 250, '_текст-5', 'field_62437a374756f'),
(6182, 250, 'текст_под_кнопкой', '*Более подробные сведения о&nbsp;препарате, особенностях применения, побочных действиях и&nbsp;др. &mdash;&nbsp;см. инструкцию по&nbsp;медицинскому применению лекарственного препарата Урорек, РУ&nbsp;ЛСР-005971/10 от&nbsp;25.06.2010'),
(6183, 250, '_текст_под_кнопкой', 'field_62437a7c47570'),
(6184, 250, 'заголовок-6', 'Препарат Урорек (силодозин) включен в&nbsp;российские и&nbsp;международные клинические рекомендации и&nbsp;стандарты для лечения ряда урологических заболеваний:'),
(6185, 250, '_заголовок-6', 'field_6244117c68bd0'),
(6186, 250, 'список-6_0_ссылка', 'a:3:{s:5:\"title\";s:68:\"Российские клинические рекомендации\";s:3:\"url\";s:1:\"#\";s:6:\"target\";s:0:\"\";}'),
(6187, 250, '_список-6_0_ссылка', 'field_624411ce68bd2'),
(6188, 250, 'список-6_0_описание', '«Доброкачественная гиперплазия предстательной железы», 2020<sup>28</sup>'),
(6189, 250, '_список-6_0_описание', 'field_6244121168bd3'),
(6190, 250, 'список-6_1_ссылка', 'a:3:{s:5:\"title\";s:70:\"Европейские клинические рекомендации\";s:3:\"url\";s:1:\"#\";s:6:\"target\";s:0:\"\";}'),
(6191, 250, '_список-6_1_ссылка', 'field_624411ce68bd2'),
(6192, 250, 'список-6_1_описание', 'глава «Консервативное лечение ненейрогенных симптомов нарушенного мочеиспускания у мужчин, включая доброкачественную простатическую обструкцию», 2021<sup>29</sup>'),
(6193, 250, '_список-6_1_описание', 'field_6244121168bd3'),
(6194, 250, 'список-6_2_ссылка', 'a:3:{s:5:\"title\";s:154:\"Стандарт первичной медико-санитарной помощи при гиперплазии предстательной железы\";s:3:\"url\";s:1:\"#\";s:6:\"target\";s:0:\"\";}'),
(6195, 250, '_список-6_2_ссылка', 'field_624411ce68bd2'),
(6196, 250, 'список-6_2_описание', '09.11.2012<sup>30</sup> / Обновлён 13.04.2015\r\n'),
(6197, 250, '_список-6_2_описание', 'field_6244121168bd3'),
(6198, 250, 'список-6_3_ссылка', 'a:3:{s:5:\"title\";s:122:\"Стандарт специализированной медицинской помощи при задержке мочи\";s:3:\"url\";s:1:\"#\";s:6:\"target\";s:0:\"\";}'),
(6199, 250, '_список-6_3_ссылка', 'field_624411ce68bd2'),
(6200, 250, 'список-6_3_описание', '29.01.2013<sup>31</sup> / Обновлён 06.05.2015\r\n'),
(6201, 250, '_список-6_3_описание', 'field_6244121168bd3'),
(6202, 250, 'список-6_4_ссылка', 'a:3:{s:5:\"title\";s:133:\"Стандарт первичной медико-санитарной помощи при хроническом простатите\";s:3:\"url\";s:1:\"#\";s:6:\"target\";s:0:\"\";}'),
(6203, 250, '_список-6_4_ссылка', 'field_624411ce68bd2'),
(6204, 250, 'список-6_4_описание', '09.11.2012<sup>32</sup> / Обновлён 13.04.2015\r\n'),
(6205, 250, '_список-6_4_описание', 'field_6244121168bd3'),
(6206, 250, 'список-6_5_ссылка', 'a:3:{s:5:\"title\";s:168:\"Стандарт специализированной медицинской помощи при остром простатите, орхите, эпидидимите\";s:3:\"url\";s:1:\"#\";s:6:\"target\";s:0:\"\";}'),
(6207, 250, '_список-6_5_ссылка', 'field_624411ce68bd2'),
(6208, 250, 'список-6_5_описание', '09.11.2012<sup>33</sup> / Обновлён 27.05.2015'),
(6209, 250, '_список-6_5_описание', 'field_6244121168bd3'),
(6210, 250, 'список-6', '6'),
(6211, 250, '_список-6', 'field_624411be68bd1'),
(6212, 250, 'заголовок-7', 'Препарат Урорек (силодозин) зарегистрирован и&nbsp;применяется в&nbsp;разных странах мира Одобрен ЕМА*<sup>34</sup> и&nbsp;FDA**<sup>35</sup>'),
(6213, 250, '_заголовок-7', 'field_624417e3b6088'),
(6214, 250, 'текст', '<p class=\"sOtherCountries__agency\"><span>EMA</span> Европейское медицинское агентство</p>\r\n<p class=\"sOtherCountries__agency\"><span>FDA</span> Управление по&nbsp;санитарному надзору за&nbsp;качеством пищевых продуктов и&nbsp;медикаментов, США</p>'),
(6215, 250, '_текст', 'field_6244182bb6089'),
(6216, 250, 'страны_0_флаг', '105'),
(6217, 250, '_страны_0_флаг', 'field_62441880b608b'),
(6218, 250, 'страны_0_название', 'Япония'),
(6219, 250, '_страны_0_название', 'field_62441899b608c'),
(6220, 250, 'страны_0_год', '2006<sup>36,37</sup>'),
(6221, 250, '_страны_0_год', 'field_624418aab608d'),
(6222, 250, 'страны_1_флаг', '106'),
(6223, 250, '_страны_1_флаг', 'field_62441880b608b'),
(6224, 250, 'страны_1_название', 'США'),
(6225, 250, '_страны_1_название', 'field_62441899b608c'),
(6226, 250, 'страны_1_год', '2008<sup>35</sup>'),
(6227, 250, '_страны_1_год', 'field_624418aab608d'),
(6228, 250, 'страны_2_флаг', '107'),
(6229, 250, '_страны_2_флаг', 'field_62441880b608b'),
(6230, 250, 'страны_2_название', 'Страны ЕС'),
(6231, 250, '_страны_2_название', 'field_62441899b608c'),
(6232, 250, 'страны_2_год', '2010<sup>34</sup>'),
(6233, 250, '_страны_2_год', 'field_624418aab608d'),
(6234, 250, 'страны_3_флаг', '108'),
(6235, 250, '_страны_3_флаг', 'field_62441880b608b'),
(6236, 250, 'страны_3_название', 'Россия'),
(6237, 250, '_страны_3_название', 'field_62441899b608c'),
(6238, 250, 'страны_3_год', '2010<sup>1</sup>'),
(6239, 250, '_страны_3_год', 'field_624418aab608d'),
(6240, 250, 'страны', '4'),
(6241, 250, '_страны', 'field_62441847b608a'),
(6242, 250, 'текст-7', '<p class=\"sOtherCountries__agency\"><span>EMA</span> Европейское медицинское агентство</p>\r\n<p class=\"sOtherCountries__agency\"><span>FDA</span> Управление по&nbsp;санитарному надзору за&nbsp;качеством пищевых продуктов и&nbsp;медикаментов, США</p>'),
(6243, 250, '_текст-7', 'field_6244182bb6089'),
(6244, 250, 'текст-7-1', 'Производство препарата Урорек, поставляемого в&nbsp;Россию, осуществляется в&nbsp;Италии с&nbsp;использованием субстанции из&nbsp;Японии, в&nbsp;соответствии с&nbsp;необходимыми требованиями к&nbsp;производству и&nbsp;контролю качества<sup>6,1</sup>'),
(6245, 250, '_текст-7-1', 'field_62441a5acf03c'),
(6246, 250, 'заголовок-8', 'О проблеме'),
(6247, 250, '_заголовок-8', 'field_624431d91624d'),
(6248, 250, 'текст-8', 'Доброкачественная гиперплазия предстательной железы (ДГПЖ), или как ее еще называют, аденома простаты, как правило, возникает у мужчин старше 50 лет и характеризуется наличием симптомов нижних мочевыводящих путей (СНМП), увеличением предстательной железы или ее части, и нарушением оттока мочи из мочевого пузыря вследствие инфравезикальной обструкции.<sup>38</sup>\r\n\r\nРаспространенность ДГПЖ увеличивается с возрастом. Так, клинически значимая ДГПЖ проявляется у 13% мужчин в возрасте старше 50 лет, у 34% мужчин в возрасте 60 лет и у 43% в возрасте 70 лет.<sup>39</sup>\r\n\r\n&nbsp;\r\n\r\n<img class=\"alignnone wp-image-122 size-full\" src=\"http://0026urotec.loc:8888/wp-content/uploads/2022/03/about-img.png\" alt=\"\" width=\"594\" height=\"696\" />'),
(6249, 250, '_текст-8', 'field_624431f11624e'),
(6250, 250, 'текст-8-1', 'Наличие СНМП может быть ассоциировано с&nbsp;тяжелыми хроническими заболеваниями, такими как заболевания сердца, сахарный диабет, артериальная гипертензия и&nbsp;депрессия<sup>40</sup>'),
(6251, 250, '_текст-8-1', 'field_6244320b26db3'),
(6252, 250, 'иконки-8', 'a:6:{i:0;s:3:\"123\";i:1;s:3:\"124\";i:2;s:3:\"125\";i:3;s:3:\"126\";i:4;s:3:\"127\";i:5;s:3:\"128\";}'),
(6253, 250, '_иконки-8', 'field_6244322d26db4'),
(6254, 250, 'текст-8-2', '<h3>Симптомы доброкачественной гиперплазии предстательной железы</h3>\r\nСимптомы нарушенного мочеиспускания являются частой жалобой у взрослых мужчин. Они оказывают серьезное негативное влияние на качество жизни. При ДГПЖ предстательная железа увеличивается в размерах, оказывая давление на нижние мочевые пути. В результате развиваются следующие симптомы:<sup>41</sup>'),
(6255, 250, '_текст-8-2', 'field_6244335fe2373'),
(6256, 250, 'заголовок-9', 'Осложнения ДГПЖ<sup>38</sup>'),
(6257, 250, '_заголовок-9', 'field_6244377a52263'),
(6258, 250, 'изображения-9', 'a:6:{i:0;s:3:\"141\";i:1;s:3:\"142\";i:2;s:3:\"143\";i:3;s:3:\"144\";i:4;s:3:\"145\";i:5;s:3:\"146\";}'),
(6259, 250, '_изображения-9', 'field_6244379652264'),
(6260, 250, 'заголовок-10', 'Медикаментозное лечение СНМП/ДГПЖ'),
(6261, 250, '_заголовок-10', 'field_6244489614262'),
(6262, 250, 'текст-10', 'Антагонисты альфа1-адренорецепторов (альфа-адреноблокаторы) и&nbsp;ингибиторы 5&nbsp;альфа1-редуктазы (ингибиторы 5-АР) являются группами лекарственных препаратов, которые в&nbsp;настоящее время утверждены для лечения ДГПЖ. Обе группы препаратов обеспечивают надлежащее ослабление симптомов, но&nbsp;&alpha;&mdash;блокаторы обладают довольно быстрым началом действия, а&nbsp;ингибиторам 5-АР требуется несколько месяцев для получения терапевтического эффекта.<sup>42</sup>'),
(6263, 250, '_текст-10', 'field_624448ce14263'),
(6264, 250, 'карточки-10_0_заголовок', 'Альфа-адреноблокаторы'),
(6265, 250, '_карточки-10_0_заголовок', 'field_624448fc14265'),
(6266, 250, 'карточки-10_0_текст', 'представляют собой наиболее эффективный класс лекарственных препаратов, характеризующийся хорошим профилем безопасности и высокой комплаентностью, применяющийся для облегчения СНМП, связанных с ДГПЖ: они снимают спазм гладкой мускулатуры предстательной железы и шейки мочевого пузыря<sup>42</sup>'),
(6267, 250, '_карточки-10_0_текст', 'field_6244490c14266'),
(6268, 250, 'карточки-10_1_заголовок', 'Ингибиторы 5-АР'),
(6269, 250, '_карточки-10_1_заголовок', 'field_624448fc14265'),
(6270, 250, 'карточки-10_1_текст', 'приводят к редукции железистой ткани и к снижению размера предстательной железы: они блокируют конверсию тестостерона в дигидротестостерон, который стимулирует рост предстательной железы<sup>43,44</sup>.Назначаются при большом объеме предстательной железы. Для получения значимого клинического эффекта требуется несколько месяцев применения<sup>45</sup>\r\n'),
(6271, 250, '_карточки-10_1_текст', 'field_6244490c14266'),
(6272, 250, 'карточки-10', '2'),
(6273, 250, '_карточки-10', 'field_624448e214264'),
(6274, 250, 'видео', '<iframe width=\"560\" height=\"315\" src=\"https://www.youtube.com/embed/3DrU3pFXSsY\" title=\"YouTube video player\" frameborder=\"0\" allow=\"accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture\" allowfullscreen></iframe>'),
(6275, 250, '_видео', 'field_6244492214267'),
(6276, 250, 'заголовок-11', 'Часто задаваемые вопросы'),
(6277, 250, '_заголовок-11', 'field_62444b33e25d6'),
(6278, 250, 'вопросы_0_заголовок', 'Почему при приеме препарата Урорек у некоторых пациентов развивается нарушение эякуляции?'),
(6279, 250, '_вопросы_0_заголовок', 'field_62444b58e25d8'),
(6280, 250, 'вопросы_0_текст', 'Урорек — высокоселективный препарат, то есть преимущественно действует на альфа1А-адренорецепторы, которые находятся в нижних мочевых путях, предстательной железе и семенных пузырьках. Поэтому эффект развивается уже через 2–6 часов после приёма первой дозы препарата Урорек<sup>14</sup> при минимальным количестве нежелательных явлений.<sup>5</sup>\r\n\r\nНаиболее частый побочный эффект при приеме препарата Урорек — нарушение эякуляции<sup>46</sup>. Это может быть связано как с забросом эякулята при семяизвержении вместо уретры в мочевой пузырь, так и со снижением или отсутствием семенной жидкости во время эякуляции<sup>29</sup>. Силодозин снижает тонус гладкомышечных клеток семенных пузырьков, простаты и шейки мочевого пузыря, поэтому не происходит выброс семени. Этот эффект свойственен всем уроселективным альфа-адреноблокаторам<sup>53</sup> и самостоятельно исчезает после прекращения приема препарата.<sup>6</sup>\r\n\r\nЧастота эякуляторной дисфункции прямо пропорционально связана с улучшением СНМП и скорости мочеиспускания и подтверждает эффективность альфа-адреноблокатора: чем выше эффективность, тем выше частота встречаемости эякуляторной дисфункции.<sup>29</sup>\r\n\r\nНарушение эякуляции не влияет на сексуальную функцию<sup>52</sup>, не воспринимается как беспокоящий симптом подавляющим большинством пациентов и не требует отмены терапии.<sup>46</sup>'),
(6281, 250, '_вопросы_0_текст', 'field_62444b66e25d9'),
(6282, 250, 'вопросы_1_заголовок', 'Можно ли принимать Урорек при артериальной гипертензии и ишемический болезни сердца (ИБС)?'),
(6283, 250, '_вопросы_1_заголовок', 'field_62444b58e25d8'),
(6284, 250, 'вопросы_1_текст', 'Согласно инструкции по медицинскому применению, противопоказаний для применения лекарственного препарата Урорек у пациентов с СНМП/ДГПЖ и сопутствующими сердечно-сосудистыми заболеваниями нет.<sup>3</sup> Урорек не оказывает влияния на частоту сердечных сокращений (ЧСС), систолическое артериальное давление (САД) и диастолическое артериальное давление (ДАД).<sup>9</sup> Силодозин — не вызывает клинически значимого снижения артериального давления (АД)<sup>46</sup>, не усиливает действие антигипертензивных препаратов и не требует снижения дозы при одновременном приеме.<sup>7</sup> В соответствии с дизайном клинического исследования многие пациенты получали сопутствующую терапию антигипертензивными препаратами (в основном, средствами, воздействующими на ренин-ангиотензиновую систему, бета-блокаторами, антагонистами кальция и диуретиками) без повышения частоты ортостатической гипотензии.<sup>6</sup>\r\n\r\nПри приеме препарата Урорек наиболее низкий риск развития сердечно-сосудистых осложнений.<sup>5</sup>'),
(6285, 250, '_вопросы_1_текст', 'field_62444b66e25d9'),
(6286, 250, 'вопросы_2_заголовок', 'Можно ли принимать Урорек пациенту с ортостатической гипотензией в анамнезе?'),
(6287, 250, '_вопросы_2_заголовок', 'field_62444b58e25d8'),
(6288, 250, 'вопросы_2_текст', 'Повышенная селективность силодозина к альфа1A-адренорецепторам по сравнению с альфа1B-адренорецепторами выражается в пониженном риске развития сердечно-сосудистых осложнений.<sup>4</sup> Благодаря этому частота ортостатической гипотензии на фоне его приема сравнима с таковой при приеме плацебо.<sup>45,9</sup>\r\n\r\nВ отличие от других альфа-адреноблокаторов (например, все формы тамсулозина<sup>47,48</sup>), Урорек не противопоказан к приему у пациентов с ортостатической гипотензией в анамнезе. Тем не менее, пациентам с ортостатической гипотензией в анамнезе не рекомендуется принимать любые альфа-адреноблокаторы, в т.ч. Урорек.<sup>6</sup>'),
(6289, 250, '_вопросы_2_текст', 'field_62444b66e25d9'),
(6290, 250, 'вопросы_3_заголовок', 'Как долго можно принимать Урорек?'),
(6291, 250, '_вопросы_3_заголовок', 'field_62444b58e25d8'),
(6292, 250, 'вопросы_3_текст', 'Учитывая прогрессирующий характер течения доброкачественной гиперплазии предстательной железы, медикаментозную терапию следует проводить длительно (иногда в течение всей жизни пациента).<sup>49</sup>'),
(6293, 250, '_вопросы_3_текст', 'field_62444b66e25d9'),
(6294, 250, 'вопросы_4_заголовок', 'Пациенты жалуются на заложенность носа при лечении альфа-адреноблокаторами. Есть ли у препарата Урорек такое побочное действие?'),
(6295, 250, '_вопросы_4_заголовок', 'field_62444b58e25d8'),
(6296, 250, 'вопросы_4_текст', 'Заложенность носа — это возможный побочный эффект для всех альфа-адреноблокаторов. При приеме препарата Урорек он может возникать примерно в 1% случаев.<sup>46</sup>'),
(6297, 250, '_вопросы_4_текст', 'field_62444b66e25d9'),
(6298, 250, 'вопросы_5_заголовок', 'Можно ли начинать лечение препаратом Урорек с дозы 4 мг в сутки?'),
(6299, 250, '_вопросы_5_заголовок', 'field_62444b58e25d8'),
(6300, 250, 'вопросы_5_текст', 'Согласно инструкции по медицинскому применению лекарственного препарата Урорек, доза 8 мг в сутки рекомендована для лечения пациентов с СНМП/ДГПЖ. Титрование дозы при применении силодозина не требуется.\r\n\r\nУрорек 4 мг — это специальная доза для лечения пациентов с почечной недостаточностью средней степени тяжести (клиренс креатинина ≥ 30 до &lt; 50 мл/мин). Рекомендуется в течение первой недели принимать начальную дозу по 4 мг в сутки, далее при хорошей переносимости доза может быть увеличена до 8 мг в сутки.<sup>6</sup>*\r\n\r\n<small><strong>*Более подробные сведения о препарате, особенностях применения, побочных действиях и др. — см. инструкцию по медицинскому применению лекарственного препарата Урорек, РУ ЛСР-005971/10 от 25.06.2010</strong></small>'),
(6301, 250, '_вопросы_5_текст', 'field_62444b66e25d9'),
(6302, 250, 'вопросы_6_заголовок', 'Влияет ли Урорек на течение ДГПЖ или только снимает симптомы нижних мочевыводящих путей?'),
(6303, 250, '_вопросы_6_заголовок', 'field_62444b58e25d8'),
(6304, 250, 'вопросы_6_текст', 'Помимо субъективных симптомов, ДГПЖ вызывает прогрессирующее морфологическое ремоделирование мочевого пузыря с риском развития серьезных функциональных нарушений. Лечение должно не только купировать субъективные симптомы, но и включать профилактику патологического ремоделирования мочевого пузыря.<sup>161</sup>\r\n\r\nСилодозин, действующее вещество препарата Урорек, в сравнении с другими альфа-адреноблокаторами более эффективно влияет на инфравезикальную обструкцию (ИВО), что оказывает влияние на предотвращение патологического прогрессирования ремоделирования мочевого пузыря и риск развития серьезных функциональных нарушений.<sup>50,51</sup>'),
(6305, 250, '_вопросы_6_текст', 'field_62444b66e25d9'),
(6306, 250, 'вопросы_7_заголовок', 'Доступен ли Урорек по льготному отпуску?'),
(6307, 250, '_вопросы_7_заголовок', 'field_62444b58e25d8'),
(6308, 250, 'вопросы_7_текст', 'Урорек (силодозин) не включен в список жизненно важных лекарственных препаратов (ЖНВЛП)<sup>1</sup> и не входит в перечень препаратов для льготного обеспечения граждан по федеральному льготному списку.'),
(6309, 250, '_вопросы_7_текст', 'field_62444b66e25d9'),
(6310, 250, 'вопросы', '8'),
(6311, 250, '_вопросы', 'field_62444b49e25d7'),
(6312, 251, 'заголовок-1', 'УРОРЕК – оригинальный<sup>10</sup> альфа-адреноблокатор'),
(6313, 251, '_заголовок-1', 'field_62435bd26f29f'),
(6314, 251, 'текст-1', '<div class=\"headerBlock__body\">\r\n<p>Силодозин (действующее вещество препарата Урорек) обладает максимальной уроселективностью в&nbsp;своем классе, что обеспечивает его уродинамическую эффективность и&nbsp;высокую безопасность<sup>4</sup></p>\r\n</div>\r\n<div class=\"headerBlock__footer\">\r\n<p><strong>Показания к применению: </strong><br/>Лечение симптомов доброкачественной гиперплазии предстательной железы<sup>6</sup></p>\r\n</div>'),
(6315, 251, '_текст-1', 'field_62435c0c6f2a0'),
(6316, 251, 'изображение-1', '13'),
(6317, 251, '_изображение-1', 'field_62435c8b6f2a1'),
(6318, 251, 'фон-1', '17'),
(6319, 251, '_фон-1', 'field_62435db92ea96'),
(6320, 251, 'заголовок-2', 'Ключевые преимущества препарата Урорек'),
(6321, 251, '_заголовок-2', 'field_6243606295196'),
(6322, 251, 'список-2', 'Единственный оригинальный препарат из&nbsp;группы альфа1-адреноблокаторов, не&nbsp;имеющий генериков в&nbsp;РФ<sup>1</sup>'),
(6323, 251, '_список-2', 'field_6243608195197'),
(6324, 251, 'картинка_с_текстом_0_изображение', '31'),
(6325, 251, '_картинка_с_текстом_0_изображение', 'field_624363d095199'),
(6326, 251, 'картинка_с_текстом_0_описание', 'Обширная доказательная база собственных пострегистрационных клинических исследований<sup>2</sup>'),
(6327, 251, '_картинка_с_текстом_0_описание', 'field_624363e59519a'),
(6328, 251, 'картинка_с_текстом_1_изображение', '32'),
(6329, 251, '_картинка_с_текстом_1_изображение', 'field_624363d095199'),
(6330, 251, 'картинка_с_текстом_1_описание', 'Отсутствие риска замены препарата Урорек в&nbsp;аптеке (единственный препарат с&nbsp;действующим веществом силодозин)<sup>1</sup>'),
(6331, 251, '_картинка_с_текстом_1_описание', 'field_624363e59519a'),
(6332, 251, 'картинка_с_текстом_2_изображение', '33'),
(6333, 251, '_картинка_с_текстом_2_изображение', 'field_624363d095199'),
(6334, 251, 'картинка_с_текстом_2_описание', 'Большинство пациентов предпочитают принимать оригинальные препараты<sup>3</sup>'),
(6335, 251, '_картинка_с_текстом_2_описание', 'field_624363e59519a'),
(6336, 251, 'картинка_с_текстом', '3'),
(6337, 251, '_картинка_с_текстом', 'field_624363b995198'),
(6338, 251, 'второй_список', '<li>Клинические преимущества препарата Урорек (силодозин) определяются максимальной уроселективностью в&nbsp;классе альфа-адреноблокаторов<sup>4</sup></li>\r\n\r\n<li>Урорек&nbsp;&mdash; альфа-адреноблокатор последнего поколения, который эффективен в&nbsp;отношении всех СНМП (накопления, опорожнения, постмиктурических).<sup>12,13</sup> При этом Урорек обладает минимальным риском развития нежелательных явлений со&nbsp;стороны сердечно-сосудистой системы, в&nbsp;том числе&nbsp;у&nbsp;пациентов, принимающих антигипертензивные препараты<sup>46,8</sup> <small> <span>СНМП </span>симптомы нижних мочевыводящих путей</small></li>'),
(6339, 251, '_второй_список', 'field_6243640e05eda'),
(6340, 251, 'заголовок2-2', 'Максимальная уроселективность силодозина в&nbsp;классе альфа-адреноблокаторов обуславливает его уродинамическую эффективность и&nbsp;высокий профиль безопасности<sup>4</sup>'),
(6341, 251, '_заголовок2-2', 'field_6243644705edb'),
(6342, 251, 'текст3', '<ul>\r\n<li>Урорек значительно улучшает клинические проявления и&nbsp;качество жизни у&nbsp;всех пациентов с&nbsp;СНМП/ДГПЖ, в&nbsp;том числе с&nbsp;тяжелым течением<sup>11</sup>\r\n<a href=\"#modal-call-first\" class=\"link-modal-js\">Узнать больше...</a></li>\r\n\r\n<li>Урорек является препаратом выбора для пациентов с&nbsp;СНМП/ДГПЖ и&nbsp;сопутствующими сердечно-сосудистыми заболеваниями<sup>3</sup> \r\n<a href=\"#modal-call-second\" class=\"link-modal-js\">Узнать больше...</a></li>\r\n</ul>\r\n<small> <span>ДГПЖ </span>доброкачественная гиперплазия предстательной железы</small>'),
(6343, 251, '_текст3', 'field_6243647405edc'),
(6344, 251, 'изображение-2', '34'),
(6345, 251, '_изображение-2', 'field_624364dd05edd'),
(6346, 251, 'текст_в_подвале', '<h2> Максимальная уроселективность в&nbsp;классе  альфа-адреноблокаторов<sup>4</sup></h2>\r\n<div class=\"h3\"> Почему это важно? <a href=\"#modal-call-second\" class=\"link-modal-js\">Подробнее</a></div>'),
(6347, 251, '_текст_в_подвале', 'field_62436daf1f6d9'),
(6348, 251, 'заголовок-3', 'Форма выпуска препарата Урорек'),
(6349, 251, '_заголовок-3', 'field_62436efee98e7'),
(6350, 251, 'текст-3', '<p class=\"section-descr\"><span>8мг </span>- рекомендуемая доза для лечения симптомов ДГПЖ<sup>6</sup>*</p>\r\n					<p class=\"section-note col-md-10\">*Более подробные сведения о&nbsp;препарате, особенностях применения, побочных действиях и&nbsp;др. &mdash;&nbsp;смотрите инструкцию по&nbsp;медицинскому применению лекарственного препарата Урорек, РУ&nbsp;ЛСР-005971/10 от&nbsp;25.06.2010 </p>'),
(6351, 251, '_текст-3', 'field_62436f60e98e8'),
(6352, 251, 'товар_0_название', 'Урорек 8мг №30'),
(6353, 251, '_товар_0_название', 'field_62436fcce98ea'),
(6354, 251, 'товар_0_описание', 'Упаковка, рассчитанная на&nbsp;1&nbsp;месяц лечения&nbsp;/ для старта терапии'),
(6355, 251, '_товар_0_описание', 'field_62436fe1e98eb'),
(6356, 251, 'товар_0_лицензия', 'РУ: ЛСР-005971/10 от 25.06.2010'),
(6357, 251, '_товар_0_лицензия', 'field_62436ff0e98ec'),
(6358, 251, 'товар_0_изображение', '51'),
(6359, 251, '_товар_0_изображение', 'field_62437045e98ed'),
(6360, 251, 'товар_1_название', 'Урорек 8мг №90'),
(6361, 251, '_товар_1_название', 'field_62436fcce98ea'),
(6362, 251, 'товар_1_описание', 'Выгодная упаковка, рассчитанная на&nbsp;3&nbsp;месяца лечения. Самая доступная стоимость 1&nbsp;дня терапии препаратом Урорек&nbsp;<sup>27</sup>'),
(6363, 251, '_товар_1_описание', 'field_62436fe1e98eb'),
(6364, 251, 'товар_1_лицензия', 'РУ: ЛСР-005971/10 от 25.06.2010'),
(6365, 251, '_товар_1_лицензия', 'field_62436ff0e98ec'),
(6366, 251, 'товар_1_изображение', '53'),
(6367, 251, '_товар_1_изображение', 'field_62437045e98ed'),
(6368, 251, 'товар_2_название', 'Урорек 4мг №30'),
(6369, 251, '_товар_2_название', 'field_62436fcce98ea'),
(6370, 251, 'товар_2_описание', '4&nbsp;мг&nbsp;&mdash; стартовая доза для лечения симптомов ДГПЖ у&nbsp;пациентов с&nbsp;почечной недостаточностью средней степени тяжести<sup>6</sup>'),
(6371, 251, '_товар_2_описание', 'field_62436fe1e98eb'),
(6372, 251, 'товар_2_лицензия', 'РУ: ЛСР-005971/10 от 25.06.2010'),
(6373, 251, '_товар_2_лицензия', 'field_62436ff0e98ec'),
(6374, 251, 'товар_2_изображение', '52'),
(6375, 251, '_товар_2_изображение', 'field_62437045e98ed'),
(6376, 251, 'товар', '3'),
(6377, 251, '_товар', 'field_62436fbde98e9'),
(6378, 251, 'заголовок-4', 'Где купить'),
(6379, 251, '_заголовок-4', 'field_624374f73d8bd'),
(6380, 251, 'изображения', 'a:12:{i:0;s:2:\"63\";i:1;s:2:\"64\";i:2;s:2:\"65\";i:3;s:2:\"66\";i:4;s:2:\"67\";i:5;s:2:\"68\";i:6;s:2:\"69\";i:7;s:2:\"70\";i:8;s:2:\"71\";i:9;s:2:\"72\";i:10;s:2:\"73\";i:11;s:2:\"74\";}'),
(6381, 251, '_изображения', 'field_624375093d8be'),
(6382, 251, 'изображения-4', 'a:12:{i:0;s:2:\"63\";i:1;s:2:\"64\";i:2;s:2:\"65\";i:3;s:2:\"66\";i:4;s:2:\"67\";i:5;s:2:\"68\";i:6;s:2:\"69\";i:7;s:2:\"70\";i:8;s:2:\"71\";i:9;s:2:\"72\";i:10;s:2:\"73\";i:11;s:2:\"74\";}'),
(6383, 251, '_изображения-4', 'field_624375093d8be'),
(6384, 251, 'заголовок-5', 'Способ применения*<sup>6</sup>'),
(6385, 251, '_заголовок-5', 'field_624379bd4756d'),
(6386, 251, 'иконки', 'a:5:{i:0;s:2:\"83\";i:1;s:2:\"84\";i:2;s:2:\"85\";i:3;s:2:\"86\";i:4;s:2:\"87\";}'),
(6387, 251, '_иконки', 'field_624379f24756e'),
(6388, 251, 'текст-5', 'У пациентов с легкой почечной недостаточностью (клиренс креатинина ≥ 50 — ≤ 80 мл/мин) коррекция дозы не требуется. Для лечения пациентов с почечной недостаточностью средней степени тяжести (клиренс креатинина ≥ 30 — < 50 мл/мин) рекомендуется в течение первой недели принимать начальную дозу по 4 мг в сутки, при хорошей индивидуальной переносимости доза может быть увеличена до 8 мг в сутки. Применение препарата для пациентов с тяжелой почечной недостаточностью (клиренс креатинина < 30 мл / мин) не рекомендуется'),
(6389, 251, '_текст-5', 'field_62437a374756f'),
(6390, 251, 'текст_под_кнопкой', '*Более подробные сведения о&nbsp;препарате, особенностях применения, побочных действиях и&nbsp;др. &mdash;&nbsp;см. инструкцию по&nbsp;медицинскому применению лекарственного препарата Урорек, РУ&nbsp;ЛСР-005971/10 от&nbsp;25.06.2010'),
(6391, 251, '_текст_под_кнопкой', 'field_62437a7c47570'),
(6392, 251, 'заголовок-6', 'Препарат Урорек (силодозин) включен в&nbsp;российские и&nbsp;международные клинические рекомендации и&nbsp;стандарты для лечения ряда урологических заболеваний:'),
(6393, 251, '_заголовок-6', 'field_6244117c68bd0'),
(6394, 251, 'список-6_0_ссылка', 'a:3:{s:5:\"title\";s:68:\"Российские клинические рекомендации\";s:3:\"url\";s:1:\"#\";s:6:\"target\";s:0:\"\";}'),
(6395, 251, '_список-6_0_ссылка', 'field_624411ce68bd2'),
(6396, 251, 'список-6_0_описание', '«Доброкачественная гиперплазия предстательной железы», 2020<sup>28</sup>'),
(6397, 251, '_список-6_0_описание', 'field_6244121168bd3'),
(6398, 251, 'список-6_1_ссылка', 'a:3:{s:5:\"title\";s:70:\"Европейские клинические рекомендации\";s:3:\"url\";s:1:\"#\";s:6:\"target\";s:0:\"\";}'),
(6399, 251, '_список-6_1_ссылка', 'field_624411ce68bd2'),
(6400, 251, 'список-6_1_описание', 'глава «Консервативное лечение ненейрогенных симптомов нарушенного мочеиспускания у мужчин, включая доброкачественную простатическую обструкцию», 2021<sup>29</sup>'),
(6401, 251, '_список-6_1_описание', 'field_6244121168bd3'),
(6402, 251, 'список-6_2_ссылка', 'a:3:{s:5:\"title\";s:154:\"Стандарт первичной медико-санитарной помощи при гиперплазии предстательной железы\";s:3:\"url\";s:1:\"#\";s:6:\"target\";s:0:\"\";}'),
(6403, 251, '_список-6_2_ссылка', 'field_624411ce68bd2'),
(6404, 251, 'список-6_2_описание', '09.11.2012<sup>30</sup> / Обновлён 13.04.2015\r\n'),
(6405, 251, '_список-6_2_описание', 'field_6244121168bd3'),
(6406, 251, 'список-6_3_ссылка', 'a:3:{s:5:\"title\";s:122:\"Стандарт специализированной медицинской помощи при задержке мочи\";s:3:\"url\";s:1:\"#\";s:6:\"target\";s:0:\"\";}'),
(6407, 251, '_список-6_3_ссылка', 'field_624411ce68bd2'),
(6408, 251, 'список-6_3_описание', '29.01.2013<sup>31</sup> / Обновлён 06.05.2015\r\n'),
(6409, 251, '_список-6_3_описание', 'field_6244121168bd3'),
(6410, 251, 'список-6_4_ссылка', 'a:3:{s:5:\"title\";s:133:\"Стандарт первичной медико-санитарной помощи при хроническом простатите\";s:3:\"url\";s:1:\"#\";s:6:\"target\";s:0:\"\";}'),
(6411, 251, '_список-6_4_ссылка', 'field_624411ce68bd2'),
(6412, 251, 'список-6_4_описание', '09.11.2012<sup>32</sup> / Обновлён 13.04.2015\r\n'),
(6413, 251, '_список-6_4_описание', 'field_6244121168bd3'),
(6414, 251, 'список-6_5_ссылка', 'a:3:{s:5:\"title\";s:168:\"Стандарт специализированной медицинской помощи при остром простатите, орхите, эпидидимите\";s:3:\"url\";s:1:\"#\";s:6:\"target\";s:0:\"\";}'),
(6415, 251, '_список-6_5_ссылка', 'field_624411ce68bd2'),
(6416, 251, 'список-6_5_описание', '09.11.2012<sup>33</sup> / Обновлён 27.05.2015'),
(6417, 251, '_список-6_5_описание', 'field_6244121168bd3'),
(6418, 251, 'список-6', '6'),
(6419, 251, '_список-6', 'field_624411be68bd1'),
(6420, 251, 'заголовок-7', 'Препарат Урорек (силодозин) зарегистрирован и&nbsp;применяется в&nbsp;разных странах мира \r\nОдобрен ЕМА*<sup>34</sup> и&nbsp;FDA**<sup>35</sup>'),
(6421, 251, '_заголовок-7', 'field_624417e3b6088'),
(6422, 251, 'текст', '<p class=\"sOtherCountries__agency\"><span>EMA</span> Европейское медицинское агентство</p>\r\n<p class=\"sOtherCountries__agency\"><span>FDA</span> Управление по&nbsp;санитарному надзору за&nbsp;качеством пищевых продуктов и&nbsp;медикаментов, США</p>'),
(6423, 251, '_текст', 'field_6244182bb6089'),
(6424, 251, 'страны_0_флаг', '105'),
(6425, 251, '_страны_0_флаг', 'field_62441880b608b'),
(6426, 251, 'страны_0_название', 'Япония'),
(6427, 251, '_страны_0_название', 'field_62441899b608c'),
(6428, 251, 'страны_0_год', '2006<sup>36,37</sup>'),
(6429, 251, '_страны_0_год', 'field_624418aab608d'),
(6430, 251, 'страны_1_флаг', '106'),
(6431, 251, '_страны_1_флаг', 'field_62441880b608b'),
(6432, 251, 'страны_1_название', 'США'),
(6433, 251, '_страны_1_название', 'field_62441899b608c'),
(6434, 251, 'страны_1_год', '2008<sup>35</sup>'),
(6435, 251, '_страны_1_год', 'field_624418aab608d'),
(6436, 251, 'страны_2_флаг', '107'),
(6437, 251, '_страны_2_флаг', 'field_62441880b608b'),
(6438, 251, 'страны_2_название', 'Страны ЕС'),
(6439, 251, '_страны_2_название', 'field_62441899b608c'),
(6440, 251, 'страны_2_год', '2010<sup>34</sup>');
INSERT INTO `urotec_postmeta` (`meta_id`, `post_id`, `meta_key`, `meta_value`) VALUES
(6441, 251, '_страны_2_год', 'field_624418aab608d'),
(6442, 251, 'страны_3_флаг', '108'),
(6443, 251, '_страны_3_флаг', 'field_62441880b608b'),
(6444, 251, 'страны_3_название', 'Россия'),
(6445, 251, '_страны_3_название', 'field_62441899b608c'),
(6446, 251, 'страны_3_год', '2010<sup>1</sup>'),
(6447, 251, '_страны_3_год', 'field_624418aab608d'),
(6448, 251, 'страны', '4'),
(6449, 251, '_страны', 'field_62441847b608a'),
(6450, 251, 'текст-7', '<p class=\"sOtherCountries__agency\"><span>EMA</span> Европейское медицинское агентство</p>\r\n<p class=\"sOtherCountries__agency\"><span>FDA</span> Управление по&nbsp;санитарному надзору за&nbsp;качеством пищевых продуктов и&nbsp;медикаментов, США</p>'),
(6451, 251, '_текст-7', 'field_6244182bb6089'),
(6452, 251, 'текст-7-1', 'Производство препарата Урорек, поставляемого в&nbsp;Россию, осуществляется в&nbsp;Италии с&nbsp;использованием субстанции из&nbsp;Японии, в&nbsp;соответствии с&nbsp;необходимыми требованиями к&nbsp;производству и&nbsp;контролю качества<sup>6,1</sup>'),
(6453, 251, '_текст-7-1', 'field_62441a5acf03c'),
(6454, 251, 'заголовок-8', 'О проблеме'),
(6455, 251, '_заголовок-8', 'field_624431d91624d'),
(6456, 251, 'текст-8', 'Доброкачественная гиперплазия предстательной железы (ДГПЖ), или как ее еще называют, аденома простаты, как правило, возникает у мужчин старше 50 лет и характеризуется наличием симптомов нижних мочевыводящих путей (СНМП), увеличением предстательной железы или ее части, и нарушением оттока мочи из мочевого пузыря вследствие инфравезикальной обструкции.<sup>38</sup>\r\n\r\nРаспространенность ДГПЖ увеличивается с возрастом. Так, клинически значимая ДГПЖ проявляется у 13% мужчин в возрасте старше 50 лет, у 34% мужчин в возрасте 60 лет и у 43% в возрасте 70 лет.<sup>39</sup>\r\n\r\n&nbsp;\r\n\r\n<img class=\"alignnone wp-image-122 size-full\" src=\"http://0026urotec.loc:8888/wp-content/uploads/2022/03/about-img.png\" alt=\"\" width=\"594\" height=\"696\" />'),
(6457, 251, '_текст-8', 'field_624431f11624e'),
(6458, 251, 'текст-8-1', 'Наличие СНМП может быть ассоциировано с&nbsp;тяжелыми хроническими заболеваниями, такими как заболевания сердца, сахарный диабет, артериальная гипертензия и&nbsp;депрессия<sup>40</sup>'),
(6459, 251, '_текст-8-1', 'field_6244320b26db3'),
(6460, 251, 'иконки-8', 'a:6:{i:0;s:3:\"123\";i:1;s:3:\"124\";i:2;s:3:\"125\";i:3;s:3:\"126\";i:4;s:3:\"127\";i:5;s:3:\"128\";}'),
(6461, 251, '_иконки-8', 'field_6244322d26db4'),
(6462, 251, 'текст-8-2', '<h3>Симптомы доброкачественной гиперплазии предстательной железы</h3>\r\nСимптомы нарушенного мочеиспускания являются частой жалобой у взрослых мужчин. Они оказывают серьезное негативное влияние на качество жизни. При ДГПЖ предстательная железа увеличивается в размерах, оказывая давление на нижние мочевые пути. В результате развиваются следующие симптомы:<sup>41</sup>'),
(6463, 251, '_текст-8-2', 'field_6244335fe2373'),
(6464, 251, 'заголовок-9', 'Осложнения ДГПЖ<sup>38</sup>'),
(6465, 251, '_заголовок-9', 'field_6244377a52263'),
(6466, 251, 'изображения-9', 'a:6:{i:0;s:3:\"141\";i:1;s:3:\"142\";i:2;s:3:\"143\";i:3;s:3:\"144\";i:4;s:3:\"145\";i:5;s:3:\"146\";}'),
(6467, 251, '_изображения-9', 'field_6244379652264'),
(6468, 251, 'заголовок-10', 'Медикаментозное лечение СНМП/ДГПЖ'),
(6469, 251, '_заголовок-10', 'field_6244489614262'),
(6470, 251, 'текст-10', 'Антагонисты альфа1-адренорецепторов (альфа-адреноблокаторы) и&nbsp;ингибиторы 5&nbsp;альфа1-редуктазы (ингибиторы 5-АР) являются группами лекарственных препаратов, которые в&nbsp;настоящее время утверждены для лечения ДГПЖ. Обе группы препаратов обеспечивают надлежащее ослабление симптомов, но&nbsp;&alpha;&mdash;блокаторы обладают довольно быстрым началом действия, а&nbsp;ингибиторам 5-АР требуется несколько месяцев для получения терапевтического эффекта.<sup>42</sup>'),
(6471, 251, '_текст-10', 'field_624448ce14263'),
(6472, 251, 'карточки-10_0_заголовок', 'Альфа-адреноблокаторы'),
(6473, 251, '_карточки-10_0_заголовок', 'field_624448fc14265'),
(6474, 251, 'карточки-10_0_текст', 'представляют собой наиболее эффективный класс лекарственных препаратов, характеризующийся хорошим профилем безопасности и высокой комплаентностью, применяющийся для облегчения СНМП, связанных с ДГПЖ: они снимают спазм гладкой мускулатуры предстательной железы и шейки мочевого пузыря<sup>42</sup>'),
(6475, 251, '_карточки-10_0_текст', 'field_6244490c14266'),
(6476, 251, 'карточки-10_1_заголовок', 'Ингибиторы 5-АР'),
(6477, 251, '_карточки-10_1_заголовок', 'field_624448fc14265'),
(6478, 251, 'карточки-10_1_текст', 'приводят к редукции железистой ткани и к снижению размера предстательной железы: они блокируют конверсию тестостерона в дигидротестостерон, который стимулирует рост предстательной железы<sup>43,44</sup>.Назначаются при большом объеме предстательной железы. Для получения значимого клинического эффекта требуется несколько месяцев применения<sup>45</sup>\r\n'),
(6479, 251, '_карточки-10_1_текст', 'field_6244490c14266'),
(6480, 251, 'карточки-10', '2'),
(6481, 251, '_карточки-10', 'field_624448e214264'),
(6482, 251, 'видео', '<iframe width=\"560\" height=\"315\" src=\"https://www.youtube.com/embed/3DrU3pFXSsY\" title=\"YouTube video player\" frameborder=\"0\" allow=\"accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture\" allowfullscreen></iframe>'),
(6483, 251, '_видео', 'field_6244492214267'),
(6484, 251, 'заголовок-11', 'Часто задаваемые вопросы'),
(6485, 251, '_заголовок-11', 'field_62444b33e25d6'),
(6486, 251, 'вопросы_0_заголовок', 'Почему при приеме препарата Урорек у некоторых пациентов развивается нарушение эякуляции?'),
(6487, 251, '_вопросы_0_заголовок', 'field_62444b58e25d8'),
(6488, 251, 'вопросы_0_текст', 'Урорек — высокоселективный препарат, то есть преимущественно действует на альфа1А-адренорецепторы, которые находятся в нижних мочевых путях, предстательной железе и семенных пузырьках. Поэтому эффект развивается уже через 2–6 часов после приёма первой дозы препарата Урорек<sup>14</sup> при минимальным количестве нежелательных явлений.<sup>5</sup>\r\n\r\nНаиболее частый побочный эффект при приеме препарата Урорек — нарушение эякуляции<sup>46</sup>. Это может быть связано как с забросом эякулята при семяизвержении вместо уретры в мочевой пузырь, так и со снижением или отсутствием семенной жидкости во время эякуляции<sup>29</sup>. Силодозин снижает тонус гладкомышечных клеток семенных пузырьков, простаты и шейки мочевого пузыря, поэтому не происходит выброс семени. Этот эффект свойственен всем уроселективным альфа-адреноблокаторам<sup>53</sup> и самостоятельно исчезает после прекращения приема препарата.<sup>6</sup>\r\n\r\nЧастота эякуляторной дисфункции прямо пропорционально связана с улучшением СНМП и скорости мочеиспускания и подтверждает эффективность альфа-адреноблокатора: чем выше эффективность, тем выше частота встречаемости эякуляторной дисфункции.<sup>29</sup>\r\n\r\nНарушение эякуляции не влияет на сексуальную функцию<sup>52</sup>, не воспринимается как беспокоящий симптом подавляющим большинством пациентов и не требует отмены терапии.<sup>46</sup>'),
(6489, 251, '_вопросы_0_текст', 'field_62444b66e25d9'),
(6490, 251, 'вопросы_1_заголовок', 'Можно ли принимать Урорек при артериальной гипертензии и ишемический болезни сердца (ИБС)?'),
(6491, 251, '_вопросы_1_заголовок', 'field_62444b58e25d8'),
(6492, 251, 'вопросы_1_текст', 'Согласно инструкции по медицинскому применению, противопоказаний для применения лекарственного препарата Урорек у пациентов с СНМП/ДГПЖ и сопутствующими сердечно-сосудистыми заболеваниями нет.<sup>3</sup> Урорек не оказывает влияния на частоту сердечных сокращений (ЧСС), систолическое артериальное давление (САД) и диастолическое артериальное давление (ДАД).<sup>9</sup> Силодозин — не вызывает клинически значимого снижения артериального давления (АД)<sup>46</sup>, не усиливает действие антигипертензивных препаратов и не требует снижения дозы при одновременном приеме.<sup>7</sup> В соответствии с дизайном клинического исследования многие пациенты получали сопутствующую терапию антигипертензивными препаратами (в основном, средствами, воздействующими на ренин-ангиотензиновую систему, бета-блокаторами, антагонистами кальция и диуретиками) без повышения частоты ортостатической гипотензии.<sup>6</sup>\r\n\r\nПри приеме препарата Урорек наиболее низкий риск развития сердечно-сосудистых осложнений.<sup>5</sup>'),
(6493, 251, '_вопросы_1_текст', 'field_62444b66e25d9'),
(6494, 251, 'вопросы_2_заголовок', 'Можно ли принимать Урорек пациенту с ортостатической гипотензией в анамнезе?'),
(6495, 251, '_вопросы_2_заголовок', 'field_62444b58e25d8'),
(6496, 251, 'вопросы_2_текст', 'Повышенная селективность силодозина к альфа1A-адренорецепторам по сравнению с альфа1B-адренорецепторами выражается в пониженном риске развития сердечно-сосудистых осложнений.<sup>4</sup> Благодаря этому частота ортостатической гипотензии на фоне его приема сравнима с таковой при приеме плацебо.<sup>45,9</sup>\r\n\r\nВ отличие от других альфа-адреноблокаторов (например, все формы тамсулозина<sup>47,48</sup>), Урорек не противопоказан к приему у пациентов с ортостатической гипотензией в анамнезе. Тем не менее, пациентам с ортостатической гипотензией в анамнезе не рекомендуется принимать любые альфа-адреноблокаторы, в т.ч. Урорек.<sup>6</sup>'),
(6497, 251, '_вопросы_2_текст', 'field_62444b66e25d9'),
(6498, 251, 'вопросы_3_заголовок', 'Как долго можно принимать Урорек?'),
(6499, 251, '_вопросы_3_заголовок', 'field_62444b58e25d8'),
(6500, 251, 'вопросы_3_текст', 'Учитывая прогрессирующий характер течения доброкачественной гиперплазии предстательной железы, медикаментозную терапию следует проводить длительно (иногда в течение всей жизни пациента).<sup>49</sup>'),
(6501, 251, '_вопросы_3_текст', 'field_62444b66e25d9'),
(6502, 251, 'вопросы_4_заголовок', 'Пациенты жалуются на заложенность носа при лечении альфа-адреноблокаторами. Есть ли у препарата Урорек такое побочное действие?'),
(6503, 251, '_вопросы_4_заголовок', 'field_62444b58e25d8'),
(6504, 251, 'вопросы_4_текст', 'Заложенность носа — это возможный побочный эффект для всех альфа-адреноблокаторов. При приеме препарата Урорек он может возникать примерно в 1% случаев.<sup>46</sup>'),
(6505, 251, '_вопросы_4_текст', 'field_62444b66e25d9'),
(6506, 251, 'вопросы_5_заголовок', 'Можно ли начинать лечение препаратом Урорек с дозы 4 мг в сутки?'),
(6507, 251, '_вопросы_5_заголовок', 'field_62444b58e25d8'),
(6508, 251, 'вопросы_5_текст', 'Согласно инструкции по медицинскому применению лекарственного препарата Урорек, доза 8 мг в сутки рекомендована для лечения пациентов с СНМП/ДГПЖ. Титрование дозы при применении силодозина не требуется.\r\n\r\nУрорек 4 мг — это специальная доза для лечения пациентов с почечной недостаточностью средней степени тяжести (клиренс креатинина ≥ 30 до &lt; 50 мл/мин). Рекомендуется в течение первой недели принимать начальную дозу по 4 мг в сутки, далее при хорошей переносимости доза может быть увеличена до 8 мг в сутки.<sup>6</sup>*\r\n\r\n<small><strong>*Более подробные сведения о препарате, особенностях применения, побочных действиях и др. — см. инструкцию по медицинскому применению лекарственного препарата Урорек, РУ ЛСР-005971/10 от 25.06.2010</strong></small>'),
(6509, 251, '_вопросы_5_текст', 'field_62444b66e25d9'),
(6510, 251, 'вопросы_6_заголовок', 'Влияет ли Урорек на течение ДГПЖ или только снимает симптомы нижних мочевыводящих путей?'),
(6511, 251, '_вопросы_6_заголовок', 'field_62444b58e25d8'),
(6512, 251, 'вопросы_6_текст', 'Помимо субъективных симптомов, ДГПЖ вызывает прогрессирующее морфологическое ремоделирование мочевого пузыря с риском развития серьезных функциональных нарушений. Лечение должно не только купировать субъективные симптомы, но и включать профилактику патологического ремоделирования мочевого пузыря.<sup>161</sup>\r\n\r\nСилодозин, действующее вещество препарата Урорек, в сравнении с другими альфа-адреноблокаторами более эффективно влияет на инфравезикальную обструкцию (ИВО), что оказывает влияние на предотвращение патологического прогрессирования ремоделирования мочевого пузыря и риск развития серьезных функциональных нарушений.<sup>50,51</sup>'),
(6513, 251, '_вопросы_6_текст', 'field_62444b66e25d9'),
(6514, 251, 'вопросы_7_заголовок', 'Доступен ли Урорек по льготному отпуску?'),
(6515, 251, '_вопросы_7_заголовок', 'field_62444b58e25d8'),
(6516, 251, 'вопросы_7_текст', 'Урорек (силодозин) не включен в список жизненно важных лекарственных препаратов (ЖНВЛП)<sup>1</sup> и не входит в перечень препаратов для льготного обеспечения граждан по федеральному льготному списку.'),
(6517, 251, '_вопросы_7_текст', 'field_62444b66e25d9'),
(6518, 251, 'вопросы', '8'),
(6519, 251, '_вопросы', 'field_62444b49e25d7'),
(6520, 252, 'заголовок-1', 'УРОРЕК – оригинальный<sup>10</sup> альфа-адреноблокатор'),
(6521, 252, '_заголовок-1', 'field_62435bd26f29f'),
(6522, 252, 'текст-1', '<div class=\"headerBlock__body\">\r\n<p>Силодозин (действующее вещество препарата Урорек) обладает максимальной уроселективностью в&nbsp;своем классе, что обеспечивает его уродинамическую эффективность и&nbsp;высокую безопасность<sup>4</sup></p>\r\n</div>\r\n<div class=\"headerBlock__footer\">\r\n<p><strong>Показания к применению: </strong><br/>Лечение симптомов доброкачественной гиперплазии предстательной железы<sup>6</sup></p>\r\n</div>'),
(6523, 252, '_текст-1', 'field_62435c0c6f2a0'),
(6524, 252, 'изображение-1', '13'),
(6525, 252, '_изображение-1', 'field_62435c8b6f2a1'),
(6526, 252, 'фон-1', '17'),
(6527, 252, '_фон-1', 'field_62435db92ea96'),
(6528, 252, 'заголовок-2', 'Ключевые преимущества препарата Урорек'),
(6529, 252, '_заголовок-2', 'field_6243606295196'),
(6530, 252, 'список-2', 'Единственный оригинальный препарат из&nbsp;группы альфа1-адреноблокаторов, не&nbsp;имеющий генериков в&nbsp;РФ<sup>1</sup>'),
(6531, 252, '_список-2', 'field_6243608195197'),
(6532, 252, 'картинка_с_текстом_0_изображение', '31'),
(6533, 252, '_картинка_с_текстом_0_изображение', 'field_624363d095199'),
(6534, 252, 'картинка_с_текстом_0_описание', 'Обширная доказательная база собственных пострегистрационных клинических исследований<sup>2</sup>'),
(6535, 252, '_картинка_с_текстом_0_описание', 'field_624363e59519a'),
(6536, 252, 'картинка_с_текстом_1_изображение', '32'),
(6537, 252, '_картинка_с_текстом_1_изображение', 'field_624363d095199'),
(6538, 252, 'картинка_с_текстом_1_описание', 'Отсутствие риска замены препарата Урорек в&nbsp;аптеке (единственный препарат с&nbsp;действующим веществом силодозин)<sup>1</sup>'),
(6539, 252, '_картинка_с_текстом_1_описание', 'field_624363e59519a'),
(6540, 252, 'картинка_с_текстом_2_изображение', '33'),
(6541, 252, '_картинка_с_текстом_2_изображение', 'field_624363d095199'),
(6542, 252, 'картинка_с_текстом_2_описание', 'Большинство пациентов предпочитают принимать оригинальные препараты<sup>3</sup>'),
(6543, 252, '_картинка_с_текстом_2_описание', 'field_624363e59519a'),
(6544, 252, 'картинка_с_текстом', '3'),
(6545, 252, '_картинка_с_текстом', 'field_624363b995198'),
(6546, 252, 'второй_список', '<li>Клинические преимущества препарата Урорек (силодозин) определяются максимальной уроселективностью в&nbsp;классе альфа-адреноблокаторов<sup>4</sup></li>\r\n\r\n<li>Урорек&nbsp;&mdash; альфа-адреноблокатор последнего поколения, который эффективен в&nbsp;отношении всех СНМП (накопления, опорожнения, постмиктурических).<sup>12,13</sup> При этом Урорек обладает минимальным риском развития нежелательных явлений со&nbsp;стороны сердечно-сосудистой системы, в&nbsp;том числе&nbsp;у&nbsp;пациентов, принимающих антигипертензивные препараты<sup>46,8</sup> <small> <span>СНМП </span>симптомы нижних мочевыводящих путей</small></li>'),
(6547, 252, '_второй_список', 'field_6243640e05eda'),
(6548, 252, 'заголовок2-2', 'Максимальная уроселективность силодозина в&nbsp;классе альфа-адреноблокаторов обуславливает его уродинамическую эффективность и&nbsp;высокий профиль безопасности<sup>4</sup>'),
(6549, 252, '_заголовок2-2', 'field_6243644705edb'),
(6550, 252, 'текст3', '<ul>\r\n<li>Урорек значительно улучшает клинические проявления и&nbsp;качество жизни у&nbsp;всех пациентов с&nbsp;СНМП/ДГПЖ, в&nbsp;том числе с&nbsp;тяжелым течением<sup>11</sup>\r\n<a href=\"#modal-call-first\" class=\"link-modal-js\">Узнать больше...</a></li>\r\n\r\n<li>Урорек является препаратом выбора для пациентов с&nbsp;СНМП/ДГПЖ и&nbsp;сопутствующими сердечно-сосудистыми заболеваниями<sup>3</sup> \r\n<a href=\"#modal-call-second\" class=\"link-modal-js\">Узнать больше...</a></li>\r\n</ul>\r\n<small> <span>ДГПЖ </span>доброкачественная гиперплазия предстательной железы</small>'),
(6551, 252, '_текст3', 'field_6243647405edc'),
(6552, 252, 'изображение-2', '34'),
(6553, 252, '_изображение-2', 'field_624364dd05edd'),
(6554, 252, 'текст_в_подвале', '<h2> Максимальная уроселективность в&nbsp;классе  альфа-адреноблокаторов<sup>4</sup></h2>\r\n<div class=\"h3\"> Почему это важно? <a href=\"#modal-call-second\" class=\"link-modal-js\">Подробнее</a></div>'),
(6555, 252, '_текст_в_подвале', 'field_62436daf1f6d9'),
(6556, 252, 'заголовок-3', 'Форма выпуска препарата Урорек'),
(6557, 252, '_заголовок-3', 'field_62436efee98e7'),
(6558, 252, 'текст-3', '<p class=\"section-descr\"><span>8мг </span>- рекомендуемая доза для лечения симптомов ДГПЖ<sup>6</sup>*</p>\r\n					<p class=\"section-note col-md-10\">*Более подробные сведения о&nbsp;препарате, особенностях применения, побочных действиях и&nbsp;др. &mdash;&nbsp;смотрите инструкцию по&nbsp;медицинскому применению лекарственного препарата Урорек, РУ&nbsp;ЛСР-005971/10 от&nbsp;25.06.2010 </p>'),
(6559, 252, '_текст-3', 'field_62436f60e98e8'),
(6560, 252, 'товар_0_название', 'Урорек 8мг №30'),
(6561, 252, '_товар_0_название', 'field_62436fcce98ea'),
(6562, 252, 'товар_0_описание', 'Упаковка, рассчитанная на&nbsp;1&nbsp;месяц лечения&nbsp;/ для старта терапии'),
(6563, 252, '_товар_0_описание', 'field_62436fe1e98eb'),
(6564, 252, 'товар_0_лицензия', 'РУ: ЛСР-005971/10 от 25.06.2010'),
(6565, 252, '_товар_0_лицензия', 'field_62436ff0e98ec'),
(6566, 252, 'товар_0_изображение', '51'),
(6567, 252, '_товар_0_изображение', 'field_62437045e98ed'),
(6568, 252, 'товар_1_название', 'Урорек 8мг №90'),
(6569, 252, '_товар_1_название', 'field_62436fcce98ea'),
(6570, 252, 'товар_1_описание', 'Выгодная упаковка, рассчитанная на&nbsp;3&nbsp;месяца лечения. Самая доступная стоимость 1&nbsp;дня терапии препаратом Урорек&nbsp;<sup>27</sup>'),
(6571, 252, '_товар_1_описание', 'field_62436fe1e98eb'),
(6572, 252, 'товар_1_лицензия', 'РУ: ЛСР-005971/10 от 25.06.2010'),
(6573, 252, '_товар_1_лицензия', 'field_62436ff0e98ec'),
(6574, 252, 'товар_1_изображение', '53'),
(6575, 252, '_товар_1_изображение', 'field_62437045e98ed'),
(6576, 252, 'товар_2_название', 'Урорек 4мг №30'),
(6577, 252, '_товар_2_название', 'field_62436fcce98ea'),
(6578, 252, 'товар_2_описание', '4&nbsp;мг&nbsp;&mdash; стартовая доза для лечения симптомов ДГПЖ у&nbsp;пациентов с&nbsp;почечной недостаточностью средней степени тяжести<sup>6</sup>'),
(6579, 252, '_товар_2_описание', 'field_62436fe1e98eb'),
(6580, 252, 'товар_2_лицензия', 'РУ: ЛСР-005971/10 от 25.06.2010'),
(6581, 252, '_товар_2_лицензия', 'field_62436ff0e98ec'),
(6582, 252, 'товар_2_изображение', '52'),
(6583, 252, '_товар_2_изображение', 'field_62437045e98ed'),
(6584, 252, 'товар', '3'),
(6585, 252, '_товар', 'field_62436fbde98e9'),
(6586, 252, 'заголовок-4', 'Где купить'),
(6587, 252, '_заголовок-4', 'field_624374f73d8bd'),
(6588, 252, 'изображения', 'a:12:{i:0;s:2:\"63\";i:1;s:2:\"64\";i:2;s:2:\"65\";i:3;s:2:\"66\";i:4;s:2:\"67\";i:5;s:2:\"68\";i:6;s:2:\"69\";i:7;s:2:\"70\";i:8;s:2:\"71\";i:9;s:2:\"72\";i:10;s:2:\"73\";i:11;s:2:\"74\";}'),
(6589, 252, '_изображения', 'field_624375093d8be'),
(6590, 252, 'изображения-4', 'a:12:{i:0;s:2:\"63\";i:1;s:2:\"64\";i:2;s:2:\"65\";i:3;s:2:\"66\";i:4;s:2:\"67\";i:5;s:2:\"68\";i:6;s:2:\"69\";i:7;s:2:\"70\";i:8;s:2:\"71\";i:9;s:2:\"72\";i:10;s:2:\"73\";i:11;s:2:\"74\";}'),
(6591, 252, '_изображения-4', 'field_624375093d8be'),
(6592, 252, 'заголовок-5', 'Способ применения*<sup>6</sup>'),
(6593, 252, '_заголовок-5', 'field_624379bd4756d'),
(6594, 252, 'иконки', 'a:5:{i:0;s:2:\"83\";i:1;s:2:\"84\";i:2;s:2:\"85\";i:3;s:2:\"86\";i:4;s:2:\"87\";}'),
(6595, 252, '_иконки', 'field_624379f24756e'),
(6596, 252, 'текст-5', 'У пациентов с легкой почечной недостаточностью (клиренс креатинина ≥ 50 — ≤ 80 мл/мин) коррекция дозы не требуется. Для лечения пациентов с почечной недостаточностью средней степени тяжести (клиренс креатинина ≥ 30 — < 50 мл/мин) рекомендуется в течение первой недели принимать начальную дозу по 4 мг в сутки, при хорошей индивидуальной переносимости доза может быть увеличена до 8 мг в сутки. Применение препарата для пациентов с тяжелой почечной недостаточностью (клиренс креатинина < 30 мл / мин) не рекомендуется'),
(6597, 252, '_текст-5', 'field_62437a374756f'),
(6598, 252, 'текст_под_кнопкой', '*Более подробные сведения о&nbsp;препарате, особенностях применения, побочных действиях и&nbsp;др. &mdash;&nbsp;см. инструкцию по&nbsp;медицинскому применению лекарственного препарата Урорек, РУ&nbsp;ЛСР-005971/10 от&nbsp;25.06.2010'),
(6599, 252, '_текст_под_кнопкой', 'field_62437a7c47570'),
(6600, 252, 'заголовок-6', 'Препарат Урорек (силодозин) включен в&nbsp;российские и&nbsp;международные клинические рекомендации и&nbsp;стандарты для лечения ряда урологических заболеваний:'),
(6601, 252, '_заголовок-6', 'field_6244117c68bd0'),
(6602, 252, 'список-6_0_ссылка', 'a:3:{s:5:\"title\";s:68:\"Российские клинические рекомендации\";s:3:\"url\";s:1:\"#\";s:6:\"target\";s:0:\"\";}'),
(6603, 252, '_список-6_0_ссылка', 'field_624411ce68bd2'),
(6604, 252, 'список-6_0_описание', '«Доброкачественная гиперплазия предстательной железы», 2020<sup>28</sup>'),
(6605, 252, '_список-6_0_описание', 'field_6244121168bd3'),
(6606, 252, 'список-6_1_ссылка', 'a:3:{s:5:\"title\";s:70:\"Европейские клинические рекомендации\";s:3:\"url\";s:1:\"#\";s:6:\"target\";s:0:\"\";}'),
(6607, 252, '_список-6_1_ссылка', 'field_624411ce68bd2'),
(6608, 252, 'список-6_1_описание', 'глава «Консервативное лечение ненейрогенных симптомов нарушенного мочеиспускания у мужчин, включая доброкачественную простатическую обструкцию», 2021<sup>29</sup>'),
(6609, 252, '_список-6_1_описание', 'field_6244121168bd3'),
(6610, 252, 'список-6_2_ссылка', 'a:3:{s:5:\"title\";s:154:\"Стандарт первичной медико-санитарной помощи при гиперплазии предстательной железы\";s:3:\"url\";s:1:\"#\";s:6:\"target\";s:0:\"\";}'),
(6611, 252, '_список-6_2_ссылка', 'field_624411ce68bd2'),
(6612, 252, 'список-6_2_описание', '09.11.2012<sup>30</sup> / Обновлён 13.04.2015\r\n'),
(6613, 252, '_список-6_2_описание', 'field_6244121168bd3'),
(6614, 252, 'список-6_3_ссылка', 'a:3:{s:5:\"title\";s:122:\"Стандарт специализированной медицинской помощи при задержке мочи\";s:3:\"url\";s:1:\"#\";s:6:\"target\";s:0:\"\";}'),
(6615, 252, '_список-6_3_ссылка', 'field_624411ce68bd2'),
(6616, 252, 'список-6_3_описание', '29.01.2013<sup>31</sup> / Обновлён 06.05.2015\r\n'),
(6617, 252, '_список-6_3_описание', 'field_6244121168bd3'),
(6618, 252, 'список-6_4_ссылка', 'a:3:{s:5:\"title\";s:133:\"Стандарт первичной медико-санитарной помощи при хроническом простатите\";s:3:\"url\";s:1:\"#\";s:6:\"target\";s:0:\"\";}'),
(6619, 252, '_список-6_4_ссылка', 'field_624411ce68bd2'),
(6620, 252, 'список-6_4_описание', '09.11.2012<sup>32</sup> / Обновлён 13.04.2015\r\n'),
(6621, 252, '_список-6_4_описание', 'field_6244121168bd3'),
(6622, 252, 'список-6_5_ссылка', 'a:3:{s:5:\"title\";s:168:\"Стандарт специализированной медицинской помощи при остром простатите, орхите, эпидидимите\";s:3:\"url\";s:1:\"#\";s:6:\"target\";s:0:\"\";}'),
(6623, 252, '_список-6_5_ссылка', 'field_624411ce68bd2'),
(6624, 252, 'список-6_5_описание', '09.11.2012<sup>33</sup> / Обновлён 27.05.2015'),
(6625, 252, '_список-6_5_описание', 'field_6244121168bd3'),
(6626, 252, 'список-6', '6'),
(6627, 252, '_список-6', 'field_624411be68bd1'),
(6628, 252, 'заголовок-7', 'Препарат Урорек (силодозин) зарегистрирован и&nbsp;применяется в&nbsp;разных странах мира <br>\r\nОдобрен ЕМА*<sup>34</sup> и&nbsp;FDA**<sup>35</sup>'),
(6629, 252, '_заголовок-7', 'field_624417e3b6088'),
(6630, 252, 'текст', '<p class=\"sOtherCountries__agency\"><span>EMA</span> Европейское медицинское агентство</p>\r\n<p class=\"sOtherCountries__agency\"><span>FDA</span> Управление по&nbsp;санитарному надзору за&nbsp;качеством пищевых продуктов и&nbsp;медикаментов, США</p>'),
(6631, 252, '_текст', 'field_6244182bb6089'),
(6632, 252, 'страны_0_флаг', '105'),
(6633, 252, '_страны_0_флаг', 'field_62441880b608b'),
(6634, 252, 'страны_0_название', 'Япония'),
(6635, 252, '_страны_0_название', 'field_62441899b608c'),
(6636, 252, 'страны_0_год', '2006<sup>36,37</sup>'),
(6637, 252, '_страны_0_год', 'field_624418aab608d'),
(6638, 252, 'страны_1_флаг', '106'),
(6639, 252, '_страны_1_флаг', 'field_62441880b608b'),
(6640, 252, 'страны_1_название', 'США'),
(6641, 252, '_страны_1_название', 'field_62441899b608c'),
(6642, 252, 'страны_1_год', '2008<sup>35</sup>'),
(6643, 252, '_страны_1_год', 'field_624418aab608d'),
(6644, 252, 'страны_2_флаг', '107'),
(6645, 252, '_страны_2_флаг', 'field_62441880b608b'),
(6646, 252, 'страны_2_название', 'Страны ЕС'),
(6647, 252, '_страны_2_название', 'field_62441899b608c'),
(6648, 252, 'страны_2_год', '2010<sup>34</sup>'),
(6649, 252, '_страны_2_год', 'field_624418aab608d'),
(6650, 252, 'страны_3_флаг', '108'),
(6651, 252, '_страны_3_флаг', 'field_62441880b608b'),
(6652, 252, 'страны_3_название', 'Россия'),
(6653, 252, '_страны_3_название', 'field_62441899b608c'),
(6654, 252, 'страны_3_год', '2010<sup>1</sup>'),
(6655, 252, '_страны_3_год', 'field_624418aab608d'),
(6656, 252, 'страны', '4'),
(6657, 252, '_страны', 'field_62441847b608a'),
(6658, 252, 'текст-7', '<p class=\"sOtherCountries__agency\"><span>EMA</span> Европейское медицинское агентство</p>\r\n<p class=\"sOtherCountries__agency\"><span>FDA</span> Управление по&nbsp;санитарному надзору за&nbsp;качеством пищевых продуктов и&nbsp;медикаментов, США</p>'),
(6659, 252, '_текст-7', 'field_6244182bb6089'),
(6660, 252, 'текст-7-1', 'Производство препарата Урорек, поставляемого в&nbsp;Россию, осуществляется в&nbsp;Италии с&nbsp;использованием субстанции из&nbsp;Японии, в&nbsp;соответствии с&nbsp;необходимыми требованиями к&nbsp;производству и&nbsp;контролю качества<sup>6,1</sup>'),
(6661, 252, '_текст-7-1', 'field_62441a5acf03c'),
(6662, 252, 'заголовок-8', 'О проблеме'),
(6663, 252, '_заголовок-8', 'field_624431d91624d'),
(6664, 252, 'текст-8', 'Доброкачественная гиперплазия предстательной железы (ДГПЖ), или как ее еще называют, аденома простаты, как правило, возникает у мужчин старше 50 лет и характеризуется наличием симптомов нижних мочевыводящих путей (СНМП), увеличением предстательной железы или ее части, и нарушением оттока мочи из мочевого пузыря вследствие инфравезикальной обструкции.<sup>38</sup>\r\n\r\nРаспространенность ДГПЖ увеличивается с возрастом. Так, клинически значимая ДГПЖ проявляется у 13% мужчин в возрасте старше 50 лет, у 34% мужчин в возрасте 60 лет и у 43% в возрасте 70 лет.<sup>39</sup>\r\n\r\n&nbsp;\r\n\r\n<img class=\"alignnone wp-image-122 size-full\" src=\"http://0026urotec.loc:8888/wp-content/uploads/2022/03/about-img.png\" alt=\"\" width=\"594\" height=\"696\" />'),
(6665, 252, '_текст-8', 'field_624431f11624e'),
(6666, 252, 'текст-8-1', 'Наличие СНМП может быть ассоциировано с&nbsp;тяжелыми хроническими заболеваниями, такими как заболевания сердца, сахарный диабет, артериальная гипертензия и&nbsp;депрессия<sup>40</sup>'),
(6667, 252, '_текст-8-1', 'field_6244320b26db3'),
(6668, 252, 'иконки-8', 'a:6:{i:0;s:3:\"123\";i:1;s:3:\"124\";i:2;s:3:\"125\";i:3;s:3:\"126\";i:4;s:3:\"127\";i:5;s:3:\"128\";}'),
(6669, 252, '_иконки-8', 'field_6244322d26db4'),
(6670, 252, 'текст-8-2', '<h3>Симптомы доброкачественной гиперплазии предстательной железы</h3>\r\nСимптомы нарушенного мочеиспускания являются частой жалобой у взрослых мужчин. Они оказывают серьезное негативное влияние на качество жизни. При ДГПЖ предстательная железа увеличивается в размерах, оказывая давление на нижние мочевые пути. В результате развиваются следующие симптомы:<sup>41</sup>'),
(6671, 252, '_текст-8-2', 'field_6244335fe2373'),
(6672, 252, 'заголовок-9', 'Осложнения ДГПЖ<sup>38</sup>'),
(6673, 252, '_заголовок-9', 'field_6244377a52263'),
(6674, 252, 'изображения-9', 'a:6:{i:0;s:3:\"141\";i:1;s:3:\"142\";i:2;s:3:\"143\";i:3;s:3:\"144\";i:4;s:3:\"145\";i:5;s:3:\"146\";}'),
(6675, 252, '_изображения-9', 'field_6244379652264'),
(6676, 252, 'заголовок-10', 'Медикаментозное лечение СНМП/ДГПЖ'),
(6677, 252, '_заголовок-10', 'field_6244489614262'),
(6678, 252, 'текст-10', 'Антагонисты альфа1-адренорецепторов (альфа-адреноблокаторы) и&nbsp;ингибиторы 5&nbsp;альфа1-редуктазы (ингибиторы 5-АР) являются группами лекарственных препаратов, которые в&nbsp;настоящее время утверждены для лечения ДГПЖ. Обе группы препаратов обеспечивают надлежащее ослабление симптомов, но&nbsp;&alpha;&mdash;блокаторы обладают довольно быстрым началом действия, а&nbsp;ингибиторам 5-АР требуется несколько месяцев для получения терапевтического эффекта.<sup>42</sup>'),
(6679, 252, '_текст-10', 'field_624448ce14263'),
(6680, 252, 'карточки-10_0_заголовок', 'Альфа-адреноблокаторы'),
(6681, 252, '_карточки-10_0_заголовок', 'field_624448fc14265'),
(6682, 252, 'карточки-10_0_текст', 'представляют собой наиболее эффективный класс лекарственных препаратов, характеризующийся хорошим профилем безопасности и высокой комплаентностью, применяющийся для облегчения СНМП, связанных с ДГПЖ: они снимают спазм гладкой мускулатуры предстательной железы и шейки мочевого пузыря<sup>42</sup>'),
(6683, 252, '_карточки-10_0_текст', 'field_6244490c14266'),
(6684, 252, 'карточки-10_1_заголовок', 'Ингибиторы 5-АР'),
(6685, 252, '_карточки-10_1_заголовок', 'field_624448fc14265'),
(6686, 252, 'карточки-10_1_текст', 'приводят к редукции железистой ткани и к снижению размера предстательной железы: они блокируют конверсию тестостерона в дигидротестостерон, который стимулирует рост предстательной железы<sup>43,44</sup>.Назначаются при большом объеме предстательной железы. Для получения значимого клинического эффекта требуется несколько месяцев применения<sup>45</sup>\r\n'),
(6687, 252, '_карточки-10_1_текст', 'field_6244490c14266'),
(6688, 252, 'карточки-10', '2'),
(6689, 252, '_карточки-10', 'field_624448e214264'),
(6690, 252, 'видео', '<iframe width=\"560\" height=\"315\" src=\"https://www.youtube.com/embed/3DrU3pFXSsY\" title=\"YouTube video player\" frameborder=\"0\" allow=\"accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture\" allowfullscreen></iframe>'),
(6691, 252, '_видео', 'field_6244492214267'),
(6692, 252, 'заголовок-11', 'Часто задаваемые вопросы'),
(6693, 252, '_заголовок-11', 'field_62444b33e25d6'),
(6694, 252, 'вопросы_0_заголовок', 'Почему при приеме препарата Урорек у некоторых пациентов развивается нарушение эякуляции?'),
(6695, 252, '_вопросы_0_заголовок', 'field_62444b58e25d8'),
(6696, 252, 'вопросы_0_текст', 'Урорек — высокоселективный препарат, то есть преимущественно действует на альфа1А-адренорецепторы, которые находятся в нижних мочевых путях, предстательной железе и семенных пузырьках. Поэтому эффект развивается уже через 2–6 часов после приёма первой дозы препарата Урорек<sup>14</sup> при минимальным количестве нежелательных явлений.<sup>5</sup>\r\n\r\nНаиболее частый побочный эффект при приеме препарата Урорек — нарушение эякуляции<sup>46</sup>. Это может быть связано как с забросом эякулята при семяизвержении вместо уретры в мочевой пузырь, так и со снижением или отсутствием семенной жидкости во время эякуляции<sup>29</sup>. Силодозин снижает тонус гладкомышечных клеток семенных пузырьков, простаты и шейки мочевого пузыря, поэтому не происходит выброс семени. Этот эффект свойственен всем уроселективным альфа-адреноблокаторам<sup>53</sup> и самостоятельно исчезает после прекращения приема препарата.<sup>6</sup>\r\n\r\nЧастота эякуляторной дисфункции прямо пропорционально связана с улучшением СНМП и скорости мочеиспускания и подтверждает эффективность альфа-адреноблокатора: чем выше эффективность, тем выше частота встречаемости эякуляторной дисфункции.<sup>29</sup>\r\n\r\nНарушение эякуляции не влияет на сексуальную функцию<sup>52</sup>, не воспринимается как беспокоящий симптом подавляющим большинством пациентов и не требует отмены терапии.<sup>46</sup>'),
(6697, 252, '_вопросы_0_текст', 'field_62444b66e25d9'),
(6698, 252, 'вопросы_1_заголовок', 'Можно ли принимать Урорек при артериальной гипертензии и ишемический болезни сердца (ИБС)?'),
(6699, 252, '_вопросы_1_заголовок', 'field_62444b58e25d8'),
(6700, 252, 'вопросы_1_текст', 'Согласно инструкции по медицинскому применению, противопоказаний для применения лекарственного препарата Урорек у пациентов с СНМП/ДГПЖ и сопутствующими сердечно-сосудистыми заболеваниями нет.<sup>3</sup> Урорек не оказывает влияния на частоту сердечных сокращений (ЧСС), систолическое артериальное давление (САД) и диастолическое артериальное давление (ДАД).<sup>9</sup> Силодозин — не вызывает клинически значимого снижения артериального давления (АД)<sup>46</sup>, не усиливает действие антигипертензивных препаратов и не требует снижения дозы при одновременном приеме.<sup>7</sup> В соответствии с дизайном клинического исследования многие пациенты получали сопутствующую терапию антигипертензивными препаратами (в основном, средствами, воздействующими на ренин-ангиотензиновую систему, бета-блокаторами, антагонистами кальция и диуретиками) без повышения частоты ортостатической гипотензии.<sup>6</sup>\r\n\r\nПри приеме препарата Урорек наиболее низкий риск развития сердечно-сосудистых осложнений.<sup>5</sup>'),
(6701, 252, '_вопросы_1_текст', 'field_62444b66e25d9'),
(6702, 252, 'вопросы_2_заголовок', 'Можно ли принимать Урорек пациенту с ортостатической гипотензией в анамнезе?'),
(6703, 252, '_вопросы_2_заголовок', 'field_62444b58e25d8'),
(6704, 252, 'вопросы_2_текст', 'Повышенная селективность силодозина к альфа1A-адренорецепторам по сравнению с альфа1B-адренорецепторами выражается в пониженном риске развития сердечно-сосудистых осложнений.<sup>4</sup> Благодаря этому частота ортостатической гипотензии на фоне его приема сравнима с таковой при приеме плацебо.<sup>45,9</sup>\r\n\r\nВ отличие от других альфа-адреноблокаторов (например, все формы тамсулозина<sup>47,48</sup>), Урорек не противопоказан к приему у пациентов с ортостатической гипотензией в анамнезе. Тем не менее, пациентам с ортостатической гипотензией в анамнезе не рекомендуется принимать любые альфа-адреноблокаторы, в т.ч. Урорек.<sup>6</sup>'),
(6705, 252, '_вопросы_2_текст', 'field_62444b66e25d9'),
(6706, 252, 'вопросы_3_заголовок', 'Как долго можно принимать Урорек?'),
(6707, 252, '_вопросы_3_заголовок', 'field_62444b58e25d8'),
(6708, 252, 'вопросы_3_текст', 'Учитывая прогрессирующий характер течения доброкачественной гиперплазии предстательной железы, медикаментозную терапию следует проводить длительно (иногда в течение всей жизни пациента).<sup>49</sup>'),
(6709, 252, '_вопросы_3_текст', 'field_62444b66e25d9'),
(6710, 252, 'вопросы_4_заголовок', 'Пациенты жалуются на заложенность носа при лечении альфа-адреноблокаторами. Есть ли у препарата Урорек такое побочное действие?'),
(6711, 252, '_вопросы_4_заголовок', 'field_62444b58e25d8'),
(6712, 252, 'вопросы_4_текст', 'Заложенность носа — это возможный побочный эффект для всех альфа-адреноблокаторов. При приеме препарата Урорек он может возникать примерно в 1% случаев.<sup>46</sup>'),
(6713, 252, '_вопросы_4_текст', 'field_62444b66e25d9'),
(6714, 252, 'вопросы_5_заголовок', 'Можно ли начинать лечение препаратом Урорек с дозы 4 мг в сутки?'),
(6715, 252, '_вопросы_5_заголовок', 'field_62444b58e25d8'),
(6716, 252, 'вопросы_5_текст', 'Согласно инструкции по медицинскому применению лекарственного препарата Урорек, доза 8 мг в сутки рекомендована для лечения пациентов с СНМП/ДГПЖ. Титрование дозы при применении силодозина не требуется.\r\n\r\nУрорек 4 мг — это специальная доза для лечения пациентов с почечной недостаточностью средней степени тяжести (клиренс креатинина ≥ 30 до &lt; 50 мл/мин). Рекомендуется в течение первой недели принимать начальную дозу по 4 мг в сутки, далее при хорошей переносимости доза может быть увеличена до 8 мг в сутки.<sup>6</sup>*\r\n\r\n<small><strong>*Более подробные сведения о препарате, особенностях применения, побочных действиях и др. — см. инструкцию по медицинскому применению лекарственного препарата Урорек, РУ ЛСР-005971/10 от 25.06.2010</strong></small>'),
(6717, 252, '_вопросы_5_текст', 'field_62444b66e25d9'),
(6718, 252, 'вопросы_6_заголовок', 'Влияет ли Урорек на течение ДГПЖ или только снимает симптомы нижних мочевыводящих путей?'),
(6719, 252, '_вопросы_6_заголовок', 'field_62444b58e25d8'),
(6720, 252, 'вопросы_6_текст', 'Помимо субъективных симптомов, ДГПЖ вызывает прогрессирующее морфологическое ремоделирование мочевого пузыря с риском развития серьезных функциональных нарушений. Лечение должно не только купировать субъективные симптомы, но и включать профилактику патологического ремоделирования мочевого пузыря.<sup>161</sup>\r\n\r\nСилодозин, действующее вещество препарата Урорек, в сравнении с другими альфа-адреноблокаторами более эффективно влияет на инфравезикальную обструкцию (ИВО), что оказывает влияние на предотвращение патологического прогрессирования ремоделирования мочевого пузыря и риск развития серьезных функциональных нарушений.<sup>50,51</sup>'),
(6721, 252, '_вопросы_6_текст', 'field_62444b66e25d9'),
(6722, 252, 'вопросы_7_заголовок', 'Доступен ли Урорек по льготному отпуску?'),
(6723, 252, '_вопросы_7_заголовок', 'field_62444b58e25d8'),
(6724, 252, 'вопросы_7_текст', 'Урорек (силодозин) не включен в список жизненно важных лекарственных препаратов (ЖНВЛП)<sup>1</sup> и не входит в перечень препаратов для льготного обеспечения граждан по федеральному льготному списку.'),
(6725, 252, '_вопросы_7_текст', 'field_62444b66e25d9'),
(6726, 252, 'вопросы', '8'),
(6727, 252, '_вопросы', 'field_62444b49e25d7'),
(6728, 253, 'заголовок-1', 'УРОРЕК – оригинальный<sup>10</sup> альфа-адреноблокатор'),
(6729, 253, '_заголовок-1', 'field_62435bd26f29f'),
(6730, 253, 'текст-1', '<div class=\"headerBlock__body\">\r\n<p>Силодозин (действующее вещество препарата Урорек) обладает максимальной уроселективностью в&nbsp;своем классе, что обеспечивает его уродинамическую эффективность и&nbsp;высокую безопасность<sup>4</sup></p>\r\n</div>\r\n<div class=\"headerBlock__footer\">\r\n<p><strong>Показания к применению: </strong><br/>Лечение симптомов доброкачественной гиперплазии предстательной железы<sup>6</sup></p>\r\n</div>'),
(6731, 253, '_текст-1', 'field_62435c0c6f2a0'),
(6732, 253, 'изображение-1', '13'),
(6733, 253, '_изображение-1', 'field_62435c8b6f2a1'),
(6734, 253, 'фон-1', '17'),
(6735, 253, '_фон-1', 'field_62435db92ea96'),
(6736, 253, 'заголовок-2', 'Ключевые преимущества препарата Урорек'),
(6737, 253, '_заголовок-2', 'field_6243606295196'),
(6738, 253, 'список-2', 'Единственный оригинальный препарат из&nbsp;группы альфа1-адреноблокаторов, не&nbsp;имеющий генериков в&nbsp;РФ<sup>1</sup>'),
(6739, 253, '_список-2', 'field_6243608195197'),
(6740, 253, 'картинка_с_текстом_0_изображение', '31'),
(6741, 253, '_картинка_с_текстом_0_изображение', 'field_624363d095199'),
(6742, 253, 'картинка_с_текстом_0_описание', 'Обширная доказательная база собственных пострегистрационных клинических исследований<sup>2</sup>'),
(6743, 253, '_картинка_с_текстом_0_описание', 'field_624363e59519a'),
(6744, 253, 'картинка_с_текстом_1_изображение', '32'),
(6745, 253, '_картинка_с_текстом_1_изображение', 'field_624363d095199'),
(6746, 253, 'картинка_с_текстом_1_описание', 'Отсутствие риска замены препарата Урорек в&nbsp;аптеке (единственный препарат с&nbsp;действующим веществом силодозин)<sup>1</sup>'),
(6747, 253, '_картинка_с_текстом_1_описание', 'field_624363e59519a'),
(6748, 253, 'картинка_с_текстом_2_изображение', '33'),
(6749, 253, '_картинка_с_текстом_2_изображение', 'field_624363d095199'),
(6750, 253, 'картинка_с_текстом_2_описание', 'Большинство пациентов предпочитают принимать оригинальные препараты<sup>3</sup>'),
(6751, 253, '_картинка_с_текстом_2_описание', 'field_624363e59519a'),
(6752, 253, 'картинка_с_текстом', '3'),
(6753, 253, '_картинка_с_текстом', 'field_624363b995198'),
(6754, 253, 'второй_список', '<li>Клинические преимущества препарата Урорек (силодозин) определяются максимальной уроселективностью в&nbsp;классе альфа-адреноблокаторов<sup>4</sup></li>\r\n\r\n<li>Урорек&nbsp;&mdash; альфа-адреноблокатор последнего поколения, который эффективен в&nbsp;отношении всех СНМП (накопления, опорожнения, постмиктурических).<sup>12,13</sup> При этом Урорек обладает минимальным риском развития нежелательных явлений со&nbsp;стороны сердечно-сосудистой системы, в&nbsp;том числе&nbsp;у&nbsp;пациентов, принимающих антигипертензивные препараты<sup>46,8</sup> <small> <span>СНМП </span>симптомы нижних мочевыводящих путей</small></li>'),
(6755, 253, '_второй_список', 'field_6243640e05eda'),
(6756, 253, 'заголовок2-2', 'Максимальная уроселективность силодозина в&nbsp;классе альфа-адреноблокаторов обуславливает его уродинамическую эффективность и&nbsp;высокий профиль безопасности<sup>4</sup>'),
(6757, 253, '_заголовок2-2', 'field_6243644705edb'),
(6758, 253, 'текст3', '<ul>\r\n<li>Урорек значительно улучшает клинические проявления и&nbsp;качество жизни у&nbsp;всех пациентов с&nbsp;СНМП/ДГПЖ, в&nbsp;том числе с&nbsp;тяжелым течением<sup>11</sup>\r\n<a href=\"#modal-call-first\" class=\"link-modal-js\">Узнать больше...</a></li>\r\n\r\n<li>Урорек является препаратом выбора для пациентов с&nbsp;СНМП/ДГПЖ и&nbsp;сопутствующими сердечно-сосудистыми заболеваниями<sup>3</sup> \r\n<a href=\"#modal-call-second\" class=\"link-modal-js\">Узнать больше...</a></li>\r\n</ul>\r\n<small> <span>ДГПЖ </span>доброкачественная гиперплазия предстательной железы</small>'),
(6759, 253, '_текст3', 'field_6243647405edc'),
(6760, 253, 'изображение-2', '34'),
(6761, 253, '_изображение-2', 'field_624364dd05edd'),
(6762, 253, 'текст_в_подвале', '<h2> Максимальная уроселективность в&nbsp;классе  альфа-адреноблокаторов<sup>4</sup></h2>\r\n<div class=\"h3\"> Почему это важно? <a href=\"#modal-call-second\" class=\"link-modal-js\">Подробнее</a></div>'),
(6763, 253, '_текст_в_подвале', 'field_62436daf1f6d9'),
(6764, 253, 'заголовок-3', 'Форма выпуска препарата Урорек'),
(6765, 253, '_заголовок-3', 'field_62436efee98e7'),
(6766, 253, 'текст-3', '<p class=\"section-descr\"><span>8мг </span>- рекомендуемая доза для лечения симптомов ДГПЖ<sup>6</sup>*</p>\r\n					<p class=\"section-note col-md-10\">*Более подробные сведения о&nbsp;препарате, особенностях применения, побочных действиях и&nbsp;др. &mdash;&nbsp;смотрите инструкцию по&nbsp;медицинскому применению лекарственного препарата Урорек, РУ&nbsp;ЛСР-005971/10 от&nbsp;25.06.2010 </p>'),
(6767, 253, '_текст-3', 'field_62436f60e98e8'),
(6768, 253, 'товар_0_название', 'Урорек 8мг №30'),
(6769, 253, '_товар_0_название', 'field_62436fcce98ea'),
(6770, 253, 'товар_0_описание', 'Упаковка, рассчитанная на&nbsp;1&nbsp;месяц лечения&nbsp;/ для старта терапии'),
(6771, 253, '_товар_0_описание', 'field_62436fe1e98eb'),
(6772, 253, 'товар_0_лицензия', 'РУ: ЛСР-005971/10 от 25.06.2010'),
(6773, 253, '_товар_0_лицензия', 'field_62436ff0e98ec'),
(6774, 253, 'товар_0_изображение', '51'),
(6775, 253, '_товар_0_изображение', 'field_62437045e98ed'),
(6776, 253, 'товар_1_название', 'Урорек 8мг №90'),
(6777, 253, '_товар_1_название', 'field_62436fcce98ea'),
(6778, 253, 'товар_1_описание', 'Выгодная упаковка, рассчитанная на&nbsp;3&nbsp;месяца лечения. Самая доступная стоимость 1&nbsp;дня терапии препаратом Урорек&nbsp;<sup>27</sup>'),
(6779, 253, '_товар_1_описание', 'field_62436fe1e98eb'),
(6780, 253, 'товар_1_лицензия', 'РУ: ЛСР-005971/10 от 25.06.2010'),
(6781, 253, '_товар_1_лицензия', 'field_62436ff0e98ec'),
(6782, 253, 'товар_1_изображение', '53'),
(6783, 253, '_товар_1_изображение', 'field_62437045e98ed'),
(6784, 253, 'товар_2_название', 'Урорек 4мг №30'),
(6785, 253, '_товар_2_название', 'field_62436fcce98ea'),
(6786, 253, 'товар_2_описание', '4&nbsp;мг&nbsp;&mdash; стартовая доза для лечения симптомов ДГПЖ у&nbsp;пациентов с&nbsp;почечной недостаточностью средней степени тяжести<sup>6</sup>'),
(6787, 253, '_товар_2_описание', 'field_62436fe1e98eb'),
(6788, 253, 'товар_2_лицензия', 'РУ: ЛСР-005971/10 от 25.06.2010'),
(6789, 253, '_товар_2_лицензия', 'field_62436ff0e98ec'),
(6790, 253, 'товар_2_изображение', '52'),
(6791, 253, '_товар_2_изображение', 'field_62437045e98ed'),
(6792, 253, 'товар', '3'),
(6793, 253, '_товар', 'field_62436fbde98e9'),
(6794, 253, 'заголовок-4', 'Где купить'),
(6795, 253, '_заголовок-4', 'field_624374f73d8bd'),
(6796, 253, 'изображения', 'a:12:{i:0;s:2:\"63\";i:1;s:2:\"64\";i:2;s:2:\"65\";i:3;s:2:\"66\";i:4;s:2:\"67\";i:5;s:2:\"68\";i:6;s:2:\"69\";i:7;s:2:\"70\";i:8;s:2:\"71\";i:9;s:2:\"72\";i:10;s:2:\"73\";i:11;s:2:\"74\";}'),
(6797, 253, '_изображения', 'field_624375093d8be'),
(6798, 253, 'изображения-4', 'a:12:{i:0;s:2:\"63\";i:1;s:2:\"64\";i:2;s:2:\"65\";i:3;s:2:\"66\";i:4;s:2:\"67\";i:5;s:2:\"68\";i:6;s:2:\"69\";i:7;s:2:\"70\";i:8;s:2:\"71\";i:9;s:2:\"72\";i:10;s:2:\"73\";i:11;s:2:\"74\";}'),
(6799, 253, '_изображения-4', 'field_624375093d8be'),
(6800, 253, 'заголовок-5', 'Способ применения*<sup>6</sup>'),
(6801, 253, '_заголовок-5', 'field_624379bd4756d'),
(6802, 253, 'иконки', 'a:5:{i:0;s:2:\"83\";i:1;s:2:\"84\";i:2;s:2:\"85\";i:3;s:2:\"86\";i:4;s:2:\"87\";}'),
(6803, 253, '_иконки', 'field_624379f24756e'),
(6804, 253, 'текст-5', 'У пациентов с легкой почечной недостаточностью (клиренс креатинина ≥ 50 — ≤ 80 мл/мин) коррекция дозы не требуется. Для лечения пациентов с почечной недостаточностью средней степени тяжести (клиренс креатинина ≥ 30 — < 50 мл/мин) рекомендуется в течение первой недели принимать начальную дозу по 4 мг в сутки, при хорошей индивидуальной переносимости доза может быть увеличена до 8 мг в сутки. Применение препарата для пациентов с тяжелой почечной недостаточностью (клиренс креатинина < 30 мл / мин) не рекомендуется'),
(6805, 253, '_текст-5', 'field_62437a374756f'),
(6806, 253, 'текст_под_кнопкой', '*Более подробные сведения о&nbsp;препарате, особенностях применения, побочных действиях и&nbsp;др. &mdash;&nbsp;см. инструкцию по&nbsp;медицинскому применению лекарственного препарата Урорек, РУ&nbsp;ЛСР-005971/10 от&nbsp;25.06.2010'),
(6807, 253, '_текст_под_кнопкой', 'field_62437a7c47570'),
(6808, 253, 'заголовок-6', 'Препарат Урорек (силодозин) включен в&nbsp;российские и&nbsp;международные клинические рекомендации и&nbsp;стандарты для лечения ряда урологических заболеваний:'),
(6809, 253, '_заголовок-6', 'field_6244117c68bd0'),
(6810, 253, 'список-6_0_ссылка', 'a:3:{s:5:\"title\";s:68:\"Российские клинические рекомендации\";s:3:\"url\";s:1:\"#\";s:6:\"target\";s:0:\"\";}'),
(6811, 253, '_список-6_0_ссылка', 'field_624411ce68bd2'),
(6812, 253, 'список-6_0_описание', '«Доброкачественная гиперплазия предстательной железы», 2020<sup>28</sup>'),
(6813, 253, '_список-6_0_описание', 'field_6244121168bd3'),
(6814, 253, 'список-6_1_ссылка', 'a:3:{s:5:\"title\";s:70:\"Европейские клинические рекомендации\";s:3:\"url\";s:1:\"#\";s:6:\"target\";s:0:\"\";}'),
(6815, 253, '_список-6_1_ссылка', 'field_624411ce68bd2'),
(6816, 253, 'список-6_1_описание', 'глава «Консервативное лечение ненейрогенных симптомов нарушенного мочеиспускания у мужчин, включая доброкачественную простатическую обструкцию», 2021<sup>29</sup>'),
(6817, 253, '_список-6_1_описание', 'field_6244121168bd3'),
(6818, 253, 'список-6_2_ссылка', 'a:3:{s:5:\"title\";s:154:\"Стандарт первичной медико-санитарной помощи при гиперплазии предстательной железы\";s:3:\"url\";s:1:\"#\";s:6:\"target\";s:0:\"\";}'),
(6819, 253, '_список-6_2_ссылка', 'field_624411ce68bd2'),
(6820, 253, 'список-6_2_описание', '09.11.2012<sup>30</sup> / Обновлён 13.04.2015\r\n'),
(6821, 253, '_список-6_2_описание', 'field_6244121168bd3'),
(6822, 253, 'список-6_3_ссылка', 'a:3:{s:5:\"title\";s:122:\"Стандарт специализированной медицинской помощи при задержке мочи\";s:3:\"url\";s:1:\"#\";s:6:\"target\";s:0:\"\";}'),
(6823, 253, '_список-6_3_ссылка', 'field_624411ce68bd2'),
(6824, 253, 'список-6_3_описание', '29.01.2013<sup>31</sup> / Обновлён 06.05.2015\r\n'),
(6825, 253, '_список-6_3_описание', 'field_6244121168bd3'),
(6826, 253, 'список-6_4_ссылка', 'a:3:{s:5:\"title\";s:133:\"Стандарт первичной медико-санитарной помощи при хроническом простатите\";s:3:\"url\";s:1:\"#\";s:6:\"target\";s:0:\"\";}'),
(6827, 253, '_список-6_4_ссылка', 'field_624411ce68bd2'),
(6828, 253, 'список-6_4_описание', '09.11.2012<sup>32</sup> / Обновлён 13.04.2015\r\n'),
(6829, 253, '_список-6_4_описание', 'field_6244121168bd3'),
(6830, 253, 'список-6_5_ссылка', 'a:3:{s:5:\"title\";s:168:\"Стандарт специализированной медицинской помощи при остром простатите, орхите, эпидидимите\";s:3:\"url\";s:1:\"#\";s:6:\"target\";s:0:\"\";}'),
(6831, 253, '_список-6_5_ссылка', 'field_624411ce68bd2'),
(6832, 253, 'список-6_5_описание', '09.11.2012<sup>33</sup> / Обновлён 27.05.2015'),
(6833, 253, '_список-6_5_описание', 'field_6244121168bd3'),
(6834, 253, 'список-6', '6'),
(6835, 253, '_список-6', 'field_624411be68bd1'),
(6836, 253, 'заголовок-7', 'Препарат Урорек (силодозин) зарегистрирован и&nbsp;применяется в&nbsp;разных странах мира <br>\r\nОдобрен ЕМА*<sup>34</sup> и&nbsp;FDA**<sup>35</sup>'),
(6837, 253, '_заголовок-7', 'field_624417e3b6088'),
(6838, 253, 'текст', '<p class=\"sOtherCountries__agency\"><span>EMA</span> Европейское медицинское агентство</p>\r\n<p class=\"sOtherCountries__agency\"><span>FDA</span> Управление по&nbsp;санитарному надзору за&nbsp;качеством пищевых продуктов и&nbsp;медикаментов, США</p>'),
(6839, 253, '_текст', 'field_6244182bb6089'),
(6840, 253, 'страны_0_флаг', '105'),
(6841, 253, '_страны_0_флаг', 'field_62441880b608b'),
(6842, 253, 'страны_0_название', 'Япония'),
(6843, 253, '_страны_0_название', 'field_62441899b608c'),
(6844, 253, 'страны_0_год', '2006<sup>36,37</sup>'),
(6845, 253, '_страны_0_год', 'field_624418aab608d'),
(6846, 253, 'страны_1_флаг', '106'),
(6847, 253, '_страны_1_флаг', 'field_62441880b608b'),
(6848, 253, 'страны_1_название', 'США'),
(6849, 253, '_страны_1_название', 'field_62441899b608c'),
(6850, 253, 'страны_1_год', '2008<sup>35</sup>'),
(6851, 253, '_страны_1_год', 'field_624418aab608d'),
(6852, 253, 'страны_2_флаг', '107'),
(6853, 253, '_страны_2_флаг', 'field_62441880b608b'),
(6854, 253, 'страны_2_название', 'Страны ЕС'),
(6855, 253, '_страны_2_название', 'field_62441899b608c'),
(6856, 253, 'страны_2_год', '2010<sup>34</sup>');
INSERT INTO `urotec_postmeta` (`meta_id`, `post_id`, `meta_key`, `meta_value`) VALUES
(6857, 253, '_страны_2_год', 'field_624418aab608d'),
(6858, 253, 'страны_3_флаг', '108'),
(6859, 253, '_страны_3_флаг', 'field_62441880b608b'),
(6860, 253, 'страны_3_название', 'Россия'),
(6861, 253, '_страны_3_название', 'field_62441899b608c'),
(6862, 253, 'страны_3_год', '2010<sup>1</sup>'),
(6863, 253, '_страны_3_год', 'field_624418aab608d'),
(6864, 253, 'страны', '4'),
(6865, 253, '_страны', 'field_62441847b608a'),
(6866, 253, 'текст-7', '<p class=\"sOtherCountries__agency\"><span>EMA</span> Европейское медицинское агентство</p>\r\n<p class=\"sOtherCountries__agency\"><span>FDA</span> Управление по&nbsp;санитарному надзору за&nbsp;качеством пищевых продуктов и&nbsp;медикаментов, США</p>'),
(6867, 253, '_текст-7', 'field_6244182bb6089'),
(6868, 253, 'текст-7-1', 'Производство препарата Урорек, поставляемого в&nbsp;Россию, осуществляется в&nbsp;Италии с&nbsp;использованием субстанции из&nbsp;Японии, в&nbsp;соответствии с&nbsp;необходимыми требованиями к&nbsp;производству и&nbsp;контролю качества<sup>6,1</sup>'),
(6869, 253, '_текст-7-1', 'field_62441a5acf03c'),
(6870, 253, 'заголовок-8', 'О проблеме'),
(6871, 253, '_заголовок-8', 'field_624431d91624d'),
(6872, 253, 'текст-8', 'Доброкачественная гиперплазия предстательной железы (ДГПЖ), или как ее еще называют, аденома простаты, как правило, возникает у мужчин старше 50 лет и характеризуется наличием симптомов нижних мочевыводящих путей (СНМП), увеличением предстательной железы или ее части, и нарушением оттока мочи из мочевого пузыря вследствие инфравезикальной обструкции.<sup>38</sup>\r\n\r\nРаспространенность ДГПЖ увеличивается с возрастом. Так, клинически значимая ДГПЖ проявляется у 13% мужчин в возрасте старше 50 лет, у 34% мужчин в возрасте 60 лет и у 43% в возрасте 70 лет.<sup>39</sup>\r\n\r\n<img class=\"alignnone wp-image-122 size-full\" src=\"http://0026urotec.loc:8888/wp-content/uploads/2022/03/about-img.png\" alt=\"\" width=\"594\" height=\"696\" />'),
(6873, 253, '_текст-8', 'field_624431f11624e'),
(6874, 253, 'текст-8-1', 'Наличие СНМП может быть ассоциировано с&nbsp;тяжелыми хроническими заболеваниями, такими как заболевания сердца, сахарный диабет, артериальная гипертензия и&nbsp;депрессия<sup>40</sup>'),
(6875, 253, '_текст-8-1', 'field_6244320b26db3'),
(6876, 253, 'иконки-8', 'a:6:{i:0;s:3:\"123\";i:1;s:3:\"124\";i:2;s:3:\"125\";i:3;s:3:\"126\";i:4;s:3:\"127\";i:5;s:3:\"128\";}'),
(6877, 253, '_иконки-8', 'field_6244322d26db4'),
(6878, 253, 'текст-8-2', '<h3>Симптомы доброкачественной гиперплазии предстательной железы</h3>\r\nСимптомы нарушенного мочеиспускания являются частой жалобой у взрослых мужчин. Они оказывают серьезное негативное влияние на качество жизни. При ДГПЖ предстательная железа увеличивается в размерах, оказывая давление на нижние мочевые пути. В результате развиваются следующие симптомы:<sup>41</sup>'),
(6879, 253, '_текст-8-2', 'field_6244335fe2373'),
(6880, 253, 'заголовок-9', 'Осложнения ДГПЖ<sup>38</sup>'),
(6881, 253, '_заголовок-9', 'field_6244377a52263'),
(6882, 253, 'изображения-9', 'a:6:{i:0;s:3:\"141\";i:1;s:3:\"142\";i:2;s:3:\"143\";i:3;s:3:\"144\";i:4;s:3:\"145\";i:5;s:3:\"146\";}'),
(6883, 253, '_изображения-9', 'field_6244379652264'),
(6884, 253, 'заголовок-10', 'Медикаментозное лечение СНМП/ДГПЖ'),
(6885, 253, '_заголовок-10', 'field_6244489614262'),
(6886, 253, 'текст-10', 'Антагонисты альфа1-адренорецепторов (альфа-адреноблокаторы) и&nbsp;ингибиторы 5&nbsp;альфа1-редуктазы (ингибиторы 5-АР) являются группами лекарственных препаратов, которые в&nbsp;настоящее время утверждены для лечения ДГПЖ. Обе группы препаратов обеспечивают надлежащее ослабление симптомов, но&nbsp;&alpha;&mdash;блокаторы обладают довольно быстрым началом действия, а&nbsp;ингибиторам 5-АР требуется несколько месяцев для получения терапевтического эффекта.<sup>42</sup>'),
(6887, 253, '_текст-10', 'field_624448ce14263'),
(6888, 253, 'карточки-10_0_заголовок', 'Альфа-адреноблокаторы'),
(6889, 253, '_карточки-10_0_заголовок', 'field_624448fc14265'),
(6890, 253, 'карточки-10_0_текст', 'представляют собой наиболее эффективный класс лекарственных препаратов, характеризующийся хорошим профилем безопасности и высокой комплаентностью, применяющийся для облегчения СНМП, связанных с ДГПЖ: они снимают спазм гладкой мускулатуры предстательной железы и шейки мочевого пузыря<sup>42</sup>'),
(6891, 253, '_карточки-10_0_текст', 'field_6244490c14266'),
(6892, 253, 'карточки-10_1_заголовок', 'Ингибиторы 5-АР'),
(6893, 253, '_карточки-10_1_заголовок', 'field_624448fc14265'),
(6894, 253, 'карточки-10_1_текст', 'приводят к редукции железистой ткани и к снижению размера предстательной железы: они блокируют конверсию тестостерона в дигидротестостерон, который стимулирует рост предстательной железы<sup>43,44</sup>.Назначаются при большом объеме предстательной железы. Для получения значимого клинического эффекта требуется несколько месяцев применения<sup>45</sup>\r\n'),
(6895, 253, '_карточки-10_1_текст', 'field_6244490c14266'),
(6896, 253, 'карточки-10', '2'),
(6897, 253, '_карточки-10', 'field_624448e214264'),
(6898, 253, 'видео', '<iframe width=\"560\" height=\"315\" src=\"https://www.youtube.com/embed/3DrU3pFXSsY\" title=\"YouTube video player\" frameborder=\"0\" allow=\"accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture\" allowfullscreen></iframe>'),
(6899, 253, '_видео', 'field_6244492214267'),
(6900, 253, 'заголовок-11', 'Часто задаваемые вопросы'),
(6901, 253, '_заголовок-11', 'field_62444b33e25d6'),
(6902, 253, 'вопросы_0_заголовок', 'Почему при приеме препарата Урорек у некоторых пациентов развивается нарушение эякуляции?'),
(6903, 253, '_вопросы_0_заголовок', 'field_62444b58e25d8'),
(6904, 253, 'вопросы_0_текст', 'Урорек — высокоселективный препарат, то есть преимущественно действует на альфа1А-адренорецепторы, которые находятся в нижних мочевых путях, предстательной железе и семенных пузырьках. Поэтому эффект развивается уже через 2–6 часов после приёма первой дозы препарата Урорек<sup>14</sup> при минимальным количестве нежелательных явлений.<sup>5</sup>\r\n\r\nНаиболее частый побочный эффект при приеме препарата Урорек — нарушение эякуляции<sup>46</sup>. Это может быть связано как с забросом эякулята при семяизвержении вместо уретры в мочевой пузырь, так и со снижением или отсутствием семенной жидкости во время эякуляции<sup>29</sup>. Силодозин снижает тонус гладкомышечных клеток семенных пузырьков, простаты и шейки мочевого пузыря, поэтому не происходит выброс семени. Этот эффект свойственен всем уроселективным альфа-адреноблокаторам<sup>53</sup> и самостоятельно исчезает после прекращения приема препарата.<sup>6</sup>\r\n\r\nЧастота эякуляторной дисфункции прямо пропорционально связана с улучшением СНМП и скорости мочеиспускания и подтверждает эффективность альфа-адреноблокатора: чем выше эффективность, тем выше частота встречаемости эякуляторной дисфункции.<sup>29</sup>\r\n\r\nНарушение эякуляции не влияет на сексуальную функцию<sup>52</sup>, не воспринимается как беспокоящий симптом подавляющим большинством пациентов и не требует отмены терапии.<sup>46</sup>'),
(6905, 253, '_вопросы_0_текст', 'field_62444b66e25d9'),
(6906, 253, 'вопросы_1_заголовок', 'Можно ли принимать Урорек при артериальной гипертензии и ишемический болезни сердца (ИБС)?'),
(6907, 253, '_вопросы_1_заголовок', 'field_62444b58e25d8'),
(6908, 253, 'вопросы_1_текст', 'Согласно инструкции по медицинскому применению, противопоказаний для применения лекарственного препарата Урорек у пациентов с СНМП/ДГПЖ и сопутствующими сердечно-сосудистыми заболеваниями нет.<sup>3</sup> Урорек не оказывает влияния на частоту сердечных сокращений (ЧСС), систолическое артериальное давление (САД) и диастолическое артериальное давление (ДАД).<sup>9</sup> Силодозин — не вызывает клинически значимого снижения артериального давления (АД)<sup>46</sup>, не усиливает действие антигипертензивных препаратов и не требует снижения дозы при одновременном приеме.<sup>7</sup> В соответствии с дизайном клинического исследования многие пациенты получали сопутствующую терапию антигипертензивными препаратами (в основном, средствами, воздействующими на ренин-ангиотензиновую систему, бета-блокаторами, антагонистами кальция и диуретиками) без повышения частоты ортостатической гипотензии.<sup>6</sup>\r\n\r\nПри приеме препарата Урорек наиболее низкий риск развития сердечно-сосудистых осложнений.<sup>5</sup>'),
(6909, 253, '_вопросы_1_текст', 'field_62444b66e25d9'),
(6910, 253, 'вопросы_2_заголовок', 'Можно ли принимать Урорек пациенту с ортостатической гипотензией в анамнезе?'),
(6911, 253, '_вопросы_2_заголовок', 'field_62444b58e25d8'),
(6912, 253, 'вопросы_2_текст', 'Повышенная селективность силодозина к альфа1A-адренорецепторам по сравнению с альфа1B-адренорецепторами выражается в пониженном риске развития сердечно-сосудистых осложнений.<sup>4</sup> Благодаря этому частота ортостатической гипотензии на фоне его приема сравнима с таковой при приеме плацебо.<sup>45,9</sup>\r\n\r\nВ отличие от других альфа-адреноблокаторов (например, все формы тамсулозина<sup>47,48</sup>), Урорек не противопоказан к приему у пациентов с ортостатической гипотензией в анамнезе. Тем не менее, пациентам с ортостатической гипотензией в анамнезе не рекомендуется принимать любые альфа-адреноблокаторы, в т.ч. Урорек.<sup>6</sup>'),
(6913, 253, '_вопросы_2_текст', 'field_62444b66e25d9'),
(6914, 253, 'вопросы_3_заголовок', 'Как долго можно принимать Урорек?'),
(6915, 253, '_вопросы_3_заголовок', 'field_62444b58e25d8'),
(6916, 253, 'вопросы_3_текст', 'Учитывая прогрессирующий характер течения доброкачественной гиперплазии предстательной железы, медикаментозную терапию следует проводить длительно (иногда в течение всей жизни пациента).<sup>49</sup>'),
(6917, 253, '_вопросы_3_текст', 'field_62444b66e25d9'),
(6918, 253, 'вопросы_4_заголовок', 'Пациенты жалуются на заложенность носа при лечении альфа-адреноблокаторами. Есть ли у препарата Урорек такое побочное действие?'),
(6919, 253, '_вопросы_4_заголовок', 'field_62444b58e25d8'),
(6920, 253, 'вопросы_4_текст', 'Заложенность носа — это возможный побочный эффект для всех альфа-адреноблокаторов. При приеме препарата Урорек он может возникать примерно в 1% случаев.<sup>46</sup>'),
(6921, 253, '_вопросы_4_текст', 'field_62444b66e25d9'),
(6922, 253, 'вопросы_5_заголовок', 'Можно ли начинать лечение препаратом Урорек с дозы 4 мг в сутки?'),
(6923, 253, '_вопросы_5_заголовок', 'field_62444b58e25d8'),
(6924, 253, 'вопросы_5_текст', 'Согласно инструкции по медицинскому применению лекарственного препарата Урорек, доза 8 мг в сутки рекомендована для лечения пациентов с СНМП/ДГПЖ. Титрование дозы при применении силодозина не требуется.\r\n\r\nУрорек 4 мг — это специальная доза для лечения пациентов с почечной недостаточностью средней степени тяжести (клиренс креатинина ≥ 30 до &lt; 50 мл/мин). Рекомендуется в течение первой недели принимать начальную дозу по 4 мг в сутки, далее при хорошей переносимости доза может быть увеличена до 8 мг в сутки.<sup>6</sup>*\r\n\r\n<small><strong>*Более подробные сведения о препарате, особенностях применения, побочных действиях и др. — см. инструкцию по медицинскому применению лекарственного препарата Урорек, РУ ЛСР-005971/10 от 25.06.2010</strong></small>'),
(6925, 253, '_вопросы_5_текст', 'field_62444b66e25d9'),
(6926, 253, 'вопросы_6_заголовок', 'Влияет ли Урорек на течение ДГПЖ или только снимает симптомы нижних мочевыводящих путей?'),
(6927, 253, '_вопросы_6_заголовок', 'field_62444b58e25d8'),
(6928, 253, 'вопросы_6_текст', 'Помимо субъективных симптомов, ДГПЖ вызывает прогрессирующее морфологическое ремоделирование мочевого пузыря с риском развития серьезных функциональных нарушений. Лечение должно не только купировать субъективные симптомы, но и включать профилактику патологического ремоделирования мочевого пузыря.<sup>161</sup>\r\n\r\nСилодозин, действующее вещество препарата Урорек, в сравнении с другими альфа-адреноблокаторами более эффективно влияет на инфравезикальную обструкцию (ИВО), что оказывает влияние на предотвращение патологического прогрессирования ремоделирования мочевого пузыря и риск развития серьезных функциональных нарушений.<sup>50,51</sup>'),
(6929, 253, '_вопросы_6_текст', 'field_62444b66e25d9'),
(6930, 253, 'вопросы_7_заголовок', 'Доступен ли Урорек по льготному отпуску?'),
(6931, 253, '_вопросы_7_заголовок', 'field_62444b58e25d8'),
(6932, 253, 'вопросы_7_текст', 'Урорек (силодозин) не включен в список жизненно важных лекарственных препаратов (ЖНВЛП)<sup>1</sup> и не входит в перечень препаратов для льготного обеспечения граждан по федеральному льготному списку.'),
(6933, 253, '_вопросы_7_текст', 'field_62444b66e25d9'),
(6934, 253, 'вопросы', '8'),
(6935, 253, '_вопросы', 'field_62444b49e25d7'),
(6936, 256, 'заголовок-1', 'УРОРЕК – оригинальный<sup>10</sup> альфа-адреноблокатор'),
(6937, 256, '_заголовок-1', 'field_62435bd26f29f'),
(6938, 256, 'текст-1', '<div class=\"headerBlock__body\">\r\n<p>Силодозин (действующее вещество препарата Урорек) обладает максимальной уроселективностью в&nbsp;своем классе, что обеспечивает его уродинамическую эффективность и&nbsp;высокую безопасность<sup>4</sup></p>\r\n</div>\r\n<div class=\"headerBlock__footer\">\r\n<p><strong>Показания к применению: </strong><br/>Лечение симптомов доброкачественной гиперплазии предстательной железы<sup>6</sup></p>\r\n</div>'),
(6939, 256, '_текст-1', 'field_62435c0c6f2a0'),
(6940, 256, 'изображение-1', '13'),
(6941, 256, '_изображение-1', 'field_62435c8b6f2a1'),
(6942, 256, 'фон-1', '17'),
(6943, 256, '_фон-1', 'field_62435db92ea96'),
(6944, 256, 'заголовок-2', 'Ключевые преимущества препарата Урорек'),
(6945, 256, '_заголовок-2', 'field_6243606295196'),
(6946, 256, 'список-2', 'Единственный оригинальный препарат из&nbsp;группы альфа1-адреноблокаторов, не&nbsp;имеющий генериков в&nbsp;РФ<sup>1</sup>'),
(6947, 256, '_список-2', 'field_6243608195197'),
(6948, 256, 'картинка_с_текстом_0_изображение', '31'),
(6949, 256, '_картинка_с_текстом_0_изображение', 'field_624363d095199'),
(6950, 256, 'картинка_с_текстом_0_описание', 'Обширная доказательная база собственных пострегистрационных клинических исследований<sup>2</sup>'),
(6951, 256, '_картинка_с_текстом_0_описание', 'field_624363e59519a'),
(6952, 256, 'картинка_с_текстом_1_изображение', '32'),
(6953, 256, '_картинка_с_текстом_1_изображение', 'field_624363d095199'),
(6954, 256, 'картинка_с_текстом_1_описание', 'Отсутствие риска замены препарата Урорек в&nbsp;аптеке (единственный препарат с&nbsp;действующим веществом силодозин)<sup>1</sup>'),
(6955, 256, '_картинка_с_текстом_1_описание', 'field_624363e59519a'),
(6956, 256, 'картинка_с_текстом_2_изображение', '33'),
(6957, 256, '_картинка_с_текстом_2_изображение', 'field_624363d095199'),
(6958, 256, 'картинка_с_текстом_2_описание', 'Большинство пациентов предпочитают принимать оригинальные препараты<sup>3</sup>'),
(6959, 256, '_картинка_с_текстом_2_описание', 'field_624363e59519a'),
(6960, 256, 'картинка_с_текстом', '3'),
(6961, 256, '_картинка_с_текстом', 'field_624363b995198'),
(6962, 256, 'второй_список', '<li>Клинические преимущества препарата Урорек (силодозин) определяются максимальной уроселективностью в&nbsp;классе альфа-адреноблокаторов<sup>4</sup></li>\r\n\r\n<li>Урорек&nbsp;&mdash; альфа-адреноблокатор последнего поколения, который эффективен в&nbsp;отношении всех СНМП (накопления, опорожнения, постмиктурических).<sup>12,13</sup> При этом Урорек обладает минимальным риском развития нежелательных явлений со&nbsp;стороны сердечно-сосудистой системы, в&nbsp;том числе&nbsp;у&nbsp;пациентов, принимающих антигипертензивные препараты<sup>46,8</sup> <small> <span>СНМП </span>симптомы нижних мочевыводящих путей</small></li>'),
(6963, 256, '_второй_список', 'field_6243640e05eda'),
(6964, 256, 'заголовок2-2', 'Максимальная уроселективность силодозина в&nbsp;классе альфа-адреноблокаторов обуславливает его уродинамическую эффективность и&nbsp;высокий профиль безопасности<sup>4</sup>'),
(6965, 256, '_заголовок2-2', 'field_6243644705edb'),
(6966, 256, 'текст3', '<ul>\r\n<li>Урорек значительно улучшает клинические проявления и&nbsp;качество жизни у&nbsp;всех пациентов с&nbsp;СНМП/ДГПЖ, в&nbsp;том числе с&nbsp;тяжелым течением<sup>11</sup>\r\n<a href=\"#modal-call-first\" class=\"link-modal-js\">Узнать больше...</a></li>\r\n\r\n<li>Урорек является препаратом выбора для пациентов с&nbsp;СНМП/ДГПЖ и&nbsp;сопутствующими сердечно-сосудистыми заболеваниями<sup>3</sup> \r\n<a href=\"#modal-call-second\" class=\"link-modal-js\">Узнать больше...</a></li>\r\n</ul>\r\n<small> <span>ДГПЖ </span>доброкачественная гиперплазия предстательной железы</small>'),
(6967, 256, '_текст3', 'field_6243647405edc'),
(6968, 256, 'изображение-2', '34'),
(6969, 256, '_изображение-2', 'field_624364dd05edd'),
(6970, 256, 'текст_в_подвале', '<h2> Максимальная уроселективность в&nbsp;классе  альфа-адреноблокаторов<sup>4</sup></h2>\r\n<div class=\"h3\"> Почему это важно? <a href=\"#modal-call-3\" class=\"link-modal-js\">Подробнее</a></div>'),
(6971, 256, '_текст_в_подвале', 'field_62436daf1f6d9'),
(6972, 256, 'заголовок-3', 'Форма выпуска препарата Урорек'),
(6973, 256, '_заголовок-3', 'field_62436efee98e7'),
(6974, 256, 'текст-3', '<p class=\"section-descr\"><span>8мг </span>- рекомендуемая доза для лечения симптомов ДГПЖ<sup>6</sup>*</p>\r\n					<p class=\"section-note col-md-10\">*Более подробные сведения о&nbsp;препарате, особенностях применения, побочных действиях и&nbsp;др. &mdash;&nbsp;смотрите инструкцию по&nbsp;медицинскому применению лекарственного препарата Урорек, РУ&nbsp;ЛСР-005971/10 от&nbsp;25.06.2010 </p>'),
(6975, 256, '_текст-3', 'field_62436f60e98e8'),
(6976, 256, 'товар_0_название', 'Урорек 8мг №30'),
(6977, 256, '_товар_0_название', 'field_62436fcce98ea'),
(6978, 256, 'товар_0_описание', 'Упаковка, рассчитанная на&nbsp;1&nbsp;месяц лечения&nbsp;/ для старта терапии'),
(6979, 256, '_товар_0_описание', 'field_62436fe1e98eb'),
(6980, 256, 'товар_0_лицензия', 'РУ: ЛСР-005971/10 от 25.06.2010'),
(6981, 256, '_товар_0_лицензия', 'field_62436ff0e98ec'),
(6982, 256, 'товар_0_изображение', '51'),
(6983, 256, '_товар_0_изображение', 'field_62437045e98ed'),
(6984, 256, 'товар_1_название', 'Урорек 8мг №90'),
(6985, 256, '_товар_1_название', 'field_62436fcce98ea'),
(6986, 256, 'товар_1_описание', 'Выгодная упаковка, рассчитанная на&nbsp;3&nbsp;месяца лечения. Самая доступная стоимость 1&nbsp;дня терапии препаратом Урорек&nbsp;<sup>27</sup>'),
(6987, 256, '_товар_1_описание', 'field_62436fe1e98eb'),
(6988, 256, 'товар_1_лицензия', 'РУ: ЛСР-005971/10 от 25.06.2010'),
(6989, 256, '_товар_1_лицензия', 'field_62436ff0e98ec'),
(6990, 256, 'товар_1_изображение', '53'),
(6991, 256, '_товар_1_изображение', 'field_62437045e98ed'),
(6992, 256, 'товар_2_название', 'Урорек 4мг №30'),
(6993, 256, '_товар_2_название', 'field_62436fcce98ea'),
(6994, 256, 'товар_2_описание', '4&nbsp;мг&nbsp;&mdash; стартовая доза для лечения симптомов ДГПЖ у&nbsp;пациентов с&nbsp;почечной недостаточностью средней степени тяжести<sup>6</sup>'),
(6995, 256, '_товар_2_описание', 'field_62436fe1e98eb'),
(6996, 256, 'товар_2_лицензия', 'РУ: ЛСР-005971/10 от 25.06.2010'),
(6997, 256, '_товар_2_лицензия', 'field_62436ff0e98ec'),
(6998, 256, 'товар_2_изображение', '52'),
(6999, 256, '_товар_2_изображение', 'field_62437045e98ed'),
(7000, 256, 'товар', '3'),
(7001, 256, '_товар', 'field_62436fbde98e9'),
(7002, 256, 'заголовок-4', 'Где купить'),
(7003, 256, '_заголовок-4', 'field_624374f73d8bd'),
(7004, 256, 'изображения', 'a:12:{i:0;s:2:\"63\";i:1;s:2:\"64\";i:2;s:2:\"65\";i:3;s:2:\"66\";i:4;s:2:\"67\";i:5;s:2:\"68\";i:6;s:2:\"69\";i:7;s:2:\"70\";i:8;s:2:\"71\";i:9;s:2:\"72\";i:10;s:2:\"73\";i:11;s:2:\"74\";}'),
(7005, 256, '_изображения', 'field_624375093d8be'),
(7006, 256, 'изображения-4', 'a:12:{i:0;s:2:\"63\";i:1;s:2:\"64\";i:2;s:2:\"65\";i:3;s:2:\"66\";i:4;s:2:\"67\";i:5;s:2:\"68\";i:6;s:2:\"69\";i:7;s:2:\"70\";i:8;s:2:\"71\";i:9;s:2:\"72\";i:10;s:2:\"73\";i:11;s:2:\"74\";}'),
(7007, 256, '_изображения-4', 'field_624375093d8be'),
(7008, 256, 'заголовок-5', 'Способ применения*<sup>6</sup>'),
(7009, 256, '_заголовок-5', 'field_624379bd4756d'),
(7010, 256, 'иконки', 'a:5:{i:0;s:2:\"83\";i:1;s:2:\"84\";i:2;s:2:\"85\";i:3;s:2:\"86\";i:4;s:2:\"87\";}'),
(7011, 256, '_иконки', 'field_624379f24756e'),
(7012, 256, 'текст-5', 'У пациентов с легкой почечной недостаточностью (клиренс креатинина ≥ 50 — ≤ 80 мл/мин) коррекция дозы не требуется. Для лечения пациентов с почечной недостаточностью средней степени тяжести (клиренс креатинина ≥ 30 — < 50 мл/мин) рекомендуется в течение первой недели принимать начальную дозу по 4 мг в сутки, при хорошей индивидуальной переносимости доза может быть увеличена до 8 мг в сутки. Применение препарата для пациентов с тяжелой почечной недостаточностью (клиренс креатинина < 30 мл / мин) не рекомендуется'),
(7013, 256, '_текст-5', 'field_62437a374756f'),
(7014, 256, 'текст_под_кнопкой', '*Более подробные сведения о&nbsp;препарате, особенностях применения, побочных действиях и&nbsp;др. &mdash;&nbsp;см. инструкцию по&nbsp;медицинскому применению лекарственного препарата Урорек, РУ&nbsp;ЛСР-005971/10 от&nbsp;25.06.2010'),
(7015, 256, '_текст_под_кнопкой', 'field_62437a7c47570'),
(7016, 256, 'заголовок-6', 'Препарат Урорек (силодозин) включен в&nbsp;российские и&nbsp;международные клинические рекомендации и&nbsp;стандарты для лечения ряда урологических заболеваний:'),
(7017, 256, '_заголовок-6', 'field_6244117c68bd0'),
(7018, 256, 'список-6_0_ссылка', 'a:3:{s:5:\"title\";s:68:\"Российские клинические рекомендации\";s:3:\"url\";s:1:\"#\";s:6:\"target\";s:0:\"\";}'),
(7019, 256, '_список-6_0_ссылка', 'field_624411ce68bd2'),
(7020, 256, 'список-6_0_описание', '«Доброкачественная гиперплазия предстательной железы», 2020<sup>28</sup>'),
(7021, 256, '_список-6_0_описание', 'field_6244121168bd3'),
(7022, 256, 'список-6_1_ссылка', 'a:3:{s:5:\"title\";s:70:\"Европейские клинические рекомендации\";s:3:\"url\";s:1:\"#\";s:6:\"target\";s:0:\"\";}'),
(7023, 256, '_список-6_1_ссылка', 'field_624411ce68bd2'),
(7024, 256, 'список-6_1_описание', 'глава «Консервативное лечение ненейрогенных симптомов нарушенного мочеиспускания у мужчин, включая доброкачественную простатическую обструкцию», 2021<sup>29</sup>'),
(7025, 256, '_список-6_1_описание', 'field_6244121168bd3'),
(7026, 256, 'список-6_2_ссылка', 'a:3:{s:5:\"title\";s:154:\"Стандарт первичной медико-санитарной помощи при гиперплазии предстательной железы\";s:3:\"url\";s:1:\"#\";s:6:\"target\";s:0:\"\";}'),
(7027, 256, '_список-6_2_ссылка', 'field_624411ce68bd2'),
(7028, 256, 'список-6_2_описание', '09.11.2012<sup>30</sup> / Обновлён 13.04.2015\r\n'),
(7029, 256, '_список-6_2_описание', 'field_6244121168bd3'),
(7030, 256, 'список-6_3_ссылка', 'a:3:{s:5:\"title\";s:122:\"Стандарт специализированной медицинской помощи при задержке мочи\";s:3:\"url\";s:1:\"#\";s:6:\"target\";s:0:\"\";}'),
(7031, 256, '_список-6_3_ссылка', 'field_624411ce68bd2'),
(7032, 256, 'список-6_3_описание', '29.01.2013<sup>31</sup> / Обновлён 06.05.2015\r\n'),
(7033, 256, '_список-6_3_описание', 'field_6244121168bd3'),
(7034, 256, 'список-6_4_ссылка', 'a:3:{s:5:\"title\";s:133:\"Стандарт первичной медико-санитарной помощи при хроническом простатите\";s:3:\"url\";s:1:\"#\";s:6:\"target\";s:0:\"\";}'),
(7035, 256, '_список-6_4_ссылка', 'field_624411ce68bd2'),
(7036, 256, 'список-6_4_описание', '09.11.2012<sup>32</sup> / Обновлён 13.04.2015\r\n'),
(7037, 256, '_список-6_4_описание', 'field_6244121168bd3'),
(7038, 256, 'список-6_5_ссылка', 'a:3:{s:5:\"title\";s:168:\"Стандарт специализированной медицинской помощи при остром простатите, орхите, эпидидимите\";s:3:\"url\";s:1:\"#\";s:6:\"target\";s:0:\"\";}'),
(7039, 256, '_список-6_5_ссылка', 'field_624411ce68bd2'),
(7040, 256, 'список-6_5_описание', '09.11.2012<sup>33</sup> / Обновлён 27.05.2015'),
(7041, 256, '_список-6_5_описание', 'field_6244121168bd3'),
(7042, 256, 'список-6', '6'),
(7043, 256, '_список-6', 'field_624411be68bd1'),
(7044, 256, 'заголовок-7', 'Препарат Урорек (силодозин) зарегистрирован и&nbsp;применяется в&nbsp;разных странах мира <br>\r\nОдобрен ЕМА*<sup>34</sup> и&nbsp;FDA**<sup>35</sup>'),
(7045, 256, '_заголовок-7', 'field_624417e3b6088'),
(7046, 256, 'текст', '<p class=\"sOtherCountries__agency\"><span>EMA</span> Европейское медицинское агентство</p>\r\n<p class=\"sOtherCountries__agency\"><span>FDA</span> Управление по&nbsp;санитарному надзору за&nbsp;качеством пищевых продуктов и&nbsp;медикаментов, США</p>'),
(7047, 256, '_текст', 'field_6244182bb6089'),
(7048, 256, 'страны_0_флаг', '105'),
(7049, 256, '_страны_0_флаг', 'field_62441880b608b'),
(7050, 256, 'страны_0_название', 'Япония'),
(7051, 256, '_страны_0_название', 'field_62441899b608c'),
(7052, 256, 'страны_0_год', '2006<sup>36,37</sup>'),
(7053, 256, '_страны_0_год', 'field_624418aab608d'),
(7054, 256, 'страны_1_флаг', '106'),
(7055, 256, '_страны_1_флаг', 'field_62441880b608b'),
(7056, 256, 'страны_1_название', 'США'),
(7057, 256, '_страны_1_название', 'field_62441899b608c'),
(7058, 256, 'страны_1_год', '2008<sup>35</sup>'),
(7059, 256, '_страны_1_год', 'field_624418aab608d'),
(7060, 256, 'страны_2_флаг', '107'),
(7061, 256, '_страны_2_флаг', 'field_62441880b608b'),
(7062, 256, 'страны_2_название', 'Страны ЕС'),
(7063, 256, '_страны_2_название', 'field_62441899b608c'),
(7064, 256, 'страны_2_год', '2010<sup>34</sup>'),
(7065, 256, '_страны_2_год', 'field_624418aab608d'),
(7066, 256, 'страны_3_флаг', '108'),
(7067, 256, '_страны_3_флаг', 'field_62441880b608b'),
(7068, 256, 'страны_3_название', 'Россия'),
(7069, 256, '_страны_3_название', 'field_62441899b608c'),
(7070, 256, 'страны_3_год', '2010<sup>1</sup>'),
(7071, 256, '_страны_3_год', 'field_624418aab608d'),
(7072, 256, 'страны', '4'),
(7073, 256, '_страны', 'field_62441847b608a'),
(7074, 256, 'текст-7', '<p class=\"sOtherCountries__agency\"><span>EMA</span> Европейское медицинское агентство</p>\r\n<p class=\"sOtherCountries__agency\"><span>FDA</span> Управление по&nbsp;санитарному надзору за&nbsp;качеством пищевых продуктов и&nbsp;медикаментов, США</p>'),
(7075, 256, '_текст-7', 'field_6244182bb6089'),
(7076, 256, 'текст-7-1', 'Производство препарата Урорек, поставляемого в&nbsp;Россию, осуществляется в&nbsp;Италии с&nbsp;использованием субстанции из&nbsp;Японии, в&nbsp;соответствии с&nbsp;необходимыми требованиями к&nbsp;производству и&nbsp;контролю качества<sup>6,1</sup>'),
(7077, 256, '_текст-7-1', 'field_62441a5acf03c'),
(7078, 256, 'заголовок-8', 'О проблеме'),
(7079, 256, '_заголовок-8', 'field_624431d91624d'),
(7080, 256, 'текст-8', 'Доброкачественная гиперплазия предстательной железы (ДГПЖ), или как ее еще называют, аденома простаты, как правило, возникает у мужчин старше 50 лет и характеризуется наличием симптомов нижних мочевыводящих путей (СНМП), увеличением предстательной железы или ее части, и нарушением оттока мочи из мочевого пузыря вследствие инфравезикальной обструкции.<sup>38</sup>\r\n\r\nРаспространенность ДГПЖ увеличивается с возрастом. Так, клинически значимая ДГПЖ проявляется у 13% мужчин в возрасте старше 50 лет, у 34% мужчин в возрасте 60 лет и у 43% в возрасте 70 лет.<sup>39</sup>\r\n\r\n<img class=\"alignnone wp-image-122 size-full\" src=\"http://0026urotec.loc:8888/wp-content/uploads/2022/03/about-img.png\" alt=\"\" width=\"594\" height=\"696\" />'),
(7081, 256, '_текст-8', 'field_624431f11624e'),
(7082, 256, 'текст-8-1', 'Наличие СНМП может быть ассоциировано с&nbsp;тяжелыми хроническими заболеваниями, такими как заболевания сердца, сахарный диабет, артериальная гипертензия и&nbsp;депрессия<sup>40</sup>'),
(7083, 256, '_текст-8-1', 'field_6244320b26db3'),
(7084, 256, 'иконки-8', 'a:6:{i:0;s:3:\"123\";i:1;s:3:\"124\";i:2;s:3:\"125\";i:3;s:3:\"126\";i:4;s:3:\"127\";i:5;s:3:\"128\";}'),
(7085, 256, '_иконки-8', 'field_6244322d26db4'),
(7086, 256, 'текст-8-2', '<h3>Симптомы доброкачественной гиперплазии предстательной железы</h3>\r\nСимптомы нарушенного мочеиспускания являются частой жалобой у взрослых мужчин. Они оказывают серьезное негативное влияние на качество жизни. При ДГПЖ предстательная железа увеличивается в размерах, оказывая давление на нижние мочевые пути. В результате развиваются следующие симптомы:<sup>41</sup>'),
(7087, 256, '_текст-8-2', 'field_6244335fe2373'),
(7088, 256, 'заголовок-9', 'Осложнения ДГПЖ<sup>38</sup>'),
(7089, 256, '_заголовок-9', 'field_6244377a52263'),
(7090, 256, 'изображения-9', 'a:6:{i:0;s:3:\"141\";i:1;s:3:\"142\";i:2;s:3:\"143\";i:3;s:3:\"144\";i:4;s:3:\"145\";i:5;s:3:\"146\";}'),
(7091, 256, '_изображения-9', 'field_6244379652264'),
(7092, 256, 'заголовок-10', 'Медикаментозное лечение СНМП/ДГПЖ'),
(7093, 256, '_заголовок-10', 'field_6244489614262'),
(7094, 256, 'текст-10', 'Антагонисты альфа1-адренорецепторов (альфа-адреноблокаторы) и&nbsp;ингибиторы 5&nbsp;альфа1-редуктазы (ингибиторы 5-АР) являются группами лекарственных препаратов, которые в&nbsp;настоящее время утверждены для лечения ДГПЖ. Обе группы препаратов обеспечивают надлежащее ослабление симптомов, но&nbsp;&alpha;&mdash;блокаторы обладают довольно быстрым началом действия, а&nbsp;ингибиторам 5-АР требуется несколько месяцев для получения терапевтического эффекта.<sup>42</sup>'),
(7095, 256, '_текст-10', 'field_624448ce14263'),
(7096, 256, 'карточки-10_0_заголовок', 'Альфа-адреноблокаторы'),
(7097, 256, '_карточки-10_0_заголовок', 'field_624448fc14265'),
(7098, 256, 'карточки-10_0_текст', 'представляют собой наиболее эффективный класс лекарственных препаратов, характеризующийся хорошим профилем безопасности и высокой комплаентностью, применяющийся для облегчения СНМП, связанных с ДГПЖ: они снимают спазм гладкой мускулатуры предстательной железы и шейки мочевого пузыря<sup>42</sup>'),
(7099, 256, '_карточки-10_0_текст', 'field_6244490c14266'),
(7100, 256, 'карточки-10_1_заголовок', 'Ингибиторы 5-АР'),
(7101, 256, '_карточки-10_1_заголовок', 'field_624448fc14265'),
(7102, 256, 'карточки-10_1_текст', 'приводят к редукции железистой ткани и к снижению размера предстательной железы: они блокируют конверсию тестостерона в дигидротестостерон, который стимулирует рост предстательной железы<sup>43,44</sup>.Назначаются при большом объеме предстательной железы. Для получения значимого клинического эффекта требуется несколько месяцев применения<sup>45</sup>\r\n'),
(7103, 256, '_карточки-10_1_текст', 'field_6244490c14266'),
(7104, 256, 'карточки-10', '2'),
(7105, 256, '_карточки-10', 'field_624448e214264'),
(7106, 256, 'видео', '<iframe width=\"560\" height=\"315\" src=\"https://www.youtube.com/embed/3DrU3pFXSsY\" title=\"YouTube video player\" frameborder=\"0\" allow=\"accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture\" allowfullscreen></iframe>'),
(7107, 256, '_видео', 'field_6244492214267'),
(7108, 256, 'заголовок-11', 'Часто задаваемые вопросы'),
(7109, 256, '_заголовок-11', 'field_62444b33e25d6'),
(7110, 256, 'вопросы_0_заголовок', 'Почему при приеме препарата Урорек у некоторых пациентов развивается нарушение эякуляции?'),
(7111, 256, '_вопросы_0_заголовок', 'field_62444b58e25d8'),
(7112, 256, 'вопросы_0_текст', 'Урорек — высокоселективный препарат, то есть преимущественно действует на альфа1А-адренорецепторы, которые находятся в нижних мочевых путях, предстательной железе и семенных пузырьках. Поэтому эффект развивается уже через 2–6 часов после приёма первой дозы препарата Урорек<sup>14</sup> при минимальным количестве нежелательных явлений.<sup>5</sup>\r\n\r\nНаиболее частый побочный эффект при приеме препарата Урорек — нарушение эякуляции<sup>46</sup>. Это может быть связано как с забросом эякулята при семяизвержении вместо уретры в мочевой пузырь, так и со снижением или отсутствием семенной жидкости во время эякуляции<sup>29</sup>. Силодозин снижает тонус гладкомышечных клеток семенных пузырьков, простаты и шейки мочевого пузыря, поэтому не происходит выброс семени. Этот эффект свойственен всем уроселективным альфа-адреноблокаторам<sup>53</sup> и самостоятельно исчезает после прекращения приема препарата.<sup>6</sup>\r\n\r\nЧастота эякуляторной дисфункции прямо пропорционально связана с улучшением СНМП и скорости мочеиспускания и подтверждает эффективность альфа-адреноблокатора: чем выше эффективность, тем выше частота встречаемости эякуляторной дисфункции.<sup>29</sup>\r\n\r\nНарушение эякуляции не влияет на сексуальную функцию<sup>52</sup>, не воспринимается как беспокоящий симптом подавляющим большинством пациентов и не требует отмены терапии.<sup>46</sup>'),
(7113, 256, '_вопросы_0_текст', 'field_62444b66e25d9'),
(7114, 256, 'вопросы_1_заголовок', 'Можно ли принимать Урорек при артериальной гипертензии и ишемический болезни сердца (ИБС)?'),
(7115, 256, '_вопросы_1_заголовок', 'field_62444b58e25d8'),
(7116, 256, 'вопросы_1_текст', 'Согласно инструкции по медицинскому применению, противопоказаний для применения лекарственного препарата Урорек у пациентов с СНМП/ДГПЖ и сопутствующими сердечно-сосудистыми заболеваниями нет.<sup>3</sup> Урорек не оказывает влияния на частоту сердечных сокращений (ЧСС), систолическое артериальное давление (САД) и диастолическое артериальное давление (ДАД).<sup>9</sup> Силодозин — не вызывает клинически значимого снижения артериального давления (АД)<sup>46</sup>, не усиливает действие антигипертензивных препаратов и не требует снижения дозы при одновременном приеме.<sup>7</sup> В соответствии с дизайном клинического исследования многие пациенты получали сопутствующую терапию антигипертензивными препаратами (в основном, средствами, воздействующими на ренин-ангиотензиновую систему, бета-блокаторами, антагонистами кальция и диуретиками) без повышения частоты ортостатической гипотензии.<sup>6</sup>\r\n\r\nПри приеме препарата Урорек наиболее низкий риск развития сердечно-сосудистых осложнений.<sup>5</sup>'),
(7117, 256, '_вопросы_1_текст', 'field_62444b66e25d9'),
(7118, 256, 'вопросы_2_заголовок', 'Можно ли принимать Урорек пациенту с ортостатической гипотензией в анамнезе?'),
(7119, 256, '_вопросы_2_заголовок', 'field_62444b58e25d8'),
(7120, 256, 'вопросы_2_текст', 'Повышенная селективность силодозина к альфа1A-адренорецепторам по сравнению с альфа1B-адренорецепторами выражается в пониженном риске развития сердечно-сосудистых осложнений.<sup>4</sup> Благодаря этому частота ортостатической гипотензии на фоне его приема сравнима с таковой при приеме плацебо.<sup>45,9</sup>\r\n\r\nВ отличие от других альфа-адреноблокаторов (например, все формы тамсулозина<sup>47,48</sup>), Урорек не противопоказан к приему у пациентов с ортостатической гипотензией в анамнезе. Тем не менее, пациентам с ортостатической гипотензией в анамнезе не рекомендуется принимать любые альфа-адреноблокаторы, в т.ч. Урорек.<sup>6</sup>'),
(7121, 256, '_вопросы_2_текст', 'field_62444b66e25d9'),
(7122, 256, 'вопросы_3_заголовок', 'Как долго можно принимать Урорек?'),
(7123, 256, '_вопросы_3_заголовок', 'field_62444b58e25d8'),
(7124, 256, 'вопросы_3_текст', 'Учитывая прогрессирующий характер течения доброкачественной гиперплазии предстательной железы, медикаментозную терапию следует проводить длительно (иногда в течение всей жизни пациента).<sup>49</sup>'),
(7125, 256, '_вопросы_3_текст', 'field_62444b66e25d9'),
(7126, 256, 'вопросы_4_заголовок', 'Пациенты жалуются на заложенность носа при лечении альфа-адреноблокаторами. Есть ли у препарата Урорек такое побочное действие?'),
(7127, 256, '_вопросы_4_заголовок', 'field_62444b58e25d8'),
(7128, 256, 'вопросы_4_текст', 'Заложенность носа — это возможный побочный эффект для всех альфа-адреноблокаторов. При приеме препарата Урорек он может возникать примерно в 1% случаев.<sup>46</sup>'),
(7129, 256, '_вопросы_4_текст', 'field_62444b66e25d9'),
(7130, 256, 'вопросы_5_заголовок', 'Можно ли начинать лечение препаратом Урорек с дозы 4 мг в сутки?'),
(7131, 256, '_вопросы_5_заголовок', 'field_62444b58e25d8'),
(7132, 256, 'вопросы_5_текст', 'Согласно инструкции по медицинскому применению лекарственного препарата Урорек, доза 8 мг в сутки рекомендована для лечения пациентов с СНМП/ДГПЖ. Титрование дозы при применении силодозина не требуется.\r\n\r\nУрорек 4 мг — это специальная доза для лечения пациентов с почечной недостаточностью средней степени тяжести (клиренс креатинина ≥ 30 до &lt; 50 мл/мин). Рекомендуется в течение первой недели принимать начальную дозу по 4 мг в сутки, далее при хорошей переносимости доза может быть увеличена до 8 мг в сутки.<sup>6</sup>*\r\n\r\n<small><strong>*Более подробные сведения о препарате, особенностях применения, побочных действиях и др. — см. инструкцию по медицинскому применению лекарственного препарата Урорек, РУ ЛСР-005971/10 от 25.06.2010</strong></small>'),
(7133, 256, '_вопросы_5_текст', 'field_62444b66e25d9'),
(7134, 256, 'вопросы_6_заголовок', 'Влияет ли Урорек на течение ДГПЖ или только снимает симптомы нижних мочевыводящих путей?'),
(7135, 256, '_вопросы_6_заголовок', 'field_62444b58e25d8'),
(7136, 256, 'вопросы_6_текст', 'Помимо субъективных симптомов, ДГПЖ вызывает прогрессирующее морфологическое ремоделирование мочевого пузыря с риском развития серьезных функциональных нарушений. Лечение должно не только купировать субъективные симптомы, но и включать профилактику патологического ремоделирования мочевого пузыря.<sup>161</sup>\r\n\r\nСилодозин, действующее вещество препарата Урорек, в сравнении с другими альфа-адреноблокаторами более эффективно влияет на инфравезикальную обструкцию (ИВО), что оказывает влияние на предотвращение патологического прогрессирования ремоделирования мочевого пузыря и риск развития серьезных функциональных нарушений.<sup>50,51</sup>'),
(7137, 256, '_вопросы_6_текст', 'field_62444b66e25d9'),
(7138, 256, 'вопросы_7_заголовок', 'Доступен ли Урорек по льготному отпуску?'),
(7139, 256, '_вопросы_7_заголовок', 'field_62444b58e25d8'),
(7140, 256, 'вопросы_7_текст', 'Урорек (силодозин) не включен в список жизненно важных лекарственных препаратов (ЖНВЛП)<sup>1</sup> и не входит в перечень препаратов для льготного обеспечения граждан по федеральному льготному списку.'),
(7141, 256, '_вопросы_7_текст', 'field_62444b66e25d9'),
(7142, 256, 'вопросы', '8'),
(7143, 256, '_вопросы', 'field_62444b49e25d7');

-- --------------------------------------------------------

--
-- Table structure for table `urotec_posts`
--

CREATE TABLE `urotec_posts` (
  `ID` bigint(20) UNSIGNED NOT NULL,
  `post_author` bigint(20) UNSIGNED NOT NULL DEFAULT '0',
  `post_date` datetime NOT NULL DEFAULT '0000-00-00 00:00:00',
  `post_date_gmt` datetime NOT NULL DEFAULT '0000-00-00 00:00:00',
  `post_content` longtext COLLATE utf8mb4_unicode_520_ci NOT NULL,
  `post_title` text COLLATE utf8mb4_unicode_520_ci NOT NULL,
  `post_excerpt` text COLLATE utf8mb4_unicode_520_ci NOT NULL,
  `post_status` varchar(20) COLLATE utf8mb4_unicode_520_ci NOT NULL DEFAULT 'publish',
  `comment_status` varchar(20) COLLATE utf8mb4_unicode_520_ci NOT NULL DEFAULT 'open',
  `ping_status` varchar(20) COLLATE utf8mb4_unicode_520_ci NOT NULL DEFAULT 'open',
  `post_password` varchar(255) COLLATE utf8mb4_unicode_520_ci NOT NULL DEFAULT '',
  `post_name` varchar(200) COLLATE utf8mb4_unicode_520_ci NOT NULL DEFAULT '',
  `to_ping` text COLLATE utf8mb4_unicode_520_ci NOT NULL,
  `pinged` text COLLATE utf8mb4_unicode_520_ci NOT NULL,
  `post_modified` datetime NOT NULL DEFAULT '0000-00-00 00:00:00',
  `post_modified_gmt` datetime NOT NULL DEFAULT '0000-00-00 00:00:00',
  `post_content_filtered` longtext COLLATE utf8mb4_unicode_520_ci NOT NULL,
  `post_parent` bigint(20) UNSIGNED NOT NULL DEFAULT '0',
  `guid` varchar(255) COLLATE utf8mb4_unicode_520_ci NOT NULL DEFAULT '',
  `menu_order` int(11) NOT NULL DEFAULT '0',
  `post_type` varchar(20) COLLATE utf8mb4_unicode_520_ci NOT NULL DEFAULT 'post',
  `post_mime_type` varchar(100) COLLATE utf8mb4_unicode_520_ci NOT NULL DEFAULT '',
  `comment_count` bigint(20) NOT NULL DEFAULT '0'
) ENGINE=InnoDB DEFAULT CHARSET=utf8mb4 COLLATE=utf8mb4_unicode_520_ci;

--
-- Dumping data for table `urotec_posts`
--

INSERT INTO `urotec_posts` (`ID`, `post_author`, `post_date`, `post_date_gmt`, `post_content`, `post_title`, `post_excerpt`, `post_status`, `comment_status`, `ping_status`, `post_password`, `post_name`, `to_ping`, `pinged`, `post_modified`, `post_modified_gmt`, `post_content_filtered`, `post_parent`, `guid`, `menu_order`, `post_type`, `post_mime_type`, `comment_count`) VALUES
(1, 1, '2022-03-29 22:05:03', '2022-03-29 19:05:03', '<!-- wp:paragraph -->\n<p>Клинические преимущества препарата Урорек (силодозин) определяются максимальной уроселективностью в&nbsp;классе альфа-адреноблокаторов4 Урорек&nbsp;— альфа-адреноблокатор последнего поколения, который эффективен в&nbsp;отношении всех СНМП (накопления, опорожнения, постмиктурических).12,13 При этом Урорек обладает минимальным риском развития нежелательных явлений со&nbsp;стороны сердечно-сосудистой системы, в&nbsp;т.ч.&nbsp;у&nbsp;пациентов, принимающих антигипертензивные препараты46,8</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>Клинические преимущества препарата Урорек (силодозин) определяются максимальной уроселективностью в&nbsp;классе альфа-адреноблокаторов4 Урорек&nbsp;— альфа-адреноблокатор последнего поколения, который эффективен в&nbsp;отношении всех</p>\n<!-- /wp:paragraph -->', 'Заголовок для статьи или материала в одну или несколько строк для наглядности', '', 'publish', 'open', 'open', '', 'privet-mir', '', '', '2022-03-30 20:44:33', '2022-03-30 17:44:33', '', 0, 'http://0026urotec.loc:8888/?p=1', 0, 'post', '', 1),
(2, 1, '2022-03-29 22:05:03', '2022-03-29 19:05:03', '<!-- wp:shortcode -->\n[headerblock]\n<!-- /wp:shortcode -->\n\n<!-- wp:shortcode -->\n[sAdv]\n<!-- /wp:shortcode -->\n\n<!-- wp:shortcode -->\n[sCatalog]\n<!-- /wp:shortcode -->\n\n<!-- wp:shortcode -->\n[sWhereBuy]\n<!-- /wp:shortcode -->\n\n<!-- wp:shortcode -->\n[sMethod]\n<!-- /wp:shortcode -->\n\n<!-- wp:shortcode -->\n[sRecomendation]\n<!-- /wp:shortcode -->\n\n<!-- wp:shortcode -->\n[sOtherCountries]\n<!-- /wp:shortcode -->\n\n<!-- wp:shortcode -->\n[sAbout]\n<!-- /wp:shortcode -->\n\n<!-- wp:shortcode -->\n[sComplications]\n<!-- /wp:shortcode -->\n\n<!-- wp:shortcode -->\n[sTreatment]\n<!-- /wp:shortcode -->\n\n<!-- wp:shortcode -->\n[sFAQ]\n<!-- /wp:shortcode -->', 'Главная', '', 'publish', 'closed', 'open', '', 'sample-page', '', '', '2022-04-05 21:41:37', '2022-04-05 18:41:37', '', 0, 'http://0026urotec.loc:8888/?page_id=2', 0, 'page', '', 0),
(3, 1, '2022-03-29 22:05:03', '2022-03-29 19:05:03', '<!-- wp:heading --><h2>Кто мы</h2><!-- /wp:heading --><!-- wp:paragraph --><p><strong class=\"privacy-policy-tutorial\">Предлагаемый текст: </strong>Наш адрес сайта: http://0026urotec.loc:8888.</p><!-- /wp:paragraph --><!-- wp:heading --><h2>Комментарии</h2><!-- /wp:heading --><!-- wp:paragraph --><p><strong class=\"privacy-policy-tutorial\">Предлагаемый текст: </strong>Если посетитель оставляет комментарий на сайте, мы собираем данные указанные в форме комментария, а также IP адрес посетителя и данные user-agent браузера с целью определения спама.</p><!-- /wp:paragraph --><!-- wp:paragraph --><p>Анонимизированная строка создаваемая из вашего адреса email (\"хеш\") может предоставляться сервису Gravatar, чтобы определить используете ли вы его. Политика конфиденциальности Gravatar доступна здесь: https://automattic.com/privacy/ . После одобрения комментария ваше изображение профиля будет видимым публично в контексте вашего комментария.</p><!-- /wp:paragraph --><!-- wp:heading --><h2>Медиафайлы</h2><!-- /wp:heading --><!-- wp:paragraph --><p><strong class=\"privacy-policy-tutorial\">Предлагаемый текст: </strong>Если вы зарегистрированный пользователь и загружаете фотографии на сайт, вам возможно следует избегать загрузки изображений с метаданными EXIF, так как они могут содержать данные вашего месторасположения по GPS. Посетители могут извлечь эту информацию скачав изображения с сайта.</p><!-- /wp:paragraph --><!-- wp:heading --><h2>Куки</h2><!-- /wp:heading --><!-- wp:paragraph --><p><strong class=\"privacy-policy-tutorial\">Предлагаемый текст: </strong>Если вы оставляете комментарий на нашем сайте, вы можете включить сохранение вашего имени, адреса email и вебсайта в куки. Это делается для вашего удобства, чтобы не заполнять данные снова при повторном комментировании. Эти куки хранятся в течение одного года.</p><!-- /wp:paragraph --><!-- wp:paragraph --><p>Если у вас есть учетная запись на сайте и вы войдете в неё, мы установим временный куки для определения поддержки куки вашим браузером, куки не содержит никакой личной информации и удаляется при закрытии вашего браузера.</p><!-- /wp:paragraph --><!-- wp:paragraph --><p>При входе в учетную запись мы также устанавливаем несколько куки с данными входа и настройками экрана. Куки входа хранятся в течение двух дней, куки с настройками экрана - год. Если вы выберете возможность \"Запомнить меня\", данные о входе будут сохраняться в течение двух недель. При выходе из учетной записи куки входа будут удалены.</p><!-- /wp:paragraph --><!-- wp:paragraph --><p>При редактировании или публикации статьи в браузере будет сохранен дополнительный куки, он не содержит персональных данных и содержит только ID записи отредактированной вами, истекает через 1 день.</p><!-- /wp:paragraph --><!-- wp:heading --><h2>Встраиваемое содержимое других вебсайтов</h2><!-- /wp:heading --><!-- wp:paragraph --><p><strong class=\"privacy-policy-tutorial\">Предлагаемый текст: </strong>Статьи на этом сайте могут включать встраиваемое содержимое (например видео, изображения, статьи и др.), подобное содержимое ведет себя так же, как если бы посетитель зашел на другой сайт.</p><!-- /wp:paragraph --><!-- wp:paragraph --><p>Эти сайты могут собирать данные о вас, использовать куки, внедрять дополнительное отслеживание третьей стороной и следить за вашим взаимодействием с внедренным содержимым, включая отслеживание взаимодействия, если у вас есть учетная запись и вы авторизовались на том сайте.</p><!-- /wp:paragraph --><!-- wp:heading --><h2>С кем мы делимся вашими данными</h2><!-- /wp:heading --><!-- wp:paragraph --><p><strong class=\"privacy-policy-tutorial\">Предлагаемый текст: </strong>Если вы запросите сброс пароля, ваш IP будет указан в email-сообщении о сбросе.</p><!-- /wp:paragraph --><!-- wp:heading --><h2>Как долго мы храним ваши данные</h2><!-- /wp:heading --><!-- wp:paragraph --><p><strong class=\"privacy-policy-tutorial\">Предлагаемый текст: </strong>Если вы оставляете комментарий, то сам комментарий и его метаданные сохраняются неопределенно долго. Это делается для того, чтобы определять и одобрять последующие комментарии автоматически, вместо помещения их в очередь на одобрение.</p><!-- /wp:paragraph --><!-- wp:paragraph --><p>Для пользователей с регистрацией на нашем сайте мы храним ту личную информацию, которую они указывают в своем профиле. Все пользователи могут видеть, редактировать или удалить свою информацию из профиля в любое время (кроме имени пользователя). Администрация вебсайта также может видеть и изменять эту информацию.</p><!-- /wp:paragraph --><!-- wp:heading --><h2>Какие у вас права на ваши данные</h2><!-- /wp:heading --><!-- wp:paragraph --><p><strong class=\"privacy-policy-tutorial\">Предлагаемый текст: </strong>При наличии учетной записи на сайте или если вы оставляли комментарии, то вы можете запросить файл экспорта персональных данных, которые мы сохранили о вас, включая предоставленные вами данные. Вы также можете запросить удаление этих данных, это не включает данные, которые мы обязаны хранить в административных целях, по закону или целях безопасности.</p><!-- /wp:paragraph --><!-- wp:heading --><h2>Куда мы отправляем ваши данные</h2><!-- /wp:heading --><!-- wp:paragraph --><p><strong class=\"privacy-policy-tutorial\">Предлагаемый текст: </strong>Комментарии пользователей могут проверяться автоматическим сервисом определения спама.</p><!-- /wp:paragraph -->', 'Политика конфиденциальности', '', 'draft', 'closed', 'open', '', 'privacy-policy', '', '', '2022-03-29 22:05:03', '2022-03-29 19:05:03', '', 0, 'http://0026urotec.loc:8888/?page_id=3', 0, 'page', '', 0),
(4, 1, '2022-03-29 22:05:15', '0000-00-00 00:00:00', '', 'Черновик', '', 'auto-draft', 'open', 'open', '', '', '', '', '2022-03-29 22:05:15', '0000-00-00 00:00:00', '', 0, 'http://0026urotec.loc:8888/?p=4', 0, 'post', '', 0),
(5, 1, '2022-03-29 22:13:25', '2022-03-29 19:13:25', '{\"version\": 2, \"isGlobalStylesUserThemeJSON\": true }', 'Custom Styles', '', 'publish', 'closed', 'closed', '', 'wp-global-styles-mega', '', '', '2022-03-29 22:13:25', '2022-03-29 19:13:25', '', 0, 'http://0026urotec.loc:8888/2022/03/29/wp-global-styles-mega/', 0, 'wp_global_styles', '', 0),
(7, 1, '2022-03-29 22:18:23', '2022-03-29 19:18:23', '<!-- wp:shortcode -->\n[header]\n<!-- /wp:shortcode -->\n\n<!-- wp:paragraph -->\n<p></p>\n<!-- /wp:paragraph -->', 'Главная', '', 'inherit', 'closed', 'closed', '', '2-revision-v1', '', '', '2022-03-29 22:18:23', '2022-03-29 19:18:23', '', 2, 'http://0026urotec.loc:8888/?p=7', 0, 'revision', '', 0),
(8, 1, '2022-03-29 22:23:44', '2022-03-29 19:23:44', 'a:7:{s:8:\"location\";a:1:{i:0;a:1:{i:0;a:3:{s:5:\"param\";s:4:\"page\";s:8:\"operator\";s:2:\"==\";s:5:\"value\";s:1:\"2\";}}}s:8:\"position\";s:6:\"normal\";s:5:\"style\";s:7:\"default\";s:15:\"label_placement\";s:3:\"top\";s:21:\"instruction_placement\";s:5:\"label\";s:14:\"hide_on_screen\";s:0:\"\";s:11:\"description\";s:0:\"\";}', '01-headerblock', '01-headerblock', 'publish', 'closed', 'closed', '', 'group_62435bab1a890', '', '', '2022-03-30 17:30:18', '2022-03-30 14:30:18', '', 0, 'http://0026urotec.loc:8888/?post_type=acf-field-group&#038;p=8', 0, 'acf-field-group', '', 0),
(9, 1, '2022-03-29 22:23:44', '2022-03-29 19:23:44', 'a:8:{s:4:\"type\";s:7:\"message\";s:12:\"instructions\";s:0:\"\";s:8:\"required\";i:0;s:17:\"conditional_logic\";i:0;s:7:\"wrapper\";a:3:{s:5:\"width\";s:0:\"\";s:5:\"class\";s:0:\"\";s:2:\"id\";s:0:\"\";}s:7:\"message\";s:13:\"[headerblock]\";s:9:\"new_lines\";s:7:\"wpautop\";s:8:\"esc_html\";i:0;}', 'Название шортокода', '', 'publish', 'closed', 'closed', '', 'field_62435bb06f29e', '', '', '2022-03-30 17:30:18', '2022-03-30 14:30:18', '', 8, 'http://0026urotec.loc:8888/?post_type=acf-field&#038;p=9', 0, 'acf-field', '', 0),
(10, 1, '2022-03-29 22:23:44', '2022-03-29 19:23:44', 'a:10:{s:4:\"type\";s:8:\"textarea\";s:12:\"instructions\";s:0:\"\";s:8:\"required\";i:0;s:17:\"conditional_logic\";i:0;s:7:\"wrapper\";a:3:{s:5:\"width\";s:0:\"\";s:5:\"class\";s:0:\"\";s:2:\"id\";s:0:\"\";}s:13:\"default_value\";s:94:\"УРОРЕК – оригинальный<sup>10</sup> альфа-адреноблокатор\";s:11:\"placeholder\";s:0:\"\";s:9:\"maxlength\";s:0:\"\";s:4:\"rows\";i:2;s:9:\"new_lines\";s:0:\"\";}', 'Заголовок', 'заголовок-1', 'publish', 'closed', 'closed', '', 'field_62435bd26f29f', '', '', '2022-03-29 22:23:44', '2022-03-29 19:23:44', '', 8, 'http://0026urotec.loc:8888/?post_type=acf-field&p=10', 1, 'acf-field', '', 0),
(11, 1, '2022-03-29 22:23:44', '2022-03-29 19:23:44', 'a:10:{s:4:\"type\";s:8:\"textarea\";s:12:\"instructions\";s:0:\"\";s:8:\"required\";i:0;s:17:\"conditional_logic\";i:0;s:7:\"wrapper\";a:3:{s:5:\"width\";s:0:\"\";s:5:\"class\";s:0:\"\";s:2:\"id\";s:0:\"\";}s:13:\"default_value\";s:670:\"<div class=\"headerBlock__body\">\r\n<p>Силодозин (действующее вещество препарата Урорек) обладает максимальной уроселективностью в&nbsp;своем классе, что обеспечивает его уродинамическую эффективность и&nbsp;высокую безопасность<sup>4</sup></p>\r\n</div>\r\n<div class=\"headerBlock__footer\">\r\n<p><strong>Показания к применению: </strong><br/>Лечение симптомов доброкачественной гиперплазии предстательной железы<sup>6</sup></p>\r\n</div>\";s:11:\"placeholder\";s:0:\"\";s:9:\"maxlength\";s:0:\"\";s:4:\"rows\";s:0:\"\";s:9:\"new_lines\";s:0:\"\";}', 'Текст', 'текст-1', 'publish', 'closed', 'closed', '', 'field_62435c0c6f2a0', '', '', '2022-03-29 22:23:44', '2022-03-29 19:23:44', '', 8, 'http://0026urotec.loc:8888/?post_type=acf-field&p=11', 2, 'acf-field', '', 0),
(12, 1, '2022-03-29 22:23:44', '2022-03-29 19:23:44', 'a:15:{s:4:\"type\";s:5:\"image\";s:12:\"instructions\";s:0:\"\";s:8:\"required\";i:0;s:17:\"conditional_logic\";i:0;s:7:\"wrapper\";a:3:{s:5:\"width\";s:0:\"\";s:5:\"class\";s:0:\"\";s:2:\"id\";s:0:\"\";}s:13:\"return_format\";s:2:\"id\";s:12:\"preview_size\";s:6:\"medium\";s:7:\"library\";s:3:\"all\";s:9:\"min_width\";s:0:\"\";s:10:\"min_height\";s:0:\"\";s:8:\"min_size\";s:0:\"\";s:9:\"max_width\";s:0:\"\";s:10:\"max_height\";s:0:\"\";s:8:\"max_size\";s:0:\"\";s:10:\"mime_types\";s:0:\"\";}', 'изображение', 'изображение-1', 'publish', 'closed', 'closed', '', 'field_62435c8b6f2a1', '', '', '2022-03-29 22:27:41', '2022-03-29 19:27:41', '', 8, 'http://0026urotec.loc:8888/?post_type=acf-field&#038;p=12', 3, 'acf-field', '', 0),
(13, 1, '2022-03-29 22:24:40', '2022-03-29 19:24:40', '', 'head-img', '', 'inherit', 'open', 'closed', '', 'head-img', '', '', '2022-03-29 22:24:40', '2022-03-29 19:24:40', '', 2, 'http://0026urotec.loc:8888/wp-content/uploads/2022/03/head-img.png', 0, 'attachment', 'image/png', 0),
(14, 1, '2022-03-29 22:24:56', '2022-03-29 19:24:56', '<!-- wp:shortcode -->\n[header]\n<!-- /wp:shortcode -->\n\n<!-- wp:paragraph -->\n<p></p>\n<!-- /wp:paragraph -->', 'Главная', '', 'inherit', 'closed', 'closed', '', '2-revision-v1', '', '', '2022-03-29 22:24:56', '2022-03-29 19:24:56', '', 2, 'http://0026urotec.loc:8888/?p=14', 0, 'revision', '', 0),
(15, 1, '2022-03-29 22:28:09', '2022-03-29 19:28:09', 'a:15:{s:4:\"type\";s:5:\"image\";s:12:\"instructions\";s:0:\"\";s:8:\"required\";i:0;s:17:\"conditional_logic\";i:0;s:7:\"wrapper\";a:3:{s:5:\"width\";s:0:\"\";s:5:\"class\";s:0:\"\";s:2:\"id\";s:0:\"\";}s:13:\"return_format\";s:2:\"id\";s:12:\"preview_size\";s:6:\"medium\";s:7:\"library\";s:3:\"all\";s:9:\"min_width\";s:0:\"\";s:10:\"min_height\";s:0:\"\";s:8:\"min_size\";s:0:\"\";s:9:\"max_width\";s:0:\"\";s:10:\"max_height\";s:0:\"\";s:8:\"max_size\";s:0:\"\";s:10:\"mime_types\";s:0:\"\";}', 'фон', 'фон-1', 'publish', 'closed', 'closed', '', 'field_62435db92ea96', '', '', '2022-03-29 22:28:09', '2022-03-29 19:28:09', '', 8, 'http://0026urotec.loc:8888/?post_type=acf-field&p=15', 4, 'acf-field', '', 0),
(16, 1, '2022-03-29 22:28:25', '2022-03-29 19:28:25', '<!-- wp:shortcode -->\n[header]\n<!-- /wp:shortcode -->\n\n<!-- wp:paragraph -->\n<p></p>\n<!-- /wp:paragraph -->', 'Главная', '', 'inherit', 'closed', 'closed', '', '2-revision-v1', '', '', '2022-03-29 22:28:25', '2022-03-29 19:28:25', '', 2, 'http://0026urotec.loc:8888/?p=16', 0, 'revision', '', 0),
(17, 1, '2022-03-29 22:29:04', '2022-03-29 19:29:04', '', 'head-bg', '', 'inherit', 'open', 'closed', '', 'head-bg', '', '', '2022-03-29 22:29:04', '2022-03-29 19:29:04', '', 2, 'http://0026urotec.loc:8888/wp-content/uploads/2022/03/head-bg.jpg', 0, 'attachment', 'image/jpeg', 0),
(18, 1, '2022-03-29 22:29:14', '2022-03-29 19:29:14', '<!-- wp:shortcode -->\n[header]\n<!-- /wp:shortcode -->\n\n<!-- wp:paragraph -->\n<p></p>\n<!-- /wp:paragraph -->', 'Главная', '', 'inherit', 'closed', 'closed', '', '2-revision-v1', '', '', '2022-03-29 22:29:14', '2022-03-29 19:29:14', '', 2, 'http://0026urotec.loc:8888/?p=18', 0, 'revision', '', 0),
(19, 1, '2022-03-29 22:38:58', '2022-03-29 19:38:58', '<!-- wp:shortcode -->\n[header]\n<!-- /wp:shortcode -->\n\n<!-- wp:shortcode -->\n[sAdv]\n<!-- /wp:shortcode -->', 'Главная', '', 'inherit', 'closed', 'closed', '', '2-revision-v1', '', '', '2022-03-29 22:38:58', '2022-03-29 19:38:58', '', 2, 'http://0026urotec.loc:8888/?p=19', 0, 'revision', '', 0),
(20, 1, '2022-03-29 22:38:58', '2022-03-29 19:38:58', '<!-- wp:shortcode -->\n[header]\n<!-- /wp:shortcode -->\n\n<!-- wp:shortcode -->\n[sAdv]\n<!-- /wp:shortcode -->', 'Главная', '', 'inherit', 'closed', 'closed', '', '2-revision-v1', '', '', '2022-03-29 22:38:58', '2022-03-29 19:38:58', '', 2, 'http://0026urotec.loc:8888/?p=20', 0, 'revision', '', 0),
(21, 1, '2022-03-29 22:54:51', '2022-03-29 19:54:51', 'a:7:{s:8:\"location\";a:1:{i:0;a:1:{i:0;a:3:{s:5:\"param\";s:4:\"page\";s:8:\"operator\";s:2:\"==\";s:5:\"value\";s:1:\"2\";}}}s:8:\"position\";s:6:\"normal\";s:5:\"style\";s:7:\"default\";s:15:\"label_placement\";s:3:\"top\";s:21:\"instruction_placement\";s:5:\"label\";s:14:\"hide_on_screen\";s:0:\"\";s:11:\"description\";s:0:\"\";}', '02-sAdv', '02-sadv', 'publish', 'closed', 'closed', '', 'group_6243605e61225', '', '', '2022-03-29 23:40:07', '2022-03-29 20:40:07', '', 0, 'http://0026urotec.loc:8888/?post_type=acf-field-group&#038;p=21', 0, 'acf-field-group', '', 0),
(22, 1, '2022-03-29 22:54:51', '2022-03-29 19:54:51', 'a:10:{s:4:\"type\";s:8:\"textarea\";s:12:\"instructions\";s:0:\"\";s:8:\"required\";i:0;s:17:\"conditional_logic\";i:0;s:7:\"wrapper\";a:3:{s:5:\"width\";s:0:\"\";s:5:\"class\";s:0:\"\";s:2:\"id\";s:0:\"\";}s:13:\"default_value\";s:0:\"\";s:11:\"placeholder\";s:0:\"\";s:9:\"maxlength\";s:0:\"\";s:4:\"rows\";i:2;s:9:\"new_lines\";s:0:\"\";}', 'Заголовок', 'заголовок-2', 'publish', 'closed', 'closed', '', 'field_6243606295196', '', '', '2022-03-29 23:40:07', '2022-03-29 20:40:07', '', 21, 'http://0026urotec.loc:8888/?post_type=acf-field&#038;p=22', 1, 'acf-field', '', 0),
(23, 1, '2022-03-29 22:54:51', '2022-03-29 19:54:51', 'a:10:{s:4:\"type\";s:8:\"textarea\";s:12:\"instructions\";s:0:\"\";s:8:\"required\";i:0;s:17:\"conditional_logic\";i:0;s:7:\"wrapper\";a:3:{s:5:\"width\";s:0:\"\";s:5:\"class\";s:0:\"\";s:2:\"id\";s:0:\"\";}s:13:\"default_value\";s:204:\"Единственный оригинальный препарат из&nbsp;группы альфа1-адреноблокаторов, не&nbsp;имеющий генериков в&nbsp;РФ<sup>1</sup>\";s:11:\"placeholder\";s:0:\"\";s:9:\"maxlength\";s:0:\"\";s:4:\"rows\";i:2;s:9:\"new_lines\";s:0:\"\";}', 'Список', 'список-2', 'publish', 'closed', 'closed', '', 'field_6243608195197', '', '', '2022-03-29 23:40:07', '2022-03-29 20:40:07', '', 21, 'http://0026urotec.loc:8888/?post_type=acf-field&#038;p=23', 2, 'acf-field', '', 0),
(24, 1, '2022-03-29 22:54:51', '2022-03-29 19:54:51', 'a:10:{s:4:\"type\";s:8:\"repeater\";s:12:\"instructions\";s:0:\"\";s:8:\"required\";i:0;s:17:\"conditional_logic\";i:0;s:7:\"wrapper\";a:3:{s:5:\"width\";s:0:\"\";s:5:\"class\";s:0:\"\";s:2:\"id\";s:0:\"\";}s:9:\"collapsed\";s:0:\"\";s:3:\"min\";s:0:\"\";s:3:\"max\";s:0:\"\";s:6:\"layout\";s:5:\"table\";s:12:\"button_label\";s:0:\"\";}', 'Картинка с текстом', 'картинка_с_текстом', 'publish', 'closed', 'closed', '', 'field_624363b995198', '', '', '2022-03-29 23:40:07', '2022-03-29 20:40:07', '', 21, 'http://0026urotec.loc:8888/?post_type=acf-field&#038;p=24', 3, 'acf-field', '', 0),
(25, 1, '2022-03-29 22:54:51', '2022-03-29 19:54:51', 'a:15:{s:4:\"type\";s:5:\"image\";s:12:\"instructions\";s:0:\"\";s:8:\"required\";i:0;s:17:\"conditional_logic\";i:0;s:7:\"wrapper\";a:3:{s:5:\"width\";s:0:\"\";s:5:\"class\";s:0:\"\";s:2:\"id\";s:0:\"\";}s:13:\"return_format\";s:2:\"id\";s:12:\"preview_size\";s:6:\"medium\";s:7:\"library\";s:3:\"all\";s:9:\"min_width\";s:0:\"\";s:10:\"min_height\";s:0:\"\";s:8:\"min_size\";s:0:\"\";s:9:\"max_width\";s:0:\"\";s:10:\"max_height\";s:0:\"\";s:8:\"max_size\";s:0:\"\";s:10:\"mime_types\";s:0:\"\";}', 'Изображение', 'изображение', 'publish', 'closed', 'closed', '', 'field_624363d095199', '', '', '2022-03-29 22:54:51', '2022-03-29 19:54:51', '', 24, 'http://0026urotec.loc:8888/?post_type=acf-field&p=25', 0, 'acf-field', '', 0),
(26, 1, '2022-03-29 22:54:51', '2022-03-29 19:54:51', 'a:10:{s:4:\"type\";s:8:\"textarea\";s:12:\"instructions\";s:0:\"\";s:8:\"required\";i:0;s:17:\"conditional_logic\";i:0;s:7:\"wrapper\";a:3:{s:5:\"width\";s:0:\"\";s:5:\"class\";s:0:\"\";s:2:\"id\";s:0:\"\";}s:13:\"default_value\";s:0:\"\";s:11:\"placeholder\";s:0:\"\";s:9:\"maxlength\";s:0:\"\";s:4:\"rows\";i:2;s:9:\"new_lines\";s:0:\"\";}', 'Описание', 'описание', 'publish', 'closed', 'closed', '', 'field_624363e59519a', '', '', '2022-03-29 22:54:51', '2022-03-29 19:54:51', '', 24, 'http://0026urotec.loc:8888/?post_type=acf-field&p=26', 1, 'acf-field', '', 0),
(27, 1, '2022-03-29 22:58:57', '2022-03-29 19:58:57', 'a:10:{s:4:\"type\";s:8:\"textarea\";s:12:\"instructions\";s:0:\"\";s:8:\"required\";i:0;s:17:\"conditional_logic\";i:0;s:7:\"wrapper\";a:3:{s:5:\"width\";s:0:\"\";s:5:\"class\";s:0:\"\";s:2:\"id\";s:0:\"\";}s:13:\"default_value\";s:1050:\"<li>Клинические преимущества препарата Урорек (силодозин) определяются максимальной уроселективностью в&nbsp;классе альфа-адреноблокаторов<sup>4</sup></li>\r\n\r\n<li>Урорек&nbsp;&mdash; альфа-адреноблокатор последнего поколения, который эффективен в&nbsp;отношении всех СНМП (накопления, опорожнения, постмиктурических).<sup>12,13</sup> При этом Урорек обладает минимальным риском развития нежелательных явлений со&nbsp;стороны сердечно-сосудистой системы, в&nbsp;том числе&nbsp;у&nbsp;пациентов, принимающих антигипертензивные препараты<sup>46,8</sup> <small> <span>СНМП </span>симптомы нижних мочевыводящих путей</small></li>\";s:11:\"placeholder\";s:0:\"\";s:9:\"maxlength\";s:0:\"\";s:4:\"rows\";s:0:\"\";s:9:\"new_lines\";s:0:\"\";}', 'Второй список', 'второй_список', 'publish', 'closed', 'closed', '', 'field_6243640e05eda', '', '', '2022-03-29 23:40:07', '2022-03-29 20:40:07', '', 21, 'http://0026urotec.loc:8888/?post_type=acf-field&#038;p=27', 4, 'acf-field', '', 0),
(28, 1, '2022-03-29 22:58:57', '2022-03-29 19:58:57', 'a:10:{s:4:\"type\";s:8:\"textarea\";s:12:\"instructions\";s:0:\"\";s:8:\"required\";i:0;s:17:\"conditional_logic\";i:0;s:7:\"wrapper\";a:3:{s:5:\"width\";s:0:\"\";s:5:\"class\";s:0:\"\";s:2:\"id\";s:0:\"\";}s:13:\"default_value\";s:310:\"Максимальная уроселективность силодозина в&nbsp;классе альфа-адреноблокаторов обуславливает его уродинамическую эффективность и&nbsp;высокий профиль безопасности<sup>4</sup>\";s:11:\"placeholder\";s:0:\"\";s:9:\"maxlength\";s:0:\"\";s:4:\"rows\";i:3;s:9:\"new_lines\";s:0:\"\";}', 'Заголовок2', 'заголовок2-2', 'publish', 'closed', 'closed', '', 'field_6243644705edb', '', '', '2022-03-29 23:40:07', '2022-03-29 20:40:07', '', 21, 'http://0026urotec.loc:8888/?post_type=acf-field&#038;p=28', 5, 'acf-field', '', 0),
(29, 1, '2022-03-29 22:58:57', '2022-03-29 19:58:57', 'a:10:{s:4:\"type\";s:8:\"textarea\";s:12:\"instructions\";s:0:\"\";s:8:\"required\";i:0;s:17:\"conditional_logic\";i:0;s:7:\"wrapper\";a:3:{s:5:\"width\";s:0:\"\";s:5:\"class\";s:0:\"\";s:2:\"id\";s:0:\"\";}s:13:\"default_value\";s:768:\"<ul>\r\n<li>Урорек значительно улучшает клинические проявления и&nbsp;качество жизни у&nbsp;всех пациентов с&nbsp;СНМП/ДГПЖ, в&nbsp;том числе с&nbsp;тяжелым течением<sup>11</sup><a href=\"#\">Узнать больше...</a></li>\r\n\r\n<li>Урорек является препаратом выбора для пациентов с&nbsp;СНМП/ДГПЖ и&nbsp;сопутствующими сердечно-сосудистыми заболеваниями<sup>3</sup> <a href=\"#\">Узнать больше...</a></li>\r\n</ul>\r\n<small> <span>ДГПЖ </span>доброкачественная гиперплазия предстательной железы</small>\";s:11:\"placeholder\";s:0:\"\";s:9:\"maxlength\";s:0:\"\";s:4:\"rows\";s:0:\"\";s:9:\"new_lines\";s:0:\"\";}', 'Текст3', 'текст3', 'publish', 'closed', 'closed', '', 'field_6243647405edc', '', '', '2022-03-29 23:40:07', '2022-03-29 20:40:07', '', 21, 'http://0026urotec.loc:8888/?post_type=acf-field&#038;p=29', 6, 'acf-field', '', 0),
(30, 1, '2022-03-29 22:58:57', '2022-03-29 19:58:57', 'a:15:{s:4:\"type\";s:5:\"image\";s:12:\"instructions\";s:0:\"\";s:8:\"required\";i:0;s:17:\"conditional_logic\";i:0;s:7:\"wrapper\";a:3:{s:5:\"width\";s:0:\"\";s:5:\"class\";s:0:\"\";s:2:\"id\";s:0:\"\";}s:13:\"return_format\";s:2:\"id\";s:12:\"preview_size\";s:6:\"medium\";s:7:\"library\";s:3:\"all\";s:9:\"min_width\";s:0:\"\";s:10:\"min_height\";s:0:\"\";s:8:\"min_size\";s:0:\"\";s:9:\"max_width\";s:0:\"\";s:10:\"max_height\";s:0:\"\";s:8:\"max_size\";s:0:\"\";s:10:\"mime_types\";s:0:\"\";}', 'изображение', 'изображение-2', 'publish', 'closed', 'closed', '', 'field_624364dd05edd', '', '', '2022-03-29 23:40:07', '2022-03-29 20:40:07', '', 21, 'http://0026urotec.loc:8888/?post_type=acf-field&#038;p=30', 7, 'acf-field', '', 0),
(31, 1, '2022-03-29 23:13:03', '2022-03-29 20:13:03', '', 'adv-i-1', '', 'inherit', 'open', 'closed', '', 'adv-i-1', '', '', '2022-03-29 23:13:03', '2022-03-29 20:13:03', '', 2, 'http://0026urotec.loc:8888/wp-content/uploads/2022/03/adv-i-1.svg', 0, 'attachment', 'image/svg+xml', 0),
(32, 1, '2022-03-29 23:13:04', '2022-03-29 20:13:04', '', 'adv-i-2', '', 'inherit', 'open', 'closed', '', 'adv-i-2', '', '', '2022-03-29 23:13:04', '2022-03-29 20:13:04', '', 2, 'http://0026urotec.loc:8888/wp-content/uploads/2022/03/adv-i-2.svg', 0, 'attachment', 'image/svg+xml', 0),
(33, 1, '2022-03-29 23:13:05', '2022-03-29 20:13:05', '', 'adv-i-3', '', 'inherit', 'open', 'closed', '', 'adv-i-3', '', '', '2022-03-29 23:13:05', '2022-03-29 20:13:05', '', 2, 'http://0026urotec.loc:8888/wp-content/uploads/2022/03/adv-i-3.svg', 0, 'attachment', 'image/svg+xml', 0),
(34, 1, '2022-03-29 23:20:30', '2022-03-29 20:20:30', '', 'dad', '', 'inherit', 'open', 'closed', '', 'dad', '', '', '2022-03-29 23:20:30', '2022-03-29 20:20:30', '', 2, 'http://0026urotec.loc:8888/wp-content/uploads/2022/03/dad.png', 0, 'attachment', 'image/png', 0),
(35, 1, '2022-03-29 23:24:06', '2022-03-29 20:24:06', '<!-- wp:shortcode -->\n[header]\n<!-- /wp:shortcode -->\n\n<!-- wp:shortcode -->\n[sAdv]\n<!-- /wp:shortcode -->', 'Главная', '', 'inherit', 'closed', 'closed', '', '2-revision-v1', '', '', '2022-03-29 23:24:06', '2022-03-29 20:24:06', '', 2, 'http://0026urotec.loc:8888/?p=35', 0, 'revision', '', 0),
(36, 1, '2022-03-29 23:32:09', '2022-03-29 20:32:09', '<!-- wp:shortcode -->\n[header]\n<!-- /wp:shortcode -->\n\n<!-- wp:shortcode -->\n[sAdv]\n<!-- /wp:shortcode -->', 'Главная', '', 'inherit', 'closed', 'closed', '', '2-revision-v1', '', '', '2022-03-29 23:32:09', '2022-03-29 20:32:09', '', 2, 'http://0026urotec.loc:8888/?p=36', 0, 'revision', '', 0),
(37, 1, '2022-03-29 23:32:39', '2022-03-29 20:32:39', '<!-- wp:shortcode -->\n[header]\n<!-- /wp:shortcode -->\n\n<!-- wp:shortcode -->\n[sAdv]\n<!-- /wp:shortcode -->', 'Главная', '', 'inherit', 'closed', 'closed', '', '2-revision-v1', '', '', '2022-03-29 23:32:39', '2022-03-29 20:32:39', '', 2, 'http://0026urotec.loc:8888/?p=37', 0, 'revision', '', 0),
(38, 1, '2022-03-29 23:32:57', '2022-03-29 20:32:57', '<!-- wp:shortcode -->\n[header]\n<!-- /wp:shortcode -->\n\n<!-- wp:shortcode -->\n[sAdv]\n<!-- /wp:shortcode -->', 'Главная', '', 'inherit', 'closed', 'closed', '', '2-revision-v1', '', '', '2022-03-29 23:32:57', '2022-03-29 20:32:57', '', 2, 'http://0026urotec.loc:8888/?p=38', 0, 'revision', '', 0),
(39, 1, '2022-03-29 23:36:55', '2022-03-29 20:36:55', 'a:10:{s:4:\"type\";s:8:\"textarea\";s:12:\"instructions\";s:0:\"\";s:8:\"required\";i:0;s:17:\"conditional_logic\";i:0;s:7:\"wrapper\";a:3:{s:5:\"width\";s:0:\"\";s:5:\"class\";s:0:\"\";s:2:\"id\";s:0:\"\";}s:13:\"default_value\";s:236:\"<h2> Максимальная уроселективность в&nbsp;классе  альфа-адреноблокаторов<sup>4</sup></h2>\r\n<div class=\"h3\"> Почему это важно? <a href=\"#\">Подробнее</a></div>\";s:11:\"placeholder\";s:0:\"\";s:9:\"maxlength\";s:0:\"\";s:4:\"rows\";s:0:\"\";s:9:\"new_lines\";s:0:\"\";}', 'Текст в подвале', 'текст_в_подвале', 'publish', 'closed', 'closed', '', 'field_62436daf1f6d9', '', '', '2022-03-29 23:40:07', '2022-03-29 20:40:07', '', 21, 'http://0026urotec.loc:8888/?post_type=acf-field&#038;p=39', 8, 'acf-field', '', 0),
(40, 1, '2022-03-29 23:38:53', '2022-03-29 20:38:53', '<!-- wp:shortcode -->\n[header]\n<!-- /wp:shortcode -->\n\n<!-- wp:shortcode -->\n[sAdv]\n<!-- /wp:shortcode -->\n\n<!-- wp:shortcode -->\n[sCatalog]\n<!-- /wp:shortcode -->', 'Главная', '', 'inherit', 'closed', 'closed', '', '2-revision-v1', '', '', '2022-03-29 23:38:53', '2022-03-29 20:38:53', '', 2, 'http://0026urotec.loc:8888/?p=40', 0, 'revision', '', 0),
(41, 1, '2022-03-29 23:40:07', '2022-03-29 20:40:07', 'a:8:{s:4:\"type\";s:7:\"message\";s:12:\"instructions\";s:0:\"\";s:8:\"required\";i:0;s:17:\"conditional_logic\";i:0;s:7:\"wrapper\";a:3:{s:5:\"width\";s:0:\"\";s:5:\"class\";s:0:\"\";s:2:\"id\";s:0:\"\";}s:7:\"message\";s:6:\"[sAdv]\";s:9:\"new_lines\";s:7:\"wpautop\";s:8:\"esc_html\";i:0;}', 'Шорткод', 'шорткод', 'publish', 'closed', 'closed', '', 'field_62436e6f13fb2', '', '', '2022-03-29 23:40:07', '2022-03-29 20:40:07', '', 21, 'http://0026urotec.loc:8888/?post_type=acf-field&p=41', 0, 'acf-field', '', 0),
(42, 1, '2022-03-29 23:47:24', '2022-03-29 20:47:24', 'a:7:{s:8:\"location\";a:1:{i:0;a:1:{i:0;a:3:{s:5:\"param\";s:4:\"page\";s:8:\"operator\";s:2:\"==\";s:5:\"value\";s:1:\"2\";}}}s:8:\"position\";s:6:\"normal\";s:5:\"style\";s:7:\"default\";s:15:\"label_placement\";s:3:\"top\";s:21:\"instruction_placement\";s:5:\"label\";s:14:\"hide_on_screen\";s:0:\"\";s:11:\"description\";s:0:\"\";}', '03-catalog', '03-catalog', 'publish', 'closed', 'closed', '', 'group_62436eb2bb936', '', '', '2022-03-29 23:47:25', '2022-03-29 20:47:25', '', 0, 'http://0026urotec.loc:8888/?post_type=acf-field-group&#038;p=42', 0, 'acf-field-group', '', 0),
(43, 1, '2022-03-29 23:47:24', '2022-03-29 20:47:24', 'a:8:{s:4:\"type\";s:7:\"message\";s:12:\"instructions\";s:0:\"\";s:8:\"required\";i:0;s:17:\"conditional_logic\";i:0;s:7:\"wrapper\";a:3:{s:5:\"width\";s:0:\"\";s:5:\"class\";s:0:\"\";s:2:\"id\";s:0:\"\";}s:7:\"message\";s:10:\"[sCatalog]\";s:9:\"new_lines\";s:7:\"wpautop\";s:8:\"esc_html\";i:0;}', 'Шорткод', 'шорткод', 'publish', 'closed', 'closed', '', 'field_62436ec1e98e6', '', '', '2022-03-29 23:47:24', '2022-03-29 20:47:24', '', 42, 'http://0026urotec.loc:8888/?post_type=acf-field&p=43', 0, 'acf-field', '', 0),
(44, 1, '2022-03-29 23:47:24', '2022-03-29 20:47:24', 'a:10:{s:4:\"type\";s:4:\"text\";s:12:\"instructions\";s:0:\"\";s:8:\"required\";i:0;s:17:\"conditional_logic\";i:0;s:7:\"wrapper\";a:3:{s:5:\"width\";s:0:\"\";s:5:\"class\";s:0:\"\";s:2:\"id\";s:0:\"\";}s:13:\"default_value\";s:57:\"Форма выпуска препарата Урорек\";s:11:\"placeholder\";s:0:\"\";s:7:\"prepend\";s:0:\"\";s:6:\"append\";s:0:\"\";s:9:\"maxlength\";s:0:\"\";}', 'Заголовок', 'заголовок-3', 'publish', 'closed', 'closed', '', 'field_62436efee98e7', '', '', '2022-03-29 23:47:24', '2022-03-29 20:47:24', '', 42, 'http://0026urotec.loc:8888/?post_type=acf-field&p=44', 1, 'acf-field', '', 0),
(45, 1, '2022-03-29 23:47:24', '2022-03-29 20:47:24', 'a:10:{s:4:\"type\";s:8:\"textarea\";s:12:\"instructions\";s:0:\"\";s:8:\"required\";i:0;s:17:\"conditional_logic\";i:0;s:7:\"wrapper\";a:3:{s:5:\"width\";s:0:\"\";s:5:\"class\";s:0:\"\";s:2:\"id\";s:0:\"\";}s:13:\"default_value\";s:583:\"<p class=\"section-descr\"><span>8мг </span>- рекомендуемая доза для лечения симптомов ДГПЖ<sup>6</sup>*</p>\r\n					<p class=\"section-note col-md-10\">*Более подробные сведения о&nbsp;препарате, особенностях применения, побочных действиях и&nbsp;др. &mdash;&nbsp;смотрите инструкцию по&nbsp;медицинскому применению лекарственного препарата Урорек, РУ&nbsp;ЛСР-005971/10 от&nbsp;25.06.2010 </p>\";s:11:\"placeholder\";s:0:\"\";s:9:\"maxlength\";s:0:\"\";s:4:\"rows\";s:0:\"\";s:9:\"new_lines\";s:0:\"\";}', 'Текст', 'текст-3', 'publish', 'closed', 'closed', '', 'field_62436f60e98e8', '', '', '2022-03-29 23:47:24', '2022-03-29 20:47:24', '', 42, 'http://0026urotec.loc:8888/?post_type=acf-field&p=45', 2, 'acf-field', '', 0),
(46, 1, '2022-03-29 23:47:24', '2022-03-29 20:47:24', 'a:10:{s:4:\"type\";s:8:\"repeater\";s:12:\"instructions\";s:0:\"\";s:8:\"required\";i:0;s:17:\"conditional_logic\";i:0;s:7:\"wrapper\";a:3:{s:5:\"width\";s:0:\"\";s:5:\"class\";s:0:\"\";s:2:\"id\";s:0:\"\";}s:9:\"collapsed\";s:0:\"\";s:3:\"min\";s:0:\"\";s:3:\"max\";s:0:\"\";s:6:\"layout\";s:5:\"table\";s:12:\"button_label\";s:0:\"\";}', 'Товар', 'товар', 'publish', 'closed', 'closed', '', 'field_62436fbde98e9', '', '', '2022-03-29 23:47:24', '2022-03-29 20:47:24', '', 42, 'http://0026urotec.loc:8888/?post_type=acf-field&p=46', 3, 'acf-field', '', 0),
(47, 1, '2022-03-29 23:47:24', '2022-03-29 20:47:24', 'a:10:{s:4:\"type\";s:4:\"text\";s:12:\"instructions\";s:0:\"\";s:8:\"required\";i:0;s:17:\"conditional_logic\";i:0;s:7:\"wrapper\";a:3:{s:5:\"width\";s:0:\"\";s:5:\"class\";s:0:\"\";s:2:\"id\";s:0:\"\";}s:13:\"default_value\";s:0:\"\";s:11:\"placeholder\";s:0:\"\";s:7:\"prepend\";s:0:\"\";s:6:\"append\";s:0:\"\";s:9:\"maxlength\";s:0:\"\";}', 'Название', 'название', 'publish', 'closed', 'closed', '', 'field_62436fcce98ea', '', '', '2022-03-29 23:47:24', '2022-03-29 20:47:24', '', 46, 'http://0026urotec.loc:8888/?post_type=acf-field&p=47', 0, 'acf-field', '', 0),
(48, 1, '2022-03-29 23:47:24', '2022-03-29 20:47:24', 'a:10:{s:4:\"type\";s:8:\"textarea\";s:12:\"instructions\";s:0:\"\";s:8:\"required\";i:0;s:17:\"conditional_logic\";i:0;s:7:\"wrapper\";a:3:{s:5:\"width\";s:0:\"\";s:5:\"class\";s:0:\"\";s:2:\"id\";s:0:\"\";}s:13:\"default_value\";s:0:\"\";s:11:\"placeholder\";s:0:\"\";s:9:\"maxlength\";s:0:\"\";s:4:\"rows\";s:0:\"\";s:9:\"new_lines\";s:0:\"\";}', 'Описание', 'описание', 'publish', 'closed', 'closed', '', 'field_62436fe1e98eb', '', '', '2022-03-29 23:47:24', '2022-03-29 20:47:24', '', 46, 'http://0026urotec.loc:8888/?post_type=acf-field&p=48', 1, 'acf-field', '', 0),
(49, 1, '2022-03-29 23:47:24', '2022-03-29 20:47:24', 'a:10:{s:4:\"type\";s:4:\"text\";s:12:\"instructions\";s:0:\"\";s:8:\"required\";i:0;s:17:\"conditional_logic\";i:0;s:7:\"wrapper\";a:3:{s:5:\"width\";s:0:\"\";s:5:\"class\";s:0:\"\";s:2:\"id\";s:0:\"\";}s:13:\"default_value\";s:0:\"\";s:11:\"placeholder\";s:0:\"\";s:7:\"prepend\";s:0:\"\";s:6:\"append\";s:0:\"\";s:9:\"maxlength\";s:0:\"\";}', 'Лицензия', 'лицензия', 'publish', 'closed', 'closed', '', 'field_62436ff0e98ec', '', '', '2022-03-29 23:47:24', '2022-03-29 20:47:24', '', 46, 'http://0026urotec.loc:8888/?post_type=acf-field&p=49', 2, 'acf-field', '', 0),
(50, 1, '2022-03-29 23:47:24', '2022-03-29 20:47:24', 'a:15:{s:4:\"type\";s:5:\"image\";s:12:\"instructions\";s:0:\"\";s:8:\"required\";i:0;s:17:\"conditional_logic\";i:0;s:7:\"wrapper\";a:3:{s:5:\"width\";s:0:\"\";s:5:\"class\";s:0:\"\";s:2:\"id\";s:0:\"\";}s:13:\"return_format\";s:2:\"id\";s:12:\"preview_size\";s:6:\"medium\";s:7:\"library\";s:3:\"all\";s:9:\"min_width\";s:0:\"\";s:10:\"min_height\";s:0:\"\";s:8:\"min_size\";s:0:\"\";s:9:\"max_width\";s:0:\"\";s:10:\"max_height\";s:0:\"\";s:8:\"max_size\";s:0:\"\";s:10:\"mime_types\";s:0:\"\";}', 'Изображение', 'изображение', 'publish', 'closed', 'closed', '', 'field_62437045e98ed', '', '', '2022-03-29 23:47:24', '2022-03-29 20:47:24', '', 46, 'http://0026urotec.loc:8888/?post_type=acf-field&p=50', 3, 'acf-field', '', 0),
(51, 1, '2022-03-29 23:53:34', '2022-03-29 20:53:34', '', 'catalog-img-1', '', 'inherit', 'open', 'closed', '', 'catalog-img-1', '', '', '2022-03-29 23:53:34', '2022-03-29 20:53:34', '', 2, 'http://0026urotec.loc:8888/wp-content/uploads/2022/03/catalog-img-1.png', 0, 'attachment', 'image/png', 0),
(52, 1, '2022-03-29 23:53:35', '2022-03-29 20:53:35', '', 'catalog-img-3', '', 'inherit', 'open', 'closed', '', 'catalog-img-3', '', '', '2022-03-29 23:53:35', '2022-03-29 20:53:35', '', 2, 'http://0026urotec.loc:8888/wp-content/uploads/2022/03/catalog-img-3.png', 0, 'attachment', 'image/png', 0),
(53, 1, '2022-03-29 23:53:44', '2022-03-29 20:53:44', '', 'catalog-img-2', '', 'inherit', 'open', 'closed', '', 'catalog-img-2', '', '', '2022-03-29 23:53:44', '2022-03-29 20:53:44', '', 2, 'http://0026urotec.loc:8888/wp-content/uploads/2022/03/catalog-img-2.png', 0, 'attachment', 'image/png', 0),
(54, 1, '2022-03-29 23:56:01', '2022-03-29 20:56:01', '<!-- wp:shortcode -->\n[header]\n<!-- /wp:shortcode -->\n\n<!-- wp:shortcode -->\n[sAdv]\n<!-- /wp:shortcode -->\n\n<!-- wp:shortcode -->\n[sCatalog]\n<!-- /wp:shortcode -->', 'Главная', '', 'inherit', 'closed', 'closed', '', '2-revision-v1', '', '', '2022-03-29 23:56:01', '2022-03-29 20:56:01', '', 2, 'http://0026urotec.loc:8888/?p=54', 0, 'revision', '', 0),
(55, 1, '2022-03-30 00:00:33', '2022-03-29 21:00:33', '<!-- wp:shortcode -->\n[header]\n<!-- /wp:shortcode -->\n\n<!-- wp:shortcode -->\n[sAdv]\n<!-- /wp:shortcode -->\n\n<!-- wp:shortcode -->\n[sCatalog]\n<!-- /wp:shortcode -->', 'Главная', '', 'inherit', 'closed', 'closed', '', '2-revision-v1', '', '', '2022-03-30 00:00:33', '2022-03-29 21:00:33', '', 2, 'http://0026urotec.loc:8888/?p=55', 0, 'revision', '', 0),
(56, 1, '2022-03-30 00:01:34', '2022-03-29 21:01:34', '<!-- wp:shortcode -->\n[header]\n<!-- /wp:shortcode -->\n\n<!-- wp:shortcode -->\n[sAdv]\n<!-- /wp:shortcode -->\n\n<!-- wp:shortcode -->\n[sCatalog]\n<!-- /wp:shortcode -->', 'Главная', '', 'inherit', 'closed', 'closed', '', '2-revision-v1', '', '', '2022-03-30 00:01:34', '2022-03-29 21:01:34', '', 2, 'http://0026urotec.loc:8888/?p=56', 0, 'revision', '', 0),
(57, 1, '2022-03-30 00:06:36', '2022-03-29 21:06:36', '<!-- wp:shortcode -->\n[header]\n<!-- /wp:shortcode -->\n\n<!-- wp:shortcode -->\n[sAdv]\n<!-- /wp:shortcode -->\n\n<!-- wp:shortcode -->\n[sCatalog]\n<!-- /wp:shortcode -->\n\n<!-- wp:shortcode -->\n[sWhereBuy]\n<!-- /wp:shortcode -->', 'Главная', '', 'inherit', 'closed', 'closed', '', '2-revision-v1', '', '', '2022-03-30 00:06:36', '2022-03-29 21:06:36', '', 2, 'http://0026urotec.loc:8888/?p=57', 0, 'revision', '', 0),
(58, 1, '2022-03-30 00:06:37', '2022-03-29 21:06:37', '<!-- wp:shortcode -->\n[header]\n<!-- /wp:shortcode -->\n\n<!-- wp:shortcode -->\n[sAdv]\n<!-- /wp:shortcode -->\n\n<!-- wp:shortcode -->\n[sCatalog]\n<!-- /wp:shortcode -->\n\n<!-- wp:shortcode -->\n[sWhereBuy]\n<!-- /wp:shortcode -->', 'Главная', '', 'inherit', 'closed', 'closed', '', '2-revision-v1', '', '', '2022-03-30 00:06:37', '2022-03-29 21:06:37', '', 2, 'http://0026urotec.loc:8888/?p=58', 0, 'revision', '', 0),
(59, 1, '2022-03-30 00:07:59', '2022-03-29 21:07:59', 'a:7:{s:8:\"location\";a:1:{i:0;a:1:{i:0;a:3:{s:5:\"param\";s:4:\"page\";s:8:\"operator\";s:2:\"==\";s:5:\"value\";s:1:\"2\";}}}s:8:\"position\";s:6:\"normal\";s:5:\"style\";s:7:\"default\";s:15:\"label_placement\";s:3:\"top\";s:21:\"instruction_placement\";s:5:\"label\";s:14:\"hide_on_screen\";s:0:\"\";s:11:\"description\";s:0:\"\";}', '04-sWhereBuy', '04-swherebuy', 'publish', 'closed', 'closed', '', 'group_624374e245d29', '', '', '2022-04-01 17:48:14', '2022-04-01 14:48:14', '', 0, 'http://0026urotec.loc:8888/?post_type=acf-field-group&#038;p=59', 0, 'acf-field-group', '', 0),
(60, 1, '2022-03-30 00:07:59', '2022-03-29 21:07:59', 'a:8:{s:4:\"type\";s:7:\"message\";s:12:\"instructions\";s:0:\"\";s:8:\"required\";i:0;s:17:\"conditional_logic\";i:0;s:7:\"wrapper\";a:3:{s:5:\"width\";s:0:\"\";s:5:\"class\";s:0:\"\";s:2:\"id\";s:0:\"\";}s:7:\"message\";s:11:\"[sWhereBuy]\";s:9:\"new_lines\";s:7:\"wpautop\";s:8:\"esc_html\";i:0;}', 'Шорткод', 'шорткод', 'publish', 'closed', 'closed', '', 'field_624374e53d8bc', '', '', '2022-03-30 00:07:59', '2022-03-29 21:07:59', '', 59, 'http://0026urotec.loc:8888/?post_type=acf-field&p=60', 0, 'acf-field', '', 0),
(61, 1, '2022-03-30 00:07:59', '2022-03-29 21:07:59', 'a:10:{s:4:\"type\";s:4:\"text\";s:12:\"instructions\";s:0:\"\";s:8:\"required\";i:0;s:17:\"conditional_logic\";i:0;s:7:\"wrapper\";a:3:{s:5:\"width\";s:0:\"\";s:5:\"class\";s:0:\"\";s:2:\"id\";s:0:\"\";}s:13:\"default_value\";s:19:\"Где купить\";s:11:\"placeholder\";s:0:\"\";s:7:\"prepend\";s:0:\"\";s:6:\"append\";s:0:\"\";s:9:\"maxlength\";s:0:\"\";}', 'Заголовок', 'заголовок-4', 'publish', 'closed', 'closed', '', 'field_624374f73d8bd', '', '', '2022-03-30 00:07:59', '2022-03-29 21:07:59', '', 59, 'http://0026urotec.loc:8888/?post_type=acf-field&p=61', 1, 'acf-field', '', 0),
(62, 1, '2022-03-30 00:07:59', '2022-03-29 21:07:59', 'a:18:{s:4:\"type\";s:7:\"gallery\";s:12:\"instructions\";s:0:\"\";s:8:\"required\";i:0;s:17:\"conditional_logic\";i:0;s:7:\"wrapper\";a:3:{s:5:\"width\";s:0:\"\";s:5:\"class\";s:0:\"\";s:2:\"id\";s:0:\"\";}s:13:\"return_format\";s:5:\"array\";s:12:\"preview_size\";s:6:\"medium\";s:6:\"insert\";s:6:\"append\";s:7:\"library\";s:3:\"all\";s:3:\"min\";s:0:\"\";s:3:\"max\";s:0:\"\";s:9:\"min_width\";s:0:\"\";s:10:\"min_height\";s:0:\"\";s:8:\"min_size\";s:0:\"\";s:9:\"max_width\";s:0:\"\";s:10:\"max_height\";s:0:\"\";s:8:\"max_size\";s:0:\"\";s:10:\"mime_types\";s:0:\"\";}', 'Изображения', 'изображения-4', 'publish', 'closed', 'closed', '', 'field_624375093d8be', '', '', '2022-04-01 17:38:32', '2022-04-01 14:38:32', '', 59, 'http://0026urotec.loc:8888/?post_type=acf-field&#038;p=62', 2, 'acf-field', '', 0),
(63, 1, '2022-03-30 00:17:28', '2022-03-29 21:17:28', '', 'https://www.eapteka.ru/', '', 'inherit', 'open', 'closed', '', 'tobuy-img-1', '', '', '2022-04-01 17:40:54', '2022-04-01 14:40:54', '', 2, 'http://0026urotec.loc:8888/wp-content/uploads/2022/03/tobuy-img-1.png', 0, 'attachment', 'image/png', 0),
(64, 1, '2022-03-30 00:17:28', '2022-03-29 21:17:28', '', 'https://apteka.ru/', '', 'inherit', 'open', 'closed', '', 'tobuy-img-2', '', '', '2022-04-01 17:41:29', '2022-04-01 14:41:29', '', 2, 'http://0026urotec.loc:8888/wp-content/uploads/2022/03/tobuy-img-2.png', 0, 'attachment', 'image/png', 0),
(65, 1, '2022-03-30 00:17:29', '2022-03-29 21:17:29', '', 'https://zdravcity.ru/', '', 'inherit', 'open', 'closed', '', 'tobuy-img-3', '', '', '2022-04-01 17:41:55', '2022-04-01 14:41:55', '', 2, 'http://0026urotec.loc:8888/wp-content/uploads/2022/03/tobuy-img-3.png', 0, 'attachment', 'image/png', 0),
(66, 1, '2022-03-30 00:17:29', '2022-03-29 21:17:29', '', 'https://stolichki.ru/', '', 'inherit', 'open', 'closed', '', 'tobuy-img-4', '', '', '2022-04-01 17:42:48', '2022-04-01 14:42:48', '', 2, 'http://0026urotec.loc:8888/wp-content/uploads/2022/03/tobuy-img-4.png', 0, 'attachment', 'image/png', 0),
(67, 1, '2022-03-30 00:17:30', '2022-03-29 21:17:30', '', 'https://samson-pharma.ru/', '', 'inherit', 'open', 'closed', '', 'tobuy-img-5', '', '', '2022-04-01 17:43:30', '2022-04-01 14:43:30', '', 2, 'http://0026urotec.loc:8888/wp-content/uploads/2022/03/tobuy-img-5.png', 0, 'attachment', 'image/png', 0),
(68, 1, '2022-03-30 00:17:31', '2022-03-29 21:17:31', '', 'https://healthplanet.by/', '', 'inherit', 'open', 'closed', '', 'tobuy-img-6', '', '', '2022-04-01 17:43:46', '2022-04-01 14:43:46', '', 2, 'http://0026urotec.loc:8888/wp-content/uploads/2022/03/tobuy-img-6.png', 0, 'attachment', 'image/png', 0),
(69, 1, '2022-03-30 00:17:31', '2022-03-29 21:17:31', '', 'https://apteka.magnit.ru/', '', 'inherit', 'open', 'closed', '', 'tobuy-img-7', '', '', '2022-04-01 17:44:20', '2022-04-01 14:44:20', '', 2, 'http://0026urotec.loc:8888/wp-content/uploads/2022/03/tobuy-img-7.png', 0, 'attachment', 'image/png', 0),
(70, 1, '2022-03-30 00:17:32', '2022-03-29 21:17:32', '', 'https://www.aptekaonline.ru/', '', 'inherit', 'open', 'closed', '', 'tobuy-img-8', '', '', '2022-04-01 17:44:42', '2022-04-01 14:44:42', '', 2, 'http://0026urotec.loc:8888/wp-content/uploads/2022/03/tobuy-img-8.png', 0, 'attachment', 'image/png', 0),
(71, 1, '2022-03-30 00:17:32', '2022-03-29 21:17:32', '', 'https://www.asna.ru/', '', 'inherit', 'open', 'closed', '', 'tobuy-img-9', '', '', '2022-04-01 17:44:58', '2022-04-01 14:44:58', '', 2, 'http://0026urotec.loc:8888/wp-content/uploads/2022/03/tobuy-img-9.png', 0, 'attachment', 'image/png', 0),
(72, 1, '2022-03-30 00:17:33', '2022-03-29 21:17:33', '', 'https://www.proapteka.ru/', '', 'inherit', 'open', 'closed', '', 'tobuy-img-10', '', '', '2022-04-01 17:45:14', '2022-04-01 14:45:14', '', 2, 'http://0026urotec.loc:8888/wp-content/uploads/2022/03/tobuy-img-10.png', 0, 'attachment', 'image/png', 0),
(73, 1, '2022-03-30 00:17:33', '2022-03-29 21:17:33', '', 'https://neopharm.ru/', '', 'inherit', 'open', 'closed', '', 'tobuy-img-11', '', '', '2022-04-01 17:45:35', '2022-04-01 14:45:35', '', 2, 'http://0026urotec.loc:8888/wp-content/uploads/2022/03/tobuy-img-11.png', 0, 'attachment', 'image/png', 0),
(74, 1, '2022-03-30 00:17:34', '2022-03-29 21:17:34', '', 'https://budzdorov.ru/', '', 'inherit', 'open', 'closed', '', 'tobuy-img-12', '', '', '2022-04-01 17:45:58', '2022-04-01 14:45:58', '', 2, 'http://0026urotec.loc:8888/wp-content/uploads/2022/03/tobuy-img-12.png', 0, 'attachment', 'image/png', 0),
(75, 1, '2022-03-30 00:17:59', '2022-03-29 21:17:59', '<!-- wp:shortcode -->\n[header]\n<!-- /wp:shortcode -->\n\n<!-- wp:shortcode -->\n[sAdv]\n<!-- /wp:shortcode -->\n\n<!-- wp:shortcode -->\n[sCatalog]\n<!-- /wp:shortcode -->\n\n<!-- wp:shortcode -->\n[sWhereBuy]\n<!-- /wp:shortcode -->', 'Главная', '', 'inherit', 'closed', 'closed', '', '2-revision-v1', '', '', '2022-03-30 00:17:59', '2022-03-29 21:17:59', '', 2, 'http://0026urotec.loc:8888/?p=75', 0, 'revision', '', 0),
(76, 1, '2022-03-30 00:21:47', '2022-03-29 21:21:47', '<!-- wp:shortcode -->\n[header]\n<!-- /wp:shortcode -->\n\n<!-- wp:shortcode -->\n[sAdv]\n<!-- /wp:shortcode -->\n\n<!-- wp:shortcode -->\n[sCatalog]\n<!-- /wp:shortcode -->\n\n<!-- wp:shortcode -->\n[sWhereBuy]\n<!-- /wp:shortcode -->', 'Главная', '', 'inherit', 'closed', 'closed', '', '2-revision-v1', '', '', '2022-03-30 00:21:47', '2022-03-29 21:21:47', '', 2, 'http://0026urotec.loc:8888/?p=76', 0, 'revision', '', 0),
(77, 1, '2022-03-30 00:26:38', '2022-03-29 21:26:38', '<!-- wp:shortcode -->\n[header]\n<!-- /wp:shortcode -->\n\n<!-- wp:shortcode -->\n[sAdv]\n<!-- /wp:shortcode -->\n\n<!-- wp:shortcode -->\n[sCatalog]\n<!-- /wp:shortcode -->\n\n<!-- wp:shortcode -->\n[sWhereBuy]\n<!-- /wp:shortcode -->\n\n<!-- wp:shortcode -->\n[sMethod]\n<!-- /wp:shortcode -->', 'Главная', '', 'inherit', 'closed', 'closed', '', '2-revision-v1', '', '', '2022-03-30 00:26:38', '2022-03-29 21:26:38', '', 2, 'http://0026urotec.loc:8888/?p=77', 0, 'revision', '', 0),
(78, 1, '2022-03-30 00:31:07', '2022-03-29 21:31:07', 'a:7:{s:8:\"location\";a:1:{i:0;a:1:{i:0;a:3:{s:5:\"param\";s:4:\"page\";s:8:\"operator\";s:2:\"==\";s:5:\"value\";s:1:\"2\";}}}s:8:\"position\";s:6:\"normal\";s:5:\"style\";s:7:\"default\";s:15:\"label_placement\";s:3:\"top\";s:21:\"instruction_placement\";s:5:\"label\";s:14:\"hide_on_screen\";s:0:\"\";s:11:\"description\";s:0:\"\";}', '5-sMethod', '5-smethod', 'publish', 'closed', 'closed', '', 'group_624379b5ac487', '', '', '2022-03-30 00:34:02', '2022-03-29 21:34:02', '', 0, 'http://0026urotec.loc:8888/?post_type=acf-field-group&#038;p=78', 0, 'acf-field-group', '', 0),
(79, 1, '2022-03-30 00:31:07', '2022-03-29 21:31:07', 'a:10:{s:4:\"type\";s:8:\"textarea\";s:12:\"instructions\";s:0:\"\";s:8:\"required\";i:0;s:17:\"conditional_logic\";i:0;s:7:\"wrapper\";a:3:{s:5:\"width\";s:0:\"\";s:5:\"class\";s:0:\"\";s:2:\"id\";s:0:\"\";}s:13:\"default_value\";s:46:\"Способ применения*<sup>6</sup>\";s:11:\"placeholder\";s:0:\"\";s:9:\"maxlength\";s:0:\"\";s:4:\"rows\";i:2;s:9:\"new_lines\";s:0:\"\";}', 'Заголовок', 'заголовок-5', 'publish', 'closed', 'closed', '', 'field_624379bd4756d', '', '', '2022-03-30 00:31:07', '2022-03-29 21:31:07', '', 78, 'http://0026urotec.loc:8888/?post_type=acf-field&p=79', 0, 'acf-field', '', 0),
(80, 1, '2022-03-30 00:31:07', '2022-03-29 21:31:07', 'a:18:{s:4:\"type\";s:7:\"gallery\";s:12:\"instructions\";s:0:\"\";s:8:\"required\";i:0;s:17:\"conditional_logic\";i:0;s:7:\"wrapper\";a:3:{s:5:\"width\";s:0:\"\";s:5:\"class\";s:0:\"\";s:2:\"id\";s:0:\"\";}s:13:\"return_format\";s:5:\"array\";s:12:\"preview_size\";s:6:\"medium\";s:6:\"insert\";s:6:\"append\";s:7:\"library\";s:3:\"all\";s:3:\"min\";s:0:\"\";s:3:\"max\";s:0:\"\";s:9:\"min_width\";s:0:\"\";s:10:\"min_height\";s:0:\"\";s:8:\"min_size\";s:0:\"\";s:9:\"max_width\";s:0:\"\";s:10:\"max_height\";s:0:\"\";s:8:\"max_size\";s:0:\"\";s:10:\"mime_types\";s:0:\"\";}', 'Иконки', 'иконки', 'publish', 'closed', 'closed', '', 'field_624379f24756e', '', '', '2022-03-30 00:34:02', '2022-03-29 21:34:02', '', 78, 'http://0026urotec.loc:8888/?post_type=acf-field&#038;p=80', 1, 'acf-field', '', 0),
(81, 1, '2022-03-30 00:31:07', '2022-03-29 21:31:07', 'a:10:{s:4:\"type\";s:8:\"textarea\";s:12:\"instructions\";s:0:\"\";s:8:\"required\";i:0;s:17:\"conditional_logic\";i:0;s:7:\"wrapper\";a:3:{s:5:\"width\";s:0:\"\";s:5:\"class\";s:0:\"\";s:2:\"id\";s:0:\"\";}s:13:\"default_value\";s:934:\"У пациентов с легкой почечной недостаточностью (клиренс креатинина ≥ 50 — ≤ 80 мл/мин) коррекция дозы не требуется. Для лечения пациентов с почечной недостаточностью средней степени тяжести (клиренс креатинина ≥ 30 — < 50 мл/мин) рекомендуется в течение первой недели принимать начальную дозу по 4 мг в сутки, при хорошей индивидуальной переносимости доза может быть увеличена до 8 мг в сутки. Применение препарата для пациентов с тяжелой почечной недостаточностью (клиренс креатинина < 30 мл / мин) не рекомендуется\";s:11:\"placeholder\";s:0:\"\";s:9:\"maxlength\";s:0:\"\";s:4:\"rows\";s:0:\"\";s:9:\"new_lines\";s:0:\"\";}', 'Текст', 'текст-5', 'publish', 'closed', 'closed', '', 'field_62437a374756f', '', '', '2022-03-30 00:31:07', '2022-03-29 21:31:07', '', 78, 'http://0026urotec.loc:8888/?post_type=acf-field&p=81', 2, 'acf-field', '', 0),
(82, 1, '2022-03-30 00:31:07', '2022-03-29 21:31:07', 'a:10:{s:4:\"type\";s:8:\"textarea\";s:12:\"instructions\";s:0:\"\";s:8:\"required\";i:0;s:17:\"conditional_logic\";i:0;s:7:\"wrapper\";a:3:{s:5:\"width\";s:0:\"\";s:5:\"class\";s:0:\"\";s:2:\"id\";s:0:\"\";}s:13:\"default_value\";s:378:\"*Более подробные сведения о&nbsp;препарате, особенностях применения, побочных действиях и&nbsp;др. &mdash;&nbsp;см. инструкцию по&nbsp;медицинскому применению лекарственного препарата Урорек, РУ&nbsp;ЛСР-005971/10 от&nbsp;25.06.2010\";s:11:\"placeholder\";s:0:\"\";s:9:\"maxlength\";s:0:\"\";s:4:\"rows\";i:4;s:9:\"new_lines\";s:0:\"\";}', 'Текст под кнопкой', 'текст_под_кнопкой', 'publish', 'closed', 'closed', '', 'field_62437a7c47570', '', '', '2022-03-30 00:31:07', '2022-03-29 21:31:07', '', 78, 'http://0026urotec.loc:8888/?post_type=acf-field&p=82', 3, 'acf-field', '', 0),
(83, 1, '2022-03-30 00:32:21', '2022-03-29 21:32:21', '', 'method-i-1', '1 раз в день, рекомендуемая доза 8мг', 'inherit', 'open', 'closed', '', 'method-i-1', '', '', '2022-03-30 00:33:14', '2022-03-29 21:33:14', '', 2, 'http://0026urotec.loc:8888/wp-content/uploads/2022/03/method-i-1.svg', 0, 'attachment', 'image/svg+xml', 0);
INSERT INTO `urotec_posts` (`ID`, `post_author`, `post_date`, `post_date_gmt`, `post_content`, `post_title`, `post_excerpt`, `post_status`, `comment_status`, `ping_status`, `post_password`, `post_name`, `to_ping`, `pinged`, `post_modified`, `post_modified_gmt`, `post_content_filtered`, `post_parent`, `guid`, `menu_order`, `post_type`, `post_mime_type`, `comment_count`) VALUES
(84, 1, '2022-03-30 00:32:22', '2022-03-29 21:32:22', '', 'method-i-2', 'Капсула принимается целиком', 'inherit', 'open', 'closed', '', 'method-i-2', '', '', '2022-03-30 00:33:22', '2022-03-29 21:33:22', '', 2, 'http://0026urotec.loc:8888/wp-content/uploads/2022/03/method-i-2.svg', 0, 'attachment', 'image/svg+xml', 0),
(85, 1, '2022-03-30 00:32:22', '2022-03-29 21:32:22', '', 'method-i-3', 'Одновременно с приемом пищи', 'inherit', 'open', 'closed', '', 'method-i-3', '', '', '2022-03-30 00:33:30', '2022-03-29 21:33:30', '', 2, 'http://0026urotec.loc:8888/wp-content/uploads/2022/03/method-i-3.svg', 0, 'attachment', 'image/svg+xml', 0),
(86, 1, '2022-03-30 00:32:23', '2022-03-29 21:32:23', '', 'method-i-4', 'Предпочтительно в одно и тоже время суток', 'inherit', 'open', 'closed', '', 'method-i-4', '', '', '2022-03-30 00:33:38', '2022-03-29 21:33:38', '', 2, 'http://0026urotec.loc:8888/wp-content/uploads/2022/03/method-i-4.svg', 0, 'attachment', 'image/svg+xml', 0),
(87, 1, '2022-03-30 00:32:23', '2022-03-29 21:32:23', '', 'method-i-5', 'Желательно запивать стаканом воды', 'inherit', 'open', 'closed', '', 'method-i-5', '', '', '2022-03-30 00:33:47', '2022-03-29 21:33:47', '', 2, 'http://0026urotec.loc:8888/wp-content/uploads/2022/03/method-i-5.svg', 0, 'attachment', 'image/svg+xml', 0),
(88, 1, '2022-03-30 00:33:48', '2022-03-29 21:33:48', '<!-- wp:shortcode -->\n[header]\n<!-- /wp:shortcode -->\n\n<!-- wp:shortcode -->\n[sAdv]\n<!-- /wp:shortcode -->\n\n<!-- wp:shortcode -->\n[sCatalog]\n<!-- /wp:shortcode -->\n\n<!-- wp:shortcode -->\n[sWhereBuy]\n<!-- /wp:shortcode -->\n\n<!-- wp:shortcode -->\n[sMethod]\n<!-- /wp:shortcode -->', 'Главная', '', 'inherit', 'closed', 'closed', '', '2-revision-v1', '', '', '2022-03-30 00:33:48', '2022-03-29 21:33:48', '', 2, 'http://0026urotec.loc:8888/?p=88', 0, 'revision', '', 0),
(89, 1, '2022-03-30 00:41:19', '2022-03-29 21:41:19', '<!-- wp:shortcode -->\n[header]\n<!-- /wp:shortcode -->\n\n<!-- wp:shortcode -->\n[sAdv]\n<!-- /wp:shortcode -->\n\n<!-- wp:shortcode -->\n[sCatalog]\n<!-- /wp:shortcode -->\n\n<!-- wp:shortcode -->\n[sWhereBuy]\n<!-- /wp:shortcode -->\n\n<!-- wp:shortcode -->\n[sMethod]\n<!-- /wp:shortcode -->', 'Главная', '', 'inherit', 'closed', 'closed', '', '2-revision-v1', '', '', '2022-03-30 00:41:19', '2022-03-29 21:41:19', '', 2, 'http://0026urotec.loc:8888/?p=89', 0, 'revision', '', 0),
(90, 1, '2022-03-30 11:14:24', '2022-03-30 08:14:24', '<!-- wp:shortcode -->\n[header]\n<!-- /wp:shortcode -->\n\n<!-- wp:shortcode -->\n[sAdv]\n<!-- /wp:shortcode -->\n\n<!-- wp:shortcode -->\n[sCatalog]\n<!-- /wp:shortcode -->\n\n<!-- wp:shortcode -->\n[sWhereBuy]\n<!-- /wp:shortcode -->\n\n<!-- wp:shortcode -->\n[sMethod]\n<!-- /wp:shortcode -->\n\n<!-- wp:shortcode -->\n[sRecomendation]\n<!-- /wp:shortcode -->', 'Главная', '', 'inherit', 'closed', 'closed', '', '2-revision-v1', '', '', '2022-03-30 11:14:24', '2022-03-30 08:14:24', '', 2, 'http://0026urotec.loc:8888/?p=90', 0, 'revision', '', 0),
(91, 1, '2022-03-30 11:18:09', '2022-03-30 08:18:09', 'a:7:{s:8:\"location\";a:1:{i:0;a:1:{i:0;a:3:{s:5:\"param\";s:4:\"page\";s:8:\"operator\";s:2:\"==\";s:5:\"value\";s:1:\"2\";}}}s:8:\"position\";s:6:\"normal\";s:5:\"style\";s:7:\"default\";s:15:\"label_placement\";s:3:\"top\";s:21:\"instruction_placement\";s:5:\"label\";s:14:\"hide_on_screen\";s:0:\"\";s:11:\"description\";s:0:\"\";}', '6-sRecomendation', '6-srecomendation', 'publish', 'closed', 'closed', '', 'group_62441179b5084', '', '', '2022-03-30 11:24:59', '2022-03-30 08:24:59', '', 0, 'http://0026urotec.loc:8888/?post_type=acf-field-group&#038;p=91', 0, 'acf-field-group', '', 0),
(92, 1, '2022-03-30 11:18:09', '2022-03-30 08:18:09', 'a:10:{s:4:\"type\";s:8:\"textarea\";s:12:\"instructions\";s:0:\"\";s:8:\"required\";i:0;s:17:\"conditional_logic\";i:0;s:7:\"wrapper\";a:3:{s:5:\"width\";s:0:\"\";s:5:\"class\";s:0:\"\";s:2:\"id\";s:0:\"\";}s:13:\"default_value\";s:286:\"Препарат Урорек (силодозин) включен в&nbsp;российские и&nbsp;международные клинические рекомендации и&nbsp;стандарты для лечения ряда урологических заболеваний:\";s:11:\"placeholder\";s:0:\"\";s:9:\"maxlength\";s:0:\"\";s:4:\"rows\";i:2;s:9:\"new_lines\";s:0:\"\";}', 'Заголовок', 'заголовок-6', 'publish', 'closed', 'closed', '', 'field_6244117c68bd0', '', '', '2022-03-30 11:18:09', '2022-03-30 08:18:09', '', 91, 'http://0026urotec.loc:8888/?post_type=acf-field&p=92', 0, 'acf-field', '', 0),
(93, 1, '2022-03-30 11:18:09', '2022-03-30 08:18:09', 'a:10:{s:4:\"type\";s:8:\"repeater\";s:12:\"instructions\";s:0:\"\";s:8:\"required\";i:0;s:17:\"conditional_logic\";i:0;s:7:\"wrapper\";a:3:{s:5:\"width\";s:0:\"\";s:5:\"class\";s:0:\"\";s:2:\"id\";s:0:\"\";}s:9:\"collapsed\";s:0:\"\";s:3:\"min\";s:0:\"\";s:3:\"max\";s:0:\"\";s:6:\"layout\";s:5:\"block\";s:12:\"button_label\";s:0:\"\";}', 'Список', 'список-6', 'publish', 'closed', 'closed', '', 'field_624411be68bd1', '', '', '2022-03-30 11:24:59', '2022-03-30 08:24:59', '', 91, 'http://0026urotec.loc:8888/?post_type=acf-field&#038;p=93', 1, 'acf-field', '', 0),
(94, 1, '2022-03-30 11:18:09', '2022-03-30 08:18:09', 'a:6:{s:4:\"type\";s:4:\"link\";s:12:\"instructions\";s:0:\"\";s:8:\"required\";i:0;s:17:\"conditional_logic\";i:0;s:7:\"wrapper\";a:3:{s:5:\"width\";s:0:\"\";s:5:\"class\";s:0:\"\";s:2:\"id\";s:0:\"\";}s:13:\"return_format\";s:5:\"array\";}', 'Ссылка', 'ссылка', 'publish', 'closed', 'closed', '', 'field_624411ce68bd2', '', '', '2022-03-30 11:18:09', '2022-03-30 08:18:09', '', 93, 'http://0026urotec.loc:8888/?post_type=acf-field&p=94', 0, 'acf-field', '', 0),
(95, 1, '2022-03-30 11:18:09', '2022-03-30 08:18:09', 'a:10:{s:4:\"type\";s:8:\"textarea\";s:12:\"instructions\";s:0:\"\";s:8:\"required\";i:0;s:17:\"conditional_logic\";i:0;s:7:\"wrapper\";a:3:{s:5:\"width\";s:0:\"\";s:5:\"class\";s:0:\"\";s:2:\"id\";s:0:\"\";}s:13:\"default_value\";s:0:\"\";s:11:\"placeholder\";s:0:\"\";s:9:\"maxlength\";s:0:\"\";s:4:\"rows\";i:2;s:9:\"new_lines\";s:0:\"\";}', 'Описание', 'описание', 'publish', 'closed', 'closed', '', 'field_6244121168bd3', '', '', '2022-03-30 11:24:59', '2022-03-30 08:24:59', '', 93, 'http://0026urotec.loc:8888/?post_type=acf-field&#038;p=95', 1, 'acf-field', '', 0),
(96, 1, '2022-03-30 11:24:41', '2022-03-30 08:24:41', '<!-- wp:shortcode -->\n[header]\n<!-- /wp:shortcode -->\n\n<!-- wp:shortcode -->\n[sAdv]\n<!-- /wp:shortcode -->\n\n<!-- wp:shortcode -->\n[sCatalog]\n<!-- /wp:shortcode -->\n\n<!-- wp:shortcode -->\n[sWhereBuy]\n<!-- /wp:shortcode -->\n\n<!-- wp:shortcode -->\n[sMethod]\n<!-- /wp:shortcode -->\n\n<!-- wp:shortcode -->\n[sRecomendation]\n<!-- /wp:shortcode -->', 'Главная', '', 'inherit', 'closed', 'closed', '', '2-revision-v1', '', '', '2022-03-30 11:24:41', '2022-03-30 08:24:41', '', 2, 'http://0026urotec.loc:8888/?p=96', 0, 'revision', '', 0),
(97, 1, '2022-03-30 11:42:03', '2022-03-30 08:42:03', '<!-- wp:shortcode -->\n[header]\n<!-- /wp:shortcode -->\n\n<!-- wp:shortcode -->\n[sAdv]\n<!-- /wp:shortcode -->\n\n<!-- wp:shortcode -->\n[sCatalog]\n<!-- /wp:shortcode -->\n\n<!-- wp:shortcode -->\n[sWhereBuy]\n<!-- /wp:shortcode -->\n\n<!-- wp:shortcode -->\n[sMethod]\n<!-- /wp:shortcode -->\n\n<!-- wp:shortcode -->\n[sRecomendation]\n<!-- /wp:shortcode -->\n\n<!-- wp:shortcode -->\n[sOtherCountries]\n<!-- /wp:shortcode -->', 'Главная', '', 'inherit', 'closed', 'closed', '', '2-revision-v1', '', '', '2022-03-30 11:42:03', '2022-03-30 08:42:03', '', 2, 'http://0026urotec.loc:8888/?p=97', 0, 'revision', '', 0),
(98, 1, '2022-03-30 11:47:39', '2022-03-30 08:47:39', 'a:7:{s:8:\"location\";a:1:{i:0;a:1:{i:0;a:3:{s:5:\"param\";s:4:\"page\";s:8:\"operator\";s:2:\"==\";s:5:\"value\";s:1:\"2\";}}}s:8:\"position\";s:6:\"normal\";s:5:\"style\";s:7:\"default\";s:15:\"label_placement\";s:3:\"top\";s:21:\"instruction_placement\";s:5:\"label\";s:14:\"hide_on_screen\";s:0:\"\";s:11:\"description\";s:0:\"\";}', '7-sOtherCountries', '7-sothercountries', 'publish', 'closed', 'closed', '', 'group_624417df679a2', '', '', '2022-03-30 13:32:46', '2022-03-30 10:32:46', '', 0, 'http://0026urotec.loc:8888/?post_type=acf-field-group&#038;p=98', 0, 'acf-field-group', '', 0),
(99, 1, '2022-03-30 11:47:39', '2022-03-30 08:47:39', 'a:10:{s:4:\"type\";s:8:\"textarea\";s:12:\"instructions\";s:0:\"\";s:8:\"required\";i:0;s:17:\"conditional_logic\";i:0;s:7:\"wrapper\";a:3:{s:5:\"width\";s:0:\"\";s:5:\"class\";s:0:\"\";s:2:\"id\";s:0:\"\";}s:13:\"default_value\";s:220:\"Препарат Урорек (силодозин) зарегистрирован и&nbsp;применяется в&nbsp;разных странах мира Одобрен ЕМА*<sup>34</sup> и&nbsp;FDA**<sup>35</sup>\";s:11:\"placeholder\";s:0:\"\";s:9:\"maxlength\";s:0:\"\";s:4:\"rows\";i:2;s:9:\"new_lines\";s:0:\"\";}', 'Заголовок', 'заголовок-7', 'publish', 'closed', 'closed', '', 'field_624417e3b6088', '', '', '2022-03-30 13:32:46', '2022-03-30 10:32:46', '', 98, 'http://0026urotec.loc:8888/?post_type=acf-field&#038;p=99', 1, 'acf-field', '', 0),
(100, 1, '2022-03-30 11:47:39', '2022-03-30 08:47:39', 'a:10:{s:4:\"type\";s:8:\"textarea\";s:12:\"instructions\";s:0:\"\";s:8:\"required\";i:0;s:17:\"conditional_logic\";i:0;s:7:\"wrapper\";a:3:{s:5:\"width\";s:0:\"\";s:5:\"class\";s:0:\"\";s:2:\"id\";s:0:\"\";}s:13:\"default_value\";s:350:\"<p class=\"sOtherCountries__agency\"><span>EMA</span> Европейское медицинское агентство</p>\r\n<p class=\"sOtherCountries__agency\"><span>FDA</span> Управление по&nbsp;санитарному надзору за&nbsp;качеством пищевых продуктов и&nbsp;медикаментов, США</p>\";s:11:\"placeholder\";s:0:\"\";s:9:\"maxlength\";s:0:\"\";s:4:\"rows\";s:0:\"\";s:9:\"new_lines\";s:0:\"\";}', 'Текст', 'текст-7', 'publish', 'closed', 'closed', '', 'field_6244182bb6089', '', '', '2022-03-30 13:32:46', '2022-03-30 10:32:46', '', 98, 'http://0026urotec.loc:8888/?post_type=acf-field&#038;p=100', 2, 'acf-field', '', 0),
(101, 1, '2022-03-30 11:47:39', '2022-03-30 08:47:39', 'a:10:{s:4:\"type\";s:8:\"repeater\";s:12:\"instructions\";s:0:\"\";s:8:\"required\";i:0;s:17:\"conditional_logic\";i:0;s:7:\"wrapper\";a:3:{s:5:\"width\";s:0:\"\";s:5:\"class\";s:0:\"\";s:2:\"id\";s:0:\"\";}s:9:\"collapsed\";s:0:\"\";s:3:\"min\";s:0:\"\";s:3:\"max\";s:0:\"\";s:6:\"layout\";s:5:\"table\";s:12:\"button_label\";s:0:\"\";}', 'Страны', 'страны', 'publish', 'closed', 'closed', '', 'field_62441847b608a', '', '', '2022-03-30 13:32:46', '2022-03-30 10:32:46', '', 98, 'http://0026urotec.loc:8888/?post_type=acf-field&#038;p=101', 3, 'acf-field', '', 0),
(102, 1, '2022-03-30 11:47:39', '2022-03-30 08:47:39', 'a:15:{s:4:\"type\";s:5:\"image\";s:12:\"instructions\";s:0:\"\";s:8:\"required\";i:0;s:17:\"conditional_logic\";i:0;s:7:\"wrapper\";a:3:{s:5:\"width\";s:0:\"\";s:5:\"class\";s:0:\"\";s:2:\"id\";s:0:\"\";}s:13:\"return_format\";s:2:\"id\";s:12:\"preview_size\";s:6:\"medium\";s:7:\"library\";s:3:\"all\";s:9:\"min_width\";s:0:\"\";s:10:\"min_height\";s:0:\"\";s:8:\"min_size\";s:0:\"\";s:9:\"max_width\";s:0:\"\";s:10:\"max_height\";s:0:\"\";s:8:\"max_size\";s:0:\"\";s:10:\"mime_types\";s:0:\"\";}', 'Флаг', 'флаг', 'publish', 'closed', 'closed', '', 'field_62441880b608b', '', '', '2022-03-30 11:47:39', '2022-03-30 08:47:39', '', 101, 'http://0026urotec.loc:8888/?post_type=acf-field&p=102', 0, 'acf-field', '', 0),
(103, 1, '2022-03-30 11:47:39', '2022-03-30 08:47:39', 'a:10:{s:4:\"type\";s:4:\"text\";s:12:\"instructions\";s:0:\"\";s:8:\"required\";i:0;s:17:\"conditional_logic\";i:0;s:7:\"wrapper\";a:3:{s:5:\"width\";s:0:\"\";s:5:\"class\";s:0:\"\";s:2:\"id\";s:0:\"\";}s:13:\"default_value\";s:0:\"\";s:11:\"placeholder\";s:0:\"\";s:7:\"prepend\";s:0:\"\";s:6:\"append\";s:0:\"\";s:9:\"maxlength\";s:0:\"\";}', 'Название', 'название', 'publish', 'closed', 'closed', '', 'field_62441899b608c', '', '', '2022-03-30 11:47:39', '2022-03-30 08:47:39', '', 101, 'http://0026urotec.loc:8888/?post_type=acf-field&p=103', 1, 'acf-field', '', 0),
(104, 1, '2022-03-30 11:47:39', '2022-03-30 08:47:39', 'a:10:{s:4:\"type\";s:8:\"textarea\";s:12:\"instructions\";s:0:\"\";s:8:\"required\";i:0;s:17:\"conditional_logic\";i:0;s:7:\"wrapper\";a:3:{s:5:\"width\";s:0:\"\";s:5:\"class\";s:0:\"\";s:2:\"id\";s:0:\"\";}s:13:\"default_value\";s:0:\"\";s:11:\"placeholder\";s:0:\"\";s:9:\"maxlength\";s:0:\"\";s:4:\"rows\";i:1;s:9:\"new_lines\";s:0:\"\";}', 'Год', 'год', 'publish', 'closed', 'closed', '', 'field_624418aab608d', '', '', '2022-03-30 11:47:39', '2022-03-30 08:47:39', '', 101, 'http://0026urotec.loc:8888/?post_type=acf-field&p=104', 2, 'acf-field', '', 0),
(105, 1, '2022-03-30 11:52:15', '2022-03-30 08:52:15', '', 'countries-img-1', '', 'inherit', 'open', 'closed', '', 'countries-img-1', '', '', '2022-03-30 11:52:15', '2022-03-30 08:52:15', '', 2, 'http://0026urotec.loc:8888/wp-content/uploads/2022/03/countries-img-1.png', 0, 'attachment', 'image/png', 0),
(106, 1, '2022-03-30 11:52:16', '2022-03-30 08:52:16', '', 'countries-img-2', '', 'inherit', 'open', 'closed', '', 'countries-img-2', '', '', '2022-03-30 11:52:16', '2022-03-30 08:52:16', '', 2, 'http://0026urotec.loc:8888/wp-content/uploads/2022/03/countries-img-2.png', 0, 'attachment', 'image/png', 0),
(107, 1, '2022-03-30 11:52:17', '2022-03-30 08:52:17', '', 'countries-img-3', '', 'inherit', 'open', 'closed', '', 'countries-img-3', '', '', '2022-03-30 11:52:17', '2022-03-30 08:52:17', '', 2, 'http://0026urotec.loc:8888/wp-content/uploads/2022/03/countries-img-3.png', 0, 'attachment', 'image/png', 0),
(108, 1, '2022-03-30 11:52:17', '2022-03-30 08:52:17', '', 'countries-img-4', '', 'inherit', 'open', 'closed', '', 'countries-img-4', '', '', '2022-03-30 11:52:17', '2022-03-30 08:52:17', '', 2, 'http://0026urotec.loc:8888/wp-content/uploads/2022/03/countries-img-4.png', 0, 'attachment', 'image/png', 0),
(109, 1, '2022-03-30 11:52:52', '2022-03-30 08:52:52', 'a:10:{s:4:\"type\";s:8:\"textarea\";s:12:\"instructions\";s:0:\"\";s:8:\"required\";i:0;s:17:\"conditional_logic\";i:0;s:7:\"wrapper\";a:3:{s:5:\"width\";s:0:\"\";s:5:\"class\";s:0:\"\";s:2:\"id\";s:0:\"\";}s:13:\"default_value\";s:418:\"Производство препарата Урорек, поставляемого в&nbsp;Россию, осуществляется в&nbsp;Италии с&nbsp;использованием субстанции из&nbsp;Японии, в&nbsp;соответствии с&nbsp;необходимыми требованиями к&nbsp;производству и&nbsp;контролю качества<sup>6,1</sup>\";s:11:\"placeholder\";s:0:\"\";s:9:\"maxlength\";s:0:\"\";s:4:\"rows\";i:2;s:9:\"new_lines\";s:0:\"\";}', 'Текст', 'текст-7-1', 'publish', 'closed', 'closed', '', 'field_62441a5acf03c', '', '', '2022-03-30 13:32:46', '2022-03-30 10:32:46', '', 98, 'http://0026urotec.loc:8888/?post_type=acf-field&#038;p=109', 4, 'acf-field', '', 0),
(110, 1, '2022-03-30 11:52:57', '2022-03-30 08:52:57', '<!-- wp:shortcode -->\n[header]\n<!-- /wp:shortcode -->\n\n<!-- wp:shortcode -->\n[sAdv]\n<!-- /wp:shortcode -->\n\n<!-- wp:shortcode -->\n[sCatalog]\n<!-- /wp:shortcode -->\n\n<!-- wp:shortcode -->\n[sWhereBuy]\n<!-- /wp:shortcode -->\n\n<!-- wp:shortcode -->\n[sMethod]\n<!-- /wp:shortcode -->\n\n<!-- wp:shortcode -->\n[sRecomendation]\n<!-- /wp:shortcode -->\n\n<!-- wp:shortcode -->\n[sOtherCountries]\n<!-- /wp:shortcode -->', 'Главная', '', 'inherit', 'closed', 'closed', '', '2-revision-v1', '', '', '2022-03-30 11:52:57', '2022-03-30 08:52:57', '', 2, 'http://0026urotec.loc:8888/?p=110', 0, 'revision', '', 0),
(111, 1, '2022-03-30 13:21:14', '2022-03-30 10:21:14', '<!-- wp:shortcode -->\n[header]\n<!-- /wp:shortcode -->\n\n<!-- wp:shortcode -->\n[sAdv]\n<!-- /wp:shortcode -->\n\n<!-- wp:shortcode -->\n[sCatalog]\n<!-- /wp:shortcode -->\n\n<!-- wp:shortcode -->\n[sWhereBuy]\n<!-- /wp:shortcode -->\n\n<!-- wp:shortcode -->\n[sMethod]\n<!-- /wp:shortcode -->\n\n<!-- wp:shortcode -->\n[sRecomendation]\n<!-- /wp:shortcode -->\n\n<!-- wp:shortcode -->\n[sOtherCountries]\n<!-- /wp:shortcode -->', 'Главная', '', 'inherit', 'closed', 'closed', '', '2-revision-v1', '', '', '2022-03-30 13:21:14', '2022-03-30 10:21:14', '', 2, 'http://0026urotec.loc:8888/?p=111', 0, 'revision', '', 0),
(112, 1, '2022-03-30 13:22:36', '2022-03-30 10:22:36', '<!-- wp:shortcode -->\n[header]\n<!-- /wp:shortcode -->\n\n<!-- wp:shortcode -->\n[sAdv]\n<!-- /wp:shortcode -->\n\n<!-- wp:shortcode -->\n[sCatalog]\n<!-- /wp:shortcode -->\n\n<!-- wp:shortcode -->\n[sWhereBuy]\n<!-- /wp:shortcode -->\n\n<!-- wp:shortcode -->\n[sMethod]\n<!-- /wp:shortcode -->\n\n<!-- wp:shortcode -->\n[sRecomendation]\n<!-- /wp:shortcode -->\n\n<!-- wp:shortcode -->\n[sOtherCountries]\n<!-- /wp:shortcode -->', 'Главная', '', 'inherit', 'closed', 'closed', '', '2-revision-v1', '', '', '2022-03-30 13:22:36', '2022-03-30 10:22:36', '', 2, 'http://0026urotec.loc:8888/?p=112', 0, 'revision', '', 0),
(113, 1, '2022-03-30 13:23:16', '2022-03-30 10:23:16', '<!-- wp:shortcode -->\n[header]\n<!-- /wp:shortcode -->\n\n<!-- wp:shortcode -->\n[sAdv]\n<!-- /wp:shortcode -->\n\n<!-- wp:shortcode -->\n[sCatalog]\n<!-- /wp:shortcode -->\n\n<!-- wp:shortcode -->\n[sWhereBuy]\n<!-- /wp:shortcode -->\n\n<!-- wp:shortcode -->\n[sMethod]\n<!-- /wp:shortcode -->\n\n<!-- wp:shortcode -->\n[sRecomendation]\n<!-- /wp:shortcode -->\n\n<!-- wp:shortcode -->\n[sOtherCountries]\n<!-- /wp:shortcode -->', 'Главная', '', 'inherit', 'closed', 'closed', '', '2-revision-v1', '', '', '2022-03-30 13:23:16', '2022-03-30 10:23:16', '', 2, 'http://0026urotec.loc:8888/?p=113', 0, 'revision', '', 0),
(114, 1, '2022-03-30 13:32:13', '2022-03-30 10:32:13', '<!-- wp:shortcode -->\n[header]\n<!-- /wp:shortcode -->\n\n<!-- wp:shortcode -->\n[sAdv]\n<!-- /wp:shortcode -->\n\n<!-- wp:shortcode -->\n[sCatalog]\n<!-- /wp:shortcode -->\n\n<!-- wp:shortcode -->\n[sWhereBuy]\n<!-- /wp:shortcode -->\n\n<!-- wp:shortcode -->\n[sMethod]\n<!-- /wp:shortcode -->\n\n<!-- wp:shortcode -->\n[sRecomendation]\n<!-- /wp:shortcode -->\n\n<!-- wp:shortcode -->\n[sOtherCountries]\n<!-- /wp:shortcode -->\n\n<!-- wp:shortcode -->\n[sAbout]\n<!-- /wp:shortcode -->', 'Главная', '', 'inherit', 'closed', 'closed', '', '2-revision-v1', '', '', '2022-03-30 13:32:13', '2022-03-30 10:32:13', '', 2, 'http://0026urotec.loc:8888/?p=114', 0, 'revision', '', 0),
(115, 1, '2022-03-30 13:32:14', '2022-03-30 10:32:14', '<!-- wp:shortcode -->\n[header]\n<!-- /wp:shortcode -->\n\n<!-- wp:shortcode -->\n[sAdv]\n<!-- /wp:shortcode -->\n\n<!-- wp:shortcode -->\n[sCatalog]\n<!-- /wp:shortcode -->\n\n<!-- wp:shortcode -->\n[sWhereBuy]\n<!-- /wp:shortcode -->\n\n<!-- wp:shortcode -->\n[sMethod]\n<!-- /wp:shortcode -->\n\n<!-- wp:shortcode -->\n[sRecomendation]\n<!-- /wp:shortcode -->\n\n<!-- wp:shortcode -->\n[sOtherCountries]\n<!-- /wp:shortcode -->\n\n<!-- wp:shortcode -->\n[sAbout]\n<!-- /wp:shortcode -->', 'Главная', '', 'inherit', 'closed', 'closed', '', '2-revision-v1', '', '', '2022-03-30 13:32:14', '2022-03-30 10:32:14', '', 2, 'http://0026urotec.loc:8888/?p=115', 0, 'revision', '', 0),
(116, 1, '2022-03-30 13:32:46', '2022-03-30 10:32:46', 'a:8:{s:4:\"type\";s:7:\"message\";s:12:\"instructions\";s:0:\"\";s:8:\"required\";i:0;s:17:\"conditional_logic\";i:0;s:7:\"wrapper\";a:3:{s:5:\"width\";s:0:\"\";s:5:\"class\";s:0:\"\";s:2:\"id\";s:0:\"\";}s:7:\"message\";s:17:\"[sOtherCountries]\";s:9:\"new_lines\";s:7:\"wpautop\";s:8:\"esc_html\";i:0;}', 'Шорткод', 'шорткод', 'publish', 'closed', 'closed', '', 'field_624431b25537f', '', '', '2022-03-30 13:32:46', '2022-03-30 10:32:46', '', 98, 'http://0026urotec.loc:8888/?post_type=acf-field&p=116', 0, 'acf-field', '', 0),
(117, 1, '2022-03-30 13:33:46', '2022-03-30 10:33:46', 'a:7:{s:8:\"location\";a:1:{i:0;a:1:{i:0;a:3:{s:5:\"param\";s:4:\"page\";s:8:\"operator\";s:2:\"==\";s:5:\"value\";s:1:\"2\";}}}s:8:\"position\";s:6:\"normal\";s:5:\"style\";s:7:\"default\";s:15:\"label_placement\";s:3:\"top\";s:21:\"instruction_placement\";s:5:\"label\";s:14:\"hide_on_screen\";s:0:\"\";s:11:\"description\";s:0:\"\";}', '8-sAbout', '8-sabout', 'publish', 'closed', 'closed', '', 'group_624431d03e98c', '', '', '2022-03-30 13:39:47', '2022-03-30 10:39:47', '', 0, 'http://0026urotec.loc:8888/?post_type=acf-field-group&#038;p=117', 0, 'acf-field-group', '', 0),
(118, 1, '2022-03-30 13:33:46', '2022-03-30 10:33:46', 'a:10:{s:4:\"type\";s:4:\"text\";s:12:\"instructions\";s:0:\"\";s:8:\"required\";i:0;s:17:\"conditional_logic\";i:0;s:7:\"wrapper\";a:3:{s:5:\"width\";s:0:\"\";s:5:\"class\";s:0:\"\";s:2:\"id\";s:0:\"\";}s:13:\"default_value\";s:19:\"О проблеме\";s:11:\"placeholder\";s:0:\"\";s:7:\"prepend\";s:0:\"\";s:6:\"append\";s:0:\"\";s:9:\"maxlength\";s:0:\"\";}', 'Заголовок', 'заголовок-8', 'publish', 'closed', 'closed', '', 'field_624431d91624d', '', '', '2022-03-30 13:33:46', '2022-03-30 10:33:46', '', 117, 'http://0026urotec.loc:8888/?post_type=acf-field&p=118', 0, 'acf-field', '', 0),
(119, 1, '2022-03-30 13:33:46', '2022-03-30 10:33:46', 'a:10:{s:4:\"type\";s:7:\"wysiwyg\";s:12:\"instructions\";s:0:\"\";s:8:\"required\";i:0;s:17:\"conditional_logic\";i:0;s:7:\"wrapper\";a:3:{s:5:\"width\";s:0:\"\";s:5:\"class\";s:0:\"\";s:2:\"id\";s:0:\"\";}s:13:\"default_value\";s:0:\"\";s:4:\"tabs\";s:3:\"all\";s:7:\"toolbar\";s:4:\"full\";s:12:\"media_upload\";i:1;s:5:\"delay\";i:0;}', 'Текст', 'текст-8', 'publish', 'closed', 'closed', '', 'field_624431f11624e', '', '', '2022-03-30 13:34:55', '2022-03-30 10:34:55', '', 117, 'http://0026urotec.loc:8888/?post_type=acf-field&#038;p=119', 1, 'acf-field', '', 0),
(120, 1, '2022-03-30 13:34:55', '2022-03-30 10:34:55', 'a:10:{s:4:\"type\";s:8:\"textarea\";s:12:\"instructions\";s:0:\"\";s:8:\"required\";i:0;s:17:\"conditional_logic\";i:0;s:7:\"wrapper\";a:3:{s:5:\"width\";s:0:\"\";s:5:\"class\";s:0:\"\";s:2:\"id\";s:0:\"\";}s:13:\"default_value\";s:0:\"\";s:11:\"placeholder\";s:0:\"\";s:9:\"maxlength\";s:0:\"\";s:4:\"rows\";i:2;s:9:\"new_lines\";s:0:\"\";}', 'Текст', 'текст-8-1', 'publish', 'closed', 'closed', '', 'field_6244320b26db3', '', '', '2022-03-30 13:39:23', '2022-03-30 10:39:23', '', 117, 'http://0026urotec.loc:8888/?post_type=acf-field&#038;p=120', 2, 'acf-field', '', 0),
(121, 1, '2022-03-30 13:34:55', '2022-03-30 10:34:55', 'a:18:{s:4:\"type\";s:7:\"gallery\";s:12:\"instructions\";s:0:\"\";s:8:\"required\";i:0;s:17:\"conditional_logic\";i:0;s:7:\"wrapper\";a:3:{s:5:\"width\";s:0:\"\";s:5:\"class\";s:0:\"\";s:2:\"id\";s:0:\"\";}s:13:\"return_format\";s:5:\"array\";s:12:\"preview_size\";s:6:\"medium\";s:6:\"insert\";s:6:\"append\";s:7:\"library\";s:3:\"all\";s:3:\"min\";s:0:\"\";s:3:\"max\";s:0:\"\";s:9:\"min_width\";s:0:\"\";s:10:\"min_height\";s:0:\"\";s:8:\"min_size\";s:0:\"\";s:9:\"max_width\";s:0:\"\";s:10:\"max_height\";s:0:\"\";s:8:\"max_size\";s:0:\"\";s:10:\"mime_types\";s:0:\"\";}', 'Иконки', 'иконки-8', 'publish', 'closed', 'closed', '', 'field_6244322d26db4', '', '', '2022-03-30 13:34:55', '2022-03-30 10:34:55', '', 117, 'http://0026urotec.loc:8888/?post_type=acf-field&p=121', 3, 'acf-field', '', 0),
(122, 1, '2022-03-30 13:36:22', '2022-03-30 10:36:22', '', 'about-img', '', 'inherit', 'open', 'closed', '', 'about-img', '', '', '2022-03-30 13:36:22', '2022-03-30 10:36:22', '', 2, 'http://0026urotec.loc:8888/wp-content/uploads/2022/03/about-img.png', 0, 'attachment', 'image/png', 0),
(123, 1, '2022-03-30 13:37:10', '2022-03-30 10:37:10', '', 'symptoms-i-1', 'Учащенное мочеиспускание', 'inherit', 'open', 'closed', '', 'symptoms-i-1', '', '', '2022-03-30 13:37:35', '2022-03-30 10:37:35', '', 2, 'http://0026urotec.loc:8888/wp-content/uploads/2022/03/symptoms-i-1.png', 0, 'attachment', 'image/png', 0),
(124, 1, '2022-03-30 13:37:11', '2022-03-30 10:37:11', '', 'symptoms-i-2', 'Ослабление струи мочи', 'inherit', 'open', 'closed', '', 'symptoms-i-2', '', '', '2022-03-30 13:37:46', '2022-03-30 10:37:46', '', 2, 'http://0026urotec.loc:8888/wp-content/uploads/2022/03/symptoms-i-2.png', 0, 'attachment', 'image/png', 0),
(125, 1, '2022-03-30 13:37:11', '2022-03-30 10:37:11', '', 'symptoms-i-3', 'Недержание мочи', 'inherit', 'open', 'closed', '', 'symptoms-i-3', '', '', '2022-03-30 13:37:56', '2022-03-30 10:37:56', '', 2, 'http://0026urotec.loc:8888/wp-content/uploads/2022/03/symptoms-i-3.png', 0, 'attachment', 'image/png', 0),
(126, 1, '2022-03-30 13:37:12', '2022-03-30 10:37:12', '', 'symptoms-i-4', 'Неотложные позывы к мочеиспусканию', 'inherit', 'open', 'closed', '', 'symptoms-i-4', '', '', '2022-03-30 13:38:04', '2022-03-30 10:38:04', '', 2, 'http://0026urotec.loc:8888/wp-content/uploads/2022/03/symptoms-i-4.png', 0, 'attachment', 'image/png', 0),
(127, 1, '2022-03-30 13:37:13', '2022-03-30 10:37:13', '', 'symptoms-i-5', 'Ноктурия (ночное мочеиспускание)', 'inherit', 'open', 'closed', '', 'symptoms-i-5', '', '', '2022-03-30 13:38:16', '2022-03-30 10:38:16', '', 2, 'http://0026urotec.loc:8888/wp-content/uploads/2022/03/symptoms-i-5.png', 0, 'attachment', 'image/png', 0),
(128, 1, '2022-03-30 13:37:13', '2022-03-30 10:37:13', '', 'symptoms-i-6', 'Ощущение неполного опорожнения мочевого пузыря', 'inherit', 'open', 'closed', '', 'symptoms-i-6', '', '', '2022-03-30 13:38:31', '2022-03-30 10:38:31', '', 2, 'http://0026urotec.loc:8888/wp-content/uploads/2022/03/symptoms-i-6.png', 0, 'attachment', 'image/png', 0),
(129, 1, '2022-03-30 13:38:51', '2022-03-30 10:38:51', '<!-- wp:shortcode -->\n[header]\n<!-- /wp:shortcode -->\n\n<!-- wp:shortcode -->\n[sAdv]\n<!-- /wp:shortcode -->\n\n<!-- wp:shortcode -->\n[sCatalog]\n<!-- /wp:shortcode -->\n\n<!-- wp:shortcode -->\n[sWhereBuy]\n<!-- /wp:shortcode -->\n\n<!-- wp:shortcode -->\n[sMethod]\n<!-- /wp:shortcode -->\n\n<!-- wp:shortcode -->\n[sRecomendation]\n<!-- /wp:shortcode -->\n\n<!-- wp:shortcode -->\n[sOtherCountries]\n<!-- /wp:shortcode -->\n\n<!-- wp:shortcode -->\n[sAbout]\n<!-- /wp:shortcode -->', 'Главная', '', 'inherit', 'closed', 'closed', '', '2-revision-v1', '', '', '2022-03-30 13:38:51', '2022-03-30 10:38:51', '', 2, 'http://0026urotec.loc:8888/?p=129', 0, 'revision', '', 0),
(130, 1, '2022-03-30 13:39:15', '2022-03-30 10:39:15', '<!-- wp:shortcode -->\n[header]\n<!-- /wp:shortcode -->\n\n<!-- wp:shortcode -->\n[sAdv]\n<!-- /wp:shortcode -->\n\n<!-- wp:shortcode -->\n[sCatalog]\n<!-- /wp:shortcode -->\n\n<!-- wp:shortcode -->\n[sWhereBuy]\n<!-- /wp:shortcode -->\n\n<!-- wp:shortcode -->\n[sMethod]\n<!-- /wp:shortcode -->\n\n<!-- wp:shortcode -->\n[sRecomendation]\n<!-- /wp:shortcode -->\n\n<!-- wp:shortcode -->\n[sOtherCountries]\n<!-- /wp:shortcode -->\n\n<!-- wp:shortcode -->\n[sAbout]\n<!-- /wp:shortcode -->', 'Главная', '', 'inherit', 'closed', 'closed', '', '2-revision-v1', '', '', '2022-03-30 13:39:15', '2022-03-30 10:39:15', '', 2, 'http://0026urotec.loc:8888/?p=130', 0, 'revision', '', 0),
(131, 1, '2022-03-30 13:39:47', '2022-03-30 10:39:47', 'a:10:{s:4:\"type\";s:7:\"wysiwyg\";s:12:\"instructions\";s:0:\"\";s:8:\"required\";i:0;s:17:\"conditional_logic\";i:0;s:7:\"wrapper\";a:3:{s:5:\"width\";s:0:\"\";s:5:\"class\";s:0:\"\";s:2:\"id\";s:0:\"\";}s:13:\"default_value\";s:0:\"\";s:4:\"tabs\";s:3:\"all\";s:7:\"toolbar\";s:4:\"full\";s:12:\"media_upload\";i:0;s:5:\"delay\";i:0;}', 'Текст', 'текст-8-2', 'publish', 'closed', 'closed', '', 'field_6244335fe2373', '', '', '2022-03-30 13:39:47', '2022-03-30 10:39:47', '', 117, 'http://0026urotec.loc:8888/?post_type=acf-field&p=131', 4, 'acf-field', '', 0),
(132, 1, '2022-03-30 13:40:20', '2022-03-30 10:40:20', '<!-- wp:shortcode -->\n[header]\n<!-- /wp:shortcode -->\n\n<!-- wp:shortcode -->\n[sAdv]\n<!-- /wp:shortcode -->\n\n<!-- wp:shortcode -->\n[sCatalog]\n<!-- /wp:shortcode -->\n\n<!-- wp:shortcode -->\n[sWhereBuy]\n<!-- /wp:shortcode -->\n\n<!-- wp:shortcode -->\n[sMethod]\n<!-- /wp:shortcode -->\n\n<!-- wp:shortcode -->\n[sRecomendation]\n<!-- /wp:shortcode -->\n\n<!-- wp:shortcode -->\n[sOtherCountries]\n<!-- /wp:shortcode -->\n\n<!-- wp:shortcode -->\n[sAbout]\n<!-- /wp:shortcode -->', 'Главная', '', 'inherit', 'closed', 'closed', '', '2-revision-v1', '', '', '2022-03-30 13:40:20', '2022-03-30 10:40:20', '', 2, 'http://0026urotec.loc:8888/?p=132', 0, 'revision', '', 0),
(133, 1, '2022-03-30 13:41:18', '2022-03-30 10:41:18', '<!-- wp:shortcode -->\n[header]\n<!-- /wp:shortcode -->\n\n<!-- wp:shortcode -->\n[sAdv]\n<!-- /wp:shortcode -->\n\n<!-- wp:shortcode -->\n[sCatalog]\n<!-- /wp:shortcode -->\n\n<!-- wp:shortcode -->\n[sWhereBuy]\n<!-- /wp:shortcode -->\n\n<!-- wp:shortcode -->\n[sMethod]\n<!-- /wp:shortcode -->\n\n<!-- wp:shortcode -->\n[sRecomendation]\n<!-- /wp:shortcode -->\n\n<!-- wp:shortcode -->\n[sOtherCountries]\n<!-- /wp:shortcode -->\n\n<!-- wp:shortcode -->\n[sAbout]\n<!-- /wp:shortcode -->', 'Главная', '', 'inherit', 'closed', 'closed', '', '2-revision-v1', '', '', '2022-03-30 13:41:18', '2022-03-30 10:41:18', '', 2, 'http://0026urotec.loc:8888/?p=133', 0, 'revision', '', 0),
(135, 1, '2022-03-30 13:58:18', '2022-03-30 10:58:18', 'a:7:{s:8:\"location\";a:1:{i:0;a:1:{i:0;a:3:{s:5:\"param\";s:4:\"page\";s:8:\"operator\";s:2:\"==\";s:5:\"value\";s:1:\"2\";}}}s:8:\"position\";s:6:\"normal\";s:5:\"style\";s:7:\"default\";s:15:\"label_placement\";s:3:\"top\";s:21:\"instruction_placement\";s:5:\"label\";s:14:\"hide_on_screen\";s:0:\"\";s:11:\"description\";s:0:\"\";}', '9-sComplications', '9-scomplications', 'publish', 'closed', 'closed', '', 'group_6244374609ec9', '', '', '2022-03-30 13:58:18', '2022-03-30 10:58:18', '', 0, 'http://0026urotec.loc:8888/?post_type=acf-field-group&#038;p=135', 0, 'acf-field-group', '', 0),
(136, 1, '2022-03-30 13:58:18', '2022-03-30 10:58:18', 'a:8:{s:4:\"type\";s:7:\"message\";s:12:\"instructions\";s:0:\"\";s:8:\"required\";i:0;s:17:\"conditional_logic\";i:0;s:7:\"wrapper\";a:3:{s:5:\"width\";s:0:\"\";s:5:\"class\";s:0:\"\";s:2:\"id\";s:0:\"\";}s:7:\"message\";s:16:\"[sComplications]\";s:9:\"new_lines\";s:7:\"wpautop\";s:8:\"esc_html\";i:0;}', 'Шорткод', 'шорткод', 'publish', 'closed', 'closed', '', 'field_6244375b52262', '', '', '2022-03-30 13:58:18', '2022-03-30 10:58:18', '', 135, 'http://0026urotec.loc:8888/?post_type=acf-field&p=136', 0, 'acf-field', '', 0),
(137, 1, '2022-03-30 13:58:18', '2022-03-30 10:58:18', 'a:10:{s:4:\"type\";s:8:\"textarea\";s:12:\"instructions\";s:0:\"\";s:8:\"required\";i:0;s:17:\"conditional_logic\";i:0;s:7:\"wrapper\";a:3:{s:5:\"width\";s:0:\"\";s:5:\"class\";s:0:\"\";s:2:\"id\";s:0:\"\";}s:13:\"default_value\";s:42:\"Осложнения ДГПЖ<sup>38</sup>\";s:11:\"placeholder\";s:0:\"\";s:9:\"maxlength\";s:0:\"\";s:4:\"rows\";i:2;s:9:\"new_lines\";s:0:\"\";}', 'Заголовок', 'заголовок-9', 'publish', 'closed', 'closed', '', 'field_6244377a52263', '', '', '2022-03-30 13:58:18', '2022-03-30 10:58:18', '', 135, 'http://0026urotec.loc:8888/?post_type=acf-field&p=137', 1, 'acf-field', '', 0),
(138, 1, '2022-03-30 13:58:18', '2022-03-30 10:58:18', 'a:18:{s:4:\"type\";s:7:\"gallery\";s:12:\"instructions\";s:0:\"\";s:8:\"required\";i:0;s:17:\"conditional_logic\";i:0;s:7:\"wrapper\";a:3:{s:5:\"width\";s:0:\"\";s:5:\"class\";s:0:\"\";s:2:\"id\";s:0:\"\";}s:13:\"return_format\";s:5:\"array\";s:12:\"preview_size\";s:6:\"medium\";s:6:\"insert\";s:6:\"append\";s:7:\"library\";s:3:\"all\";s:3:\"min\";s:0:\"\";s:3:\"max\";s:0:\"\";s:9:\"min_width\";s:0:\"\";s:10:\"min_height\";s:0:\"\";s:8:\"min_size\";s:0:\"\";s:9:\"max_width\";s:0:\"\";s:10:\"max_height\";s:0:\"\";s:8:\"max_size\";s:0:\"\";s:10:\"mime_types\";s:0:\"\";}', 'Изображения', 'изображения-9', 'publish', 'closed', 'closed', '', 'field_6244379652264', '', '', '2022-03-30 13:58:18', '2022-03-30 10:58:18', '', 135, 'http://0026urotec.loc:8888/?post_type=acf-field&p=138', 2, 'acf-field', '', 0),
(139, 1, '2022-03-30 13:59:03', '2022-03-30 10:59:03', '<!-- wp:shortcode -->\n[header]\n<!-- /wp:shortcode -->\n\n<!-- wp:shortcode -->\n[sAdv]\n<!-- /wp:shortcode -->\n\n<!-- wp:shortcode -->\n[sCatalog]\n<!-- /wp:shortcode -->\n\n<!-- wp:shortcode -->\n[sWhereBuy]\n<!-- /wp:shortcode -->\n\n<!-- wp:shortcode -->\n[sMethod]\n<!-- /wp:shortcode -->\n\n<!-- wp:shortcode -->\n[sRecomendation]\n<!-- /wp:shortcode -->\n\n<!-- wp:shortcode -->\n[sOtherCountries]\n<!-- /wp:shortcode -->\n\n<!-- wp:shortcode -->\n[sAbout]\n<!-- /wp:shortcode -->\n\n<!-- wp:shortcode -->\n[sComplications]\n<!-- /wp:shortcode -->', 'Главная', '', 'inherit', 'closed', 'closed', '', '2-revision-v1', '', '', '2022-03-30 13:59:03', '2022-03-30 10:59:03', '', 2, 'http://0026urotec.loc:8888/?p=139', 0, 'revision', '', 0),
(140, 1, '2022-03-30 13:59:04', '2022-03-30 10:59:04', '<!-- wp:shortcode -->\n[header]\n<!-- /wp:shortcode -->\n\n<!-- wp:shortcode -->\n[sAdv]\n<!-- /wp:shortcode -->\n\n<!-- wp:shortcode -->\n[sCatalog]\n<!-- /wp:shortcode -->\n\n<!-- wp:shortcode -->\n[sWhereBuy]\n<!-- /wp:shortcode -->\n\n<!-- wp:shortcode -->\n[sMethod]\n<!-- /wp:shortcode -->\n\n<!-- wp:shortcode -->\n[sRecomendation]\n<!-- /wp:shortcode -->\n\n<!-- wp:shortcode -->\n[sOtherCountries]\n<!-- /wp:shortcode -->\n\n<!-- wp:shortcode -->\n[sAbout]\n<!-- /wp:shortcode -->\n\n<!-- wp:shortcode -->\n[sComplications]\n<!-- /wp:shortcode -->', 'Главная', '', 'inherit', 'closed', 'closed', '', '2-revision-v1', '', '', '2022-03-30 13:59:04', '2022-03-30 10:59:04', '', 2, 'http://0026urotec.loc:8888/?p=140', 0, 'revision', '', 0),
(141, 1, '2022-03-30 14:53:24', '2022-03-30 11:53:24', '', 'complex-img-1', 'Острая задержка мочеиспускания', 'inherit', 'open', 'closed', '', 'complex-img-1', '', '', '2022-03-30 14:53:51', '2022-03-30 11:53:51', '', 2, 'http://0026urotec.loc:8888/wp-content/uploads/2022/03/complex-img-1.png', 0, 'attachment', 'image/png', 0),
(142, 1, '2022-03-30 14:53:25', '2022-03-30 11:53:25', '', 'complex-img-2', 'Рецидивирующая инфекция мочевыводящих путей', 'inherit', 'open', 'closed', '', 'complex-img-2', '', '', '2022-03-30 14:54:05', '2022-03-30 11:54:05', '', 2, 'http://0026urotec.loc:8888/wp-content/uploads/2022/03/complex-img-2.png', 0, 'attachment', 'image/png', 0),
(143, 1, '2022-03-30 14:53:26', '2022-03-30 11:53:26', '', 'complex-img-3', 'Камни мочевого пузыря', 'inherit', 'open', 'closed', '', 'complex-img-3', '', '', '2022-03-30 14:54:18', '2022-03-30 11:54:18', '', 2, 'http://0026urotec.loc:8888/wp-content/uploads/2022/03/complex-img-3.png', 0, 'attachment', 'image/png', 0),
(144, 1, '2022-03-30 14:53:26', '2022-03-30 11:53:26', '', 'complex-img-4', 'Гематурия <span>(обычно из&nbsp;варикозно расширенных вен шейки мочевого пузыря)</span>', 'inherit', 'open', 'closed', '', 'complex-img-4', '', '', '2022-03-30 14:54:28', '2022-03-30 11:54:28', '', 2, 'http://0026urotec.loc:8888/wp-content/uploads/2022/03/complex-img-4.png', 0, 'attachment', 'image/png', 0),
(145, 1, '2022-03-30 14:53:27', '2022-03-30 11:53:27', '', 'complex-img-5', 'Двусторонний уретерогидронефроз и&nbsp;почечная недостаточность (нефропатия)', 'inherit', 'open', 'closed', '', 'complex-img-5', '', '', '2022-03-30 14:54:35', '2022-03-30 11:54:35', '', 2, 'http://0026urotec.loc:8888/wp-content/uploads/2022/03/complex-img-5.png', 0, 'attachment', 'image/png', 0),
(146, 1, '2022-03-30 14:53:27', '2022-03-30 11:53:27', '', 'complex-img-6', 'Дивертикулы мочевого пузыря', 'inherit', 'open', 'closed', '', 'complex-img-6', '', '', '2022-03-30 14:55:31', '2022-03-30 11:55:31', '', 2, 'http://0026urotec.loc:8888/wp-content/uploads/2022/03/complex-img-6.png', 0, 'attachment', 'image/png', 0),
(147, 1, '2022-03-30 14:55:33', '2022-03-30 11:55:33', '<!-- wp:shortcode -->\n[header]\n<!-- /wp:shortcode -->\n\n<!-- wp:shortcode -->\n[sAdv]\n<!-- /wp:shortcode -->\n\n<!-- wp:shortcode -->\n[sCatalog]\n<!-- /wp:shortcode -->\n\n<!-- wp:shortcode -->\n[sWhereBuy]\n<!-- /wp:shortcode -->\n\n<!-- wp:shortcode -->\n[sMethod]\n<!-- /wp:shortcode -->\n\n<!-- wp:shortcode -->\n[sRecomendation]\n<!-- /wp:shortcode -->\n\n<!-- wp:shortcode -->\n[sOtherCountries]\n<!-- /wp:shortcode -->\n\n<!-- wp:shortcode -->\n[sAbout]\n<!-- /wp:shortcode -->\n\n<!-- wp:shortcode -->\n[sComplications]\n<!-- /wp:shortcode -->', 'Главная', '', 'inherit', 'closed', 'closed', '', '2-revision-v1', '', '', '2022-03-30 14:55:33', '2022-03-30 11:55:33', '', 2, 'http://0026urotec.loc:8888/?p=147', 0, 'revision', '', 0),
(148, 1, '2022-03-30 15:09:42', '2022-03-30 12:09:42', '<!-- wp:shortcode -->\n[header]\n<!-- /wp:shortcode -->\n\n<!-- wp:shortcode -->\n[sAdv]\n<!-- /wp:shortcode -->\n\n<!-- wp:shortcode -->\n[sCatalog]\n<!-- /wp:shortcode -->\n\n<!-- wp:shortcode -->\n[sWhereBuy]\n<!-- /wp:shortcode -->\n\n<!-- wp:shortcode -->\n[sMethod]\n<!-- /wp:shortcode -->\n\n<!-- wp:shortcode -->\n[sRecomendation]\n<!-- /wp:shortcode -->\n\n<!-- wp:shortcode -->\n[sOtherCountries]\n<!-- /wp:shortcode -->\n\n<!-- wp:shortcode -->\n[sAbout]\n<!-- /wp:shortcode -->\n\n<!-- wp:shortcode -->\n[sComplications]\n<!-- /wp:shortcode -->\n\n<!-- wp:shortcode -->\n[sTreatment]\n<!-- /wp:shortcode -->', 'Главная', '', 'inherit', 'closed', 'closed', '', '2-revision-v1', '', '', '2022-03-30 15:09:42', '2022-03-30 12:09:42', '', 2, 'http://0026urotec.loc:8888/?p=148', 0, 'revision', '', 0),
(149, 1, '2022-03-30 15:09:43', '2022-03-30 12:09:43', '<!-- wp:shortcode -->\n[header]\n<!-- /wp:shortcode -->\n\n<!-- wp:shortcode -->\n[sAdv]\n<!-- /wp:shortcode -->\n\n<!-- wp:shortcode -->\n[sCatalog]\n<!-- /wp:shortcode -->\n\n<!-- wp:shortcode -->\n[sWhereBuy]\n<!-- /wp:shortcode -->\n\n<!-- wp:shortcode -->\n[sMethod]\n<!-- /wp:shortcode -->\n\n<!-- wp:shortcode -->\n[sRecomendation]\n<!-- /wp:shortcode -->\n\n<!-- wp:shortcode -->\n[sOtherCountries]\n<!-- /wp:shortcode -->\n\n<!-- wp:shortcode -->\n[sAbout]\n<!-- /wp:shortcode -->\n\n<!-- wp:shortcode -->\n[sComplications]\n<!-- /wp:shortcode -->\n\n<!-- wp:shortcode -->\n[sTreatment]\n<!-- /wp:shortcode -->', 'Главная', '', 'inherit', 'closed', 'closed', '', '2-revision-v1', '', '', '2022-03-30 15:09:43', '2022-03-30 12:09:43', '', 2, 'http://0026urotec.loc:8888/?p=149', 0, 'revision', '', 0),
(150, 1, '2022-03-30 15:13:12', '2022-03-30 12:13:12', 'a:7:{s:8:\"location\";a:1:{i:0;a:1:{i:0;a:3:{s:5:\"param\";s:4:\"page\";s:8:\"operator\";s:2:\"==\";s:5:\"value\";s:1:\"2\";}}}s:8:\"position\";s:6:\"normal\";s:5:\"style\";s:7:\"default\";s:15:\"label_placement\";s:3:\"top\";s:21:\"instruction_placement\";s:5:\"label\";s:14:\"hide_on_screen\";s:0:\"\";s:11:\"description\";s:0:\"\";}', '10-sTreatment', '10-streatment', 'publish', 'closed', 'closed', '', 'group_6244488cdb75f', '', '', '2022-03-30 15:16:40', '2022-03-30 12:16:40', '', 0, 'http://0026urotec.loc:8888/?post_type=acf-field-group&#038;p=150', 0, 'acf-field-group', '', 0),
(151, 1, '2022-03-30 15:13:12', '2022-03-30 12:13:12', 'a:10:{s:4:\"type\";s:8:\"textarea\";s:12:\"instructions\";s:0:\"\";s:8:\"required\";i:0;s:17:\"conditional_logic\";i:0;s:7:\"wrapper\";a:3:{s:5:\"width\";s:0:\"\";s:5:\"class\";s:0:\"\";s:2:\"id\";s:0:\"\";}s:13:\"default_value\";s:63:\"Медикаментозное лечение СНМП/ДГПЖ\";s:11:\"placeholder\";s:0:\"\";s:9:\"maxlength\";s:0:\"\";s:4:\"rows\";i:2;s:9:\"new_lines\";s:0:\"\";}', 'Заголовок', 'заголовок-10', 'publish', 'closed', 'closed', '', 'field_6244489614262', '', '', '2022-03-30 15:13:12', '2022-03-30 12:13:12', '', 150, 'http://0026urotec.loc:8888/?post_type=acf-field&p=151', 0, 'acf-field', '', 0),
(152, 1, '2022-03-30 15:13:12', '2022-03-30 12:13:12', 'a:10:{s:4:\"type\";s:8:\"textarea\";s:12:\"instructions\";s:0:\"\";s:8:\"required\";i:0;s:17:\"conditional_logic\";i:0;s:7:\"wrapper\";a:3:{s:5:\"width\";s:0:\"\";s:5:\"class\";s:0:\"\";s:2:\"id\";s:0:\"\";}s:13:\"default_value\";s:829:\"Антагонисты альфа1-адренорецепторов (альфа-адреноблокаторы) и&nbsp;ингибиторы 5&nbsp;альфа1-редуктазы (ингибиторы 5-АР) являются группами лекарственных препаратов, которые в&nbsp;настоящее время утверждены для лечения ДГПЖ. Обе группы препаратов обеспечивают надлежащее ослабление симптомов, но&nbsp;&alpha;&mdash;блокаторы обладают довольно быстрым началом действия, а&nbsp;ингибиторам 5-АР требуется несколько месяцев для получения терапевтического эффекта.<sup>42</sup>\";s:11:\"placeholder\";s:0:\"\";s:9:\"maxlength\";s:0:\"\";s:4:\"rows\";i:4;s:9:\"new_lines\";s:0:\"\";}', 'Текст', 'текст-10', 'publish', 'closed', 'closed', '', 'field_624448ce14263', '', '', '2022-03-30 15:13:12', '2022-03-30 12:13:12', '', 150, 'http://0026urotec.loc:8888/?post_type=acf-field&p=152', 1, 'acf-field', '', 0),
(153, 1, '2022-03-30 15:13:12', '2022-03-30 12:13:12', 'a:10:{s:4:\"type\";s:8:\"repeater\";s:12:\"instructions\";s:0:\"\";s:8:\"required\";i:0;s:17:\"conditional_logic\";i:0;s:7:\"wrapper\";a:3:{s:5:\"width\";s:0:\"\";s:5:\"class\";s:0:\"\";s:2:\"id\";s:0:\"\";}s:9:\"collapsed\";s:0:\"\";s:3:\"min\";s:0:\"\";s:3:\"max\";s:0:\"\";s:6:\"layout\";s:5:\"table\";s:12:\"button_label\";s:0:\"\";}', 'Карточки', 'карточки-10', 'publish', 'closed', 'closed', '', 'field_624448e214264', '', '', '2022-03-30 15:13:12', '2022-03-30 12:13:12', '', 150, 'http://0026urotec.loc:8888/?post_type=acf-field&p=153', 2, 'acf-field', '', 0),
(154, 1, '2022-03-30 15:13:12', '2022-03-30 12:13:12', 'a:10:{s:4:\"type\";s:8:\"textarea\";s:12:\"instructions\";s:0:\"\";s:8:\"required\";i:0;s:17:\"conditional_logic\";i:0;s:7:\"wrapper\";a:3:{s:5:\"width\";s:0:\"\";s:5:\"class\";s:0:\"\";s:2:\"id\";s:0:\"\";}s:13:\"default_value\";s:0:\"\";s:11:\"placeholder\";s:0:\"\";s:9:\"maxlength\";s:0:\"\";s:4:\"rows\";i:1;s:9:\"new_lines\";s:0:\"\";}', 'Заголовок', 'заголовок', 'publish', 'closed', 'closed', '', 'field_624448fc14265', '', '', '2022-03-30 15:13:12', '2022-03-30 12:13:12', '', 153, 'http://0026urotec.loc:8888/?post_type=acf-field&p=154', 0, 'acf-field', '', 0),
(155, 1, '2022-03-30 15:13:12', '2022-03-30 12:13:12', 'a:10:{s:4:\"type\";s:8:\"textarea\";s:12:\"instructions\";s:0:\"\";s:8:\"required\";i:0;s:17:\"conditional_logic\";i:0;s:7:\"wrapper\";a:3:{s:5:\"width\";s:0:\"\";s:5:\"class\";s:0:\"\";s:2:\"id\";s:0:\"\";}s:13:\"default_value\";s:0:\"\";s:11:\"placeholder\";s:0:\"\";s:9:\"maxlength\";s:0:\"\";s:4:\"rows\";i:4;s:9:\"new_lines\";s:0:\"\";}', 'Текст', 'текст', 'publish', 'closed', 'closed', '', 'field_6244490c14266', '', '', '2022-03-30 15:13:12', '2022-03-30 12:13:12', '', 153, 'http://0026urotec.loc:8888/?post_type=acf-field&p=155', 1, 'acf-field', '', 0),
(156, 1, '2022-03-30 15:13:12', '2022-03-30 12:13:12', 'a:10:{s:4:\"type\";s:8:\"textarea\";s:12:\"instructions\";s:0:\"\";s:8:\"required\";i:0;s:17:\"conditional_logic\";i:0;s:7:\"wrapper\";a:3:{s:5:\"width\";s:0:\"\";s:5:\"class\";s:0:\"\";s:2:\"id\";s:0:\"\";}s:13:\"default_value\";s:248:\"<iframe width=\"560\" height=\"315\" src=\"https://www.youtube.com/embed/3DrU3pFXSsY\" title=\"YouTube video player\" frameborder=\"0\" allow=\"accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture\" allowfullscreen></iframe>\";s:11:\"placeholder\";s:0:\"\";s:9:\"maxlength\";s:0:\"\";s:4:\"rows\";i:4;s:9:\"new_lines\";s:0:\"\";}', 'Видео', 'видео', 'publish', 'closed', 'closed', '', 'field_6244492214267', '', '', '2022-03-30 15:13:12', '2022-03-30 12:13:12', '', 150, 'http://0026urotec.loc:8888/?post_type=acf-field&p=156', 3, 'acf-field', '', 0),
(157, 1, '2022-03-30 15:18:29', '2022-03-30 12:18:29', '<!-- wp:shortcode -->\n[header]\n<!-- /wp:shortcode -->\n\n<!-- wp:shortcode -->\n[sAdv]\n<!-- /wp:shortcode -->\n\n<!-- wp:shortcode -->\n[sCatalog]\n<!-- /wp:shortcode -->\n\n<!-- wp:shortcode -->\n[sWhereBuy]\n<!-- /wp:shortcode -->\n\n<!-- wp:shortcode -->\n[sMethod]\n<!-- /wp:shortcode -->\n\n<!-- wp:shortcode -->\n[sRecomendation]\n<!-- /wp:shortcode -->\n\n<!-- wp:shortcode -->\n[sOtherCountries]\n<!-- /wp:shortcode -->\n\n<!-- wp:shortcode -->\n[sAbout]\n<!-- /wp:shortcode -->\n\n<!-- wp:shortcode -->\n[sComplications]\n<!-- /wp:shortcode -->\n\n<!-- wp:shortcode -->\n[sTreatment]\n<!-- /wp:shortcode -->', 'Главная', '', 'inherit', 'closed', 'closed', '', '2-revision-v1', '', '', '2022-03-30 15:18:29', '2022-03-30 12:18:29', '', 2, 'http://0026urotec.loc:8888/?p=157', 0, 'revision', '', 0),
(159, 1, '2022-03-30 15:22:38', '2022-03-30 12:22:38', 'a:7:{s:8:\"location\";a:1:{i:0;a:1:{i:0;a:3:{s:5:\"param\";s:4:\"page\";s:8:\"operator\";s:2:\"==\";s:5:\"value\";s:1:\"2\";}}}s:8:\"position\";s:6:\"normal\";s:5:\"style\";s:7:\"default\";s:15:\"label_placement\";s:3:\"top\";s:21:\"instruction_placement\";s:5:\"label\";s:14:\"hide_on_screen\";s:0:\"\";s:11:\"description\";s:0:\"\";}', '11-sFAQ', '11-sfaq', 'publish', 'closed', 'closed', '', 'group_62444b3089fac', '', '', '2022-03-30 15:48:40', '2022-03-30 12:48:40', '', 0, 'http://0026urotec.loc:8888/?post_type=acf-field-group&#038;p=159', 0, 'acf-field-group', '', 0),
(160, 1, '2022-03-30 15:22:38', '2022-03-30 12:22:38', 'a:10:{s:4:\"type\";s:4:\"text\";s:12:\"instructions\";s:0:\"\";s:8:\"required\";i:0;s:17:\"conditional_logic\";i:0;s:7:\"wrapper\";a:3:{s:5:\"width\";s:0:\"\";s:5:\"class\";s:0:\"\";s:2:\"id\";s:0:\"\";}s:13:\"default_value\";s:46:\"Часто задаваемые вопросы\";s:11:\"placeholder\";s:0:\"\";s:7:\"prepend\";s:0:\"\";s:6:\"append\";s:0:\"\";s:9:\"maxlength\";s:0:\"\";}', 'Заголовок', 'заголовок-11', 'publish', 'closed', 'closed', '', 'field_62444b33e25d6', '', '', '2022-03-30 15:22:38', '2022-03-30 12:22:38', '', 159, 'http://0026urotec.loc:8888/?post_type=acf-field&p=160', 0, 'acf-field', '', 0),
(161, 1, '2022-03-30 15:22:38', '2022-03-30 12:22:38', 'a:10:{s:4:\"type\";s:8:\"repeater\";s:12:\"instructions\";s:0:\"\";s:8:\"required\";i:0;s:17:\"conditional_logic\";i:0;s:7:\"wrapper\";a:3:{s:5:\"width\";s:0:\"\";s:5:\"class\";s:0:\"\";s:2:\"id\";s:0:\"\";}s:9:\"collapsed\";s:0:\"\";s:3:\"min\";s:0:\"\";s:3:\"max\";s:0:\"\";s:6:\"layout\";s:5:\"block\";s:12:\"button_label\";s:0:\"\";}', 'Вопросы', 'вопросы', 'publish', 'closed', 'closed', '', 'field_62444b49e25d7', '', '', '2022-03-30 15:48:40', '2022-03-30 12:48:40', '', 159, 'http://0026urotec.loc:8888/?post_type=acf-field&#038;p=161', 1, 'acf-field', '', 0),
(162, 1, '2022-03-30 15:22:38', '2022-03-30 12:22:38', 'a:10:{s:4:\"type\";s:8:\"textarea\";s:12:\"instructions\";s:0:\"\";s:8:\"required\";i:0;s:17:\"conditional_logic\";i:0;s:7:\"wrapper\";a:3:{s:5:\"width\";s:0:\"\";s:5:\"class\";s:0:\"\";s:2:\"id\";s:0:\"\";}s:13:\"default_value\";s:0:\"\";s:11:\"placeholder\";s:0:\"\";s:9:\"maxlength\";s:0:\"\";s:4:\"rows\";i:2;s:9:\"new_lines\";s:0:\"\";}', 'Заголовок', 'заголовок', 'publish', 'closed', 'closed', '', 'field_62444b58e25d8', '', '', '2022-03-30 15:22:38', '2022-03-30 12:22:38', '', 161, 'http://0026urotec.loc:8888/?post_type=acf-field&p=162', 0, 'acf-field', '', 0),
(163, 1, '2022-03-30 15:22:38', '2022-03-30 12:22:38', 'a:10:{s:4:\"type\";s:7:\"wysiwyg\";s:12:\"instructions\";s:0:\"\";s:8:\"required\";i:0;s:17:\"conditional_logic\";i:0;s:7:\"wrapper\";a:3:{s:5:\"width\";s:0:\"\";s:5:\"class\";s:0:\"\";s:2:\"id\";s:0:\"\";}s:13:\"default_value\";s:0:\"\";s:4:\"tabs\";s:3:\"all\";s:7:\"toolbar\";s:5:\"basic\";s:12:\"media_upload\";i:0;s:5:\"delay\";i:0;}', 'Текст', 'текст', 'publish', 'closed', 'closed', '', 'field_62444b66e25d9', '', '', '2022-03-30 15:22:38', '2022-03-30 12:22:38', '', 161, 'http://0026urotec.loc:8888/?post_type=acf-field&p=163', 1, 'acf-field', '', 0),
(164, 1, '2022-03-30 15:45:05', '2022-03-30 12:45:05', '<!-- wp:shortcode -->\n[header]\n<!-- /wp:shortcode -->\n\n<!-- wp:shortcode -->\n[sAdv]\n<!-- /wp:shortcode -->\n\n<!-- wp:shortcode -->\n[sCatalog]\n<!-- /wp:shortcode -->\n\n<!-- wp:shortcode -->\n[sWhereBuy]\n<!-- /wp:shortcode -->\n\n<!-- wp:shortcode -->\n[sMethod]\n<!-- /wp:shortcode -->\n\n<!-- wp:shortcode -->\n[sRecomendation]\n<!-- /wp:shortcode -->\n\n<!-- wp:shortcode -->\n[sOtherCountries]\n<!-- /wp:shortcode -->\n\n<!-- wp:shortcode -->\n[sAbout]\n<!-- /wp:shortcode -->\n\n<!-- wp:shortcode -->\n[sComplications]\n<!-- /wp:shortcode -->\n\n<!-- wp:shortcode -->\n[sTreatment]\n<!-- /wp:shortcode -->\n\n<!-- wp:shortcode -->\n[sFAQ]\n<!-- /wp:shortcode -->', 'Главная', '', 'inherit', 'closed', 'closed', '', '2-revision-v1', '', '', '2022-03-30 15:45:05', '2022-03-30 12:45:05', '', 2, 'http://0026urotec.loc:8888/?p=164', 0, 'revision', '', 0),
(165, 1, '2022-03-30 15:45:06', '2022-03-30 12:45:06', '<!-- wp:shortcode -->\n[header]\n<!-- /wp:shortcode -->\n\n<!-- wp:shortcode -->\n[sAdv]\n<!-- /wp:shortcode -->\n\n<!-- wp:shortcode -->\n[sCatalog]\n<!-- /wp:shortcode -->\n\n<!-- wp:shortcode -->\n[sWhereBuy]\n<!-- /wp:shortcode -->\n\n<!-- wp:shortcode -->\n[sMethod]\n<!-- /wp:shortcode -->\n\n<!-- wp:shortcode -->\n[sRecomendation]\n<!-- /wp:shortcode -->\n\n<!-- wp:shortcode -->\n[sOtherCountries]\n<!-- /wp:shortcode -->\n\n<!-- wp:shortcode -->\n[sAbout]\n<!-- /wp:shortcode -->\n\n<!-- wp:shortcode -->\n[sComplications]\n<!-- /wp:shortcode -->\n\n<!-- wp:shortcode -->\n[sTreatment]\n<!-- /wp:shortcode -->\n\n<!-- wp:shortcode -->\n[sFAQ]\n<!-- /wp:shortcode -->', 'Главная', '', 'inherit', 'closed', 'closed', '', '2-revision-v1', '', '', '2022-03-30 15:45:06', '2022-03-30 12:45:06', '', 2, 'http://0026urotec.loc:8888/?p=165', 0, 'revision', '', 0),
(166, 1, '2022-03-30 15:51:11', '2022-03-30 12:51:11', '<!-- wp:shortcode -->\n[header]\n<!-- /wp:shortcode -->\n\n<!-- wp:shortcode -->\n[sAdv]\n<!-- /wp:shortcode -->\n\n<!-- wp:shortcode -->\n[sCatalog]\n<!-- /wp:shortcode -->\n\n<!-- wp:shortcode -->\n[sWhereBuy]\n<!-- /wp:shortcode -->\n\n<!-- wp:shortcode -->\n[sMethod]\n<!-- /wp:shortcode -->\n\n<!-- wp:shortcode -->\n[sRecomendation]\n<!-- /wp:shortcode -->\n\n<!-- wp:shortcode -->\n[sOtherCountries]\n<!-- /wp:shortcode -->\n\n<!-- wp:shortcode -->\n[sAbout]\n<!-- /wp:shortcode -->\n\n<!-- wp:shortcode -->\n[sComplications]\n<!-- /wp:shortcode -->\n\n<!-- wp:shortcode -->\n[sTreatment]\n<!-- /wp:shortcode -->\n\n<!-- wp:shortcode -->\n[sFAQ]\n<!-- /wp:shortcode -->', 'Главная', '', 'inherit', 'closed', 'closed', '', '2-revision-v1', '', '', '2022-03-30 15:51:11', '2022-03-30 12:51:11', '', 2, 'http://0026urotec.loc:8888/?p=166', 0, 'revision', '', 0);
INSERT INTO `urotec_posts` (`ID`, `post_author`, `post_date`, `post_date_gmt`, `post_content`, `post_title`, `post_excerpt`, `post_status`, `comment_status`, `ping_status`, `post_password`, `post_name`, `to_ping`, `pinged`, `post_modified`, `post_modified_gmt`, `post_content_filtered`, `post_parent`, `guid`, `menu_order`, `post_type`, `post_mime_type`, `comment_count`) VALUES
(167, 1, '2022-03-30 15:51:49', '2022-03-30 12:51:49', '<!-- wp:shortcode -->\n[header]\n<!-- /wp:shortcode -->\n\n<!-- wp:shortcode -->\n[sAdv]\n<!-- /wp:shortcode -->\n\n<!-- wp:shortcode -->\n[sCatalog]\n<!-- /wp:shortcode -->\n\n<!-- wp:shortcode -->\n[sWhereBuy]\n<!-- /wp:shortcode -->\n\n<!-- wp:shortcode -->\n[sMethod]\n<!-- /wp:shortcode -->\n\n<!-- wp:shortcode -->\n[sRecomendation]\n<!-- /wp:shortcode -->\n\n<!-- wp:shortcode -->\n[sOtherCountries]\n<!-- /wp:shortcode -->\n\n<!-- wp:shortcode -->\n[sAbout]\n<!-- /wp:shortcode -->\n\n<!-- wp:shortcode -->\n[sComplications]\n<!-- /wp:shortcode -->\n\n<!-- wp:shortcode -->\n[sTreatment]\n<!-- /wp:shortcode -->\n\n<!-- wp:shortcode -->\n[sFAQ]\n<!-- /wp:shortcode -->', 'Главная', '', 'inherit', 'closed', 'closed', '', '2-revision-v1', '', '', '2022-03-30 15:51:49', '2022-03-30 12:51:49', '', 2, 'http://0026urotec.loc:8888/?p=167', 0, 'revision', '', 0),
(168, 1, '2022-03-30 16:38:27', '2022-03-30 13:38:27', 'a:7:{s:8:\"location\";a:1:{i:0;a:1:{i:0;a:3:{s:5:\"param\";s:12:\"options_page\";s:8:\"operator\";s:2:\"==\";s:5:\"value\";s:22:\"theme-general-settings\";}}}s:8:\"position\";s:6:\"normal\";s:5:\"style\";s:7:\"default\";s:15:\"label_placement\";s:3:\"top\";s:21:\"instruction_placement\";s:5:\"label\";s:14:\"hide_on_screen\";s:0:\"\";s:11:\"description\";s:0:\"\";}', 'Общие данные', 'obshhie-dannye', 'publish', 'closed', 'closed', '', 'group_62445bfd173c1', '', '', '2022-04-05 21:42:47', '2022-04-05 18:42:47', '', 0, 'http://0026urotec.loc:8888/?post_type=acf-field-group&#038;p=168', 0, 'acf-field-group', '', 0),
(169, 1, '2022-03-30 16:38:27', '2022-03-30 13:38:27', 'a:15:{s:4:\"type\";s:5:\"image\";s:12:\"instructions\";s:0:\"\";s:8:\"required\";i:0;s:17:\"conditional_logic\";i:0;s:7:\"wrapper\";a:3:{s:5:\"width\";s:0:\"\";s:5:\"class\";s:0:\"\";s:2:\"id\";s:0:\"\";}s:13:\"return_format\";s:2:\"id\";s:12:\"preview_size\";s:6:\"medium\";s:7:\"library\";s:3:\"all\";s:9:\"min_width\";s:0:\"\";s:10:\"min_height\";s:0:\"\";s:8:\"min_size\";s:0:\"\";s:9:\"max_width\";s:0:\"\";s:10:\"max_height\";s:0:\"\";s:8:\"max_size\";s:0:\"\";s:10:\"mime_types\";s:0:\"\";}', 'Лого в шапке', 'лого_в_шапке', 'publish', 'closed', 'closed', '', 'field_62445c114bad0', '', '', '2022-03-31 13:56:40', '2022-03-31 10:56:40', '', 168, 'http://0026urotec.loc:8888/?post_type=acf-field&#038;p=169', 1, 'acf-field', '', 0),
(170, 1, '2022-03-30 16:38:27', '2022-03-30 13:38:27', 'a:15:{s:4:\"type\";s:5:\"image\";s:12:\"instructions\";s:0:\"\";s:8:\"required\";i:0;s:17:\"conditional_logic\";i:0;s:7:\"wrapper\";a:3:{s:5:\"width\";s:0:\"\";s:5:\"class\";s:0:\"\";s:2:\"id\";s:0:\"\";}s:13:\"return_format\";s:2:\"id\";s:12:\"preview_size\";s:6:\"medium\";s:7:\"library\";s:3:\"all\";s:9:\"min_width\";s:0:\"\";s:10:\"min_height\";s:0:\"\";s:8:\"min_size\";s:0:\"\";s:9:\"max_width\";s:0:\"\";s:10:\"max_height\";s:0:\"\";s:8:\"max_size\";s:0:\"\";s:10:\"mime_types\";s:0:\"\";}', 'Лого в подвале', 'лого_в_подвале', 'publish', 'closed', 'closed', '', 'field_62445c8d4bad1', '', '', '2022-03-31 13:56:40', '2022-03-31 10:56:40', '', 168, 'http://0026urotec.loc:8888/?post_type=acf-field&#038;p=170', 2, 'acf-field', '', 0),
(171, 1, '2022-03-30 16:38:27', '2022-03-30 13:38:27', 'a:10:{s:4:\"type\";s:4:\"text\";s:12:\"instructions\";s:0:\"\";s:8:\"required\";i:0;s:17:\"conditional_logic\";i:0;s:7:\"wrapper\";a:3:{s:5:\"width\";s:0:\"\";s:5:\"class\";s:0:\"\";s:2:\"id\";s:0:\"\";}s:13:\"default_value\";s:0:\"\";s:11:\"placeholder\";s:0:\"\";s:7:\"prepend\";s:0:\"\";s:6:\"append\";s:0:\"\";s:9:\"maxlength\";s:0:\"\";}', 'Адрес', 'адрес', 'publish', 'closed', 'closed', '', 'field_62445cd94bad2', '', '', '2022-03-31 13:56:40', '2022-03-31 10:56:40', '', 168, 'http://0026urotec.loc:8888/?post_type=acf-field&#038;p=171', 3, 'acf-field', '', 0),
(172, 1, '2022-03-30 16:38:27', '2022-03-30 13:38:27', 'a:10:{s:4:\"type\";s:4:\"text\";s:12:\"instructions\";s:0:\"\";s:8:\"required\";i:0;s:17:\"conditional_logic\";i:0;s:7:\"wrapper\";a:3:{s:5:\"width\";s:0:\"\";s:5:\"class\";s:0:\"\";s:2:\"id\";s:0:\"\";}s:13:\"default_value\";s:0:\"\";s:11:\"placeholder\";s:0:\"\";s:7:\"prepend\";s:0:\"\";s:6:\"append\";s:0:\"\";s:9:\"maxlength\";s:0:\"\";}', 'Телефон', 'телефон', 'publish', 'closed', 'closed', '', 'field_62445d0a4bad3', '', '', '2022-03-31 13:56:40', '2022-03-31 10:56:40', '', 168, 'http://0026urotec.loc:8888/?post_type=acf-field&#038;p=172', 4, 'acf-field', '', 0),
(173, 1, '2022-03-30 16:38:27', '2022-03-30 13:38:27', 'a:10:{s:4:\"type\";s:4:\"text\";s:12:\"instructions\";s:0:\"\";s:8:\"required\";i:0;s:17:\"conditional_logic\";i:0;s:7:\"wrapper\";a:3:{s:5:\"width\";s:0:\"\";s:5:\"class\";s:0:\"\";s:2:\"id\";s:0:\"\";}s:13:\"default_value\";s:0:\"\";s:11:\"placeholder\";s:0:\"\";s:7:\"prepend\";s:0:\"\";s:6:\"append\";s:0:\"\";s:9:\"maxlength\";s:0:\"\";}', 'Факс', 'факс', 'publish', 'closed', 'closed', '', 'field_62445d0f4bad4', '', '', '2022-03-31 13:56:40', '2022-03-31 10:56:40', '', 168, 'http://0026urotec.loc:8888/?post_type=acf-field&#038;p=173', 5, 'acf-field', '', 0),
(174, 1, '2022-03-30 16:38:27', '2022-03-30 13:38:27', 'a:9:{s:4:\"type\";s:5:\"email\";s:12:\"instructions\";s:0:\"\";s:8:\"required\";i:0;s:17:\"conditional_logic\";i:0;s:7:\"wrapper\";a:3:{s:5:\"width\";s:0:\"\";s:5:\"class\";s:0:\"\";s:2:\"id\";s:0:\"\";}s:13:\"default_value\";s:0:\"\";s:11:\"placeholder\";s:0:\"\";s:7:\"prepend\";s:0:\"\";s:6:\"append\";s:0:\"\";}', 'Email', 'email', 'publish', 'closed', 'closed', '', 'field_62445d164bad5', '', '', '2022-03-31 13:56:40', '2022-03-31 10:56:40', '', 168, 'http://0026urotec.loc:8888/?post_type=acf-field&#038;p=174', 6, 'acf-field', '', 0),
(175, 1, '2022-03-30 16:38:27', '2022-03-30 13:38:27', 'a:10:{s:4:\"type\";s:7:\"wysiwyg\";s:12:\"instructions\";s:0:\"\";s:8:\"required\";i:0;s:17:\"conditional_logic\";i:0;s:7:\"wrapper\";a:3:{s:5:\"width\";s:0:\"\";s:5:\"class\";s:0:\"\";s:2:\"id\";s:0:\"\";}s:13:\"default_value\";s:0:\"\";s:4:\"tabs\";s:3:\"all\";s:7:\"toolbar\";s:5:\"basic\";s:12:\"media_upload\";i:0;s:5:\"delay\";i:0;}', 'Источники', 'источники', 'publish', 'closed', 'closed', '', 'field_62445d424bad6', '', '', '2022-03-31 13:56:40', '2022-03-31 10:56:40', '', 168, 'http://0026urotec.loc:8888/?post_type=acf-field&#038;p=175', 7, 'acf-field', '', 0),
(176, 1, '2022-03-30 16:42:23', '2022-03-30 13:42:23', '', 'logo', '', 'inherit', 'open', 'closed', '', 'logo', '', '', '2022-03-30 16:42:23', '2022-03-30 13:42:23', '', 0, 'http://0026urotec.loc:8888/wp-content/uploads/2022/03/logo.svg', 0, 'attachment', 'image/svg+xml', 0),
(177, 1, '2022-03-30 16:43:12', '2022-03-30 13:43:12', '', 'recordati-logo', '', 'inherit', 'open', 'closed', '', 'recordati-logo', '', '', '2022-03-30 16:43:12', '2022-03-30 13:43:12', '', 0, 'http://0026urotec.loc:8888/wp-content/uploads/2022/03/recordati-logo.png', 0, 'attachment', 'image/png', 0),
(178, 1, '2022-03-31 12:55:17', '2022-03-30 14:15:49', '', 'О проблеме', '', 'publish', 'closed', 'closed', '', 'o-probleme', '', '', '2022-03-31 12:55:17', '2022-03-31 09:55:17', '', 0, 'http://0026urotec.loc:8888/?p=178', 1, 'nav_menu_item', '', 0),
(179, 1, '2022-03-31 12:55:17', '2022-03-30 14:15:49', '', 'Где купить', '', 'publish', 'closed', 'closed', '', 'gde-kupit', '', '', '2022-03-31 12:55:17', '2022-03-31 09:55:17', '', 0, 'http://0026urotec.loc:8888/?p=179', 2, 'nav_menu_item', '', 0),
(180, 1, '2022-03-31 12:55:17', '2022-03-30 14:15:49', '', 'Вопросы и ответы', '', 'publish', 'closed', 'closed', '', 'voprosy-i-otvety', '', '', '2022-03-31 12:55:17', '2022-03-31 09:55:17', '', 0, 'http://0026urotec.loc:8888/?p=180', 3, 'nav_menu_item', '', 0),
(182, 1, '2022-03-31 15:52:54', '2022-03-30 16:40:17', '', 'Политика конфиденциальности', '', 'publish', 'closed', 'closed', '', 'politika-konfidencialnosti-2', '', '', '2022-03-31 15:52:54', '2022-03-31 12:52:54', '', 0, 'http://0026urotec.loc:8888/?p=182', 1, 'nav_menu_item', '', 0),
(185, 1, '2022-03-30 17:30:04', '2022-03-30 14:30:04', '<!-- wp:shortcode -->\n[headerblock]\n<!-- /wp:shortcode -->\n\n<!-- wp:shortcode -->\n[sAdv]\n<!-- /wp:shortcode -->\n\n<!-- wp:shortcode -->\n[sCatalog]\n<!-- /wp:shortcode -->\n\n<!-- wp:shortcode -->\n[sWhereBuy]\n<!-- /wp:shortcode -->\n\n<!-- wp:shortcode -->\n[sMethod]\n<!-- /wp:shortcode -->\n\n<!-- wp:shortcode -->\n[sRecomendation]\n<!-- /wp:shortcode -->\n\n<!-- wp:shortcode -->\n[sOtherCountries]\n<!-- /wp:shortcode -->\n\n<!-- wp:shortcode -->\n[sAbout]\n<!-- /wp:shortcode -->\n\n<!-- wp:shortcode -->\n[sComplications]\n<!-- /wp:shortcode -->\n\n<!-- wp:shortcode -->\n[sTreatment]\n<!-- /wp:shortcode -->\n\n<!-- wp:shortcode -->\n[sFAQ]\n<!-- /wp:shortcode -->', 'Главная', '', 'inherit', 'closed', 'closed', '', '2-revision-v1', '', '', '2022-03-30 17:30:04', '2022-03-30 14:30:04', '', 2, 'http://0026urotec.loc:8888/?p=185', 0, 'revision', '', 0),
(190, 1, '2022-03-30 19:51:56', '2022-03-30 16:51:56', '', 'unsplash_lQGJCMY5qcM', '', 'inherit', 'open', 'closed', '', 'unsplash_lqgjcmy5qcm', '', '', '2022-03-30 19:51:56', '2022-03-30 16:51:56', '', 1, 'http://0026urotec.loc:8888/wp-content/uploads/2022/03/unsplash_lQGJCMY5qcM.jpg', 0, 'attachment', 'image/jpeg', 0),
(191, 1, '2022-03-30 19:52:15', '2022-03-30 16:52:15', '<!-- wp:paragraph -->\n<p>Клинические преимущества препарата Урорек (силодозин) определяются максимальной уроселективностью в&nbsp;классе альфа-адреноблокаторов4 Урорек&nbsp;— альфа-адреноблокатор последнего поколения, который эффективен в&nbsp;отношении всех СНМП (накопления, опорожнения, постмиктурических).12,13 При этом Урорек обладает минимальным риском развития нежелательных явлений со&nbsp;стороны сердечно-сосудистой системы, в&nbsp;т.ч.&nbsp;у&nbsp;пациентов, принимающих антигипертензивные препараты46,8</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>Клинические преимущества препарата Урорек (силодозин) определяются максимальной уроселективностью в&nbsp;классе альфа-адреноблокаторов4 Урорек&nbsp;— альфа-адреноблокатор последнего поколения, который эффективен в&nbsp;отношении всех</p>\n<!-- /wp:paragraph -->', 'Заголовок для статьи или материала в одну или несколько строк для наглядности', '', 'inherit', 'closed', 'closed', '', '1-revision-v1', '', '', '2022-03-30 19:52:15', '2022-03-30 16:52:15', '', 1, 'http://0026urotec.loc:8888/?p=191', 0, 'revision', '', 0),
(192, 1, '2022-03-30 19:52:31', '2022-03-30 16:52:31', '', 'unsplash_lQGJCMY5qcM', '', 'inherit', 'open', 'closed', '', 'unsplash_lqgjcmy5qcm-2', '', '', '2022-03-30 19:52:31', '2022-03-30 16:52:31', '', 1, 'http://0026urotec.loc:8888/wp-content/uploads/2022/03/unsplash_lQGJCMY5qcM-1.jpg', 0, 'attachment', 'image/jpeg', 0),
(193, 1, '2022-03-30 20:26:25', '2022-03-30 17:26:25', '<!-- wp:paragraph -->\n<p>Клинические преимущества препарата Урорек (силодозин) определяются максимальной уроселективностью в&nbsp;классе альфа-адреноблокаторов4 Урорек&nbsp;— альфа-адреноблокатор последнего поколения, который эффективен в&nbsp;отношении всех СНМП (накопления, опорожнения, постмиктурических).12,13 При этом Урорек обладает минимальным риском развития нежелательных явлений со&nbsp;стороны сердечно-сосудистой системы, в&nbsp;т.ч.&nbsp;у&nbsp;пациентов, принимающих антигипертензивные препараты46,8</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>Клинические преимущества препарата Урорек (силодозин) определяются максимальной уроселективностью в&nbsp;классе альфа-адреноблокаторов4 Урорек&nbsp;— альфа-адреноблокатор последнего поколения, который эффективен в&nbsp;отношении всех</p>\n<!-- /wp:paragraph -->', '1Заголовок для статьи или материала в одну или несколько строк для наглядности', '', 'publish', 'open', 'open', '', 'zagolovok-dlya-stati-ili-materiala-v-odnu-ili-neskolko-strok-dlya-naglyadnosti', '', '', '2022-03-30 20:26:52', '2022-03-30 17:26:52', '', 0, 'http://0026urotec.loc:8888/?p=193', 0, 'post', '', 0),
(194, 1, '2022-03-30 20:26:25', '2022-03-30 17:26:25', '<!-- wp:paragraph -->\n<p>Клинические преимущества препарата Урорек (силодозин) определяются максимальной уроселективностью в&nbsp;классе альфа-адреноблокаторов4 Урорек&nbsp;— альфа-адреноблокатор последнего поколения, который эффективен в&nbsp;отношении всех СНМП (накопления, опорожнения, постмиктурических).12,13 При этом Урорек обладает минимальным риском развития нежелательных явлений со&nbsp;стороны сердечно-сосудистой системы, в&nbsp;т.ч.&nbsp;у&nbsp;пациентов, принимающих антигипертензивные препараты46,8</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>Клинические преимущества препарата Урорек (силодозин) определяются максимальной уроселективностью в&nbsp;классе альфа-адреноблокаторов4 Урорек&nbsp;— альфа-адреноблокатор последнего поколения, который эффективен в&nbsp;отношении всех</p>\n<!-- /wp:paragraph -->', 'Заголовок для статьи или материала в одну или несколько строк для наглядности', '', 'inherit', 'closed', 'closed', '', '193-revision-v1', '', '', '2022-03-30 20:26:25', '2022-03-30 17:26:25', '', 193, 'http://0026urotec.loc:8888/?p=194', 0, 'revision', '', 0),
(195, 1, '2022-03-30 20:26:52', '2022-03-30 17:26:52', '<!-- wp:paragraph -->\n<p>Клинические преимущества препарата Урорек (силодозин) определяются максимальной уроселективностью в&nbsp;классе альфа-адреноблокаторов4 Урорек&nbsp;— альфа-адреноблокатор последнего поколения, который эффективен в&nbsp;отношении всех СНМП (накопления, опорожнения, постмиктурических).12,13 При этом Урорек обладает минимальным риском развития нежелательных явлений со&nbsp;стороны сердечно-сосудистой системы, в&nbsp;т.ч.&nbsp;у&nbsp;пациентов, принимающих антигипертензивные препараты46,8</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>Клинические преимущества препарата Урорек (силодозин) определяются максимальной уроселективностью в&nbsp;классе альфа-адреноблокаторов4 Урорек&nbsp;— альфа-адреноблокатор последнего поколения, который эффективен в&nbsp;отношении всех</p>\n<!-- /wp:paragraph -->', '1Заголовок для статьи или материала в одну или несколько строк для наглядности', '', 'inherit', 'closed', 'closed', '', '193-revision-v1', '', '', '2022-03-30 20:26:52', '2022-03-30 17:26:52', '', 193, 'http://0026urotec.loc:8888/?p=195', 0, 'revision', '', 0),
(196, 1, '2022-03-30 20:44:20', '2022-03-30 17:44:20', '', 'art-4', '', 'inherit', 'open', 'closed', '', 'art-4', '', '', '2022-03-30 20:44:20', '2022-03-30 17:44:20', '', 1, 'http://0026urotec.loc:8888/wp-content/uploads/2022/03/art-4.jpg', 0, 'attachment', 'image/jpeg', 0),
(197, 1, '2022-03-30 21:01:38', '2022-03-30 18:01:38', '<!-- wp:paragraph -->\n<p>Клинические преимущества препарата Урорек (силодозин) определяются максимальной уроселективностью в&nbsp;классе альфа-адреноблокаторов4 Урорек&nbsp;— альфа-адреноблокатор последнего поколения, который эффективен в&nbsp;отношении всех СНМП (накопления, опорожнения, постмиктурических).12,13 При этом Урорек обладает минимальным риском развития нежелательных явлений со&nbsp;стороны сердечно-сосудистой системы, в&nbsp;т.ч.&nbsp;у&nbsp;пациентов, принимающих антигипертензивные препараты46,8</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>Клинические преимущества препарата Урорек (силодозин) определяются максимальной уроселективностью в&nbsp;классе альфа-адреноблокаторов4 Урорек&nbsp;— альфа-адреноблокатор последнего поколения, который эффективен в&nbsp;отношении всех</p>\n<!-- /wp:paragraph -->', 'Заголовок для статьи или материала в одну или несколько строк для наглядности', '', 'publish', 'open', 'open', '', 'zagolovok-dlya-stati-ili-materiala-v-odnu-ili-neskolko-strok-dlya-naglyadnosti-2', '', '', '2022-03-30 21:01:38', '2022-03-30 18:01:38', '', 0, 'http://0026urotec.loc:8888/?p=197', 0, 'post', '', 0),
(198, 1, '2022-03-30 20:45:56', '2022-03-30 17:45:56', '', 'art-5', '', 'inherit', 'open', 'closed', '', 'art-5', '', '', '2022-03-30 20:45:56', '2022-03-30 17:45:56', '', 197, 'http://0026urotec.loc:8888/wp-content/uploads/2022/03/art-5.jpg', 0, 'attachment', 'image/jpeg', 0),
(199, 1, '2022-03-30 21:01:38', '2022-03-30 18:01:38', '<!-- wp:paragraph -->\n<p>Клинические преимущества препарата Урорек (силодозин) определяются максимальной уроселективностью в&nbsp;классе альфа-адреноблокаторов4 Урорек&nbsp;— альфа-адреноблокатор последнего поколения, который эффективен в&nbsp;отношении всех СНМП (накопления, опорожнения, постмиктурических).12,13 При этом Урорек обладает минимальным риском развития нежелательных явлений со&nbsp;стороны сердечно-сосудистой системы, в&nbsp;т.ч.&nbsp;у&nbsp;пациентов, принимающих антигипертензивные препараты46,8</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>Клинические преимущества препарата Урорек (силодозин) определяются максимальной уроселективностью в&nbsp;классе альфа-адреноблокаторов4 Урорек&nbsp;— альфа-адреноблокатор последнего поколения, который эффективен в&nbsp;отношении всех</p>\n<!-- /wp:paragraph -->', 'Заголовок для статьи или материала в одну или несколько строк для наглядности', '', 'inherit', 'closed', 'closed', '', '197-revision-v1', '', '', '2022-03-30 21:01:38', '2022-03-30 18:01:38', '', 197, 'http://0026urotec.loc:8888/?p=199', 0, 'revision', '', 0),
(200, 1, '2022-03-30 21:04:31', '2022-03-30 18:04:31', '', 'Статьи и материалы', '', 'publish', 'closed', 'closed', '', 'blog', '', '', '2022-03-31 15:50:00', '2022-03-31 12:50:00', '', 0, 'http://0026urotec.loc:8888/?page_id=200', 0, 'page', '', 0),
(201, 1, '2022-03-30 21:04:31', '2022-03-30 18:04:31', '<!-- wp:preformatted -->\n<pre id=\"block-0e7cb5f3-2354-4016-ab91-037a4d425335\" class=\"wp-block-preformatted\">Статьи и материалы</pre>\n<!-- /wp:preformatted -->\n\n<!-- wp:paragraph -->\n<p></p>\n<!-- /wp:paragraph -->', '', '', 'inherit', 'closed', 'closed', '', '200-revision-v1', '', '', '2022-03-30 21:04:31', '2022-03-30 18:04:31', '', 200, 'http://0026urotec.loc:8888/?p=201', 0, 'revision', '', 0),
(202, 1, '2022-03-30 21:06:43', '2022-03-30 18:06:43', '<!-- wp:paragraph -->\n<p>Клинические преимущества препарата Урорек (силодозин) определяются максимальной уроселективностью в&nbsp;классе альфа-адреноблокаторов4 Урорек&nbsp;— альфа-адреноблокатор последнего поколения, который эффективен в&nbsp;отношении всех СНМП (накопления, опорожнения, постмиктурических).12,13 При этом Урорек обладает минимальным риском развития нежелательных явлений со&nbsp;стороны сердечно-сосудистой системы, в&nbsp;т.ч.&nbsp;у&nbsp;пациентов, принимающих антигипертензивные препараты46,8</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>Клинические преимущества препарата Урорек (силодозин) определяются максимальной уроселективностью в&nbsp;классе альфа-адреноблокаторов4 Урорек&nbsp;— альфа-адреноблокатор последнего поколения, который эффективен в&nbsp;отношении всех</p>\n<!-- /wp:paragraph -->', 'Заголовок для статьи или материала в одну или несколько строк для наглядности', '', 'publish', 'open', 'open', '', 'zagolovok-dlya-stati-ili-materiala-v-odnu-ili-neskolko-strok-dlya-naglyadnosti-7', '', '', '2022-03-30 21:07:58', '2022-03-30 18:07:58', '', 0, 'http://0026urotec.loc:8888/?p=202', 0, 'post', '', 0),
(203, 1, '2022-03-30 21:06:43', '2022-03-30 18:06:43', '<!-- wp:paragraph -->\n<p>Клинические преимущества препарата Урорек (силодозин) определяются максимальной уроселективностью в&nbsp;классе альфа-адреноблокаторов4 Урорек&nbsp;— альфа-адреноблокатор последнего поколения, который эффективен в&nbsp;отношении всех СНМП (накопления, опорожнения, постмиктурических).12,13 При этом Урорек обладает минимальным риском развития нежелательных явлений со&nbsp;стороны сердечно-сосудистой системы, в&nbsp;т.ч.&nbsp;у&nbsp;пациентов, принимающих антигипертензивные препараты46,8</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>Клинические преимущества препарата Урорек (силодозин) определяются максимальной уроселективностью в&nbsp;классе альфа-адреноблокаторов4 Урорек&nbsp;— альфа-адреноблокатор последнего поколения, который эффективен в&nbsp;отношении всех</p>\n<!-- /wp:paragraph -->', '1Заголовок для статьи или материала в одну или несколько строк для наглядности', '', 'publish', 'open', 'open', '', '1zagolovok-dlya-stati-ili-materiala-v-odnu-ili-neskolko-strok-dlya-naglyadnosti-3', '', '', '2022-03-30 21:08:04', '2022-03-30 18:08:04', '', 0, 'http://0026urotec.loc:8888/?p=203', 0, 'post', '', 0),
(204, 1, '2022-03-30 21:06:43', '2022-03-30 18:06:43', '<!-- wp:paragraph -->\n<p>Клинические преимущества препарата Урорек (силодозин) определяются максимальной уроселективностью в&nbsp;классе альфа-адреноблокаторов4 Урорек&nbsp;— альфа-адреноблокатор последнего поколения, который эффективен в&nbsp;отношении всех СНМП (накопления, опорожнения, постмиктурических).12,13 При этом Урорек обладает минимальным риском развития нежелательных явлений со&nbsp;стороны сердечно-сосудистой системы, в&nbsp;т.ч.&nbsp;у&nbsp;пациентов, принимающих антигипертензивные препараты46,8</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>Клинические преимущества препарата Урорек (силодозин) определяются максимальной уроселективностью в&nbsp;классе альфа-адреноблокаторов4 Урорек&nbsp;— альфа-адреноблокатор последнего поколения, который эффективен в&nbsp;отношении всех</p>\n<!-- /wp:paragraph -->', 'Заголовок для статьи или материала в одну или несколько строк для наглядности', '', 'publish', 'open', 'open', '', 'zagolovok-dlya-stati-ili-materiala-v-odnu-ili-neskolko-strok-dlya-naglyadnosti-8', '', '', '2022-03-30 21:08:11', '2022-03-30 18:08:11', '', 0, 'http://0026urotec.loc:8888/?p=204', 0, 'post', '', 0),
(205, 1, '2022-03-30 21:06:54', '2022-03-30 18:06:54', '<!-- wp:paragraph -->\n<p>Клинические преимущества препарата Урорек (силодозин) определяются максимальной уроселективностью в&nbsp;классе альфа-адреноблокаторов4 Урорек&nbsp;— альфа-адреноблокатор последнего поколения, который эффективен в&nbsp;отношении всех СНМП (накопления, опорожнения, постмиктурических).12,13 При этом Урорек обладает минимальным риском развития нежелательных явлений со&nbsp;стороны сердечно-сосудистой системы, в&nbsp;т.ч.&nbsp;у&nbsp;пациентов, принимающих антигипертензивные препараты46,8</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>Клинические преимущества препарата Урорек (силодозин) определяются максимальной уроселективностью в&nbsp;классе альфа-адреноблокаторов4 Урорек&nbsp;— альфа-адреноблокатор последнего поколения, который эффективен в&nbsp;отношении всех</p>\n<!-- /wp:paragraph -->', 'Заголовок для статьи или материала в одну или несколько строк для наглядности', '', 'publish', 'open', 'open', '', 'zagolovok-dlya-stati-ili-materiala-v-odnu-ili-neskolko-strok-dlya-naglyadnosti-6', '', '', '2022-03-30 21:07:48', '2022-03-30 18:07:48', '', 0, 'http://0026urotec.loc:8888/?p=205', 0, 'post', '', 0),
(206, 1, '2022-03-30 21:06:54', '2022-03-30 18:06:54', '<!-- wp:paragraph -->\n<p>Клинические преимущества препарата Урорек (силодозин) определяются максимальной уроселективностью в&nbsp;классе альфа-адреноблокаторов4 Урорек&nbsp;— альфа-адреноблокатор последнего поколения, который эффективен в&nbsp;отношении всех СНМП (накопления, опорожнения, постмиктурических).12,13 При этом Урорек обладает минимальным риском развития нежелательных явлений со&nbsp;стороны сердечно-сосудистой системы, в&nbsp;т.ч.&nbsp;у&nbsp;пациентов, принимающих антигипертензивные препараты46,8</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>Клинические преимущества препарата Урорек (силодозин) определяются максимальной уроселективностью в&nbsp;классе альфа-адреноблокаторов4 Урорек&nbsp;— альфа-адреноблокатор последнего поколения, который эффективен в&nbsp;отношении всех</p>\n<!-- /wp:paragraph -->', '1Заголовок для статьи или материала в одну или несколько строк для наглядности', '', 'publish', 'open', 'open', '', '1zagolovok-dlya-stati-ili-materiala-v-odnu-ili-neskolko-strok-dlya-naglyadnosti-2', '', '', '2022-03-30 21:07:54', '2022-03-30 18:07:54', '', 0, 'http://0026urotec.loc:8888/?p=206', 0, 'post', '', 0),
(207, 1, '2022-03-30 21:06:55', '2022-03-30 18:06:55', '<!-- wp:paragraph -->\n<p>Клинические преимущества препарата Урорек (силодозин) определяются максимальной уроселективностью в&nbsp;классе альфа-адреноблокаторов4 Урорек&nbsp;— альфа-адреноблокатор последнего поколения, который эффективен в&nbsp;отношении всех СНМП (накопления, опорожнения, постмиктурических).12,13 При этом Урорек обладает минимальным риском развития нежелательных явлений со&nbsp;стороны сердечно-сосудистой системы, в&nbsp;т.ч.&nbsp;у&nbsp;пациентов, принимающих антигипертензивные препараты46,8</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>Клинические преимущества препарата Урорек (силодозин) определяются максимальной уроселективностью в&nbsp;классе альфа-адреноблокаторов4 Урорек&nbsp;— альфа-адреноблокатор последнего поколения, который эффективен в&nbsp;отношении всех</p>\n<!-- /wp:paragraph -->', 'Заголовок для статьи или материала в одну или несколько строк для наглядности', '', 'publish', 'open', 'open', '', 'zagolovok-dlya-stati-ili-materiala-v-odnu-ili-neskolko-strok-dlya-naglyadnosti-3', '', '', '2022-03-30 21:07:17', '2022-03-30 18:07:17', '', 0, 'http://0026urotec.loc:8888/?p=207', 0, 'post', '', 0),
(208, 1, '2022-03-30 21:06:55', '2022-03-30 18:06:55', '<!-- wp:paragraph -->\n<p>Клинические преимущества препарата Урорек (силодозин) определяются максимальной уроселективностью в&nbsp;классе альфа-адреноблокаторов4 Урорек&nbsp;— альфа-адреноблокатор последнего поколения, который эффективен в&nbsp;отношении всех СНМП (накопления, опорожнения, постмиктурических).12,13 При этом Урорек обладает минимальным риском развития нежелательных явлений со&nbsp;стороны сердечно-сосудистой системы, в&nbsp;т.ч.&nbsp;у&nbsp;пациентов, принимающих антигипертензивные препараты46,8</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>Клинические преимущества препарата Урорек (силодозин) определяются максимальной уроселективностью в&nbsp;классе альфа-адреноблокаторов4 Урорек&nbsp;— альфа-адреноблокатор последнего поколения, который эффективен в&nbsp;отношении всех</p>\n<!-- /wp:paragraph -->', 'Заголовок для статьи или материала в одну или несколько строк для наглядности', '', 'publish', 'open', 'open', '', 'zagolovok-dlya-stati-ili-materiala-v-odnu-ili-neskolko-strok-dlya-naglyadnosti-4', '', '', '2022-03-30 21:07:25', '2022-03-30 18:07:25', '', 0, 'http://0026urotec.loc:8888/?p=208', 0, 'post', '', 0),
(209, 1, '2022-03-30 21:06:55', '2022-03-30 18:06:55', '<!-- wp:paragraph -->\n<p>Клинические преимущества препарата Урорек (силодозин) определяются максимальной уроселективностью в&nbsp;классе альфа-адреноблокаторов4 Урорек&nbsp;— альфа-адреноблокатор последнего поколения, который эффективен в&nbsp;отношении всех СНМП (накопления, опорожнения, постмиктурических).12,13 При этом Урорек обладает минимальным риском развития нежелательных явлений со&nbsp;стороны сердечно-сосудистой системы, в&nbsp;т.ч.&nbsp;у&nbsp;пациентов, принимающих антигипертензивные препараты46,8</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>Клинические преимущества препарата Урорек (силодозин) определяются максимальной уроселективностью в&nbsp;классе альфа-адреноблокаторов4 Урорек&nbsp;— альфа-адреноблокатор последнего поколения, который эффективен в&nbsp;отношении всех</p>\n<!-- /wp:paragraph -->', '1Заголовок для статьи или материала в одну или несколько строк для наглядности', '', 'publish', 'open', 'open', '', '1zagolovok-dlya-stati-ili-materiala-v-odnu-ili-neskolko-strok-dlya-naglyadnosti', '', '', '2022-03-30 21:07:36', '2022-03-30 18:07:36', '', 0, 'http://0026urotec.loc:8888/?p=209', 0, 'post', '', 0),
(210, 1, '2022-03-30 21:06:55', '2022-03-30 18:06:55', '<!-- wp:paragraph -->\n<p>Клинические преимущества препарата Урорек (силодозин) определяются максимальной уроселективностью в&nbsp;классе альфа-адреноблокаторов4 Урорек&nbsp;— альфа-адреноблокатор последнего поколения, который эффективен в&nbsp;отношении всех СНМП (накопления, опорожнения, постмиктурических).12,13 При этом Урорек обладает минимальным риском развития нежелательных явлений со&nbsp;стороны сердечно-сосудистой системы, в&nbsp;т.ч.&nbsp;у&nbsp;пациентов, принимающих антигипертензивные препараты46,8</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>Клинические преимущества препарата Урорек (силодозин) определяются максимальной уроселективностью в&nbsp;классе альфа-адреноблокаторов4 Урорек&nbsp;— альфа-адреноблокатор последнего поколения, который эффективен в&nbsp;отношении всех</p>\n<!-- /wp:paragraph -->', 'Заголовок для статьи или материала в одну или несколько строк для наглядности', '', 'publish', 'open', 'open', '', 'zagolovok-dlya-stati-ili-materiala-v-odnu-ili-neskolko-strok-dlya-naglyadnosti-5', '', '', '2022-03-30 21:07:42', '2022-03-30 18:07:42', '', 0, 'http://0026urotec.loc:8888/?p=210', 0, 'post', '', 0),
(211, 1, '2022-03-30 21:07:17', '2022-03-30 18:07:17', '<!-- wp:paragraph -->\n<p>Клинические преимущества препарата Урорек (силодозин) определяются максимальной уроселективностью в&nbsp;классе альфа-адреноблокаторов4 Урорек&nbsp;— альфа-адреноблокатор последнего поколения, который эффективен в&nbsp;отношении всех СНМП (накопления, опорожнения, постмиктурических).12,13 При этом Урорек обладает минимальным риском развития нежелательных явлений со&nbsp;стороны сердечно-сосудистой системы, в&nbsp;т.ч.&nbsp;у&nbsp;пациентов, принимающих антигипертензивные препараты46,8</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>Клинические преимущества препарата Урорек (силодозин) определяются максимальной уроселективностью в&nbsp;классе альфа-адреноблокаторов4 Урорек&nbsp;— альфа-адреноблокатор последнего поколения, который эффективен в&nbsp;отношении всех</p>\n<!-- /wp:paragraph -->', 'Заголовок для статьи или материала в одну или несколько строк для наглядности', '', 'inherit', 'closed', 'closed', '', '207-revision-v1', '', '', '2022-03-30 21:07:17', '2022-03-30 18:07:17', '', 207, 'http://0026urotec.loc:8888/?p=211', 0, 'revision', '', 0),
(212, 1, '2022-03-30 21:07:25', '2022-03-30 18:07:25', '<!-- wp:paragraph -->\n<p>Клинические преимущества препарата Урорек (силодозин) определяются максимальной уроселективностью в&nbsp;классе альфа-адреноблокаторов4 Урорек&nbsp;— альфа-адреноблокатор последнего поколения, который эффективен в&nbsp;отношении всех СНМП (накопления, опорожнения, постмиктурических).12,13 При этом Урорек обладает минимальным риском развития нежелательных явлений со&nbsp;стороны сердечно-сосудистой системы, в&nbsp;т.ч.&nbsp;у&nbsp;пациентов, принимающих антигипертензивные препараты46,8</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>Клинические преимущества препарата Урорек (силодозин) определяются максимальной уроселективностью в&nbsp;классе альфа-адреноблокаторов4 Урорек&nbsp;— альфа-адреноблокатор последнего поколения, который эффективен в&nbsp;отношении всех</p>\n<!-- /wp:paragraph -->', 'Заголовок для статьи или материала в одну или несколько строк для наглядности', '', 'inherit', 'closed', 'closed', '', '208-revision-v1', '', '', '2022-03-30 21:07:25', '2022-03-30 18:07:25', '', 208, 'http://0026urotec.loc:8888/?p=212', 0, 'revision', '', 0),
(213, 1, '2022-03-30 21:07:36', '2022-03-30 18:07:36', '<!-- wp:paragraph -->\n<p>Клинические преимущества препарата Урорек (силодозин) определяются максимальной уроселективностью в&nbsp;классе альфа-адреноблокаторов4 Урорек&nbsp;— альфа-адреноблокатор последнего поколения, который эффективен в&nbsp;отношении всех СНМП (накопления, опорожнения, постмиктурических).12,13 При этом Урорек обладает минимальным риском развития нежелательных явлений со&nbsp;стороны сердечно-сосудистой системы, в&nbsp;т.ч.&nbsp;у&nbsp;пациентов, принимающих антигипертензивные препараты46,8</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>Клинические преимущества препарата Урорек (силодозин) определяются максимальной уроселективностью в&nbsp;классе альфа-адреноблокаторов4 Урорек&nbsp;— альфа-адреноблокатор последнего поколения, который эффективен в&nbsp;отношении всех</p>\n<!-- /wp:paragraph -->', '1Заголовок для статьи или материала в одну или несколько строк для наглядности', '', 'inherit', 'closed', 'closed', '', '209-revision-v1', '', '', '2022-03-30 21:07:36', '2022-03-30 18:07:36', '', 209, 'http://0026urotec.loc:8888/?p=213', 0, 'revision', '', 0),
(214, 1, '2022-03-30 21:07:42', '2022-03-30 18:07:42', '<!-- wp:paragraph -->\n<p>Клинические преимущества препарата Урорек (силодозин) определяются максимальной уроселективностью в&nbsp;классе альфа-адреноблокаторов4 Урорек&nbsp;— альфа-адреноблокатор последнего поколения, который эффективен в&nbsp;отношении всех СНМП (накопления, опорожнения, постмиктурических).12,13 При этом Урорек обладает минимальным риском развития нежелательных явлений со&nbsp;стороны сердечно-сосудистой системы, в&nbsp;т.ч.&nbsp;у&nbsp;пациентов, принимающих антигипертензивные препараты46,8</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>Клинические преимущества препарата Урорек (силодозин) определяются максимальной уроселективностью в&nbsp;классе альфа-адреноблокаторов4 Урорек&nbsp;— альфа-адреноблокатор последнего поколения, который эффективен в&nbsp;отношении всех</p>\n<!-- /wp:paragraph -->', 'Заголовок для статьи или материала в одну или несколько строк для наглядности', '', 'inherit', 'closed', 'closed', '', '210-revision-v1', '', '', '2022-03-30 21:07:42', '2022-03-30 18:07:42', '', 210, 'http://0026urotec.loc:8888/?p=214', 0, 'revision', '', 0),
(215, 1, '2022-03-30 21:07:48', '2022-03-30 18:07:48', '<!-- wp:paragraph -->\n<p>Клинические преимущества препарата Урорек (силодозин) определяются максимальной уроселективностью в&nbsp;классе альфа-адреноблокаторов4 Урорек&nbsp;— альфа-адреноблокатор последнего поколения, который эффективен в&nbsp;отношении всех СНМП (накопления, опорожнения, постмиктурических).12,13 При этом Урорек обладает минимальным риском развития нежелательных явлений со&nbsp;стороны сердечно-сосудистой системы, в&nbsp;т.ч.&nbsp;у&nbsp;пациентов, принимающих антигипертензивные препараты46,8</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>Клинические преимущества препарата Урорек (силодозин) определяются максимальной уроселективностью в&nbsp;классе альфа-адреноблокаторов4 Урорек&nbsp;— альфа-адреноблокатор последнего поколения, который эффективен в&nbsp;отношении всех</p>\n<!-- /wp:paragraph -->', 'Заголовок для статьи или материала в одну или несколько строк для наглядности', '', 'inherit', 'closed', 'closed', '', '205-revision-v1', '', '', '2022-03-30 21:07:48', '2022-03-30 18:07:48', '', 205, 'http://0026urotec.loc:8888/?p=215', 0, 'revision', '', 0),
(216, 1, '2022-03-30 21:07:54', '2022-03-30 18:07:54', '<!-- wp:paragraph -->\n<p>Клинические преимущества препарата Урорек (силодозин) определяются максимальной уроселективностью в&nbsp;классе альфа-адреноблокаторов4 Урорек&nbsp;— альфа-адреноблокатор последнего поколения, который эффективен в&nbsp;отношении всех СНМП (накопления, опорожнения, постмиктурических).12,13 При этом Урорек обладает минимальным риском развития нежелательных явлений со&nbsp;стороны сердечно-сосудистой системы, в&nbsp;т.ч.&nbsp;у&nbsp;пациентов, принимающих антигипертензивные препараты46,8</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>Клинические преимущества препарата Урорек (силодозин) определяются максимальной уроселективностью в&nbsp;классе альфа-адреноблокаторов4 Урорек&nbsp;— альфа-адреноблокатор последнего поколения, который эффективен в&nbsp;отношении всех</p>\n<!-- /wp:paragraph -->', '1Заголовок для статьи или материала в одну или несколько строк для наглядности', '', 'inherit', 'closed', 'closed', '', '206-revision-v1', '', '', '2022-03-30 21:07:54', '2022-03-30 18:07:54', '', 206, 'http://0026urotec.loc:8888/?p=216', 0, 'revision', '', 0),
(217, 1, '2022-03-30 21:07:58', '2022-03-30 18:07:58', '<!-- wp:paragraph -->\n<p>Клинические преимущества препарата Урорек (силодозин) определяются максимальной уроселективностью в&nbsp;классе альфа-адреноблокаторов4 Урорек&nbsp;— альфа-адреноблокатор последнего поколения, который эффективен в&nbsp;отношении всех СНМП (накопления, опорожнения, постмиктурических).12,13 При этом Урорек обладает минимальным риском развития нежелательных явлений со&nbsp;стороны сердечно-сосудистой системы, в&nbsp;т.ч.&nbsp;у&nbsp;пациентов, принимающих антигипертензивные препараты46,8</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>Клинические преимущества препарата Урорек (силодозин) определяются максимальной уроселективностью в&nbsp;классе альфа-адреноблокаторов4 Урорек&nbsp;— альфа-адреноблокатор последнего поколения, который эффективен в&nbsp;отношении всех</p>\n<!-- /wp:paragraph -->', 'Заголовок для статьи или материала в одну или несколько строк для наглядности', '', 'inherit', 'closed', 'closed', '', '202-revision-v1', '', '', '2022-03-30 21:07:58', '2022-03-30 18:07:58', '', 202, 'http://0026urotec.loc:8888/?p=217', 0, 'revision', '', 0),
(218, 1, '2022-03-30 21:08:04', '2022-03-30 18:08:04', '<!-- wp:paragraph -->\n<p>Клинические преимущества препарата Урорек (силодозин) определяются максимальной уроселективностью в&nbsp;классе альфа-адреноблокаторов4 Урорек&nbsp;— альфа-адреноблокатор последнего поколения, который эффективен в&nbsp;отношении всех СНМП (накопления, опорожнения, постмиктурических).12,13 При этом Урорек обладает минимальным риском развития нежелательных явлений со&nbsp;стороны сердечно-сосудистой системы, в&nbsp;т.ч.&nbsp;у&nbsp;пациентов, принимающих антигипертензивные препараты46,8</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>Клинические преимущества препарата Урорек (силодозин) определяются максимальной уроселективностью в&nbsp;классе альфа-адреноблокаторов4 Урорек&nbsp;— альфа-адреноблокатор последнего поколения, который эффективен в&nbsp;отношении всех</p>\n<!-- /wp:paragraph -->', '1Заголовок для статьи или материала в одну или несколько строк для наглядности', '', 'inherit', 'closed', 'closed', '', '203-revision-v1', '', '', '2022-03-30 21:08:04', '2022-03-30 18:08:04', '', 203, 'http://0026urotec.loc:8888/?p=218', 0, 'revision', '', 0),
(219, 1, '2022-03-30 21:08:11', '2022-03-30 18:08:11', '<!-- wp:paragraph -->\n<p>Клинические преимущества препарата Урорек (силодозин) определяются максимальной уроселективностью в&nbsp;классе альфа-адреноблокаторов4 Урорек&nbsp;— альфа-адреноблокатор последнего поколения, который эффективен в&nbsp;отношении всех СНМП (накопления, опорожнения, постмиктурических).12,13 При этом Урорек обладает минимальным риском развития нежелательных явлений со&nbsp;стороны сердечно-сосудистой системы, в&nbsp;т.ч.&nbsp;у&nbsp;пациентов, принимающих антигипертензивные препараты46,8</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>Клинические преимущества препарата Урорек (силодозин) определяются максимальной уроселективностью в&nbsp;классе альфа-адреноблокаторов4 Урорек&nbsp;— альфа-адреноблокатор последнего поколения, который эффективен в&nbsp;отношении всех</p>\n<!-- /wp:paragraph -->', 'Заголовок для статьи или материала в одну или несколько строк для наглядности', '', 'inherit', 'closed', 'closed', '', '204-revision-v1', '', '', '2022-03-30 21:08:11', '2022-03-30 18:08:11', '', 204, 'http://0026urotec.loc:8888/?p=219', 0, 'revision', '', 0),
(220, 1, '2022-03-30 22:07:57', '2022-03-30 19:07:57', '<!-- wp:preformatted -->\n<pre id=\"block-0e7cb5f3-2354-4016-ab91-037a4d425335\" class=\"wp-block-preformatted\">Статьи и материалы</pre>\n<!-- /wp:preformatted -->\n\n<!-- wp:paragraph -->\n<p></p>\n<!-- /wp:paragraph -->', 'Статьи и материалы', '', 'inherit', 'closed', 'closed', '', '200-revision-v1', '', '', '2022-03-30 22:07:57', '2022-03-30 19:07:57', '', 200, 'http://0026urotec.loc:8888/?p=220', 0, 'revision', '', 0),
(221, 1, '2022-03-30 22:10:58', '2022-03-30 19:10:58', '', 'Статьи и материалы', '', 'inherit', 'closed', 'closed', '', '200-revision-v1', '', '', '2022-03-30 22:10:58', '2022-03-30 19:10:58', '', 200, 'http://0026urotec.loc:8888/?p=221', 0, 'revision', '', 0),
(222, 1, '2022-03-31 12:55:17', '2022-03-30 19:37:30', ' ', '', '', 'publish', 'closed', 'closed', '', '222', '', '', '2022-03-31 12:55:17', '2022-03-31 09:55:17', '', 0, 'http://0026urotec.loc:8888/?p=222', 4, 'nav_menu_item', '', 0),
(223, 1, '2022-03-30 23:34:52', '2022-03-30 20:34:52', '<!-- wp:shortcode -->\n[headerblock]\n<!-- /wp:shortcode -->\n\n<!-- wp:shortcode -->\n[sAdv]\n<!-- /wp:shortcode -->\n\n<!-- wp:shortcode -->\n[sCatalog]\n<!-- /wp:shortcode -->\n\n<!-- wp:shortcode -->\n[sWhereBuy]\n<!-- /wp:shortcode -->\n\n<!-- wp:shortcode -->\n[sMethod]\n<!-- /wp:shortcode -->\n\n<!-- wp:shortcode -->\n[sRecomendation]\n<!-- /wp:shortcode -->\n\n<!-- wp:shortcode -->\n[sOtherCountries]\n<!-- /wp:shortcode -->\n\n<!-- wp:shortcode -->\n[sAbout]\n<!-- /wp:shortcode -->\n\n<!-- wp:shortcode -->\n[sComplications]\n<!-- /wp:shortcode -->\n\n<!-- wp:shortcode -->\n[sTreatment]\n<!-- /wp:shortcode -->\n\n<!-- wp:shortcode -->\n[sFAQ]\n<!-- /wp:shortcode -->', 'Главная', '', 'inherit', 'closed', 'closed', '', '2-revision-v1', '', '', '2022-03-30 23:34:52', '2022-03-30 20:34:52', '', 2, 'http://0026urotec.loc:8888/?p=223', 0, 'revision', '', 0),
(224, 1, '2022-03-31 13:39:33', '2022-03-31 10:39:33', '<!-- wp:shortcode -->\n[headerblock]\n<!-- /wp:shortcode -->\n\n<!-- wp:shortcode -->\n[sAdv]\n<!-- /wp:shortcode -->\n\n<!-- wp:shortcode -->\n[sCatalog]\n<!-- /wp:shortcode -->\n\n<!-- wp:shortcode -->\n[sWhereBuy]\n<!-- /wp:shortcode -->\n\n<!-- wp:shortcode -->\n[sMethod]\n<!-- /wp:shortcode -->\n\n<!-- wp:shortcode -->\n[sRecomendation]\n<!-- /wp:shortcode -->\n\n<!-- wp:shortcode -->\n[sOtherCountries]\n<!-- /wp:shortcode -->\n\n<!-- wp:shortcode -->\n[sAbout]\n<!-- /wp:shortcode -->\n\n<!-- wp:shortcode -->\n[sComplications]\n<!-- /wp:shortcode -->\n\n<!-- wp:shortcode -->\n[sTreatment]\n<!-- /wp:shortcode -->\n\n<!-- wp:shortcode -->\n[sFAQ]\n<!-- /wp:shortcode -->', 'Главная', '', 'inherit', 'closed', 'closed', '', '2-revision-v1', '', '', '2022-03-31 13:39:33', '2022-03-31 10:39:33', '', 2, 'http://0026urotec.loc:8888/?p=224', 0, 'revision', '', 0),
(225, 1, '2022-03-31 13:40:47', '2022-03-31 10:40:47', '<!-- wp:shortcode -->\n[headerblock]\n<!-- /wp:shortcode -->\n\n<!-- wp:shortcode -->\n[sAdv]\n<!-- /wp:shortcode -->\n\n<!-- wp:shortcode -->\n[sCatalog]\n<!-- /wp:shortcode -->\n\n<!-- wp:shortcode -->\n[sWhereBuy]\n<!-- /wp:shortcode -->\n\n<!-- wp:shortcode -->\n[sMethod]\n<!-- /wp:shortcode -->\n\n<!-- wp:shortcode -->\n[sRecomendation]\n<!-- /wp:shortcode -->\n\n<!-- wp:shortcode -->\n[sOtherCountries]\n<!-- /wp:shortcode -->\n\n<!-- wp:shortcode -->\n[sAbout]\n<!-- /wp:shortcode -->\n\n<!-- wp:shortcode -->\n[sComplications]\n<!-- /wp:shortcode -->\n\n<!-- wp:shortcode -->\n[sTreatment]\n<!-- /wp:shortcode -->\n\n<!-- wp:shortcode -->\n[sFAQ]\n<!-- /wp:shortcode -->', 'Главная', '', 'inherit', 'closed', 'closed', '', '2-revision-v1', '', '', '2022-03-31 13:40:47', '2022-03-31 10:40:47', '', 2, 'http://0026urotec.loc:8888/?p=225', 0, 'revision', '', 0),
(226, 1, '2022-03-31 13:41:44', '2022-03-31 10:41:44', '<!-- wp:shortcode -->\n[headerblock]\n<!-- /wp:shortcode -->\n\n<!-- wp:shortcode -->\n[sAdv]\n<!-- /wp:shortcode -->\n\n<!-- wp:shortcode -->\n[sCatalog]\n<!-- /wp:shortcode -->\n\n<!-- wp:shortcode -->\n[sWhereBuy]\n<!-- /wp:shortcode -->\n\n<!-- wp:shortcode -->\n[sMethod]\n<!-- /wp:shortcode -->\n\n<!-- wp:shortcode -->\n[sRecomendation]\n<!-- /wp:shortcode -->\n\n<!-- wp:shortcode -->\n[sOtherCountries]\n<!-- /wp:shortcode -->\n\n<!-- wp:shortcode -->\n[sAbout]\n<!-- /wp:shortcode -->\n\n<!-- wp:shortcode -->\n[sComplications]\n<!-- /wp:shortcode -->\n\n<!-- wp:shortcode -->\n[sTreatment]\n<!-- /wp:shortcode -->\n\n<!-- wp:shortcode -->\n[sFAQ]\n<!-- /wp:shortcode -->', 'Главная', '', 'inherit', 'closed', 'closed', '', '2-revision-v1', '', '', '2022-03-31 13:41:44', '2022-03-31 10:41:44', '', 2, 'http://0026urotec.loc:8888/?p=226', 0, 'revision', '', 0),
(227, 1, '2022-03-31 13:56:40', '2022-03-31 10:56:40', 'a:7:{s:4:\"type\";s:3:\"tab\";s:12:\"instructions\";s:0:\"\";s:8:\"required\";i:0;s:17:\"conditional_logic\";i:0;s:7:\"wrapper\";a:3:{s:5:\"width\";s:0:\"\";s:5:\"class\";s:0:\"\";s:2:\"id\";s:0:\"\";}s:9:\"placement\";s:3:\"top\";s:8:\"endpoint\";i:0;}', 'Общие данные', 'первая_модалка_копия', 'publish', 'closed', 'closed', '', 'field_624588cae7ec8', '', '', '2022-03-31 13:56:40', '2022-03-31 10:56:40', '', 168, 'http://0026urotec.loc:8888/?post_type=acf-field&p=227', 0, 'acf-field', '', 0),
(228, 1, '2022-03-31 13:56:40', '2022-03-31 10:56:40', 'a:7:{s:4:\"type\";s:3:\"tab\";s:12:\"instructions\";s:0:\"\";s:8:\"required\";i:0;s:17:\"conditional_logic\";i:0;s:7:\"wrapper\";a:3:{s:5:\"width\";s:0:\"\";s:5:\"class\";s:0:\"\";s:2:\"id\";s:0:\"\";}s:9:\"placement\";s:3:\"top\";s:8:\"endpoint\";i:0;}', 'Первая модалка', 'первая_модалка', 'publish', 'closed', 'closed', '', 'field_624588abe7ec7', '', '', '2022-03-31 13:56:40', '2022-03-31 10:56:40', '', 168, 'http://0026urotec.loc:8888/?post_type=acf-field&p=228', 8, 'acf-field', '', 0),
(229, 1, '2022-03-31 13:56:40', '2022-03-31 10:56:40', 'a:10:{s:4:\"type\";s:7:\"wysiwyg\";s:12:\"instructions\";s:0:\"\";s:8:\"required\";i:0;s:17:\"conditional_logic\";i:0;s:7:\"wrapper\";a:3:{s:5:\"width\";s:0:\"\";s:5:\"class\";s:0:\"\";s:2:\"id\";s:0:\"\";}s:13:\"default_value\";s:0:\"\";s:4:\"tabs\";s:3:\"all\";s:7:\"toolbar\";s:4:\"full\";s:12:\"media_upload\";i:1;s:5:\"delay\";i:0;}', 'Текст', 'текст-мод', 'publish', 'closed', 'closed', '', 'field_624588d7e7ec9', '', '', '2022-04-05 21:38:32', '2022-04-05 18:38:32', '', 168, 'http://0026urotec.loc:8888/?post_type=acf-field&#038;p=229', 9, 'acf-field', '', 0),
(230, 1, '2022-03-31 14:05:58', '2022-03-31 11:05:58', 'a:7:{s:4:\"type\";s:3:\"tab\";s:12:\"instructions\";s:0:\"\";s:8:\"required\";i:0;s:17:\"conditional_logic\";i:0;s:7:\"wrapper\";a:3:{s:5:\"width\";s:0:\"\";s:5:\"class\";s:0:\"\";s:2:\"id\";s:0:\"\";}s:9:\"placement\";s:3:\"top\";s:8:\"endpoint\";i:0;}', 'Вторая модалка', 'вторая_модалка', 'publish', 'closed', 'closed', '', 'field_62458afa4139c', '', '', '2022-04-05 21:38:32', '2022-04-05 18:38:32', '', 168, 'http://0026urotec.loc:8888/?post_type=acf-field&#038;p=230', 10, 'acf-field', '', 0),
(231, 1, '2022-03-31 14:05:58', '2022-03-31 11:05:58', 'a:10:{s:4:\"type\";s:7:\"wysiwyg\";s:12:\"instructions\";s:0:\"\";s:8:\"required\";i:0;s:17:\"conditional_logic\";i:0;s:7:\"wrapper\";a:3:{s:5:\"width\";s:0:\"\";s:5:\"class\";s:0:\"\";s:2:\"id\";s:0:\"\";}s:13:\"default_value\";s:0:\"\";s:4:\"tabs\";s:3:\"all\";s:7:\"toolbar\";s:4:\"full\";s:12:\"media_upload\";i:1;s:5:\"delay\";i:0;}', 'Текст', 'текст-мод2', 'publish', 'closed', 'closed', '', 'field_62458b094139d', '', '', '2022-04-05 21:42:47', '2022-04-05 18:42:47', '', 168, 'http://0026urotec.loc:8888/?post_type=acf-field&#038;p=231', 13, 'acf-field', '', 0),
(232, 1, '2022-03-31 14:26:37', '2022-03-31 11:26:37', 'a:10:{s:4:\"type\";s:7:\"wysiwyg\";s:12:\"instructions\";s:0:\"\";s:8:\"required\";i:0;s:17:\"conditional_logic\";i:0;s:7:\"wrapper\";a:3:{s:5:\"width\";s:0:\"\";s:5:\"class\";s:0:\"\";s:2:\"id\";s:0:\"\";}s:13:\"default_value\";s:0:\"\";s:4:\"tabs\";s:3:\"all\";s:7:\"toolbar\";s:5:\"basic\";s:12:\"media_upload\";i:0;s:5:\"delay\";i:0;}', 'Текст вверху', 'текст_вверху', 'publish', 'closed', 'closed', '', 'field_62458fbbf228d', '', '', '2022-04-05 21:38:32', '2022-04-05 18:38:32', '', 168, 'http://0026urotec.loc:8888/?post_type=acf-field&#038;p=232', 11, 'acf-field', '', 0),
(233, 1, '2022-03-31 14:35:31', '2022-03-31 11:35:31', 'a:10:{s:4:\"type\";s:8:\"repeater\";s:12:\"instructions\";s:0:\"\";s:8:\"required\";i:0;s:17:\"conditional_logic\";i:0;s:7:\"wrapper\";a:3:{s:5:\"width\";s:0:\"\";s:5:\"class\";s:0:\"\";s:2:\"id\";s:0:\"\";}s:9:\"collapsed\";s:0:\"\";s:3:\"min\";s:0:\"\";s:3:\"max\";s:0:\"\";s:6:\"layout\";s:5:\"block\";s:12:\"button_label\";s:0:\"\";}', 'Столбик', 'столбик', 'publish', 'closed', 'closed', '', 'field_624591aa67a0b', '', '', '2022-04-05 21:42:47', '2022-04-05 18:42:47', '', 168, 'http://0026urotec.loc:8888/?post_type=acf-field&#038;p=233', 12, 'acf-field', '', 0),
(235, 1, '2022-03-31 14:35:31', '2022-03-31 11:35:31', 'a:10:{s:4:\"type\";s:8:\"textarea\";s:12:\"instructions\";s:0:\"\";s:8:\"required\";i:0;s:17:\"conditional_logic\";i:0;s:7:\"wrapper\";a:3:{s:5:\"width\";s:0:\"\";s:5:\"class\";s:0:\"\";s:2:\"id\";s:0:\"\";}s:13:\"default_value\";s:0:\"\";s:11:\"placeholder\";s:0:\"\";s:9:\"maxlength\";s:0:\"\";s:4:\"rows\";i:1;s:9:\"new_lines\";s:0:\"\";}', 'Заголовок', 'заголовок', 'publish', 'closed', 'closed', '', 'field_624591cd67a0d', '', '', '2022-03-31 14:38:52', '2022-03-31 11:38:52', '', 233, 'http://0026urotec.loc:8888/?post_type=acf-field&#038;p=235', 0, 'acf-field', '', 0),
(236, 1, '2022-03-31 14:35:31', '2022-03-31 11:35:31', 'a:10:{s:4:\"type\";s:7:\"wysiwyg\";s:12:\"instructions\";s:0:\"\";s:8:\"required\";i:0;s:17:\"conditional_logic\";i:0;s:7:\"wrapper\";a:3:{s:5:\"width\";s:0:\"\";s:5:\"class\";s:0:\"\";s:2:\"id\";s:0:\"\";}s:13:\"default_value\";s:0:\"\";s:4:\"tabs\";s:3:\"all\";s:7:\"toolbar\";s:4:\"full\";s:12:\"media_upload\";i:1;s:5:\"delay\";i:0;}', 'Текст', 'текст', 'publish', 'closed', 'closed', '', 'field_624591eb67a0e', '', '', '2022-03-31 14:38:52', '2022-03-31 11:38:52', '', 233, 'http://0026urotec.loc:8888/?post_type=acf-field&#038;p=236', 1, 'acf-field', '', 0),
(237, 1, '2022-03-31 14:47:14', '2022-03-31 11:47:14', '', 'modal-row-img-1', '', 'inherit', 'open', 'closed', '', 'modal-row-img-1', '', '', '2022-03-31 14:47:14', '2022-03-31 11:47:14', '', 0, 'http://0026urotec.loc:8888/wp-content/uploads/2022/03/modal-row-img-1.png', 0, 'attachment', 'image/png', 0);
INSERT INTO `urotec_posts` (`ID`, `post_author`, `post_date`, `post_date_gmt`, `post_content`, `post_title`, `post_excerpt`, `post_status`, `comment_status`, `ping_status`, `post_password`, `post_name`, `to_ping`, `pinged`, `post_modified`, `post_modified_gmt`, `post_content_filtered`, `post_parent`, `guid`, `menu_order`, `post_type`, `post_mime_type`, `comment_count`) VALUES
(238, 1, '2022-03-31 14:47:31', '2022-03-31 11:47:31', '', 'modal-row-img-2', '', 'inherit', 'open', 'closed', '', 'modal-row-img-2', '', '', '2022-03-31 14:47:31', '2022-03-31 11:47:31', '', 0, 'http://0026urotec.loc:8888/wp-content/uploads/2022/03/modal-row-img-2.png', 0, 'attachment', 'image/png', 0),
(239, 1, '2022-03-31 14:48:33', '2022-03-31 11:48:33', '', 'modal-row-img-3', '', 'inherit', 'open', 'closed', '', 'modal-row-img-3', '', '', '2022-03-31 14:48:33', '2022-03-31 11:48:33', '', 0, 'http://0026urotec.loc:8888/wp-content/uploads/2022/03/modal-row-img-3.png', 0, 'attachment', 'image/png', 0),
(240, 1, '2022-03-31 15:43:32', '2022-03-31 12:43:32', '<!-- wp:heading {\"level\":3} -->\n<h3>Торговое название</h3>\n<!-- /wp:heading -->\n\n<!-- wp:paragraph -->\n<p>Урорек</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:heading {\"level\":3} -->\n<h3>Международное непатентованное название</h3>\n<!-- /wp:heading -->\n\n<!-- wp:paragraph -->\n<p>Силодозин</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:heading {\"level\":3} -->\n<h3>Лекарственная форма</h3>\n<!-- /wp:heading -->\n\n<!-- wp:paragraph -->\n<p>Капсулы твердые 4 мг, 8 мг</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:heading {\"level\":3} -->\n<h3>Состав</h3>\n<!-- /wp:heading -->\n\n<!-- wp:paragraph -->\n<p>Одна таблетка содержит</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p><em>активное вещество</em>&nbsp;- силодозин 4.0 мг; 8.0 мг;</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p><em>вспомогательные вещества</em>: маннитол, крахмал прежелатинизированый (состоит из: крахмала прежелатинизированного (кукурузного) (Starch 1500ТМ) и крахмала прежелатинизированного (кукурузного) (РСSТМ РС-10)), натрия лаурилсульфат, магния стеарат;</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p><em>состав желатиновой капсулы</em>&nbsp;<em>для дозировки 4 мг</em>: желатин, титана диоксид (Е 171), железа (III) оксид желтый (Е 172).</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p><em>состав желатиновой капсулы</em>&nbsp;<em>для дозировки 8 мг</em>: желатин, титана диоксид (Е 171).</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:heading {\"level\":3} -->\n<h3>Описание</h3>\n<!-- /wp:heading -->\n\n<!-- wp:paragraph -->\n<p>Твердые желатиновые капсулы желтого цвета размером № 3. Содержимое капсул – мелкокристаллический порошок от белого до светло-желтого цвета (для дозировки 4 мг).</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>Твердые желатиновые капсулы белого цвета размером № 0. Содержимое капсул – мелкокристаллический порошок от белого до светло-желтого цвета (для дозировки 8 мг).</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:heading {\"level\":3} -->\n<h3>Фармакотерапевтическая группа</h3>\n<!-- /wp:heading -->\n\n<!-- wp:paragraph -->\n<p>Препараты для лечения доброкачественной гипертрофии простаты. Альфа-адреноблокаторы. Силодозин.</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>Код АТХ G04CA04</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:heading {\"level\":3} -->\n<h3>Фармакологические свойства</h3>\n<!-- /wp:heading -->\n\n<!-- wp:paragraph -->\n<p><em><strong>Фармакокинетика</strong></em></p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>Фармакокинетика силодозина и его основных метаболитов оценивалась у взрослых мужчин с и без доброкачественной гиперплазии предстательной железы после однократного и многократного применения в дозах от 0.1 мг до 48 мг в сутки. Фармакокинетика силодозина является линейной во всем диапазоне доз.</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>Действие основного метаболита в плазме, глюкуронида силодозина (KMD‑3213G), при равновесном состоянии приблизительно в 3 раза больше, чем действие исходного вещества. Силодозин и его глюкуронид достигают равновесного состояния через 3 и 5 дней лечения, соответственно.</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>Всасывание</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>Силодозин хорошо всасывается после перорального приема, абсорбция пропорциональна дозе. Абсолютная биодоступность составляет около 32 %. Пища снижает максимальную концентрацию (Сmax) примерно на 30 %, увеличивая время достижения максимальной концентрации (tmax) примерно до 1 ч и оказывает минимальное влияние на площадь под кривой «концентрация-время» (АUС). После перорального приема 8 мг один раз в день сразу после завтрака в течение 7 дней отмечены следующие фармакокинетические параметры: Сmax- 87±51 ng/ml (sd), tmax 2.5&nbsp;часов (диапазон 1.0-3.0), AUC - 433±286 ng&nbsp;•&nbsp;h/ml.</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>Распределение</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>Объем распределения силодозина составляет 0,81 л/кг, связывание с белками плазмы составляет 96,6 %. Силодозин метаболизируется по­средством глюкуронирования (с участием UGТ2В7), с участием алкогольдегидрогеназы и альдегид- дегидрогеназы, окислительных пу­тей, в основном с участием СYРЗА4. Основной активный метаболит в плазме карбамоил- глюкуронид (КМD-3213G) достигает плазменной концентрации в 4 раза большей, чем сам силодозин. Связывание силодозина глюкуронида с белками плазмы составляет 91 %. Силодозин не обладает потенциалом индукции или ингибирования изоферментов цитохрома Р450.</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>Выведение</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>После перорального применения 14C‑маркированного силодозина, выведение радиоактивных веществ через 7 дней было, около 33,5 % силодозина выводится через почки и 54,9 % через кишечник. Клиренс силодозина составляет около 0,28 л/ч/кг. Силодозин экскретируется в основном в виде метаболитов и в очень малом количестве в неизмененном виде с мочой. Конечный период полувыведения Т1/2 силодозина и глюкуронида составляет 11 часов и 18 часов соответственно.</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>Особые группы пациентов</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p><em>Пациенты пожилого возраста</em></p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>Фармакокинетика силодозина и его основных метаболитов значительно не менялось у пожилых пациентов, клиренс силодозина не меняется у пациентов старше 75 лет.</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p><em>Применение в педиатрии</em>.</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>Лекарственное средство не рекомендуется детям и подросткам до 18 лет ввиду отсутствия данных по безопасности и эффективности.</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p><em>Печеночная недостаточность</em></p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>В исследовании однократной дозы фармакокинетики силодозина не менялось у 9 пациентов с печеночной недостаточностью средней степени (7-9 по шкале Чайлда-Пью) в сравнении с 9 здоровыми добровольцами. По результатам этого исследования следует применять с осторожностью, поскольку у пациентов были нормальные биохимические показатели, что указывает на нормальную метаболическую функцию, и их отнесли к категории пациентов с печеночной недостаточностью средней степени на основе асцита и печеночной энцефалопатии.</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p><em>Почечная недостаточность</em></p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>В исследовании однократной дозы действие силодозина (несвязанного) у пациентов с легкой степенью (n=8) и средней степенью почечной недостаточности (n=8) привело к повышению максимальной концентрации в 1.6 раза и средней концентрации препарата в моче в 1.7 раза в сравнении с пациентами с нормальной почечной функцией (n=8). У пациентов с тяжелой степенью почечной недостаточности (n=5) максимальная концентрация повышалась в 2.2 раза и средняя концентрация препарата в моче - в 3.7 раза. Действие основных метаболитов, глюкуронида силодозина и KMD3293, также усиливалось. Поскольку имеются только ограниченные данные в отношении применения препарата пациентами с почечной недостаточностью средней степени (n=35), рекомендуется начинать с уменьшенной дозы 4 мг.</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>Для пациентов с легкой почечной недостаточностью (клиренс креатинина &gt; 50 - &lt; 80 мл/мин) не требуется коррекция дозы. Для пациентов с почечной недоста­точностью средней степени тяжести (клиренс креатинина &gt; 30 &lt; 50 мл/мин) рекомендуется низкая начальная доза - 4 мг. Для пациентов с тяжелой почечной недоста­точностью (клиренс креатинина &lt;30 мл/мин) назначение силодозина не рекомендуется.</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p><em><strong>Фармакодинамика</strong></em></p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>Силодозин является высокоселективным для α1A адренорецепторов, которые находятся, главным образом, в предстательной железе, шейке мочевого пузыря, капсуле предстательной железы и в предстательной части уретры. Блокирование этих α1A адренорецепторов вызывает расслабление гладких мышц этих тканей, что уменьшает сопротивление выходного отверстия мочевого пузыря, не влияя на сокращение гладких мышц-сжимателей. Это вызывает развитие раздражающего и обструктивного симптомов (симптомов со стороны нижних мочевыводящих путей), связанных с доброкачественной гиперплазией предстательной железы.</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>Силодозин обладает более низким сродством для α1B адренорецепторов, которые, главным образом, находятся в сердечно-сосудистой системе.</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>В исследованиях<em>&nbsp;</em><em>in</em><em>&nbsp;</em><em>vitro</em><em>&nbsp;</em>было показано, что сродство силодозина к α1A-адренорецепторам в 162 раза превосходит его способность взаимодействовать с α1В -адренорецепторами, которые расположены в гладких мышцах сосудов.&nbsp;<em>Клиническая эффективность и безопасность</em></p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>Свыше 800 пациентов с симптомами доброкачественной гиперплазии предстательной железы средней и тяжелой степени (по международной шкале оценки простатических симптомов, исходное значение≥13) принимали силодозин 8 мг один раз в сутки в двух плацебо контролируемых клинических исследованиях этапа III, проведенных в США, и в одном плацебо контролируемом и контролируемом по действующему препарату клиническом исследовании, проведенном в Европе. Во всех исследованиях пациентов, которые не реагировали на плацебо в течение 4 недель вводной фазы применения плацебо, методом случайной выборки отобрали для лечения препаратом – объектом исследования. Во всех исследованиях у пациентов, принимавших силодозин, быстрее уменьшались раздражающий и обструктивный симптомы, связанные с доброкачественной гиперплазией предстательной железы, в сравнении с плацебо по оценкам через 12 недель лечения.</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>В клиническом исследовании, контролируемом по действующему препарату, которое было проведено в Европе, применение 8 мг силодозина один раз в сутки не уступало применению тамсулозина 0.4 мг один раз в сутки: средняя откорректированная разница (95 % CI) в общем бале по шкале IPSS между лечением пациентов «без нарушения протокола», была 0.4 (от 0.4 до 1.1). Частота положительного ответа на лечение (т.е. улучшение общего балла по шкале IPSS минимум на 25 %) была значительно выше при применении силодозина (68 %) и тамсулозина (65 %), в сравнении с плацебо (53 %).</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>На долгосрочной открытой фазе дополнительного лечения этих контролируемых исследований, в которых пациенты принимали силодозин до 1 года, облегчение симптомов, вызванное силодозином на 12 неделе лечения, поддерживалось в течение 1 года.</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>На фазе IV клинического исследования, которое было проведено в Европе, со средним исходным общим баллом IPSS 18.9 пунктов, 77.1% пациентов отреагировали на силодозин (по оценкам изменения исходного значения общего балла IPSS не менее, чем на 25%). Приблизительно половина пациентов сообщала об облегчении большинства симптомов, на которые жаловались пациенты (т.е. частое мочеиспускание, ночные позывы, императивные позывы к мочеиспусканию, капельное выделение мочи и неполное опустошение мочевого пузыря), по оценкам опросников ICS-почты.</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>Значительное снижение артериального давления в положении лёжа на спине не наблюдалось во всех клинических исследованиях, которые были проведены в отношении силодозина.</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>Силодозин 8 мг и 24 мг в сутки не оказывал статистически значимого действия на интервалы ЭКГ или сердечную реполяризацию в отношении плацебо.</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>Блокада α1A -адренорецепторов снижает тонус гладкой мускулатуры в этих тканях, что ведет к улучшению оттока мочи из мочевого пузыря. Одновременно уменьшаются симпто­мы обструкции и раздражения, связанные с доброкачественной гиперплазией предстательной железы. Благодаря высокой селективности силодозин не вызывает клинически значимого снижения артериального давления (АД) у пациентов с исходно нормальным АД.</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:heading {\"level\":3} -->\n<h3>Показания к применению</h3>\n<!-- /wp:heading -->\n\n<!-- wp:paragraph -->\n<p>- лечение признаков и симптомов доброкачественной гиперплазии предстательной железы у взрослых мужчин.</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:heading {\"level\":3} -->\n<h3>Способ применения и дозы</h3>\n<!-- /wp:heading -->\n\n<!-- wp:paragraph -->\n<p>Капсулу следует принимать во время еды, предпочтительно в одно и то же время суток. Капсулу не следует крошить или жевать, капсулу необходимо проглатывать целиком, запивая стаканом воды.</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>Рекомендованная доза – по 1 капсуле Урорека 8 мг в сутки. Для отдельных категорий пациентов рекомендуется одна капсула Урорека 4 мг в сутки</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p><em>Пациенты пожилого возраста</em></p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>Для пациентов пожилого возраста корректировка дозы не требуется</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p><em>Почечная недостаточность</em></p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>Для пациентов с легкой степенью почечной недостаточности (клиренс креатинина ≥от 50 до ≤80&nbsp;мл/мин) корректировка дозы не требуется.</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>Для пациентов со средней степенью почечной недостаточности (клиренс креатинина ≥от 30 до &lt;50&nbsp;мл/мин) рекомендуется начинать с дозы 4 мг в сутки, по истечении одной недели можно увеличить дозу до 8 мг в сутки, в зависимости от реакции пациента. Использование препарата для пациентов с тяжелой степенью почечной недостаточности (клиренс креатинина &lt;30&nbsp;мл/мин) корректировка дозы не требуется.</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p><em>Печеночная недостаточность</em></p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>Для пациентов с легкой и средней степенью печеночной недостаточности корректировка дозы не требуется.</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>Поскольку данные отсутствуют, использование препарата пациентами с тяжелой степенью печеночной недостаточности не рекомендуется.</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:heading {\"level\":3} -->\n<h3>Побочные действия</h3>\n<!-- /wp:heading -->\n\n<!-- wp:paragraph -->\n<p>Безопасность силодозина оценивалась в четырех двойных слепых контролируемых клинических исследованиях II‑III фаз (с участием 931 пациента, которые принимали силодозин 8 мг один раз в сутки, и 733 пациентов, которые принимали плацебо) и в двух долгосрочных открытых исследованиях продленной фазы. В целом, 1,581 пациентов принимали силодозин в дозе 8 мг один раз в сутки. Из них 961 пациентов принимали препарат в течение 6 месяцев и 384 пациентов – в течение 1 года.</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>Самыми частыми побочными реакциями, о которых сообщалось в плацебо контролируемых клинических исследованиях при долгосрочном применении силидозина, были нарушения эякуляции, а именно, обратная эякуляция и анэякуляция (уменьшения объема эякуляции или ее отсутствие), с частотой 23%. Это может временно влиять на способность к зачатию. Такие нарушения исчезают через несколько дней после прекращения лечения.</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>Ниже перечислены нежелательные побочные реакции, отмеченные во всех клинических исследованиях и на протяжении международного постмаркетингового опыта применения, в отношении которых существует причинно-следственная связь, согласно классификации MedDRA в соответствии с поражением органов и систем органов и частотой развития: очень часто (≥1/10); часто (≥1/100 to &lt;1/10); нечасто (≥1/1,000 to &lt;1/100); редко (≥1/10,000 до &lt;1/1,000); очень редко (&lt;1/10,000), не известно (невозможно оценить по имеющимся данным). В каждой группы наблюдавшиеся побочные реакции представлены в порядке снижения степени серьезности.</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p><em>Очень часто</em></p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>- нарушения эякуляции, включая обратную эякуляцию и анаэкуляцию</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p><em>Часто</em></p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>- головокружение, ортостатическая гипотензия</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>- заложенность носа,</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>- диарея</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p><em>Нечасто</em></p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>- снижение либидо</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>- тахикардия1</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>- гипотензия1</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>- тошнота, сухость во рту</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>- ненормальные печеночные пробы1</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>- кожная сыпь1, зуд1, крапивница1, лекарственная сыпь1</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>- эректильная дисфункция</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p><em>Редко</em></p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>- обморок, потеря сознания1</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>- учащенная пульсация1</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p><em>Очень редко</em></p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>- аллергические реакции, включая отечность лица, проглатывание языка и отек глотки1</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p><em>Не известно</em></p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>- интраоперационный синдром дряблой радужки</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>1 – побочные реакции по добровольным отчетам в процессе международного пострегистрационного применения препарата (частота рассчитывалась по случаям, описанным в клинических исследованиях фазы I-IV и в неинтервенционных исследованиях).</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>Описание отдельных побочных реакций</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p><em>Ортостатическая гипотензия</em></p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>Частота возникновения ортостатической гипотензии в плацебо контролируемых клинических исследованиях была 1.2% при применении силодозина и 1.0% при применении плацебо. Ортостатическая гипотензия иногда приводила к обморокам.</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p><em>Интраоперационный синдром дряблой радужки</em><em>&nbsp;(</em><em>IFIS</em><em>)</em></p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>Об IFIS сообщалось по результатам хирургических операций по поводу катаракты.</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>Отчеты о подозреваемых побочных реакциях</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>Сообщение о подозреваемых побочных реакциях после регистрации медицинского препарата очень важно. Оно позволяет продолжать контролировать соотношение польза/риск медицинского препарата</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:heading {\"level\":3} -->\n<h3>Противопоказания</h3>\n<!-- /wp:heading -->\n\n<!-- wp:paragraph -->\n<p>- повышенная чувствительность к действующему веществу или к какому-либо вспомогательному веществу</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:list -->\n<ul><li>ортостатическая гипотензия в анамнезе</li><li>печеночная недостаточность</li></ul>\n<!-- /wp:list -->\n\n<!-- wp:paragraph -->\n<p>- детский возраст до 18 лет</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>- почечная недостаточность (клиренс креатинина менее 10 мл/мин)</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:heading {\"level\":3} -->\n<h3>Лекарственные взаимодействия</h3>\n<!-- /wp:heading -->\n\n<!-- wp:paragraph -->\n<p>Силодозин активно метаболизируется, особенно через CYP3A4, алкогольдегидразу и UGT2B7. Силодозин также является субстратом для P-гликопротеина. Вещества, которые подавляют (например, кетоконазол, итраконазол, ритонавир или циклоспорин) или вызывают появление (например, рифампицин, барбитураты, карбамазепин, фенитоин) таких ферментов и транспортеров, могут влиять на концентрацию силодозина и его активного метаболита в плазме.</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>Альфа-блокаторы</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>Соответствующая информация о безопасном применении силодозина вместе с другими антагонистами α‑адренорецепторов отсутствует. Следовательно, одновременное применение других антагонистов α‑адренорецепторов не рекомендуется.</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>Ингибиторы CYP3A4</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>В исследовании лекарственного взаимодействия, при одновременном применении силодозина и высокоактивного ингибитора CYP3A4 (кетоконазола 400 мг) наблюдалось повышение максимальных концентраций силодозина в плазме в 3.7 раза и повышение времени воздействия силодозина в 3.1 раза (средней концентрации в моче). Не рекомендуется одновременное применение высокоактивных ингибиторов CYP3A4 (например, кетоконазола, итраконазола, ритонавира или циклоспорина).</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>При одновременном применении силодозина и ингибитора CYP3A4 средней степени активности, например, дилтиазема, наблюдалось увеличение средней концентрации силодозина в моче приблизительно на 30%, однако максимальная концентрация и период полураспада не изменялись. Это изменение не имеет клинического значения, поэтому корректировка дозы не требуется.</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>Ингибиторы PDE‑5</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>Минимальные фармакодинамические взаимодействия наблюдались между силодозином и максимальными дозами силденафила или тадалафила. В плацебо контролируемом исследовании на 24 субъектах в возрасте 45-78 лет, которые получали силодозин, одновременное применение силденафила 100 мг или тадалафила 20 мг не вызывало клинически значимого уменьшения среднего систолического или диастолического кровяного давления по оценкам ортостатических исследований (стоя и лёжа). У субъектов старше 65 лет, среднее уменьшение в различных точках времени было между 5 и 15 мм рт. ст. (систолического) и между 0 и 10 мм рт. ст. (диастолического). Положительные ортостатические пробы были лишь немного более частыми во время одновременного применения лекарственных препаратов; однако, головокружение или другие симптомы не наблюдались. Состояние пациентов, принимающих ингибиторы PDE‑5 одновременно с силодозином, должно контролироваться на предмет возможных побочных реакций.</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>Гипотензивные препараты</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>В программе клинического исследования многие пациенты одновременно принимали гипотензивные препараты (большинство из них действовало на ренин-ангиотензиновую систему, бета-блокаторы, антагонисты кальция и диуретики) без повышения частоты ортостатической гипотензии. Тем не менее, рекомендуется проявлять осторожность при одновременном применении препарата с гипотензивными препаратами и контролировать состояние пациентов на предмет возможных побочных реакций.</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>Дигоксин</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>Равновесные уровни дигоксина, субстрата P‑гликопротеина, значительно не изменялись в результате одновременного применения силодозина 8 мг один раз в сутки. Корректировка дозы не требовалась.</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:heading {\"level\":3} -->\n<h3>Особые указания</h3>\n<!-- /wp:heading -->\n\n<!-- wp:paragraph -->\n<p>Интраоперационный синдром дряблой радужки (IFIS)</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>IFIS (разновидность синдрома узкого зрачка) наблюдался во время хирургической операции по удалению катаракты у некоторых пациентов, принимающих α1‑блокаторы или ранее принимавших α1‑блокаторы. Это может осложнять подобные операции.</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>Не рекомендуется начинать лечение силодозином для пациентов, которым планируется провести хирургическую операцию по поводу катаракты. Рекомендуется прекращать лечение α1‑блокаторами за 1-2 недели до хирургической операции, однако, преимущества и продолжительность прекращения лечения до хирургической операции по поводу катаракты не установлены.</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>Во время оценки до проведения хирургической операции хирурги-офтальмологи и другие специалисты по офтальмологии должны учитывать, принимают ли пациенты, которым предстоит хирургическая операция по поводу катаракты, силодозин, чтобы обеспечить принятие соответствующих мер в отношении IFIS во время операции.</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>Ортостатическое действие</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>Частота ортостатического действия силодозина очень низкая. Однако у некоторых пациентов может произойти снижение кровяного давления, что в редких случаях приводит к обморокам. При первых признаках ортостатической гипотензии (например, постуральное головокружение), пациенту следует сесть или лечь, и оставаться в таком положении до тех пор, пока симптомы не исчезнут. Пациентам с ортостатической гипотензией лечение силодозином не рекомендовано.</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>Почечная недостаточность</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>Пациентам с тяжелой почечной недостаточностью (CLCR &lt;30&nbsp;мл/мин) лечение силодозином не рекомендуется.</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>Печеночная недостаточность</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>Поскольку данные в отношении применения препарата пациентами с тяжелой степенью печеночной недостаточности отсутствуют, использование силодозина такими пациентами не рекомендуется.</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>Рак предстательной железы</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>Поскольку у ДГПЖ и рака предстательной железы одинаковые симптомы, и они могут сосуществовать, пациенты, у которых подозревается ДГПЖ, должны пройти обследование до начала лечения силодозином, чтобы исключить рак предстательной железы. Пальцевое ректальное исследование и, если необходимо, определение простатического специфического антигена (PSA) должно быть выполнено перед началом лечения, и должно регулярно повторяться после этого.</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>Лечение силодозином приводит к уменьшению количества спермы во время оргазма, что может временно влиять на оплодотворяющую способность спермы. Такое действие прекращается после прекращения применения силодозина.</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p><em>Беременность и грудное вскармливание</em></p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>Силодозин предназначен только для мужчин.</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p><em>Фертильность</em></p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>В клинических исследованиях при применении силодозина наблюдалась эякуляция с пониженным количеством спермы или без спермы из-за фармакодинамических особенностей силодозина. Перед началом лечения пациента необходимо проинформировать о том, что это может произойти, и о том, что препарат влияет на оплодотворяющую способность спермы.</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p><em>Особенности влияния лекарственного средства на&nbsp;&nbsp;&nbsp;способность управлять транспортным средством или&nbsp;&nbsp;потенциально опасными механизмами</em></p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>Урорек в незначительной или в средней степени может повлиять на способность управлять транспортными средствами и механизмами. Пациентов необходимо проинформировать о возможных симптомах, связанных с постуральной гипотензией (головокружение), и о том, что они должны быть осторожны в управлении транспортными средствами и механизмами.</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:heading {\"level\":3} -->\n<h3>Передозировка</h3>\n<!-- /wp:heading -->\n\n<!-- wp:paragraph -->\n<p><em>Симптомы:</em>&nbsp;тяжелая артериальная гипотензия.</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p><em>Лечение:</em>&nbsp;Применение силодозина в дозах до 48 мг/сутки оценивалось у здоровых мужчин. Постуральная гипотензия была побочной реакцией, ограничивающей дозу. Если прием препарата произошел недавно, эффективным будет промывание желудка. Если передозировка силодозина привела к гипотензии, необходимо провести сердечно-легочную реанимацию. Диализ, маловероятно, будет эффективным, поскольку силодозин высоко (96.6%) связывается с белками.</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:heading {\"level\":3} -->\n<h3>Форма выпуска и упаковка</h3>\n<!-- /wp:heading -->\n\n<!-- wp:paragraph -->\n<p>По 10 капсул помещают в контурную ячейковую упаковку из непрозрачной пленки ПВХ/ПВДХ и фольги алюминиевой.</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>По 1, 3 или 5 контурных ячейковых упаковок вместе с инструкцией по медицинскому применению на государственном и русском языках помещают в пачку из картона.</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:heading {\"level\":3} -->\n<h3>Условия хранения</h3>\n<!-- /wp:heading -->\n\n<!-- wp:paragraph -->\n<p>Хранить в сухом, защищенном от света месте, при температуре не выше 30 0С, в оригинальной упаковке.</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>Хранить в недоступном для детей месте.</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:heading {\"level\":3} -->\n<h3>Срок хранения</h3>\n<!-- /wp:heading -->\n\n<!-- wp:paragraph -->\n<p>3 года</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>Не применять по истечении срока годности.</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:heading {\"level\":3} -->\n<h3>Условия отпуска из аптек</h3>\n<!-- /wp:heading -->\n\n<!-- wp:paragraph -->\n<p>По рецепту</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:heading {\"level\":3} -->\n<h3>Производитель</h3>\n<!-- /wp:heading -->\n\n<!-- wp:paragraph -->\n<p>«Recordati Industria Chimica е Farmaceutica&nbsp;S.P.A.»</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>Via M. Civitali 1, 20148, Milan, Italy / Виа М. Чивитали 1, 20148, Милан, Италия</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:heading {\"level\":3} -->\n<h3>Владелец регистрационного удостоверения</h3>\n<!-- /wp:heading -->\n\n<!-- wp:paragraph -->\n<p>«Recordati Ireland Ltd.»</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>Raheens East Ringaskiddy, Co. Cork, Ireland / Рахинз Ист, Рингаскидди, Ко. Корк, Ирландия</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p><strong>Адрес организации, принимающей на территории Республики Казахстан претензии от потребителей по качеству продукции</strong></p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>Представительство ТОО «FIC MEDICAL» (ФИК МЕДИКАЛЬ) в Республике Казахстан, ул. Толе би 69, офис 33, 050000, Алматы, Казахстан</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>тел.: +7 (727) 272 93 08, факс: +7 (727) 272 90 25</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>e-mail: fic_kz@ficmedical.kz</p>\n<!-- /wp:paragraph -->', 'Инструкция к препарату', '', 'publish', 'closed', 'closed', '', 'instrukciya-k-preparatu', '', '', '2022-03-31 15:50:54', '2022-03-31 12:50:54', '', 0, 'http://0026urotec.loc:8888/?page_id=240', 0, 'page', '', 0);
INSERT INTO `urotec_posts` (`ID`, `post_author`, `post_date`, `post_date_gmt`, `post_content`, `post_title`, `post_excerpt`, `post_status`, `comment_status`, `ping_status`, `post_password`, `post_name`, `to_ping`, `pinged`, `post_modified`, `post_modified_gmt`, `post_content_filtered`, `post_parent`, `guid`, `menu_order`, `post_type`, `post_mime_type`, `comment_count`) VALUES
(241, 1, '2022-03-31 15:43:32', '2022-03-31 12:43:32', '<!-- wp:heading {\"level\":3} -->\n<h3>Торговое название</h3>\n<!-- /wp:heading -->\n\n<!-- wp:paragraph -->\n<p>Урорек</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:heading {\"level\":3} -->\n<h3>Международное непатентованное название</h3>\n<!-- /wp:heading -->\n\n<!-- wp:paragraph -->\n<p>Силодозин</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:heading {\"level\":3} -->\n<h3>Лекарственная форма</h3>\n<!-- /wp:heading -->\n\n<!-- wp:paragraph -->\n<p>Капсулы твердые 4 мг, 8 мг</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:heading {\"level\":3} -->\n<h3>Состав</h3>\n<!-- /wp:heading -->\n\n<!-- wp:paragraph -->\n<p>Одна таблетка содержит</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p><em>активное вещество</em>&nbsp;- силодозин 4.0 мг; 8.0 мг;</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p><em>вспомогательные вещества</em>: маннитол, крахмал прежелатинизированый (состоит из: крахмала прежелатинизированного (кукурузного) (Starch 1500ТМ) и крахмала прежелатинизированного (кукурузного) (РСSТМ РС-10)), натрия лаурилсульфат, магния стеарат;</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p><em>состав желатиновой капсулы</em>&nbsp;<em>для дозировки 4 мг</em>: желатин, титана диоксид (Е 171), железа (III) оксид желтый (Е 172).</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p><em>состав желатиновой капсулы</em>&nbsp;<em>для дозировки 8 мг</em>: желатин, титана диоксид (Е 171).</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:heading {\"level\":3} -->\n<h3>Описание</h3>\n<!-- /wp:heading -->\n\n<!-- wp:paragraph -->\n<p>Твердые желатиновые капсулы желтого цвета размером № 3. Содержимое капсул – мелкокристаллический порошок от белого до светло-желтого цвета (для дозировки 4 мг).</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>Твердые желатиновые капсулы белого цвета размером № 0. Содержимое капсул – мелкокристаллический порошок от белого до светло-желтого цвета (для дозировки 8 мг).</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:heading {\"level\":3} -->\n<h3>Фармакотерапевтическая группа</h3>\n<!-- /wp:heading -->\n\n<!-- wp:paragraph -->\n<p>Препараты для лечения доброкачественной гипертрофии простаты. Альфа-адреноблокаторы. Силодозин.</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>Код АТХ G04CA04</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:heading {\"level\":3} -->\n<h3>Фармакологические свойства</h3>\n<!-- /wp:heading -->\n\n<!-- wp:paragraph -->\n<p><em><strong>Фармакокинетика</strong></em></p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>Фармакокинетика силодозина и его основных метаболитов оценивалась у взрослых мужчин с и без доброкачественной гиперплазии предстательной железы после однократного и многократного применения в дозах от 0.1 мг до 48 мг в сутки. Фармакокинетика силодозина является линейной во всем диапазоне доз.</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>Действие основного метаболита в плазме, глюкуронида силодозина (KMD‑3213G), при равновесном состоянии приблизительно в 3 раза больше, чем действие исходного вещества. Силодозин и его глюкуронид достигают равновесного состояния через 3 и 5 дней лечения, соответственно.</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>Всасывание</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>Силодозин хорошо всасывается после перорального приема, абсорбция пропорциональна дозе. Абсолютная биодоступность составляет около 32 %. Пища снижает максимальную концентрацию (Сmax) примерно на 30 %, увеличивая время достижения максимальной концентрации (tmax) примерно до 1 ч и оказывает минимальное влияние на площадь под кривой «концентрация-время» (АUС). После перорального приема 8 мг один раз в день сразу после завтрака в течение 7 дней отмечены следующие фармакокинетические параметры: Сmax- 87±51 ng/ml (sd), tmax 2.5&nbsp;часов (диапазон 1.0-3.0), AUC - 433±286 ng&nbsp;•&nbsp;h/ml.</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>Распределение</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>Объем распределения силодозина составляет 0,81 л/кг, связывание с белками плазмы составляет 96,6 %. Силодозин метаболизируется по­средством глюкуронирования (с участием UGТ2В7), с участием алкогольдегидрогеназы и альдегид- дегидрогеназы, окислительных пу­тей, в основном с участием СYРЗА4. Основной активный метаболит в плазме карбамоил- глюкуронид (КМD-3213G) достигает плазменной концентрации в 4 раза большей, чем сам силодозин. Связывание силодозина глюкуронида с белками плазмы составляет 91 %. Силодозин не обладает потенциалом индукции или ингибирования изоферментов цитохрома Р450.</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>Выведение</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>После перорального применения 14C‑маркированного силодозина, выведение радиоактивных веществ через 7 дней было, около 33,5 % силодозина выводится через почки и 54,9 % через кишечник. Клиренс силодозина составляет около 0,28 л/ч/кг. Силодозин экскретируется в основном в виде метаболитов и в очень малом количестве в неизмененном виде с мочой. Конечный период полувыведения Т1/2 силодозина и глюкуронида составляет 11 часов и 18 часов соответственно.</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>Особые группы пациентов</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p><em>Пациенты пожилого возраста</em></p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>Фармакокинетика силодозина и его основных метаболитов значительно не менялось у пожилых пациентов, клиренс силодозина не меняется у пациентов старше 75 лет.</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p><em>Применение в педиатрии</em>.</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>Лекарственное средство не рекомендуется детям и подросткам до 18 лет ввиду отсутствия данных по безопасности и эффективности.</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p><em>Печеночная недостаточность</em></p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>В исследовании однократной дозы фармакокинетики силодозина не менялось у 9 пациентов с печеночной недостаточностью средней степени (7-9 по шкале Чайлда-Пью) в сравнении с 9 здоровыми добровольцами. По результатам этого исследования следует применять с осторожностью, поскольку у пациентов были нормальные биохимические показатели, что указывает на нормальную метаболическую функцию, и их отнесли к категории пациентов с печеночной недостаточностью средней степени на основе асцита и печеночной энцефалопатии.</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p><em>Почечная недостаточность</em></p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>В исследовании однократной дозы действие силодозина (несвязанного) у пациентов с легкой степенью (n=8) и средней степенью почечной недостаточности (n=8) привело к повышению максимальной концентрации в 1.6 раза и средней концентрации препарата в моче в 1.7 раза в сравнении с пациентами с нормальной почечной функцией (n=8). У пациентов с тяжелой степенью почечной недостаточности (n=5) максимальная концентрация повышалась в 2.2 раза и средняя концентрация препарата в моче - в 3.7 раза. Действие основных метаболитов, глюкуронида силодозина и KMD3293, также усиливалось. Поскольку имеются только ограниченные данные в отношении применения препарата пациентами с почечной недостаточностью средней степени (n=35), рекомендуется начинать с уменьшенной дозы 4 мг.</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>Для пациентов с легкой почечной недостаточностью (клиренс креатинина &gt; 50 - &lt; 80 мл/мин) не требуется коррекция дозы. Для пациентов с почечной недоста­точностью средней степени тяжести (клиренс креатинина &gt; 30 &lt; 50 мл/мин) рекомендуется низкая начальная доза - 4 мг. Для пациентов с тяжелой почечной недоста­точностью (клиренс креатинина &lt;30 мл/мин) назначение силодозина не рекомендуется.</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p><em><strong>Фармакодинамика</strong></em></p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>Силодозин является высокоселективным для α1A адренорецепторов, которые находятся, главным образом, в предстательной железе, шейке мочевого пузыря, капсуле предстательной железы и в предстательной части уретры. Блокирование этих α1A адренорецепторов вызывает расслабление гладких мышц этих тканей, что уменьшает сопротивление выходного отверстия мочевого пузыря, не влияя на сокращение гладких мышц-сжимателей. Это вызывает развитие раздражающего и обструктивного симптомов (симптомов со стороны нижних мочевыводящих путей), связанных с доброкачественной гиперплазией предстательной железы.</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>Силодозин обладает более низким сродством для α1B адренорецепторов, которые, главным образом, находятся в сердечно-сосудистой системе.</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>В исследованиях<em>&nbsp;</em><em>in</em><em>&nbsp;</em><em>vitro</em><em>&nbsp;</em>было показано, что сродство силодозина к α1A-адренорецепторам в 162 раза превосходит его способность взаимодействовать с α1В -адренорецепторами, которые расположены в гладких мышцах сосудов.&nbsp;<em>Клиническая эффективность и безопасность</em></p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>Свыше 800 пациентов с симптомами доброкачественной гиперплазии предстательной железы средней и тяжелой степени (по международной шкале оценки простатических симптомов, исходное значение≥13) принимали силодозин 8 мг один раз в сутки в двух плацебо контролируемых клинических исследованиях этапа III, проведенных в США, и в одном плацебо контролируемом и контролируемом по действующему препарату клиническом исследовании, проведенном в Европе. Во всех исследованиях пациентов, которые не реагировали на плацебо в течение 4 недель вводной фазы применения плацебо, методом случайной выборки отобрали для лечения препаратом – объектом исследования. Во всех исследованиях у пациентов, принимавших силодозин, быстрее уменьшались раздражающий и обструктивный симптомы, связанные с доброкачественной гиперплазией предстательной железы, в сравнении с плацебо по оценкам через 12 недель лечения.</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>В клиническом исследовании, контролируемом по действующему препарату, которое было проведено в Европе, применение 8 мг силодозина один раз в сутки не уступало применению тамсулозина 0.4 мг один раз в сутки: средняя откорректированная разница (95 % CI) в общем бале по шкале IPSS между лечением пациентов «без нарушения протокола», была 0.4 (от 0.4 до 1.1). Частота положительного ответа на лечение (т.е. улучшение общего балла по шкале IPSS минимум на 25 %) была значительно выше при применении силодозина (68 %) и тамсулозина (65 %), в сравнении с плацебо (53 %).</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>На долгосрочной открытой фазе дополнительного лечения этих контролируемых исследований, в которых пациенты принимали силодозин до 1 года, облегчение симптомов, вызванное силодозином на 12 неделе лечения, поддерживалось в течение 1 года.</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>На фазе IV клинического исследования, которое было проведено в Европе, со средним исходным общим баллом IPSS 18.9 пунктов, 77.1% пациентов отреагировали на силодозин (по оценкам изменения исходного значения общего балла IPSS не менее, чем на 25%). Приблизительно половина пациентов сообщала об облегчении большинства симптомов, на которые жаловались пациенты (т.е. частое мочеиспускание, ночные позывы, императивные позывы к мочеиспусканию, капельное выделение мочи и неполное опустошение мочевого пузыря), по оценкам опросников ICS-почты.</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>Значительное снижение артериального давления в положении лёжа на спине не наблюдалось во всех клинических исследованиях, которые были проведены в отношении силодозина.</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>Силодозин 8 мг и 24 мг в сутки не оказывал статистически значимого действия на интервалы ЭКГ или сердечную реполяризацию в отношении плацебо.</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>Блокада α1A -адренорецепторов снижает тонус гладкой мускулатуры в этих тканях, что ведет к улучшению оттока мочи из мочевого пузыря. Одновременно уменьшаются симпто­мы обструкции и раздражения, связанные с доброкачественной гиперплазией предстательной железы. Благодаря высокой селективности силодозин не вызывает клинически значимого снижения артериального давления (АД) у пациентов с исходно нормальным АД.</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:heading {\"level\":3} -->\n<h3>Показания к применению</h3>\n<!-- /wp:heading -->\n\n<!-- wp:paragraph -->\n<p>- лечение признаков и симптомов доброкачественной гиперплазии предстательной железы у взрослых мужчин.</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:heading {\"level\":3} -->\n<h3>Способ применения и дозы</h3>\n<!-- /wp:heading -->\n\n<!-- wp:paragraph -->\n<p>Капсулу следует принимать во время еды, предпочтительно в одно и то же время суток. Капсулу не следует крошить или жевать, капсулу необходимо проглатывать целиком, запивая стаканом воды.</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>Рекомендованная доза – по 1 капсуле Урорека 8 мг в сутки. Для отдельных категорий пациентов рекомендуется одна капсула Урорека 4 мг в сутки</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p><em>Пациенты пожилого возраста</em></p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>Для пациентов пожилого возраста корректировка дозы не требуется</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p><em>Почечная недостаточность</em></p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>Для пациентов с легкой степенью почечной недостаточности (клиренс креатинина ≥от 50 до ≤80&nbsp;мл/мин) корректировка дозы не требуется.</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>Для пациентов со средней степенью почечной недостаточности (клиренс креатинина ≥от 30 до &lt;50&nbsp;мл/мин) рекомендуется начинать с дозы 4 мг в сутки, по истечении одной недели можно увеличить дозу до 8 мг в сутки, в зависимости от реакции пациента. Использование препарата для пациентов с тяжелой степенью почечной недостаточности (клиренс креатинина &lt;30&nbsp;мл/мин) корректировка дозы не требуется.</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p><em>Печеночная недостаточность</em></p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>Для пациентов с легкой и средней степенью печеночной недостаточности корректировка дозы не требуется.</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>Поскольку данные отсутствуют, использование препарата пациентами с тяжелой степенью печеночной недостаточности не рекомендуется.</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:heading {\"level\":3} -->\n<h3>Побочные действия</h3>\n<!-- /wp:heading -->\n\n<!-- wp:paragraph -->\n<p>Безопасность силодозина оценивалась в четырех двойных слепых контролируемых клинических исследованиях II‑III фаз (с участием 931 пациента, которые принимали силодозин 8 мг один раз в сутки, и 733 пациентов, которые принимали плацебо) и в двух долгосрочных открытых исследованиях продленной фазы. В целом, 1,581 пациентов принимали силодозин в дозе 8 мг один раз в сутки. Из них 961 пациентов принимали препарат в течение 6 месяцев и 384 пациентов – в течение 1 года.</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>Самыми частыми побочными реакциями, о которых сообщалось в плацебо контролируемых клинических исследованиях при долгосрочном применении силидозина, были нарушения эякуляции, а именно, обратная эякуляция и анэякуляция (уменьшения объема эякуляции или ее отсутствие), с частотой 23%. Это может временно влиять на способность к зачатию. Такие нарушения исчезают через несколько дней после прекращения лечения.</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>Ниже перечислены нежелательные побочные реакции, отмеченные во всех клинических исследованиях и на протяжении международного постмаркетингового опыта применения, в отношении которых существует причинно-следственная связь, согласно классификации MedDRA в соответствии с поражением органов и систем органов и частотой развития: очень часто (≥1/10); часто (≥1/100 to &lt;1/10); нечасто (≥1/1,000 to &lt;1/100); редко (≥1/10,000 до &lt;1/1,000); очень редко (&lt;1/10,000), не известно (невозможно оценить по имеющимся данным). В каждой группы наблюдавшиеся побочные реакции представлены в порядке снижения степени серьезности.</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p><em>Очень часто</em></p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>- нарушения эякуляции, включая обратную эякуляцию и анаэкуляцию</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p><em>Часто</em></p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>- головокружение, ортостатическая гипотензия</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>- заложенность носа,</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>- диарея</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p><em>Нечасто</em></p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>- снижение либидо</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>- тахикардия1</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>- гипотензия1</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>- тошнота, сухость во рту</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>- ненормальные печеночные пробы1</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>- кожная сыпь1, зуд1, крапивница1, лекарственная сыпь1</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>- эректильная дисфункция</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p><em>Редко</em></p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>- обморок, потеря сознания1</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>- учащенная пульсация1</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p><em>Очень редко</em></p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>- аллергические реакции, включая отечность лица, проглатывание языка и отек глотки1</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p><em>Не известно</em></p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>- интраоперационный синдром дряблой радужки</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>1 – побочные реакции по добровольным отчетам в процессе международного пострегистрационного применения препарата (частота рассчитывалась по случаям, описанным в клинических исследованиях фазы I-IV и в неинтервенционных исследованиях).</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>Описание отдельных побочных реакций</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p><em>Ортостатическая гипотензия</em></p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>Частота возникновения ортостатической гипотензии в плацебо контролируемых клинических исследованиях была 1.2% при применении силодозина и 1.0% при применении плацебо. Ортостатическая гипотензия иногда приводила к обморокам.</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p><em>Интраоперационный синдром дряблой радужки</em><em>&nbsp;(</em><em>IFIS</em><em>)</em></p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>Об IFIS сообщалось по результатам хирургических операций по поводу катаракты.</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>Отчеты о подозреваемых побочных реакциях</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>Сообщение о подозреваемых побочных реакциях после регистрации медицинского препарата очень важно. Оно позволяет продолжать контролировать соотношение польза/риск медицинского препарата</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:heading {\"level\":3} -->\n<h3>Противопоказания</h3>\n<!-- /wp:heading -->\n\n<!-- wp:paragraph -->\n<p>- повышенная чувствительность к действующему веществу или к какому-либо вспомогательному веществу</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:list -->\n<ul><li>ортостатическая гипотензия в анамнезе</li><li>печеночная недостаточность</li></ul>\n<!-- /wp:list -->\n\n<!-- wp:paragraph -->\n<p>- детский возраст до 18 лет</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>- почечная недостаточность (клиренс креатинина менее 10 мл/мин)</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:heading {\"level\":3} -->\n<h3>Лекарственные взаимодействия</h3>\n<!-- /wp:heading -->\n\n<!-- wp:paragraph -->\n<p>Силодозин активно метаболизируется, особенно через CYP3A4, алкогольдегидразу и UGT2B7. Силодозин также является субстратом для P-гликопротеина. Вещества, которые подавляют (например, кетоконазол, итраконазол, ритонавир или циклоспорин) или вызывают появление (например, рифампицин, барбитураты, карбамазепин, фенитоин) таких ферментов и транспортеров, могут влиять на концентрацию силодозина и его активного метаболита в плазме.</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>Альфа-блокаторы</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>Соответствующая информация о безопасном применении силодозина вместе с другими антагонистами α‑адренорецепторов отсутствует. Следовательно, одновременное применение других антагонистов α‑адренорецепторов не рекомендуется.</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>Ингибиторы CYP3A4</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>В исследовании лекарственного взаимодействия, при одновременном применении силодозина и высокоактивного ингибитора CYP3A4 (кетоконазола 400 мг) наблюдалось повышение максимальных концентраций силодозина в плазме в 3.7 раза и повышение времени воздействия силодозина в 3.1 раза (средней концентрации в моче). Не рекомендуется одновременное применение высокоактивных ингибиторов CYP3A4 (например, кетоконазола, итраконазола, ритонавира или циклоспорина).</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>При одновременном применении силодозина и ингибитора CYP3A4 средней степени активности, например, дилтиазема, наблюдалось увеличение средней концентрации силодозина в моче приблизительно на 30%, однако максимальная концентрация и период полураспада не изменялись. Это изменение не имеет клинического значения, поэтому корректировка дозы не требуется.</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>Ингибиторы PDE‑5</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>Минимальные фармакодинамические взаимодействия наблюдались между силодозином и максимальными дозами силденафила или тадалафила. В плацебо контролируемом исследовании на 24 субъектах в возрасте 45-78 лет, которые получали силодозин, одновременное применение силденафила 100 мг или тадалафила 20 мг не вызывало клинически значимого уменьшения среднего систолического или диастолического кровяного давления по оценкам ортостатических исследований (стоя и лёжа). У субъектов старше 65 лет, среднее уменьшение в различных точках времени было между 5 и 15 мм рт. ст. (систолического) и между 0 и 10 мм рт. ст. (диастолического). Положительные ортостатические пробы были лишь немного более частыми во время одновременного применения лекарственных препаратов; однако, головокружение или другие симптомы не наблюдались. Состояние пациентов, принимающих ингибиторы PDE‑5 одновременно с силодозином, должно контролироваться на предмет возможных побочных реакций.</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>Гипотензивные препараты</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>В программе клинического исследования многие пациенты одновременно принимали гипотензивные препараты (большинство из них действовало на ренин-ангиотензиновую систему, бета-блокаторы, антагонисты кальция и диуретики) без повышения частоты ортостатической гипотензии. Тем не менее, рекомендуется проявлять осторожность при одновременном применении препарата с гипотензивными препаратами и контролировать состояние пациентов на предмет возможных побочных реакций.</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>Дигоксин</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>Равновесные уровни дигоксина, субстрата P‑гликопротеина, значительно не изменялись в результате одновременного применения силодозина 8 мг один раз в сутки. Корректировка дозы не требовалась.</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:heading {\"level\":3} -->\n<h3>Особые указания</h3>\n<!-- /wp:heading -->\n\n<!-- wp:paragraph -->\n<p>Интраоперационный синдром дряблой радужки (IFIS)</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>IFIS (разновидность синдрома узкого зрачка) наблюдался во время хирургической операции по удалению катаракты у некоторых пациентов, принимающих α1‑блокаторы или ранее принимавших α1‑блокаторы. Это может осложнять подобные операции.</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>Не рекомендуется начинать лечение силодозином для пациентов, которым планируется провести хирургическую операцию по поводу катаракты. Рекомендуется прекращать лечение α1‑блокаторами за 1-2 недели до хирургической операции, однако, преимущества и продолжительность прекращения лечения до хирургической операции по поводу катаракты не установлены.</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>Во время оценки до проведения хирургической операции хирурги-офтальмологи и другие специалисты по офтальмологии должны учитывать, принимают ли пациенты, которым предстоит хирургическая операция по поводу катаракты, силодозин, чтобы обеспечить принятие соответствующих мер в отношении IFIS во время операции.</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>Ортостатическое действие</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>Частота ортостатического действия силодозина очень низкая. Однако у некоторых пациентов может произойти снижение кровяного давления, что в редких случаях приводит к обморокам. При первых признаках ортостатической гипотензии (например, постуральное головокружение), пациенту следует сесть или лечь, и оставаться в таком положении до тех пор, пока симптомы не исчезнут. Пациентам с ортостатической гипотензией лечение силодозином не рекомендовано.</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>Почечная недостаточность</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>Пациентам с тяжелой почечной недостаточностью (CLCR &lt;30&nbsp;мл/мин) лечение силодозином не рекомендуется.</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>Печеночная недостаточность</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>Поскольку данные в отношении применения препарата пациентами с тяжелой степенью печеночной недостаточности отсутствуют, использование силодозина такими пациентами не рекомендуется.</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>Рак предстательной железы</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>Поскольку у ДГПЖ и рака предстательной железы одинаковые симптомы, и они могут сосуществовать, пациенты, у которых подозревается ДГПЖ, должны пройти обследование до начала лечения силодозином, чтобы исключить рак предстательной железы. Пальцевое ректальное исследование и, если необходимо, определение простатического специфического антигена (PSA) должно быть выполнено перед началом лечения, и должно регулярно повторяться после этого.</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>Лечение силодозином приводит к уменьшению количества спермы во время оргазма, что может временно влиять на оплодотворяющую способность спермы. Такое действие прекращается после прекращения применения силодозина.</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p><em>Беременность и грудное вскармливание</em></p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>Силодозин предназначен только для мужчин.</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p><em>Фертильность</em></p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>В клинических исследованиях при применении силодозина наблюдалась эякуляция с пониженным количеством спермы или без спермы из-за фармакодинамических особенностей силодозина. Перед началом лечения пациента необходимо проинформировать о том, что это может произойти, и о том, что препарат влияет на оплодотворяющую способность спермы.</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p><em>Особенности влияния лекарственного средства на&nbsp;&nbsp;&nbsp;способность управлять транспортным средством или&nbsp;&nbsp;потенциально опасными механизмами</em></p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>Урорек в незначительной или в средней степени может повлиять на способность управлять транспортными средствами и механизмами. Пациентов необходимо проинформировать о возможных симптомах, связанных с постуральной гипотензией (головокружение), и о том, что они должны быть осторожны в управлении транспортными средствами и механизмами.</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:heading {\"level\":3} -->\n<h3>Передозировка</h3>\n<!-- /wp:heading -->\n\n<!-- wp:paragraph -->\n<p><em>Симптомы:</em>&nbsp;тяжелая артериальная гипотензия.</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p><em>Лечение:</em>&nbsp;Применение силодозина в дозах до 48 мг/сутки оценивалось у здоровых мужчин. Постуральная гипотензия была побочной реакцией, ограничивающей дозу. Если прием препарата произошел недавно, эффективным будет промывание желудка. Если передозировка силодозина привела к гипотензии, необходимо провести сердечно-легочную реанимацию. Диализ, маловероятно, будет эффективным, поскольку силодозин высоко (96.6%) связывается с белками.</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:heading {\"level\":3} -->\n<h3>Форма выпуска и упаковка</h3>\n<!-- /wp:heading -->\n\n<!-- wp:paragraph -->\n<p>По 10 капсул помещают в контурную ячейковую упаковку из непрозрачной пленки ПВХ/ПВДХ и фольги алюминиевой.</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>По 1, 3 или 5 контурных ячейковых упаковок вместе с инструкцией по медицинскому применению на государственном и русском языках помещают в пачку из картона.</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:heading {\"level\":3} -->\n<h3>Условия хранения</h3>\n<!-- /wp:heading -->\n\n<!-- wp:paragraph -->\n<p>Хранить в сухом, защищенном от света месте, при температуре не выше 30 0С, в оригинальной упаковке.</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>Хранить в недоступном для детей месте.</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:heading {\"level\":3} -->\n<h3>Срок хранения</h3>\n<!-- /wp:heading -->\n\n<!-- wp:paragraph -->\n<p>3 года</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>Не применять по истечении срока годности.</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:heading {\"level\":3} -->\n<h3>Условия отпуска из аптек</h3>\n<!-- /wp:heading -->\n\n<!-- wp:paragraph -->\n<p>По рецепту</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:heading {\"level\":3} -->\n<h3>Производитель</h3>\n<!-- /wp:heading -->\n\n<!-- wp:paragraph -->\n<p>«Recordati Industria Chimica е Farmaceutica&nbsp;S.P.A.»</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>Via M. Civitali 1, 20148, Milan, Italy / Виа М. Чивитали 1, 20148, Милан, Италия</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:heading {\"level\":3} -->\n<h3>Владелец регистрационного удостоверения</h3>\n<!-- /wp:heading -->\n\n<!-- wp:paragraph -->\n<p>«Recordati Ireland Ltd.»</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>Raheens East Ringaskiddy, Co. Cork, Ireland / Рахинз Ист, Рингаскидди, Ко. Корк, Ирландия</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p><strong>Адрес организации, принимающей на территории Республики Казахстан претензии от потребителей по качеству продукции</strong></p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>Представительство ТОО «FIC MEDICAL» (ФИК МЕДИКАЛЬ) в Республике Казахстан, ул. Толе би 69, офис 33, 050000, Алматы, Казахстан</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>тел.: +7 (727) 272 93 08, факс: +7 (727) 272 90 25</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>e-mail: fic_kz@ficmedical.kz</p>\n<!-- /wp:paragraph -->', 'Инструкция к препарату', '', 'inherit', 'closed', 'closed', '', '240-revision-v1', '', '', '2022-03-31 15:43:32', '2022-03-31 12:43:32', '', 240, 'http://0026urotec.loc:8888/?p=241', 0, 'revision', '', 0);
INSERT INTO `urotec_posts` (`ID`, `post_author`, `post_date`, `post_date_gmt`, `post_content`, `post_title`, `post_excerpt`, `post_status`, `comment_status`, `ping_status`, `post_password`, `post_name`, `to_ping`, `pinged`, `post_modified`, `post_modified_gmt`, `post_content_filtered`, `post_parent`, `guid`, `menu_order`, `post_type`, `post_mime_type`, `comment_count`) VALUES
(243, 1, '2022-03-31 15:45:17', '2022-03-31 12:45:17', '<!-- wp:code -->\n<pre class=\"wp-block-code\"><code>&lt;div class=\"container section\"></code></pre>\n<!-- /wp:code -->\n\n<!-- wp:heading {\"level\":3} -->\n<h3>Торговое название</h3>\n<!-- /wp:heading -->\n\n<!-- wp:paragraph -->\n<p>Урорек</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:heading {\"level\":3} -->\n<h3>Международное непатентованное название</h3>\n<!-- /wp:heading -->\n\n<!-- wp:paragraph -->\n<p>Силодозин</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:heading {\"level\":3} -->\n<h3>Лекарственная форма</h3>\n<!-- /wp:heading -->\n\n<!-- wp:paragraph -->\n<p>Капсулы твердые 4 мг, 8 мг</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:heading {\"level\":3} -->\n<h3>Состав</h3>\n<!-- /wp:heading -->\n\n<!-- wp:paragraph -->\n<p>Одна таблетка содержит</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p><em>активное вещество</em>&nbsp;- силодозин 4.0 мг; 8.0 мг;</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p><em>вспомогательные вещества</em>: маннитол, крахмал прежелатинизированый (состоит из: крахмала прежелатинизированного (кукурузного) (Starch 1500ТМ) и крахмала прежелатинизированного (кукурузного) (РСSТМ РС-10)), натрия лаурилсульфат, магния стеарат;</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p><em>состав желатиновой капсулы</em>&nbsp;<em>для дозировки 4 мг</em>: желатин, титана диоксид (Е 171), железа (III) оксид желтый (Е 172).</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p><em>состав желатиновой капсулы</em>&nbsp;<em>для дозировки 8 мг</em>: желатин, титана диоксид (Е 171).</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:heading {\"level\":3} -->\n<h3>Описание</h3>\n<!-- /wp:heading -->\n\n<!-- wp:paragraph -->\n<p>Твердые желатиновые капсулы желтого цвета размером № 3. Содержимое капсул – мелкокристаллический порошок от белого до светло-желтого цвета (для дозировки 4 мг).</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>Твердые желатиновые капсулы белого цвета размером № 0. Содержимое капсул – мелкокристаллический порошок от белого до светло-желтого цвета (для дозировки 8 мг).</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:heading {\"level\":3} -->\n<h3>Фармакотерапевтическая группа</h3>\n<!-- /wp:heading -->\n\n<!-- wp:paragraph -->\n<p>Препараты для лечения доброкачественной гипертрофии простаты. Альфа-адреноблокаторы. Силодозин.</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>Код АТХ G04CA04</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:heading {\"level\":3} -->\n<h3>Фармакологические свойства</h3>\n<!-- /wp:heading -->\n\n<!-- wp:paragraph -->\n<p><em><strong>Фармакокинетика</strong></em></p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>Фармакокинетика силодозина и его основных метаболитов оценивалась у взрослых мужчин с и без доброкачественной гиперплазии предстательной железы после однократного и многократного применения в дозах от 0.1 мг до 48 мг в сутки. Фармакокинетика силодозина является линейной во всем диапазоне доз.</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>Действие основного метаболита в плазме, глюкуронида силодозина (KMD‑3213G), при равновесном состоянии приблизительно в 3 раза больше, чем действие исходного вещества. Силодозин и его глюкуронид достигают равновесного состояния через 3 и 5 дней лечения, соответственно.</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>Всасывание</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>Силодозин хорошо всасывается после перорального приема, абсорбция пропорциональна дозе. Абсолютная биодоступность составляет около 32 %. Пища снижает максимальную концентрацию (Сmax) примерно на 30 %, увеличивая время достижения максимальной концентрации (tmax) примерно до 1 ч и оказывает минимальное влияние на площадь под кривой «концентрация-время» (АUС). После перорального приема 8 мг один раз в день сразу после завтрака в течение 7 дней отмечены следующие фармакокинетические параметры: Сmax- 87±51 ng/ml (sd), tmax 2.5&nbsp;часов (диапазон 1.0-3.0), AUC - 433±286 ng&nbsp;•&nbsp;h/ml.</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>Распределение</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>Объем распределения силодозина составляет 0,81 л/кг, связывание с белками плазмы составляет 96,6 %. Силодозин метаболизируется по­средством глюкуронирования (с участием UGТ2В7), с участием алкогольдегидрогеназы и альдегид- дегидрогеназы, окислительных пу­тей, в основном с участием СYРЗА4. Основной активный метаболит в плазме карбамоил- глюкуронид (КМD-3213G) достигает плазменной концентрации в 4 раза большей, чем сам силодозин. Связывание силодозина глюкуронида с белками плазмы составляет 91 %. Силодозин не обладает потенциалом индукции или ингибирования изоферментов цитохрома Р450.</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>Выведение</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>После перорального применения 14C‑маркированного силодозина, выведение радиоактивных веществ через 7 дней было, около 33,5 % силодозина выводится через почки и 54,9 % через кишечник. Клиренс силодозина составляет около 0,28 л/ч/кг. Силодозин экскретируется в основном в виде метаболитов и в очень малом количестве в неизмененном виде с мочой. Конечный период полувыведения Т1/2 силодозина и глюкуронида составляет 11 часов и 18 часов соответственно.</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>Особые группы пациентов</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p><em>Пациенты пожилого возраста</em></p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>Фармакокинетика силодозина и его основных метаболитов значительно не менялось у пожилых пациентов, клиренс силодозина не меняется у пациентов старше 75 лет.</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p><em>Применение в педиатрии</em>.</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>Лекарственное средство не рекомендуется детям и подросткам до 18 лет ввиду отсутствия данных по безопасности и эффективности.</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p><em>Печеночная недостаточность</em></p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>В исследовании однократной дозы фармакокинетики силодозина не менялось у 9 пациентов с печеночной недостаточностью средней степени (7-9 по шкале Чайлда-Пью) в сравнении с 9 здоровыми добровольцами. По результатам этого исследования следует применять с осторожностью, поскольку у пациентов были нормальные биохимические показатели, что указывает на нормальную метаболическую функцию, и их отнесли к категории пациентов с печеночной недостаточностью средней степени на основе асцита и печеночной энцефалопатии.</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p><em>Почечная недостаточность</em></p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>В исследовании однократной дозы действие силодозина (несвязанного) у пациентов с легкой степенью (n=8) и средней степенью почечной недостаточности (n=8) привело к повышению максимальной концентрации в 1.6 раза и средней концентрации препарата в моче в 1.7 раза в сравнении с пациентами с нормальной почечной функцией (n=8). У пациентов с тяжелой степенью почечной недостаточности (n=5) максимальная концентрация повышалась в 2.2 раза и средняя концентрация препарата в моче - в 3.7 раза. Действие основных метаболитов, глюкуронида силодозина и KMD3293, также усиливалось. Поскольку имеются только ограниченные данные в отношении применения препарата пациентами с почечной недостаточностью средней степени (n=35), рекомендуется начинать с уменьшенной дозы 4 мг.</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>Для пациентов с легкой почечной недостаточностью (клиренс креатинина &gt; 50 - &lt; 80 мл/мин) не требуется коррекция дозы. Для пациентов с почечной недоста­точностью средней степени тяжести (клиренс креатинина &gt; 30 &lt; 50 мл/мин) рекомендуется низкая начальная доза - 4 мг. Для пациентов с тяжелой почечной недоста­точностью (клиренс креатинина &lt;30 мл/мин) назначение силодозина не рекомендуется.</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p><em><strong>Фармакодинамика</strong></em></p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>Силодозин является высокоселективным для α1A адренорецепторов, которые находятся, главным образом, в предстательной железе, шейке мочевого пузыря, капсуле предстательной железы и в предстательной части уретры. Блокирование этих α1A адренорецепторов вызывает расслабление гладких мышц этих тканей, что уменьшает сопротивление выходного отверстия мочевого пузыря, не влияя на сокращение гладких мышц-сжимателей. Это вызывает развитие раздражающего и обструктивного симптомов (симптомов со стороны нижних мочевыводящих путей), связанных с доброкачественной гиперплазией предстательной железы.</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>Силодозин обладает более низким сродством для α1B адренорецепторов, которые, главным образом, находятся в сердечно-сосудистой системе.</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>В исследованиях<em>&nbsp;</em><em>in</em><em>&nbsp;</em><em>vitro</em><em>&nbsp;</em>было показано, что сродство силодозина к α1A-адренорецепторам в 162 раза превосходит его способность взаимодействовать с α1В -адренорецепторами, которые расположены в гладких мышцах сосудов.&nbsp;<em>Клиническая эффективность и безопасность</em></p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>Свыше 800 пациентов с симптомами доброкачественной гиперплазии предстательной железы средней и тяжелой степени (по международной шкале оценки простатических симптомов, исходное значение≥13) принимали силодозин 8 мг один раз в сутки в двух плацебо контролируемых клинических исследованиях этапа III, проведенных в США, и в одном плацебо контролируемом и контролируемом по действующему препарату клиническом исследовании, проведенном в Европе. Во всех исследованиях пациентов, которые не реагировали на плацебо в течение 4 недель вводной фазы применения плацебо, методом случайной выборки отобрали для лечения препаратом – объектом исследования. Во всех исследованиях у пациентов, принимавших силодозин, быстрее уменьшались раздражающий и обструктивный симптомы, связанные с доброкачественной гиперплазией предстательной железы, в сравнении с плацебо по оценкам через 12 недель лечения.</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>В клиническом исследовании, контролируемом по действующему препарату, которое было проведено в Европе, применение 8 мг силодозина один раз в сутки не уступало применению тамсулозина 0.4 мг один раз в сутки: средняя откорректированная разница (95 % CI) в общем бале по шкале IPSS между лечением пациентов «без нарушения протокола», была 0.4 (от 0.4 до 1.1). Частота положительного ответа на лечение (т.е. улучшение общего балла по шкале IPSS минимум на 25 %) была значительно выше при применении силодозина (68 %) и тамсулозина (65 %), в сравнении с плацебо (53 %).</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>На долгосрочной открытой фазе дополнительного лечения этих контролируемых исследований, в которых пациенты принимали силодозин до 1 года, облегчение симптомов, вызванное силодозином на 12 неделе лечения, поддерживалось в течение 1 года.</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>На фазе IV клинического исследования, которое было проведено в Европе, со средним исходным общим баллом IPSS 18.9 пунктов, 77.1% пациентов отреагировали на силодозин (по оценкам изменения исходного значения общего балла IPSS не менее, чем на 25%). Приблизительно половина пациентов сообщала об облегчении большинства симптомов, на которые жаловались пациенты (т.е. частое мочеиспускание, ночные позывы, императивные позывы к мочеиспусканию, капельное выделение мочи и неполное опустошение мочевого пузыря), по оценкам опросников ICS-почты.</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>Значительное снижение артериального давления в положении лёжа на спине не наблюдалось во всех клинических исследованиях, которые были проведены в отношении силодозина.</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>Силодозин 8 мг и 24 мг в сутки не оказывал статистически значимого действия на интервалы ЭКГ или сердечную реполяризацию в отношении плацебо.</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>Блокада α1A -адренорецепторов снижает тонус гладкой мускулатуры в этих тканях, что ведет к улучшению оттока мочи из мочевого пузыря. Одновременно уменьшаются симпто­мы обструкции и раздражения, связанные с доброкачественной гиперплазией предстательной железы. Благодаря высокой селективности силодозин не вызывает клинически значимого снижения артериального давления (АД) у пациентов с исходно нормальным АД.</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:heading {\"level\":3} -->\n<h3>Показания к применению</h3>\n<!-- /wp:heading -->\n\n<!-- wp:paragraph -->\n<p>- лечение признаков и симптомов доброкачественной гиперплазии предстательной железы у взрослых мужчин.</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:heading {\"level\":3} -->\n<h3>Способ применения и дозы</h3>\n<!-- /wp:heading -->\n\n<!-- wp:paragraph -->\n<p>Капсулу следует принимать во время еды, предпочтительно в одно и то же время суток. Капсулу не следует крошить или жевать, капсулу необходимо проглатывать целиком, запивая стаканом воды.</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>Рекомендованная доза – по 1 капсуле Урорека 8 мг в сутки. Для отдельных категорий пациентов рекомендуется одна капсула Урорека 4 мг в сутки</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p><em>Пациенты пожилого возраста</em></p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>Для пациентов пожилого возраста корректировка дозы не требуется</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p><em>Почечная недостаточность</em></p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>Для пациентов с легкой степенью почечной недостаточности (клиренс креатинина ≥от 50 до ≤80&nbsp;мл/мин) корректировка дозы не требуется.</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>Для пациентов со средней степенью почечной недостаточности (клиренс креатинина ≥от 30 до &lt;50&nbsp;мл/мин) рекомендуется начинать с дозы 4 мг в сутки, по истечении одной недели можно увеличить дозу до 8 мг в сутки, в зависимости от реакции пациента. Использование препарата для пациентов с тяжелой степенью почечной недостаточности (клиренс креатинина &lt;30&nbsp;мл/мин) корректировка дозы не требуется.</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p><em>Печеночная недостаточность</em></p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>Для пациентов с легкой и средней степенью печеночной недостаточности корректировка дозы не требуется.</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>Поскольку данные отсутствуют, использование препарата пациентами с тяжелой степенью печеночной недостаточности не рекомендуется.</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:heading {\"level\":3} -->\n<h3>Побочные действия</h3>\n<!-- /wp:heading -->\n\n<!-- wp:paragraph -->\n<p>Безопасность силодозина оценивалась в четырех двойных слепых контролируемых клинических исследованиях II‑III фаз (с участием 931 пациента, которые принимали силодозин 8 мг один раз в сутки, и 733 пациентов, которые принимали плацебо) и в двух долгосрочных открытых исследованиях продленной фазы. В целом, 1,581 пациентов принимали силодозин в дозе 8 мг один раз в сутки. Из них 961 пациентов принимали препарат в течение 6 месяцев и 384 пациентов – в течение 1 года.</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>Самыми частыми побочными реакциями, о которых сообщалось в плацебо контролируемых клинических исследованиях при долгосрочном применении силидозина, были нарушения эякуляции, а именно, обратная эякуляция и анэякуляция (уменьшения объема эякуляции или ее отсутствие), с частотой 23%. Это может временно влиять на способность к зачатию. Такие нарушения исчезают через несколько дней после прекращения лечения.</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>Ниже перечислены нежелательные побочные реакции, отмеченные во всех клинических исследованиях и на протяжении международного постмаркетингового опыта применения, в отношении которых существует причинно-следственная связь, согласно классификации MedDRA в соответствии с поражением органов и систем органов и частотой развития: очень часто (≥1/10); часто (≥1/100 to &lt;1/10); нечасто (≥1/1,000 to &lt;1/100); редко (≥1/10,000 до &lt;1/1,000); очень редко (&lt;1/10,000), не известно (невозможно оценить по имеющимся данным). В каждой группы наблюдавшиеся побочные реакции представлены в порядке снижения степени серьезности.</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p><em>Очень часто</em></p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>- нарушения эякуляции, включая обратную эякуляцию и анаэкуляцию</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p><em>Часто</em></p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>- головокружение, ортостатическая гипотензия</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>- заложенность носа,</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>- диарея</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p><em>Нечасто</em></p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>- снижение либидо</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>- тахикардия1</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>- гипотензия1</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>- тошнота, сухость во рту</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>- ненормальные печеночные пробы1</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>- кожная сыпь1, зуд1, крапивница1, лекарственная сыпь1</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>- эректильная дисфункция</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p><em>Редко</em></p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>- обморок, потеря сознания1</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>- учащенная пульсация1</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p><em>Очень редко</em></p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>- аллергические реакции, включая отечность лица, проглатывание языка и отек глотки1</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p><em>Не известно</em></p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>- интраоперационный синдром дряблой радужки</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>1 – побочные реакции по добровольным отчетам в процессе международного пострегистрационного применения препарата (частота рассчитывалась по случаям, описанным в клинических исследованиях фазы I-IV и в неинтервенционных исследованиях).</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>Описание отдельных побочных реакций</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p><em>Ортостатическая гипотензия</em></p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>Частота возникновения ортостатической гипотензии в плацебо контролируемых клинических исследованиях была 1.2% при применении силодозина и 1.0% при применении плацебо. Ортостатическая гипотензия иногда приводила к обморокам.</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p><em>Интраоперационный синдром дряблой радужки</em><em>&nbsp;(</em><em>IFIS</em><em>)</em></p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>Об IFIS сообщалось по результатам хирургических операций по поводу катаракты.</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>Отчеты о подозреваемых побочных реакциях</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>Сообщение о подозреваемых побочных реакциях после регистрации медицинского препарата очень важно. Оно позволяет продолжать контролировать соотношение польза/риск медицинского препарата</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:heading {\"level\":3} -->\n<h3>Противопоказания</h3>\n<!-- /wp:heading -->\n\n<!-- wp:paragraph -->\n<p>- повышенная чувствительность к действующему веществу или к какому-либо вспомогательному веществу</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:list -->\n<ul><li>ортостатическая гипотензия в анамнезе</li><li>печеночная недостаточность</li></ul>\n<!-- /wp:list -->\n\n<!-- wp:paragraph -->\n<p>- детский возраст до 18 лет</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>- почечная недостаточность (клиренс креатинина менее 10 мл/мин)</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:heading {\"level\":3} -->\n<h3>Лекарственные взаимодействия</h3>\n<!-- /wp:heading -->\n\n<!-- wp:paragraph -->\n<p>Силодозин активно метаболизируется, особенно через CYP3A4, алкогольдегидразу и UGT2B7. Силодозин также является субстратом для P-гликопротеина. Вещества, которые подавляют (например, кетоконазол, итраконазол, ритонавир или циклоспорин) или вызывают появление (например, рифампицин, барбитураты, карбамазепин, фенитоин) таких ферментов и транспортеров, могут влиять на концентрацию силодозина и его активного метаболита в плазме.</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>Альфа-блокаторы</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>Соответствующая информация о безопасном применении силодозина вместе с другими антагонистами α‑адренорецепторов отсутствует. Следовательно, одновременное применение других антагонистов α‑адренорецепторов не рекомендуется.</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>Ингибиторы CYP3A4</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>В исследовании лекарственного взаимодействия, при одновременном применении силодозина и высокоактивного ингибитора CYP3A4 (кетоконазола 400 мг) наблюдалось повышение максимальных концентраций силодозина в плазме в 3.7 раза и повышение времени воздействия силодозина в 3.1 раза (средней концентрации в моче). Не рекомендуется одновременное применение высокоактивных ингибиторов CYP3A4 (например, кетоконазола, итраконазола, ритонавира или циклоспорина).</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>При одновременном применении силодозина и ингибитора CYP3A4 средней степени активности, например, дилтиазема, наблюдалось увеличение средней концентрации силодозина в моче приблизительно на 30%, однако максимальная концентрация и период полураспада не изменялись. Это изменение не имеет клинического значения, поэтому корректировка дозы не требуется.</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>Ингибиторы PDE‑5</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>Минимальные фармакодинамические взаимодействия наблюдались между силодозином и максимальными дозами силденафила или тадалафила. В плацебо контролируемом исследовании на 24 субъектах в возрасте 45-78 лет, которые получали силодозин, одновременное применение силденафила 100 мг или тадалафила 20 мг не вызывало клинически значимого уменьшения среднего систолического или диастолического кровяного давления по оценкам ортостатических исследований (стоя и лёжа). У субъектов старше 65 лет, среднее уменьшение в различных точках времени было между 5 и 15 мм рт. ст. (систолического) и между 0 и 10 мм рт. ст. (диастолического). Положительные ортостатические пробы были лишь немного более частыми во время одновременного применения лекарственных препаратов; однако, головокружение или другие симптомы не наблюдались. Состояние пациентов, принимающих ингибиторы PDE‑5 одновременно с силодозином, должно контролироваться на предмет возможных побочных реакций.</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>Гипотензивные препараты</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>В программе клинического исследования многие пациенты одновременно принимали гипотензивные препараты (большинство из них действовало на ренин-ангиотензиновую систему, бета-блокаторы, антагонисты кальция и диуретики) без повышения частоты ортостатической гипотензии. Тем не менее, рекомендуется проявлять осторожность при одновременном применении препарата с гипотензивными препаратами и контролировать состояние пациентов на предмет возможных побочных реакций.</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>Дигоксин</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>Равновесные уровни дигоксина, субстрата P‑гликопротеина, значительно не изменялись в результате одновременного применения силодозина 8 мг один раз в сутки. Корректировка дозы не требовалась.</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:heading {\"level\":3} -->\n<h3>Особые указания</h3>\n<!-- /wp:heading -->\n\n<!-- wp:paragraph -->\n<p>Интраоперационный синдром дряблой радужки (IFIS)</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>IFIS (разновидность синдрома узкого зрачка) наблюдался во время хирургической операции по удалению катаракты у некоторых пациентов, принимающих α1‑блокаторы или ранее принимавших α1‑блокаторы. Это может осложнять подобные операции.</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>Не рекомендуется начинать лечение силодозином для пациентов, которым планируется провести хирургическую операцию по поводу катаракты. Рекомендуется прекращать лечение α1‑блокаторами за 1-2 недели до хирургической операции, однако, преимущества и продолжительность прекращения лечения до хирургической операции по поводу катаракты не установлены.</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>Во время оценки до проведения хирургической операции хирурги-офтальмологи и другие специалисты по офтальмологии должны учитывать, принимают ли пациенты, которым предстоит хирургическая операция по поводу катаракты, силодозин, чтобы обеспечить принятие соответствующих мер в отношении IFIS во время операции.</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>Ортостатическое действие</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>Частота ортостатического действия силодозина очень низкая. Однако у некоторых пациентов может произойти снижение кровяного давления, что в редких случаях приводит к обморокам. При первых признаках ортостатической гипотензии (например, постуральное головокружение), пациенту следует сесть или лечь, и оставаться в таком положении до тех пор, пока симптомы не исчезнут. Пациентам с ортостатической гипотензией лечение силодозином не рекомендовано.</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>Почечная недостаточность</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>Пациентам с тяжелой почечной недостаточностью (CLCR &lt;30&nbsp;мл/мин) лечение силодозином не рекомендуется.</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>Печеночная недостаточность</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>Поскольку данные в отношении применения препарата пациентами с тяжелой степенью печеночной недостаточности отсутствуют, использование силодозина такими пациентами не рекомендуется.</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>Рак предстательной железы</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>Поскольку у ДГПЖ и рака предстательной железы одинаковые симптомы, и они могут сосуществовать, пациенты, у которых подозревается ДГПЖ, должны пройти обследование до начала лечения силодозином, чтобы исключить рак предстательной железы. Пальцевое ректальное исследование и, если необходимо, определение простатического специфического антигена (PSA) должно быть выполнено перед началом лечения, и должно регулярно повторяться после этого.</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>Лечение силодозином приводит к уменьшению количества спермы во время оргазма, что может временно влиять на оплодотворяющую способность спермы. Такое действие прекращается после прекращения применения силодозина.</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p><em>Беременность и грудное вскармливание</em></p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>Силодозин предназначен только для мужчин.</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p><em>Фертильность</em></p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>В клинических исследованиях при применении силодозина наблюдалась эякуляция с пониженным количеством спермы или без спермы из-за фармакодинамических особенностей силодозина. Перед началом лечения пациента необходимо проинформировать о том, что это может произойти, и о том, что препарат влияет на оплодотворяющую способность спермы.</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p><em>Особенности влияния лекарственного средства на&nbsp;&nbsp;&nbsp;способность управлять транспортным средством или&nbsp;&nbsp;потенциально опасными механизмами</em></p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>Урорек в незначительной или в средней степени может повлиять на способность управлять транспортными средствами и механизмами. Пациентов необходимо проинформировать о возможных симптомах, связанных с постуральной гипотензией (головокружение), и о том, что они должны быть осторожны в управлении транспортными средствами и механизмами.</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:heading {\"level\":3} -->\n<h3>Передозировка</h3>\n<!-- /wp:heading -->\n\n<!-- wp:paragraph -->\n<p><em>Симптомы:</em>&nbsp;тяжелая артериальная гипотензия.</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p><em>Лечение:</em>&nbsp;Применение силодозина в дозах до 48 мг/сутки оценивалось у здоровых мужчин. Постуральная гипотензия была побочной реакцией, ограничивающей дозу. Если прием препарата произошел недавно, эффективным будет промывание желудка. Если передозировка силодозина привела к гипотензии, необходимо провести сердечно-легочную реанимацию. Диализ, маловероятно, будет эффективным, поскольку силодозин высоко (96.6%) связывается с белками.</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:heading {\"level\":3} -->\n<h3>Форма выпуска и упаковка</h3>\n<!-- /wp:heading -->\n\n<!-- wp:paragraph -->\n<p>По 10 капсул помещают в контурную ячейковую упаковку из непрозрачной пленки ПВХ/ПВДХ и фольги алюминиевой.</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>По 1, 3 или 5 контурных ячейковых упаковок вместе с инструкцией по медицинскому применению на государственном и русском языках помещают в пачку из картона.</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:heading {\"level\":3} -->\n<h3>Условия хранения</h3>\n<!-- /wp:heading -->\n\n<!-- wp:paragraph -->\n<p>Хранить в сухом, защищенном от света месте, при температуре не выше 30 0С, в оригинальной упаковке.</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>Хранить в недоступном для детей месте.</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:heading {\"level\":3} -->\n<h3>Срок хранения</h3>\n<!-- /wp:heading -->\n\n<!-- wp:paragraph -->\n<p>3 года</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>Не применять по истечении срока годности.</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:heading {\"level\":3} -->\n<h3>Условия отпуска из аптек</h3>\n<!-- /wp:heading -->\n\n<!-- wp:paragraph -->\n<p>По рецепту</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:heading {\"level\":3} -->\n<h3>Производитель</h3>\n<!-- /wp:heading -->\n\n<!-- wp:paragraph -->\n<p>«Recordati Industria Chimica е Farmaceutica&nbsp;S.P.A.»</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>Via M. Civitali 1, 20148, Milan, Italy / Виа М. Чивитали 1, 20148, Милан, Италия</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:heading {\"level\":3} -->\n<h3>Владелец регистрационного удостоверения</h3>\n<!-- /wp:heading -->\n\n<!-- wp:paragraph -->\n<p>«Recordati Ireland Ltd.»</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>Raheens East Ringaskiddy, Co. Cork, Ireland / Рахинз Ист, Рингаскидди, Ко. Корк, Ирландия</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p><strong>Адрес организации, принимающей на территории Республики Казахстан претензии от потребителей по качеству продукции</strong></p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>Представительство ТОО «FIC MEDICAL» (ФИК МЕДИКАЛЬ) в Республике Казахстан, ул. Толе би 69, офис 33, 050000, Алматы, Казахстан</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>тел.: +7 (727) 272 93 08, факс: +7 (727) 272 90 25</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>e-mail: fic_kz@ficmedical.kz</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:code -->\n<pre class=\"wp-block-code\"><code>&lt;/div></code></pre>\n<!-- /wp:code -->', 'Инструкция к препарату', '', 'inherit', 'closed', 'closed', '', '240-revision-v1', '', '', '2022-03-31 15:45:17', '2022-03-31 12:45:17', '', 240, 'http://0026urotec.loc:8888/?p=243', 0, 'revision', '', 0);
INSERT INTO `urotec_posts` (`ID`, `post_author`, `post_date`, `post_date_gmt`, `post_content`, `post_title`, `post_excerpt`, `post_status`, `comment_status`, `ping_status`, `post_password`, `post_name`, `to_ping`, `pinged`, `post_modified`, `post_modified_gmt`, `post_content_filtered`, `post_parent`, `guid`, `menu_order`, `post_type`, `post_mime_type`, `comment_count`) VALUES
(244, 1, '2022-03-31 15:48:27', '2022-03-31 12:48:27', '<!-- wp:heading {\"level\":3} -->\n<h3>Торговое название</h3>\n<!-- /wp:heading -->\n\n<!-- wp:paragraph -->\n<p>Урорек</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:heading {\"level\":3} -->\n<h3>Международное непатентованное название</h3>\n<!-- /wp:heading -->\n\n<!-- wp:paragraph -->\n<p>Силодозин</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:heading {\"level\":3} -->\n<h3>Лекарственная форма</h3>\n<!-- /wp:heading -->\n\n<!-- wp:paragraph -->\n<p>Капсулы твердые 4 мг, 8 мг</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:heading {\"level\":3} -->\n<h3>Состав</h3>\n<!-- /wp:heading -->\n\n<!-- wp:paragraph -->\n<p>Одна таблетка содержит</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p><em>активное вещество</em>&nbsp;- силодозин 4.0 мг; 8.0 мг;</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p><em>вспомогательные вещества</em>: маннитол, крахмал прежелатинизированый (состоит из: крахмала прежелатинизированного (кукурузного) (Starch 1500ТМ) и крахмала прежелатинизированного (кукурузного) (РСSТМ РС-10)), натрия лаурилсульфат, магния стеарат;</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p><em>состав желатиновой капсулы</em>&nbsp;<em>для дозировки 4 мг</em>: желатин, титана диоксид (Е 171), железа (III) оксид желтый (Е 172).</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p><em>состав желатиновой капсулы</em>&nbsp;<em>для дозировки 8 мг</em>: желатин, титана диоксид (Е 171).</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:heading {\"level\":3} -->\n<h3>Описание</h3>\n<!-- /wp:heading -->\n\n<!-- wp:paragraph -->\n<p>Твердые желатиновые капсулы желтого цвета размером № 3. Содержимое капсул – мелкокристаллический порошок от белого до светло-желтого цвета (для дозировки 4 мг).</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>Твердые желатиновые капсулы белого цвета размером № 0. Содержимое капсул – мелкокристаллический порошок от белого до светло-желтого цвета (для дозировки 8 мг).</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:heading {\"level\":3} -->\n<h3>Фармакотерапевтическая группа</h3>\n<!-- /wp:heading -->\n\n<!-- wp:paragraph -->\n<p>Препараты для лечения доброкачественной гипертрофии простаты. Альфа-адреноблокаторы. Силодозин.</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>Код АТХ G04CA04</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:heading {\"level\":3} -->\n<h3>Фармакологические свойства</h3>\n<!-- /wp:heading -->\n\n<!-- wp:paragraph -->\n<p><em><strong>Фармакокинетика</strong></em></p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>Фармакокинетика силодозина и его основных метаболитов оценивалась у взрослых мужчин с и без доброкачественной гиперплазии предстательной железы после однократного и многократного применения в дозах от 0.1 мг до 48 мг в сутки. Фармакокинетика силодозина является линейной во всем диапазоне доз.</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>Действие основного метаболита в плазме, глюкуронида силодозина (KMD‑3213G), при равновесном состоянии приблизительно в 3 раза больше, чем действие исходного вещества. Силодозин и его глюкуронид достигают равновесного состояния через 3 и 5 дней лечения, соответственно.</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>Всасывание</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>Силодозин хорошо всасывается после перорального приема, абсорбция пропорциональна дозе. Абсолютная биодоступность составляет около 32 %. Пища снижает максимальную концентрацию (Сmax) примерно на 30 %, увеличивая время достижения максимальной концентрации (tmax) примерно до 1 ч и оказывает минимальное влияние на площадь под кривой «концентрация-время» (АUС). После перорального приема 8 мг один раз в день сразу после завтрака в течение 7 дней отмечены следующие фармакокинетические параметры: Сmax- 87±51 ng/ml (sd), tmax 2.5&nbsp;часов (диапазон 1.0-3.0), AUC - 433±286 ng&nbsp;•&nbsp;h/ml.</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>Распределение</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>Объем распределения силодозина составляет 0,81 л/кг, связывание с белками плазмы составляет 96,6 %. Силодозин метаболизируется по­средством глюкуронирования (с участием UGТ2В7), с участием алкогольдегидрогеназы и альдегид- дегидрогеназы, окислительных пу­тей, в основном с участием СYРЗА4. Основной активный метаболит в плазме карбамоил- глюкуронид (КМD-3213G) достигает плазменной концентрации в 4 раза большей, чем сам силодозин. Связывание силодозина глюкуронида с белками плазмы составляет 91 %. Силодозин не обладает потенциалом индукции или ингибирования изоферментов цитохрома Р450.</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>Выведение</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>После перорального применения 14C‑маркированного силодозина, выведение радиоактивных веществ через 7 дней было, около 33,5 % силодозина выводится через почки и 54,9 % через кишечник. Клиренс силодозина составляет около 0,28 л/ч/кг. Силодозин экскретируется в основном в виде метаболитов и в очень малом количестве в неизмененном виде с мочой. Конечный период полувыведения Т1/2 силодозина и глюкуронида составляет 11 часов и 18 часов соответственно.</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>Особые группы пациентов</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p><em>Пациенты пожилого возраста</em></p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>Фармакокинетика силодозина и его основных метаболитов значительно не менялось у пожилых пациентов, клиренс силодозина не меняется у пациентов старше 75 лет.</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p><em>Применение в педиатрии</em>.</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>Лекарственное средство не рекомендуется детям и подросткам до 18 лет ввиду отсутствия данных по безопасности и эффективности.</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p><em>Печеночная недостаточность</em></p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>В исследовании однократной дозы фармакокинетики силодозина не менялось у 9 пациентов с печеночной недостаточностью средней степени (7-9 по шкале Чайлда-Пью) в сравнении с 9 здоровыми добровольцами. По результатам этого исследования следует применять с осторожностью, поскольку у пациентов были нормальные биохимические показатели, что указывает на нормальную метаболическую функцию, и их отнесли к категории пациентов с печеночной недостаточностью средней степени на основе асцита и печеночной энцефалопатии.</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p><em>Почечная недостаточность</em></p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>В исследовании однократной дозы действие силодозина (несвязанного) у пациентов с легкой степенью (n=8) и средней степенью почечной недостаточности (n=8) привело к повышению максимальной концентрации в 1.6 раза и средней концентрации препарата в моче в 1.7 раза в сравнении с пациентами с нормальной почечной функцией (n=8). У пациентов с тяжелой степенью почечной недостаточности (n=5) максимальная концентрация повышалась в 2.2 раза и средняя концентрация препарата в моче - в 3.7 раза. Действие основных метаболитов, глюкуронида силодозина и KMD3293, также усиливалось. Поскольку имеются только ограниченные данные в отношении применения препарата пациентами с почечной недостаточностью средней степени (n=35), рекомендуется начинать с уменьшенной дозы 4 мг.</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>Для пациентов с легкой почечной недостаточностью (клиренс креатинина &gt; 50 - &lt; 80 мл/мин) не требуется коррекция дозы. Для пациентов с почечной недоста­точностью средней степени тяжести (клиренс креатинина &gt; 30 &lt; 50 мл/мин) рекомендуется низкая начальная доза - 4 мг. Для пациентов с тяжелой почечной недоста­точностью (клиренс креатинина &lt;30 мл/мин) назначение силодозина не рекомендуется.</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p><em><strong>Фармакодинамика</strong></em></p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>Силодозин является высокоселективным для α1A адренорецепторов, которые находятся, главным образом, в предстательной железе, шейке мочевого пузыря, капсуле предстательной железы и в предстательной части уретры. Блокирование этих α1A адренорецепторов вызывает расслабление гладких мышц этих тканей, что уменьшает сопротивление выходного отверстия мочевого пузыря, не влияя на сокращение гладких мышц-сжимателей. Это вызывает развитие раздражающего и обструктивного симптомов (симптомов со стороны нижних мочевыводящих путей), связанных с доброкачественной гиперплазией предстательной железы.</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>Силодозин обладает более низким сродством для α1B адренорецепторов, которые, главным образом, находятся в сердечно-сосудистой системе.</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>В исследованиях<em>&nbsp;</em><em>in</em><em>&nbsp;</em><em>vitro</em><em>&nbsp;</em>было показано, что сродство силодозина к α1A-адренорецепторам в 162 раза превосходит его способность взаимодействовать с α1В -адренорецепторами, которые расположены в гладких мышцах сосудов.&nbsp;<em>Клиническая эффективность и безопасность</em></p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>Свыше 800 пациентов с симптомами доброкачественной гиперплазии предстательной железы средней и тяжелой степени (по международной шкале оценки простатических симптомов, исходное значение≥13) принимали силодозин 8 мг один раз в сутки в двух плацебо контролируемых клинических исследованиях этапа III, проведенных в США, и в одном плацебо контролируемом и контролируемом по действующему препарату клиническом исследовании, проведенном в Европе. Во всех исследованиях пациентов, которые не реагировали на плацебо в течение 4 недель вводной фазы применения плацебо, методом случайной выборки отобрали для лечения препаратом – объектом исследования. Во всех исследованиях у пациентов, принимавших силодозин, быстрее уменьшались раздражающий и обструктивный симптомы, связанные с доброкачественной гиперплазией предстательной железы, в сравнении с плацебо по оценкам через 12 недель лечения.</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>В клиническом исследовании, контролируемом по действующему препарату, которое было проведено в Европе, применение 8 мг силодозина один раз в сутки не уступало применению тамсулозина 0.4 мг один раз в сутки: средняя откорректированная разница (95 % CI) в общем бале по шкале IPSS между лечением пациентов «без нарушения протокола», была 0.4 (от 0.4 до 1.1). Частота положительного ответа на лечение (т.е. улучшение общего балла по шкале IPSS минимум на 25 %) была значительно выше при применении силодозина (68 %) и тамсулозина (65 %), в сравнении с плацебо (53 %).</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>На долгосрочной открытой фазе дополнительного лечения этих контролируемых исследований, в которых пациенты принимали силодозин до 1 года, облегчение симптомов, вызванное силодозином на 12 неделе лечения, поддерживалось в течение 1 года.</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>На фазе IV клинического исследования, которое было проведено в Европе, со средним исходным общим баллом IPSS 18.9 пунктов, 77.1% пациентов отреагировали на силодозин (по оценкам изменения исходного значения общего балла IPSS не менее, чем на 25%). Приблизительно половина пациентов сообщала об облегчении большинства симптомов, на которые жаловались пациенты (т.е. частое мочеиспускание, ночные позывы, императивные позывы к мочеиспусканию, капельное выделение мочи и неполное опустошение мочевого пузыря), по оценкам опросников ICS-почты.</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>Значительное снижение артериального давления в положении лёжа на спине не наблюдалось во всех клинических исследованиях, которые были проведены в отношении силодозина.</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>Силодозин 8 мг и 24 мг в сутки не оказывал статистически значимого действия на интервалы ЭКГ или сердечную реполяризацию в отношении плацебо.</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>Блокада α1A -адренорецепторов снижает тонус гладкой мускулатуры в этих тканях, что ведет к улучшению оттока мочи из мочевого пузыря. Одновременно уменьшаются симпто­мы обструкции и раздражения, связанные с доброкачественной гиперплазией предстательной железы. Благодаря высокой селективности силодозин не вызывает клинически значимого снижения артериального давления (АД) у пациентов с исходно нормальным АД.</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:heading {\"level\":3} -->\n<h3>Показания к применению</h3>\n<!-- /wp:heading -->\n\n<!-- wp:paragraph -->\n<p>- лечение признаков и симптомов доброкачественной гиперплазии предстательной железы у взрослых мужчин.</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:heading {\"level\":3} -->\n<h3>Способ применения и дозы</h3>\n<!-- /wp:heading -->\n\n<!-- wp:paragraph -->\n<p>Капсулу следует принимать во время еды, предпочтительно в одно и то же время суток. Капсулу не следует крошить или жевать, капсулу необходимо проглатывать целиком, запивая стаканом воды.</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>Рекомендованная доза – по 1 капсуле Урорека 8 мг в сутки. Для отдельных категорий пациентов рекомендуется одна капсула Урорека 4 мг в сутки</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p><em>Пациенты пожилого возраста</em></p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>Для пациентов пожилого возраста корректировка дозы не требуется</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p><em>Почечная недостаточность</em></p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>Для пациентов с легкой степенью почечной недостаточности (клиренс креатинина ≥от 50 до ≤80&nbsp;мл/мин) корректировка дозы не требуется.</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>Для пациентов со средней степенью почечной недостаточности (клиренс креатинина ≥от 30 до &lt;50&nbsp;мл/мин) рекомендуется начинать с дозы 4 мг в сутки, по истечении одной недели можно увеличить дозу до 8 мг в сутки, в зависимости от реакции пациента. Использование препарата для пациентов с тяжелой степенью почечной недостаточности (клиренс креатинина &lt;30&nbsp;мл/мин) корректировка дозы не требуется.</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p><em>Печеночная недостаточность</em></p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>Для пациентов с легкой и средней степенью печеночной недостаточности корректировка дозы не требуется.</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>Поскольку данные отсутствуют, использование препарата пациентами с тяжелой степенью печеночной недостаточности не рекомендуется.</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:heading {\"level\":3} -->\n<h3>Побочные действия</h3>\n<!-- /wp:heading -->\n\n<!-- wp:paragraph -->\n<p>Безопасность силодозина оценивалась в четырех двойных слепых контролируемых клинических исследованиях II‑III фаз (с участием 931 пациента, которые принимали силодозин 8 мг один раз в сутки, и 733 пациентов, которые принимали плацебо) и в двух долгосрочных открытых исследованиях продленной фазы. В целом, 1,581 пациентов принимали силодозин в дозе 8 мг один раз в сутки. Из них 961 пациентов принимали препарат в течение 6 месяцев и 384 пациентов – в течение 1 года.</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>Самыми частыми побочными реакциями, о которых сообщалось в плацебо контролируемых клинических исследованиях при долгосрочном применении силидозина, были нарушения эякуляции, а именно, обратная эякуляция и анэякуляция (уменьшения объема эякуляции или ее отсутствие), с частотой 23%. Это может временно влиять на способность к зачатию. Такие нарушения исчезают через несколько дней после прекращения лечения.</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>Ниже перечислены нежелательные побочные реакции, отмеченные во всех клинических исследованиях и на протяжении международного постмаркетингового опыта применения, в отношении которых существует причинно-следственная связь, согласно классификации MedDRA в соответствии с поражением органов и систем органов и частотой развития: очень часто (≥1/10); часто (≥1/100 to &lt;1/10); нечасто (≥1/1,000 to &lt;1/100); редко (≥1/10,000 до &lt;1/1,000); очень редко (&lt;1/10,000), не известно (невозможно оценить по имеющимся данным). В каждой группы наблюдавшиеся побочные реакции представлены в порядке снижения степени серьезности.</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p><em>Очень часто</em></p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>- нарушения эякуляции, включая обратную эякуляцию и анаэкуляцию</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p><em>Часто</em></p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>- головокружение, ортостатическая гипотензия</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>- заложенность носа,</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>- диарея</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p><em>Нечасто</em></p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>- снижение либидо</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>- тахикардия1</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>- гипотензия1</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>- тошнота, сухость во рту</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>- ненормальные печеночные пробы1</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>- кожная сыпь1, зуд1, крапивница1, лекарственная сыпь1</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>- эректильная дисфункция</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p><em>Редко</em></p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>- обморок, потеря сознания1</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>- учащенная пульсация1</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p><em>Очень редко</em></p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>- аллергические реакции, включая отечность лица, проглатывание языка и отек глотки1</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p><em>Не известно</em></p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>- интраоперационный синдром дряблой радужки</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>1 – побочные реакции по добровольным отчетам в процессе международного пострегистрационного применения препарата (частота рассчитывалась по случаям, описанным в клинических исследованиях фазы I-IV и в неинтервенционных исследованиях).</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>Описание отдельных побочных реакций</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p><em>Ортостатическая гипотензия</em></p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>Частота возникновения ортостатической гипотензии в плацебо контролируемых клинических исследованиях была 1.2% при применении силодозина и 1.0% при применении плацебо. Ортостатическая гипотензия иногда приводила к обморокам.</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p><em>Интраоперационный синдром дряблой радужки</em><em>&nbsp;(</em><em>IFIS</em><em>)</em></p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>Об IFIS сообщалось по результатам хирургических операций по поводу катаракты.</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>Отчеты о подозреваемых побочных реакциях</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>Сообщение о подозреваемых побочных реакциях после регистрации медицинского препарата очень важно. Оно позволяет продолжать контролировать соотношение польза/риск медицинского препарата</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:heading {\"level\":3} -->\n<h3>Противопоказания</h3>\n<!-- /wp:heading -->\n\n<!-- wp:paragraph -->\n<p>- повышенная чувствительность к действующему веществу или к какому-либо вспомогательному веществу</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:list -->\n<ul><li>ортостатическая гипотензия в анамнезе</li><li>печеночная недостаточность</li></ul>\n<!-- /wp:list -->\n\n<!-- wp:paragraph -->\n<p>- детский возраст до 18 лет</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>- почечная недостаточность (клиренс креатинина менее 10 мл/мин)</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:heading {\"level\":3} -->\n<h3>Лекарственные взаимодействия</h3>\n<!-- /wp:heading -->\n\n<!-- wp:paragraph -->\n<p>Силодозин активно метаболизируется, особенно через CYP3A4, алкогольдегидразу и UGT2B7. Силодозин также является субстратом для P-гликопротеина. Вещества, которые подавляют (например, кетоконазол, итраконазол, ритонавир или циклоспорин) или вызывают появление (например, рифампицин, барбитураты, карбамазепин, фенитоин) таких ферментов и транспортеров, могут влиять на концентрацию силодозина и его активного метаболита в плазме.</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>Альфа-блокаторы</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>Соответствующая информация о безопасном применении силодозина вместе с другими антагонистами α‑адренорецепторов отсутствует. Следовательно, одновременное применение других антагонистов α‑адренорецепторов не рекомендуется.</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>Ингибиторы CYP3A4</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>В исследовании лекарственного взаимодействия, при одновременном применении силодозина и высокоактивного ингибитора CYP3A4 (кетоконазола 400 мг) наблюдалось повышение максимальных концентраций силодозина в плазме в 3.7 раза и повышение времени воздействия силодозина в 3.1 раза (средней концентрации в моче). Не рекомендуется одновременное применение высокоактивных ингибиторов CYP3A4 (например, кетоконазола, итраконазола, ритонавира или циклоспорина).</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>При одновременном применении силодозина и ингибитора CYP3A4 средней степени активности, например, дилтиазема, наблюдалось увеличение средней концентрации силодозина в моче приблизительно на 30%, однако максимальная концентрация и период полураспада не изменялись. Это изменение не имеет клинического значения, поэтому корректировка дозы не требуется.</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>Ингибиторы PDE‑5</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>Минимальные фармакодинамические взаимодействия наблюдались между силодозином и максимальными дозами силденафила или тадалафила. В плацебо контролируемом исследовании на 24 субъектах в возрасте 45-78 лет, которые получали силодозин, одновременное применение силденафила 100 мг или тадалафила 20 мг не вызывало клинически значимого уменьшения среднего систолического или диастолического кровяного давления по оценкам ортостатических исследований (стоя и лёжа). У субъектов старше 65 лет, среднее уменьшение в различных точках времени было между 5 и 15 мм рт. ст. (систолического) и между 0 и 10 мм рт. ст. (диастолического). Положительные ортостатические пробы были лишь немного более частыми во время одновременного применения лекарственных препаратов; однако, головокружение или другие симптомы не наблюдались. Состояние пациентов, принимающих ингибиторы PDE‑5 одновременно с силодозином, должно контролироваться на предмет возможных побочных реакций.</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>Гипотензивные препараты</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>В программе клинического исследования многие пациенты одновременно принимали гипотензивные препараты (большинство из них действовало на ренин-ангиотензиновую систему, бета-блокаторы, антагонисты кальция и диуретики) без повышения частоты ортостатической гипотензии. Тем не менее, рекомендуется проявлять осторожность при одновременном применении препарата с гипотензивными препаратами и контролировать состояние пациентов на предмет возможных побочных реакций.</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>Дигоксин</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>Равновесные уровни дигоксина, субстрата P‑гликопротеина, значительно не изменялись в результате одновременного применения силодозина 8 мг один раз в сутки. Корректировка дозы не требовалась.</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:heading {\"level\":3} -->\n<h3>Особые указания</h3>\n<!-- /wp:heading -->\n\n<!-- wp:paragraph -->\n<p>Интраоперационный синдром дряблой радужки (IFIS)</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>IFIS (разновидность синдрома узкого зрачка) наблюдался во время хирургической операции по удалению катаракты у некоторых пациентов, принимающих α1‑блокаторы или ранее принимавших α1‑блокаторы. Это может осложнять подобные операции.</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>Не рекомендуется начинать лечение силодозином для пациентов, которым планируется провести хирургическую операцию по поводу катаракты. Рекомендуется прекращать лечение α1‑блокаторами за 1-2 недели до хирургической операции, однако, преимущества и продолжительность прекращения лечения до хирургической операции по поводу катаракты не установлены.</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>Во время оценки до проведения хирургической операции хирурги-офтальмологи и другие специалисты по офтальмологии должны учитывать, принимают ли пациенты, которым предстоит хирургическая операция по поводу катаракты, силодозин, чтобы обеспечить принятие соответствующих мер в отношении IFIS во время операции.</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>Ортостатическое действие</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>Частота ортостатического действия силодозина очень низкая. Однако у некоторых пациентов может произойти снижение кровяного давления, что в редких случаях приводит к обморокам. При первых признаках ортостатической гипотензии (например, постуральное головокружение), пациенту следует сесть или лечь, и оставаться в таком положении до тех пор, пока симптомы не исчезнут. Пациентам с ортостатической гипотензией лечение силодозином не рекомендовано.</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>Почечная недостаточность</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>Пациентам с тяжелой почечной недостаточностью (CLCR &lt;30&nbsp;мл/мин) лечение силодозином не рекомендуется.</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>Печеночная недостаточность</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>Поскольку данные в отношении применения препарата пациентами с тяжелой степенью печеночной недостаточности отсутствуют, использование силодозина такими пациентами не рекомендуется.</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>Рак предстательной железы</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>Поскольку у ДГПЖ и рака предстательной железы одинаковые симптомы, и они могут сосуществовать, пациенты, у которых подозревается ДГПЖ, должны пройти обследование до начала лечения силодозином, чтобы исключить рак предстательной железы. Пальцевое ректальное исследование и, если необходимо, определение простатического специфического антигена (PSA) должно быть выполнено перед началом лечения, и должно регулярно повторяться после этого.</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>Лечение силодозином приводит к уменьшению количества спермы во время оргазма, что может временно влиять на оплодотворяющую способность спермы. Такое действие прекращается после прекращения применения силодозина.</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p><em>Беременность и грудное вскармливание</em></p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>Силодозин предназначен только для мужчин.</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p><em>Фертильность</em></p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>В клинических исследованиях при применении силодозина наблюдалась эякуляция с пониженным количеством спермы или без спермы из-за фармакодинамических особенностей силодозина. Перед началом лечения пациента необходимо проинформировать о том, что это может произойти, и о том, что препарат влияет на оплодотворяющую способность спермы.</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p><em>Особенности влияния лекарственного средства на&nbsp;&nbsp;&nbsp;способность управлять транспортным средством или&nbsp;&nbsp;потенциально опасными механизмами</em></p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>Урорек в незначительной или в средней степени может повлиять на способность управлять транспортными средствами и механизмами. Пациентов необходимо проинформировать о возможных симптомах, связанных с постуральной гипотензией (головокружение), и о том, что они должны быть осторожны в управлении транспортными средствами и механизмами.</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:heading {\"level\":3} -->\n<h3>Передозировка</h3>\n<!-- /wp:heading -->\n\n<!-- wp:paragraph -->\n<p><em>Симптомы:</em>&nbsp;тяжелая артериальная гипотензия.</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p><em>Лечение:</em>&nbsp;Применение силодозина в дозах до 48 мг/сутки оценивалось у здоровых мужчин. Постуральная гипотензия была побочной реакцией, ограничивающей дозу. Если прием препарата произошел недавно, эффективным будет промывание желудка. Если передозировка силодозина привела к гипотензии, необходимо провести сердечно-легочную реанимацию. Диализ, маловероятно, будет эффективным, поскольку силодозин высоко (96.6%) связывается с белками.</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:heading {\"level\":3} -->\n<h3>Форма выпуска и упаковка</h3>\n<!-- /wp:heading -->\n\n<!-- wp:paragraph -->\n<p>По 10 капсул помещают в контурную ячейковую упаковку из непрозрачной пленки ПВХ/ПВДХ и фольги алюминиевой.</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>По 1, 3 или 5 контурных ячейковых упаковок вместе с инструкцией по медицинскому применению на государственном и русском языках помещают в пачку из картона.</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:heading {\"level\":3} -->\n<h3>Условия хранения</h3>\n<!-- /wp:heading -->\n\n<!-- wp:paragraph -->\n<p>Хранить в сухом, защищенном от света месте, при температуре не выше 30 0С, в оригинальной упаковке.</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>Хранить в недоступном для детей месте.</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:heading {\"level\":3} -->\n<h3>Срок хранения</h3>\n<!-- /wp:heading -->\n\n<!-- wp:paragraph -->\n<p>3 года</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>Не применять по истечении срока годности.</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:heading {\"level\":3} -->\n<h3>Условия отпуска из аптек</h3>\n<!-- /wp:heading -->\n\n<!-- wp:paragraph -->\n<p>По рецепту</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:heading {\"level\":3} -->\n<h3>Производитель</h3>\n<!-- /wp:heading -->\n\n<!-- wp:paragraph -->\n<p>«Recordati Industria Chimica е Farmaceutica&nbsp;S.P.A.»</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>Via M. Civitali 1, 20148, Milan, Italy / Виа М. Чивитали 1, 20148, Милан, Италия</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:heading {\"level\":3} -->\n<h3>Владелец регистрационного удостоверения</h3>\n<!-- /wp:heading -->\n\n<!-- wp:paragraph -->\n<p>«Recordati Ireland Ltd.»</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>Raheens East Ringaskiddy, Co. Cork, Ireland / Рахинз Ист, Рингаскидди, Ко. Корк, Ирландия</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p><strong>Адрес организации, принимающей на территории Республики Казахстан претензии от потребителей по качеству продукции</strong></p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>Представительство ТОО «FIC MEDICAL» (ФИК МЕДИКАЛЬ) в Республике Казахстан, ул. Толе би 69, офис 33, 050000, Алматы, Казахстан</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>тел.: +7 (727) 272 93 08, факс: +7 (727) 272 90 25</p>\n<!-- /wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>e-mail: fic_kz@ficmedical.kz</p>\n<!-- /wp:paragraph -->', 'Инструкция к препарату', '', 'inherit', 'closed', 'closed', '', '240-revision-v1', '', '', '2022-03-31 15:48:27', '2022-03-31 12:48:27', '', 240, 'http://0026urotec.loc:8888/?p=244', 0, 'revision', '', 0),
(245, 1, '2022-03-31 15:52:54', '2022-03-31 12:52:54', ' ', '', '', 'publish', 'closed', 'closed', '', '245', '', '', '2022-03-31 15:52:54', '2022-03-31 12:52:54', '', 0, 'http://0026urotec.loc:8888/?p=245', 2, 'nav_menu_item', '', 0),
(246, 1, '2022-04-01 17:33:30', '2022-04-01 14:33:30', '<!-- wp:shortcode -->\n[headerblock]\n<!-- /wp:shortcode -->\n\n<!-- wp:shortcode -->\n[sAdv]\n<!-- /wp:shortcode -->\n\n<!-- wp:shortcode -->\n[sCatalog]\n<!-- /wp:shortcode -->\n\n<!-- wp:shortcode -->\n[sWhereBuy]\n<!-- /wp:shortcode -->\n\n<!-- wp:shortcode -->\n[sMethod]\n<!-- /wp:shortcode -->\n\n<!-- wp:shortcode -->\n[sRecomendation]\n<!-- /wp:shortcode -->\n\n<!-- wp:shortcode -->\n[sOtherCountries]\n<!-- /wp:shortcode -->\n\n<!-- wp:shortcode -->\n[sAbout]\n<!-- /wp:shortcode -->\n\n<!-- wp:shortcode -->\n[sComplications]\n<!-- /wp:shortcode -->\n\n<!-- wp:shortcode -->\n[sTreatment]\n<!-- /wp:shortcode -->\n\n<!-- wp:shortcode -->\n[sFAQ]\n<!-- /wp:shortcode -->', 'Главная', '', 'inherit', 'closed', 'closed', '', '2-revision-v1', '', '', '2022-04-01 17:33:30', '2022-04-01 14:33:30', '', 2, 'http://0026urotec.loc:8888/?p=246', 0, 'revision', '', 0),
(247, 1, '2022-04-01 17:45:59', '2022-04-01 14:45:59', '<!-- wp:shortcode -->\n[headerblock]\n<!-- /wp:shortcode -->\n\n<!-- wp:shortcode -->\n[sAdv]\n<!-- /wp:shortcode -->\n\n<!-- wp:shortcode -->\n[sCatalog]\n<!-- /wp:shortcode -->\n\n<!-- wp:shortcode -->\n[sWhereBuy]\n<!-- /wp:shortcode -->\n\n<!-- wp:shortcode -->\n[sMethod]\n<!-- /wp:shortcode -->\n\n<!-- wp:shortcode -->\n[sRecomendation]\n<!-- /wp:shortcode -->\n\n<!-- wp:shortcode -->\n[sOtherCountries]\n<!-- /wp:shortcode -->\n\n<!-- wp:shortcode -->\n[sAbout]\n<!-- /wp:shortcode -->\n\n<!-- wp:shortcode -->\n[sComplications]\n<!-- /wp:shortcode -->\n\n<!-- wp:shortcode -->\n[sTreatment]\n<!-- /wp:shortcode -->\n\n<!-- wp:shortcode -->\n[sFAQ]\n<!-- /wp:shortcode -->', 'Главная', '', 'inherit', 'closed', 'closed', '', '2-revision-v1', '', '', '2022-04-01 17:45:59', '2022-04-01 14:45:59', '', 2, 'http://0026urotec.loc:8888/?p=247', 0, 'revision', '', 0),
(248, 1, '2022-04-01 17:52:11', '2022-04-01 14:52:11', '<!-- wp:shortcode -->\n[headerblock]\n<!-- /wp:shortcode -->\n\n<!-- wp:shortcode -->\n[sAdv]\n<!-- /wp:shortcode -->\n\n<!-- wp:shortcode -->\n[sCatalog]\n<!-- /wp:shortcode -->\n\n<!-- wp:shortcode -->\n[sWhereBuy]\n<!-- /wp:shortcode -->\n\n<!-- wp:shortcode -->\n[sMethod]\n<!-- /wp:shortcode -->\n\n<!-- wp:shortcode -->\n[sRecomendation]\n<!-- /wp:shortcode -->\n\n<!-- wp:shortcode -->\n[sOtherCountries]\n<!-- /wp:shortcode -->\n\n<!-- wp:shortcode -->\n[sAbout]\n<!-- /wp:shortcode -->\n\n<!-- wp:shortcode -->\n[sComplications]\n<!-- /wp:shortcode -->\n\n<!-- wp:shortcode -->\n[sTreatment]\n<!-- /wp:shortcode -->\n\n<!-- wp:shortcode -->\n[sFAQ]\n<!-- /wp:shortcode -->', 'Главная', '', 'inherit', 'closed', 'closed', '', '2-revision-v1', '', '', '2022-04-01 17:52:11', '2022-04-01 14:52:11', '', 2, 'http://0026urotec.loc:8888/?p=248', 0, 'revision', '', 0),
(249, 1, '2022-04-01 17:53:41', '2022-04-01 14:53:41', '<!-- wp:shortcode -->\n[headerblock]\n<!-- /wp:shortcode -->\n\n<!-- wp:shortcode -->\n[sAdv]\n<!-- /wp:shortcode -->\n\n<!-- wp:shortcode -->\n[sCatalog]\n<!-- /wp:shortcode -->\n\n<!-- wp:shortcode -->\n[sWhereBuy]\n<!-- /wp:shortcode -->\n\n<!-- wp:shortcode -->\n[sMethod]\n<!-- /wp:shortcode -->\n\n<!-- wp:shortcode -->\n[sRecomendation]\n<!-- /wp:shortcode -->\n\n<!-- wp:shortcode -->\n[sOtherCountries]\n<!-- /wp:shortcode -->\n\n<!-- wp:shortcode -->\n[sAbout]\n<!-- /wp:shortcode -->\n\n<!-- wp:shortcode -->\n[sComplications]\n<!-- /wp:shortcode -->\n\n<!-- wp:shortcode -->\n[sTreatment]\n<!-- /wp:shortcode -->\n\n<!-- wp:shortcode -->\n[sFAQ]\n<!-- /wp:shortcode -->', 'Главная', '', 'inherit', 'closed', 'closed', '', '2-revision-v1', '', '', '2022-04-01 17:53:41', '2022-04-01 14:53:41', '', 2, 'http://0026urotec.loc:8888/?p=249', 0, 'revision', '', 0),
(250, 1, '2022-04-01 17:53:59', '2022-04-01 14:53:59', '<!-- wp:shortcode -->\n[headerblock]\n<!-- /wp:shortcode -->\n\n<!-- wp:shortcode -->\n[sAdv]\n<!-- /wp:shortcode -->\n\n<!-- wp:shortcode -->\n[sCatalog]\n<!-- /wp:shortcode -->\n\n<!-- wp:shortcode -->\n[sWhereBuy]\n<!-- /wp:shortcode -->\n\n<!-- wp:shortcode -->\n[sMethod]\n<!-- /wp:shortcode -->\n\n<!-- wp:shortcode -->\n[sRecomendation]\n<!-- /wp:shortcode -->\n\n<!-- wp:shortcode -->\n[sOtherCountries]\n<!-- /wp:shortcode -->\n\n<!-- wp:shortcode -->\n[sAbout]\n<!-- /wp:shortcode -->\n\n<!-- wp:shortcode -->\n[sComplications]\n<!-- /wp:shortcode -->\n\n<!-- wp:shortcode -->\n[sTreatment]\n<!-- /wp:shortcode -->\n\n<!-- wp:shortcode -->\n[sFAQ]\n<!-- /wp:shortcode -->', 'Главная', '', 'inherit', 'closed', 'closed', '', '2-revision-v1', '', '', '2022-04-01 17:53:59', '2022-04-01 14:53:59', '', 2, 'http://0026urotec.loc:8888/?p=250', 0, 'revision', '', 0),
(251, 1, '2022-04-01 17:57:34', '2022-04-01 14:57:34', '<!-- wp:shortcode -->\n[headerblock]\n<!-- /wp:shortcode -->\n\n<!-- wp:shortcode -->\n[sAdv]\n<!-- /wp:shortcode -->\n\n<!-- wp:shortcode -->\n[sCatalog]\n<!-- /wp:shortcode -->\n\n<!-- wp:shortcode -->\n[sWhereBuy]\n<!-- /wp:shortcode -->\n\n<!-- wp:shortcode -->\n[sMethod]\n<!-- /wp:shortcode -->\n\n<!-- wp:shortcode -->\n[sRecomendation]\n<!-- /wp:shortcode -->\n\n<!-- wp:shortcode -->\n[sOtherCountries]\n<!-- /wp:shortcode -->\n\n<!-- wp:shortcode -->\n[sAbout]\n<!-- /wp:shortcode -->\n\n<!-- wp:shortcode -->\n[sComplications]\n<!-- /wp:shortcode -->\n\n<!-- wp:shortcode -->\n[sTreatment]\n<!-- /wp:shortcode -->\n\n<!-- wp:shortcode -->\n[sFAQ]\n<!-- /wp:shortcode -->', 'Главная', '', 'inherit', 'closed', 'closed', '', '2-revision-v1', '', '', '2022-04-01 17:57:34', '2022-04-01 14:57:34', '', 2, 'http://0026urotec.loc:8888/?p=251', 0, 'revision', '', 0),
(252, 1, '2022-04-01 17:58:03', '2022-04-01 14:58:03', '<!-- wp:shortcode -->\n[headerblock]\n<!-- /wp:shortcode -->\n\n<!-- wp:shortcode -->\n[sAdv]\n<!-- /wp:shortcode -->\n\n<!-- wp:shortcode -->\n[sCatalog]\n<!-- /wp:shortcode -->\n\n<!-- wp:shortcode -->\n[sWhereBuy]\n<!-- /wp:shortcode -->\n\n<!-- wp:shortcode -->\n[sMethod]\n<!-- /wp:shortcode -->\n\n<!-- wp:shortcode -->\n[sRecomendation]\n<!-- /wp:shortcode -->\n\n<!-- wp:shortcode -->\n[sOtherCountries]\n<!-- /wp:shortcode -->\n\n<!-- wp:shortcode -->\n[sAbout]\n<!-- /wp:shortcode -->\n\n<!-- wp:shortcode -->\n[sComplications]\n<!-- /wp:shortcode -->\n\n<!-- wp:shortcode -->\n[sTreatment]\n<!-- /wp:shortcode -->\n\n<!-- wp:shortcode -->\n[sFAQ]\n<!-- /wp:shortcode -->', 'Главная', '', 'inherit', 'closed', 'closed', '', '2-revision-v1', '', '', '2022-04-01 17:58:03', '2022-04-01 14:58:03', '', 2, 'http://0026urotec.loc:8888/?p=252', 0, 'revision', '', 0),
(253, 1, '2022-04-01 20:00:51', '2022-04-01 17:00:51', '<!-- wp:shortcode -->\n[headerblock]\n<!-- /wp:shortcode -->\n\n<!-- wp:shortcode -->\n[sAdv]\n<!-- /wp:shortcode -->\n\n<!-- wp:shortcode -->\n[sCatalog]\n<!-- /wp:shortcode -->\n\n<!-- wp:shortcode -->\n[sWhereBuy]\n<!-- /wp:shortcode -->\n\n<!-- wp:shortcode -->\n[sMethod]\n<!-- /wp:shortcode -->\n\n<!-- wp:shortcode -->\n[sRecomendation]\n<!-- /wp:shortcode -->\n\n<!-- wp:shortcode -->\n[sOtherCountries]\n<!-- /wp:shortcode -->\n\n<!-- wp:shortcode -->\n[sAbout]\n<!-- /wp:shortcode -->\n\n<!-- wp:shortcode -->\n[sComplications]\n<!-- /wp:shortcode -->\n\n<!-- wp:shortcode -->\n[sTreatment]\n<!-- /wp:shortcode -->\n\n<!-- wp:shortcode -->\n[sFAQ]\n<!-- /wp:shortcode -->', 'Главная', '', 'inherit', 'closed', 'closed', '', '2-revision-v1', '', '', '2022-04-01 20:00:51', '2022-04-01 17:00:51', '', 2, 'http://0026urotec.loc:8888/?p=253', 0, 'revision', '', 0),
(254, 1, '2022-04-05 21:38:32', '2022-04-05 18:38:32', 'a:7:{s:4:\"type\";s:3:\"tab\";s:12:\"instructions\";s:0:\"\";s:8:\"required\";i:0;s:17:\"conditional_logic\";i:0;s:7:\"wrapper\";a:3:{s:5:\"width\";s:0:\"\";s:5:\"class\";s:0:\"\";s:2:\"id\";s:0:\"\";}s:9:\"placement\";s:3:\"top\";s:8:\"endpoint\";i:0;}', 'Третья модалка', '_копия', 'publish', 'closed', 'closed', '', 'field_624c8c73a268d', '', '', '2022-04-05 21:42:47', '2022-04-05 18:42:47', '', 168, 'http://0026urotec.loc:8888/?post_type=acf-field&#038;p=254', 14, 'acf-field', '', 0),
(255, 1, '2022-04-05 21:38:32', '2022-04-05 18:38:32', 'a:10:{s:4:\"type\";s:7:\"wysiwyg\";s:12:\"instructions\";s:0:\"\";s:8:\"required\";i:0;s:17:\"conditional_logic\";i:0;s:7:\"wrapper\";a:3:{s:5:\"width\";s:0:\"\";s:5:\"class\";s:0:\"\";s:2:\"id\";s:0:\"\";}s:13:\"default_value\";s:0:\"\";s:4:\"tabs\";s:3:\"all\";s:7:\"toolbar\";s:4:\"full\";s:12:\"media_upload\";i:1;s:5:\"delay\";i:0;}', 'Текст', 'текст-мод_3', 'publish', 'closed', 'closed', '', 'field_624c8c8ba268e', '', '', '2022-04-05 21:42:47', '2022-04-05 18:42:47', '', 168, 'http://0026urotec.loc:8888/?post_type=acf-field&#038;p=255', 15, 'acf-field', '', 0),
(256, 1, '2022-04-05 21:41:37', '2022-04-05 18:41:37', '<!-- wp:shortcode -->\n[headerblock]\n<!-- /wp:shortcode -->\n\n<!-- wp:shortcode -->\n[sAdv]\n<!-- /wp:shortcode -->\n\n<!-- wp:shortcode -->\n[sCatalog]\n<!-- /wp:shortcode -->\n\n<!-- wp:shortcode -->\n[sWhereBuy]\n<!-- /wp:shortcode -->\n\n<!-- wp:shortcode -->\n[sMethod]\n<!-- /wp:shortcode -->\n\n<!-- wp:shortcode -->\n[sRecomendation]\n<!-- /wp:shortcode -->\n\n<!-- wp:shortcode -->\n[sOtherCountries]\n<!-- /wp:shortcode -->\n\n<!-- wp:shortcode -->\n[sAbout]\n<!-- /wp:shortcode -->\n\n<!-- wp:shortcode -->\n[sComplications]\n<!-- /wp:shortcode -->\n\n<!-- wp:shortcode -->\n[sTreatment]\n<!-- /wp:shortcode -->\n\n<!-- wp:shortcode -->\n[sFAQ]\n<!-- /wp:shortcode -->', 'Главная', '', 'inherit', 'closed', 'closed', '', '2-revision-v1', '', '', '2022-04-05 21:41:37', '2022-04-05 18:41:37', '', 2, 'http://0026urotec.loc:8888/?p=256', 0, 'revision', '', 0);

-- --------------------------------------------------------

--
-- Table structure for table `urotec_termmeta`
--

CREATE TABLE `urotec_termmeta` (
  `meta_id` bigint(20) UNSIGNED NOT NULL,
  `term_id` bigint(20) UNSIGNED NOT NULL DEFAULT '0',
  `meta_key` varchar(255) COLLATE utf8mb4_unicode_520_ci DEFAULT NULL,
  `meta_value` longtext COLLATE utf8mb4_unicode_520_ci
) ENGINE=InnoDB DEFAULT CHARSET=utf8mb4 COLLATE=utf8mb4_unicode_520_ci;

-- --------------------------------------------------------

--
-- Table structure for table `urotec_terms`
--

CREATE TABLE `urotec_terms` (
  `term_id` bigint(20) UNSIGNED NOT NULL,
  `name` varchar(200) COLLATE utf8mb4_unicode_520_ci NOT NULL DEFAULT '',
  `slug` varchar(200) COLLATE utf8mb4_unicode_520_ci NOT NULL DEFAULT '',
  `term_group` bigint(10) NOT NULL DEFAULT '0'
) ENGINE=InnoDB DEFAULT CHARSET=utf8mb4 COLLATE=utf8mb4_unicode_520_ci;

--
-- Dumping data for table `urotec_terms`
--

INSERT INTO `urotec_terms` (`term_id`, `name`, `slug`, `term_group`) VALUES
(1, 'Без рубрики', 'bez-rubriki', 0),
(2, 'mega', 'mega', 0),
(3, 'Меню в шапке', 'menju-v-shapke', 0),
(4, 'Меню в подвале', 'menju-v-podvale', 0);

-- --------------------------------------------------------

--
-- Table structure for table `urotec_term_relationships`
--

CREATE TABLE `urotec_term_relationships` (
  `object_id` bigint(20) UNSIGNED NOT NULL DEFAULT '0',
  `term_taxonomy_id` bigint(20) UNSIGNED NOT NULL DEFAULT '0',
  `term_order` int(11) NOT NULL DEFAULT '0'
) ENGINE=InnoDB DEFAULT CHARSET=utf8mb4 COLLATE=utf8mb4_unicode_520_ci;

--
-- Dumping data for table `urotec_term_relationships`
--

INSERT INTO `urotec_term_relationships` (`object_id`, `term_taxonomy_id`, `term_order`) VALUES
(1, 1, 0),
(5, 2, 0),
(178, 3, 0),
(179, 3, 0),
(180, 3, 0),
(182, 4, 0),
(193, 1, 0),
(197, 1, 0),
(202, 1, 0),
(203, 1, 0),
(204, 1, 0),
(205, 1, 0),
(206, 1, 0),
(207, 1, 0),
(208, 1, 0),
(209, 1, 0),
(210, 1, 0),
(222, 3, 0),
(245, 4, 0);

-- --------------------------------------------------------

--
-- Table structure for table `urotec_term_taxonomy`
--

CREATE TABLE `urotec_term_taxonomy` (
  `term_taxonomy_id` bigint(20) UNSIGNED NOT NULL,
  `term_id` bigint(20) UNSIGNED NOT NULL DEFAULT '0',
  `taxonomy` varchar(32) COLLATE utf8mb4_unicode_520_ci NOT NULL DEFAULT '',
  `description` longtext COLLATE utf8mb4_unicode_520_ci NOT NULL,
  `parent` bigint(20) UNSIGNED NOT NULL DEFAULT '0',
  `count` bigint(20) NOT NULL DEFAULT '0'
) ENGINE=InnoDB DEFAULT CHARSET=utf8mb4 COLLATE=utf8mb4_unicode_520_ci;

--
-- Dumping data for table `urotec_term_taxonomy`
--

INSERT INTO `urotec_term_taxonomy` (`term_taxonomy_id`, `term_id`, `taxonomy`, `description`, `parent`, `count`) VALUES
(1, 1, 'category', '', 0, 12),
(2, 2, 'wp_theme', '', 0, 1),
(3, 3, 'nav_menu', '', 0, 4),
(4, 4, 'nav_menu', '', 0, 2);

-- --------------------------------------------------------

--
-- Table structure for table `urotec_usermeta`
--

CREATE TABLE `urotec_usermeta` (
  `umeta_id` bigint(20) UNSIGNED NOT NULL,
  `user_id` bigint(20) UNSIGNED NOT NULL DEFAULT '0',
  `meta_key` varchar(255) COLLATE utf8mb4_unicode_520_ci DEFAULT NULL,
  `meta_value` longtext COLLATE utf8mb4_unicode_520_ci
) ENGINE=InnoDB DEFAULT CHARSET=utf8mb4 COLLATE=utf8mb4_unicode_520_ci;

--
-- Dumping data for table `urotec_usermeta`
--

INSERT INTO `urotec_usermeta` (`umeta_id`, `user_id`, `meta_key`, `meta_value`) VALUES
(1, 1, 'nickname', 'urotec_admin'),
(2, 1, 'first_name', ''),
(3, 1, 'last_name', ''),
(4, 1, 'description', ''),
(5, 1, 'rich_editing', 'true'),
(6, 1, 'syntax_highlighting', 'true'),
(7, 1, 'comment_shortcuts', 'false'),
(8, 1, 'admin_color', 'fresh'),
(9, 1, 'use_ssl', '0'),
(10, 1, 'show_admin_bar_front', 'true'),
(11, 1, 'locale', ''),
(12, 1, 'urotec_capabilities', 'a:1:{s:13:\"administrator\";b:1;}'),
(13, 1, 'urotec_user_level', '10'),
(14, 1, 'dismissed_wp_pointers', ''),
(15, 1, 'show_welcome_panel', '1'),
(16, 1, 'session_tokens', 'a:1:{s:64:\"04a9f8aa128a1d616da6c8d8f96d52011767328ced3b474b7f1e6f84faf03278\";a:4:{s:10:\"expiration\";i:1649790313;s:2:\"ip\";s:3:\"::1\";s:2:\"ua\";s:120:\"Mozilla/5.0 (Macintosh; Intel Mac OS X 10_15_7) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/99.0.4844.83 Safari/537.36\";s:5:\"login\";i:1648580713;}}'),
(17, 1, 'urotec_dashboard_quick_press_last_post_id', '4'),
(18, 1, 'urotec_user-settings', 'libraryContent=browse&editor=tinymce&hidetb=0&advImgDetails=hide'),
(19, 1, 'urotec_user-settings-time', '1649184573'),
(20, 1, 'closedpostboxes_page', 'a:9:{i:0;s:23:\"acf-group_62435bab1a890\";i:1;s:23:\"acf-group_62436eb2bb936\";i:2;s:23:\"acf-group_624374e245d29\";i:3;s:23:\"acf-group_624379b5ac487\";i:4;s:23:\"acf-group_62441179b5084\";i:5;s:23:\"acf-group_624417df679a2\";i:6;s:23:\"acf-group_6244374609ec9\";i:7;s:23:\"acf-group_6244488cdb75f\";i:8;s:23:\"acf-group_62444b3089fac\";}'),
(21, 1, 'metaboxhidden_page', 'a:0:{}'),
(22, 1, 'meta-box-order_page', 'a:4:{s:6:\"normal\";s:263:\"acf-group_62435bab1a890,acf-group_6243605e61225,acf-group_62436eb2bb936,acf-group_624374e245d29,acf-group_624379b5ac487,acf-group_62441179b5084,acf-group_624417df679a2,acf-group_624431d03e98c,acf-group_6244374609ec9,acf-group_6244488cdb75f,acf-group_62444b3089fac\";s:8:\"advanced\";s:0:\"\";s:4:\"side\";s:0:\"\";s:15:\"acf_after_title\";s:0:\"\";}'),
(23, 1, 'managenav-menuscolumnshidden', 'a:5:{i:0;s:11:\"link-target\";i:1;s:11:\"css-classes\";i:2;s:3:\"xfn\";i:3;s:11:\"description\";i:4;s:15:\"title-attribute\";}'),
(24, 1, 'metaboxhidden_nav-menus', 'a:1:{i:0;s:12:\"add-post_tag\";}'),
(25, 1, 'nav_menu_recently_edited', '4');

-- --------------------------------------------------------

--
-- Table structure for table `urotec_users`
--

CREATE TABLE `urotec_users` (
  `ID` bigint(20) UNSIGNED NOT NULL,
  `user_login` varchar(60) COLLATE utf8mb4_unicode_520_ci NOT NULL DEFAULT '',
  `user_pass` varchar(255) COLLATE utf8mb4_unicode_520_ci NOT NULL DEFAULT '',
  `user_nicename` varchar(50) COLLATE utf8mb4_unicode_520_ci NOT NULL DEFAULT '',
  `user_email` varchar(100) COLLATE utf8mb4_unicode_520_ci NOT NULL DEFAULT '',
  `user_url` varchar(100) COLLATE utf8mb4_unicode_520_ci NOT NULL DEFAULT '',
  `user_registered` datetime NOT NULL DEFAULT '0000-00-00 00:00:00',
  `user_activation_key` varchar(255) COLLATE utf8mb4_unicode_520_ci NOT NULL DEFAULT '',
  `user_status` int(11) NOT NULL DEFAULT '0',
  `display_name` varchar(250) COLLATE utf8mb4_unicode_520_ci NOT NULL DEFAULT ''
) ENGINE=InnoDB DEFAULT CHARSET=utf8mb4 COLLATE=utf8mb4_unicode_520_ci;

--
-- Dumping data for table `urotec_users`
--

INSERT INTO `urotec_users` (`ID`, `user_login`, `user_pass`, `user_nicename`, `user_email`, `user_url`, `user_registered`, `user_activation_key`, `user_status`, `display_name`) VALUES
(1, 'urotec_admin', '$P$B/EgQZhEGzhgpbeWuEZd0/aZqa2Xkd/', 'urotec_admin', 'wol1414@gmail.com', 'http://0026urotec.loc:8888', '2022-03-29 19:05:03', '', 0, 'urotec_admin');

--
-- Indexes for dumped tables
--

--
-- Indexes for table `urotec_commentmeta`
--
ALTER TABLE `urotec_commentmeta`
  ADD PRIMARY KEY (`meta_id`),
  ADD KEY `comment_id` (`comment_id`),
  ADD KEY `meta_key` (`meta_key`(191));

--
-- Indexes for table `urotec_comments`
--
ALTER TABLE `urotec_comments`
  ADD PRIMARY KEY (`comment_ID`),
  ADD KEY `comment_post_ID` (`comment_post_ID`),
  ADD KEY `comment_approved_date_gmt` (`comment_approved`,`comment_date_gmt`),
  ADD KEY `comment_date_gmt` (`comment_date_gmt`),
  ADD KEY `comment_parent` (`comment_parent`),
  ADD KEY `comment_author_email` (`comment_author_email`(10));

--
-- Indexes for table `urotec_links`
--
ALTER TABLE `urotec_links`
  ADD PRIMARY KEY (`link_id`),
  ADD KEY `link_visible` (`link_visible`);

--
-- Indexes for table `urotec_options`
--
ALTER TABLE `urotec_options`
  ADD PRIMARY KEY (`option_id`),
  ADD UNIQUE KEY `option_name` (`option_name`),
  ADD KEY `autoload` (`autoload`);

--
-- Indexes for table `urotec_postmeta`
--
ALTER TABLE `urotec_postmeta`
  ADD PRIMARY KEY (`meta_id`),
  ADD KEY `post_id` (`post_id`),
  ADD KEY `meta_key` (`meta_key`(191));

--
-- Indexes for table `urotec_posts`
--
ALTER TABLE `urotec_posts`
  ADD PRIMARY KEY (`ID`),
  ADD KEY `post_name` (`post_name`(191)),
  ADD KEY `type_status_date` (`post_type`,`post_status`,`post_date`,`ID`),
  ADD KEY `post_parent` (`post_parent`),
  ADD KEY `post_author` (`post_author`);

--
-- Indexes for table `urotec_termmeta`
--
ALTER TABLE `urotec_termmeta`
  ADD PRIMARY KEY (`meta_id`),
  ADD KEY `term_id` (`term_id`),
  ADD KEY `meta_key` (`meta_key`(191));

--
-- Indexes for table `urotec_terms`
--
ALTER TABLE `urotec_terms`
  ADD PRIMARY KEY (`term_id`),
  ADD KEY `slug` (`slug`(191)),
  ADD KEY `name` (`name`(191));

--
-- Indexes for table `urotec_term_relationships`
--
ALTER TABLE `urotec_term_relationships`
  ADD PRIMARY KEY (`object_id`,`term_taxonomy_id`),
  ADD KEY `term_taxonomy_id` (`term_taxonomy_id`);

--
-- Indexes for table `urotec_term_taxonomy`
--
ALTER TABLE `urotec_term_taxonomy`
  ADD PRIMARY KEY (`term_taxonomy_id`),
  ADD UNIQUE KEY `term_id_taxonomy` (`term_id`,`taxonomy`),
  ADD KEY `taxonomy` (`taxonomy`);

--
-- Indexes for table `urotec_usermeta`
--
ALTER TABLE `urotec_usermeta`
  ADD PRIMARY KEY (`umeta_id`),
  ADD KEY `user_id` (`user_id`),
  ADD KEY `meta_key` (`meta_key`(191));

--
-- Indexes for table `urotec_users`
--
ALTER TABLE `urotec_users`
  ADD PRIMARY KEY (`ID`),
  ADD KEY `user_login_key` (`user_login`),
  ADD KEY `user_nicename` (`user_nicename`),
  ADD KEY `user_email` (`user_email`);

--
-- AUTO_INCREMENT for dumped tables
--

--
-- AUTO_INCREMENT for table `urotec_commentmeta`
--
ALTER TABLE `urotec_commentmeta`
  MODIFY `meta_id` bigint(20) UNSIGNED NOT NULL AUTO_INCREMENT;

--
-- AUTO_INCREMENT for table `urotec_comments`
--
ALTER TABLE `urotec_comments`
  MODIFY `comment_ID` bigint(20) UNSIGNED NOT NULL AUTO_INCREMENT, AUTO_INCREMENT=2;

--
-- AUTO_INCREMENT for table `urotec_links`
--
ALTER TABLE `urotec_links`
  MODIFY `link_id` bigint(20) UNSIGNED NOT NULL AUTO_INCREMENT;

--
-- AUTO_INCREMENT for table `urotec_options`
--
ALTER TABLE `urotec_options`
  MODIFY `option_id` bigint(20) UNSIGNED NOT NULL AUTO_INCREMENT, AUTO_INCREMENT=476;

--
-- AUTO_INCREMENT for table `urotec_postmeta`
--
ALTER TABLE `urotec_postmeta`
  MODIFY `meta_id` bigint(20) UNSIGNED NOT NULL AUTO_INCREMENT, AUTO_INCREMENT=7144;

--
-- AUTO_INCREMENT for table `urotec_posts`
--
ALTER TABLE `urotec_posts`
  MODIFY `ID` bigint(20) UNSIGNED NOT NULL AUTO_INCREMENT, AUTO_INCREMENT=257;

--
-- AUTO_INCREMENT for table `urotec_termmeta`
--
ALTER TABLE `urotec_termmeta`
  MODIFY `meta_id` bigint(20) UNSIGNED NOT NULL AUTO_INCREMENT;

--
-- AUTO_INCREMENT for table `urotec_terms`
--
ALTER TABLE `urotec_terms`
  MODIFY `term_id` bigint(20) UNSIGNED NOT NULL AUTO_INCREMENT, AUTO_INCREMENT=5;

--
-- AUTO_INCREMENT for table `urotec_term_taxonomy`
--
ALTER TABLE `urotec_term_taxonomy`
  MODIFY `term_taxonomy_id` bigint(20) UNSIGNED NOT NULL AUTO_INCREMENT, AUTO_INCREMENT=5;

--
-- AUTO_INCREMENT for table `urotec_usermeta`
--
ALTER TABLE `urotec_usermeta`
  MODIFY `umeta_id` bigint(20) UNSIGNED NOT NULL AUTO_INCREMENT, AUTO_INCREMENT=26;

--
-- AUTO_INCREMENT for table `urotec_users`
--
ALTER TABLE `urotec_users`
  MODIFY `ID` bigint(20) UNSIGNED NOT NULL AUTO_INCREMENT, AUTO_INCREMENT=2;
COMMIT;

/*!40101 SET CHARACTER_SET_CLIENT=@OLD_CHARACTER_SET_CLIENT */;
/*!40101 SET CHARACTER_SET_RESULTS=@OLD_CHARACTER_SET_RESULTS */;
/*!40101 SET COLLATION_CONNECTION=@OLD_COLLATION_CONNECTION */;
